x,y,sample_id,dna_mutation_id,clust,member_prob,patient_id,type,age_at_initial_pathologic_diagnosis,gender,race,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome_first_course,OS,OS.time,DSS,DSS.time,DFI,DFI.time,PFI,PFI.time,Redaction,ajcc_pathologic_tumor_stage.y,ajcc_tumor_pathologic_pt,ajcc_metastasis_pathologic_pm,subtype_selected,clust_knn
-3.948447487,1.509303216,TCGA-G3-A25S-01A,TCGA-G3-A25S-01A-11D-A16V-10,0,NA,TCGA-G3-A25S,LIHC,64,MALE,WHITE,Hepatocellular Carcinoma,G2,2009,[Not Available],-23571,Dead,WITH TUMOR,NA,416,[Not Available],Extrahepatic Recurrence,"Other, specify",Bone and Lung,37,[Not Available],1,416,1,416,NA,NA,1,37,NA,Stage I,T1,M0,LIHC.iCluster:3,10
-4.767774451,0.604600993,TCGA-53-7813-01A,TCGA-53-7813-01A-11D-2167-08,0,NA,TCGA-53-7813,LUAD,51,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-18875,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,424,0,424,NA,NA,0,424,NA,Stage IIIB,T4,M0,LUAD.2,10
9.168827648,-2.807840118,TCGA-12-1602-01A,TCGA-12-1602-01A-01W-0643-08,1,0.694568857,TCGA-12-1602,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-21492,Dead,WITH TUMOR,195,206,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],140,[Not Available],1,206,1,206,NA,NA,1,140,NA,NA,NA,NA,NA,1
9.683197436,-2.42274479,TCGA-DD-A119-01A,TCGA-DD-A119-01A-11D-A12Z-10,1,0.789034731,TCGA-DD-A119,LIHC,40,MALE,ASIAN,Hepatocellular Carcinoma,G3,2003,[Not Available],-14613,Dead,NA,NA,223,[Not Available],NA,NA,NA,NA,[Not Available],1,223,NA,223,NA,NA,0,223,NA,Stage IV,T3a,M1,LIHC.iCluster:1,1
1.305405184,3.393119733,TCGA-DD-A11D-01A,TCGA-DD-A11D-01A-11D-A12Z-10,0,NA,TCGA-DD-A11D,LIHC,57,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2006,[Not Available],-21003,Dead,WITH TUMOR,NA,1560,[Not Available],Intrahepatic Recurrence,Liver,NA,498,[Not Available],1,1560,1,1560,1,498,1,498,NA,Stage I,T1,M0,LIHC.iCluster:3,1
-5.879711307,3.245029248,TCGA-G9-6361-01A,TCGA-G9-6361-01A-21D-1961-08,11,0.383844334,TCGA-G9-6361,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-22565,Alive,TUMOR FREE,1415,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1415,0,1415,0,1415,0,1415,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,8
9.767935263,-1.978705329,TCGA-G9-6351-01A,TCGA-G9-6351-01A-21D-1961-08,1,0.780475408,TCGA-G9-6351,PRAD,51,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-18723,Alive,TUMOR FREE,2048,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2048,0,2048,0,2048,0,2048,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
8.820921826,-2.683142943,TCGA-EJ-7125-01A,TCGA-EJ-7125-01A-11D-1961-08,1,0.613207587,TCGA-EJ-7125,PRAD,44,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2005,[Not Available],-16425,Alive,TUMOR FREE,2850,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2850,0,2850,0,2850,0,2850,NA,[Not Applicable],T2c,[Not Applicable],PRAD.7-IDH1,1
8.827491748,-4.096401154,TCGA-EJ-7793-01A,TCGA-EJ-7793-01A-31D-2260-08,1,0.750103616,TCGA-EJ-7793,PRAD,49,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-17982,Alive,TUMOR FREE,114,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,114,0,114,0,114,0,114,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
10.0877062,-2.270780973,TCGA-EL-A3T7-01A,TCGA-EL-A3T7-01A-11D-A22D-08,1,0.793614214,TCGA-EL-A3T7,THCA,47,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-17302,Alive,TUMOR FREE,1256,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1256,0,1256,0,1256,0,1256,NA,Stage II,T2,M0,THCA.5,1
9.758434582,-4.043947609,TCGA-EJ-5511-01A,TCGA-EJ-5511-01A-01D-1576-08,1,0.681731416,TCGA-EJ-5511,PRAD,55,MALE,BLACK OR AFRICAN AMERICAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20409,Alive,TUMOR FREE,1476,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1476,0,1476,0,1476,0,1476,NA,[Not Applicable],T3a,[Not Applicable],PRAD.3-ETV4,1
9.680174776,-2.093642303,TCGA-78-7163-01A,TCGA-78-7163-01A-12D-2063-08,1,0.780457098,TCGA-78-7163,LUAD,60,MALE,WHITE,Lung Adenocarcinoma,[Not Available],1992,[Not Available],-22002,Alive,TUMOR FREE,7248,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,7248,0,7248,0,7248,0,7248,NA,Stage IB,T2,M0,LUAD.1,1
9.014619173,-4.70148282,TCGA-G9-6362-01A,TCGA-G9-6362-01A-11D-1786-08,1,0.792235918,TCGA-G9-6362,PRAD,57,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-21149,Alive,WITH TUMOR,1443,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1443,0,1443,NA,NA,0,1443,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.079902067,-5.123720452,TCGA-EJ-5527-01A,TCGA-EJ-5527-01A-01D-1576-08,1,0.850581509,TCGA-EJ-5527,PRAD,69,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25234,Alive,TUMOR FREE,1778,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1778,0,1778,0,1778,0,1778,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-6.153172557,3.423358313,TCGA-EM-A22K-01A,TCGA-EM-A22K-01A-11D-A17V-08,11,0.440687023,TCGA-EM-A22K,THCA,46,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-16890,Alive,TUMOR FREE,479,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,479,0,479,NA,NA,0,479,NA,Stage IVA,T1b,MX,THCA.1,8
7.878974283,-1.395175355,TCGA-G9-6378-01A,TCGA-G9-6378-01A-11D-1786-08,1,0.186268946,TCGA-G9-6378,PRAD,54,MALE,BLACK OR AFRICAN AMERICAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-19879,Alive,TUMOR FREE,1155,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1155,0,1155,0,1155,0,1155,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
9.405839759,-1.921864946,TCGA-19-5960-01A,TCGA-19-5960-01A-11D-1696-08,1,0.75582021,TCGA-19-5960,GBM,56,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-20641,Dead,WITH TUMOR,NA,455,[Not Available],Recurrence,[Not Applicable],[Not Applicable],382,Stable Disease,1,455,1,455,NA,NA,1,382,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-6.404370554,1.278791119,TCGA-CC-A1HT-01A,TCGA-CC-A1HT-01A-11D-A12Z-10,10,0.253750906,TCGA-CC-A1HT,LIHC,50,MALE,ASIAN,Hepatocellular Carcinoma,G3,2010,[Not Available],-18553,Dead,TUMOR FREE,NA,101,[Not Available],NA,NA,NA,NA,[Not Available],1,101,0,101,NA,NA,0,101,NA,Stage IIIA,T3,M0,LIHC.iCluster:1,9
-7.154579437,-2.250416582,TCGA-78-7633-01A,TCGA-78-7633-01A-11D-2063-08,6,0.264381895,TCGA-78-7633,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24713,Dead,WITH TUMOR,NA,1528,[Not Available],Locoregional Recurrence,NA,NA,1450,Complete Remission/Response,1,1528,1,1528,1,1450,1,1450,NA,Stage IB,T2,M0,LUAD.1,2
10.15509027,-1.889741657,TCGA-26-5134-01A,TCGA-26-5134-01A-01D-1486-08,1,0.846011579,TCGA-26-5134,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-27111,Alive,TUMOR FREE,167,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,167,0,167,NA,NA,0,167,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-6.584069344,-1.236161738,TCGA-19-2629-01A,TCGA-19-2629-01A-01D-1495-08,7,0.259916513,TCGA-19-2629,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-22257,Dead,WITH TUMOR,501,737,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],145,[Not Available],1,737,1,737,NA,NA,1,145,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,2
0.174077891,3.21921045,TCGA-EP-A2KA-01A,TCGA-EP-A2KA-01A-11D-A183-10,4,0.404719721,TCGA-EP-A2KA,LIHC,52,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2011,[Not Available],-19214,Dead,WITH TUMOR,NA,627,[Not Available],Extrahepatic Recurrence,Lung,NA,293,[Not Available],1,627,1,627,1,293,1,293,NA,Stage IIIA,T3a,MX,LIHC.iCluster:2,3
9.251840323,-5.448534789,TCGA-HC-7818-01A,TCGA-HC-7818-01A-11D-2114-08,1,0.857298314,TCGA-HC-7818,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24391,Alive,TUMOR FREE,938,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,938,0,938,0,938,0,938,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
7.727321837,-3.408961053,TCGA-HC-7077-01A,TCGA-HC-7077-01A-11D-1961-08,0,NA,TCGA-HC-7077,PRAD,64,MALE,BLACK OR AFRICAN AMERICAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-23636,Alive,TUMOR FREE,2115,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2115,0,2115,0,2115,0,2115,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,3
-4.611795669,-1.650499022,TCGA-YF-AA3L-01A,TCGA-YF-AA3L-01A-11D-A38G-08,8,0.3336056,TCGA-YF-AA3L,BLCA,47,FEMALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-17268,Alive,TUMOR FREE,364,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,364,0,364,0,364,0,364,NA,Stage II,T2b,MX,NA,10
9.107376987,-5.297746089,TCGA-G9-6343-01A,TCGA-G9-6343-01A-21D-1961-08,1,0.801304276,TCGA-G9-6343,PRAD,62,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-22843,Alive,TUMOR FREE,2450,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2450,0,2450,0,2450,0,2450,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-6.910359752,-1.806247591,TCGA-YF-AA3M-01A,TCGA-YF-AA3M-01A-11D-A42E-08,0,NA,TCGA-YF-AA3M,BLCA,57,MALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-21097,Alive,WITH TUMOR,415,NA,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis,381,Complete Remission/Response,0,415,0,415,1,381,1,381,NA,Stage II,T2a,MX,NA,2
-3.211579151,-3.55366875,TCGA-IH-A3EA-01A,TCGA-IH-A3EA-01A-11D-A20D-08,8,0.54129496,TCGA-IH-A3EA,SKCM,61,MALE,WHITE,NA,[Not Available],2008,[Not Available],-22577,Alive,WITH TUMOR,524,NA,[Not Available],Distant Metastasis,Brain,NA,314,[Not Available],0,524,0,524,NA,NA,1,314,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
9.445859637,-5.546763508,TCGA-DE-A4M8-01A,TCGA-DE-A4M8-01A-21D-A257-08,1,0.879136279,TCGA-DE-A4M8,THCA,61,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-22357,Alive,TUMOR FREE,564,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,564,0,564,0,564,0,564,NA,Stage III,T2,M0,THCA.NA,1
9.711067297,-2.273510323,TCGA-CH-5752-01A,TCGA-CH-5752-01A-11D-1576-08,1,0.772213284,TCGA-CH-5752,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-24290,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,943,0,943,0,943,0,943,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-6.122971165,3.574550324,TCGA-44-6146-01A,TCGA-44-6146-01A-31D-A27T-08,11,0.540577765,TCGA-44-6146,LUAD,64,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-23378,Alive,TUMOR FREE,728,NA,[Not Available],Locoregional Recurrence,NA,NA,631,Complete Remission/Response,0,728,0,728,1,631,1,631,NA,Stage IIB,T3,M0,LUAD.1,8
8.995021239,-5.447431403,TCGA-EJ-5506-01A,TCGA-EJ-5506-01A-01D-1576-08,1,0.795938891,TCGA-EJ-5506,PRAD,67,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24617,Alive,TUMOR FREE,1381,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1381,0,1381,0,1381,0,1381,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.514840146,-5.608212436,TCGA-EM-A1YD-01A,TCGA-EM-A1YD-01A-11D-A14W-08,1,0.881934868,TCGA-EM-A1YD,THCA,53,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007,[Not Available],-19366,Alive,TUMOR FREE,1734,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1734,0,1734,0,1734,0,1734,NA,Stage II,T2,MX,THCA.1,1
9.209360278,-5.035092055,TCGA-CH-5792-01A,TCGA-CH-5792-01A-11D-1576-08,1,0.824025449,TCGA-CH-5792,PRAD,57,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-21002,Alive,WITH TUMOR,91,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,91,0,91,NA,NA,0,91,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
9.422553521,-5.609202918,TCGA-G9-6385-01A,TCGA-G9-6385-01A-11D-1786-08,1,0.865141613,TCGA-G9-6385,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24399,Alive,TUMOR FREE,830,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,830,0,830,0,830,0,830,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.908559902,-1.801420402,TCGA-EM-A1CU-01A,TCGA-EM-A1CU-01A-11D-A13W-08,1,0.814312555,TCGA-EM-A1CU,THCA,31,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-11470,Alive,TUMOR FREE,636,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,636,0,636,NA,NA,0,636,NA,Stage I,T3,M0,THCA.3,1
9.891124577,-1.765732421,TCGA-ET-A3BT-01A,TCGA-ET-A3BT-01A-11D-A19J-08,1,0.826080924,TCGA-ET-A3BT,THCA,60,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2007,[Not Available],-22108,Alive,TUMOR FREE,2665,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,267,[Not Available],0,2665,0,2665,NA,NA,1,267,NA,Stage IVA,T2,MX,THCA.4,1
-7.346554045,2.110093124,TCGA-76-6656-01A,TCGA-76-6656-01A-11D-1845-08,9,0.236786829,TCGA-76-6656,GBM,66,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-24265,Dead,NA,147,147,[Not Available],NA,NA,NA,NA,[Not Available],1,147,NA,147,NA,NA,0,147,NA,NA,NA,NA,NA,7
-4.191417729,0.274858724,TCGA-97-7938-01A,TCGA-97-7938-01A-11D-2167-08,0,NA,TCGA-97-7938,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27980,Dead,TUMOR FREE,NA,18,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,18,0,18,0,18,0,18,NA,Stage IA,T1a,MX,LUAD.5,10
-6.582039031,-1.283693587,TCGA-XF-AAN1-01A,TCGA-XF-AAN1-01A-31D-A42E-08,7,0.304695629,TCGA-XF-AAN1,BLCA,75,FEMALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-27687,Dead,WITH TUMOR,NA,941,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis and vagina,650,Partial Remission/Response,1,941,1,941,NA,NA,1,650,NA,Stage III,T4a,M0,NA,2
9.926146616,-1.739085478,TCGA-XF-AAN4-01A,TCGA-XF-AAN4-01A-11D-A42E-08,1,0.822628432,TCGA-XF-AAN4,BLCA,77,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-28302,Dead,TUMOR FREE,NA,823,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,823,0,823,0,823,0,823,NA,Stage III,T3b,MX,NA,1
3.970088549,1.291871902,TCGA-12-1089-01A,TCGA-12-1089-01A-01W-0611-08,2,0.254439423,TCGA-12-1089,GBM,64,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-23419,Dead,WITH TUMOR,177,177,[Not Available],NA,NA,NA,NA,[Not Available],1,177,1,177,NA,NA,1,177,NA,NA,NA,NA,NA,6
-4.483756318,-0.598863382,TCGA-28-5211-01C,TCGA-28-5211-01C-11D-1845-08,0,NA,TCGA-28-5211,GBM,42,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-15507,Alive,WITH TUMOR,358,NA,[Not Available],NA,[Not Applicable],[Not Applicable],225,[Not Available],0,358,0,358,NA,NA,1,225,NA,NA,NA,NA,NA,10
-4.530873693,-1.641365834,TCGA-XF-AAN5-01A,TCGA-XF-AAN5-01A-11D-A42E-08,8,0.445157494,TCGA-XF-AAN5,BLCA,61,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-22411,Alive,TUMOR FREE,2293,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2293,0,2293,0,2293,0,2293,NA,Stage III,T3b,MX,NA,10
-3.64157266,0.670510236,TCGA-L4-A4E5-01A,TCGA-L4-A4E5-01A-11D-A24P-08,0,NA,TCGA-L4-A4E5,LUAD,48,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-17680,Alive,TUMOR FREE,578,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,578,0,578,0,578,0,578,NA,Stage I,T1,M0,NA,10
-5.899591543,-1.310354337,TCGA-XF-AAN7-01A,TCGA-XF-AAN7-01A-11D-A42E-08,0,NA,TCGA-XF-AAN7,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-21951,Dead,WITH TUMOR,NA,565,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,321,Complete Remission/Response,1,565,1,565,NA,NA,1,321,NA,Stage IV,T3a,MX,NA,2
9.569403524,-5.385968241,TCGA-XF-AAN8-01A,TCGA-XF-AAN8-01A-11D-A42E-08,1,0.844641513,TCGA-XF-AAN8,BLCA,74,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-27309,Dead,NA,NA,118,[Not Available],NA,NA,NA,NA,[Unknown],1,118,NA,118,NA,NA,0,118,NA,Stage III,T3b,MX,NA,1
-3.218891672,-3.488086552,TCGA-YC-A89H-01A,TCGA-YC-A89H-01A-11D-A364-08,8,0.492643309,TCGA-YC-A89H,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-28741,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,573,0,573,0,573,0,573,NA,Stage II,[Not Available],MX,NA,10
8.94102415,-2.74652378,TCGA-YC-A9TC-01A,TCGA-YC-A9TC-01A-22D-A391-08,4,0.438873231,TCGA-YC-A9TC,BLCA,71,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-26283,Dead,WITH TUMOR,NA,20,[Not Available],NA,NA,NA,NA,Progressive Disease,1,20,1,20,NA,NA,1,20,NA,Stage IV,[Not Available],M1,NA,6
9.712237735,-1.928191559,TCGA-CH-5794-01A,TCGA-CH-5794-01A-11D-1576-08,1,0.819104475,TCGA-CH-5794,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-23924,Alive,TUMOR FREE,882,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,882,0,882,0,882,0,882,NA,[Not Applicable],T2b,[Not Applicable],PRAD.1-ERG,1
9.319289166,-5.575593729,TCGA-EJ-5522-01A,TCGA-EJ-5522-01A-01D-1576-08,1,0.860217219,TCGA-EJ-5522,PRAD,51,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-18802,Alive,TUMOR FREE,2079,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2079,0,2079,0,2079,0,2079,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-3.645786314,0.545918503,TCGA-34-2609-01A,TCGA-34-2609-01A-01D-1522-08,0,NA,TCGA-34-2609,LUSC,81,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-29871,Dead,WITH TUMOR,951,951,[Not Available],NA,NA,NA,387,Complete Remission/Response,1,951,1,951,1,387,1,387,NA,Stage IIB,T2,M0,NA,10
4.413179326,1.153544239,TCGA-HI-7170-01A,TCGA-HI-7170-01A-11D-2114-08,2,0.697330627,TCGA-HI-7170,PRAD,58,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-21199,Alive,TUMOR FREE,2522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2522,0,2522,0,2522,0,2522,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,5
10.04799708,-2.239280727,TCGA-EJ-7328-01A,TCGA-EJ-7328-01A-31D-2114-08,1,0.741245554,TCGA-EJ-7328,PRAD,70,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25756,Alive,TUMOR FREE,842,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,842,0,842,0,842,0,842,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
7.940606422,-3.664788285,TCGA-J4-8198-01A,TCGA-J4-8198-01A-11D-2260-08,1,0.365711153,TCGA-J4-8198,PRAD,49,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-17935,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,614,0,614,0,614,0,614,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
7.763956057,-1.383621054,TCGA-DJ-A2Q1-01A,TCGA-DJ-A2Q1-01A-22D-A19J-08,1,0.162857921,TCGA-DJ-A2Q1,THCA,44,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-16371,Alive,TUMOR FREE,1148,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1148,0,1148,0,1148,0,1148,NA,Stage I,T1b,M0,THCA.2,1
-4.058546341,-2.033722825,TCGA-XF-AAN0-01A,TCGA-XF-AAN0-01A-11D-A42E-08,8,0.475793346,TCGA-XF-AAN0,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-24877,Dead,WITH TUMOR,NA,1718,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Scrotum and Perineum,603,Complete Remission/Response,1,1718,1,1718,NA,NA,1,603,NA,Stage IV,T4a,M0,NA,10
4.351521764,1.162345456,TCGA-CH-5739-01A,TCGA-CH-5739-01A-11D-1576-08,2,0.692427707,TCGA-CH-5739,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-23953,Alive,TUMOR FREE,671,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,671,0,671,0,671,0,671,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,5
-8.092348404,2.087329847,TCGA-EJ-7331-01A,TCGA-EJ-7331-01A-11D-2114-08,9,0.488019899,TCGA-EJ-7331,PRAD,64,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23458,Alive,TUMOR FREE,742,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,742,0,742,0,742,0,742,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,7
2.936431546,3.443615215,TCGA-DE-A4MB-01A,TCGA-DE-A4MB-01A-11D-A257-08,0,NA,TCGA-DE-A4MB,THCA,79,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-29011,Alive,WITH TUMOR,352,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,352,0,352,NA,NA,0,352,NA,Stage IVA,T3,M0,THCA.NA,3
9.294260711,-5.593372961,TCGA-EJ-7327-01A,TCGA-EJ-7327-01A-11D-2114-08,1,0.851419169,TCGA-EJ-7327,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22475,Alive,TUMOR FREE,923,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,923,0,923,0,923,0,923,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.070313274,-5.223225288,TCGA-G9-6373-01A,TCGA-G9-6373-01A-11D-1786-08,1,0.724897111,TCGA-G9-6373,PRAD,68,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-24887,Alive,TUMOR FREE,811,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,811,0,811,0,811,0,811,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-5.029576733,-1.622727783,TCGA-55-6985-01A,TCGA-55-6985-01A-11D-1945-08,8,0.062935511,TCGA-55-6985,LUAD,58,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-21381,Alive,TUMOR FREE,1233,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1233,0,1233,0,1233,0,1233,NA,Stage IB,T2,MX,LUAD.5,10
10.01051966,-1.7464742,TCGA-DJ-A2QA-01A,TCGA-DJ-A2QA-01A-11D-A18F-08,1,0.822206734,TCGA-DJ-A2QA,THCA,56,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-20784,Alive,TUMOR FREE,1020,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1020,0,1020,0,1020,0,1020,NA,Stage III,T3,M0,THCA.5,1
-5.870032063,-1.969750951,TCGA-XF-AAMX-01A,TCGA-XF-AAMX-01A-11D-A42E-08,0,NA,TCGA-XF-AAMX,BLCA,87,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-31884,Dead,TUMOR FREE,NA,206,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,206,0,206,0,206,0,206,NA,Stage III,T3b,MX,NA,10
-4.832238756,1.5708042,TCGA-55-8510-01A,TCGA-55-8510-01A-11D-2393-08,0,NA,TCGA-55-8510,LUAD,55,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20410,Alive,TUMOR FREE,539,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,539,0,539,0,539,0,539,NA,Stage IB,T2a,MX,NA,10
0.053615695,5.067477087,TCGA-02-2483-01A,TCGA-02-2483-01A-01D-1494-08,4,0.711226125,TCGA-02-2483,GBM,43,MALE,ASIAN,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-15964,Alive,WITH TUMOR,466,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,466,0,466,NA,NA,0,466,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,6
9.320287537,-1.634610043,TCGA-06-0648-01A,TCGA-06-0648-01A-01D-1492-08,1,0.783867025,TCGA-06-0648,GBM,77,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-28477,Dead,WITH TUMOR,294,298,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],202,[Not Available],1,298,1,298,NA,NA,1,202,NA,NA,NA,NA,NA,1
-6.076317448,3.515507842,TCGA-XF-AAMH-01A,TCGA-XF-AAMH-01A-11D-A42E-08,11,0.556123937,TCGA-XF-AAMH,BLCA,80,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-29547,Dead,WITH TUMOR,NA,344,[Not Available],Distant Metastasis,"Other, specify",lumbar spine and right hemipelvis,313,Progressive Disease,1,344,1,344,NA,NA,1,313,NA,Stage IV,T3b,MX,NA,8
-1.827332048,1.041636215,TCGA-XF-AAMJ-01A,TCGA-XF-AAMJ-01A-11D-A42E-08,5,0.593782522,TCGA-XF-AAMJ,BLCA,70,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-25838,Dead,TUMOR FREE,NA,1670,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1670,0,1670,0,1670,0,1670,NA,Stage III,T3b,M0,NA,4
4.370803857,0.978675349,TCGA-BC-A10W-01A,TCGA-BC-A10W-01A-11D-A12Z-10,2,0.062349692,TCGA-BC-A10W,LIHC,50,MALE,ASIAN,Hepatocellular Carcinoma,G3,2002,[Not Available],-18562,Dead,WITH TUMOR,NA,91,[Not Available],NA,NA,NA,NA,[Not Available],1,91,1,91,NA,NA,1,91,NA,[Not Available],T4,MX,LIHC.iCluster:1,6
-3.910195019,-2.080067751,TCGA-XF-AAML-01A,TCGA-XF-AAML-01A-11D-A42E-08,8,0.367891162,TCGA-XF-AAML,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-27422,Dead,TUMOR FREE,NA,232,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,232,0,232,0,232,0,232,NA,Stage II,T2b,MX,NA,10
-6.77896656,-2.329721215,TCGA-XF-AAMQ-01A,TCGA-XF-AAMQ-01A-11D-A42E-08,0,NA,TCGA-XF-AAMQ,BLCA,59,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-21660,Alive,TUMOR FREE,2177,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2177,0,2177,0,2177,0,2177,NA,Stage II,T2a,MX,NA,10
-7.057020355,-2.407486728,TCGA-19-0957-01C,TCGA-19-0957-01C-01W-0643-08,6,0.13753856,TCGA-19-0957,GBM,48,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-17714,Dead,WITH TUMOR,666,666,[Not Available],Recurrence,[Not Applicable],[Not Applicable],50,[Not Available],1,666,1,666,NA,NA,1,50,NA,NA,NA,NA,NA,2
-5.725170894,-2.180517201,TCGA-XF-AAMR-01A,TCGA-XF-AAMR-01A-31D-A42E-08,0,NA,TCGA-XF-AAMR,BLCA,48,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-17670,Alive,TUMOR FREE,2790,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2790,0,2790,0,2790,0,2790,NA,Stage III,T3b,MX,NA,2
-0.713708241,2.540367342,TCGA-XF-AAMT-01A,TCGA-XF-AAMT-01A-11D-A42E-08,4,0.146334021,TCGA-XF-AAMT,BLCA,75,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-27397,Dead,WITH TUMOR,NA,90,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,90,1,90,NA,NA,1,90,NA,Stage IV,T3b,MX,NA,6
-5.298309741,2.691027612,TCGA-XF-AAMW-01A,TCGA-XF-AAMW-01A-11D-A42E-08,12,0.282252367,TCGA-XF-AAMW,BLCA,79,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-28903,Dead,WITH TUMOR,NA,253,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,253,1,253,NA,NA,1,253,NA,Stage IV,T2b,[Discrepancy],NA,8
9.259310382,-5.170925431,TCGA-CH-5772-01A,TCGA-CH-5772-01A-11D-1576-08,1,0.832974088,TCGA-CH-5772,PRAD,63,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23194,Alive,TUMOR FREE,486,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,486,0,486,0,486,0,486,NA,[Not Applicable],T3a,[Not Applicable],PRAD.7-IDH1,1
9.491763748,-2.542908374,TCGA-HC-7231-01A,TCGA-HC-7231-01A-11D-2114-08,1,0.758715968,TCGA-HC-7231,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24278,Alive,TUMOR FREE,939,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,939,0,939,0,939,0,939,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-4.741965353,1.423615611,TCGA-68-8250-01A,TCGA-68-8250-01A-11D-2293-08,0,NA,TCGA-68-8250,LUSC,66,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24118,Alive,TUMOR FREE,244,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,244,0,244,NA,NA,0,244,NA,Stage IA,T1a,MX,NA,10
9.689947332,-2.778626572,TCGA-G9-6384-01A,TCGA-G9-6384-01A-11D-1786-08,1,0.773073631,TCGA-G9-6384,PRAD,53,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-19620,Alive,TUMOR FREE,765,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,765,0,765,0,765,0,765,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.03197753,-5.459629469,TCGA-HC-7750-01A,TCGA-HC-7750-01A-11D-2114-08,1,0.829557708,TCGA-HC-7750,PRAD,50,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-18580,Alive,TUMOR FREE,522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,522,0,522,0,522,0,522,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-7.839921176,2.252016307,TCGA-EB-A3HV-01A,TCGA-EB-A3HV-01A-11D-A21A-08,9,0.461877419,TCGA-EB-A3HV,SKCM,37,MALE,WHITE,NA,[Not Available],2011,[Not Available],-13712,Alive,WITH TUMOR,39,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,39,0,39,NA,NA,0,39,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,7
0.415857239,2.252568958,TCGA-DE-A2OL-01A,TCGA-DE-A2OL-01A-11D-A18F-08,0,NA,TCGA-DE-A2OL,THCA,44,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-16253,Alive,TUMOR FREE,1145,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1145,0,1145,0,1145,0,1145,NA,Stage I,T2,MX,THCA.1,6
0.465308892,2.208378623,TCGA-G9-6371-01A,TCGA-G9-6371-01A-11D-1786-08,0,NA,TCGA-G9-6371,PRAD,58,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-21365,Alive,TUMOR FREE,1226,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1226,0,1226,0,1226,0,1226,NA,[Not Applicable],T2c,[Not Applicable],PRAD.3-ETV4,6
-5.771481587,2.395433353,TCGA-XF-AAMF-01A,TCGA-XF-AAMF-01A-21D-A42E-08,0,NA,TCGA-XF-AAMF,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-25023,Dead,WITH TUMOR,NA,329,[Not Available],Distant Metastasis,Lung,NA,157,Stable Disease,1,329,1,329,NA,NA,1,157,NA,Stage IV,T4,MX,NA,7
9.367367459,-5.567274664,TCGA-G9-6494-01A,TCGA-G9-6494-01A-11D-1786-08,1,0.879321347,TCGA-G9-6494,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24381,Alive,WITH TUMOR,1771,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1771,0,1771,NA,NA,0,1771,NA,[Not Applicable],T4,[Not Applicable],PRAD.2-ETV1,1
-7.347313197,-2.379281235,TCGA-HI-7171-01A,TCGA-HI-7171-01A-12D-2114-08,6,0.339722496,TCGA-HI-7171,PRAD,56,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-20776,Dead,WITH TUMOR,NA,1329,[Unknown],NA,NA,NA,NA,Stable Disease,1,1329,1,1329,NA,NA,1,1329,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,2
-0.751730531,2.332867103,TCGA-G9-6366-01A,TCGA-G9-6366-01A-11D-2114-08,0,NA,TCGA-G9-6366,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-22428,Alive,NA,1947,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1947,0,1947,0,1947,0,1947,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
-4.282901174,1.079720196,TCGA-56-7223-01A,TCGA-56-7223-01A-11D-2042-08,0,NA,TCGA-56-7223,LUSC,66,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24288,Dead,WITH TUMOR,NA,442,[Not Available],Locoregional Recurrence,NA,NA,132,Progressive Disease,1,442,1,442,NA,NA,1,132,NA,Stage IIIA,T3,MX,NA,10
9.928509012,-1.742619322,TCGA-G9-6369-01A,TCGA-G9-6369-01A-21D-1961-08,1,0.86256285,TCGA-G9-6369,PRAD,55,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20238,Alive,TUMOR FREE,1215,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1215,0,1215,0,1215,0,1215,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.041201969,-1.691911765,TCGA-86-8668-01A,TCGA-86-8668-01A-11D-2393-08,1,0.589125387,TCGA-86-8668,LUAD,61,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22383,Alive,TUMOR FREE,423,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,423,0,423,0,423,0,423,NA,Stage IA,T1b,M0,NA,7
4.368837601,1.187696606,TCGA-CH-5765-01A,TCGA-CH-5765-01A-11D-1576-08,2,0.690598467,TCGA-CH-5765,PRAD,55,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-20364,Alive,TUMOR FREE,700,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,700,0,700,0,700,0,700,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,5
9.538252588,-5.687307333,TCGA-FY-A3I5-01B,TCGA-FY-A3I5-01B-11D-A21Z-08,1,0.879188563,TCGA-FY-A3I5,THCA,64,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-23654,Alive,TUMOR FREE,238,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,238,0,238,0,238,0,238,NA,Stage III,T3,MX,THCA.1,1
10.08450065,-1.779405,TCGA-FE-A23A-01A,TCGA-FE-A23A-01A-11D-A17V-08,1,0.855946622,TCGA-FE-A23A,THCA,27,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-10177,Alive,TUMOR FREE,2489,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2489,0,2489,0,2489,0,2489,NA,Stage I,T2,MX,THCA.4,1
-7.649240805,1.847914092,TCGA-XF-AAME-01A,TCGA-XF-AAME-01A-12D-A42E-08,9,0.287136346,TCGA-XF-AAME,BLCA,64,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-23448,Dead,WITH TUMOR,NA,2828,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Vagina,1651,Progressive Disease,1,2828,1,2828,NA,NA,1,1651,NA,Stage II,T2b,MX,NA,7
0.018673773,4.766911698,TCGA-CV-7247-01A,TCGA-CV-7247-01A-11D-2012-08,4,0.656347432,TCGA-CV-7247,HNSC,55,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1995,[Not Available],-20433,Dead,WITH TUMOR,NA,577,[Not Available],NA,NA,NA,NA,[Not Available],1,577,1,577,NA,NA,1,577,NA,Stage III,T3,[Not Available],HNSC.Classical,6
4.261710054,1.237831241,TCGA-14-0817-01A,TCGA-14-0817-01A-01D-1492-08,2,0.694616609,TCGA-14-0817,GBM,69,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-25425,Dead,NA,164,164,[Not Available],NA,NA,NA,NA,[Not Available],1,164,NA,164,NA,NA,0,164,NA,NA,NA,NA,GBM_LGG.Classic-like,5
-3.734615313,-2.502778601,TCGA-XF-A9T0-01A,TCGA-XF-A9T0-01A-11D-A391-08,8,0.457282167,TCGA-XF-A9T0,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-25190,Alive,TUMOR FREE,799,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,799,0,799,0,799,0,799,NA,Stage III,T3b,MX,NA,10
-7.342106209,2.467314934,TCGA-XF-A9T2-01A,TCGA-XF-A9T2-01A-11D-A42E-08,0,NA,TCGA-XF-A9T2,BLCA,54,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-19945,Dead,NA,NA,575,[Not Available],NA,NA,NA,NA,[Unknown],1,575,NA,575,NA,NA,0,575,NA,Stage III,T3b,MX,NA,6
-4.110488345,-2.245657053,TCGA-XF-A9T3-01A,TCGA-XF-A9T3-01A-11D-A42E-08,8,0.424768372,TCGA-XF-A9T3,BLCA,69,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-25532,Alive,TUMOR FREE,68,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,68,0,68,NA,NA,0,68,NA,Stage IV,T3b,MX,NA,10
-6.139948915,3.532432764,TCGA-XF-A9T4-01A,TCGA-XF-A9T4-01A-11D-A391-08,11,0.493493124,TCGA-XF-A9T4,BLCA,48,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-17728,Dead,WITH TUMOR,NA,495,[Not Available],Distant Metastasis,Lung,NA,182,Partial Remission/Response,1,495,1,495,NA,NA,1,182,NA,Stage IV,T2b,MX,NA,8
-3.793945319,-2.461620944,TCGA-XF-A9T5-01A,TCGA-XF-A9T5-01A-11D-A42E-08,8,0.442423012,TCGA-XF-A9T5,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-28578,Alive,TUMOR FREE,2027,NA,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Vagina,664,Complete Remission/Response,0,2027,0,2027,NA,NA,1,664,NA,Stage IV,T3a,MX,NA,10
7.64632943,-3.377425358,TCGA-19-1790-01B,TCGA-19-1790-01B-01D-1353-08,1,0.24515274,TCGA-19-1790,GBM,56,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-20626,Dead,WITH TUMOR,154,154,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88,[Not Available],1,154,1,154,NA,NA,1,88,NA,NA,NA,NA,NA,6
-4.105548787,-2.015014081,TCGA-XF-A9T6-01A,TCGA-XF-A9T6-01A-11D-A42E-08,8,0.265205027,TCGA-XF-A9T6,BLCA,88,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-32207,Alive,NA,64,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,64,0,64,NA,NA,0,64,NA,Stage III,T3b,MX,NA,10
-3.8745914,-2.435142971,TCGA-XF-A9T8-01A,TCGA-XF-A9T8-01A-11D-A391-08,8,0.424482252,TCGA-XF-A9T8,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-23403,Dead,NA,NA,418,[Not Available],NA,NA,NA,NA,[Unknown],1,418,NA,418,NA,NA,0,418,NA,Stage III,T3b,MX,NA,10
10.06097888,-1.653697774,TCGA-EM-A3FJ-01A,TCGA-EM-A3FJ-01A-11D-A21A-08,1,0.891451832,TCGA-EM-A3FJ,THCA,24,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-9042,Alive,TUMOR FREE,850,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,850,0,850,0,850,0,850,NA,Stage I,T1a,MX,THCA.5,1
10.02655207,-1.520722283,TCGA-DE-A0Y3-01B,TCGA-DE-A0Y3-01B-11D-A10S-08,1,0.876858059,TCGA-DE-A0Y3,THCA,60,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-22239,Alive,TUMOR FREE,1526,NA,[Not Available],Distant Metastasis,Lung,NA,30,[Not Available],0,1526,0,1526,NA,NA,1,30,NA,Stage IVC,T4a,M1,THCA.3,1
-6.071979389,3.463404296,TCGA-EL-A3CZ-01A,TCGA-EL-A3CZ-01A-11D-A19J-08,11,0.502239464,TCGA-EL-A3CZ,THCA,37,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-13718,Alive,WITH TUMOR,2418,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,1426,[Not Available],0,2418,0,2418,NA,NA,1,1426,NA,Stage I,T1,M0,THCA.1,8
-4.138473726,0.764937982,TCGA-85-8288-01A,TCGA-85-8288-01A-11D-2293-08,0,NA,TCGA-85-8288,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25629,Dead,TUMOR FREE,NA,402,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,402,0,402,0,402,0,402,NA,Stage IIA,T1b,M0,NA,3
-4.758039381,1.203511299,TCGA-EB-A41B-01A,TCGA-EB-A41B-01A-11D-A24R-08,0,NA,TCGA-EB-A41B,SKCM,76,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-27998,Alive,TUMOR FREE,291,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,291,0,291,NA,NA,0,291,NA,Stage IIC,T4b,M0,SKCM.RAS_Hotspot_Mutants,10
10.00376471,-1.564879735,TCGA-DJ-A2Q6-01A,TCGA-DJ-A2Q6-01A-11D-A18F-08,1,0.888484588,TCGA-DJ-A2Q6,THCA,38,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-14193,Alive,TUMOR FREE,1109,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1109,0,1109,0,1109,0,1109,NA,Stage I,T1b,M0,THCA.4,1
-7.652164192,2.154529502,TCGA-93-7348-01A,TCGA-93-7348-01A-21D-2036-08,9,0.408138009,TCGA-93-7348,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27456,Alive,TUMOR FREE,531,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,531,0,531,0,531,0,531,NA,Stage IA,T1a,MX,LUAD.5,7
-4.357389147,-1.65825994,TCGA-XF-A9SY-01A,TCGA-XF-A9SY-01A-21D-A42E-08,8,0.440983532,TCGA-XF-A9SY,BLCA,60,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-22212,Alive,WITH TUMOR,640,NA,[Not Available],Distant Metastasis,"Other, specify",Groin,168,Progressive Disease,0,640,0,640,NA,NA,1,168,NA,Stage IV,T3b,MX,NA,10
-6.91348838,-2.242367917,TCGA-XF-A9SZ-01A,TCGA-XF-A9SZ-01A-11D-A391-08,0,NA,TCGA-XF-A9SZ,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-29100,Dead,WITH TUMOR,NA,859,[Not Available],Distant Metastasis,Lung,NA,854,Complete Remission/Response,1,859,1,859,NA,NA,1,854,NA,Stage IV,T3b,MX,NA,2
-4.152641167,-2.100524908,TCGA-CR-6481-01A,TCGA-CR-6481-01A-11D-1870-08,8,0.442531229,TCGA-CR-6481,HNSC,47,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-17203,Alive,TUMOR FREE,311,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,311,0,311,NA,NA,0,311,NA,[Not Available],[Not Available],[Not Available],HNSC.Atypical,10
-7.865374134,2.181119815,TCGA-06-0128-01A,TCGA-06-0128-01A-01D-1490-08,9,0.519169285,TCGA-06-0128,GBM,66,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-24217,Dead,WITH TUMOR,691,691,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],190,[Not Available],1,691,1,691,NA,NA,1,190,NA,NA,NA,NA,NA,7
-6.395516305,1.738202647,TCGA-02-0003-01A,TCGA-02-0003-01A-01D-1490-08,10,0.31332033,TCGA-02-0003,GBM,50,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-18341,Dead,WITH TUMOR,144,144,[Not Available],Recurrence,[Not Applicable],[Not Applicable],40,[Not Available],1,144,1,144,NA,NA,1,40,NA,NA,NA,NA,NA,7
-5.337085582,1.760668371,TCGA-XF-A8HI-01A,TCGA-XF-A8HI-01A-11D-A38G-08,0,NA,TCGA-XF-A8HI,BLCA,57,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-21059,Dead,WITH TUMOR,NA,544,[Not Available],Distant Metastasis,Lung,NA,468,Progressive Disease,1,544,1,544,NA,NA,1,468,NA,Stage IV,T2b,MX,NA,7
-6.429991905,-1.321114948,TCGA-44-7659-01A,TCGA-44-7659-01A-11D-2063-08,7,0.390663872,TCGA-44-7659,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25730,Alive,TUMOR FREE,691,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,691,0,691,0,691,0,691,NA,Stage IA,T1b,MX,LUAD.4,2
3.762582764,1.394819657,TCGA-XF-A9SG-01A,TCGA-XF-A9SG-01A-12D-A42E-08,0,NA,TCGA-XF-A9SG,BLCA,81,MALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-29825,Alive,TUMOR FREE,1479,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1479,0,1479,0,1479,0,1479,NA,Stage II,T2a,MX,NA,10
-5.293526916,0.996177507,TCGA-CV-7424-01A,TCGA-CV-7424-01A-11D-2078-08,0,NA,TCGA-CV-7424,HNSC,67,MALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G2,1997,[Not Available],-24775,Dead,WITH TUMOR,NA,453,[Not Available],NA,NA,NA,NA,[Not Available],1,453,1,453,NA,NA,1,453,NA,Stage IVA,T3,[Not Available],HNSC.Classical,9
2.130306337,1.843006386,TCGA-XF-A9SH-01A,TCGA-XF-A9SH-01A-11D-A391-08,3,0.5860408,TCGA-XF-A9SH,BLCA,65,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-24060,Dead,WITH TUMOR,NA,1971,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,547,Stable Disease,1,1971,1,1971,NA,NA,1,547,NA,Stage II,T2b,M0,NA,3
-4.457565578,-1.797686959,TCGA-XF-A9SI-01A,TCGA-XF-A9SI-01A-11D-A391-08,8,0.39573665,TCGA-XF-A9SI,BLCA,73,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-26719,Alive,TUMOR FREE,2423,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2423,0,2423,0,2423,0,2423,NA,Stage II,T2b,MX,NA,10
8.543254238,-3.755706329,TCGA-XF-A9SW-01A,TCGA-XF-A9SW-01A-11D-A42E-08,1,0.719930514,TCGA-XF-A9SW,BLCA,85,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-31049,Dead,WITH TUMOR,NA,362,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,362,1,362,NA,NA,1,362,NA,Stage IV,T3b,MX,NA,1
-7.012988102,-2.360017757,TCGA-XF-A9SX-01A,TCGA-XF-A9SX-01A-21D-A391-08,6,0.125639765,TCGA-XF-A9SX,BLCA,63,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-23349,Dead,WITH TUMOR,NA,719,[Not Available],Distant Metastasis,Lung,NA,475,Progressive Disease,1,719,1,719,NA,NA,1,475,NA,Stage IV,T3b,MX,NA,2
9.95641875,-1.597100588,TCGA-FY-A3TY-01A,TCGA-FY-A3TY-01A-11D-A22Z-08,1,0.881982648,TCGA-FY-A3TY,THCA,61,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-22556,Alive,TUMOR FREE,709,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,709,0,709,0,709,0,709,NA,Stage III,T3,MX,THCA.2,1
-3.967129925,-1.441436836,TCGA-22-1016-01A,TCGA-22-1016-01A-01D-1521-08,8,0.102298064,TCGA-22-1016,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-24078,Dead,TUMOR FREE,802,822,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,822,0,822,0,822,0,822,NA,Stage IB,T2,M0,LUSC.secretory,10
-5.772486142,-2.051633368,TCGA-D9-A3Z4-01A,TCGA-D9-A3Z4-01A-11D-A23B-08,0,NA,TCGA-D9-A3Z4,SKCM,54,MALE,WHITE,NA,[Not Available],2012,[Not Available],-19749,Dead,WITH TUMOR,NA,519,[Not Available],Regional lymph node,"Other, Specify",lymph node,192,[Not Available],1,519,1,519,NA,NA,1,192,NA,Stage IIIC,T4b,M0,SKCM.RAS_Hotspot_Mutants,2
7.786948882,-3.479188623,TCGA-FY-A3NM-01A,TCGA-FY-A3NM-01A-11D-A21A-08,1,0.34644065,TCGA-FY-A3NM,THCA,48,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-17734,Alive,TUMOR FREE,885,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,885,0,885,0,885,0,885,NA,Stage III,T3,MX,THCA.1,1
9.813968684,-1.717566,TCGA-DJ-A3V4-01A,TCGA-DJ-A3V4-01A-11D-A22Z-08,1,0.858852471,TCGA-DJ-A3V4,THCA,60,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-22218,Alive,TUMOR FREE,1294,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1294,0,1294,0,1294,0,1294,NA,Stage III,T3,M0,THCA.2,1
-4.56230277,-0.108307996,TCGA-97-7937-01A,TCGA-97-7937-01A-11D-2167-08,0,NA,TCGA-97-7937,LUAD,65,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23919,Alive,TUMOR FREE,564,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,564,0,564,NA,NA,0,564,NA,Stage IB,T2a,MX,LUAD.3,10
-3.191013137,-3.496560437,TCGA-SY-A9G5-01A,TCGA-SY-A9G5-01A-11D-A38G-08,8,0.541898413,TCGA-SY-A9G5,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-24260,Alive,TUMOR FREE,1186,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1186,0,1186,0,1186,0,1186,NA,Stage III,T4a,M0,NA,10
-5.651269658,2.426431385,TCGA-XF-A8HB-01A,TCGA-XF-A8HB-01A-11D-A364-08,12,0.098506754,TCGA-XF-A8HB,BLCA,50,FEMALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-18544,Alive,TUMOR FREE,1370,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1370,0,1370,0,1370,0,1370,NA,Stage II,T2b,MX,NA,8
1.324906682,2.206499937,TCGA-XF-A8HC-01A,TCGA-XF-A8HC-01A-11D-A364-08,0,NA,TCGA-XF-A8HC,BLCA,79,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-28996,Dead,NA,NA,200,[Not Available],NA,NA,NA,NA,[Unknown],1,200,NA,200,NA,NA,0,200,NA,Stage IV,T3a,MX,NA,3
-7.487354996,-2.392854442,TCGA-XF-A8HH-01A,TCGA-XF-A8HH-01A-11D-A38G-08,6,0.357671888,TCGA-XF-A8HH,BLCA,61,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-22393,Dead,WITH TUMOR,NA,57,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,57,1,57,NA,NA,1,57,NA,Stage IV,T3b,M0,NA,2
-4.510174225,-1.346644303,TCGA-HQ-A5NE-01A,TCGA-HQ-A5NE-01A-12D-A289-08,8,0.28885828,TCGA-HQ-A5NE,BLCA,57,MALE,[Not Evaluated],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-20647,Dead,WITH TUMOR,NA,370,[Not Available],Distant Metastasis,Renal Pelvis,NA,211,Complete Remission/Response,1,370,1,370,1,211,1,211,NA,Stage III,T3,M0,NA,10
-6.479089861,1.683761031,TCGA-16-0846-01A,TCGA-16-0846-01A-01D-1492-08,10,0.156473598,TCGA-16-0846,GBM,85,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-31111,Dead,WITH TUMOR,119,119,[Not Available],NA,NA,NA,NA,[Not Available],1,119,1,119,NA,NA,1,119,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-0.51949395,2.5434081,TCGA-LT-A8JT-01A,TCGA-LT-A8JT-01A-11D-A364-08,4,0.118425712,TCGA-LT-A8JT,BLCA,69,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-25498,Alive,TUMOR FREE,641,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,641,0,641,0,641,0,641,NA,Stage II,T2a,M0,NA,6
8.731760381,-1.910434656,TCGA-06-1804-01A,TCGA-06-1804-01A-01D-1696-08,1,0.562954378,TCGA-06-1804,GBM,81,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-29802,Dead,WITH TUMOR,414,414,[Not Available],NA,NA,NA,NA,[Not Available],1,414,1,414,NA,NA,1,414,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-1.963346547,2.309061001,TCGA-R3-A69X-01A,TCGA-R3-A69X-01A-22D-A30E-08,0,NA,TCGA-R3-A69X,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25576,Alive,TUMOR FREE,433,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,433,0,433,0,433,0,433,NA,Stage III,T3a,M0,NA,10
-3.566930104,-2.722089621,TCGA-S5-A6DX-01A,TCGA-S5-A6DX-01A-11D-A31L-08,8,0.419477704,TCGA-S5-A6DX,BLCA,83,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-30594,Dead,WITH TUMOR,NA,56,[Not Available],NA,NA,NA,NA,[Unknown],1,56,1,56,NA,NA,1,56,NA,Stage IV,T4a,MX,NA,10
-4.180896352,-1.673110292,TCGA-S5-AA26-01A,TCGA-S5-AA26-01A-11D-A38G-08,8,0.368051881,TCGA-S5-AA26,BLCA,46,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-16972,Alive,TUMOR FREE,503,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,503,0,503,0,503,0,503,NA,Stage III,T3a,MX,NA,10
9.616164574,-2.226118666,TCGA-SY-A9G0-01A,TCGA-SY-A9G0-01A-12D-A38G-08,1,0.801299111,TCGA-SY-A9G0,BLCA,82,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-30205,Dead,TUMOR FREE,NA,1008,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1008,0,1008,NA,NA,0,1008,NA,Stage IV,T4,M0,NA,1
9.822230032,-1.659052294,TCGA-CE-A483-01A,TCGA-CE-A483-01A-11D-A23U-08,1,0.844876884,TCGA-CE-A483,THCA,34,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-12768,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,457,0,457,0,457,0,457,NA,Stage I,T2,M0,THCA.3,1
9.499944406,-5.689488382,TCGA-BJ-A0ZA-01A,TCGA-BJ-A0ZA-01A-11D-A10S-08,1,0.885029964,TCGA-BJ-A0ZA,THCA,67,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-24528,Alive,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,574,0,574,0,574,0,574,NA,Stage II,T2,M0,THCA.1,1
9.951766257,-1.649094476,TCGA-E3-A3E3-01A,TCGA-E3-A3E3-01A-11D-A20C-08,1,0.833368606,TCGA-E3-A3E3,THCA,49,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-18140,Alive,TUMOR FREE,1595,NA,[Not Available],Distant Metastasis,Lymph Node Only,NA,445,[Not Available],0,1595,0,1595,1,445,1,445,NA,Stage II,T2,M0,THCA.3,1
-4.967712447,-1.913207567,TCGA-E8-A2EA-01A,TCGA-E8-A2EA-01A-11D-A17V-08,0,NA,TCGA-E8-A2EA,THCA,52,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-19159,Alive,TUMOR FREE,1085,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1085,0,1085,0,1085,0,1085,NA,Stage I,T1b,M0,THCA.4,10
10.07300895,-1.4610482,TCGA-MK-A4N9-01A,TCGA-MK-A4N9-01A-11D-A257-08,1,0.883073606,TCGA-MK-A4N9,THCA,41,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-15255,Alive,TUMOR FREE,919,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,919,0,919,0,919,0,919,NA,Stage I,T3,M0,THCA.5,1
9.861784104,-1.835480415,TCGA-DE-A0XZ-01A,TCGA-DE-A0XZ-01A-11D-A17V-08,1,0.854865589,TCGA-DE-A0XZ,THCA,65,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-24020,Alive,TUMOR FREE,1090,NA,[Not Available],NA,NA,NA,204,[Not Available],0,1090,0,1090,1,204,1,204,NA,Stage III,T1,M0,THCA.2,1
-6.102435587,3.528437294,TCGA-EM-A22L-01A,TCGA-EM-A22L-01A-11D-A17V-08,11,0.496500644,TCGA-EM-A22L,THCA,33,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-12092,Alive,TUMOR FREE,318,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,318,0,318,0,318,0,318,NA,Stage I,T2,MX,THCA.1,8
-5.549641745,-1.366668546,TCGA-92-8063-01A,TCGA-92-8063-01A-11D-2244-08,0,NA,TCGA-92-8063,LUSC,52,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-19193,Alive,TUMOR FREE,122,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,122,0,122,0,122,0,122,NA,Stage IIIA,T2b,MX,NA,10
10.12598955,-1.82383653,TCGA-ET-A3BV-01A,TCGA-ET-A3BV-01A-11D-A19J-08,1,0.862309843,TCGA-ET-A3BV,THCA,47,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-17441,Alive,TUMOR FREE,2294,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,1204,[Not Available],0,2294,0,2294,1,1204,1,1204,NA,Stage III,T2,MX,THCA.NA,1
10.04305203,-1.519577678,TCGA-EL-A3D1-01A,TCGA-EL-A3D1-01A-11D-A19J-08,1,0.869931254,TCGA-EL-A3D1,THCA,39,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-14245,Alive,TUMOR FREE,2997,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2997,0,2997,0,2997,0,2997,NA,Stage I,T2,M0,THCA.NA,1
2.624403993,1.719473779,TCGA-J2-A4AE-01A,TCGA-J2-A4AE-01A-21D-A24D-08,3,0.122266139,TCGA-J2-A4AE,LUAD,77,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28163,Alive,TUMOR FREE,1079,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1079,0,1079,0,1079,0,1079,NA,Stage IA,T1a,MX,NA,3
-4.474541643,-0.698463232,TCGA-22-4599-01A,TCGA-22-4599-01A-01D-1441-08,0,NA,TCGA-22-4599,LUSC,73,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-26925,Dead,NA,1161,1161,[Not Available],NA,NA,NA,NA,[Not Available],1,1161,NA,1161,NA,NA,0,1161,NA,Stage IB,T2a,M0,LUSC.primitive,10
8.733660871,-1.891974067,TCGA-76-4931-01A,TCGA-76-4931-01A-01D-1486-08,1,0.574033173,TCGA-76-4931,GBM,70,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-25812,Dead,WITH TUMOR,279,279,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],112,[Not Available],1,279,1,279,NA,NA,1,112,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-3.965071537,1.076281479,TCGA-CV-7242-01A,TCGA-CV-7242-01A-11D-2012-08,0,NA,TCGA-CV-7242,HNSC,60,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-22136,Alive,TUMOR FREE,1095,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1095,0,1095,NA,NA,0,1095,NA,Stage II,T2,[Not Available],HNSC.Atypical,10
4.440288257,1.060973491,TCGA-32-4211-01A,TCGA-32-4211-01A-01D-1353-08,2,0.719439904,TCGA-32-4211,GBM,56,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-20748,Dead,WITH TUMOR,383,383,[Not Available],NA,NA,NA,NA,[Not Available],1,383,1,383,NA,NA,1,383,NA,NA,NA,NA,NA,5
9.161593792,-5.380195172,TCGA-BJ-A0ZC-01A,TCGA-BJ-A0ZC-01A-12D-A13W-08,1,0.8256529,TCGA-BJ-A0ZC,THCA,55,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-20282,Alive,TUMOR FREE,352,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,352,0,352,0,352,0,352,NA,Stage I,T1,M0,THCA.1,1
9.994320244,-1.601171878,TCGA-EL-A3ZQ-01A,TCGA-EL-A3ZQ-01A-11D-A23M-08,1,0.887971974,TCGA-EL-A3ZQ,THCA,78,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-28783,Alive,TUMOR FREE,1862,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1862,0,1862,0,1862,0,1862,NA,Stage II,T2,M0,THCA.5,1
-6.087118689,3.493155354,TCGA-BJ-A0ZE-01A,TCGA-BJ-A0ZE-01A-11D-A10S-08,11,0.584551314,TCGA-BJ-A0ZE,THCA,63,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-23250,Alive,TUMOR FREE,509,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,509,0,509,NA,NA,0,509,NA,Stage III,T3,M0,THCA.1,8
-6.131257193,3.481118743,TCGA-BJ-A18Y-01A,TCGA-BJ-A18Y-01A-11D-A13W-08,11,0.482640442,TCGA-BJ-A18Y,THCA,29,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-10832,Alive,TUMOR FREE,1563,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1563,0,1563,0,1563,0,1563,NA,Stage I,T1b,MX,THCA.1,8
10.02193227,-1.534598336,TCGA-ET-A3DO-01A,TCGA-ET-A3DO-01A-11D-A19J-08,1,0.870229178,TCGA-ET-A3DO,THCA,33,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-12158,Alive,TUMOR FREE,3552,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,570,[Not Available],0,3552,0,3552,1,570,1,570,NA,Stage I,T2,MX,THCA.4,1
-4.58806428,-1.360748809,TCGA-49-6742-01A,TCGA-49-6742-01A-11D-1855-08,8,0.202805779,TCGA-49-6742,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25839,Dead,WITH TUMOR,NA,488,[Not Available],NA,NA,NA,214,Progressive Disease,1,488,1,488,NA,NA,1,214,NA,Stage IIA,T2a,M0,LUAD.1,10
-6.923417339,2.365742642,TCGA-66-2780-01A,TCGA-66-2780-01A-01D-1522-08,0,NA,TCGA-66-2780,LUSC,65,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-23955,Dead,NA,NA,366,[Not Available],NA,NA,NA,NA,[Not Available],1,366,NA,366,NA,NA,0,366,NA,Stage IB,T2,M0,LUSC.basal,6
10.2202547,-1.679729592,TCGA-E8-A433-01A,TCGA-E8-A433-01A-11D-A23M-08,1,0.804567677,TCGA-E8-A433,THCA,25,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-9145,Alive,TUMOR FREE,951,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,951,0,951,0,951,0,951,NA,Stage I,T2,M0,THCA.4,1
-6.096960561,3.441092246,TCGA-EL-A3GW-01A,TCGA-EL-A3GW-01A-11D-A202-08,11,0.5330549,TCGA-EL-A3GW,THCA,37,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-13670,Alive,TUMOR FREE,1527,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1527,0,1527,0,1527,0,1527,NA,Stage I,T2,M0,THCA.1,8
-6.007563918,1.276691306,TCGA-92-8064-01A,TCGA-92-8064-01A-11D-2244-08,10,0.066430875,TCGA-92-8064,LUSC,58,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-21417,Alive,TUMOR FREE,160,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,160,0,160,0,160,0,160,NA,[Discrepancy],T2b,MX,NA,10
-3.973921124,-2.419065119,TCGA-46-3765-01A,TCGA-46-3765-01A-01D-0983-08,8,0.408116612,TCGA-46-3765,LUSC,59,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-21762,Alive,TUMOR FREE,405,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,405,0,405,0,405,0,405,NA,Stage IA,T1,M0,LUSC.classical,10
-5.558489963,2.09108568,TCGA-78-7166-01A,TCGA-78-7166-01A-12D-2063-08,0,NA,TCGA-78-7166,LUAD,84,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-30869,Dead,NA,NA,258,[Not Available],NA,NA,NA,NA,[Not Available],1,258,NA,258,NA,NA,0,258,NA,Stage IIB,T2,M0,LUAD.1,9
-6.104037026,3.564498668,TCGA-DC-6160-01A,TCGA-DC-6160-01A-11D-1657-10,11,0.532146139,TCGA-DC-6160,READ,68,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-24990,Alive,TUMOR FREE,1339,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,1339,0,1339,NA,NA,0,1339,NA,Stage I,T2,M0,GI.CIN,8
0.863440202,3.807576405,TCGA-G3-A25Z-01A,TCGA-G3-A25Z-01A-11D-A16V-10,0,NA,TCGA-G3-A25Z,LIHC,58,MALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-21509,Alive,TUMOR FREE,655,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,655,0,655,0,655,0,655,NA,Stage I,T1,M0,LIHC.iCluster:3,6
-7.083141557,-1.863036099,TCGA-G3-A25Y-01A,TCGA-G3-A25Y-01A-11D-A16V-10,6,0.028009318,TCGA-G3-A25Y,LIHC,52,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2006,[Not Available],-19055,Dead,WITH TUMOR,NA,452,[Not Available],Locoregional Recurrence,Liver,NA,355,[Not Available],1,452,1,452,1,355,1,355,NA,Stage I,T1,M0,LIHC.iCluster:1,2
1.031365199,3.616506015,TCGA-EI-6508-01A,TCGA-EI-6508-01A-11D-1733-10,0,NA,TCGA-EI-6508,READ,48,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-17827,Alive,TUMOR FREE,636,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,636,0,636,NA,NA,0,636,NA,Stage IIIB,T3,M0,GI.CIN,6
-5.34184938,2.533631502,TCGA-EI-6510-01A,TCGA-EI-6510-01A-11D-1733-10,12,0.38026794,TCGA-EI-6510,READ,77,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-28328,Alive,TUMOR FREE,556,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,556,0,556,NA,NA,0,556,NA,[Discrepancy],T2,MX,GI.GS,8
-3.58818953,-2.701778756,TCGA-AG-3891-01A,TCGA-AG-3891-01A-01W-1073-09,8,0.397388559,TCGA-AG-3891,READ,66,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-24411,Alive,TUMOR FREE,548,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,548,0,548,NA,NA,0,548,NA,Stage I,T2,M0,NA,10
-0.393357925,4.802954192,TCGA-AG-A01J-01A,TCGA-AG-A01J-01A-01W-A00E-09,4,0.310737951,TCGA-AG-A01J,READ,59,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-21581,Alive,WITH TUMOR,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage IIA,T3,M0,NA,6
0.267712864,4.723464014,TCGA-DC-6157-01A,TCGA-DC-6157-01A-11D-1657-10,4,0.48675368,TCGA-DC-6157,READ,48,MALE,BLACK OR AFRICAN AMERICAN,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-17807,Alive,TUMOR FREE,1581,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,1581,0,1581,NA,NA,0,1581,NA,Stage I,T2,M0,GI.CIN,6
-6.015545986,1.445939974,TCGA-AG-3742-01A,TCGA-AG-3742-01A-11D-1657-10,10,0.107899075,TCGA-AG-3742,READ,85,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2004,[Not Available],-31078,Alive,WITH TUMOR,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage I,T1,M0,GI.CIN,9
-3.286867537,1.829577698,TCGA-LG-A6GG-01A,TCGA-LG-A6GG-01A-11D-A30V-10,0,NA,TCGA-LG-A6GG,LIHC,79,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-28871,Alive,TUMOR FREE,387,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,387,0,387,0,387,0,387,NA,Stage II,T2,M0,LIHC.iCluster:3,6
-7.72334886,-2.402572971,TCGA-KR-A7K2-01A,TCGA-KR-A7K2-01A-12D-A33Q-10,6,0.510352501,TCGA-KR-A7K2,LIHC,64,MALE,WHITE,Hepatocholangiocarcinoma (Mixed),G1,2013,[Not Available],-23699,Alive,TUMOR FREE,829,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,829,0,829,0,829,0,829,NA,Stage I,T1,M0,NA,2
2.242697071,1.67455341,TCGA-KR-A7K7-01A,TCGA-KR-A7K7-01A-11D-A33K-10,3,0.329405897,TCGA-KR-A7K7,LIHC,61,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-22587,Alive,WITH TUMOR,951,NA,[Not Available],Extrahepatic Recurrence,"Other, specify",Adrenal bilateral,239,[Not Available],0,951,0,951,1,239,1,239,NA,Stage II,T2,M0,LIHC.iCluster:3,3
0.615326412,2.07193154,TCGA-HP-A5MZ-01A,TCGA-HP-A5MZ-01A-21D-A27I-10,0,NA,TCGA-HP-A5MZ,LIHC,78,MALE,[Not Evaluated],Hepatocellular Carcinoma,G2,NA,[Not Available],-22702,Dead,TUMOR FREE,NA,91,[Not Available],NA,NA,NA,NA,[Not Available],1,91,0,91,0,91,0,91,NA,Stage I,T1,M0,LIHC.iCluster:1,3
9.236340788,-1.768906643,TCGA-KR-A7K0-01A,TCGA-KR-A7K0-01A-12D-A33Q-10,1,0.599931229,TCGA-KR-A7K0,LIHC,65,MALE,WHITE,Hepatocellular Carcinoma,G1,2013,[Not Available],-23974,Dead,TUMOR FREE,NA,65,[Not Available],NA,NA,NA,NA,[Not Available],1,65,0,65,0,65,0,65,NA,Stage I,T1,M0,LIHC.iCluster:2,1
-4.353459472,2.799656199,TCGA-G3-A7M9-01A,TCGA-G3-A7M9-01A-23D-A34Z-10,0,NA,TCGA-G3-A7M9,LIHC,70,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-25588,Dead,NA,NA,56,[Not Available],NA,NA,NA,NA,[Not Available],1,56,NA,56,0,56,0,56,NA,Stage IIIB,T3b,MX,LIHC.iCluster:1,3
-5.647641486,1.228926449,TCGA-AH-6544-01A,TCGA-AH-6544-01A-11D-1826-10,0,NA,TCGA-AH-6544,READ,60,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-21977,Alive,WITH TUMOR,1173,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1173,0,1173,NA,NA,0,1173,NA,[Not Available],T3,M1,GI.CIN,9
-2.907342242,-4.020446947,TCGA-AG-3892-01A,TCGA-AG-3892-01A-01W-1073-09,8,0.110550475,TCGA-AG-3892,READ,57,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-20880,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,396,0,396,0,396,0,396,NA,Stage I,T1,M0,GI.HM-SNV,10
4.328178312,1.187982397,TCGA-CH-5738-01A,TCGA-CH-5738-01A-11D-1576-08,2,0.707903675,TCGA-CH-5738,PRAD,72,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-26329,Alive,TUMOR FREE,212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,212,0,212,0,212,0,212,NA,[Not Applicable],[Discrepancy],[Not Applicable],PRAD.4-FLI1,5
-0.420957685,3.610783341,TCGA-CH-5737-01A,TCGA-CH-5737-01A-11D-1576-08,4,0.265694772,TCGA-CH-5737,PRAD,73,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-26753,Alive,TUMOR FREE,91,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,91,0,91,NA,NA,0,91,NA,[Not Applicable],T2c,[Not Applicable],PRAD.6-FOXA1,6
9.936943892,-1.884422284,TCGA-A3-A8CQ-01A,TCGA-A3-A8CQ-01A-11D-A36X-10,1,0.85065902,TCGA-A3-A8CQ,KIRC,59,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2011,[Not Available],-21572,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,3,0,3,NA,NA,0,3,NA,Stage I,T1a,MX,NA,1
-0.135874489,4.981942355,TCGA-CC-A3MA-01A,TCGA-CC-A3MA-01A-11D-A20W-10,4,0.625204231,TCGA-CC-A3MA,LIHC,61,MALE,ASIAN,Hepatocellular Carcinoma,G2,2011,[Not Available],-22375,Dead,WITH TUMOR,NA,303,[Not Available],Locoregional Recurrence,NA,NA,261,[Not Available],1,303,1,303,1,261,1,261,NA,Stage IIIA,T3,M0,LIHC.iCluster:1,6
9.929085923,-1.572704146,TCGA-44-2661-01A,TCGA-44-2661-01A-01D-1105-08,1,0.774646058,TCGA-44-2661,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-25313,Alive,TUMOR FREE,1159,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1159,0,1159,0,1159,0,1159,NA,Stage IA,T1,M0,NA,1
-6.79774722,-1.631348197,TCGA-CC-5264-01A,TCGA-CC-5264-01A-01D-A12Z-10,0,NA,TCGA-CC-5264,LIHC,71,MALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-25979,Dead,TUMOR FREE,NA,102,[Not Available],NA,NA,NA,NA,[Not Available],1,102,0,102,NA,NA,0,102,NA,Stage IIIA,T3,M0,LIHC.iCluster:3,2
-6.086243623,3.521623752,TCGA-ED-A97K-01A,TCGA-ED-A97K-01A-21D-A382-10,11,0.477918615,TCGA-ED-A97K,LIHC,54,MALE,ASIAN,Hepatocholangiocarcinoma (Mixed),G2,2013,[Not Available],-20073,Alive,TUMOR FREE,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,0,6,0,6,NA,Stage IIIA,T3a,M0,NA,8
4.214252428,1.262464481,TCGA-A3-A8OX-01A,TCGA-A3-A8OX-01A-11D-A36X-10,2,0.554332864,TCGA-A3-A8OX,KIRC,65,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2012,[Not Available],-23998,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,Stage I,T1a,MX,NA,5
9.738633876,-2.899615989,TCGA-EJ-7794-01A,TCGA-EJ-7794-01A-11D-2114-08,1,0.717089695,TCGA-EJ-7794,PRAD,67,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24478,Alive,TUMOR FREE,1306,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1306,0,1306,0,1306,0,1306,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-6.946717221,1.923606907,TCGA-CM-4752-01A,TCGA-CM-4752-01A-01D-1408-10,0,NA,TCGA-CM-4752,COAD,58,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-21519,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,396,0,396,0,396,0,396,NA,Stage IIA,T3,M0,GI.CIN,8
-0.000201217,4.68688296,TCGA-CH-5761-01A,TCGA-CH-5761-01A-11D-1576-08,4,0.615595996,TCGA-CH-5761,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-22433,Alive,TUMOR FREE,28,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,28,0,28,NA,NA,0,28,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,6
-1.895858599,1.038878515,TCGA-EJ-7317-01A,TCGA-EJ-7317-01A-31D-2114-08,5,0.618281483,TCGA-EJ-7317,PRAD,71,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-26064,Alive,TUMOR FREE,771,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,771,0,771,0,771,0,771,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,4
9.79817011,-1.895036173,TCGA-G9-7525-01A,TCGA-G9-7525-01A-31D-2260-08,1,0.808805811,TCGA-G9-7525,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-23481,Alive,TUMOR FREE,994,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,994,0,994,0,994,0,994,NA,[Not Applicable],T2c,[Not Applicable],NA,1
0.015497181,5.228022405,TCGA-HC-7230-01A,TCGA-HC-7230-01A-11D-2114-08,4,0.713399786,TCGA-HC-7230,PRAD,50,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-18577,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1001,0,1001,0,1001,0,1001,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,6
-4.374344161,-1.734638583,TCGA-EB-A1NK-01A,TCGA-EB-A1NK-01A-11D-A196-08,8,0.447445842,TCGA-EB-A1NK,SKCM,48,MALE,WHITE,NA,[Not Available],2010,[Not Available],-17569,Alive,TUMOR FREE,1039,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1039,0,1039,NA,NA,0,1039,NA,Stage IIC,T4b,M0,SKCM.RAS_Hotspot_Mutants,10
9.516848071,-5.634589058,TCGA-G9-6370-01A,TCGA-G9-6370-01A-11D-1786-08,1,0.877493117,TCGA-G9-6370,PRAD,52,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-19149,Alive,TUMOR FREE,1156,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1156,0,1156,0,1156,0,1156,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
2.219525449,1.825185531,TCGA-76-6661-01B,TCGA-76-6661-01B-11D-1845-08,3,0.378884512,TCGA-76-6661,GBM,54,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-19965,Dead,WITH TUMOR,NA,727,[Not Available],NA,NA,NA,NA,[Unknown],1,727,1,727,NA,NA,1,727,NA,NA,NA,NA,NA,3
9.911057794,-1.568760869,TCGA-EJ-7783-01A,TCGA-EJ-7783-01A-11D-2114-08,1,0.862412004,TCGA-EJ-7783,PRAD,70,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25600,Alive,TUMOR FREE,787,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,787,0,787,0,787,0,787,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-6.111898608,-1.502515548,TCGA-AG-A01W-01A,TCGA-AG-A01W-01A-21W-A096-10,0,NA,TCGA-AG-A01W,READ,67,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2004,[Not Available],-24745,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage II,T3,M0,GI.CIN,2
8.870161143,-4.888849535,TCGA-CH-5741-01A,TCGA-CH-5741-01A-11D-1576-08,1,0.805219233,TCGA-CH-5741,PRAD,56,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-20759,Alive,TUMOR FREE,395,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,395,0,395,0,395,0,395,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-8.03579482,1.985096115,TCGA-12-0688-01A,TCGA-12-0688-01A-02D-1492-08,9,0.611408959,TCGA-12-0688,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-27085,Dead,WITH TUMOR,734,811,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],228,[Not Available],1,811,1,811,NA,NA,1,228,NA,NA,NA,NA,NA,7
-0.435228204,4.640509405,TCGA-CC-A3MB-01A,TCGA-CC-A3MB-01A-11D-A20W-10,4,0.478285527,TCGA-CC-A3MB,LIHC,36,MALE,ASIAN,Hepatocellular Carcinoma,G1,2011,[Not Available],-13255,Dead,WITH TUMOR,NA,315,[Not Available],New Primary Tumor,Lung,NA,260,[Not Available],1,315,1,315,0,315,1,260,NA,Stage IIIA,T3,M0,LIHC.iCluster:2,6
-4.279173268,-2.124497738,TCGA-44-8119-01A,TCGA-44-8119-01A-11D-2238-08,8,0.473079878,TCGA-44-8119,LUAD,73,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27003,Alive,TUMOR FREE,285,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,285,0,285,0,285,0,285,NA,Stage IIB,T3,M0,NA,10
-3.871617838,-2.350038125,TCGA-AA-3821-01A,TCGA-AA-3821-01A-01W-0995-10,8,0.442058181,TCGA-AA-3821,COAD,81,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],-29706,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,31,0,31,NA,NA,0,31,NA,Stage I,T2,M0,GI.HM-indel,10
9.141605496,-5.408316462,TCGA-HC-7080-01A,TCGA-HC-7080-01A-11D-1961-08,1,0.845981308,TCGA-HC-7080,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24243,Alive,TUMOR FREE,1106,NA,[Not Available],New Primary Tumor,NA,NA,894,Complete Remission/Response,0,1106,0,1106,0,1106,1,894,NA,[Not Applicable],T2a,[Not Applicable],PRAD.5-SPOP,1
-7.270382474,-2.444573704,TCGA-G9-7521-01A,TCGA-G9-7521-01A-11D-2260-08,6,0.340363247,TCGA-G9-7521,PRAD,52,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-19216,Alive,[Discrepancy],942,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,942,0,942,NA,NA,0,942,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,2
9.347465613,-5.054275805,TCGA-EJ-5508-01A,TCGA-EJ-5508-01A-02D-1576-08,1,0.763210237,TCGA-EJ-5508,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23758,Alive,TUMOR FREE,1965,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1965,0,1965,0,1965,0,1965,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
4.290877354,1.159601313,TCGA-FC-7708-01A,TCGA-FC-7708-01A-11D-2114-08,2,0.640149574,TCGA-FC-7708,PRAD,52,MALE,ASIAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19144,Alive,TUMOR FREE,864,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,864,0,864,0,864,0,864,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,5
-0.169886795,4.956919859,TCGA-EJ-5514-01A,TCGA-EJ-5514-01A-01D-1576-08,4,0.60918726,TCGA-EJ-5514,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-24165,Alive,TUMOR FREE,1829,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1829,0,1829,0,1829,0,1829,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,6
-7.582343781,-2.480529879,TCGA-G9-6336-01A,TCGA-G9-6336-01A-11D-1786-08,6,0.41205678,TCGA-G9-6336,PRAD,57,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-20851,Alive,TUMOR FREE,2068,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2068,0,2068,0,2068,0,2068,NA,[Not Applicable],[Not Available],[Not Applicable],PRAD.1-ERG,2
2.089463344,1.831701243,TCGA-G9-7519-01A,TCGA-G9-7519-01A-11D-2260-08,3,0.515925056,TCGA-G9-7519,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-21276,Alive,TUMOR FREE,849,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,849,0,849,0,849,0,849,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,3
-4.618815851,-0.378116458,TCGA-19-1389-01A,TCGA-19-1389-01A-01W-0643-08,0,NA,TCGA-19-1389,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-18659,Dead,WITH TUMOR,141,141,[Not Available],Recurrence,[Not Applicable],[Not Applicable],81,[Not Available],1,141,1,141,NA,NA,1,81,NA,NA,NA,NA,NA,10
-0.061856515,4.772674771,TCGA-06-6694-01A,TCGA-06-6694-01A-12D-1845-08,4,0.606557466,TCGA-06-6694,GBM,76,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1994,[Not Available],-27909,Dead,WITH TUMOR,224,224,[Not Available],NA,NA,NA,NA,[Not Available],1,224,1,224,NA,NA,1,224,NA,NA,NA,NA,NA,6
9.318586821,-2.39725408,TCGA-CC-A123-01A,TCGA-CC-A123-01A-11D-A12Z-10,1,0.708366868,TCGA-CC-A123,LIHC,24,FEMALE,ASIAN,Hepatocellular Carcinoma,G1,2010,[Not Available],-9107,Alive,WITH TUMOR,219,NA,[Not Available],New Primary Tumor,Lung,NA,145,[Not Available],0,219,0,219,NA,NA,1,145,NA,Stage IIIA,T3,M0,LIHC.NA,1
0.852661616,3.634610307,TCGA-28-1752-01A,TCGA-28-1752-01A-01W-0643-08,0,NA,TCGA-28-1752,GBM,42,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-15565,Alive,WITH TUMOR,258,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,258,0,258,NA,NA,0,258,NA,NA,NA,NA,NA,6
-7.101625253,-2.276063318,TCGA-3P-A9WA-01A,TCGA-3P-A9WA-01A-11D-A403-09,6,0.225731296,TCGA-3P-A9WA,OV,55,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2013,[Not Available],-20211,Alive,TUMOR FREE,420,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,420,0,420,0,420,0,420,NA,Stage IIB,[Not Applicable],[Not Applicable],NA,2
-0.733002033,2.90216246,TCGA-VG-A8LO-01A,TCGA-VG-A8LO-01A-11D-A403-09,4,0.052665868,TCGA-VG-A8LO,OV,55,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,GB,2013,[Not Available],-20274,Dead,WITH TUMOR,NA,24,[Not Available],NA,NA,NA,NA,[Not Applicable],1,24,1,24,NA,NA,1,24,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
-6.062038827,-1.568115658,TCGA-93-7347-01A,TCGA-93-7347-01A-11D-2184-08,0,NA,TCGA-93-7347,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27949,Alive,TUMOR FREE,683,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,683,0,683,0,683,0,683,NA,Stage IA,T1a,MX,LUAD.5,2
9.686185184,-2.216655078,TCGA-G6-A8L7-01A,TCGA-G6-A8L7-01A-11D-A36X-10,1,0.790557121,TCGA-G6-A8L7,KIRC,81,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-29883,Alive,TUMOR FREE,2133,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2133,0,2133,0,2133,0,2133,NA,Stage I,T1b,MX,NA,1
4.286890947,1.11118027,TCGA-MM-A563-01A,TCGA-MM-A563-01A-11D-A25V-10,2,0.710207296,TCGA-MM-A563,KIRC,41,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-15037,Alive,TUMOR FREE,591,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,591,0,591,0,591,0,591,NA,[Discrepancy],T3,MX,NA,5
9.640969992,-1.817419455,TCGA-CH-5744-01A,TCGA-CH-5744-01A-11D-1576-08,1,0.836456985,TCGA-CH-5744,PRAD,64,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23621,Alive,TUMOR FREE,60,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,60,0,60,NA,NA,0,60,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.201484951,-4.294703258,TCGA-MM-A564-01A,TCGA-MM-A564-01A-11D-A25V-10,1,0.742066686,TCGA-MM-A564,KIRC,68,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-24916,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,607,0,607,0,607,0,607,NA,Stage II,T2a,MX,NA,1
-6.989535065,-2.438639491,TCGA-AZ-4681-01A,TCGA-AZ-4681-01A-01D-1408-10,6,0.087588709,TCGA-AZ-4681,COAD,79,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2004,[Not Available],-28906,Alive,TUMOR FREE,3247,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3247,0,3247,0,3247,0,3247,NA,Stage IIA,T3,M0,GI.CIN,2
1.996148622,1.940943681,TCGA-MM-A84U-01A,TCGA-MM-A84U-01A-11D-A36X-10,3,0.474614857,TCGA-MM-A84U,KIRC,58,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2013,[Not Available],-21375,Alive,TUMOR FREE,700,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,700,0,700,0,700,0,700,NA,Stage I,T1a,MX,NA,3
-7.522459377,-2.309354219,TCGA-MW-A4EC-01A,TCGA-MW-A4EC-01A-11D-A25V-10,6,0.421091385,TCGA-MW-A4EC,KIRC,72,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-26649,Alive,TUMOR FREE,498,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,498,0,498,0,498,0,498,NA,Stage I,T1a,MX,NA,2
1.748425665,2.030393677,TCGA-G9-6377-01A,TCGA-G9-6377-01A-11D-1961-08,3,0.288460342,TCGA-G9-6377,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-22419,Alive,TUMOR FREE,958,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,958,0,958,0,958,0,958,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,3
-6.006896207,2.798409621,TCGA-55-8097-01A,TCGA-55-8097-01A-11D-2238-08,0,NA,TCGA-55-8097,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22260,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,476,0,476,0,476,0,476,NA,Stage IA,T1a,MX,NA,8
8.876980414,-4.849764882,TCGA-G9-6365-01A,TCGA-G9-6365-01A-11D-1786-08,1,0.827790201,TCGA-G9-6365,PRAD,71,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-26207,Alive,TUMOR FREE,1363,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1363,0,1363,0,1363,0,1363,NA,[Not Applicable],T4,[Not Applicable],PRAD.1-ERG,1
9.387466847,-5.641115416,TCGA-CH-5764-01A,TCGA-CH-5764-01A-21D-1576-08,1,0.856283451,TCGA-CH-5764,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24257,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.298358404,-3.659200232,TCGA-EJ-5494-01A,TCGA-EJ-5494-01A-01D-1576-08,1,0.719975013,TCGA-EJ-5494,PRAD,50,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-18596,Alive,TUMOR FREE,1477,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1477,0,1477,0,1477,0,1477,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,1
8.853502331,-5.160738114,TCGA-G9-6496-01A,TCGA-G9-6496-01A-11D-1786-08,1,0.840894677,TCGA-G9-6496,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-22602,Alive,TUMOR FREE,1726,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1726,0,1726,0,1726,0,1726,NA,[Not Applicable],T2c,[Not Applicable],NA,1
2.098288263,1.824374896,TCGA-EJ-5510-01A,TCGA-EJ-5510-01A-01D-1576-08,3,0.578764509,TCGA-EJ-5510,PRAD,48,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-17895,Alive,TUMOR FREE,1887,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1887,0,1887,0,1887,0,1887,NA,[Not Applicable],T2c,[Not Applicable],PRAD.2-ETV1,3
8.848495615,-4.819175572,TCGA-EJ-5499-01A,TCGA-EJ-5499-01A-01D-1576-08,1,0.822486789,TCGA-EJ-5499,PRAD,61,MALE,ASIAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-22286,Alive,TUMOR FREE,1415,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1415,0,1415,0,1415,0,1415,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-3.21139763,-3.36556725,TCGA-EB-A431-01A,TCGA-EB-A431-01A-11D-A25O-08,8,0.582884749,TCGA-EB-A431,SKCM,34,MALE,WHITE,NA,[Not Available],2012,[Not Available],-12484,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,568,0,568,NA,NA,0,568,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-7.41823091,1.876422685,TCGA-EJ-5525-01A,TCGA-EJ-5525-01A-01D-1576-08,9,0.181047094,TCGA-EJ-5525,PRAD,67,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-24535,Alive,WITH TUMOR,1115,NA,[Not Available],Distant Metastasis,Bone,NA,546,Progressive Disease,0,1115,0,1115,NA,NA,1,546,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,7
9.224467081,-2.42429285,TCGA-EB-A42Y-01A,TCGA-EB-A42Y-01A-12D-A24R-08,1,0.698727946,TCGA-EB-A42Y,SKCM,73,FEMALE,ASIAN,NA,[Not Available],2012,[Not Available],-26712,Dead,WITH TUMOR,NA,721,[Not Available],Regional lymph node,NA,NA,721,[Not Available],1,721,1,721,NA,NA,1,721,NA,Stage IIC,T4b,M0,SKCM.Triple_WT,1
9.369027545,-5.116703428,TCGA-EJ-7791-01A,TCGA-EJ-7791-01A-11D-2114-08,1,0.846713362,TCGA-EJ-7791,PRAD,67,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24621,Alive,TUMOR FREE,1118,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1118,0,1118,0,1118,0,1118,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
0.065637211,3.33369771,TCGA-12-1600-01A,TCGA-12-1600-01A-01W-0643-08,4,0.408666744,TCGA-12-1600,GBM,86,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-31419,Dead,WITH TUMOR,414,448,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],404,[Not Available],1,448,1,448,NA,NA,1,404,NA,NA,NA,NA,NA,3
4.12295685,1.212540353,TCGA-12-0822-01A,TCGA-12-0822-01A-01W-0424-08,2,0.575917414,TCGA-12-0822,GBM,46,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-16803,Dead,WITH TUMOR,715,715,[Not Available],Recurrence,[Not Applicable],[Not Applicable],91,[Not Available],1,715,1,715,NA,NA,1,91,NA,NA,NA,NA,NA,5
-7.368177862,-2.307119665,TCGA-BW-A5NQ-01A,TCGA-BW-A5NQ-01A-11D-A27I-10,6,0.386687609,TCGA-BW-A5NQ,LIHC,63,MALE,WHITE,Hepatocellular Carcinoma,G3,2010,[Not Available],-23353,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage I,T1,MX,LIHC.iCluster:3,2
-3.411895426,-3.426436959,TCGA-4R-AA8I-01A,TCGA-4R-AA8I-01A-11D-A382-10,8,0.596734604,TCGA-4R-AA8I,LIHC,66,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-24279,Dead,WITH TUMOR,NA,262,[Not Available],Locoregional Recurrence,Liver,NA,158,[Not Available],1,262,1,262,1,158,1,158,NA,Stage II,T2,MX,NA,10
-0.917797416,4.015374599,TCGA-DD-A1EL-01A,TCGA-DD-A1EL-01A-11D-A152-10,4,0.440154528,TCGA-DD-A1EL,LIHC,23,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G3,2009,[Not Available],-8573,Dead,WITH TUMOR,NA,415,[Not Available],NA,NA,NA,NA,[Not Available],1,415,1,415,NA,NA,1,415,NA,Stage II,T2,M0,LIHC.iCluster:3,5
8.278126067,-3.60656551,TCGA-BC-A8YO-01A,TCGA-BC-A8YO-01A-11D-A36X-10,1,0.5948331,TCGA-BC-A8YO,LIHC,66,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2013,[Not Available],-24189,Alive,WITH TUMOR,562,NA,[Not Available],Locoregional Recurrence,Liver,NA,220,[Not Available],0,562,0,562,1,220,1,220,NA,Stage IIIC,T4,M0,NA,1
-6.110077029,-1.258627085,TCGA-50-5944-01A,TCGA-50-5944-01A-11D-1753-08,7,0.275705027,TCGA-50-5944,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25440,Alive,TUMOR FREE,1750,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1750,0,1750,0,1750,0,1750,NA,Stage IA,T1,M0,LUAD.1,2
8.950190428,-2.555587902,TCGA-BC-A10Z-01A,TCGA-BC-A10Z-01A-11D-A12Z-10,1,0.603089734,TCGA-BC-A10Z,LIHC,62,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2003,[Not Available],-22913,Dead,TUMOR FREE,NA,34,[Not Available],NA,NA,NA,NA,[Not Available],1,34,0,34,0,34,0,34,NA,Stage I,T1,MX,LIHC.iCluster:3,6
0.166975912,3.372672194,TCGA-49-4490-01A,TCGA-49-4490-01A-21D-1855-08,4,0.374616807,TCGA-49-4490,LUAD,45,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1993,[Not Available],-16634,Dead,WITH TUMOR,NA,385,[Not Available],NA,NA,NA,NA,[Not Available],1,385,1,385,NA,NA,1,385,NA,Stage IIIA,T3,M0,LUAD.5,3
9.882166084,-1.573177273,TCGA-G6-A8L6-01A,TCGA-G6-A8L6-01A-11D-A36X-10,1,0.860732975,TCGA-G6-A8L6,KIRC,55,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2013,[Not Available],-20306,Dead,WITH TUMOR,NA,313,[Not Available],NA,NA,NA,304,Progressive Disease,1,313,1,313,NA,NA,1,304,NA,Stage IV,T2a,MX,NA,1
4.281247059,1.239608631,TCGA-EJ-7115-01A,TCGA-EJ-7115-01A-11D-2114-08,2,0.623044846,TCGA-EJ-7115,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-23986,Alive,TUMOR FREE,2687,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2687,0,2687,0,2687,0,2687,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,5
9.592857326,-5.716903166,TCGA-EJ-5503-01A,TCGA-EJ-5503-01A-01D-1576-08,1,0.88097121,TCGA-EJ-5503,PRAD,50,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-18395,Alive,TUMOR FREE,1391,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1391,0,1391,0,1391,0,1391,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.912718175,-2.1461695,TCGA-HI-7169-01A,TCGA-HI-7169-01A-11D-2114-08,1,0.703621321,TCGA-HI-7169,PRAD,55,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-20133,Alive,TUMOR FREE,2684,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2684,0,2684,0,2684,0,2684,NA,[Not Applicable],T3a,[Not Applicable],NA,1
8.920909525,-4.694653487,TCGA-EB-A4IQ-01A,TCGA-EB-A4IQ-01A-12D-A25O-08,1,0.825386402,TCGA-EB-A4IQ,SKCM,42,FEMALE,ASIAN,NA,[Not Available],2012,[Not Available],-15516,Dead,TUMOR FREE,NA,636,[Not Available],Locoregional Recurrence|Regional lymph node,[Not Available]|[Not Available],[Not Applicable]|[Not Applicable],337,[Not Available],1,636,0,636,NA,NA,1,337,NA,Stage IIIB,T4b,M0,SKCM.Triple_WT,1
9.978087222,-1.716991663,TCGA-H9-7775-01A,TCGA-H9-7775-01A-11D-2114-08,1,0.803224096,TCGA-H9-7775,PRAD,68,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24898,Alive,TUMOR FREE,185,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,185,0,185,0,185,0,185,NA,[Not Applicable],T2c,[Not Applicable],PRAD.4-FLI1,1
9.76326879,-4.219098268,TCGA-EJ-7784-01A,TCGA-EJ-7784-01A-11D-2114-08,1,0.661299952,TCGA-EJ-7784,PRAD,63,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23183,Alive,TUMOR FREE,781,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,781,0,781,0,781,0,781,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.351192447,-5.565913134,TCGA-HC-7079-01A,TCGA-HC-7079-01A-11D-1961-08,1,0.875431433,TCGA-HC-7079,PRAD,51,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-18734,Alive,WITH TUMOR,1184,NA,[Not Available],Biochemical evidence of disease,NA,NA,380,Partial Remission/Response,0,1184,0,1184,NA,NA,1,380,NA,[Not Applicable],T3a,[Not Applicable],PRAD.4-FLI1,1
8.009273797,-3.90412297,TCGA-CH-5768-01A,TCGA-CH-5768-01A-11D-1576-08,1,0.526925379,TCGA-CH-5768,PRAD,72,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-26480,Alive,TUMOR FREE,731,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,731,0,731,0,731,0,731,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,3
-0.166186541,4.753126773,TCGA-HC-7213-01A,TCGA-HC-7213-01A-11D-2114-08,4,0.604989853,TCGA-HC-7213,PRAD,53,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-19699,Alive,TUMOR FREE,1219,NA,[Not Available],Biochemical evidence of disease,NA,NA,170,Partial Remission/Response,0,1219,0,1219,NA,NA,1,170,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,6
8.245560266,-3.92693067,TCGA-CH-5790-01A,TCGA-CH-5790-01A-11D-1576-08,1,0.55490489,TCGA-CH-5790,PRAD,64,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-23529,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,974,0,974,0,974,0,974,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
4.248359819,1.248038212,TCGA-MA-AA43-01A,TCGA-MA-AA43-01A-11D-A42O-09,2,0.604394918,TCGA-MA-AA43,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2013,Peri (6-12 months since last menstrual period),-17658,Alive,TUMOR FREE,346,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,346,0,346,0,346,0,346,NA,Stage IIIB,T3b,MX,NA,5
-4.223820982,-1.331648018,TCGA-MA-AA42-01A,TCGA-MA-AA42-01A-12D-A387-09,8,0.264264583,TCGA-MA-AA42,CESC,75,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27460,Alive,TUMOR FREE,259,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,259,0,259,0,259,0,259,NA,Stage IIB,T2b,M0,NA,10
-3.758681059,-2.45478161,TCGA-MA-AA41-01A,TCGA-MA-AA41-01A-11D-A387-09,8,0.417551861,TCGA-MA-AA41,CESC,33,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12398,Alive,WITH TUMOR,279,NA,NA,NA,NA,NA,NA,Progressive Disease,0,279,0,279,NA,NA,0,279,NA,Stage IIB,T2,M1,NA,10
-3.934105599,0.83307707,TCGA-MA-AA3Z-01A,TCGA-MA-AA3Z-01A-11D-A387-09,0,NA,TCGA-MA-AA3Z,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15762,Alive,TUMOR FREE,595,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,595,0,595,0,595,0,595,NA,Stage IB2,T1b2,M0,NA,10
-2.933329199,2.138655347,TCGA-VS-A9U7-01A,TCGA-VS-A9U7-01A-11D-A42O-09,0,NA,TCGA-VS-A9U7,CESC,30,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11210,Alive,TUMOR FREE,1472,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1472,0,1472,0,1472,0,1472,NA,Stage IB1,T1b,M0,NA,6
-3.754820272,-2.577003142,TCGA-VS-A9U6-01A,TCGA-VS-A9U6-01A-11D-A42O-09,8,0.454727692,TCGA-VS-A9U6,CESC,52,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19109,Alive,WITH TUMOR,1320,NA,NA,Distant Metastasis,NA,Diaphragm,711,Stable Disease,0,1320,0,1320,NA,NA,1,711,NA,Stage IVB,T4,M1,NA,10
-7.693427799,1.966614278,TCGA-AD-6890-01A,TCGA-AD-6890-01A-11D-1924-10,9,0.604748664,TCGA-AD-6890,COAD,65,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-23769,Alive,TUMOR FREE,746,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,746,0,746,0,746,0,746,NA,[Not Available],T1,MX,GI.CIN,7
-3.859897843,-2.568627969,TCGA-VS-A953-01A,TCGA-VS-A953-01A-11D-A387-09,8,0.400560399,TCGA-VS-A953,CESC,63,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,GX,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23277,Dead,WITH TUMOR,NA,477,Cervical Cancer,NA,NA,NA,NA,Partial Remission/Response,1,477,1,477,NA,NA,1,477,NA,Stage IVA,T4,MX,NA,10
-7.734732991,-2.350060015,TCGA-VS-A94W-01A,TCGA-VS-A94W-01A-12D-A37N-09,6,0.460418705,TCGA-VS-A94W,CESC,39,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14399,Alive,TUMOR FREE,1243,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1243,0,1243,0,1243,0,1243,NA,Stage IIB,T2b,MX,NA,2
-6.544323135,-1.838111508,TCGA-MA-AA3Y-01A,TCGA-MA-AA3Y-01A-11D-A387-09,0,NA,TCGA-MA-AA3Y,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17795,Alive,TUMOR FREE,542,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,542,0,542,0,542,0,542,NA,Stage IB1,T1b1,M0,NA,10
-7.159200262,2.103993445,TCGA-G4-6295-01A,TCGA-G4-6295-01A-11D-1719-10,9,0.055630977,TCGA-G4-6295,COAD,70,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2004,[Not Available],-25758,Alive,TUMOR FREE,254,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,254,0,254,NA,NA,0,254,NA,Stage II,T3,M0,GI.CIN,9
-7.086137543,1.81702762,TCGA-MA-AA3X-01A,TCGA-MA-AA3X-01A-22D-A42O-09,0,NA,TCGA-MA-AA3X,CESC,50,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18412,Alive,TUMOR FREE,617,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,617,0,617,0,617,0,617,NA,Stage IIIB,T3b,MX,NA,7
8.996176219,-4.448329198,TCGA-MA-AA3W-01A,TCGA-MA-AA3W-01A-11D-A387-09,1,0.822907329,TCGA-MA-AA3W,CESC,54,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20066,Alive,TUMOR FREE,685,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,685,0,685,0,685,0,685,NA,Stage IB1,T1b1,M0,NA,1
8.938101838,-3.783390891,TCGA-UZ-A9PZ-01A,TCGA-UZ-A9PZ-01A-11D-A42J-10,1,0.655753341,TCGA-UZ-A9PZ,KIRP,65,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-23741,Alive,TUMOR FREE,657,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,657,0,657,0,657,0,657,NA,Stage III,T3a,MX,NA,1
-0.090273994,3.927692811,TCGA-UZ-A9PX-01A,TCGA-UZ-A9PX-01A-11D-A42J-10,4,0.320965327,TCGA-UZ-A9PX,KIRP,73,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-26663,Alive,TUMOR FREE,1981,NA,[Not Available],NA,NA,NA,308,Complete Remission/Response,0,1981,0,1981,1,308,1,308,NA,Stage I,T1,MX,NA,10
9.088818406,-3.79924036,TCGA-UZ-A9PV-01A,TCGA-UZ-A9PV-01A-11D-A42J-10,1,0.663923875,TCGA-UZ-A9PV,KIRP,65,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-23741,Alive,TUMOR FREE,1444,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1444,0,1444,0,1444,0,1444,NA,Stage I,T1,MX,NA,1
-6.397685028,-1.440870289,TCGA-4J-AA1J-01A,TCGA-4J-AA1J-01A-21D-A387-09,7,0.277722496,TCGA-4J-AA1J,CESC,31,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11611,Alive,TUMOR FREE,542,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,542,0,542,0,542,0,542,NA,Stage IB2,T1b2,M0,NA,2
-0.36599048,4.371782385,TCGA-V9-A7HT-01A,TCGA-V9-A7HT-01A-11D-A33Q-10,4,0.507482214,TCGA-V9-A7HT,KIRP,67,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-24610,Alive,TUMOR FREE,965,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,965,0,965,0,965,0,965,NA,Stage II,T2,MX,NA,6
-0.409962329,2.49429242,TCGA-UZ-A9Q1-01A,TCGA-UZ-A9Q1-01A-11D-A42J-10,4,0.15309638,TCGA-UZ-A9Q1,KIRP,88,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-32142,Alive,TUMOR FREE,1562,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1562,0,1562,0,1562,0,1562,NA,Stage I,T1b,MX,NA,3
1.165756915,3.390518403,TCGA-UZ-A9Q0-01A,TCGA-UZ-A9Q0-01A-12D-A42J-10,0,NA,TCGA-UZ-A9Q0,KIRP,60,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-21915,Alive,TUMOR FREE,3368,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3368,0,3368,0,3368,0,3368,NA,Stage I,T1,MX,NA,1
-6.47070195,-1.180235186,TCGA-F4-6855-01A,TCGA-F4-6855-01A-11D-1924-10,7,0.349208759,TCGA-F4-6855,COAD,70,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-25890,Alive,TUMOR FREE,1442,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1442,0,1442,0,1442,0,1442,NA,Stage IIA,T3,M0,GI.GS,2
7.794473312,-1.451210698,TCGA-UZ-A9PU-01A,TCGA-UZ-A9PU-01A-11D-A42J-10,1,0.197498005,TCGA-UZ-A9PU,KIRP,77,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-28124,Dead,TUMOR FREE,NA,933,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,933,0,933,0,933,0,933,NA,Stage I,T1b,MX,NA,1
-6.788817876,-2.354581913,TCGA-UZ-A9PS-01A,TCGA-UZ-A9PS-01A-11D-A42J-10,6,0.099911731,TCGA-UZ-A9PS,KIRP,62,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-22646,Alive,TUMOR FREE,2167,NA,[Not Available],NA,NA,NA,55,Complete Remission/Response,0,2167,0,2167,1,55,1,55,NA,Stage II,T2,MX,NA,2
7.695613988,-1.246605739,TCGA-UZ-A9PR-01A,TCGA-UZ-A9PR-01A-11D-A42J-10,1,0.095627387,TCGA-UZ-A9PR,KIRP,84,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-30681,Alive,TUMOR FREE,2627,NA,[Not Available],NA,NA,NA,2494,Complete Remission/Response,0,2627,0,2627,1,2494,1,2494,NA,Stage I,T1b,MX,NA,1
2.585486532,2.672491246,TCGA-UZ-A9PN-01A,TCGA-UZ-A9PN-01A-11D-A382-10,3,0.001130506,TCGA-UZ-A9PN,KIRP,54,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-19724,Dead,WITH TUMOR,NA,1136,[Not Available],NA,NA,NA,679,Complete Remission/Response,1,1136,1,1136,1,679,1,679,NA,Stage III,T3,MX,NA,3
1.391081922,3.259050071,TCGA-UZ-A9PM-01A,TCGA-UZ-A9PM-01A-21D-A382-10,0,NA,TCGA-UZ-A9PM,KIRP,62,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-22646,Alive,TUMOR FREE,3811,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3811,0,3811,0,3811,0,3811,NA,Stage II,T2,MX,NA,1
8.474398721,-4.206616895,TCGA-UZ-A9PL-01A,TCGA-UZ-A9PL-01A-11D-A382-10,1,0.622454105,TCGA-UZ-A9PL,KIRP,59,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-21550,Alive,TUMOR FREE,3152,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3152,0,3152,0,3152,0,3152,NA,Stage II,T2,MX,NA,1
-3.146282553,-3.577857432,TCGA-AA-3715-01A,TCGA-AA-3715-01A-01W-0900-09,8,0.577605805,TCGA-AA-3715,COAD,77,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-28428,Dead,WITH TUMOR,NA,579,[Not Available],NA,NA,NA,153,[Unknown],1,579,1,579,NA,NA,1,153,NA,Stage II,T3,M0,GI.HM-indel,10
2.36708835,1.884787689,TCGA-UZ-A9PP-01A,TCGA-UZ-A9PP-01A-11D-A42J-10,3,0.093602707,TCGA-UZ-A9PP,KIRP,60,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-21915,Alive,TUMOR FREE,3010,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3010,0,3010,0,3010,0,3010,NA,Stage I,T1a,MX,NA,3
9.044305416,-4.903947784,TCGA-UZ-A9PO-01A,TCGA-UZ-A9PO-01A-11D-A382-10,1,0.831503478,TCGA-UZ-A9PO,KIRP,80,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-29220,Alive,TUMOR FREE,1911,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1911,0,1911,0,1911,0,1911,NA,Stage I,T1a,MX,NA,1
-3.150516906,-3.596173717,TCGA-AA-3663-01A,TCGA-AA-3663-01A-01D-1719-10,8,0.51428687,TCGA-AA-3663,COAD,42,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-15675,Alive,TUMOR FREE,212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,212,0,212,0,212,0,212,NA,Stage II,T3,M0,GI.HM-indel,10
-5.225580773,2.360905251,TCGA-CM-6166-01A,TCGA-CM-6166-01A-11D-1650-10,12,0.16868551,TCGA-CM-6166,COAD,48,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-17807,Alive,TUMOR FREE,669,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,669,0,669,NA,NA,0,669,NA,Stage I,T2,M0,GI.CIN,8
0.902193133,3.539997827,TCGA-AA-3693-01A,TCGA-AA-3693-01A-01W-0900-09,0,NA,TCGA-AA-3693,COAD,77,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-28459,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IV,T4,M1,GI.CIN,6
9.035089489,-5.346012474,TCGA-AA-3521-01A,TCGA-AA-3521-01A-01D-1953-10,1,0.766813628,TCGA-AA-3521,COAD,87,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-31805,Alive,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage II,T3,M0,NA,1
-5.100155684,2.453222346,TCGA-F4-6854-01A,TCGA-F4-6854-01A-11D-1924-10,12,0.258253025,TCGA-F4-6854,COAD,77,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-28272,Alive,TUMOR FREE,16,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,16,0,16,0,16,0,16,NA,Stage IIA,T3,M0,GI.CIN,10
-5.854116251,2.861298453,TCGA-AA-3506-01A,TCGA-AA-3506-01A-01D-2188-10,0,NA,TCGA-AA-3506,COAD,77,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2004,[Not Available],-28275,Alive,WITH TUMOR,1765,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1765,0,1765,NA,NA,0,1765,NA,Stage I,T2,M0,GI.GS,8
-7.383368215,2.372055098,TCGA-AA-3842-01A,TCGA-AA-3842-01A-01W-0995-10,9,0.162747205,TCGA-AA-3842,COAD,51,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-18842,Alive,TUMOR FREE,1126,NA,[Not Available],NA,NA,NA,396,Complete Remission/Response,0,1126,0,1126,1,396,1,396,NA,Stage IIIA,T2,M0,GI.CIN,7
-5.170967604,2.236140127,TCGA-AA-3976-01A,TCGA-AA-3976-01A-01W-0995-10,12,0.120856848,TCGA-AA-3976,COAD,70,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-25599,Alive,WITH TUMOR,791,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,791,0,791,0,791,0,791,NA,Stage IIIA,T2,M0,GI.CIN,8
-5.957740574,1.423175903,TCGA-G4-6306-01A,TCGA-G4-6306-01A-11D-1771-10,10,0.111930526,TCGA-G4-6306,COAD,71,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-26163,Alive,TUMOR FREE,1359,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1359,0,1359,NA,NA,0,1359,NA,[Discrepancy],T2,M0,GI.CIN,9
9.768254084,-1.450763448,TCGA-MK-A4N6-01A,TCGA-MK-A4N6-01A-11D-A257-08,1,0.761646453,TCGA-MK-A4N6,THCA,35,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-12904,Alive,TUMOR FREE,1098,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1098,0,1098,0,1098,0,1098,NA,Stage I,T3,M0,THCA.4,1
-6.418276441,1.628887864,TCGA-14-1456-01B,TCGA-14-1456-01B-01D-1494-08,10,0.272951615,TCGA-14-1456,GBM,23,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-8710,Alive,WITH TUMOR,1246,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],98,[Not Available],0,1246,0,1246,NA,NA,1,98,NA,NA,NA,NA,NA,7
10.08686772,-1.479038791,TCGA-ET-A2MZ-01A,TCGA-ET-A2MZ-01A-12D-A19J-08,1,0.817079029,TCGA-ET-A2MZ,THCA,39,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-14408,Alive,TUMOR FREE,1133,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1133,0,1133,NA,NA,0,1133,NA,Stage I,T1b,MX,THCA.5,1
-7.785712735,-2.414532802,TCGA-EL-A3GX-01A,TCGA-EL-A3GX-01A-11D-A202-08,6,0.531848088,TCGA-EL-A3GX,THCA,41,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000,[Not Available],-15212,Alive,TUMOR FREE,4494,NA,[Not Available],Locoregional Recurrence,"Other, specify",Left Thyroid Bed,439,[Not Available],0,4494,0,4494,1,439,1,439,NA,Stage I,T2,M0,THCA.4,2
9.369947704,-4.987215508,TCGA-DJ-A2PO-01A,TCGA-DJ-A2PO-01A-21D-A19J-08,1,0.83204876,TCGA-DJ-A2PO,THCA,54,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-20058,Alive,TUMOR FREE,243,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,243,0,243,0,243,0,243,NA,Stage I,T1a,M0,THCA.2,1
8.149980017,-4.435063163,TCGA-FY-A40N-01A,TCGA-FY-A40N-01A-11D-A23M-08,1,0.573027575,TCGA-FY-A40N,THCA,55,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-20320,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,579,0,579,0,579,0,579,NA,Stage I,T1a,MX,THCA.2,1
8.738121187,-4.746076367,TCGA-DJ-A3UZ-01A,TCGA-DJ-A3UZ-01A-11D-A22Z-08,1,0.796436037,TCGA-DJ-A3UZ,THCA,70,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-25846,Alive,TUMOR FREE,1246,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1246,0,1246,0,1246,0,1246,NA,Stage III,T3,M0,THCA.2,1
9.433767343,-5.543583354,TCGA-EM-A2CO-01A,TCGA-EM-A2CO-01A-11D-A19J-08,1,0.856140758,TCGA-EM-A2CO,THCA,77,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-28424,Alive,TUMOR FREE,184,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,184,0,184,0,184,0,184,NA,Stage II,T2,MX,THCA.1,1
8.980482159,-3.414981583,TCGA-EL-A3TB-01A,TCGA-EL-A3TB-01A-11D-A22D-08,1,0.715954687,TCGA-EL-A3TB,THCA,47,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-17195,Alive,TUMOR FREE,2519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2519,0,2519,0,2519,0,2519,NA,Stage III,T3,M0,THCA.5,1
10.07961615,-1.581844613,TCGA-FE-A234-01A,TCGA-FE-A234-01A-11D-A14W-08,1,0.870914205,TCGA-FE-A234,THCA,26,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-9724,Alive,WITH TUMOR,2075,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,483,[Not Available],0,2075,0,2075,1,483,1,483,NA,Stage I,T2,MX,THCA.4,1
-4.57533914,0.206773045,TCGA-22-4604-01A,TCGA-22-4604-01A-01D-1267-08,0,NA,TCGA-22-4604,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-26952,Dead,WITH TUMOR,NA,399,[Not Available],NA,NA,NA,306,[Not Available],1,399,1,399,NA,NA,1,306,NA,Stage IIA,T2a,M0,LUSC.classical,10
4.302251129,1.179291592,TCGA-60-2707-01A,TCGA-60-2707-01A-01D-1522-08,2,0.691961909,TCGA-60-2707,LUSC,70,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-25758,Dead,WITH TUMOR,NA,667,[Not Available],NA,NA,NA,579,Complete Remission/Response,1,667,1,667,1,579,1,579,NA,Stage IB,T2,M0,LUSC.basal,5
-0.953028145,4.558720886,TCGA-CV-5966-01A,TCGA-CV-5966-01A-11D-1683-08,4,0.42767645,TCGA-CV-5966,HNSC,63,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2005,[Not Available],-23119,Dead,TUMOR FREE,NA,545,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,545,0,545,NA,NA,0,545,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,6
4.446715965,1.096679176,TCGA-15-0742-01A,TCGA-15-0742-01A-01D-1492-08,2,0.372371769,TCGA-15-0742,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-24050,Dead,NA,NA,419,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],232,[Not Available],1,419,NA,419,NA,NA,1,232,NA,NA,NA,NA,GBM_LGG.NA,5
4.364994376,1.233179252,TCGA-F7-8298-01A,TCGA-F7-8298-01A-11D-2394-08,2,0.48880289,TCGA-F7-8298,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-21445,Alive,TUMOR FREE,995,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,995,0,995,0,995,0,995,NA,Stage I,T1,M0,NA,1
9.79973573,-1.966442264,TCGA-DJ-A13O-01A,TCGA-DJ-A13O-01A-11D-A10S-08,1,0.802377106,TCGA-DJ-A13O,THCA,56,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-20779,Alive,TUMOR FREE,1161,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1161,0,1161,0,1161,0,1161,NA,Stage I,T1b,M0,THCA.2,1
9.669018218,-4.740580218,TCGA-06-5414-01A,TCGA-06-5414-01A-01D-1486-08,1,0.747652608,TCGA-06-5414,GBM,61,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-22527,Alive,WITH TUMOR,273,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],167,[Not Available],0,273,0,273,NA,NA,1,167,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-1.805170523,1.054473756,TCGA-ET-A3BO-01A,TCGA-ET-A3BO-01A-11D-A19J-08,5,0.571794638,TCGA-ET-A3BO,THCA,44,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010,[Not Available],-16110,Alive,TUMOR FREE,1533,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1533,0,1533,NA,NA,0,1533,NA,Stage I,T3,MX,THCA.4,4
4.413501671,1.068882877,TCGA-EL-A3CS-01A,TCGA-EL-A3CS-01A-21D-A19J-08,2,0.719609833,TCGA-EL-A3CS,THCA,62,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-22993,Dead,WITH TUMOR,NA,1385,[Not Available],NA,NA,NA,NA,[Not Available],1,1385,1,1385,NA,NA,1,1385,NA,Stage IVA,T4a,M0,THCA.3,5
-7.962997501,2.032177391,TCGA-E1-A7YS-01A,TCGA-E1-A7YS-01A-11D-A34A-08,9,0.65985492,TCGA-E1-A7YS,LGG,71,MALE,BLACK OR AFRICAN AMERICAN,Oligodendroglioma,G3,2007,[Not Available],-26159,Dead,WITH TUMOR,NA,466,[Not Available],NA,NA,NA,NA,Stable Disease,1,466,1,466,NA,NA,1,466,NA,NA,NA,NA,GBM_LGG.Codel,7
9.550595624,-5.660832598,TCGA-J8-A4HW-01A,TCGA-J8-A4HW-01A-11D-A257-08,1,0.882474297,TCGA-J8-A4HW,THCA,59,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-21587,Alive,TUMOR FREE,79,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,79,0,79,0,79,0,79,NA,Stage III,T2,M0,THCA.3,1
10.09641998,-1.756867197,TCGA-EM-A22P-01A,TCGA-EM-A22P-01A-11D-A19J-08,1,0.876498559,TCGA-EM-A22P,THCA,64,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-23723,Alive,TUMOR FREE,1256,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1256,0,1256,NA,NA,0,1256,NA,Stage IVA,T1b,MX,THCA.4,1
9.581027032,-2.142676155,TCGA-EM-A3O8-01A,TCGA-EM-A3O8-01A-11D-A21Z-08,1,0.783810734,TCGA-EM-A3O8,THCA,33,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-12405,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,381,0,381,0,381,0,381,NA,Stage I,T1b,MX,THCA.1,1
10.20645532,-1.914015341,TCGA-EM-A22O-01A,TCGA-EM-A22O-01A-11D-A17V-08,1,0.691337193,TCGA-EM-A22O,THCA,75,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-27758,Alive,TUMOR FREE,1344,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1344,0,1344,NA,NA,0,1344,NA,Stage IVA,T4a,MX,THCA.3,1
-6.873281542,-2.108947064,TCGA-21-1081-01A,TCGA-21-1081-01A-01D-1521-08,6,0.200674515,TCGA-21-1081,LUSC,69,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1996,[Not Available],-25440,Dead,WITH TUMOR,284,284,[Not Available],NA,NA,NA,NA,[Not Available],1,284,1,284,NA,NA,1,284,NA,Stage IIB,T2,M0,LUSC.basal,2
9.530423388,-5.608688663,TCGA-DJ-A4V0-01A,TCGA-DJ-A4V0-01A-11D-A257-08,1,0.884867654,TCGA-DJ-A4V0,THCA,36,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-13168,Alive,TUMOR FREE,1081,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1081,0,1081,0,1081,0,1081,NA,Stage I,T2,M0,THCA.2,1
-0.348755212,4.379464314,TCGA-E1-A7YK-01A,TCGA-E1-A7YK-01A-11D-A34A-08,4,0.529266932,TCGA-E1-A7YK,LGG,52,MALE,WHITE,Astrocytoma,G3,2009,[Not Available],-19236,Dead,NA,NA,378,[Not Available],NA,NA,NA,NA,Stable Disease,1,378,NA,378,NA,NA,0,378,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-6.116752375,-1.286466651,TCGA-44-6778-01A,TCGA-44-6778-01A-11D-1855-08,7,0.102413388,TCGA-44-6778,LUAD,59,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-21725,Alive,TUMOR FREE,1864,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1864,0,1864,0,1864,0,1864,NA,Stage IA,T1,MX,NA,10
-6.283085069,-2.024990544,TCGA-98-8022-01A,TCGA-98-8022-01A-11D-2244-08,0,NA,TCGA-98-8022,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-22487,Dead,TUMOR FREE,NA,933,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,933,0,933,0,933,0,933,NA,Stage IA,T1a,M0,NA,2
8.678615127,-1.900389536,TCGA-E1-A7YQ-01A,TCGA-E1-A7YQ-01A-11D-A34J-08,1,0.57575971,TCGA-E1-A7YQ,LGG,58,FEMALE,BLACK OR AFRICAN AMERICAN,Oligodendroglioma,G3,2000,[Not Available],-21341,Dead,WITH TUMOR,NA,1578,[Not Available],NA,NA,NA,580,Stable Disease,1,1578,1,1578,NA,NA,1,580,NA,NA,NA,NA,GBM_LGG.Classic-like,1
8.897426473,-4.948409257,TCGA-E1-A7YO-01A,TCGA-E1-A7YO-01A-11D-A34A-08,1,0.827932867,TCGA-E1-A7YO,LGG,45,MALE,WHITE,Oligodendroglioma,G3,1995,[Not Available],-16770,Dead,WITH TUMOR,NA,2282,[Not Available],NA,NA,NA,1977,Stable Disease,1,2282,1,2282,NA,NA,1,1977,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.197587627,1.103668696,TCGA-60-2710-01A,TCGA-60-2710-01A-01D-1522-08,0,NA,TCGA-60-2710,LUSC,67,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-24669,Alive,TUMOR FREE,2024,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2024,0,2024,0,2024,0,2024,NA,Stage IIA,T1,M0,LUSC.classical,6
-2.921534108,1.606589645,TCGA-CV-7415-01A,TCGA-CV-7415-01A-11D-2078-08,0,NA,TCGA-CV-7415,HNSC,60,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1995,[Not Available],-22062,Dead,WITH TUMOR,NA,695,[Not Available],NA,NA,NA,NA,[Not Available],1,695,1,695,NA,NA,1,695,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,10
-0.128085304,4.582548993,TCGA-E1-A7YH-01A,TCGA-E1-A7YH-01A-11D-A34A-08,4,0.538185646,TCGA-E1-A7YH,LGG,47,FEMALE,WHITE,Astrocytoma,G3,2005,[Not Available],-17465,Dead,WITH TUMOR,NA,2835,[Not Available],NA,NA,NA,689,Stable Disease,1,2835,1,2835,NA,NA,1,689,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.925347289,1.890454528,TCGA-E1-A7YD-01A,TCGA-E1-A7YD-01A-11D-A34A-08,0,NA,TCGA-E1-A7YD,LGG,57,MALE,WHITE,Astrocytoma,G3,1998,[Not Available],-21020,Dead,WITH TUMOR,NA,435,[Not Available],NA,NA,NA,284,Stable Disease,1,435,1,435,NA,NA,1,284,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
0.360010935,3.449176148,TCGA-QS-A8F1-01A,TCGA-QS-A8F1-01A-21D-A37N-09,4,0.27345321,TCGA-QS-A8F1,UCEC,85,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31386,Dead,WITH TUMOR,NA,135,[Not Available],NA,NA,NA,NA,Progressive Disease,1,135,1,135,NA,NA,1,135,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,3
-1.570559685,3.195212386,TCGA-QS-A744-01A,TCGA-QS-A744-01A-11D-A34Q-09,2,0.074433881,TCGA-QS-A744,UCEC,86,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31520,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,451,0,451,NA,NA,0,451,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,5
-6.226438546,1.339866873,TCGA-KP-A3W3-01A,TCGA-KP-A3W3-01A-11D-A228-09,10,0.25981325,TCGA-KP-A3W3,UCEC,72,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26310,Alive,WITH TUMOR,794,NA,[Not Available],Distant Metastasis,Liver,NA,661,Complete Remission/Response,0,794,0,794,1,661,1,661,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
0.490573124,2.241852052,TCGA-85-6175-01A,TCGA-85-6175-01A-11D-1817-08,0,NA,TCGA-85-6175,LUSC,63,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-23228,Dead,WITH TUMOR,NA,294,[Not Available],NA,NA,NA,NA,Stable Disease,1,294,1,294,NA,NA,1,294,NA,Stage IIB,T3,M0,LUSC.secretory,6
0.165571683,5.154645322,TCGA-SL-A6J9-01A,TCGA-SL-A6J9-01A-11D-A31U-09,4,0.562524187,TCGA-SL-A6J9,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26701,Alive,NA,2,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2,0,2,NA,NA,0,2,NA,Stage IB,[Not Applicable],[Not Applicable],NA,6
9.428916334,-2.624236972,TCGA-SJ-A6ZJ-01A,TCGA-SJ-A6ZJ-01A-12D-A34Q-09,1,0.744697221,TCGA-SJ-A6ZJ,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22597,Alive,TUMOR FREE,556,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,556,0,556,0,556,0,556,NA,Stage IB,[Not Applicable],[Not Applicable],NA,1
-3.110849536,-3.732767624,TCGA-SJ-A6ZI-01A,TCGA-SJ-A6ZI-01A-12D-A34Q-09,8,0.401039717,TCGA-SJ-A6ZI,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2013,[Unknown],-23653,Alive,TUMOR FREE,631,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,631,0,631,0,631,0,631,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-7.923163512,2.089172916,TCGA-21-1071-01A,TCGA-21-1071-01A-01D-1521-08,9,0.528673436,TCGA-21-1071,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-24515,Dead,WITH TUMOR,1426,1426,[Not Available],NA,NA,NA,993,[Not Available],1,1426,1,1426,NA,NA,1,993,NA,Stage IB,T2,M0,LUSC.classical,7
4.335366208,1.013826102,TCGA-FD-A3B4-01A,TCGA-FD-A3B4-01A-12D-A202-08,2,0.52369013,TCGA-FD-A3B4,BLCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-20379,Dead,WITH TUMOR,NA,510,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Left posterior pelvic wall,359,Complete Remission/Response,1,510,1,510,1,359,1,359,NA,Stage III,T4a,MX,NA,3
9.730710945,-2.412315844,TCGA-CR-7369-01A,TCGA-CR-7369-01A-11D-2129-08,1,0.752835976,TCGA-CR-7369,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-21897,Dead,TUMOR FREE,NA,1090,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1090,0,1090,NA,NA,0,1090,NA,Stage IVA,T4a,M0,HNSC.Atypical,1
-7.63787176,2.040270993,TCGA-12-0819-01A,TCGA-12-0819-01A-01W-0424-08,9,0.375116962,TCGA-12-0819,GBM,49,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],1995,[Not Available],-18160,Dead,WITH TUMOR,754,754,[Not Available],Recurrence,[Not Applicable],[Not Applicable],428,[Not Available],1,754,1,754,NA,NA,1,428,NA,NA,NA,NA,NA,7
-0.5688743,3.58229733,TCGA-KP-A3W1-01A,TCGA-KP-A3W1-01A-11D-A228-09,4,0.266125609,TCGA-KP-A3W1,UCEC,76,FEMALE,[Not Evaluated],Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27902,Alive,TUMOR FREE,288,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,288,0,288,0,288,0,288,NA,Stage IA,[Not Applicable],[Not Applicable],NA,6
-4.439896128,1.774984226,TCGA-KP-A3W0-01A,TCGA-KP-A3W0-01A-21D-A228-09,0,NA,TCGA-KP-A3W0,UCEC,72,FEMALE,[Not Evaluated],Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26378,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,404,0,404,0,404,0,404,NA,Stage IB,[Not Applicable],[Not Applicable],NA,8
-1.169304937,3.850760533,TCGA-KP-A3VZ-01A,TCGA-KP-A3VZ-01A-11D-A228-09,4,0.291213982,TCGA-KP-A3VZ,UCEC,69,FEMALE,WHITE,Serous endometrial adenocarcinoma,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25366,Alive,WITH TUMOR,722,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,722,0,722,NA,NA,0,722,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
-3.1357956,-3.665752679,TCGA-DF-A2KV-01A,TCGA-DF-A2KV-01A-11D-A17W-09,8,0.495372696,TCGA-DF-A2KV,UCEC,55,FEMALE,[Not Evaluated],Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20160,Alive,TUMOR FREE,2717,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2717,0,2717,NA,NA,0,2717,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-6.303778231,1.235681597,TCGA-D1-A3JQ-01A,TCGA-D1-A3JQ-01A-11D-A228-09,10,0.021536578,TCGA-D1-A3JQ,UCEC,61,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22297,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,526,0,526,0,526,0,526,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,7
0.353089826,3.60359514,TCGA-JU-AAVI-01A,TCGA-JU-AAVI-01A-11D-A403-09,4,0.278950555,TCGA-JU-AAVI,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22289,Dead,WITH TUMOR,NA,540,[Not Available],Distant Metastasis,"Other, specify",Porta Hepatis,505,Complete Remission/Response,1,540,1,540,1,505,1,505,NA,Stage IIIC1,[Not Applicable],[Not Applicable],NA,3
9.365108544,-5.496498449,TCGA-60-2706-01A,TCGA-60-2706-01A-01W-0877-08,1,0.856626243,TCGA-60-2706,LUSC,58,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-21477,Alive,TUMOR FREE,2820,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2820,0,2820,0,2820,0,2820,NA,Stage IA,T1,M0,NA,1
-6.203161236,1.590528995,TCGA-EO-A3L0-01A,TCGA-EO-A3L0-01A-11D-A228-09,10,0.355789814,TCGA-EO-A3L0,UCEC,76,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003,Alive,TUMOR FREE,1554,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1554,0,1554,0,1554,0,1554,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
-2.908114965,-4.066822811,TCGA-EO-A3KX-01A,TCGA-EO-A3KX-01A-11D-A228-09,8,0.150163092,TCGA-EO-A3KX,UCEC,80,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29260,Alive,TUMOR FREE,1170,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1170,0,1170,0,1170,0,1170,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-2.810006088,-4.236891592,TCGA-EO-A3B0-01A,TCGA-EO-A3B0-01A-12D-A19Y-09,0,NA,TCGA-EO-A3B0,UCEC,43,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2011,Indeterminate (neither Pre or Postmenopausal),-15954,Alive,TUMOR FREE,1412,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,1412,0,1412,NA,NA,0,1412,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,10
-3.922713274,1.198433972,TCGA-GC-A3YS-01A,TCGA-GC-A3YS-01A-11D-A23M-08,0,NA,TCGA-GC-A3YS,BLCA,61,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-22515,Alive,TUMOR FREE,758,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,758,0,758,NA,NA,0,758,NA,Stage IV,T3a,MX,BLCA.3,6
2.140565863,1.80213641,TCGA-CV-7437-01A,TCGA-CV-7437-01A-21D-2129-08,3,0.444834823,TCGA-CV-7437,HNSC,77,MALE,[Not Available],Head & Neck Squamous Cell Carcinoma,GX,1996,[Not Available],-28221,Dead,WITH TUMOR,NA,506,[Not Available],NA,NA,NA,NA,[Not Available],1,506,1,506,NA,NA,1,506,NA,Stage II,T2,[Not Available],HNSC.Classical,3
-3.655015161,-2.778700748,TCGA-BT-A3PH-01A,TCGA-BT-A3PH-01A-11D-A21Z-08,8,0.434899161,TCGA-BT-A3PH,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-28030,Dead,WITH TUMOR,NA,142,[Not Available],NA,NA,NA,NA,Progressive Disease,1,142,1,142,NA,NA,1,142,NA,Stage IV,T3b,MX,BLCA.1,10
-5.258566016,2.664487335,TCGA-D1-A3JP-01A,TCGA-D1-A3JP-01A-31D-A228-09,12,0.359211263,TCGA-D1-A3JP,UCEC,61,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22538,Alive,TUMOR FREE,515,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,515,0,515,NA,NA,0,515,NA,Stage IA,[Not Applicable],[Not Applicable],NA,8
9.150418698,-5.505543281,TCGA-B5-A3FH-01A,TCGA-B5-A3FH-01A-11D-A19Y-09,1,0.767764891,TCGA-B5-A3FH,UCEC,74,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27221,Alive,TUMOR FREE,841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,841,0,841,0,841,0,841,NA,Stage IA,[Not Applicable],[Not Applicable],NA,1
0.076123038,4.923548796,TCGA-AX-A3FV-01A,TCGA-AX-A3FV-01A-11D-A228-09,4,0.665345156,TCGA-AX-A3FV,UCEC,62,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,[Not Available],-22752,Alive,NA,-6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,6
-4.424915089,-0.482763537,TCGA-AJ-A8CV-01A,TCGA-AJ-A8CV-01A-11D-A37N-09,0,NA,TCGA-AJ-A8CV,UCEC,58,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21336,Alive,TUMOR FREE,1068,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1068,0,1068,0,1068,0,1068,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
9.594035623,-2.924529887,TCGA-ZJ-AB0I-01A,TCGA-ZJ-AB0I-01A-11D-A42O-09,1,0.750620428,TCGA-ZJ-AB0I,CESC,25,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,[Not Available],2006,[Unknown],-9486,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T2b,MX,NA,5
-7.605343434,2.169406251,TCGA-ZJ-AB0H-01A,TCGA-ZJ-AB0H-01A-11D-A42O-09,9,0.269634431,TCGA-ZJ-AB0H,CESC,48,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,[Not Available],2006,[Unknown],-17869,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIIB,T3b,M0,NA,7
-7.562439244,2.310226282,TCGA-AJ-A5DV-01A,TCGA-AJ-A5DV-01A-11D-A27P-09,9,0.11145087,TCGA-AJ-A5DV,UCEC,65,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23892,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,679,0,679,0,679,0,679,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
9.774524872,-2.883536247,TCGA-2E-A9G8-01A,TCGA-2E-A9G8-01A-11D-A403-09,1,0.76325404,TCGA-2E-A9G8,UCEC,59,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,1249,NA,[Not Available],Locoregional Recurrence,"Other, specify",abdominal wall,335,Progressive Disease,0,1249,0,1249,NA,NA,1,335,NA,Stage III,[Not Applicable],[Not Applicable],NA,1
-6.316281535,2.375586267,TCGA-ZX-AA5X-01A,TCGA-ZX-AA5X-01A-11D-A42O-09,0,NA,TCGA-ZX-AA5X,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23440,Alive,WITH TUMOR,119,NA,NA,NA,NA,NA,NA,[Not Applicable],0,119,0,119,NA,NA,0,119,NA,Stage IIIB,TX,MX,NA,6
-6.792804076,-2.157574256,TCGA-CX-7219-01A,TCGA-CX-7219-01A-11D-2012-08,6,0.103990524,TCGA-CX-7219,HNSC,47,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-17222,Alive,TUMOR FREE,1045,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1045,0,1045,NA,NA,0,1045,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,2
-5.153129811,0.920503719,TCGA-GC-A3I6-01A,TCGA-GC-A3I6-01A-11D-A20D-08,0,NA,TCGA-GC-A3I6,BLCA,45,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-16504,Dead,WITH TUMOR,NA,630,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,546,Progressive Disease,1,630,1,630,NA,NA,1,546,NA,Stage III,T3a,M0,BLCA.3,9
-0.91383724,4.484196248,TCGA-ZJ-AAXT-01A,TCGA-ZJ-AAXT-01A-11D-A42O-09,4,0.446230595,TCGA-ZJ-AAXT,CESC,54,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,[Unknown],-19847,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIIB,T3b,M0,NA,6
0.174292044,4.758127067,TCGA-ZJ-AAXN-01A,TCGA-ZJ-AAXN-01A-11D-A42O-09,4,0.62205621,TCGA-ZJ-AAXN,CESC,34,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,[Not Available],2010,[Unknown],-12701,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IB2,T1b2,M0,NA,1
-7.24368241,2.107391413,TCGA-ZJ-AAXI-01A,TCGA-ZJ-AAXI-01A-11D-A42O-09,9,0.273920361,TCGA-ZJ-AAXI,CESC,67,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2010,[Unknown],-24497,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T2b,M0,NA,7
9.507417416,-3.149945886,TCGA-ZJ-AAXF-01A,TCGA-ZJ-AAXF-01A-31D-A42O-09,1,0.733966747,TCGA-ZJ-AAXF,CESC,62,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G3,2010,[Unknown],-22709,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T2b,M0,NA,1
-0.159926738,5.083716778,TCGA-CV-7435-01A,TCGA-CV-7435-01A-11D-2129-08,4,0.672153696,TCGA-CV-7435,HNSC,57,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-21049,Dead,TUMOR FREE,NA,4680,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,4680,0,4680,NA,NA,0,4680,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,6
-4.40749181,-1.51498334,TCGA-ZJ-AAXU-01A,TCGA-ZJ-AAXU-01A-11D-A42O-09,8,0.387300564,TCGA-ZJ-AAXU,CESC,51,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,[Unknown],-18773,Alive,NA,5,NA,NA,NA,NA,NA,NA,[Unknown],0,5,0,5,NA,NA,0,5,NA,Stage IIB,T2b,M0,NA,10
-7.690990773,-2.412729428,TCGA-ZJ-AAX4-01A,TCGA-ZJ-AAX4-01A-11D-A42O-09,6,0.512322121,TCGA-ZJ-AAX4,CESC,85,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2008,[Unknown],-31258,Alive,NA,21,NA,NA,NA,NA,NA,NA,[Unknown],0,21,0,21,NA,NA,0,21,NA,Stage II,T2,M0,NA,2
-5.744225595,-1.056023145,TCGA-ZJ-AAXD-01A,TCGA-ZJ-AAXD-01A-21D-A42O-09,0,NA,TCGA-ZJ-AAXD,CESC,35,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2010,[Unknown],-12968,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIIB,T3b,M0,NA,2
-1.951312403,1.552235517,TCGA-ZJ-AAXB-01A,TCGA-ZJ-AAXB-01A-11D-A42O-09,0,NA,TCGA-ZJ-AAXB,CESC,42,FEMALE,WHITE,Endocervical Adenocarcinoma of the Usual Type,G3,2009,[Unknown],-15492,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IB2,T1b2,M0,NA,6
9.966267538,-2.092616838,TCGA-ZJ-AAXA-01A,TCGA-ZJ-AAXA-01A-11D-A42O-09,1,0.783901112,TCGA-ZJ-AAXA,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,[Unknown],-23603,Alive,NA,43,NA,NA,NA,NA,NA,NA,[Unknown],0,43,0,43,NA,NA,0,43,NA,Stage IB1,T1b,MX,NA,1
-7.629530319,2.050323214,TCGA-ZJ-AAX8-01A,TCGA-ZJ-AAX8-01A-11D-A42O-09,9,0.391989916,TCGA-ZJ-AAX8,CESC,58,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2009,[Unknown],-21481,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIIB,T3b,M0,NA,7
-4.452452868,-1.057875171,TCGA-CU-A3YL-01A,TCGA-CU-A3YL-01A-11D-A22Z-08,8,0.145541717,TCGA-CU-A3YL,BLCA,67,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-24524,Alive,TUMOR FREE,906,NA,[Not Available],Distant Metastasis,Lung,NA,370,Complete Remission/Response,0,906,0,906,1,370,1,370,NA,Stage III,T4a,M0,BLCA.1,10
-0.729177304,2.255229686,TCGA-ZJ-A8QO-01A,TCGA-ZJ-A8QO-01A-11D-A37N-09,0,NA,TCGA-ZJ-A8QO,CESC,73,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,[Not Available],2007,[Unknown],-26723,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,[Not Available],[Not Available],[Not Available],NA,1
-6.435679573,-2.007271366,TCGA-FD-A3SM-01A,TCGA-FD-A3SM-01A-11D-A22Z-08,0,NA,TCGA-FD-A3SM,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-25852,Dead,WITH TUMOR,NA,547,[Not Available],Distant Metastasis,Lymph Node Only,NA,144,[Unknown],1,547,1,547,NA,NA,1,144,NA,Stage IV,T3a,M1,BLCA.2,2
9.030016055,-2.282318347,TCGA-XS-A8TJ-01A,TCGA-XS-A8TJ-01A-11D-A36J-09,1,0.686793891,TCGA-XS-A8TJ,CESC,41,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15298,Alive,TUMOR FREE,890,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,890,0,890,0,890,0,890,NA,Stage IB1,T1b1,M0,NA,6
-5.716646731,-2.173630521,TCGA-VS-AA62-01A,TCGA-VS-AA62-01A-11D-A42O-09,0,NA,TCGA-VS-AA62,CESC,51,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,Peri (6-12 months since last menstrual period),-18792,Dead,WITH TUMOR,NA,469,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,469,1,469,NA,NA,1,469,NA,Stage IIB,T2b,MX,NA,2
-7.088915358,1.513173571,TCGA-VS-A9V4-01A,TCGA-VS-A9V4-01A-12D-A42O-09,0,NA,TCGA-VS-A9V4,CESC,63,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23334,Dead,WITH TUMOR,NA,132,Cervical Cancer,New Primary Tumor,NA,Sigmoid colon,100,[Unknown],1,132,1,132,NA,NA,1,100,NA,Stage IVA,T4,MX,NA,7
2.027734531,1.927256513,TCGA-ZJ-A8QR-01A,TCGA-ZJ-A8QR-01A-11D-A37N-09,3,0.062362691,TCGA-ZJ-A8QR,CESC,38,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Cervical Squamous Cell Carcinoma,GX,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14225,Dead,NA,NA,582,NA,NA,NA,NA,NA,[Unknown],1,582,NA,582,NA,NA,0,582,NA,Stage I,TX,MX,NA,3
-6.393235291,2.06342855,TCGA-VS-A9V3-01A,TCGA-VS-A9V3-01A-11D-A42O-09,0,NA,TCGA-VS-A9V3,CESC,62,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2013,[Not Evaluated],-22990,Alive,WITH TUMOR,540,NA,NA,Distant Metastasis,"Other, specify",Mediastinal lymph nodes,456,Complete Remission/Response,0,540,0,540,NA,NA,1,456,NA,Stage IVB,T4,MX,NA,9
-6.35576736,1.971334134,TCGA-VS-A9UY-01A,TCGA-VS-A9UY-01A-11D-A42O-09,0,NA,TCGA-VS-A9UY,CESC,29,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2012,[Unknown],-10707,Dead,WITH TUMOR,NA,555,Cervical Cancer,Distant Metastasis,Head & Neck,NA,412,Progressive Disease,1,555,1,555,NA,NA,1,412,NA,Stage IVB,T1b2,MX,NA,9
-1.128135227,2.129465355,TCGA-VS-A9UV-01A,TCGA-VS-A9UV-01A-11D-A42O-09,0,NA,TCGA-VS-A9UV,CESC,74,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,GX,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27348,Dead,WITH TUMOR,NA,104,Cervical Cancer,NA,NA,NA,NA,[Unknown],1,104,1,104,NA,NA,1,104,NA,Stage IVA,T4,MX,NA,6
-6.313006585,1.243999828,TCGA-VS-A9UT-01A,TCGA-VS-A9UT-01A-11D-A42O-09,10,0.104548392,TCGA-VS-A9UT,CESC,72,FEMALE,ASIAN,Mucinous Adenocarcinoma of Endocervical Type,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26603,Alive,TUMOR FREE,482,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,482,0,482,0,482,0,482,NA,Stage IB,T1b1,MX,NA,7
-7.223143524,1.947973408,TCGA-DK-A1AG-01A,TCGA-DK-A1AG-01A-11D-A13W-08,9,0.08000633,TCGA-DK-A1AG,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-24095,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,475,0,475,0,475,0,475,NA,Stage III,T3,M0,BLCA.1,7
-6.504637862,-1.964373631,TCGA-CF-A27C-01A,TCGA-CF-A27C-01A-11D-A16O-08,0,NA,TCGA-CF-A27C,BLCA,52,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-19270,Alive,TUMOR FREE,425,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,425,0,425,0,425,0,425,NA,Stage III,T3,M0,BLCA.1,2
9.639139116,-2.372415786,TCGA-VS-A9UO-01A,TCGA-VS-A9UO-01A-11D-A42O-09,1,0.713106197,TCGA-VS-A9UO,CESC,43,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2011,Peri (6-12 months since last menstrual period),-15813,Alive,TUMOR FREE,1456,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1456,0,1456,0,1456,0,1456,NA,Stage IIB,T2b,MX,NA,1
-3.876604189,-2.380314336,TCGA-VS-A9UJ-01A,TCGA-VS-A9UJ-01A-11D-A42O-09,8,0.459200956,TCGA-VS-A9UJ,CESC,55,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,GX,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20264,Dead,WITH TUMOR,NA,52,Cervical Cancer,NA,NA,NA,NA,[Not Available],1,52,1,52,NA,NA,1,52,NA,Stage IIB,T2b,MX,NA,10
-5.680454804,1.310846579,TCGA-VS-A9UI-01A,TCGA-VS-A9UI-01A-11D-A42O-09,0,NA,TCGA-VS-A9UI,CESC,76,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27838,Dead,TUMOR FREE,NA,1372,NA,NA,NA,NA,NA,Complete Remission/Response,1,1372,0,1372,0,1372,0,1372,NA,Stage IIB,T2b,MX,NA,9
-4.357030847,-0.977658871,TCGA-VS-A9UD-01A,TCGA-VS-A9UD-01A-11D-A42O-09,8,0.063851826,TCGA-VS-A9UD,CESC,73,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26815,Alive,TUMOR FREE,739,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,739,0,739,0,739,0,739,NA,Stage IIIA,T3a,MX,NA,10
-7.586220446,1.826320727,TCGA-VS-A9UR-01A,TCGA-VS-A9UR-01A-11D-A42O-09,9,0.272815204,TCGA-VS-A9UR,CESC,53,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,GX,2013,[Unknown],-19688,Alive,WITH TUMOR,793,NA,NA,Distant Metastasis,"Other, specify",Retroperitoneal,675,Complete Remission/Response,0,793,0,793,1,675,1,675,NA,Stage IIA,T2a,MX,NA,9
-7.956107784,2.095064828,TCGA-VS-A9UQ-01A,TCGA-VS-A9UQ-01A-21D-A42O-09,9,0.466642814,TCGA-VS-A9UQ,CESC,32,FEMALE,[Unknown],Mucinous Adenocarcinoma of Endocervical Type,G2,2011,Peri (6-12 months since last menstrual period),-11853,Alive,TUMOR FREE,1263,NA,NA,Distant Metastasis,"Other, specify",Ovary,561,Complete Remission/Response,0,1263,0,1263,1,561,1,561,NA,Stage IB,T1b,MX,NA,7
-4.598724905,0.376707254,TCGA-VS-A9UP-01A,TCGA-VS-A9UP-01A-11D-A42O-09,0,NA,TCGA-VS-A9UP,CESC,43,FEMALE,[Unknown],Mucinous Adenocarcinoma of Endocervical Type,G3,2011,Peri (6-12 months since last menstrual period),-15849,Alive,WITH TUMOR,1444,NA,NA,Distant Metastasis,"Other, specify",Paraortic lymph nodes,352,Complete Remission/Response,0,1444,0,1444,1,352,1,352,NA,Stage IIA,T2a,MX,NA,10
-5.828758341,1.467530313,TCGA-VS-A9UC-01A,TCGA-VS-A9UC-01A-11D-A42O-09,0,NA,TCGA-VS-A9UC,CESC,32,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2012,Peri (6-12 months since last menstrual period),-11790,Alive,WITH TUMOR,825,NA,NA,NA,NA,NA,NA,Stable Disease,0,825,0,825,NA,NA,0,825,NA,Stage IIB,T2b,MX,NA,10
-1.508464846,2.338528778,TCGA-VS-A9UB-01A,TCGA-VS-A9UB-01A-22D-A42O-09,0,NA,TCGA-VS-A9UB,CESC,54,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19737,Alive,TUMOR FREE,911,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,911,0,911,0,911,0,911,NA,Stage IIB,T2b,MX,NA,6
-5.698465562,-1.744573424,TCGA-VS-A9UA-01A,TCGA-VS-A9UA-01A-11D-A42O-09,0,NA,TCGA-VS-A9UA,CESC,60,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22221,Alive,TUMOR FREE,867,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,867,0,867,0,867,0,867,NA,Stage IIIA,T3,MX,NA,10
-4.163819953,-1.746574472,TCGA-44-A4SS-01A,TCGA-44-A4SS-01A-11D-A24P-08,8,0.422637389,TCGA-44-A4SS,LUAD,73,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26991,Alive,TUMOR FREE,415,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,415,0,415,0,415,0,415,NA,Stage IA,T1b,M0,NA,10
-6.395416551,1.631555172,TCGA-06-2570-01A,TCGA-06-2570-01A-01D-1495-08,10,0.186926978,TCGA-06-2570,GBM,21,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-7936,Alive,TUMOR FREE,958,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,958,0,958,NA,NA,0,958,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,7
-1.603842572,1.048279061,TCGA-TM-A84C-01A,TCGA-TM-A84C-01A-11D-A36O-08,5,0.487295951,TCGA-TM-A84C,LGG,32,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-11849,Dead,WITH TUMOR,NA,492,[Not Available],NA,NA,NA,NA,Progressive Disease,1,492,1,492,NA,NA,1,492,NA,NA,NA,NA,GBM_LGG.PA-like,1
8.919577211,-5.091001844,TCGA-VV-A829-01A,TCGA-VV-A829-01A-21D-A36O-08,1,0.837372231,TCGA-VV-A829,LGG,44,MALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-16163,Alive,TUMOR FREE,1127,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1127,0,1127,NA,NA,0,1127,NA,NA,NA,NA,GBM_LGG.Codel,1
0.211182091,3.414068011,TCGA-70-6723-01A,TCGA-70-6723-01A-11D-1817-08,4,0.294465989,TCGA-70-6723,LUSC,65,MALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-24035,Alive,WITH TUMOR,375,NA,[Not Available],Locoregional Recurrence,NA,NA,312,Progressive Disease,0,375,0,375,NA,NA,1,312,NA,Stage IIA,T3,M0,LUSC.classical,3
9.99168825,-1.812963399,TCGA-S9-A89V-01A,TCGA-S9-A89V-01A-11D-A36O-08,1,0.867101487,TCGA-S9-A89V,LGG,70,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-25570,Alive,WITH TUMOR,569,NA,[Not Available],NA,NA,NA,129,Progressive Disease,0,569,0,569,NA,NA,1,129,NA,NA,NA,NA,GBM_LGG.PA-like,1
-7.285712535,-1.944282449,TCGA-86-8055-01A,TCGA-86-8055-01A-11D-2238-08,6,0.107306313,TCGA-86-8055,LUAD,79,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-29124,Dead,TUMOR FREE,NA,124,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,124,0,124,0,124,0,124,NA,Stage IIA,T2a,M0,NA,2
-4.796090274,2.285218963,TCGA-EQ-8122-01A,TCGA-EQ-8122-01A-11D-2340-08,0,NA,TCGA-EQ-8122,STAD,71,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-26289,Dead,NA,NA,243,[Not Available],NA,NA,NA,NA,[Not Available],1,243,NA,243,NA,NA,0,243,NA,Stage IIB,T3,MX,GI.CIN,3
-4.6145847,-0.288646878,TCGA-68-7757-01B,TCGA-68-7757-01B-11D-2293-08,0,NA,TCGA-68-7757,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-27272,Alive,NA,211,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,211,0,211,NA,NA,0,211,NA,Stage IA,T1b,MX,NA,10
-8.034154316,1.976065641,TCGA-06-2562-01A,TCGA-06-2562-01A-01D-1494-08,9,0.614891909,TCGA-06-2562,GBM,81,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-29753,Dead,WITH TUMOR,NA,382,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],151,[Not Available],1,382,1,382,NA,NA,1,151,NA,NA,NA,NA,GBM_LGG.Classic-like,7
4.459994597,1.080069785,TCGA-32-2632-01A,TCGA-32-2632-01A-01D-1495-08,2,0.335936746,TCGA-32-2632,GBM,80,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-29281,Dead,WITH TUMOR,NA,269,[Not Available],NA,NA,NA,NA,Progressive Disease,1,269,1,269,NA,NA,1,269,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,5
-5.736641131,3.126768933,TCGA-50-5936-01A,TCGA-50-5936-01A-11D-1625-08,0,NA,TCGA-50-5936,LUAD,58,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-21238,Dead,WITH TUMOR,NA,257,[Not Available],NA,NA,NA,150,Progressive Disease,1,257,1,257,NA,NA,1,150,NA,Stage IIIA,T2,M0,LUAD.6,10
8.695939018,-3.219016821,TCGA-14-0812-01B,TCGA-14-0812-01B-01W-0643-08,1,0.664703822,TCGA-14-0812,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-24085,Dead,WITH TUMOR,99,99,[Not Available],NA,NA,NA,NA,[Not Available],1,99,1,99,NA,NA,1,99,NA,NA,NA,NA,NA,1
4.339330556,1.129839761,TCGA-HT-A5R7-01A,TCGA-HT-A5R7-01A-11D-A289-08,2,0.708847225,TCGA-HT-A5R7,LGG,33,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-12092,Alive,TUMOR FREE,615,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,615,0,615,0,615,0,615,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
-0.418912134,4.978333552,TCGA-P5-A5F2-01A,TCGA-P5-A5F2-01A-11D-A289-08,4,0.535830323,TCGA-P5-A5F2,LGG,36,FEMALE,WHITE,Astrocytoma,G2,2012,[Not Available],-13396,Alive,WITH TUMOR,242,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,242,0,242,NA,NA,0,242,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.134655185,4.890000536,TCGA-P5-A5F4-01A,TCGA-P5-A5F4-01A-11D-A289-08,4,0.677850856,TCGA-P5-A5F4,LGG,35,FEMALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-12851,Alive,[Discrepancy],231,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,231,0,231,NA,NA,0,231,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.660170165,-5.049739157,TCGA-QH-A86X-01A,TCGA-QH-A86X-01A-11D-A36O-08,1,0.829671783,TCGA-QH-A86X,LGG,33,MALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-12385,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,337,0,337,0,337,0,337,NA,NA,NA,NA,GBM_LGG.Codel,1
0.131680427,5.113879864,TCGA-QH-A870-01A,TCGA-QH-A870-01A-11D-A36O-08,4,0.693690521,TCGA-QH-A870,LGG,38,FEMALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-14082,Alive,WITH TUMOR,395,NA,[Not Available],NA,NA,NA,335,Complete Remission/Response,0,395,0,395,1,335,1,335,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.557053824,-4.175828712,TCGA-S9-A7R1-01A,TCGA-S9-A7R1-01A-12D-A34J-08,1,0.73207704,TCGA-S9-A7R1,LGG,35,MALE,WHITE,Oligodendroglioma,G2,1999,[Not Available],-12828,Dead,WITH TUMOR,NA,5166,[Not Available],NA,NA,NA,3637,Stable Disease,1,5166,1,5166,NA,NA,1,3637,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.653891957,3.987997961,TCGA-85-8049-01A,TCGA-85-8049-01A-11D-2244-08,4,0.449415703,TCGA-85-8049,LUSC,57,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-20995,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,579,0,579,0,579,0,579,NA,Stage IB,T2a,M0,NA,6
-3.397981363,-3.120229003,TCGA-95-7567-01A,TCGA-95-7567-01A-11D-2063-08,8,0.557385606,TCGA-95-7567,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22437,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,568,0,568,NA,NA,0,568,NA,Stage IIB,T2b,M0,LUAD.3,10
-5.771158876,-2.215112421,TCGA-CG-4301-01A,TCGA-CG-4301-01A-01D-1158-08,0,NA,TCGA-CG-4301,STAD,75,FEMALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006,[Not Available],-27516,Alive,WITH TUMOR,92,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,92,0,92,NA,NA,0,92,NA,Stage IV,T4,M1,GI.CIN,2
8.791206263,-1.91527583,TCGA-FG-A87Q-01A,TCGA-FG-A87Q-01A-11D-A36O-08,1,0.597742609,TCGA-FG-A87Q,LGG,61,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-22565,Alive,TUMOR FREE,174,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,174,0,174,0,174,0,174,NA,NA,NA,NA,GBM_LGG.Classic-like,1
9.504053183,-5.559253965,TCGA-HT-8015-01B,TCGA-HT-8015-01B-11D-A289-08,1,0.872644286,TCGA-HT-8015,LGG,21,MALE,WHITE,Astrocytoma,G2,2008,[Not Available],-7760,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3,0,3,0,3,0,3,NA,NA,NA,NA,GBM_LGG.PA-like,1
-4.258536502,1.604675763,TCGA-63-5131-01A,TCGA-63-5131-01A-01D-1441-08,0,NA,TCGA-63-5131,LUSC,NA,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],NA,Dead,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,NA,0,NA,0,NA,0,NA,NA,Stage IIB,T2,M0,LUSC.primitive,10
-1.276418336,3.580278264,TCGA-BR-7723-01A,TCGA-BR-7723-01A-11D-2053-08,4,0.292534461,TCGA-BR-7723,STAD,59,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-21839,Dead,WITH TUMOR,NA,874,[Not Available],Distant Metastasis,Liver,NA,559,Complete Remission/Response,1,874,1,874,1,559,1,559,NA,Stage IIIB,T3,M0,GI.CIN,5
8.249200967,-4.099807519,TCGA-CD-5802-01A,TCGA-CD-5802-01A-11D-1600-08,1,0.813743674,TCGA-CD-5802,STAD,58,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-21331,Alive,TUMOR FREE,406,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,406,0,406,0,406,0,406,NA,Stage II,T3,M0,NA,1
9.229433004,-4.14012742,TCGA-FG-A87N-01A,TCGA-FG-A87N-01A-11D-A36O-08,1,0.749833054,TCGA-FG-A87N,LGG,37,FEMALE,ASIAN,Astrocytoma,G3,2013,[Not Available],-13606,Alive,WITH TUMOR,567,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,567,0,567,NA,NA,0,567,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,1
-7.47470693,-2.529001746,TCGA-55-6543-01A,TCGA-55-6543-01A-11D-1753-08,6,0.275743684,TCGA-55-6543,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],NA,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,435,0,435,0,435,0,435,NA,Stage IA,T1b,MX,LUAD.5,2
8.867875503,-2.008624687,TCGA-06-0174-01A,TCGA-06-0174-01A-01D-1491-08,1,0.609839477,TCGA-06-0174,GBM,54,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-19824,Dead,WITH TUMOR,67,98,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],47,[Not Available],1,98,1,98,NA,NA,1,47,NA,NA,NA,NA,GBM_LGG.NA,1
-6.289535501,1.582301116,TCGA-76-6286-01A,TCGA-76-6286-01A-11D-1845-08,10,0.297723009,TCGA-76-6286,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-22173,Dead,WITH TUMOR,638,638,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],180,[Not Available],1,638,1,638,NA,NA,1,180,NA,NA,NA,NA,NA,7
8.803923844,-3.97828446,TCGA-DU-A7TG-01A,TCGA-DU-A7TG-01A-21D-A34J-08,1,0.728906591,TCGA-DU-A7TG,LGG,40,MALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-14671,Dead,NA,NA,1351,[Not Available],NA,NA,NA,NA,[Unknown],1,1351,NA,1351,NA,NA,0,1351,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
2.111412128,1.795805111,TCGA-DU-A7TJ-01A,TCGA-DU-A7TJ-01A-11D-A34J-08,3,0.418955222,TCGA-DU-A7TJ,LGG,55,MALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G3,2013,[Not Available],-20394,Alive,WITH TUMOR,17,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,17,0,17,NA,NA,0,17,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,3
9.005486718,-1.902544401,TCGA-12-0670-01B,TCGA-12-0670-01B-01W-0424-08,1,0.626813264,TCGA-12-0670,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2001,[Not Available],-22189,Dead,NA,790,790,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],379,[Not Available],1,790,NA,790,NA,NA,1,379,NA,NA,NA,NA,NA,1
-6.564258521,1.579132416,TCGA-06-5417-01A,TCGA-06-5417-01A-01D-1486-08,10,0.254576222,TCGA-06-5417,GBM,45,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-16572,Alive,WITH TUMOR,155,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,155,0,155,NA,NA,0,155,NA,NA,NA,NA,GBM_LGG.NA,7
9.853366755,-3.558064914,TCGA-F6-A8O3-01A,TCGA-F6-A8O3-01A-11D-A36O-08,1,0.635401683,TCGA-F6-A8O3,LGG,34,MALE,ASIAN,Oligodendroglioma,G2,2013,[Not Available],-12578,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,7,0,7,0,7,0,7,NA,NA,NA,NA,GBM_LGG.Codel,1
9.499258436,-5.647620746,TCGA-38-A44F-01A,TCGA-38-A44F-01A-11D-A24D-08,1,0.886424137,TCGA-38-A44F,LUAD,80,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-29534,Alive,TUMOR FREE,133,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,133,0,133,0,133,0,133,NA,Stage IB,T2a,M0,NA,1
-0.007808007,4.976551236,TCGA-F6-A8O4-01A,TCGA-F6-A8O4-01A-11D-A36O-08,4,0.695242839,TCGA-F6-A8O4,LGG,44,MALE,ASIAN,Astrocytoma,G2,2013,[Not Available],-16202,Alive,TUMOR FREE,6,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,6,0,6,0,6,0,6,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
7.784240107,-3.466122451,TCGA-FG-A70Y-01A,TCGA-FG-A70Y-01A-12D-A34J-08,1,0.328303283,TCGA-FG-A70Y,LGG,20,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-7421,Alive,WITH TUMOR,868,NA,[Not Available],NA,NA,NA,490,Complete Remission/Response,0,868,0,868,1,490,1,490,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-0.561586595,4.887966766,TCGA-FG-A711-01A,TCGA-FG-A711-01A-21D-A33T-08,4,0.572850266,TCGA-FG-A711,LGG,33,FEMALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-12248,Dead,WITH TUMOR,NA,1481,[Not Available],NA,NA,NA,347,Progressive Disease,1,1481,1,1481,NA,NA,1,347,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
1.547423874,2.327054506,TCGA-CG-5724-01A,TCGA-CG-5724-01A-11D-1600-08,3,0.029214918,TCGA-CG-5724,STAD,59,MALE,[Not Available],"Stomach, Adenocarcinoma, Diffuse Type",G3,2003,[Not Available],-21762,Dead,WITH TUMOR,NA,366,[Not Available],NA,NA,NA,122,Progressive Disease,1,366,1,366,NA,NA,1,122,NA,Stage IV,T3,M1,GI.CIN,3
-1.232129823,4.298312666,TCGA-37-4141-01A,TCGA-37-4141-01A-02D-1352-08,4,0.264713383,TCGA-37-4141,LUSC,65,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-24048,Alive,TUMOR FREE,12,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,12,0,12,NA,NA,0,12,NA,Stage IA,T1b,M0,LUSC.primitive,6
-1.837637055,1.551247708,TCGA-BR-6565-01A,TCGA-BR-6565-01A-11D-1800-08,4,0.283832503,TCGA-BR-6565,STAD,67,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-24495,Dead,WITH TUMOR,NA,279,[Not Available],NA,NA,NA,NA,Stable Disease,1,279,1,279,NA,NA,1,279,NA,Stage IIB,T4a,M0,GI.CIN,3
-4.521934637,0.731050318,TCGA-86-8674-01A,TCGA-86-8674-01A-21D-2393-08,0,NA,TCGA-86-8674,LUAD,50,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-18479,Alive,TUMOR FREE,806,NA,[Not Available],Locoregional Recurrence,NA,NA,334,Complete Remission/Response,0,806,0,806,1,334,1,334,NA,Stage IIA,T2a,M0,NA,10
-4.579164188,-0.65406919,TCGA-33-6737-01A,TCGA-33-6737-01A-11D-1817-08,8,0.03962045,TCGA-33-6737,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-26033,Dead,WITH TUMOR,NA,601,[Not Available],NA,NA,NA,NA,Progressive Disease,1,601,1,601,NA,NA,1,601,NA,Stage IIIA,T2,M0,NA,10
8.862384437,-1.922669883,TCGA-DU-A7TD-01A,TCGA-DU-A7TD-01A-12D-A34A-08,1,0.623823665,TCGA-DU-A7TD,LGG,52,MALE,WHITE,Oligoastrocytoma,G3,2012,[Not Available],-19025,Dead,WITH TUMOR,NA,228,[Not Available],NA,NA,NA,188,Progressive Disease,1,228,1,228,NA,NA,1,188,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-1.126578872,3.486605122,TCGA-50-6673-01A,TCGA-50-6673-01A-11D-1945-08,4,0.256353545,TCGA-50-6673,LUAD,84,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-30689,Dead,NA,NA,22,[Not Available],NA,NA,NA,NA,[Unknown],1,22,NA,22,NA,NA,0,22,NA,Stage I,T1,M0,LUAD.5,5
-0.10334919,4.632540819,TCGA-CN-4733-01A,TCGA-CN-4733-01A-02D-1870-08,4,0.457873959,TCGA-CN-4733,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-22561,Alive,TUMOR FREE,1586,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1586,0,1586,0,1586,0,1586,NA,Stage III,T1,[Not Available],HNSC.Mesenchymal,6
0.13525326,3.498502522,TCGA-28-1746-01A,TCGA-28-1746-01A-01W-0643-08,4,0.414719807,TCGA-28-1746,GBM,77,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-28302,Alive,NA,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,NA,NA,0,6,NA,NA,NA,NA,NA,3
9.88819075,-1.938489502,TCGA-DH-A7US-01A,TCGA-DH-A7US-01A-11D-A33T-08,1,0.842378278,TCGA-DH-A7US,LGG,50,MALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-18429,Alive,WITH TUMOR,706,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,706,0,706,NA,NA,0,706,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.007529586,4.781457011,TCGA-DH-A7UT-01A,TCGA-DH-A7UT-01A-12D-A34A-08,4,0.603125732,TCGA-DH-A7UT,LGG,30,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-11014,Dead,WITH TUMOR,NA,531,[Not Available],NA,NA,NA,404,Stable Disease,1,531,1,531,NA,NA,1,404,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.359507091,-1.7479681,TCGA-32-1986-01A,TCGA-32-1986-01A-01D-1494-08,1,0.769053122,TCGA-32-1986,GBM,68,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-25061,Dead,WITH TUMOR,386,386,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],233,[Not Available],1,386,1,386,NA,NA,1,233,NA,NA,NA,NA,NA,1
-0.100643367,4.553446974,TCGA-DH-A7UU-01A,TCGA-DH-A7UU-01A-12D-A34A-08,4,0.452674403,TCGA-DH-A7UU,LGG,43,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-16037,Alive,WITH TUMOR,417,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,417,0,417,NA,NA,0,417,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.403522328,-2.39881075,TCGA-DH-A7UV-01A,TCGA-DH-A7UV-01A-12D-A34A-08,6,0.327917601,TCGA-DH-A7UV,LGG,49,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-18161,Alive,WITH TUMOR,566,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,566,0,566,NA,NA,0,566,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
0.138214578,4.845756701,TCGA-DU-A7TA-01A,TCGA-DU-A7TA-01A-11D-A33T-08,4,0.641039696,TCGA-DU-A7TA,LGG,32,MALE,WHITE,Oligodendroglioma,G2,2007,[Not Available],-11764,Alive,TUMOR FREE,2565,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,2565,0,2565,NA,NA,0,2565,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
4.385691807,1.081516066,TCGA-DU-A7TB-01A,TCGA-DU-A7TB-01A-11D-A33T-08,2,0.704804666,TCGA-DU-A7TB,LGG,56,MALE,ASIAN,Oligodendroglioma,G2,2010,[Not Available],-20704,Alive,TUMOR FREE,1567,NA,[Not Available],NA,NA,NA,74,Progressive Disease,0,1567,0,1567,NA,NA,1,74,NA,NA,NA,NA,GBM_LGG.PA-like,5
0.156533539,4.927834957,TCGA-DU-A7TC-01A,TCGA-DU-A7TC-01A-21D-A34J-08,4,0.660734146,TCGA-DU-A7TC,LGG,32,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-11884,Alive,WITH TUMOR,1137,NA,[Not Available],NA,NA,NA,1114,[Discrepancy],0,1137,0,1137,NA,NA,1,1114,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.537861856,-2.074942162,TCGA-66-2771-01A,TCGA-66-2771-01A-01D-0983-08,0,NA,TCGA-66-2771,LUSC,60,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-22219,Alive,TUMOR FREE,578,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,578,0,578,0,578,0,578,NA,Stage IIB,T2,M0,LUSC.secretory,10
8.9167862,-2.104352845,TCGA-CG-4440-01A,TCGA-CG-4440-01A-01D-1158-08,1,0.610924517,TCGA-CG-4440,STAD,68,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006,[Not Available],-25171,Dead,NA,NA,122,[Not Available],NA,NA,NA,NA,[Not Available],1,122,NA,122,NA,NA,0,122,NA,Stage IV,T3,M1,GI.CIN,6
-1.821576195,2.78116688,TCGA-75-7031-01A,TCGA-75-7031-01A-11D-1945-08,0,NA,TCGA-75-7031,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage IB,T2,M0,LUAD.2,9
-7.096122942,-2.227091738,TCGA-85-7950-01A,TCGA-85-7950-01A-11D-2184-08,6,0.27928092,TCGA-85-7950,LUSC,46,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-16975,Alive,TUMOR FREE,576,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,576,0,576,0,576,0,576,NA,Stage IB,T2a,M0,NA,2
8.995472528,-5.369694536,TCGA-BR-8291-01A,TCGA-BR-8291-01A-11D-2340-08,1,0.845037356,TCGA-BR-8291,STAD,61,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",GX,2011,[Not Available],-22552,Dead,TUMOR FREE,NA,607,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,607,0,607,0,607,0,607,NA,Stage IIB,T3,M0,GI.CIN,1
0.343591599,4.982913413,TCGA-DB-A75O-01A,TCGA-DB-A75O-01A-11D-A32B-08,4,0.604626766,TCGA-DB-A75O,LGG,29,MALE,WHITE,Astrocytoma,G3,2010,[Not Available],-10812,Alive,NA,935,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,935,0,935,NA,NA,0,935,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
10.10427306,-1.552224394,TCGA-DB-A75P-01A,TCGA-DB-A75P-01A-11D-A32B-08,1,0.857690594,TCGA-DB-A75P,LGG,25,FEMALE,[Unknown],Astrocytoma,G2,2013,[Not Available],-9413,Alive,TUMOR FREE,492,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,492,0,492,0,492,0,492,NA,NA,NA,NA,GBM_LGG.PA-like,1
8.919801462,-4.575253728,TCGA-DH-A7UR-01A,TCGA-DH-A7UR-01A-11D-A33T-08,1,0.778802613,TCGA-DH-A7UR,LGG,59,FEMALE,WHITE,Oligodendroglioma,G3,2008,[Not Available],-21803,Alive,TUMOR FREE,1650,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1650,0,1650,0,1650,0,1650,NA,NA,NA,NA,GBM_LGG.Codel,1
10.04829694,-1.907367268,TCGA-06-2569-01A,TCGA-06-2569-01A-01D-1494-08,1,0.719593938,TCGA-06-2569,GBM,24,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-8922,Alive,WITH TUMOR,13,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,13,0,13,NA,NA,0,13,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,1
-7.230266734,-2.281306582,TCGA-19-2623-01A,TCGA-19-2623-01A-01D-1495-08,6,0.327016068,TCGA-19-2623,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-23835,Alive,TUMOR FREE,229,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,229,0,229,NA,NA,0,229,NA,NA,NA,NA,NA,2
-1.549154023,2.56068539,TCGA-VQ-AA6B-01A,TCGA-VQ-AA6B-01A-11D-A410-08,0,NA,TCGA-VQ-AA6B,STAD,48,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-17852,Alive,TUMOR FREE,1002,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1002,0,1002,0,1002,0,1002,NA,Stage IIIB,T3,M0,GI.CIN,3
-0.776108141,4.824245835,TCGA-VQ-AA6G-01A,TCGA-VQ-AA6G-01A-11D-A410-08,4,0.498787512,TCGA-VQ-AA6G,STAD,68,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-25091,Dead,WITH TUMOR,NA,792,Stomach Cancer,Distant Metastasis,Lung,NA,469,Progressive Disease,1,792,1,792,NA,NA,1,469,NA,Stage IIA,T3,M0,GI.CIN,6
0.401485494,4.407114735,TCGA-VQ-AA6J-01A,TCGA-VQ-AA6J-01A-11D-A410-08,4,0.315722767,TCGA-VQ-AA6J,STAD,75,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-27506,Alive,TUMOR FREE,838,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,838,0,838,0,838,0,838,NA,Stage IIIB,T4a,M0,GI.CIN,1
2.172665113,1.804161596,TCGA-DB-A75K-01A,TCGA-DB-A75K-01A-11D-A32B-08,3,0.525961216,TCGA-DB-A75K,LGG,55,FEMALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-20241,Alive,TUMOR FREE,368,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,368,0,368,0,368,0,368,NA,NA,NA,NA,GBM_LGG.Codel,3
-8.158448231,2.03775128,TCGA-19-5955-01A,TCGA-19-5955-01A-11D-1696-08,9,0.367930541,TCGA-19-5955,GBM,83,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-30550,Dead,NA,54,54,[Not Available],NA,NA,NA,NA,[Not Available],1,54,NA,54,NA,NA,0,54,NA,NA,NA,NA,NA,7
-0.11719009,4.143171835,TCGA-DB-A75L-01A,TCGA-DB-A75L-01A-11D-A32B-08,4,0.462682653,TCGA-DB-A75L,LGG,36,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-13338,Alive,TUMOR FREE,342,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,342,0,342,0,342,0,342,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.024270741,5.020403792,TCGA-DB-A75M-01A,TCGA-DB-A75M-01A-11D-A32B-08,4,0.719813938,TCGA-DB-A75M,LGG,47,MALE,WHITE,Astrocytoma,G2,2013,[Not Available],-17289,Alive,TUMOR FREE,544,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,544,0,544,0,544,0,544,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.133435891,-4.662509263,TCGA-CG-5719-01A,TCGA-CG-5719-01A-11D-1600-08,1,0.841717556,TCGA-CG-5719,STAD,54,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2010,[Not Available],-19966,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage IV,T4,M1,GI.CIN,1
-3.113617905,-3.634396741,TCGA-CG-4305-01A,TCGA-CG-4305-01A-01D-1158-08,8,0.540864591,TCGA-CG-4305,STAD,69,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-25295,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,457,[Unknown],0,485,0,485,NA,NA,1,457,NA,Stage II,T2a,M0,GI.HM-indel,10
-4.660300301,-1.571727024,TCGA-56-7222-01A,TCGA-56-7222-01A-11D-2042-08,8,0.215749974,TCGA-56-7222,LUSC,60,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-22097,Dead,WITH TUMOR,NA,562,[Not Available],NA,NA,NA,427,Complete Remission/Response,1,562,1,562,1,427,1,427,NA,Stage IB,T2a,M0,NA,10
-3.16261909,-3.537212155,TCGA-21-1079-01A,TCGA-21-1079-01A-01W-0782-08,8,0.570471065,TCGA-21-1079,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1995,[Not Available],-26176,Dead,WITH TUMOR,965,965,[Not Available],NA,NA,NA,317,[Not Available],1,965,1,965,NA,NA,1,317,NA,Stage IIIA,T3,M0,NA,10
9.416434994,-2.161343752,TCGA-55-6980-01A,TCGA-55-6980-01A-11D-1945-08,1,0.744101326,TCGA-55-6980,LUAD,56,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],NA,Alive,TUMOR FREE,2109,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2109,0,2109,0,2109,0,2109,NA,Stage IA,T1,M0,LUAD.5,1
9.182946898,-3.661887333,TCGA-06-6695-01A,TCGA-06-6695-01A-11D-1845-08,1,0.730813324,TCGA-06-6695,GBM,64,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-23426,Alive,WITH TUMOR,253,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],133,[Not Available],0,253,0,253,NA,NA,1,133,NA,NA,NA,NA,NA,1
9.642437118,-3.293689616,TCGA-06-0124-01A,TCGA-06-0124-01A-01D-1490-08,1,0.664083604,TCGA-06-0124,GBM,67,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-24591,Dead,WITH TUMOR,123,620,[Not Available],NA,NA,NA,NA,[Not Available],1,620,1,620,NA,NA,1,620,NA,NA,NA,NA,NA,1
-6.192447713,3.328844328,TCGA-81-5911-01A,TCGA-81-5911-01A-12D-1845-08,11,0.329529139,TCGA-81-5911,GBM,33,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-12292,Alive,WITH TUMOR,539,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],277,[Not Available],0,539,0,539,NA,NA,1,277,NA,NA,NA,NA,NA,8
-5.848824529,1.315710032,TCGA-BR-7197-01A,TCGA-BR-7197-01A-11D-2201-08,10,0.027436784,TCGA-BR-7197,STAD,69,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",GX,2011,[Not Available],-25445,Alive,TUMOR FREE,280,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,280,0,280,0,280,0,280,NA,Stage II,T3,M0,GI.CIN,3
-5.701549569,3.066409317,TCGA-BR-6705-01A,TCGA-BR-6705-01A-12D-1882-08,0,NA,TCGA-BR-6705,STAD,68,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25073,Dead,WITH TUMOR,NA,779,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,779,1,779,NA,NA,1,779,NA,Stage IIIB,T3,M0,GI.CIN,10
-4.173701576,-1.184315957,TCGA-39-5034-01A,TCGA-39-5034-01A-01D-1441-08,8,0.11781047,TCGA-39-5034,LUSC,73,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-26682,Dead,NA,1107,1107,[Not Available],NA,NA,NA,352,Complete Remission/Response,1,1107,NA,1107,1,352,1,352,NA,Stage IIB,T3,M0,NA,10
-1.016270644,3.283335895,TCGA-IN-7806-01A,TCGA-IN-7806-01A-11D-2053-08,4,0.174311925,TCGA-IN-7806,STAD,50,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-18404,Alive,TUMOR FREE,1106,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1106,0,1106,0,1106,0,1106,NA,Stage IIB,T3,M0,GI.CIN,4
-4.402209838,-1.647099905,TCGA-68-8251-01A,TCGA-68-8251-01A-11D-2293-08,8,0.45582885,TCGA-68-8251,LUSC,78,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-28739,Alive,TUMOR FREE,406,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,406,0,406,NA,NA,0,406,NA,Stage IB,T2a,M0,NA,10
-4.079398825,-1.916187299,TCGA-50-5941-01A,TCGA-50-5941-01A-11D-1753-08,8,0.30909643,TCGA-50-5941,LUAD,55,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-20350,Alive,TUMOR FREE,1474,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1474,0,1474,0,1474,0,1474,NA,Stage IIIA,T2a,M0,LUAD.5,10
8.624824966,-1.922024568,TCGA-06-0125-01A,TCGA-06-0125-01A-01D-1490-08,1,0.540760201,TCGA-06-0125,GBM,63,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2001,[Not Available],-23343,Dead,WITH TUMOR,1439,1448,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],797,[Not Available],1,1448,1,1448,NA,NA,1,797,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-7.920315188,-2.566838796,TCGA-02-2470-01A,TCGA-02-2470-01A-01D-1494-08,6,0.521532536,TCGA-02-2470,GBM,57,MALE,WHITE,Treated primary GBM,[Not Available],2007,[Not Available],-21021,Dead,WITH TUMOR,393,393,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],183,[Not Available],1,393,1,393,NA,NA,1,183,NA,NA,NA,NA,NA,2
-2.056309028,1.353399609,TCGA-CN-4740-01A,TCGA-CN-4740-01A-01D-1434-08,5,0.570499462,TCGA-CN-4740,HNSC,79,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-29186,Dead,WITH TUMOR,NA,839,[Not Available],NA,NA,PTERYGOID FOSSA,224,Complete Remission/Response,1,839,1,839,NA,NA,1,224,NA,Stage IVA,T4a,M0,HNSC.Mesenchymal,4
8.792982185,-3.618695604,TCGA-EQ-5647-01A,TCGA-EQ-5647-01A-01D-1600-08,1,0.731686859,TCGA-EQ-5647,STAD,86,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-31431,Dead,WITH TUMOR,NA,19,[Not Available],NA,NA,NA,NA,[Not Available],1,19,1,19,NA,NA,1,19,NA,Stage IV,T4,M1,NA,1
-0.135698454,3.470034323,TCGA-D7-6526-01A,TCGA-D7-6526-01A-11D-1800-08,4,0.208477757,TCGA-D7-6526,STAD,67,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-24477,Alive,TUMOR FREE,523,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,523,0,523,0,523,0,523,NA,Stage IIIA,T3,M0,GI.CIN,6
-3.853272309,-2.351521315,TCGA-90-7769-01A,TCGA-90-7769-01A-11D-2122-08,8,0.389657553,TCGA-90-7769,LUSC,55,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-20276,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,358,0,358,0,358,0,358,NA,Stage IIB,T2b,MX,NA,10
-4.65273524,1.588004877,TCGA-85-7710-01A,TCGA-85-7710-01A-11D-2122-08,0,NA,TCGA-85-7710,LUSC,59,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-21790,Alive,TUMOR FREE,42,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,42,0,42,0,42,0,42,NA,Stage IA,T1b,M0,NA,10
-3.852821491,-2.493049331,TCGA-19-1787-01B,TCGA-19-1787-01B-01D-1495-08,8,0.438016818,TCGA-19-1787,GBM,48,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-17894,Dead,WITH TUMOR,385,385,[Not Available],Recurrence,[Not Applicable],[Not Applicable],308,[Not Available],1,385,1,385,NA,NA,1,308,NA,NA,NA,NA,GBM_LGG.NA,10
-7.269770031,2.065233346,TCGA-14-1453-01A,TCGA-14-1453-01A-01W-0611-08,9,0.327913571,TCGA-14-1453,GBM,69,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-25297,Dead,WITH TUMOR,35,35,[Not Available],NA,NA,NA,NA,[Not Available],1,35,1,35,NA,NA,1,35,NA,NA,NA,NA,NA,7
9.414903034,-4.389625246,TCGA-HF-7133-01A,TCGA-HF-7133-01A-11D-2053-08,1,0.731356703,TCGA-HF-7133,STAD,NA,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007,[Not Available],NA,Alive,TUMOR FREE,1918,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1918,0,1918,NA,NA,0,1918,NA,Stage IV,T2b,M0,GI.CIN,1
-4.583465801,-1.508212118,TCGA-BR-4363-01A,TCGA-BR-4363-01A-01D-1158-08,8,0.351743732,TCGA-BR-4363,STAD,60,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-22196,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],T3,MX,GI.HM-indel,10
-4.535732323,0.978649048,TCGA-21-5786-01A,TCGA-21-5786-01A-01D-1632-08,0,NA,TCGA-21-5786,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-23649,Alive,TUMOR FREE,1032,NA,[Not Available],Locoregional Recurrence,NA,NA,817,Complete Remission/Response,0,1032,0,1032,1,817,1,817,NA,Stage IB,T2,M0,LUSC.basal,10
9.428213442,-5.340584865,TCGA-BR-4279-01A,TCGA-BR-4279-01A-01D-1126-08,1,0.813337803,TCGA-BR-4279,STAD,43,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009,[Not Available],-16065,Dead,NA,NA,291,[Not Available],NA,NA,NA,NA,[Not Available],1,291,NA,291,NA,NA,0,291,NA,Stage II,T2a,M0,GI.CIN,1
-6.04229129,-1.452821398,TCGA-77-8140-01A,TCGA-77-8140-01A-11D-2244-08,0,NA,TCGA-77-8140,LUSC,66,FEMALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-24415,Dead,NA,NA,351,[Not Available],NA,NA,NA,NA,[Not Applicable],1,351,NA,351,NA,NA,0,351,NA,Stage IIB,T2,M0,NA,10
-7.065899758,-2.288599294,TCGA-22-4609-01A,TCGA-22-4609-01A-21D-2122-08,6,0.258389212,TCGA-22-4609,LUSC,81,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-29844,Dead,TUMOR FREE,NA,291,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,291,0,291,0,291,0,291,NA,Stage IA,T1,M0,NA,2
-7.851951663,1.890627882,TCGA-44-5643-01A,TCGA-44-5643-01A-01D-1625-08,9,0.500074124,TCGA-44-5643,LUAD,53,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-19426,Alive,TUMOR FREE,1013,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1013,0,1013,NA,NA,0,1013,NA,Stage IIIA,T2b,M0,NA,7
-0.150454621,4.923349457,TCGA-G9-7510-01A,TCGA-G9-7510-01A-11D-2260-08,4,0.694146578,TCGA-G9-7510,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24187,Alive,TUMOR FREE,1185,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1185,0,1185,0,1185,0,1185,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,6
9.422679286,-5.501886666,TCGA-EJ-5501-01A,TCGA-EJ-5501-01A-01D-1576-08,1,0.855066378,TCGA-EJ-5501,PRAD,55,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20409,Alive,TUMOR FREE,1365,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1365,0,1365,0,1365,0,1365,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,1
8.729302942,-5.012631002,TCGA-CH-5740-01A,TCGA-CH-5740-01A-11D-1576-08,1,0.836164885,TCGA-CH-5740,PRAD,57,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20880,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
0.391316078,4.270953252,TCGA-EJ-5518-01A,TCGA-EJ-5518-01A-01D-1576-08,4,0.233672034,TCGA-EJ-5518,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24313,Alive,WITH TUMOR,2118,NA,[Not Available],Distant Metastasis,Bone,NA,2104,Progressive Disease,0,2118,0,2118,NA,NA,1,2104,NA,[Not Applicable],T4,[Not Applicable],PRAD.8-other,6
9.542199486,-5.612773189,TCGA-CH-5746-01A,TCGA-CH-5746-01A-11D-1576-08,1,0.875985371,TCGA-CH-5746,PRAD,57,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-20941,Alive,TUMOR FREE,731,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,731,0,731,0,731,0,731,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
8.951250922,-5.143437429,TCGA-HC-8265-01A,TCGA-HC-8265-01A-11D-2260-08,1,0.780410029,TCGA-HC-8265,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24382,Alive,TUMOR FREE,483,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,483,0,483,0,483,0,483,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,1
9.227994893,-5.607038451,TCGA-EJ-5512-01A,TCGA-EJ-5512-01A-01D-1576-08,1,0.860153305,TCGA-EJ-5512,PRAD,46,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-17127,Alive,TUMOR FREE,1733,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1733,0,1733,0,1733,0,1733,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
2.129421762,1.840605953,TCGA-HC-7211-01A,TCGA-HC-7211-01A-11D-2114-08,3,0.335079161,TCGA-HC-7211,PRAD,62,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-22768,Alive,TUMOR FREE,1221,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1221,0,1221,0,1221,0,1221,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,3
-0.192199831,4.753536662,TCGA-G9-6342-01A,TCGA-G9-6342-01A-11D-1961-08,4,0.693034213,TCGA-G9-6342,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-22472,Alive,TUMOR FREE,1696,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1696,0,1696,0,1696,0,1696,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
8.996403671,-5.531085693,TCGA-EJ-7321-01A,TCGA-EJ-7321-01A-31D-2260-08,1,0.80095163,TCGA-EJ-7321,PRAD,57,MALE,BLACK OR AFRICAN AMERICAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21108,Alive,TUMOR FREE,824,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,824,0,824,0,824,0,824,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-0.136716083,4.792849954,TCGA-G9-6499-01A,TCGA-G9-6499-01A-12D-1961-08,4,0.701938445,TCGA-G9-6499,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24388,Alive,TUMOR FREE,1543,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1543,0,1543,0,1543,0,1543,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,6
2.159278828,1.745321513,TCGA-HC-7209-01A,TCGA-HC-7209-01A-11D-2114-08,3,0.494841648,TCGA-HC-7209,PRAD,60,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22129,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,440,0,440,0,440,0,440,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,3
9.22927792,-5.199760947,TCGA-EJ-5497-01A,TCGA-EJ-5497-01A-02D-1576-08,1,0.850471178,TCGA-EJ-5497,PRAD,47,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-17523,Alive,TUMOR FREE,405,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,405,0,405,0,405,0,405,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.528611451,-4.988560165,TCGA-EJ-5504-01A,TCGA-EJ-5504-01A-01D-1576-08,1,0.838419607,TCGA-EJ-5504,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24072,Alive,WITH TUMOR,1427,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1427,0,1427,NA,NA,0,1427,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,1
9.290036119,-5.066363987,TCGA-EJ-5516-01A,TCGA-EJ-5516-01A-01D-1576-08,1,0.848353115,TCGA-EJ-5516,PRAD,49,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-17980,Alive,TUMOR FREE,1889,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1889,0,1889,0,1889,0,1889,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.628661787,-5.722546057,TCGA-CH-5745-01A,TCGA-CH-5745-01A-11D-1576-08,1,0.88587423,TCGA-CH-5745,PRAD,68,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24837,Alive,TUMOR FREE,91,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,91,0,91,NA,NA,0,91,NA,[Not Applicable],T3a,[Not Applicable],NA,1
0.029597595,3.147071506,TCGA-62-A470-01A,TCGA-62-A470-01A-11D-A24D-08,4,0.343560495,TCGA-62-A470,LUAD,84,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-30689,Dead,WITH TUMOR,NA,1194,[Not Available],Locoregional Recurrence,NA,NA,539,Complete Remission/Response,1,1194,1,1194,1,539,1,539,NA,Stage IB,T2,M0,NA,3
-5.294939729,2.359664697,TCGA-L9-A443-01A,TCGA-L9-A443-01A-12D-A24D-08,12,0.21827331,TCGA-L9-A443,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23062,Dead,TUMOR FREE,NA,193,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,193,0,193,0,193,0,193,NA,Stage IA,T1a,MX,NA,9
9.247654868,-5.31534885,TCGA-EJ-7788-01A,TCGA-EJ-7788-01A-11D-2114-08,1,0.823552145,TCGA-EJ-7788,PRAD,53,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19623,Alive,TUMOR FREE,859,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,859,0,859,0,859,0,859,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,1
-8.036222638,1.909058545,TCGA-HC-7078-01A,TCGA-HC-7078-01A-11D-2114-08,9,0.636536061,TCGA-HC-7078,PRAD,69,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-25402,Alive,TUMOR FREE,1985,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1985,0,1985,0,1985,0,1985,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,7
9.87312598,-1.80521373,TCGA-HC-7752-01A,TCGA-HC-7752-01A-11D-2114-08,1,0.819202977,TCGA-HC-7752,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22366,Alive,TUMOR FREE,782,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,782,0,782,0,782,0,782,NA,[Not Applicable],T2c,[Not Applicable],NA,1
2.915312054,3.440271072,TCGA-EJ-5530-01A,TCGA-EJ-5530-01A-01D-1576-08,0,NA,TCGA-EJ-5530,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-22316,Alive,TUMOR FREE,1832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1832,0,1832,0,1832,0,1832,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,3
9.331891311,-5.40729585,TCGA-CH-5789-01A,TCGA-CH-5789-01A-11D-1576-08,1,0.867518307,TCGA-CH-5789,PRAD,61,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-22494,Alive,TUMOR FREE,304,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,304,0,304,0,304,0,304,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-6.29796992,3.531806036,TCGA-HC-7740-01A,TCGA-HC-7740-01A-11D-2114-08,11,0.292430736,TCGA-HC-7740,PRAD,59,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21883,Alive,TUMOR FREE,717,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,717,0,717,0,717,0,717,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,7
8.748950433,-4.062285012,TCGA-EJ-7123-01A,TCGA-EJ-7123-01A-11D-1961-08,1,0.734695792,TCGA-EJ-7123,PRAD,59,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-21741,Alive,TUMOR FREE,2572,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2572,0,2572,0,2572,0,2572,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
9.273672099,-5.360677053,TCGA-EJ-5502-01A,TCGA-EJ-5502-01A-01D-1576-08,1,0.857913216,TCGA-EJ-5502,PRAD,50,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-18447,Alive,TUMOR FREE,1171,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1171,0,1171,0,1171,0,1171,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.00053814,-5.581761633,TCGA-HC-7744-01A,TCGA-HC-7744-01A-11D-2114-08,1,0.756477113,TCGA-HC-7744,PRAD,46,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-17065,Alive,TUMOR FREE,531,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,531,0,531,0,531,0,531,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.508072589,-5.66733543,TCGA-G9-7523-01A,TCGA-G9-7523-01A-11D-2260-08,1,0.860718968,TCGA-G9-7523,PRAD,44,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-16269,Alive,TUMOR FREE,857,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,857,0,857,0,857,0,857,NA,[Not Applicable],T3a,[Not Applicable],PRAD.7-IDH1,1
4.290023451,1.061183087,TCGA-G9-6329-01A,TCGA-G9-6329-01A-13D-1961-08,2,0.635285586,TCGA-G9-6329,PRAD,67,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-24797,Alive,TUMOR FREE,1266,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1266,0,1266,0,1266,0,1266,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,5
-1.347006402,2.935404422,TCGA-HQ-A2OF-01A,TCGA-HQ-A2OF-01A-11D-A26M-08,4,0.092541989,TCGA-HQ-A2OF,BLCA,52,FEMALE,[Not Evaluated],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-19016,Alive,TUMOR FREE,1947,NA,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,907,Complete Remission/Response,0,1947,0,1947,1,907,1,907,NA,Stage III,T3b,M0,NA,6
-1.77826165,0.992254226,TCGA-HQ-A5ND-01A,TCGA-HQ-A5ND-01A-11D-A26M-08,5,0.553264125,TCGA-HQ-A5ND,BLCA,78,MALE,[Not Evaluated],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-28555,Dead,WITH TUMOR,NA,274,[Not Available],Distant Metastasis,Lymph Node Only,NA,84,Progressive Disease,1,274,1,274,NA,NA,1,84,NA,Stage IV,T3b,M0,NA,4
-5.279628106,1.921010828,TCGA-55-7727-01A,TCGA-55-7727-01A-11D-2167-08,0,NA,TCGA-55-7727,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25929,Alive,TUMOR FREE,119,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,119,0,119,0,119,0,119,NA,Stage IIIA,T1a,MX,LUAD.3,10
-6.299831734,-1.430669722,TCGA-GU-A766-01A,TCGA-GU-A766-01A-11D-A32B-08,7,0.156617451,TCGA-GU-A766,BLCA,62,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-22774,Alive,WITH TUMOR,480,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,480,0,480,NA,NA,0,480,NA,Stage II,T2a,MX,NA,2
-4.112193342,-1.879818124,TCGA-GU-A767-01A,TCGA-GU-A767-01A-11D-A32B-08,8,0.39339004,TCGA-GU-A767,BLCA,81,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-29739,Dead,WITH TUMOR,NA,144,[Not Available],NA,NA,NA,NA,Progressive Disease,1,144,1,144,NA,NA,1,144,NA,Stage IV,T3b,MX,NA,10
-4.245081904,-0.694996568,TCGA-GU-AATO-01A,TCGA-GU-AATO-01A-11D-A391-08,0,NA,TCGA-GU-AATO,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-27684,Dead,WITH TUMOR,NA,324,[Not Available],NA,NA,NA,NA,Progressive Disease,1,324,1,324,NA,NA,1,324,NA,Stage IV,T4a,MX,NA,10
-4.412419365,-1.812456271,TCGA-GU-AATP-01A,TCGA-GU-AATP-01A-11D-A391-08,8,0.433947296,TCGA-GU-AATP,BLCA,74,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27049,Alive,WITH TUMOR,1003,NA,[Not Available],New Primary Tumor,Urethra,NA,596,Progressive Disease,0,1003,0,1003,NA,NA,1,596,NA,Stage IV,T2,MX,NA,10
-5.802830763,0.890677454,TCGA-GU-AATQ-01A,TCGA-GU-AATQ-01A-11D-A391-08,0,NA,TCGA-GU-AATQ,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-25185,Dead,WITH TUMOR,NA,213,[Not Available],NA,NA,NA,NA,Stable Disease,1,213,1,213,NA,NA,1,213,NA,Stage III,T3b,MX,NA,9
9.540217605,-2.139156193,TCGA-HC-7748-01A,TCGA-HC-7748-01A-11D-2114-08,1,0.742654877,TCGA-HC-7748,PRAD,60,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22072,Alive,TUMOR FREE,792,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,792,0,792,0,792,0,792,NA,[Not Applicable],T2a,[Not Applicable],PRAD.1-ERG,1
9.071786878,-4.301842257,TCGA-CH-5791-01A,TCGA-CH-5791-01A-11D-1576-08,1,0.766902722,TCGA-CH-5791,PRAD,72,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-26390,Alive,NA,1004,NA,[Not Available],New Primary Tumor,NA,NA,396,Complete Remission/Response,0,1004,0,1004,0,1004,1,396,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.66831158,-2.320893904,TCGA-G9-6363-01A,TCGA-G9-6363-01A-21D-1786-08,1,0.770823694,TCGA-G9-6363,PRAD,64,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-23480,Alive,TUMOR FREE,1378,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1378,0,1378,0,1378,0,1378,NA,[Not Applicable],T4,[Not Applicable],PRAD.1-ERG,1
9.440112963,-5.204703434,TCGA-EJ-5531-01A,TCGA-EJ-5531-01A-01D-1576-08,1,0.818950629,TCGA-EJ-5531,PRAD,62,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-22760,Alive,TUMOR FREE,1273,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1273,0,1273,0,1273,0,1273,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
9.642364559,-2.357222235,TCGA-EJ-7785-01A,TCGA-EJ-7785-01A-11D-2114-08,1,0.77363928,TCGA-EJ-7785,PRAD,54,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19939,Alive,TUMOR FREE,1177,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1177,0,1177,0,1177,0,1177,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.070315775,-4.981516023,TCGA-G9-7522-01A,TCGA-G9-7522-01A-11D-2260-08,1,0.840998169,TCGA-G9-7522,PRAD,49,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-18033,Alive,TUMOR FREE,1078,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1078,0,1078,0,1078,0,1078,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
0.427771531,2.203891861,TCGA-G9-6348-01A,TCGA-G9-6348-01A-11D-1786-08,0,NA,TCGA-G9-6348,PRAD,68,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24936,Alive,TUMOR FREE,1515,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1515,0,1515,0,1515,0,1515,NA,[Not Applicable],T2c,[Not Applicable],PRAD.2-ETV1,6
9.294245146,-5.443817031,TCGA-EJ-5532-01A,TCGA-EJ-5532-01A-01D-1576-08,1,0.770291144,TCGA-EJ-5532,PRAD,57,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-21110,Alive,TUMOR FREE,1828,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1828,0,1828,0,1828,0,1828,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
-0.769828386,4.846747333,TCGA-76-4934-01A,TCGA-76-4934-01A-01D-1486-08,4,0.524159139,TCGA-76-4934,GBM,66,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-24319,Dead,TUMOR FREE,77,77,[Not Available],NA,NA,NA,NA,[Not Available],1,77,0,77,NA,NA,0,77,NA,NA,NA,NA,NA,6
-7.112743799,-2.325376371,TCGA-GU-A762-01A,TCGA-GU-A762-01A-11D-A339-08,6,0.034117957,TCGA-GU-A762,BLCA,87,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-31812,Dead,WITH TUMOR,NA,232,[Not Available],NA,NA,NA,NA,Progressive Disease,1,232,1,232,NA,NA,1,232,NA,Stage IV,T4a,MX,NA,2
-7.278128915,-2.543151534,TCGA-GU-A763-01A,TCGA-GU-A763-01A-11D-A32B-08,6,0.170156361,TCGA-GU-A763,BLCA,72,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26527,Alive,WITH TUMOR,997,NA,[Not Available],Distant Metastasis,Lung,NA,303,Stable Disease,0,997,0,997,NA,NA,1,303,NA,Stage III,T4,M0,NA,2
-0.018426226,3.216021431,TCGA-GU-A764-01A,TCGA-GU-A764-01A-11D-A34U-08,4,0.444926153,TCGA-GU-A764,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24343,Alive,TUMOR FREE,610,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,610,0,610,0,610,0,610,NA,Stage II,T2b,MX,NA,3
-2.306086185,2.378768311,TCGA-55-6981-01A,TCGA-55-6981-01A-11D-1945-08,0,NA,TCGA-55-6981,LUAD,53,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-19497,Dead,TUMOR FREE,NA,1379,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1379,0,1379,0,1379,0,1379,NA,Stage IIIA,T1,M0,LUAD.3,10
-3.04296487,-3.753644833,TCGA-AZ-6601-01A,TCGA-AZ-6601-01A-11D-1771-10,8,0.372087149,TCGA-AZ-6601,COAD,68,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-25082,Dead,WITH TUMOR,NA,3042,[Not Available],Locoregional Disease,NA,NA,2270,Progressive Disease,1,3042,1,3042,NA,NA,1,2270,NA,Stage II,T3,M0,NA,10
-1.086861325,3.753504865,TCGA-FD-A6TF-01A,TCGA-FD-A6TF-01A-52D-A32B-08,4,0.364724979,TCGA-FD-A6TF,BLCA,80,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-29317,Dead,TUMOR FREE,NA,69,[Not Available],NA,NA,NA,NA,Progressive Disease,1,69,0,69,NA,NA,0,69,NA,Stage IV,T3b,M1,NA,5
-2.067374923,2.317831125,TCGA-FD-A6TK-01A,TCGA-FD-A6TK-01A-42D-A339-08,0,NA,TCGA-FD-A6TK,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-21942,Alive,TUMOR FREE,330,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,330,0,330,0,330,0,330,NA,Stage III,T3a,MX,NA,3
-5.38955005,1.150749489,TCGA-55-7726-01A,TCGA-55-7726-01A-11D-2167-08,0,NA,TCGA-55-7726,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26451,Alive,TUMOR FREE,652,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,652,0,652,0,652,0,652,NA,Stage IA,T1b,MX,LUAD.6,9
-4.133134399,-2.141796147,TCGA-G2-AA3B-01A,TCGA-G2-AA3B-01A-11D-A391-08,8,0.419086328,TCGA-G2-AA3B,BLCA,75,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-27646,Alive,TUMOR FREE,2008,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2008,0,2008,0,2008,0,2008,NA,Stage II,T2,M0,NA,10
-5.396360159,1.253680335,TCGA-G2-AA3C-01A,TCGA-G2-AA3C-01A-21D-A391-08,0,NA,TCGA-G2-AA3C,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-24267,Dead,WITH TUMOR,NA,211,[Not Available],NA,NA,NA,NA,[Unknown],1,211,1,211,NA,NA,1,211,NA,Stage IV,T3b,M0,NA,10
-4.389576895,1.14022341,TCGA-G2-AA3D-01A,TCGA-G2-AA3D-01A-11D-A391-08,0,NA,TCGA-G2-AA3D,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-22205,Alive,TUMOR FREE,2139,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2139,0,2139,NA,NA,0,2139,NA,Stage IV,T3,M0,NA,10
-0.22854228,4.228218758,TCGA-G2-AA3F-01A,TCGA-G2-AA3F-01A-12D-A42E-08,4,0.447642585,TCGA-G2-AA3F,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-28457,Alive,TUMOR FREE,893,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,893,0,893,NA,NA,0,893,NA,Stage IV,T3,M0,NA,6
9.0125695,-4.912315995,TCGA-CH-5750-01A,TCGA-CH-5750-01A-11D-1576-08,1,0.835232069,TCGA-CH-5750,PRAD,72,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-26389,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,396,0,396,0,396,0,396,NA,[Not Applicable],T2c,[Not Applicable],PRAD.2-ETV1,1
-5.815149508,-1.172992173,TCGA-GD-A76B-01A,TCGA-GD-A76B-01A-11D-A32B-08,0,NA,TCGA-GD-A76B,BLCA,86,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-31571,Alive,TUMOR FREE,224,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,224,0,224,0,224,0,224,NA,Stage II,T2b,MX,NA,2
8.93210038,-5.306772915,TCGA-HC-7742-01A,TCGA-HC-7742-01A-11D-2114-08,1,0.700164026,TCGA-HC-7742,PRAD,58,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21323,Alive,WITH TUMOR,938,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,938,0,938,NA,NA,0,938,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,3
-1.757347622,2.358413823,TCGA-EB-A3XC-01A,TCGA-EB-A3XC-01A-11D-A23B-08,0,NA,TCGA-EB-A3XC,SKCM,74,MALE,WHITE,NA,[Not Available],2012,[Not Available],-27124,Alive,TUMOR FREE,650,NA,[Not Available],Distant Metastasis|Regional lymph node,"Other, Specify|[Not Available]",Chest wall|[Not Applicable],74,[Not Available],0,650,0,650,NA,NA,1,74,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
8.912517203,-5.167289701,TCGA-HC-7821-01A,TCGA-HC-7821-01A-12D-2114-08,1,0.82818857,TCGA-HC-7821,PRAD,54,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19894,Alive,WITH TUMOR,956,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,956,0,956,0,956,0,956,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-1.461454803,3.686237441,TCGA-G4-6310-01A,TCGA-G4-6310-01A-11D-1719-10,4,0.210734666,TCGA-G4-6310,COAD,69,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-25243,Alive,TUMOR FREE,1935,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1935,0,1935,0,1935,0,1935,NA,Stage IIIB,T3,M0,NA,6
4.352952275,1.205831088,TCGA-EJ-5519-01A,TCGA-EJ-5519-01A-01D-1576-08,2,0.701287468,TCGA-EJ-5519,PRAD,64,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23669,Alive,TUMOR FREE,1962,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1962,0,1962,0,1962,0,1962,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,5
-0.157542667,5.195962419,TCGA-EJ-5521-01A,TCGA-EJ-5521-01A-01D-1576-08,4,0.555657145,TCGA-EJ-5521,PRAD,63,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23304,Alive,TUMOR FREE,2279,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2279,0,2279,0,2279,0,2279,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,6
4.143676084,1.182838429,TCGA-CH-5769-01A,TCGA-CH-5769-01A-11D-1576-08,2,0.406961978,TCGA-CH-5769,PRAD,48,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-17807,Alive,WITH TUMOR,62,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,62,0,62,NA,NA,0,62,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,5
8.777838611,-4.540989021,TCGA-HC-7749-01A,TCGA-HC-7749-01A-11D-2114-08,1,0.755745008,TCGA-HC-7749,PRAD,70,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25688,Alive,TUMOR FREE,724,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,724,0,724,0,724,0,724,NA,[Not Applicable],T3a,[Not Applicable],PRAD.3-ETV4,1
9.36493755,-2.406717034,TCGA-G9-6364-01A,TCGA-G9-6364-01A-21D-1786-08,1,0.726934467,TCGA-G9-6364,PRAD,72,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-26603,Alive,TUMOR FREE,1198,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1198,0,1198,0,1198,0,1198,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-7.800305011,-2.364005205,TCGA-CH-5766-01A,TCGA-CH-5766-01A-11D-1576-08,6,0.331265446,TCGA-CH-5766,PRAD,55,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-20392,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,2
9.235960131,-5.257549496,TCGA-EJ-5498-01A,TCGA-EJ-5498-01A-01D-1576-08,1,0.803914889,TCGA-EJ-5498,PRAD,56,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20472,Alive,TUMOR FREE,1720,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1720,0,1720,0,1720,0,1720,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-7.653534643,2.094755012,TCGA-27-2527-01A,TCGA-27-2527-01A-01D-1494-08,9,0.477074197,TCGA-27-2527,GBM,81,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-29619,Dead,WITH TUMOR,438,438,[Not Available],NA,NA,NA,NA,[Not Available],1,438,1,438,NA,NA,1,438,NA,NA,NA,NA,NA,7
-6.463376121,-1.210822611,TCGA-E7-A6MF-01A,TCGA-E7-A6MF-01A-12D-A32B-08,7,0.234208429,TCGA-E7-A6MF,BLCA,37,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013,[Not Available],-13867,Alive,TUMOR FREE,750,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,750,0,750,0,750,0,750,NA,Stage II,T2a,M0,NA,2
-3.213118621,-3.439361578,TCGA-E7-A7XN-01A,TCGA-E7-A7XN-01A-11D-A34U-08,8,0.639438132,TCGA-E7-A7XN,BLCA,66,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-24466,Alive,WITH TUMOR,428,NA,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,190,Progressive Disease,0,428,0,428,NA,NA,1,190,NA,Stage III,T3,M0,NA,10
-5.432905413,1.0369895,TCGA-FD-A6TB-01A,TCGA-FD-A6TB-01A-12D-A339-08,0,NA,TCGA-FD-A6TB,BLCA,82,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-30185,Alive,TUMOR FREE,572,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,572,0,572,0,572,0,572,NA,Stage III,T3a,MX,NA,10
-4.135395726,-0.145863552,TCGA-50-6594-01A,TCGA-50-6594-01A-11D-1753-08,0,NA,TCGA-50-6594,LUAD,79,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-28924,Dead,WITH TUMOR,NA,370,[Not Available],Distant Metastasis,NA,NA,285,Progressive Disease,1,370,1,370,NA,NA,1,285,NA,Stage IIIA,T3,M0,NA,10
0.10579344,4.904083838,TCGA-CF-A5U8-01A,TCGA-CF-A5U8-01A-11D-A289-08,4,0.667466517,TCGA-CF-A5U8,BLCA,59,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-21734,Alive,TUMOR FREE,399,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,399,0,399,0,399,0,399,NA,Stage II,T2,M0,NA,6
-4.423237627,1.662046982,TCGA-CF-A5UA-01A,TCGA-CF-A5UA-01A-11D-A289-08,0,NA,TCGA-CF-A5UA,BLCA,67,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-24625,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,365,0,365,0,365,0,365,NA,Stage II,T2,M0,NA,9
8.088328435,-2.886069366,TCGA-DK-AA6T-01A,TCGA-DK-AA6T-01A-11D-A391-08,1,0.169436789,TCGA-DK-AA6T,BLCA,63,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23198,Alive,TUMOR FREE,572,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,572,0,572,0,572,0,572,NA,Stage II,[Not Available],M0,NA,1
-5.745702425,1.041230796,TCGA-DK-AA6X-01A,TCGA-DK-AA6X-01A-12D-A42E-08,0,NA,TCGA-DK-AA6X,BLCA,63,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23208,Alive,TUMOR FREE,467,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,467,0,467,NA,NA,0,467,NA,Stage II,[Not Available],M0,NA,9
-1.90765707,2.091558809,TCGA-E7-A6ME-01A,TCGA-E7-A6ME-01A-22D-A32B-08,0,NA,TCGA-E7-A6ME,BLCA,75,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-27670,Alive,TUMOR FREE,731,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,731,0,731,0,731,0,731,NA,Stage II,T2b,M0,NA,3
0.086102558,5.061458909,TCGA-EJ-5507-01A,TCGA-EJ-5507-01A-01D-1576-08,4,0.600997041,TCGA-EJ-5507,PRAD,54,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-19759,Alive,TUMOR FREE,1457,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1457,0,1457,0,1457,0,1457,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,6
8.629535504,-1.939679275,TCGA-EJ-5495-01A,TCGA-EJ-5495-01A-01D-1576-08,1,0.543834547,TCGA-EJ-5495,PRAD,68,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-24904,Alive,TUMOR FREE,1760,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1760,0,1760,0,1760,0,1760,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-7.079219788,-2.30781658,TCGA-A6-3810-01A,TCGA-A6-3810-01A-01D-A270-10,6,0.355682223,TCGA-A6-3810,COAD,62,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-22999,Alive,TUMOR FREE,1111,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1111,0,1111,0,1111,0,1111,NA,Stage IIA,T3,M0,NA,2
8.74089715,-4.077209568,TCGA-EJ-5509-01A,TCGA-EJ-5509-01A-01D-1576-08,1,0.716025416,TCGA-EJ-5509,PRAD,63,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-23368,Alive,TUMOR FREE,1464,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1464,0,1464,0,1464,0,1464,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
-3.420037735,-3.207588652,TCGA-CM-4743-01A,TCGA-CM-4743-01A-01D-1719-10,8,0.610123578,TCGA-CM-4743,COAD,69,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-25291,Alive,TUMOR FREE,701,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,701,0,701,0,701,0,701,NA,Stage IIA,T3,M0,GI.HM-indel,10
-4.120906568,0.181452817,TCGA-EJ-7782-01A,TCGA-EJ-7782-01A-11D-2114-08,0,NA,TCGA-EJ-7782,PRAD,71,MALE,BLACK OR AFRICAN AMERICAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-25965,Alive,TUMOR FREE,1167,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1167,0,1167,0,1167,0,1167,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,10
8.619708908,-3.9338702,TCGA-CH-5788-01A,TCGA-CH-5788-01A-11D-1576-08,1,0.716212835,TCGA-CH-5788,PRAD,69,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-25233,Alive,WITH TUMOR,821,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,821,0,821,NA,NA,0,821,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,1
-6.036227688,3.502980391,TCGA-CH-5771-01A,TCGA-CH-5771-01A-21D-1576-08,11,0.521305656,TCGA-CH-5771,PRAD,63,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23101,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,396,0,396,0,396,0,396,NA,[Not Applicable],T2c,[Not Applicable],PRAD.3-ETV4,8
8.96097893,-5.245930315,TCGA-EJ-5526-01A,TCGA-EJ-5526-01A-01D-1576-08,1,0.851106161,TCGA-EJ-5526,PRAD,56,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20558,Alive,WITH TUMOR,1909,NA,[Not Available],Locoregional Recurrence,NA,NA,537,Progressive Disease,0,1909,0,1909,NA,NA,1,537,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-0.515738991,4.484531014,TCGA-4Z-AA7O-01A,TCGA-4Z-AA7O-01A-31D-A391-08,4,0.435888836,TCGA-4Z-AA7O,BLCA,64,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23645,Alive,TUMOR FREE,512,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,512,0,512,0,512,0,512,NA,Stage II,T2a,M0,NA,6
4.226063615,1.251208745,TCGA-12-0828-01A,TCGA-12-0828-01A-01W-0424-08,2,0.503224524,TCGA-12-0828,GBM,57,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-20909,Dead,WITH TUMOR,272,272,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],13,[Not Available],1,272,1,272,NA,NA,1,13,NA,NA,NA,NA,NA,5
-4.697099237,-1.567668242,TCGA-4Z-AA7R-01A,TCGA-4Z-AA7R-01A-11D-A391-08,8,0.291027899,TCGA-4Z-AA7R,BLCA,73,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-26781,Dead,WITH TUMOR,NA,522,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,353,Partial Remission/Response,1,522,1,522,NA,NA,1,353,NA,Stage IV,T4b,M0,NA,10
-0.595798912,4.785529366,TCGA-49-4494-01A,TCGA-49-4494-01A-01D-1265-08,4,0.520928369,TCGA-49-4494,LUAD,77,MALE,WHITE,Lung Adenocarcinoma,[Not Available],1995,[Not Available],-28387,Dead,WITH TUMOR,NA,1081,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1081,1,1081,NA,NA,1,1081,NA,Stage IIIA,T3,M0,LUAD.3,9
-4.879408932,-1.659191218,TCGA-4Z-AA7Y-01A,TCGA-4Z-AA7Y-01A-11D-A391-08,8,0.243736619,TCGA-4Z-AA7Y,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-22056,Alive,TUMOR FREE,1522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1522,0,1522,0,1522,0,1522,NA,Stage II,T2a,M0,NA,10
-4.635032805,0.424700539,TCGA-4Z-AA81-01A,TCGA-4Z-AA81-01A-11D-A391-08,0,NA,TCGA-4Z-AA81,BLCA,80,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-29457,Dead,TUMOR FREE,NA,1270,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1270,0,1270,0,1270,0,1270,NA,Stage II,T2b,M0,NA,10
-1.902218247,1.313979339,TCGA-4Z-AA83-01A,TCGA-4Z-AA83-01A-11D-A391-08,5,0.277067349,TCGA-4Z-AA83,BLCA,52,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-19280,Alive,TUMOR FREE,2024,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2024,0,2024,0,2024,0,2024,NA,Stage II,T2a,M0,NA,4
-0.690431856,4.364815642,TCGA-2F-A9KP-01A,TCGA-2F-A9KP-01A-11D-A38G-08,4,0.400209187,TCGA-2F-A9KP,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-24428,Dead,WITH TUMOR,NA,364,[Not Available],Distant Metastasis,Liver,NA,343,Progressive Disease,1,364,1,364,NA,NA,1,343,NA,Stage IV,T3a,MX,NA,6
-4.667378036,2.044976981,TCGA-2F-A9KQ-01A,TCGA-2F-A9KQ-01A-11D-A38G-08,0,NA,TCGA-2F-A9KQ,BLCA,69,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-25259,Alive,TUMOR FREE,2886,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2886,0,2886,0,2886,0,2886,NA,Stage III,T3a,M0,NA,8
8.588985287,-2.32603288,TCGA-86-8669-01A,TCGA-86-8669-01A-11D-2393-08,1,0.589150683,TCGA-86-8669,LUAD,64,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23443,Alive,TUMOR FREE,938,NA,[Not Available],Distant Metastasis,NA,NA,849,Complete Remission/Response,0,938,0,938,1,849,1,849,NA,Stage IA,T1b,M0,NA,6
-0.794363301,3.969778054,TCGA-CH-5762-01A,TCGA-CH-5762-01A-11D-1576-08,4,0.390076156,TCGA-CH-5762,PRAD,60,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2005,[Not Available],-22068,Alive,[Discrepancy],1339,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1339,0,1339,0,1339,0,1339,NA,[Not Applicable],T3b,[Not Applicable],PRAD.3-ETV4,5
-4.535959895,0.098779128,TCGA-2F-A9KR-01A,TCGA-2F-A9KR-01A-11D-A38G-08,0,NA,TCGA-2F-A9KR,BLCA,59,FEMALE,[Not Evaluated],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000,[Not Available],-21848,Dead,WITH TUMOR,NA,3183,[Not Available],Distant Metastasis,Lung,NA,3086,Complete Remission/Response,1,3183,1,3183,1,3086,1,3086,NA,Stage III,T3a,M0,NA,10
-4.352268179,-0.619383121,TCGA-2F-A9KT-01A,TCGA-2F-A9KT-01A-11D-A38G-08,0,NA,TCGA-2F-A9KT,BLCA,83,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-30520,Alive,TUMOR FREE,3314,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3314,0,3314,0,3314,0,3314,NA,Stage II,T2b,M0,NA,10
9.143202148,-4.710289056,TCGA-HC-7075-01A,TCGA-HC-7075-01A-11D-1961-08,1,0.803055205,TCGA-HC-7075,PRAD,63,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],NA,Alive,TUMOR FREE,601,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,601,0,601,0,601,0,601,NA,[Not Applicable],T2a,[Not Applicable],PRAD.8-other,1
-6.658763722,2.125399465,TCGA-2F-A9KW-01A,TCGA-2F-A9KW-01A-11D-A38G-08,0,NA,TCGA-2F-A9KW,BLCA,67,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-24703,Dead,WITH TUMOR,NA,254,[Not Available],Distant Metastasis,Bone,NA,85,Stable Disease,1,254,1,254,NA,NA,1,85,NA,Stage III,T3b,MX,NA,9
-6.406794772,-1.115551127,TCGA-AY-6386-01A,TCGA-AY-6386-01A-21D-1719-10,7,0.276401527,TCGA-AY-6386,COAD,66,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-24453,Alive,TUMOR FREE,542,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,542,0,542,0,542,0,542,NA,Stage IIIB,T3,M0,GI.GS,2
-7.738924317,-2.443536764,TCGA-HC-7736-01A,TCGA-HC-7736-01A-11D-2114-08,6,0.550993985,TCGA-HC-7736,PRAD,59,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-21703,Alive,TUMOR FREE,1103,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1103,0,1103,0,1103,0,1103,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,2
-2.881516259,-4.08191002,TCGA-BR-4361-01A,TCGA-BR-4361-01A-01D-1158-08,8,0.118280892,TCGA-BR-4361,STAD,66,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-24260,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIIA,T4,M0,GI.HM-indel,10
9.615875957,-1.864445828,TCGA-HC-7747-01A,TCGA-HC-7747-01A-11D-2114-08,1,0.764452098,TCGA-HC-7747,PRAD,52,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19188,Alive,TUMOR FREE,748,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,748,0,748,0,748,0,748,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-4.760153553,0.191833369,TCGA-B7-5818-01A,TCGA-B7-5818-01A-11D-1600-08,0,NA,TCGA-B7-5818,STAD,62,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-22792,Alive,TUMOR FREE,356,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,356,0,356,NA,NA,0,356,NA,Stage IB,T2,M0,GI.EBV,10
9.065815704,-3.767849243,TCGA-06-5418-01A,TCGA-06-5418-01A-01D-1486-08,1,0.737058935,TCGA-06-5418,GBM,75,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-27584,Dead,WITH TUMOR,83,83,[Not Available],NA,NA,NA,NA,[Not Available],1,83,1,83,NA,NA,1,83,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-6.345453167,1.41726694,TCGA-VW-A8FI-01A,TCGA-VW-A8FI-01A-11D-A36O-08,10,0.211177181,TCGA-VW-A8FI,LGG,66,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-24411,Dead,WITH TUMOR,NA,245,[Not Available],NA,NA,NA,NA,Stable Disease,1,245,1,245,NA,NA,1,245,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-6.094442461,3.447894214,TCGA-W9-A837-01A,TCGA-W9-A837-01A-11D-A36O-08,11,0.593063432,TCGA-W9-A837,LGG,47,MALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],NA,Alive,WITH TUMOR,1553,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1553,0,1553,NA,NA,0,1553,NA,NA,NA,NA,GBM_LGG.Codel,8
-4.499464203,-0.822825248,TCGA-99-8025-01A,TCGA-99-8025-01A-11D-2238-08,8,0.12360432,TCGA-99-8025,LUAD,72,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-26634,Alive,TUMOR FREE,1060,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1060,0,1060,0,1060,0,1060,NA,Stage IIIA,T3,M0,NA,10
-3.706616847,-2.518079479,TCGA-2F-A9KO-01A,TCGA-2F-A9KO-01A-11D-A38G-08,8,0.408004896,TCGA-2F-A9KO,BLCA,63,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-23323,Dead,WITH TUMOR,NA,734,[Not Available],Distant Metastasis,Liver,NA,651,Progressive Disease,1,734,1,734,NA,NA,1,651,NA,Stage IV,T3,M0,NA,10
-5.988704003,1.671496835,TCGA-G4-6297-01A,TCGA-G4-6297-01A-11D-1719-10,10,0.093235983,TCGA-G4-6297,COAD,55,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2005,[Not Available],-20103,Alive,WITH TUMOR,2506,NA,[Not Available],NA,NA,NA,439,[Not Available],0,2506,0,2506,NA,NA,1,439,NA,Stage IV,T3,M1,GI.CIN,7
-6.984379463,1.556173118,TCGA-50-5044-01A,TCGA-50-5044-01A-21D-1855-08,0,NA,TCGA-50-5044,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-26567,Dead,WITH TUMOR,NA,624,[Not Available],Distant Metastasis,NA,NA,483,Progressive Disease,1,624,1,624,NA,NA,1,483,NA,Stage IIIB,T4,M0,LUAD.6,9
9.970760982,-2.323643488,TCGA-CH-5763-01A,TCGA-CH-5763-01A-11D-1576-08,1,0.776739377,TCGA-CH-5763,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-24380,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,365,0,365,0,365,0,365,NA,[Not Applicable],T3a,[Not Applicable],PRAD.3-ETV4,1
-0.190914969,4.604097873,TCGA-VV-A86M-01A,TCGA-VV-A86M-01A-11D-A36O-08,4,0.553313681,TCGA-VV-A86M,LGG,36,FEMALE,[Not Evaluated],Astrocytoma,G3,2013,[Not Available],-13453,Alive,TUMOR FREE,487,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,487,0,487,NA,NA,0,487,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.758908938,-3.948163984,TCGA-EJ-7330-01A,TCGA-EJ-7330-01A-11D-2114-08,1,0.725143219,TCGA-EJ-7330,PRAD,68,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25050,Alive,TUMOR FREE,191,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,191,0,191,NA,NA,0,191,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
9.333135393,-4.837968338,TCGA-VW-A7QS-01A,TCGA-VW-A7QS-01A-12D-A33T-08,1,0.785033836,TCGA-VW-A7QS,LGG,35,FEMALE,ASIAN,Oligodendroglioma,G3,2011,[Not Available],-12820,Alive,WITH TUMOR,706,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,706,0,706,NA,NA,0,706,NA,NA,NA,NA,GBM_LGG.Codel,1
9.849840003,-2.859679763,TCGA-EJ-7781-01A,TCGA-EJ-7781-01A-11D-2114-08,1,0.743230551,TCGA-EJ-7781,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23937,Alive,TUMOR FREE,1073,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1073,0,1073,0,1073,0,1073,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-4.503376515,1.967517475,TCGA-A6-5662-01A,TCGA-A6-5662-01A-01D-1650-10,0,NA,TCGA-A6-5662,COAD,46,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-16873,Alive,WITH TUMOR,718,NA,[Not Available],NA,NA,NA,495,[Not Available],0,718,0,718,NA,NA,1,495,NA,Stage IVA,T3,M1,GI.CIN,8
9.386898569,-5.319341199,TCGA-G9-6333-01A,TCGA-G9-6333-01A-12D-1961-08,1,0.847354991,TCGA-G9-6333,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-24249,Alive,TUMOR FREE,2465,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2465,0,2465,0,2465,0,2465,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
9.959170994,-1.609098782,TCGA-E8-A417-01A,TCGA-E8-A417-01A-21D-A23M-08,1,0.879407531,TCGA-E8-A417,THCA,38,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-14019,Alive,TUMOR FREE,938,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,938,0,938,0,938,0,938,NA,Stage I,T2,M0,THCA.3,1
9.04193873,-4.320403239,TCGA-CH-5753-01A,TCGA-CH-5753-01A-11D-1576-08,1,0.731943983,TCGA-CH-5753,PRAD,70,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-25780,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,1
10.01823556,-1.579601741,TCGA-E3-A3E1-01A,TCGA-E3-A3E1-01A-11D-A20C-08,1,0.871248298,TCGA-E3-A3E1,THCA,46,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-16895,Alive,TUMOR FREE,2449,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2449,0,2449,0,2449,0,2449,NA,Stage I,T1,M0,THCA.3,1
9.452561108,-5.345855773,TCGA-G9-6367-01A,TCGA-G9-6367-01A-11D-1786-08,1,0.860357695,TCGA-G9-6367,PRAD,60,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-22176,Alive,WITH TUMOR,1222,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1222,0,1222,NA,NA,0,1222,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
9.301278911,-1.934684039,TCGA-FE-A230-01A,TCGA-FE-A230-01A-11D-A14W-08,1,0.698267282,TCGA-FE-A230,THCA,30,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-10999,Alive,TUMOR FREE,2173,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,526,[Not Available],0,2173,0,2173,1,526,1,526,NA,Stage I,T3,MX,THCA.4,1
8.933178092,-5.131528864,TCGA-EJ-7789-01A,TCGA-EJ-7789-01A-11D-2114-08,1,0.828043597,TCGA-EJ-7789,PRAD,66,MALE,BLACK OR AFRICAN AMERICAN,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24107,Alive,TUMOR FREE,1105,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1105,0,1105,0,1105,0,1105,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,3
8.950299138,-4.308103983,TCGA-EJ-7792-01A,TCGA-EJ-7792-01A-11D-2114-08,1,0.756538108,TCGA-EJ-7792,PRAD,53,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-19454,Alive,TUMOR FREE,1396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1396,0,1396,0,1396,0,1396,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
9.389502489,-5.387377854,TCGA-EJ-7314-01A,TCGA-EJ-7314-01A-31D-2114-08,1,0.828522065,TCGA-EJ-7314,PRAD,62,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22766,Alive,TUMOR FREE,1150,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1150,0,1150,0,1150,0,1150,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-3.709741995,0.957160269,TCGA-BR-4191-01A,TCGA-BR-4191-01A-02D-1126-08,1,0.392807585,TCGA-BR-4191,STAD,72,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-26562,Dead,NA,NA,558,[Not Available],NA,NA,NA,NA,[Not Available],1,558,NA,558,NA,NA,0,558,NA,[Not Available],TX,M0,GI.CIN,6
-0.017493168,5.047180281,TCGA-RY-A845-01A,TCGA-RY-A845-01A-11D-A36O-08,4,0.652125586,TCGA-RY-A845,LGG,40,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-14617,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,596,0,596,NA,NA,0,596,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.302745301,-3.324915235,TCGA-G4-6320-01A,TCGA-G4-6320-01A-11D-1719-10,8,0.56910476,TCGA-G4-6320,COAD,73,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-26840,Alive,TUMOR FREE,804,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,804,0,804,NA,NA,0,804,NA,Stage III,T3,MX,GI.HM-indel,10
-0.078220862,4.963289698,TCGA-TQ-A7RH-01A,TCGA-TQ-A7RH-01A-12D-A34A-08,4,0.607750577,TCGA-TQ-A7RH,LGG,39,MALE,BLACK OR AFRICAN AMERICAN,Oligoastrocytoma,G2,2013,[Not Available],-14524,Alive,WITH TUMOR,486,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,486,0,486,NA,NA,0,486,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.419523666,-3.009512151,TCGA-RY-A847-01A,TCGA-RY-A847-01A-11D-A36O-08,1,0.765526165,TCGA-RY-A847,LGG,45,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-16732,Alive,TUMOR FREE,933,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,933,0,933,NA,NA,0,933,NA,NA,NA,NA,GBM_LGG.Codel,1
-3.225091158,-3.43519942,TCGA-CM-6171-01A,TCGA-CM-6171-01A-11D-1650-10,8,0.61151239,TCGA-CM-6171,COAD,77,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-28307,Alive,TUMOR FREE,427,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,427,0,427,NA,NA,0,427,NA,Stage I,T2,M0,GI.HM-indel,10
-7.218423289,2.459507696,TCGA-A6-5666-01A,TCGA-A6-5666-01A-01D-1650-10,9,0.042882269,TCGA-A6-5666,COAD,78,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-28514,Alive,WITH TUMOR,995,NA,[Not Available],NA,NA,NA,509,Complete Remission/Response,0,995,0,995,1,509,1,509,NA,Stage IIC,T4b,M0,GI.CIN,7
9.591362897,-2.417198481,TCGA-RY-A840-01A,TCGA-RY-A840-01A-11D-A36O-08,1,0.76301461,TCGA-RY-A840,LGG,47,MALE,[Unknown],Oligodendroglioma,G3,2012,[Not Available],-17501,Alive,WITH TUMOR,854,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,854,0,854,NA,NA,0,854,NA,NA,NA,NA,GBM_LGG.Codel,1
7.809865998,-1.38235318,TCGA-P5-A731-01A,TCGA-P5-A731-01A-11D-A32B-08,1,0.130892244,TCGA-P5-A731,LGG,59,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-21715,Alive,TUMOR FREE,274,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,274,0,274,NA,NA,0,274,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
0.10231918,5.005667557,TCGA-RY-A83Z-01A,TCGA-RY-A83Z-01A-11D-A36O-08,4,0.558865875,TCGA-RY-A83Z,LGG,54,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-19903,Alive,WITH TUMOR,301,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,301,0,301,NA,NA,0,301,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,6
9.964622299,-1.621401652,TCGA-RY-A83Y-01A,TCGA-RY-A83Y-01A-11D-A36O-08,1,0.876580784,TCGA-RY-A83Y,LGG,45,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-16470,Alive,TUMOR FREE,166,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,166,0,166,NA,NA,0,166,NA,NA,NA,NA,GBM_LGG.Codel,1
9.204520273,-4.734679463,TCGA-RY-A83X-01A,TCGA-RY-A83X-01A-11D-A36O-08,1,0.748075445,TCGA-RY-A83X,LGG,46,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-16911,Alive,TUMOR FREE,939,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,939,0,939,NA,NA,0,939,NA,NA,NA,NA,GBM_LGG.Codel,1
9.60151277,-5.424466799,TCGA-P5-A730-01A,TCGA-P5-A730-01A-11D-A32B-08,1,0.858536658,TCGA-P5-A730,LGG,22,MALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-8043,Alive,TUMOR FREE,333,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,333,0,333,0,333,0,333,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.622328767,2.436820343,TCGA-CM-4747-01A,TCGA-CM-4747-01A-01D-1408-10,9,0.076276182,TCGA-CM-4747,COAD,47,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-17198,Alive,[Discrepancy],761,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,761,0,761,NA,NA,0,761,NA,Stage IVA,T4a,M1a,GI.CIN,7
-0.195407101,4.921587437,TCGA-P5-A72W-01A,TCGA-P5-A72W-01A-11D-A32B-08,4,0.701013584,TCGA-P5-A72W,LGG,35,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-12848,Alive,TUMOR FREE,317,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,317,0,317,0,317,0,317,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.277930755,-2.425126247,TCGA-P5-A72U-01A,TCGA-P5-A72U-01A-31D-A32B-08,6,0.244772115,TCGA-P5-A72U,LGG,71,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-26002,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,7,0,7,0,7,0,7,NA,NA,NA,NA,GBM_LGG.Classic-like,2
10.21502692,-1.638803564,TCGA-HT-A74L-01A,TCGA-HT-A74L-01A-11D-A32B-08,1,0.884588844,TCGA-HT-A74L,LGG,22,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-8240,Alive,WITH TUMOR,336,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,336,0,336,NA,NA,0,336,NA,NA,NA,NA,GBM_LGG.Codel,1
9.311900375,-2.333722836,TCGA-P5-A72Z-01A,TCGA-P5-A72Z-01A-11D-A32B-08,1,0.759878335,TCGA-P5-A72Z,LGG,64,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-23482,Alive,TUMOR FREE,354,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,354,0,354,0,354,0,354,NA,NA,NA,NA,GBM_LGG.Codel,1
9.3622147,-5.681601974,TCGA-AA-3556-01A,TCGA-AA-3556-01A-01D-1953-10,1,0.838379089,TCGA-AA-3556,COAD,78,MALE,[Not Available],[Not Available],[Not Available],2008,[Not Available],-28704,Alive,WITH TUMOR,700,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,700,0,700,NA,NA,0,700,NA,Stage I,T2,M0,NA,1
9.049361448,-2.757145216,TCGA-HT-A74K-01A,TCGA-HT-A74K-01A-11D-A32B-08,1,0.681039008,TCGA-HT-A74K,LGG,58,FEMALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-21189,Alive,TUMOR FREE,467,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,467,0,467,0,467,0,467,NA,NA,NA,NA,GBM_LGG.Codel,1
8.77232577,-1.837903357,TCGA-HT-A61C-01A,TCGA-HT-A61C-01A-11D-A29Q-08,1,0.557767868,TCGA-HT-A61C,LGG,66,MALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-24276,Dead,WITH TUMOR,NA,537,[Not Available],NA,NA,NA,476,Complete Remission/Response,1,537,1,537,1,476,1,476,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
8.807877132,-1.904260309,TCGA-HT-A619-01A,TCGA-HT-A619-01A-11D-A29Q-08,1,0.626089597,TCGA-HT-A619,LGG,51,FEMALE,ASIAN,Oligodendroglioma,G3,2012,[Not Available],-18857,Alive,TUMOR FREE,651,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,651,0,651,0,651,0,651,NA,NA,NA,NA,NA,1
-7.601538954,-2.403346404,TCGA-AA-3678-01A,TCGA-AA-3678-01A-01W-0900-09,6,0.507756143,TCGA-AA-3678,COAD,60,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-22219,Alive,TUMOR FREE,1430,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1430,0,1430,0,1430,0,1430,NA,Stage III,T2,M0,GI.CIN,2
-6.327603226,-1.26897756,TCGA-D5-6920-01A,TCGA-D5-6920-01A-11D-1924-10,7,0.166842659,TCGA-D5-6920,COAD,77,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-28124,Alive,TUMOR FREE,377,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,377,0,377,NA,NA,0,377,NA,Stage IIA,T3,M0,GI.GS,2
-0.025377598,4.881254288,TCGA-E1-A7Z6-01A,TCGA-E1-A7Z6-01A-11D-A34J-08,4,0.559542146,TCGA-E1-A7Z6,LGG,41,FEMALE,WHITE,Astrocytoma,G2,2009,[Not Available],-14985,Dead,WITH TUMOR,NA,984,[Not Available],NA,NA,NA,294,Progressive Disease,1,984,1,984,NA,NA,1,294,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.972626568,-5.108845502,TCGA-E1-A7Z4-01A,TCGA-E1-A7Z4-01A-11D-A34J-08,1,0.839131154,TCGA-E1-A7Z4,LGG,35,MALE,WHITE,Astrocytoma,G2,1999,[Not Available],-12849,Dead,WITH TUMOR,NA,4412,[Not Available],NA,NA,NA,846,Progressive Disease,1,4412,1,4412,NA,NA,1,846,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-0.175151292,4.582352607,TCGA-E1-A7YV-01A,TCGA-E1-A7YV-01A-11D-A34J-08,4,0.577358742,TCGA-E1-A7YV,LGG,26,FEMALE,WHITE,Oligoastrocytoma,G3,2010,[Not Available],-9546,Dead,WITH TUMOR,NA,987,[Not Available],NA,NA,NA,97,Progressive Disease,1,987,1,987,NA,NA,1,97,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,6
9.725202268,-4.258914171,TCGA-E1-A7Z3-01A,TCGA-E1-A7Z3-01A-11D-A34J-08,1,0.660619912,TCGA-E1-A7Z3,LGG,31,FEMALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G2,1992,[Not Available],-11330,Dead,WITH TUMOR,NA,2235,[Not Available],NA,NA,NA,1569,Progressive Disease,1,2235,1,2235,NA,NA,1,1569,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-7.504186849,-2.379880619,TCGA-E1-A7YW-01A,TCGA-E1-A7YW-01A-11D-A34J-08,6,0.432533533,TCGA-E1-A7YW,LGG,28,MALE,WHITE,Oligoastrocytoma,G2,2002,[Not Available],-10571,Dead,WITH TUMOR,NA,1120,[Not Available],NA,NA,NA,409,Progressive Disease,1,1120,1,1120,NA,NA,1,409,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
-3.125813345,-3.677978451,TCGA-AA-3947-01A,TCGA-AA-3947-01A-01D-1981-10,8,0.436469554,TCGA-AA-3947,COAD,60,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-22035,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1004,0,1004,0,1004,0,1004,NA,Stage IIB,T4,M0,GI.HM-indel,10
-0.208702658,4.521608309,TCGA-BG-A3PP-01A,TCGA-BG-A3PP-01A-11D-A228-09,4,0.581494829,TCGA-BG-A3PP,UCEC,82,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30227,Alive,WITH TUMOR,681,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vagina apex,665,Progressive Disease,0,681,0,681,NA,NA,1,665,NA,Stage II,[Not Applicable],[Not Applicable],NA,6
-5.441342697,0.957495408,TCGA-EY-A547-01A,TCGA-EY-A547-01A-11D-A27P-09,0,NA,TCGA-EY-A547,UCEC,75,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27686,Alive,TUMOR FREE,545,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,545,0,545,0,545,0,545,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-5.652581409,2.198027342,TCGA-AZ-4616-01A,TCGA-AZ-4616-01A-21D-1835-10,12,0.016901081,TCGA-AZ-4616,COAD,82,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-30043,Dead,WITH TUMOR,NA,156,[Not Available],NA,NA,NA,NA,[Not Available],1,156,1,156,NA,NA,1,156,NA,Stage IV,T3,M1,GI.CIN,7
0.001159664,3.225487025,TCGA-EY-A4KR-01A,TCGA-EY-A4KR-01A-11D-A27P-09,4,0.372793512,TCGA-EY-A4KR,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20669,Dead,WITH TUMOR,NA,346,[Not Available],NA,NA,NA,NA,Progressive Disease,1,346,1,346,NA,NA,1,346,NA,Stage IIIC1,[Not Applicable],[Not Applicable],NA,3
-6.335410437,1.310968951,TCGA-EY-A3QX-01A,TCGA-EY-A3QX-01A-11D-A228-09,10,0.162132132,TCGA-EY-A3QX,UCEC,64,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23663,Dead,WITH TUMOR,NA,989,[Not Available],Locoregional Recurrence,"Other, specify",Peritoneum,896,Complete Remission/Response,1,989,1,989,NA,NA,1,896,NA,Stage IVB,[Not Applicable],[Not Applicable],NA,5
-0.255341219,3.752433396,TCGA-EY-A54A-01A,TCGA-EY-A54A-01A-11D-A27P-09,4,0.127725851,TCGA-EY-A54A,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24822,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,447,0,447,0,447,0,447,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,3
-5.345978593,2.704801557,TCGA-KJ-A3U4-01A,TCGA-KJ-A3U4-01A-11D-A228-09,12,0.139106978,TCGA-KJ-A3U4,UCEC,55,FEMALE,WHITE,Serous endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20392,Alive,TUMOR FREE,1095,NA,[Not Available],Locoregional Recurrence,"Other, specify",abdominal,306,[Discrepancy],0,1095,0,1095,NA,NA,1,306,NA,Stage IA,[Not Applicable],[Not Applicable],NA,8
-3.373208757,-3.148906391,TCGA-EY-A5W2-01A,TCGA-EY-A5W2-01A-11D-A31U-09,8,0.539226908,TCGA-EY-A5W2,UCEC,72,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26498,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,516,0,516,0,516,0,516,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-7.535735583,2.377973911,TCGA-BK-A56F-01A,TCGA-BK-A56F-01A-32D-A27P-09,9,0.227910613,TCGA-BK-A56F,UCEC,75,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27523,Alive,TUMOR FREE,401,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,401,0,401,0,401,0,401,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
0.12911655,4.695219811,TCGA-BK-A4ZD-01A,TCGA-BK-A4ZD-01A-11D-A27P-09,4,0.55361339,TCGA-BK-A4ZD,UCEC,42,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536,Alive,TUMOR FREE,506,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,506,0,506,0,506,0,506,NA,Stage IA,[Not Applicable],[Not Applicable],NA,6
-6.285216751,-1.416666324,TCGA-A5-A1OH-01A,TCGA-A5-A1OH-01A-21D-A228-09,7,0.17522888,TCGA-A5-A1OH,UCEC,86,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31451,Alive,TUMOR FREE,1105,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1105,0,1105,0,1105,0,1105,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,2
0.240713826,3.501031438,TCGA-FI-A3PV-01A,TCGA-FI-A3PV-01A-11D-A228-09,4,0.218142175,TCGA-FI-A3PV,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,High Grade,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24898,Dead,WITH TUMOR,NA,1249,[Not Available],NA,NA,NA,NA,[Not Available],1,1249,1,1249,NA,NA,1,1249,NA,Stage IA,[Not Applicable],[Not Applicable],NA,3
-7.817840254,-2.409557644,TCGA-IM-A41Y-01A,TCGA-IM-A41Y-01A-11D-A23U-08,6,0.460043653,TCGA-IM-A41Y,THCA,42,FEMALE,WHITE,"Other, specify",[Not Available],2012,[Not Available],-15694,Alive,TUMOR FREE,664,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,664,0,664,0,664,0,664,NA,Stage I,T3,MX,THCA.3,2
-3.910168078,-1.941065243,TCGA-BG-A3EW-01A,TCGA-BG-A3EW-01A-11D-A228-09,8,0.340477064,TCGA-BG-A3EW,UCEC,62,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22705,Alive,TUMOR FREE,344,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,344,0,344,0,344,0,344,NA,Stage III,[Not Applicable],[Not Applicable],NA,10
-0.308373524,4.245249175,TCGA-PG-A5BC-01A,TCGA-PG-A5BC-01A-12D-A27P-09,4,0.510669986,TCGA-PG-A5BC,UCEC,72,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436,Alive,TUMOR FREE,707,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,707,0,707,0,707,0,707,NA,Stage II,[Not Applicable],[Not Applicable],NA,6
-3.304864479,-3.365570166,TCGA-EY-A549-01A,TCGA-EY-A549-01A-11D-A27P-09,8,0.60661106,TCGA-EY-A549,UCEC,78,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28570,Alive,TUMOR FREE,605,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,605,0,605,0,605,0,605,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-3.534697673,-2.778911773,TCGA-EY-A548-01A,TCGA-EY-A548-01A-11D-A27P-09,8,0.406379696,TCGA-EY-A548,UCEC,83,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30544,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,430,0,430,0,430,0,430,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-6.139441234,-1.224200072,TCGA-BG-A0MK-01A,TCGA-BG-A0MK-01A-51D-A19Y-09,7,0.169546462,TCGA-BG-A0MK,UCEC,52,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19034,Dead,WITH TUMOR,NA,1317,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1317,1,1317,NA,NA,1,1317,NA,Stage IIB,[Not Applicable],[Not Applicable],NA,2
-6.213006614,-1.398470005,TCGA-A6-6654-01A,TCGA-A6-6654-01A-21D-1835-10,7,0.282436336,TCGA-A6-6654,COAD,65,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-23953,Alive,TUMOR FREE,726,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,726,0,726,0,726,0,726,NA,Stage IIIB,T3,M0,GI.CIN,2
-4.64278527,2.114036423,TCGA-DM-A28K-01A,TCGA-DM-A28K-01A-21D-A16V-10,0,NA,TCGA-DM-A28K,COAD,75,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2003,[Not Available],-27428,Alive,NA,2988,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2988,0,2988,NA,NA,0,2988,NA,Stage IIA,T3,M0,GI.CIN,8
9.565650453,-4.114182722,TCGA-CQ-5325-01A,TCGA-CQ-5325-01A-01D-1683-08,1,0.720507788,TCGA-CQ-5325,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-23833,Dead,WITH TUMOR,NA,654,[Not Available],NA,Oral Cavity,NA,204,Complete Remission/Response,1,654,1,654,1,204,1,204,NA,Stage I,T1,[Not Available],HNSC.Mesenchymal,1
-6.152399576,1.271083037,TCGA-77-6844-01A,TCGA-77-6844-01A-11D-1945-08,0,NA,TCGA-77-6844,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-27220,Dead,NA,NA,2284,[Not Available],NA,NA,NA,1788,Complete Remission/Response,1,2284,NA,2284,1,1788,1,1788,NA,Stage IIIA,T3,M0,NA,10
-3.470772095,-3.206567633,TCGA-CN-4723-01A,TCGA-CN-4723-01A-01D-1434-08,8,0.640108992,TCGA-CN-4723,HNSC,67,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-24815,Alive,TUMOR FREE,1699,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1699,0,1699,NA,NA,0,1699,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,10
9.466415703,-3.128485345,TCGA-08-0386-01A,TCGA-08-0386-01A-01D-1492-08,1,0.720988313,TCGA-08-0386,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-27053,Dead,WITH TUMOR,478,548,[Not Available],Recurrence,[Not Applicable],[Not Applicable],427,[Not Available],1,548,1,548,NA,NA,1,427,NA,NA,NA,NA,GBM_LGG.NA,1
-5.052750934,-1.10352058,TCGA-CR-7394-01A,TCGA-CR-7394-01A-11D-2012-08,0,NA,TCGA-CR-7394,HNSC,70,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-25581,Alive,TUMOR FREE,1346,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1346,0,1346,NA,NA,0,1346,NA,Stage IVA,T4a,M0,HNSC.Basal,10
-7.598455436,1.911750106,TCGA-34-5234-01A,TCGA-34-5234-01A-01D-1632-08,9,0.357110256,TCGA-34-5234,LUSC,71,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-26072,Alive,TUMOR FREE,2271,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2271,0,2271,0,2271,0,2271,NA,Stage IA,T1,M0,LUSC.secretory,9
9.664894544,-2.236739828,TCGA-43-7657-01A,TCGA-43-7657-01A-31D-2122-08,1,0.746474549,TCGA-43-7657,LUSC,68,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25042,Alive,TUMOR FREE,236,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,236,0,236,0,236,0,236,NA,Stage IA,T1,MX,NA,1
-6.163907435,-2.10539274,TCGA-CV-7248-01A,TCGA-CV-7248-01A-11D-2012-08,0,NA,TCGA-CV-7248,HNSC,63,FEMALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2001,[Not Available],-23082,Dead,TUMOR FREE,NA,521,[Not Available],NA,NA,NA,NA,[Not Available],1,521,0,521,NA,NA,0,521,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,2
-1.883988505,1.087262582,TCGA-FA-A86F-01A,TCGA-FA-A86F-01A-11D-A382-10,5,0.577883739,TCGA-FA-A86F,DLBC,64,FEMALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013,[Not Available],-23641,Alive,WITH TUMOR,553,NA,[Not Available],NA,"Other, specify","Inguinal, mediastinal, submandibular, hilar",150,Partial Remission/Response,0,553,0,553,NA,NA,1,150,NA,NA,NA,NA,NA,4
-2.056711683,1.18576459,TCGA-FA-A82F-01A,TCGA-FA-A82F-01A-11D-A382-10,5,0.628652297,TCGA-FA-A82F,DLBC,48,FEMALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013,[Not Available],-17819,Alive,TUMOR FREE,427,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,427,0,427,0,427,0,427,NA,NA,NA,NA,NA,4
8.967023881,-3.874709606,TCGA-FF-A7CX-01A,TCGA-FF-A7CX-01A-12D-A382-10,1,0.743167214,TCGA-FF-A7CX,DLBC,46,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011,[Not Available],-16924,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,385,0,385,NA,NA,0,385,NA,NA,NA,NA,NA,1
-1.929378062,1.099328271,TCGA-FF-A7CW-01A,TCGA-FF-A7CW-01A-11D-A382-10,5,0.573004307,TCGA-FF-A7CW,DLBC,72,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012,[Not Available],-26520,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,791,0,791,0,791,0,791,NA,NA,NA,NA,NA,4
-2.661238176,1.227673098,TCGA-FF-A7CR-01A,TCGA-FF-A7CR-01A-11D-A382-10,5,0.129167889,TCGA-FF-A7CR,DLBC,61,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012,[Not Available],-22471,Dead,WITH TUMOR,NA,313,[Not Available],NA,"Other, specify",Skin (Calf and Chest wall),290,Progressive Disease,1,313,1,313,NA,NA,1,290,NA,NA,NA,NA,NA,6
10.12646398,-2.045557777,TCGA-FA-A6HO-01A,TCGA-FA-A6HO-01A-11D-A31X-10,1,0.761323125,TCGA-FA-A6HO,DLBC,58,FEMALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013,[Not Available],-21330,Alive,WITH TUMOR,749,NA,[Not Available],NA,Paraaortic lymph nodes,NA,739,Complete Remission/Response,0,749,0,749,1,739,1,739,NA,NA,NA,NA,NA,1
-6.323853965,-2.012327583,TCGA-FA-A6HN-01A,TCGA-FA-A6HN-01A-11D-A31X-10,0,NA,TCGA-FA-A6HN,DLBC,73,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013,[Not Available],-27025,Dead,TUMOR FREE,NA,58,[Not Available],NA,NA,NA,NA,Progressive Disease,1,58,0,58,NA,NA,0,58,NA,NA,NA,NA,NA,2
-1.814837586,1.04079439,TCGA-FA-A4XK-01A,TCGA-FA-A4XK-01A-11D-A31X-10,5,0.600577125,TCGA-FA-A4XK,DLBC,40,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012,[Not Available],-14723,Dead,TUMOR FREE,NA,708,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,708,0,708,0,708,0,708,NA,NA,NA,NA,NA,4
-6.519978568,-2.097139907,TCGA-FA-A4BB-01A,TCGA-FA-A4BB-01A-11D-A31X-10,0,NA,TCGA-FA-A4BB,DLBC,67,MALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012,[Not Available],-24590,Alive,TUMOR FREE,132,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,132,0,132,NA,NA,0,132,NA,NA,NA,NA,NA,2
-5.566490738,2.275041748,TCGA-FA-8693-01A,TCGA-FA-8693-01A-11D-2397-10,12,0.168666935,TCGA-FA-8693,DLBC,75,MALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2012,[Not Available],-27468,Alive,TUMOR FREE,132,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,132,0,132,0,132,0,132,NA,NA,NA,NA,NA,6
0.040352377,4.884968388,TCGA-WY-A85D-01A,TCGA-WY-A85D-01A-11D-A36O-08,4,0.554892319,TCGA-WY-A85D,LGG,60,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-21979,Alive,WITH TUMOR,1147,NA,[Not Available],NA,NA,NA,887,Partial Remission/Response,0,1147,0,1147,NA,NA,1,887,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.087374617,5.024795038,TCGA-WY-A85C-01A,TCGA-WY-A85C-01A-11D-A36O-08,4,0.686268826,TCGA-WY-A85C,LGG,36,MALE,WHITE,Astrocytoma,G2,2010,[Not Available],-13506,Alive,WITH TUMOR,1426,NA,[Not Available],NA,NA,NA,809,Progressive Disease,0,1426,0,1426,NA,NA,1,809,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.40089234,1.659419977,TCGA-WY-A85E-01A,TCGA-WY-A85E-01A-11D-A36O-08,0,NA,TCGA-WY-A85E,LGG,48,FEMALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-17878,Alive,WITH TUMOR,633,NA,[Not Available],NA,NA,NA,532,Partial Remission/Response,0,633,0,633,NA,NA,1,532,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,9
-0.008702772,5.047445678,TCGA-WY-A85A-01A,TCGA-WY-A85A-01A-21D-A36O-08,4,0.700135666,TCGA-WY-A85A,LGG,20,MALE,WHITE,Astrocytoma,G2,2010,[Not Available],-7380,Alive,TUMOR FREE,1320,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1320,0,1320,NA,NA,0,1320,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.594283237,4.953575813,TCGA-WY-A858-01A,TCGA-WY-A858-01A-11D-A36O-08,4,0.526081452,TCGA-WY-A858,LGG,32,FEMALE,WHITE,Astrocytoma,G3,2010,[Not Available],-11855,Alive,TUMOR FREE,1337,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1337,0,1337,0,1337,0,1337,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.657834403,3.702797523,TCGA-WY-A859-01A,TCGA-WY-A859-01A-12D-A36O-08,4,0.293998039,TCGA-WY-A859,LGG,34,FEMALE,WHITE,Astrocytoma,G2,2010,[Not Available],-12631,Alive,WITH TUMOR,1213,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1213,0,1213,NA,NA,0,1213,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
0.924559995,3.745367386,TCGA-TQ-A7RJ-01A,TCGA-TQ-A7RJ-01A-11D-A33T-08,0,NA,TCGA-TQ-A7RJ,LGG,25,FEMALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-9209,Alive,WITH TUMOR,1229,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1229,0,1229,NA,NA,0,1229,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.027311523,-4.487212791,TCGA-TQ-A7RI-01A,TCGA-TQ-A7RI-01A-11D-A33T-08,1,0.788153321,TCGA-TQ-A7RI,LGG,37,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-13799,Alive,TUMOR FREE,62,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,62,0,62,NA,NA,0,62,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.01575984,4.425017088,TCGA-ED-A8O5-01A,TCGA-ED-A8O5-01A-11D-A35Z-10,4,0.415700848,TCGA-ED-A8O5,LIHC,59,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-21648,Alive,TUMOR FREE,406,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,406,0,406,0,406,0,406,NA,Stage IIIA,T3a,M0,NA,6
-6.445988111,-1.215074965,TCGA-C5-A7CO-01A,TCGA-C5-A7CO-01A-11D-A351-09,7,0.307756823,TCGA-C5-A7CO,CESC,68,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25045,Alive,TUMOR FREE,4482,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,4482,0,4482,0,4482,0,4482,NA,Stage IB2,[Not Available],[Not Available],NA,2
9.556826999,-3.343314181,TCGA-C5-A7UC-01A,TCGA-C5-A7UC-01A-11D-A351-09,1,0.71185655,TCGA-C5-A7UC,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2002,[Not Available],-17765,Dead,TUMOR FREE,NA,523,NA,NA,NA,NA,NA,[Not Available],1,523,0,523,NA,NA,0,523,NA,Stage IB,T1b,M0,NA,1
-6.715230804,-1.496251476,TCGA-G3-A6UC-01A,TCGA-G3-A6UC-01A-21D-A33K-10,7,0.201693758,TCGA-G3-A6UC,LIHC,65,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-23793,Alive,WITH TUMOR,671,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,639,[Not Available],0,671,0,671,1,639,1,639,NA,Stage IIIB,T3b,M0,LIHC.iCluster:3,2
-8.015182573,2.065079087,TCGA-C5-A7CJ-01A,TCGA-C5-A7CJ-01A-11D-A32I-09,9,0.623958723,TCGA-C5-A7CJ,CESC,42,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2002,[Not Available],-15652,Dead,TUMOR FREE,NA,3097,NA,NA,NA,NA,NA,[Not Available],1,3097,0,3097,NA,NA,0,3097,NA,Stage IIA,T2a,MX,NA,7
-2.438274167,2.413058434,TCGA-C5-A7CL-01A,TCGA-C5-A7CL-01A-11D-A32I-09,0,NA,TCGA-C5-A7CL,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2002,[Not Available],-17869,Dead,WITH TUMOR,NA,471,Cervical Cancer,NA,NA,NA,NA,[Not Available],1,471,1,471,NA,NA,1,471,NA,Stage IIIB,[Not Available],[Not Available],NA,10
-4.06763797,-2.235836491,TCGA-55-6969-01A,TCGA-55-6969-01A-11D-1945-08,8,0.293065837,TCGA-55-6969,LUAD,52,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-19270,Alive,TUMOR FREE,1239,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1239,0,1239,NA,NA,0,1239,NA,Stage IB,T2,M0,NA,10
-0.701879715,2.275243099,TCGA-C5-A7CG-01A,TCGA-C5-A7CG-01A-11D-A32I-09,0,NA,TCGA-C5-A7CG,CESC,55,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,1997,[Not Available],-20242,Alive,TUMOR FREE,6408,NA,NA,NA,NA,NA,NA,[Not Available],0,6408,0,6408,NA,NA,0,6408,NA,Stage IB,T1b,MX,NA,1
4.34546815,1.213221158,TCGA-A4-A6HP-01A,TCGA-A4-A6HP-01A-11D-A31X-10,2,0.71665318,TCGA-A4-A6HP,KIRP,66,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-24447,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage I,T1a,MX,KIRP.C1,5
8.120407285,-2.344161848,TCGA-C5-A7CH-01A,TCGA-C5-A7CH-01A-11D-A33O-09,1,0.468042862,TCGA-C5-A7CH,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2001,[Not Available],-15777,Alive,TUMOR FREE,4694,NA,NA,NA,NA,NA,NA,[Not Available],0,4694,0,4694,NA,NA,0,4694,NA,Stage IIB,[Not Available],[Not Available],NA,3
10.15523106,-1.903247167,TCGA-ED-A8O6-01A,TCGA-ED-A8O6-01A-11D-A35Z-10,1,0.841735536,TCGA-ED-A8O6,LIHC,50,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-18572,Dead,TUMOR FREE,NA,56,[Not Available],NA,NA,NA,NA,[Not Available],1,56,0,56,0,56,0,56,NA,Stage IIIA,T3a,M0,NA,1
-1.567724833,2.931059836,TCGA-FR-A728-01A,TCGA-FR-A728-01A-11D-A32N-08,0,NA,TCGA-FR-A728,SKCM,54,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-19936,Alive,TUMOR FREE,583,NA,[Not Available],Locoregional Recurrence,NA,NA,64,[Not Available],0,583,0,583,NA,NA,1,64,NA,Stage IIIB,T4b,M0,NA,10
-7.678825602,-2.446818203,TCGA-C5-A2LT-01A,TCGA-C5-A2LT-01A-11D-A18J-09,6,0.551824458,TCGA-C5-A2LT,CESC,38,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2001,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13966,Alive,TUMOR FREE,2226,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2226,0,2226,0,2226,0,2226,NA,Stage IB,T1b,M0,NA,2
-6.104755078,3.526692747,TCGA-DD-A4NB-01A,TCGA-DD-A4NB-01A-12D-A25V-10,11,0.586726552,TCGA-DD-A4NB,LIHC,25,MALE,WHITE,Fibrolamellar Carcinoma,G2,2011,[Not Available],-9426,Alive,TUMOR FREE,989,NA,[Not Available],Extrahepatic Recurrence,"Other, specify",retroperitoneal lymph nodes,912,[Not Available],0,989,0,989,1,912,1,912,NA,Stage I,T1,M0,LIHC.iCluster:1,8
-4.965039548,1.124350146,TCGA-DK-A6B5-01A,TCGA-DK-A6B5-01A-11D-A31L-08,0,NA,TCGA-DK-A6B5,BLCA,45,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-16453,Alive,TUMOR FREE,1542,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1542,0,1542,NA,NA,0,1542,NA,Stage IV,T4a,M0,NA,10
-5.954164252,1.920612076,TCGA-C5-A7UE-01A,TCGA-C5-A7UE-01A-11D-A33O-09,0,NA,TCGA-C5-A7UE,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2001,[Not Available],-16473,Alive,TUMOR FREE,4738,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,4738,0,4738,0,4738,0,4738,NA,Stage IB1,[Not Available],[Not Available],NA,9
-0.059815559,4.671015395,TCGA-F5-6464-01A,TCGA-F5-6464-01A-11D-1733-10,4,0.572893307,TCGA-F5-6464,READ,77,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-28168,Dead,NA,NA,303,[Not Available],NA,NA,NA,NA,[Not Available],1,303,NA,303,NA,NA,0,303,NA,Stage IIIC,T4b,M0,GI.CIN,6
8.624692269,-1.87246549,TCGA-28-5209-01A,TCGA-28-5209-01A-01D-1486-08,1,0.530179511,TCGA-28-5209,GBM,66,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-24362,Alive,NA,442,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,442,0,442,NA,NA,0,442,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-5.358145604,2.603090389,TCGA-CL-5917-01A,TCGA-CL-5917-01A-11D-1657-10,12,0.336528575,TCGA-CL-5917,READ,71,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2006,[Not Available],-26084,Alive,TUMOR FREE,2376,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2376,0,2376,0,2376,0,2376,NA,Stage IIIC,T3,MX,GI.CIN,8
-7.921549035,2.046688448,TCGA-C5-A2LS-01A,TCGA-C5-A2LS-01A-22D-A22X-09,9,0.572827879,TCGA-C5-A2LS,CESC,37,FEMALE,WHITE,Endocervical Adenocarcinoma of the Usual Type,G1,2005,[Not Available],-13857,Alive,TUMOR FREE,1345,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1345,0,1345,0,1345,0,1345,NA,Stage IB2,T1b2,M0,NA,7
-3.022606487,-3.834661029,TCGA-MX-A5UJ-01A,TCGA-MX-A5UJ-01A-11D-A31L-08,8,0.424195489,TCGA-MX-A5UJ,STAD,86,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-31517,Alive,TUMOR FREE,600,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,600,0,600,0,600,0,600,NA,Stage IIIA,T3,M0,GI.HM-indel,10
-0.426004679,4.733384378,TCGA-BI-A20A-01A,TCGA-BI-A20A-01A-11D-A14W-08,4,0.514543694,TCGA-BI-A20A,CESC,49,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,[Not Available],-18215,Alive,TUMOR FREE,720,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,720,0,720,0,720,0,720,NA,Stage IB1,T1b1,M0,NA,6
-5.685282216,3.236008937,TCGA-C5-A1ME-01A,TCGA-C5-A1ME-01A-11D-A13W-08,0,NA,TCGA-C5-A1ME,CESC,40,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G1,2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14970,Alive,TUMOR FREE,1756,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1756,0,1756,0,1756,0,1756,NA,Stage IB1,T1b1,M0,NA,8
-6.151680742,1.101405458,TCGA-DK-A6B2-01A,TCGA-DK-A6B2-01A-11D-A30E-08,0,NA,TCGA-DK-A6B2,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25625,Alive,WITH TUMOR,477,NA,[Not Available],Distant Metastasis,Liver,NA,268,Complete Remission/Response,0,477,0,477,NA,NA,1,268,NA,Stage IV,T3,M0,NA,9
-2.976850115,-3.97077165,TCGA-L9-A7SV-01A,TCGA-L9-A7SV-01A-11D-A397-08,8,0.276954754,TCGA-L9-A7SV,LUAD,69,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-25298,Alive,TUMOR FREE,565,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,565,0,565,0,565,0,565,NA,Stage IIA,T2a,M0,NA,10
-3.760891141,-2.318635793,TCGA-L9-A8F4-01A,TCGA-L9-A8F4-01A-11D-A397-08,8,0.429506363,TCGA-L9-A8F4,LUAD,64,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-23617,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,476,0,476,NA,NA,0,476,NA,Stage IB,T2a,MX,NA,10
-3.235402784,-3.468958314,TCGA-55-A490-01A,TCGA-55-A490-01A-11D-A24D-08,8,0.489051463,TCGA-55-A490,LUAD,78,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28728,Dead,TUMOR FREE,NA,99,[Not Available],NA,NA,NA,NA,[Not Applicable],1,99,0,99,NA,NA,0,99,NA,Stage IIA,T2b,MX,NA,10
-6.264263358,-1.374090788,TCGA-L9-A5IP-01A,TCGA-L9-A5IP-01A-21D-A397-08,7,0.241745947,TCGA-L9-A5IP,LUAD,40,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-14681,Dead,WITH TUMOR,NA,58,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,49,Progressive Disease,1,58,1,58,NA,NA,1,49,NA,Stage IV,T3,M1b,NA,2
-0.106639574,3.277954954,TCGA-L9-A743-01A,TCGA-L9-A743-01A-43D-A397-08,4,0.372243468,TCGA-L9-A743,LUAD,56,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-20780,Alive,TUMOR FREE,664,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,664,0,664,0,664,0,664,NA,Stage IIA,T2a,M0,NA,3
9.359530766,-5.464337971,TCGA-EJ-A46I-01A,TCGA-EJ-A46I-01A-12D-A26M-08,1,0.827965772,TCGA-EJ-A46I,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21046,Alive,TUMOR FREE,668,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,668,0,668,0,668,0,668,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
-7.602636321,2.174312748,TCGA-97-8552-01A,TCGA-97-8552-01A-11D-2393-08,9,0.298964089,TCGA-97-8552,LUAD,55,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20331,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,626,0,626,0,626,0,626,NA,Stage I,T1a,MX,NA,7
9.048807574,-2.065424419,TCGA-L9-A50W-01A,TCGA-L9-A50W-01A-12D-A397-08,1,0.657686867,TCGA-L9-A50W,LUAD,75,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27414,Dead,WITH TUMOR,NA,442,[Not Available],Distant Metastasis,NA,NA,389,Complete Remission/Response,1,442,1,442,1,389,1,389,NA,Stage IIA,T1b,MX,NA,1
-0.176682054,4.824261507,TCGA-DU-A7T8-01A,TCGA-DU-A7T8-01A-21D-A34J-08,4,0.624837442,TCGA-DU-A7T8,LGG,35,MALE,WHITE,Oligoastrocytoma,G3,2003,[Not Available],-13108,Dead,WITH TUMOR,NA,4229,[Not Available],NA,NA,NA,3009,Stable Disease,1,4229,1,4229,NA,NA,1,3009,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.891955558,4.608549935,TCGA-97-8547-01A,TCGA-97-8547-01A-11D-2393-08,4,0.459212838,TCGA-97-8547,LUAD,78,FEMALE,[Not Evaluated],Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28801,Alive,TUMOR FREE,657,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,657,0,657,0,657,0,657,NA,Stage IIIA,T2a,MX,NA,6
-6.54750209,-1.485990998,TCGA-AG-3909-01A,TCGA-AG-3909-01A-01W-1073-09,7,0.247519061,TCGA-AG-3909,READ,69,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-25537,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,608,0,608,0,608,0,608,NA,Stage IIIB,T3,M0,GI.CIN,2
0.047848581,4.912623371,TCGA-26-5133-01A,TCGA-26-5133-01A-01D-1486-08,4,0.697007241,TCGA-26-5133,GBM,59,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-21560,Alive,TUMOR FREE,452,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],370,[Not Available],0,452,0,452,NA,NA,1,370,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,6
9.750116938,-3.788698952,TCGA-Y6-A8TL-01A,TCGA-Y6-A8TL-01A-21D-A377-08,1,0.647550917,TCGA-Y6-A8TL,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23776,Alive,TUMOR FREE,992,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,992,0,992,NA,NA,0,992,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
9.414885389,-2.605667604,TCGA-HW-A5KK-01A,TCGA-HW-A5KK-01A-11D-A27K-08,1,0.775418514,TCGA-HW-A5KK,LGG,64,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-23484,Dead,WITH TUMOR,NA,388,[Not Available],NA,NA,NA,NA,Progressive Disease,1,388,1,388,NA,NA,1,388,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-7.760333587,-2.491365497,TCGA-S9-A6WI-01A,TCGA-S9-A6WI-01A-21D-A33T-08,6,0.481752309,TCGA-S9-A6WI,LGG,56,FEMALE,WHITE,Oligoastrocytoma,G2,2006,[Not Available],-20609,Alive,WITH TUMOR,2585,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,2585,0,2585,NA,NA,0,2585,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
8.885835397,-4.857196129,TCGA-XA-A8JR-01A,TCGA-XA-A8JR-01A-11D-A364-08,1,0.826324763,TCGA-XA-A8JR,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-25090,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,376,0,376,0,376,0,376,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-0.069458901,4.715814648,TCGA-14-4157-01A,TCGA-14-4157-01A-01D-1353-08,4,0.585039908,TCGA-14-4157,GBM,40,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-14816,Alive,NA,104,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],96,[Not Available],0,104,0,104,NA,NA,1,96,NA,NA,NA,NA,NA,6
0.432766757,1.843604759,TCGA-49-6761-01A,TCGA-49-6761-01A-31D-1945-08,0,NA,TCGA-49-6761,LUAD,68,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24849,Alive,TUMOR FREE,354,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,354,0,354,0,354,0,354,NA,Stage IIIA,T1,MX,LUAD.3,3
-6.166519886,-1.566137207,TCGA-ED-A7PZ-01A,TCGA-ED-A7PZ-01A-11D-A33Q-10,7,0.043112861,TCGA-ED-A7PZ,LIHC,61,MALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-22601,Alive,TUMOR FREE,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,0,6,0,6,NA,Stage II,T2,M0,LIHC.iCluster:3,10
8.916547176,-1.975788055,TCGA-WW-A8ZI-01A,TCGA-WW-A8ZI-01A-11D-A377-08,1,0.665480638,TCGA-WW-A8ZI,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-25593,Alive,TUMOR FREE,449,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,449,0,449,0,449,0,449,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-7.031361339,-2.455840824,TCGA-DK-A6B1-01A,TCGA-DK-A6B1-01A-12D-A30E-08,6,0.131765818,TCGA-DK-A6B1,BLCA,67,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-24607,Alive,TUMOR FREE,2049,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2049,0,2049,0,2049,0,2049,NA,Stage II,T2a,M0,NA,2
8.954961472,-5.050074924,TCGA-VN-A88Q-01A,TCGA-VN-A88Q-01A-11D-A34U-08,1,0.832095959,TCGA-VN-A88Q,PRAD,60,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2010,[Not Available],-22087,Alive,TUMOR FREE,1366,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1366,0,1366,0,1366,0,1366,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.779279032,-3.901469938,TCGA-P4-A5ED-01A,TCGA-P4-A5ED-01A-11D-A28G-10,1,0.637939973,TCGA-P4-A5ED,KIRP,51,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-18698,Alive,TUMOR FREE,2816,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2816,0,2816,0,2816,0,2816,NA,Stage I,T1a,MX,KIRP.C2a,1
8.85897234,-4.507474792,TCGA-VN-A88R-01A,TCGA-VN-A88R-01A-11D-A364-08,1,0.736121401,TCGA-VN-A88R,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-19513,Alive,NA,784,NA,[Not Available],Biochemical evidence of disease,NA,NA,512,Partial Remission/Response,0,784,0,784,NA,NA,1,512,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
9.00073595,-5.318653486,TCGA-VN-A88O-01A,TCGA-VN-A88O-01A-11D-A34U-08,1,0.842778415,TCGA-VN-A88O,PRAD,49,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-17945,Alive,TUMOR FREE,481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,481,0,481,0,481,0,481,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
4.339895523,1.146481913,TCGA-VN-A88P-01A,TCGA-VN-A88P-01A-11D-A34U-08,2,0.550265085,TCGA-VN-A88P,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21916,Alive,TUMOR FREE,1260,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1260,0,1260,0,1260,0,1260,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,5
0.096925832,3.378481621,TCGA-DY-A1DD-01A,TCGA-DY-A1DD-01A-21D-A152-10,4,0.388773431,TCGA-DY-A1DD,READ,77,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],1999,[Not Available],-28159,Dead,NA,1741,1741,[Not Available],NA,NA,NA,NA,[Not Available],1,1741,NA,1741,NA,NA,0,1741,NA,Stage IIIB,T3,M0,GI.CIN,3
4.499178602,1.210277587,TCGA-49-4501-01A,TCGA-49-4501-01A-01D-1265-08,2,0.71561339,TCGA-49-4501,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1996,[Not Available],-24817,Dead,WITH TUMOR,NA,1421,[Not Available],NA,NA,NA,545,Complete Remission/Response,1,1421,1,1421,1,545,1,545,NA,Stage IB,T2,M0,LUAD.5,5
9.436448519,-5.023678156,TCGA-M7-A720-01A,TCGA-M7-A720-01A-12D-A32B-08,1,0.828415509,TCGA-M7-A720,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-19642,Alive,TUMOR FREE,384,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,384,0,384,0,384,0,384,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-7.808666375,-2.425178037,TCGA-DD-A73D-01A,TCGA-DD-A73D-01A-12D-A32G-10,6,0.461224332,TCGA-DD-A73D,LIHC,68,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-24941,Alive,WITH TUMOR,693,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,592,[Not Available],0,693,0,693,1,592,1,592,NA,Stage II,T2,MX,LIHC.iCluster:3,2
9.506747338,-5.450341369,TCGA-19-5952-01A,TCGA-19-5952-01A-11D-1696-08,1,0.844937078,TCGA-19-5952,GBM,62,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-22841,Dead,NA,567,575,[Not Available],NA,NA,NA,NA,[Not Available],1,575,NA,575,NA,NA,0,575,NA,NA,NA,NA,NA,1
2.106482283,1.806002642,TCGA-VN-A88M-01A,TCGA-VN-A88M-01A-11D-A34U-08,3,0.515195022,TCGA-VN-A88M,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20157,Alive,TUMOR FREE,189,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,189,0,189,0,189,0,189,NA,[Not Applicable],T2c,[Not Applicable],NA,3
-6.557899188,-2.156617666,TCGA-PQ-A6FI-01A,TCGA-PQ-A6FI-01A-11D-A31L-08,0,NA,TCGA-PQ-A6FI,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-25672,Alive,TUMOR FREE,372,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,372,0,372,0,372,0,372,NA,Stage II,T2a,MX,NA,2
9.949281396,-1.643261761,TCGA-H9-A6BY-01A,TCGA-H9-A6BY-01A-11D-A30E-08,1,0.825744478,TCGA-H9-A6BY,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23297,Alive,NA,112,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,112,0,112,NA,NA,0,112,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.543686024,-4.034206414,TCGA-VN-A88K-01A,TCGA-VN-A88K-01A-11D-A34U-08,1,0.723175433,TCGA-VN-A88K,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21524,Alive,NA,776,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,776,0,776,0,776,0,776,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.188871552,-5.097121599,TCGA-VN-A88L-01A,TCGA-VN-A88L-01A-11D-A34U-08,1,0.817838301,TCGA-VN-A88L,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20026,Alive,TUMOR FREE,746,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,746,0,746,0,746,0,746,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
1.662569758,1.970618835,TCGA-F9-A7VF-01A,TCGA-F9-A7VF-01A-11D-A33Q-10,3,0.194334771,TCGA-F9-A7VF,KIRP,75,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-27446,Alive,TUMOR FREE,73,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,73,0,73,0,73,0,73,NA,Stage I,T1a,M0,NA,3
-5.794448857,2.858352704,TCGA-50-5051-01A,TCGA-50-5051-01A-21D-1855-08,12,0.034546895,TCGA-50-5051,LUAD,42,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-15585,Dead,WITH TUMOR,NA,478,[Not Available],Distant Metastasis,NA,NA,184,Progressive Disease,1,478,1,478,NA,NA,1,184,NA,Stage IIIA,T2,M0,LUAD.3,8
9.388926576,-5.528770819,TCGA-QU-A6IP-01A,TCGA-QU-A6IP-01A-11D-A31L-08,1,0.876699789,TCGA-QU-A6IP,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2004,[Not Available],-24212,Alive,TUMOR FREE,2620,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2620,0,2620,0,2620,0,2620,NA,[Not Applicable],T2a,[Not Applicable],PRAD.1-ERG,1
9.273432675,-2.509748856,TCGA-VN-A88I-01A,TCGA-VN-A88I-01A-11D-A34U-08,1,0.669434449,TCGA-VN-A88I,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21576,Alive,WITH TUMOR,269,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,269,0,269,NA,NA,0,269,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
9.578370526,-3.061168821,TCGA-PJ-A8JU-01A,TCGA-PJ-A8JU-01A-11D-A35Z-10,9,0.244153839,TCGA-PJ-A8JU,KIRP,81,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-29830,Alive,TUMOR FREE,380,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,380,0,380,0,380,0,380,NA,Stage I,T1a,MX,NA,1
9.262631141,-2.184960407,TCGA-QU-A6IL-01A,TCGA-QU-A6IL-01A-11D-A31L-08,1,0.710317208,TCGA-QU-A6IL,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2002,[Not Available],-23710,Alive,TUMOR FREE,97,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,97,0,97,0,97,0,97,NA,[Not Applicable],T2c,[Not Applicable],NA,1
2.009900877,1.870896214,TCGA-QU-A6IM-01A,TCGA-QU-A6IM-01A-11D-A31L-08,3,0.571086744,TCGA-QU-A6IM,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2003,[Not Available],-21792,Alive,TUMOR FREE,1247,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1247,0,1247,0,1247,0,1247,NA,[Not Applicable],T2a,[Not Applicable],NA,3
9.761651716,-4.138128219,TCGA-M7-A725-01A,TCGA-M7-A725-01A-12D-A32B-08,1,0.685255225,TCGA-M7-A725,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20474,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,573,0,573,0,573,0,573,NA,[Not Applicable],T3b,[Not Applicable],PRAD.3-ETV4,1
-2.886404377,-4.108810708,TCGA-F5-6814-01A,TCGA-F5-6814-01A-31D-1924-10,8,0.005948279,TCGA-F5-6814,READ,57,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-20828,Alive,TUMOR FREE,1131,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1131,0,1131,0,1131,0,1131,NA,Stage IIA,T3,M0,GI.HM-SNV,10
-6.382911696,-1.548533716,TCGA-EF-5830-01A,TCGA-EF-5830-01A-01D-1657-10,7,0.268554326,TCGA-EF-5830,READ,54,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-19802,Alive,TUMOR FREE,106,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,106,0,106,NA,NA,0,106,NA,Stage IIB,T4a,M0,GI.CIN,2
-0.270635346,4.663804462,TCGA-DD-A1EG-01A,TCGA-DD-A1EG-01A-11D-A20W-10,4,0.501149213,TCGA-DD-A1EG,LIHC,76,MALE,WHITE,Hepatocellular Carcinoma,G3,2007,[Not Available],-28108,Dead,WITH TUMOR,NA,1372,[Not Available],Intrahepatic Recurrence,Liver,NA,875,[Not Available],1,1372,1,1372,1,875,1,875,NA,Stage I,T1,M0,LIHC.iCluster:3,6
9.378307838,-5.522916503,TCGA-EJ-8468-01A,TCGA-EJ-8468-01A-21D-2395-08,1,0.857839737,TCGA-EJ-8468,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-23371,Alive,TUMOR FREE,2347,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2347,0,2347,0,2347,0,2347,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
9.458999193,-5.181506958,TCGA-M7-A723-01A,TCGA-M7-A723-01A-12D-A32B-08,1,0.806082576,TCGA-M7-A723,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20064,Alive,TUMOR FREE,763,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,763,0,763,0,763,0,763,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.196086056,-3.60455698,TCGA-06-6699-01A,TCGA-06-6699-01A-11D-1845-08,1,0.719711703,TCGA-06-6699,GBM,58,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-21190,Alive,WITH TUMOR,47,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,47,0,47,NA,NA,0,47,NA,NA,NA,NA,NA,1
-4.524953889,-1.610381353,TCGA-55-8620-01A,TCGA-55-8620-01A-11D-2393-08,8,0.380812088,TCGA-55-8620,LUAD,60,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22091,Dead,WITH TUMOR,NA,375,[Not Available],NA,NA,NA,NA,Progressive Disease,1,375,1,375,NA,NA,1,375,NA,Stage IV,T1a,M1b,NA,10
1.858310875,1.898583847,TCGA-M7-A722-01A,TCGA-M7-A722-01A-12D-A364-08,3,0.274365879,TCGA-M7-A722,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23880,Alive,TUMOR FREE,1060,NA,[Not Available],Biochemical evidence of disease,NA,NA,559,Partial Remission/Response,0,1060,0,1060,NA,NA,1,559,NA,[Not Applicable],T3a,[Not Applicable],NA,3
9.140275515,-2.678636754,TCGA-MX-A5UG-01A,TCGA-MX-A5UG-01A-21D-A31L-08,1,0.719049941,TCGA-MX-A5UG,STAD,78,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2007,[Not Available],-28714,Dead,TUMOR FREE,NA,113,Stomach Cancer,NA,NA,NA,NA,[Not Applicable],1,113,1,113,NA,NA,0,113,NA,Stage IIIA,T3,M0,GI.GS,3
0.668072549,4.465132524,TCGA-P4-A5E6-01A,TCGA-P4-A5E6-01A-11D-A28G-10,1,0.461221396,TCGA-P4-A5E6,KIRP,67,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-24615,Alive,TUMOR FREE,3035,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3035,0,3035,0,3035,0,3035,NA,Stage III,T1b,MX,KIRP.C2a,1
2.33904639,1.879893093,TCGA-MH-A55W-01A,TCGA-MH-A55W-01A-11D-A26P-10,3,0.15050822,TCGA-MH-A55W,KIRP,50,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-18573,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1043,0,1043,0,1043,0,1043,NA,Stage I,T1b,MX,KIRP.C1,3
9.005032132,-5.611225461,TCGA-G9-6379-01A,TCGA-G9-6379-01A-11D-A31L-08,1,0.759411553,TCGA-G9-6379,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25126,Alive,TUMOR FREE,1778,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1778,0,1778,0,1778,0,1778,NA,[Not Applicable],T3b,[Not Applicable],NA,1
8.659128261,-3.662030298,TCGA-KK-A5A1-01A,TCGA-KK-A5A1-01A-11D-A29Q-08,1,0.684440976,TCGA-KK-A5A1,PRAD,72,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2003,[Not Available],-26415,Dead,NA,NA,2469,[Not Available],Locoregional Recurrence,NA,NA,203,Partial Remission/Response,1,2469,NA,2469,NA,NA,1,203,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.507259791,-2.480069438,TCGA-J4-A83N-01A,TCGA-J4-A83N-01A-11D-A34U-08,1,0.774856784,TCGA-J4-A83N,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20841,Alive,TUMOR FREE,992,NA,[Not Available],New Primary Tumor,NA,NA,433,Complete Remission/Response,0,992,0,992,0,992,1,433,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.250868188,-4.403204802,TCGA-M7-A71Y-01A,TCGA-M7-A71Y-01A-22D-A32B-08,1,0.789873394,TCGA-M7-A71Y,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20357,Alive,TUMOR FREE,493,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,493,0,493,0,493,0,493,NA,[Not Applicable],T2c,[Not Applicable],PRAD.2-ETV1,1
8.820323802,-4.561800097,TCGA-J4-A83L-01A,TCGA-J4-A83L-01A-11D-A34U-08,1,0.767266277,TCGA-J4-A83L,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22338,Alive,TUMOR FREE,720,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,720,0,720,0,720,0,720,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-0.462143277,4.984188406,TCGA-06-0644-01A,TCGA-06-0644-01A-02D-1492-08,4,0.534047306,TCGA-06-0644,GBM,71,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-26247,Dead,WITH TUMOR,NA,384,[Not Available],Recurrence,[Not Applicable],[Not Applicable],85,[Not Available],1,384,1,384,NA,NA,1,85,NA,NA,NA,NA,GBM_LGG.NA,6
9.326491697,-5.139936035,TCGA-06-0152-01A,TCGA-06-0152-01A-02D-1492-08,1,0.788903441,TCGA-06-0152,GBM,68,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1995,[Not Available],-24844,Dead,WITH TUMOR,359,375,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],299,[Not Available],1,375,1,375,NA,NA,1,299,NA,NA,NA,NA,NA,1
-4.23654742,-0.431681574,TCGA-EB-A3XB-01A,TCGA-EB-A3XB-01A-11D-A23B-08,0,NA,TCGA-EB-A3XB,SKCM,63,MALE,WHITE,NA,[Not Available],2011,[Not Available],-23091,Alive,TUMOR FREE,796,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,796,0,796,NA,NA,0,796,NA,Stage II,T4,M0,SKCM.BRAF_Hotspot_Mutants,10
8.437165775,-1.883288946,TCGA-67-6217-01A,TCGA-67-6217-01A-11D-1753-08,1,0.46254661,TCGA-67-6217,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-26920,Alive,WITH TUMOR,422,NA,[Not Available],NA,NA,NA,296,Progressive Disease,0,422,0,422,NA,NA,1,296,NA,Stage IIA,T2a,M0,LUAD.5,6
9.903328806,-2.055231453,TCGA-J4-A83J-01A,TCGA-J4-A83J-01A-11D-A364-08,1,0.801878232,TCGA-J4-A83J,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24960,Alive,TUMOR FREE,696,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,696,0,696,0,696,0,696,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.123575613,-4.377222667,TCGA-J4-A6M7-01A,TCGA-J4-A6M7-01A-11D-A31L-08,1,0.759271974,TCGA-J4-A6M7,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-19640,Alive,TUMOR FREE,512,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,512,0,512,0,512,0,512,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-5.79951731,-2.020849951,TCGA-MH-A561-01A,TCGA-MH-A561-01A-11D-A26P-10,0,NA,TCGA-MH-A561,KIRP,66,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-24271,Alive,TUMOR FREE,841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,841,0,841,0,841,0,841,NA,Stage I,T1a,MX,KIRP.C1,3
8.927943213,-5.153146737,TCGA-J4-A6G3-01A,TCGA-J4-A6G3-01A-11D-A30X-08,1,0.771595998,TCGA-J4-A6G3,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20836,Alive,WITH TUMOR,849,NA,[Not Available],Biochemical evidence of disease,NA,NA,618,Partial Remission/Response,0,849,0,849,NA,NA,1,618,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,1
-8.138740333,2.053669666,TCGA-R8-A6MO-01A,TCGA-R8-A6MO-01A-11D-A33T-08,9,0.649313776,TCGA-R8-A6MO,LGG,53,FEMALE,ASIAN,Oligodendroglioma,G2,2009,[Not Available],-19432,Alive,NA,993,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,993,0,993,NA,NA,0,993,NA,NA,NA,NA,GBM_LGG.Codel,7
9.423589062,-5.269375598,TCGA-J4-A6G1-01A,TCGA-J4-A6G1-01A-11D-A30X-08,1,0.845155057,TCGA-J4-A6G1,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24945,Alive,TUMOR FREE,769,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,769,0,769,0,769,0,769,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.972712524,-1.647059046,TCGA-Q2-A5QZ-01A,TCGA-Q2-A5QZ-01A-11D-A28G-10,1,0.867663979,TCGA-Q2-A5QZ,KIRP,61,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-22531,Alive,NA,428,NA,[Not Available],NA,NA,NA,412,Complete Remission/Response,0,428,0,428,1,412,1,412,NA,Stage III,T3a,MX,KIRP.C2b,1
-0.049637111,4.389573785,TCGA-06-1800-01A,TCGA-06-1800-01A-01W-0643-08,4,0.479648676,TCGA-06-1800,GBM,61,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-22332,Dead,WITH TUMOR,815,815,[Not Available],Recurrence,[Not Applicable],[Not Applicable],750,[Not Available],1,815,1,815,NA,NA,1,750,NA,NA,NA,NA,NA,6
-5.700443976,-2.235391031,TCGA-ED-A4XI-01A,TCGA-ED-A4XI-01A-11D-A25V-10,0,NA,TCGA-ED-A4XI,LIHC,58,MALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-21497,Alive,TUMOR FREE,819,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,819,0,819,0,819,0,819,NA,Stage II,T2,M0,LIHC.iCluster:1,6
-3.703812591,-2.861186256,TCGA-50-5946-01A,TCGA-50-5946-01A-11D-1753-08,8,0.373449512,TCGA-50-5946,LUAD,62,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-22852,Alive,WITH TUMOR,1617,NA,[Not Available],Distant Metastasis,NA,NA,221,Progressive Disease,0,1617,0,1617,NA,NA,1,221,NA,Stage IA,T1,MX,NA,10
9.529160891,-5.374835412,TCGA-J4-A67S-01A,TCGA-J4-A67S-01A-11D-A30E-08,1,0.819192578,TCGA-J4-A67S,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23332,Alive,WITH TUMOR,833,NA,[Not Available],Biochemical evidence of disease,NA,NA,708,Complete Remission/Response,0,833,0,833,1,708,1,708,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-4.208607027,-0.616375928,TCGA-GD-A6C6-01A,TCGA-GD-A6C6-01A-21D-A31L-08,0,NA,TCGA-GD-A6C6,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-23631,Alive,TUMOR FREE,67,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,67,0,67,0,67,0,67,NA,Stage III,T3a,MX,NA,10
0.503423831,2.223550214,TCGA-J4-A67T-01A,TCGA-J4-A67T-01A-11D-A30X-08,0,NA,TCGA-J4-A67T,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23211,Alive,TUMOR FREE,183,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,183,0,183,0,183,0,183,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,6
9.464250785,-3.879189247,TCGA-J4-A67Q-01A,TCGA-J4-A67Q-01A-21D-A30E-08,1,0.657059598,TCGA-J4-A67Q,PRAD,77,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-28447,Alive,TUMOR FREE,975,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,975,0,975,0,975,0,975,NA,[Not Applicable],T2c,[Not Applicable],NA,1
4.342680514,1.215250658,TCGA-J4-A67R-01A,TCGA-J4-A67R-01A-21D-A30E-08,2,0.713523729,TCGA-J4-A67R,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23807,Alive,TUMOR FREE,910,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,910,0,910,0,910,0,910,NA,[Not Applicable],T2c,[Not Applicable],NA,5
9.474929549,-1.664425287,TCGA-DK-A6B0-01A,TCGA-DK-A6B0-01A-11D-A31L-08,1,0.68645593,TCGA-DK-A6B0,BLCA,61,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-22439,Alive,TUMOR FREE,2330,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2330,0,2330,0,2330,0,2330,NA,Stage II,T2b,M0,NA,1
8.798506139,-4.45933804,TCGA-O9-A75Z-01A,TCGA-O9-A75Z-01A-11D-A33Q-10,1,0.795347931,TCGA-O9-A75Z,KIRP,44,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-16183,Alive,NA,471,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,471,0,471,NA,NA,0,471,NA,Stage I,T1a,MX,NA,1
-7.668902779,-2.425996624,TCGA-AG-3598-01A,TCGA-AG-3598-01A-01D-1989-10,6,0.431415686,TCGA-AG-3598,READ,69,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-25324,Alive,TUMOR FREE,1522,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1522,0,1522,NA,NA,0,1522,NA,Stage IIA,T3,M0,NA,2
8.948203642,-4.68504967,TCGA-75-6203-01A,TCGA-75-6203-01A-11D-1753-08,1,0.832274559,TCGA-75-6203,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,NA,0,NA,0,NA,0,NA,NA,Stage IIIA,T2,M0,LUAD.5,1
-3.265380145,-3.578115741,TCGA-EI-6882-01A,TCGA-EI-6882-01A-11D-1924-10,8,0.444026993,TCGA-EI-6882,READ,59,MALE,WHITE,Rectal Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-21682,Alive,TUMOR FREE,262,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,262,0,262,NA,NA,0,262,NA,Stage IIA,T3,M0,GI.HM-indel,10
9.058378221,-4.747193204,TCGA-J4-A67K-01A,TCGA-J4-A67K-01A-21D-A30E-08,1,0.827827333,TCGA-J4-A67K,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24908,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1004,0,1004,0,1004,0,1004,NA,[Not Applicable],T2c,[Not Applicable],NA,3
-0.772433898,3.755711634,TCGA-J4-A67L-01A,TCGA-J4-A67L-01A-11D-A30E-08,4,0.352050118,TCGA-J4-A67L,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-20034,Alive,TUMOR FREE,770,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,770,0,770,0,770,0,770,NA,[Not Applicable],T3a,[Not Applicable],NA,5
-3.537410203,0.903427686,TCGA-78-7147-01A,TCGA-78-7147-01A-11D-2036-08,0,NA,TCGA-78-7147,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-24809,Dead,WITH TUMOR,NA,586,[Not Available],NA,NA,NA,578,[Not Available],1,586,1,586,NA,NA,1,578,NA,Stage IIB,T2,M0,LUAD.3,10
9.700359682,-2.249634181,TCGA-HC-A6HY-01A,TCGA-HC-A6HY-01A-11D-A31L-08,1,0.755316799,TCGA-HC-A6HY,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-18779,Alive,TUMOR FREE,134,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,134,0,134,NA,NA,0,134,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-7.812880931,2.289075743,TCGA-HC-A6AN-01A,TCGA-HC-A6AN-01A-11D-A30E-08,9,0.319554318,TCGA-HC-A6AN,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24697,Alive,WITH TUMOR,49,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,49,0,49,NA,NA,0,49,NA,[Not Applicable],T3a,[Not Applicable],NA,7
-0.035781407,5.07358344,TCGA-HC-A632-01A,TCGA-HC-A632-01A-11D-A29Q-08,4,0.71305373,TCGA-HC-A632,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24916,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,61,0,61,NA,NA,0,61,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,6
0.275927756,2.508745078,TCGA-HC-8264-01B,TCGA-HC-8264-01B-11D-2395-08,4,0.095237382,TCGA-HC-8264,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22177,Alive,WITH TUMOR,48,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,48,0,48,NA,NA,0,48,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,6
9.492644169,-5.618426911,TCGA-HC-8266-01A,TCGA-HC-8266-01A-11D-2260-08,1,0.88180892,TCGA-HC-8266,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20280,Alive,WITH TUMOR,473,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,473,0,473,NA,NA,0,473,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
-0.38521214,4.741771617,TCGA-EI-7004-01A,TCGA-EI-7004-01A-11D-1924-10,4,0.525936565,TCGA-EI-7004,READ,37,FEMALE,WHITE,Rectal Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-13566,Alive,TUMOR FREE,257,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,257,0,257,NA,NA,0,257,NA,[Discrepancy],T4a,M0,GI.CIN,6
-5.441785239,2.311934693,TCGA-05-4433-01A,TCGA-05-4433-01A-22D-1855-08,12,0.29093856,TCGA-05-4433,LUAD,82,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-30194,Alive,TUMOR FREE,730,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,730,0,730,NA,NA,0,730,NA,Stage IB,T2,M0,LUAD.6,8
9.597271065,-5.366806685,TCGA-HC-8260-01A,TCGA-HC-8260-01A-11D-2260-08,1,0.768634155,TCGA-HC-8260,PRAD,43,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-15884,Alive,TUMOR FREE,686,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,686,0,686,0,686,0,686,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.401620179,-5.648868816,TCGA-HC-8261-01A,TCGA-HC-8261-01A-11D-2260-08,1,0.751855075,TCGA-HC-8261,PRAD,48,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-17874,Alive,TUMOR FREE,546,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,546,0,546,0,546,0,546,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
-5.115478365,1.126956478,TCGA-55-7815-01A,TCGA-55-7815-01A-11D-2167-08,0,NA,TCGA-55-7815,LUAD,76,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2011,[Not Available],-28119,Alive,WITH TUMOR,773,NA,[Not Available],Locoregional Recurrence,NA,NA,466,Complete Remission/Response,0,773,0,773,1,466,1,466,NA,Stage IB,T2a,MX,LUAD.6,9
9.97694106,-2.209536403,TCGA-HC-8259-01A,TCGA-HC-8259-01A-11D-2260-08,1,0.741978286,TCGA-HC-8259,PRAD,50,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-18309,Alive,TUMOR FREE,924,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,924,0,924,0,924,0,924,NA,[Not Applicable],T2a,[Not Applicable],NA,1
10.21031772,-1.796835877,TCGA-HC-8256-01A,TCGA-HC-8256-01A-11D-2260-08,1,0.796738543,TCGA-HC-8256,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19598,Alive,TUMOR FREE,860,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,860,0,860,0,860,0,860,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
8.708005315,-4.450059923,TCGA-06-0645-01A,TCGA-06-0645-01A-01D-1492-08,1,0.744350118,TCGA-06-0645,GBM,55,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-20449,Dead,WITH TUMOR,98,175,[Not Available],NA,NA,NA,NA,[Not Available],1,175,1,175,NA,NA,1,175,NA,NA,NA,NA,GBM_LGG.NA,1
8.875962805,-3.414080581,TCGA-HC-8257-01A,TCGA-HC-8257-01A-11D-2260-08,1,0.721258003,TCGA-HC-8257,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25629,Alive,TUMOR FREE,726,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,726,0,726,0,726,0,726,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.214702624,-5.534043759,TCGA-HC-7820-01A,TCGA-HC-7820-01A-11D-2114-08,1,0.858979111,TCGA-HC-7820,PRAD,72,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-26576,Alive,TUMOR FREE,747,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,747,0,747,0,747,0,747,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.429047146,-5.527810734,TCGA-HC-8213-01A,TCGA-HC-8213-01A-11D-A29Q-08,1,0.847018473,TCGA-HC-8213,PRAD,48,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-17673,Alive,TUMOR FREE,589,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,589,0,589,0,589,0,589,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.432876108,-3.055994317,TCGA-HC-7819-01A,TCGA-HC-7819-01A-11D-2114-08,1,0.74890335,TCGA-HC-7819,PRAD,53,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19663,Alive,TUMOR FREE,543,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,543,0,543,0,543,0,543,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-7.965405965,2.034970606,TCGA-76-4927-01A,TCGA-76-4927-01A-01D-1486-08,9,0.44141494,TCGA-76-4927,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-21193,Dead,WITH TUMOR,535,535,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],416,[Not Available],1,535,1,535,NA,NA,1,416,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-6.609193591,-1.550449311,TCGA-DY-A1DC-01A,TCGA-DY-A1DC-01A-31D-A152-10,0,NA,TCGA-DY-A1DC,READ,72,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2000,[Not Available],-26436,Dead,NA,NA,1258,[Not Available],Locoregional Disease,NA,NA,630,[Not Available],1,1258,NA,1258,NA,NA,1,630,NA,Stage IIA,T3,M0,GI.CIN,2
-3.71648309,0.187814785,TCGA-91-6830-01A,TCGA-91-6830-01A-11D-1945-08,0,NA,TCGA-91-6830,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-23922,Alive,WITH TUMOR,60,NA,[Not Available],Distant Metastasis,NA,NA,18,[Unknown],0,60,0,60,NA,NA,1,18,NA,Stage IIA,T1,MX,NA,10
0.342816903,2.198324963,TCGA-HC-8262-01A,TCGA-HC-8262-01A-11D-2260-08,0,NA,TCGA-HC-8262,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-20946,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,679,0,679,0,679,0,679,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,6
-4.085925407,-1.940038712,TCGA-EB-A4IS-01A,TCGA-EB-A4IS-01A-21D-A25O-08,8,0.421613438,TCGA-EB-A4IS,SKCM,77,MALE,WHITE,NA,[Not Available],2012,[Not Available],-28315,Alive,TUMOR FREE,774,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,774,0,774,NA,NA,0,774,NA,Stage IIB,T3b,M0,SKCM.BRAF_Hotspot_Mutants,10
-3.852405097,-1.790745839,TCGA-EB-A5UM-01A,TCGA-EB-A5UM-01A-11D-A30X-08,8,0.234576549,TCGA-EB-A5UM,SKCM,48,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-17867,Alive,TUMOR FREE,779,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,779,0,779,NA,NA,0,779,NA,Stage IIC,T4b,M0,NA,10
9.698763145,-2.567149036,TCGA-ED-A7PX-01A,TCGA-ED-A7PX-01A-51D-A34Z-10,1,0.773230341,TCGA-ED-A7PX,LIHC,48,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-17638,Alive,TUMOR FREE,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,0,6,0,6,NA,Stage II,T2,M0,LIHC.iCluster:1,1
0.312786514,5.031665533,TCGA-HT-7477-01B,TCGA-HT-7477-01B-11D-A289-08,4,0.695070364,TCGA-HT-7477,LGG,62,MALE,WHITE,Astrocytoma,G3,2011,[Not Available],-22948,Alive,TUMOR FREE,738,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,738,0,738,0,738,0,738,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.505529416,-5.613626353,TCGA-J4-A67O-01A,TCGA-J4-A67O-01A-11D-A30E-08,1,0.883421416,TCGA-J4-A67O,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-21714,Alive,TUMOR FREE,839,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,839,0,839,0,839,0,839,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-1.780831549,0.998783306,TCGA-EB-A550-01A,TCGA-EB-A550-01A-61D-A27K-08,5,0.618282752,TCGA-EB-A550,SKCM,75,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-27556,Dead,TUMOR FREE,NA,264,[Not Available],NA,NA,NA,NA,[Not Available],1,264,0,264,NA,NA,0,264,NA,Stage IIC,T4b,M0,SKCM.-,4
9.271539743,-5.258649363,TCGA-G9-6354-01A,TCGA-G9-6354-01A-11D-A30X-08,1,0.789774595,TCGA-G9-6354,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20403,Alive,TUMOR FREE,2066,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2066,0,2066,0,2066,0,2066,NA,[Not Applicable],T2b,[Not Applicable],NA,1
-4.150283003,-1.594470822,TCGA-EB-A44O-01A,TCGA-EB-A44O-01A-11D-A25O-08,8,0.298749229,TCGA-EB-A44O,SKCM,69,MALE,WHITE,NA,[Not Available],2012,[Not Available],-25537,Alive,WITH TUMOR,81,NA,[Not Available],Regional lymph node,NA,NA,60,[Not Available],0,81,0,81,NA,NA,1,60,NA,Stage IIB,T4a,M0,SKCM.RAS_Hotspot_Mutants,10
0.22140577,4.589104979,TCGA-EB-A57M-01A,TCGA-EB-A57M-01A-51D-A30X-08,4,0.58094722,TCGA-EB-A57M,SKCM,56,MALE,ASIAN,NA,[Not Available],2012,[Not Available],-20698,Dead,TUMOR FREE,NA,472,[Not Available],NA,NA,NA,NA,[Not Available],1,472,0,472,NA,NA,0,472,NA,Stage IIIB,T4b,M0,NA,6
8.925429519,-4.585536214,TCGA-DD-A73F-01A,TCGA-DD-A73F-01A-11D-A32G-10,1,0.698935477,TCGA-DD-A73F,LIHC,77,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2010,[Not Available],-28234,Alive,TUMOR FREE,1085,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1085,0,1085,0,1085,0,1085,NA,Stage I,T1,M0,LIHC.iCluster:3,1
9.691665226,-1.826837671,TCGA-EJ-A46G-01A,TCGA-EJ-A46G-01A-31D-A26M-08,1,0.843018398,TCGA-EJ-A46G,PRAD,71,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012,[Not Available],-26219,Alive,TUMOR FREE,668,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,668,0,668,0,668,0,668,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
4.547166282,1.127559937,TCGA-NI-A4U2-01A,TCGA-NI-A4U2-01A-11D-A28X-10,2,0.666000959,TCGA-NI-A4U2,LIHC,71,MALE,WHITE,Hepatocellular Carcinoma,G1,2005,[Not Available],-26011,Dead,WITH TUMOR,NA,1791,[Not Available],Locoregional Recurrence,Liver,NA,106,[Not Available],1,1791,1,1791,1,106,1,106,NA,Stage IIIA,T3,MX,LIHC.iCluster:2,5
1.042203831,3.627312957,TCGA-S9-A6TZ-01A,TCGA-S9-A6TZ-01A-21D-A32B-08,0,NA,TCGA-S9-A6TZ,LGG,39,FEMALE,WHITE,Astrocytoma,G2,2011,[Not Available],-14592,Alive,WITH TUMOR,1120,NA,[Not Available],NA,NA,NA,552,Partial Remission/Response,0,1120,0,1120,NA,NA,1,552,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.818211041,-2.556834818,TCGA-E7-A7DV-01A,TCGA-E7-A7DV-01A-11D-A339-08,8,0.443444839,TCGA-E7-A7DV,BLCA,44,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-16145,Alive,WITH TUMOR,37,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,37,0,37,NA,NA,0,37,NA,Stage IV,T4,MX,NA,10
-0.615500149,2.205547245,TCGA-P4-A5EA-01A,TCGA-P4-A5EA-01A-11D-A28G-10,0,NA,TCGA-P4-A5EA,KIRP,54,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-19748,Dead,WITH TUMOR,NA,201,[Not Available],NA,NA,NA,44,Complete Remission/Response,1,201,1,201,1,44,1,44,NA,Stage III,T3a,MX,KIRP.C2c - CIMP,3
-6.052967835,3.59770009,TCGA-A4-8312-01A,TCGA-A4-8312-01A-11D-2396-08,11,0.424077505,TCGA-A4-8312,KIRP,60,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-22231,Alive,TUMOR FREE,708,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,708,0,708,0,708,0,708,NA,Stage I,T1,MX,KIRP.C2a,8
1.984391411,1.932335521,TCGA-A4-A5DU-01A,TCGA-A4-A5DU-01A-11D-A28G-10,3,0.518114119,TCGA-A4-A5DU,KIRP,45,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-16779,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,496,0,496,0,496,0,496,NA,Stage I,T1a,MX,KIRP.C1,3
-7.100917425,-2.187094365,TCGA-FW-A5DX-01A,TCGA-FW-A5DX-01A-11D-A27K-08,6,0.198533375,TCGA-FW-A5DX,SKCM,71,MALE,WHITE,NA,[Not Available],2012,[Not Available],-26056,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,640,0,640,NA,NA,0,640,NA,Stage IIIC,T4a,[Not Available],SKCM.BRAF_Hotspot_Mutants,2
9.321722003,-5.511399609,TCGA-M7-A71Z-01A,TCGA-M7-A71Z-01A-12D-A32B-08,1,0.84293784,TCGA-M7-A71Z,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22785,Alive,TUMOR FREE,643,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,643,0,643,0,643,0,643,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-6.265394313,3.460103092,TCGA-DD-A73B-01A,TCGA-DD-A73B-01A-12D-A32G-10,11,0.292195303,TCGA-DD-A73B,LIHC,72,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-26390,Dead,WITH TUMOR,NA,283,[Not Available],Locoregional Recurrence,Liver,NA,240,[Not Available],1,283,1,283,1,240,1,240,NA,Stage I,T1,M0,LIHC.iCluster:2,8
-7.423518315,-2.486049044,TCGA-EB-A4OY-01A,TCGA-EB-A4OY-01A-11D-A25O-08,6,0.444927613,TCGA-EB-A4OY,SKCM,65,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-23773,Alive,TUMOR FREE,977,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,977,0,977,NA,NA,0,977,NA,Stage IIIB,T4b,M0,SKCM.Triple_WT,2
4.4339465,1.145120614,TCGA-R8-A73M-01A,TCGA-R8-A73M-01A-11D-A32B-08,2,0.613631548,TCGA-R8-A73M,LGG,48,FEMALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-17610,Alive,NA,1806,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1806,0,1806,NA,NA,0,1806,NA,NA,NA,NA,NA,5
-0.682182396,4.36833246,TCGA-AH-6643-01A,TCGA-AH-6643-01A-11D-1826-10,4,0.359537086,TCGA-AH-6643,READ,50,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-18273,Dead,WITH TUMOR,NA,1314,[Not Available],NA,NA,NA,1026,Complete Remission/Response,1,1314,1,1314,1,1026,1,1026,NA,Stage IIIC,T3,M0,GI.CIN,3
0.216076926,4.81034915,TCGA-PQ-A6FN-01A,TCGA-PQ-A6FN-01A-11D-A31L-08,4,0.622142456,TCGA-PQ-A6FN,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-28546,Alive,NA,507,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,507,0,507,NA,NA,0,507,NA,Stage III,T3a,MX,NA,6
0.061660055,4.752016906,TCGA-12-0691-01A,TCGA-12-0691-01A-01W-0348-08,4,0.640889828,TCGA-12-0691,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1999,[Not Available],-23019,Dead,WITH TUMOR,186,369,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],98,[Not Available],1,369,1,369,NA,NA,1,98,NA,NA,NA,NA,NA,6
-3.404413603,-3.160454328,TCGA-DK-A6B6-01A,TCGA-DK-A6B6-01A-11D-A30E-08,8,0.449046367,TCGA-DK-A6B6,BLCA,57,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-21007,Alive,TUMOR FREE,1115,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1115,0,1115,0,1115,0,1115,NA,Stage II,[Not Available],MX,NA,10
-7.346334505,-1.914465105,TCGA-DK-A6AV-01A,TCGA-DK-A6AV-01A-12D-A30E-08,6,0.039813904,TCGA-DK-A6AV,BLCA,82,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-30089,Alive,TUMOR FREE,1952,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1952,0,1952,0,1952,0,1952,NA,Stage II,T2a,M0,NA,2
-1.758410646,1.039957539,TCGA-KV-A6GE-01A,TCGA-KV-A6GE-01A-11D-A31X-10,5,0.556147571,TCGA-KV-A6GE,KIRP,65,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-23979,Alive,TUMOR FREE,885,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,885,0,885,0,885,0,885,NA,Stage I,T1a,MX,KIRP.C1,4
9.544267358,-4.005218039,TCGA-A4-A5Y1-01A,TCGA-A4-A5Y1-01A-11D-A28G-10,1,0.708219593,TCGA-A4-A5Y1,KIRP,75,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-27541,Dead,WITH TUMOR,NA,395,[Not Available],NA,NA,NA,296,Complete Remission/Response,1,395,1,395,1,296,1,296,NA,Stage III,T1b,MX,KIRP.C2b,1
-1.065327202,4.374220436,TCGA-DC-5869-01A,TCGA-DC-5869-01A-01D-1657-10,4,0.444912813,TCGA-DC-5869,READ,62,FEMALE,BLACK OR AFRICAN AMERICAN,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-22676,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,943,0,943,NA,NA,0,943,NA,Stage IIIB,T3,M0,GI.CIN,6
9.211821903,-5.510120195,TCGA-B9-A5W7-01A,TCGA-B9-A5W7-01A-11D-A31X-10,1,0.827050522,TCGA-B9-A5W7,KIRP,47,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-17465,Alive,TUMOR FREE,585,NA,[Not Available],NA,NA,NA,564,Complete Remission/Response,0,585,0,585,1,564,1,564,NA,Stage I,T1a,[Not Available],KIRP.C1,1
0.003617911,5.157231629,TCGA-HT-A5R5-01A,TCGA-HT-A5R5-01A-11D-A289-08,4,0.604646444,TCGA-HT-A5R5,LGG,33,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-12403,Alive,TUMOR FREE,4,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4,0,4,0,4,0,4,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.37743099,-5.609724475,TCGA-EJ-A46D-01A,TCGA-EJ-A46D-01A-21D-A257-08,1,0.850553013,TCGA-EJ-A46D,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-19466,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,626,0,626,0,626,0,626,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-5.456188517,-1.644819773,TCGA-C5-A8XH-01A,TCGA-C5-A8XH-01A-11D-A37N-09,0,NA,TCGA-C5-A8XH,CESC,39,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-14444,Dead,TUMOR FREE,NA,1394,NA,NA,NA,NA,NA,[Not Available],1,1394,0,1394,NA,NA,0,1394,NA,Stage IB1,T1b1,MX,NA,10
2.036630189,1.86203075,TCGA-C5-A7X8-01A,TCGA-C5-A7X8-01A-11D-A36J-09,3,0.579920083,TCGA-C5-A7X8,CESC,35,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2003,[Not Available],-12977,Alive,TUMOR FREE,83,NA,NA,NA,NA,NA,NA,[Not Available],0,83,0,83,NA,NA,0,83,NA,Stage IB1,T2a,M0,NA,3
-2.95490687,-3.98632597,TCGA-DK-A6AW-01A,TCGA-DK-A6AW-01A-11D-A30E-08,8,0.110909268,TCGA-DK-A6AW,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-25644,Alive,TUMOR FREE,1621,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1621,0,1621,0,1621,0,1621,NA,Stage II,T2a,M0,NA,10
9.105764991,-2.263660154,TCGA-C5-A7XC-01A,TCGA-C5-A7XC-01A-11D-A387-09,1,0.710234155,TCGA-C5-A7XC,CESC,26,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2004,[Not Available],-9776,Alive,TUMOR FREE,1551,NA,NA,NA,NA,NA,NA,[Not Available],0,1551,0,1551,NA,NA,0,1551,NA,Stage IB1,T1b,M0,NA,6
9.417137362,-4.823437784,TCGA-C5-A7X3-01A,TCGA-C5-A7X3-01A-11D-A351-09,1,0.821438884,TCGA-C5-A7X3,CESC,70,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,1997,[Not Available],-25665,Dead,TUMOR FREE,NA,284,NA,NA,NA,NA,NA,[Not Available],1,284,0,284,NA,NA,0,284,NA,Stage IIIB,[Not Available],[Not Available],NA,1
9.36058875,-5.000574918,TCGA-QH-A65Z-01A,TCGA-QH-A65Z-01A-11D-A29Q-08,1,0.798839959,TCGA-QH-A65Z,LGG,54,MALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-19921,Alive,TUMOR FREE,427,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,427,0,427,NA,NA,0,427,NA,NA,NA,NA,GBM_LGG.Codel,1
-6.974535039,-1.871844937,TCGA-C5-A7X5-01A,TCGA-C5-A7X5-01A-11D-A36J-09,0,NA,TCGA-C5-A7X5,CESC,72,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2003,[Not Available],-26542,Dead,WITH TUMOR,NA,414,Cervical Cancer,NA,NA,NA,NA,[Not Available],1,414,1,414,NA,NA,1,414,NA,Stage IVB,[Not Available],[Not Available],NA,10
-4.903559369,0.681638758,TCGA-C5-A7UH-01A,TCGA-C5-A7UH-01A-11D-A351-09,0,NA,TCGA-C5-A7UH,CESC,55,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2003,[Not Available],-20189,Alive,TUMOR FREE,3988,NA,NA,NA,NA,NA,NA,[Not Available],0,3988,0,3988,NA,NA,0,3988,NA,Stage IIIB,[Not Available],[Not Available],NA,10
-7.337994262,-2.420512388,TCGA-C5-A7UI-01A,TCGA-C5-A7UI-01A-11D-A36J-09,6,0.345902434,TCGA-C5-A7UI,CESC,42,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2004,[Not Available],-15349,Dead,TUMOR FREE,NA,2888,NA,NA,NA,NA,NA,[Not Available],1,2888,0,2888,NA,NA,0,2888,NA,Stage IB1,T1b1,MX,NA,2
-7.315728114,-2.409173508,TCGA-ED-A7XP-01A,TCGA-ED-A7XP-01A-11D-A34Z-10,6,0.240983625,TCGA-ED-A7XP,LIHC,53,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-19504,Alive,WITH TUMOR,400,NA,[Not Available],Locoregional Recurrence,Liver,NA,187,[Not Available],0,400,0,400,1,187,1,187,NA,Stage II,T2,M0,LIHC.iCluster:1,2
-6.313857068,-1.566029069,TCGA-EI-7002-01A,TCGA-EI-7002-01A-11D-1924-10,7,0.042500237,TCGA-EI-7002,READ,58,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-21192,Alive,TUMOR FREE,364,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,364,0,364,NA,NA,0,364,NA,Stage IV,T3,M1,GI.CIN,2
-6.505727925,2.90448086,TCGA-DX-A3LU-01A,TCGA-DX-A3LU-01A-11D-A21Q-09,0,NA,TCGA-DX-A3LU,SARC,60,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2007,[Not Available],-21915,Alive,TUMOR FREE,2641,NA,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,290,[Not Available],0,2641,0,2641,NA,NA,1,290,NA,NA,NA,NA,NA,7
4.354098401,1.126923959,TCGA-DX-A3LS-01A,TCGA-DX-A3LS-01A-11D-A21Q-09,2,0.717052633,TCGA-DX-A3LS,SARC,78,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-28649,Dead,WITH TUMOR,NA,275,[Not Available],Distant Metastasis,Lung,NA,114,[Not Available],1,275,1,275,NA,NA,1,114,NA,NA,NA,NA,NA,5
1.923198181,1.874880842,TCGA-DX-A3LY-01B,TCGA-DX-A3LY-01B-11D-A27P-09,3,0.534116488,TCGA-DX-A3LY,SARC,66,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-24166,Alive,TUMOR FREE,1017,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1017,0,1017,0,1017,0,1017,NA,NA,NA,NA,NA,3
-0.130421648,4.168410551,TCGA-DX-A3LW-01A,TCGA-DX-A3LW-01A-21D-A21Q-09,4,0.386211208,TCGA-DX-A3LW,SARC,43,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2004,[Not Available],-15969,Alive,WITH TUMOR,4150,NA,[Not Available],Locoregional Recurrence,NA,NA,1125,[Not Available],0,4150,0,4150,NA,NA,1,1125,NA,NA,NA,NA,NA,1
-7.795883129,2.119524787,TCGA-AA-3548-01A,TCGA-AA-3548-01A-01D-1953-10,9,0.440181161,TCGA-AA-3548,COAD,71,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-26175,Alive,TUMOR FREE,1034,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1034,0,1034,0,1034,0,1034,NA,Stage IIIC,T3,M0,NA,7
-0.138151905,4.094963936,TCGA-DX-A2IZ-01A,TCGA-DX-A2IZ-01A-11D-A21Q-09,4,0.463046813,TCGA-DX-A2IZ,SARC,60,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2007,[Not Available],-22245,Alive,TUMOR FREE,261,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,261,0,261,0,261,0,261,NA,NA,NA,NA,NA,1
8.838730129,-4.988366705,TCGA-DX-A240-01A,TCGA-DX-A240-01A-32D-A27P-09,1,0.845729068,TCGA-DX-A240,SARC,51,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2006,[Not Available],-18721,Alive,TUMOR FREE,1834,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1834,0,1834,0,1834,0,1834,NA,NA,NA,NA,NA,1
4.345180156,1.187407597,TCGA-DX-A23R-01A,TCGA-DX-A23R-01A-11D-A26G-09,2,0.684711995,TCGA-DX-A23R,SARC,55,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2002,[Not Available],-20442,Alive,TUMOR FREE,2271,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2271,0,2271,NA,NA,0,2271,NA,NA,NA,NA,NA,5
9.008838223,-5.300831596,TCGA-DX-A23Y-01A,TCGA-DX-A23Y-01A-11D-A27P-09,1,0.855189261,TCGA-DX-A23Y,SARC,80,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2006,[Not Available],-29272,Dead,WITH TUMOR,NA,191,[Not Available],Locoregional Recurrence,NA,NA,172,[Not Available],1,191,1,191,NA,NA,1,172,NA,NA,NA,NA,NA,1
-3.154637283,-3.510829498,TCGA-F4-6856-01A,TCGA-F4-6856-01A-11D-1924-10,8,0.647000462,TCGA-F4-6856,COAD,45,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-16519,Alive,TUMOR FREE,1074,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1074,0,1074,0,1074,0,1074,NA,Stage I,T2,M0,GI.HM-indel,10
9.136152064,-4.945692637,TCGA-DX-A1L3-01A,TCGA-DX-A1L3-01A-11D-A24N-09,1,0.838922859,TCGA-DX-A1L3,SARC,60,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2009,[Not Available],-22240,Dead,WITH TUMOR,NA,1020,[Not Available],Locoregional Recurrence,NA,NA,437,[Not Available],1,1020,1,1020,NA,NA,1,437,NA,NA,NA,NA,NA,1
-5.744246862,-2.249324536,TCGA-DX-A1L2-01A,TCGA-DX-A1L2-01A-22D-A24N-09,0,NA,TCGA-DX-A1L2,SARC,78,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2008,[Not Available],-28692,Alive,WITH TUMOR,2586,NA,[Not Available],Locoregional Recurrence,NA,NA,1480,[Not Available],0,2586,0,2586,1,1480,1,1480,NA,NA,NA,NA,NA,2
2.425528788,1.835886393,TCGA-DX-A1KW-01A,TCGA-DX-A1KW-01A-22D-A24N-09,0,NA,TCGA-DX-A1KW,SARC,67,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2009,[Not Available],-24647,Dead,NA,NA,995,[Not Available],NA,NA,NA,NA,[Not Available],1,995,NA,995,NA,NA,0,995,NA,NA,NA,NA,NA,3
10.06514821,-2.149405763,TCGA-DX-A1KU-01A,TCGA-DX-A1KU-01A-32D-A24N-09,1,0.802189987,TCGA-DX-A1KU,SARC,82,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2010,[Not Available],-30054,Dead,WITH TUMOR,NA,427,[Not Available],Distant Metastasis,"Other, specify",Abdomen,94,[Not Available],1,427,1,427,NA,NA,1,94,NA,NA,NA,NA,NA,1
0.209910664,3.437259994,TCGA-3R-A8YX-01A,TCGA-3R-A8YX-01A-11D-A37C-09,4,0.284991333,TCGA-3R-A8YX,SARC,66,MALE,[Not Evaluated],Dedifferentiated liposarcoma,[Not Available],2013,[Not Available],-24412,Dead,WITH TUMOR,NA,17,[Not Available],NA,NA,NA,NA,[Not Available],1,17,1,17,NA,NA,1,17,NA,NA,NA,NA,NA,3
-0.133194569,4.89771174,TCGA-3B-A9I3-01A,TCGA-3B-A9I3-01A-11D-A38Z-09,4,0.645331268,TCGA-3B-A9I3,SARC,62,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-22985,Alive,TUMOR FREE,808,NA,[Not Available],New Primary Tumor,"Other, specify",Axillary Lymph Node,87,[Not Available],0,808,0,808,NA,NA,1,87,NA,NA,NA,NA,NA,6
7.793991816,-1.384554241,TCGA-DX-A1L0-01A,TCGA-DX-A1L0-01A-11D-A24N-09,1,0.134721158,TCGA-DX-A1L0,SARC,58,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2008,[Not Available],-21434,Dead,WITH TUMOR,NA,564,[Not Available],Locoregional Recurrence,NA,NA,103,[Not Available],1,564,1,564,NA,NA,1,103,NA,NA,NA,NA,NA,1
2.013408953,1.806545196,TCGA-DX-A1KX-01A,TCGA-DX-A1KX-01A-22D-A24N-09,3,0.605740833,TCGA-DX-A1KX,SARC,67,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2009,[Not Available],-24784,Alive,TUMOR FREE,2087,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2087,0,2087,0,2087,0,2087,NA,NA,NA,NA,NA,3
-0.23030206,4.623506404,TCGA-3B-A9I1-01A,TCGA-3B-A9I1-01A-11D-A38Z-09,4,0.565136689,TCGA-3B-A9I1,SARC,56,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-20629,Dead,WITH TUMOR,NA,567,[Not Available],Distant Metastasis,"Other, specify",Pelvis,192,[Not Available],1,567,1,567,NA,NA,1,192,NA,NA,NA,NA,NA,6
9.389993904,-5.206640433,TCGA-3B-A9I0-01A,TCGA-3B-A9I0-01A-11D-A38Z-09,1,0.792093731,TCGA-3B-A9I0,SARC,33,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-12148,Alive,WITH TUMOR,1096,NA,[Not Available],Distant Metastasis,Liver,NA,503,[Not Available],0,1096,0,1096,1,503,1,503,NA,NA,NA,NA,NA,1
-0.779340373,3.89411291,TCGA-3B-A9HZ-01A,TCGA-3B-A9HZ-01A-11D-A38Z-09,4,0.381082351,TCGA-3B-A9HZ,SARC,66,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-24433,Alive,WITH TUMOR,1170,NA,[Not Available],Distant Metastasis,Lung,NA,309,[Not Available],0,1170,0,1170,NA,NA,1,309,NA,NA,NA,NA,NA,5
-4.316589719,-1.279272106,TCGA-3B-A9HT-01A,TCGA-3B-A9HT-01A-11D-A38Z-09,8,0.29569166,TCGA-3B-A9HT,SARC,53,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-19637,Alive,TUMOR FREE,1665,NA,[Not Available],New Primary Tumor,Liver,NA,670,[Not Available],0,1665,0,1665,0,1665,1,670,NA,NA,NA,NA,NA,10
9.723585328,-1.91670931,TCGA-3B-A9HS-01A,TCGA-3B-A9HS-01A-11D-A38Z-09,1,0.745124084,TCGA-3B-A9HS,SARC,60,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2008,[Not Available],-21946,Dead,WITH TUMOR,NA,1366,[Not Available],Locoregional Recurrence,NA,NA,139,[Not Available],1,1366,1,1366,1,139,1,139,NA,NA,NA,NA,NA,1
9.657875999,-2.267329595,TCGA-3B-A9HR-01A,TCGA-3B-A9HR-01A-11D-A387-09,1,0.779184848,TCGA-3B-A9HR,SARC,38,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-14041,Dead,WITH TUMOR,NA,2694,[Not Available],Distant Metastasis,Lung,NA,496,[Not Available],1,2694,1,2694,1,496,1,496,NA,NA,NA,NA,NA,1
9.548258851,-2.282602283,TCGA-3B-A9HQ-01A,TCGA-3B-A9HQ-01A-11D-A387-09,1,0.761317096,TCGA-3B-A9HQ,SARC,66,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-24386,Alive,NA,2085,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2085,0,2085,0,2085,0,2085,NA,NA,NA,NA,NA,1
-0.205265833,5.094930605,TCGA-3B-A9HY-01A,TCGA-3B-A9HY-01A-11D-A38Z-09,4,0.710057405,TCGA-3B-A9HY,SARC,49,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-18109,Alive,TUMOR FREE,314,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,314,0,314,0,314,0,314,NA,NA,NA,NA,NA,6
-0.083396214,4.721580392,TCGA-3B-A9HV-01A,TCGA-3B-A9HV-01A-11D-A38Z-09,4,0.588161665,TCGA-3B-A9HV,SARC,48,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-17638,Dead,WITH TUMOR,NA,437,[Not Available],Distant Metastasis,Lung,NA,41,[Not Available],1,437,1,437,NA,NA,1,41,NA,NA,NA,NA,NA,6
-0.853570089,4.457226928,TCGA-3B-A9HU-01A,TCGA-3B-A9HU-01A-11D-A38Z-09,4,0.477005877,TCGA-3B-A9HU,SARC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-19669,Alive,WITH TUMOR,768,NA,[Not Available],Distant Metastasis,Lung,NA,631,[Not Available],0,768,0,768,1,631,1,631,NA,NA,NA,NA,NA,6
-0.589915055,5.055510324,TCGA-3B-A9HP-01A,TCGA-3B-A9HP-01A-11D-A387-09,4,0.535960077,TCGA-3B-A9HP,SARC,57,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-21094,Dead,WITH TUMOR,NA,1627,[Not Available],Distant Metastasis,Lung,NA,517,[Not Available],1,1627,1,1627,NA,NA,1,517,NA,NA,NA,NA,NA,6
8.907298772,-4.035779463,TCGA-AA-3549-01A,TCGA-AA-3549-01A-02D-1953-10,1,0.735878374,TCGA-AA-3549,COAD,69,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-25415,Alive,TUMOR FREE,639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,639,0,639,0,639,0,639,NA,Stage I,T2,M0,NA,1
-7.195884446,-2.480391467,TCGA-3B-A9HL-01A,TCGA-3B-A9HL-01A-11D-A387-09,6,0.267218215,TCGA-3B-A9HL,SARC,67,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-24628,Dead,TUMOR FREE,NA,599,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,229,[Not Available],1,599,0,599,NA,NA,1,229,NA,NA,NA,NA,NA,2
-7.012692338,-2.04437514,TCGA-RQ-A6JB-01A,TCGA-RQ-A6JB-01A-11D-A31X-10,6,0.115533105,TCGA-RQ-A6JB,DLBC,62,FEMALE,WHITE,Primary DLBCL of the CNS,[Not Available],2011,[Not Available],-22859,Alive,NA,1,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1,0,1,NA,NA,0,1,NA,NA,NA,NA,NA,2
-0.20729885,2.819353106,TCGA-RQ-A68N-01A,TCGA-RQ-A68N-01A-11D-A31X-10,4,0.044789183,TCGA-RQ-A68N,DLBC,63,MALE,WHITE,Primary DLBCL of the CNS,[Not Available],2012,[Not Available],-23127,Alive,TUMOR FREE,788,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,788,0,788,NA,NA,0,788,NA,NA,NA,NA,NA,3
7.805946129,-1.375601941,TCGA-GS-A9U4-01A,TCGA-GS-A9U4-01A-11D-A38X-10,1,0.154353127,TCGA-GS-A9U4,DLBC,27,FEMALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011,[Not Available],-10075,Dead,WITH TUMOR,NA,391,[Not Available],NA,Cervical Lymph Nodes,NA,106,Progressive Disease,1,391,1,391,NA,NA,1,106,NA,NA,NA,NA,NA,1
7.824207448,-3.580144047,TCGA-3B-A9HI-01A,TCGA-3B-A9HI-01A-11D-A387-09,1,0.347754029,TCGA-3B-A9HI,SARC,68,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2009,[Not Available],-24984,Alive,WITH TUMOR,1521,NA,[Not Available],Locoregional Recurrence,NA,NA,606,[Not Available],0,1521,0,1521,NA,NA,1,606,NA,NA,NA,NA,NA,1
-5.172108171,2.461201525,TCGA-AA-3844-01A,TCGA-AA-3844-01A-01W-0995-10,12,0.195902113,TCGA-AA-3844,COAD,78,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-28521,Alive,WITH TUMOR,454,NA,[Not Available],NA,NA,NA,365,Progressive Disease,0,454,0,454,NA,NA,1,365,NA,Stage IIIC,T3,M0,GI.CIN,8
9.759111652,-1.480847472,TCGA-GS-A9U3-01A,TCGA-GS-A9U3-01A-11D-A38X-10,1,0.86535694,TCGA-GS-A9U3,DLBC,77,FEMALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2005,[Not Available],-28474,Alive,TUMOR FREE,3394,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3394,0,3394,0,3394,0,3394,NA,NA,NA,NA,NA,1
-4.300893469,-1.745496818,TCGA-GS-A9TZ-01A,TCGA-GS-A9TZ-01A-11D-A38X-10,8,0.454721164,TCGA-GS-A9TZ,DLBC,51,MALE,WHITE,Primary mediastinal (thymic) DLBCL,[Not Available],2012,[Not Available],-18691,Alive,TUMOR FREE,765,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,765,0,765,NA,NA,0,765,NA,NA,NA,NA,NA,10
-5.688320541,-2.054910731,TCGA-GS-A9TY-01A,TCGA-GS-A9TY-01A-11D-A38X-10,0,NA,TCGA-GS-A9TY,DLBC,82,FEMALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2005,[Not Available],-30256,Alive,WITH TUMOR,3333,NA,[Not Available],NA,Pleura/Pleural effusion,NA,3255,Complete Remission/Response,0,3333,0,3333,1,3255,1,3255,NA,NA,NA,NA,NA,2
-0.746674936,2.296414231,TCGA-GR-A4D9-01B,TCGA-GR-A4D9-01B-11D-A31X-10,0,NA,TCGA-GR-A4D9,DLBC,66,FEMALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2009,[Not Available],-24405,Alive,WITH TUMOR,1739,NA,[Not Available],NA,Soft Tissue,NA,1218,Complete Remission/Response,0,1739,0,1739,NA,NA,1,1218,NA,NA,NA,NA,NA,6
-7.843279102,1.979445155,TCGA-GS-A9TX-01A,TCGA-GS-A9TX-01A-11D-A382-10,9,0.317921458,TCGA-GS-A9TX,DLBC,37,MALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011,[Not Available],-13708,Alive,TUMOR FREE,1373,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1373,0,1373,0,1373,0,1373,NA,NA,NA,NA,NA,1
-4.96847455,-1.988877575,TCGA-GS-A9TW-01A,TCGA-GS-A9TW-01A-11D-A382-10,8,0.025538144,TCGA-GS-A9TW,DLBC,23,FEMALE,WHITE,Primary mediastinal (thymic) DLBCL,[Not Available],2010,[Not Available],-8493,Alive,TUMOR FREE,1617,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1617,0,1617,0,1617,0,1617,NA,NA,NA,NA,NA,10
-7.246053813,-2.517143814,TCGA-GS-A9TV-01A,TCGA-GS-A9TV-01A-11D-A382-10,6,0.264066845,TCGA-GS-A9TV,DLBC,40,FEMALE,WHITE,Primary mediastinal (thymic) DLBCL,[Not Available],2013,[Not Available],-14838,Alive,TUMOR FREE,730,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,730,0,730,0,730,0,730,NA,NA,NA,NA,NA,2
9.302159361,-4.836190817,TCGA-GS-A9TU-01A,TCGA-GS-A9TU-01A-11D-A382-10,1,0.812237864,TCGA-GS-A9TU,DLBC,45,MALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2004,[Not Available],-16720,Alive,TUMOR FREE,3897,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3897,0,3897,0,3897,0,3897,NA,NA,NA,NA,NA,1
-0.787726306,2.265156748,TCGA-GR-A4D6-01A,TCGA-GR-A4D6-01A-11D-A31X-10,0,NA,TCGA-GR-A4D6,DLBC,54,FEMALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010,[Not Available],-19838,Alive,TUMOR FREE,1334,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1334,0,1334,0,1334,0,1334,NA,NA,NA,NA,NA,6
1.235668203,3.414347345,TCGA-GR-A4D5-01A,TCGA-GR-A4D5-01A-11D-A31X-10,0,NA,TCGA-GR-A4D5,DLBC,46,FEMALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010,[Not Available],-17023,Alive,TUMOR FREE,1299,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1299,0,1299,NA,NA,0,1299,NA,NA,NA,NA,NA,1
-7.18872545,-2.280296774,TCGA-AY-4071-01A,TCGA-AY-4071-01A-01W-1073-09,6,0.287156119,TCGA-AY-4071,COAD,63,FEMALE,WHITE,[Not Available],[Not Available],2009,[Not Available],-23320,Dead,TUMOR FREE,NA,29,[Not Available],NA,NA,NA,NA,[Not Available],1,29,0,29,NA,NA,0,29,NA,Stage I,T1,[Not Available],GI.CIN,2
-6.747886703,-1.340241064,TCGA-G4-6323-01A,TCGA-G4-6323-01A-11D-1719-10,0,NA,TCGA-G4-6323,COAD,50,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-18334,Alive,TUMOR FREE,419,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,419,0,419,NA,NA,0,419,NA,Stage IA,Tis,MX,GI.GS,2
-6.046059708,2.964464494,TCGA-YC-A8S6-01A,TCGA-YC-A8S6-01A-31D-A38G-08,0,NA,TCGA-YC-A8S6,BLCA,71,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-26130,Alive,TUMOR FREE,293,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,293,0,293,0,293,0,293,NA,Stage II,T2a,MX,NA,8
-0.984067918,4.369773616,TCGA-44-A4SU-01A,TCGA-44-A4SU-01A-11D-A24P-08,4,0.414389615,TCGA-44-A4SU,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24820,Dead,WITH TUMOR,NA,409,[Not Available],Locoregional Recurrence,NA,NA,260,Complete Remission/Response,1,409,1,409,1,260,1,260,NA,Stage IA,T1a,MX,NA,6
-5.697981997,-2.237095905,TCGA-Y8-A8RZ-01A,TCGA-Y8-A8RZ-01A-11D-A36X-10,0,NA,TCGA-Y8-A8RZ,KIRP,55,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-20386,Alive,TUMOR FREE,205,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,205,0,205,0,205,0,205,NA,Stage I,T1,MX,NA,2
1.168301304,3.480962396,TCGA-Y8-A898-01A,TCGA-Y8-A898-01A-11D-A34Z-10,0,NA,TCGA-Y8-A898,KIRP,69,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-25344,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,475,0,475,0,475,0,475,NA,Stage I,T1a,MX,NA,1
9.363273234,-4.196451608,TCGA-HC-7738-01A,TCGA-HC-7738-01A-11D-2114-08,1,0.686261299,TCGA-HC-7738,PRAD,58,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21195,Alive,WITH TUMOR,964,NA,[Not Available],Biochemical evidence of disease,"Other, specify",biochemical recurrence only,420,Partial Remission/Response,0,964,0,964,NA,NA,1,420,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-4.337503864,-1.759585295,TCGA-XF-A8HG-01A,TCGA-XF-A8HG-01A-11D-A364-08,8,0.435904862,TCGA-XF-A8HG,BLCA,69,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-25421,Dead,WITH TUMOR,NA,467,[Not Available],Distant Metastasis,Liver,NA,398,Complete Remission/Response,1,467,1,467,1,398,1,398,NA,Stage III,T3b,MX,NA,10
-7.452866063,-2.073025754,TCGA-Y8-A896-01A,TCGA-Y8-A896-01A-11D-A35Z-10,6,0.153500689,TCGA-Y8-A896,KIRP,62,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-22750,Alive,TUMOR FREE,567,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,567,0,567,0,567,0,567,NA,Stage III,T3a,MX,NA,2
-7.301981492,-1.912760637,TCGA-XF-A8HF-01A,TCGA-XF-A8HF-01A-11D-A364-08,6,0.018047158,TCGA-XF-A8HF,BLCA,80,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-29288,Dead,TUMOR FREE,NA,2954,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2954,0,2954,0,2954,0,2954,NA,Stage III,T3a,M0,NA,2
-7.232928553,-2.337725253,TCGA-14-1458-01A,TCGA-14-1458-01A-01W-0643-08,6,0.340455155,TCGA-14-1458,GBM,54,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-19899,Dead,NA,187,203,[Not Available],Recurrence,[Not Applicable],[Not Applicable],81,[Not Available],1,203,NA,203,NA,NA,1,81,NA,NA,NA,NA,NA,2
-7.612193126,-2.498694922,TCGA-06-0209-01A,TCGA-06-0209-01A-01D-1491-08,6,0.531810115,TCGA-06-0209,GBM,76,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1997,[Not Available],-27877,Dead,WITH TUMOR,119,232,[Not Available],NA,NA,NA,NA,[Not Available],1,232,1,232,NA,NA,1,232,NA,NA,NA,NA,NA,2
1.065789538,2.804947494,TCGA-Y8-A895-01A,TCGA-Y8-A895-01A-11D-A35Z-10,0,NA,TCGA-Y8-A895,KIRP,74,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-27139,Alive,TUMOR FREE,484,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,484,0,484,0,484,0,484,NA,Stage I,T1b,MX,NA,1
-3.813283068,-1.985272085,TCGA-64-5778-01A,TCGA-64-5778-01A-01D-1625-08,8,0.254477798,TCGA-64-5778,LUAD,60,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-21927,Alive,WITH TUMOR,1305,NA,[Not Available],Distant Metastasis,NA,NA,962,Complete Remission/Response,0,1305,0,1305,1,962,1,962,NA,Stage IB,T2,M0,LUAD.5,10
8.886127336,-4.621782493,TCGA-HC-7745-01A,TCGA-HC-7745-01A-11D-2114-08,1,0.783157613,TCGA-HC-7745,PRAD,65,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24078,Alive,TUMOR FREE,721,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,721,0,721,0,721,0,721,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-1.88869923,1.238761238,TCGA-44-6775-01A,TCGA-44-6775-01A-31D-A27T-08,5,0.656244288,TCGA-44-6775,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26415,Alive,WITH TUMOR,705,NA,[Not Available],Locoregional Recurrence,NA,NA,684,Complete Remission/Response,0,705,0,705,1,684,1,684,NA,Stage IB,T2a,MX,LUAD.5,4
8.646692786,-1.831222117,TCGA-14-2554-01A,TCGA-14-2554-01A-01D-1494-08,1,0.500401722,TCGA-14-2554,GBM,52,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-19090,Dead,WITH TUMOR,532,532,[Not Available],NA,NA,NA,NA,[Not Available],1,532,1,532,NA,NA,1,532,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-2.912705552,-4.087259249,TCGA-19-5956-01A,TCGA-19-5956-01A-11D-1696-08,8,0.015264851,TCGA-19-5956,GBM,53,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-19591,Dead,WITH TUMOR,NA,684,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],647,Stable Disease,1,684,1,684,NA,NA,1,647,NA,NA,NA,NA,NA,10
8.691690293,-3.281517102,TCGA-12-0827-01A,TCGA-12-0827-01A-01W-0424-08,1,0.663702955,TCGA-12-0827,GBM,38,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1999,[Not Available],-14093,Dead,WITH TUMOR,1179,1179,[Not Available],NA,NA,NA,NA,[Not Available],1,1179,1,1179,NA,NA,1,1179,NA,NA,NA,NA,NA,1
0.274942526,3.552722125,TCGA-27-1835-01A,TCGA-27-1835-01A-01D-1494-08,4,0.269809156,TCGA-27-1835,GBM,53,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-19444,Dead,WITH TUMOR,648,648,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],157,[Not Available],1,648,1,648,NA,NA,1,157,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,3
-6.25733695,1.567937341,TCGA-06-0210-01B,TCGA-06-0210-01B-01D-1491-08,10,0.369761496,TCGA-06-0210,GBM,72,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1997,[Not Available],-26600,Dead,WITH TUMOR,151,225,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],67,[Not Available],1,225,1,225,NA,NA,1,67,NA,NA,NA,NA,GBM_LGG.NA,7
-5.38610586,2.192117169,TCGA-86-8359-01A,TCGA-86-8359-01A-11D-2323-08,12,0.102327567,TCGA-86-8359,LUAD,52,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-19088,Dead,TUMOR FREE,NA,444,[Not Available],NA,NA,NA,NA,[Unknown],1,444,0,444,NA,NA,0,444,NA,Stage IIIA,T3,M0,NA,8
-0.863787504,2.489030374,TCGA-CM-6163-01A,TCGA-CM-6163-01A-11D-1650-10,4,0.055729794,TCGA-CM-6163,COAD,74,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-27150,Alive,TUMOR FREE,427,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,427,0,427,NA,NA,0,427,NA,Stage I,T1,M0,GI.CIN,6
-0.686843308,4.508824538,TCGA-A6-6649-01A,TCGA-A6-6649-01A-11D-1771-10,4,0.531794866,TCGA-A6-6649,COAD,66,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-24237,Alive,TUMOR FREE,735,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,735,0,735,0,735,0,735,NA,Stage IIIB,T3,M0,GI.CIN,6
9.287824456,-4.732752035,TCGA-06-0122-01A,TCGA-06-0122-01A-01D-1490-08,1,0.73870392,TCGA-06-0122,GBM,84,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-30968,Dead,NA,8,187,[Not Available],NA,NA,NA,NA,[Not Available],1,187,NA,187,NA,NA,0,187,NA,NA,NA,NA,NA,1
-7.266572135,-2.292401965,TCGA-12-3651-01A,TCGA-12-3651-01A-01W-0922-08,6,0.316806408,TCGA-12-3651,GBM,77,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-28277,Dead,WITH TUMOR,358,386,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],358,[Not Available],1,386,1,386,NA,NA,1,358,NA,NA,NA,NA,NA,2
-1.791237503,2.757915563,TCGA-AA-3968-01A,TCGA-AA-3968-01A-01W-0995-10,0,NA,TCGA-AA-3968,COAD,55,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-20089,Alive,TUMOR FREE,669,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,669,0,669,0,669,0,669,NA,Stage I,T2,M0,GI.CIN,3
-6.014684893,3.251921415,TCGA-97-7941-01A,TCGA-97-7941-01A-11D-2184-08,11,0.117188386,TCGA-97-7941,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26298,Alive,TUMOR FREE,484,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,484,0,484,0,484,0,484,NA,Stage IA,T1b,MX,LUAD.5,8
-0.607973191,3.266745721,TCGA-91-7771-01A,TCGA-91-7771-01A-11D-2167-08,4,0.401524804,TCGA-91-7771,LUAD,62,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22926,Alive,TUMOR FREE,492,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,492,0,492,0,492,0,492,NA,Stage IIB,T3,MX,LUAD.6,6
-0.09595528,2.327610571,TCGA-26-6173-01A,TCGA-26-6173-01A-11D-1845-08,4,0.136809017,TCGA-26-6173,GBM,57,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-21093,Alive,TUMOR FREE,241,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,241,0,241,NA,NA,0,241,NA,NA,NA,NA,NA,6
9.676375773,-3.493663722,TCGA-DX-A6BG-01A,TCGA-DX-A6BG-01A-11D-A307-09,1,0.685682669,TCGA-DX-A6BG,SARC,51,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2012,[Not Available],-18682,Alive,WITH TUMOR,1121,NA,[Not Available],Locoregional Recurrence,NA,NA,149,[Not Available],0,1121,0,1121,1,149,1,149,NA,NA,NA,NA,NA,1
7.845706815,-1.341119541,TCGA-DX-A6BF-01A,TCGA-DX-A6BF-01A-11D-A307-09,1,0.186685003,TCGA-DX-A6BF,SARC,82,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2012,[Not Available],-30071,Alive,WITH TUMOR,972,NA,[Not Available],Locoregional Recurrence,"Other, specify",NA,947,[Not Available],0,972,0,972,NA,NA,1,947,NA,NA,NA,NA,NA,1
9.808859031,-1.873554967,TCGA-DX-A6BE-01A,TCGA-DX-A6BE-01A-41D-A32I-09,1,0.806923864,TCGA-DX-A6BE,SARC,77,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-28368,Alive,TUMOR FREE,881,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,881,0,881,0,881,0,881,NA,NA,NA,NA,NA,1
-0.346196174,4.574574486,TCGA-DX-A6B7-01A,TCGA-DX-A6B7-01A-11D-A307-09,4,0.558030602,TCGA-DX-A6B7,SARC,55,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-20365,Alive,TUMOR FREE,1143,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1143,0,1143,0,1143,0,1143,NA,NA,NA,NA,NA,6
-0.173656945,4.754866868,TCGA-DX-A48V-01A,TCGA-DX-A48V-01A-11D-A307-09,4,0.563341185,TCGA-DX-A48V,SARC,78,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-28754,Alive,TUMOR FREE,1820,NA,[Not Available],Distant Metastasis,"Other, specify",Flank,1407,[Not Available],0,1820,0,1820,1,1407,1,1407,NA,NA,NA,NA,NA,6
-0.264255246,5.223563417,TCGA-DX-A48U-01A,TCGA-DX-A48U-01A-11D-A307-09,4,0.613395553,TCGA-DX-A48U,SARC,57,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2005,[Not Available],-20853,Alive,TUMOR FREE,3310,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3310,0,3310,0,3310,0,3310,NA,NA,NA,NA,NA,6
0.051564055,4.527600905,TCGA-DX-A6BB-01A,TCGA-DX-A6BB-01A-12D-A32I-09,4,0.424650824,TCGA-DX-A6BB,SARC,74,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-27150,Alive,WITH TUMOR,1105,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1105,0,1105,NA,NA,0,1105,NA,NA,NA,NA,NA,6
-0.453519837,5.066534393,TCGA-DX-A6BA-01A,TCGA-DX-A6BA-01A-11D-A307-09,4,0.59626981,TCGA-DX-A6BA,SARC,53,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2008,[Not Available],-19455,Alive,WITH TUMOR,2515,NA,[Not Available],Locoregional Recurrence,NA,NA,408,[Not Available],0,2515,0,2515,1,408,1,408,NA,NA,NA,NA,NA,6
8.757600425,-3.744809789,TCGA-DX-A6B9-01A,TCGA-DX-A6B9-01A-12D-A32I-09,1,0.736512846,TCGA-DX-A6B9,SARC,45,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-16561,Alive,TUMOR FREE,1138,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1138,0,1138,0,1138,0,1138,NA,NA,NA,NA,NA,1
-0.222432238,4.797708509,TCGA-DX-A6B8-01A,TCGA-DX-A6B8-01A-11D-A307-09,4,0.616083283,TCGA-DX-A6B8,SARC,80,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2002,[Not Available],-29513,Dead,WITH TUMOR,NA,485,[Not Available],Distant Metastasis,Lung,NA,42,[Not Available],1,485,1,485,1,42,1,42,NA,NA,NA,NA,NA,6
8.973885373,-3.745753707,TCGA-DX-A48R-01A,TCGA-DX-A48R-01A-11D-A307-09,1,0.753595959,TCGA-DX-A48R,SARC,41,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2002,[Not Available],-15107,Alive,WITH TUMOR,805,NA,[Not Available],Locoregional Recurrence,NA,NA,315,[Not Available],0,805,0,805,NA,NA,1,315,NA,NA,NA,NA,NA,1
-0.17110106,5.009574579,TCGA-DX-A48O-01A,TCGA-DX-A48O-01A-11D-A307-09,4,0.683562533,TCGA-DX-A48O,SARC,63,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-23364,Alive,TUMOR FREE,1605,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1605,0,1605,0,1605,0,1605,NA,NA,NA,NA,NA,3
9.069481077,-3.96374571,TCGA-DX-A48N-01A,TCGA-DX-A48N-01A-11D-A307-09,1,0.749068244,TCGA-DX-A48N,SARC,47,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2012,[Not Available],-17364,Alive,TUMOR FREE,1073,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1073,0,1073,NA,NA,0,1073,NA,NA,NA,NA,NA,1
8.59628504,-3.84793149,TCGA-DX-A3UE-01A,TCGA-DX-A3UE-01A-11D-A307-09,1,0.732527742,TCGA-DX-A3UE,SARC,66,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-24388,Dead,WITH TUMOR,NA,1061,[Not Available],Distant Metastasis,NA,NA,224,[Not Available],1,1061,1,1061,1,224,1,224,NA,NA,NA,NA,NA,1
9.868415926,-2.075590425,TCGA-DX-A3UD-01A,TCGA-DX-A3UD-01A-11D-A307-09,1,0.813217032,TCGA-DX-A3UD,SARC,56,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-20703,Alive,WITH TUMOR,1534,NA,[Not Available],Locoregional Recurrence,NA,NA,603,[Not Available],0,1534,0,1534,1,603,1,603,NA,NA,NA,NA,NA,1
-7.795039363,-2.456124435,TCGA-DX-A48K-01A,TCGA-DX-A48K-01A-11D-A307-09,6,0.549590138,TCGA-DX-A48K,SARC,65,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-23756,Alive,TUMOR FREE,1399,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1399,0,1399,0,1399,0,1399,NA,NA,NA,NA,NA,2
-0.246650992,4.606292416,TCGA-DX-A48J-01A,TCGA-DX-A48J-01A-21D-A307-09,4,0.584091312,TCGA-DX-A48J,SARC,44,MALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2003,[Not Available],-16279,Dead,WITH TUMOR,NA,296,[Not Available],Locoregional Recurrence,NA,NA,97,[Not Available],1,296,1,296,1,97,1,97,NA,NA,NA,NA,NA,6
-0.240488928,4.318775788,TCGA-DX-A3UF-01A,TCGA-DX-A3UF-01A-11D-A307-09,4,0.539308886,TCGA-DX-A3UF,SARC,65,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-23993,Dead,WITH TUMOR,NA,2599,[Not Available],Locoregional Recurrence,NA,NA,964,[Not Available],1,2599,1,2599,NA,NA,1,964,NA,NA,NA,NA,NA,6
8.844618751,-2.002730192,TCGA-26-1439-01A,TCGA-26-1439-01A-01D-1353-08,1,0.637047775,TCGA-26-1439,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-23302,Dead,WITH TUMOR,NA,422,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],284,[Not Available],1,422,1,422,NA,NA,1,284,NA,NA,NA,NA,NA,1
9.108216974,-4.963175697,TCGA-DX-A3UB-01A,TCGA-DX-A3UB-01A-11D-A307-09,1,0.837287655,TCGA-DX-A3UB,SARC,54,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2009,[Not Available],-19862,Alive,TUMOR FREE,2247,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2247,0,2247,0,2247,0,2247,NA,NA,NA,NA,NA,1
4.556491432,1.067663857,TCGA-DX-A3UA-01A,TCGA-DX-A3UA-01A-12D-A307-09,2,0.64649487,TCGA-DX-A3UA,SARC,47,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2009,[Not Available],-17342,Dead,[Discrepancy],NA,325,[Not Available],NA,NA,NA,NA,[Not Available],1,325,NA,325,0,325,0,325,NA,NA,NA,NA,NA,5
1.984726108,1.952387219,TCGA-DX-A3U9-01A,TCGA-DX-A3U9-01A-11D-A307-09,3,0.459063908,TCGA-DX-A3U9,SARC,84,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2005,[Not Available],-31010,Dead,WITH TUMOR,NA,456,[Not Available],Locoregional Recurrence,NA,NA,203,[Not Available],1,456,1,456,NA,NA,1,203,NA,NA,NA,NA,NA,3
-7.79698835,2.079450153,TCGA-DX-A3U8-01A,TCGA-DX-A3U8-01A-11D-A29N-09,9,0.528951321,TCGA-DX-A3U8,SARC,43,MALE,[Unknown],Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-15751,Dead,WITH TUMOR,NA,138,[Not Available],Distant Metastasis,Lung,NA,128,[Not Available],1,138,1,138,1,128,1,128,NA,NA,NA,NA,NA,7
-7.314532039,2.615938871,TCGA-19-2631-01A,TCGA-19-2631-01A-01D-1353-08,0,NA,TCGA-19-2631,GBM,74,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-27200,Dead,TUMOR FREE,213,213,[Not Available],NA,NA,NA,NA,[Not Available],1,213,0,213,NA,NA,0,213,NA,NA,NA,NA,NA,7
-0.073805384,5.007292777,TCGA-DX-A3M1-01A,TCGA-DX-A3M1-01A-11D-A228-09,4,0.71330228,TCGA-DX-A3M1,SARC,79,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2010,[Not Available],-28932,Alive,WITH TUMOR,1359,NA,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,1212,[Not Available],0,1359,0,1359,NA,NA,1,1212,NA,NA,NA,NA,NA,1
9.215538435,-2.976095777,TCGA-DX-A3U7-01A,TCGA-DX-A3U7-01A-11D-A29N-09,1,0.73270991,TCGA-DX-A3U7,SARC,67,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2009,[Not Available],-24723,Dead,WITH TUMOR,NA,1552,[Not Available],Distant Metastasis,Lung,NA,349,[Not Available],1,1552,1,1552,1,349,1,349,NA,NA,NA,NA,NA,3
8.953893032,-5.21452868,TCGA-DX-A3U6-01A,TCGA-DX-A3U6-01A-11D-A29N-09,1,0.816336746,TCGA-DX-A3U6,SARC,63,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-23193,Dead,WITH TUMOR,NA,1088,[Not Available],Locoregional Recurrence,NA,NA,160,[Not Available],1,1088,1,1088,1,160,1,160,NA,NA,NA,NA,NA,1
8.990346602,-3.745056529,TCGA-DX-A3U5-01A,TCGA-DX-A3U5-01A-11D-A228-09,1,0.720299281,TCGA-DX-A3U5,SARC,52,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-19088,Alive,TUMOR FREE,969,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,969,0,969,NA,NA,0,969,NA,NA,NA,NA,NA,1
-0.181950667,4.387262758,TCGA-DX-A3M2-01A,TCGA-DX-A3M2-01A-21D-A228-09,4,0.566871158,TCGA-DX-A3M2,SARC,59,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-21689,Alive,WITH TUMOR,1055,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1055,0,1055,NA,NA,0,1055,NA,NA,NA,NA,NA,6
8.694570298,-4.952942626,TCGA-06-5411-01A,TCGA-06-5411-01A-01D-1696-08,1,0.811867318,TCGA-06-5411,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-18832,Dead,WITH TUMOR,254,254,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],214,[Not Available],1,254,1,254,NA,NA,1,214,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.359732414,-5.476330001,TCGA-G9-6347-01A,TCGA-G9-6347-01A-11D-A31L-08,1,0.847636482,TCGA-G9-6347,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-21721,Alive,TUMOR FREE,2089,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2089,0,2089,0,2089,0,2089,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-7.763604167,2.300669546,TCGA-76-6657-01A,TCGA-76-6657-01A-11D-1845-08,9,0.306106854,TCGA-76-6657,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-27341,Dead,WITH TUMOR,153,153,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],135,[Not Available],1,153,1,153,NA,NA,1,135,NA,NA,NA,NA,NA,7
0.603890396,3.129093861,TCGA-HE-A5NI-01A,TCGA-HE-A5NI-01A-11D-A26P-10,4,0.070237276,TCGA-HE-A5NI,KIRP,73,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-26985,Alive,TUMOR FREE,360,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,360,0,360,0,360,0,360,NA,Stage I,T1a,M0,KIRP.C1,3
-0.468501566,2.198309275,TCGA-HE-A5NJ-01A,TCGA-HE-A5NJ-01A-11D-A26P-10,4,0.026341405,TCGA-HE-A5NJ,KIRP,58,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-21485,Alive,TUMOR FREE,1726,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1726,0,1726,0,1726,0,1726,NA,[Not Available],T1b,M0,KIRP.C1,3
8.924099479,-5.203095292,TCGA-FC-A8O0-01A,TCGA-FC-A8O0-01A-41D-A377-08,1,0.850314195,TCGA-FC-A8O0,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-25115,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,616,0,616,0,616,0,616,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
2.14311313,1.884403417,TCGA-G9-6339-01A,TCGA-G9-6339-01A-12D-A30X-08,3,0.562252021,TCGA-G9-6339,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-21305,Alive,TUMOR FREE,2551,NA,[Not Available],Biochemical evidence of disease,NA,NA,1634,Complete Remission/Response,0,2551,0,2551,1,1634,1,1634,NA,[Not Applicable],T3b,[Not Applicable],NA,3
-7.139686464,-2.682622934,TCGA-FD-A6TH-01A,TCGA-FD-A6TH-01A-11D-A32B-08,0,NA,TCGA-FD-A6TH,BLCA,63,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23236,Dead,WITH TUMOR,NA,131,[Not Available],Distant Metastasis,Lung,NA,126,Complete Remission/Response,1,131,1,131,NA,NA,1,126,NA,Stage IV,T3,MX,NA,6
-5.612906548,1.26388634,TCGA-FD-A6TI-01A,TCGA-FD-A6TI-01A-11D-A32B-08,0,NA,TCGA-FD-A6TI,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-26874,Dead,TUMOR FREE,NA,294,[Not Available],NA,NA,NA,NA,[Unknown],1,294,0,294,NA,NA,0,294,NA,Stage IV,T4b,MX,NA,9
9.264969331,-2.687036017,TCGA-G7-A8LD-01A,TCGA-G7-A8LD-01A-11D-A35Z-10,1,0.748179439,TCGA-G7-A8LD,KIRP,71,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-25977,Dead,WITH TUMOR,NA,514,[Not Available],NA,NA,NA,209,Complete Remission/Response,1,514,1,514,1,209,1,209,NA,Stage III,T3a,MX,NA,1
4.347391363,1.194143494,TCGA-FC-A4JI-01A,TCGA-FC-A4JI-01A-11D-A257-08,2,0.674269408,TCGA-FC-A4JI,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-25931,Alive,TUMOR FREE,877,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,877,0,877,0,877,0,877,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,5
-4.471744409,-1.991859111,TCGA-FD-A6TG-01A,TCGA-FD-A6TG-01A-11D-A32B-08,8,0.332585533,TCGA-FD-A6TG,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-26893,Dead,TUMOR FREE,NA,93,[Not Available],NA,NA,NA,NA,[Not Applicable],1,93,0,93,NA,NA,0,93,NA,Stage IV,T3a,MX,NA,10
0.228489998,4.949079658,TCGA-DC-4749-01A,TCGA-DC-4749-01A-01D-1733-10,4,0.627093428,TCGA-DC-4749,READ,57,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-21092,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,762,0,762,0,762,0,762,NA,Stage I,T2,M0,GI.CIN,6
0.231195502,2.530423471,TCGA-EI-6883-01A,TCGA-EI-6883-01A-31D-1924-10,4,0.193206656,TCGA-EI-6883,READ,63,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-23268,Alive,TUMOR FREE,350,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,350,0,350,NA,NA,0,350,NA,Stage IIC,T3,M0,GI.CIN,6
-7.13428661,-1.996164626,TCGA-15-1446-01A,TCGA-15-1446-01A-01W-0611-08,0,NA,TCGA-15-1446,GBM,55,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-20355,Alive,WITH TUMOR,581,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],443,[Not Available],0,581,0,581,NA,NA,1,443,NA,NA,NA,NA,NA,2
9.990971604,-1.858987528,TCGA-EJ-A65M-01A,TCGA-EJ-A65M-01A-11D-A29Q-08,1,0.839671509,TCGA-EJ-A65M,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23767,Alive,TUMOR FREE,230,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,230,0,230,0,230,0,230,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-5.061973388,-1.522586249,TCGA-FD-A6TE-01A,TCGA-FD-A6TE-01A-12D-A339-08,0,NA,TCGA-FD-A6TE,BLCA,54,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-19874,Alive,TUMOR FREE,376,NA,[Not Available],Distant Metastasis,"Other, specify",sacrum,321,[Unknown],0,376,0,376,NA,NA,1,321,NA,Stage IV,T3a,MX,NA,10
-1.275275663,4.066341025,TCGA-06-0184-01A,TCGA-06-0184-01A-01D-1491-08,4,0.117087242,TCGA-06-0184,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-23317,Dead,WITH TUMOR,NA,2126,[Not Available],NA,[Not Applicable],[Not Applicable],1276,[Not Available],1,2126,1,2126,NA,NA,1,1276,NA,NA,NA,NA,GBM_LGG.NA,6
-3.415831993,-3.109141543,TCGA-12-0829-01A,TCGA-12-0829-01A-01W-0424-08,8,0.515126424,TCGA-12-0829,GBM,75,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-27471,Dead,WITH TUMOR,626,626,[Not Available],Recurrence,[Not Applicable],[Not Applicable],473,[Not Available],1,626,1,626,NA,NA,1,473,NA,NA,NA,NA,NA,10
9.235699091,-4.466929302,TCGA-EJ-A65J-01A,TCGA-EJ-A65J-01A-11D-A30X-08,1,0.783734364,TCGA-EJ-A65J,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22904,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,451,0,451,0,451,0,451,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
-5.683487715,-1.200119155,TCGA-FD-A6TD-01A,TCGA-FD-A6TD-01A-51D-A339-08,0,NA,TCGA-FD-A6TD,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-28328,Dead,TUMOR FREE,NA,386,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,386,0,386,0,386,0,386,NA,Stage III,T3a,MX,NA,10
-7.228808665,-1.936186293,TCGA-75-5125-01A,TCGA-75-5125-01A-01D-1753-08,6,0.120566943,TCGA-75-5125,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Dead,WITH TUMOR,NA,2027,[Not Available],NA,NA,NA,1752,Complete Remission/Response,1,2027,1,2027,1,1752,1,1752,NA,Stage IIB,T2,M0,NA,2
9.442219377,-1.489944349,TCGA-EJ-A65E-01A,TCGA-EJ-A65E-01A-11D-A29Q-08,1,0.679759261,TCGA-EJ-A65E,PRAD,67,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012,[Not Available],-24558,Alive,TUMOR FREE,417,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,417,0,417,0,417,0,417,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,1
-3.31238161,-3.337325192,TCGA-FD-A6TC-01A,TCGA-FD-A6TC-01A-21D-A339-08,8,0.526153855,TCGA-FD-A6TC,BLCA,79,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-28963,Alive,TUMOR FREE,187,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,187,0,187,0,187,0,187,NA,Stage III,T4a,MX,NA,10
-7.586093673,2.284230826,TCGA-EJ-A65D-01A,TCGA-EJ-A65D-01A-11D-A30E-08,9,0.056045373,TCGA-EJ-A65D,PRAD,66,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012,[Not Available],-24297,Alive,TUMOR FREE,393,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,393,0,393,0,393,0,393,NA,[Not Applicable],T3a,[Not Applicable],NA,7
-4.2909757,-1.726930416,TCGA-FD-A6TA-01A,TCGA-FD-A6TA-01A-12D-A339-08,8,0.382954888,TCGA-FD-A6TA,BLCA,58,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-21196,Alive,TUMOR FREE,1912,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1912,0,1912,NA,NA,0,1912,NA,Stage IV,T3b,MX,NA,10
8.639393626,-4.506800458,TCGA-EJ-A65B-01A,TCGA-EJ-A65B-01A-12D-A30E-08,1,0.811574533,TCGA-EJ-A65B,PRAD,55,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012,[Not Available],-20204,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,710,0,710,0,710,0,710,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-5.144097258,1.774335851,TCGA-EI-6512-01A,TCGA-EI-6512-01A-11D-1733-10,0,NA,TCGA-EI-6512,READ,64,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-23537,Alive,TUMOR FREE,538,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,538,0,538,NA,NA,0,538,NA,Stage IIIB,T3,M0,GI.CIN,8
-5.769755929,2.105006782,TCGA-AG-A020-01A,TCGA-AG-A020-01A-21W-A096-10,0,NA,TCGA-AG-A020,READ,57,FEMALE,[Not Available],Rectal Mucinous Adenocarcinoma,[Not Available],2005,[Not Available],-20851,Alive,WITH TUMOR,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage III,T3,M0,GI.CIN,7
-0.509194249,4.185312879,TCGA-06-0241-01A,TCGA-06-0241-01A-02D-1491-08,4,0.48248782,TCGA-06-0241,GBM,65,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-24101,Dead,WITH TUMOR,NA,1481,[Not Available],Recurrence,[Not Applicable],[Not Applicable],196,[Not Available],1,1481,1,1481,NA,NA,1,196,NA,NA,NA,NA,NA,6
9.461236792,-4.649740765,TCGA-F9-A97G-01A,TCGA-F9-A97G-01A-11D-A382-10,1,0.744250887,TCGA-F9-A97G,KIRP,79,MALE,ASIAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-29156,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,13,0,13,0,13,0,13,NA,Stage III,T3,M0,NA,1
8.540304946,-3.720407425,TCGA-06-0646-01A,TCGA-06-0646-01A-01D-1492-08,1,0.65665315,TCGA-06-0646,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-22273,Dead,WITH TUMOR,136,175,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],90,[Not Available],1,175,1,175,NA,NA,1,90,NA,NA,NA,NA,GBM_LGG.NA,1
4.399778908,1.121175556,TCGA-F9-A7Q0-01A,TCGA-F9-A7Q0-01A-11D-A35Z-10,2,0.70397568,TCGA-F9-A7Q0,KIRP,37,FEMALE,ASIAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-13523,Alive,TUMOR FREE,398,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,398,0,398,0,398,0,398,NA,Stage I,T1b,M0,NA,5
-7.200457716,-2.369950304,TCGA-38-4626-01A,TCGA-38-4626-01A-01D-1553-08,6,0.334284128,TCGA-38-4626,LUAD,57,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-20903,Alive,TUMOR FREE,3674,NA,[Not Available],New Primary Tumor,NA,NA,2518,Complete Remission/Response,0,3674,0,3674,0,3674,1,2518,NA,[Discrepancy],T2b,M0,LUAD.5,2
9.231722729,-1.557615398,TCGA-BJ-A18Z-01A,TCGA-BJ-A18Z-01A-21D-A13W-08,1,0.746994815,TCGA-BJ-A18Z,THCA,58,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-21519,Alive,TUMOR FREE,1263,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1263,0,1263,NA,NA,0,1263,NA,Stage IVA,T3,MX,THCA.4,1
9.668133952,-5.440050086,TCGA-06-5859-01A,TCGA-06-5859-01A-01D-1696-08,1,0.837071857,TCGA-06-5859,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-23211,Alive,WITH TUMOR,139,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,139,0,139,NA,NA,0,139,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-7.577728613,-2.078585642,TCGA-B9-A8YH-01A,TCGA-B9-A8YH-01A-11D-A36X-10,6,0.264284437,TCGA-B9-A8YH,KIRP,52,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-19051,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,532,0,532,0,532,0,532,NA,Stage I,T1a,MX,NA,2
-3.138141889,1.027543083,TCGA-19-1388-01A,TCGA-19-1388-01A-01W-0643-08,0,NA,TCGA-19-1388,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-21368,Dead,WITH TUMOR,394,394,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],148,[Not Available],1,394,1,394,NA,NA,1,148,NA,NA,NA,NA,NA,6
-6.662312155,1.302251243,TCGA-B9-A8YI-01A,TCGA-B9-A8YI-01A-21D-A36X-10,0,NA,TCGA-B9-A8YI,KIRP,79,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-28917,Alive,TUMOR FREE,374,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,374,0,374,0,374,0,374,NA,Stage I,T1b,MX,NA,9
-0.356590749,4.61445454,TCGA-B1-A656-01A,TCGA-B1-A656-01A-11D-A31X-10,4,0.484715799,TCGA-B1-A656,KIRP,64,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-23702,Alive,TUMOR FREE,618,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,618,0,618,0,618,0,618,NA,Stage I,T1a,M0,KIRP.C2a,6
9.560663094,-2.308708459,TCGA-B3-A6W5-01A,TCGA-B3-A6W5-01A-12D-A33Q-10,1,0.796452431,TCGA-B3-A6W5,KIRP,43,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-15945,Alive,TUMOR FREE,309,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,309,0,309,0,309,0,309,NA,Stage I,T1,MX,NA,1
-4.716532941,-1.305595014,TCGA-86-7701-01A,TCGA-86-7701-01A-11D-2167-08,8,0.161678602,TCGA-86-7701,LUAD,66,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24209,Alive,WITH TUMOR,947,NA,[Not Available],Distant Metastasis,NA,NA,424,Complete Remission/Response,0,947,0,947,NA,NA,1,424,NA,Stage IV,T2,M1,NA,10
0.212406099,3.45720538,TCGA-B1-A655-01A,TCGA-B1-A655-01A-11D-A31Z-10,4,0.349618338,TCGA-B1-A655,KIRP,77,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-28433,Alive,TUMOR FREE,510,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,510,0,510,0,510,0,510,NA,Stage I,T1a,M0,KIRP.C2a,3
9.468597425,-2.745075808,TCGA-75-6212-01A,TCGA-75-6212-01A-11D-1753-08,1,0.773073631,TCGA-75-6212,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Dead,WITH TUMOR,NA,1516,[Not Available],New Primary Tumor,NA,NA,1340,Complete Remission/Response,1,1516,1,1516,0,1516,1,1340,NA,Stage IIB,T2,M0,LUAD.5,1
9.928346678,-1.649382215,TCGA-B1-A47N-01A,TCGA-B1-A47N-01A-11D-A25F-10,1,0.871058703,TCGA-B1-A47N,KIRP,62,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-22800,Alive,TUMOR FREE,1110,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1110,0,1110,0,1110,0,1110,NA,Stage I,T1a,MX,KIRP.C1,1
1.092465907,3.511303118,TCGA-B1-A654-01A,TCGA-B1-A654-01A-11D-A31X-10,0,NA,TCGA-B1-A654,KIRP,43,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-15721,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,616,0,616,0,616,0,616,NA,Stage I,T1a,M0,KIRP.C1,1
-1.839108875,2.794185268,TCGA-06-0649-01B,TCGA-06-0649-01B-01D-1492-08,4,0.302310906,TCGA-06-0649,GBM,73,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-26796,Dead,WITH TUMOR,62,64,[Not Available],NA,NA,NA,NA,[Not Available],1,64,1,64,NA,NA,1,64,NA,NA,NA,NA,GBM_LGG.NA,6
0.240402529,5.328866089,TCGA-B1-A47M-01A,TCGA-B1-A47M-01A-11D-A25F-10,4,0.219827918,TCGA-B1-A47M,KIRP,79,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-29068,Alive,WITH TUMOR,659,NA,[Not Available],NA,NA,NA,408,[Unknown],0,659,0,659,NA,NA,1,408,NA,Stage III,T3a,MX,KIRP.C1,6
8.997320242,-2.287581362,TCGA-B8-A8YJ-01A,TCGA-B8-A8YJ-01A-13D-A38X-10,1,0.698112698,TCGA-B8-A8YJ,KIRC,60,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2013,[Not Available],-21994,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,431,0,431,0,431,0,431,NA,Stage I,T1b,[Not Available],NA,1
-7.420078693,1.666513126,TCGA-CU-A72E-01A,TCGA-CU-A72E-01A-12D-A339-08,9,0.176830135,TCGA-CU-A72E,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-27963,Dead,WITH TUMOR,NA,413,[Not Available],New Primary Tumor,Lymph Node Only,NA,256,Partial Remission/Response,1,413,1,413,NA,NA,1,256,NA,Stage IV,T3b,M0,NA,7
-4.89608436,-1.409260282,TCGA-05-4250-01A,TCGA-05-4250-01A-01D-1105-08,8,0.259867848,TCGA-05-4250,LUAD,79,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],-29068,Dead,NA,NA,121,[Not Available],NA,NA,NA,NA,[Not Available],1,121,NA,121,NA,NA,0,121,NA,Stage IIIA,T3,M0,NA,10
7.874470092,-3.392553441,TCGA-B8-A7U6-01A,TCGA-B8-A7U6-01A-12D-A36X-10,1,0.378551111,TCGA-B8-A7U6,KIRC,54,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2013,[Not Available],-19803,Alive,TUMOR FREE,495,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,495,0,495,0,495,0,495,NA,Stage I,T1a,[Not Available],NA,1
2.080615545,1.823493658,TCGA-B8-A54G-01A,TCGA-B8-A54G-01A-11D-A25V-10,3,0.499972019,TCGA-B8-A54G,KIRC,50,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2012,[Not Available],-18612,Alive,TUMOR FREE,53,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,53,0,53,0,53,0,53,NA,Stage I,T1a,MX,NA,3
8.094536754,-1.496313196,TCGA-B8-A54H-01A,TCGA-B8-A54H-01A-11D-A33K-10,1,0.314916117,TCGA-B8-A54H,KIRC,69,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2012,[Not Available],-25243,Alive,TUMOR FREE,256,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,256,0,256,0,256,0,256,NA,Stage II,T2a,MX,NA,1
-7.240953497,-2.207562866,TCGA-14-1034-01A,TCGA-14-1034-01A-01D-1492-08,6,0.376891193,TCGA-14-1034,GBM,60,FEMALE,[Not Available],Untreated primary (de novo) GBM,[Not Available],1999,[Not Available],-22029,Dead,WITH TUMOR,485,485,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],282,[Not Available],1,485,1,485,NA,NA,1,282,NA,NA,NA,NA,GBM_LGG.Classic-like,2
9.299811186,-5.139572957,TCGA-B8-A54F-01A,TCGA-B8-A54F-01A-11D-A25V-10,1,0.838920772,TCGA-B8-A54F,KIRC,49,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-18028,Alive,TUMOR FREE,519,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,519,0,519,0,519,0,519,NA,Stage I,T1a,MX,NA,1
-7.33910398,2.419478901,TCGA-CI-6622-01A,TCGA-CI-6622-01A-11D-1826-10,9,0.077054813,TCGA-CI-6622,READ,74,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-27336,Alive,TUMOR FREE,1362,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1362,0,1362,NA,NA,0,1362,NA,Stage IIB,T4,M0,GI.CIN,7
-4.098836516,-2.032248422,TCGA-GN-A263-01A,TCGA-GN-A263-01A-11D-A196-08,8,0.396867642,TCGA-GN-A263,SKCM,24,MALE,WHITE,NA,[Not Available],2004,[Not Available],-8952,Dead,WITH TUMOR,NA,467,[Not Available],Distant Metastasis,Liver,NA,39,[Not Available],1,467,1,467,NA,NA,1,39,NA,Stage IV,T4b,M1c,SKCM.BRAF_Hotspot_Mutants,10
-1.632325238,2.386255924,TCGA-55-A491-01A,TCGA-55-A491-01A-11D-A24D-08,0,NA,TCGA-55-A491,LUAD,81,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-29593,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,626,0,626,0,626,0,626,NA,Stage IA,T1b,MX,NA,10
9.475242146,-4.980926953,TCGA-AT-A5NU-01A,TCGA-AT-A5NU-01A-11D-A28G-10,1,0.780957991,TCGA-AT-A5NU,KIRP,77,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-28137,Alive,NA,67,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,67,0,67,NA,NA,0,67,NA,Stage I,T1a,MX,KIRP.C1,1
-5.706028108,-2.268343936,TCGA-A4-A772-01A,TCGA-A4-A772-01A-11D-A33Q-10,0,NA,TCGA-A4-A772,KIRP,39,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-14278,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,0,0,0,NA,NA,0,0,NA,Stage I,T1b,MX,NA,2
4.439138152,1.029486318,TCGA-AL-A5DJ-01A,TCGA-AL-A5DJ-01A-11D-A26P-10,2,0.720718987,TCGA-AL-A5DJ,KIRP,54,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-20079,Dead,WITH TUMOR,NA,1498,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1498,1,1498,NA,NA,1,1498,NA,Stage III,T3a,MX,NA,5
-3.023552333,0.851564351,TCGA-BT-A42C-01A,TCGA-BT-A42C-01A-11D-A23M-08,0,NA,TCGA-BT-A42C,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-23584,Alive,TUMOR FREE,873,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,873,0,873,0,873,0,873,NA,Stage II,[Not Available],M0,BLCA.1,10
-2.51554498,1.128854315,TCGA-BT-A42F-01A,TCGA-BT-A42F-01A-11D-A23U-08,5,0.212993873,TCGA-BT-A42F,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-23713,Alive,TUMOR FREE,864,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,864,0,864,NA,NA,0,864,NA,Stage IV,T4a,MX,NA,10
-7.974076359,1.934787961,TCGA-06-0750-01A,TCGA-06-0750-01A-01D-1492-08,9,0.66672119,TCGA-06-0750,GBM,43,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-16018,Dead,WITH TUMOR,28,28,[Not Available],NA,NA,NA,NA,[Not Available],1,28,1,28,NA,NA,1,28,NA,NA,NA,NA,GBM_LGG.NA,7
-6.265647015,3.396395445,TCGA-BT-A42B-01A,TCGA-BT-A42B-01A-32D-A23M-08,11,0.308736568,TCGA-BT-A42B,BLCA,59,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-21788,Dead,WITH TUMOR,NA,534,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,534,1,534,NA,NA,1,534,NA,Stage IV,T3a,MX,NA,8
8.822270723,-3.998523499,TCGA-87-5896-01A,TCGA-87-5896-01A-01D-1696-08,1,0.711830972,TCGA-87-5896,GBM,50,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-18391,Alive,TUMOR FREE,800,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,800,0,800,0,800,0,800,NA,NA,NA,NA,NA,1
0.500158072,2.172283487,TCGA-27-2518-01A,TCGA-27-2518-01A-01D-1494-08,0,NA,TCGA-27-2518,GBM,52,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-19130,Dead,WITH TUMOR,753,753,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],539,[Not Available],1,753,1,753,NA,NA,1,539,NA,NA,NA,NA,NA,6
7.906961927,-1.4099524,TCGA-ZS-A9CF-01A,TCGA-ZS-A9CF-01A-11D-A382-10,1,0.242774651,TCGA-ZS-A9CF,LIHC,64,MALE,WHITE,Hepatocellular Carcinoma,G2,2008,[Not Available],-23510,Alive,TUMOR FREE,2412,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,636,[Not Available],0,2412,0,2412,1,636,1,636,NA,Stage II,T2,MX,NA,6
-5.54259946,2.226049492,TCGA-55-6970-01A,TCGA-55-6970-01A-11D-1945-08,12,0.035300956,TCGA-55-6970,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-24773,Dead,WITH TUMOR,NA,464,[Not Available],Locoregional Recurrence,NA,NA,457,Stable Disease,1,464,1,464,NA,NA,1,457,NA,Stage IIIA,T2,MX,LUAD.6,9
-7.858900166,2.346267614,TCGA-ZS-A9CE-01A,TCGA-ZS-A9CE-01A-11D-A36X-10,9,0.455292474,TCGA-ZS-A9CE,LIHC,79,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2011,[Not Available],-29051,Alive,TUMOR FREE,1241,NA,[Not Available],New Primary Tumor,"Other, specify",Right Temple,892,[Not Available],0,1241,0,1241,0,1241,1,892,NA,Stage II,T2,MX,NA,7
-5.22695949,2.389712106,TCGA-AG-3902-01A,TCGA-AG-3902-01A-01W-1073-09,12,0.252245628,TCGA-AG-3902,READ,61,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-22492,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,974,0,974,NA,NA,0,974,NA,Stage IIA,T3,M0,GI.CIN,9
9.655274432,-2.826523535,TCGA-AG-3605-01A,TCGA-AG-3605-01A-01D-1989-10,1,0.782410844,TCGA-AG-3605,READ,85,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-31078,Alive,WITH TUMOR,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage IV,T3,M1,NA,1
9.017836408,-3.4203542,TCGA-44-3919-01A,TCGA-44-3919-01A-02D-1458-08,1,0.741434162,TCGA-44-3919,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-26081,Dead,WITH TUMOR,NA,1026,[Not Available],Locoregional Recurrence,NA,NA,921,Complete Remission/Response,1,1026,1,1026,1,921,1,921,NA,Stage IA,T1,M0,LUAD.3,1
9.661514996,-1.977054729,TCGA-ZP-A9D4-01A,TCGA-ZP-A9D4-01A-11D-A36X-10,1,0.808471136,TCGA-ZP-A9D4,LIHC,64,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-23656,Alive,TUMOR FREE,395,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,395,0,395,0,395,0,395,NA,[Not Available],T1,MX,NA,1
9.206115332,-3.462072357,TCGA-O8-A75V-01A,TCGA-O8-A75V-01A-11D-A32G-10,1,0.737665497,TCGA-O8-A75V,LIHC,54,MALE,[Unknown],Hepatocellular Carcinoma,G2,2013,[Not Available],-19850,Alive,TUMOR FREE,538,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,538,0,538,NA,NA,0,538,NA,Stage I,T1,MX,LIHC.iCluster:2,1
-0.471843924,4.594106133,TCGA-YA-A8S7-01A,TCGA-YA-A8S7-01A-11D-A36X-10,4,0.467280924,TCGA-YA-A8S7,LIHC,68,MALE,WHITE,Hepatocellular Carcinoma,G3,2012,[Not Available],-25188,Dead,WITH TUMOR,NA,412,[Not Available],Extrahepatic Recurrence,Brain,NA,398,[Not Available],1,412,1,412,1,398,1,398,NA,Stage IIIA,T3a,MX,NA,3
8.691019507,-3.684118412,TCGA-MR-A8JO-01A,TCGA-MR-A8JO-01A-12D-A35Z-10,1,0.73537486,TCGA-MR-A8JO,LIHC,34,MALE,WHITE,Fibrolamellar Carcinoma,G3,2013,[Not Available],-12669,Alive,TUMOR FREE,330,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,330,0,330,NA,NA,0,330,NA,Stage I,T1,MX,NA,1
-1.135341756,3.607417905,TCGA-NI-A8LF-01A,TCGA-NI-A8LF-01A-11D-A35Z-10,4,0.297255758,TCGA-NI-A8LF,LIHC,74,MALE,WHITE,Hepatocellular Carcinoma,G3,2012,[Not Available],-27162,Alive,TUMOR FREE,799,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,799,0,799,0,799,0,799,NA,Stage I,T1,MX,NA,5
-2.267169123,1.22442479,TCGA-MI-A75I-01A,TCGA-MI-A75I-01A-11D-A32G-10,5,0.387396169,TCGA-MI-A75I,LIHC,61,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G1,2011,[Not Available],-22341,Alive,NA,630,NA,[Not Available],NA,Liver,NA,265,[Not Available],0,630,0,630,1,265,1,265,NA,[Not Available],T2,MX,LIHC.iCluster:3,4
9.423994185,-5.498870446,TCGA-06-5415-01A,TCGA-06-5415-01A-01D-1486-08,1,0.795542223,TCGA-06-5415,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-22213,Alive,WITH TUMOR,260,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,260,0,260,NA,NA,0,260,NA,NA,NA,NA,GBM_LGG.Classic-like,1
0.112163535,4.834160121,TCGA-06-2558-01A,TCGA-06-2558-01A-01D-1494-08,4,0.718271875,TCGA-06-2558,GBM,75,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-27511,Dead,NA,23,380,[Not Available],NA,NA,NA,NA,[Not Available],1,380,NA,380,NA,NA,0,380,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-1.184270926,3.347568547,TCGA-MI-A75H-01A,TCGA-MI-A75H-01A-11D-A32G-10,0,NA,TCGA-MI-A75H,LIHC,77,MALE,WHITE,Hepatocellular Carcinoma,[Not Available],2012,[Not Available],-28371,Alive,WITH TUMOR,747,NA,[Not Available],Locoregional Recurrence,Liver,NA,301,[Not Available],0,747,0,747,1,301,1,301,NA,[Not Available],[Not Available],MX,LIHC.iCluster:3,5
-4.858538477,-0.9555256,TCGA-55-7576-01A,TCGA-55-7576-01A-11D-2063-08,8,0.107914385,TCGA-55-7576,LUAD,54,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-19917,Alive,TUMOR FREE,670,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,670,0,670,0,670,0,670,NA,Stage IB,T2a,M0,LUAD.3,10
-5.956384169,3.198671914,TCGA-AG-3894-01A,TCGA-AG-3894-01A-01W-1073-09,11,0.357678079,TCGA-AG-3894,READ,65,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-23954,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,426,0,426,0,426,0,426,NA,Stage IIA,T3,M0,GI.GS,8
-4.189232527,1.244064529,TCGA-62-A46P-01A,TCGA-62-A46P-01A-11D-A24D-08,0,NA,TCGA-62-A46P,LUAD,65,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-23993,Dead,TUMOR FREE,NA,594,[Not Available],Distant Metastasis,NA,NA,267,Complete Remission/Response,1,594,0,594,1,267,1,267,NA,Stage IB,T2,M0,NA,10
0.164297006,4.246218396,TCGA-MI-A75E-01A,TCGA-MI-A75E-01A-11D-A32G-10,4,0.360141153,TCGA-MI-A75E,LIHC,61,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-22457,Alive,TUMOR FREE,507,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,507,0,507,0,507,0,507,NA,Stage IIIC,T4,M0,LIHC.iCluster:2,6
-5.833456306,2.859869853,TCGA-MI-A75C-01A,TCGA-MI-A75C-01A-11D-A32G-10,0,NA,TCGA-MI-A75C,LIHC,64,MALE,WHITE,Hepatocellular Carcinoma,G3,2012,[Not Available],-23441,Alive,TUMOR FREE,291,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,291,0,291,0,291,0,291,NA,Stage I,T1,M0,LIHC.iCluster:2,9
-1.772186064,1.028578415,TCGA-LG-A9QD-01A,TCGA-LG-A9QD-01A-11D-A382-10,5,0.582217465,TCGA-LG-A9QD,LIHC,68,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-24969,Alive,WITH TUMOR,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,366,0,366,0,366,0,366,NA,Stage IIIA,T3a,M0,NA,4
9.848450292,-1.930009329,TCGA-LG-A9QC-01A,TCGA-LG-A9QC-01A-11D-A36X-10,1,0.81313834,TCGA-LG-A9QC,LIHC,48,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-17842,Alive,TUMOR FREE,425,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,425,0,425,0,425,0,425,NA,Stage I,T1,M0,NA,1
9.460399184,-3.274901563,TCGA-12-1597-01B,TCGA-12-1597-01B-01D-1495-08,1,0.721970362,TCGA-12-1597,GBM,62,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-22865,Dead,WITH TUMOR,427,675,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],180,[Not Available],1,675,1,675,NA,NA,1,180,NA,NA,NA,NA,GBM_LGG.Classic-like,1
9.19627327,-5.389393633,TCGA-44-6148-01A,TCGA-44-6148-01A-11D-1753-08,1,0.848269426,TCGA-44-6148,LUAD,60,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22138,Alive,TUMOR FREE,704,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,704,0,704,0,704,0,704,NA,Stage IA,T1b,M0,NA,1
-3.968962752,-2.321470147,TCGA-78-7220-01A,TCGA-78-7220-01A-11D-2036-08,8,0.471182189,TCGA-78-7220,LUAD,53,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2000,[Not Available],-19480,Dead,WITH TUMOR,NA,807,[Not Available],NA,NA,NA,531,[Not Available],1,807,1,807,NA,NA,1,531,NA,Stage IIIA,T2,M0,NA,10
-5.488812053,1.528389947,TCGA-19-1385-01A,TCGA-19-1385-01A-02W-0643-08,0,NA,TCGA-19-1385,GBM,69,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-25459,Dead,WITH TUMOR,327,327,[Not Available],Recurrence,[Not Applicable],[Not Applicable],177,[Not Available],1,327,1,327,NA,NA,1,177,NA,NA,NA,NA,NA,9
-7.647094865,2.107322723,TCGA-14-0862-01B,TCGA-14-0862-01B-01D-1845-08,9,0.486011689,TCGA-14-0862,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-22179,Dead,WITH TUMOR,88,88,[Not Available],NA,NA,NA,NA,[Not Available],1,88,1,88,NA,NA,1,88,NA,NA,NA,NA,NA,7
-1.311661605,3.500596751,TCGA-19-2621-01B,TCGA-19-2621-01B-01W-0922-08,0,NA,TCGA-19-2621,GBM,83,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-30429,Dead,NA,33,33,[Not Available],NA,NA,NA,NA,[Not Available],1,33,NA,33,NA,NA,0,33,NA,NA,NA,NA,NA,10
-4.135201531,-2.050326307,TCGA-78-7150-01A,TCGA-78-7150-01A-21D-2036-08,8,0.353631718,TCGA-78-7150,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-21891,Dead,WITH TUMOR,NA,666,[Not Available],NA,NA,NA,139,[Not Available],1,666,1,666,NA,NA,1,139,NA,Stage IIB,T2,M0,LUAD.2,10
-0.64810619,2.701812595,TCGA-06-1084-01A,TCGA-06-1084-01A-01W-0611-08,4,0.098985538,TCGA-06-1084,GBM,54,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-19899,Dead,WITH TUMOR,NA,728,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],208,[Not Available],1,728,1,728,NA,NA,1,208,NA,NA,NA,NA,NA,6
-6.363983294,-1.120816269,TCGA-05-4415-01A,TCGA-05-4415-01A-22D-1855-08,7,0.252855236,TCGA-05-4415,LUAD,57,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-20880,Dead,WITH TUMOR,NA,91,[Not Available],NA,NA,NA,60,Progressive Disease,1,91,1,91,NA,NA,1,60,NA,Stage IIIB,T4,M0,LUAD.6,2
9.815585738,-2.232159961,TCGA-J7-8537-01A,TCGA-J7-8537-01A-11D-2396-08,1,0.771021663,TCGA-J7-8537,KIRP,37,FEMALE,ASIAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-13628,Dead,WITH TUMOR,NA,321,[Not Available],NA,NA,NA,220,Complete Remission/Response,1,321,1,321,1,220,1,220,NA,Stage III,T3,M0,KIRP.C2b,3
-0.407648151,4.501424901,TCGA-HT-7611-01A,TCGA-HT-7611-01A-11D-2395-08,4,0.565100298,TCGA-HT-7611,LGG,36,MALE,WHITE,Oligoastrocytoma,G2,2007,[Not Available],-13314,Alive,TUMOR FREE,1752,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1752,0,1752,0,1752,0,1752,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
4.444919881,1.089878945,TCGA-MH-A562-01A,TCGA-MH-A562-01A-11D-A26P-10,2,0.723097019,TCGA-MH-A562,KIRP,57,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-20933,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,616,0,616,0,616,0,616,NA,Stage I,T1a,MX,KIRP.C1,1
8.461979941,-3.447980608,TCGA-FG-A710-01A,TCGA-FG-A710-01A-12D-A33T-08,1,0.656740884,TCGA-FG-A710,LGG,50,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-18415,Alive,WITH TUMOR,1115,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1115,0,1115,NA,NA,0,1115,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.783583994,4.421435779,TCGA-ED-A7XO-01A,TCGA-ED-A7XO-01A-11D-A34Z-10,4,0.437117789,TCGA-ED-A7XO,LIHC,29,MALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-10828,Alive,WITH TUMOR,427,NA,[Not Available],Locoregional Recurrence,Liver,NA,262,[Not Available],0,427,0,427,1,262,1,262,NA,Stage IIIA,T3a,M0,LIHC.NA,6
9.636129804,-4.759926408,TCGA-IZ-A6M8-01A,TCGA-IZ-A6M8-01A-11D-A31X-10,1,0.753261217,TCGA-IZ-A6M8,KIRP,69,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-25545,Alive,TUMOR FREE,497,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,497,0,497,0,497,0,497,NA,Stage I,T1a,MX,KIRP.C1,1
8.174761413,-2.528783916,TCGA-F9-A8NY-01A,TCGA-F9-A8NY-01A-11D-A35Z-10,1,0.502891905,TCGA-F9-A8NY,KIRP,38,FEMALE,ASIAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-14101,Alive,TUMOR FREE,36,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,36,0,36,NA,NA,0,36,NA,Stage IV,T4,M1,NA,1
-0.730688463,2.65410707,TCGA-DD-A73E-01A,TCGA-DD-A73E-01A-12D-A32G-10,4,0.023658367,TCGA-DD-A73E,LIHC,66,MALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-24377,Alive,TUMOR FREE,44,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,44,0,44,0,44,0,44,NA,Stage I,T1,M0,LIHC.iCluster:3,6
-6.605203236,-1.286134645,TCGA-GJ-A6C0-01A,TCGA-GJ-A6C0-01A-12D-A30V-10,7,0.176037485,TCGA-GJ-A6C0,LIHC,75,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-27626,Dead,NA,NA,31,[Not Available],NA,NA,NA,NA,[Not Available],1,31,NA,31,NA,NA,0,31,NA,Stage II,T2,MX,NA,2
9.129073489,-5.074499615,TCGA-R8-A6ML-01A,TCGA-R8-A6ML-01A-11D-A32B-08,1,0.829354966,TCGA-R8-A6ML,LGG,52,MALE,WHITE,Oligodendroglioma,G3,2005,[Not Available],-19185,Alive,NA,2860,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2860,0,2860,NA,NA,0,2860,NA,NA,NA,NA,GBM_LGG.Codel,1
8.84180931,-2.042398739,TCGA-DD-A1EK-01A,TCGA-DD-A1EK-01A-11D-A20W-10,1,0.621907291,TCGA-DD-A1EK,LIHC,64,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2008,[Not Available],-23437,Dead,WITH TUMOR,NA,558,[Not Available],Locoregional Recurrence,Liver,NA,167,[Not Available],1,558,1,558,NA,NA,1,167,NA,Stage IVB,T4,M1,LIHC.iCluster:3,3
7.885479819,-1.39345546,TCGA-ED-A7PY-01A,TCGA-ED-A7PY-01A-11D-A33Q-10,1,0.157150724,TCGA-ED-A7PY,LIHC,20,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-7556,Alive,TUMOR FREE,390,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,390,0,390,0,390,0,390,NA,Stage II,T2,M0,LIHC.iCluster:1,1
-7.070901803,-2.266756082,TCGA-A4-7997-01A,TCGA-A4-7997-01A-11D-2201-08,6,0.237096743,TCGA-A4-7997,KIRP,67,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-24486,Alive,TUMOR FREE,927,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,927,0,927,NA,NA,0,927,NA,Stage I,T1b,M0,KIRP.C1,2
-7.419512727,2.207542617,TCGA-P4-A5E7-01A,TCGA-P4-A5E7-01A-31D-A28G-10,9,0.187194169,TCGA-P4-A5E7,KIRP,74,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-27029,Alive,TUMOR FREE,2649,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2649,0,2649,0,2649,0,2649,NA,Stage I,T1b,MX,KIRP.C1,7
1.194579676,3.404710017,TCGA-DD-A73A-01A,TCGA-DD-A73A-01A-12D-A32G-10,0,NA,TCGA-DD-A73A,LIHC,71,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-26136,Alive,TUMOR FREE,728,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,728,0,728,0,728,0,728,NA,Stage I,T1,M0,LIHC.iCluster:3,1
2.206129902,1.772246358,TCGA-DD-A73G-01A,TCGA-DD-A73G-01A-22D-A32G-10,3,0.42266147,TCGA-DD-A73G,LIHC,73,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2005,[Not Available],-26949,Alive,TUMOR FREE,3478,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3478,0,3478,0,3478,0,3478,NA,Stage I,T1,M0,LIHC.iCluster:1,3
2.131167534,1.806856551,TCGA-F9-A4JJ-01A,TCGA-F9-A4JJ-01A-11D-A25F-10,3,0.403966347,TCGA-F9-A4JJ,KIRP,35,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-12893,Dead,WITH TUMOR,NA,325,[Not Available],NA,NA,NA,109,[Unknown],1,325,1,325,NA,NA,1,109,NA,Stage III,T3a,MX,KIRP.C2c - CIMP,3
9.082440161,-4.947854984,TCGA-G3-A5SI-01A,TCGA-G3-A5SI-01A-31D-A27I-10,1,0.836058916,TCGA-G3-A5SI,LIHC,44,MALE,ASIAN,Hepatocellular Carcinoma,G2,2011,[Not Available],-16126,Dead,WITH TUMOR,NA,768,[Not Available],Intrahepatic Recurrence,Liver,NA,348,[Not Available],1,768,1,768,1,348,1,348,NA,Stage II,T2,M0,LIHC.iCluster:2,1
-7.701651947,-2.615680604,TCGA-MH-A560-01A,TCGA-MH-A560-01A-11D-A26P-10,6,0.46664593,TCGA-MH-A560,KIRP,62,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-22866,Alive,TUMOR FREE,924,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,924,0,924,0,924,0,924,NA,Stage I,T1a,MX,KIRP.C2a,6
10.08984639,-1.550133124,TCGA-KV-A74V-01A,TCGA-KV-A74V-01A-11D-A33Q-10,1,0.777083303,TCGA-KV-A74V,KIRP,40,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-14834,Alive,TUMOR FREE,347,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,347,0,347,0,347,0,347,NA,Stage I,T1a,M0,NA,1
-6.981412743,1.378593046,TCGA-MH-A55Z-01A,TCGA-MH-A55Z-01A-11D-A26P-10,0,NA,TCGA-MH-A55Z,KIRP,65,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-24017,Alive,TUMOR FREE,845,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,845,0,845,0,845,0,845,NA,Stage I,T1b,MX,KIRP.C1,5
7.827526273,-3.570564109,TCGA-ED-A82E-01A,TCGA-ED-A82E-01A-11D-A34Z-10,1,0.347064036,TCGA-ED-A82E,LIHC,60,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-22234,Alive,TUMOR FREE,408,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,408,0,408,0,408,0,408,NA,Stage IIIA,T3a,M0,LIHC.iCluster:1,1
4.1624486,0.97515149,TCGA-AA-3950-01A,TCGA-AA-3950-01A-02W-0995-10,2,0.322142903,TCGA-AA-3950,COAD,79,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-29130,Alive,TUMOR FREE,730,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,730,0,730,0,730,0,730,NA,Stage IIA,T3,M0,GI.GS,3
-0.047429582,4.797195733,TCGA-EI-6511-01A,TCGA-EI-6511-01A-11D-1733-10,4,0.698288711,TCGA-EI-6511,READ,52,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-19237,Alive,TUMOR FREE,482,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,482,0,482,NA,NA,0,482,NA,Stage IIIB,T3,M0,GI.CIN,6
-7.57978025,-2.396215286,TCGA-Y8-A894-01A,TCGA-Y8-A894-01A-11D-A35Z-10,6,0.478736209,TCGA-Y8-A894,KIRP,57,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-20964,Alive,TUMOR FREE,567,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,567,0,567,0,567,0,567,NA,Stage I,T1a,MX,NA,2
9.561618135,-4.727660428,TCGA-HC-7232-01A,TCGA-HC-7232-01A-11D-2114-08,1,0.792014825,TCGA-HC-7232,PRAD,66,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24324,Alive,WITH TUMOR,1161,NA,[Not Available],Biochemical evidence of disease,NA,NA,766,Complete Remission/Response,0,1161,0,1161,1,766,1,766,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
7.831260166,-3.537760899,TCGA-SX-A7SU-01A,TCGA-SX-A7SU-01A-11D-A35Z-10,1,0.314819255,TCGA-SX-A7SU,KIRP,47,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-17349,Alive,TUMOR FREE,1331,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1331,0,1331,0,1331,0,1331,NA,Stage I,T1,M0,NA,1
-3.815531514,-2.557590532,TCGA-XF-A8HE-01A,TCGA-XF-A8HE-01A-11D-A364-08,8,0.429735831,TCGA-XF-A8HE,BLCA,47,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-17212,Alive,TUMOR FREE,3817,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3817,0,3817,0,3817,0,3817,NA,Stage III,T3b,MX,NA,10
-7.852297406,-2.445458665,TCGA-SX-A7SS-01A,TCGA-SX-A7SS-01A-11D-A35Z-10,6,0.26938875,TCGA-SX-A7SS,KIRP,67,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-24660,Alive,TUMOR FREE,1615,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1615,0,1615,0,1615,0,1615,NA,Stage I,T1,M0,NA,1
-4.28574065,-2.059832858,TCGA-XF-A8HD-01A,TCGA-XF-A8HD-01A-11D-A364-08,8,0.469270166,TCGA-XF-A8HD,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-28305,Alive,TUMOR FREE,2964,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2964,0,2964,0,2964,0,2964,NA,Stage III,T3a,MX,NA,10
9.51790407,-5.274771049,TCGA-HC-7210-01A,TCGA-HC-7210-01A-11D-2114-08,1,0.851396557,TCGA-HC-7210,PRAD,74,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-27343,Alive,TUMOR FREE,868,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,868,0,868,0,868,0,868,NA,[Not Applicable],T2a,[Not Applicable],PRAD.6-FOXA1,1
0.60853069,2.613646399,TCGA-SX-A7SR-01A,TCGA-SX-A7SR-01A-12D-A35Z-10,0,NA,TCGA-SX-A7SR,KIRP,66,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-24237,Alive,TUMOR FREE,805,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,805,0,805,0,805,0,805,NA,Stage II,T2a,M0,NA,1
2.663002209,1.859025606,TCGA-P4-A5EB-01A,TCGA-P4-A5EB-01A-11D-A28G-10,0,NA,TCGA-P4-A5EB,KIRP,83,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-30395,Alive,TUMOR FREE,3015,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3015,0,3015,0,3015,0,3015,NA,Stage I,T1b,MX,KIRP.C1,3
-0.218313168,4.953061871,TCGA-CI-6619-01B,TCGA-CI-6619-01B-11D-1826-10,4,0.59112086,TCGA-CI-6619,READ,41,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-15322,Alive,NA,184,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,184,0,184,NA,NA,0,184,NA,Stage IV,T3,M1,GI.CIN,3
-6.49796445,-1.222195428,TCGA-HC-7081-01A,TCGA-HC-7081-01A-11D-1961-08,7,0.279294106,TCGA-HC-7081,PRAD,62,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],NA,Alive,WITH TUMOR,1136,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1136,0,1136,NA,NA,0,1136,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,2
0.124602307,4.87044012,TCGA-28-5219-01A,TCGA-28-5219-01A-01D-1486-08,4,0.696625444,TCGA-28-5219,GBM,47,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-17254,Alive,TUMOR FREE,690,NA,[Not Available],NA,[Not Applicable],[Not Applicable],258,[Not Applicable],0,690,0,690,NA,NA,1,258,NA,NA,NA,NA,NA,6
-4.787078726,0.571396441,TCGA-K4-A83P-01A,TCGA-K4-A83P-01A-11D-A34U-08,0,NA,TCGA-K4-A83P,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013,[Not Available],-28463,Alive,WITH TUMOR,495,NA,[Not Available],Distant Metastasis,Liver,NA,70,Partial Remission/Response,0,495,0,495,NA,NA,1,70,NA,Stage IV,T4a,MX,NA,10
7.816619189,-1.38916825,TCGA-SX-A7SO-01A,TCGA-SX-A7SO-01A-11D-A34Z-10,1,0.15380377,TCGA-SX-A7SO,KIRP,64,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-23534,Alive,TUMOR FREE,1257,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1257,0,1257,0,1257,0,1257,NA,Stage I,T1b,M0,NA,1
-6.357631709,-1.442662394,TCGA-50-7109-01A,TCGA-50-7109-01A-11D-2036-08,7,0.352174458,TCGA-50-7109,LUAD,60,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21979,Dead,WITH TUMOR,NA,308,[Not Available],Distant Metastasis,NA,NA,15,Progressive Disease,1,308,1,308,NA,NA,1,15,NA,Stage IA,T1,M0,LUAD.2,2
0.693030872,2.397925615,TCGA-SX-A7SM-01A,TCGA-SX-A7SM-01A-11D-A34Z-10,0,NA,TCGA-SX-A7SM,KIRP,60,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-22044,Dead,WITH TUMOR,NA,363,[Not Available],NA,NA,NA,NA,Progressive Disease,1,363,1,363,NA,NA,1,363,NA,Stage IV,T3a,M1,NA,6
7.946994183,-1.452436577,TCGA-SX-A7SN-01A,TCGA-SX-A7SN-01A-11D-A34Z-10,1,0.206657143,TCGA-SX-A7SN,KIRP,52,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-19116,Alive,TUMOR FREE,578,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,578,0,578,0,578,0,578,NA,Stage I,T1b,M0,NA,5
-7.711383511,-2.431383059,TCGA-SX-A7SL-01A,TCGA-SX-A7SL-01A-11D-A34Z-10,6,0.409278835,TCGA-SX-A7SL,KIRP,74,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-27063,Alive,TUMOR FREE,823,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,823,0,823,0,823,0,823,NA,Stage I,T1a,M0,NA,2
-4.399341129,-1.827565973,TCGA-K4-A5RJ-01A,TCGA-K4-A5RJ-01A-11D-A289-08,8,0.424890621,TCGA-K4-A5RJ,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27518,Alive,TUMOR FREE,539,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,539,0,539,0,539,0,539,NA,Stage II,T2b,MX,NA,10
-7.572763969,-2.398789793,TCGA-SX-A71W-01A,TCGA-SX-A71W-01A-12D-A34Z-10,6,0.402262723,TCGA-SX-A71W,KIRP,66,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-24110,Alive,TUMOR FREE,1076,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1076,0,1076,0,1076,0,1076,NA,Stage I,T1b,M0,NA,2
9.723152198,-2.21086052,TCGA-SX-A7SP-01A,TCGA-SX-A7SP-01A-11D-A34Z-10,1,0.740447432,TCGA-SX-A7SP,KIRP,66,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-24382,Dead,TUMOR FREE,NA,496,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,496,0,496,0,496,0,496,NA,Stage I,T1b,M0,NA,1
4.318780421,1.280344683,TCGA-SX-A7SQ-01A,TCGA-SX-A7SQ-01A-12D-A35Z-10,2,0.692934006,TCGA-SX-A7SQ,KIRP,48,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-17696,Alive,TUMOR FREE,1266,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1266,0,1266,0,1266,0,1266,NA,Stage I,T1,M0,NA,5
-6.038101415,3.625655448,TCGA-DC-6681-01A,TCGA-DC-6681-01A-11D-1826-10,11,0.264234297,TCGA-DC-6681,READ,70,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-25659,Alive,TUMOR FREE,790,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,790,0,790,NA,NA,0,790,NA,Stage IVA,T3,M1a,GI.CIN,8
-5.599738997,2.537953743,TCGA-AG-3731-01A,TCGA-AG-3731-01A-11D-1733-10,12,0.150817758,TCGA-AG-3731,READ,65,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2004,[Not Available],-23923,Alive,TUMOR FREE,1126,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1126,0,1126,NA,NA,0,1126,NA,Stage IV,T3,M1,GI.CIN,8
-5.676338004,2.106333183,TCGA-SX-A71S-01A,TCGA-SX-A71S-01A-11D-A33Q-10,0,NA,TCGA-SX-A71S,KIRP,66,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-24211,Alive,TUMOR FREE,1504,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1504,0,1504,0,1504,0,1504,NA,Stage I,T1,M0,NA,9
9.139649103,-4.185424092,TCGA-SX-A71U-01A,TCGA-SX-A71U-01A-12D-A33Q-10,1,0.735427704,TCGA-SX-A71U,KIRP,57,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-21079,Alive,TUMOR FREE,1357,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1357,0,1357,0,1357,0,1357,NA,Stage I,T1a,M0,NA,1
-4.052427472,-0.931546182,TCGA-GV-A6ZA-01A,TCGA-GV-A6ZA-01A-12D-A339-08,0,NA,TCGA-GV-A6ZA,BLCA,54,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-19871,Alive,TUMOR FREE,691,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,691,0,691,0,691,0,691,NA,Stage II,T2b,MX,NA,10
9.058241682,-4.546376207,TCGA-SX-A71R-01A,TCGA-SX-A71R-01A-12D-A33Q-10,1,0.758603235,TCGA-SX-A71R,KIRP,51,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-18742,Alive,TUMOR FREE,1457,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1457,0,1457,0,1457,0,1457,NA,Stage I,T1a,M0,NA,1
-0.700454877,2.24815845,TCGA-MH-A856-01A,TCGA-MH-A856-01A-11D-A34Z-10,0,NA,TCGA-MH-A856,KIRP,54,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-20006,Alive,TUMOR FREE,947,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,947,0,947,0,947,0,947,NA,Stage I,T1a,M0,NA,1
-0.846775725,2.531095821,TCGA-75-5147-01A,TCGA-75-5147-01A-01D-1625-08,4,0.147842556,TCGA-75-5147,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,1333,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1333,0,1333,0,1333,0,1333,NA,Stage IB,T2,M0,LUAD.5,6
9.497363171,-2.520327401,TCGA-P4-A5E8-01A,TCGA-P4-A5E8-01A-11D-A28G-10,1,0.74886887,TCGA-P4-A5E8,KIRP,57,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-21132,Dead,WITH TUMOR,NA,1306,[Not Available],NA,NA,NA,42,[Not Available],1,1306,1,1306,NA,NA,1,42,NA,Stage III,T2a,M0,KIRP.C2c - CIMP,1
8.982277062,-4.186844613,TCGA-DE-A69K-01A,TCGA-DE-A69K-01A-11D-A397-08,1,0.752377966,TCGA-DE-A69K,THCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013,[Not Available],-21403,Alive,WITH TUMOR,434,NA,[Not Available],Biochemical evidence of disease,NA,NA,434,[Not Available],0,434,0,434,NA,NA,1,434,NA,Stage III,T3,M0,NA,1
-6.3767072,-1.357657442,TCGA-MH-A854-01A,TCGA-MH-A854-01A-11D-A34Z-10,7,0.320311942,TCGA-MH-A854,KIRP,62,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-22804,Alive,TUMOR FREE,536,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,536,0,536,0,536,0,536,NA,Stage I,T1b,MX,NA,2
-4.750817167,-1.948179361,TCGA-GC-A6I1-01A,TCGA-GC-A6I1-01A-12D-A31L-08,8,0.173493813,TCGA-GC-A6I1,BLCA,90,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-32873,Dead,TUMOR FREE,NA,272,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,272,0,272,0,272,0,272,NA,Stage II,T2b,MX,NA,10
3.938936924,1.290821172,TCGA-SX-A71V-01A,TCGA-SX-A71V-01A-11D-A33Q-10,2,0.358614277,TCGA-SX-A71V,KIRP,80,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-29332,Alive,TUMOR FREE,876,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,876,0,876,0,876,0,876,NA,Stage I,T1,M0,NA,3
-0.060793829,3.426716949,TCGA-AF-3914-01A,TCGA-AF-3914-01A-01W-1073-09,4,0.277398195,TCGA-AF-3914,READ,39,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-14426,Alive,WITH TUMOR,1146,NA,[Not Available],Locoregional Disease,NA,NA,846,Complete Remission/Response,0,1146,0,1146,1,846,1,846,NA,Stage IIIB,T3,M0,NA,3
9.108456626,-5.588601235,TCGA-AA-3558-01A,TCGA-AA-3558-01A-01D-1953-10,1,0.795994529,TCGA-AA-3558,COAD,70,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-25752,Alive,TUMOR FREE,638,NA,[Not Available],NA,NA,NA,92,Complete Remission/Response,0,638,0,638,1,92,1,92,NA,Stage I,T2,M0,NA,1
-0.862422808,3.706020052,TCGA-CA-6719-01A,TCGA-CA-6719-01A-11D-1835-10,4,0.261566331,TCGA-CA-6719,COAD,77,MALE,ASIAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-28343,Alive,WITH TUMOR,435,NA,[Not Available],NA,NA,NA,354,Progressive Disease,0,435,0,435,NA,NA,1,354,NA,Stage IIA,T3,M0,GI.CIN,6
-6.254838839,-1.192179922,TCGA-AD-6901-01A,TCGA-AD-6901-01A-11D-1924-10,7,0.274416979,TCGA-AD-6901,COAD,78,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-28579,Dead,WITH TUMOR,NA,682,[Not Available],Metastatic,NA,NA,468,Complete Remission/Response,1,682,1,682,1,468,1,468,NA,[Not Available],T3,MX,GI.CIN,2
9.988597323,-1.733945788,TCGA-G4-6321-01A,TCGA-G4-6321-01A-11D-1719-10,1,0.818968397,TCGA-G4-6321,COAD,60,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-21921,Alive,TUMOR FREE,672,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,672,0,672,NA,NA,0,672,NA,Stage III,T2,MX,GI.GS,1
0.136605531,3.328223045,TCGA-AA-3875-01A,TCGA-AA-3875-01A-01W-0900-09,4,0.411933305,TCGA-AA-3875,COAD,78,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-28640,Alive,WITH TUMOR,549,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,549,0,549,NA,NA,0,549,NA,Stage I,T1,M0,GI.CIN,3
-5.099557772,1.733551269,TCGA-G4-6625-01A,TCGA-G4-6625-01A-21D-1771-10,0,NA,TCGA-G4-6625,COAD,77,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2004,[Not Available],-28163,Alive,TUMOR FREE,2792,NA,[Not Available],NA,NA,NA,2564,[Not Available],0,2792,0,2792,NA,NA,1,2564,NA,Stage IIA,T3,M0,NA,8
-0.416033078,2.996995403,TCGA-DM-A0XF-01A,TCGA-DM-A0XF-01A-11D-A152-10,0,NA,TCGA-DM-A0XF,COAD,68,FEMALE,WHITE,[Discrepancy],[Not Available],1999,[Not Available],-25032,Dead,NA,NA,1162,[Not Available],NA,NA,NA,NA,[Not Available],1,1162,NA,1162,NA,NA,0,1162,NA,Stage IIIC,T3,M0,GI.CIN,3
-6.340561616,1.59354868,TCGA-06-6698-01A,TCGA-06-6698-01A-11D-1845-08,10,0.186762263,TCGA-06-6698,GBM,53,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-19591,Alive,WITH TUMOR,145,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,145,0,145,NA,NA,0,145,NA,NA,NA,NA,NA,7
-6.45851445,-1.410544026,TCGA-86-7711-01A,TCGA-86-7711-01A-11D-2063-08,7,0.229727586,TCGA-86-7711,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25719,Dead,WITH TUMOR,NA,1046,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1046,1,1046,NA,NA,1,1046,NA,Stage IIA,T2a,M0,NA,2
-7.65721166,2.354325838,TCGA-28-1751-01A,TCGA-28-1751-01A-02W-0643-08,9,0.425465229,TCGA-28-1751,GBM,61,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-22291,Alive,WITH TUMOR,232,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],219,[Not Available],0,232,0,232,NA,NA,1,219,NA,NA,NA,NA,NA,7
9.310598646,-3.468866445,TCGA-06-5410-01A,TCGA-06-5410-01A-01D-1696-08,1,0.691586903,TCGA-06-5410,GBM,72,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-26395,Dead,WITH TUMOR,108,108,[Not Available],NA,NA,NA,NA,[Not Available],1,108,1,108,NA,NA,1,108,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,1
-7.738557227,1.866730638,TCGA-14-0790-01B,TCGA-14-0790-01B-01D-1494-08,9,0.453243822,TCGA-14-0790,GBM,64,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-23674,Dead,WITH TUMOR,419,419,[Not Available],NA,NA,NA,NA,[Not Available],1,419,1,419,NA,NA,1,419,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-0.655578359,3.833580332,TCGA-49-4507-01A,TCGA-49-4507-01A-01D-1265-08,4,0.216434811,TCGA-49-4507,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1997,[Not Available],-26851,Dead,WITH TUMOR,NA,268,[Not Available],NA,NA,NA,158,Progressive Disease,1,268,1,268,NA,NA,1,158,NA,Stage IIIA,T3,M0,LUAD.6,6
8.851219966,-4.749178578,TCGA-27-2526-01A,TCGA-27-2526-01A-01D-1494-08,1,0.793957483,TCGA-27-2526,GBM,79,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-28977,Dead,WITH TUMOR,87,87,[Not Available],NA,NA,NA,NA,[Not Available],1,87,1,87,NA,NA,1,87,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-5.247425957,1.844691894,TCGA-97-8179-01A,TCGA-97-8179-01A-11D-2284-08,0,NA,TCGA-97-8179,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26305,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,435,0,435,0,435,0,435,NA,Stage IA,T1a,M0,NA,9
-4.851543369,-1.808125201,TCGA-28-1760-01A,TCGA-28-1760-01A-01W-0643-08,8,0.151026834,TCGA-28-1760,GBM,48,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-17758,Alive,WITH TUMOR,143,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],105,[Not Available],0,143,0,143,NA,NA,1,105,NA,NA,NA,NA,NA,10
-0.591260135,4.220961945,TCGA-CM-4750-01A,TCGA-CM-4750-01A-01D-1408-10,4,0.465175953,TCGA-CM-4750,COAD,34,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-12478,Alive,TUMOR FREE,244,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,244,0,244,0,244,0,244,NA,Stage IIIA,T1,M0,GI.CIN,6
0.238643787,4.380570291,TCGA-12-1088-01A,TCGA-12-1088-01A-01W-0611-08,4,0.521299251,TCGA-12-1088,GBM,53,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1989,[Not Available],-19667,Dead,NA,3881,3881,[Not Available],NA,NA,NA,NA,[Not Available],1,3881,NA,3881,NA,NA,0,3881,NA,NA,NA,NA,NA,6
7.735060671,-3.403994734,TCGA-12-1599-01A,TCGA-12-1599-01A-01W-0643-08,1,0.333248562,TCGA-12-1599,GBM,47,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-17432,Dead,WITH TUMOR,769,781,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],89,[Not Available],1,781,1,781,NA,NA,1,89,NA,NA,NA,NA,NA,1
-7.369687058,-2.308059501,TCGA-CR-6474-01A,TCGA-CR-6474-01A-11D-1870-08,6,0.267893706,TCGA-CR-6474,HNSC,51,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-18840,Dead,WITH TUMOR,NA,564,[Not Available],NA,Cervical Lymph Nodes,Right neck,220,Complete Remission/Response,1,564,1,564,NA,NA,1,220,NA,Stage IVA,T2,M0,HNSC.Mesenchymal,2
9.396042317,-2.767580679,TCGA-DJ-A13R-01A,TCGA-DJ-A13R-01A-11D-A10S-08,1,0.76948361,TCGA-DJ-A13R,THCA,50,MALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-18354,Alive,TUMOR FREE,565,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,565,0,565,0,565,0,565,NA,Stage III,T3,M0,THCA.1,1
8.706328116,-1.853238349,TCGA-19-1789-01A,TCGA-19-1789-01A-01W-0643-08,1,0.554945707,TCGA-19-1789,GBM,69,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-25282,Dead,NA,99,99,[Not Available],NA,NA,NA,NA,[Not Available],1,99,NA,99,NA,NA,0,99,NA,NA,NA,NA,NA,1
-1.897970932,1.280917624,TCGA-B5-A0K8-01A,TCGA-B5-A0K8-01A-11D-A14K-09,5,0.643928668,TCGA-B5-A0K8,UCEC,71,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25992,Alive,TUMOR FREE,847,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,847,0,847,0,847,0,847,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN high,4
-6.848212002,-2.261937698,TCGA-CQ-5327-01A,TCGA-CQ-5327-01A-01D-1683-08,6,0.147576367,TCGA-CQ-5327,HNSC,61,FEMALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-22307,Alive,TUMOR FREE,1660,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1660,0,1660,NA,NA,0,1660,NA,Stage IVA,T3,[Not Available],NA,10
0.0683397,4.596545453,TCGA-14-3477-01A,TCGA-14-3477-01A-01W-0922-08,4,0.580155319,TCGA-14-3477,GBM,38,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-14082,Alive,WITH TUMOR,115,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,115,0,115,NA,NA,0,115,NA,NA,NA,NA,NA,6
-3.971640825,1.541954932,TCGA-CG-4469-01A,TCGA-CG-4469-01A-01D-1158-08,0,NA,TCGA-CG-4469,STAD,70,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009,[Not Available],-25598,Dead,NA,NA,215,[Not Available],NA,NA,NA,NA,[Not Available],1,215,NA,215,NA,NA,0,215,NA,Stage IV,T3,M0,GI.CIN,10
-3.239040068,-3.341823278,TCGA-66-2785-01A,TCGA-66-2785-01A-01D-1522-08,8,0.623895436,TCGA-66-2785,LUSC,65,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-23772,Alive,TUMOR FREE,60,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,60,0,60,NA,NA,0,60,NA,Stage IB,T2,M0,LUSC.secretory,10
-4.330754439,-1.722696801,TCGA-66-2769-01A,TCGA-66-2769-01A-02D-1522-08,8,0.464094005,TCGA-66-2769,LUSC,75,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-27515,Dead,NA,NA,215,[Not Available],NA,NA,NA,NA,[Not Available],1,215,NA,215,NA,NA,0,215,NA,Stage IIIB,T4,M0,NA,10
-0.514710982,3.879118053,TCGA-77-8139-01A,TCGA-77-8139-01A-11D-2244-08,4,0.371245603,TCGA-77-8139,LUSC,72,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-26464,Alive,TUMOR FREE,3166,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3166,0,3166,0,3166,0,3166,NA,Stage IIB,T3,M0,NA,6
-3.941402429,-2.351542522,TCGA-39-5031-01A,TCGA-39-5031-01A-01D-1441-08,8,0.465984063,TCGA-39-5031,LUSC,76,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-28106,Dead,TUMOR FREE,NA,1841,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1841,0,1841,0,1841,0,1841,NA,Stage IA,T1a,M0,LUSC.basal,10
-2.156435279,2.441186027,TCGA-37-4132-01A,TCGA-37-4132-01A-01D-1352-08,0,NA,TCGA-37-4132,LUSC,61,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-22520,Alive,TUMOR FREE,227,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,227,0,227,NA,NA,0,227,NA,Stage IV,T2,M1,NA,10
9.170546705,-4.035390385,TCGA-AX-A0IS-01A,TCGA-AX-A0IS-01A-12D-A10M-09,4,0.622027066,TCGA-AX-A0IS,UCEC,52,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19173,Dead,WITH TUMOR,NA,1858,[Not Available],NA,NA,NA,448,Complete Remission/Response,1,1858,1,1858,1,448,1,448,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.CN low,1
-1.065024077,3.374916532,TCGA-CN-6020-01A,TCGA-CN-6020-01A-11D-1683-08,4,0.172458682,TCGA-CN-6020,HNSC,58,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-21232,Dead,TUMOR FREE,NA,205,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,205,0,205,NA,NA,0,205,NA,Stage III,T2,[Not Available],HNSC.Basal,5
10.04662204,-1.614893672,TCGA-J8-A3YG-01A,TCGA-J8-A3YG-01A-11D-A22Z-08,1,0.876969573,TCGA-J8-A3YG,THCA,54,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-19785,Alive,TUMOR FREE,678,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,678,0,678,0,678,0,678,NA,Stage III,T2,M0,THCA.3,1
-0.6942894,2.26364582,TCGA-DQ-7593-01A,TCGA-DQ-7593-01A-11D-2229-08,0,NA,TCGA-DQ-7593,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G4,2011,[Not Available],-21439,Alive,TUMOR FREE,1224,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1224,0,1224,NA,NA,0,1224,NA,[Not Available],TX,[Not Available],NA,1
-0.872238636,4.770742499,TCGA-D7-6518-01A,TCGA-D7-6518-01A-11D-1800-08,4,0.45914338,TCGA-D7-6518,STAD,75,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-27594,Alive,TUMOR FREE,582,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,582,0,582,0,582,0,582,NA,Stage IIIA,T2,M0,GI.CIN,6
-3.743669374,-2.325073489,TCGA-60-2714-01A,TCGA-60-2714-01A-01D-1522-08,8,0.41575371,TCGA-60-2714,LUSC,66,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-24169,Alive,TUMOR FREE,1531,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1531,0,1531,0,1531,0,1531,NA,Stage IIB,T2,M0,NA,10
-1.934979788,2.617512199,TCGA-56-6545-01A,TCGA-56-6545-01A-11D-1817-08,0,NA,TCGA-56-6545,LUSC,77,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-28400,Alive,TUMOR FREE,666,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,666,0,666,0,666,0,666,NA,Stage IB,T2a,M0,LUSC.secretory,10
0.203742719,4.770647504,TCGA-BR-A4IU-01A,TCGA-BR-A4IU-01A-22D-A25D-08,4,0.694416752,TCGA-BR-A4IU,STAD,34,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-12601,Alive,TUMOR FREE,838,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,838,0,838,0,838,0,838,NA,Stage IIIA,T4a,M0,GI.GS,6
-6.494505265,-1.8983664,TCGA-85-7699-01A,TCGA-85-7699-01A-11D-2122-08,0,NA,TCGA-85-7699,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26965,Dead,WITH TUMOR,NA,1001,[Not Available],Distant Metastasis,NA,NA,760,Complete Remission/Response,1,1001,1,1001,1,760,1,760,NA,Stage IIIA,T4,M0,NA,2
-3.682509874,-2.550527261,TCGA-66-2773-01A,TCGA-66-2773-01A-01D-1267-08,8,0.436272167,TCGA-66-2773,LUSC,69,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-25355,Dead,TUMOR FREE,NA,92,[Not Available],NA,NA,NA,NA,[Not Available],1,92,0,92,NA,NA,0,92,NA,Stage IB,T2,M0,LUSC.basal,10
-5.194982244,2.379658807,TCGA-CG-5727-01A,TCGA-CG-5727-01A-11D-1600-08,12,0.175896939,TCGA-CG-5727,STAD,66,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005,[Not Available],-24289,Alive,TUMOR FREE,2405,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2405,0,2405,0,2405,0,2405,NA,Stage II,T3,M0,NA,9
-7.032048902,-2.260684558,TCGA-39-5019-01A,TCGA-39-5019-01A-01D-1817-08,6,0.303879137,TCGA-39-5019,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-25756,Alive,TUMOR FREE,3387,NA,[Not Available],NA,NA,NA,378,Complete Remission/Response,0,3387,0,3387,1,378,1,378,NA,Stage IB,T2a,M0,LUSC.classical,2
9.598808373,-1.532766864,TCGA-05-4434-01A,TCGA-05-4434-01A-01D-1265-08,1,0.71568196,TCGA-05-4434,LUAD,67,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-24472,Dead,NA,NA,457,[Not Available],NA,NA,NA,NA,[Not Available],1,457,NA,457,NA,NA,0,457,NA,Stage IV,T4,M1,NA,1
-3.727239889,-2.851430146,TCGA-BK-A13B-01A,TCGA-BK-A13B-01A-51D-A228-09,8,0.423046141,TCGA-BK-A13B,UCEC,58,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21493,Alive,WITH TUMOR,966,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal,760,Complete Remission/Response,0,966,0,966,1,760,1,760,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
10.02530823,-1.531501828,TCGA-DJ-A1QM-01A,TCGA-DJ-A1QM-01A-11D-A14W-08,1,0.889296647,TCGA-DJ-A1QM,THCA,42,MALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-15418,Alive,TUMOR FREE,183,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,183,0,183,0,183,0,183,NA,Stage I,T1a,M0,THCA.2,1
-6.478872235,-1.403989774,TCGA-BB-4227-01A,TCGA-BB-4227-01A-01D-1870-08,0,NA,TCGA-BB-4227,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-24322,Alive,WITH TUMOR,134,NA,[Not Available],Locoregional Recurrence,Hypopharynx,NA,85,Stable Disease,0,134,0,134,NA,NA,1,85,NA,Stage IVA,T4a,[Not Available],NA,10
4.375226985,1.138768298,TCGA-DJ-A2Q4-01A,TCGA-DJ-A2Q4-01A-21D-A18F-08,2,0.691043591,TCGA-DJ-A2Q4,THCA,53,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-19689,Alive,TUMOR FREE,1032,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1032,0,1032,0,1032,0,1032,NA,Stage III,T1b,M0,THCA.3,5
-4.100675012,-2.1626887,TCGA-B5-A0JU-01B,TCGA-B5-A0JU-01B-11D-A14G-09,8,0.429096794,TCGA-B5-A0JU,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21159,Alive,TUMOR FREE,1802,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1802,0,1802,NA,NA,0,1802,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-0.850825297,4.046062718,TCGA-85-7843-01A,TCGA-85-7843-01A-11D-2122-08,4,0.34492321,TCGA-85-7843,LUSC,50,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-18353,Alive,NA,35,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,35,0,35,NA,NA,0,35,NA,Stage IIA,T2a,M0,NA,6
-3.178620624,-3.502229834,TCGA-21-1080-01A,TCGA-21-1080-01A-01W-0782-08,8,0.503058068,TCGA-21-1080,LUSC,66,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1996,[Not Available],-24253,Alive,TUMOR FREE,3724,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3724,0,3724,NA,NA,0,3724,NA,Stage IB,T2,M0,NA,10
-0.333372195,3.779187629,TCGA-AJ-A3BD-01A,TCGA-AJ-A3BD-01A-11D-A19Y-09,4,0.088582582,TCGA-AJ-A3BD,UCEC,57,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998,Alive,TUMOR FREE,1039,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1039,0,1039,0,1039,0,1039,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,6
-6.381050762,-1.870711407,TCGA-18-4083-01A,TCGA-18-4083-01A-01D-1352-08,0,NA,TCGA-18-4083,LUSC,63,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-23125,Dead,TUMOR FREE,NA,188,[Not Available],NA,NA,NA,NA,[Unknown],1,188,0,188,NA,NA,0,188,NA,Stage IIB,T2,M0,LUSC.classical,10
-7.374406938,2.294450636,TCGA-BG-A0M0-01A,TCGA-BG-A0M0-01A-11W-A10C-09,9,0.150623327,TCGA-BG-A0M0,UCEC,66,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24427,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,588,0,588,0,588,0,588,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,7
-7.423488284,-2.163975078,TCGA-66-2757-01A,TCGA-66-2757-01A-01D-1522-08,6,0.306201973,TCGA-66-2757,LUSC,65,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-24014,Dead,WITH TUMOR,NA,1338,[Not Available],NA,NA,NA,912,[Not Applicable],1,1338,1,1338,NA,NA,1,912,NA,Stage IA,T1,M0,LUSC.primitive,2
8.783528087,-3.731868838,TCGA-BG-A0LW-01A,TCGA-BG-A0LW-01A-11W-A062-09,1,0.72479034,TCGA-BG-A0LW,UCEC,47,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Indeterminate (neither Pre or Postmenopausal),-17369,Alive,TUMOR FREE,566,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,566,0,566,0,566,0,566,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,1
9.071926552,-5.052348273,TCGA-CN-6017-01A,TCGA-CN-6017-01A-11D-1683-08,1,0.845090961,TCGA-CN-6017,HNSC,55,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-20358,Dead,TUMOR FREE,NA,853,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,853,0,853,NA,NA,0,853,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,1
10.11635757,-1.566748723,TCGA-EM-A2P1-01A,TCGA-EM-A2P1-01A-11D-A202-08,1,0.836081692,TCGA-EM-A2P1,THCA,33,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-12320,Alive,WITH TUMOR,531,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,363,[Not Available],0,531,0,531,1,363,1,363,NA,Stage I,T2,MX,THCA.4,1
9.583284072,-5.679656492,TCGA-EM-A3AN-01A,TCGA-EM-A3AN-01A-11D-A202-08,1,0.869403788,TCGA-EM-A3AN,THCA,36,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-13188,Alive,TUMOR FREE,1006,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1006,0,1006,NA,NA,0,1006,NA,Stage I,T1b,MX,THCA.5,1
9.765205131,-1.696037266,TCGA-DJ-A13P-01A,TCGA-DJ-A13P-01A-11D-A10S-08,1,0.812073485,TCGA-DJ-A13P,THCA,52,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999,[Not Available],-19297,Alive,TUMOR FREE,5150,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5150,0,5150,0,5150,0,5150,NA,Stage II,T2,M0,THCA.5,1
-4.535282554,-1.491666537,TCGA-B5-A0K6-01A,TCGA-B5-A0K6-01A-11W-A062-09,8,0.404522997,TCGA-B5-A0K6,UCEC,58,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515,Alive,TUMOR FREE,1953,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1953,0,1953,0,1953,0,1953,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-1.437307233,3.487718998,TCGA-77-8138-01A,TCGA-77-8138-01A-11D-2244-08,4,0.154125524,TCGA-77-8138,LUSC,74,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-27225,Dead,WITH TUMOR,NA,539,[Not Available],Locoregional Recurrence,NA,NA,289,[Not Applicable],1,539,1,539,NA,NA,1,289,NA,Stage IB,T2,M0,NA,5
-3.095246787,-3.539084729,TCGA-AX-A3FT-01A,TCGA-AX-A3FT-01A-11D-A228-09,8,0.553294792,TCGA-AX-A3FT,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543,Alive,NA,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,NA,NA,0,6,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-0.078019081,4.174613526,TCGA-43-6647-01A,TCGA-43-6647-01A-11D-1817-08,4,0.449354315,TCGA-43-6647,LUSC,69,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-25378,Alive,TUMOR FREE,757,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,757,0,757,0,757,0,757,NA,Stage IIB,T2b,MX,LUSC.secretory,6
-7.593438953,2.350782751,TCGA-B5-A0JT-01A,TCGA-B5-A0JT-01A-21D-A122-09,9,0.182227775,TCGA-B5-A0JT,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041,Alive,TUMOR FREE,1682,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1682,0,1682,0,1682,0,1682,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-3.63147527,0.676604357,TCGA-33-6738-01A,TCGA-33-6738-01A-11D-1945-08,0,NA,TCGA-33-6738,LUSC,80,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-29368,Alive,TUMOR FREE,1927,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1927,0,1927,0,1927,0,1927,NA,Stage IIIA,T1,MX,NA,10
-4.356663826,-1.726664758,TCGA-AX-A2IO-01A,TCGA-AX-A2IO-01A-11D-A17W-09,8,0.425107115,TCGA-AX-A2IO,UCEC,83,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30539,Alive,TUMOR FREE,1975,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1975,0,1975,NA,NA,0,1975,NA,Stage IIA,[Not Applicable],[Not Applicable],NA,10
-3.266920089,-3.478149656,TCGA-85-6561-01A,TCGA-85-6561-01A-11D-1817-08,8,0.445789295,TCGA-85-6561,LUSC,66,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24234,Alive,TUMOR FREE,1224,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1224,0,1224,0,1224,0,1224,NA,Stage IB,T2a,M0,LUSC.classical,10
-4.423637688,-1.942409286,TCGA-B5-A11U-01A,TCGA-B5-A11U-01A-11D-A122-09,8,0.320902964,TCGA-B5-A11U,UCEC,74,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27160,Alive,TUMOR FREE,509,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,509,0,509,NA,NA,0,509,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.833934899,2.473062192,TCGA-CV-7434-01A,TCGA-CV-7434-01A-11D-2129-08,4,0.095322917,TCGA-CV-7434,HNSC,64,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-23465,Dead,TUMOR FREE,NA,218,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,218,0,218,NA,NA,0,218,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,6
9.524587301,-4.691170284,TCGA-ET-A2N1-01A,TCGA-ET-A2N1-01A-11D-A18F-08,1,0.781271879,TCGA-ET-A2N1,THCA,47,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-17272,Alive,TUMOR FREE,1653,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1653,0,1653,0,1653,0,1653,NA,Stage III,T2,MX,NA,1
-6.300635301,-2.062622436,TCGA-CR-6478-01A,TCGA-CR-6478-01A-11D-1870-08,0,NA,TCGA-CR-6478,HNSC,66,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-24244,Dead,NA,NA,183,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,183,NA,183,NA,NA,0,183,NA,[Not Available],[Not Available],[Not Available],HNSC.Mesenchymal,2
-5.983505561,-1.197928721,TCGA-CN-6021-01A,TCGA-CN-6021-01A-11D-1683-08,0,NA,TCGA-CN-6021,HNSC,63,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-23212,Dead,WITH TUMOR,NA,276,[Not Available],NA,NA,NA,NA,Progressive Disease,1,276,1,276,NA,NA,1,276,NA,[Not Available],TX,[Not Available],HNSC.Atypical,10
-1.865203502,1.197894571,TCGA-CQ-5332-01A,TCGA-CQ-5332-01A-01D-1683-08,5,0.642711233,TCGA-CQ-5332,HNSC,87,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-32032,Dead,NA,317,317,[Not Available],NA,NA,NA,NA,[Not Available],1,317,NA,317,NA,NA,0,317,NA,Stage III,T3,[Not Available],HNSC.Classical,4
-5.992201134,1.288265334,TCGA-CV-7438-01A,TCGA-CV-7438-01A-21D-2129-08,10,0.016043114,TCGA-CV-7438,HNSC,87,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2000,[Not Available],-32021,Dead,WITH TUMOR,NA,194,[Not Available],NA,NA,NA,NA,[Not Available],1,194,1,194,NA,NA,1,194,NA,Stage I,T1,[Not Available],HNSC.Mesenchymal,9
-7.090419766,-2.068342249,TCGA-BR-8289-01A,TCGA-BR-8289-01A-11D-2340-08,6,0.191912227,TCGA-BR-8289,STAD,57,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-20849,Dead,TUMOR FREE,NA,81,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,81,0,81,NA,NA,0,81,NA,Stage IV,T4,M1,GI.CIN,2
-7.990389666,2.073393713,TCGA-E2-A15C-01A,TCGA-E2-A15C-01A-31D-A12B-09,9,0.614149746,TCGA-E2-A15C,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22583,Alive,TUMOR FREE,694,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,694,0,694,0,694,0,694,NA,Stage I,T1c,M0,BRCA.LumA,7
9.505465392,-5.33723528,TCGA-MH-A857-01A,TCGA-MH-A857-01A-11D-A34Z-10,1,0.811639487,TCGA-MH-A857,KIRP,63,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-23114,Alive,TUMOR FREE,890,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,890,0,890,NA,NA,0,890,NA,Stage I,T1a,M0,NA,1
0.092237953,5.12556521,TCGA-TM-A84L-01A,TCGA-TM-A84L-01A-11D-A36O-08,4,0.551139339,TCGA-TM-A84L,LGG,31,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-11498,Dead,WITH TUMOR,NA,1242,[Not Available],NA,NA,NA,987,Complete Remission/Response,1,1242,1,1242,1,987,1,987,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
7.53243391,-3.133448851,TCGA-49-AAR3-01A,TCGA-49-AAR3-01A-11D-A410-08,1,0.281232078,TCGA-49-AAR3,LUAD,69,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25469,Alive,[Discrepancy],1893,NA,[Not Available],Locoregional Recurrence,NA,NA,1893,Complete Remission/Response,0,1893,0,1893,1,1893,1,1893,NA,Stage IIB,T2,MX,NA,6
1.979744937,1.842642086,TCGA-WN-A9G9-01A,TCGA-WN-A9G9-01A-12D-A36X-10,3,0.599551001,TCGA-WN-A9G9,KIRP,55,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],NA,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,791,Complete Remission/Response,0,791,0,791,1,791,1,791,NA,Stage I,T1b,MX,NA,3
-3.958937587,0.751172894,TCGA-49-AAR2-01A,TCGA-49-AAR2-01A-11D-A397-08,0,NA,TCGA-49-AAR2,LUAD,64,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-23479,Alive,TUMOR FREE,2224,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2224,0,2224,0,2224,0,2224,NA,Stage IB,T2,MX,NA,10
9.157762658,-5.528765455,TCGA-TM-A84O-01A,TCGA-TM-A84O-01A-11D-A36O-08,1,0.854270589,TCGA-TM-A84O,LGG,61,FEMALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-22327,Dead,WITH TUMOR,NA,1011,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1011,1,1011,NA,NA,1,1011,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.559356588,3.700742126,TCGA-49-AAR0-01A,TCGA-49-AAR0-01A-21D-A397-08,4,0.178649835,TCGA-49-AAR0,LUAD,57,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-20932,Alive,TUMOR FREE,4765,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4765,0,4765,0,4765,0,4765,NA,Stage IA,T1,MX,NA,6
-1.11655366,3.723554178,TCGA-49-AAQV-01A,TCGA-49-AAQV-01A-11D-A397-08,4,0.28932755,TCGA-49-AAQV,LUAD,63,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23370,Dead,TUMOR FREE,NA,677,[Not Available],Distant Metastasis,NA,NA,509,Complete Remission/Response,1,677,0,677,1,509,1,509,NA,Stage II,T1,MX,NA,5
-4.884184127,-1.765069385,TCGA-55-7570-01A,TCGA-55-7570-01A-11D-2036-08,8,0.052113697,TCGA-55-7570,LUAD,60,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22218,Alive,TUMOR FREE,824,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,824,0,824,0,824,0,824,NA,Stage IA,T1a,MX,NA,10
-5.902232339,1.619194251,TCGA-AR-A250-01A,TCGA-AR-A250-01A-31D-A167-09,0,NA,TCGA-AR-A250,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21309,Alive,TUMOR FREE,2707,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2707,0,2707,0,2707,0,2707,NA,Stage IIA,T2,M0,BRCA.LumB,3
1.948255365,1.921477612,TCGA-GL-A9DE-01A,TCGA-GL-A9DE-01A-11D-A36X-10,3,0.607223204,TCGA-GL-A9DE,KIRP,74,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-27330,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,496,0,496,0,496,0,496,NA,Stage I,T1b,MX,NA,3
8.853520211,-4.471543389,TCGA-TM-A84B-01A,TCGA-TM-A84B-01A-11D-A36O-08,1,0.758640786,TCGA-TM-A84B,LGG,40,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-14933,Dead,WITH TUMOR,NA,758,[Not Available],NA,NA,NA,NA,Progressive Disease,1,758,1,758,NA,NA,1,758,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-7.721477367,-2.451668475,TCGA-HE-A5NK-01A,TCGA-HE-A5NK-01A-11D-A26P-10,6,0.566509398,TCGA-HE-A5NK,KIRP,82,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-30088,Alive,TUMOR FREE,2228,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2228,0,2228,0,2228,0,2228,NA,[Not Available],T1b,M0,NA,2
0.01676049,2.386535105,TCGA-IA-A83S-01A,TCGA-IA-A83S-01A-11D-A34Z-10,4,0.128884717,TCGA-IA-A83S,KIRP,81,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2003,[Not Available],-29677,Dead,NA,NA,2609,[Not Available],NA,NA,NA,NA,[Unknown],1,2609,NA,2609,NA,NA,0,2609,NA,[Discrepancy],TX,MX,NA,10
8.862580861,-1.992373159,TCGA-TM-A84G-01A,TCGA-TM-A84G-01A-11D-A36O-08,1,0.616848064,TCGA-TM-A84G,LGG,54,FEMALE,WHITE,Oligodendroglioma,G3,2010,[Not Available],-20014,Alive,TUMOR FREE,1236,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1236,0,1236,0,1236,0,1236,NA,NA,NA,NA,GBM_LGG.Codel,1
9.743336585,-1.912643714,TCGA-IA-A83T-01A,TCGA-IA-A83T-01A-11D-A34Z-10,1,0.728470316,TCGA-IA-A83T,KIRP,80,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-29430,Dead,NA,NA,2684,[Not Available],NA,NA,NA,NA,Stable Disease,1,2684,NA,2684,NA,NA,0,2684,NA,[Discrepancy],TX,MX,NA,1
9.292145549,-4.34322915,TCGA-TM-A84H-01A,TCGA-TM-A84H-01A-11D-A36O-08,1,0.742193137,TCGA-TM-A84H,LGG,44,FEMALE,WHITE,Oligoastrocytoma,G3,2012,[Not Available],-16277,Alive,TUMOR FREE,926,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,926,0,926,0,926,0,926,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-0.79209476,3.744272074,TCGA-TM-A84I-01A,TCGA-TM-A84I-01A-11D-A36O-08,4,0.3739541,TCGA-TM-A84I,LGG,30,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-11221,Alive,TUMOR FREE,854,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,854,0,854,0,854,0,854,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,5
2.097176092,1.840004266,TCGA-IA-A83W-01A,TCGA-IA-A83W-01A-11D-A34Z-10,3,0.518483296,TCGA-IA-A83W,KIRP,70,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2003,[Not Available],-25678,Dead,TUMOR FREE,NA,2043,[Not Available],NA,NA,NA,1408,Complete Remission/Response,1,2043,0,2043,1,1408,1,1408,NA,Stage I,T1,M0,NA,3
9.605554403,-5.663907448,TCGA-MH-A855-01A,TCGA-MH-A855-01A-11D-A34Z-10,1,0.878659601,TCGA-MH-A855,KIRP,52,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-19029,Alive,TUMOR FREE,369,NA,[Not Available],NA,NA,NA,0,Complete Remission/Response,0,369,0,369,1,0,1,0,NA,Stage II,T2b,MX,NA,1
-0.120390107,5.056548083,TCGA-TM-A84J-01A,TCGA-TM-A84J-01A-11D-A36O-08,4,0.651447248,TCGA-TM-A84J,LGG,63,MALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-23091,Alive,WITH TUMOR,735,NA,[Not Available],NA,NA,NA,454,Progressive Disease,0,735,0,735,NA,NA,1,454,NA,NA,NA,NA,GBM_LGG.PA-like,6
2.268479896,1.77764035,TCGA-GL-A9DD-01A,TCGA-GL-A9DD-01A-11D-A36X-10,3,0.381042168,TCGA-GL-A9DD,KIRP,69,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-25483,Alive,TUMOR FREE,341,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,341,0,341,0,341,0,341,NA,Stage I,T1a,MX,NA,3
-0.022136595,4.854280356,TCGA-TM-A7CA-01A,TCGA-TM-A7CA-01A-21D-A33T-08,4,0.66929718,TCGA-TM-A7CA,LGG,44,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-16415,Alive,TUMOR FREE,1058,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1058,0,1058,0,1058,0,1058,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.103529746,5.049861243,TCGA-TM-A7CF-01A,TCGA-TM-A7CF-01A-11D-A32B-08,4,0.658005094,TCGA-TM-A7CF,LGG,41,FEMALE,WHITE,Astrocytoma,G2,2009,[Not Available],-15178,Alive,WITH TUMOR,1989,NA,[Not Available],NA,NA,NA,924,Complete Remission/Response,0,1989,0,1989,1,924,1,924,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.62315303,-1.665179964,TCGA-35-5375-01A,TCGA-35-5375-01A-01D-1625-08,8,0.445199897,TCGA-35-5375,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-22628,Alive,TUMOR FREE,264,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,264,0,264,NA,NA,0,264,NA,Stage IIIA,T2,M0,NA,10
3.941065837,1.370511803,TCGA-2K-A9WE-01A,TCGA-2K-A9WE-01A-11D-A382-10,2,0.178787178,TCGA-2K-A9WE,KIRP,53,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-19603,Alive,TUMOR FREE,214,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,214,0,214,0,214,0,214,NA,Stage II,T2b,M0,NA,5
2.099016054,1.822319857,TCGA-B1-A47O-01A,TCGA-B1-A47O-01A-11D-A25F-10,3,0.512889841,TCGA-B1-A47O,KIRP,54,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-19823,Alive,TUMOR FREE,842,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,842,0,842,0,842,0,842,NA,Stage I,T1b,MX,NA,3
0.045444032,5.074456541,TCGA-S9-A7R8-01A,TCGA-S9-A7R8-01A-11D-A34J-08,4,0.70376668,TCGA-S9-A7R8,LGG,44,FEMALE,WHITE,Astrocytoma,G3,2004,[Not Available],-16275,Dead,WITH TUMOR,NA,961,[Not Available],NA,NA,NA,698,Progressive Disease,1,961,1,961,NA,NA,1,698,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.736321678,-4.650251524,TCGA-B1-A657-01A,TCGA-B1-A657-01A-11D-A31X-10,1,0.786567415,TCGA-B1-A657,KIRP,54,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-19806,Alive,TUMOR FREE,641,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,641,0,641,0,641,0,641,NA,Stage I,T1b,M0,KIRP.C1,1
-0.191793966,4.361159848,TCGA-S9-A89Z-01A,TCGA-S9-A89Z-01A-11D-A36O-08,4,0.504328753,TCGA-S9-A89Z,LGG,40,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-14858,Alive,WITH TUMOR,623,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,623,0,623,NA,NA,0,623,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.259847818,-2.729030202,TCGA-G7-A8LB-01A,TCGA-G7-A8LB-01A-11D-A35Z-10,1,0.698371094,TCGA-G7-A8LB,KIRP,70,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-25782,Alive,WITH TUMOR,547,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,547,0,547,NA,NA,0,547,NA,Stage IV,T2a,MX,NA,1
8.59623395,-1.773263304,TCGA-TM-A7C3-01A,TCGA-TM-A7C3-01A-11D-A32B-08,1,0.510607203,TCGA-TM-A7C3,LGG,43,FEMALE,WHITE,Astrocytoma,G3,2009,[Not Available],-16021,Dead,WITH TUMOR,NA,1666,[Not Available],NA,NA,NA,713,Complete Remission/Response,1,1666,1,1666,1,713,1,713,NA,NA,NA,NA,GBM_LGG.Classic-like,1
4.311033451,1.169551239,TCGA-G7-A8LC-01A,TCGA-G7-A8LC-01A-11D-A35Z-10,2,0.716584935,TCGA-G7-A8LC,KIRP,61,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-22553,Alive,TUMOR FREE,702,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,702,0,702,0,702,0,702,NA,Stage I,T1a,MX,NA,5
9.541954608,-3.09731023,TCGA-G7-A8LE-01A,TCGA-G7-A8LE-01A-11D-A35Z-10,1,0.742579781,TCGA-G7-A8LE,KIRP,62,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-22810,Alive,TUMOR FREE,2453,NA,[Not Available],NA,NA,NA,1447,Complete Remission/Response,0,2453,0,2453,1,1447,1,1447,NA,Stage I,T1a,MX,NA,1
-5.791838005,2.422292387,TCGA-GL-A9DC-01A,TCGA-GL-A9DC-01A-11D-A36X-10,0,NA,TCGA-GL-A9DC,KIRP,66,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-24348,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,392,0,392,0,392,0,392,NA,Stage I,T1b,MX,NA,9
10.08977049,-1.52094876,TCGA-TM-A7C5-01A,TCGA-TM-A7C5-01A-11D-A32B-08,1,0.871882985,TCGA-TM-A7C5,LGG,30,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-11286,Alive,TUMOR FREE,1500,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1500,0,1500,0,1500,0,1500,NA,NA,NA,NA,GBM_LGG.Codel,1
-3.313274999,-3.381960158,TCGA-B7-5816-01A,TCGA-B7-5816-01A-21D-1600-08,8,0.590152356,TCGA-B7-5816,STAD,51,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-18698,Alive,TUMOR FREE,812,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,812,0,812,0,812,0,812,NA,Stage IIB,T4a,M0,GI.HM-indel,10
-6.363381592,-1.414761787,TCGA-BR-6454-01A,TCGA-BR-6454-01A-11D-1800-08,7,0.364579428,TCGA-BR-6454,STAD,58,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-21501,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIA,T3,M0,GI.CIN,2
0.114942151,2.941683195,TCGA-D7-5579-01A,TCGA-D7-5579-01A-01D-1600-08,4,0.149364535,TCGA-D7-5579,STAD,74,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010,[Not Available],-27175,Alive,TUMOR FREE,636,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,636,0,636,0,636,0,636,NA,Stage IIIA,T3,M0,NA,3
8.874598165,-4.269438839,TCGA-BK-A13C-01A,TCGA-BK-A13C-01A-11D-A122-09,1,0.756122169,TCGA-BK-A13C,UCEC,47,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2010,Peri (6-12 months since last menstrual period),-17317,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,760,0,760,0,760,0,760,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,1
8.940405848,-4.853102472,TCGA-S9-A7QY-01A,TCGA-S9-A7QY-01A-11D-A34A-08,1,0.801672172,TCGA-S9-A7QY,LGG,35,FEMALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-12853,Alive,WITH TUMOR,863,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,863,0,863,NA,NA,0,863,NA,NA,NA,NA,GBM_LGG.Codel,1
8.841090122,-4.181206477,TCGA-S9-A7QZ-01A,TCGA-S9-A7QZ-01A-12D-A34J-08,1,0.723541468,TCGA-S9-A7QZ,LGG,41,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-15300,Alive,WITH TUMOR,826,NA,[Not Available],NA,NA,NA,774,Partial Remission/Response,0,826,0,826,NA,NA,1,774,NA,NA,NA,NA,GBM_LGG.Codel,1
8.758620337,-1.878058034,TCGA-S9-A7R2-01A,TCGA-S9-A7R2-01A-21D-A34J-08,1,0.569983406,TCGA-S9-A7R2,LGG,69,MALE,WHITE,Astrocytoma,G3,2008,[Not Available],-25419,Dead,WITH TUMOR,NA,316,[Not Available],NA,NA,NA,NA,Progressive Disease,1,316,1,316,NA,NA,1,316,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
4.334909928,1.082437249,TCGA-S9-A7R4-01A,TCGA-S9-A7R4-01A-12D-A34J-08,2,0.616810833,TCGA-S9-A7R4,LGG,46,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-17134,Alive,WITH TUMOR,914,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,914,0,914,NA,NA,0,914,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
-6.486897532,1.673266018,TCGA-S9-A7R7-01A,TCGA-S9-A7R7-01A-11D-A34J-08,10,0.167623165,TCGA-S9-A7R7,LGG,27,MALE,WHITE,Astrocytoma,G2,2006,[Not Available],-10108,Alive,WITH TUMOR,3000,NA,[Not Available],NA,NA,NA,144,Progressive Disease,0,3000,0,3000,NA,NA,1,144,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,7
-3.576799804,-2.797040508,TCGA-46-3769-01A,TCGA-46-3769-01A-01D-0983-08,8,0.39125246,TCGA-46-3769,LUSC,57,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-20941,Alive,TUMOR FREE,135,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,135,0,135,0,135,0,135,NA,[Discrepancy],T4,M0,LUSC.secretory,10
-5.407300411,1.735185896,TCGA-44-7671-01A,TCGA-44-7671-01A-11D-2063-08,0,NA,TCGA-44-7671,LUAD,64,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-23538,Alive,WITH TUMOR,889,NA,[Not Available],Locoregional Recurrence,NA,NA,883,Complete Remission/Response,0,889,0,889,1,883,1,883,NA,Stage IB,T2a,M0,LUAD.1,9
-0.792293919,2.779119358,TCGA-18-3417-01A,TCGA-18-3417-01A-01D-1441-08,4,0.003312114,TCGA-18-3417,LUSC,65,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-24019,Dead,TUMOR FREE,NA,1097,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1097,0,1097,NA,NA,0,1097,NA,Stage IV,T2,M1,LUSC.secretory,10
9.344626089,-4.647924658,TCGA-S9-A7J2-01A,TCGA-S9-A7J2-01A-11D-A34A-08,1,0.798934908,TCGA-S9-A7J2,LGG,25,MALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-9345,Alive,WITH TUMOR,62,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,62,0,62,NA,NA,0,62,NA,NA,NA,NA,GBM_LGG.Codel,1
9.364763687,-4.499130056,TCGA-S9-A7J3-01A,TCGA-S9-A7J3-01A-21D-A34J-08,1,0.775169341,TCGA-S9-A7J3,LGG,52,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-19056,Alive,WITH TUMOR,629,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,629,0,629,NA,NA,0,629,NA,NA,NA,NA,GBM_LGG.Codel,1
0.011582849,4.794080485,TCGA-S9-A7QW-01A,TCGA-S9-A7QW-01A-11D-A34A-08,4,0.70781438,TCGA-S9-A7QW,LGG,54,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-19869,Alive,WITH TUMOR,458,NA,[Not Available],NA,NA,NA,382,Complete Remission/Response,0,458,0,458,1,382,1,382,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.380481747,-0.919993189,TCGA-60-2720-01A,TCGA-60-2720-01A-01D-1522-08,0,NA,TCGA-60-2720,LUSC,60,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-22238,Alive,TUMOR FREE,97,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,97,0,97,NA,NA,0,97,NA,Stage IB,T2,M0,LUSC.basal,10
-0.772627336,3.819007206,TCGA-S9-A7QX-01A,TCGA-S9-A7QX-01A-11D-A34A-08,4,0.359812412,TCGA-S9-A7QX,LGG,36,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-13332,Alive,WITH TUMOR,564,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,564,0,564,NA,NA,0,564,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
-5.499205222,1.089146859,TCGA-AH-6644-01A,TCGA-AH-6644-01A-21D-1826-10,0,NA,TCGA-AH-6644,READ,73,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-26892,Alive,TUMOR FREE,838,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,838,0,838,0,838,0,838,NA,[Not Available],T3,MX,GI.CIN,9
-3.205858441,-3.460792163,TCGA-CG-4306-01A,TCGA-CG-4306-01A-01D-1158-08,8,0.532762856,TCGA-CG-4306,STAD,90,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006,[Not Available],-32871,Dead,NA,NA,31,[Not Available],NA,NA,NA,NA,[Not Available],1,31,NA,31,NA,NA,0,31,NA,Stage IV,T3,M1,GI.HM-indel,10
-4.27795639,-1.693287436,TCGA-CD-5801-01A,TCGA-CD-5801-01A-11D-1600-08,8,0.403858601,TCGA-CD-5801,STAD,69,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],NA,Dead,WITH TUMOR,NA,401,[Not Available],NA,NA,NA,NA,Progressive Disease,1,401,1,401,NA,NA,1,401,NA,Stage IIIA,T3,M0,GI.EBV,10
8.995035316,-5.009340979,TCGA-28-5215-01A,TCGA-28-5215-01A-01D-1486-08,1,0.814222141,TCGA-28-5215,GBM,62,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-22686,Dead,WITH TUMOR,237,335,[Not Available],NA,[Not Applicable],[Not Applicable],164,[Not Available],1,335,1,335,NA,NA,1,164,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-5.196652062,1.842467169,TCGA-AF-6136-01A,TCGA-AF-6136-01A-11D-1826-10,0,NA,TCGA-AF-6136,READ,72,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-26490,Alive,WITH TUMOR,741,NA,[Not Available],NA,NA,NA,199,Progressive Disease,0,741,0,741,NA,NA,1,199,NA,Stage IIIB,T3,MX,GI.CIN,9
9.938044608,-1.72821557,TCGA-EL-A4JX-01A,TCGA-EL-A4JX-01A-12D-A257-08,1,0.87897168,TCGA-EL-A4JX,THCA,31,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-11465,Alive,TUMOR FREE,1398,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1398,0,1398,0,1398,0,1398,NA,Stage I,T3,MX,THCA.4,1
-2.829765435,-4.199097717,TCGA-AX-A05Z-01A,TCGA-AX-A05Z-01A-11W-A027-09,0,NA,TCGA-AX-A05Z,UCEC,37,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G2,2006,Indeterminate (neither Pre or Postmenopausal),-13529,Alive,TUMOR FREE,2175,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2175,0,2175,0,2175,0,2175,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.POLE,10
9.385168812,-2.939358285,TCGA-S9-A7IQ-01A,TCGA-S9-A7IQ-01A-21D-A34A-08,1,0.754087833,TCGA-S9-A7IQ,LGG,45,FEMALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-16512,Alive,WITH TUMOR,1099,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1099,0,1099,NA,NA,0,1099,NA,NA,NA,NA,GBM_LGG.Codel,1
8.693152657,-1.875685496,TCGA-S9-A7IX-01A,TCGA-S9-A7IX-01A-12D-A34A-08,1,0.532008444,TCGA-S9-A7IX,LGG,57,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-21095,Dead,WITH TUMOR,NA,819,[Not Available],NA,NA,NA,350,Progressive Disease,1,819,1,819,NA,NA,1,350,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
8.822677654,-4.9068841,TCGA-S9-A7IY-01A,TCGA-S9-A7IY-01A-11D-A34A-08,1,0.834989656,TCGA-S9-A7IY,LGG,39,MALE,WHITE,Oligoastrocytoma,G3,2012,[Not Available],-14422,Alive,WITH TUMOR,715,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,715,0,715,NA,NA,0,715,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.712288846,-2.403965188,TCGA-S9-A7IZ-01A,TCGA-S9-A7IZ-01A-11D-A34A-08,6,0.498407101,TCGA-S9-A7IZ,LGG,48,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-17874,Alive,WITH TUMOR,608,NA,[Not Available],NA,NA,NA,467,Partial Remission/Response,0,608,0,608,NA,NA,1,467,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
-5.339103099,2.623608604,TCGA-S9-A7J0-01A,TCGA-S9-A7J0-01A-11D-A34A-08,12,0.333632164,TCGA-S9-A7J0,LGG,30,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-10989,Alive,WITH TUMOR,609,NA,[Not Available],NA,NA,NA,390,Partial Remission/Response,0,609,0,609,NA,NA,1,390,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,8
-6.081228148,3.479705661,TCGA-69-8254-01A,TCGA-69-8254-01A-11D-2284-08,11,0.550939935,TCGA-69-8254,LUAD,85,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-31134,Alive,TUMOR FREE,409,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,409,0,409,0,409,0,409,NA,[Not Available],T2b,[Not Available],NA,8
-5.211534983,-0.644542434,TCGA-44-7669-01A,TCGA-44-7669-01A-21D-2063-08,0,NA,TCGA-44-7669,LUAD,59,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-21893,Dead,WITH TUMOR,NA,574,[Not Available],NA,NA,NA,390,Complete Remission/Response,1,574,1,574,1,390,1,390,NA,Stage IIA,T1b,MX,NA,10
-4.366313019,-1.689548707,TCGA-77-8136-01A,TCGA-77-8136-01A-11D-2244-08,8,0.423711662,TCGA-77-8136,LUSC,74,FEMALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-27193,Dead,NA,NA,1189,[Not Available],Distant Metastasis,NA,NA,301,[Not Applicable],1,1189,NA,1189,NA,NA,1,301,NA,Stage IIB,T2,M0,NA,10
9.056652897,-5.058302662,TCGA-S9-A6WM-01A,TCGA-S9-A6WM-01A-12D-A33T-08,1,0.840672224,TCGA-S9-A6WM,LGG,59,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-21761,Alive,WITH TUMOR,604,NA,[Not Available],NA,NA,NA,505,Partial Remission/Response,0,604,0,604,NA,NA,1,505,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-7.850771059,2.14957232,TCGA-S9-A6WN-01A,TCGA-S9-A6WN-01A-12D-A33T-08,9,0.647787952,TCGA-S9-A6WN,LGG,38,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-13961,Alive,WITH TUMOR,805,NA,[Not Available],NA,NA,NA,303,Progressive Disease,0,805,0,805,NA,NA,1,303,NA,NA,NA,NA,GBM_LGG.Codel,7
-0.134596202,5.132033722,TCGA-S9-A6WO-01A,TCGA-S9-A6WO-01A-21D-A34A-08,4,0.688336534,TCGA-S9-A6WO,LGG,29,MALE,WHITE,Astrocytoma,G2,2013,[Not Available],-10933,Alive,WITH TUMOR,566,NA,[Not Available],NA,NA,NA,187,Progressive Disease,0,566,0,566,NA,NA,1,187,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.269762968,0.704467458,TCGA-21-1076-01A,TCGA-21-1076-01A-02D-1521-08,0,NA,TCGA-21-1076,LUSC,54,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-19863,Alive,TUMOR FREE,1852,NA,[Not Available],NA,NA,NA,1575,[Not Available],0,1852,0,1852,NA,NA,1,1575,NA,Stage IB,T2,M0,LUSC.secretory,10
9.361445891,-4.092416694,TCGA-S9-A6WP-01A,TCGA-S9-A6WP-01A-12D-A34A-08,1,0.726867844,TCGA-S9-A6WP,LGG,42,MALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-15658,Alive,WITH TUMOR,567,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,567,0,567,NA,NA,0,567,NA,NA,NA,NA,GBM_LGG.Codel,1
9.267348968,-5.429048556,TCGA-BR-8295-01A,TCGA-BR-8295-01A-11D-2340-08,1,0.855223609,TCGA-BR-8295,STAD,60,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-22256,Dead,WITH TUMOR,NA,67,[Not Available],NA,NA,NA,NA,Progressive Disease,1,67,1,67,NA,NA,1,67,NA,Stage IIB,T4a,M0,NA,1
-3.413594392,-3.420145552,TCGA-B5-A11Y-01A,TCGA-B5-A11Y-01A-21D-A10M-09,8,0.612872941,TCGA-B5-A11Y,UCEC,59,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21860,Alive,TUMOR FREE,560,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,560,0,560,0,560,0,560,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,10
-6.326072361,-1.218549608,TCGA-AG-A036-01A,TCGA-AG-A036-01A-12W-A096-10,7,0.300651121,TCGA-AG-A036,READ,71,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2002,[Not Available],-26206,Alive,TUMOR FREE,3562,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3562,0,3562,0,3562,0,3562,NA,Stage III,T3,M0,NA,2
8.83504938,-2.675131673,TCGA-BR-7957-01A,TCGA-BR-7957-01A-11D-2201-08,1,0.626506699,TCGA-BR-7957,STAD,50,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",GX,2011,[Not Available],-18517,Dead,TUMOR FREE,NA,276,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,276,0,276,NA,NA,0,276,NA,Stage IV,T3,M1,GI.CIN,1
-6.30279774,1.324847912,TCGA-AX-A1CC-01A,TCGA-AX-A1CC-01A-11D-A135-09,10,0.262167643,TCGA-AX-A1CC,UCEC,65,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23795,Alive,TUMOR FREE,788,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,788,0,788,NA,NA,0,788,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-7.570595063,1.829610072,TCGA-19-5947-01A,TCGA-19-5947-01A-11D-1696-08,9,0.174047237,TCGA-19-5947,GBM,47,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-17218,Dead,WITH TUMOR,202,202,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],43,[Not Available],1,202,1,202,NA,NA,1,43,NA,NA,NA,NA,NA,7
-5.96472401,-1.695543023,TCGA-EM-A2CN-01A,TCGA-EM-A2CN-01A-11D-A19J-08,0,NA,TCGA-EM-A2CN,THCA,62,MALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-22817,Alive,WITH TUMOR,715,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,715,0,715,NA,NA,0,715,NA,Stage IVC,T3,M1,THCA.1,2
-8.009238887,2.105939695,TCGA-BG-A0RY-01A,TCGA-BG-A0RY-01A-11D-A10B-09,9,0.539700459,TCGA-BG-A0RY,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24952,Alive,TUMOR FREE,469,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,469,0,469,0,469,0,469,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
0.31245254,2.256832814,TCGA-A2-A0YM-01A,TCGA-A2-A0YM-01A-11D-A10G-09,4,0.011755745,TCGA-A2-A0YM,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24831,Alive,TUMOR FREE,965,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,965,0,965,0,965,0,965,NA,Stage IIA,T2,M0,BRCA.Basal,6
-5.967558245,1.818530761,TCGA-AR-A1AS-01A,TCGA-AR-A1AS-01A-11D-A12Q-09,10,0.07240888,TCGA-AR-A1AS,BRCA,54,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20028,Alive,TUMOR FREE,1150,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1150,0,1150,0,1150,0,1150,NA,Stage IIB,T2,M0,BRCA.LumA,7
-4.51731319,0.0056986,TCGA-44-2668-01A,TCGA-44-2668-01A-01D-A271-08,0,NA,TCGA-44-2668,LUAD,51,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-18856,Dead,WITH TUMOR,NA,761,[Not Available],NA,NA,NA,433,Complete Remission/Response,1,761,1,761,1,433,1,433,NA,Stage IB,T2,M0,NA,10
-5.134589937,2.055665177,TCGA-34-5240-01A,TCGA-34-5240-01A-01D-1441-08,0,NA,TCGA-34-5240,LUSC,73,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-26735,Alive,TUMOR FREE,1541,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1541,0,1541,0,1541,0,1541,NA,Stage IIB,T2,M0,LUSC.classical,9
-4.957007805,0.646500962,TCGA-D7-6528-01A,TCGA-D7-6528-01A-11D-1800-08,0,NA,TCGA-D7-6528,STAD,70,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-25815,Alive,TUMOR FREE,463,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,463,0,463,0,463,0,463,NA,Stage IB,T2,M0,GI.HM-SNV,10
-6.515981775,-1.24444923,TCGA-52-7811-01A,TCGA-52-7811-01A-11D-2122-08,7,0.239926104,TCGA-52-7811,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-24782,Dead,WITH TUMOR,NA,266,[Not Available],Distant Metastasis,NA,NA,153,Progressive Disease,1,266,1,266,NA,NA,1,153,NA,Stage IB,T2,M0,NA,2
-3.32204386,-3.498892713,TCGA-AX-A3FS-01A,TCGA-AX-A3FS-01A-11D-A228-09,8,0.598807833,TCGA-AX-A3FS,UCEC,82,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30102,Alive,NA,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,7,0,7,NA,NA,0,7,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-0.734101868,3.892997478,TCGA-AF-2690-01A,TCGA-AF-2690-01A-02D-1733-10,4,0.292704712,TCGA-AF-2690,READ,76,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-28119,Dead,TUMOR FREE,NA,524,[Not Available],NA,NA,NA,NA,[Not Available],1,524,0,524,NA,NA,0,524,NA,Stage IIIC,T3,M0,GI.CIN,6
-1.987119723,1.102836126,TCGA-BR-6453-01A,TCGA-BR-6453-01A-11D-1800-08,5,0.62280831,TCGA-BR-6453,STAD,54,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-20061,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,485,0,485,0,485,0,485,NA,Stage IIA,T2,M0,GI.GS,4
9.327479497,-5.554654334,TCGA-BB-4217-01A,TCGA-BB-4217-01A-11D-2078-08,1,0.84863355,TCGA-BB-4217,HNSC,68,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-25020,Alive,WITH TUMOR,187,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,187,0,187,NA,NA,0,187,NA,Stage IVA,T4a,M0,HNSC.Atypical,1
9.953441054,-1.712642274,TCGA-J8-A3YH-01A,TCGA-J8-A3YH-01A-11D-A22Z-08,1,0.854366598,TCGA-J8-A3YH,THCA,39,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-14470,Alive,TUMOR FREE,175,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,175,0,175,0,175,0,175,NA,Stage I,T3,M0,THCA.5,1
0.146911393,4.92880557,TCGA-06-6701-01A,TCGA-06-6701-01A-11D-1845-08,4,0.69602579,TCGA-06-6701,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-22051,Alive,WITH TUMOR,151,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,151,0,151,NA,NA,0,151,NA,NA,NA,NA,NA,6
10.05439028,-1.491330256,TCGA-ET-A39O-01A,TCGA-ET-A39O-01A-11D-A19J-08,1,0.868645434,TCGA-ET-A39O,THCA,39,MALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2006,[Not Available],-14295,Alive,TUMOR FREE,3059,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3059,0,3059,0,3059,0,3059,NA,Stage I,T1,MX,THCA.4,1
-7.274288606,-2.144893463,TCGA-CV-5444-01A,TCGA-CV-5444-01A-02D-1512-08,6,0.368822973,TCGA-CV-5444,HNSC,64,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G3,2004,[Not Available],-23650,Alive,TUMOR FREE,2437,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2437,0,2437,NA,NA,0,2437,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,2
-0.733901802,4.207238881,TCGA-AN-A0FL-01A,TCGA-AN-A0FL-01A-11W-A050-09,4,0.356799918,TCGA-AN-A0FL,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805,Alive,TUMOR FREE,231,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,231,0,231,0,231,0,231,NA,Stage IIA,T2,M0,BRCA.Basal,6
-6.706724443,-2.144855126,TCGA-85-8070-01A,TCGA-85-8070-01A-11D-2244-08,6,0.034678508,TCGA-85-8070,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26183,Alive,TUMOR FREE,960,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,960,0,960,0,960,0,960,NA,Stage IB,T2,M0,NA,2
-5.033856299,1.798392591,TCGA-44-3917-01A,TCGA-44-3917-01A-01D-A271-08,0,NA,TCGA-44-3917,LUAD,33,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-12179,Alive,TUMOR FREE,1183,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1183,0,1183,0,1183,0,1183,NA,Stage IB,T2,M0,NA,10
-0.295475241,4.629962361,TCGA-34-2608-01A,TCGA-34-2608-01A-02D-1522-08,4,0.559572165,TCGA-34-2608,LUSC,84,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1999,[Not Available],-30958,Dead,TUMOR FREE,1000,1000,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1000,0,1000,0,1000,0,1000,NA,Stage IB,T2,M0,LUSC.secretory,6
9.391000104,-5.418824466,TCGA-GM-A2DM-01A,TCGA-GM-A2DM-01A-11D-A17W-09,1,0.865824442,TCGA-GM-A2DM,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21160,Alive,TUMOR FREE,3226,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3226,0,3226,0,3226,0,3226,NA,Stage IIA,T2,M0,BRCA.LumA,1
-7.852895504,2.30948394,TCGA-FP-7916-01A,TCGA-FP-7916-01A-11D-2201-08,9,0.376825246,TCGA-FP-7916,STAD,77,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-28475,Dead,WITH TUMOR,NA,428,[Not Available],NA,NA,NA,NA,Progressive Disease,1,428,1,428,NA,NA,1,428,NA,Stage IIIC,T4a,MX,GI.EBV,7
-0.343896364,3.569517963,TCGA-22-5474-01A,TCGA-22-5474-01A-01D-1632-08,4,0.181939183,TCGA-22-5474,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-27271,Dead,TUMOR FREE,445,445,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,445,0,445,0,445,0,445,NA,Stage IB,T2a,M0,LUSC.classical,6
-5.645162435,1.58664145,TCGA-BR-8297-01A,TCGA-BR-8297-01A-12D-2340-08,0,NA,TCGA-BR-8297,STAD,58,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",GX,2012,[Not Available],-21224,Alive,WITH TUMOR,225,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,225,0,225,NA,NA,0,225,NA,Stage IIIC,T4b,M0,GI.CIN,10
9.498272254,-5.705416763,TCGA-AH-6547-01A,TCGA-AH-6547-01A-11D-1826-10,1,0.888956831,TCGA-AH-6547,READ,79,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-29030,Dead,TUMOR FREE,NA,76,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,76,0,76,0,76,0,76,NA,[Not Available],T3,MX,GI.GS,1
-3.383671765,-3.242415718,TCGA-CG-5733-01A,TCGA-CG-5733-01A-11D-1600-08,8,0.54603302,TCGA-CG-5733,STAD,83,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003,[Not Available],-30650,Dead,WITH TUMOR,NA,641,[Not Available],NA,NA,NA,427,Progressive Disease,1,641,1,641,NA,NA,1,427,NA,Stage IIIA,T2,M0,NA,10
9.958276183,-1.659615857,TCGA-FY-A3RA-01A,TCGA-FY-A3RA-01A-11D-A21Z-08,1,0.860141125,TCGA-FY-A3RA,THCA,21,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-7900,Alive,TUMOR FREE,550,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,550,0,550,0,550,0,550,NA,Stage I,T2,MX,THCA.3,1
9.840504376,-1.619166063,TCGA-EM-A3AK-01A,TCGA-EM-A3AK-01A-11D-A202-08,1,0.867147852,TCGA-EM-A3AK,THCA,62,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-22911,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,477,0,477,0,477,0,477,NA,Stage I,T1b,MX,THCA.5,1
2.974676951,3.568112232,TCGA-D8-A1XU-01A,TCGA-D8-A1XU-01A-11D-A14K-09,0,NA,TCGA-D8-A1XU,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20715,Alive,TUMOR FREE,395,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,395,0,395,0,395,0,395,NA,Stage IA,T1c,M0,BRCA.LumA,1
-7.401312343,-2.585009209,TCGA-B6-A1KC-01B,TCGA-B6-A1KC-01B-11D-A159-09,6,0.280729583,TCGA-B6-A1KC,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24791,Alive,TUMOR FREE,1326,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1326,0,1326,0,1326,0,1326,NA,Stage IIB,T2,M0,BRCA.LumB,2
-3.949445487,-2.400611339,TCGA-60-2724-01A,TCGA-60-2724-01A-01D-1522-08,8,0.463294977,TCGA-60-2724,LUSC,47,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-17462,Alive,TUMOR FREE,717,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,717,0,717,NA,NA,0,717,NA,Stage IIIA,T3,M0,LUSC.basal,10
-3.888619632,1.425031783,TCGA-56-6546-01A,TCGA-56-6546-01A-11D-1817-08,0,NA,TCGA-56-6546,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24594,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage IIA,T2b,MX,LUSC.secretory,10
-0.031546641,4.736599265,TCGA-BR-A4J8-01A,TCGA-BR-A4J8-01A-11D-A25D-08,4,0.505789182,TCGA-BR-A4J8,STAD,71,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-26048,Alive,TUMOR FREE,411,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,411,0,411,0,411,0,411,NA,Stage IIIB,T3,M0,GI.CIN,6
-2.037577614,2.475969016,TCGA-51-4081-01A,TCGA-51-4081-01A-01D-1458-08,0,NA,TCGA-51-4081,LUSC,55,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-20261,Alive,TUMOR FREE,911,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,911,0,911,NA,NA,0,911,NA,Stage IIB,T2a,M0,LUSC.classical,6
-7.492054277,-2.052714416,TCGA-BR-A4QI-01A,TCGA-BR-A4QI-01A-12D-A25D-08,6,0.166715862,TCGA-BR-A4QI,STAD,70,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-25928,Dead,WITH TUMOR,NA,652,[Not Available],Distant Metastasis,"Other, specify",Pancreas,383,Complete Remission/Response,1,652,1,652,1,383,1,383,NA,Stage IIA,T3,M0,GI.CIN,2
-6.55352077,2.10865168,TCGA-A5-A2K2-01A,TCGA-A5-A2K2-01A-11D-A18P-09,0,NA,TCGA-A5-A2K2,UCEC,77,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28456,Alive,TUMOR FREE,3595,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3595,0,3595,0,3595,0,3595,NA,Stage IA,[Not Applicable],[Not Applicable],NA,9
-5.759797424,-1.286997852,TCGA-HD-8635-01A,TCGA-HD-8635-01A-11D-2394-08,0,NA,TCGA-HD-8635,HNSC,61,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-22340,Alive,TUMOR FREE,695,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,695,0,695,0,695,0,695,NA,Stage III,T1,MX,NA,2
-6.259541503,1.156409839,TCGA-EO-A2CH-01A,TCGA-EO-A2CH-01A-11D-A17W-09,10,0.028772504,TCGA-EO-A2CH,UCEC,73,FEMALE,[Not Available],Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26966,Dead,WITH TUMOR,NA,590,[Not Available],Metastatic,Liver,NA,304,Progressive Disease,1,590,1,590,NA,NA,1,304,NA,Stage IVB,[Not Applicable],[Not Applicable],NA,7
9.484781011,-2.005759208,TCGA-FK-A3SH-01A,TCGA-FK-A3SH-01A-11D-A22D-08,1,0.767496662,TCGA-FK-A3SH,THCA,50,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-18609,Alive,TUMOR FREE,1463,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1463,0,1463,0,1463,0,1463,NA,Stage III,T2,MX,THCA.5,1
-1.718894292,0.930167299,TCGA-BH-A0C1-01B,TCGA-BH-A0C1-01B-11D-A12B-09,5,0.51308354,TCGA-BH-A0C1,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22377,Dead,WITH TUMOR,NA,1411,[Not Available],Distant Metastasis,Bone,NA,1123,[Not Available],1,1411,1,1411,1,1123,1,1123,NA,Stage IIIA,T3,M0,BRCA.LumA,4
-1.771851101,3.573018348,TCGA-39-5039-01A,TCGA-39-5039-01A-01D-1441-08,0,NA,TCGA-39-5039,LUSC,76,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-27781,Dead,TUMOR FREE,544,544,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,544,0,544,0,544,0,544,NA,Stage IIA,T2b,M0,LUSC.basal,6
-4.22742542,0.832481983,TCGA-18-3412-01A,TCGA-18-3412-01A-01D-0983-08,0,NA,TCGA-18-3412,LUSC,52,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-19025,Dead,WITH TUMOR,NA,345,[Not Available],Distant Metastasis,NA,NA,273,Progressive Disease,1,345,1,345,NA,NA,1,273,NA,Stage IB,T2,M0,LUSC.classical,10
8.492584047,-1.674095561,TCGA-22-5485-01A,TCGA-22-5485-01A-01D-1632-08,1,0.513458737,TCGA-22-5485,LUSC,58,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-21488,Dead,WITH TUMOR,916,916,[Not Available],NA,NA,NA,840,Complete Remission/Response,1,916,1,916,1,840,1,840,NA,Stage IA,T1a,M0,LUSC.classical,6
-3.136830917,0.856909592,TCGA-60-2704-01A,TCGA-60-2704-01A-11D-2042-08,0,NA,TCGA-60-2704,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-26927,Dead,WITH TUMOR,NA,1154,[Not Available],NA,NA,NA,532,[Not Available],1,1154,1,1154,NA,NA,1,532,NA,Stage IIB,T2,M0,NA,10
1.073234531,3.549140878,TCGA-77-8007-01A,TCGA-77-8007-01A-11D-2184-08,0,NA,TCGA-77-8007,LUSC,68,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-25102,Dead,NA,NA,198,[Not Available],NA,NA,NA,139,[Not Available],1,198,NA,198,NA,NA,1,139,NA,Stage IIB,T2,M0,NA,1
-5.680634065,1.886997128,TCGA-75-5146-01A,TCGA-75-5146-01A-01D-1625-08,10,0.000931194,TCGA-75-5146,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,2368,NA,[Not Available],New Primary Tumor,NA,NA,1773,Complete Remission/Response,0,2368,0,2368,0,2368,1,1773,NA,Stage IB,T2,M0,LUAD.5,10
-6.16899025,1.90004006,TCGA-D7-6820-01A,TCGA-D7-6820-01A-11D-1882-08,10,0.175570414,TCGA-D7-6820,STAD,64,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-23486,Alive,TUMOR FREE,344,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,344,0,344,0,344,0,344,NA,Stage IIB,T2,M0,GI.CIN,8
-7.937721592,1.840572294,TCGA-D1-A17L-01A,TCGA-D1-A17L-01A-11D-A12J-09,9,0.535127941,TCGA-D1-A17L,UCEC,81,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29899,Alive,TUMOR FREE,802,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,802,0,802,0,802,0,802,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-0.068992852,4.901601163,TCGA-S9-A6WG-01A,TCGA-S9-A6WG-01A-11D-A33T-08,4,0.594081252,TCGA-S9-A6WG,LGG,31,MALE,WHITE,Astrocytoma,G3,2007,[Not Available],-11509,Alive,WITH TUMOR,2602,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,2602,0,2602,NA,NA,0,2602,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.022646037,-2.762751303,TCGA-S9-A6WH-01A,TCGA-S9-A6WH-01A-12D-A33T-08,1,0.759049228,TCGA-S9-A6WH,LGG,73,FEMALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-26904,Alive,WITH TUMOR,1173,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1173,0,1173,NA,NA,0,1173,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.241946749,4.636834885,TCGA-B6-A0I2-01A,TCGA-B6-A0I2-01A-11W-A050-09,4,0.687576413,TCGA-B6-A0I2,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1995,Indeterminate (neither Pre or Postmenopausal),-16702,Alive,TUMOR FREE,4361,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4361,0,4361,NA,NA,0,4361,NA,Stage IA,T1c,M0,BRCA.Basal,6
0.117449953,5.041830065,TCGA-S9-A6U6-01A,TCGA-S9-A6U6-01A-12D-A33T-08,4,0.704420195,TCGA-S9-A6U6,LGG,28,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-10253,Alive,TUMOR FREE,1069,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1069,0,1069,0,1069,0,1069,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.09368106,4.980765353,TCGA-S9-A6U9-01A,TCGA-S9-A6U9-01A-11D-A32B-08,4,0.673886607,TCGA-S9-A6U9,LGG,36,MALE,WHITE,Astrocytoma,G3,2006,[Not Available],-13460,Alive,WITH TUMOR,2918,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,2918,0,2918,NA,NA,0,2918,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.753256618,-2.459016747,TCGA-S9-A6UA-01A,TCGA-S9-A6UA-01A-12D-A33T-08,6,0.220381369,TCGA-S9-A6UA,LGG,66,MALE,WHITE,Astrocytoma,G3,2008,[Not Available],-24242,Dead,WITH TUMOR,NA,178,[Not Available],NA,NA,NA,161,Progressive Disease,1,178,1,178,NA,NA,1,161,NA,NA,NA,NA,GBM_LGG.PA-like,2
8.797234622,-5.108562591,TCGA-S9-A6TY-01A,TCGA-S9-A6TY-01A-12D-A32B-08,1,0.804569367,TCGA-S9-A6TY,LGG,50,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-18564,Alive,WITH TUMOR,1076,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1076,0,1076,NA,NA,0,1076,NA,NA,NA,NA,GBM_LGG.Codel,1
-8.073006992,2.22104565,TCGA-S9-A6U0-01A,TCGA-S9-A6U0-01A-12D-A32B-08,9,0.66407492,TCGA-S9-A6U0,LGG,46,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-16890,Dead,WITH TUMOR,NA,742,[Not Available],NA,NA,NA,692,Partial Remission/Response,1,742,1,742,NA,NA,1,692,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
8.441696639,-3.577135686,TCGA-S9-A6U1-01A,TCGA-S9-A6U1-01A-21D-A33T-08,1,0.665543835,TCGA-S9-A6U1,LGG,22,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-8271,Alive,TUMOR FREE,785,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,785,0,785,0,785,0,785,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
8.258942727,-4.006940774,TCGA-S9-A6U5-01A,TCGA-S9-A6U5-01A-12D-A33T-08,1,0.530969025,TCGA-S9-A6U5,LGG,33,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-12417,Alive,TUMOR FREE,992,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,992,0,992,0,992,0,992,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.399320037,-1.299038145,TCGA-AN-A0XW-01A,TCGA-AN-A0XW-01A-11D-A10G-09,8,0.358266889,TCGA-AN-A0XW,BRCA,36,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13208,Alive,TUMOR FREE,170,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,170,0,170,0,170,0,170,NA,Stage IIIA,T2,M0,BRCA.LumA,10
0.073912174,5.204857384,TCGA-S9-A6TS-01A,TCGA-S9-A6TS-01A-12D-A33T-08,4,0.666624057,TCGA-S9-A6TS,LGG,48,FEMALE,WHITE,Astrocytoma,G3,2006,[Not Available],-17857,Dead,WITH TUMOR,NA,1891,[Not Available],NA,NA,NA,1324,Progressive Disease,1,1891,1,1891,NA,NA,1,1324,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.122379165,5.10538914,TCGA-S9-A6TV-01A,TCGA-S9-A6TV-01A-12D-A34J-08,4,0.703351107,TCGA-S9-A6TV,LGG,50,MALE,WHITE,Oligoastrocytoma,G3,2010,[Not Available],-18321,Alive,TUMOR FREE,571,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,571,0,571,0,571,0,571,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.974547131,1.920818613,TCGA-S9-A6TW-01A,TCGA-S9-A6TW-01A-12D-A32B-08,9,0.450312218,TCGA-S9-A6TW,LGG,40,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-14679,Alive,TUMOR FREE,1250,NA,[Not Available],NA,NA,NA,861,Partial Remission/Response,0,1250,0,1250,NA,NA,1,861,NA,NA,NA,NA,GBM_LGG.Codel,7
9.346214916,-4.197138947,TCGA-S9-A6TX-01A,TCGA-S9-A6TX-01A-21D-A32B-08,1,0.719408809,TCGA-S9-A6TX,LGG,46,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-17025,Alive,WITH TUMOR,1245,NA,[Not Available],NA,NA,NA,856,Complete Remission/Response,0,1245,0,1245,1,856,1,856,NA,NA,NA,NA,GBM_LGG.Codel,1
9.585156375,-5.683005703,TCGA-GM-A2DC-01A,TCGA-GM-A2DC-01A-11D-A18P-09,1,0.881058072,TCGA-GM-A2DC,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21122,Alive,TUMOR FREE,2535,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2535,0,2535,0,2535,0,2535,NA,Stage IIA,T1c,M0,BRCA.LumA,1
9.210468768,-5.327374167,TCGA-QH-A6X3-01A,TCGA-QH-A6X3-01A-21D-A32B-08,1,0.851241703,TCGA-QH-A6X3,LGG,27,MALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-10184,Alive,TUMOR FREE,313,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,313,0,313,0,313,0,313,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
7.811801487,-1.387054495,TCGA-QH-A6X4-01A,TCGA-QH-A6X4-01A-51D-A32B-08,1,0.163238451,TCGA-QH-A6X4,LGG,47,MALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-17258,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,442,0,442,0,442,0,442,NA,NA,NA,NA,GBM_LGG.Codel,1
9.515209608,-5.340380587,TCGA-QH-A6X5-01A,TCGA-QH-A6X5-01A-12D-A32B-08,1,0.849212947,TCGA-QH-A6X5,LGG,58,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-21239,Alive,NA,497,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,497,0,497,NA,NA,0,497,NA,NA,NA,NA,GBM_LGG.Codel,1
8.917591643,-4.092582828,TCGA-QH-A6X8-01A,TCGA-QH-A6X8-01A-12D-A32B-08,1,0.752749429,TCGA-QH-A6X8,LGG,56,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-20771,Alive,WITH TUMOR,509,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,509,0,509,NA,NA,0,509,NA,NA,NA,NA,GBM_LGG.Codel,1
9.723869623,-1.38018318,TCGA-A2-A0ET-01A,TCGA-A2-A0ET-01A-31D-A045-09,1,0.732004336,TCGA-A2-A0ET,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21464,Alive,TUMOR FREE,1066,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1066,0,1066,0,1066,0,1066,NA,Stage IIIA,T2,M0,BRCA.LumA,1
0.070204712,5.038460588,TCGA-QH-A6XA-01A,TCGA-QH-A6XA-01A-12D-A32B-08,4,0.700764436,TCGA-QH-A6XA,LGG,23,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-8508,Alive,TUMOR FREE,502,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,502,0,502,0,502,0,502,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.045105276,5.028323327,TCGA-QH-A6CW-01A,TCGA-QH-A6CW-01A-11D-A32B-08,4,0.71307874,TCGA-QH-A6CW,LGG,43,MALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-15847,Alive,TUMOR FREE,414,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,414,0,414,NA,NA,0,414,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.909724784,-4.255280671,TCGA-QH-A6CY-01A,TCGA-QH-A6CY-01A-11D-A32B-08,1,0.742936824,TCGA-QH-A6CY,LGG,38,MALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-14140,Alive,WITH TUMOR,408,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,408,0,408,NA,NA,0,408,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.661648922,5.104714954,TCGA-QH-A6CZ-01A,TCGA-QH-A6CZ-01A-11D-A32B-08,4,0.47022791,TCGA-QH-A6CZ,LGG,38,MALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-14007,Alive,TUMOR FREE,279,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,279,0,279,NA,NA,0,279,NA,NA,NA,NA,GBM_LGG.Codel,6
-6.440363318,1.730662671,TCGA-DC-6158-01A,TCGA-DC-6158-01A-11D-1657-10,10,0.261634511,TCGA-DC-6158,READ,70,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-25842,Dead,TUMOR FREE,NA,334,[Not Available],NA,NA,NA,NA,[Not Available],1,334,0,334,NA,NA,0,334,NA,Stage I,T2,M0,GI.CIN,7
8.94276968,-4.910050084,TCGA-AO-A1KT-01A,TCGA-AO-A1KT-01A-11D-A13L-09,1,0.706903956,TCGA-AO-A1KT,BRCA,78,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28660,Alive,TUMOR FREE,541,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,541,0,541,0,541,0,541,NA,Stage IIA,T1,M0,BRCA.LumB,1
9.11984511,-5.13856059,TCGA-QH-A65R-01A,TCGA-QH-A65R-01A-21D-A31L-08,1,0.828547895,TCGA-QH-A65R,LGG,38,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-14073,Alive,WITH TUMOR,461,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,461,0,461,NA,NA,0,461,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.210326365,5.227874298,TCGA-QH-A65S-01A,TCGA-QH-A65S-01A-11D-A29Q-08,4,0.700169825,TCGA-QH-A65S,LGG,32,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-11861,Alive,[Discrepancy],77,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,77,0,77,NA,NA,0,77,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.039580513,-4.920055013,TCGA-QH-A65X-01A,TCGA-QH-A65X-01A-11D-A32B-08,1,0.800089876,TCGA-QH-A65X,LGG,28,FEMALE,WHITE,Oligoastrocytoma,G3,2013,[Not Available],-10440,Alive,TUMOR FREE,482,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,482,0,482,NA,NA,0,482,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.057091337,1.953048878,TCGA-QH-A6CS-01A,TCGA-QH-A6CS-01A-11D-A31L-08,0,NA,TCGA-QH-A6CS,LGG,41,MALE,WHITE,Astrocytoma,G3,2013,[Not Available],-15092,Alive,WITH TUMOR,588,NA,[Not Available],NA,NA,NA,498,Stable Disease,0,588,0,588,NA,NA,1,498,NA,NA,NA,NA,GBM_LGG.PA-like,7
9.374203131,-2.001972664,TCGA-QH-A6CV-01A,TCGA-QH-A6CV-01A-11D-A31L-08,1,0.777885935,TCGA-QH-A6CV,LGG,51,MALE,ASIAN,Oligoastrocytoma,G3,2013,[Not Available],-18955,Alive,WITH TUMOR,442,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,442,0,442,NA,NA,0,442,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-7.433645651,-2.41260794,TCGA-P5-A5EV-01A,TCGA-P5-A5EV-01A-11D-A27K-08,6,0.393900098,TCGA-P5-A5EV,LGG,39,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-14310,Alive,WITH TUMOR,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,7,0,7,NA,NA,0,7,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
4.319055238,1.230219596,TCGA-P5-A5EX-01A,TCGA-P5-A5EX-01A-12D-A289-08,2,0.715749853,TCGA-P5-A5EX,LGG,41,FEMALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-15091,Alive,TUMOR FREE,243,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,243,0,243,NA,NA,0,243,NA,NA,NA,NA,GBM_LGG.Codel,5
9.568250565,-5.632491214,TCGA-P5-A5EY-01A,TCGA-P5-A5EY-01A-11D-A27K-08,1,0.877610307,TCGA-P5-A5EY,LGG,21,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-7716,Alive,NA,72,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,72,0,72,NA,NA,0,72,NA,NA,NA,NA,GBM_LGG.PA-like,1
-6.452180791,-1.449642088,TCGA-DY-A1H8-01A,TCGA-DY-A1H8-01A-21D-A152-10,7,0.307180749,TCGA-DY-A1H8,READ,77,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2000,[Not Available],-28459,Dead,NA,992,992,[Not Available],NA,NA,NA,NA,[Not Available],1,992,NA,992,NA,NA,0,992,NA,Stage IIIA,T2,M0,GI.CIN,2
-7.660171659,2.381431398,TCGA-DU-A76R-01A,TCGA-DU-A76R-01A-11D-A32B-08,9,0.324017758,TCGA-DU-A76R,LGG,51,MALE,WHITE,Oligodendroglioma,G3,2006,[Not Available],-18939,Dead,WITH TUMOR,NA,648,[Not Available],NA,NA,NA,338,Progressive Disease,1,648,1,648,NA,NA,1,338,NA,NA,NA,NA,GBM_LGG.Codel,7
9.695117419,-3.001378728,TCGA-HT-A617-01A,TCGA-HT-A617-01A-11D-A29Q-08,1,0.736223509,TCGA-HT-A617,LGG,47,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Oligodendroglioma,G2,2010,[Not Available],-17331,Alive,NA,491,NA,[Not Available],NA,NA,NA,395,Progressive Disease,0,491,0,491,NA,NA,1,395,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-7.486636977,-2.398433794,TCGA-HT-A618-01A,TCGA-HT-A618-01A-11D-A29Q-08,6,0.331218604,TCGA-HT-A618,LGG,37,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-13595,Alive,TUMOR FREE,512,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,512,0,512,0,512,0,512,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
9.401675223,-5.493670306,TCGA-HT-A61A-01A,TCGA-HT-A61A-01A-11D-A29Q-08,1,0.847062685,TCGA-HT-A61A,LGG,20,FEMALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-7664,Alive,TUMOR FREE,194,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,194,0,194,0,194,0,194,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-5.363542779,1.864248299,TCGA-97-8174-01A,TCGA-97-8174-01A-11D-2284-08,0,NA,TCGA-97-8174,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24725,Dead,NA,NA,164,[Not Available],NA,NA,NA,NA,[Not Available],1,164,NA,164,NA,NA,0,164,NA,Stage IIA,T2b,M0,NA,9
-7.873653932,1.93203114,TCGA-KT-A7W1-01A,TCGA-KT-A7W1-01A-11D-A34A-08,9,0.347549786,TCGA-KT-A7W1,LGG,45,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-16560,Alive,TUMOR FREE,438,NA,[Not Available],NA,NA,NA,84,Progressive Disease,0,438,0,438,NA,NA,1,84,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-6.453110172,1.669282454,TCGA-P5-A5EU-01A,TCGA-P5-A5EU-01A-11D-A27K-08,10,0.205199215,TCGA-P5-A5EU,LGG,35,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-12851,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,7
-1.835586004,0.97627673,TCGA-DU-A6S8-01A,TCGA-DU-A6S8-01A-12D-A32B-08,5,0.523296092,TCGA-DU-A6S8,LGG,74,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-27084,Alive,WITH TUMOR,678,NA,[Not Available],NA,NA,NA,641,Progressive Disease,0,678,0,678,NA,NA,1,641,NA,NA,NA,NA,GBM_LGG.Codel,4
8.926155333,-4.776434584,TCGA-DU-A76L-01A,TCGA-DU-A76L-01A-11D-A32B-08,1,0.804174646,TCGA-DU-A76L,LGG,54,MALE,WHITE,Oligodendroglioma,G3,2000,[Not Available],-19823,Dead,WITH TUMOR,NA,814,[Not Available],NA,NA,NA,410,Progressive Disease,1,814,1,814,NA,NA,1,410,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
0.169825255,4.913798597,TCGA-DU-A6S7-01A,TCGA-DU-A6S7-01A-21D-A32B-08,4,0.715650845,TCGA-DU-A6S7,LGG,27,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-10170,Alive,TUMOR FREE,638,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,638,0,638,NA,NA,0,638,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.985994268,4.65435225,TCGA-RD-A8N9-01A,TCGA-RD-A8N9-01A-12D-A397-08,4,0.363500734,TCGA-RD-A8N9,STAD,63,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2009,[Not Available],-23059,Alive,TUMOR FREE,1083,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1083,0,1083,0,1083,0,1083,NA,Stage II,T2,M0,GI.CIN,6
-3.834919466,-2.574030807,TCGA-RD-A8NB-01A,TCGA-RD-A8NB-01A-12D-A397-08,8,0.435917358,TCGA-RD-A8NB,STAD,80,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2000,[Not Available],-29503,Dead,WITH TUMOR,NA,513,Stomach Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,NA,230,Partial Remission/Response,1,513,1,513,NA,NA,1,230,NA,Stage IIIA,T3,M0,GI.HM-indel,10
-0.540720546,4.942638628,TCGA-SW-A7EB-01A,TCGA-SW-A7EB-01A-11D-A34U-08,4,0.520274423,TCGA-SW-A7EB,STAD,45,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2013,[Not Available],-16475,Alive,TUMOR FREE,176,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,176,0,176,NA,NA,0,176,NA,Stage IIIA,T3,M0,GI.CIN,6
-1.833569834,1.078312817,TCGA-ZA-A8F6-01A,TCGA-ZA-A8F6-01A-23D-A364-08,5,0.562150015,TCGA-ZA-A8F6,STAD,71,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013,[Not Available],-26122,Alive,TUMOR FREE,525,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,525,0,525,0,525,0,525,NA,Stage IB,T2,MX,GI.CIN,4
-0.812016278,3.687023874,TCGA-ZQ-A9CR-01A,TCGA-ZQ-A9CR-01A-11D-A397-08,4,0.340360971,TCGA-ZQ-A9CR,STAD,79,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013,[Not Available],-29107,Dead,NA,NA,24,[Unknown],NA,NA,NA,NA,[Unknown],1,24,NA,24,NA,NA,0,24,NA,Stage IIIC,T4a,MX,GI.CIN,5
2.009593163,1.858479084,TCGA-DU-A6S2-01A,TCGA-DU-A6S2-01A-21D-A32B-08,3,0.617363545,TCGA-DU-A6S2,LGG,37,FEMALE,BLACK OR AFRICAN AMERICAN,Oligodendroglioma,G2,2013,[Not Available],-13597,Alive,TUMOR FREE,777,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,777,0,777,NA,NA,0,777,NA,NA,NA,NA,GBM_LGG.Codel,3
-6.01370919,-1.257468739,TCGA-DC-6682-01A,TCGA-DC-6682-01A-11D-1826-10,0,NA,TCGA-DC-6682,READ,57,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-21062,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,762,0,762,NA,NA,0,762,NA,Stage IIA,T3,M0,GI.CIN,2
9.245739067,-5.410426606,TCGA-RD-A8N4-01A,TCGA-RD-A8N4-01A-21D-A364-08,1,0.853683004,TCGA-RD-A8N4,STAD,58,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2006,[Not Available],-21324,Alive,TUMOR FREE,2171,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2171,0,2171,0,2171,0,2171,NA,Stage IIIA,T3,M0,GI.GS,1
8.865070889,-4.594043257,TCGA-RD-A8N5-01A,TCGA-RD-A8N5-01A-12D-A364-08,1,0.764348473,TCGA-RD-A8N5,STAD,78,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006,[Not Available],-28589,Dead,TUMOR FREE,NA,1747,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,1747,0,1747,0,1747,0,1747,NA,Stage IIIA,T3,M0,GI.CIN,1
0.067844185,3.856745564,TCGA-50-5939-01A,TCGA-50-5939-01A-11D-1625-08,4,0.151087652,TCGA-50-5939,LUAD,85,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-31236,Dead,TUMOR FREE,NA,460,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,460,0,460,0,460,0,460,NA,Stage IB,T2,M0,LUAD.6,3
9.701987865,-1.970096476,TCGA-RD-A7BS-01A,TCGA-RD-A7BS-01A-11D-A32N-08,1,0.810680044,TCGA-RD-A7BS,STAD,46,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2001,[Not Available],-16847,Dead,WITH TUMOR,NA,336,Stomach Cancer,Distant Metastasis,Liver,NA,244,Complete Remission/Response,1,336,1,336,1,244,1,244,NA,Stage IIIA,T3,M0,GI.GS,1
8.803902461,-1.815670579,TCGA-RD-A7BT-01A,TCGA-RD-A7BT-01A-11D-A33T-08,1,0.525595522,TCGA-RD-A7BT,STAD,66,MALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2002,[Not Available],-24107,Dead,WITH TUMOR,NA,262,Stomach Cancer,Distant Metastasis,"Other, specify",Adrenal gland,123,Progressive Disease,1,262,1,262,NA,NA,1,123,NA,Stage IV,T3,M0,NA,6
-6.091171859,3.584690089,TCGA-QD-A8IV-01A,TCGA-QD-A8IV-01A-11D-A397-08,11,0.591082919,TCGA-QD-A8IV,THCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013,[Not Available],-18288,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,392,0,392,NA,NA,0,392,NA,Stage IVA,T3,MX,NA,8
9.796545561,-4.067570692,TCGA-RD-A8MV-01A,TCGA-RD-A8MV-01A-11D-A364-08,1,0.726951382,TCGA-RD-A8MV,STAD,56,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2001,[Not Available],-20771,Alive,TUMOR FREE,3720,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3720,0,3720,0,3720,0,3720,NA,Stage IIIB,T3,M0,GI.CIN,1
9.556095273,-5.638186943,TCGA-RD-A8N0-01A,TCGA-RD-A8N0-01A-12D-A364-08,1,0.880883379,TCGA-RD-A8N0,STAD,53,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2006,[Not Available],-19491,Alive,TUMOR FREE,1236,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1236,0,1236,0,1236,0,1236,NA,Stage IIIB,T3,M0,GI.GS,1
0.249835238,4.669974776,TCGA-RD-A8N1-01A,TCGA-RD-A8N1-01A-12D-A364-08,4,0.45224117,TCGA-RD-A8N1,STAD,70,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2001,[Not Available],-25737,Alive,TUMOR FREE,3519,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3519,0,3519,0,3519,0,3519,NA,Stage IIIB,T3,M0,GI.CIN,3
9.314243163,-5.204558722,TCGA-RD-A8N2-01A,TCGA-RD-A8N2-01A-12D-A364-08,1,0.842809019,TCGA-RD-A8N2,STAD,59,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2002,[Not Available],-21749,Alive,TUMOR FREE,3540,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3540,0,3540,0,3540,0,3540,NA,Stage IB,T2,M0,GI.GS,1
-3.369463468,-3.24642778,TCGA-BR-7707-01A,TCGA-BR-7707-01A-11D-2053-08,8,0.608606933,TCGA-BR-7707,STAD,69,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25325,Alive,TUMOR FREE,1090,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1090,0,1090,0,1090,0,1090,NA,Stage IB,T2,M0,GI.HM-indel,10
-5.166786743,2.052140974,TCGA-AG-4022-01A,TCGA-AG-4022-01A-01D-1733-10,0,NA,TCGA-AG-4022,READ,59,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2006,[Not Available],-21823,Alive,TUMOR FREE,1400,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1400,0,1400,0,1400,0,1400,NA,Stage II,T3,M0,GI.CIN,8
-6.172471254,3.596541944,TCGA-MK-A84Z-01A,TCGA-MK-A84Z-01A-11D-A397-08,11,0.408141622,TCGA-MK-A84Z,THCA,74,MALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2013,[Not Available],-27185,Alive,TUMOR FREE,728,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,728,0,728,NA,NA,0,728,NA,Stage III,T3,MX,NA,8
9.525605667,-4.707590561,TCGA-AG-3584-01A,TCGA-AG-3584-01A-01D-1989-10,1,0.764893418,TCGA-AG-3584,READ,60,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-22189,Dead,WITH TUMOR,NA,730,[Not Available],NA,NA,NA,NA,Progressive Disease,1,730,1,730,NA,NA,1,730,NA,Stage IV,T3,M1,NA,1
-3.142425932,-3.556320491,TCGA-HF-A5NB-01A,TCGA-HF-A5NB-01A-11D-A31L-08,8,0.593907214,TCGA-HF-A5NB,STAD,75,FEMALE,[Not Evaluated],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,NA,[Not Available],-27676,Alive,TUMOR FREE,928,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,928,0,928,0,928,0,928,NA,Stage IIIC,T4a,M0,GI.HM-indel,10
9.134465802,-5.296524738,TCGA-EL-A3ZN-01A,TCGA-EL-A3ZN-01A-11D-A23M-08,1,0.857221074,TCGA-EL-A3ZN,THCA,28,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-10266,Alive,TUMOR FREE,1614,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1614,0,1614,0,1614,0,1614,NA,Stage I,T3,M0,THCA.5,1
-0.213694874,4.405517924,TCGA-KB-A6F5-01A,TCGA-KB-A6F5-01A-12D-A33T-08,4,0.555217203,TCGA-KB-A6F5,STAD,73,MALE,[Not Evaluated],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-26881,Alive,TUMOR FREE,169,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,169,0,169,0,169,0,169,NA,Stage IIIA,T3,M0,NA,6
9.33198472,-4.580896486,TCGA-FY-A76V-01A,TCGA-FY-A76V-01A-11D-A397-08,1,0.760122895,TCGA-FY-A76V,THCA,54,MALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013,[Not Available],-19872,Alive,TUMOR FREE,51,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,51,0,51,0,51,0,51,NA,Stage II,T2,MX,NA,1
8.877229852,-4.534688121,TCGA-ZG-A8QZ-01A,TCGA-ZG-A8QZ-01A-11D-A377-08,1,0.812164463,TCGA-ZG-A8QZ,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23980,Alive,TUMOR FREE,308,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,308,0,308,NA,NA,0,308,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-0.687428427,3.675875701,TCGA-D7-A6F0-01A,TCGA-D7-A6F0-01A-11D-A31L-08,4,0.37136868,TCGA-D7-A6F0,STAD,79,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013,[Not Available],-28923,Alive,TUMOR FREE,678,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,678,0,678,0,678,0,678,NA,Stage IB,T2,M0,GI.CIN,5
-0.422908074,4.822132044,TCGA-D7-A6F2-01A,TCGA-D7-A6F2-01A-12D-A31L-08,4,0.529505823,TCGA-D7-A6F2,STAD,62,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-22801,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,476,0,476,0,476,0,476,NA,Stage IB,T2,M0,GI.CIN,6
9.511651579,-2.822417536,TCGA-D7-A748-01A,TCGA-D7-A748-01A-12D-A32N-08,1,0.772912913,TCGA-D7-A748,STAD,41,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2013,[Not Available],-15190,Dead,WITH TUMOR,NA,132,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,NA,NA,99,Progressive Disease,1,132,1,132,NA,NA,1,99,NA,Stage IV,T4a,M1,GI.GS,1
-3.204751547,-3.584287343,TCGA-50-5930-01A,TCGA-50-5930-01A-11D-1753-08,8,0.48651195,TCGA-50-5930,LUAD,47,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-17238,Dead,WITH TUMOR,NA,282,[Not Available],Distant Metastasis,NA,NA,177,Progressive Disease,1,282,1,282,NA,NA,1,177,NA,Stage IIIA,T2,M0,NA,10
-5.837075724,3.245973375,TCGA-D7-A74A-01A,TCGA-D7-A74A-01A-11D-A32N-08,0,NA,TCGA-D7-A74A,STAD,61,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2013,[Not Available],-22435,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,607,0,607,0,607,0,607,NA,Stage IIIA,T3,M0,GI.CIN,8
9.931507802,-1.753583023,TCGA-DE-A7U5-01A,TCGA-DE-A7U5-01A-11D-A397-08,1,0.810538512,TCGA-DE-A7U5,THCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2013,[Not Available],-13411,Alive,NA,84,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,84,0,84,NA,NA,0,84,NA,Stage I,T2,M0,NA,1
9.083277521,-4.656837774,TCGA-DJ-A4UP-01A,TCGA-DJ-A4UP-01A-11D-A257-08,1,0.783970883,TCGA-DJ-A4UP,THCA,15,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-5655,Alive,TUMOR FREE,916,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,916,0,916,0,916,0,916,NA,Stage I,T1b,M0,THCA.2,1
0.208457657,4.863838625,TCGA-F1-A72C-01A,TCGA-F1-A72C-01A-21D-A33T-08,4,0.72135997,TCGA-F1-A72C,STAD,68,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013,[Not Available],-25104,Alive,WITH TUMOR,346,NA,[Not Available],Distant Metastasis,Liver,NA,343,Complete Remission/Response,0,346,0,346,1,343,1,343,NA,Stage IIA,T3,M0,GI.CIN,6
-1.873395312,1.066350165,TCGA-EL-A3GZ-01A,TCGA-EL-A3GZ-01A-11D-A20C-08,5,0.632522627,TCGA-EL-A3GZ,THCA,34,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2001,[Not Available],-12665,Alive,TUMOR FREE,4258,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4258,0,4258,0,4258,0,4258,NA,Stage I,T1,M0,THCA.5,4
9.176744688,-1.977654002,TCGA-FP-A8CX-01A,TCGA-FP-A8CX-01A-11D-A364-08,1,0.679189868,TCGA-FP-A8CX,STAD,60,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2013,[Not Available],-22000,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,7,0,7,NA,NA,0,7,NA,Stage IIIC,T4b,MX,GI.CIN,1
8.832746611,-4.850372326,TCGA-EL-A3H3-01A,TCGA-EL-A3H3-01A-11D-A202-08,1,0.79873935,TCGA-EL-A3H3,THCA,19,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-7000,Alive,TUMOR FREE,1319,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1319,0,1319,0,1319,0,1319,NA,Stage I,T2,M0,THCA.2,1
-3.470763268,-2.900061313,TCGA-BR-4370-01A,TCGA-BR-4370-01A-01D-1158-08,8,0.481797701,TCGA-BR-4370,STAD,74,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-27344,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],TX,M0,GI.HM-indel,10
-3.290232685,-3.45994449,TCGA-BR-4292-01A,TCGA-BR-4292-01A-01D-1126-08,8,0.539600805,TCGA-BR-4292,STAD,73,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2009,[Not Available],-26670,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],T1,M0,GI.HM-indel,10
9.213740861,-4.203682354,TCGA-CN-5363-01A,TCGA-CN-5363-01A-01D-1434-08,1,0.714493822,TCGA-CN-5363,HNSC,48,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G3,2007,[Not Available],-17635,Dead,WITH TUMOR,NA,253,[Not Available],NA,Distant Metastasis,BONE,53,Complete Remission/Response,1,253,1,253,NA,NA,1,53,NA,Stage IVB,T4a,M0,HNSC.Mesenchymal,6
9.843812454,-1.760688202,TCGA-BJ-A290-01A,TCGA-BJ-A290-01A-11D-A17V-08,1,0.868914788,TCGA-BJ-A290,THCA,70,MALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010,[Not Available],-25803,Alive,WITH TUMOR,919,NA,[Not Available],Distant Metastasis,Lung,NA,329,[Not Available],0,919,0,919,NA,NA,1,329,NA,Stage III,T3,M0,THCA.5,1
-0.200634556,4.826328745,TCGA-CV-5976-01A,TCGA-CV-5976-01A-11D-1683-08,4,0.653609922,TCGA-CV-5976,HNSC,50,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2006,[Not Available],-18267,Alive,TUMOR FREE,1478,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1478,0,1478,NA,NA,0,1478,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,6
9.447749084,-2.550541257,TCGA-ET-A3BX-01A,TCGA-ET-A3BX-01A-11D-A19J-08,1,0.772934363,TCGA-ET-A3BX,THCA,24,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-8791,Alive,TUMOR FREE,1596,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1596,0,1596,0,1596,0,1596,NA,Stage I,T3,MX,THCA.3,1
-4.247737171,0.719211333,TCGA-CR-7399-01A,TCGA-CR-7399-01A-11D-2012-08,0,NA,TCGA-CR-7399,HNSC,60,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-22182,Alive,TUMOR FREE,181,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,181,0,181,NA,NA,0,181,NA,Stage IVA,T3,M0,HNSC.Atypical,10
-5.124836698,1.041758328,TCGA-34-5927-01A,TCGA-34-5927-01A-11D-1817-08,0,NA,TCGA-34-5927,LUSC,70,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-25857,Alive,TUMOR FREE,1361,NA,[Not Available],Distant Metastasis,NA,NA,245,[Unknown],0,1361,0,1361,NA,NA,1,245,NA,Stage IA,T1,M0,LUSC.primitive,10
-3.827339942,-2.001298708,TCGA-95-7947-01A,TCGA-95-7947-01A-11D-2184-08,8,0.333728271,TCGA-95-7947,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24752,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,477,0,477,0,477,0,477,NA,Stage IA,T1a,M0,LUAD.5,10
9.991017662,-1.650462534,TCGA-DJ-A13T-01A,TCGA-DJ-A13T-01A-11D-A10S-08,1,0.857018054,TCGA-DJ-A13T,THCA,37,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-13668,Alive,TUMOR FREE,1709,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1709,0,1709,0,1709,0,1709,NA,Stage I,T2,M0,THCA.5,1
0.469600633,2.186780549,TCGA-22-4596-01A,TCGA-22-4596-01A-01D-1267-08,0,NA,TCGA-22-4596,LUSC,69,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-25448,Dead,TUMOR FREE,17,17,[Not Available],NA,NA,NA,NA,[Not Available],1,17,0,17,NA,NA,0,17,NA,Stage IB,T1b,M0,NA,6
9.414070009,-5.037505567,TCGA-CE-A3MD-01A,TCGA-CE-A3MD-01A-11D-A20C-08,1,0.847184692,TCGA-CE-A3MD,THCA,31,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-11399,Alive,TUMOR FREE,389,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,389,0,389,0,389,0,389,NA,Stage I,T2,M0,THCA.5,1
-6.39646228,-1.261429419,TCGA-CQ-6222-01A,TCGA-CQ-6222-01A-11D-1912-08,7,0.339949469,TCGA-CQ-6222,HNSC,63,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-23326,Alive,TUMOR FREE,2016,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2016,0,2016,NA,NA,0,2016,NA,Stage IVA,T2,[Not Available],NA,2
9.475114452,-5.462301148,TCGA-BJ-A28Z-01A,TCGA-BJ-A28Z-01A-11D-A16O-08,1,0.818731762,TCGA-BJ-A28Z,THCA,46,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-16912,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,337,0,337,NA,NA,0,337,NA,Stage III,T3,M0,THCA.2,1
-6.055764571,1.639632614,TCGA-CV-6945-01A,TCGA-CV-6945-01A-11D-1912-08,10,0.239755672,TCGA-CV-6945,HNSC,41,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1993,[Not Available],-15158,Dead,WITH TUMOR,NA,366,[Not Available],NA,NA,NA,NA,[Not Available],1,366,1,366,NA,NA,1,366,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,7
-7.452717587,1.821271601,TCGA-06-0877-01A,TCGA-06-0877-01A-01D-1492-08,9,0.285383126,TCGA-06-0877,GBM,78,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-28760,Alive,WITH TUMOR,204,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,204,0,204,NA,NA,0,204,NA,NA,NA,NA,NA,7
-3.984599216,-2.166925481,TCGA-78-7536-01A,TCGA-78-7536-01A-11D-2063-08,8,0.450628916,TCGA-78-7536,LUAD,69,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-25558,Dead,WITH TUMOR,NA,244,[Not Available],NA,NA,NA,231,Progressive Disease,1,244,1,244,NA,NA,1,231,NA,Stage IIIA,T2,M0,LUAD.2,10
-1.490111037,3.04397214,TCGA-66-2786-01A,TCGA-66-2786-01A-01D-1522-08,4,0.013358393,TCGA-66-2786,LUSC,68,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-25051,Alive,TUMOR FREE,790,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,790,0,790,NA,NA,0,790,NA,Stage IA,T1,M0,LUSC.secretory,10
-0.320833583,4.625534472,TCGA-CV-5977-01A,TCGA-CV-5977-01A-11D-1683-08,4,0.586534434,TCGA-CV-5977,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-24115,Alive,TUMOR FREE,1840,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1840,0,1840,NA,NA,0,1840,NA,Stage IVA,T3,[Not Available],HNSC.Basal,6
10.15311668,-1.516900912,TCGA-FE-A231-01A,TCGA-FE-A231-01A-11D-A14W-08,1,0.877636585,TCGA-FE-A231,THCA,70,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-25703,Alive,TUMOR FREE,961,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,961,0,961,NA,NA,0,961,NA,Stage IVA,T3,MX,THCA.3,1
-7.888370861,-2.45764036,TCGA-EM-A2OZ-01A,TCGA-EM-A2OZ-01A-11D-A202-08,6,0.558916549,TCGA-EM-A2OZ,THCA,66,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-24195,Alive,TUMOR FREE,1033,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1033,0,1033,0,1033,0,1033,NA,Stage I,T1b,MX,THCA.3,2
-3.50349465,1.60805826,TCGA-60-2703-01A,TCGA-60-2703-01A-11D-2042-08,0,NA,TCGA-60-2703,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-27003,Dead,NA,NA,2945,[Not Available],NA,NA,NA,1757,Complete Remission/Response,1,2945,NA,2945,1,1757,1,1757,NA,Stage IIB,T2,M0,NA,10
-2.737165939,2.026034237,TCGA-CN-6012-01A,TCGA-CN-6012-01A-11D-1683-08,0,NA,TCGA-CN-6012,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-24286,Alive,TUMOR FREE,1460,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1460,0,1460,NA,NA,0,1460,NA,Stage IVA,T3,[Not Available],HNSC.Atypical,6
-1.455791426,3.004285736,TCGA-CN-6997-01A,TCGA-CN-6997-01A-11D-2012-08,0,NA,TCGA-CN-6997,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-24298,Dead,TUMOR FREE,NA,988,[Not Available],NA,Distant Metastasis,LUNG,279,Complete Remission/Response,1,988,0,988,NA,NA,1,279,NA,Stage IVA,T3,[Not Available],HNSC.Classical,10
-1.934875459,1.230638848,TCGA-85-7698-01A,TCGA-85-7698-01A-11D-2122-08,5,0.644083987,TCGA-85-7698,LUSC,48,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-17651,Alive,TUMOR FREE,952,NA,[Not Available],Distant Metastasis,NA,NA,650,Complete Remission/Response,0,952,0,952,1,650,1,650,NA,Stage IA,T1b,M0,NA,4
-6.413288684,-1.594039739,TCGA-CV-7407-01A,TCGA-CV-7407-01A-11D-2078-08,7,0.173516689,TCGA-CV-7407,HNSC,67,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1992,[Not Available],-24475,Dead,NA,NA,1081,[Not Available],NA,NA,NA,NA,[Not Available],1,1081,NA,1081,NA,NA,0,1081,NA,Stage II,T2,[Not Available],HNSC.Atypical,2
7.677870465,-3.377415448,TCGA-CR-5247-01A,TCGA-CR-5247-01A-01D-2012-08,1,0.286400637,TCGA-CR-5247,HNSC,48,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2006,[Not Available],-17810,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,358,0,358,0,358,0,358,NA,[Not Available],TX,[Not Available],HNSC.Classical,1
-3.236090969,-3.393918913,TCGA-CR-7402-01A,TCGA-CR-7402-01A-11D-2012-08,8,0.542143794,TCGA-CR-7402,HNSC,68,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-25138,Alive,TUMOR FREE,911,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,911,0,911,0,911,0,911,NA,[Not Available],TX,[Not Available],HNSC.Atypical,10
-7.381282193,-2.397405709,TCGA-43-6773-01A,TCGA-43-6773-01A-41D-1945-08,6,0.375399911,TCGA-43-6773,LUSC,76,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-28036,Dead,TUMOR FREE,NA,116,[Not Available],NA,NA,NA,NA,[Not Available],1,116,0,116,NA,NA,0,116,NA,Stage IIB,T2,MX,NA,2
9.507407345,-1.942031356,TCGA-19-5953-01B,TCGA-19-5953-01B-12D-1845-08,1,0.747779968,TCGA-19-5953,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-21204,Dead,WITH TUMOR,144,144,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],119,[Not Available],1,144,1,144,NA,NA,1,119,NA,NA,NA,NA,NA,1
-1.820860104,1.070760013,TCGA-D8-A27R-01A,TCGA-D8-A27R-01A-11D-A16D-09,5,0.589384455,TCGA-D8-A27R,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15122,Alive,TUMOR FREE,307,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,307,0,307,0,307,0,307,NA,Stage IIIC,T2,M0,BRCA.LumB,4
2.134414876,1.765819219,TCGA-CG-5732-01A,TCGA-CG-5732-01A-11D-1600-08,3,0.591430789,TCGA-CG-5732,STAD,66,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2003,[Not Available],-24379,Dead,WITH TUMOR,NA,2100,[Not Available],NA,NA,NA,1949,[Discrepancy],1,2100,1,2100,NA,NA,1,1949,NA,Stage IV,T2,M0,GI.CIN,3
8.88241986,-4.968920949,TCGA-FK-A4UB-01A,TCGA-FK-A4UB-01A-11D-A257-08,1,0.840767067,TCGA-FK-A4UB,THCA,51,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-18792,Alive,TUMOR FREE,3531,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3531,0,3531,NA,NA,0,3531,NA,Stage III,T3,MX,THCA.5,1
-0.675454355,2.201393859,TCGA-ZG-A8QW-01A,TCGA-ZG-A8QW-01A-11D-A377-08,0,NA,TCGA-ZG-A8QW,PRAD,72,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-26632,Alive,TUMOR FREE,94,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,94,0,94,NA,NA,0,94,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
-0.685483321,4.267327291,TCGA-D7-A6EV-01A,TCGA-D7-A6EV-01A-11D-A31L-08,4,0.421113828,TCGA-D7-A6EV,STAD,71,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013,[Not Available],-26226,Alive,TUMOR FREE,342,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,342,0,342,0,342,0,342,NA,Stage IIB,T2,M0,GI.CIN,10
9.466641476,-5.529864756,TCGA-ZG-A8QX-01A,TCGA-ZG-A8QX-01A-11D-A377-08,1,0.829542593,TCGA-ZG-A8QX,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20683,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,442,0,442,NA,NA,0,442,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
-1.997367464,2.474835889,TCGA-D7-A6EX-01A,TCGA-D7-A6EX-01A-11D-A31L-08,0,NA,TCGA-D7-A6EX,STAD,72,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013,[Not Available],-26525,Alive,TUMOR FREE,344,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,344,0,344,0,344,0,344,NA,Stage IIIA,T3,M0,GI.CIN,6
8.988431494,-4.882777272,TCGA-A2-A1G6-01A,TCGA-A2-A1G6-01A-11D-A13L-09,1,0.813089649,TCGA-A2-A1G6,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18514,Alive,TUMOR FREE,501,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,501,0,501,0,501,0,501,NA,Stage IIIA,T2,M0,BRCA.Normal,1
7.917766763,-1.364763034,TCGA-ZG-A8QY-01A,TCGA-ZG-A8QY-01A-11D-A377-08,1,0.204369203,TCGA-ZG-A8QY,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24731,Alive,WITH TUMOR,404,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,404,0,404,NA,NA,0,404,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,1
-3.228263559,-3.552185123,TCGA-D7-A6EY-01A,TCGA-D7-A6EY-01A-21D-A31L-08,8,0.492780364,TCGA-D7-A6EY,STAD,72,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013,[Not Available],-26526,Dead,WITH TUMOR,NA,348,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,348,1,348,NA,NA,1,348,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-6.203347597,0.601117209,TCGA-D7-A6EZ-01A,TCGA-D7-A6EZ-01A-11D-A31L-08,0,NA,TCGA-D7-A6EZ,STAD,66,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013,[Not Available],-24425,Dead,WITH TUMOR,NA,618,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,618,1,618,NA,NA,1,618,NA,Stage IIIA,T3,M0,GI.EBV,10
-6.63271412,-1.240225298,TCGA-C8-A133-01A,TCGA-C8-A133-01A-32D-A12B-09,7,0.196801683,TCGA-C8-A133,BRCA,65,FEMALE,WHITE,"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23922,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIIA,T3,M0,BRCA.LumA,2
0.101752879,4.679196005,TCGA-C8-A1HG-01A,TCGA-C8-A1HG-01A-11D-A135-09,4,0.586129095,TCGA-C8-A1HG,BRCA,50,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,345,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,345,0,345,0,345,0,345,NA,Stage IIA,T2,M0,BRCA.LumB,6
-3.705377565,-2.86211884,TCGA-44-5644-01A,TCGA-44-5644-01A-21D-2036-08,8,0.423547592,TCGA-44-5644,LUAD,51,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-18644,Alive,TUMOR FREE,863,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,863,0,863,0,863,0,863,NA,Stage IB,T2a,[Not Available],NA,10
-5.235782017,1.72482459,TCGA-21-1075-01A,TCGA-21-1075-01A-01W-0782-08,0,NA,TCGA-21-1075,LUSC,57,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-21093,Alive,TUMOR FREE,2134,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2134,0,2134,NA,NA,0,2134,NA,Stage IIB,T2,M0,NA,10
8.851729828,-4.974437995,TCGA-YL-A9WI-01A,TCGA-YL-A9WI-01A-11D-A377-08,1,0.839607438,TCGA-YL-A9WI,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-23184,Alive,TUMOR FREE,1623,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1623,0,1623,NA,NA,0,1623,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,3
9.47469235,-5.158337916,TCGA-06-A5U1-01A,TCGA-06-A5U1-01A-11D-A33T-08,1,0.807405772,TCGA-06-A5U1,GBM,78,FEMALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2011,[Not Available],-28545,Dead,WITH TUMOR,NA,57,[Not Available],NA,NA,NA,NA,Progressive Disease,1,57,1,57,NA,NA,1,57,NA,NA,NA,NA,NA,1
-0.230696858,5.081629478,TCGA-YL-A9WK-01A,TCGA-YL-A9WK-01A-11D-A377-08,4,0.632538728,TCGA-YL-A9WK,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23272,Alive,WITH TUMOR,2136,NA,[Not Available],Biochemical evidence of disease,NA,NA,1009,Stable Disease,0,2136,0,2136,NA,NA,1,1009,NA,[Not Applicable],T3b,[Not Applicable],NA,6
8.716809282,-1.886864706,TCGA-06-A6S1-01A,TCGA-06-A6S1-01A-11D-A33T-08,1,0.54742212,TCGA-06-A6S1,GBM,53,FEMALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-19443,Dead,WITH TUMOR,NA,78,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],46,Progressive Disease,1,78,1,78,NA,NA,1,46,NA,NA,NA,NA,NA,1
-6.24242684,-2.110616291,TCGA-56-7579-01A,TCGA-56-7579-01A-11D-2042-08,0,NA,TCGA-56-7579,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-22632,Dead,WITH TUMOR,NA,951,[Not Available],Locoregional Recurrence,NA,NA,149,Progressive Disease,1,951,1,951,NA,NA,1,149,NA,Stage IIIA,T3,M0,NA,2
9.596826408,-1.9354226,TCGA-YL-A9WL-01A,TCGA-YL-A9WL-01A-11D-A41K-08,1,0.774084275,TCGA-YL-A9WL,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21626,Alive,WITH TUMOR,740,NA,[Not Available],Biochemical evidence of disease,NA,NA,740,Complete Remission/Response,0,740,0,740,1,740,1,740,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-0.888190826,3.703778002,TCGA-19-A6J5-01A,TCGA-19-A6J5-01A-21D-A33T-08,4,0.387715985,TCGA-19-A6J5,GBM,40,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-14970,Alive,WITH TUMOR,868,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],784,Stable Disease,0,868,0,868,NA,NA,1,784,NA,NA,NA,NA,NA,5
0.079767313,4.964892036,TCGA-YL-A9WX-01A,TCGA-YL-A9WX-01A-21D-A41K-08,4,0.699006806,TCGA-YL-A9WX,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25008,Alive,WITH TUMOR,1518,NA,[Not Available],Biochemical evidence of disease,NA,NA,1506,Stable Disease,0,1518,0,1518,NA,NA,1,1506,NA,[Not Applicable],T3b,[Not Applicable],NA,6
-4.075469005,-2.179252898,TCGA-CG-4437-01A,TCGA-CG-4437-01A-01D-1800-08,8,0.348913741,TCGA-CG-4437,STAD,83,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006,[Not Available],-30467,Alive,TUMOR FREE,245,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,245,0,245,0,245,0,245,NA,Stage II,T2,M0,GI.HM-SNV,10
-5.445241057,1.657351413,TCGA-BR-7901-01A,TCGA-BR-7901-01A-11D-2201-08,0,NA,TCGA-BR-7901,STAD,74,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-27031,Dead,TUMOR FREE,NA,105,[Not Available],Locoregional Recurrence,NA,NA,91,Complete Remission/Response,1,105,0,105,1,91,1,91,NA,Stage IIB,T3,M0,GI.CIN,9
-3.326892445,-3.301728096,TCGA-CG-5726-01A,TCGA-CG-5726-01A-11D-1600-08,8,0.644845626,TCGA-CG-5726,STAD,73,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2004,[Not Available],-26998,Dead,TUMOR FREE,NA,881,[Not Available],NA,NA,NA,NA,[Not Available],1,881,0,881,NA,NA,0,881,NA,Stage IA,T1,M0,GI.HM-indel,10
9.79614214,-1.672440159,TCGA-DJ-A3UK-01A,TCGA-DJ-A3UK-01A-11D-A22D-08,1,0.875750517,TCGA-DJ-A3UK,THCA,35,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-13145,Alive,TUMOR FREE,1123,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1123,0,1123,0,1123,0,1123,NA,Stage I,T1b,M0,THCA.5,1
9.52163144,-5.668229116,TCGA-FK-A3SE-01A,TCGA-FK-A3SE-01A-11D-A22D-08,1,0.862155268,TCGA-FK-A3SE,THCA,31,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-11472,Alive,TUMOR FREE,670,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,670,0,670,0,670,0,670,NA,Stage I,T2,MX,THCA.3,1
8.654984986,-4.725170814,TCGA-YL-A8SO-01B,TCGA-YL-A8SO-01B-31D-A377-08,1,0.775823249,TCGA-YL-A8SO,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2004,[Not Available],-23584,Alive,NA,3479,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,3479,0,3479,NA,NA,0,3479,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
4.515496031,1.115781406,TCGA-YL-A8SP-01B,TCGA-YL-A8SP-01B-11D-A377-08,2,0.682689838,TCGA-YL-A8SP,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-21455,Alive,WITH TUMOR,2366,NA,[Not Available],Biochemical evidence of disease,NA,NA,2036,Stable Disease,0,2366,0,2366,NA,NA,1,2036,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,5
8.978110764,-4.559308755,TCGA-YL-A8SQ-01B,TCGA-YL-A8SQ-01B-11D-A377-08,1,0.740475509,TCGA-YL-A8SQ,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-22482,Alive,WITH TUMOR,2083,NA,[Not Available],Biochemical evidence of disease,NA,NA,329,Stable Disease,0,2083,0,2083,NA,NA,1,329,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
9.083927258,-1.922155471,TCGA-YL-A8SR-01B,TCGA-YL-A8SR-01B-11D-A377-08,1,0.682614761,TCGA-YL-A8SR,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23488,Alive,NA,273,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,273,0,273,NA,NA,0,273,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
10.07237037,-2.049077867,TCGA-A2-A0SV-01A,TCGA-A2-A0SV-01A-11D-A099-09,1,0.69991679,TCGA-A2-A0SV,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126,Dead,WITH TUMOR,NA,825,[Not Available],NA,NA,NA,NA,[Not Available],1,825,1,825,NA,NA,1,825,NA,Stage IV,T2,M1,BRCA.LumB,1
-4.69915514,0.969288072,TCGA-75-6211-01A,TCGA-75-6211-01A-11D-1753-08,0,NA,TCGA-75-6211,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2009,[Not Available],NA,Dead,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,NA,1,NA,NA,NA,1,NA,NA,Stage IB,T2,M0,LUAD.2,10
-3.774941808,0.323230224,TCGA-95-7944-01A,TCGA-95-7944-01A-11D-2184-08,0,NA,TCGA-95-7944,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26003,Alive,TUMOR FREE,377,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,377,0,377,NA,NA,0,377,NA,Stage IA,T1a,M0,NA,10
-7.816826309,2.076168562,TCGA-63-7023-01A,TCGA-63-7023-01A-11D-1945-08,9,0.502414374,TCGA-63-7023,LUSC,NA,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],NA,Alive,TUMOR FREE,1682,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1682,0,1682,0,1682,0,1682,NA,Stage IIA,T1,M0,NA,7
-7.085476829,2.155705162,TCGA-77-8145-01A,TCGA-77-8145-01A-11D-2244-08,0,NA,TCGA-77-8145,LUSC,73,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2000,[Not Available],-26707,Dead,NA,NA,212,[Not Available],Distant Metastasis,NA,NA,136,[Unknown],1,212,NA,212,NA,NA,1,136,NA,Stage IIIB,T4,M0,NA,9
8.934004877,-4.240457424,TCGA-YL-A8SI-01A,TCGA-YL-A8SI-01A-11D-A41K-08,1,0.750951518,TCGA-YL-A8SI,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-25292,Alive,TUMOR FREE,1614,NA,[Not Available],Biochemical evidence of disease,NA,NA,1423,Complete Remission/Response,0,1614,0,1614,1,1423,1,1423,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-7.378376587,-2.044858646,TCGA-77-A5GA-01A,TCGA-77-A5GA-01A-11D-A27K-08,6,0.076694681,TCGA-77-A5GA,LUSC,76,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-27762,Alive,NA,1280,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1280,0,1280,0,1280,0,1280,NA,Stage IB,T2a,M0,NA,2
-1.250329453,3.270903283,TCGA-94-7033-01A,TCGA-94-7033-01A-11D-1945-08,4,0.086210543,TCGA-94-7033,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26948,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,640,0,640,0,640,0,640,NA,Stage IB,T2,MX,NA,6
-7.030748868,-2.172827254,TCGA-77-A5GF-01A,TCGA-77-A5GF-01A-21D-A27K-08,6,0.255844012,TCGA-77-A5GF,LUSC,70,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25654,Dead,WITH TUMOR,NA,840,[Not Available],Locoregional Recurrence,NA,NA,722,Complete Remission/Response,1,840,1,840,1,722,1,722,NA,Stage IIA,T2a,M0,NA,2
-0.08052543,5.268552284,TCGA-YL-A8SJ-01B,TCGA-YL-A8SJ-01B-11D-A377-08,4,0.638194894,TCGA-YL-A8SJ,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-21916,Alive,WITH TUMOR,1395,NA,[Not Available],Biochemical evidence of disease,NA,NA,752,Complete Remission/Response,0,1395,0,1395,1,752,1,752,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,6
-3.575633494,0.701164145,TCGA-85-A5B5-01A,TCGA-85-A5B5-01A-21D-A26M-08,0,NA,TCGA-85-A5B5,LUSC,58,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-21450,Alive,TUMOR FREE,111,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,111,0,111,0,111,0,111,NA,Stage IA,T1b,M0,NA,10
9.811582463,-4.379490661,TCGA-YL-A8SK-01B,TCGA-YL-A8SK-01B-21D-A377-08,1,0.709175388,TCGA-YL-A8SK,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24759,Alive,NA,1408,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1408,0,1408,NA,NA,0,1408,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
1.327331786,2.311379368,TCGA-90-A59Q-01A,TCGA-90-A59Q-01A-11D-A26M-08,0,NA,TCGA-90-A59Q,LUSC,61,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-22420,Dead,WITH TUMOR,NA,322,[Not Available],Distant Metastasis,NA,NA,274,Complete Remission/Response,1,322,1,322,1,274,1,274,NA,Stage IIA,T2a,MX,NA,3
-4.798482828,-1.293513039,TCGA-94-A4VJ-01A,TCGA-94-A4VJ-01A-11D-A257-08,8,0.243457718,TCGA-94-A4VJ,LUSC,71,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25991,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,430,0,430,0,430,0,430,NA,Stage IA,T1b,M0,NA,10
-7.621053632,2.169119289,TCGA-YL-A8SL-01B,TCGA-YL-A8SL-01B-21D-A377-08,9,0.373925759,TCGA-YL-A8SL,PRAD,74,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-27033,Alive,TUMOR FREE,987,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,987,0,987,0,987,0,987,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,7
-3.287496086,-3.387157005,TCGA-AG-A02N-01A,TCGA-AG-A02N-01A-11W-A096-10,8,0.636698068,TCGA-AG-A02N,READ,67,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2005,[Not Available],-24687,Alive,WITH TUMOR,1885,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1885,0,1885,NA,NA,0,1885,NA,Stage II,T3,M0,GI.HM-indel,10
9.005446903,-3.473639585,TCGA-06-0145-01A,TCGA-06-0145-01A-01D-0507-08,1,0.716526928,TCGA-06-0145,GBM,53,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-19661,Dead,WITH TUMOR,71,71,[Not Available],NA,NA,NA,NA,[Not Available],1,71,1,71,NA,NA,1,71,NA,NA,NA,NA,NA,1
-6.179141912,1.501590165,TCGA-D7-5578-01A,TCGA-D7-5578-01A-01D-1600-08,10,0.237182429,TCGA-D7-5578,STAD,80,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2010,[Not Available],-29390,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,NA,NA,0,385,NA,Stage IIIA,T3,M0,GI.CIN,9
9.704456529,-2.912797255,TCGA-EM-A1CW-01A,TCGA-EM-A1CW-01A-21D-A13W-08,1,0.721469875,TCGA-EM-A1CW,THCA,39,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-14263,Alive,TUMOR FREE,549,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,549,0,549,0,549,0,549,NA,Stage I,T3,MX,THCA.1,1
-8.000505976,2.084651906,TCGA-A2-A0EM-01A,TCGA-A2-A0EM-01A-11W-A050-09,9,0.610506832,TCGA-A2-A0EM,BRCA,73,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26845,Alive,TUMOR FREE,3094,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3094,0,3094,0,3094,0,3094,NA,Stage IA,T1,M0,BRCA.LumA,7
-1.819579607,1.039801676,TCGA-EM-A1CT-01A,TCGA-EM-A1CT-01A-11D-A13W-08,5,0.611592583,TCGA-EM-A1CT,THCA,76,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-27944,Alive,TUMOR FREE,553,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,553,0,553,NA,NA,0,553,NA,Stage IVA,T1b,MX,THCA.3,4
-7.695839895,2.011183623,TCGA-DQ-5630-01A,TCGA-DQ-5630-01A-01D-1870-08,9,0.554321583,TCGA-DQ-5630,HNSC,73,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-26855,Alive,TUMOR FREE,1030,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1030,0,1030,0,1030,0,1030,NA,[Not Available],TX,[Not Available],HNSC.Mesenchymal,7
0.936734007,3.572575538,TCGA-YL-A8SB-01A,TCGA-YL-A8SB-01A-31D-A377-08,4,0.041466873,TCGA-YL-A8SB,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-22991,Alive,WITH TUMOR,1719,NA,[Not Available],Biochemical evidence of disease,NA,NA,1384,Stable Disease,0,1719,0,1719,NA,NA,1,1384,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,3
9.159129852,-5.442936331,TCGA-YL-A8SF-01A,TCGA-YL-A8SF-01A-11D-A377-08,1,0.842972119,TCGA-YL-A8SF,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-22844,Alive,NA,1373,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1373,0,1373,NA,NA,0,1373,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-6.329156045,1.714766493,TCGA-B6-A0IK-01A,TCGA-B6-A0IK-01A-12W-A071-09,10,0.049220654,TCGA-B6-A0IK,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1994,Indeterminate (neither Pre or Postmenopausal),-23150,Dead,WITH TUMOR,NA,571,[Not Available],Distant Metastasis,Brain,NA,489,[Not Available],1,571,1,571,1,489,1,489,NA,Stage IIIB,T4,M0,BRCA.Her2,9
8.942209568,-2.152512575,TCGA-YL-A8SH-01B,TCGA-YL-A8SH-01B-11D-A377-08,1,0.65286219,TCGA-YL-A8SH,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25395,Dead,TUMOR FREE,NA,875,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,875,0,875,0,875,0,875,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
-6.187800263,-1.402657261,TCGA-AY-A69D-01A,TCGA-AY-A69D-01A-11D-A36X-10,7,0.155540899,TCGA-AY-A69D,COAD,55,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2012,[Not Available],-20299,Alive,TUMOR FREE,543,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,543,0,543,0,543,0,543,NA,Stage IIA,T3,M0,GI.CIN,2
-1.297887426,3.634337119,TCGA-63-7022-01A,TCGA-63-7022-01A-11D-1945-08,4,0.182613828,TCGA-63-7022,LUSC,NA,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],NA,Alive,TUMOR FREE,2073,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2073,0,2073,0,2073,0,2073,NA,Stage IA,T1,M0,NA,6
-3.626016208,0.906863699,TCGA-34-2605-01A,TCGA-34-2605-01A-01D-1522-08,0,NA,TCGA-34-2605,LUSC,76,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-27833,Dead,WITH TUMOR,881,881,[Not Available],NA,NA,NA,394,Complete Remission/Response,1,881,1,881,1,394,1,394,NA,Stage IIIB,T4,M0,NA,10
-1.721376128,2.099555685,TCGA-56-1622-01A,TCGA-56-1622-01A-01D-1521-08,0,NA,TCGA-56-1622,LUSC,58,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-21371,Dead,WITH TUMOR,NA,881,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,881,1,881,NA,NA,1,881,NA,Stage IB,T2,M0,LUSC.primitive,3
-1.523241608,2.874883105,TCGA-77-7142-01A,TCGA-77-7142-01A-11D-2042-08,0,NA,TCGA-77-7142,LUSC,59,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-21796,Alive,TUMOR FREE,2227,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2227,0,2227,NA,NA,0,2227,NA,Stage IB,T2,M0,NA,10
-4.205970919,-2.161547091,TCGA-21-1082-01A,TCGA-21-1082-01A-01D-1521-08,8,0.412924464,TCGA-21-1082,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1997,[Not Available],-22492,Alive,TUMOR FREE,3644,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3644,0,3644,NA,NA,0,3644,NA,Stage IB,T2,M0,NA,10
-6.793817321,2.294800568,TCGA-95-7948-01A,TCGA-95-7948-01A-11D-2184-08,0,NA,TCGA-95-7948,LUAD,42,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-15363,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,476,0,476,0,476,0,476,NA,Stage IB,T2a,M0,LUAD.3,9
-6.630202492,-2.213931272,TCGA-77-8128-01A,TCGA-77-8128-01A-11D-2244-08,0,NA,TCGA-77-8128,LUSC,60,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],1999,[Not Available],-21986,Dead,NA,NA,1150,[Not Available],NA,NA,NA,NA,[Not Applicable],1,1150,NA,1150,NA,NA,0,1150,NA,Stage IIIA,T2,M0,NA,2
-6.835319206,-2.362252444,TCGA-37-4133-01A,TCGA-37-4133-01A-01D-1352-08,6,0.230781349,TCGA-37-4133,LUSC,63,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-23083,Alive,TUMOR FREE,238,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,238,0,238,NA,NA,0,238,NA,Stage IIIA,T4,M0,LUSC.classical,2
9.073857803,-4.557266911,TCGA-YL-A8S8-01A,TCGA-YL-A8S8-01A-11D-A377-08,1,0.809900835,TCGA-YL-A8S8,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-25119,Alive,WITH TUMOR,1890,NA,[Not Available],Biochemical evidence of disease,NA,NA,679,Stable Disease,0,1890,0,1890,NA,NA,1,679,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
-4.196462538,-2.125028775,TCGA-22-5473-01A,TCGA-22-5473-01A-01D-1632-08,8,0.297164954,TCGA-22-5473,LUSC,78,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-28826,Dead,TUMOR FREE,NA,1933,[Not Available],NA,NA,NA,1655,Complete Remission/Response,1,1933,0,1933,1,1655,1,1655,NA,[Discrepancy],T3,M0,LUSC.classical,10
-4.371359378,-1.999970931,TCGA-22-4613-01A,TCGA-22-4613-01A-01D-1441-08,8,0.459290967,TCGA-22-4613,LUSC,73,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-26722,Dead,NA,358,358,[Not Available],NA,NA,NA,NA,[Not Available],1,358,NA,358,NA,NA,0,358,NA,Stage IA,T1b,M0,LUSC.classical,10
9.520320953,-4.630574672,TCGA-YL-A8SA-01A,TCGA-YL-A8SA-01A-21D-A377-08,1,0.825966704,TCGA-YL-A8SA,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25340,Alive,NA,512,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,512,0,512,NA,NA,0,512,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-3.1787729,-3.606072269,TCGA-60-2698-01A,TCGA-60-2698-01A-01D-1522-08,8,0.546154323,TCGA-60-2698,LUSC,62,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1993,[Not Available],-22800,Dead,WITH TUMOR,NA,311,[Not Available],NA,NA,NA,114,[Not Available],1,311,1,311,NA,NA,1,114,NA,Stage IIB,T2,M0,LUSC.secretory,10
9.320119091,-2.676104696,TCGA-BR-A4J6-01A,TCGA-BR-A4J6-01A-11D-A25D-08,1,0.741672589,TCGA-BR-A4J6,STAD,69,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-25279,Alive,TUMOR FREE,20,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,20,0,20,0,20,0,20,NA,Stage IIA,T3,M0,GI.CIN,1
9.018459235,-5.301843224,TCGA-ET-A40S-01A,TCGA-ET-A40S-01A-11D-A23M-08,1,0.835025239,TCGA-ET-A40S,THCA,62,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-22733,Alive,TUMOR FREE,1223,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1223,0,1223,NA,NA,0,1223,NA,Stage II,T2,MX,THCA.2,1
9.912387831,-1.669515132,TCGA-E8-A434-01A,TCGA-E8-A434-01A-11D-A23M-08,1,0.8687312,TCGA-E8-A434,THCA,56,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-20492,Alive,TUMOR FREE,953,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,953,0,953,0,953,0,953,NA,Stage I,T1a,M0,THCA.2,1
0.461165834,2.25496795,TCGA-12-3653-01A,TCGA-12-3653-01A-01D-1495-08,0,NA,TCGA-12-3653,GBM,34,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-12529,Dead,WITH TUMOR,357,442,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],224,[Not Available],1,442,1,442,NA,NA,1,224,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
10.00558493,-1.570532923,TCGA-FE-A235-01A,TCGA-FE-A235-01A-11D-A16O-08,1,0.862460062,TCGA-FE-A235,THCA,26,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-9859,Alive,TUMOR FREE,3571,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3571,0,3571,0,3571,0,3571,NA,Stage I,T2,MX,THCA.5,1
10.05096019,-1.921886936,TCGA-J8-A42S-01A,TCGA-J8-A42S-01A-11D-A23M-08,1,0.802276565,TCGA-J8-A42S,THCA,45,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-16609,Alive,NA,75,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,75,0,75,0,75,0,75,NA,Stage III,T1b,MX,THCA.2,1
9.085918617,-5.386610579,TCGA-XK-AAJT-01A,TCGA-XK-AAJT-01A-11D-A41K-08,1,0.828163778,TCGA-XK-AAJT,PRAD,75,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-27428,Alive,TUMOR FREE,1434,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1434,0,1434,NA,NA,0,1434,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.528623126,-5.646538174,TCGA-XK-AAJU-01A,TCGA-XK-AAJU-01A-11D-A41K-08,1,0.877057128,TCGA-XK-AAJU,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-23958,Alive,TUMOR FREE,1576,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1576,0,1576,0,1576,0,1576,NA,[Not Applicable],T2c,[Not Applicable],NA,1
8.125439711,-2.449425246,TCGA-YL-A8HJ-01A,TCGA-YL-A8HJ-01A-11D-A364-08,1,0.473127929,TCGA-YL-A8HJ,PRAD,58,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2009,[Not Available],-21416,Alive,TUMOR FREE,1611,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1611,0,1611,0,1611,0,1611,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
0.476284035,3.790265014,TCGA-YL-A8HK-01A,TCGA-YL-A8HK-01A-11D-A364-08,4,0.150373532,TCGA-YL-A8HK,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-21850,Alive,WITH TUMOR,1491,NA,[Not Available],Biochemical evidence of disease,NA,NA,1376,Complete Remission/Response,0,1491,0,1491,1,1376,1,1376,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,3
-0.203750236,4.786737712,TCGA-YL-A8HL-01A,TCGA-YL-A8HL-01A-11D-A364-08,4,0.621234612,TCGA-YL-A8HL,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-21249,Alive,NA,1565,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1565,0,1565,NA,NA,0,1565,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,6
-1.907798678,1.105176497,TCGA-60-2715-01A,TCGA-60-2715-01A-01D-1522-08,5,0.597960601,TCGA-60-2715,LUSC,51,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-18990,Dead,WITH TUMOR,NA,1075,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1075,1,1075,NA,NA,1,1075,NA,Stage IA,T1,M0,NA,4
-5.114400711,1.764743498,TCGA-55-7728-01A,TCGA-55-7728-01A-11D-2184-08,0,NA,TCGA-55-7728,LUAD,64,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23505,Alive,TUMOR FREE,704,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,704,0,704,0,704,0,704,NA,Stage IB,T2a,MX,LUAD.6,9
8.726292377,-4.390545478,TCGA-68-7756-01A,TCGA-68-7756-01A-11D-2122-08,1,0.752952092,TCGA-68-7756,LUSC,84,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-30763,Alive,NA,202,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,202,0,202,NA,NA,0,202,NA,Stage IIIA,T4,MX,NA,1
-1.972797488,2.73335975,TCGA-60-2713-01A,TCGA-60-2713-01A-01D-1522-08,0,NA,TCGA-60-2713,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-23630,Alive,NA,1731,NA,[Not Available],NA,NA,NA,1356,Complete Remission/Response,0,1731,0,1731,1,1356,1,1356,NA,Stage IB,T2,M0,LUSC.primitive,10
8.353376316,-3.185140899,TCGA-XK-AAJP-01A,TCGA-XK-AAJP-01A-11D-A41K-08,1,0.601193184,TCGA-XK-AAJP,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24320,Alive,TUMOR FREE,1259,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1259,0,1259,0,1259,0,1259,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-3.915116154,-2.32360787,TCGA-51-6867-01A,TCGA-51-6867-01A-11D-2042-08,8,0.396006985,TCGA-51-6867,LUSC,72,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-26523,Dead,WITH TUMOR,NA,1856,[Not Available],NA,NA,NA,788,Complete Remission/Response,1,1856,1,1856,1,788,1,788,NA,Stage I,T1,M0,NA,10
-4.42950354,-1.089124544,TCGA-66-2727-01A,TCGA-66-2727-01A-01D-0983-08,0,NA,TCGA-66-2727,LUSC,55,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-20150,Dead,NA,NA,516,[Not Available],NA,NA,NA,NA,[Not Available],1,516,NA,516,NA,NA,0,516,NA,Stage IB,T2,M0,LUSC.classical,10
9.805458949,-4.564629191,TCGA-XK-AAJR-01A,TCGA-XK-AAJR-01A-11D-A41K-08,1,0.678428102,TCGA-XK-AAJR,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22643,Alive,TUMOR FREE,1124,NA,[Not Available],Biochemical evidence of disease,NA,NA,131,Complete Remission/Response,0,1124,0,1124,1,131,1,131,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-3.772661927,-2.395998131,TCGA-37-5819-01A,TCGA-37-5819-01A-01D-1632-08,8,0.422944522,TCGA-37-5819,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-23726,Alive,TUMOR FREE,103,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,103,0,103,NA,NA,0,103,NA,Stage IIIA,T2,M0,LUSC.primitive,10
9.194291244,-3.05361952,TCGA-BR-A4J2-01A,TCGA-BR-A4J2-01A-21D-A25D-08,1,0.721403546,TCGA-BR-A4J2,STAD,70,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-25891,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,431,0,431,0,431,0,431,NA,Stage IIB,T4a,M0,GI.GS,1
-7.6769348,2.177075595,TCGA-BR-4253-01A,TCGA-BR-4253-01A-01D-1126-08,9,0.388302141,TCGA-BR-4253,STAD,80,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-29397,Dead,NA,NA,124,[Not Available],NA,NA,NA,NA,[Not Available],1,124,NA,124,NA,NA,0,124,NA,Stage IIIA,T3,M0,GI.EBV,7
9.914227406,-1.744113292,TCGA-DJ-A2PN-01A,TCGA-DJ-A2PN-01A-21D-A19J-08,1,0.849566758,TCGA-DJ-A2PN,THCA,70,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-25690,Alive,TUMOR FREE,307,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,307,0,307,0,307,0,307,NA,Stage I,T1b,M0,THCA.3,1
8.621605162,-1.819463271,TCGA-27-1831-01A,TCGA-27-1831-01A-01D-1494-08,1,0.552324899,TCGA-27-1831,GBM,66,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-24447,Dead,WITH TUMOR,505,505,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],144,[Not Available],1,505,1,505,NA,NA,1,144,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.965476252,-1.623152551,TCGA-KS-A41J-01A,TCGA-KS-A41J-01A-11D-A23M-08,1,0.871979431,TCGA-KS-A41J,THCA,28,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000,[Not Available],-10411,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,477,0,477,0,477,0,477,NA,Stage I,T2,M0,THCA.3,1
-6.018238816,2.261515141,TCGA-CV-6938-01A,TCGA-CV-6938-01A-11D-1912-08,0,NA,TCGA-CV-6938,HNSC,87,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,1996,[Not Available],-31825,Dead,TUMOR FREE,NA,144,[Not Available],NA,NA,NA,NA,[Not Available],1,144,0,144,NA,NA,0,144,NA,Stage II,T2,[Not Available],HNSC.Basal,9
9.431469677,-5.707011046,TCGA-DJ-A3V3-01A,TCGA-DJ-A3V3-01A-11D-A22Z-08,1,0.878907125,TCGA-DJ-A3V3,THCA,57,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-20997,Alive,TUMOR FREE,931,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,931,0,931,0,931,0,931,NA,Stage II,T2,M0,THCA.2,1
-0.523876191,4.632710824,TCGA-27-1836-01A,TCGA-27-1836-01A-01D-1494-08,4,0.567102489,TCGA-27-1836,GBM,33,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-12060,Dead,WITH TUMOR,NA,914,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],172,[Not Available],1,914,1,914,NA,NA,1,172,NA,NA,NA,NA,NA,6
7.843429811,-1.350747044,TCGA-DJ-A2Q5-01A,TCGA-DJ-A2Q5-01A-11D-A18F-08,1,0.185142747,TCGA-DJ-A2Q5,THCA,51,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-18727,Alive,TUMOR FREE,1140,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1140,0,1140,NA,NA,0,1140,NA,Stage IVA,T2,M0,THCA.2,1
9.161323028,-5.065212417,TCGA-XK-AAIR-01A,TCGA-XK-AAIR-01A-11D-A41K-08,1,0.81613009,TCGA-XK-AAIR,PRAD,75,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-27703,Alive,TUMOR FREE,972,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,972,0,972,0,972,0,972,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-7.863090129,2.193640167,TCGA-E2-A154-01A,TCGA-E2-A154-01A-11D-A10Y-09,9,0.621039144,TCGA-E2-A154,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24999,Alive,TUMOR FREE,591,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,591,0,591,0,591,0,591,NA,Stage I,T1c,M0,BRCA.LumA,7
1.828486241,2.015679597,TCGA-CN-4728-01A,TCGA-CN-4728-01A-01D-1434-08,3,0.205743967,TCGA-CN-4728,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-20660,Alive,TUMOR FREE,1724,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1724,0,1724,NA,NA,0,1724,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,3
4.319758199,1.153211281,TCGA-XK-AAIV-01A,TCGA-XK-AAIV-01A-11D-A41K-08,2,0.645239664,TCGA-XK-AAIV,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23325,Alive,TUMOR FREE,1133,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1133,0,1133,0,1133,0,1133,NA,[Not Applicable],T3b,[Not Applicable],NA,5
-2.761315728,-4.309388378,TCGA-XK-AAIW-01A,TCGA-XK-AAIW-01A-11D-A41K-08,0,NA,TCGA-XK-AAIW,PRAD,78,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-28721,Alive,TUMOR FREE,1218,NA,[Not Available],New Primary Tumor,NA,NA,427,Complete Remission/Response,0,1218,0,1218,0,1218,1,427,NA,[Not Applicable],T3b,[Not Applicable],NA,10
-7.297229141,1.497043155,TCGA-XK-AAJ3-01A,TCGA-XK-AAJ3-01A-11D-A41K-08,0,NA,TCGA-XK-AAJ3,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20604,Alive,TUMOR FREE,1262,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1262,0,1262,0,1262,0,1262,NA,[Not Applicable],T3a,[Not Applicable],NA,7
9.316171976,-2.830799968,TCGA-XK-AAJA-01A,TCGA-XK-AAJA-01A-11D-A41K-08,1,0.732421886,TCGA-XK-AAJA,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-22771,Alive,NA,930,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,930,0,930,0,930,0,930,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-5.875032846,1.457414587,TCGA-43-8115-01A,TCGA-43-8115-01A-11D-2244-08,0,NA,TCGA-43-8115,LUSC,72,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26406,Alive,TUMOR FREE,407,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,407,0,407,NA,NA,0,407,NA,Stage IIA,T2a,MX,NA,9
-1.144802021,4.530119885,TCGA-51-4080-01A,TCGA-51-4080-01A-01D-1458-08,4,0.276352375,TCGA-51-4080,LUSC,65,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-24054,Dead,TUMOR FREE,NA,12,[Not Available],NA,NA,NA,NA,[Not Available],1,12,0,12,NA,NA,0,12,NA,Stage IIIB,T4,[Not Available],LUSC.classical,6
-7.115081229,-2.214841908,TCGA-39-5028-01A,TCGA-39-5028-01A-01D-1441-08,6,0.329120891,TCGA-39-5028,LUSC,75,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-27707,Dead,NA,52,52,[Not Available],NA,NA,NA,NA,[Not Available],1,52,NA,52,NA,NA,0,52,NA,Stage IIIA,T4,M0,LUSC.basal,2
2.113854571,1.823623235,TCGA-BH-A0HW-01A,TCGA-BH-A0HW-01A-11W-A050-09,3,0.513365959,TCGA-BH-A0HW,BRCA,62,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22962,Alive,TUMOR FREE,1561,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1561,0,1561,0,1561,0,1561,NA,Stage IA,T1c,M0,BRCA.LumB,3
3.423077015,1.536691351,TCGA-43-6771-01A,TCGA-43-6771-01A-11D-1817-08,0,NA,TCGA-43-6771,LUSC,85,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-31052,Dead,WITH TUMOR,NA,166,[Not Available],NA,NA,NA,154,Progressive Disease,1,166,1,166,NA,NA,1,154,NA,Stage IB,T2,MX,LUSC.basal,6
-4.178636335,-2.022975572,TCGA-93-8067-01A,TCGA-93-8067-01A-11D-2284-08,8,0.415057649,TCGA-93-8067,LUAD,77,MALE,ASIAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-28453,Alive,TUMOR FREE,186,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,186,0,186,0,186,0,186,NA,Stage IB,T2a,MX,NA,10
-2.891403606,-4.114043976,TCGA-18-3409-01A,TCGA-18-3409-01A-01D-0983-08,8,0.012255246,TCGA-18-3409,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-27154,Alive,TUMOR FREE,3747,NA,[Not Available],New Primary Tumor,NA,NA,2291,Complete Remission/Response,0,3747,0,3747,0,3747,1,2291,NA,Stage IA,T1,M0,NA,10
9.204342674,-5.542716571,TCGA-XJ-A9DQ-01A,TCGA-XJ-A9DQ-01A-11D-A377-08,1,0.847637721,TCGA-XJ-A9DQ,PRAD,48,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],NA,Alive,NA,91,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,91,0,91,NA,NA,0,91,NA,[Not Applicable],T2a,[Not Applicable],NA,1
-3.359848866,-3.399619305,TCGA-CG-4460-01A,TCGA-CG-4460-01A-01D-1158-08,8,0.546886579,TCGA-CG-4460,STAD,66,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-24229,Dead,WITH TUMOR,NA,669,[Not Available],NA,NA,NA,487,Partial Remission/Response,1,669,1,669,NA,NA,1,487,NA,Stage IV,T4,M1,NA,10
-0.966937258,2.281339949,TCGA-77-8008-01A,TCGA-77-8008-01A-21D-2184-08,4,0.045874499,TCGA-77-8008,LUSC,68,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-24948,Dead,NA,NA,2639,[Not Available],NA,NA,NA,NA,[Not Available],1,2639,NA,2639,NA,NA,0,2639,NA,Stage IB,T2,M0,NA,3
9.094283872,-2.989140789,TCGA-XJ-A9DX-01A,TCGA-XJ-A9DX-01A-11D-A377-08,1,0.726811717,TCGA-XJ-A9DX,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],NA,Alive,TUMOR FREE,973,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,973,0,973,NA,NA,0,973,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-5.983100688,1.372204562,TCGA-60-2721-01A,TCGA-60-2721-01A-01D-1522-08,10,0.089970152,TCGA-60-2721,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-27007,Alive,TUMOR FREE,983,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,983,0,983,0,983,0,983,NA,Stage IB,T2,M0,LUSC.basal,9
-0.437381826,2.998944616,TCGA-34-7107-01A,TCGA-34-7107-01A-11D-1945-08,0,NA,TCGA-34-7107,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25677,Dead,NA,NA,34,[Not Available],NA,NA,NA,NA,[Not Available],1,34,NA,34,NA,NA,0,34,NA,Stage II,T2a,M0,NA,3
-1.114758017,3.685162531,TCGA-D7-6822-01A,TCGA-D7-6822-01A-11D-1882-08,4,0.28811581,TCGA-D7-6822,STAD,77,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-28214,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,375,0,375,0,375,0,375,NA,Stage IB,T2,M0,GI.CIN,6
-0.264166454,4.049410602,TCGA-CN-6016-01A,TCGA-CN-6016-01A-11D-1683-08,4,0.472201402,TCGA-CN-6016,HNSC,64,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-23664,Alive,TUMOR FREE,1443,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1443,0,1443,NA,NA,0,1443,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,6
9.131845253,-5.550743999,TCGA-EL-A3T0-01A,TCGA-EL-A3T0-01A-22D-A22D-08,1,0.843429949,TCGA-EL-A3T0,THCA,45,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2001,[Not Available],-16798,Alive,TUMOR FREE,4335,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4335,0,4335,0,4335,0,4335,NA,Stage III,T3,M0,THCA.2,1
9.479372469,-5.519732716,TCGA-DJ-A3UV-01A,TCGA-DJ-A3UV-01A-11D-A22D-08,1,0.832658225,TCGA-DJ-A3UV,THCA,18,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-6850,Alive,TUMOR FREE,1466,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1466,0,1466,0,1466,0,1466,NA,Stage I,T1,M0,NA,1
-0.179120956,4.462033758,TCGA-32-1970-01A,TCGA-32-1970-01A-01D-1494-08,4,0.465764236,TCGA-32-1970,GBM,59,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-21613,Dead,WITH TUMOR,468,468,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],408,[Not Available],1,468,1,468,NA,NA,1,408,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-4.523317571,1.439971971,TCGA-CN-4739-01A,TCGA-CN-4739-01A-02D-1512-08,0,NA,TCGA-CN-4739,HNSC,71,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-26081,Dead,WITH TUMOR,NA,1394,[Not Available],Locoregional Recurrence,Oropharynx,"OROPHARYNX, OVERLAPPING",1302,Complete Remission/Response,1,1394,1,1394,NA,NA,1,1302,NA,Stage IVA,T4a,M0,HNSC.Atypical,9
9.251454291,-4.747131864,TCGA-EM-A1CS-01A,TCGA-EM-A1CS-01A-11D-A13W-08,1,0.793160713,TCGA-EM-A1CS,THCA,55,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-20284,Alive,TUMOR FREE,817,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,817,0,817,0,817,0,817,NA,Stage I,T1,MX,THCA.5,1
-2.526472609,1.256215843,TCGA-98-7454-01A,TCGA-98-7454-01A-11D-2042-08,5,0.321192632,TCGA-98-7454,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26827,Alive,TUMOR FREE,652,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,652,0,652,0,652,0,652,NA,Stage IB,T2a,M0,NA,4
-3.881599947,-2.396520707,TCGA-77-7141-01A,TCGA-77-7141-01A-11D-2042-08,8,0.371803892,TCGA-77-7141,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-23584,Alive,NA,15,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,15,0,15,NA,NA,0,15,NA,Stage IB,T2,M0,NA,10
-3.024842708,2.068479366,TCGA-66-2792-01A,TCGA-66-2792-01A-01D-0983-08,0,NA,TCGA-66-2792,LUSC,58,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-21428,Alive,TUMOR FREE,913,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,913,0,913,0,913,0,913,NA,Stage IIB,T2,M0,LUSC.classical,6
-5.813577953,1.388622391,TCGA-66-2783-01A,TCGA-66-2783-01A-01D-1267-08,0,NA,TCGA-66-2783,LUSC,67,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-24686,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,759,0,759,0,759,0,759,NA,Stage IIIB,T2,M0,LUSC.classical,9
-5.242835746,1.639055149,TCGA-44-6145-01A,TCGA-44-6145-01A-11D-1753-08,0,NA,TCGA-44-6145,LUAD,62,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22745,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,595,0,595,0,595,0,595,NA,Stage IA,T1,M0,LUAD.6,9
-5.277019849,-1.312025432,TCGA-18-3407-01A,TCGA-18-3407-01A-01D-0983-08,0,NA,TCGA-18-3407,LUSC,72,MALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-26615,Dead,TUMOR FREE,NA,136,[Not Available],NA,NA,NA,NA,[Not Applicable],1,136,0,136,NA,NA,0,136,NA,Stage IB,T2,M0,LUSC.classical,10
-1.14126965,3.077902452,TCGA-77-7140-01A,TCGA-77-7140-01A-41D-2042-08,0,NA,TCGA-77-7140,LUSC,69,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-25303,Dead,NA,NA,632,[Not Available],NA,NA,NA,250,[Not Available],1,632,NA,632,NA,NA,1,250,NA,Stage IIB,T2,M0,NA,10
-0.893407448,4.678092357,TCGA-CG-4449-01A,TCGA-CG-4449-01A-01D-1158-08,4,0.422984803,TCGA-CG-4449,STAD,81,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007,[Not Available],-29705,Alive,WITH TUMOR,580,NA,[Not Available],NA,NA,NA,336,Partial Remission/Response,0,580,0,580,NA,NA,1,336,NA,Stage II,T2,M0,GI.CIN,6
-4.507954111,-1.622113667,TCGA-18-3410-01A,TCGA-18-3410-01A-01D-0983-08,8,0.449813662,TCGA-18-3410,LUSC,81,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-29827,Dead,TUMOR FREE,NA,146,[Not Available],NA,NA,NA,NA,[Not Applicable],1,146,0,146,NA,NA,0,146,NA,Stage IIB,T3,M0,LUSC.secretory,10
-5.060378735,2.279575331,TCGA-22-5482-01A,TCGA-22-5482-01A-01D-1632-08,12,0.238541782,TCGA-22-5482,LUSC,81,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-29657,Dead,TUMOR FREE,357,357,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,357,0,357,0,357,0,357,NA,Stage IB,T2a,M0,LUSC.classical,6
0.756719622,3.596586087,TCGA-77-8148-01A,TCGA-77-8148-01A-11D-2244-08,0,NA,TCGA-77-8148,LUSC,68,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-24918,Alive,NA,2023,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2023,0,2023,0,2023,0,2023,NA,Stage IIIA,T3,M0,NA,10
9.898660058,-1.808538784,TCGA-FY-A3YR-01A,TCGA-FY-A3YR-01A-11D-A22Z-08,1,0.842684168,TCGA-FY-A3YR,THCA,64,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-23395,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,528,0,528,0,528,0,528,NA,Stage III,T3,MX,THCA.4,1
-6.085397059,1.709076127,TCGA-CD-5800-01A,TCGA-CD-5800-01A-11D-1600-08,10,0.046857414,TCGA-CD-5800,STAD,51,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G1,2010,[Not Available],NA,Alive,TUMOR FREE,400,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,400,0,400,0,400,0,400,NA,Stage II,T3,M0,GI.CIN,9
-1.169658955,4.15184586,TCGA-06-0876-01A,TCGA-06-0876-01A-01D-1492-08,4,0.405535111,TCGA-06-0876,GBM,72,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-26372,Alive,WITH TUMOR,1405,NA,[Not Available],NA,[Not Applicable],[Not Applicable],424,[Not Available],0,1405,0,1405,NA,NA,1,424,NA,NA,NA,NA,NA,6
-5.174694969,1.545410903,TCGA-BA-4075-01A,TCGA-BA-4075-01A-01D-1434-08,0,NA,TCGA-BA-4075,HNSC,49,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2004,[Not Available],-17951,Dead,WITH TUMOR,NA,283,[Not Available],NA,Oral Cavity,NA,236,Progressive Disease,1,283,1,283,NA,NA,1,236,NA,Stage III,T3,M0,NA,10
10.0409761,-1.54357936,TCGA-ET-A39M-01A,TCGA-ET-A39M-01A-11D-A19J-08,1,0.874607824,TCGA-ET-A39M,THCA,34,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-12441,Alive,TUMOR FREE,2582,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2582,0,2582,0,2582,0,2582,NA,Stage I,T2,MX,THCA.5,1
-6.220950208,1.148420736,TCGA-CV-7422-01A,TCGA-CV-7422-01A-21D-2078-08,10,0.058779816,TCGA-CV-7422,HNSC,60,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,1997,[Not Available],-22098,Dead,WITH TUMOR,NA,1037,[Not Available],Locoregional Recurrence,Larynx,tracheal,733,Complete Remission/Response,1,1037,1,1037,NA,NA,1,733,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,9
8.243058048,-3.953873782,TCGA-AR-A0TW-01A,TCGA-AR-A0TW-01A-11D-A099-09,1,0.542976797,TCGA-AR-A0TW,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18263,Alive,TUMOR FREE,3009,NA,[Not Available],NA,NA,NA,739,[Not Available],0,3009,0,3009,1,739,1,739,NA,Stage IIIA,T3,M0,BRCA.LumA,1
-6.431867842,1.622477149,TCGA-C8-A26W-01A,TCGA-C8-A26W-01A-11D-A16D-09,10,0.347518833,TCGA-C8-A26W,BRCA,58,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21391,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,381,0,381,0,381,0,381,NA,Stage IIB,T2,M0,BRCA.LumB,7
-3.493844428,0.600842263,TCGA-22-5491-01A,TCGA-22-5491-01A-01D-1632-08,0,NA,TCGA-22-5491,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-27145,Dead,NA,1713,1713,[Not Available],NA,NA,NA,NA,[Not Available],1,1713,NA,1713,NA,NA,0,1713,NA,Stage IA,T1a,M0,LUSC.classical,10
8.78864858,-3.837249701,TCGA-BR-7959-01A,TCGA-BR-7959-01A-11D-2340-08,1,0.702069964,TCGA-BR-7959,STAD,59,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2011,[Not Available],-21730,Alive,TUMOR FREE,1010,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1010,0,1010,0,1010,0,1010,NA,Stage IIIA,T4a,M0,GI.CIN,1
-0.359454021,4.213463918,TCGA-77-7338-01A,TCGA-77-7338-01A-11D-2042-08,4,0.43294618,TCGA-77-7338,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1995,[Not Available],-23480,Dead,NA,NA,5,[Not Available],NA,NA,NA,NA,[Not Available],1,5,NA,5,NA,NA,0,5,NA,Stage IB,T2,M0,NA,6
2.094135739,2.023838446,TCGA-66-2781-01A,TCGA-66-2781-01A-01D-1522-08,3,0.094458349,TCGA-66-2781,LUSC,67,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-24471,Alive,TUMOR FREE,121,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,121,0,121,NA,NA,0,121,NA,Stage IB,T2,M0,LUSC.basal,3
-3.778232045,-2.55769462,TCGA-18-3416-01A,TCGA-18-3416-01A-01D-0983-08,8,0.417107509,TCGA-18-3416,LUSC,83,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-30435,Dead,WITH TUMOR,NA,973,[Not Available],Distant Metastasis,NA,NA,940,Complete Remission/Response,1,973,1,973,1,940,1,940,NA,Stage IIB,T2,M0,LUSC.classical,10
-4.660273815,-0.782048185,TCGA-70-6722-01A,TCGA-70-6722-01A-11D-1817-08,0,NA,TCGA-70-6722,LUSC,47,MALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-17328,Alive,WITH TUMOR,367,NA,[Not Available],Locoregional Recurrence,NA,NA,293,Progressive Disease,0,367,0,367,NA,NA,1,293,NA,Stage IIIA,T3,M0,LUSC.secretory,10
-5.036719457,-1.960466692,TCGA-43-7656-01A,TCGA-43-7656-01A-11D-2122-08,0,NA,TCGA-43-7656,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25991,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,596,0,596,0,596,0,596,NA,Stage IA,T1b,MX,NA,10
-4.178998839,-0.473528053,TCGA-96-7544-01A,TCGA-96-7544-01A-11D-2042-08,0,NA,TCGA-96-7544,LUSC,83,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-30548,Dead,TUMOR FREE,NA,2160,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2160,0,2160,0,2160,0,2160,NA,Stage IIB,T2,MX,NA,10
8.813196233,-3.544397198,TCGA-EL-A3CX-01A,TCGA-EL-A3CX-01A-11D-A19J-08,1,0.717703952,TCGA-EL-A3CX,THCA,22,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-8344,Alive,TUMOR FREE,3243,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3243,0,3243,0,3243,0,3243,NA,Stage I,T2,M0,THCA.1,1
-0.197408989,4.338538189,TCGA-22-1011-01A,TCGA-22-1011-01A-01D-1521-08,4,0.50451722,TCGA-22-1011,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-26732,Dead,TUMOR FREE,53,53,[Not Available],NA,NA,NA,NA,[Not Available],1,53,0,53,NA,NA,0,53,NA,Stage IB,T2,M0,LUSC.basal,6
-4.744341248,0.002700219,TCGA-43-6143-01A,TCGA-43-6143-01A-11D-1817-08,0,NA,TCGA-43-6143,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-25820,Alive,TUMOR FREE,699,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,699,0,699,0,699,0,699,NA,Stage IB,T2,M0,LUSC.primitive,10
-3.397205887,0.653586445,TCGA-22-1002-01A,TCGA-22-1002-01A-01D-1521-08,0,NA,TCGA-22-1002,LUSC,69,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-25359,Dead,TUMOR FREE,131,131,[Not Available],NA,NA,NA,NA,[Not Available],1,131,0,131,NA,NA,0,131,NA,Stage IA,T1,M0,LUSC.secretory,10
-1.963715415,1.165978665,TCGA-BA-5558-01A,TCGA-BA-5558-01A-01D-1512-08,5,0.661087603,TCGA-BA-5558,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2006,[Not Available],-23984,Alive,TUMOR FREE,1995,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1995,0,1995,NA,NA,0,1995,NA,[Not Available],TX,[Not Available],HNSC.Basal,4
-6.308404461,-1.530867131,TCGA-D6-8569-01A,TCGA-D6-8569-01A-11D-2394-08,7,0.249688739,TCGA-D6-8569,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-19212,Alive,TUMOR FREE,770,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,770,0,770,NA,NA,0,770,NA,Stage II,T2,M0,NA,2
9.18422152,-2.595735825,TCGA-BJ-A3PR-01A,TCGA-BJ-A3PR-01A-11D-A21Z-08,1,0.714599071,TCGA-BJ-A3PR,THCA,69,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-25565,Alive,TUMOR FREE,1107,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1107,0,1107,0,1107,0,1107,NA,Stage I,T1a,M0,THCA.4,1
-4.646557154,-1.342311861,TCGA-AR-A2LE-01A,TCGA-AR-A2LE-01A-11D-A17W-09,8,0.315664203,TCGA-AR-A2LE,BRCA,69,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25499,Alive,TUMOR FREE,5062,NA,[Not Available],New Primary Tumor,"Other, specify",Endometrium,4203,[Not Available],0,5062,0,5062,0,5062,1,4203,NA,Stage I,T1,M0,BRCA.LumA,10
10.00952075,-1.559046544,TCGA-ET-A3BS-01A,TCGA-ET-A3BS-01A-11D-A202-08,1,0.867696519,TCGA-ET-A3BS,THCA,42,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-15421,Alive,TUMOR FREE,176,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,176,0,176,0,176,0,176,NA,Stage I,T3,MX,THCA.2,1
0.168428995,3.342437856,TCGA-E2-A1L7-01A,TCGA-E2-A1L7-01A-11D-A142-09,4,0.354817837,TCGA-E2-A1L7,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14854,Alive,TUMOR FREE,1836,NA,[Not Available],New Primary Tumor,"Other, specify",left breast,1619,[Not Available],0,1836,0,1836,1,1619,1,1619,NA,Stage IIIA,T2,M0,BRCA.LumB,3
-3.786568437,-2.342037644,TCGA-66-2734-01A,TCGA-66-2734-01A-01D-0983-08,8,0.426286662,TCGA-66-2734,LUSC,62,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-22919,Alive,TUMOR FREE,1311,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,1311,0,1311,NA,NA,0,1311,NA,Stage IB,T2,M0,LUSC.basal,10
-5.993798082,2.671754081,TCGA-60-2708-01A,TCGA-60-2708-01A-01D-1522-08,0,NA,TCGA-60-2708,LUSC,64,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-23691,Alive,TUMOR FREE,2447,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2447,0,2447,0,2447,0,2447,NA,Stage IIB,T2,M0,LUSC.basal,6
-1.274323197,3.950515949,TCGA-BR-4366-01A,TCGA-BR-4366-01A-01D-1158-08,4,0.310887041,TCGA-BR-4366,STAD,87,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-32024,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],TX,M0,GI.CIN,6
-4.613902535,1.072258987,TCGA-18-5592-01A,TCGA-18-5592-01A-01D-1632-08,0,NA,TCGA-18-5592,LUSC,57,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-21020,Alive,TUMOR FREE,1519,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1519,0,1519,NA,NA,0,1519,NA,Stage IIB,T3,M0,LUSC.classical,10
-3.852465037,-2.274028734,TCGA-34-2604-01A,TCGA-34-2604-01A-01D-1522-08,8,0.390339284,TCGA-34-2604,LUSC,81,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1999,[Not Available],-29827,Dead,TUMOR FREE,958,958,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,958,0,958,0,958,0,958,NA,Stage IB,T2,M0,NA,10
-4.325193559,-0.278189188,TCGA-64-1678-01A,TCGA-64-1678-01A-01D-1040-01,0,NA,TCGA-64-1678,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-25931,Alive,TUMOR FREE,1189,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1189,0,1189,0,1189,0,1189,NA,[Discrepancy],T2b,M0,LUAD.2,10
-4.569220147,-1.691281103,TCGA-66-2791-01A,TCGA-66-2791-01A-01D-0983-08,8,0.336613284,TCGA-66-2791,LUSC,66,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-24138,Dead,NA,NA,153,[Not Available],NA,NA,NA,NA,[Not Available],1,153,NA,153,NA,NA,0,153,NA,Stage IIIB,T2,M0,LUSC.classical,10
8.887711588,-4.70825156,TCGA-BR-A4J1-01A,TCGA-BR-A4J1-01A-11D-A25D-08,1,0.803752953,TCGA-BR-A4J1,STAD,63,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23266,Dead,NA,NA,22,[Unknown],NA,NA,NA,NA,[Unknown],1,22,NA,22,NA,NA,0,22,NA,Stage IIIA,T4a,M0,GI.CIN,1
-4.525185762,-1.559461066,TCGA-85-8276-01A,TCGA-85-8276-01A-11D-2293-08,8,0.274787021,TCGA-85-8276,LUSC,62,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-22707,Alive,WITH TUMOR,1050,NA,[Not Available],Distant Metastasis,NA,NA,1048,Complete Remission/Response,0,1050,0,1050,1,1048,1,1048,NA,Stage IIA,T1b,M0,NA,10
-4.600807627,-1.896153743,TCGA-51-4079-01A,TCGA-51-4079-01A-01D-1458-08,8,0.296993144,TCGA-51-4079,LUSC,73,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-26899,Dead,NA,NA,12,[Not Available],NA,NA,NA,NA,[Not Available],1,12,NA,12,NA,NA,0,12,NA,Stage IB,T2,[Not Available],LUSC.classical,10
-3.361928204,0.675238859,TCGA-18-3406-01A,TCGA-18-3406-01A-01D-0983-08,0,NA,TCGA-18-3406,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-24477,Dead,WITH TUMOR,NA,371,[Not Available],Locoregional Recurrence,NA,NA,357,Progressive Disease,1,371,1,371,NA,NA,1,357,NA,Stage IA,T1,M0,LUSC.basal,10
0.057085241,3.088986806,TCGA-BR-7717-01A,TCGA-BR-7717-01A-11D-2053-08,4,0.18951389,TCGA-BR-7717,STAD,63,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-23102,Dead,TUMOR FREE,NA,552,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,552,0,552,NA,NA,0,552,NA,Stage IV,T4,M0,GI.CIN,3
-1.485504994,3.131379157,TCGA-66-2742-01A,TCGA-66-2742-01A-01D-0983-08,0,NA,TCGA-66-2742,LUSC,70,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-25688,Alive,TUMOR FREE,641,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,641,0,641,NA,NA,0,641,NA,Stage IV,T2,M1,LUSC.basal,6
9.697014909,-2.021513299,TCGA-DO-A1K0-01A,TCGA-DO-A1K0-01A-11D-A13W-08,1,0.799851916,TCGA-DO-A1K0,THCA,30,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-11216,Alive,WITH TUMOR,655,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,577,[Not Available],0,655,0,655,1,577,1,577,NA,Stage I,T3,MX,THCA.3,1
-5.891342735,1.229036368,TCGA-CF-A9FF-01A,TCGA-CF-A9FF-01A-11D-A38G-08,0,NA,TCGA-CF-A9FF,BLCA,52,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-19195,Alive,TUMOR FREE,361,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,361,0,361,0,361,0,361,NA,Stage II,T2,M0,NA,10
-2.887428588,-4.112156262,TCGA-AJ-A5DW-01A,TCGA-AJ-A5DW-01A-11D-A27P-09,0,NA,TCGA-AJ-A5DW,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20711,Alive,TUMOR FREE,390,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,390,0,390,0,390,0,390,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
2.632457635,1.839972357,TCGA-CF-A8HY-01A,TCGA-CF-A8HY-01A-11D-A364-08,0,NA,TCGA-CF-A8HY,BLCA,59,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-21636,Alive,TUMOR FREE,345,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,345,0,345,0,345,0,345,NA,Stage II,T2,M0,NA,3
-2.887216875,-4.114231762,TCGA-NH-A5IV-01A,TCGA-NH-A5IV-01A-42D-A36X-10,8,0.065862181,TCGA-NH-A5IV,COAD,90,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2012,[Not Available],-32872,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,588,0,588,0,588,0,588,NA,Stage IIA,T3,MX,GI.HM-indel,10
-7.124383352,2.259911721,TCGA-BK-A6W4-01A,TCGA-BK-A6W4-01A-12D-A34Q-09,9,0.057748781,TCGA-BK-A6W4,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22766,Alive,TUMOR FREE,300,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,300,0,300,0,300,0,300,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
-7.757694659,-2.52696284,TCGA-CF-A8HX-01A,TCGA-CF-A8HX-01A-11D-A364-08,6,0.516128296,TCGA-CF-A8HX,BLCA,55,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-20259,Alive,TUMOR FREE,345,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,345,0,345,0,345,0,345,NA,Stage II,T2,M0,NA,2
-3.312670118,-3.345511988,TCGA-EO-A3AZ-01A,TCGA-EO-A3AZ-01A-12D-A19Y-09,8,0.580144876,TCGA-EO-A3AZ,UCEC,80,FEMALE,[Not Available],Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29234,Alive,TUMOR FREE,826,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,826,0,826,0,826,0,826,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-0.413687302,3.747454687,TCGA-EO-A3KU-01A,TCGA-EO-A3KU-01A-11D-A228-09,4,0.223207291,TCGA-EO-A3KU,UCEC,68,FEMALE,[Not Available],Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,677,0,677,0,677,0,677,NA,Stage II,[Not Applicable],[Not Applicable],NA,6
-7.074020077,1.922393718,TCGA-4Z-AA89-01A,TCGA-4Z-AA89-01A-11D-A391-08,9,0.017965299,TCGA-4Z-AA89,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-22271,Alive,WITH TUMOR,1029,NA,[Not Available],New Primary Tumor,Lung,NA,648,Complete Remission/Response,0,1029,0,1029,NA,NA,1,648,NA,Stage IV,T4b,M0,NA,9
-4.477725069,-0.254786783,TCGA-4Z-AA87-01A,TCGA-4Z-AA87-01A-11D-A391-08,0,NA,TCGA-4Z-AA87,BLCA,72,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-26430,Alive,WITH TUMOR,1454,NA,[Not Available],Distant Metastasis,Bone,NA,221,[Unknown],0,1454,0,1454,NA,NA,1,221,NA,Stage III,T4a,M0,NA,10
-2.933247024,-4.057841244,TCGA-AA-3984-01A,TCGA-AA-3984-01A-02D-1981-10,8,0.096488265,TCGA-AA-3984,COAD,61,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-22585,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIA,T3,M0,GI.HM-SNV,10
-7.815438504,2.209695801,TCGA-LL-A9Q3-01A,TCGA-LL-A9Q3-01A-11D-A41F-09,9,0.380575765,TCGA-LL-A9Q3,BRCA,69,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,532,0,532,0,532,0,532,NA,Stage IIIC,T3,MX,BRCA.LumA,7
-0.84787185,2.35680789,TCGA-CN-A6V6-01A,TCGA-CN-A6V6-01A-12D-A34J-08,4,0.052608859,TCGA-CN-A6V6,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,2013,[Not Available],-21811,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,635,0,635,NA,NA,0,635,NA,Stage IVA,T2,MX,NA,6
9.025033171,-3.231459645,TCGA-CF-A7I0-01A,TCGA-CF-A7I0-01A-22D-A34U-08,1,0.716546132,TCGA-CF-A7I0,BLCA,54,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013,[Not Available],-20059,Alive,TUMOR FREE,368,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,368,0,368,0,368,0,368,NA,Stage II,T2,M0,NA,1
8.974523649,-4.990799694,TCGA-W8-A86G-01A,TCGA-W8-A86G-01A-21D-A36J-09,1,0.758209547,TCGA-W8-A86G,BRCA,66,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24125,Alive,TUMOR FREE,347,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,347,0,347,0,347,0,347,NA,Stage IIA,T2a,MX,BRCA.LumA,1
8.787502778,-5.023595722,TCGA-CN-A6UY-01A,TCGA-CN-A6UY-01A-12D-A34J-08,1,0.7810376,TCGA-CN-A6UY,HNSC,57,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-20967,Alive,TUMOR FREE,713,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,713,0,713,NA,NA,0,713,NA,Stage IVA,T3,MX,NA,1
-1.306366672,3.090777884,TCGA-CN-A497-01A,TCGA-CN-A497-01A-11D-A24D-08,0,NA,TCGA-CN-A497,HNSC,63,MALE,[Unknown],Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-23310,Alive,TUMOR FREE,1065,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1065,0,1065,NA,NA,0,1065,NA,Stage III,T1,MX,NA,10
-6.304057369,-1.241502298,TCGA-EI-6881-01A,TCGA-EI-6881-01A-11D-1924-10,7,0.258604797,TCGA-EI-6881,READ,60,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-22057,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,499,0,499,NA,NA,0,499,NA,Stage IIIA,T3,M0,GI.CIN,2
-7.364977974,2.631557171,TCGA-5S-A9Q8-01A,TCGA-5S-A9Q8-01A-11D-A403-09,9,0.043829724,TCGA-5S-A9Q8,UCEC,51,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2013,[Unknown],-18785,Alive,NA,313,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,313,0,313,0,313,0,313,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,7
-7.848928499,-2.442450657,TCGA-AN-A0FZ-01A,TCGA-AN-A0FZ-01A-11W-A050-09,6,0.47327427,TCGA-AN-A0FZ,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIIA,T2,M0,BRCA.LumA,2
-3.961822725,-2.327948336,TCGA-4Z-AA84-01A,TCGA-4Z-AA84-01A-11D-A391-08,8,0.427554612,TCGA-4Z-AA84,BLCA,61,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-22397,Alive,WITH TUMOR,460,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,460,0,460,NA,NA,0,460,NA,Stage IV,T3a,M1,NA,10
-0.621261863,4.372561196,TCGA-LL-A7SZ-01A,TCGA-LL-A7SZ-01A-32D-A351-09,4,0.491888622,TCGA-LL-A7SZ,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18161,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,594,0,594,0,594,0,594,NA,Stage IIB,T2,MX,BRCA.LumA,6
7.76197456,-3.448806983,TCGA-X4-A8KS-01A,TCGA-X4-A8KS-01A-12D-A364-08,1,0.315918697,TCGA-X4-A8KS,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22571,Alive,TUMOR FREE,979,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,979,0,979,NA,NA,0,979,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-5.296484186,2.706561293,TCGA-4Z-AA82-01A,TCGA-4Z-AA82-01A-11D-A391-08,12,0.228153419,TCGA-4Z-AA82,BLCA,59,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-21893,Dead,WITH TUMOR,NA,1556,[Not Available],Distant Metastasis,Bone,NA,1150,Complete Remission/Response,1,1556,1,1556,NA,NA,1,1150,NA,Stage IV,T2a,M0,NA,8
9.338037696,-4.726729436,TCGA-XJ-A83G-01A,TCGA-XJ-A83G-01A-11D-A34U-08,1,0.815676877,TCGA-XJ-A83G,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],NA,Alive,TUMOR FREE,1461,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1461,0,1461,0,1461,0,1461,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,1
-4.307977316,-0.654454442,TCGA-4Z-AA80-01A,TCGA-4Z-AA80-01A-11D-A391-08,0,NA,TCGA-4Z-AA80,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26873,Dead,TUMOR FREE,NA,19,[Not Available],NA,NA,NA,NA,[Not Applicable],1,19,0,19,NA,NA,0,19,NA,Stage II,T2a,M0,NA,10
-7.916729347,1.961850491,TCGA-LL-A7T0-01A,TCGA-LL-A7T0-01A-31D-A351-09,9,0.595767904,TCGA-LL-A7T0,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25867,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,376,0,376,0,376,0,376,NA,Stage IIB,T2,M0,BRCA.LumB,7
-3.957988467,-0.64963554,TCGA-A8-A09G-01A,TCGA-A8-A09G-01A-21W-A019-09,0,NA,TCGA-A8-A09G,BRCA,79,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29006,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIIC,T3,M0,BRCA.Her2,10
-4.196940558,-0.391300736,TCGA-68-A59J-01A,TCGA-68-A59J-01A-21D-A26M-08,0,NA,TCGA-68-A59J,LUSC,74,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-27031,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,448,0,448,0,448,0,448,NA,Stage IB,T2a,MX,NA,10
8.890922185,-4.477931994,TCGA-XJ-A9DK-01A,TCGA-XJ-A9DK-01A-11D-A377-08,1,0.802458154,TCGA-XJ-A9DK,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],NA,Alive,TUMOR FREE,275,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,275,0,275,0,275,0,275,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-6.700301275,-2.066542002,TCGA-LL-A8F5-01A,TCGA-LL-A8F5-01A-11D-A36J-09,6,0.034217014,TCGA-LL-A8F5,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22544,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,596,0,596,0,596,0,596,NA,Stage IIA,T2,MX,BRCA.Basal,2
-2.343963472,1.260816278,TCGA-4Z-AA86-01A,TCGA-4Z-AA86-01A-11D-A391-08,5,0.347731033,TCGA-4Z-AA86,BLCA,66,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-24465,Dead,WITH TUMOR,NA,311,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvis,136,Complete Remission/Response,1,311,1,311,NA,NA,1,136,NA,Stage IV,T3a,M0,NA,10
-3.787051655,-0.127281492,TCGA-4Z-AA7Q-01A,TCGA-4Z-AA7Q-01A-11D-A391-08,0,NA,TCGA-4Z-AA7Q,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-28981,Dead,TUMOR FREE,NA,510,[Not Available],NA,NA,NA,NA,[Not Applicable],1,510,0,510,NA,NA,0,510,NA,Stage III,T3a,M0,NA,10
-4.005940353,-2.35549401,TCGA-4Z-AA7W-01A,TCGA-4Z-AA7W-01A-11D-A391-08,8,0.419445997,TCGA-4Z-AA7W,BLCA,55,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-20424,Alive,WITH TUMOR,840,NA,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Rectum,760,Complete Remission/Response,0,840,0,840,1,760,1,760,NA,Stage II,T2a,M0,NA,10
8.559734977,-1.979081454,TCGA-LL-A73Z-01A,TCGA-LL-A73Z-01A-11D-A32I-09,1,0.526102348,TCGA-LL-A73Z,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20118,Dead,WITH TUMOR,NA,227,[Not Available],Distant Metastasis,Brain,NA,192,[Not Available],1,227,1,227,NA,NA,1,192,NA,Stage IV,T1c,M1,BRCA.Normal,1
-0.708271901,2.339000202,TCGA-BB-A6UM-01A,TCGA-BB-A6UM-01A-12D-A34J-08,0,NA,TCGA-BB-A6UM,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,2010,[Not Available],-19194,Alive,TUMOR FREE,393,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,393,0,393,0,393,0,393,NA,Stage III,T1,MX,NA,1
-7.765770906,-2.515440588,TCGA-4Z-AA7S-01A,TCGA-4Z-AA7S-01A-11D-A391-08,6,0.522857219,TCGA-4Z-AA7S,BLCA,66,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-24111,Dead,TUMOR FREE,NA,1064,[Not Available],NA,NA,NA,NA,[Not Applicable],1,1064,0,1064,NA,NA,0,1064,NA,Stage III,T4a,M0,NA,2
-6.191914122,2.379602343,TCGA-LL-A740-01A,TCGA-LL-A740-01A-21D-A32I-09,0,NA,TCGA-LL-A740,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22416,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,441,0,441,0,441,0,441,NA,Stage IA,T1c,MX,BRCA.LumA,7
9.552478815,-4.230335785,TCGA-VP-AA1N-01A,TCGA-VP-AA1N-01A-31D-A41K-08,1,0.733735245,TCGA-VP-AA1N,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-25781,Alive,TUMOR FREE,1365,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1365,0,1365,0,1365,0,1365,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-0.203076581,4.318293855,TCGA-BB-A5HZ-01A,TCGA-BB-A5HZ-01A-21D-A28R-08,4,0.478190507,TCGA-BB-A5HZ,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-23906,Alive,WITH TUMOR,827,NA,[Not Available],Distant Metastasis,Distant Metastasis,Adrenal Gland,438,Complete Remission/Response,0,827,0,827,NA,NA,1,438,NA,Stage IVA,T4a,M0,NA,6
0.192156475,4.958117604,TCGA-F5-6811-01A,TCGA-F5-6811-01A-11D-1826-10,4,0.70288162,TCGA-F5-6811,READ,72,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-26575,Alive,TUMOR FREE,979,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,979,0,979,0,979,0,979,NA,Stage IIA,T3,M0,GI.CIN,6
-4.656315869,2.129285097,TCGA-HD-A6I0-01A,TCGA-HD-A6I0-01A-11D-A31L-08,0,NA,TCGA-HD-A6I0,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2013,[Not Available],-20491,Alive,TUMOR FREE,210,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,210,0,210,NA,NA,0,210,NA,Stage IVA,T4a,MX,NA,8
-4.150162337,-2.063468975,TCGA-CQ-7071-01A,TCGA-CQ-7071-01A-12D-A30E-08,8,0.457597642,TCGA-CQ-7071,HNSC,76,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-27928,Alive,TUMOR FREE,1311,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1311,0,1311,NA,NA,0,1311,NA,Stage III,T2,M0,NA,10
-6.354898397,1.326164889,TCGA-F7-A50G-01A,TCGA-F7-A50G-01A-11D-A25Y-08,10,0.075775008,TCGA-F7-A50G,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-24285,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,616,0,616,0,616,0,616,NA,Stage III,T3,M0,NA,7
-1.104779104,3.374263284,TCGA-BB-A5HU-01A,TCGA-BB-A5HU-01A-11D-A28R-08,4,0.163811283,TCGA-BB-A5HU,HNSC,47,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-17502,Alive,TUMOR FREE,782,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,782,0,782,NA,NA,0,782,NA,Stage IVA,T4,M0,NA,6
9.733844444,-3.001870959,TCGA-VP-A87C-01A,TCGA-VP-A87C-01A-11D-A34U-08,1,0.707073228,TCGA-VP-A87C,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-24608,Alive,TUMOR FREE,1690,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1690,0,1690,0,1690,0,1690,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-4.299283538,-2.037506452,TCGA-4Z-AA7M-01A,TCGA-4Z-AA7M-01A-11D-A391-08,8,0.434032353,TCGA-4Z-AA7M,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23817,Alive,TUMOR FREE,495,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,495,0,495,0,495,0,495,NA,Stage III,T3a,M0,NA,10
2.958315948,3.549729425,TCGA-LL-A6FQ-01A,TCGA-LL-A6FQ-01A-11D-A31U-09,0,NA,TCGA-LL-A6FQ,BRCA,77,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28375,Alive,NA,80,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,80,0,80,0,80,0,80,NA,Stage IIIA,T2,MX,BRCA.LumA,1
8.76072166,-4.159995661,TCGA-VP-A87D-01A,TCGA-VP-A87D-01A-11D-A34U-08,1,0.718216055,TCGA-VP-A87D,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-19818,Alive,TUMOR FREE,1853,NA,[Not Available],Biochemical evidence of disease,NA,NA,1194,Complete Remission/Response,0,1853,0,1853,1,1194,1,1194,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
0.09226764,4.935314402,TCGA-Z5-AAPL-01A,TCGA-Z5-AAPL-01A-12D-A40W-08,4,0.657342106,TCGA-Z5-AAPL,PAAD,74,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-27152,Alive,TUMOR FREE,467,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,467,0,467,0,467,0,467,NA,Stage IIA,T3,M0,NA,6
-3.274921982,-3.363438581,TCGA-QS-A5YQ-01A,TCGA-QS-A5YQ-01A-11D-A31U-09,8,0.577052287,TCGA-QS-A5YQ,UCEC,55,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20425,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,759,0,759,0,759,0,759,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,10
0.251056869,5.357992154,TCGA-LL-A6FR-01A,TCGA-LL-A6FR-01A-12D-A31U-09,4,0.36634752,TCGA-LL-A6FR,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18520,Alive,TUMOR FREE,489,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,489,0,489,0,489,0,489,NA,Stage IIA,T2,MX,BRCA.Basal,6
-5.298651545,2.304470312,TCGA-YH-A8SY-01A,TCGA-YH-A8SY-01A-11D-A377-08,12,0.265366716,TCGA-YH-A8SY,PAAD,73,FEMALE,WHITE,[Discrepancy],G2,2011,[Not Available],-26859,Alive,NA,388,NA,NA,NA,NA,NA,NA,[Unknown],0,388,0,388,NA,NA,0,388,NA,[Discrepancy],T3,MX,NA,8
9.437838113,-5.326173377,TCGA-VP-A87E-01A,TCGA-VP-A87E-01A-31D-A34U-08,1,0.83099482,TCGA-VP-A87E,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-21811,Alive,TUMOR FREE,2037,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2037,0,2037,0,2037,0,2037,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-0.68842941,4.586769826,TCGA-CQ-A4CE-01A,TCGA-CQ-A4CE-01A-11D-A25Y-08,4,0.488855255,TCGA-CQ-A4CE,HNSC,76,FEMALE,[Not Evaluated],Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-27793,Alive,TUMOR FREE,897,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,897,0,897,0,897,0,897,NA,Stage II,T2,M0,NA,6
-2.140143077,1.253679497,TCGA-LL-A73Y-01A,TCGA-LL-A73Y-01A-11D-A33E-09,5,0.58750703,TCGA-LL-A73Y,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24647,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,477,0,477,0,477,0,477,NA,Stage IA,T1c,MX,BRCA.Basal,10
-7.560613993,2.337214618,TCGA-VP-A87H-01A,TCGA-VP-A87H-01A-11D-A34U-08,9,0.03679331,TCGA-VP-A87H,PRAD,76,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-28060,Alive,TUMOR FREE,663,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,663,0,663,0,663,0,663,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,7
-8.005549769,2.049596303,TCGA-AP-A5FX-01A,TCGA-AP-A5FX-01A-11D-A27P-09,9,0.606788838,TCGA-AP-A5FX,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25063,Dead,WITH TUMOR,NA,1099,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneal LN; vulvar mass,407,Complete Remission/Response,1,1099,1,1099,1,407,1,407,NA,Stage IIIC1,[Not Applicable],[Not Applicable],NA,7
-0.818001745,4.689417863,TCGA-BH-A0H7-01A,TCGA-BH-A0H7-01A-13W-A071-09,4,0.565937148,TCGA-BH-A0H7,BRCA,65,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23972,Alive,TUMOR FREE,702,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,702,0,702,0,702,0,702,NA,Stage IIIA,T1c,M0,BRCA.LumA,6
-3.411603391,0.881232597,TCGA-BB-A5HY-01A,TCGA-BB-A5HY-01A-11D-A28R-08,0,NA,TCGA-BB-A5HY,HNSC,64,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2012,[Not Available],-23640,Dead,WITH TUMOR,NA,321,[Not Available],Distant Metastasis,Distant Metastasis,Cerebellum,230,Complete Remission/Response,1,321,1,321,NA,NA,1,230,NA,Stage IVA,T3,M0,NA,10
8.128109278,-4.177306905,TCGA-4Z-AA7N-01A,TCGA-4Z-AA7N-01A-11D-A391-08,1,0.857532596,TCGA-4Z-AA7N,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-24090,Dead,TUMOR FREE,NA,1367,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1367,0,1367,0,1367,0,1367,NA,Stage III,T3a,M0,NA,1
-4.238818265,-1.276869849,TCGA-MT-A67F-01A,TCGA-MT-A67F-01A-11D-A30E-08,8,0.293540835,TCGA-MT-A67F,HNSC,60,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-22057,Alive,TUMOR FREE,384,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,384,0,384,NA,NA,0,384,NA,Stage IVA,T4,MX,NA,10
-6.587352998,-1.409824123,TCGA-HV-A5A3-01A,TCGA-HV-A5A3-01A-11D-A26I-08,7,0.194274814,TCGA-HV-A5A3,PAAD,50,MALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-18475,Dead,TUMOR FREE,NA,128,NA,NA,NA,NA,NA,Complete Remission/Response,1,128,0,128,0,128,0,128,NA,Stage IIA,T3,MX,NA,2
-0.491322499,4.972829663,TCGA-VP-A876-01A,TCGA-VP-A876-01A-11D-A34U-08,4,0.53967323,TCGA-VP-A876,PRAD,46,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2005,[Not Available],-16934,Alive,TUMOR FREE,3333,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3333,0,3333,0,3333,0,3333,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,6
-0.981252452,3.827088926,TCGA-LL-A5YO-01A,TCGA-LL-A5YO-01A-21D-A28B-09,4,0.378138386,TCGA-LL-A5YO,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18354,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,440,0,440,0,440,0,440,NA,Stage IA,T1b,MX,BRCA.Her2,5
-5.865961872,1.988752306,TCGA-FZ-5919-01A,TCGA-FZ-5919-01A-11D-1609-08,0,NA,TCGA-FZ-5919,PAAD,59,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2007,[Not Available],-21611,Dead,WITH TUMOR,NA,741,Pancreatic Cancer,Distant Metastasis,Liver,NA,55,Progressive Disease,1,741,1,741,NA,NA,1,55,NA,Stage IIB,T3,MX,NA,8
8.432653478,-3.483996487,TCGA-VP-A878-01A,TCGA-VP-A878-01A-31D-A34U-08,1,0.627406565,TCGA-VP-A878,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-21402,Alive,WITH TUMOR,3130,NA,[Not Available],Biochemical evidence of disease,NA,NA,98,Partial Remission/Response,0,3130,0,3130,NA,NA,1,98,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
-5.512834751,2.599457047,TCGA-FB-AAQ6-01A,TCGA-FB-AAQ6-01A-11D-A40W-08,12,0.197331178,TCGA-FB-AAQ6,PAAD,85,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-31319,Dead,WITH TUMOR,NA,244,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,NA,213,Progressive Disease,1,244,1,244,NA,NA,1,213,NA,Stage IA,T1,MX,NA,8
-7.300729188,-2.07030396,TCGA-LL-A5YP-01A,TCGA-LL-A5YP-01A-21D-A28B-09,6,0.067997092,TCGA-LL-A5YP,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18041,Alive,NA,450,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,450,0,450,0,450,0,450,NA,Stage IIB,T2,M0,BRCA.Basal,2
-5.478031062,2.541898656,TCGA-FB-AAQ2-01A,TCGA-FB-AAQ2-01A-31D-A40W-08,12,0.400357394,TCGA-FB-AAQ2,PAAD,81,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-29585,Dead,WITH TUMOR,NA,153,NA,Distant Metastasis,Liver,NA,92,Partial Remission/Response,1,153,1,153,NA,NA,1,92,NA,Stage IIB,T3,MX,NA,8
9.3202023,-2.07665342,TCGA-VP-A87B-01A,TCGA-VP-A87B-01A-11D-A34U-08,1,0.749720342,TCGA-VP-A87B,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-23271,Alive,WITH TUMOR,2722,NA,[Not Available],New Primary Tumor,Lung,NA,2473,Complete Remission/Response,0,2722,0,2722,0,2722,1,2473,NA,[Not Applicable],T2b,[Not Applicable],PRAD.5-SPOP,1
-6.488628759,-1.454187089,TCGA-AG-3881-01A,TCGA-AG-3881-01A-01W-0899-10,7,0.154852971,TCGA-AG-3881,READ,83,FEMALE,[Not Available],[Not Available],[Not Available],2008,[Not Available],-30467,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,579,0,579,NA,NA,0,579,NA,Stage IIA,T3,M0,GI.CIN,2
-6.794964831,-1.582150135,TCGA-KU-A66T-01A,TCGA-KU-A66T-01A-11D-A30E-08,7,0.028325995,TCGA-KU-A66T,HNSC,53,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-19405,Alive,TUMOR FREE,552,NA,[Not Available],Locoregional Recurrence,Oral Cavity,Toungue,552,Complete Remission/Response,0,552,0,552,NA,NA,1,552,NA,Stage IVA,T4,MX,NA,2
2.10234738,1.879382112,TCGA-E9-A1R7-01A,TCGA-E9-A1R7-01A-11D-A14K-09,3,0.593052992,TCGA-E9-A1R7,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23397,Alive,TUMOR FREE,1467,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1467,0,1467,0,1467,0,1467,NA,Stage IIA,T2,M0,BRCA.LumB,3
-3.932599918,-1.456867179,TCGA-CV-A461-01A,TCGA-CV-A461-01A-41D-A25Y-08,8,0.139389374,TCGA-CV-A461,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2004,[Not Available],-23955,Dead,TUMOR FREE,NA,2064,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2064,0,2064,0,2064,0,2064,NA,[Not Available],[Not Available],[Not Available],NA,10
-1.869298275,1.18723811,TCGA-P3-A6T3-01A,TCGA-P3-A6T3-01A-11D-A34J-08,5,0.626632096,TCGA-P3-A6T3,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-18143,Dead,WITH TUMOR,NA,577,[Not Available],Distant Metastasis,Distant Metastasis,Lung,242,Complete Remission/Response,1,577,1,577,NA,NA,1,242,NA,Stage IVA,T3,MX,NA,4
-0.871158327,4.121902392,TCGA-MT-A67D-01A,TCGA-MT-A67D-01A-31D-A30E-08,4,0.375638878,TCGA-MT-A67D,HNSC,55,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-20386,Alive,NA,56,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,56,0,56,0,56,0,56,NA,Stage II,T2,M0,NA,6
-6.073342529,3.488264404,TCGA-FB-AAPU-01A,TCGA-FB-AAPU-01A-31D-A40W-08,11,0.58153649,TCGA-FB-AAPU,PAAD,41,FEMALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-15129,Dead,WITH TUMOR,NA,381,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,381,1,381,NA,NA,1,381,NA,Stage IIA,T3,MX,NA,8
-7.960891047,2.14764496,TCGA-QU-A6IN-01A,TCGA-QU-A6IN-01A-11D-A31L-08,9,0.413688587,TCGA-QU-A6IN,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2003,[Not Available],-22286,Alive,TUMOR FREE,4264,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4264,0,4264,0,4264,0,4264,NA,[Not Applicable],T2c,[Not Applicable],NA,7
-7.894994501,2.312417091,TCGA-B6-A40B-01A,TCGA-B6-A40B-01A-11D-A23C-09,9,0.266688183,TCGA-B6-A40B,BRCA,76,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27811,Alive,TUMOR FREE,3152,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3152,0,3152,0,3152,0,3152,NA,Stage I,T1b,M0,BRCA.LumA,7
9.061751067,-1.395960656,TCGA-P3-A6T6-01A,TCGA-P3-A6T6-01A-11D-A34J-08,1,0.537723837,TCGA-P3-A6T6,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2009,[Not Available],-19694,Dead,WITH TUMOR,NA,395,[Not Available],Distant Metastasis,Distant Metastasis,lung,273,Complete Remission/Response,1,395,1,395,NA,NA,1,273,NA,Stage IVA,T4a,MX,NA,6
-0.157497676,4.687399199,TCGA-FB-AAPS-01A,TCGA-FB-AAPS-01A-12D-A397-08,4,0.583387742,TCGA-FB-AAPS,PAAD,62,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-22981,Alive,NA,228,NA,NA,NA,NA,NA,NA,[Unknown],0,228,0,228,NA,NA,0,228,NA,Stage IIB,T2,MX,NA,6
9.244521405,-5.260656631,TCGA-QU-A6IO-01A,TCGA-QU-A6IO-01A-11D-A31L-08,1,0.840706933,TCGA-QU-A6IO,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2003,[Not Available],-19564,Alive,TUMOR FREE,3716,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3716,0,3716,0,3716,0,3716,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.290113567,-3.022084104,TCGA-P3-A6SW-01A,TCGA-P3-A6SW-01A-11D-A34J-08,1,0.695411184,TCGA-P3-A6SW,HNSC,50,MALE,WHITE,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2005,[Not Available],-18536,Alive,TUMOR FREE,1120,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1120,0,1120,NA,NA,0,1120,NA,Stage IVB,T3,MX,NA,1
-6.074301355,3.555894591,TCGA-FB-AAPQ-01A,TCGA-FB-AAPQ-01A-11D-A40W-08,11,0.456324865,TCGA-FB-AAPQ,PAAD,65,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-24078,Dead,NA,NA,1130,NA,NA,NA,NA,NA,Progressive Disease,1,1130,NA,1130,NA,NA,0,1130,NA,Stage IIB,T3,MX,NA,8
0.392415429,2.263357581,TCGA-B6-A40C-01A,TCGA-B6-A40C-01A-11D-A23C-09,0,NA,TCGA-B6-A40C,BRCA,51,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2005,[Unknown],-18852,Alive,TUMOR FREE,2164,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2164,0,2164,0,2164,0,2164,NA,Stage IIB,T3,M0,BRCA.LumA,6
-0.892259412,4.195957697,TCGA-FB-AAPP-01A,TCGA-FB-AAPP-01A-12D-A40W-08,4,0.367869506,TCGA-FB-AAPP,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2009,[Not Available],-26239,Dead,WITH TUMOR,NA,485,Pancreatic Cancer,Distant Metastasis,Lung,NA,150,Progressive Disease,1,485,1,485,NA,NA,1,150,NA,Stage IIB,T3,MX,NA,3
-7.750238276,-2.44179041,TCGA-TP-A8TV-01A,TCGA-TP-A8TV-01A-11D-A41K-08,6,0.480326703,TCGA-TP-A8TV,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22872,Alive,TUMOR FREE,610,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,610,0,610,0,610,0,610,NA,[Not Applicable],T2c,[Not Applicable],NA,2
9.336000178,-5.465244394,TCGA-VN-A943-01A,TCGA-VN-A943-01A-11D-A41K-08,1,0.824932578,TCGA-VN-A943,PRAD,71,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-26162,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,496,0,496,0,496,0,496,NA,[Not Applicable],T2c,[Not Applicable],NA,1
8.765476064,-3.855276008,TCGA-E2-A572-01A,TCGA-E2-A572-01A-13D-A31U-09,1,0.724806655,TCGA-E2-A572,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26399,Alive,TUMOR FREE,1208,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1208,0,1208,0,1208,0,1208,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-1.955360271,1.181303192,TCGA-HD-A633-01A,TCGA-HD-A633-01A-11D-A28R-08,5,0.633015228,TCGA-HD-A633,HNSC,74,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-27057,Alive,WITH TUMOR,421,NA,[Not Available],Locoregional Recurrence,Oral Cavity,Buccal Space & Infratemporal Fossa,419,Complete Remission/Response,0,421,0,421,NA,NA,1,419,NA,Stage IVA,T4a,MX,NA,4
-5.3106255,2.65566583,TCGA-FB-AAQ1-01A,TCGA-FB-AAQ1-01A-12D-A40W-08,12,0.295935021,TCGA-FB-AAQ1,PAAD,49,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-18172,Dead,WITH TUMOR,NA,123,NA,NA,NA,NA,NA,Stable Disease,1,123,1,123,NA,NA,1,123,NA,Stage IIB,T3,MX,NA,8
-0.647540514,4.043127209,TCGA-VP-A872-01A,TCGA-VP-A872-01A-11D-A34U-08,4,0.403751031,TCGA-VP-A872,PRAD,60,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2005,[Not Available],-22098,Alive,TUMOR FREE,3631,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3631,0,3631,0,3631,0,3631,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,5
-7.537351486,-2.392661584,TCGA-E9-A6HE-01A,TCGA-E9-A6HE-01A-11D-A31U-09,6,0.324305819,TCGA-E9-A6HE,BRCA,45,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16697,Alive,TUMOR FREE,847,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,847,0,847,0,847,0,847,NA,Stage IIIC,T3,MX,BRCA.LumA,2
-5.396759386,2.566435148,TCGA-FB-AAPZ-01A,TCGA-FB-AAPZ-01A-11D-A40W-08,12,0.408982717,TCGA-FB-AAPZ,PAAD,54,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-19847,Alive,TUMOR FREE,716,NA,NA,Distant Metastasis,"Other, specify",Adrenal and right buttock,716,Complete Remission/Response,0,716,0,716,1,716,1,716,NA,Stage IIB,T2,MX,NA,8
9.713056339,-4.70277869,TCGA-VP-A875-01A,TCGA-VP-A875-01A-31D-A34U-08,1,0.781483944,TCGA-VP-A875,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2005,[Not Available],-24742,Alive,TUMOR FREE,2309,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2309,0,2309,0,2309,0,2309,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-5.724466329,-2.247632465,TCGA-B6-A0WZ-01A,TCGA-B6-A0WZ-01A-11D-A10G-09,0,NA,TCGA-B6-A0WZ,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-18584,Alive,TUMOR FREE,6292,NA,[Not Available],New Primary Tumor,Bone,NA,5117,[Not Available],0,6292,0,6292,0,6292,1,5117,NA,Stage II,T2,M0,BRCA.LumA,2
-7.655857993,1.796723583,TCGA-LL-A5YN-01A,TCGA-LL-A5YN-01A-11D-A28B-09,9,0.420397012,TCGA-LL-A5YN,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16884,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,447,0,447,0,447,0,447,NA,Stage IIA,T2,M0,BRCA.LumA,7
-6.063052462,3.504893212,TCGA-FB-AAPY-01A,TCGA-FB-AAPY-01A-11D-A40W-08,11,0.50206564,TCGA-FB-AAPY,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-26085,Dead,TUMOR FREE,NA,1059,NA,NA,NA,NA,NA,Complete Remission/Response,1,1059,0,1059,0,1059,0,1059,NA,Stage IIB,T2,MX,NA,8
-1.255379485,4.303600947,TCGA-3A-A9J0-01A,TCGA-3A-A9J0-01A-11D-A40W-08,4,0.398125702,TCGA-3A-A9J0,PAAD,75,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-27453,Alive,WITH TUMOR,743,NA,NA,Distant Metastasis,Lung,NA,363,Progressive Disease,0,743,0,743,NA,NA,1,363,NA,Stage IIB,T3,MX,NA,6
-5.361377074,2.679539589,TCGA-3A-A9IZ-01A,TCGA-3A-A9IZ-01A-12D-A40W-08,12,0.250865739,TCGA-3A-A9IZ,PAAD,47,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-17294,Dead,WITH TUMOR,NA,308,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,NA,109,Progressive Disease,1,308,1,308,NA,NA,1,109,NA,Stage IIB,T3,MX,NA,8
-6.408404499,1.649217933,TCGA-B6-A401-01A,TCGA-B6-A401-01A-11D-A23C-09,10,0.257144109,TCGA-B6-A401,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2007,[Unknown],-17438,Alive,TUMOR FREE,2596,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2596,0,2596,0,2596,0,2596,NA,Stage IIA,T1c,M0,BRCA.LumA,7
9.481284841,-5.725532308,TCGA-3A-A9IX-01A,TCGA-3A-A9IX-01A-11D-A40W-08,1,0.871914016,TCGA-3A-A9IX,PAAD,40,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-14729,Alive,TUMOR FREE,1037,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1037,0,1037,0,1037,0,1037,NA,Stage IA,T1,MX,NA,1
9.195274268,-5.516011196,TCGA-KK-A8IL-01A,TCGA-KK-A8IL-01A-11D-A364-08,1,0.806613259,TCGA-KK-A8IL,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-23849,Dead,NA,NA,628,[Unknown],NA,NA,NA,NA,[Unknown],1,628,NA,628,NA,NA,0,628,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
0.461244429,2.209300951,TCGA-28-1747-01C,TCGA-28-1747-01C-01D-1494-08,0,NA,TCGA-28-1747,GBM,44,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-16301,Dead,NA,77,77,[Not Available],NA,NA,NA,NA,[Not Available],1,77,NA,77,NA,NA,0,77,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
8.951252058,-4.774079008,TCGA-CG-5716-01A,TCGA-CG-5716-01A-21D-1800-08,1,0.814718666,TCGA-CG-5716,STAD,86,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-31411,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IV,T4a,M1,NA,1
-2.155153342,1.835888116,TCGA-MT-A67A-01A,TCGA-MT-A67A-01A-11D-A30E-08,5,0.171432006,TCGA-MT-A67A,HNSC,85,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-31161,Alive,TUMOR FREE,914,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,914,0,914,0,914,0,914,NA,Stage I,T1,MX,NA,4
-2.056343361,1.82274005,TCGA-CV-A6JE-01A,TCGA-CV-A6JE-01A-11D-A31L-08,5,0.095643184,TCGA-CV-A6JE,HNSC,78,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-28658,Alive,TUMOR FREE,1075,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1075,0,1075,0,1075,0,1075,NA,[Not Available],[Not Available],[Not Available],NA,3
-6.363890783,1.151896844,TCGA-CQ-A4C6-01A,TCGA-CQ-A4C6-01A-11D-A25D-08,10,0.235161017,TCGA-CQ-A4C6,HNSC,63,MALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-23205,Alive,TUMOR FREE,1353,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1353,0,1353,0,1353,0,1353,NA,Stage II,T2,M0,NA,8
-5.937535141,1.923503265,TCGA-CV-A45O-01A,TCGA-CV-A45O-01A-21D-A24D-08,0,NA,TCGA-CV-A45O,HNSC,57,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1994,[Not Available],-20868,Alive,TUMOR FREE,851,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,851,0,851,NA,NA,0,851,NA,[Not Available],[Not Available],[Not Available],NA,9
-5.882128872,3.222929852,TCGA-49-4506-01A,TCGA-49-4506-01A-01D-1265-08,0,NA,TCGA-49-4506,LUAD,68,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1997,[Not Available],-25132,Dead,[Discrepancy],NA,999,[Not Available],Locoregional Recurrence,NA,NA,692,Complete Remission/Response,1,999,NA,999,1,692,1,692,NA,Stage IIB,T2,M0,LUAD.6,8
-6.329196591,1.645080845,TCGA-P3-A6T0-01A,TCGA-P3-A6T0-01A-12D-A34J-08,10,0.281701614,TCGA-P3-A6T0,HNSC,47,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-17259,Alive,TUMOR FREE,578,NA,[Not Available],Locoregional Disease,Oral Cavity,NA,365,Complete Remission/Response,0,578,0,578,NA,NA,1,365,NA,Stage IVA,T4a,MX,NA,7
8.781270892,-4.441684074,TCGA-3A-A9IJ-01A,TCGA-3A-A9IJ-01A-11D-A397-08,1,0.772413805,TCGA-3A-A9IJ,PAAD,65,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2009,[Not Available],-23791,Alive,TUMOR FREE,1854,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1854,0,1854,0,1854,0,1854,NA,Stage IB,T2,MX,NA,1
9.13299192,-4.051677139,TCGA-KK-A6E7-01A,TCGA-KK-A6E7-01A-11D-A31L-08,1,0.751735988,TCGA-KK-A6E7,PRAD,46,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-17074,Alive,WITH TUMOR,2760,NA,[Not Available],Biochemical evidence of disease,NA,NA,925,Partial Remission/Response,0,2760,0,2760,NA,NA,1,925,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-5.433941133,2.098203938,TCGA-AC-A8OP-01A,TCGA-AC-A8OP-01A-11D-A36J-09,0,NA,TCGA-AC-A8OP,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26550,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,614,0,614,0,614,0,614,NA,Stage IA,T1c,MX,BRCA.LumA,6
-5.303329486,2.637504162,TCGA-3A-A9IH-01A,TCGA-3A-A9IH-01A-12D-A397-08,12,0.283606792,TCGA-3A-A9IH,PAAD,66,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24174,Alive,WITH TUMOR,1021,NA,NA,Distant Metastasis,Lung,NA,763,Stable Disease,0,1021,0,1021,NA,NA,1,763,NA,Stage IA,T1,MX,NA,8
-6.787590874,-1.951627061,TCGA-P3-A6SX-01A,TCGA-P3-A6SX-01A-11D-A34J-08,6,0.001143594,TCGA-P3-A6SX,HNSC,67,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2005,[Not Available],-24715,Dead,TUMOR FREE,NA,1430,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1430,0,1430,NA,NA,0,1430,NA,Stage III,T2,MX,NA,2
-6.110913712,3.141843858,TCGA-3A-A9IC-01A,TCGA-3A-A9IC-01A-11D-A38G-08,11,0.256688835,TCGA-3A-A9IC,PAAD,61,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-22400,Dead,WITH TUMOR,NA,738,Pancreatic Cancer,NA,NA,NA,NA,Stable Disease,1,738,1,738,NA,NA,1,738,NA,Stage IIB,T3,MX,NA,7
-0.144438823,2.638939306,TCGA-AC-A8OQ-01A,TCGA-AC-A8OQ-01A-11D-A41F-09,4,0.046487257,TCGA-AC-A8OQ,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26535,Alive,TUMOR FREE,34,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,34,0,34,0,34,0,34,NA,Stage IIB,T2,MX,BRCA.Basal,6
-5.468358766,2.579777786,TCGA-3A-A9IB-01A,TCGA-3A-A9IB-01A-21D-A397-08,12,0.246514189,TCGA-3A-A9IB,PAAD,69,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-25312,Dead,NA,NA,224,NA,NA,NA,NA,NA,[Unknown],1,224,NA,224,NA,NA,0,224,NA,Stage IIB,T3,MX,NA,7
9.487522435,-3.485140397,TCGA-KK-A7AZ-01A,TCGA-KK-A7AZ-01A-12D-A32B-08,1,0.674393004,TCGA-KK-A7AZ,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20507,Alive,NA,1519,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1519,0,1519,NA,NA,0,1519,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.746462082,-4.272448446,TCGA-3A-A9IV-01A,TCGA-3A-A9IV-01A-11D-A40W-08,1,0.643821621,TCGA-3A-A9IV,PAAD,59,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2011,[Not Available],-21732,Alive,TUMOR FREE,1103,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1103,0,1103,0,1103,0,1103,NA,Stage IB,T2,MX,NA,1
2.05640923,1.847732702,TCGA-KK-A7B1-01A,TCGA-KK-A7B1-01A-11D-A32B-08,3,0.556773852,TCGA-KK-A7B1,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23803,Alive,NA,1063,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1063,0,1063,0,1063,0,1063,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,3
-6.592569139,-1.369448472,TCGA-AC-A8OR-01A,TCGA-AC-A8OR-01A-21D-A41F-09,7,0.217707993,TCGA-AC-A8OR,BRCA,75,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27605,Alive,TUMOR FREE,40,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,40,0,40,0,40,0,40,NA,Stage IA,T1c,MX,BRCA.LumA,2
-6.022855986,3.501255041,TCGA-3A-A9IU-01A,TCGA-3A-A9IU-01A-11D-A397-08,11,0.438344117,TCGA-3A-A9IU,PAAD,65,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-23998,Dead,WITH TUMOR,NA,458,Pancreatic Cancer,Distant Metastasis,Liver,NA,371,[Unknown],1,458,1,458,NA,NA,1,371,NA,Stage IIB,T3,MX,NA,8
9.802554234,-2.309727734,TCGA-KK-A7B2-01A,TCGA-KK-A7B2-01A-12D-A32B-08,1,0.727272165,TCGA-KK-A7B2,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24845,Alive,WITH TUMOR,1099,NA,[Not Available],Biochemical evidence of disease,NA,NA,692,Stable Disease,0,1099,0,1099,NA,NA,1,692,NA,[Not Applicable],T3a,[Not Applicable],NA,1
8.998320873,-3.092551418,TCGA-3A-A9IO-01A,TCGA-3A-A9IO-01A-11D-A38G-08,1,0.751337354,TCGA-3A-A9IO,PAAD,55,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2009,[Not Available],-20451,Alive,TUMOR FREE,1942,NA,NA,NA,NA,NA,NA,[Unknown],0,1942,0,1942,NA,NA,0,1942,NA,[Not Available],TX,MX,NA,1
8.694594667,-3.666363425,TCGA-KK-A8IB-01A,TCGA-KK-A8IB-01A-11D-A364-08,1,0.637047152,TCGA-KK-A8IB,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24041,Alive,NA,83,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,83,0,83,NA,NA,0,83,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,1
-7.257517366,1.490204435,TCGA-AQ-A7U7-01A,TCGA-AQ-A7U7-01A-22D-A351-09,0,NA,TCGA-AQ-A7U7,BRCA,55,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20239,Dead,TUMOR FREE,NA,584,[Not Available],NA,NA,NA,NA,[Not Available],1,584,0,584,0,584,0,584,NA,Stage IIIA,T2,M0,BRCA.LumA,7
9.174759253,-5.48807605,TCGA-3A-A9IL-01A,TCGA-3A-A9IL-01A-11D-A38G-08,1,0.80787303,TCGA-3A-A9IL,PAAD,39,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2007,[Not Available],-14599,Alive,TUMOR FREE,2741,NA,NA,NA,NA,NA,NA,[Unknown],0,2741,0,2741,NA,NA,0,2741,NA,Stage I,T1,MX,NA,1
-4.753999067,1.346379699,TCGA-DY-A1DF-01A,TCGA-DY-A1DF-01A-11D-A152-10,0,NA,TCGA-DY-A1DF,READ,73,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2001,[Not Available],-26763,Dead,NA,734,734,[Not Available],NA,NA,NA,NA,[Not Available],1,734,NA,734,NA,NA,0,734,NA,Stage IIIC,T3,M0,GI.CIN,9
8.724836404,-2.003002644,TCGA-3A-A9I5-01A,TCGA-3A-A9I5-01A-11D-A38G-08,1,0.615700463,TCGA-3A-A9I5,PAAD,57,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2009,[Not Available],-21175,Alive,TUMOR FREE,1794,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1794,0,1794,0,1794,0,1794,NA,[Discrepancy],[Discrepancy],MX,NA,1
7.830410798,-1.357625115,TCGA-BR-7722-01A,TCGA-BR-7722-01A-31D-2201-08,1,0.140128317,TCGA-BR-7722,STAD,62,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-22701,Dead,TUMOR FREE,NA,466,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,466,0,466,0,466,0,466,NA,Stage IIB,T3,M0,GI.CIN,1
9.062943906,-2.980320206,TCGA-2L-AAQM-01A,TCGA-2L-AAQM-01A-11D-A397-08,1,0.70978065,TCGA-2L-AAQM,PAAD,52,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-19315,Alive,TUMOR FREE,1383,NA,NA,NA,NA,NA,NA,Stable Disease,0,1383,0,1383,NA,NA,0,1383,NA,Stage IIB,T3,MX,NA,1
2.407695817,3.520342209,TCGA-AC-A6IX-01A,TCGA-AC-A6IX-01A-12D-A32I-09,0,NA,TCGA-AC-A6IX,BRCA,49,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Peri (6-12 months since last menstrual period),-17969,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,373,0,373,0,373,0,373,NA,Stage IIIC,T2,MX,BRCA.LumA,1
8.817735309,-4.982706479,TCGA-KK-A6E6-01A,TCGA-KK-A6E6-01A-11D-A30X-08,1,0.79770911,TCGA-KK-A6E6,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2002,[Not Available],-25320,Alive,TUMOR FREE,3447,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3447,0,3447,NA,NA,0,3447,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
1.067531378,3.565471543,TCGA-AG-4007-01A,TCGA-AG-4007-01A-01D-1989-10,0,NA,TCGA-AG-4007,READ,87,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-31776,Alive,WITH TUMOR,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage IV,T4,M1,NA,6
-0.856997469,3.279979534,TCGA-AC-A6IW-01A,TCGA-AC-A6IW-01A-12D-A33E-09,4,0.138949474,TCGA-AC-A6IW,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26896,Alive,TUMOR FREE,413,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,413,0,413,0,413,0,413,NA,Stage IIA,T2,MX,BRCA.Basal,6
8.594556492,-3.096617521,TCGA-F7-A622-01A,TCGA-F7-A622-01A-11D-A28R-08,1,0.643634705,TCGA-F7-A622,HNSC,75,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-27456,Dead,WITH TUMOR,NA,359,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,359,1,359,NA,NA,1,359,NA,Stage III,T3,M0,NA,1
10.12776822,-1.467689075,TCGA-KK-A6E5-01A,TCGA-KK-A6E5-01A-11D-A30X-08,1,0.822163481,TCGA-KK-A6E5,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-23144,Alive,TUMOR FREE,2073,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2073,0,2073,0,2073,0,2073,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
0.267449067,4.609892339,TCGA-CQ-A4CB-01A,TCGA-CQ-A4CB-01A-11D-A25D-08,4,0.442517722,TCGA-CQ-A4CB,HNSC,59,MALE,[Not Evaluated],Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-21574,Alive,TUMOR FREE,893,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,893,0,893,0,893,0,893,NA,Stage III,T1,M0,NA,6
-2.822141118,1.500156978,TCGA-CQ-A4CD-01A,TCGA-CQ-A4CD-01A-21D-A25D-08,0,NA,TCGA-CQ-A4CD,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-25497,Alive,TUMOR FREE,1022,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1022,0,1022,NA,NA,0,1022,NA,Stage IVA,T4a,M0,NA,9
-5.265909447,2.550716306,TCGA-2L-AAQJ-01A,TCGA-2L-AAQJ-01A-12D-A397-08,12,0.318741064,TCGA-2L-AAQJ,PAAD,49,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-18103,Dead,WITH TUMOR,NA,394,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,394,1,394,NA,NA,1,394,NA,Stage III,T4,MX,NA,8
-6.121361827,-1.442064816,TCGA-CV-A6JD-01A,TCGA-CV-A6JD-01A-11D-A31L-08,0,NA,TCGA-CV-A6JD,HNSC,82,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2012,[Not Available],-29988,Dead,TUMOR FREE,NA,182,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,182,0,182,NA,NA,0,182,NA,[Not Available],[Not Available],[Not Available],NA,2
8.936111123,-1.876976917,TCGA-MT-A67G-01A,TCGA-MT-A67G-01A-11D-A30E-08,1,0.567906854,TCGA-MT-A67G,HNSC,53,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-19394,Alive,[Discrepancy],190,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,190,0,190,NA,NA,0,190,NA,Stage IVA,T1,MX,NA,1
-5.494503765,2.465635082,TCGA-P3-A6T2-01A,TCGA-P3-A6T2-01A-11D-A34J-08,12,0.279200023,TCGA-P3-A6T2,HNSC,45,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-16588,Alive,TUMOR FREE,2298,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2298,0,2298,NA,NA,0,2298,NA,Stage IVA,T3,MX,NA,8
-0.796936081,2.506120241,TCGA-P3-A6T4-01A,TCGA-P3-A6T4-01A-11D-A34J-08,4,0.119000733,TCGA-P3-A6T4,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-20027,Dead,WITH TUMOR,NA,62,[Not Available],NA,NA,NA,NA,Progressive Disease,1,62,1,62,NA,NA,1,62,NA,Stage IVA,T4a,MX,NA,6
-3.836369202,-2.395520402,TCGA-NJ-A4YQ-01A,TCGA-NJ-A4YQ-01A-11D-A25L-08,8,0.416425393,TCGA-NJ-A4YQ,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25427,Alive,TUMOR FREE,1432,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1432,0,1432,NA,NA,0,1432,NA,Stage IA,T1b,M0,NA,10
-0.302291373,4.100901996,TCGA-A7-A6VY-01A,TCGA-A7-A6VY-01A-12D-A33E-09,4,0.42688315,TCGA-A7-A6VY,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17640,Alive,TUMOR FREE,266,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,266,0,266,0,266,0,266,NA,Stage IIB,T2,M0,BRCA.Basal,6
-6.459186992,1.452573692,TCGA-BA-A4IF-01A,TCGA-BA-A4IF-01A-11D-A25Y-08,10,0.339805134,TCGA-BA-A4IF,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-21635,Alive,TUMOR FREE,895,NA,[Not Available],New Primary Tumor,NA,LUL Lung,463,Complete Remission/Response,0,895,0,895,NA,NA,1,463,NA,[Not Available],TX,MX,NA,7
-4.116563998,-1.970453863,TCGA-NJ-A4YP-01A,TCGA-NJ-A4YP-01A-11D-A25L-08,8,0.409295925,TCGA-NJ-A4YP,LUAD,52,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-19106,Alive,TUMOR FREE,50,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,50,0,50,NA,NA,0,50,NA,Stage IB,T2a,M0,NA,10
-0.789722777,4.980147143,TCGA-KK-A6DY-01A,TCGA-KK-A6DY-01A-12D-A30X-08,4,0.455836491,TCGA-KK-A6DY,PRAD,50,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2002,[Not Available],-18420,Alive,WITH TUMOR,4295,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,4295,0,4295,NA,NA,0,4295,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,6
-4.497743341,-1.359289219,TCGA-NJ-A4YI-01A,TCGA-NJ-A4YI-01A-11D-A25L-08,8,0.404229142,TCGA-NJ-A4YI,LUAD,87,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-31867,Dead,NA,NA,4,[Not Available],NA,NA,NA,NA,[Unknown],1,4,NA,4,NA,NA,0,4,NA,Stage IIIA,T2,M0,NA,10
8.126661578,-3.724345208,TCGA-KK-A6E0-01A,TCGA-KK-A6E0-01A-11D-A30X-08,1,0.523599918,TCGA-KK-A6E0,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21700,Alive,TUMOR FREE,1483,NA,[Not Available],Biochemical evidence of disease,NA,NA,941,Complete Remission/Response,0,1483,0,1483,1,941,1,941,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
-3.954719819,-2.455449525,TCGA-AC-A5XS-01A,TCGA-AC-A5XS-01A-11D-A29N-09,8,0.319909291,TCGA-AC-A5XS,BRCA,74,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-27160,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,588,0,588,0,588,0,588,NA,Stage IIA,T2,MX,BRCA.LumA,10
-0.359358082,4.134053573,TCGA-CQ-A4C9-01A,TCGA-CQ-A4C9-01A-11D-A25D-08,4,0.408888871,TCGA-CQ-A4C9,HNSC,56,MALE,[Not Evaluated],Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-20732,Alive,WITH TUMOR,707,NA,[Not Available],Locoregional Disease,Oral Cavity,NA,287,Complete Remission/Response,0,707,0,707,1,287,1,287,NA,Stage III,T2,M0,NA,5
-4.512410383,1.52270481,TCGA-NJ-A4YG-01A,TCGA-NJ-A4YG-01A-22D-A25L-08,0,NA,TCGA-NJ-A4YG,LUAD,65,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-23812,Alive,TUMOR FREE,2261,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,2261,0,2261,NA,NA,0,2261,NA,Stage IB,T2,M0,NA,9
8.922553491,-4.460088765,TCGA-KK-A6E1-01A,TCGA-KK-A6E1-01A-11D-A30X-08,1,0.783957412,TCGA-KK-A6E1,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-21063,Alive,TUMOR FREE,2198,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2198,0,2198,0,2198,0,2198,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-0.090781789,5.030485687,TCGA-AC-A62V-01A,TCGA-AC-A62V-01A-11D-A31U-09,4,0.599515056,TCGA-AC-A62V,BRCA,58,MALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Evaluated],-21389,Dead,WITH TUMOR,NA,348,[Not Available],NA,NA,NA,NA,[Not Available],1,348,1,348,NA,NA,1,348,NA,Stage IV,T2,M1,BRCA.LumB,6
-0.722303046,4.421573248,TCGA-O1-A52J-01A,TCGA-O1-A52J-01A-11D-A25L-08,4,0.469274961,TCGA-O1-A52J,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-27223,Dead,WITH TUMOR,NA,1798,[Not Available],Locoregional Recurrence,NA,NA,898,[Unknown],1,1798,1,1798,NA,NA,1,898,NA,Stage IA,T1,MX,NA,6
-5.208951955,2.609660975,TCGA-NJ-A55R-01A,TCGA-NJ-A55R-01A-11D-A25L-08,0,NA,TCGA-NJ-A55R,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24738,Alive,TUMOR FREE,603,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,603,0,603,NA,NA,0,603,NA,Stage IA,T1b,MX,NA,10
10.084542,-1.741676614,TCGA-KK-A6E2-01A,TCGA-KK-A6E2-01A-11D-A30X-08,1,0.818841828,TCGA-KK-A6E2,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2000,[Not Available],-19974,Alive,TUMOR FREE,5024,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,5024,0,5024,0,5024,0,5024,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
0.179562653,4.651516524,TCGA-AC-A62X-01A,TCGA-AC-A62X-01A-11D-A29N-09,4,0.596288415,TCGA-AC-A62X,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26627,Alive,TUMOR FREE,417,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,417,0,417,0,417,0,417,NA,Stage IIA,T2,MX,BRCA.Basal,6
-5.885746983,3.17646334,TCGA-NJ-A55O-01A,TCGA-NJ-A55O-01A-11D-A25L-08,0,NA,TCGA-NJ-A55O,LUAD,56,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-20628,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,13,0,13,NA,NA,0,13,NA,Stage IIA,T1b,M0,NA,10
8.779052848,-4.075811817,TCGA-KK-A6E3-01A,TCGA-KK-A6E3-01A-21D-A30E-08,1,0.733498087,TCGA-KK-A6E3,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2004,[Not Available],-20547,Alive,TUMOR FREE,2056,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2056,0,2056,NA,NA,0,2056,NA,[Not Applicable],T2c,[Not Applicable],NA,1
8.151795477,-3.465824976,TCGA-NJ-A55A-01A,TCGA-NJ-A55A-01A-11D-A25L-08,1,0.580669113,TCGA-NJ-A55A,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-28022,Alive,TUMOR FREE,15,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,15,0,15,NA,NA,0,15,NA,Stage IB,T2,M0,NA,1
-3.808995534,-2.592862057,TCGA-NJ-A4YF-01A,TCGA-NJ-A4YF-01A-12D-A25L-08,8,0.435435163,TCGA-NJ-A4YF,LUAD,50,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-18584,Alive,TUMOR FREE,2161,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,2161,0,2161,NA,NA,0,2161,NA,Stage IA,T1,M0,NA,10
-5.251291886,2.621528146,TCGA-AH-6549-01A,TCGA-AH-6549-01A-11D-1826-10,12,0.343748449,TCGA-AH-6549,READ,66,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-24337,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,532,0,532,0,532,0,532,NA,[Not Available],T3,MX,NA,8
-6.470464479,-2.121699542,TCGA-BR-A4IY-01A,TCGA-BR-A4IY-01A-11D-A25D-08,0,NA,TCGA-BR-A4IY,STAD,58,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-21314,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,392,0,392,0,392,0,392,NA,Stage IIB,T4a,M0,GI.CIN,2
-5.107818689,2.035521141,TCGA-F5-6863-01A,TCGA-F5-6863-01A-11D-1924-10,0,NA,TCGA-F5-6863,READ,71,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-25936,Dead,WITH TUMOR,NA,361,[Not Available],NA,NA,NA,191,[Unknown],1,361,1,361,NA,NA,1,191,NA,Stage IIIB,T4a,M0,GI.CIN,8
10.02617158,-1.59603519,TCGA-DJ-A1QD-01A,TCGA-DJ-A1QD-01A-11D-A14W-08,1,0.888260192,TCGA-DJ-A1QD,THCA,20,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-7460,Alive,TUMOR FREE,1462,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1462,0,1462,0,1462,0,1462,NA,Stage I,T2,M0,THCA.3,1
9.32852394,-1.497912019,TCGA-27-2521-01A,TCGA-27-2521-01A-01D-1494-08,1,0.651833483,TCGA-27-2521,GBM,34,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-12685,Dead,WITH TUMOR,NA,510,[Not Available],NA,NA,NA,NA,[Not Available],1,510,1,510,NA,NA,1,510,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,6
-0.259016866,4.957880777,TCGA-A7-A6VW-01A,TCGA-A7-A6VW-01A-21D-A33E-09,4,0.574861974,TCGA-A7-A6VW,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17539,Alive,TUMOR FREE,285,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,285,0,285,NA,NA,0,285,NA,Stage IIA,T2,M0,BRCA.Basal,6
9.098469114,-3.62200937,TCGA-KK-A59X-01A,TCGA-KK-A59X-01A-11D-A29Q-08,1,0.714615306,TCGA-KK-A59X,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-20416,Alive,WITH TUMOR,2535,NA,[Not Available],Locoregional Recurrence,"Other, specify",Bladder,2233,[Unknown],0,2535,0,2535,NA,NA,1,2233,NA,[Not Applicable],T3b,[Not Applicable],PRAD.5-SPOP,1
10.0361131,-2.008154938,TCGA-EL-A3MX-01A,TCGA-EL-A3MX-01A-11D-A21A-08,1,0.730537862,TCGA-EL-A3MX,THCA,66,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-24178,Dead,WITH TUMOR,NA,1753,[Not Available],Distant Metastasis,"Other, specify",Femur,1708,[Not Available],1,1753,1,1753,NA,NA,1,1708,NA,Stage IVC,T4,M1,THCA.5,1
1.35491216,3.319071302,TCGA-KK-A59Y-01A,TCGA-KK-A59Y-01A-11D-A26M-08,0,NA,TCGA-KK-A59Y,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20768,Alive,TUMOR FREE,1968,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1968,0,1968,0,1968,0,1968,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-6.241139978,1.614688347,TCGA-A7-A6VX-01A,TCGA-A7-A6VX-01A-12D-A33E-09,10,0.317481451,TCGA-A7-A6VX,BRCA,68,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25066,Alive,TUMOR FREE,317,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,317,0,317,0,317,0,317,NA,Stage IIA,T2,M0,BRCA.LumB,9
9.781240952,-4.229642301,TCGA-97-A4M6-01A,TCGA-97-A4M6-01A-11D-A24P-08,1,0.696680269,TCGA-97-A4M6,LUAD,45,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-16764,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,568,0,568,0,568,0,568,NA,Stage IA,T1a,M0,NA,1
9.136499997,-5.261175939,TCGA-LD-A7W6-01A,TCGA-LD-A7W6-01A-81D-A351-09,1,0.843613569,TCGA-LD-A7W6,BRCA,54,FEMALE,WHITE,"Other, specify",[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20077,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,404,0,404,0,404,0,404,NA,Stage IIB,T2,M0,BRCA.LumA,1
-6.497337451,-1.372145681,TCGA-97-A4M5-01A,TCGA-97-A4M5-01A-11D-A24P-08,7,0.370984603,TCGA-97-A4M5,LUAD,83,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-30665,Alive,TUMOR FREE,634,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,634,0,634,0,634,0,634,NA,Stage IA,T1b,M0,NA,2
3.710236623,1.416945775,TCGA-AC-A3W5-01A,TCGA-AC-A3W5-01A-11D-A228-09,0,NA,TCGA-AC-A3W5,BRCA,65,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2011,[Not Evaluated],-24029,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,504,0,504,NA,NA,0,504,NA,Stage IIA,T2,MX,BRCA.Her2,6
-4.667551795,0.050588979,TCGA-LD-A74U-01A,TCGA-LD-A74U-01A-13D-A33E-09,0,NA,TCGA-LD-A74U,BRCA,79,FEMALE,WHITE,"Other, specify",[Not Available],2013,[Not Available],-28981,Alive,WITH TUMOR,402,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,402,0,402,0,402,0,402,NA,Stage IIIC,T3,M0,BRCA.LumA,10
-0.461352025,3.802449945,TCGA-E2-A574-01A,TCGA-E2-A574-01A-11D-A29N-09,4,0.222792903,TCGA-E2-A574,BRCA,44,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16195,Alive,TUMOR FREE,1179,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1179,0,1179,0,1179,0,1179,NA,Stage IIA,T2,M0,BRCA.Basal,6
-6.942905465,-2.316087247,TCGA-S3-A6ZG-01A,TCGA-S3-A6ZG-01A-22D-A32I-09,6,0.078302648,TCGA-S3-A6ZG,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed Histology (please specify),[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26141,Alive,TUMOR FREE,562,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,562,0,562,0,562,0,562,NA,Stage IIB,T2,M0,BRCA.LumA,2
-6.293545333,-1.401180288,TCGA-35-4123-01A,TCGA-35-4123-01A-01D-1105-08,7,0.196597964,TCGA-35-4123,LUAD,38,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-14064,Alive,TUMOR FREE,182,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,182,0,182,NA,NA,0,182,NA,Stage IA,T1,M0,NA,2
-4.188203478,0.897486698,TCGA-CN-A63W-01A,TCGA-CN-A63W-01A-11D-A30E-08,0,NA,TCGA-CN-A63W,HNSC,48,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-17693,Dead,TUMOR FREE,NA,377,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,377,0,377,NA,NA,0,377,NA,Stage IVA,T4a,MX,NA,10
-5.076921271,2.169326765,TCGA-97-8176-01A,TCGA-97-8176-01A-11D-2393-08,12,0.186455929,TCGA-97-8176,LUAD,63,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23170,Dead,TUMOR FREE,NA,468,[Not Available],Distant Metastasis,NA,NA,39,Stable Disease,1,468,0,468,NA,NA,1,39,NA,Stage IIIA,T3,M0,NA,9
-3.542834763,1.365338919,TCGA-97-8172-01A,TCGA-97-8172-01A-11D-2284-08,0,NA,TCGA-97-8172,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27416,Alive,TUMOR FREE,545,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,545,0,545,0,545,0,545,NA,Stage IB,T2a,M0,NA,10
0.165847149,2.578690013,TCGA-G9-A9S4-01A,TCGA-G9-A9S4-01A-11D-A41K-08,4,0.186043684,TCGA-G9-A9S4,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22684,Alive,TUMOR FREE,906,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,906,0,906,0,906,0,906,NA,[Not Applicable],T3b,[Not Applicable],NA,6
-0.701968194,3.603905119,TCGA-IQ-A61I-01A,TCGA-IQ-A61I-01A-11D-A30E-08,4,0.257505047,TCGA-IQ-A61I,HNSC,63,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G3,2012,[Not Available],-23035,Dead,TUMOR FREE,NA,2,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2,0,2,NA,NA,0,2,NA,Stage IVA,T1,M0,NA,5
-7.762523224,2.110301877,TCGA-UF-A7JV-01A,TCGA-UF-A7JV-01A-11D-A34J-08,9,0.419813845,TCGA-UF-A7JV,HNSC,62,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-22985,Dead,WITH TUMOR,NA,90,[Not Available],NA,Oropharynx,Oropharynx and cervical lymph node,55,Complete Remission/Response,1,90,1,90,NA,NA,1,55,NA,Stage IVA,T4a,M0,NA,7
-0.306458425,4.598862796,TCGA-93-A4JP-01A,TCGA-93-A4JP-01A-11D-A24P-08,4,0.567299262,TCGA-93-A4JP,LUAD,64,MALE,ASIAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23620,Alive,WITH TUMOR,578,NA,[Not Available],Distant Metastasis,NA,NA,497,Partial Remission/Response,0,578,0,578,NA,NA,1,497,NA,Stage IV,TX,M1b,NA,6
9.102768804,-5.045780406,TCGA-G9-A9S7-01A,TCGA-G9-A9S7-01A-11D-A41K-08,1,0.80932192,TCGA-G9-A9S7,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20213,Alive,WITH TUMOR,728,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,728,0,728,NA,NA,0,728,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-0.019390548,5.043645696,TCGA-93-A4JN-01A,TCGA-93-A4JN-01A-11D-A24P-08,4,0.636305044,TCGA-93-A4JN,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26273,Alive,WITH TUMOR,718,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,718,0,718,NA,NA,0,718,NA,Stage IV,T2a,M1a,NA,6
9.206630138,-5.339391235,TCGA-J9-A52B-01A,TCGA-J9-A52B-01A-11D-A26M-08,1,0.814927947,TCGA-J9-A52B,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22849,Alive,NA,422,NA,[Not Available],Biochemical evidence of disease,NA,NA,57,Complete Remission/Response,0,422,0,422,1,57,1,57,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.496456654,-1.719261365,TCGA-5T-A9QA-01A,TCGA-5T-A9QA-01A-11D-A41F-09,1,0.688567849,TCGA-5T-A9QA,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,"Other, specify",[Not Available],2013,[Unknown],-19031,Alive,NA,303,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,303,0,303,NA,NA,0,303,NA,Stage IIA,T2,MX,BRCA.LumB,1
-4.198789562,-2.10581943,TCGA-J9-A52C-01A,TCGA-J9-A52C-01A-11D-A26M-08,8,0.373889504,TCGA-J9-A52C,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20966,Alive,NA,178,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,178,0,178,NA,NA,0,178,NA,[Not Applicable],T3b,[Not Applicable],NA,10
-7.936784286,2.069915713,TCGA-A7-A5ZW-01A,TCGA-A7-A5ZW-01A-12D-A29N-09,9,0.599812864,TCGA-A7-A5ZW,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Peri (6-12 months since last menstrual period),-17529,Alive,TUMOR FREE,326,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,326,0,326,0,326,0,326,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-5.029567113,1.390642885,TCGA-97-A4M3-01A,TCGA-97-A4M3-01A-11D-A24P-08,0,NA,TCGA-97-A4M3,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-25384,Alive,TUMOR FREE,540,NA,[Not Available],New Primary Tumor,NA,NA,54,Complete Remission/Response,0,540,0,540,0,540,1,54,NA,Stage IA,T1b,M0,NA,9
-6.477504662,-1.245546326,TCGA-A7-A5ZX-01A,TCGA-A7-A5ZX-01A-12D-A29N-09,7,0.343796595,TCGA-A7-A5ZX,BRCA,48,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17683,Alive,TUMOR FREE,336,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,336,0,336,NA,NA,0,336,NA,Stage IIIC,T2,M0,BRCA.LumA,2
8.842392249,-2.063176243,TCGA-97-A4M1-01A,TCGA-97-A4M1-01A-11D-A24P-08,1,0.645373038,TCGA-97-A4M1,LUAD,52,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-19272,Alive,TUMOR FREE,601,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,601,0,601,0,601,0,601,NA,Stage IA,T1a,M0,NA,1
-3.44137328,-3.134766523,TCGA-53-7624-01A,TCGA-53-7624-01A-11D-2063-08,8,0.619008319,TCGA-53-7624,LUAD,40,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-14794,Dead,WITH TUMOR,NA,1043,[Not Available],Distant Metastasis,NA,NA,400,Progressive Disease,1,1043,1,1043,NA,NA,1,400,NA,Stage IV,T2,M1,NA,10
8.997640743,-5.460582378,TCGA-J9-A52E-01A,TCGA-J9-A52E-01A-11D-A26M-08,1,0.791290009,TCGA-J9-A52E,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23741,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,323,0,323,NA,NA,0,323,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-0.719163747,3.772744265,TCGA-A7-A6VV-01A,TCGA-A7-A6VV-01A-22D-A33E-09,4,0.297323603,TCGA-A7-A6VV,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Peri (6-12 months since last menstrual period),-18695,Alive,TUMOR FREE,313,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,313,0,313,0,313,0,313,NA,Stage IIA,T2,M0,BRCA.Basal,5
-4.632642544,-1.607391335,TCGA-97-A4M0-01A,TCGA-97-A4M0-01A-11D-A24P-08,8,0.363733819,TCGA-97-A4M0,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22206,Alive,TUMOR FREE,652,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,652,0,652,0,652,0,652,NA,Stage IB,T2a,M0,NA,10
-1.353408388,3.73569471,TCGA-55-A48Z-01A,TCGA-55-A48Z-01A-12D-A24P-08,4,0.331570333,TCGA-55-A48Z,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22056,Alive,WITH TUMOR,651,NA,[Not Available],Distant Metastasis,NA,NA,536,Stable Disease,0,651,0,651,NA,NA,1,536,NA,Stage IIIB,T1a,MX,NA,5
-3.718934456,-2.898324678,TCGA-KK-A59V-01A,TCGA-KK-A59V-01A-11D-A29Q-08,8,0.419781742,TCGA-KK-A59V,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2005,[Not Available],-23483,Alive,TUMOR FREE,3440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3440,0,3440,0,3440,0,3440,NA,[Not Applicable],T3b,[Not Applicable],NA,10
-0.019081644,2.66356737,TCGA-97-A4LX-01A,TCGA-97-A4LX-01A-11D-A24P-08,4,0.186343018,TCGA-97-A4LX,LUAD,81,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-29915,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,614,0,614,0,614,0,614,NA,Stage IB,T2a,M0,NA,6
-5.789743032,3.074441723,TCGA-CM-5863-01A,TCGA-CM-5863-01A-21D-1835-10,11,0.303715049,TCGA-CM-5863,COAD,60,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-22127,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,457,0,457,NA,NA,0,457,NA,Stage IIIB,T3,M0,GI.GS,8
-7.922861836,2.087892331,TCGA-19-5958-01A,TCGA-19-5958-01A-11D-1696-08,9,0.505994733,TCGA-19-5958,GBM,56,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-20466,Dead,WITH TUMOR,NA,428,[Not Available],Recurrence,[Not Applicable],[Not Applicable],356,Progressive Disease,1,428,1,428,NA,NA,1,356,NA,NA,NA,NA,NA,7
9.633434637,-2.391271006,TCGA-BR-6563-01A,TCGA-BR-6563-01A-13D-2053-08,1,0.732835548,TCGA-BR-6563,STAD,60,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-21936,Alive,TUMOR FREE,1190,NA,[Not Available],New Primary Tumor,NA,NA,148,Complete Remission/Response,0,1190,0,1190,0,1190,1,148,NA,Stage IIB,T3,M0,GI.GS,1
9.817368939,-2.302549608,TCGA-D7-6522-01A,TCGA-D7-6522-01A-11D-1800-08,1,0.744508824,TCGA-D7-6522,STAD,58,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-21465,Alive,TUMOR FREE,566,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,566,0,566,0,566,0,566,NA,Stage IB,T2,M0,GI.GS,1
-6.08075676,3.552442433,TCGA-DJ-A13M-01A,TCGA-DJ-A13M-01A-11D-A10S-08,11,0.484188867,TCGA-DJ-A13M,THCA,28,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-10530,Alive,TUMOR FREE,1484,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1484,0,1484,0,1484,0,1484,NA,Stage I,T1b,M0,THCA.1,8
-6.929077078,2.166515049,TCGA-AG-3878-01A,TCGA-AG-3878-01A-02W-0899-10,0,NA,TCGA-AG-3878,READ,64,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-23527,Alive,WITH TUMOR,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage I,T2,M0,GI.GS,7
-6.015571768,3.465554686,TCGA-EL-A4JV-01A,TCGA-EL-A4JV-01A-11D-A257-08,11,0.587012651,TCGA-EL-A4JV,THCA,41,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-15065,Alive,TUMOR FREE,1748,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1748,0,1748,0,1748,0,1748,NA,Stage I,T2,M0,THCA.1,8
10.03606122,-1.591523913,TCGA-EL-A3TA-01A,TCGA-EL-A3TA-01A-12D-A22D-08,1,0.865163488,TCGA-EL-A3TA,THCA,42,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-15366,Alive,TUMOR FREE,2035,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2035,0,2035,0,2035,0,2035,NA,Stage I,T2,M0,THCA.2,1
-7.898155132,2.035645761,TCGA-EA-A3QE-01A,TCGA-EA-A3QE-01A-21D-A21Q-09,9,0.531413411,TCGA-EA-A3QE,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16460,Alive,TUMOR FREE,761,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,761,0,761,0,761,0,761,NA,Stage IB,T1b,M0,NA,7
-0.32338353,4.822047673,TCGA-C5-A1MJ-01A,TCGA-C5-A1MJ-01A-11D-A14W-08,4,0.64034689,TCGA-C5-A1MJ,CESC,61,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22308,Dead,TUMOR FREE,NA,14,NA,NA,NA,NA,NA,[Not Available],1,14,0,14,NA,NA,0,14,NA,Stage IB1,T1b1,MX,NA,6
-1.016608563,3.850884008,TCGA-QK-A6II-01A,TCGA-QK-A6II-01A-11D-A31L-08,4,0.129451884,TCGA-QK-A6II,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-19113,Dead,WITH TUMOR,NA,284,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,NA,176,Progressive Disease,1,284,1,284,NA,NA,1,176,NA,Stage IVA,T4a,M0,NA,6
-0.759290516,2.186299327,TCGA-EA-A5O9-01A,TCGA-EA-A5O9-01A-11D-A28B-09,0,NA,TCGA-EA-A5O9,CESC,39,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14472,Alive,TUMOR FREE,788,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,788,0,788,0,788,0,788,NA,Stage IB2,T1b2,M0,NA,1
0.093806594,5.013119388,TCGA-55-A57B-01A,TCGA-55-A57B-01A-12D-A397-08,4,0.703826092,TCGA-55-A57B,LUAD,80,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-29452,Alive,TUMOR FREE,546,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,546,0,546,0,546,0,546,NA,Stage IA,T1b,M0,NA,6
8.752726992,-4.732482096,TCGA-G9-7509-01A,TCGA-G9-7509-01A-11D-A41K-08,1,0.786498776,TCGA-G9-7509,PRAD,48,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-17538,Alive,TUMOR FREE,1610,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1610,0,1610,0,1610,0,1610,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-6.382575675,3.234129165,TCGA-C5-A3HF-01A,TCGA-C5-A3HF-01A-11D-A20U-09,0,NA,TCGA-C5-A3HF,CESC,24,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,1996,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9115,Dead,WITH TUMOR,NA,543,Cervical Cancer,Distant Metastasis,"Other, specify",Pelvis,450,[Not Available],1,543,1,543,NA,NA,1,450,NA,Stage IB2,[Not Available],[Not Available],NA,7
-4.271810553,-1.580068982,TCGA-55-8203-01A,TCGA-55-8203-01A-11D-2238-08,8,0.377824423,TCGA-55-8203,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25477,Alive,TUMOR FREE,547,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,547,0,547,0,547,0,547,NA,Stage IA,T1b,M0,NA,10
-0.537955393,4.761701179,TCGA-G9-A9S0-01A,TCGA-G9-A9S0-01A-11D-A41K-08,4,0.573093727,TCGA-G9-A9S0,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19530,Dead,WITH TUMOR,NA,791,Prostate Cancer,Distant Metastasis,Bone,NA,423,Progressive Disease,1,791,1,791,NA,NA,1,423,NA,[Not Applicable],T3b,[Not Applicable],NA,6
8.795368106,-3.866849763,TCGA-50-8457-01A,TCGA-50-8457-01A-11D-2323-08,1,0.730529446,TCGA-50-8457,LUAD,63,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23055,Alive,TUMOR FREE,1125,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1125,0,1125,0,1125,0,1125,NA,Stage IA,T1a,M0,NA,1
8.878514266,-4.667392109,TCGA-RA-A741-01A,TCGA-RA-A741-01A-11D-A33O-09,1,0.823040393,TCGA-RA-A741,CESC,34,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12607,Alive,TUMOR FREE,444,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,444,0,444,0,444,0,444,NA,Stage IIB,[Not Available],[Not Available],NA,1
1.390223358,2.18430209,TCGA-EK-A2H0-01A,TCGA-EK-A2H0-01A-11D-A17W-09,0,NA,TCGA-EK-A2H0,CESC,24,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-8918,Alive,TUMOR FREE,1847,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1847,0,1847,0,1847,0,1847,NA,Stage IIB,[Not Available],[Not Available],NA,3
-3.309264129,-3.280116328,TCGA-49-AARE-01A,TCGA-49-AARE-01A-11D-A410-08,8,0.614773507,TCGA-49-AARE,LUAD,51,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],1999,[Not Available],-18893,Dead,WITH TUMOR,NA,1229,[Not Available],Locoregional Recurrence,NA,NA,388,Complete Remission/Response,1,1229,1,1229,1,388,1,388,NA,Stage IA,T1,MX,NA,10
7.767411654,-1.337590039,TCGA-AC-A62Y-01A,TCGA-AC-A62Y-01A-11D-A29N-09,1,0.143991729,TCGA-AC-A62Y,BRCA,79,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28876,Alive,TUMOR FREE,530,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,530,0,530,NA,NA,0,530,NA,Stage IIB,T2,MX,BRCA.LumA,1
-4.026334478,-2.037288296,TCGA-49-AAR9-01A,TCGA-49-AAR9-01A-21D-A410-08,8,0.369567823,TCGA-49-AAR9,LUAD,61,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],1999,[Not Available],-22510,Dead,WITH TUMOR,NA,260,[Not Available],NA,NA,NA,NA,Progressive Disease,1,260,1,260,NA,NA,1,260,NA,Stage IIB,T3,MX,NA,10
9.529587327,-5.615336915,TCGA-EJ-A8FO-01A,TCGA-EJ-A8FO-01A-21D-A364-08,1,0.88022387,TCGA-EJ-A8FO,PRAD,51,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2013,[Not Available],-18875,Alive,TUMOR FREE,282,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,282,0,282,0,282,0,282,NA,[Not Applicable],T3a,[Not Applicable],NA,1
7.686266441,-3.337671923,TCGA-QK-A6IF-01A,TCGA-QK-A6IF-01A-11D-A31L-08,1,0.299179941,TCGA-QK-A6IF,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,2013,[Not Available],-22463,Alive,TUMOR FREE,704,NA,[Not Available],Distant Metastasis,Distant Metastasis,pulmonary nodules throughout both lungs,502,Complete Remission/Response,0,704,0,704,NA,NA,1,502,NA,[Not Available],[Not Available],[Not Available],NA,1
-4.051732567,-1.916790246,TCGA-49-AAR4-01A,TCGA-49-AAR4-01A-12D-A410-08,8,0.366433583,TCGA-49-AAR4,LUAD,51,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-18939,Dead,WITH TUMOR,NA,879,[Not Available],NA,NA,NA,NA,Stable Disease,1,879,1,879,NA,NA,1,879,NA,Stage IIIA,T2,MX,NA,10
9.556062048,-5.697196784,TCGA-EJ-A8FP-01A,TCGA-EJ-A8FP-01A-21D-A364-08,1,0.852805794,TCGA-EJ-A8FP,PRAD,59,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2013,[Not Available],-21769,Alive,TUMOR FREE,299,NA,[Not Available],Biochemical evidence of disease,NA,NA,117,Complete Remission/Response,0,299,0,299,1,117,1,117,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-5.679968436,1.628018132,TCGA-AD-6965-01A,TCGA-AD-6965-01A-11D-1924-10,0,NA,TCGA-AD-6965,COAD,62,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-22853,Alive,WITH TUMOR,805,NA,[Not Available],NA,NA,NA,648,Complete Remission/Response,0,805,0,805,1,648,1,648,NA,Stage IIIC,T4a,M0,GI.CIN,8
-6.540708448,-1.952851998,TCGA-QK-A6IG-01A,TCGA-QK-A6IG-01A-11D-A31L-08,0,NA,TCGA-QK-A6IG,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-25334,Dead,WITH TUMOR,NA,222,[Not Available],Locoregional Disease,Cervical Lymph Nodes,Left level Ib lymph node,142,Progressive Disease,1,222,1,222,NA,NA,1,142,NA,Stage III,T2,M0,NA,2
-5.389007506,2.717771813,TCGA-4B-A93V-01A,TCGA-4B-A93V-01A-11D-A397-08,12,0.092559446,TCGA-4B-A93V,LUAD,52,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-19035,Dead,WITH TUMOR,NA,300,[Not Available],Distant Metastasis,NA,NA,251,Progressive Disease,1,300,1,300,NA,NA,1,251,NA,Stage IA,T1b,M0,NA,8
-5.740091351,1.467731657,TCGA-67-6215-01A,TCGA-67-6215-01A-11D-1753-08,10,0.226009671,TCGA-67-6215,LUAD,52,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-19310,Alive,TUMOR FREE,174,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,174,0,174,0,174,0,174,NA,Stage IB,T2a,M0,LUAD.4,10
4.315933865,1.195287497,TCGA-EJ-A8FS-01A,TCGA-EJ-A8FS-01A-11D-A34U-08,2,0.625379666,TCGA-EJ-A8FS,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24380,Alive,TUMOR FREE,266,NA,[Not Available],Biochemical evidence of disease,NA,NA,216,Complete Remission/Response,0,266,0,266,1,216,1,216,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,5
9.547319486,-5.652921299,TCGA-49-AARR-01A,TCGA-49-AARR-01A-11D-A410-08,1,0.871654134,TCGA-49-AARR,LUAD,68,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-24942,Alive,WITH TUMOR,4992,NA,[Not Available],New Primary Tumor,NA,NA,1099,Complete Remission/Response,0,4992,0,4992,1,4812,1,1099,NA,Stage IA,T1,MX,NA,1
9.539446395,-5.249838564,TCGA-EJ-A8FU-01A,TCGA-EJ-A8FU-01A-11D-A364-08,1,0.852972656,TCGA-EJ-A8FU,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23472,Alive,TUMOR FREE,138,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,138,0,138,0,138,0,138,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,1
-1.780164079,1.345791335,TCGA-QK-A6IH-01A,TCGA-QK-A6IH-01A-11D-A31L-08,5,0.488639613,TCGA-QK-A6IH,HNSC,65,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-23936,Alive,WITH TUMOR,653,NA,[Not Available],NA,Distant Metastasis,Lung,228,Progressive Disease,0,653,0,653,NA,NA,1,228,NA,Stage IVB,T4b,M0,NA,4
-4.02121089,-1.984174392,TCGA-49-AARO-01A,TCGA-49-AARO-01A-12D-A410-08,8,0.356121478,TCGA-49-AARO,LUAD,39,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-14527,Alive,WITH TUMOR,3759,NA,[Not Available],Locoregional Recurrence,NA,NA,1144,Complete Remission/Response,0,3759,0,3759,1,1144,1,1144,NA,Stage IA,T1a,MX,NA,10
-3.743042314,-2.595317621,TCGA-49-AARN-01A,TCGA-49-AARN-01A-21D-A410-08,8,0.422807305,TCGA-49-AARN,LUAD,56,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2000,[Not Available],-20605,Dead,NA,NA,1135,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1135,NA,1135,0,1135,0,1135,NA,Stage IA,T1,MX,NA,10
9.099025948,-3.866099944,TCGA-EJ-AB27-01A,TCGA-EJ-AB27-01A-11D-A41K-08,1,0.740747251,TCGA-EJ-AB27,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-18648,Alive,TUMOR FREE,145,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,145,0,145,0,145,0,145,NA,[Not Applicable],T2c,[Not Applicable],NA,1
0.0746175,4.851625144,TCGA-14-1825-01A,TCGA-14-1825-01A-01D-1494-08,4,0.567106997,TCGA-14-1825,GBM,70,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-25684,Dead,WITH TUMOR,NA,232,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],82,[Not Available],1,232,1,232,NA,NA,1,82,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-3.285046318,-3.311331762,TCGA-AA-3672-01A,TCGA-AA-3672-01A-01W-0900-09,8,0.628716572,TCGA-AA-3672,COAD,90,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-32873,Alive,TUMOR FREE,28,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,28,0,28,NA,NA,0,28,NA,Stage III,T3,M0,NA,10
-7.939199565,2.030868985,TCGA-AA-3527-01A,TCGA-AA-3527-01A-01D-1953-10,9,0.560208707,TCGA-AA-3527,COAD,90,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-32871,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIA,T3,M0,NA,7
-6.029169467,3.421571263,TCGA-AM-5820-01A,TCGA-AM-5820-01A-01D-1650-10,11,0.549858622,TCGA-AM-5820,COAD,59,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-21902,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,14,0,14,NA,NA,0,14,NA,Stage IVA,T4a,M1,GI.CIN,8
-6.512468098,-1.403319714,TCGA-A6-2680-01A,TCGA-A6-2680-01A-01D-1554-10,7,0.281882192,TCGA-A6-2680,COAD,72,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-26533,Alive,TUMOR FREE,1068,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1068,0,1068,0,1068,0,1068,NA,Stage II,T3,M0,NA,2
9.001442064,-3.806372804,TCGA-AA-A00Z-01A,TCGA-AA-A00Z-01A-01D-A17O-10,1,0.748327113,TCGA-AA-A00Z,COAD,70,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-25872,Alive,TUMOR FREE,669,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,669,0,669,0,669,0,669,NA,Stage IIA,T3,M0,NA,1
-6.066956855,3.43338896,TCGA-DM-A282-01A,TCGA-DM-A282-01A-12D-A16V-10,11,0.436560706,TCGA-DM-A282,COAD,60,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-22265,Alive,NA,4233,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4233,0,4233,NA,NA,0,4233,NA,Stage IIA,T3,M0,GI.CIN,8
-6.155996521,-1.648077246,TCGA-77-A5G8-01B,TCGA-77-A5G8-01B-11D-A27K-08,0,NA,TCGA-77-A5G8,LUSC,70,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-25921,Alive,NA,1884,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1884,0,1884,NA,NA,0,1884,NA,Stage IIB,T3,M0,NA,10
-2.977925862,-3.965452205,TCGA-AD-A5EJ-01A,TCGA-AD-A5EJ-01A-11D-A28G-10,8,0.286080163,TCGA-AD-A5EJ,COAD,74,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2012,[Not Available],-27180,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIA,T3,MX,GI.HM-indel,10
-5.337460428,2.253216114,TCGA-NH-A6GA-01A,TCGA-NH-A6GA-01A-11D-A36X-10,12,0.02385521,TCGA-NH-A6GA,COAD,58,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2013,[Not Available],-21313,Dead,WITH TUMOR,NA,302,[Not Available],NA,NA,NA,6,Progressive Disease,1,302,1,302,NA,NA,1,6,NA,Stage IIIC,T4a,MX,GI.CIN,8
-4.477034032,1.692095437,TCGA-NH-A6GB-01A,TCGA-NH-A6GB-01A-11D-A36X-10,0,NA,TCGA-NH-A6GB,COAD,71,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2013,[Not Available],-26100,Alive,WITH TUMOR,476,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,476,0,476,NA,NA,0,476,NA,Stage IIIC,T3,MX,GI.CIN,9
-5.075744459,2.057001058,TCGA-NH-A6GC-01A,TCGA-NH-A6GC-01A-12D-A40P-10,0,NA,TCGA-NH-A6GC,COAD,66,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2013,[Not Available],-24355,Alive,NA,389,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,389,0,389,NA,NA,0,389,NA,Stage IVB,T4b,M1b,GI.CIN,8
-3.946341011,-2.007321608,TCGA-34-8454-01A,TCGA-34-8454-01A-11D-2323-08,8,0.458780197,TCGA-34-8454,LUSC,62,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-22913,Alive,TUMOR FREE,1180,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1180,0,1180,0,1180,0,1180,NA,Stage IIIA,T3,M0,NA,10
-4.010868544,0.668590393,TCGA-34-8455-01A,TCGA-34-8455-01A-11D-2323-08,0,NA,TCGA-34-8455,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24624,Dead,WITH TUMOR,NA,123,[Not Available],NA,NA,NA,NA,Progressive Disease,1,123,1,123,NA,NA,1,123,NA,Stage IV,T4,M1a,NA,10
-2.476601364,1.192029955,TCGA-77-A5G1-01A,TCGA-77-A5G1-01A-11D-A27K-08,5,0.220030394,TCGA-77-A5G1,LUSC,75,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-27555,Alive,NA,4026,NA,[Not Available],New Primary Tumor,NA,NA,2197,Complete Remission/Response,0,4026,0,4026,0,4026,1,2197,NA,Stage IIIA,T3,M0,NA,10
-0.297146059,5.005430205,TCGA-OY-A56P-01A,TCGA-OY-A56P-01A-12D-A403-09,4,0.434412868,TCGA-OY-A56P,OV,48,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2010,[Not Available],-17580,Alive,WITH TUMOR,1207,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],794,Complete Remission/Response,0,1207,0,1207,1,794,1,794,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,6
-6.871718406,-2.434198501,TCGA-OY-A56Q-01A,TCGA-OY-A56Q-01A-11D-A403-09,6,0.086080637,TCGA-OY-A56Q,OV,78,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2012,[Not Available],-28623,Alive,TUMOR FREE,576,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,576,0,576,0,576,0,576,NA,Stage IIA,[Not Applicable],[Not Applicable],NA,2
0.10020526,3.415308169,TCGA-WR-A838-01A,TCGA-WR-A838-01A-12D-A403-09,4,0.400210401,TCGA-WR-A838,OV,72,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2013,[Not Available],-26418,Dead,WITH TUMOR,NA,304,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],245,Progressive Disease,1,304,1,304,NA,NA,1,245,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
9.201437963,-1.518593525,TCGA-EO-A3KW-01A,TCGA-EO-A3KW-01A-11D-A228-09,1,0.655619534,TCGA-EO-A3KW,UCEC,72,FEMALE,[Not Available],Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26492,Alive,TUMOR FREE,497,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,497,0,497,0,497,0,497,NA,Stage IA,[Not Applicable],[Not Applicable],NA,1
-6.019390735,-1.307786997,TCGA-QS-A5YR-01A,TCGA-QS-A5YR-01A-31D-A31U-09,0,NA,TCGA-QS-A5YR,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22372,Alive,WITH TUMOR,719,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,719,0,719,NA,NA,0,719,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,2
-7.061167463,1.569478259,TCGA-G4-6627-01A,TCGA-G4-6627-01A-11D-2188-10,0,NA,TCGA-G4-6627,COAD,84,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-30697,Alive,TUMOR FREE,2275,NA,[Not Available],NA,NA,NA,1003,Complete Remission/Response,0,2275,0,2275,1,1003,1,1003,NA,Stage IIA,T3,M0,GI.GS,8
8.010665967,-2.158027854,TCGA-13-A5FT-01A,TCGA-13-A5FT-01A-11D-A403-09,1,0.440556087,TCGA-13-A5FT,OV,67,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2009,[Not Available],-24743,Alive,TUMOR FREE,2143,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2143,0,2143,0,2143,0,2143,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-0.30921252,4.624256152,TCGA-13-A5FU-01A,TCGA-13-A5FU-01A-11D-A403-09,4,0.573337028,TCGA-13-A5FU,OV,60,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2009,[Not Available],-22256,Dead,WITH TUMOR,NA,256,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,256,1,256,NA,NA,1,256,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
0.008432788,4.408975942,TCGA-29-A5NZ-01A,TCGA-29-A5NZ-01A-11D-A403-09,4,0.513850387,TCGA-29-A5NZ,OV,66,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2011,[Not Available],-24161,Dead,WITH TUMOR,NA,1088,[Not Available],Recurrence,[Not Applicable],[Not Applicable],358,Complete Remission/Response,1,1088,1,1088,1,358,1,358,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-3.70688023,1.223166688,TCGA-59-A5PD-01A,TCGA-59-A5PD-01A-11D-A403-09,0,NA,TCGA-59-A5PD,OV,55,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2011,[Not Available],-20263,Dead,WITH TUMOR,NA,624,[Not Available],Recurrence,[Not Applicable],[Not Applicable],145,Complete Remission/Response,1,624,1,624,1,145,1,145,NA,Stage IC,[Not Applicable],[Not Applicable],NA,6
-3.648606943,1.025158283,TCGA-CR-7398-01A,TCGA-CR-7398-01A-11D-2012-08,0,NA,TCGA-CR-7398,HNSC,53,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-19468,Alive,TUMOR FREE,156,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,156,0,156,0,156,0,156,NA,Stage II,T2,[Not Available],HNSC.Classical,10
-7.736155215,-2.419499882,TCGA-06-0132-01A,TCGA-06-0132-01A-02D-1491-08,6,0.490162244,TCGA-06-0132,GBM,49,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-18125,Dead,WITH TUMOR,570,771,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],482,[Not Available],1,771,1,771,NA,NA,1,482,NA,NA,NA,NA,GBM_LGG.NA,2
-1.069689369,3.809487533,TCGA-LB-A7SX-01A,TCGA-LB-A7SX-01A-11D-A33T-08,4,0.345093981,TCGA-LB-A7SX,PAAD,74,FEMALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27295,Dead,NA,NA,393,"Other, non-malignant disease",NA,NA,NA,NA,Stable Disease,1,393,0,393,NA,NA,0,393,NA,Stage IIB,T3,MX,NA,5
-6.027899623,3.430406005,TCGA-H8-A6C1-01A,TCGA-H8-A6C1-01A-11D-A32N-08,11,0.580256827,TCGA-H8-A6C1,PAAD,53,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2012,[Not Available],-19677,Alive,WITH TUMOR,671,NA,NA,Distant Metastasis,Liver,NA,455,[Discrepancy],0,671,0,671,NA,NA,1,455,NA,Stage IIA,T3,MX,NA,8
9.106635713,-5.387689464,TCGA-Q3-A5QY-01A,TCGA-Q3-A5QY-01A-12D-A32N-08,1,0.783355061,TCGA-Q3-A5QY,PAAD,58,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-21277,Alive,NA,416,NA,NA,NA,NA,NA,NA,[Discrepancy],0,416,0,416,NA,NA,0,416,NA,Stage IIB,T3,MX,NA,1
0.044018681,4.408634003,TCGA-76-4925-01A,TCGA-76-4925-01A-01D-1486-08,4,0.506440051,TCGA-76-4925,GBM,76,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-28011,Dead,NA,146,146,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88,[Not Available],1,146,NA,146,NA,NA,1,88,NA,NA,NA,NA,GBM_LGG.Classic-like,6
-5.760794514,3.105965878,TCGA-FZ-5923-01A,TCGA-FZ-5923-01A-12D-1609-08,11,0.131746847,TCGA-FZ-5923,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2008,[Not Available],-26216,Dead,WITH TUMOR,NA,619,NA,NA,NA,NA,NA,Progressive Disease,1,619,1,619,NA,NA,1,619,NA,Stage IV,T4,M1,NA,8
-6.117525359,3.52784154,TCGA-US-A779-01A,TCGA-US-A779-01A-11D-A32N-08,11,0.51860665,TCGA-US-A779,PAAD,54,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-20051,Dead,WITH TUMOR,NA,511,Pancreatic Cancer,NA,NA,NA,NA,[Not Available],1,511,1,511,NA,NA,1,511,NA,Stage IIB,T3,MX,NA,8
-5.323961183,2.064437665,TCGA-XD-AAUI-01A,TCGA-XD-AAUI-01A-42D-A40W-08,12,0.029135926,TCGA-XD-AAUI,PAAD,50,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-18607,Dead,WITH TUMOR,NA,366,Pancreatic Cancer,Distant Metastasis,Liver,NA,175,Progressive Disease,1,366,1,366,NA,NA,1,175,NA,Stage IIB,T3,MX,NA,8
8.218129427,-3.702139775,TCGA-06-5856-01A,TCGA-06-5856-01A-01D-1696-08,1,0.522772152,TCGA-06-5856,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-21232,Dead,WITH TUMOR,114,114,[Not Available],NA,NA,NA,NA,[Not Available],1,114,1,114,NA,NA,1,114,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-5.308732085,2.599881335,TCGA-XD-AAUL-01A,TCGA-XD-AAUL-01A-21D-A397-08,12,0.344588896,TCGA-XD-AAUL,PAAD,56,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-20607,Alive,TUMOR FREE,498,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,498,0,498,0,498,0,498,NA,Stage IIA,T3,MX,NA,8
-6.023409902,3.213441208,TCGA-4T-AA8H-01A,TCGA-4T-AA8H-01A-11D-A40P-10,11,0.094373704,TCGA-4T-AA8H,COAD,42,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2013,[Not Available],-15494,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,385,0,385,0,385,0,385,NA,Stage IIA,T3,MX,GI.CIN,8
-6.076596536,3.583727096,TCGA-FZ-5920-01A,TCGA-FZ-5920-01A-11D-1609-08,11,0.542444777,TCGA-FZ-5920,PAAD,52,MALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G3,2007,[Not Available],-19287,Dead,NA,NA,61,NA,NA,NA,NA,NA,[Unknown],1,61,NA,61,NA,NA,0,61,NA,Stage IIB,T3,M0,NA,8
-1.436954872,3.41263148,TCGA-50-6593-01A,TCGA-50-6593-01A-11D-1753-08,4,0.100480098,TCGA-50-6593,LUAD,49,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-18152,Dead,WITH TUMOR,NA,336,[Not Available],Distant Metastasis,NA,NA,266,Progressive Disease,1,336,1,336,NA,NA,1,266,NA,Stage IIIA,T1,M0,LUAD.3,10
-6.14318372,3.543980393,TCGA-FB-A5VM-01A,TCGA-FB-A5VM-01A-11D-A32N-08,11,0.500716765,TCGA-FB-A5VM,PAAD,74,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-27362,Dead,WITH TUMOR,NA,498,Pancreatic Cancer,Distant Metastasis,Liver,NA,177,Progressive Disease,1,498,1,498,NA,NA,1,177,NA,Stage IB,T2,M0,NA,8
-0.036803994,3.199289023,TCGA-AY-A8YK-01A,TCGA-AY-A8YK-01A-11D-A40P-10,4,0.347393869,TCGA-AY-A8YK,COAD,44,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2013,[Not Available],-16140,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,573,0,573,NA,NA,0,573,NA,Stage IVA,T3,M1,GI.CIN,3
-6.454521786,-1.428096589,TCGA-NH-A50U-01A,TCGA-NH-A50U-01A-33D-A36X-10,7,0.337176328,TCGA-NH-A50U,COAD,42,MALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2012,[Not Available],-15450,Dead,WITH TUMOR,NA,334,[Not Available],NA,NA,NA,276,Partial Remission/Response,1,334,1,334,NA,NA,1,276,NA,Stage IVA,T4a,M1a,GI.CIN,2
-1.268667152,4.332656158,TCGA-NH-A8F7-01A,TCGA-NH-A8F7-01A-11D-A40P-10,4,0.111931123,TCGA-NH-A8F7,COAD,53,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2013,[Not Available],-19535,Alive,WITH TUMOR,543,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,543,0,543,NA,NA,0,543,NA,Stage IIA,T3,MX,GI.CIN,6
-0.237172869,4.977209231,TCGA-66-2765-01A,TCGA-66-2765-01A-01D-1522-08,4,0.543838623,TCGA-66-2765,LUSC,64,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-23465,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,61,0,61,NA,NA,0,61,NA,Stage IB,T2,M0,LUSC.basal,6
-0.347894903,4.148076685,TCGA-D7-6521-01A,TCGA-D7-6521-01A-11D-1800-08,4,0.565196505,TCGA-D7-6521,STAD,65,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-23776,Alive,WITH TUMOR,564,NA,[Not Available],Locoregional Recurrence,"Other, specify",NA,192,Progressive Disease,0,564,0,564,NA,NA,1,192,NA,[Discrepancy],T2b,M0,GI.CIN,6
-1.093397735,4.092543609,TCGA-52-7622-01A,TCGA-52-7622-01A-11D-2122-08,4,0.325013934,TCGA-52-7622,LUSC,62,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-22807,Alive,TUMOR FREE,862,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,862,0,862,0,862,0,862,NA,Stage IA,T1a,M0,NA,6
-0.430750373,5.052688016,TCGA-XD-AAUG-01A,TCGA-XD-AAUG-01A-61D-A40W-08,4,0.440521379,TCGA-XD-AAUG,PAAD,66,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-24291,Alive,TUMOR FREE,420,NA,NA,NA,NA,NA,NA,[Discrepancy],0,420,0,420,NA,NA,0,420,NA,Stage IV,T3,M1,NA,6
-4.44875255,-0.555810111,TCGA-86-8672-01A,TCGA-86-8672-01A-21D-2393-08,0,NA,TCGA-86-8672,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21682,Dead,TUMOR FREE,NA,19,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,19,0,19,0,19,0,19,NA,Stage IIB,T3,M0,NA,10
9.046097897,-5.167717615,TCGA-XD-AAUH-01A,TCGA-XD-AAUH-01A-42D-A40W-08,1,0.853965185,TCGA-XD-AAUH,PAAD,57,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-20858,Alive,NA,395,NA,NA,New Primary Tumor,"Other, specify",Left shoulder,87,[Unknown],0,395,0,395,NA,NA,1,87,NA,Stage IIB,T3,M0,NA,1
4.386603269,1.100882895,TCGA-EB-A42Z-01A,TCGA-EB-A42Z-01A-12D-A24R-08,2,0.730741007,TCGA-EB-A42Z,SKCM,49,MALE,ASIAN,NA,[Not Available],2012,[Not Available],-18157,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,441,0,441,NA,NA,0,441,NA,Stage IIIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,5
-7.079116131,-2.52287778,TCGA-22-0944-01A,TCGA-22-0944-01A-01D-1521-08,0,NA,TCGA-22-0944,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2000,[Not Available],-22329,Dead,TUMOR FREE,223,223,[Not Available],NA,NA,NA,NA,[Not Available],1,223,0,223,NA,NA,0,223,NA,Stage IB,T2,M0,LUSC.classical,2
-3.802854441,-2.587055766,TCGA-BR-4256-01A,TCGA-BR-4256-01A-01D-1126-08,8,0.421354337,TCGA-BR-4256,STAD,80,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-29441,Dead,NA,NA,284,[Not Available],NA,NA,NA,NA,[Not Available],1,284,NA,284,NA,NA,0,284,NA,[Not Available],TX,M0,GI.HM-indel,10
-3.786085785,-2.744081536,TCGA-21-1083-01A,TCGA-21-1083-01A-01D-1521-08,8,0.443446175,TCGA-21-1083,LUSC,75,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1997,[Not Available],-27708,Dead,TUMOR FREE,267,1315,[Not Available],NA,NA,NA,NA,[Not Available],1,1315,0,1315,NA,NA,0,1315,NA,Stage IA,T1,M0,NA,10
-7.493471562,2.072681247,TCGA-CV-7410-01A,TCGA-CV-7410-01A-21D-2078-08,9,0.358013312,TCGA-CV-7410,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,1993,[Not Available],-22302,Dead,WITH TUMOR,NA,6417,[Not Available],NA,NA,NA,NA,[Not Available],1,6417,1,6417,NA,NA,1,6417,NA,Stage III,T2,[Not Available],HNSC.Mesenchymal,7
9.173440941,-4.777059247,TCGA-06-0939-01A,TCGA-06-0939-01A-01D-1353-08,1,0.849434393,TCGA-06-0939,GBM,79,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-28893,Dead,WITH TUMOR,NA,814,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],329,[Not Available],1,814,1,814,NA,NA,1,329,NA,NA,NA,NA,NA,1
-3.376894356,-3.154925031,TCGA-32-2616-01A,TCGA-32-2616-01A-01D-1495-08,8,0.567766664,TCGA-32-2616,GBM,48,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-17781,Dead,WITH TUMOR,224,224,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],182,[Not Available],1,224,1,224,NA,NA,1,182,NA,NA,NA,NA,GBM_LGG.NA,10
0.024283727,5.111950165,TCGA-06-0195-01B,TCGA-06-0195-01B-01D-1491-08,4,0.555124133,TCGA-06-0195,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1994,[Not Available],-23132,Dead,WITH TUMOR,214,225,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],147,[Not Available],1,225,1,225,NA,NA,1,147,NA,NA,NA,NA,NA,6
-5.611382273,2.589584374,TCGA-IB-AAUU-01A,TCGA-IB-AAUU-01A-11D-A377-08,12,0.089266157,TCGA-IB-AAUU,PAAD,35,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-13127,Alive,TUMOR FREE,245,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,245,0,245,0,245,0,245,NA,Stage IIB,T3,M0,NA,8
9.577361087,-5.650418572,TCGA-IB-AAUV-01A,TCGA-IB-AAUV-01A-11D-A38G-08,1,0.884451156,TCGA-IB-AAUV,PAAD,49,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-18059,Alive,TUMOR FREE,404,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,404,0,404,0,404,0,404,NA,Stage IIB,T3,M0,NA,1
9.58354833,-5.585562997,TCGA-IB-AAUW-01A,TCGA-IB-AAUW-01A-12D-A38G-08,1,0.873942121,TCGA-IB-AAUW,PAAD,63,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-23306,Dead,WITH TUMOR,NA,230,NA,Locoregional Recurrence,Tumor Bed,NA,185,Complete Remission/Response,1,230,1,230,1,185,1,185,NA,Stage IIB,T3,M0,NA,1
-3.762042379,-2.338175273,TCGA-55-6979-01A,TCGA-55-6979-01A-11D-1945-08,8,0.415636224,TCGA-55-6979,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-21780,Dead,WITH TUMOR,NA,237,[Not Available],Distant Metastasis,NA,NA,195,Progressive Disease,1,237,1,237,NA,NA,1,195,NA,Stage IIB,T2,M0,LUAD.5,10
-6.059846444,3.450763716,TCGA-Q3-AA2A-01A,TCGA-Q3-AA2A-01A-11D-A377-08,11,0.549042717,TCGA-Q3-AA2A,PAAD,64,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-23685,Alive,TUMOR FREE,95,NA,NA,NA,NA,NA,NA,[Unknown],0,95,0,95,NA,NA,0,95,NA,Stage IB,T3,MX,NA,8
-7.284294113,1.560599891,TCGA-RB-A7B8-01A,TCGA-RB-A7B8-01A-12D-A33T-08,9,0.045109592,TCGA-RB-A7B8,PAAD,81,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2013,[Not Available],-29585,Dead,TUMOR FREE,NA,466,Pancreatic Cancer,Locoregional Recurrence,NA,NA,449,Complete Remission/Response,1,466,1,466,1,449,1,449,NA,Stage IIB,T3,MX,NA,7
0.684363772,4.485188037,TCGA-RB-AA9M-01A,TCGA-RB-AA9M-01A-11D-A397-08,4,0.050052519,TCGA-RB-AA9M,PAAD,43,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-15807,Alive,WITH TUMOR,286,NA,NA,Distant Metastasis,Liver,NA,258,Progressive Disease,0,286,0,286,NA,NA,1,258,NA,Stage IIB,T1,MX,NA,6
-3.85766083,-2.053205704,TCGA-34-5231-01A,TCGA-34-5231-01A-21D-1817-08,8,0.389941258,TCGA-34-5231,LUSC,72,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-26525,Dead,TUMOR FREE,NA,1984,[Not Available],NA,NA,NA,NA,Stable Disease,1,1984,0,1984,NA,NA,0,1984,NA,Stage IA,T1,M0,LUSC.primitive,10
-4.634667425,-0.856462128,TCGA-92-7340-01A,TCGA-92-7340-01A-21D-2042-08,0,NA,TCGA-92-7340,LUSC,45,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-16447,Alive,WITH TUMOR,82,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,82,0,82,NA,NA,0,82,NA,Stage IIA,T2a,MX,NA,10
-2.212996215,2.228576276,TCGA-34-5236-01A,TCGA-34-5236-01A-21D-1817-08,0,NA,TCGA-34-5236,LUSC,60,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-21935,Dead,WITH TUMOR,NA,276,[Not Available],Locoregional Recurrence,NA,NA,113,Progressive Disease,1,276,1,276,NA,NA,1,113,NA,Stage IIB,T3,M0,LUSC.classical,6
-5.299415799,2.809280759,TCGA-CD-5798-01A,TCGA-CD-5798-01A-11D-1600-08,12,0.116828708,TCGA-CD-5798,STAD,82,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2010,[Not Available],-30310,Alive,TUMOR FREE,408,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,408,0,408,0,408,0,408,NA,Stage II,T3,M0,GI.GS,9
8.928929996,-4.283167412,TCGA-IB-AAUS-01A,TCGA-IB-AAUS-01A-12D-A38G-08,1,0.72301651,TCGA-IB-AAUS,PAAD,84,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-30684,Alive,WITH TUMOR,225,NA,NA,NA,NA,NA,NA,[Not Applicable],0,225,0,225,NA,NA,0,225,NA,Stage IIB,T3,M0,NA,1
-3.743898875,-2.626865794,TCGA-06-1802-01A,TCGA-06-1802-01A-01W-0643-08,8,0.405646182,TCGA-06-1802,GBM,61,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-22537,Dead,WITH TUMOR,NA,466,[Not Available],Recurrence,[Not Applicable],[Not Applicable],81,[Not Available],1,466,1,466,NA,NA,1,81,NA,NA,NA,NA,NA,10
9.347923511,-5.213136792,TCGA-06-0139-01A,TCGA-06-0139-01A-01D-1490-08,1,0.802370881,TCGA-06-0139,GBM,40,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-14729,Dead,WITH TUMOR,327,362,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],152,[Not Available],1,362,1,362,NA,NA,1,152,NA,NA,NA,NA,NA,1
-3.059784946,-3.727938811,TCGA-CN-6010-01A,TCGA-CN-6010-01A-11D-1683-08,8,0.397053754,TCGA-CN-6010,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-19475,Alive,TUMOR FREE,1523,NA,[Not Available],New Primary Tumor,NA,nasal cavity,540,Complete Remission/Response,0,1523,0,1523,NA,NA,1,540,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,10
-6.040725223,3.496233225,TCGA-IB-AAUO-01A,TCGA-IB-AAUO-01A-12D-A38G-08,11,0.556965575,TCGA-IB-AAUO,PAAD,64,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-23622,Dead,WITH TUMOR,NA,239,NA,Distant Metastasis,Liver,NA,74,Partial Remission/Response,1,239,1,239,NA,NA,1,74,NA,Stage IIB,T3,M0,NA,8
9.311525228,-4.339780179,TCGA-IB-AAUP-01A,TCGA-IB-AAUP-01A-11D-A377-08,1,0.762664188,TCGA-IB-AAUP,PAAD,68,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-24864,Alive,TUMOR FREE,431,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,431,0,431,0,431,0,431,NA,Stage IIB,T3,M0,NA,1
-5.329295533,2.639642814,TCGA-IB-AAUQ-01A,TCGA-IB-AAUQ-01A-22D-A40W-08,12,0.279681274,TCGA-IB-AAUQ,PAAD,50,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-18315,Dead,WITH TUMOR,NA,183,Pancreatic Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,NA,107,Partial Remission/Response,1,183,1,183,NA,NA,1,107,NA,Stage IIB,T3,M0,NA,8
9.583884831,-5.597429371,TCGA-IB-AAUR-01A,TCGA-IB-AAUR-01A-21D-A38G-08,1,0.854776621,TCGA-IB-AAUR,PAAD,67,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-24576,Alive,WITH TUMOR,338,NA,NA,Locoregional Recurrence,Tumor Bed,NA,318,Partial Remission/Response,0,338,0,338,NA,NA,1,318,NA,Stage IIB,T3,M0,NA,1
-3.042199428,-3.881778836,TCGA-F1-6177-01A,TCGA-F1-6177-01A-11D-1800-08,8,0.22568581,TCGA-F1-6177,STAD,90,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009,[Not Available],-32873,Alive,TUMOR FREE,200,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,200,0,200,0,200,0,200,NA,Stage I,T1b,MX,GI.HM-indel,10
-3.621585658,1.122577452,TCGA-46-6026-01A,TCGA-46-6026-01A-11D-1817-08,0,NA,TCGA-46-6026,LUSC,81,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-29890,Alive,TUMOR FREE,423,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,423,0,423,0,423,0,423,NA,Stage IIB,T2a,M0,LUSC.primitive,10
-3.810378447,-2.553868086,TCGA-37-3789-01A,TCGA-37-3789-01A-01D-0983-08,8,0.43208357,TCGA-37-3789,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-23782,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,13,0,13,NA,NA,0,13,NA,Stage IB,T2,[Not Available],LUSC.basal,10
-3.218835114,-3.50127324,TCGA-BR-A4QL-01A,TCGA-BR-A4QL-01A-31D-A25D-08,8,0.496197767,TCGA-BR-A4QL,STAD,75,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-27668,Dead,TUMOR FREE,NA,491,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,491,0,491,0,491,0,491,NA,Stage IIIB,T3,M0,NA,10
-1.059663084,4.160372587,TCGA-52-7809-01A,TCGA-52-7809-01A-21D-2122-08,4,0.261640364,TCGA-52-7809,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-27233,Dead,WITH TUMOR,NA,166,[Not Available],NA,NA,NA,NA,Progressive Disease,1,166,1,166,NA,NA,1,166,NA,Stage IB,T2,M0,NA,10
-3.803823708,0.912934824,TCGA-99-7458-01A,TCGA-99-7458-01A-11D-2036-08,0,NA,TCGA-99-7458,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-27359,Alive,WITH TUMOR,747,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,747,0,747,NA,NA,0,747,NA,Stage IIIA,T4,M0,LUAD.5,10
9.541428837,-2.83982779,TCGA-06-0187-01A,TCGA-06-0187-01A-01D-1491-08,1,0.766541054,TCGA-06-0187,GBM,69,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-25318,Dead,WITH TUMOR,801,828,[Not Available],Recurrence,[Not Applicable],[Not Applicable],531,[Not Available],1,828,1,828,NA,NA,1,531,NA,NA,NA,NA,GBM_LGG.NA,1
-0.833839405,2.417103619,TCGA-CV-7178-01A,TCGA-CV-7178-01A-21D-2012-08,0,NA,TCGA-CV-7178,HNSC,64,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2000,[Not Available],-23430,Dead,WITH TUMOR,NA,2166,[Not Available],NA,NA,NA,NA,[Not Available],1,2166,1,2166,NA,NA,1,2166,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,6
9.149590461,-4.031077875,TCGA-76-4932-01A,TCGA-76-4932-01A-01D-1486-08,1,0.749970709,TCGA-76-4932,GBM,50,FEMALE,WHITE,Treated primary GBM,[Not Available],2006,[Not Available],-18433,Dead,WITH TUMOR,1458,1458,[Not Available],NA,NA,NA,NA,[Not Available],1,1458,1,1458,NA,NA,1,1458,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-7.77647432,2.455319434,TCGA-BR-6707-01A,TCGA-BR-6707-01A-11D-1882-08,9,0.4559189,TCGA-BR-6707,STAD,75,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-27529,Alive,WITH TUMOR,491,NA,[Not Available],Locoregional Recurrence,NA,NA,426,Complete Remission/Response,0,491,0,491,1,426,1,426,NA,Stage IIA,T3,M0,GI.EBV,7
-3.446432428,-3.143324696,TCGA-GF-A2C7-01A,TCGA-GF-A2C7-01A-11D-A197-08,8,0.394606221,TCGA-GF-A2C7,SKCM,48,MALE,WHITE,NA,[Not Available],2011,[Not Available],-17545,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,21,0,21,NA,NA,0,21,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
2.042829863,1.821476596,TCGA-BR-A4J9-01A,TCGA-BR-A4J9-01A-12D-A25D-08,3,0.538011132,TCGA-BR-A4J9,STAD,55,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-20093,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,14,0,14,0,14,0,14,NA,Stage IIA,T3,M0,GI.GS,3
-1.999510212,2.508005767,TCGA-85-8071-01A,TCGA-85-8071-01A-11D-2244-08,0,NA,TCGA-85-8071,LUSC,52,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-19158,Alive,TUMOR FREE,815,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,815,0,815,0,815,0,815,NA,Stage IIA,T1a,M0,NA,10
-3.357345293,-3.104951305,TCGA-05-4410-01A,TCGA-05-4410-01A-21D-1855-08,8,0.589700997,TCGA-05-4410,LUAD,62,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],-22888,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IB,T2,M0,LUAD.3,10
-0.974690918,4.276278132,TCGA-F1-6875-01A,TCGA-F1-6875-01A-11D-2053-08,4,0.408963514,TCGA-F1-6875,STAD,79,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,1996,[Not Available],-29209,Dead,TUMOR FREE,NA,2197,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2197,0,2197,0,2197,0,2197,NA,Stage IA,T2,M0,GI.CIN,6
-4.770200368,-1.272761645,TCGA-18-3411-01A,TCGA-18-3411-01A-01D-0983-08,8,0.169321515,TCGA-18-3411,LUSC,63,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-23370,Alive,TUMOR FREE,3576,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,3576,0,3576,NA,NA,0,3576,NA,Stage IIIA,T2,M0,LUSC.classical,10
-5.529384518,2.771370809,TCGA-27-1830-01A,TCGA-27-1830-01A-01D-1494-08,0,NA,TCGA-27-1830,GBM,57,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-21131,Dead,WITH TUMOR,146,154,[Not Available],Recurrence,[Not Applicable],[Not Applicable],124,[Not Available],1,154,1,154,NA,NA,1,124,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,8
-3.31299336,-3.24016074,TCGA-BR-4201-01A,TCGA-BR-4201-01A-01D-1126-08,8,0.493164135,TCGA-BR-4201,STAD,66,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008,[Not Available],-24354,Dead,NA,NA,940,[Not Available],NA,NA,NA,NA,Stable Disease,1,940,NA,940,NA,NA,0,940,NA,[Not Available],T2a,M0,GI.HM-indel,10
-7.147370173,2.22918662,TCGA-BR-6455-01A,TCGA-BR-6455-01A-11D-1800-08,9,0.165985732,TCGA-BR-6455,STAD,59,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-21865,Dead,WITH TUMOR,NA,422,[Not Available],Distant Metastasis,Liver,NA,385,Stable Disease,1,422,1,422,NA,NA,1,385,NA,Stage IIB,T3,M0,GI.EBV,8
2.90553773,3.581186709,TCGA-90-7766-01A,TCGA-90-7766-01A-21D-2122-08,0,NA,TCGA-90-7766,LUSC,66,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24354,Alive,WITH TUMOR,289,NA,[Not Available],Locoregional Recurrence,NA,NA,289,Progressive Disease,0,289,0,289,NA,NA,1,289,NA,Stage IA,T1b,MX,NA,6
-6.090215344,-1.439331558,TCGA-21-1077-01A,TCGA-21-1077-01A-01D-1521-08,7,0.01861873,TCGA-21-1077,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-23523,Dead,WITH TUMOR,1058,1058,[Not Available],NA,NA,NA,644,[Not Available],1,1058,1,1058,NA,NA,1,644,NA,Stage IIB,T2,M0,NA,2
9.455348911,-4.641500598,TCGA-94-7557-01A,TCGA-94-7557-01A-11D-2122-08,1,0.742496556,TCGA-94-7557,LUSC,73,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26802,Dead,TUMOR FREE,NA,5,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,5,0,5,0,5,0,5,NA,Stage IB,T2,M0,NA,1
8.846680135,-1.53559325,TCGA-06-0192-01B,TCGA-06-0192-01B-01D-1492-08,1,0.570230548,TCGA-06-0192,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-21243,Dead,WITH TUMOR,NA,1185,[Not Available],Locoregional Disease,[Not Applicable],[Not Applicable],648,[Not Available],1,1185,1,1185,NA,NA,1,648,NA,NA,NA,NA,NA,1
-6.57981307,-1.288197935,TCGA-12-0656-01A,TCGA-12-0656-01A-03W-0348-08,7,0.313507911,TCGA-12-0656,GBM,48,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],1997,[Not Available],-17865,Dead,WITH TUMOR,2005,2883,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],1467,[Not Available],1,2883,1,2883,NA,NA,1,1467,NA,NA,NA,NA,NA,2
-5.23574193,1.352133607,TCGA-CX-7085-01A,TCGA-CX-7085-01A-21D-2012-08,0,NA,TCGA-CX-7085,HNSC,77,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-28221,Alive,WITH TUMOR,321,NA,[Not Available],Locoregional Recurrence,Oropharynx,Submandibular gland,92,Complete Remission/Response,0,321,0,321,1,92,1,92,NA,Stage I,T1,[Not Available],HNSC.Mesenchymal,10
8.819391627,-4.827961024,TCGA-CG-4455-01A,TCGA-CG-4455-01A-01D-1158-08,1,0.811317159,TCGA-CG-4455,STAD,72,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2008,[Not Available],-26421,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,366,0,366,0,366,0,366,NA,Stage II,T2b,M0,NA,1
-3.201492222,-3.671051855,TCGA-BR-4368-01A,TCGA-BR-4368-01A-01D-1158-08,8,0.53456186,TCGA-BR-4368,STAD,78,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-28770,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IV,T4,M0,GI.HM-indel,10
-4.606989411,-1.483807045,TCGA-66-2758-01A,TCGA-66-2758-01A-02D-1522-08,8,0.317719624,TCGA-66-2758,LUSC,71,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-26209,Alive,TUMOR FREE,639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,639,0,639,0,639,0,639,NA,Stage IB,T2,M0,LUSC.primitive,10
-3.310539562,-3.414544293,TCGA-BR-7851-01A,TCGA-BR-7851-01A-11D-2201-08,8,0.564652758,TCGA-BR-7851,STAD,74,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-27091,Dead,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,NA,0,NA,0,NA,0,NA,NA,Stage IIB,T4a,M0,GI.HM-indel,10
-4.9271791,-1.558964312,TCGA-37-3783-01A,TCGA-37-3783-01A-01D-1267-08,8,0.138195629,TCGA-37-3783,LUSC,51,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-18728,Alive,TUMOR FREE,122,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,122,0,122,NA,NA,0,122,NA,Stage IIIA,T3,M0,LUSC.basal,10
9.203447325,-2.523452932,TCGA-55-8621-01A,TCGA-55-8621-01A-11D-2393-08,1,0.715602329,TCGA-55-8621,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27485,Alive,TUMOR FREE,515,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,515,0,515,0,515,0,515,NA,Stage IA,T1a,MX,NA,3
-0.97696482,3.985669507,TCGA-96-8169-01A,TCGA-96-8169-01A-11D-2293-08,4,0.316311367,TCGA-96-8169,LUSC,67,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24674,Alive,TUMOR FREE,557,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,557,0,557,0,557,0,557,NA,Stage IA,T1a,M0,NA,6
-5.30794952,-1.785502318,TCGA-39-5016-01A,TCGA-39-5016-01A-01D-1441-08,0,NA,TCGA-39-5016,LUSC,44,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-16306,Alive,TUMOR FREE,3850,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3850,0,3850,0,3850,0,3850,NA,Stage IIA,T2a,M0,LUSC.classical,10
-1.479319449,3.497087695,TCGA-77-7335-01A,TCGA-77-7335-01A-11D-2042-08,4,0.126705373,TCGA-77-7335,LUSC,62,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1996,[Not Available],-22863,Dead,NA,NA,2133,[Not Available],NA,NA,NA,NA,[Not Available],1,2133,NA,2133,NA,NA,0,2133,NA,Stage IIIB,T4,M0,NA,6
-4.663253627,0.5161914,TCGA-85-8277-01A,TCGA-85-8277-01A-11D-2293-08,0,NA,TCGA-85-8277,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25793,Dead,TUMOR FREE,NA,307,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,307,0,307,0,307,0,307,NA,Stage IIIA,T3,M0,NA,9
-6.032966277,3.490453128,TCGA-12-3649-01A,TCGA-12-3649-01A-01D-1495-08,11,0.46503174,TCGA-12-3649,GBM,76,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-27846,Dead,WITH TUMOR,351,463,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],351,[Not Available],1,463,1,463,NA,NA,1,351,NA,NA,NA,NA,NA,8
-5.865242248,-2.023025178,TCGA-66-2767-01A,TCGA-66-2767-01A-01D-1522-08,0,NA,TCGA-66-2767,LUSC,62,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-22888,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,61,0,61,NA,NA,0,61,NA,Stage IIIB,T2,M0,LUSC.secretory,10
-4.540376189,0.972391029,TCGA-77-7463-01A,TCGA-77-7463-01A-11D-2042-08,0,NA,TCGA-77-7463,LUSC,75,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-27520,Dead,NA,NA,1423,[Not Available],NA,NA,NA,NA,[Not Available],1,1423,NA,1423,NA,NA,0,1423,NA,Stage IB,T2,M0,NA,10
9.994721868,-1.6212334,TCGA-EM-A3O7-01A,TCGA-EM-A3O7-01A-11D-A21Z-08,1,0.874608973,TCGA-EM-A3O7,THCA,46,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-16842,Alive,TUMOR FREE,223,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,223,0,223,0,223,0,223,NA,Stage III,T3,MX,THCA.5,1
2.111898782,1.786262357,TCGA-EM-A3AL-01A,TCGA-EM-A3AL-01A-11D-A202-08,3,0.518242333,TCGA-EM-A3AL,THCA,45,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-16439,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,430,0,430,0,430,0,430,NA,Stage I,T1b,MX,THCA.1,3
1.209278079,3.438802465,TCGA-EM-A3FN-01A,TCGA-EM-A3FN-01A-11D-A21A-08,0,NA,TCGA-EM-A3FN,THCA,42,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-15655,Alive,TUMOR FREE,367,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,367,0,367,0,367,0,367,NA,Stage I,T3,MX,THCA.1,1
9.654702174,-1.376345986,TCGA-EL-A4JZ-01A,TCGA-EL-A4JZ-01A-11D-A257-08,1,0.706600653,TCGA-EL-A4JZ,THCA,55,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-20290,Alive,TUMOR FREE,1856,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1856,0,1856,0,1856,0,1856,NA,Stage III,T3,M0,THCA.4,1
-6.079896016,3.518563981,TCGA-EM-A3OA-01A,TCGA-EM-A3OA-01A-11D-A21Z-08,11,0.59464551,TCGA-EM-A3OA,THCA,55,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-20284,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,822,0,822,0,822,0,822,NA,Stage II,T2,MX,THCA.1,8
2.108835112,1.805662887,TCGA-EM-A4FH-01A,TCGA-EM-A4FH-01A-11D-A257-08,3,0.450634679,TCGA-EM-A4FH,THCA,69,MALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-25500,Alive,TUMOR FREE,892,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,892,0,892,0,892,0,892,NA,Stage III,T3,MX,THCA.1,3
-4.709763,1.055975393,TCGA-44-6144-01A,TCGA-44-6144-01A-11D-1753-08,0,NA,TCGA-44-6144,LUAD,58,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21283,Alive,WITH TUMOR,723,NA,[Not Available],NA,NA,NA,399,Complete Remission/Response,0,723,0,723,1,399,1,399,NA,Stage IA,T1a,M0,NA,10
-3.264326798,-3.249267016,TCGA-EB-A3Y7-01A,TCGA-EB-A3Y7-01A-11D-A23B-08,8,0.544909798,TCGA-EB-A3Y7,SKCM,86,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-31622,Dead,TUMOR FREE,NA,326,[Not Available],NA,NA,NA,NA,[Not Available],1,326,0,326,NA,NA,0,326,NA,Stage IIIB,T3a,M0,SKCM.NF1_Any_Mutants,10
-0.991022741,3.56726246,TCGA-VQ-AA68-01A,TCGA-VQ-AA68-01A-11D-A410-08,4,0.408795413,TCGA-VQ-AA68,STAD,52,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-19304,Alive,TUMOR FREE,1328,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1328,0,1328,0,1328,0,1328,NA,Stage IIIC,T4a,M0,GI.CIN,5
2.97892816,3.57848012,TCGA-BJ-A4O9-01A,TCGA-BJ-A4O9-01A-11D-A257-08,0,NA,TCGA-BJ-A4O9,THCA,51,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-18938,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,714,0,714,NA,NA,0,714,NA,Stage II,T2,M0,THCA.3,1
9.096549744,-5.302946136,TCGA-BJ-A45E-01A,TCGA-BJ-A45E-01A-11D-A23U-08,1,0.773253591,TCGA-BJ-A45E,THCA,46,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-17115,Alive,TUMOR FREE,639,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,639,0,639,NA,NA,0,639,NA,Stage I,T1a,M0,THCA.NA,1
9.681221789,-5.508104672,TCGA-EL-A3D5-01A,TCGA-EL-A3D5-01A-22D-A202-08,1,0.854468887,TCGA-EL-A3D5,THCA,44,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-16217,Alive,TUMOR FREE,1737,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1737,0,1737,NA,NA,0,1737,NA,Stage I,T3,M0,NA,1
0.051647607,4.372016236,TCGA-VQ-A91Y-01A,TCGA-VQ-A91Y-01A-11D-A410-08,4,0.43713656,TCGA-VQ-A91Y,STAD,67,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011,[Not Available],-24774,Dead,WITH TUMOR,NA,296,Stomach Cancer,Distant Metastasis,Lung,NA,258,Progressive Disease,1,296,1,296,NA,NA,1,258,NA,Stage IIIC,T4a,M0,GI.CIN,6
-0.760265441,3.881294803,TCGA-VQ-A91Z-01A,TCGA-VQ-A91Z-01A-11D-A410-08,4,0.396166994,TCGA-VQ-A91Z,STAD,67,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-24652,Alive,WITH TUMOR,1690,NA,[Not Available],Locoregional Recurrence,NA,NA,1310,Complete Remission/Response,0,1690,0,1690,1,1310,1,1310,NA,Stage IIIA,T3,M0,GI.CIN,5
-6.777434051,-1.930125008,TCGA-VQ-A922-01A,TCGA-VQ-A922-01A-11D-A410-08,6,0.028255868,TCGA-VQ-A922,STAD,70,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-25700,Dead,NA,262,275,Stomach Cancer,Distant Metastasis,Liver,NA,252,Progressive Disease,1,275,1,275,NA,NA,1,252,NA,Stage IV,T4,M0,GI.CIN,2
9.813578515,-2.67405393,TCGA-EL-A3CL-01A,TCGA-EL-A3CL-01A-11D-A19J-08,1,0.7851472,TCGA-EL-A3CL,THCA,70,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1994,[Not Available],-25761,Dead,NA,NA,963,[Not Available],NA,NA,NA,NA,[Not Available],1,963,NA,963,0,963,0,963,NA,Stage II,T2,M0,THCA.5,1
-3.368564641,-3.183866665,TCGA-VQ-A924-01A,TCGA-VQ-A924-01A-11D-A410-08,8,0.582397882,TCGA-VQ-A924,STAD,69,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008,[Not Available],-25351,Dead,WITH TUMOR,NA,1686,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,1686,1,1686,NA,NA,1,1686,NA,Stage II,T3,M0,GI.HM-indel,10
-1.842450305,1.047387628,TCGA-VQ-A925-01A,TCGA-VQ-A925-01A-11D-A410-08,5,0.603015374,TCGA-VQ-A925,STAD,66,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-24230,Dead,WITH TUMOR,NA,138,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,138,1,138,NA,NA,1,138,NA,Stage IIIA,T3,M0,GI.CIN,4
8.944333071,-4.704507403,TCGA-VQ-A927-01A,TCGA-VQ-A927-01A-12D-A410-08,1,0.784478217,TCGA-VQ-A927,STAD,81,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G1,2013,[Not Available],-29676,Dead,WITH TUMOR,NA,200,[Not Available],NA,NA,NA,NA,Stable Disease,1,200,1,200,NA,NA,1,200,NA,Stage IIIB,T3,M0,GI.GS,1
-7.673844356,-2.400075057,TCGA-VQ-A928-01A,TCGA-VQ-A928-01A-11D-A410-08,6,0.390389279,TCGA-VQ-A928,STAD,49,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2010,[Not Available],-18058,Dead,WITH TUMOR,NA,174,Stomach Cancer,Distant Metastasis,Liver,NA,148,Progressive Disease,1,174,1,174,NA,NA,1,148,NA,Stage IV,T3,M0,GI.GS,2
-6.833222486,-2.05316117,TCGA-VQ-A91X-01A,TCGA-VQ-A91X-01A-12D-A410-08,6,0.177917078,TCGA-VQ-A91X,STAD,74,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],-27314,Dead,TUMOR FREE,NA,289,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,289,0,289,0,289,0,289,NA,Stage IIIB,T3,M0,GI.CIN,2
9.017683705,-3.830463914,TCGA-BJ-A3F0-01A,TCGA-BJ-A3F0-01A-11D-A202-08,1,0.650050081,TCGA-BJ-A3F0,THCA,64,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-23545,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,424,0,424,0,424,0,424,NA,Stage I,T1b,M0,THCA.1,1
-7.5220834,2.37852069,TCGA-VQ-A91W-01A,TCGA-VQ-A91W-01A-11D-A410-08,9,0.10887757,TCGA-VQ-A91W,STAD,30,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009,[Not Available],-10963,Alive,NA,1851,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1851,0,1851,0,1851,0,1851,NA,Stage IIIA,T3,M0,GI.EBV,7
-4.056203706,-2.136975617,TCGA-A3-A6NL-01A,TCGA-A3-A6NL-01A-11D-A33K-10,8,0.477599103,TCGA-A3-A6NL,KIRC,49,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-17952,Alive,TUMOR FREE,689,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,689,0,689,0,689,0,689,NA,Stage I,T1b,MX,NA,10
8.229730708,-4.038403166,TCGA-EM-A3FP-01A,TCGA-EM-A3FP-01A-11D-A21A-08,1,0.526938815,TCGA-EM-A3FP,THCA,71,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-26158,Alive,TUMOR FREE,529,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,529,0,529,0,529,0,529,NA,Stage II,T2,MX,THCA.1,1
9.037840679,-2.606591064,TCGA-DJ-A3VL-01A,TCGA-DJ-A3VL-01A-11D-A23M-08,1,0.729102765,TCGA-DJ-A3VL,THCA,38,MALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-14219,Alive,TUMOR FREE,713,NA,[Not Available],New Primary Tumor,"Other, specify",Bowel,411,[Not Available],0,713,0,713,0,713,1,411,NA,Stage I,T1a,M0,THCA.1,1
10.05812348,-1.531758376,TCGA-EM-A3FO-01A,TCGA-EM-A3FO-01A-11D-A21A-08,1,0.829000132,TCGA-EM-A3FO,THCA,40,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-14864,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,532,0,532,0,532,0,532,NA,Stage I,T3,MX,THCA.5,1
2.939511352,3.57854063,TCGA-FY-A4B4-01A,TCGA-FY-A4B4-01A-11D-A23U-08,0,NA,TCGA-FY-A4B4,THCA,62,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-22830,Alive,TUMOR FREE,657,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,657,0,657,NA,NA,0,657,NA,Stage III,T1b,MX,THCA.3,1
-6.456077454,2.447914389,TCGA-VQ-A8PZ-01A,TCGA-VQ-A8PZ-01A-11D-A410-08,0,NA,TCGA-VQ-A8PZ,STAD,56,FEMALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2008,[Not Available],-20735,Alive,TUMOR FREE,2233,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2233,0,2233,0,2233,0,2233,NA,Stage II,T3,M0,NA,8
-7.570211211,-2.306979441,TCGA-VQ-A91A-01A,TCGA-VQ-A91A-01A-11D-A410-08,6,0.370779284,TCGA-VQ-A91A,STAD,67,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G1,2011,[Not Available],-24670,Alive,TUMOR FREE,1200,NA,[Not Available],New Primary Tumor,NA,NA,129,Complete Remission/Response,0,1200,0,1200,0,1200,1,129,NA,Stage IIIB,T3,M0,GI.CIN,2
-5.501498191,2.769152587,TCGA-50-5068-01A,TCGA-50-5068-01A-01D-1625-08,12,0.09976778,TCGA-50-5068,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-21728,Dead,WITH TUMOR,1499,1499,[Not Available],Distant Metastasis,NA,NA,686,Progressive Disease,1,1499,1,1499,NA,NA,1,686,NA,Stage IIB,T2,MX,LUAD.5,8
7.806463034,-1.339466174,TCGA-BJ-A28S-01A,TCGA-BJ-A28S-01A-11D-A19J-08,1,0.158297984,TCGA-BJ-A28S,THCA,79,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-29143,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,640,0,640,NA,NA,0,640,NA,Stage II,T2,M0,THCA.1,1
-2.968893338,-3.958605204,TCGA-VQ-A91D-01A,TCGA-VQ-A91D-01A-11D-A410-08,8,0.27632556,TCGA-VQ-A91D,STAD,70,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-25686,Dead,WITH TUMOR,NA,356,Stomach Cancer,Locoregional Recurrence,NA,NA,351,Progressive Disease,1,356,1,356,NA,NA,1,351,NA,Stage IIIC,T4b,M0,GI.HM-indel,10
-3.208343294,-3.481346144,TCGA-VQ-A91E-01A,TCGA-VQ-A91E-01A-31D-A410-08,8,0.634939147,TCGA-VQ-A91E,STAD,67,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013,[Not Available],-24549,Alive,TUMOR FREE,664,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,664,0,664,0,664,0,664,NA,Stage IIIB,T4b,M0,NA,10
-5.082472104,1.224043382,TCGA-49-4505-01A,TCGA-49-4505-01A-01D-1931-08,0,NA,TCGA-49-4505,LUAD,61,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1996,[Not Available],-22628,Dead,WITH TUMOR,NA,428,[Not Available],Distant Metastasis|New Primary Tumor,NA,NA,417,Complete Remission/Response,1,428,1,428,1,417,1,417,NA,Stage IIB,T2,M0,LUAD.3,10
-3.439994184,-3.218240581,TCGA-VQ-A91K-01A,TCGA-VQ-A91K-01A-11D-A410-08,8,0.562896472,TCGA-VQ-A91K,STAD,69,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009,[Not Available],-25424,Alive,TUMOR FREE,1862,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1862,0,1862,0,1862,0,1862,NA,Stage IIIA,T3,M0,GI.HM-indel,10
9.058263445,-4.849713843,TCGA-6D-AA2E-01A,TCGA-6D-AA2E-01A-11D-A36X-10,1,0.81705081,TCGA-6D-AA2E,KIRC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2013,[Not Available],-25043,Alive,TUMOR FREE,362,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,362,0,362,NA,NA,0,362,NA,Stage I,T1b,MX,NA,1
4.419398811,1.095416699,TCGA-VQ-A91Q-01A,TCGA-VQ-A91Q-01A-12D-A410-08,2,0.677171744,TCGA-VQ-A91Q,STAD,61,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2009,[Not Available],-22303,Dead,WITH TUMOR,NA,633,Stomach Cancer,Locoregional Recurrence,NA,NA,551,Complete Remission/Response,1,633,1,633,NA,NA,1,551,NA,Stage IV,T3,M0,GI.CIN,5
-1.124866741,3.720015491,TCGA-VQ-A91U-01A,TCGA-VQ-A91U-01A-11D-A410-08,4,0.244054493,TCGA-VQ-A91U,STAD,78,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-28791,Dead,NA,NA,52,[Unknown],NA,NA,NA,NA,[Unknown],1,52,NA,52,NA,NA,0,52,NA,Stage IIIA,T3,M0,GI.CIN,6
-4.344635765,-1.131160688,TCGA-16-0848-01A,TCGA-16-0848-01A-01D-1492-08,8,0.204375637,TCGA-16-0848,GBM,57,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-20848,Dead,WITH TUMOR,302,535,[Not Available],Recurrence,[Not Applicable],[Not Applicable],129,[Not Available],1,535,1,535,NA,NA,1,129,NA,NA,NA,NA,NA,10
10.01477204,-1.515813629,TCGA-EM-A3SZ-01A,TCGA-EM-A3SZ-01A-11D-A22Z-08,1,0.879210693,TCGA-EM-A3SZ,THCA,42,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-15659,Alive,TUMOR FREE,389,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,389,0,389,0,389,0,389,NA,Stage I,T2,MX,THCA.4,1
-6.03406268,3.105843834,TCGA-VQ-A8PU-01A,TCGA-VQ-A8PU-01A-12D-A410-08,0,NA,TCGA-VQ-A8PU,STAD,72,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-26625,Dead,TUMOR FREE,NA,832,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,832,0,832,0,832,0,832,NA,Stage IIIA,T4a,M0,GI.CIN,8
-3.77542412,-2.420312107,TCGA-VQ-A8PX-01A,TCGA-VQ-A8PX-01A-12D-A410-08,8,0.436626467,TCGA-VQ-A8PX,STAD,51,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009,[Not Available],-18902,Alive,TUMOR FREE,1964,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1964,0,1964,0,1964,0,1964,NA,Stage IA,T1,M0,GI.HM-indel,10
9.830854786,-1.55463944,TCGA-EL-A3D0-01A,TCGA-EL-A3D0-01A-12D-A202-08,1,0.866427395,TCGA-EL-A3D0,THCA,61,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2001,[Not Available],-22622,Alive,WITH TUMOR,4254,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4254,0,4254,NA,NA,0,4254,NA,Stage III,T4,M0,NA,1
7.81531271,-1.392620199,TCGA-EL-A3CW-01A,TCGA-EL-A3CW-01A-11D-A19J-08,1,0.181605018,TCGA-EL-A3CW,THCA,87,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000,[Not Available],-31934,Dead,NA,NA,1734,[Not Available],NA,NA,NA,NA,[Not Available],1,1734,NA,1734,0,1734,0,1734,NA,Stage III,T2,M0,THCA.2,1
-1.423171354,3.193791335,TCGA-VQ-A8PJ-01A,TCGA-VQ-A8PJ-01A-11D-A410-08,0,NA,TCGA-VQ-A8PJ,STAD,53,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2011,[Not Available],-19390,Dead,WITH TUMOR,NA,82,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,82,1,82,NA,NA,1,82,NA,Stage IV,T4,M1,GI.CIN,5
0.219376904,2.489516791,TCGA-VQ-A8PK-01A,TCGA-VQ-A8PK-01A-12D-A410-08,4,0.13666198,TCGA-VQ-A8PK,STAD,58,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-21419,Dead,WITH TUMOR,NA,543,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,Liver,NA,263,Progressive Disease,1,543,1,543,NA,NA,1,263,NA,Stage IIIB,T3,M0,GI.CIN,6
-6.106083613,3.575964467,TCGA-44-A47F-01A,TCGA-44-A47F-01A-11D-A24D-08,11,0.577569628,TCGA-44-A47F,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27122,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,337,0,337,0,337,0,337,NA,Stage IIB,T2b,M0,NA,8
0.162993148,2.573267539,TCGA-VQ-A8PM-01A,TCGA-VQ-A8PM-01A-21D-A410-08,4,0.154223512,TCGA-VQ-A8PM,STAD,56,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2009,[Not Available],-20665,Dead,WITH TUMOR,NA,57,"Other, non-malignant disease",NA,NA,NA,NA,[Not Applicable],1,57,0,57,NA,NA,1,57,NA,Stage IV,T4,M0,GI.CIN,6
-3.780448781,-2.598977751,TCGA-VQ-A8PO-01A,TCGA-VQ-A8PO-01A-11D-A410-08,8,0.435867494,TCGA-VQ-A8PO,STAD,74,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2008,[Not Available],-27250,Dead,NA,NA,282,Stomach Cancer,Locoregional Recurrence,NA,NA,256,Progressive Disease,1,282,1,282,NA,NA,1,256,NA,Stage IIB,T4a,M0,GI.HM-indel,10
-3.320536562,-3.290213295,TCGA-VQ-A8PP-01A,TCGA-VQ-A8PP-01A-21D-A410-08,8,0.627138829,TCGA-VQ-A8PP,STAD,76,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008,[Not Available],-27774,Dead,WITH TUMOR,NA,712,Stomach Cancer,Locoregional Recurrence,NA,NA,502,Progressive Disease,1,712,1,712,NA,NA,1,502,NA,Stage IV,T4,M0,GI.HM-indel,10
9.020133056,-4.602232201,TCGA-VQ-A8PQ-01A,TCGA-VQ-A8PQ-01A-11D-A410-08,1,0.812157382,TCGA-VQ-A8PQ,STAD,50,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008,[Not Available],-18318,Dead,WITH TUMOR,NA,476,Stomach Cancer,Locoregional Recurrence,NA,NA,91,Progressive Disease,1,476,1,476,NA,NA,1,91,NA,Stage IV,T4,M1,GI.GS,1
-3.137903756,-3.551821973,TCGA-VQ-A8PT-01A,TCGA-VQ-A8PT-01A-11D-A410-08,8,0.612766789,TCGA-VQ-A8PT,STAD,65,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23797,Alive,TUMOR FREE,900,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,900,0,900,0,900,0,900,NA,Stage IIIB,T4b,M0,NA,10
-4.323998808,-1.864967796,TCGA-GN-A269-01A,TCGA-GN-A269-01A-11D-A19A-08,8,0.469139864,TCGA-GN-A269,SKCM,70,MALE,WHITE,NA,[Not Available],2006,[Not Available],-25583,Dead,WITH TUMOR,NA,170,[Not Available],NA,NA,NA,NA,[Not Available],1,170,1,170,NA,NA,1,170,NA,Stage IIIC,T4b,M0,NA,10
-3.44186655,-3.179854084,TCGA-AN-A0AK-01A,TCGA-AN-A0AK-01A-21W-A019-09,8,0.42247347,TCGA-AN-A0AK,BRCA,76,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27977,Alive,TUMOR FREE,224,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,224,0,224,0,224,0,224,NA,Stage IIA,T2,M0,BRCA.LumB,10
9.103850334,-5.539873336,TCGA-28-5218-01A,TCGA-28-5218-01A-01D-1486-08,1,0.827384424,TCGA-28-5218,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-23096,Dead,NA,128,157,[Not Available],NA,NA,NA,NA,[Not Available],1,157,NA,157,NA,NA,0,157,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,1
-4.781157815,-1.667555196,TCGA-28-1757-01A,TCGA-28-1757-01A-02W-0643-08,8,0.217509086,TCGA-28-1757,GBM,71,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-26189,Alive,NA,4,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4,0,4,NA,NA,0,4,NA,NA,NA,NA,NA,10
-6.116450283,3.506088152,TCGA-EM-A4FK-01A,TCGA-EM-A4FK-01A-11D-A257-08,11,0.579256774,TCGA-EM-A4FK,THCA,33,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-12383,Alive,TUMOR FREE,649,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,649,0,649,0,649,0,649,NA,Stage I,T2,MX,THCA.1,8
-7.833227025,2.154037724,TCGA-28-6450-01A,TCGA-28-6450-01A-11D-1696-08,9,0.47799191,TCGA-28-6450,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-22177,Dead,WITH TUMOR,165,165,[Not Available],NA,NA,NA,NA,[Not Available],1,165,1,165,NA,NA,1,165,NA,NA,NA,NA,NA,7
4.351731031,1.122401998,TCGA-EM-A4FQ-01A,TCGA-EM-A4FQ-01A-11D-A257-08,2,0.673195137,TCGA-EM-A4FQ,THCA,42,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-15534,Alive,TUMOR FREE,683,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,683,0,683,0,683,0,683,NA,Stage I,T2,MX,THCA.4,5
-3.87413513,-2.550733155,TCGA-VQ-A8PB-01A,TCGA-VQ-A8PB-01A-11D-A397-08,8,0.387223697,TCGA-VQ-A8PB,STAD,65,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011,[Not Available],-23927,Dead,TUMOR FREE,NA,1043,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1043,0,1043,0,1043,0,1043,NA,Stage II,T3,M0,GI.HM-indel,10
9.714558233,-1.656218149,TCGA-EL-A3CT-01A,TCGA-EL-A3CT-01A-12D-A202-08,1,0.779508198,TCGA-EL-A3CT,THCA,78,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-28597,Dead,NA,NA,1854,[Not Available],NA,NA,NA,NA,[Not Available],1,1854,NA,1854,NA,NA,0,1854,NA,Stage IVA,T4a,M0,THCA.4,1
9.26386593,-1.574272457,TCGA-BH-A0DH-01A,TCGA-BH-A0DH-01A-11D-A099-09,1,0.731498522,TCGA-BH-A0DH,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23366,Alive,TUMOR FREE,1156,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1156,0,1156,0,1156,0,1156,NA,Stage IIB,T2,M0,BRCA.LumA,1
9.359851461,-2.273766555,TCGA-VQ-A8PD-01A,TCGA-VQ-A8PD-01A-11D-A410-08,1,0.742091215,TCGA-VQ-A8PD,STAD,69,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-25244,Dead,WITH TUMOR,NA,496,[Not Available],Distant Metastasis,"Other, specify",NA,134,Progressive Disease,1,496,1,496,NA,NA,1,134,NA,Stage IIIC,T4a,M0,GI.GS,1
0.388789971,4.596855857,TCGA-VQ-A8PE-01A,TCGA-VQ-A8PE-01A-11D-A410-08,4,0.405877935,TCGA-VQ-A8PE,STAD,78,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-28755,Dead,WITH TUMOR,NA,675,[Not Available],Locoregional Recurrence,NA,NA,265,Progressive Disease,1,675,1,675,NA,NA,1,265,NA,Stage IIIB,T3,M0,GI.CIN,6
-4.644843703,-1.078245049,TCGA-EW-A1IZ-01A,TCGA-EW-A1IZ-01A-11D-A188-09,8,0.090534272,TCGA-EW-A1IZ,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19706,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,554,0,554,0,554,0,554,NA,Stage IIIA,T2,MX,BRCA.LumA,10
-0.47603303,2.30109953,TCGA-B6-A1KF-01A,TCGA-B6-A1KF-01A-11D-A13L-09,4,0.014706867,TCGA-B6-A1KF,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24891,Alive,TUMOR FREE,3088,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3088,0,3088,0,3088,0,3088,NA,Stage IIB,T2,M0,BRCA.Basal,3
-4.10187159,-1.400331482,TCGA-86-8279-01A,TCGA-86-8279-01A-11D-2284-08,8,0.219175831,TCGA-86-8279,LUAD,46,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-17032,Alive,TUMOR FREE,949,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,949,0,949,0,949,0,949,NA,Stage IIA,T2a,M0,NA,10
-0.486939594,3.004075278,TCGA-55-1596-01A,TCGA-55-1596-01A-01D-1040-01,4,0.009521419,TCGA-55-1596,LUAD,55,MALE,ASIAN,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-20381,Alive,TUMOR FREE,2065,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2065,0,2065,0,2065,0,2065,NA,Stage IIB,T2,M0,LUAD.2,3
-6.227370655,3.65636854,TCGA-EM-A4FV-01A,TCGA-EM-A4FV-01A-11D-A257-08,11,0.512058461,TCGA-EM-A4FV,THCA,64,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-23627,Alive,TUMOR FREE,744,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,744,0,744,0,744,0,744,NA,Stage I,T1b,MX,THCA.2,8
-4.202324481,-1.915907778,TCGA-55-8094-01A,TCGA-55-8094-01A-11D-2238-08,8,0.299945911,TCGA-55-8094,LUAD,51,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-18903,Alive,WITH TUMOR,541,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,541,0,541,NA,NA,0,541,NA,Stage IV,T2b,M1b,NA,10
-3.60881648,-3.101464047,TCGA-86-8358-01A,TCGA-86-8358-01A-11D-2323-08,8,0.605342719,TCGA-86-8358,LUAD,44,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-16409,Alive,TUMOR FREE,653,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,653,0,653,0,653,0,653,NA,Stage IB,T2a,M0,NA,10
-2.849621407,-4.182104437,TCGA-VQ-A8P2-01A,TCGA-VQ-A8P2-01A-11D-A364-08,0,NA,TCGA-VQ-A8P2,STAD,68,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011,[Not Available],-25129,Alive,TUMOR FREE,1160,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1160,0,1160,0,1160,0,1160,NA,Stage IIIA,T4a,M0,GI.HM-indel,10
4.471125247,1.170322707,TCGA-VQ-A8P8-01A,TCGA-VQ-A8P8-01A-11D-A397-08,2,0.673462439,TCGA-VQ-A8P8,STAD,72,FEMALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-26443,Alive,TUMOR FREE,942,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,942,0,942,0,942,0,942,NA,Stage IIB,T4a,M0,GI.GS,5
8.742726725,-1.912896472,TCGA-12-3650-01A,TCGA-12-3650-01A-01D-1495-08,1,0.562640908,TCGA-12-3650,GBM,46,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-17138,Dead,WITH TUMOR,333,333,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],239,[Not Available],1,333,1,333,NA,NA,1,239,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-7.407060383,2.667491484,TCGA-BJ-A3EZ-01A,TCGA-BJ-A3EZ-01A-11D-A202-08,0,NA,TCGA-BJ-A3EZ,THCA,51,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-18882,Alive,TUMOR FREE,487,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,487,0,487,NA,NA,0,487,NA,Stage IVA,T3,M0,THCA.3,7
10.06764759,-1.838872145,TCGA-EM-A3O3-01A,TCGA-EM-A3O3-01A-11D-A21Z-08,1,0.835738891,TCGA-EM-A3O3,THCA,83,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-30500,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,441,0,441,0,441,0,441,NA,Stage III,T2,MX,THCA.4,1
-2.059831612,1.191645942,TCGA-VQ-A8DZ-01A,TCGA-VQ-A8DZ-01A-11D-A364-08,5,0.629405546,TCGA-VQ-A8DZ,STAD,70,MALE,BLACK OR AFRICAN AMERICAN,"Stomach Adenocarcinoma, Signet Ring Type",G3,2011,[Not Available],-25863,Dead,WITH TUMOR,NA,396,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,396,1,396,NA,NA,1,396,NA,Stage IV,T4,M1,GI.CIN,4
8.603193277,-4.518227263,TCGA-EM-A3FR-01A,TCGA-EM-A3FR-01A-11D-A21Z-08,1,0.787772893,TCGA-EM-A3FR,THCA,55,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-20349,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,457,0,457,0,457,0,457,NA,Stage III,T2,MX,THCA.1,1
-7.386428325,-2.037275344,TCGA-VQ-A8E0-01A,TCGA-VQ-A8E0-01A-11D-A410-08,6,0.145188377,TCGA-VQ-A8E0,STAD,68,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-24848,Dead,WITH TUMOR,NA,562,Stomach Cancer,Distant Metastasis,Liver,NA,531,Progressive Disease,1,562,1,562,NA,NA,1,531,NA,Stage IIIA,T3,M0,GI.CIN,2
-6.109895474,3.542258988,TCGA-EM-A4G1-01A,TCGA-EM-A4G1-01A-11D-A257-08,11,0.56014284,TCGA-EM-A4G1,THCA,26,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-9844,Alive,TUMOR FREE,416,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,416,0,416,0,416,0,416,NA,Stage I,T1b,MX,THCA.1,8
-6.030644099,2.103301416,TCGA-VQ-A8E2-01A,TCGA-VQ-A8E2-01A-11D-A364-08,10,0,TCGA-VQ-A8E2,STAD,57,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-21112,Alive,TUMOR FREE,1319,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1319,0,1319,0,1319,0,1319,NA,Stage IIIB,T3,M0,GI.CIN,9
-3.758353846,-2.65735813,TCGA-VQ-A8E3-01A,TCGA-VQ-A8E3-01A-11D-A397-08,8,0.361895739,TCGA-VQ-A8E3,STAD,79,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-28919,Dead,NA,NA,661,[Unknown],Locoregional Recurrence,NA,NA,538,[Unknown],1,661,NA,661,NA,NA,1,538,NA,Stage IIA,T3,M0,GI.HM-indel,10
-7.291361459,1.498255152,TCGA-D8-A145-01A,TCGA-D8-A145-01A-11D-A10Y-09,0,NA,TCGA-D8-A145,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29280,Alive,TUMOR FREE,410,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,410,0,410,0,410,0,410,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-5.563491909,-1.537275527,TCGA-49-6744-01A,TCGA-49-6744-01A-11D-1855-08,0,NA,TCGA-49-6744,LUAD,64,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-23484,Alive,TUMOR FREE,1683,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1683,0,1683,0,1683,0,1683,NA,Stage IIA,T2a,MX,LUAD.5,2
1.652149992,2.154503459,TCGA-VQ-A8DL-01A,TCGA-VQ-A8DL-01A-11D-A364-08,3,0.097005476,TCGA-VQ-A8DL,STAD,69,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-25299,Dead,TUMOR FREE,NA,28,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,28,0,28,0,28,0,28,NA,Stage IIA,T3,M0,NA,6
0.079924848,3.774638864,TCGA-VQ-A8DT-01A,TCGA-VQ-A8DT-01A-11D-A364-08,4,0.071824979,TCGA-VQ-A8DT,STAD,43,MALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],-15937,Alive,WITH TUMOR,1484,NA,[Not Available],Distant Metastasis,Liver,NA,1376,Complete Remission/Response,0,1484,0,1484,1,1376,1,1376,NA,Stage IIIB,T3,M0,GI.GS,10
-1.515164879,3.223885769,TCGA-VQ-A8DU-01A,TCGA-VQ-A8DU-01A-11D-A364-08,0,NA,TCGA-VQ-A8DU,STAD,63,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-23042,Dead,WITH TUMOR,NA,166,Stomach Cancer,Distant Metastasis,Liver,NA,158,Progressive Disease,1,166,1,166,NA,NA,1,158,NA,Stage IIIA,T3,M0,GI.CIN,6
-0.937961529,3.703332619,TCGA-VQ-A8DV-01A,TCGA-VQ-A8DV-01A-12D-A364-08,4,0.353832638,TCGA-VQ-A8DV,STAD,48,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-17630,Dead,WITH TUMOR,NA,403,Stomach Cancer,Distant Metastasis,Liver,NA,288,Progressive Disease,1,403,1,403,NA,NA,1,288,NA,Stage IB,T2,M0,GI.CIN,5
-0.341981391,4.634015591,TCGA-FP-8099-01A,TCGA-FP-8099-01A-11D-2340-08,4,0.426059056,TCGA-FP-8099,STAD,79,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-29129,Alive,TUMOR FREE,519,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,519,0,519,0,519,0,519,NA,Stage IIA,T3,MX,GI.CIN,5
-5.734686126,-2.136865305,TCGA-BH-A0DZ-01A,TCGA-BH-A0DZ-01A-11W-A019-09,0,NA,TCGA-BH-A0DZ,BRCA,43,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15980,Alive,TUMOR FREE,495,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,495,0,495,0,495,0,495,NA,Stage IIB,T2,M0,BRCA.LumA,10
-0.671095781,2.220866892,TCGA-32-1976-01A,TCGA-32-1976-01A-01W-0837-08,0,NA,TCGA-32-1976,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-23798,Dead,NA,15,15,[Not Available],NA,NA,NA,NA,[Not Available],1,15,NA,15,NA,NA,0,15,NA,NA,NA,NA,NA,1
7.762726931,-1.337018604,TCGA-26-5132-01A,TCGA-26-5132-01A-01D-1486-08,1,0.114686082,TCGA-26-5132,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-27196,Alive,TUMOR FREE,286,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,286,0,286,NA,NA,0,286,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-0.738262448,4.504910886,TCGA-IN-A7NR-01A,TCGA-IN-A7NR-01A-11D-A34U-08,4,0.340414411,TCGA-IN-A7NR,STAD,64,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013,[Not Available],-23415,Alive,TUMOR FREE,198,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,198,0,198,NA,NA,0,198,NA,Stage IV,T3,M1,GI.CIN,3
-0.274353305,4.062741044,TCGA-IN-A7NT-01A,TCGA-IN-A7NT-01A-21D-A34U-08,4,0.359003688,TCGA-IN-A7NT,STAD,73,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013,[Not Available],-26727,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,323,0,323,0,323,0,323,NA,Stage IIB,T3,M0,GI.CIN,5
-5.719389657,-2.201596526,TCGA-KB-A93H-01A,TCGA-KB-A93H-01A-11D-A397-08,0,NA,TCGA-KB-A93H,STAD,79,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011,[Not Available],-28966,Alive,TUMOR FREE,1145,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1145,0,1145,0,1145,0,1145,NA,Stage IIB,T3,M0,NA,2
0.29677727,2.324980148,TCGA-MX-A663-01A,TCGA-MX-A663-01A-11D-A31L-08,4,0.04762575,TCGA-MX-A663,STAD,66,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-24421,Dead,WITH TUMOR,NA,300,[Not Available],Distant Metastasis,"Other, specify",Liver and left supraclavicular lymph node,218,Complete Remission/Response,1,300,1,300,1,218,1,218,NA,Stage IIA,T3,M0,GI.CIN,6
-6.049787949,3.505409376,TCGA-86-8076-01A,TCGA-86-8076-01A-31D-2238-08,11,0.51561488,TCGA-86-8076,LUAD,42,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-15605,Alive,TUMOR FREE,993,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,993,0,993,0,993,0,993,NA,Stage IA,T1,M0,NA,8
-3.823503945,-2.665736568,TCGA-SW-A7EA-01A,TCGA-SW-A7EA-01A-12D-A34U-08,8,0.431989935,TCGA-SW-A7EA,STAD,61,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",GX,2013,[Not Available],-22294,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,579,0,579,0,579,0,579,NA,Stage IB,T2,M0,GI.HM-indel,10
9.433745815,-5.122914225,TCGA-AN-A0XV-01A,TCGA-AN-A0XV-01A-11D-A10G-09,1,0.834897583,TCGA-AN-A0XV,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24779,Alive,TUMOR FREE,162,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,162,0,162,0,162,0,162,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-3.212052168,-3.327166077,TCGA-33-4566-01A,TCGA-33-4566-01A-01D-1441-08,8,0.582227504,TCGA-33-4566,LUSC,40,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1996,[Not Available],-14643,Dead,NA,NA,5287,[Not Available],NA,NA,NA,NA,[Unknown],1,5287,NA,5287,NA,NA,0,5287,NA,Stage IB,T2,M0,LUSC.secretory,10
-4.322487014,-0.821623844,TCGA-IN-A6RO-01A,TCGA-IN-A6RO-01A-12D-A33T-08,0,NA,TCGA-IN-A6RO,STAD,70,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-25789,Dead,WITH TUMOR,NA,NA,[Unknown],Distant Metastasis,NA,NA,154,[Discrepancy],1,NA,1,NA,NA,NA,1,154,NA,Stage IA,T1b,M0,GI.CIN,10
4.382378661,1.145801334,TCGA-50-5055-01A,TCGA-50-5055-01A-01D-1625-08,2,0.706101422,TCGA-50-5055,LUAD,79,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-28988,Dead,WITH TUMOR,NA,1830,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,771,Stable Disease,1,1830,1,1830,NA,NA,1,771,NA,Stage IIA,T1,M0,LUAD.6,5
-4.248327216,-0.902020817,TCGA-EB-A24C-01A,TCGA-EB-A24C-01A-11D-A197-08,8,0.047179073,TCGA-EB-A24C,SKCM,56,MALE,WHITE,NA,[Not Available],2011,[Not Available],-20539,Alive,TUMOR FREE,632,NA,[Not Available],Regional lymph node,NA,NA,465,[Not Available],0,632,0,632,NA,NA,1,465,NA,[Not Available],T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-6.004655516,1.481845617,TCGA-IN-A6RP-01A,TCGA-IN-A6RP-01A-21D-A33T-08,10,0.194378561,TCGA-IN-A6RP,STAD,63,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23282,Alive,WITH TUMOR,196,NA,[Not Available],Distant Metastasis,Liver,NA,150,Progressive Disease,0,196,0,196,NA,NA,1,150,NA,[Discrepancy],T1b,M0,NA,9
-0.261939894,4.284671549,TCGA-22-5480-01A,TCGA-22-5480-01A-01D-1632-08,4,0.479246535,TCGA-22-5480,LUSC,66,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-24245,Dead,WITH TUMOR,2170,2170,[Not Available],NA,NA,NA,1779,Complete Remission/Response,1,2170,1,2170,1,1779,1,1779,NA,Stage IA,T1b,M0,LUSC.secretory,6
-2.053504249,2.454151297,TCGA-EB-A3XF-01A,TCGA-EB-A3XF-01A-31D-A23B-08,0,NA,TCGA-EB-A3XF,SKCM,57,MALE,WHITE,NA,[Not Available],2012,[Not Available],-20910,Alive,TUMOR FREE,278,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,278,0,278,NA,NA,0,278,NA,Stage IIC,T4b,M0,SKCM.-,10
-0.662937838,2.797491395,TCGA-IN-A6RR-01A,TCGA-IN-A6RR-01A-12D-A32N-08,4,0.194572931,TCGA-IN-A6RR,STAD,84,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013,[Not Available],-30734,Dead,TUMOR FREE,NA,205,[Not Available],NA,NA,NA,NA,[Unknown],1,205,0,205,NA,NA,0,205,NA,[Discrepancy],T3,M0,GI.CIN,6
-0.092949752,3.220585248,TCGA-CG-4300-01A,TCGA-CG-4300-01A-01D-1158-08,4,0.29933752,TCGA-CG-4300,STAD,79,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006,[Not Available],-29128,Dead,NA,NA,609,[Not Available],NA,NA,NA,NA,[Not Available],1,609,NA,609,NA,NA,0,609,NA,Stage IIIB,T3,M0,NA,3
-0.61497894,4.725033641,TCGA-IN-A6RS-01A,TCGA-IN-A6RS-01A-12D-A34U-08,4,0.553295518,TCGA-IN-A6RS,STAD,76,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013,[Not Available],-27808,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,383,0,383,0,383,0,383,NA,Stage IA,T1b,M0,GI.CIN,6
-6.90177054,2.015216028,TCGA-02-2466-01A,TCGA-02-2466-01A-01W-0837-08,9,0.055043671,TCGA-02-2466,GBM,61,MALE,WHITE,Treated primary GBM,[Not Available],2007,[Not Available],-22457,Dead,WITH TUMOR,511,511,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],128,[Not Available],1,511,1,511,NA,NA,1,128,NA,NA,NA,NA,NA,7
9.506389798,-5.520643967,TCGA-AO-A0J8-01A,TCGA-AO-A0J8-01A-21D-A045-09,1,0.814880883,TCGA-AO-A0J8,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22284,Alive,TUMOR FREE,680,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,680,0,680,0,680,0,680,NA,Stage IIA,T2,M0,BRCA.LumA,1
-6.001698892,1.858076693,TCGA-27-1838-01A,TCGA-27-1838-01A-01D-1494-08,0,NA,TCGA-27-1838,GBM,59,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-21706,Dead,WITH TUMOR,350,350,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],119,[Not Available],1,350,1,350,NA,NA,1,119,NA,NA,NA,NA,NA,7
-5.97330423,3.053803293,TCGA-FZ-5922-01A,TCGA-FZ-5922-01A-11D-1609-08,0,NA,TCGA-FZ-5922,PAAD,81,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-29633,Dead,WITH TUMOR,NA,1101,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,NA,740,Progressive Disease,1,1101,1,1101,NA,NA,1,740,NA,Stage IIA,T3,M0,NA,8
-5.836732528,2.544898182,TCGA-PZ-A5RE-01A,TCGA-PZ-A5RE-01A-11D-A32N-08,0,NA,TCGA-PZ-A5RE,PAAD,44,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-16255,Dead,WITH TUMOR,NA,470,Pancreatic Cancer,Distant Metastasis,Liver,NA,393,[Unknown],1,470,1,470,NA,NA,1,393,NA,Stage IIB,T3,MX,NA,8
9.232271862,-4.049466587,TCGA-US-A77E-01A,TCGA-US-A77E-01A-11D-A32N-08,1,0.750179335,TCGA-US-A77E,PAAD,73,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-26745,Dead,WITH TUMOR,NA,430,Pancreatic Cancer,Distant Metastasis,Liver,NA,166,[Not Available],1,430,1,430,NA,NA,1,166,NA,Stage IIB,T3,MX,NA,1
-0.846222118,3.667438294,TCGA-RU-A8FL-01A,TCGA-RU-A8FL-01A-11D-A36X-10,4,0.265713234,TCGA-RU-A8FL,COAD,51,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-18975,Alive,WITH TUMOR,1177,NA,[Not Available],Metastatic,NA,NA,256,Partial Remission/Response,0,1177,0,1177,NA,NA,1,256,NA,Stage IIIB,T3,MX,GI.CIN,6
-6.096637466,3.574743824,TCGA-FB-A7DR-01A,TCGA-FB-A7DR-01A-21D-A33T-08,11,0.395034207,TCGA-FB-A7DR,PAAD,48,MALE,ASIAN,Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2012,[Not Available],-17649,Dead,TUMOR FREE,NA,353,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,1,353,1,353,0,353,0,353,NA,Stage IIA,T3,M0,NA,8
-2.891860651,-4.167998228,TCGA-WS-AB45-01A,TCGA-WS-AB45-01A-11D-A40P-10,0,NA,TCGA-WS-AB45,COAD,52,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],NA,Alive,TUMOR FREE,2130,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2130,0,2130,0,2130,0,2130,NA,Stage IIA,T3,MX,GI.HM-indel,10
-5.287939147,2.629377846,TCGA-IB-A6UG-01A,TCGA-IB-A6UG-01A-32D-A33T-08,12,0.280550197,TCGA-IB-A6UG,PAAD,65,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-23751,Dead,WITH TUMOR,NA,41,"Other, non-malignant disease",NA,NA,NA,NA,Partial Remission/Response,1,41,0,41,NA,NA,1,41,NA,Stage IIB,T3,M0,NA,8
-7.010728575,2.017855711,TCGA-D7-A747-01A,TCGA-D7-A747-01A-22D-A33T-08,0,NA,TCGA-D7-A747,STAD,57,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2013,[Not Available],-20923,Dead,WITH TUMOR,NA,255,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,255,1,255,NA,NA,1,255,NA,Stage IIB,T3,M0,GI.CIN,7
-0.230532516,4.260827819,TCGA-IN-A6RI-01A,TCGA-IN-A6RI-01A-11D-A32N-08,4,0.449849088,TCGA-IN-A6RI,STAD,45,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-16788,Alive,TUMOR FREE,559,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,559,0,559,0,559,0,559,NA,Stage I,T1b,M0,GI.CIN,6
8.857482557,-3.048464395,TCGA-IN-A6RJ-01A,TCGA-IN-A6RJ-01A-21D-A33T-08,1,0.680909826,TCGA-IN-A6RJ,STAD,64,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23439,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage IA,T1b,M0,GI.CIN,3
-3.877054624,-1.753228442,TCGA-IN-A6RL-01A,TCGA-IN-A6RL-01A-11D-A32N-08,8,0.329225996,TCGA-IN-A6RL,STAD,84,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-30783,Dead,WITH TUMOR,NA,406,[Not Available],Distant Metastasis,NA,NA,307,Complete Remission/Response,1,406,1,406,1,307,1,307,NA,[Discrepancy],T2,M0,GI.HM-SNV,10
8.888569178,-3.459253737,TCGA-97-8171-01A,TCGA-97-8171-01A-11D-2284-08,1,0.708697484,TCGA-97-8171,LUAD,81,MALE,ASIAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-29627,Alive,WITH TUMOR,568,NA,[Not Available],Distant Metastasis,NA,NA,441,Progressive Disease,0,568,0,568,NA,NA,1,441,NA,Stage IV,T2a,M1a,NA,1
-0.419764198,5.057101484,TCGA-IN-A6RN-01A,TCGA-IN-A6RN-01A-12D-A33T-08,4,0.424816527,TCGA-IN-A6RN,STAD,72,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-26409,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,594,0,594,0,594,0,594,NA,Stage IIA,T1b,M0,GI.CIN,6
-7.74891759,2.0162548,TCGA-A2-A0YL-01A,TCGA-A2-A0YL-01A-21D-A10G-09,9,0.376849052,TCGA-A2-A0YL,BRCA,48,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17702,Alive,TUMOR FREE,1474,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1474,0,1474,0,1474,0,1474,NA,Stage IIIA,T3,M0,BRCA.LumA,7
-5.525950529,2.291689869,TCGA-22-0940-01A,TCGA-22-0940-01A-01D-1521-08,12,0.174030805,TCGA-22-0940,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2000,[Not Available],-26272,Dead,WITH TUMOR,608,669,[Not Available],NA,NA,NA,NA,[Not Available],1,669,1,669,NA,NA,1,669,NA,Stage IIA,T1,M0,NA,9
-6.836596456,-2.378150294,TCGA-05-5715-01A,TCGA-05-5715-01A-01D-1625-08,6,0.028576164,TCGA-05-5715,LUAD,69,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25383,Alive,TUMOR FREE,62,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,62,0,62,NA,NA,0,62,NA,Stage IB,T2a,M0,LUAD.4,2
-0.271363711,4.030935979,TCGA-QG-A5Z1-01A,TCGA-QG-A5Z1-01A-11D-A28G-10,4,0.515951763,TCGA-QG-A5Z1,COAD,71,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-26220,Dead,TUMOR FREE,NA,256,[Not Available],NA,NA,NA,NA,[Not Available],1,256,0,256,NA,NA,0,256,NA,Stage IIIB,T3,MX,GI.CIN,6
-3.764516584,-2.870984485,TCGA-EB-A24D-01A,TCGA-EB-A24D-01A-11D-A197-08,8,0.443421434,TCGA-EB-A24D,SKCM,72,MALE,WHITE,NA,[Not Available],2011,[Not Available],-26439,Alive,TUMOR FREE,645,NA,[Not Available],Regional lymph node,NA,NA,500,[Not Available],0,645,0,645,NA,NA,1,500,NA,Stage IIIB,T4a,M0,SKCM.BRAF_Hotspot_Mutants,10
-0.072262032,5.157891535,TCGA-16-0850-01A,TCGA-16-0850-01A-01W-0424-08,4,0.717866936,TCGA-16-0850,GBM,52,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-19281,Dead,WITH TUMOR,496,498,[Not Available],Recurrence,[Not Applicable],[Not Applicable],83,[Not Available],1,498,1,498,NA,NA,1,83,NA,NA,NA,NA,NA,6
-6.004970977,1.428871154,TCGA-D8-A1XL-01A,TCGA-D8-A1XL-01A-11D-A14K-09,10,0.192164642,TCGA-D8-A1XL,BRCA,34,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12668,Alive,TUMOR FREE,606,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,606,0,606,0,606,0,606,NA,Stage IIB,T2,MX,BRCA.LumB,7
9.357963412,-2.814163201,TCGA-BH-A0HU-01A,TCGA-BH-A0HU-01A-11W-A050-09,1,0.769119497,TCGA-BH-A0HU,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Peri (6-12 months since last menstrual period),-19216,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,392,0,392,0,392,0,392,NA,Stage IA,T1c,M0,BRCA.LumB,1
8.961153359,-5.435347065,TCGA-D8-A1XV-01A,TCGA-D8-A1XV-01A-11D-A14K-09,1,0.846697556,TCGA-D8-A1XV,BRCA,84,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30830,Alive,TUMOR FREE,461,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,461,0,461,0,461,0,461,NA,Stage IIA,T2,M0,BRCA.LumA,1
2.793052143,3.675279856,TCGA-BH-A0BR-01A,TCGA-BH-A0BR-01A-21W-A12T-09,0,NA,TCGA-BH-A0BR,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21622,Alive,TUMOR FREE,2330,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2330,0,2330,0,2330,0,2330,NA,Stage I,T1c,M0,BRCA.LumA,6
-7.647494506,-2.53675381,TCGA-BH-A1FJ-01A,TCGA-BH-A1FJ-01A-11D-A13L-09,6,0.548635645,TCGA-BH-A1FJ,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-24262,Dead,NA,NA,1927,[Not Available],NA,NA,NA,NA,[Not Available],1,1927,NA,1927,NA,NA,0,1927,NA,Stage IIIA,T3,M0,BRCA.LumB,2
-7.978954802,2.135660747,TCGA-B6-A1KI-01A,TCGA-B6-A1KI-01A-11D-A14K-09,9,0.530848148,TCGA-B6-A1KI,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23031,Alive,TUMOR FREE,2236,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2236,0,2236,0,2236,0,2236,NA,Stage I,T1c,M0,BRCA.LumA,7
-7.849903364,2.466654575,TCGA-A2-A0SY-01A,TCGA-A2-A0SY-01A-31D-A099-09,9,0.407328765,TCGA-A2-A0SY,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22928,Alive,TUMOR FREE,1347,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1347,0,1347,0,1347,0,1347,NA,Stage IIIA,T3,M0,BRCA.LumA,7
-7.940963382,2.039989403,TCGA-AR-A0TQ-01A,TCGA-AR-A0TQ-01A-11D-A099-09,9,0.61221708,TCGA-AR-A0TQ,BRCA,27,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9873,Alive,TUMOR FREE,2991,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2991,0,2991,0,2991,0,2991,NA,Stage IIIA,T3,M0,BRCA.LumB,7
-6.657321031,-1.756957268,TCGA-A8-A09A-01A,TCGA-A8-A09A-01A-11W-A019-09,0,NA,TCGA-A8-A09A,BRCA,40,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14883,Alive,WITH TUMOR,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,304,0,304,NA,NA,0,304,NA,Stage X,T2,M0,BRCA.LumA,2
9.731366034,-1.890762653,TCGA-EM-A4FF-01A,TCGA-EM-A4FF-01A-11D-A257-08,1,0.838771099,TCGA-EM-A4FF,THCA,40,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-14796,Alive,TUMOR FREE,2573,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,1785,[Not Available],0,2573,0,2573,NA,NA,1,1785,NA,Stage I,T1b,MX,THCA.4,1
0.003191954,4.784677194,TCGA-C8-A27A-01A,TCGA-C8-A27A-01A-11D-A167-09,4,0.580732383,TCGA-C8-A27A,BRCA,48,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-17779,Alive,TUMOR FREE,747,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,747,0,747,0,747,0,747,NA,Stage IIB,T2,M0,BRCA.LumB,6
-6.459786532,1.567418496,TCGA-A8-A081-01A,TCGA-A8-A081-01A-11W-A019-09,10,0.173616296,TCGA-A8-A081,BRCA,80,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29555,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIA,T2,M0,BRCA.LumB,7
9.860816137,-1.937958545,TCGA-EM-A4FM-01A,TCGA-EM-A4FM-01A-11D-A257-08,1,0.818981692,TCGA-EM-A4FM,THCA,59,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-21595,Alive,WITH TUMOR,162,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,162,0,162,NA,NA,0,162,NA,Stage IVA,T3,MX,THCA.4,1
-7.954293891,1.957046679,TCGA-C8-A12N-01A,TCGA-C8-A12N-01A-11D-A10Y-09,9,0.616471692,TCGA-C8-A12N,BRCA,58,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,358,0,358,0,358,0,358,NA,Stage IIA,T2,M0,BRCA.LumA,7
-6.105445881,3.556136461,TCGA-BJ-A2N7-01A,TCGA-BJ-A2N7-01A-11D-A18F-08,11,0.5736626,TCGA-BJ-A2N7,THCA,30,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-11188,Alive,TUMOR FREE,559,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,559,0,559,0,559,0,559,NA,Stage I,T3,M0,THCA.1,8
9.893241208,-1.618199339,TCGA-EM-A3SX-01A,TCGA-EM-A3SX-01A-11D-A22Z-08,1,0.882940528,TCGA-EM-A3SX,THCA,28,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-10447,Alive,WITH TUMOR,908,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,908,0,908,NA,NA,0,908,NA,Stage I,T3,MX,THCA.5,1
9.751514281,-1.721229459,TCGA-EM-A4FN-01A,TCGA-EM-A4FN-01A-11D-A257-08,1,0.822656546,TCGA-EM-A4FN,THCA,49,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-18185,Alive,TUMOR FREE,802,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,802,0,802,NA,NA,0,802,NA,Stage IVA,T1b,MX,THCA.3,1
-0.706009296,4.776621559,TCGA-EL-A3D6-01A,TCGA-EL-A3D6-01A-12D-A202-08,4,0.503804427,TCGA-EL-A3D6,THCA,51,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],1999,[Not Available],-18640,Alive,NA,3296,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3296,0,3296,NA,NA,0,3296,NA,Stage III,T3,M0,THCA.4,6
9.528774905,-5.692686684,TCGA-EM-A4FR-01A,TCGA-EM-A4FR-01A-11D-A257-08,1,0.858397135,TCGA-EM-A4FR,THCA,28,MALE,[Unknown],"Other, specify",[Not Available],2012,[Not Available],-10316,Alive,TUMOR FREE,655,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,655,0,655,0,655,0,655,NA,Stage I,T3,MX,THCA.1,1
-6.062687991,3.565809684,TCGA-BJ-A45F-01A,TCGA-BJ-A45F-01A-12D-A23U-08,11,0.560001196,TCGA-BJ-A45F,THCA,59,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-21713,Alive,TUMOR FREE,105,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,105,0,105,NA,NA,0,105,NA,Stage I,T1b,M0,THCA.1,8
-5.935257419,3.101917042,TCGA-EM-A4FU-01A,TCGA-EM-A4FU-01A-11D-A257-08,11,0.064896216,TCGA-EM-A4FU,THCA,35,MALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2009,[Not Available],-12912,Alive,TUMOR FREE,1840,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,781,[Not Available],0,1840,0,1840,1,781,1,781,NA,Stage I,T3,MX,THCA.1,8
-6.042184134,3.456806401,TCGA-BJ-A45G-01A,TCGA-BJ-A45G-01A-11D-A23U-08,11,0.588588719,TCGA-BJ-A45G,THCA,48,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-17831,Alive,TUMOR FREE,725,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,725,0,725,NA,NA,0,725,NA,Stage III,T2,M0,THCA.1,8
9.164390685,-5.148646751,TCGA-BJ-A45K-01A,TCGA-BJ-A45K-01A-11D-A23U-08,1,0.840859477,TCGA-BJ-A45K,THCA,33,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-12138,Alive,TUMOR FREE,705,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,705,0,705,NA,NA,0,705,NA,Stage I,T2,M0,THCA.1,1
-7.83114577,-2.527798585,TCGA-D8-A1X6-01A,TCGA-D8-A1X6-01A-11D-A14K-09,6,0.514884753,TCGA-D8-A1X6,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29256,Alive,TUMOR FREE,541,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,541,0,541,0,541,0,541,NA,Stage IIIA,T3,MX,BRCA.LumB,2
-6.234809167,3.68291665,TCGA-EM-A3ST-01A,TCGA-EM-A3ST-01A-11D-A22Z-08,11,0.382368125,TCGA-EM-A3ST,THCA,62,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-22990,Alive,WITH TUMOR,1182,NA,[Not Available],Biochemical evidence of disease,NA,NA,966,[Not Available],0,1182,0,1182,1,966,1,966,NA,Stage III,T3,MX,THCA.1,8
-8.005183415,2.086892998,TCGA-A2-A04Q-01A,TCGA-A2-A04Q-01A-21W-A050-09,9,0.645935442,TCGA-A2-A04Q,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17660,Alive,TUMOR FREE,2385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2385,0,2385,0,2385,0,2385,NA,Stage IA,T1,M0,BRCA.Basal,7
10.04081854,-1.719726405,TCGA-BJ-A45J-01A,TCGA-BJ-A45J-01A-11D-A23U-08,1,0.836564987,TCGA-BJ-A45J,THCA,39,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2012,[Not Available],-14510,Alive,TUMOR FREE,658,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,658,0,658,NA,NA,0,658,NA,Stage I,T1a,M0,THCA.3,1
-6.506633028,-1.490023415,TCGA-FB-A78T-01A,TCGA-FB-A78T-01A-12D-A32N-08,7,0.342516697,TCGA-FB-A78T,PAAD,71,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-26179,Dead,NA,NA,375,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,1,375,1,375,0,375,0,375,NA,Stage IIB,T3,M0,NA,2
2.003691484,1.85982722,TCGA-BJ-A4O8-01A,TCGA-BJ-A4O8-01A-11D-A257-08,3,0.603545572,TCGA-BJ-A4O8,THCA,47,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-17430,Alive,TUMOR FREE,591,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,591,0,591,0,591,0,591,NA,Stage III,T3,M0,THCA.4,3
9.620092466,-4.278793693,TCGA-EM-A3FL-01A,TCGA-EM-A3FL-01A-11D-A21A-08,1,0.733906904,TCGA-EM-A3FL,THCA,63,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-23183,Alive,TUMOR FREE,1441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1441,0,1441,0,1441,0,1441,NA,Stage I,T1b,MX,THCA.1,1
-6.060504409,3.58637489,TCGA-BJ-A2N8-01A,TCGA-BJ-A2N8-01A-11D-A18F-08,11,0.49543673,TCGA-BJ-A2N8,THCA,30,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-11024,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,504,0,504,NA,NA,0,504,NA,Stage I,T1b,M0,THCA.1,8
10.01875364,-1.624847399,TCGA-EM-A4FO-01A,TCGA-EM-A4FO-01A-11D-A257-08,1,0.866799811,TCGA-EM-A4FO,THCA,72,MALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-26589,Alive,TUMOR FREE,802,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,802,0,802,0,802,0,802,NA,Stage I,T1b,MX,THCA.2,1
9.751116569,-2.007160952,TCGA-EL-A4K0-01A,TCGA-EL-A4K0-01A-11D-A257-08,1,0.803148711,TCGA-EL-A4K0,THCA,54,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-20042,Alive,TUMOR FREE,944,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,944,0,944,NA,NA,0,944,NA,Stage I,T1,M0,THCA.5,1
10.06747129,-1.495809333,TCGA-FY-A4B3-01A,TCGA-FY-A4B3-01A-11D-A23U-08,1,0.876259884,TCGA-FY-A4B3,THCA,51,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-18969,Alive,WITH TUMOR,427,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,427,0,427,NA,NA,0,427,NA,Stage III,T3,MX,THCA.3,1
10.07476266,-1.52534347,TCGA-BJ-A45H-01A,TCGA-BJ-A45H-01A-12D-A23U-08,1,0.863244183,TCGA-BJ-A45H,THCA,45,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-16541,Alive,WITH TUMOR,865,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,865,0,865,NA,NA,0,865,NA,Stage III,T3,M0,THCA.2,1
1.866125979,1.90948423,TCGA-IM-A4EB-01A,TCGA-IM-A4EB-01A-11D-A257-08,3,0.448595176,TCGA-IM-A4EB,THCA,37,MALE,WHITE,"Other, specify",[Not Available],2012,[Not Available],-13635,Alive,TUMOR FREE,780,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,780,0,780,0,780,0,780,NA,Stage I,T3,MX,THCA.4,3
2.042419035,1.92572807,TCGA-AQ-A1H3-01A,TCGA-AQ-A1H3-01A-31D-A13L-09,3,0.606353403,TCGA-AQ-A1H3,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18177,Alive,TUMOR FREE,989,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,989,0,989,0,989,0,989,NA,Stage IIIC,T2,MX,BRCA.LumA,3
9.426408073,-4.4019622,TCGA-EM-A3SY-01A,TCGA-EM-A3SY-01A-11D-A22Z-08,1,0.758099068,TCGA-EM-A3SY,THCA,36,MALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-13461,Alive,TUMOR FREE,411,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,411,0,411,0,411,0,411,NA,Stage I,T1b,MX,THCA.1,1
-5.94069484,3.210023977,TCGA-86-7953-01A,TCGA-86-7953-01A-11D-2184-08,11,0.126081844,TCGA-86-7953,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25315,Alive,TUMOR FREE,997,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,997,0,997,0,997,0,997,NA,Stage IA,T1b,M0,NA,8
-5.729737074,-2.17702046,TCGA-AG-A01Y-01A,TCGA-AG-A01Y-01A-41W-A096-10,0,NA,TCGA-AG-A01Y,READ,49,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2004,[Not Available],-18112,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage II,T3,M0,GI.CIN,2
-7.432533347,2.025180117,TCGA-E2-A15G-01A,TCGA-E2-A15G-01A-11D-A12B-09,9,0.39903515,TCGA-E2-A15G,BRCA,76,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28013,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,554,0,554,0,554,0,554,NA,Stage IIA,T2,M0,BRCA.LumA,7
-4.285046241,-1.317445154,TCGA-BH-A0HA-01A,TCGA-BH-A0HA-01A-11D-A12Q-09,8,0.300536099,TCGA-BH-A0HA,BRCA,31,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11379,Alive,TUMOR FREE,1611,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1611,0,1611,0,1611,0,1611,NA,Stage I,T1c,M0,BRCA.LumA,10
-3.874416,-2.034083723,TCGA-F1-A448-01A,TCGA-F1-A448-01A-11D-A24D-08,8,0.455942159,TCGA-F1-A448,STAD,70,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012,[Not Available],-25846,Alive,TUMOR FREE,647,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,647,0,647,0,647,0,647,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-5.188661814,2.585217258,TCGA-FZ-5926-01A,TCGA-FZ-5926-01A-11D-1609-08,12,0.285569026,TCGA-FZ-5926,PAAD,73,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2001,[Not Available],-26881,Dead,WITH TUMOR,NA,541,NA,NA,NA,NA,NA,Progressive Disease,1,541,1,541,NA,NA,1,541,NA,Stage III,T3,M0,NA,8
-6.112816727,3.613447698,TCGA-HZ-A8P0-01A,TCGA-HZ-A8P0-01A-11D-A36O-08,11,0.546864007,TCGA-HZ-A8P0,PAAD,76,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-27850,Alive,TUMOR FREE,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T3,MX,NA,8
-4.490906112,1.850313363,TCGA-IB-7654-01A,TCGA-IB-7654-01A-11D-2154-08,0,NA,TCGA-IB-7654,PAAD,80,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-29292,Dead,WITH TUMOR,NA,476,Other malignancy,NA,NA,NA,NA,Progressive Disease,1,476,0,476,NA,NA,1,476,NA,Stage IIB,T2,M0,NA,8
-5.353170753,2.562619211,TCGA-IB-A6UF-01A,TCGA-IB-A6UF-01A-23D-A33T-08,12,0.344170783,TCGA-IB-A6UF,PAAD,63,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-23152,Alive,WITH TUMOR,666,NA,NA,Distant Metastasis,Liver,NA,593,Partial Remission/Response,0,666,0,666,NA,NA,1,593,NA,Stage IIB,T3,M0,NA,8
-5.935487855,3.073511195,TCGA-IB-AAUM-01A,TCGA-IB-AAUM-01A-11D-A377-08,12,0,TCGA-IB-AAUM,PAAD,76,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-28013,Alive,WITH TUMOR,8,NA,NA,NA,NA,NA,NA,Partial Remission/Response,0,8,0,8,NA,NA,0,8,NA,Stage IIB,T2,M0,NA,8
7.948731819,-1.61073821,TCGA-A8-A09B-01A,TCGA-A8-A09B-01A-11W-A019-09,1,0.207258277,TCGA-A8-A09B,BRCA,58,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21520,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,0,365,0,365,NA,Stage IIIB,T4b,M0,BRCA.LumA,1
-7.816082151,-2.459070827,TCGA-E2-A1IH-01A,TCGA-E2-A1IH-01A-11D-A188-09,6,0.375908545,TCGA-E2-A1IH,BRCA,80,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29444,Alive,TUMOR FREE,1026,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1026,0,1026,0,1026,0,1026,NA,Stage I,T1c,M0,BRCA.LumA,2
-5.392763434,2.719955401,TCGA-IB-AAUN-01A,TCGA-IB-AAUN-01A-12D-A38G-08,12,0.339320388,TCGA-IB-AAUN,PAAD,74,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27128,Dead,NA,NA,144,NA,Locoregional Recurrence,"Other, specify",NA,131,Complete Remission/Response,1,144,NA,144,1,131,1,131,NA,Stage IB,T2,M0,NA,8
-5.352942698,2.60952764,TCGA-FZ-5924-01A,TCGA-FZ-5924-01A-13D-1609-08,12,0.340183273,TCGA-FZ-5924,PAAD,83,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-30571,Dead,WITH TUMOR,NA,480,NA,NA,NA,NA,NA,Progressive Disease,1,480,1,480,NA,NA,1,480,NA,Stage IIA,T3,M0,NA,8
-1.282853693,4.085694129,TCGA-BA-4074-01A,TCGA-BA-4074-01A-01D-1434-08,4,0.239071658,TCGA-BA-4074,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2003,[Not Available],-25282,Dead,WITH TUMOR,NA,462,[Not Available],NA,Distant Metastasis,bone (humerus),396,Complete Remission/Response,1,462,1,462,NA,NA,1,396,NA,Stage IVA,T2,M0,HNSC.Mesenchymal,6
-8.042858462,2.006535183,TCGA-A2-A25C-01A,TCGA-A2-A25C-01A-11D-A167-09,9,0.593757774,TCGA-A2-A25C,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18508,Alive,TUMOR FREE,523,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,523,0,523,0,523,0,523,NA,Stage IIB,T2,M0,BRCA.LumB,7
-7.854239789,1.770027683,TCGA-D8-A1JD-01A,TCGA-D8-A1JD-01A-11D-A13L-09,9,0.435069445,TCGA-D8-A1JD,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15166,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,552,0,552,0,552,0,552,NA,Stage IIB,T2,M0,BRCA.LumB,7
1.886767155,1.761200568,TCGA-JX-A5QV-01A,TCGA-JX-A5QV-01A-22D-A28B-09,3,0.47575045,TCGA-JX-A5QV,CESC,37,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13667,Alive,TUMOR FREE,636,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,636,0,636,0,636,0,636,NA,Stage IB1,T1b1,M0,NA,3
-1.065112922,2.78043495,TCGA-CR-7365-01A,TCGA-CR-7365-01A-11D-2012-08,4,0.048675511,TCGA-CR-7365,HNSC,60,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-22101,Alive,TUMOR FREE,1191,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1191,0,1191,NA,NA,0,1191,NA,Stage IVA,T4a,M0,HNSC.Basal,6
7.978034929,-1.319592896,TCGA-12-5299-01A,TCGA-12-5299-01A-02D-1486-08,1,0.210928785,TCGA-12-5299,GBM,56,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-20463,Dead,WITH TUMOR,98,98,[Not Available],NA,NA,NA,NA,[Not Available],1,98,1,98,NA,NA,1,98,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.941116822,-1.61424133,TCGA-J8-A3O2-01A,TCGA-J8-A3O2-01A-11D-A23M-08,1,0.886365504,TCGA-J8-A3O2,THCA,39,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-14339,Alive,TUMOR FREE,342,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,342,0,342,NA,NA,0,342,NA,Stage I,T3,M0,THCA.2,1
-4.75555102,-1.493154163,TCGA-CN-5360-01A,TCGA-CN-5360-01A-01D-1434-08,8,0.286019042,TCGA-CN-5360,HNSC,68,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-25034,Alive,TUMOR FREE,2169,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2169,0,2169,NA,NA,0,2169,NA,Stage IVA,T4a,M0,HNSC.Atypical,10
-3.854986716,0.269065953,TCGA-EK-A2RA-01A,TCGA-EK-A2RA-01A-11D-A18J-09,0,NA,TCGA-EK-A2RA,CESC,74,FEMALE,[Not Available],Cervical Squamous Cell Carcinoma,G3,2011,[Not Available],-27209,Alive,WITH TUMOR,1246,NA,NA,NA,NA,NA,NA,[Not Available],0,1246,0,1246,NA,NA,0,1246,NA,Stage IIA2,T2a2,MX,NA,10
8.862043063,-4.716926394,TCGA-32-4209-01A,TCGA-32-4209-01A-01D-1353-08,1,0.693403011,TCGA-32-4209,GBM,40,MALE,WHITE,Treated primary GBM,[Not Available],2009,[Not Available],-14903,Dead,WITH TUMOR,NA,618,[Not Available],Recurrence,[Not Applicable],[Not Applicable],94,[Not Available],1,618,1,618,NA,NA,1,94,NA,NA,NA,NA,NA,1
-6.299663919,1.416405962,TCGA-CR-7367-01A,TCGA-CR-7367-01A-11D-2012-08,10,0.361073451,TCGA-CR-7367,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2008,[Not Available],-19116,Alive,TUMOR FREE,1440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1440,0,1440,NA,NA,0,1440,NA,Stage IVA,T4a,M0,HNSC.Mesenchymal,9
-0.876629662,3.759020795,TCGA-GH-A9DA-01A,TCGA-GH-A9DA-01A-21D-A37N-09,4,0.335575958,TCGA-GH-A9DA,CESC,27,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2013,[Not Evaluated],-10160,Alive,TUMOR FREE,540,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,540,0,540,0,540,0,540,NA,Stage IB1,T1b,MX,NA,5
-0.909900213,2.639849016,TCGA-HG-A9SC-01A,TCGA-HG-A9SC-01A-21D-A42O-09,4,0.153371865,TCGA-HG-A9SC,CESC,49,FEMALE,WHITE,Adenosquamous,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17963,Alive,TUMOR FREE,504,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,504,0,504,0,504,0,504,NA,Stage IIB,T2b,MX,NA,6
9.564201617,-5.728354577,TCGA-EM-A3AO-01A,TCGA-EM-A3AO-01A-11D-A202-08,1,0.875084803,TCGA-EM-A3AO,THCA,61,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-22347,Alive,TUMOR FREE,1354,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1354,0,1354,NA,NA,0,1354,NA,Stage IVA,T2,MX,THCA.5,1
-7.488652352,2.344867548,TCGA-JW-A5VH-01A,TCGA-JW-A5VH-01A-11D-A28B-09,9,0.209289769,TCGA-JW-A5VH,CESC,53,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19423,Dead,WITH TUMOR,NA,100,Cervical Cancer,Distant Metastasis,"Other, specify",Brain,94,Progressive Disease,1,100,1,100,NA,NA,1,94,NA,Stage IVB,T4,M1,NA,7
-5.67321616,1.223148367,TCGA-JW-AAVH-01A,TCGA-JW-AAVH-01A-11D-A387-09,0,NA,TCGA-JW-AAVH,CESC,46,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16894,Alive,TUMOR FREE,552,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,552,0,552,0,552,0,552,NA,Stage IB1,T1b1,M0,NA,9
9.306399543,-3.183300916,TCGA-JX-A3PZ-01A,TCGA-JX-A3PZ-01A-11D-A21Q-09,1,0.679992703,TCGA-JX-A3PZ,CESC,25,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,1995,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9303,Dead,WITH TUMOR,NA,642,Cervical Cancer,Locoregional Recurrence,"Other, specify",Pelvis,491,Complete Remission/Response,1,642,1,642,1,491,1,491,NA,Stage IB,T1b,M0,NA,1
-3.620413433,-2.618296079,TCGA-JX-A3Q0-01A,TCGA-JX-A3Q0-01A-11D-A21Q-09,8,0.372661891,TCGA-JX-A3Q0,CESC,63,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23313,Alive,TUMOR FREE,6375,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,6375,0,6375,0,6375,0,6375,NA,Stage III,T3,M0,NA,10
10.08514441,-1.49620971,TCGA-JX-A3Q8-01A,TCGA-JX-A3Q8-01A-11D-A21Q-09,1,0.839399611,TCGA-JX-A3Q8,CESC,40,FEMALE,ASIAN,Endocervical Type of Adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14839,Alive,TUMOR FREE,1357,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1357,0,1357,0,1357,0,1357,NA,Stage IB1,T1b1,MX,NA,1
-1.806105084,3.820620681,TCGA-55-6712-01A,TCGA-55-6712-01A-11D-1855-08,0,NA,TCGA-55-6712,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],NA,Dead,WITH TUMOR,NA,171,[Not Available],NA,NA,NA,NA,Progressive Disease,1,171,1,171,NA,NA,1,171,NA,Stage IIA,T2a,MX,LUAD.3,6
7.740548105,-3.492732364,TCGA-36-2544-01A,TCGA-36-2544-01A-01D-1526-09,1,0.316068558,TCGA-36-2544,OV,58,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2008,[Not Available],-21384,Alive,WITH TUMOR,638,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],325,Partial Remission/Response,0,638,0,638,NA,NA,1,325,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-0.405368551,4.66249274,TCGA-24-1842-01A,TCGA-24-1842-01A-01W-0639-09,4,0.548628882,TCGA-24-1842,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-18227,Alive,TUMOR FREE,253,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,253,0,253,0,253,0,253,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-4.783415285,2.141774476,TCGA-46-6025-01A,TCGA-46-6025-01A-11D-1817-08,0,NA,TCGA-46-6025,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-26168,Alive,TUMOR FREE,324,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,324,0,324,0,324,0,324,NA,Stage IIB,T2b,M0,LUSC.classical,9
-0.240521531,3.713887496,TCGA-24-2271-01A,TCGA-24-2271-01A-01W-0799-08,4,0.098600831,TCGA-24-2271,OV,55,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,1999,[Not Available],-20399,Dead,WITH TUMOR,962,962,[Not Available],Recurrence,[Not Applicable],[Not Applicable],827,[Not Available],1,962,1,962,NA,NA,1,827,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-0.517274988,5.11415166,TCGA-13-1482-01A,TCGA-13-1482-01A-01W-0549-09,4,0.455984151,TCGA-13-1482,OV,52,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2000,[Not Available],-19178,Dead,WITH TUMOR,1877,1877,[Not Available],Recurrence,[Not Applicable],[Not Applicable],602,Partial Remission/Response,1,1877,1,1877,NA,NA,1,602,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
9.732429394,-1.864040807,TCGA-CG-5720-01A,TCGA-CG-5720-01A-11D-1600-08,1,0.793391716,TCGA-CG-5720,STAD,71,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003,[Not Available],-26176,Dead,TUMOR FREE,NA,30,[Not Available],NA,NA,NA,NA,[Not Available],1,30,0,30,NA,NA,0,30,NA,Stage IB,T2,M0,GI.CIN,1
-4.540254535,1.514776579,TCGA-CR-7377-01A,TCGA-CR-7377-01A-11D-2012-08,0,NA,TCGA-CR-7377,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-21371,Dead,NA,NA,279,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,279,NA,279,NA,NA,0,279,NA,Stage IVA,T4a,M0,HNSC.Mesenchymal,10
0.520250763,2.223471151,TCGA-27-1837-01A,TCGA-27-1837-01A-01D-1494-08,0,NA,TCGA-27-1837,GBM,36,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-13368,Dead,WITH TUMOR,427,427,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],136,[Not Available],1,427,1,427,NA,NA,1,136,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
9.598689418,-2.763675257,TCGA-EM-A2OW-01A,TCGA-EM-A2OW-01A-11D-A202-08,1,0.788909183,TCGA-EM-A2OW,THCA,37,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-13761,Alive,TUMOR FREE,1227,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1227,0,1227,0,1227,0,1227,NA,Stage I,T1b,MX,THCA.1,1
-0.144972993,5.163347652,TCGA-06-0686-01A,TCGA-06-0686-01A-01D-1492-08,4,0.582564781,TCGA-06-0686,GBM,53,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-19503,Dead,WITH TUMOR,NA,432,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],160,[Not Available],1,432,1,432,NA,NA,1,160,NA,NA,NA,NA,GBM_LGG.NA,1
-3.528732067,1.243521248,TCGA-46-3767-01A,TCGA-46-3767-01A-01D-0983-08,0,NA,TCGA-46-3767,LUSC,76,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-27912,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,396,0,396,0,396,0,396,NA,Stage IA,T1a,M0,LUSC.secretory,10
-5.133240623,1.030069603,TCGA-AG-3592-01A,TCGA-AG-3592-01A-02D-1733-10,0,NA,TCGA-AG-3592,READ,68,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-25141,Alive,TUMOR FREE,1035,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1035,0,1035,NA,NA,0,1035,NA,Stage IIA,T3,M0,GI.CIN,10
-7.057615453,2.339174044,TCGA-21-1078-01A,TCGA-21-1078-01A-01D-1521-08,0,NA,TCGA-21-1078,LUSC,77,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-28125,Dead,WITH TUMOR,469,474,[Not Available],NA,NA,NA,257,[Not Available],1,474,1,474,NA,NA,1,257,NA,Stage IB,T2,M0,NA,7
-0.369871052,4.957174886,TCGA-13-0891-01A,TCGA-13-0891-01A-01W-0420-08,4,0.552842705,TCGA-13-0891,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-26886,Dead,WITH TUMOR,NA,3128,[Not Available],Recurrence,[Not Applicable],[Not Applicable],762,Complete Remission/Response,1,3128,1,3128,NA,NA,1,762,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
-4.046528869,1.32508052,TCGA-D7-6527-01A,TCGA-D7-6527-01A-11D-1800-08,0,NA,TCGA-D7-6527,STAD,62,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2010,[Not Available],-22793,Dead,WITH TUMOR,NA,312,[Not Available],Distant Metastasis,Liver,NA,75,Progressive Disease,1,312,1,312,NA,NA,1,75,NA,Stage II,T2,M0,GI.CIN,10
-0.091213213,5.128573008,TCGA-30-1862-01A,TCGA-30-1862-01A-02W-0699-08,4,0.711343629,TCGA-30-1862,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2003,[Not Available],-23895,Dead,WITH TUMOR,186,186,[Not Available],NA,NA,NA,NA,[Not Available],1,186,1,186,NA,NA,1,186,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-6.249103115,1.760793924,TCGA-D1-A2G7-01A,TCGA-D1-A2G7-01A-21D-A17W-09,10,0.32989475,TCGA-D1-A2G7,UCEC,65,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2007,Peri (6-12 months since last menstrual period),-23913,Dead,TUMOR FREE,NA,1793,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1793,0,1793,0,1793,0,1793,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
-1.508381809,3.02788972,TCGA-34-5929-01A,TCGA-34-5929-01A-11D-1817-08,4,0.079847584,TCGA-34-5929,LUSC,78,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-28844,Dead,TUMOR FREE,NA,151,[Not Available],NA,NA,NA,NA,Stable Disease,1,151,0,151,NA,NA,0,151,NA,Stage IB,T2,M0,LUSC.primitive,10
-3.25785038,-3.361598617,TCGA-13-0889-01A,TCGA-13-0889-01A-01W-0420-08,8,0.503113666,TCGA-13-0889,OV,75,FEMALE,WHITE,Serous Cystadenocarcinoma,GX,2003,[Not Available],-27674,Dead,TUMOR FREE,NA,2894,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2894,0,2894,NA,NA,0,2894,NA,Stage IV,[Not Applicable],[Not Applicable],NA,10
-7.497562762,2.198619589,TCGA-D7-5577-01A,TCGA-D7-5577-01A-01D-1600-08,9,0.303927127,TCGA-D7-5577,STAD,53,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-19668,Dead,WITH TUMOR,NA,782,[Not Available],Distant Metastasis,"Other, specify","liver,  peritoneal surfaces, non-regional/distant lymph nodes",376,Progressive Disease,1,782,1,782,NA,NA,1,376,NA,Stage IIIA,T2,M0,GI.EBV,10
7.678482337,-3.387202601,TCGA-DE-A0Y2-01A,TCGA-DE-A0Y2-01A-11D-A10S-08,1,0.291555731,TCGA-DE-A0Y2,THCA,30,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-11227,Alive,TUMOR FREE,658,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,658,0,658,0,658,0,658,NA,Stage I,T2,M0,THCA.3,1
-5.701248448,0.968360132,TCGA-CN-6013-01A,TCGA-CN-6013-01A-11D-1683-08,0,NA,TCGA-CN-6013,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-20703,Dead,WITH TUMOR,NA,727,[Not Available],NA,Distant Metastasis,LUNG,323,Complete Remission/Response,1,727,1,727,NA,NA,1,323,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,10
9.747893377,-1.979291964,TCGA-06-2557-01A,TCGA-06-2557-01A-01D-1494-08,1,0.81176782,TCGA-06-2557,GBM,76,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-27980,Dead,WITH TUMOR,33,33,[Not Available],NA,NA,NA,NA,[Not Available],1,33,1,33,NA,NA,1,33,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-6.992425486,-2.414775821,TCGA-HF-7134-01A,TCGA-HF-7134-01A-11D-2053-08,6,0.192816293,TCGA-HF-7134,STAD,NA,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],NA,Alive,TUMOR FREE,1588,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1588,0,1588,0,1588,0,1588,NA,Stage IA,T1,M0,NA,2
-7.300559514,-1.951246355,TCGA-22-4591-01A,TCGA-22-4591-01A-01D-1267-08,6,0.162490394,TCGA-22-4591,LUSC,80,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-29250,Dead,WITH TUMOR,623,623,[Not Available],NA,NA,NA,443,Partial Remission/Response,1,623,1,623,NA,NA,1,443,NA,Stage IIIA,T3,M0,LUSC.primitive,2
-5.194564765,2.136052502,TCGA-D7-6815-01A,TCGA-D7-6815-01A-11D-1882-08,12,0.078505373,TCGA-D7-6815,STAD,70,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-25811,Alive,TUMOR FREE,486,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,486,0,486,0,486,0,486,NA,Stage IIB,T2,M0,GI.CIN,10
-0.714368395,2.287173245,TCGA-33-4589-01A,TCGA-33-4589-01A-01D-1441-08,0,NA,TCGA-33-4589,LUSC,62,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1992,[Not Available],-22754,Dead,TUMOR FREE,NA,47,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,47,0,47,0,47,0,47,NA,Stage IIB,T2,M0,NA,6
-4.323208845,-0.4676129,TCGA-18-3414-01A,TCGA-18-3414-01A-01D-0983-08,0,NA,TCGA-18-3414,LUSC,73,MALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-26938,Dead,TUMOR FREE,NA,716,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,716,0,716,NA,NA,0,716,NA,Stage IV,T4,M1,LUSC.basal,10
-4.51621857,1.859167711,TCGA-EY-A1GT-01A,TCGA-EY-A1GT-01A-11D-A13L-09,0,NA,TCGA-EY-A1GT,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25151,Alive,TUMOR FREE,490,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,490,0,490,0,490,0,490,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,9
-4.395665477,1.860247384,TCGA-IQ-7630-01A,TCGA-IQ-7630-01A-11D-2078-08,0,NA,TCGA-IQ-7630,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-18131,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,485,0,485,0,485,0,485,NA,Stage II,T2,M0,HNSC.Basal,4
0.111804154,3.315367133,TCGA-06-2567-01A,TCGA-06-2567-01A-01D-1494-08,4,0.379973936,TCGA-06-2567,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-23759,Dead,WITH TUMOR,133,133,[Not Available],NA,NA,NA,NA,[Not Available],1,133,1,133,NA,NA,1,133,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,3
4.483565673,1.064454299,TCGA-KS-A4I7-01A,TCGA-KS-A4I7-01A-11D-A257-08,2,0.639012415,TCGA-KS-A4I7,THCA,61,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-22398,Alive,TUMOR FREE,987,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,987,0,987,0,987,0,987,NA,Stage I,T1b,M0,THCA.5,5
9.646891767,-2.229119688,TCGA-FE-A3PB-01A,TCGA-FE-A3PB-01A-11D-A21Z-08,1,0.775433322,TCGA-FE-A3PB,THCA,33,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-12136,Alive,TUMOR FREE,2590,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2590,0,2590,0,2590,0,2590,NA,Stage I,T3,MX,THCA.4,1
-3.070782455,-3.480587747,TCGA-CG-5728-01A,TCGA-CG-5728-01A-11D-1600-08,8,0.569405865,TCGA-CG-5728,STAD,88,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003,[Not Available],-32293,Alive,WITH TUMOR,1980,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1980,0,1980,NA,NA,0,1980,NA,Stage IB,T2,M0,NA,10
3.917045867,1.279948445,TCGA-67-6216-01A,TCGA-67-6216-01A-11D-1753-08,2,0.337772458,TCGA-67-6216,LUAD,57,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-20967,Alive,TUMOR FREE,141,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,141,0,141,0,141,0,141,NA,Stage IA,T1a,M0,LUAD.4,3
-1.792200139,1.051226341,TCGA-CG-4304-01A,TCGA-CG-4304-01A-01D-1158-08,5,0.570986838,TCGA-CG-4304,STAD,84,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-31017,Alive,NA,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage IB,T2a,M0,GI.CIN,4
-4.424693493,-0.071606089,TCGA-22-1005-01A,TCGA-22-1005-01A-01D-1521-08,0,NA,TCGA-22-1005,LUSC,63,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-23322,Dead,TUMOR FREE,1953,1953,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1953,0,1953,0,1953,0,1953,NA,Stage IA,T1,M0,NA,10
-4.699418832,0.912369668,TCGA-77-6845-01A,TCGA-77-6845-01A-11D-1945-08,0,NA,TCGA-77-6845,LUSC,69,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-25321,Dead,NA,NA,708,[Not Available],NA,NA,NA,NA,[Not Available],1,708,NA,708,NA,NA,0,708,NA,Stage IIB,T3,M0,NA,10
-7.70197792,-2.355472654,TCGA-BR-A4IV-01A,TCGA-BR-A4IV-01A-31D-A25D-08,6,0.483122917,TCGA-BR-A4IV,STAD,47,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-17515,Dead,WITH TUMOR,NA,869,[Not Available],Locoregional Recurrence,NA,NA,737,Complete Remission/Response,1,869,1,869,1,737,1,737,NA,Stage IIIB,T4a,M0,GI.GS,2
0.015343862,5.068042556,TCGA-13-0714-01A,TCGA-13-0714-01A-01W-0371-08,4,0.706978617,TCGA-13-0714,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-20109,Dead,WITH TUMOR,189,189,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],110,Progressive Disease,1,189,1,189,NA,NA,1,110,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
-3.98989747,-2.057302467,TCGA-56-7822-01A,TCGA-56-7822-01A-11D-2122-08,8,0.448796614,TCGA-56-7822,LUSC,75,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-27755,Dead,WITH TUMOR,NA,532,[Not Available],NA,NA,NA,301,[Unknown],1,532,1,532,NA,NA,1,301,NA,Stage IIB,T2b,M0,NA,10
0.126510293,5.268563492,TCGA-61-1741-01A,TCGA-61-1741-01A-02W-0639-09,4,0.627413645,TCGA-61-1741,OV,76,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-27762,Dead,WITH TUMOR,1024,1024,[Not Available],Recurrence,[Not Applicable],[Not Applicable],488,Complete Remission/Response,1,1024,1,1024,1,488,1,488,NA,Stage IIIB,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
-3.594314064,-2.611061977,TCGA-E6-A2P8-01A,TCGA-E6-A2P8-01A-11D-A19Y-09,8,0.359414,TCGA-E6-A2P8,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19448,Dead,WITH TUMOR,NA,72,[Not Available],Metastatic,Lung,NA,60,Progressive Disease,1,72,1,72,NA,NA,1,60,NA,Stage IV,[Not Applicable],[Not Applicable],NA,10
2.040929663,1.823120941,TCGA-ET-A39K-01A,TCGA-ET-A39K-01A-11D-A19J-08,3,0.568272255,TCGA-ET-A39K,THCA,48,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-17789,Alive,TUMOR FREE,3267,NA,[Not Available],Locoregional Recurrence,NA,NA,711,[Not Available],0,3267,0,3267,NA,NA,1,711,NA,Stage III,T3,MX,THCA.5,3
0.027866671,4.566133358,TCGA-CQ-6221-01A,TCGA-CQ-6221-01A-11D-2078-08,4,0.407575616,TCGA-CQ-6221,HNSC,79,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-29026,Alive,TUMOR FREE,1000,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1000,0,1000,0,1000,0,1000,NA,[Not Available],T2,[Not Available],NA,6
-6.5789577,-2.286978508,TCGA-CV-6954-01A,TCGA-CV-6954-01A-11D-1912-08,6,0.043281224,TCGA-CV-6954,HNSC,59,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,1998,[Not Available],-21557,Dead,TUMOR FREE,NA,2002,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2002,0,2002,NA,NA,0,2002,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,2
9.027019437,-2.617356865,TCGA-EL-A3T6-01A,TCGA-EL-A3T6-01A-11D-A21Z-08,1,0.687186549,TCGA-EL-A3T6,THCA,34,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003,[Not Available],-12777,Alive,TUMOR FREE,2988,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2988,0,2988,0,2988,0,2988,NA,Stage I,T3,M0,THCA.4,1
-7.051357067,1.957582589,TCGA-D1-A2G5-01A,TCGA-D1-A2G5-01A-11D-A17D-09,0,NA,TCGA-D1-A2G5,UCEC,50,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18322,Alive,WITH TUMOR,1455,NA,[Not Available],Distant Metastasis,"Other, specify",omentum,1122,Complete Remission/Response,0,1455,0,1455,1,1122,1,1122,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,9
-3.802886494,-2.54401821,TCGA-43-2581-01A,TCGA-43-2581-01A-01D-1522-08,8,0.405363471,TCGA-43-2581,LUSC,47,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-17447,Alive,TUMOR FREE,1176,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1176,0,1176,0,1176,0,1176,NA,Stage IIIA,T3,M0,NA,10
9.466786013,-2.484536174,TCGA-BG-A0MI-01A,TCGA-BG-A0MI-01A-11W-A062-09,1,0.755877437,TCGA-BG-A0MI,UCEC,83,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30334,Dead,TUMOR FREE,NA,714,[Not Available],NA,NA,NA,NA,[Not Available],1,714,0,714,NA,NA,0,714,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,1
-4.163679085,-1.808068948,TCGA-21-5787-01A,TCGA-21-5787-01A-01D-1632-08,8,0.425319085,TCGA-21-5787,LUSC,65,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-24071,Dead,WITH TUMOR,329,329,[Not Available],NA,NA,NA,103,Progressive Disease,1,329,1,329,NA,NA,1,103,NA,Stage IIIA,T2,M0,LUSC.secretory,10
-7.266781386,-2.226571527,TCGA-D6-6825-01A,TCGA-D6-6825-01A-21D-1912-08,6,0.368517088,TCGA-D6-6825,HNSC,73,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-26976,Alive,TUMOR FREE,491,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,491,0,491,0,491,0,491,NA,Stage I,T1,[Not Available],HNSC.Basal,2
8.834481741,-3.979680475,TCGA-27-1834-01A,TCGA-27-1834-01A-01D-1494-08,1,0.724438541,TCGA-27-1834,GBM,56,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-20568,Dead,WITH TUMOR,1008,1233,[Not Available],Recurrence,[Not Applicable],[Not Applicable],335,[Not Available],1,1233,1,1233,NA,NA,1,335,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-7.562254251,-2.430768768,TCGA-DE-A3KN-01A,TCGA-DE-A3KN-01A-11D-A20C-08,6,0.405666439,TCGA-DE-A3KN,THCA,49,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-18098,Alive,TUMOR FREE,831,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,831,0,831,NA,NA,0,831,NA,Stage IVA,T3,M0,THCA.5,2
9.75667752,-1.517679948,TCGA-J8-A3YF-01A,TCGA-J8-A3YF-01A-12D-A23M-08,1,0.888059678,TCGA-J8-A3YF,THCA,83,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-30661,Alive,TUMOR FREE,751,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,751,0,751,0,751,0,751,NA,Stage III,T1,M0,THCA.4,1
-7.231459594,1.553978758,TCGA-AX-A062-01A,TCGA-AX-A062-01A-11W-A027-09,0,NA,TCGA-AX-A062,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2005,Indeterminate (neither Pre or Postmenopausal),-19643,Alive,TUMOR FREE,1399,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1399,0,1399,0,1399,0,1399,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
9.579702417,-2.367309118,TCGA-60-2697-01A,TCGA-60-2697-01A-11D-2122-08,1,0.777327054,TCGA-60-2697,LUSC,41,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],1992,[Not Available],-14984,Dead,WITH TUMOR,NA,372,[Not Available],NA,NA,NA,200,Complete Remission/Response,1,372,1,372,1,200,1,200,NA,Stage IIA,T2,M0,NA,1
-3.144099793,-3.39955975,TCGA-D1-A174-01A,TCGA-D1-A174-01A-11D-A12J-09,8,0.624254304,TCGA-D1-A174,UCEC,51,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Indeterminate (neither Pre or Postmenopausal),-18702,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,594,0,594,0,594,0,594,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-4.486152606,-0.007581882,TCGA-56-7730-01A,TCGA-56-7730-01A-11D-2122-08,0,NA,TCGA-56-7730,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26699,Dead,WITH TUMOR,NA,198,[Not Available],NA,NA,NA,NA,Progressive Disease,1,198,1,198,NA,NA,1,198,NA,Stage IIA,T2b,M0,NA,10
9.496289104,-5.224642337,TCGA-ET-A39N-01A,TCGA-ET-A39N-01A-11D-A19J-08,1,0.83893542,TCGA-ET-A39N,THCA,35,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-12904,Alive,TUMOR FREE,3751,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3751,0,3751,0,3751,0,3751,NA,Stage I,T3,MX,THCA.1,1
-0.000778101,4.109036686,TCGA-HD-8224-01A,TCGA-HD-8224-01A-11D-2394-08,4,0.407243434,TCGA-HD-8224,HNSC,63,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-23069,Dead,WITH TUMOR,NA,446,[Not Available],Distant Metastasis,Distant Metastasis,Lung,171,Progressive Disease,1,446,1,446,NA,NA,1,171,NA,Stage IVA,T3,M0,NA,6
-4.374748299,0.765180666,TCGA-CN-6992-01A,TCGA-CN-6992-01A-11D-1912-08,0,NA,TCGA-CN-6992,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-22598,Alive,TUMOR FREE,1066,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1066,0,1066,NA,NA,0,1066,NA,Stage IVA,T3,[Not Available],HNSC.Classical,10
-5.274732277,2.489577462,TCGA-AF-4110-01A,TCGA-AF-4110-01A-02D-1733-10,12,0.372226171,TCGA-AF-4110,READ,77,MALE,WHITE,[Not Available],[Not Available],2010,[Not Available],-28289,Alive,TUMOR FREE,912,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,912,0,912,NA,NA,0,912,NA,Stage IVA,T4a,MX,GI.CIN,8
-6.816653515,2.356941105,TCGA-BR-8686-01A,TCGA-BR-8686-01A-11D-2394-08,0,NA,TCGA-BR-8686,STAD,69,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-25372,Dead,TUMOR FREE,NA,635,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,635,0,635,0,635,0,635,NA,Stage IIIB,T4b,M0,GI.EBV,7
-3.370128395,-3.276301212,TCGA-BR-8361-01A,TCGA-BR-8361-01A-11D-2340-08,8,0.606838786,TCGA-BR-8361,STAD,71,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-25999,Alive,TUMOR FREE,946,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,946,0,946,0,946,0,946,NA,Stage IIIC,T4b,M0,GI.HM-indel,10
9.260606379,-5.373651904,TCGA-3A-A9IR-01A,TCGA-3A-A9IR-01A-11D-A38G-08,1,0.854862136,TCGA-3A-A9IR,PAAD,64,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-23406,Alive,TUMOR FREE,1542,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1542,0,1542,0,1542,0,1542,NA,Stage IB,T2,MX,NA,1
-6.471331719,-2.038505807,TCGA-D7-8570-01A,TCGA-D7-8570-01A-11D-2340-08,7,0,TCGA-D7-8570,STAD,44,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011,[Not Available],-16150,Alive,WITH TUMOR,752,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,752,0,752,0,752,0,752,NA,Stage IIIB,T3,M0,GI.EBV,2
-7.817156702,-2.451364205,TCGA-3A-A9IS-01A,TCGA-3A-A9IS-01A-21D-A397-08,6,0.350168622,TCGA-3A-A9IS,PAAD,67,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-24621,Alive,TUMOR FREE,998,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,998,0,998,0,998,0,998,NA,Stage IB,T2,MX,NA,2
-3.218823403,-3.295253795,TCGA-55-7907-01A,TCGA-55-7907-01A-11D-2167-08,8,0.523407474,TCGA-55-7907,LUAD,77,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-28201,Dead,WITH TUMOR,NA,343,[Not Available],Distant Metastasis,NA,NA,294,Complete Remission/Response,1,343,1,343,1,294,1,294,NA,Stage IIA,T2a,MX,LUAD.3,10
0.143209635,4.455189331,TCGA-3E-AAAY-01A,TCGA-3E-AAAY-01A-11D-A38G-08,4,0.521655612,TCGA-3E-AAAY,PAAD,67,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-24760,Alive,[Discrepancy],2285,NA,NA,Distant Metastasis,Lung,NA,987,Complete Remission/Response,0,2285,0,2285,1,987,1,987,NA,Stage IIB,T3,MX,NA,6
-2.721772827,1.068119584,TCGA-78-7154-01A,TCGA-78-7154-01A-11D-2036-08,5,0.102945343,TCGA-78-7154,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-26481,Dead,NA,NA,593,[Not Available],NA,NA,NA,NA,[Not Available],1,593,NA,593,NA,NA,0,593,NA,Stage IIIA,T3,M0,LUAD.4,4
-6.022058197,3.457933949,TCGA-3E-AAAZ-01A,TCGA-3E-AAAZ-01A-11D-A38G-08,11,0.527823456,TCGA-3E-AAAZ,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-26234,Dead,WITH TUMOR,NA,2182,"Other, specify",New Primary Tumor,Lung,NA,1600,[Unknown],1,2182,0,2182,NA,NA,1,1600,NA,Stage IIA,T3,MX,NA,8
-5.43523601,2.506133025,TCGA-FB-AAQ0-01A,TCGA-FB-AAQ0-01A-31D-A40W-08,12,0.354370151,TCGA-FB-AAQ0,PAAD,68,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-24988,Dead,TUMOR FREE,NA,473,NA,NA,NA,NA,NA,Complete Remission/Response,1,473,0,473,0,473,0,473,NA,Stage IIA,T3,MX,NA,8
-4.512596614,1.884302957,TCGA-FB-AAQ3-01A,TCGA-FB-AAQ3-01A-11D-A40W-08,0,NA,TCGA-FB-AAQ3,PAAD,65,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-23953,Dead,TUMOR FREE,NA,31,Surgical Complications,NA,NA,NA,NA,Complete Remission/Response,1,31,0,31,0,31,0,31,NA,Stage IIB,T3,MX,NA,8
-5.198810647,2.40446039,TCGA-FZ-5921-01A,TCGA-FZ-5921-01A-11D-1609-08,12,0.326019889,TCGA-FZ-5921,PAAD,85,FEMALE,[Unknown],Pancreas-Adenocarcinoma Ductal Type,GX,2007,[Not Available],-31074,Dead,WITH TUMOR,NA,155,NA,Locoregional Recurrence,Peritoneal Surfaces,NA,103,Progressive Disease,1,155,1,155,NA,NA,1,103,NA,Stage IIB,T3,M0,NA,8
9.466663332,-4.88158775,TCGA-3A-A9IN-01A,TCGA-3A-A9IN-01A-11D-A397-08,1,0.787571599,TCGA-3A-A9IN,PAAD,62,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2008,[Not Available],-22799,Alive,TUMOR FREE,2084,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2084,0,2084,0,2084,0,2084,NA,Stage IB,T2,MX,NA,1
-6.187282161,3.555369295,TCGA-3A-A9I7-01A,TCGA-3A-A9I7-01A-21D-A38G-08,11,0.550247731,TCGA-3A-A9I7,PAAD,45,MALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-16766,Alive,WITH TUMOR,1323,NA,NA,Locoregional Recurrence,Peritoneal Surfaces,NA,1309,[Unknown],0,1323,0,1323,NA,NA,1,1309,NA,Stage IIB,T3,MX,NA,8
-5.361929414,2.322355234,TCGA-3A-A9I9-01A,TCGA-3A-A9I9-01A-11D-A38G-08,12,0.160060083,TCGA-3A-A9I9,PAAD,67,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-24731,Dead,WITH TUMOR,NA,634,Pancreatic Cancer,Locoregional Recurrence,Liver,NA,513,Stable Disease,1,634,1,634,NA,NA,1,513,NA,Stage IIA,T3,MX,NA,9
9.051556413,-5.283070048,TCGA-BR-A44T-01A,TCGA-BR-A44T-01A-32D-A24D-08,1,0.785150807,TCGA-BR-A44T,STAD,53,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-19407,Alive,WITH TUMOR,1038,NA,[Not Available],Locoregional Recurrence,NA,NA,682,Complete Remission/Response,0,1038,0,1038,1,682,1,682,NA,Stage IIA,T3,M0,GI.GS,1
-0.360741534,4.826858744,TCGA-BR-8484-01A,TCGA-BR-8484-01A-11D-2394-08,4,0.594647295,TCGA-BR-8484,STAD,61,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-22583,Dead,TUMOR FREE,NA,766,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,766,0,766,0,766,0,766,NA,Stage IIIA,T4a,M0,GI.CIN,6
-6.080510099,3.585313828,TCGA-2J-AABT-01A,TCGA-2J-AABT-01A-11D-A40W-08,11,0.559501137,TCGA-2J-AABT,PAAD,72,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26379,Alive,NA,319,NA,NA,NA,NA,NA,NA,[Unknown],0,319,0,319,NA,NA,0,319,NA,Stage IIB,T3,M0,NA,8
9.895548347,-4.137841368,TCGA-2J-AABV-01A,TCGA-2J-AABV-01A-12D-A40W-08,1,0.652930813,TCGA-2J-AABV,PAAD,74,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G4,2012,[Not Available],-27082,Dead,WITH TUMOR,NA,652,Pancreatic Cancer,Distant Metastasis,Liver,NA,126,Progressive Disease,1,652,1,652,NA,NA,1,126,NA,Stage IIB,T3,M0,NA,1
9.093923324,-5.790722394,TCGA-86-8671-01A,TCGA-86-8671-01A-11D-2393-08,1,0.876738098,TCGA-86-8671,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26448,Alive,TUMOR FREE,839,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,839,0,839,0,839,0,839,NA,Stage IIB,T2b,M0,NA,1
-5.652851824,2.392379689,TCGA-2L-AAQA-01A,TCGA-2L-AAQA-01A-21D-A38G-08,12,0.077350577,TCGA-2L-AAQA,PAAD,76,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-28074,Dead,WITH TUMOR,NA,143,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,143,1,143,NA,NA,1,143,NA,Stage IIB,T3,MX,NA,8
-5.340966063,2.69148364,TCGA-2L-AAQE-01A,TCGA-2L-AAQE-01A-11D-A397-08,12,0.227149829,TCGA-2L-AAQE,PAAD,56,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-20618,Dead,WITH TUMOR,NA,684,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,684,1,684,NA,NA,1,684,NA,Stage IIB,T3,M0,NA,8
-5.284048682,2.596341611,TCGA-2L-AAQI-01A,TCGA-2L-AAQI-01A-12D-A397-08,12,0.351930658,TCGA-2L-AAQI,PAAD,66,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-24381,Dead,WITH TUMOR,NA,103,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,103,1,103,NA,NA,1,103,NA,Stage IIB,T3,MX,NA,8
-5.297367405,2.678614323,TCGA-2L-AAQL-01A,TCGA-2L-AAQL-01A-11D-A38G-08,12,0.296659494,TCGA-2L-AAQL,PAAD,82,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-30092,Dead,WITH TUMOR,NA,292,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,292,1,292,NA,NA,1,292,NA,Stage IIB,T3,MX,NA,8
9.508976818,-4.711707932,TCGA-AG-3599-01A,TCGA-AG-3599-01A-02D-1989-10,1,0.728491946,TCGA-AG-3599,READ,70,MALE,[Not Available],[Not Available],[Not Available],2007,[Not Available],-25749,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,366,0,366,NA,NA,0,366,NA,Stage I,T2,M0,NA,1
-1.332795428,4.201225117,TCGA-FP-8631-01A,TCGA-FP-8631-01A-11D-2394-08,4,0.381895316,TCGA-FP-8631,STAD,68,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-24898,Alive,TUMOR FREE,17,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,17,0,17,NA,NA,0,17,NA,Stage IIIA,T3,MX,GI.CIN,5
8.306232144,-4.451239643,TCGA-16-0861-01A,TCGA-16-0861-01A-01D-1492-08,1,0.573758785,TCGA-16-0861,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-23778,NA,NA,131,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],94,[Not Available],0,131,NA,131,NA,NA,1,94,NA,NA,NA,NA,NA,1
-4.72762205,-0.45996914,TCGA-55-A48X-01A,TCGA-55-A48X-01A-11D-A24D-08,0,NA,TCGA-55-A48X,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23341,Alive,TUMOR FREE,689,NA,[Not Available],New Primary Tumor,NA,NA,615,Complete Remission/Response,0,689,0,689,0,689,1,615,NA,Stage IIA,T1b,M0,NA,10
-0.805059159,4.484855697,TCGA-2J-AABP-01A,TCGA-2J-AABP-01A-11D-A40W-08,4,0.500168127,TCGA-2J-AABP,PAAD,58,FEMALE,WHITE,Pancreas-Undifferentiated Carcinoma,G4,2013,[Not Available],-21484,Alive,TUMOR FREE,463,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,463,0,463,0,463,0,463,NA,Stage IIB,T3,M0,NA,6
4.411740646,1.086031741,TCGA-2J-AABR-01A,TCGA-2J-AABR-01A-11D-A40W-08,2,0.68265616,TCGA-2J-AABR,PAAD,60,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-22131,Alive,WITH TUMOR,438,NA,NA,Distant Metastasis,Liver,NA,327,Progressive Disease,0,438,0,438,NA,NA,1,327,NA,Stage IIA,T3,M0,NA,5
-3.315960899,-3.429480754,TCGA-FP-A4BE-01A,TCGA-FP-A4BE-01A-12D-A24D-08,8,0.636931343,TCGA-FP-A4BE,STAD,55,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-20148,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,337,0,337,0,337,0,337,NA,Stage IIA,T3,M0,NA,10
-0.533198494,4.653347654,TCGA-55-7227-01A,TCGA-55-7227-01A-11D-2036-08,4,0.52753639,TCGA-55-7227,LUAD,77,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-28458,Dead,WITH TUMOR,NA,952,[Not Available],Locoregional Recurrence,NA,NA,255,Complete Remission/Response,1,952,1,952,1,255,1,255,NA,Stage IIIA,T3,MX,NA,6
-6.095415186,3.562203853,TCGA-2J-AABE-01A,TCGA-2J-AABE-01A-12D-A40W-08,11,0.519477935,TCGA-2J-AABE,PAAD,73,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26943,Alive,TUMOR FREE,676,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,676,0,676,0,676,0,676,NA,Stage IIA,T3,M0,NA,8
-5.355325093,2.572938101,TCGA-2J-AABF-01A,TCGA-2J-AABF-01A-31D-A40W-08,12,0.337841588,TCGA-2J-AABF,PAAD,73,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-26936,Dead,WITH TUMOR,NA,691,Pancreatic Cancer,Distant Metastasis,"Other, specify",Liver/lung,443,Progressive Disease,1,691,1,691,NA,NA,1,443,NA,Stage IIB,T3,M0,NA,8
-3.492440205,-3.240289414,TCGA-HU-A4GT-01A,TCGA-HU-A4GT-01A-21D-A25D-08,8,0.52097138,TCGA-HU-A4GT,STAD,71,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011,[Not Available],-26231,Alive,TUMOR FREE,198,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,198,0,198,0,198,0,198,NA,Stage IIA,T3,M0,GI.HM-indel,10
-6.255538256,3.47047105,TCGA-2J-AABH-01A,TCGA-2J-AABH-01A-21D-A40W-08,11,0.520670167,TCGA-2J-AABH,PAAD,61,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G3,2011,[Not Available],-22425,Alive,WITH TUMOR,1287,NA,NA,Distant Metastasis,"Other, specify",perigastric mass,1287,Complete Remission/Response,0,1287,0,1287,1,1287,1,1287,NA,Stage IIA,T3,M0,NA,8
-6.495725845,-1.446864402,TCGA-2J-AABI-01A,TCGA-2J-AABI-01A-12D-A40W-08,7,0.300882464,TCGA-2J-AABI,PAAD,55,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G3,2011,[Not Available],-20316,Alive,WITH TUMOR,969,NA,NA,Distant Metastasis,Liver,NA,728,Progressive Disease,0,969,0,969,NA,NA,1,728,NA,Stage IIA,T3,M0,NA,2
-5.172622087,2.147353857,TCGA-2J-AABK-01A,TCGA-2J-AABK-01A-31D-A40W-08,0,NA,TCGA-2J-AABK,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26188,Alive,TUMOR FREE,484,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,484,0,484,0,484,0,484,NA,Stage IIB,T3,M0,NA,8
-1.072588634,3.182430421,TCGA-55-6987-01A,TCGA-55-6987-01A-11D-1945-08,0,NA,TCGA-55-6987,LUAD,77,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-28382,Alive,TUMOR FREE,2137,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2137,0,2137,0,2137,0,2137,NA,Stage IA,T1,M0,NA,6
-5.33426022,2.572843688,TCGA-2J-AABO-01A,TCGA-2J-AABO-01A-21D-A40W-08,12,0.280006806,TCGA-2J-AABO,PAAD,43,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-15869,Alive,WITH TUMOR,440,NA,NA,Distant Metastasis,Liver,NA,439,Progressive Disease,0,440,0,440,NA,NA,1,439,NA,Stage IIB,T3,M0,NA,8
0.10005811,3.312784194,TCGA-AG-3898-01A,TCGA-AG-3898-01A-01W-1073-09,4,0.340630587,TCGA-AG-3898,READ,61,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2006,[Not Available],-22492,Alive,WITH TUMOR,1461,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1461,0,1461,NA,NA,0,1461,NA,Stage IIA,T3,M0,GI.CIN,3
4.45924757,1.113403046,TCGA-14-1823-01A,TCGA-14-1823-01A-01D-1494-08,2,0.693756458,TCGA-14-1823,GBM,58,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-21384,Dead,WITH TUMOR,543,543,[Not Available],Recurrence,[Not Applicable],[Not Applicable],140,[Not Available],1,543,1,543,NA,NA,1,140,NA,NA,NA,NA,GBM_LGG.Classic-like,5
-3.277090386,-2.981207926,TCGA-BR-4257-01A,TCGA-BR-4257-01A-01D-1126-08,8,0.520663586,TCGA-BR-4257,STAD,79,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-29014,Dead,NA,NA,294,[Not Available],NA,NA,NA,NA,[Not Available],1,294,NA,294,NA,NA,0,294,NA,[Not Available],TX,M0,GI.HM-indel,10
-7.56666975,-2.5609149,TCGA-EI-6513-01A,TCGA-EI-6513-01A-21D-1733-10,6,0.515708582,TCGA-EI-6513,READ,59,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-21776,Alive,TUMOR FREE,497,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,497,0,497,NA,NA,0,497,NA,Stage IIIB,T3,M0,GI.CIN,2
-0.17002803,5.314926748,TCGA-32-1977-01A,TCGA-32-1977-01A-01D-1353-08,4,0.53032795,TCGA-32-1977,GBM,63,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-23205,Alive,WITH TUMOR,3,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3,0,3,NA,NA,0,3,NA,NA,NA,NA,NA,6
-3.11974919,-3.764927069,TCGA-CD-A4MG-01A,TCGA-CD-A4MG-01A-11D-A25D-08,8,0.316397514,TCGA-CD-A4MG,STAD,76,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-28019,Dead,WITH TUMOR,NA,200,[Not Available],Locoregional Recurrence,NA,NA,74,Complete Remission/Response,1,200,1,200,1,74,1,74,NA,Stage IIA,T3,M0,GI.HM-indel,10
-5.400741609,2.399754335,TCGA-2J-AAB6-01A,TCGA-2J-AAB6-01A-11D-A40W-08,12,0.363175988,TCGA-2J-AAB6,PAAD,75,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-27600,Dead,WITH TUMOR,NA,293,Pancreatic Cancer,Distant Metastasis,Liver,NA,169,Progressive Disease,1,293,1,293,NA,NA,1,169,NA,Stage IIA,T3,M0,NA,8
-5.340587279,2.608813364,TCGA-2J-AAB8-01A,TCGA-2J-AAB8-01A-12D-A40W-08,12,0.348294093,TCGA-2J-AAB8,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-26028,Alive,TUMOR FREE,80,NA,NA,NA,NA,NA,NA,[Unknown],0,80,0,80,NA,NA,0,80,NA,Stage IIB,T3,M0,NA,8
0.117337214,4.68088296,TCGA-2J-AAB9-01A,TCGA-2J-AAB9-01A-11D-A40W-08,4,0.629944294,TCGA-2J-AAB9,PAAD,70,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2012,[Not Available],-25920,Dead,WITH TUMOR,NA,627,Pancreatic Cancer,Distant Metastasis,Liver,NA,521,Complete Remission/Response,1,627,1,627,1,521,1,521,NA,Stage IIB,T3,M0,NA,6
10.0364867,-1.71171172,TCGA-2J-AABA-01A,TCGA-2J-AABA-01A-21D-A40W-08,1,0.788218658,TCGA-2J-AABA,PAAD,55,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-20133,Dead,WITH TUMOR,NA,607,Pancreatic Cancer,Distant Metastasis,"Other, specify",subcut nodule,160,Progressive Disease,1,607,1,607,NA,NA,1,160,NA,Stage IIB,T3,M0,NA,1
-7.740369188,2.070663203,TCGA-VS-A9V5-01A,TCGA-VS-A9V5-01A-11D-A42O-09,9,0.382283833,TCGA-VS-A9V5,CESC,50,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18577,Dead,WITH TUMOR,NA,494,NA,NA,NA,NA,NA,Progressive Disease,1,494,1,494,NA,NA,1,494,NA,Stage IIB,T2b,MX,NA,6
-5.475688589,1.329481977,TCGA-44-6776-01A,TCGA-44-6776-01A-11D-1855-08,0,NA,TCGA-44-6776,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-22150,Alive,TUMOR FREE,2616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2616,0,2616,0,2616,0,2616,NA,Stage IA,T1,MX,LUAD.1,9
0.768574258,2.490911057,TCGA-WL-A834-01A,TCGA-WL-A834-01A-11D-A351-09,0,NA,TCGA-WL-A834,CESC,57,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,791,NA,NA,NA,NA,NA,NA,Partial Remission/Response,0,791,0,791,NA,NA,0,791,NA,[Not Available],T1b1,[Not Available],NA,1
-0.813069505,4.419437187,TCGA-86-8075-01A,TCGA-86-8075-01A-11D-2238-08,4,0.461204027,TCGA-86-8075,LUAD,66,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24402,Dead,TUMOR FREE,NA,694,[Not Available],Locoregional Recurrence,NA,NA,199,Complete Remission/Response,1,694,0,694,1,199,1,199,NA,Stage IB,T2,M0,NA,6
-5.831675497,3.038562917,TCGA-2J-AAB1-01A,TCGA-2J-AAB1-01A-11D-A40W-08,11,0.171581189,TCGA-2J-AAB1,PAAD,65,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-23962,Dead,TUMOR FREE,NA,66,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,1,66,1,66,0,66,0,66,NA,Stage IIB,T3,M0,NA,7
-5.276922868,2.652807852,TCGA-2J-AAB4-01A,TCGA-2J-AAB4-01A-12D-A40W-08,12,0.258846808,TCGA-2J-AAB4,PAAD,48,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2012,[Not Available],-17794,Alive,TUMOR FREE,729,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,729,0,729,0,729,0,729,NA,Stage IIB,T2,M0,NA,8
-6.62990344,-2.203028222,TCGA-CG-4466-01A,TCGA-CG-4466-01A-01D-1158-08,6,0.048193263,TCGA-CG-4466,STAD,81,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009,[Not Available],-29739,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,577,0,577,0,577,0,577,NA,Stage IB,T2a,M0,GI.CIN,2
9.369143264,-2.756662036,TCGA-32-1980-01A,TCGA-32-1980-01A-01D-1696-08,1,0.750180882,TCGA-32-1980,GBM,72,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-26467,Dead,WITH TUMOR,36,36,[Not Available],NA,NA,NA,NA,[Not Available],1,36,1,36,NA,NA,1,36,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,1
-6.374382423,1.694849597,TCGA-AX-A1CP-01A,TCGA-AX-A1CP-01A-11D-A135-09,10,0.23253486,TCGA-AX-A1CP,UCEC,84,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30737,Alive,NA,1107,NA,[Not Available],NA,NA,NA,722,[Not Available],0,1107,0,1107,NA,NA,1,722,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
-3.172075061,-3.69722925,TCGA-EC-A24G-01A,TCGA-EC-A24G-01A-11D-A16D-09,8,0.470411978,TCGA-EC-A24G,UCEC,57,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20857,Alive,TUMOR FREE,511,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,511,0,511,0,511,0,511,NA,Stage II,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
8.679422215,-1.903994767,TCGA-14-1827-01A,TCGA-14-1827-01A-01W-0643-08,1,0.517200753,TCGA-14-1827,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-18828,Dead,NA,179,179,[Not Available],NA,NA,NA,NA,[Not Available],1,179,NA,179,NA,NA,0,179,NA,NA,NA,NA,NA,6
-3.717718778,-2.819722939,TCGA-44-8117-01A,TCGA-44-8117-01A-11D-2238-08,8,0.41252025,TCGA-44-8117,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-19855,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,385,0,385,0,385,0,385,NA,Stage IB,T2a,M0,NA,10
-5.788088371,-2.214941634,TCGA-AR-A24N-01A,TCGA-AR-A24N-01A-11D-A167-09,0,NA,TCGA-AR-A24N,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Peri (6-12 months since last menstrual period),-19989,Alive,TUMOR FREE,3035,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3035,0,3035,0,3035,0,3035,NA,Stage I,T1,M0,BRCA.LumB,2
-7.484826187,-2.493497106,TCGA-VS-A9UU-01A,TCGA-VS-A9UU-01A-11D-A42O-09,6,0.295901365,TCGA-VS-A9UU,CESC,42,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G1,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15534,Alive,TUMOR FREE,442,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,442,0,442,0,442,0,442,NA,Stage IIB,T2b,MX,NA,2
-5.535451392,-1.303607469,TCGA-VS-A9UZ-01A,TCGA-VS-A9UZ-01A-11D-A42O-09,0,NA,TCGA-VS-A9UZ,CESC,61,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2009,Peri (6-12 months since last menstrual period),-22344,Alive,TUMOR FREE,2044,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2044,0,2044,0,2044,0,2044,NA,Stage IB1,T1b,MX,NA,10
-0.635458759,2.569550042,TCGA-VS-A9V0-01A,TCGA-VS-A9V0-01A-11D-A42O-09,4,0.253026023,TCGA-VS-A9V0,CESC,58,FEMALE,[Unknown],Mucinous Adenocarcinoma of Endocervical Type,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21215,Alive,WITH TUMOR,573,NA,NA,Distant Metastasis,"Other, specify",Retroperitoneal lymph node and pelvic lymph node and lung,475,Complete Remission/Response,0,573,0,573,1,475,1,475,NA,Stage IB,T1b,MX,NA,6
-5.830567689,-2.06296859,TCGA-VS-A9V1-01A,TCGA-VS-A9V1-01A-11D-A42O-09,0,NA,TCGA-VS-A9V1,CESC,46,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17001,Dead,WITH TUMOR,NA,157,Cervical Cancer,Distant Metastasis,NA,Retroperitoneo,58,Progressive Disease,1,157,1,157,NA,NA,1,58,NA,Stage IVB,T3b,MX,NA,2
10.31276878,-1.849636044,TCGA-VS-A9V2-01A,TCGA-VS-A9V2-01A-11D-A42O-09,1,0.791517103,TCGA-VS-A9V2,CESC,29,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Peri (6-12 months since last menstrual period),-10637,Alive,TUMOR FREE,555,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,555,0,555,0,555,0,555,NA,Stage IB1,T1b,MX,NA,1
0.187579013,5.207521277,TCGA-97-7553-01A,TCGA-97-7553-01A-21D-2036-08,4,0.450462116,TCGA-97-7553,LUAD,58,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-21518,Alive,TUMOR FREE,1870,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1870,0,1870,0,1870,0,1870,NA,Stage IA,T1,MX,LUAD.5,6
-7.574563356,-2.364277238,TCGA-E2-A1AZ-01A,TCGA-E2-A1AZ-01A-11D-A12Q-09,6,0.283683765,TCGA-E2-A1AZ,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23230,Alive,TUMOR FREE,2329,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2329,0,2329,0,2329,0,2329,NA,Stage IIB,T2,M0,BRCA.Basal,2
-6.432905698,-1.521223149,TCGA-69-8255-01A,TCGA-69-8255-01A-11D-2284-08,7,0.177823547,TCGA-69-8255,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26289,Alive,NA,129,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,129,0,129,NA,NA,0,129,NA,Stage IA,T1a,M0,NA,2
-4.338011777,-1.708907224,TCGA-73-4670-01A,TCGA-73-4670-01A-01D-1265-08,8,0.325630217,TCGA-73-4670,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25526,Alive,WITH TUMOR,131,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,131,0,131,NA,NA,0,131,NA,Stage IV,T2,M1,NA,10
-1.529229234,3.811741061,TCGA-66-2794-01A,TCGA-66-2794-01A-01D-1267-08,4,0.037586418,TCGA-66-2794,LUSC,64,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-23710,Alive,TUMOR FREE,1645,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1645,0,1645,0,1645,0,1645,NA,Stage IIIB,T4,M0,LUSC.classical,6
-4.716568362,-1.10690579,TCGA-VS-A959-01A,TCGA-VS-A959-01A-11D-A42O-09,8,0.159892657,TCGA-VS-A959,CESC,76,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27897,Alive,TUMOR FREE,1561,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1561,0,1561,0,1561,0,1561,NA,Stage IIB,T2b,MX,NA,10
-6.756509585,-2.080704445,TCGA-VS-A9U5-01A,TCGA-VS-A9U5-01A-11D-A42O-09,6,0.190553849,TCGA-VS-A9U5,CESC,57,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Peri (6-12 months since last menstrual period),-21149,Alive,TUMOR FREE,1535,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1535,0,1535,0,1535,0,1535,NA,Stage IIB,T2b,MX,NA,2
-6.014972006,-1.137556678,TCGA-VS-A9UH-01A,TCGA-VS-A9UH-01A-11D-A42O-09,0,NA,TCGA-VS-A9UH,CESC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,GX,2010,[Not Available],-19454,Alive,TUMOR FREE,1427,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1427,0,1427,NA,NA,0,1427,NA,Stage IVA,T4,MX,NA,10
-6.341424604,-1.214666316,TCGA-VS-A9UL-01A,TCGA-VS-A9UL-01A-11D-A42O-09,7,0.064055782,TCGA-VS-A9UL,CESC,79,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29033,Dead,WITH TUMOR,NA,442,Cervical Cancer,Distant Metastasis,NA,Bone,336,Progressive Disease,1,442,1,442,NA,NA,1,336,NA,Stage IIIB,T3b,MX,NA,2
-0.061858446,5.293429138,TCGA-VS-A9UM-01A,TCGA-VS-A9UM-01A-11D-A42O-09,4,0.29213483,TCGA-VS-A9UM,CESC,39,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,2011,Peri (6-12 months since last menstrual period),-14255,Dead,TUMOR FREE,NA,829,NA,NA,NA,NA,NA,Complete Remission/Response,1,829,0,829,NA,NA,0,829,NA,Stage IVB,T3b,MX,NA,6
-4.698066873,0.5429077,TCGA-56-7221-01A,TCGA-56-7221-01A-11D-2042-08,0,NA,TCGA-56-7221,LUSC,79,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-28873,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,608,0,608,0,608,0,608,NA,Stage IB,T2,M0,NA,10
-0.524704288,4.615353708,TCGA-BR-4183-01A,TCGA-BR-4183-01A-02D-1126-08,4,0.526586316,TCGA-BR-4183,STAD,55,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2007,[Not Available],-20420,Dead,NA,NA,201,[Not Available],NA,NA,NA,NA,[Not Available],1,201,NA,201,NA,NA,0,201,NA,Stage IIIA,T3,M0,NA,6
-0.600115684,4.89831485,TCGA-06-0130-01A,TCGA-06-0130-01A-01D-1490-08,4,0.547053538,TCGA-06-0130,GBM,54,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-19812,Dead,WITH TUMOR,320,394,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],244,[Not Available],1,394,1,394,NA,NA,1,244,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-8.202477189,2.078621527,TCGA-DJ-A2Q9-01A,TCGA-DJ-A2Q9-01A-21D-A18F-08,9,0.425713507,TCGA-DJ-A2Q9,THCA,65,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-23951,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1092,0,1092,0,1092,0,1092,NA,Stage III,T1b,M0,THCA.4,7
8.796597717,-4.597457428,TCGA-14-1451-01A,TCGA-14-1451-01A-01W-0611-08,1,0.702350885,TCGA-14-1451,GBM,39,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-14401,Dead,WITH TUMOR,703,703,[Not Available],Recurrence,[Not Applicable],[Not Applicable],19,[Not Available],1,703,1,703,NA,NA,1,19,NA,NA,NA,NA,NA,1
-0.347959946,3.909622866,TCGA-FI-A2EY-01A,TCGA-FI-A2EY-01A-12D-A18P-09,4,0.155428012,TCGA-FI-A2EY,UCEC,63,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23042,Dead,TUMOR FREE,NA,880,[Not Available],New Primary Tumor,Lung,NA,577,Complete Remission/Response,1,880,0,880,0,880,1,577,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,6
-0.053831354,4.666464307,TCGA-14-0740-01B,TCGA-14-0740-01B-01D-1845-08,4,0.558300529,TCGA-14-0740,GBM,70,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-25627,Dead,WITH TUMOR,364,364,[Not Available],NA,NA,NA,NA,[Not Available],1,364,1,364,NA,NA,1,364,NA,NA,NA,NA,NA,6
10.0591137,-1.764957913,TCGA-L4-A4E6-01A,TCGA-L4-A4E6-01A-11D-A24D-08,1,0.807598428,TCGA-L4-A4E6,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24631,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,435,0,435,0,435,0,435,NA,Stage IA,T1,M0,NA,1
10.12370101,-1.617337354,TCGA-EL-A3GP-01A,TCGA-EL-A3GP-01A-11D-A202-08,1,0.865002614,TCGA-EL-A3GP,THCA,70,MALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-25696,Alive,NA,1506,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1506,0,1506,0,1506,0,1506,NA,Stage III,T3,M0,THCA.4,1
-3.306038186,-3.235050639,TCGA-VS-A94Z-01A,TCGA-VS-A94Z-01A-11D-A387-09,8,0.346587208,TCGA-VS-A94Z,CESC,38,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14046,Alive,TUMOR FREE,1015,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1015,0,1015,0,1015,0,1015,NA,Stage IIB,T2b,MX,NA,10
-6.807938117,1.98607173,TCGA-VS-A950-01A,TCGA-VS-A950-01A-11D-A42O-09,0,NA,TCGA-VS-A950,CESC,42,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15365,Alive,WITH TUMOR,1221,NA,NA,NA,NA,NA,NA,Partial Remission/Response,0,1221,0,1221,NA,NA,0,1221,NA,Stage IIIA,T3a,MX,NA,8
-6.533715691,-1.369328666,TCGA-VS-A952-01A,TCGA-VS-A952-01A-11D-A387-09,7,0.292106286,TCGA-VS-A952,CESC,66,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24345,Alive,TUMOR FREE,1778,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1778,0,1778,0,1778,0,1778,NA,Stage IB1,T1b,MX,NA,2
-1.800577854,1.106645007,TCGA-AN-A0XU-01A,TCGA-AN-A0XU-01A-11D-A10G-09,5,0.662969778,TCGA-AN-A0XU,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20052,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.Basal,4
-7.242547509,-2.502793876,TCGA-VS-A954-01A,TCGA-VS-A954-01A-11D-A387-09,6,0.339535741,TCGA-VS-A954,CESC,67,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24498,Alive,TUMOR FREE,1714,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1714,0,1714,0,1714,0,1714,NA,Stage IIIB,T3b,MX,NA,2
7.848995143,-1.390928593,TCGA-VS-A957-01A,TCGA-VS-A957-01A-11D-A42O-09,1,0.166408831,TCGA-VS-A957,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23585,Alive,TUMOR FREE,1688,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1688,0,1688,0,1688,0,1688,NA,Stage IB1,T1b1,MX,NA,1
-3.505614945,-3.05553624,TCGA-VS-A958-01A,TCGA-VS-A958-01A-11D-A42O-09,8,0.436057961,TCGA-VS-A958,CESC,46,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16905,Alive,TUMOR FREE,1525,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1525,0,1525,0,1525,0,1525,NA,Stage IIB,T2b,MX,NA,10
-5.280164344,1.652443801,TCGA-VS-A8QH-01A,TCGA-VS-A8QH-01A-11D-A37N-09,0,NA,TCGA-VS-A8QH,CESC,76,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27909,Dead,WITH TUMOR,NA,1210,Cervical Cancer,NA,NA,NA,NA,Partial Remission/Response,1,1210,1,1210,NA,NA,1,1210,NA,Stage IB1,TX,MX,NA,9
-7.738789172,2.203844678,TCGA-VS-A8QM-01A,TCGA-VS-A8QM-01A-11D-A37N-09,9,0.478421213,TCGA-VS-A8QM,CESC,47,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,GX,2009,[Not Available],-17168,Dead,WITH TUMOR,NA,951,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,951,1,951,NA,NA,1,951,NA,Stage IVB,TX,M1,NA,7
-4.265514236,-2.050515693,TCGA-VS-A94X-01A,TCGA-VS-A94X-01A-11D-A387-09,8,0.409041013,TCGA-VS-A94X,CESC,40,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,2010,[Not Evaluated],-14955,Dead,WITH TUMOR,NA,506,Cervical Cancer,NA,NA,NA,NA,Partial Remission/Response,1,506,1,506,NA,NA,1,506,NA,Stage IIB,T2b,MX,NA,10
-0.038843993,3.992959885,TCGA-33-4582-01A,TCGA-33-4582-01A-01D-1441-08,4,0.320085067,TCGA-33-4582,LUSC,55,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2000,[Not Available],-20402,Dead,WITH TUMOR,NA,3149,[Not Available],Locoregional Recurrence,NA,NA,2923,Complete Remission/Response,1,3149,1,3149,1,2923,1,2923,NA,Stage IA,T1,M0,LUSC.classical,6
1.909999216,1.878619877,TCGA-VS-A94Y-01A,TCGA-VS-A94Y-01A-11D-A387-09,3,0.470285302,TCGA-VS-A94Y,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465,Dead,WITH TUMOR,NA,144,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,144,1,144,NA,NA,1,144,NA,Stage IIB,T2b,MX,NA,3
-6.031832821,3.497643471,TCGA-78-7167-01A,TCGA-78-7167-01A-11D-2063-08,11,0.510430382,TCGA-78-7167,LUAD,77,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-28295,Dead,WITH TUMOR,NA,2681,[Not Available],NA,NA,NA,726,[Not Available],1,2681,1,2681,NA,NA,1,726,NA,Stage IV,T2,M1,LUAD.1,10
-7.076307271,-2.218703249,TCGA-BR-7716-01A,TCGA-BR-7716-01A-21D-2053-08,6,0.288415223,TCGA-BR-7716,STAD,62,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-22829,Alive,TUMOR FREE,1210,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1210,0,1210,0,1210,0,1210,NA,Stage IIB,T3,M0,GI.CIN,2
9.565672219,-5.667223533,TCGA-AG-3581-01A,TCGA-AG-3581-01A-01D-1989-10,1,0.884865482,TCGA-AG-3581,READ,63,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-23345,Alive,TUMOR FREE,215,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,215,0,215,NA,NA,0,215,NA,Stage I,T2,M0,NA,1
10.1797694,-1.321987373,TCGA-BR-A4J4-01A,TCGA-BR-A4J4-01A-12D-A25D-08,1,0.785017701,TCGA-BR-A4J4,STAD,39,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-14459,Alive,TUMOR FREE,16,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,16,0,16,NA,NA,0,16,NA,Stage IIIB,T4a,M0,GI.EBV,1
8.830158425,-5.441131771,TCGA-ET-A2N3-01B,TCGA-ET-A2N3-01B-21D-A23M-08,1,0.773795394,TCGA-ET-A2N3,THCA,34,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008,[Not Available],-12603,Alive,TUMOR FREE,2535,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2535,0,2535,NA,NA,0,2535,NA,Stage I,T2,MX,THCA.1,1
-0.127928092,5.1254807,TCGA-E2-A155-01A,TCGA-E2-A155-01A-11D-A12B-09,4,0.702290508,TCGA-E2-A155,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21348,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,640,0,640,0,640,0,640,NA,Stage IIB,T2,M0,BRCA.LumB,6
9.494093653,-3.292114421,TCGA-28-5208-01A,TCGA-28-5208-01A-01D-1486-08,1,0.733722385,TCGA-28-5208,GBM,52,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-19053,Dead,WITH TUMOR,NA,544,[Not Available],NA,[Not Applicable],[Not Applicable],148,Progressive Disease,1,544,1,544,NA,NA,1,148,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-6.294710719,1.596550019,TCGA-32-2491-01A,TCGA-32-2491-01A-01D-1353-08,10,0.344971423,TCGA-32-2491,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-23131,Dead,WITH TUMOR,372,372,[Not Available],Recurrence,[Not Applicable],[Not Applicable],70,[Not Available],1,372,1,372,NA,NA,1,70,NA,NA,NA,NA,NA,7
10.08884883,-1.493425316,TCGA-EL-A3CP-01A,TCGA-EL-A3CP-01A-11D-A19J-08,1,0.848845443,TCGA-EL-A3CP,THCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],1999,[Not Available],-18298,Alive,TUMOR FREE,4831,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4831,0,4831,NA,NA,0,4831,NA,[Not Available],T1,M0,THCA.5,1
-4.533313207,0.156272282,TCGA-05-5428-01A,TCGA-05-5428-01A-01D-1625-08,0,NA,TCGA-05-5428,LUAD,57,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2010,[Not Available],-21061,Alive,TUMOR FREE,670,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,670,0,670,0,670,0,670,NA,Stage IIA,T1b,M0,LUAD.3,10
9.969267377,-1.711516958,TCGA-EY-A1GH-01A,TCGA-EY-A1GH-01A-11D-A13L-09,1,0.828487234,TCGA-EY-A1GH,UCEC,70,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25802,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,710,0,710,0,710,0,710,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,1
-4.744033535,-1.908651139,TCGA-VS-A8EK-01A,TCGA-VS-A8EK-01A-12D-A37N-09,8,0.188461522,TCGA-VS-A8EK,CESC,65,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2008,[Not Evaluated],-23817,Dead,WITH TUMOR,NA,829,Cervical Cancer,NA,NA,NA,NA,Partial Remission/Response,1,829,1,829,NA,NA,1,829,NA,Stage IVA,T4,M0,NA,10
-4.421039653,-1.85841885,TCGA-VS-A8EL-01A,TCGA-VS-A8EL-01A-11D-A37N-09,8,0.422611139,TCGA-VS-A8EL,CESC,38,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14162,Alive,TUMOR FREE,1992,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1992,0,1992,0,1992,0,1992,NA,Stage IIB,T2b,M0,NA,10
0.61372963,2.192720632,TCGA-AR-A2LL-01A,TCGA-AR-A2LL-01A-11D-A17W-09,0,NA,TCGA-AR-A2LL,BRCA,70,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25747,Alive,TUMOR FREE,2012,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2012,0,2012,0,2012,0,2012,NA,Stage IIB,T3,M0,NA,6
-1.571098514,3.059507005,TCGA-VS-A8Q8-01A,TCGA-VS-A8Q8-01A-11D-A37N-09,0,NA,TCGA-VS-A8Q8,CESC,26,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9571,Dead,WITH TUMOR,NA,978,Cervical Cancer,Locoregional Recurrence,NA,Pelvis,488,Progressive Disease,1,978,1,978,NA,NA,1,488,NA,Stage IB,T1b,MX,NA,6
10.043837,-2.053216376,TCGA-VS-A8Q9-01A,TCGA-VS-A8Q9-01A-12D-A37N-09,1,0.800039617,TCGA-VS-A8Q9,CESC,79,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28881,Alive,TUMOR FREE,1630,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1630,0,1630,0,1630,0,1630,NA,Stage IB1,TX,MX,NA,1
-4.994998107,-0.9885905,TCGA-VS-A8QA-01A,TCGA-VS-A8QA-01A-11D-A37N-09,0,NA,TCGA-VS-A8QA,CESC,44,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,GX,2011,Peri (6-12 months since last menstrual period),-16072,Alive,TUMOR FREE,1099,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1099,0,1099,0,1099,0,1099,NA,Stage IB1,T1b1,MX,NA,10
-5.878307724,1.066162165,TCGA-VS-A8QC-01A,TCGA-VS-A8QC-01A-11D-A37N-09,0,NA,TCGA-VS-A8QC,CESC,51,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,Peri (6-12 months since last menstrual period),-18743,Dead,WITH TUMOR,NA,350,Cervical Cancer,Distant Metastasis,NA,Liver,263,Progressive Disease,1,350,1,350,NA,NA,1,263,NA,Stage IVA,TX,MX,NA,9
-1.215058743,2.614049167,TCGA-VS-A8QF-01A,TCGA-VS-A8QF-01A-21D-A37N-09,0,NA,TCGA-VS-A8QF,CESC,42,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15374,Alive,TUMOR FREE,1800,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1800,0,1800,0,1800,0,1800,NA,Stage IIB,TX,MX,NA,3
9.244327782,-1.550224572,TCGA-13-1507-01A,TCGA-13-1507-01A-01W-0549-09,1,0.63714812,TCGA-13-1507,OV,77,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-28445,Dead,WITH TUMOR,NA,1993,[Not Available],NA,[Not Applicable],[Not Applicable],324,Complete Remission/Response,1,1993,1,1993,1,324,1,324,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,1
-0.764349429,4.26185349,TCGA-86-8074-01A,TCGA-86-8074-01A-11D-2238-08,4,0.425562171,TCGA-86-8074,LUAD,62,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22862,Alive,TUMOR FREE,24,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,24,0,24,NA,NA,0,24,NA,Stage IIA,T1b,M0,NA,3
-0.312664025,4.18894646,TCGA-13-1506-01A,TCGA-13-1506-01A-01W-0549-09,4,0.485121645,TCGA-13-1506,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-16734,Dead,WITH TUMOR,NA,1039,[Not Available],NA,[Not Applicable],[Not Applicable],666,Complete Remission/Response,1,1039,1,1039,1,666,1,666,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
-3.519532931,1.105740804,TCGA-43-2578-01A,TCGA-43-2578-01A-01D-1522-08,0,NA,TCGA-43-2578,LUSC,59,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-21747,Dead,TUMOR FREE,NA,684,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,684,0,684,0,684,0,684,NA,Stage IA,T1,M0,LUSC.primitive,10
0.001364364,5.213735106,TCGA-61-2614-01A,TCGA-61-2614-01A-01W-1092-09,4,0.674268636,TCGA-61-2614,OV,71,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-26142,Dead,WITH TUMOR,262,262,[Not Available],Recurrence,[Not Applicable],[Not Applicable],38,Stable Disease,1,262,1,262,NA,NA,1,38,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
4.319168516,1.230670837,TCGA-VS-A8EH-01A,TCGA-VS-A8EH-01A-11D-A36J-09,2,0.657393938,TCGA-VS-A8EH,CESC,56,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,G2,2012,Peri (6-12 months since last menstrual period),-20728,Alive,TUMOR FREE,986,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,986,0,986,0,986,0,986,NA,Stage IIIB,T3b,M0,NA,5
-0.107441422,4.476439537,TCGA-61-2002-01A,TCGA-61-2002-01A-01W-0722-08,4,0.532365703,TCGA-61-2002,OV,46,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-17115,Alive,WITH TUMOR,547,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,547,0,547,NA,NA,0,547,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-1.720711112,3.265348303,TCGA-VS-A8EI-01A,TCGA-VS-A8EI-01A-11D-A37N-09,0,NA,TCGA-VS-A8EI,CESC,38,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14129,Alive,TUMOR FREE,729,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,729,0,729,0,729,0,729,NA,Stage IIB,T3b,M0,NA,6
-5.763159512,1.284889558,TCGA-60-2695-01A,TCGA-60-2695-01A-01D-1522-08,0,NA,TCGA-60-2695,LUSC,74,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-27211,Alive,TUMOR FREE,642,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,642,0,642,0,642,0,642,NA,Stage IB,T2,M0,NA,10
-5.338130992,2.573619375,TCGA-AG-3591-01A,TCGA-AG-3591-01A-01D-1733-10,12,0.333499211,TCGA-AG-3591,READ,66,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-24167,Alive,TUMOR FREE,1035,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1035,0,1035,0,1035,0,1035,NA,Stage IIA,T3,M0,GI.CIN,8
9.374714856,-5.188976479,TCGA-BR-A4IZ-01A,TCGA-BR-A4IZ-01A-32D-A25D-08,1,0.808450518,TCGA-BR-A4IZ,STAD,45,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-16695,Dead,TUMOR FREE,NA,273,[Not Available],NA,NA,NA,NA,Progressive Disease,1,273,0,273,NA,NA,0,273,NA,Stage IIIB,T4a,M0,GI.GS,1
-0.779057039,2.504677305,TCGA-VS-A8EJ-01A,TCGA-VS-A8EJ-01A-11D-A37N-09,4,0.243043661,TCGA-VS-A8EJ,CESC,60,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22000,Dead,WITH TUMOR,NA,607,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,607,1,607,NA,NA,1,607,NA,Stage IIB,T2b,M1,NA,6
9.636539295,-1.638074221,TCGA-04-1343-01A,TCGA-04-1343-01A-01W-0486-08,1,0.843751396,TCGA-04-1343,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-26428,Dead,WITH TUMOR,NA,361,[Not Available],NA,NA,NA,NA,Progressive Disease,1,361,1,361,NA,NA,1,361,NA,Stage IV,[Not Applicable],[Not Applicable],NA,1
0.449750279,2.213170708,TCGA-23-2079-01A,TCGA-23-2079-01A-01W-0722-08,0,NA,TCGA-23-2079,OV,46,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-17122,Alive,TUMOR FREE,2788,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],283,Complete Remission/Response,0,2788,0,2788,1,283,1,283,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.925807442,-2.234709037,TCGA-98-8023-01A,TCGA-98-8023-01A-11D-2244-08,6,0.114254861,TCGA-98-8023,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25732,Alive,TUMOR FREE,649,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,649,0,649,0,649,0,649,NA,Stage IIIA,T3,M0,NA,2
0.121901504,4.97595706,TCGA-59-2354-01A,TCGA-59-2354-01A-01W-0799-08,4,0.597098217,TCGA-59-2354,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],NA,Dead,WITH TUMOR,NA,1046,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],462,Stable Disease,1,1046,1,1046,NA,NA,1,462,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-3.23392015,-3.580375254,TCGA-D1-A167-01A,TCGA-D1-A167-01A-11D-A12J-09,8,0.516992267,TCGA-D1-A167,UCEC,70,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25575,Alive,TUMOR FREE,478,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,478,0,478,0,478,0,478,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.189574428,4.862555852,TCGA-16-1460-01A,TCGA-16-1460-01A-01W-0643-08,4,0.588516,TCGA-16-1460,GBM,36,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-13208,Alive,NA,195,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,195,0,195,NA,NA,0,195,NA,NA,NA,NA,NA,6
-4.445300181,-0.323542776,TCGA-CR-5248-01A,TCGA-CR-5248-01A-01D-2012-08,0,NA,TCGA-CR-5248,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2006,[Not Available],-19441,Alive,WITH TUMOR,1663,NA,[Not Available],NA,Cervical Lymph Nodes,NA,936,Complete Remission/Response,0,1663,0,1663,NA,NA,1,936,NA,[Not Available],TX,[Not Available],HNSC.Atypical,10
10.27397682,-1.318274673,TCGA-06-0745-01A,TCGA-06-0745-01A-01D-1492-08,1,0.841743745,TCGA-06-0745,GBM,59,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-21884,Dead,WITH TUMOR,164,239,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],92,[Not Available],1,239,1,239,NA,NA,1,92,NA,NA,NA,NA,GBM_LGG.NA,1
-6.837037774,-2.244442872,TCGA-28-1755-01A,TCGA-28-1755-01A-01W-0643-08,0,NA,TCGA-28-1755,GBM,52,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-19263,Dead,WITH TUMOR,47,47,[Not Available],NA,NA,NA,NA,[Not Available],1,47,1,47,NA,NA,1,47,NA,NA,NA,NA,NA,2
-3.212346096,-3.614231638,TCGA-Q1-A73O-01A,TCGA-Q1-A73O-01A-11D-A32I-09,8,0.50742597,TCGA-Q1-A73O,CESC,37,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,GX,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13601,Alive,TUMOR FREE,428,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,428,0,428,0,428,0,428,NA,Stage IB2,TX,MX,NA,10
-0.701952384,2.248848554,TCGA-Q1-A73Q-01A,TCGA-Q1-A73Q-01A-21D-A32I-09,0,NA,TCGA-Q1-A73Q,CESC,46,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16851,Alive,WITH TUMOR,284,NA,NA,NA,NA,NA,NA,[Unknown],0,284,0,284,NA,NA,0,284,NA,Stage I,TX,MX,NA,1
9.689846329,-2.425045675,TCGA-Q1-A73S-01A,TCGA-Q1-A73S-01A-11D-A33O-09,1,0.758565657,TCGA-Q1-A73S,CESC,33,FEMALE,WHITE,Adenosquamous,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12229,Alive,TUMOR FREE,688,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,688,0,688,0,688,0,688,NA,Stage IB1,T1b1,MX,NA,1
9.911944269,-2.200446278,TCGA-86-6562-01A,TCGA-86-6562-01A-11D-1753-08,1,0.782268035,TCGA-86-6562,LUAD,52,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-19301,Dead,WITH TUMOR,NA,376,[Not Available],NA,NA,NA,274,Progressive Disease,1,376,1,376,NA,NA,1,274,NA,Stage IIA,T2a,M0,LUAD.3,1
-4.430168494,-0.131004899,TCGA-UC-A7PG-01A,TCGA-UC-A7PG-01A-11D-A42O-09,0,NA,TCGA-UC-A7PG,CESC,44,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G1,2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16231,Dead,WITH TUMOR,NA,370,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,370,1,370,NA,NA,1,370,NA,Stage IIIB,T3b,MX,NA,10
-5.609231774,2.846565876,TCGA-UC-A7PI-01A,TCGA-UC-A7PI-01A-11D-A42O-09,0,NA,TCGA-UC-A7PI,CESC,44,FEMALE,WHITE,Endometrioid Adenocarcinoma of Endocervix,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16427,Alive,TUMOR FREE,2114,NA,NA,Locoregional Recurrence,"Other, specify",NA,778,Complete Remission/Response,0,2114,0,2114,1,778,1,778,NA,Stage IB1,T1b1,MX,NA,8
-0.683423916,2.206202582,TCGA-VS-A8EB-01A,TCGA-VS-A8EB-01A-11D-A36J-09,0,NA,TCGA-VS-A8EB,CESC,41,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15215,Dead,WITH TUMOR,NA,305,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,305,1,305,NA,NA,1,305,NA,Stage IIIB,T3b,M1,NA,3
-5.897964752,1.333822479,TCGA-VS-A8EC-01A,TCGA-VS-A8EC-01A-11D-A36J-09,10,0.006675316,TCGA-VS-A8EC,CESC,55,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Peri (6-12 months since last menstrual period),-20286,Alive,TUMOR FREE,1415,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1415,0,1415,0,1415,0,1415,NA,Stage IIIB,T3b,M0,NA,3
-7.895531136,2.126616045,TCGA-VS-A8EG-01A,TCGA-VS-A8EG-01A-11D-A36J-09,9,0.384438017,TCGA-VS-A8EG,CESC,36,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,GX,2011,Peri (6-12 months since last menstrual period),-13166,Alive,TUMOR FREE,1386,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1386,0,1386,0,1386,0,1386,NA,Stage IB1,T1b1,M0,NA,7
-3.87973079,1.1790829,TCGA-66-2782-01A,TCGA-66-2782-01A-01D-1522-08,0,NA,TCGA-66-2782,LUSC,71,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-26237,Dead,WITH TUMOR,NA,365,[Not Available],NA,NA,NA,304,Progressive Disease,1,365,1,365,NA,NA,1,304,NA,Stage IIB,T3,M0,LUSC.basal,10
-6.201292308,1.401674177,TCGA-73-7499-01A,TCGA-73-7499-01A-11D-2184-08,10,0.097456631,TCGA-73-7499,LUAD,81,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-29683,Dead,TUMOR FREE,NA,1531,[Not Available],Distant Metastasis,NA,NA,1447,Complete Remission/Response,1,1531,0,1531,1,1447,1,1447,NA,Stage IB,T2a,M0,LUAD.5,7
-6.719427943,2.030477269,TCGA-BR-4369-01A,TCGA-BR-4369-01A-01D-1158-08,0,NA,TCGA-BR-4369,STAD,75,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-27509,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],TX,M0,GI.CIN,9
-1.87134455,2.307358479,TCGA-LP-A5U2-01A,TCGA-LP-A5U2-01A-11D-A28B-09,0,NA,TCGA-LP-A5U2,CESC,30,FEMALE,ASIAN,Endocervical Adenocarcinoma of the Usual Type,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11049,Alive,TUMOR FREE,9,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,9,0,9,0,9,0,9,NA,Stage IIIB,T2a,MX,NA,10
-6.349989768,-1.254108463,TCGA-LP-A7HU-01A,TCGA-LP-A7HU-01A-11D-A33O-09,7,0.327330719,TCGA-LP-A7HU,CESC,53,FEMALE,ASIAN,Endocervical Type of Adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19595,Alive,TUMOR FREE,406,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,406,0,406,0,406,0,406,NA,Stage II,T2,M0,NA,2
-0.743526415,4.852273024,TCGA-92-7341-01A,TCGA-92-7341-01A-31D-2042-08,4,0.422665042,TCGA-92-7341,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26134,Alive,WITH TUMOR,106,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,106,0,106,NA,NA,0,106,NA,Stage IB,T2a,MX,NA,6
-7.289922912,2.434915924,TCGA-AX-A05W-01A,TCGA-AX-A05W-01A-21W-A027-09,9,0.076145057,TCGA-AX-A05W,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22200,Alive,TUMOR FREE,2450,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2450,0,2450,0,2450,0,2450,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-4.474313858,1.642979517,TCGA-F5-6465-01A,TCGA-F5-6465-01A-11D-1733-10,0,NA,TCGA-F5-6465,READ,64,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-23432,Alive,TUMOR FREE,1506,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1506,0,1506,0,1506,0,1506,NA,Stage IIA,T3,M0,GI.GS,9
-1.802726755,1.221664451,TCGA-BR-6456-01A,TCGA-BR-6456-01A-11D-1800-08,5,0.640072889,TCGA-BR-6456,STAD,74,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-27288,Dead,TUMOR FREE,NA,526,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,526,0,526,0,526,0,526,NA,Stage IIB,T3,M0,GI.CIN,4
-0.488255814,4.202931815,TCGA-BR-8080-01A,TCGA-BR-8080-01A-11D-2340-08,4,0.438731658,TCGA-BR-8080,STAD,72,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2011,[Not Available],-26546,Dead,TUMOR FREE,NA,292,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,292,0,292,0,292,0,292,NA,Stage IIIC,T4,M0,GI.CIN,6
0.506816932,2.199006261,TCGA-BH-A0HL-01A,TCGA-BH-A0HL-01A-11W-A050-09,0,NA,TCGA-BH-A0HL,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20804,Alive,TUMOR FREE,72,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,72,0,72,0,72,0,72,NA,Stage IIB,T2,M0,BRCA.LumA,6
4.418842111,1.184578016,TCGA-A2-A0YF-01A,TCGA-A2-A0YF-01A-21D-A10G-09,2,0.707086648,TCGA-A2-A0YF,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24660,Alive,TUMOR FREE,1535,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1535,0,1535,0,1535,0,1535,NA,Stage I,T1b,M0,BRCA.LumA,5
-6.099226347,-2.015618434,TCGA-BH-A0HP-01A,TCGA-BH-A0HP-01A-12D-A099-09,0,NA,TCGA-BH-A0HP,BRCA,65,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883,Alive,TUMOR FREE,414,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,414,0,414,0,414,0,414,NA,Stage IIIA,T3,M0,BRCA.LumA,10
-7.566070407,2.031005594,TCGA-E9-A1NI-01A,TCGA-E9-A1NI-01A-11W-A16H-09,9,0.310235603,TCGA-E9-A1NI,BRCA,51,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18985,Alive,TUMOR FREE,300,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,300,0,300,0,300,0,300,NA,Stage IIA,T2,M0,BRCA.LumB,7
-3.154262047,-3.482458784,TCGA-BH-A0HF-01A,TCGA-BH-A0HF-01A-11W-A071-09,8,0.586117271,TCGA-BH-A0HF,BRCA,77,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28233,Alive,TUMOR FREE,727,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,727,0,727,0,727,0,727,NA,Stage IA,T1c,M0,BRCA.LumA,10
-1.638599952,3.859336276,TCGA-EB-A82C-01A,TCGA-EB-A82C-01A-11D-A34U-08,0,NA,TCGA-EB-A82C,SKCM,70,FEMALE,ASIAN,NA,[Not Available],2013,[Not Available],-25850,Alive,TUMOR FREE,17,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,17,0,17,NA,NA,0,17,NA,Stage IIC,T4b,M0,NA,6
0.007037192,4.141637158,TCGA-EB-A85I-01A,TCGA-EB-A85I-01A-11D-A34U-08,4,0.467679833,TCGA-EB-A85I,SKCM,66,MALE,WHITE,NA,[Not Available],2013,[Not Available],-24408,Alive,TUMOR FREE,362,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,362,0,362,NA,NA,0,362,NA,Stage IIC,T4b,M0,NA,6
-6.104403041,-1.594910613,TCGA-EB-A85J-01A,TCGA-EB-A85J-01A-12D-A34U-08,0,NA,TCGA-EB-A85J,SKCM,66,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-24263,Alive,TUMOR FREE,360,NA,[Not Available],Regional lymph node,NA,NA,138,[Not Available],0,360,0,360,NA,NA,1,138,NA,Stage IIB,T4a,M0,NA,2
-3.560501912,0.834088383,TCGA-EB-A97M-01A,TCGA-EB-A97M-01A-11D-A38G-08,0,NA,TCGA-EB-A97M,SKCM,66,MALE,WHITE,NA,[Not Available],2013,[Not Available],-24228,Alive,TUMOR FREE,414,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,414,0,414,NA,NA,0,414,NA,Stage IIC,T4b,M0,NA,10
-7.592595057,-2.078304868,TCGA-EB-A82B-01A,TCGA-EB-A82B-01A-11D-A34U-08,6,0.084192289,TCGA-EB-A82B,SKCM,58,FEMALE,ASIAN,NA,[Not Available],2013,[Not Available],-21239,Alive,TUMOR FREE,390,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,390,0,390,NA,NA,0,390,NA,Stage III,T4b,M0,NA,2
-6.357056385,1.872833265,TCGA-A7-A26F-01A,TCGA-A7-A26F-01A-21D-A167-09,10,0.298282724,TCGA-A7-A26F,BRCA,55,FEMALE,WHITE,"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20210,Alive,TUMOR FREE,738,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,738,0,738,0,738,0,738,NA,Stage IA,T1,M0,BRCA.Basal,7
-7.591314726,1.883494815,TCGA-BH-A0BJ-01A,TCGA-BH-A0BJ-01A-11W-A071-09,9,0.322931984,TCGA-BH-A0BJ,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15027,Alive,TUMOR FREE,660,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,660,0,660,0,660,0,660,NA,Stage IIB,T2,M0,BRCA.LumA,7
-5.919883445,3.679881053,TCGA-YY-A8LH-01A,TCGA-YY-A8LH-01A-11D-A36O-08,11,0.388348447,TCGA-YY-A8LH,PAAD,61,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2009,[Not Available],-22376,Alive,TUMOR FREE,2016,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2016,0,2016,0,2016,0,2016,NA,Stage IIB,T3,MX,NA,8
-6.302972371,1.325457265,TCGA-AF-A56K-01A,TCGA-AF-A56K-01A-32D-A38X-10,10,0.185634854,TCGA-AF-A56K,READ,56,MALE,BLACK OR AFRICAN AMERICAN,Rectal Adenocarcinoma,[Not Available],2006,[Not Available],-20527,Alive,TUMOR FREE,2635,NA,[Not Available],Locoregional Disease,NA,NA,1217,Complete Remission/Response,0,2635,0,2635,1,1217,1,1217,NA,Stage IIA,T3,M0,GI.CIN,7
-1.323847761,3.760938507,TCGA-AF-A56L-01A,TCGA-AF-A56L-01A-31D-A38X-10,4,0.177628828,TCGA-AF-A56L,READ,48,FEMALE,BLACK OR AFRICAN AMERICAN,Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-17734,Alive,TUMOR FREE,2007,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2007,0,2007,0,2007,0,2007,NA,Stage IIIC,T3,M0,GI.CIN,5
-5.956712625,2.924750348,TCGA-AF-A56N-01A,TCGA-AF-A56N-01A-12D-A38X-10,0,NA,TCGA-AF-A56N,READ,47,FEMALE,BLACK OR AFRICAN AMERICAN,Rectal Adenocarcinoma,[Not Available],2012,[Not Available],-17480,Alive,TUMOR FREE,360,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,360,0,360,0,360,0,360,NA,Stage IIA,T3,M0,GI.CIN,8
-3.108350101,-3.532054681,TCGA-BF-A1PZ-01A,TCGA-BF-A1PZ-01A-11D-A19A-08,8,0.573108581,TCGA-BF-A1PZ,SKCM,71,FEMALE,WHITE,NA,[Not Available],2010,[Not Available],-26240,Alive,TUMOR FREE,853,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,853,0,853,NA,NA,0,853,NA,Stage IIB,T4a,M0,SKCM.RAS_Hotspot_Mutants,10
-6.676861833,2.201870303,TCGA-AH-6903-01A,TCGA-AH-6903-01A-11D-1924-10,0,NA,TCGA-AH-6903,READ,46,MALE,WHITE,Rectal Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-17030,Alive,TUMOR FREE,592,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,592,0,592,0,592,0,592,NA,Stage IIIB,T3,M0,GI.GS,7
1.667019263,2.091938133,TCGA-US-A776-01A,TCGA-US-A776-01A-13D-A33T-08,3,0.142829838,TCGA-US-A776,PAAD,61,MALE,WHITE,Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2011,[Not Available],-22283,Alive,TUMOR FREE,1216,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1216,0,1216,0,1216,0,1216,NA,Stage IIA,T3,MX,NA,3
-6.119326979,3.614933972,TCGA-US-A77G-01A,TCGA-US-A77G-01A-11D-A32N-08,11,0.495092152,TCGA-US-A77G,PAAD,64,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-23443,Dead,TUMOR FREE,NA,12,Surgical Complications,NA,NA,NA,NA,[Not Available],1,12,0,12,NA,NA,0,12,NA,Stage IIB,T3,MX,NA,8
-5.824869532,3.289398962,TCGA-YB-A89D-01A,TCGA-YB-A89D-01A-12D-A36O-08,11,0.362795471,TCGA-YB-A89D,PAAD,59,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-21792,Alive,TUMOR FREE,350,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,350,0,350,0,350,0,350,NA,Stage IIB,T3,MX,NA,8
8.859292779,-4.706967776,TCGA-DG-A2KH-01A,TCGA-DG-A2KH-01A-21D-A22X-09,1,0.773498672,TCGA-DG-A2KH,CESC,25,FEMALE,[Not Evaluated],Adenosquamous,GX,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9209,Alive,NA,34,NA,NA,NA,NA,NA,NA,[Unknown],0,34,0,34,NA,NA,0,34,NA,Stage IB1,T1b1,M0,NA,1
9.326135749,-5.204453531,TCGA-LB-A8F3-01A,TCGA-LB-A8F3-01A-11D-A36O-08,1,0.839611647,TCGA-LB-A8F3,PAAD,64,FEMALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-23624,Alive,TUMOR FREE,379,NA,NA,NA,NA,NA,NA,[Unknown],0,379,0,379,NA,NA,0,379,NA,Stage IIA,T3,MX,NA,1
-0.852742113,3.687044083,TCGA-DG-A2KJ-01A,TCGA-DG-A2KJ-01A-11D-A18J-09,4,0.195377438,TCGA-DG-A2KJ,CESC,50,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,G3,2006,[Unknown],-18453,Alive,TUMOR FREE,2893,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2893,0,2893,0,2893,0,2893,NA,Stage IIIB,T1b,M0,NA,5
0.216390342,5.105134593,TCGA-LB-A9Q5-01A,TCGA-LB-A9Q5-01A-11D-A397-08,4,0.708480421,TCGA-LB-A9Q5,PAAD,63,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-23218,Dead,WITH TUMOR,NA,313,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",omentum,290,[Unknown],1,313,1,313,NA,NA,1,290,NA,Stage IIB,T3,MX,NA,6
-4.228797816,-1.679190769,TCGA-DG-A2KK-01A,TCGA-DG-A2KK-01A-11D-A17W-09,8,0.407067079,TCGA-DG-A2KK,CESC,51,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18834,Alive,TUMOR FREE,2496,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2496,0,2496,0,2496,0,2496,NA,Stage IIIB,T1b1,M0,NA,10
-5.278863473,2.609308598,TCGA-M8-A5N4-01A,TCGA-M8-A5N4-01A-11D-A26I-08,12,0.221702556,TCGA-M8-A5N4,PAAD,48,FEMALE,[Not Evaluated],Pancreas-Adenocarcinoma Ductal Type,G2,NA,[Not Available],-17628,Alive,WITH TUMOR,584,NA,NA,Locoregional Recurrence,"Other, specify",retroperitoneal recurrence around the supramesenteric artery and vein and some para aortic nodes,416,Partial Remission/Response,0,584,0,584,NA,NA,1,416,NA,Stage IIA,T3,M0,NA,8
-4.555608623,1.701625301,TCGA-E9-A1R3-01A,TCGA-E9-A1R3-01A-31D-A14K-09,0,NA,TCGA-E9-A1R3,BRCA,70,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25693,Alive,TUMOR FREE,78,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,78,0,78,0,78,0,78,NA,Stage IIIC,T2,M0,BRCA.LumA,7
-6.802058706,1.607381788,TCGA-DG-A2KL-01A,TCGA-DG-A2KL-01A-11D-A17W-09,0,NA,TCGA-DG-A2KL,CESC,53,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,G1,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19539,Alive,TUMOR FREE,1367,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1367,0,1367,0,1367,0,1367,NA,Stage IIA,T2a,M0,NA,9
-5.2295654,2.655506075,TCGA-OE-A75W-01A,TCGA-OE-A75W-01A-12D-A32N-08,12,0.315337661,TCGA-OE-A75W,PAAD,75,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-27684,Dead,NA,NA,267,NA,Distant Metastasis,Liver,NA,146,Progressive Disease,1,267,NA,267,NA,NA,1,146,NA,Stage IIA,T3,M0,NA,8
-4.813945,-1.480248035,TCGA-DG-A2KM-01A,TCGA-DG-A2KM-01A-11D-A17W-09,8,0.247201184,TCGA-DG-A2KM,CESC,46,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,G2,2008,[Unknown],-16808,Alive,TUMOR FREE,1946,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1946,0,1946,0,1946,0,1946,NA,Stage IB1,T1b1,M0,NA,10
-5.963949133,3.235512443,TCGA-S4-A8RM-01A,TCGA-S4-A8RM-01A-11D-A377-08,11,0.140519596,TCGA-S4-A8RM,PAAD,67,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-24589,Alive,TUMOR FREE,737,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,737,0,737,0,737,0,737,NA,Stage IIB,T3,MX,NA,8
9.774065128,-4.293465027,TCGA-EK-A2H1-01A,TCGA-EK-A2H1-01A-11D-A17W-09,1,0.700571799,TCGA-EK-A2H1,CESC,20,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7649,Alive,TUMOR FREE,799,NA,NA,NA,NA,NA,NA,[Not Available],0,799,0,799,NA,NA,0,799,NA,Stage IB2,[Not Available],[Not Available],NA,1
-5.303394053,2.616631655,TCGA-S4-A8RO-01A,TCGA-S4-A8RO-01A-12D-A377-08,12,0.201912985,TCGA-S4-A8RO,PAAD,75,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27645,Alive,WITH TUMOR,525,NA,NA,Distant Metastasis,Lung,NA,291,Complete Remission/Response,0,525,0,525,1,291,1,291,NA,Stage IIB,T3,MX,NA,8
9.269616452,-4.355064332,TCGA-BH-A1EV-01A,TCGA-BH-A1EV-01A-11D-A135-09,1,0.744362329,TCGA-BH-A1EV,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-16504,Dead,WITH TUMOR,NA,365,[Not Available],NA,NA,NA,NA,[Not Available],1,365,1,365,NA,NA,1,365,NA,Stage IIIA,T3,M0,BRCA.Her2,1
-4.294734456,-1.607570131,TCGA-EK-A2R8-01A,TCGA-EK-A2R8-01A-21D-A18J-09,8,0.384597267,TCGA-EK-A2R8,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17692,Alive,WITH TUMOR,44,NA,NA,NA,NA,NA,NA,[Not Available],0,44,0,44,NA,NA,0,44,NA,Stage IB2,T1b2,MX,NA,10
-5.894912641,3.359628671,TCGA-S4-A8RP-01A,TCGA-S4-A8RP-01A-11D-A36O-08,11,0.275709687,TCGA-S4-A8RP,PAAD,77,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2010,[Not Available],-28353,Dead,NA,NA,702,NA,NA,NA,NA,NA,[Unknown],1,702,NA,702,NA,NA,0,702,NA,Stage IIB,T3,MX,NA,8
9.502402902,-5.624673754,TCGA-US-A774-01A,TCGA-US-A774-01A-21D-A32N-08,1,0.851892194,TCGA-US-A774,PAAD,76,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-27957,Dead,WITH TUMOR,NA,695,Pancreatic Cancer,Distant Metastasis,Liver,NA,366,Progressive Disease,1,695,1,695,NA,NA,1,366,NA,Stage IIB,T3,MX,NA,1
-5.931150907,3.202234241,TCGA-IB-A7LX-01A,TCGA-IB-A7LX-01A-12D-A36O-08,11,0.27885231,TCGA-IB-A7LX,PAAD,57,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-20898,Dead,WITH TUMOR,NA,250,Pancreatic Cancer,Distant Metastasis,Liver,NA,7,Progressive Disease,1,250,1,250,NA,NA,1,7,NA,Stage IIB,T3,MX,NA,7
-5.641102582,2.194642618,TCGA-IB-A7M4-01A,TCGA-IB-A7M4-01A-11D-A36O-08,0,NA,TCGA-IB-A7M4,PAAD,81,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-29792,Alive,TUMOR FREE,483,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,483,0,483,0,483,0,483,NA,Stage IIB,T3,MX,NA,7
-0.302482626,4.999175968,TCGA-EI-6885-01A,TCGA-EI-6885-01A-11D-1924-10,4,0.562324777,TCGA-EI-6885,READ,57,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-21140,Alive,WITH TUMOR,415,NA,[Not Available],Locoregional Disease,NA,NA,295,[Not Available],0,415,0,415,NA,NA,1,295,NA,Stage IV,T3,M1,GI.CIN,6
-6.799658951,-1.493401269,TCGA-HZ-A8P1-01A,TCGA-HZ-A8P1-01A-11D-A377-08,0,NA,TCGA-HZ-A8P1,PAAD,81,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-29631,Alive,TUMOR FREE,7,NA,NA,NA,NA,NA,NA,[Unknown],0,7,0,7,NA,NA,0,7,NA,Stage IB,T2,MX,NA,2
-7.886581915,2.010320205,TCGA-E9-A227-01A,TCGA-E9-A227-01A-11D-A159-09,9,0.601650991,TCGA-E9-A227,BRCA,42,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15602,Alive,TUMOR FREE,975,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,975,0,975,0,975,0,975,NA,Stage IIB,T2,M0,BRCA.LumA,7
8.713945706,-1.880552295,TCGA-VM-A8CD-01A,TCGA-VM-A8CD-01A-11D-A36O-08,1,0.551612151,TCGA-VM-A8CD,LGG,58,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-21200,Dead,WITH TUMOR,NA,240,[Not Available],NA,NA,NA,NA,[Unknown],1,240,1,240,NA,NA,1,240,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.023517391,-4.254167389,TCGA-VM-A8CH-01A,TCGA-VM-A8CH-01A-12D-A36O-08,1,0.765793316,TCGA-VM-A8CH,LGG,24,FEMALE,WHITE,Astrocytoma,G2,2013,[Not Available],-9005,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,714,0,714,0,714,0,714,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-4.620161689,1.927199377,TCGA-F2-A7TX-01A,TCGA-F2-A7TX-01A-33D-A38G-08,0,NA,TCGA-F2-A7TX,PAAD,77,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-28239,Dead,WITH TUMOR,NA,95,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,95,1,95,NA,NA,1,95,NA,Stage IIB,T3,M0,NA,8
-6.10579515,3.413163533,TCGA-F2-A8YN-01A,TCGA-F2-A8YN-01A-11D-A377-08,11,0.324058948,TCGA-F2-A8YN,PAAD,76,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-28047,Alive,WITH TUMOR,517,NA,NA,NA,NA,NA,NA,Progressive Disease,0,517,0,517,NA,NA,0,517,NA,Stage IIA,T3,M0,NA,8
-5.324492949,2.601173571,TCGA-HZ-A77O-01A,TCGA-HZ-A77O-01A-11D-A33T-08,12,0.265180244,TCGA-HZ-A77O,PAAD,77,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-28434,Dead,WITH TUMOR,NA,160,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,NA,98,Complete Remission/Response,1,160,1,160,1,98,1,98,NA,Stage IIB,T2,MX,NA,8
-0.337934098,4.963253647,TCGA-EW-A1P1-01A,TCGA-EW-A1P1-01A-31D-A14G-09,4,0.554799956,TCGA-EW-A1P1,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923,Alive,TUMOR FREE,1210,NA,[Not Available],Distant Metastasis,Lung,NA,1014,[Not Available],0,1210,0,1210,1,1014,1,1014,NA,Stage IIIC,T2,MX,BRCA.Normal,6
-5.791622475,-2.2087654,TCGA-HZ-A77P-01A,TCGA-HZ-A77P-01A-11D-A33T-08,0,NA,TCGA-HZ-A77P,PAAD,77,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2013,[Not Available],-28403,Alive,TUMOR FREE,330,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,330,0,330,0,330,0,330,NA,Stage IIB,T3,MX,NA,2
-5.378385198,2.688254781,TCGA-HZ-A77Q-01A,TCGA-HZ-A77Q-01A-11D-A36O-08,12,0.178112273,TCGA-HZ-A77Q,PAAD,55,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2013,[Not Available],-20366,Alive,TUMOR FREE,33,NA,NA,NA,NA,NA,NA,[Unknown],0,33,0,33,NA,NA,0,33,NA,Stage IIB,T3,MX,NA,8
9.57599238,-5.671423454,TCGA-AG-3575-01A,TCGA-AG-3575-01A-01D-1989-10,1,0.836737606,TCGA-AG-3575,READ,51,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2006,[Not Available],-18932,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,NA,NA,0,365,NA,Stage II,T3,M0,NA,1
-6.049692945,3.493025551,TCGA-VM-A8CA-01A,TCGA-VM-A8CA-01A-11D-A36O-08,11,0.52007856,TCGA-VM-A8CA,LGG,54,MALE,[Unknown],Oligodendroglioma,G2,2011,[Not Available],-19991,Alive,WITH TUMOR,411,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,411,0,411,NA,NA,0,411,NA,NA,NA,NA,GBM_LGG.Codel,8
8.753674786,-5.179488996,TCGA-VM-A8CB-01A,TCGA-VM-A8CB-01A-11D-A36O-08,1,0.825444601,TCGA-VM-A8CB,LGG,33,MALE,[Unknown],Oligodendroglioma,G3,2011,[Not Available],-12340,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,3,0,3,NA,NA,0,3,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.348331436,-2.412010723,TCGA-Y8-A897-01A,TCGA-Y8-A897-01A-11D-A35Z-10,6,0.277307891,TCGA-Y8-A897,KIRP,68,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-25047,Alive,TUMOR FREE,549,NA,[Not Available],NA,NA,NA,450,Complete Remission/Response,0,549,0,549,1,450,1,450,NA,Stage I,T1a,MX,NA,2
-0.229638366,4.85074375,TCGA-TM-A84Q-01A,TCGA-TM-A84Q-01A-11D-A36O-08,4,0.6166151,TCGA-TM-A84Q,LGG,31,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-11668,Alive,TUMOR FREE,772,NA,[Not Available],NA,NA,NA,455,Complete Remission/Response,0,772,0,772,1,455,1,455,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
1.893513293,1.875343581,TCGA-Y8-A8RY-01A,TCGA-Y8-A8RY-01A-11D-A36X-10,3,0.580767707,TCGA-Y8-A8RY,KIRP,63,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-23192,Alive,TUMOR FREE,769,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,769,0,769,0,769,0,769,NA,Stage I,T1b,MX,NA,3
9.553309262,-5.718381749,TCGA-TM-A84R-01A,TCGA-TM-A84R-01A-21D-A36O-08,1,0.866197178,TCGA-TM-A84R,LGG,46,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-16843,Alive,TUMOR FREE,566,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,566,0,566,0,566,0,566,NA,NA,NA,NA,GBM_LGG.Codel,1
8.822727861,-3.888838553,TCGA-Y8-A8S0-01A,TCGA-Y8-A8S0-01A-11D-A36X-10,1,0.740910401,TCGA-Y8-A8S0,KIRP,58,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-21383,Alive,TUMOR FREE,183,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,183,0,183,0,183,0,183,NA,Stage I,T1a,MX,NA,1
-7.960153051,2.052632855,TCGA-TM-A84S-01A,TCGA-TM-A84S-01A-11D-A36O-08,9,0.566191019,TCGA-TM-A84S,LGG,36,MALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-13424,Alive,TUMOR FREE,454,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,454,0,454,0,454,0,454,NA,NA,NA,NA,GBM_LGG.Codel,7
9.291816219,-4.989446982,TCGA-Y8-A8S1-01A,TCGA-Y8-A8S1-01A-11D-A36X-10,1,0.808798918,TCGA-Y8-A8S1,KIRP,61,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-22319,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,404,0,404,0,404,0,404,NA,Stage I,T1a,MX,NA,1
-0.778807939,3.720059727,TCGA-TM-A84T-01A,TCGA-TM-A84T-01A-11D-A36O-08,4,0.326309002,TCGA-TM-A84T,LGG,19,MALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-6994,Alive,WITH TUMOR,724,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,724,0,724,NA,NA,0,724,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
1.115050379,3.514924561,TCGA-AN-A0XT-01A,TCGA-AN-A0XT-01A-11D-A10G-09,0,NA,TCGA-AN-A0XT,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19794,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-6.412216912,1.611320596,TCGA-VM-A8C8-01A,TCGA-VM-A8C8-01A-11D-A36O-08,10,0.139653672,TCGA-VM-A8C8,LGG,50,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-18494,Alive,NA,1397,NA,[Not Available],NA,NA,NA,456,[Unknown],0,1397,0,1397,NA,NA,1,456,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,7
-7.998667035,2.054023909,TCGA-VM-A8C9-01A,TCGA-VM-A8C9-01A-11D-A36O-08,9,0.639126673,TCGA-VM-A8C9,LGG,37,FEMALE,[Not Evaluated],Astrocytoma,G2,2011,[Not Available],-13663,Alive,TUMOR FREE,1314,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1314,0,1314,0,1314,0,1314,NA,NA,NA,NA,GBM_LGG.PA-like,7
-6.261993335,1.365571173,TCGA-A1-A0SI-01A,TCGA-A1-A0SI-01A-11D-A142-09,10,0.166111766,TCGA-A1-A0SI,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-19250,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,635,0,635,0,635,0,635,NA,Stage IIB,T2,M0,BRCA.LumB,9
-7.453154329,-2.431197426,TCGA-WN-AB4C-01A,TCGA-WN-AB4C-01A-11D-A42J-10,6,0.42112682,TCGA-WN-AB4C,KIRP,60,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],NA,Alive,WITH TUMOR,1188,NA,[Not Available],NA,NA,NA,1157,Complete Remission/Response,0,1188,0,1188,1,1157,1,1157,NA,Stage I,T1a,MX,NA,2
-5.545259728,1.093125473,TCGA-CV-6941-01A,TCGA-CV-6941-01A-11D-1912-08,0,NA,TCGA-CV-6941,HNSC,51,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-18812,Dead,TUMOR FREE,NA,342,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,342,0,342,0,342,0,342,NA,Stage III,T3,[Not Available],HNSC.Classical,9
-1.077094441,4.163833265,TCGA-CQ-6220-01A,TCGA-CQ-6220-01A-11D-1912-08,4,0.326628506,TCGA-CQ-6220,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-25366,Dead,NA,NA,985,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,985,NA,985,0,985,0,985,NA,Stage III,T3,[Not Available],HNSC.Basal,6
7.956120143,-3.603988856,TCGA-CV-6940-01A,TCGA-CV-6940-01A-11D-1912-08,1,0.45053847,TCGA-CV-6940,HNSC,80,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2002,[Not Available],-29382,Dead,TUMOR FREE,NA,804,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,804,0,804,0,804,0,804,NA,Stage III,T2,[Not Available],HNSC.Classical,6
-0.252766144,4.151705286,TCGA-D7-8578-01A,TCGA-D7-8578-01A-21D-2340-08,4,0.476507949,TCGA-D7-8578,STAD,72,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-26620,Alive,WITH TUMOR,643,NA,[Not Available],Locoregional Recurrence|Distant Metastasis,Lung,NA,451,Complete Remission/Response,0,643,0,643,1,451,1,451,NA,Stage IB,T2,M0,GI.CIN,6
-0.957983972,4.355966759,TCGA-BR-8369-01A,TCGA-BR-8369-01A-11D-2340-08,4,0.341457656,TCGA-BR-8369,STAD,76,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-28051,Alive,WITH TUMOR,427,NA,[Not Available],Distant Metastasis,"Other, specify",Bone,419,Complete Remission/Response,0,427,0,427,1,419,1,419,NA,Stage IIIB,T3,M0,GI.CIN,10
9.622183136,-5.725928425,TCGA-HU-A4GJ-01A,TCGA-HU-A4GJ-01A-11D-A25D-08,1,0.837362519,TCGA-HU-A4GJ,STAD,60,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-22079,Alive,WITH TUMOR,650,NA,[Not Available],Distant Metastasis,"Other, specify",ovary,547,Progressive Disease,0,650,0,650,NA,NA,1,547,NA,Stage IIIC,T4,M0,NA,1
-0.342459773,3.853101022,TCGA-HU-A4GF-01A,TCGA-HU-A4GF-01A-11D-A24D-08,4,0.100833032,TCGA-HU-A4GF,STAD,69,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-25223,Alive,TUMOR FREE,785,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,785,0,785,0,785,0,785,NA,Stage IIA,T3,M0,GI.CIN,6
-6.462642562,1.597810637,TCGA-HT-7478-01A,TCGA-HT-7478-01A-11D-2024-08,10,0.190230466,TCGA-HT-7478,LGG,36,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-13216,Alive,TUMOR FREE,194,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,194,0,194,0,194,0,194,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,7
-7.219161754,-2.452950158,TCGA-BR-A452-01A,TCGA-BR-A452-01A-91D-A25D-08,6,0.127677837,TCGA-BR-A452,STAD,57,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-21107,Dead,TUMOR FREE,NA,229,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,229,0,229,0,229,0,229,NA,Stage IIIA,T4a,M0,GI.CIN,2
-5.98549308,3.374619538,TCGA-BR-8679-01A,TCGA-BR-8679-01A-11D-2394-08,11,0.291439444,TCGA-BR-8679,STAD,63,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-23084,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,Stage IB,T2,M0,GI.CIN,8
-4.571185166,1.158757536,TCGA-CD-8531-01A,TCGA-CD-8531-01A-11D-2340-08,0,NA,TCGA-CD-8531,STAD,66,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-24453,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,383,0,383,0,383,0,383,NA,Stage IIIA,T3,M0,GI.GS,10
0.029796411,5.008750023,TCGA-CS-6290-01A,TCGA-CS-6290-01A-11D-1705-08,4,0.719250888,TCGA-CS-6290,LGG,31,MALE,[Not Available],Astrocytoma,G3,2009,[Not Available],-11666,Dead,NA,NA,1137,[Not Available],NA,NA,NA,NA,Stable Disease,1,1137,NA,1137,NA,NA,0,1137,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.749999963,-2.129407617,TCGA-BR-A4QM-01A,TCGA-BR-A4QM-01A-12D-A25D-08,1,0.74018898,TCGA-BR-A4QM,STAD,65,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23999,Alive,WITH TUMOR,156,NA,[Not Available],Locoregional Recurrence,NA,NA,127,Complete Remission/Response,0,156,0,156,1,127,1,127,NA,Stage IIIA,T3,M0,NA,1
-3.409132273,-3.286746145,TCGA-BR-8372-01A,TCGA-BR-8372-01A-11D-2340-08,8,0.581514574,TCGA-BR-8372,STAD,63,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23346,Alive,TUMOR FREE,951,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,951,0,951,0,951,0,951,NA,Stage IIIC,T4b,M0,GI.HM-indel,10
9.909263493,-2.960162257,TCGA-FG-6688-01A,TCGA-FG-6688-01A-11D-1893-08,1,0.707540959,TCGA-FG-6688,LGG,59,FEMALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G3,2010,[Not Available],-21745,Alive,WITH TUMOR,571,NA,[Not Available],NA,NA,NA,405,Progressive Disease,0,571,0,571,NA,NA,1,405,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-5.014205165,1.042074541,TCGA-05-4418-01A,TCGA-05-4418-01A-01D-1265-08,0,NA,TCGA-05-4418,LUAD,69,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25417,Dead,NA,NA,274,[Not Available],NA,NA,NA,NA,[Not Available],1,274,NA,274,NA,NA,0,274,NA,Stage IIIA,T3,M0,LUAD.6,9
-4.251806305,-1.574547586,TCGA-78-7540-01A,TCGA-78-7540-01A-11D-2063-08,8,0.429593294,TCGA-78-7540,LUAD,66,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1999,[Not Available],-24440,Dead,NA,NA,1197,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1197,NA,1197,0,1197,0,1197,NA,Stage IB,T2,M0,LUAD.4,10
2.136295392,1.793279991,TCGA-B6-A0IM-01A,TCGA-B6-A0IM-01A-11W-A050-09,3,0.58054044,TCGA-B6-A0IM,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,"Other, specify",[Not Available],1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27557,Dead,TUMOR FREE,NA,3873,[Not Available],NA,NA,NA,NA,[Not Available],1,3873,0,3873,0,3873,0,3873,NA,Stage IIB,T3,M0,BRCA.LumA,3
-0.122398007,5.137987695,TCGA-06-0875-01A,TCGA-06-0875-01A-01D-1492-08,4,0.661695601,TCGA-06-0875,GBM,61,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-22312,Alive,TUMOR FREE,1322,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],279,[Not Available],0,1322,0,1322,NA,NA,1,279,NA,NA,NA,NA,NA,6
-7.086769729,1.699536575,TCGA-AR-A255-01A,TCGA-AR-A255-01A-11D-A167-09,0,NA,TCGA-AR-A255,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22809,Alive,TUMOR FREE,2161,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2161,0,2161,0,2161,0,2161,NA,Stage I,T1,M0,BRCA.LumA,7
9.214737409,-3.769558654,TCGA-A8-A08J-01A,TCGA-A8-A08J-01A-11W-A019-09,1,0.719735088,TCGA-A8-A08J,BRCA,52,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19266,Dead,WITH TUMOR,NA,1127,[Not Available],NA,NA,NA,NA,[Not Available],1,1127,1,1127,NA,NA,1,1127,NA,Stage IV,T4b,M1,BRCA.Her2,1
9.078255614,-3.055685776,TCGA-06-0213-01A,TCGA-06-0213-01A-01D-1491-08,1,0.652739915,TCGA-06-0213,GBM,55,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-20134,Dead,WITH TUMOR,6,16,[Not Available],NA,NA,NA,NA,[Not Available],1,16,1,16,NA,NA,1,16,NA,NA,NA,NA,NA,1
-8.115653463,2.149936868,TCGA-AN-A04A-01A,TCGA-AN-A04A-01A-21W-A050-09,9,0.428985189,TCGA-AN-A04A,BRCA,36,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Peri (6-12 months since last menstrual period),-13445,Alive,TUMOR FREE,90,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,90,0,90,NA,NA,0,90,NA,Stage IIIA,T2,M0,BRCA.LumA,7
-5.58692659,-1.230387083,TCGA-49-4514-01A,TCGA-49-4514-01A-21D-1855-08,0,NA,TCGA-49-4514,LUAD,79,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-28908,Alive,TUMOR FREE,1700,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1700,0,1700,0,1700,0,1700,NA,Stage IA,T1,M0,LUAD.6,10
-5.239325841,1.496688057,TCGA-80-5611-01A,TCGA-80-5611-01A-01D-1625-08,0,NA,TCGA-80-5611,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,2595,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2595,0,2595,0,2595,0,2595,NA,Stage IB,T2,M0,NA,9
-6.318198453,1.74634635,TCGA-BH-A1EY-01A,TCGA-BH-A1EY-01A-11D-A13L-09,10,0.339649991,TCGA-BH-A1EY,BRCA,79,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28940,Dead,WITH TUMOR,NA,538,[Not Available],Distant Metastasis,Lung,Liver,396,[Not Available],1,538,1,538,NA,NA,1,396,NA,Stage IIA,T2,M0,BRCA.LumA,7
-7.872752733,2.250699649,TCGA-32-1979-01A,TCGA-32-1979-01A-01D-1696-08,9,0.478299995,TCGA-32-1979,GBM,69,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-25252,Dead,WITH TUMOR,593,593,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],265,[Not Available],1,593,1,593,NA,NA,1,265,NA,NA,NA,NA,NA,7
7.793198183,-1.305402451,TCGA-12-5295-01A,TCGA-12-5295-01A-01D-1486-08,1,0.157536818,TCGA-12-5295,GBM,60,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-22161,Dead,WITH TUMOR,399,454,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],399,[Not Available],1,454,1,454,NA,NA,1,399,NA,NA,NA,NA,GBM_LGG.Classic-like,1
0.315520366,2.175545231,TCGA-05-4425-01A,TCGA-05-4425-01A-01D-1753-08,0,NA,TCGA-05-4425,LUAD,70,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25902,Alive,NA,669,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,669,0,669,NA,NA,0,669,NA,Stage IV,T2,M1,LUAD.4,6
-0.733068705,2.508943256,TCGA-E2-A1LK-01A,TCGA-E2-A1LK-01A-21D-A14G-09,4,0.122654446,TCGA-E2-A1LK,BRCA,84,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30757,Dead,WITH TUMOR,NA,266,[Not Available],Locoregional Disease,"Other, specify",Left axilla,155,[Not Available],1,266,1,266,1,155,1,155,NA,Stage IIIC,T4b,M0,BRCA.Basal,6
8.760031956,-3.340185864,TCGA-AR-A1AQ-01A,TCGA-AR-A1AQ-01A-11D-A12Q-09,1,0.696344875,TCGA-AR-A1AQ,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18109,Alive,TUMOR FREE,3021,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3021,0,3021,0,3021,0,3021,NA,Stage IIA,T2,M0,BRCA.Basal,1
-1.305476165,4.037683206,TCGA-AY-4070-01A,TCGA-AY-4070-01A-01W-1073-09,4,0.327268374,TCGA-AY-4070,COAD,50,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-18621,Dead,WITH TUMOR,NA,496,[Not Available],NA,NA,NA,186,[Not Available],1,496,1,496,NA,NA,1,186,NA,Stage IIIC,T3,M0,GI.CIN,10
-7.148183272,2.217607512,TCGA-AA-A01I-01A,TCGA-AA-A01I-01A-02W-A00E-09,9,0.097089599,TCGA-AA-A01I,COAD,76,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27759,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,943,0,943,0,943,0,943,NA,Stage I,T2,M0,NA,7
-5.648397882,2.988093462,TCGA-73-7498-01A,TCGA-73-7498-01A-12D-2184-08,0,NA,TCGA-73-7498,LUAD,58,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-21527,Alive,TUMOR FREE,1189,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1189,0,1189,0,1189,0,1189,NA,Stage IA,T1b,M0,LUAD.1,8
9.231094386,-4.460545203,TCGA-AC-A2FB-01A,TCGA-AC-A2FB-01A-11D-A17D-09,1,0.750021467,TCGA-AC-A2FB,BRCA,65,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,[Not Available],-23851,Alive,TUMOR FREE,1234,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1234,0,1234,0,1234,0,1234,NA,Stage IIA,T2,MX,BRCA.LumA,1
-2.475169572,1.193223421,TCGA-A2-A25B-01A,TCGA-A2-A25B-01A-11D-A167-09,5,0.307369614,TCGA-A2-A25B,BRCA,39,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14454,Alive,WITH TUMOR,1291,NA,[Not Available],Distant Metastasis,Bone,NA,1290,[Not Available],0,1291,0,1291,NA,NA,1,1290,NA,Stage IIB,T2,M0,BRCA.LumB,4
9.879685273,-1.90632261,TCGA-J2-8192-01A,TCGA-J2-8192-01A-11D-2238-08,1,0.80639415,TCGA-J2-8192,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23892,Alive,TUMOR FREE,739,NA,[Not Available],Locoregional Recurrence,NA,NA,482,Progressive Disease,0,739,0,739,NA,NA,1,482,NA,Stage IIA,T2a,MX,NA,1
-0.126119327,3.142010476,TCGA-AN-A0FX-01A,TCGA-AN-A0FX-01A-11W-A050-09,4,0.177597435,TCGA-AN-A0FX,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19309,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.Basal,3
9.359081312,-5.319047038,TCGA-A1-A0SQ-01A,TCGA-A1-A0SQ-01A-21D-A142-09,1,0.80495305,TCGA-A1-A0SQ,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16458,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,554,0,554,0,554,0,554,NA,Stage IIB,T2,MX,BRCA.LumA,1
-8.018389302,1.9855622,TCGA-B6-A0WW-01A,TCGA-B6-A0WW-01A-11D-A10G-09,9,0.561191661,TCGA-B6-A0WW,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1997,Indeterminate (neither Pre or Postmenopausal),-21479,Dead,WITH TUMOR,NA,558,[Not Available],Distant Metastasis,Liver,NA,447,[Not Available],1,558,1,558,1,447,1,447,NA,Stage X,T2,MX,BRCA.LumB,7
-7.202112628,1.443279145,TCGA-A2-A1FZ-01A,TCGA-A2-A1FZ-01A-51D-A17G-09,0,NA,TCGA-A2-A1FZ,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23055,Alive,TUMOR FREE,683,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,683,0,683,0,683,0,683,NA,Stage IIA,T2,M0,BRCA.LumA,7
4.478148922,1.028067037,TCGA-A2-A04U-01A,TCGA-A2-A04U-01A-11D-A10Y-09,2,0.526809476,TCGA-A2-A04U,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Peri (6-12 months since last menstrual period),-17474,Alive,TUMOR FREE,2654,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2654,0,2654,0,2654,0,2654,NA,Stage IIA,T2,M0,BRCA.Basal,5
-8.112208744,2.041061945,TCGA-E9-A1RI-01A,TCGA-E9-A1RI-01A-11D-A167-09,9,0.620437133,TCGA-E9-A1RI,BRCA,43,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15942,Alive,TUMOR FREE,1449,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1449,0,1449,0,1449,0,1449,NA,Stage IIIA,T1c,M0,BRCA.LumA,7
4.318438829,1.01071115,TCGA-E9-A1NE-01A,TCGA-E9-A1NE-01A-21D-A14K-09,2,0.715440734,TCGA-E9-A1NE,BRCA,28,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10564,Alive,TUMOR FREE,1088,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1088,0,1088,0,1088,0,1088,NA,Stage IIB,T2,M0,BRCA.LumA,5
8.801450949,-1.962880688,TCGA-16-1045-01B,TCGA-16-1045-01B-01D-1492-08,1,0.598100413,TCGA-16-1045,GBM,49,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-18195,Dead,WITH TUMOR,883,883,[Not Available],Recurrence,[Not Applicable],[Not Applicable],654,[Not Available],1,883,1,883,NA,NA,1,654,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.090640458,-4.936964866,TCGA-E2-A1IJ-01A,TCGA-E2-A1IJ-01A-11D-A142-09,1,0.779444768,TCGA-E2-A1IJ,BRCA,57,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20956,Alive,TUMOR FREE,865,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,865,0,865,0,865,0,865,NA,Stage I,T1c,M0,BRCA.LumA,1
1.976108508,1.948692464,TCGA-06-0747-01A,TCGA-06-0747-01A-01D-1492-08,3,0.397382097,TCGA-06-0747,GBM,53,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-19657,Dead,WITH TUMOR,82,82,[Not Available],NA,NA,NA,NA,[Not Available],1,82,1,82,NA,NA,1,82,NA,NA,NA,NA,GBM_LGG.NA,3
-7.904891777,1.804970082,TCGA-B6-A0RO-01A,TCGA-B6-A0RO-01A-22D-A099-09,9,0.647432968,TCGA-B6-A0RO,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26269,Alive,TUMOR FREE,4929,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4929,0,4929,0,4929,0,4929,NA,Stage IIIB,T4,M0,BRCA.LumA,7
-7.163325367,1.510931057,TCGA-BH-A0DP-01A,TCGA-BH-A0DP-01A-21W-A071-09,0,NA,TCGA-BH-A0DP,BRCA,60,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,476,0,476,0,476,0,476,NA,Stage IIB,T3,M0,BRCA.LumA,7
-6.678778365,-2.180509197,TCGA-A2-A0CX-01A,TCGA-A2-A0CX-01A-21W-A019-09,6,0.139536028,TCGA-A2-A0CX,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19152,Alive,TUMOR FREE,1728,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1728,0,1728,0,1728,0,1728,NA,Stage IIA,T2,M0,BRCA.Her2,2
-7.456573882,1.482412048,TCGA-AO-A0J5-01A,TCGA-AO-A0J5-01A-11W-A050-09,0,NA,TCGA-AO-A0J5,BRCA,48,FEMALE,WHITE,"Other, specify",[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17815,Dead,WITH TUMOR,NA,792,[Not Available],NA,NA,NA,NA,[Not Available],1,792,1,792,NA,NA,1,792,NA,Stage IV,T4,M1,BRCA.LumA,7
-6.288004718,1.604041665,TCGA-AR-A24S-01A,TCGA-AR-A24S-01A-11D-A167-09,10,0.290322398,TCGA-AR-A24S,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22587,Alive,NA,2976,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2976,0,2976,0,2976,0,2976,NA,Stage I,T1,M0,BRCA.LumB,7
-7.611539061,2.179128095,TCGA-E9-A1R5-01A,TCGA-E9-A1R5-01A-11D-A14K-09,9,0.336964438,TCGA-E9-A1R5,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23116,Alive,TUMOR FREE,92,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,92,0,92,0,92,0,92,NA,Stage IA,T1c,M0,BRCA.LumA,7
0.479371478,2.207028734,TCGA-B6-A0IH-01A,TCGA-B6-A0IH-01A-11D-A10Y-09,0,NA,TCGA-B6-A0IH,BRCA,81,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29907,Dead,NA,NA,3418,[Not Available],NA,NA,NA,NA,[Not Available],1,3418,NA,3418,0,3418,0,3418,NA,Stage IIIA,T3,M0,BRCA.LumA,6
-0.217132345,4.949929482,TCGA-EW-A1OY-01A,TCGA-EW-A1OY-01A-11D-A142-09,4,0.549059743,TCGA-EW-A1OY,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23266,Alive,TUMOR FREE,908,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,908,0,908,0,908,0,908,NA,Stage IIA,T2,MX,BRCA.LumB,6
-3.285722148,-3.340089916,TCGA-HU-A4H8-01A,TCGA-HU-A4H8-01A-11D-A25D-08,8,0.486281125,TCGA-HU-A4H8,STAD,77,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-28292,[Discrepancy],WITH TUMOR,428,NA,[Not Available],Distant Metastasis,NA,NA,354,Complete Remission/Response,0,428,NA,428,1,354,1,354,NA,Stage IB,T1b,M0,GI.HM-indel,10
-0.515527235,4.654621281,TCGA-64-1681-01A,TCGA-64-1681-01A-11D-2063-08,4,0.600474368,TCGA-64-1681,LUAD,61,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-22525,Dead,NA,NA,1167,[Not Available],NA,NA,NA,439,[Not Available],1,1167,NA,1167,NA,NA,1,439,NA,Stage IA,T1,M0,LUAD.5,6
9.455623599,-2.942426744,TCGA-DU-6397-01A,TCGA-DU-6397-01A-11D-1705-08,1,0.750533818,TCGA-DU-6397,LGG,45,MALE,WHITE,Oligodendroglioma,G3,1997,[Not Available],-16695,Dead,WITH TUMOR,NA,1401,[Not Available],NA,NA,NA,837,Progressive Disease,1,1401,1,1401,NA,NA,1,837,NA,NA,NA,NA,GBM_LGG.Codel,1
-8.210548665,1.98568184,TCGA-BR-8676-01A,TCGA-BR-8676-01A-11D-2394-08,9,0.57677975,TCGA-BR-8676,STAD,59,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-21619,Alive,TUMOR FREE,229,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,229,0,229,0,229,0,229,NA,Stage IIIB,T3,M0,NA,7
-2.933776358,-4.045283257,TCGA-BR-8487-01A,TCGA-BR-8487-01A-11D-2394-08,0,NA,TCGA-BR-8487,STAD,64,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23400,Alive,TUMOR FREE,34,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,34,0,34,0,34,0,34,NA,Stage IIA,T3,M0,GI.HM-indel,10
-5.647037601,-2.091618924,TCGA-BR-A4CQ-01A,TCGA-BR-A4CQ-01A-12D-A25D-08,0,NA,TCGA-BR-A4CQ,STAD,58,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-21207,Alive,WITH TUMOR,1064,NA,[Not Available],Distant Metastasis,NA,NA,962,Complete Remission/Response,0,1064,0,1064,1,962,1,962,NA,Stage IIIA,T4a,M0,NA,2
-7.823081386,2.147199553,TCGA-DU-8164-01A,TCGA-DU-8164-01A-11D-2253-08,9,0.560411886,TCGA-DU-8164,LGG,51,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-18735,Alive,TUMOR FREE,651,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,651,0,651,NA,NA,0,651,NA,NA,NA,NA,GBM_LGG.Codel,7
-0.459997368,4.965381803,TCGA-BR-8486-01A,TCGA-BR-8486-01A-31D-2394-08,4,0.57028888,TCGA-BR-8486,STAD,90,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-32872,Alive,TUMOR FREE,615,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,615,0,615,0,615,0,615,NA,Stage IA,T1b,M0,GI.CIN,6
-4.753770275,1.071783466,TCGA-05-4249-01A,TCGA-05-4249-01A-01D-1105-08,0,NA,TCGA-05-4249,LUAD,67,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],-24532,Alive,TUMOR FREE,1523,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,1523,0,1523,NA,NA,0,1523,NA,Stage IB,T2,M0,LUAD.5,10
9.608670343,-3.857456497,TCGA-E9-A228-01A,TCGA-E9-A228-01A-31D-A159-09,1,0.719464632,TCGA-E9-A228,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21294,Alive,TUMOR FREE,1285,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1285,0,1285,0,1285,0,1285,NA,Stage IIB,T2,M0,BRCA.LumB,1
-7.734525849,2.1346375,TCGA-A2-A0EW-01A,TCGA-A2-A0EW-01A-21D-A10Y-09,9,0.473722395,TCGA-A2-A0EW,BRCA,53,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19413,Dead,WITH TUMOR,NA,1884,[Not Available],Distant Metastasis,Bone,NA,1353,[Not Available],1,1884,1,1884,NA,NA,1,1353,NA,Stage IIIC,T1b,M0,BRCA.LumA,7
4.441052561,1.242066527,TCGA-D7-8574-01A,TCGA-D7-8574-01A-13D-2340-08,2,0.697449066,TCGA-D7-8574,STAD,72,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-26586,Alive,TUMOR FREE,523,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,523,0,523,0,523,0,523,NA,Stage IIIA,T2,M0,GI.GS,5
-5.706387617,-2.124715526,TCGA-BR-8373-01A,TCGA-BR-8373-01A-11D-2340-08,0,NA,TCGA-BR-8373,STAD,65,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-23744,Alive,TUMOR FREE,450,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,450,0,450,0,450,0,450,NA,Stage IIIA,T4a,M0,GI.CIN,2
9.733935294,-4.466761723,TCGA-CD-A486-01A,TCGA-CD-A486-01A-11D-A24D-08,1,0.710138945,TCGA-CD-A486,STAD,68,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-24879,Dead,WITH TUMOR,NA,192,[Not Available],Distant Metastasis,Liver,liver and lung,79,Complete Remission/Response,1,192,1,192,1,79,1,79,NA,Stage IIA,T3,M0,GI.CIN,1
0.20130602,5.008470749,TCGA-HT-7474-01A,TCGA-HT-7474-01A-11D-2024-08,4,0.61879085,TCGA-HT-7474,LGG,52,MALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-19149,Alive,TUMOR FREE,114,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,114,0,114,NA,NA,0,114,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.652027871,2.513511574,TCGA-BR-8588-01A,TCGA-BR-8588-01A-11D-2394-08,9,0.180861252,TCGA-BR-8588,STAD,55,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-20177,Alive,TUMOR FREE,389,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,389,0,389,0,389,0,389,NA,Stage IIB,T4a,M0,GI.CIN,7
0.288270776,3.506106812,TCGA-HT-7473-01A,TCGA-HT-7473-01A-11D-2024-08,4,0.276698522,TCGA-HT-7473,LGG,28,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-10306,Alive,TUMOR FREE,503,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,503,0,503,0,503,0,503,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
8.602164639,-3.542319438,TCGA-BR-8367-01A,TCGA-BR-8367-01A-11D-2340-08,1,0.690527731,TCGA-BR-8367,STAD,55,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-20441,Dead,WITH TUMOR,NA,801,[Not Available],Distant Metastasis,"Other, specify","Adrenal gland, bone",580,Complete Remission/Response,1,801,1,801,1,580,1,580,NA,Stage IIIB,T3,M0,GI.GS,1
9.505775128,-2.459845966,TCGA-BH-A18S-01A,TCGA-BH-A18S-01A-11D-A12B-09,1,0.768072394,TCGA-BH-A18S,BRCA,79,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28974,Dead,TUMOR FREE,NA,2009,[Not Available],NA,NA,NA,NA,[Not Available],1,2009,0,2009,0,2009,0,2009,NA,Stage I,T1c,M0,BRCA.LumA,1
7.757519844,-1.283948721,TCGA-A8-A09W-01A,TCGA-A8-A09W-01A-11W-A019-09,1,0.136004572,TCGA-A8-A09W,BRCA,70,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25659,Alive,NA,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage IIIB,T2,M0,BRCA.LumB,6
9.050346082,-2.242091147,TCGA-CS-6668-01A,TCGA-CS-6668-01A-11D-1893-08,1,0.675470791,TCGA-CS-6668,LGG,57,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-20836,Alive,WITH TUMOR,1519,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1519,0,1519,NA,NA,0,1519,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.213420116,-2.850133372,TCGA-FP-8211-01A,TCGA-FP-8211-01A-11D-2340-08,0,NA,TCGA-FP-8211,STAD,62,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-22957,Alive,TUMOR FREE,413,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,413,0,413,0,413,0,413,NA,Stage IIB,T3,MX,GI.CIN,1
-6.372602013,1.678469079,TCGA-44-5645-01A,TCGA-44-5645-01A-51D-A27T-08,10,0.365848378,TCGA-44-5645,LUAD,61,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-22471,Alive,TUMOR FREE,852,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,852,0,852,0,852,0,852,NA,Stage IA,T1,[Not Available],LUAD.5,7
-3.123977109,-3.636799079,TCGA-HU-A4GU-01A,TCGA-HU-A4GU-01A-11D-A25D-08,8,0.482677021,TCGA-HU-A4GU,STAD,73,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-27024,Alive,TUMOR FREE,200,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,200,0,200,0,200,0,200,NA,Stage IIB,T3,M0,GI.HM-indel,10
-7.336221378,1.830928447,TCGA-76-6280-01A,TCGA-76-6280-01A-21D-1845-08,9,0.107019648,TCGA-76-6280,GBM,57,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-20931,Dead,WITH TUMOR,346,346,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],108,[Not Available],1,346,1,346,NA,NA,1,108,NA,NA,NA,NA,NA,7
-7.670584705,-2.547173311,TCGA-BR-A4CR-01A,TCGA-BR-A4CR-01A-11D-A24D-08,6,0.429403009,TCGA-BR-A4CR,STAD,70,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-25669,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,Stage IIIC,T4b,M0,GI.CIN,2
9.582789284,-5.566782309,TCGA-HT-8012-01A,TCGA-HT-8012-01A-11D-2395-08,1,0.857826154,TCGA-HT-8012,LGG,30,FEMALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-11295,Alive,WITH TUMOR,286,NA,[Not Available],NA,NA,NA,133,Stable Disease,0,286,0,286,NA,NA,1,133,NA,NA,NA,NA,GBM_LGG.Codel,1
-3.296109651,-3.275628433,TCGA-69-7979-01A,TCGA-69-7979-01A-11D-2184-08,8,0.618020505,TCGA-69-7979,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26180,Alive,NA,408,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,408,0,408,NA,NA,0,408,NA,Stage IB,T2a,MX,NA,10
4.29458545,0.961341982,TCGA-HU-8249-01A,TCGA-HU-8249-01A-11D-2340-08,2,0.505951803,TCGA-HU-8249,STAD,76,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-28012,Alive,TUMOR FREE,881,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,881,0,881,0,881,0,881,NA,Stage IIIA,T3,M0,GI.CIN,5
8.503750979,-3.634160161,TCGA-C8-A132-01A,TCGA-C8-A132-01A-31D-A10Y-09,1,0.689087309,TCGA-C8-A132,BRCA,56,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20471,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,383,0,383,0,383,0,383,NA,Stage IIB,T2,M0,BRCA.LumA,1
-5.01979854,1.530734804,TCGA-69-7973-01A,TCGA-69-7973-01A-11D-2184-08,0,NA,TCGA-69-7973,LUAD,42,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-15355,Alive,TUMOR FREE,230,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,230,0,230,0,230,0,230,NA,Stage IB,T2a,M0,NA,9
-6.735101118,1.65588848,TCGA-HU-8608-01A,TCGA-HU-8608-01A-11D-2394-08,0,NA,TCGA-HU-8608,STAD,70,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-25789,Alive,WITH TUMOR,641,NA,[Not Available],Distant Metastasis,Lung,NA,277,Complete Remission/Response,0,641,0,641,1,277,1,277,NA,Stage IIIB,T4a,M0,GI.EBV,7
10.14875976,-1.599464026,TCGA-B6-A0WV-01A,TCGA-B6-A0WV-01A-11D-A10G-09,1,0.863401693,TCGA-B6-A0WV,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24803,Dead,TUMOR FREE,NA,2417,[Not Available],NA,NA,NA,NA,[Not Available],1,2417,0,2417,0,2417,0,2417,NA,Stage IIB,T2,M0,BRCA.LumB,1
-0.127646243,3.176385387,TCGA-C8-A1HJ-01A,TCGA-C8-A1HJ-01A-11D-A13L-09,4,0.175247635,TCGA-C8-A1HJ,BRCA,53,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-19629,Alive,TUMOR FREE,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5,0,5,0,5,0,5,NA,Stage IIA,T2,M0,BRCA.Basal,3
-5.274096891,2.285207352,TCGA-CK-4948-01B,TCGA-CK-4948-01B-11D-1650-10,12,0.054270332,TCGA-CK-4948,COAD,45,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2002,[Not Available],-16736,Alive,TUMOR FREE,4502,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4502,0,4502,0,4502,0,4502,NA,Stage III,T3,M0,GI.CIN,8
-7.764609323,-2.364930317,TCGA-A1-A0SD-01A,TCGA-A1-A0SD-01A-11D-A10Y-09,6,0.521479704,TCGA-A1-A0SD,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,[Not Available],-21793,Alive,NA,437,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,437,0,437,0,437,0,437,NA,Stage IIA,T2,M0,BRCA.LumA,2
-5.092137942,1.18631394,TCGA-AA-3819-01A,TCGA-AA-3819-01A-01W-0900-09,0,NA,TCGA-AA-3819,COAD,41,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-15280,Alive,TUMOR FREE,761,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,761,0,761,0,761,0,761,NA,Stage IIA,T3,M0,GI.CIN,10
9.47849851,-3.824287201,TCGA-HU-8610-01A,TCGA-HU-8610-01A-22D-2394-08,1,0.715813844,TCGA-HU-8610,STAD,75,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-27594,Alive,TUMOR FREE,23,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,23,0,23,NA,NA,0,23,NA,Stage IA,T1b,M0,GI.GS,1
-3.281795854,-3.475222378,TCGA-BR-8363-01A,TCGA-BR-8363-01A-11D-2340-08,8,0.62641553,TCGA-BR-8363,STAD,73,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-26976,Dead,TUMOR FREE,NA,8,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,8,0,8,0,8,0,8,NA,Stage IB,T2,M0,GI.HM-indel,10
1.2215425,3.437344759,TCGA-38-4627-01A,TCGA-38-4627-01A-01D-1553-08,0,NA,TCGA-38-4627,LUAD,64,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-23510,Dead,NA,NA,1147,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1147,NA,1147,0,1147,0,1147,NA,Stage IIA,T1b,M0,LUAD.6,1
-6.178102981,1.615965393,TCGA-BR-A4PD-01A,TCGA-BR-A4PD-01A-11D-A25D-08,10,0.279088622,TCGA-BR-A4PD,STAD,72,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-26334,Alive,TUMOR FREE,628,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,628,0,628,0,628,0,628,NA,Stage IIB,T4a,M0,GI.CIN,9
-0.125495945,4.243403724,TCGA-HT-8114-01A,TCGA-HT-8114-01A-11D-2395-08,4,0.532525591,TCGA-HT-8114,LGG,36,MALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-13198,Alive,TUMOR FREE,1040,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1040,0,1040,0,1040,0,1040,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.29571106,-3.386546795,TCGA-HU-A4GN-01A,TCGA-HU-A4GN-01A-11D-A25D-08,8,0.445661249,TCGA-HU-A4GN,STAD,61,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-22288,Alive,TUMOR FREE,912,NA,[Not Available],NA,"Other, specify",thyroid,168,Complete Remission/Response,0,912,0,912,1,168,1,168,NA,Stage IIA,T2,M0,GI.HM-indel,10
4.09547724,1.302307233,TCGA-75-5122-01A,TCGA-75-5122-01A-01D-1753-08,2,0.467967879,TCGA-75-5122,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2005,[Not Available],NA,Dead,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,NA,1,NA,NA,NA,1,NA,NA,Stage IB,T2,M0,LUAD.6,5
-6.507059973,2.265110386,TCGA-BH-A18I-01A,TCGA-BH-A18I-01A-11D-A12B-09,0,NA,TCGA-BH-A18I,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19489,Alive,TUMOR FREE,1093,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1093,0,1093,0,1093,0,1093,NA,Stage IIA,T1c,cM0 (i+),BRCA.LumA,7
0.366509063,5.076447322,TCGA-BH-A0B9-01A,TCGA-BH-A0B9-01A-11W-A071-09,4,0.692966253,TCGA-BH-A0B9,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16310,Alive,TUMOR FREE,1572,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1572,0,1572,0,1572,0,1572,NA,Stage IA,T1c,M0,BRCA.Basal,6
-0.824886344,2.370455466,TCGA-AN-A0AT-01A,TCGA-AN-A0AT-01A-11D-A045-09,4,0.169439064,TCGA-AN-A0AT,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22798,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.Basal,6
4.31651403,1.260327065,TCGA-E9-A22B-01A,TCGA-E9-A22B-01A-11D-A159-09,2,0.530707242,TCGA-E9-A22B,BRCA,71,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26278,Alive,TUMOR FREE,1167,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1167,0,1167,0,1167,0,1167,NA,Stage IA,T1c,M0,BRCA.LumA,1
-2.828358518,-4.215035053,TCGA-CK-4951-01A,TCGA-CK-4951-01A-01D-1408-10,0,NA,TCGA-CK-4951,COAD,79,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2007,[Not Available],-28982,Dead,TUMOR FREE,NA,2134,[Not Available],Locoregional Disease,NA,NA,480,[Not Available],1,2134,0,2134,NA,NA,1,480,NA,Stage IIA,T3,M0,GI.HM-indel,10
9.753909268,-1.687847935,TCGA-BR-8683-01A,TCGA-BR-8683-01A-11D-2394-08,1,0.69792683,TCGA-BR-8683,STAD,75,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-27549,Dead,TUMOR FREE,NA,300,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,300,0,300,0,300,0,300,NA,Stage IIIB,T4a,M0,GI.CIN,1
-4.141555992,-1.78293581,TCGA-38-4632-01A,TCGA-38-4632-01A-01D-1753-08,8,0.378547458,TCGA-38-4632,LUAD,42,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],1998,[Not Available],-15418,Dead,WITH TUMOR,NA,1357,[Not Available],NA,NA,NA,680,Complete Remission/Response,1,1357,1,1357,NA,NA,1,680,NA,Stage IV,T2,M1,LUAD.3,10
-7.033197867,2.059083116,TCGA-HU-A4H2-01A,TCGA-HU-A4H2-01A-11D-A25D-08,0,NA,TCGA-HU-A4H2,STAD,58,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-21496,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,394,0,394,0,394,0,394,NA,Stage IIIB,T3,M0,GI.CIN,6
9.46773151,-5.610855447,TCGA-DU-5874-01A,TCGA-DU-5874-01A-11D-1705-08,1,0.776924819,TCGA-DU-5874,LGG,62,FEMALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-22847,Alive,TUMOR FREE,461,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,461,0,461,NA,NA,0,461,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.150235649,-1.969210796,TCGA-91-6836-01A,TCGA-91-6836-01A-21D-1855-08,8,0.314116542,TCGA-91-6836,LUAD,52,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-19216,Alive,TUMOR FREE,417,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,417,0,417,0,417,0,417,NA,Stage IB,T2,MX,NA,10
-7.477562836,-2.339302597,TCGA-BR-8483-01A,TCGA-BR-8483-01A-31D-2394-08,6,0.369457198,TCGA-BR-8483,STAD,59,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-21731,Alive,TUMOR FREE,164,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,164,0,164,NA,NA,0,164,NA,Stage IIIA,T3,M0,GI.CIN,2
3.819467587,1.326411492,TCGA-BR-8485-01A,TCGA-BR-8485-01A-11D-2394-08,0,NA,TCGA-BR-8485,STAD,68,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-24845,Alive,TUMOR FREE,280,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,280,0,280,0,280,0,280,NA,Stage IIIC,T4,M0,GI.CIN,6
-4.103362723,-1.441752246,TCGA-69-7974-01A,TCGA-69-7974-01A-11D-2184-08,8,0.216879806,TCGA-69-7974,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-20021,Alive,WITH TUMOR,184,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,184,0,184,NA,NA,0,184,NA,Stage IIIA,T2a,MX,NA,10
-4.247510676,-1.808190716,TCGA-14-0866-01B,TCGA-14-0866-01B-01W-0643-08,8,0.418833228,TCGA-14-0866,GBM,55,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-20179,Dead,NA,801,801,[Not Available],Recurrence,[Not Applicable],[Not Applicable],97,[Not Available],1,801,NA,801,NA,NA,1,97,NA,NA,NA,NA,NA,10
-0.113571226,4.946295983,TCGA-A6-6782-01A,TCGA-A6-6782-01A-11D-1835-10,4,0.385202497,TCGA-A6-6782,COAD,82,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-30012,Alive,TUMOR FREE,617,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,617,0,617,0,617,0,617,NA,Stage IIB,T4a,MX,GI.CIN,6
-3.293616842,-3.43183032,TCGA-HU-8602-01A,TCGA-HU-8602-01A-11D-2394-08,8,0.630420955,TCGA-HU-8602,STAD,58,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-21522,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,679,0,679,0,679,0,679,NA,Stage IIB,T4a,M0,GI.HM-indel,10
-3.082687317,-3.718311591,TCGA-BR-8589-01A,TCGA-BR-8589-01A-11D-2394-08,8,0.43330018,TCGA-BR-8589,STAD,56,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-20727,Alive,TUMOR FREE,825,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,825,0,825,0,825,0,825,NA,Stage IIIB,T4b,M0,GI.EBV,10
9.217348588,-3.256352759,TCGA-E1-5319-01A,TCGA-E1-5319-01A-01D-1893-08,1,0.740703606,TCGA-E1-5319,LGG,48,FEMALE,WHITE,Oligodendroglioma,G2,1998,[Not Available],-17612,Dead,WITH TUMOR,NA,2907,[Not Available],NA,NA,NA,923,Stable Disease,1,2907,1,2907,NA,NA,1,923,NA,NA,NA,NA,GBM_LGG.Codel,1
-5.502997396,2.797470006,TCGA-55-7914-01A,TCGA-55-7914-01A-11D-2167-08,0,NA,TCGA-55-7914,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26105,Dead,WITH TUMOR,NA,187,[Not Available],NA,NA,NA,NA,Progressive Disease,1,187,1,187,NA,NA,1,187,NA,Stage IIA,T1b,MX,LUAD.3,10
-5.304843745,2.723013773,TCGA-CD-A489-01A,TCGA-CD-A489-01A-11D-A24D-08,12,0.324603531,TCGA-CD-A489,STAD,58,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-21517,Dead,WITH TUMOR,NA,344,[Not Available],Locoregional Recurrence,NA,NA,277,Complete Remission/Response,1,344,1,344,1,277,1,277,NA,Stage IIA,T3,M0,GI.CIN,8
-5.908861879,2.359330897,TCGA-49-6745-01A,TCGA-49-6745-01A-11D-1855-08,0,NA,TCGA-49-6745,LUAD,82,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-30133,Alive,TUMOR FREE,522,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,522,0,522,NA,NA,0,522,NA,Stage IIIA,T2a,M0,LUAD.4,8
2.133374677,1.733591997,TCGA-28-5204-01A,TCGA-28-5204-01A-01D-1486-08,3,0.431645004,TCGA-28-5204,GBM,72,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-26490,Dead,WITH TUMOR,NA,454,[Not Available],NA,NA,NA,NA,[Not Available],1,454,1,454,NA,NA,1,454,NA,NA,NA,NA,GBM_LGG.Classic-like,3
4.246377871,1.227887373,TCGA-DB-5274-01A,TCGA-DB-5274-01A-01D-1468-08,2,0.63840467,TCGA-DB-5274,LGG,37,FEMALE,WHITE,Oligoastrocytoma,G3,2006,[Not Available],-13680,Alive,TUMOR FREE,2289,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2289,0,2289,0,2289,0,2289,NA,NA,NA,NA,GBM_LGG.Codel,5
-4.390719286,1.5955452,TCGA-CA-5256-01A,TCGA-CA-5256-01A-01D-1408-10,0,NA,TCGA-CA-5256,COAD,54,FEMALE,ASIAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-19785,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage IIA,T3,M0,GI.CIN,4
-4.687279716,0.104516946,TCGA-BR-8381-01A,TCGA-BR-8381-01A-11D-2394-08,0,NA,TCGA-BR-8381,STAD,51,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-18843,Alive,TUMOR FREE,224,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,224,0,224,0,224,0,224,NA,Stage IIB,T3,M0,GI.EBV,10
-3.255605448,-3.439748777,TCGA-HU-A4G8-01A,TCGA-HU-A4G8-01A-11D-A25D-08,8,0.358996175,TCGA-HU-A4G8,STAD,71,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-26254,Alive,TUMOR FREE,690,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,690,0,690,0,690,0,690,NA,Stage IIB,T3,M0,GI.HM-indel,10
8.935995647,-4.722685126,TCGA-BR-8380-01A,TCGA-BR-8380-01A-11D-2340-08,1,0.834706639,TCGA-BR-8380,STAD,55,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-20157,Alive,WITH TUMOR,21,NA,[Not Available],Locoregional Recurrence,NA,NA,467,Complete Remission/Response,0,21,0,21,1,467,1,467,NA,Stage IIIC,T4a,M0,GI.GS,3
8.982592609,-4.4941694,TCGA-E1-5302-01A,TCGA-E1-5302-01A-01D-1468-08,1,0.79995344,TCGA-E1-5302,LGG,41,MALE,WHITE,Astrocytoma,G3,1998,[Not Available],-15230,Dead,WITH TUMOR,NA,1525,[Not Available],NA,NA,NA,1242,Stable Disease,1,1525,1,1525,NA,NA,1,1242,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-4.096509121,-0.9321302,TCGA-44-7660-01A,TCGA-44-7660-01A-11D-2063-08,0,NA,TCGA-44-7660,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26594,Alive,WITH TUMOR,592,NA,[Not Available],Locoregional Recurrence,NA,NA,253,Progressive Disease,0,592,0,592,NA,NA,1,253,NA,Stage IB,T2,MX,NA,10
-0.036003553,4.64468378,TCGA-IN-8663-01A,TCGA-IN-8663-01A-11D-2394-08,4,0.509662557,TCGA-IN-8663,STAD,68,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25172,Dead,TUMOR FREE,NA,103,"Other, non-malignant disease",NA,NA,NA,NA,[Not Available],1,103,0,103,NA,NA,0,103,NA,Stage IIB,T2,M0,GI.CIN,6
-4.558464428,0.838914228,TCGA-44-7667-01A,TCGA-44-7667-01A-31D-2063-08,0,NA,TCGA-44-7667,LUAD,49,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-18062,Alive,TUMOR FREE,1097,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1097,0,1097,0,1097,0,1097,NA,Stage IIB,T3,MX,NA,10
-4.869433989,1.281468353,TCGA-BR-8687-01A,TCGA-BR-8687-01A-11D-2394-08,0,NA,TCGA-BR-8687,STAD,67,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-24472,Dead,WITH TUMOR,NA,250,[Not Available],NA,NA,NA,NA,Stable Disease,1,250,1,250,NA,NA,1,250,NA,Stage IIIC,T4b,M0,GI.CIN,9
-7.127031666,2.38256719,TCGA-AA-A03F-01A,TCGA-AA-A03F-01A-11W-A096-10,9,0.02237114,TCGA-AA-A03F,COAD,90,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2004,[Not Available],-32873,Dead,WITH TUMOR,NA,549,[Not Available],NA,NA,NA,NA,[Unknown],1,549,1,549,NA,NA,1,549,NA,Stage III,T3,M0,GI.GS,9
-3.354167553,-3.267733263,TCGA-D5-6930-01A,TCGA-D5-6930-01A-11D-1924-10,8,0.602640734,TCGA-D5-6930,COAD,67,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-24764,Alive,TUMOR FREE,406,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,406,0,406,NA,NA,0,406,NA,Stage IIA,T3,M0,GI.HM-indel,10
9.089638586,-2.668828039,TCGA-DU-5847-01A,TCGA-DU-5847-01A-11D-1705-08,1,0.675460364,TCGA-DU-5847,LGG,34,FEMALE,WHITE,Astrocytoma,G3,2009,[Not Available],-12606,Alive,WITH TUMOR,548,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,548,0,548,NA,NA,0,548,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-2.950889267,-3.971133228,TCGA-05-4396-01A,TCGA-05-4396-01A-21D-1855-08,8,0.214962426,TCGA-05-4396,LUAD,76,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2006,[Not Available],-28094,Dead,NA,NA,303,[Not Available],NA,NA,NA,NA,[Not Available],1,303,NA,303,NA,NA,0,303,NA,Stage IIIB,T4,M0,LUAD.4,10
1.891966745,1.942714457,TCGA-CD-8534-01A,TCGA-CD-8534-01A-11D-2340-08,3,0.517322146,TCGA-CD-8534,STAD,41,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-15227,Alive,WITH TUMOR,367,NA,[Not Available],Distant Metastasis,"Other, specify","Pancreas, Transverse Colon",201,Progressive Disease,0,367,0,367,NA,NA,1,201,NA,Stage II,T3,M0,GI.GS,3
-4.068865518,-2.203722938,TCGA-91-6848-01A,TCGA-91-6848-01A-11D-1945-08,8,0.436219753,TCGA-91-6848,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-21829,Alive,TUMOR FREE,224,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,224,0,224,0,224,0,224,NA,Stage IIIA,T2,MX,NA,10
-7.707334999,2.073747314,TCGA-CS-4944-01A,TCGA-CS-4944-01A-01D-1468-08,9,0.347952824,TCGA-CS-4944,LGG,50,MALE,WHITE,Astrocytoma,G2,2010,[Not Available],-18494,Alive,WITH TUMOR,1828,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1828,0,1828,NA,NA,0,1828,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,7
-0.620933685,4.978565545,TCGA-38-6178-01A,TCGA-38-6178-01A-11D-1753-08,4,0.498387752,TCGA-38-6178,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25593,Alive,WITH TUMOR,448,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,448,0,448,NA,NA,0,448,NA,Stage IIIA,T2b,[Not Available],LUAD.5,6
0.035215204,4.868925884,TCGA-06-0744-01A,TCGA-06-0744-01A-01D-1492-08,4,0.61155846,TCGA-06-0744,GBM,66,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-24471,Dead,WITH TUMOR,NA,1426,[Not Available],NA,[Not Applicable],[Not Applicable],1277,[Not Available],1,1426,1,1426,NA,NA,1,1277,NA,NA,NA,NA,GBM_LGG.NA,6
9.481955441,-4.487419157,TCGA-02-2486-01A,TCGA-02-2486-01A-01D-1494-08,1,0.703702237,TCGA-02-2486,GBM,64,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-23394,Dead,WITH TUMOR,NA,618,[Not Available],NA,NA,NA,NA,[Not Available],1,618,1,618,NA,NA,1,618,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-0.167052601,4.646536631,TCGA-A7-A26I-01A,TCGA-A7-A26I-01A-11D-A167-09,4,0.588946519,TCGA-A7-A26I,BRCA,65,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23948,Alive,TUMOR FREE,661,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,661,0,661,0,661,0,661,NA,Stage IIA,T2,M0,BRCA.Basal,6
2.903823271,3.542014103,TCGA-GM-A2DL-01A,TCGA-GM-A2DL-01A-11D-A18P-09,0,NA,TCGA-GM-A2DL,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Peri (6-12 months since last menstrual period),-18475,Alive,TUMOR FREE,3519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3519,0,3519,0,3519,0,3519,NA,Stage I,T1c,M0,BRCA.LumA,6
-5.910642726,1.405889581,TCGA-CM-5860-01A,TCGA-CM-5860-01A-01D-1650-10,10,0.119698708,TCGA-CM-5860,COAD,44,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-16344,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,974,0,974,NA,NA,0,974,NA,Stage IIA,T3,M0,GI.CIN,7
-1.653292047,1.146913529,TCGA-BH-A1F0-01A,TCGA-BH-A1F0-01A-11D-A135-09,5,0.576132624,TCGA-BH-A1F0,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29335,Dead,WITH TUMOR,NA,785,[Not Available],NA,NA,NA,NA,[Not Available],1,785,1,785,NA,NA,1,785,NA,Stage IIA,T1a,M0,BRCA.Basal,4
0.053395392,4.927797027,TCGA-HT-7902-01A,TCGA-HT-7902-01A-12D-2395-08,4,0.709664824,TCGA-HT-7902,LGG,30,FEMALE,WHITE,Oligoastrocytoma,G2,2009,[Not Available],-11118,Alive,TUMOR FREE,956,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,956,0,956,NA,NA,0,956,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.212165952,-2.433675794,TCGA-CD-8533-01A,TCGA-CD-8533-01A-11D-2340-08,6,0.364121443,TCGA-CD-8533,STAD,48,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-17821,Alive,WITH TUMOR,468,NA,[Not Available],Distant Metastasis,"Other, specify",liver and lung,226,Complete Remission/Response,0,468,0,468,1,226,1,226,NA,Stage II,T3,M0,NA,2
0.122383398,2.7641334,TCGA-HU-A4GC-01A,TCGA-HU-A4GC-01A-12D-A25D-08,4,0.019435523,TCGA-HU-A4GC,STAD,74,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-27267,Alive,TUMOR FREE,99,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,99,0,99,NA,NA,0,99,NA,Stage IIIB,T4a,M0,GI.CIN,6
-7.047743591,1.611169256,TCGA-BR-8366-01A,TCGA-BR-8366-01A-11D-2340-08,0,NA,TCGA-BR-8366,STAD,80,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-29394,Alive,TUMOR FREE,29,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,29,0,29,0,29,0,29,NA,Stage IIA,T3,M0,GI.EBV,9
-6.807302014,-2.204593634,TCGA-CD-8530-01A,TCGA-CD-8530-01A-11D-2340-08,6,0.161389563,TCGA-CD-8530,STAD,51,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-18992,Alive,TUMOR FREE,377,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,377,0,377,0,377,0,377,NA,Stage II,T3,M0,GI.CIN,2
-3.516953004,-2.946306735,TCGA-HU-A4G9-01A,TCGA-HU-A4G9-01A-11D-A24D-08,8,0.348316215,TCGA-HU-A4G9,STAD,67,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-24753,Alive,TUMOR FREE,736,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,736,0,736,NA,NA,0,736,NA,Stage IA,T1a,M0,GI.HM-indel,10
-0.498449963,4.846154052,TCGA-HU-8244-01A,TCGA-HU-8244-01A-11D-2340-08,4,0.570576798,TCGA-HU-8244,STAD,77,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011,[Not Available],-28184,Alive,TUMOR FREE,742,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,742,0,742,0,742,0,742,NA,Stage IA,T1a,M0,NA,6
-0.446425857,4.184662011,TCGA-HT-7476-01A,TCGA-HT-7476-01A-11D-2024-08,4,0.427731084,TCGA-HT-7476,LGG,26,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-9614,Alive,TUMOR FREE,199,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,199,0,199,NA,NA,0,199,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.874409444,-1.043704005,TCGA-HU-A4H0-01A,TCGA-HU-A4H0-01A-11D-A25D-08,8,0.029713561,TCGA-HU-A4H0,STAD,72,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-26317,Alive,TUMOR FREE,64,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,64,0,64,0,64,0,64,NA,Stage IIIC,T4a,M0,GI.EBV,10
8.622247366,-2.770006432,TCGA-CD-A48A-01A,TCGA-CD-A48A-01A-12D-A24D-08,1,0.559974844,TCGA-CD-A48A,STAD,57,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-20839,Alive,TUMOR FREE,378,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,378,0,378,0,378,0,378,NA,Stage IIA,T3,M0,GI.CIN,6
-3.242617792,-3.392788317,TCGA-D7-A4YV-01A,TCGA-D7-A4YV-01A-11D-A25D-08,8,0.606934153,TCGA-D7-A4YV,STAD,69,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-25421,Dead,TUMOR FREE,NA,180,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,180,0,180,0,180,0,180,NA,Stage IIB,T3,M0,GI.HM-indel,10
-0.042959119,4.894942549,TCGA-BR-8590-01A,TCGA-BR-8590-01A-11D-2394-08,4,0.60142009,TCGA-BR-8590,STAD,62,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-22937,Dead,WITH TUMOR,NA,284,[Not Available],Distant Metastasis,Lung,NA,223,Complete Remission/Response,1,284,1,284,1,223,1,223,NA,Stage IIIC,T4b,M0,GI.CIN,6
8.808069239,-4.353592146,TCGA-DB-5278-01A,TCGA-DB-5278-01A-01D-1468-08,1,0.743676121,TCGA-DB-5278,LGG,17,MALE,WHITE,Oligodendroglioma,G2,2007,[Not Available],-6480,Alive,WITH TUMOR,2772,NA,[Not Available],NA,NA,NA,507,Stable Disease,0,2772,0,2772,NA,NA,1,507,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.995059817,4.874309049,TCGA-BR-A4PE-01A,TCGA-BR-A4PE-01A-31D-A25D-08,4,0.37018661,TCGA-BR-A4PE,STAD,68,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-24986,Alive,TUMOR FREE,621,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,621,0,621,0,621,0,621,NA,Stage IB,T2,M0,GI.CIN,6
-5.735749117,-2.10897334,TCGA-FP-A4BF-01A,TCGA-FP-A4BF-01A-12D-A24D-08,0,NA,TCGA-FP-A4BF,STAD,68,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2011,[Not Available],-25030,Dead,WITH TUMOR,NA,168,[Not Available],Distant Metastasis,Lung,NA,159,Progressive Disease,1,168,1,168,NA,NA,1,159,NA,Stage IIIA,T3,M0,GI.CIN,2
-2.82259867,-4.207454602,TCGA-BR-8680-01A,TCGA-BR-8680-01A-11D-2394-08,0,NA,TCGA-BR-8680,STAD,45,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-16637,Alive,TUMOR FREE,972,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,972,0,972,NA,NA,0,972,NA,Stage IV,T4b,M1,GI.HM-SNV,10
-3.505290859,-3.103207674,TCGA-86-6851-01A,TCGA-86-6851-01A-11D-1945-08,8,0.519655263,TCGA-86-6851,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26808,Alive,TUMOR FREE,179,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,179,0,179,0,179,0,179,NA,Stage IIA,T1b,M0,LUAD.5,10
-6.744042985,-2.278277218,TCGA-D7-A4Z0-01A,TCGA-D7-A4Z0-01A-22D-A25D-08,6,0.115174498,TCGA-D7-A4Z0,STAD,60,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012,[Not Available],-22129,Alive,TUMOR FREE,449,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,449,0,449,0,449,0,449,NA,Stage IIB,T2,M0,GI.GS,2
8.401113184,-3.320696916,TCGA-DU-5854-01A,TCGA-DU-5854-01A-11D-1705-08,1,0.635142351,TCGA-DU-5854,LGG,57,FEMALE,WHITE,Astrocytoma,G3,2010,[Not Available],-21106,Alive,WITH TUMOR,257,NA,[Not Available],NA,NA,NA,202,Progressive Disease,0,257,0,257,NA,NA,1,202,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-3.197006671,-3.446410358,TCGA-HU-A4GQ-01A,TCGA-HU-A4GQ-01A-11D-A25D-08,8,0.611169469,TCGA-HU-A4GQ,STAD,71,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-26200,Dead,[Discrepancy],NA,3,Stomach Cancer,NA,NA,NA,NA,Complete Remission/Response,1,3,1,3,0,3,0,3,NA,Stage IIIC,T4b,M0,GI.HM-indel,10
-4.861602442,2.075485223,TCGA-55-A494-01A,TCGA-55-A494-01A-11D-A24P-08,0,NA,TCGA-55-A494,LUAD,61,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22540,Alive,TUMOR FREE,481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,481,0,481,0,481,0,481,NA,Stage IB,T2a,MX,NA,9
-4.186705503,1.131358445,TCGA-D7-A4YU-01A,TCGA-D7-A4YU-01A-21D-A25D-08,0,NA,TCGA-D7-A4YU,STAD,73,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-26781,Alive,WITH TUMOR,500,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,500,0,500,NA,NA,0,500,NA,Stage IIIB,T3,M0,GI.CIN,6
0.215824869,5.279311852,TCGA-DU-5853-01A,TCGA-DU-5853-01A-11D-1893-08,4,0.457823953,TCGA-DU-5853,LGG,29,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-10624,Alive,WITH TUMOR,407,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,407,0,407,NA,NA,0,407,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-6.238163796,1.335979962,TCGA-CD-8525-01A,TCGA-CD-8525-01A-11D-2340-08,0,NA,TCGA-CD-8525,STAD,82,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010,[Not Available],-30004,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,383,0,383,0,383,0,383,NA,Stage IIIA,T3,M0,NA,7
-1.104101281,4.161352402,TCGA-78-7149-01A,TCGA-78-7149-01A-11D-2036-08,4,0.383855727,TCGA-78-7149,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-26285,Alive,NA,3940,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3940,0,3940,0,3940,0,3940,NA,Stage IIIB,T4,M0,LUAD.1,6
8.870118118,-4.858374686,TCGA-BR-8677-01A,TCGA-BR-8677-01A-11D-2394-08,1,0.795067113,TCGA-BR-8677,STAD,74,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-27223,Alive,TUMOR FREE,813,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,813,0,813,0,813,0,813,NA,Stage IIIB,T3,M0,GI.CIN,1
0.01212442,5.058196871,TCGA-DB-5276-01A,TCGA-DB-5276-01A-01D-1468-08,4,0.683360404,TCGA-DB-5276,LGG,32,MALE,WHITE,Oligoastrocytoma,G3,2007,[Not Available],-11738,Alive,TUMOR FREE,2218,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2218,0,2218,0,2218,0,2218,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.710514608,2.44847218,TCGA-D7-8575-01A,TCGA-D7-8575-01A-11D-2340-08,4,0.097650875,TCGA-D7-8575,STAD,75,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-27712,Dead,WITH TUMOR,NA,554,[Not Available],Distant Metastasis,Peritoneal Surfaces,NA,427,Complete Remission/Response,1,554,1,554,1,427,1,427,NA,Stage IIIA,T3,M0,GI.CIN,6
-3.567193931,-2.884424416,TCGA-CD-8529-01A,TCGA-CD-8529-01A-11D-2340-08,8,0.333225011,TCGA-CD-8529,STAD,65,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011,[Not Available],-23979,Alive,TUMOR FREE,374,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,374,0,374,NA,NA,0,374,NA,Stage IV,T4,M1,GI.HM-SNV,10
-3.496385119,-2.920034821,TCGA-D8-A1JA-01A,TCGA-D8-A1JA-01A-11D-A13L-09,8,0.522181501,TCGA-D8-A1JA,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21918,Alive,WITH TUMOR,502,NA,[Not Available],Locoregional Disease,NA,NA,431,[Not Available],0,502,0,502,1,431,1,431,NA,[Not Available],T4b,M0,BRCA.Her2,10
0.240922499,3.513910391,TCGA-B6-A0IJ-01A,TCGA-B6-A0IJ-01A-11W-A050-09,4,0.284979637,TCGA-B6-A0IJ,BRCA,42,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1995,Indeterminate (neither Pre or Postmenopausal),-15625,Alive,TUMOR FREE,7106,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,7106,0,7106,0,7106,0,7106,NA,Stage IIB,T3,M0,BRCA.Basal,3
-4.517376928,1.482451804,TCGA-E2-A159-01A,TCGA-E2-A159-01A-11D-A10Y-09,0,NA,TCGA-E2-A159,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18621,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,762,0,762,0,762,0,762,NA,Stage IIA,T2,M0,BRCA.Basal,9
8.833989275,-3.844130822,TCGA-A8-A09T-01A,TCGA-A8-A09T-01A-11W-A019-09,1,0.708431312,TCGA-A8-A09T,BRCA,68,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25110,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,579,0,579,0,579,0,579,NA,[Discrepancy],T1c,MX,BRCA.LumA,1
9.720601435,-4.149367557,TCGA-E2-A1IE-01A,TCGA-E2-A1IE-01A-11D-A188-09,1,0.661250819,TCGA-E2-A1IE,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22510,Alive,WITH TUMOR,2362,NA,[Not Available],Distant Metastasis,Liver,NA,1810,[Not Available],0,2362,0,2362,1,1810,1,1810,NA,Stage IIB,T2,M0,BRCA.LumA,1
-7.884665705,2.214971579,TCGA-06-5413-01A,TCGA-06-5413-01A-01D-1696-08,9,0.629092302,TCGA-06-5413,GBM,67,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-24477,Alive,WITH TUMOR,268,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],195,[Not Available],0,268,0,268,NA,NA,1,195,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-1.044342742,4.029539079,TCGA-E9-A1NF-01A,TCGA-E9-A1NF-01A-11D-A14G-09,4,0.326390786,TCGA-E9-A1NF,BRCA,60,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21981,Dead,WITH TUMOR,NA,1072,[Not Available],Distant Metastasis,Lung,NA,90,[Not Available],1,1072,1,1072,1,90,1,90,NA,Stage IIA,T2,M0,BRCA.LumB,5
9.75126967,-2.868085003,TCGA-E9-A1NA-01A,TCGA-E9-A1NA-01A-11D-A142-09,1,0.702579186,TCGA-E9-A1NA,BRCA,58,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21397,Alive,TUMOR FREE,1112,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1112,0,1112,0,1112,0,1112,NA,Stage IIA,T2,M0,BRCA.LumB,1
-2.181180056,1.269877172,TCGA-50-6591-01A,TCGA-50-6591-01A-11D-1753-08,5,0.523896187,TCGA-50-6591,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-23067,Dead,WITH TUMOR,NA,119,[Not Available],NA,NA,NA,NA,Progressive Disease,1,119,1,119,NA,NA,1,119,NA,Stage IV,T2,M1,NA,4
-6.027582384,-1.296032652,TCGA-BH-A1F8-01A,TCGA-BH-A1F8-01A-11D-A13L-09,7,0.011146429,TCGA-BH-A1F8,BRCA,90,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871,Dead,WITH TUMOR,NA,763,[Not Available],NA,NA,NA,NA,[Not Available],1,763,1,763,NA,NA,1,763,NA,Stage IIIB,T4b,M0,BRCA.LumB,2
7.760458273,-1.348273355,TCGA-EW-A1P6-01A,TCGA-EW-A1P6-01A-11D-A142-09,1,0.156046537,TCGA-EW-A1P6,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485,Alive,TUMOR FREE,562,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,562,0,562,NA,NA,0,562,NA,Stage IIB,T2,M0,BRCA.LumA,1
8.892680891,-4.88052444,TCGA-AR-A24V-01A,TCGA-AR-A24V-01A-21D-A167-09,1,0.824169238,TCGA-AR-A24V,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Peri (6-12 months since last menstrual period),-19027,Alive,TUMOR FREE,3203,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3203,0,3203,0,3203,0,3203,NA,Stage IIB,T2,M0,BRCA.LumA,1
-0.954631514,4.817214324,TCGA-EW-A1P8-01A,TCGA-EW-A1P8-01A-11D-A142-09,4,0.381208469,TCGA-EW-A1P8,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21501,Dead,WITH TUMOR,NA,239,[Not Available],Distant Metastasis,Lung,NA,207,[Not Available],1,239,1,239,1,207,1,207,NA,Stage IIIC,T2,M0,BRCA.Basal,6
-3.256473501,2.198652922,TCGA-55-A492-01A,TCGA-55-A492-01A-11D-A24D-08,0,NA,TCGA-55-A492,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-25719,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,596,0,596,0,596,0,596,NA,Stage IA,T1a,MX,NA,10
-4.15413229,-1.92973726,TCGA-50-5049-01A,TCGA-50-5049-01A-01D-1625-08,8,0.453262895,TCGA-50-5049,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-25577,Alive,WITH TUMOR,3094,NA,[Not Available],Locoregional Recurrence,NA,NA,1568,Progressive Disease,0,3094,0,3094,NA,NA,1,1568,NA,Stage IA,T2,M0,LUAD.6,10
-8.122706496,2.112653591,TCGA-BH-A0DQ-01A,TCGA-BH-A0DQ-01A-11D-A099-09,9,0.565689,TCGA-BH-A0DQ,BRCA,42,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15533,Alive,TUMOR FREE,98,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,98,0,98,0,98,0,98,NA,Stage IIB,T2,M0,BRCA.LumA,7
-4.224030849,-1.83471084,TCGA-A2-A0YK-01A,TCGA-A2-A0YK-01A-22D-A117-09,8,0.465087901,TCGA-A2-A0YK,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22625,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,588,0,588,NA,NA,0,588,NA,Stage IIA,T2,M0,BRCA.Normal,10
-7.635602504,2.114778815,TCGA-BH-A0BA-01A,TCGA-BH-A0BA-01A-11W-A071-09,9,0.388594727,TCGA-BH-A0BA,BRCA,51,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18839,Alive,TUMOR FREE,1132,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1132,0,1132,0,1132,0,1132,NA,Stage IIIC,T3,M0,BRCA.LumA,7
4.104797418,1.448024749,TCGA-AN-A0FW-01A,TCGA-AN-A0FW-01A-11W-A050-09,2,0.20805217,TCGA-AN-A0FW,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24692,Alive,TUMOR FREE,11,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,11,0,11,0,11,0,11,NA,Stage IIIA,T2,M0,BRCA.LumA,5
-7.888935207,1.974430312,TCGA-AO-A0JG-01A,TCGA-AO-A0JG-01A-31D-A099-09,9,0.612903984,TCGA-AO-A0JG,BRCA,49,FEMALE,WHITE,"Other, specify",[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18021,Alive,TUMOR FREE,798,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,798,0,798,NA,NA,0,798,NA,Stage IIIA,T2,M0,BRCA.LumA,7
9.300275835,-5.563040255,TCGA-AO-A12F-01A,TCGA-AO-A12F-01A-11D-A10Y-09,1,0.834832652,TCGA-AO-A12F,BRCA,36,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13409,Alive,TUMOR FREE,1842,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1842,0,1842,0,1842,0,1842,NA,Stage IIA,T2,M0,BRCA.Basal,1
-5.735853585,-2.197833781,TCGA-E2-A158-01A,TCGA-E2-A158-01A-11D-A12B-09,0,NA,TCGA-E2-A158,BRCA,43,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15903,Alive,TUMOR FREE,450,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,450,0,450,0,450,0,450,NA,Stage IIA,T1c,M0,BRCA.Basal,2
-6.171508264,-1.225569962,TCGA-EW-A1OV-01A,TCGA-EW-A1OV-01A-11D-A142-09,7,0.015976929,TCGA-EW-A1OV,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20764,Alive,TUMOR FREE,789,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,789,0,789,0,789,0,789,NA,Stage IIB,T2,MX,BRCA.Her2,2
-7.803697164,1.951565981,TCGA-AN-A03X-01A,TCGA-AN-A03X-01A-21W-A019-09,9,0.515256484,TCGA-AN-A03X,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27163,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.LumA,7
-7.865397932,2.043851172,TCGA-BH-A0DX-01A,TCGA-BH-A0DX-01A-11D-A10Y-09,9,0.381866387,TCGA-BH-A0DX,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22833,Alive,TUMOR FREE,2156,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2156,0,2156,0,2156,0,2156,NA,Stage I,T1b,M0,BRCA.LumA,7
9.194148711,-4.775572308,TCGA-A1-A0SE-01A,TCGA-A1-A0SE-01A-11D-A099-09,1,0.809604593,TCGA-A1-A0SE,BRCA,56,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20717,Alive,TUMOR FREE,1321,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1321,0,1321,0,1321,0,1321,NA,Stage I,T1c,M0,BRCA.LumA,1
9.259655776,-3.53553487,TCGA-AO-A1KS-01A,TCGA-AO-A1KS-01A-11D-A13L-09,1,0.682056064,TCGA-AO-A1KS,BRCA,69,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25230,Alive,TUMOR FREE,350,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,350,0,350,0,350,0,350,NA,Stage IIA,T2,M0,BRCA.LumB,1
-8.058306074,1.953729394,TCGA-A8-A07G-01A,TCGA-A8-A07G-01A-11W-A050-09,9,0.628020247,TCGA-A8-A07G,BRCA,65,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23926,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,577,0,577,0,577,0,577,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-6.451326576,1.662580272,TCGA-A7-A0CJ-01A,TCGA-A7-A0CJ-01A-21W-A019-09,10,0.068067405,TCGA-A7-A0CJ,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21014,Alive,TUMOR FREE,931,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,931,0,931,NA,NA,0,931,NA,Stage IIA,T2,M0,BRCA.LumB,7
-0.263937067,4.445607945,TCGA-B6-A0WX-01A,TCGA-B6-A0WX-01A-11D-A10G-09,4,0.532412084,TCGA-B6-A0WX,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,"Other, specify",[Not Available],1998,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14784,Dead,WITH TUMOR,NA,639,[Not Available],Distant Metastasis,Bone,NA,563,[Not Available],1,639,1,639,1,563,1,563,NA,Stage IIIA,T3,M0,BRCA.Basal,6
-7.242241991,-2.519622142,TCGA-A1-A0SJ-01A,TCGA-A1-A0SJ-01A-11D-A099-09,6,0.304444865,TCGA-A1-A0SJ,BRCA,39,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-14383,Alive,TUMOR FREE,416,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,416,0,416,0,416,0,416,NA,Stage IIIA,T3,M0,BRCA.LumA,2
0.102951784,2.455453736,TCGA-AO-A0JD-01A,TCGA-AO-A0JD-01A-11W-A071-09,4,0.101009012,TCGA-AO-A0JD,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21831,Alive,TUMOR FREE,2190,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2190,0,2190,0,2190,0,2190,NA,Stage IIIA,T3,M0,BRCA.LumB,6
-7.811033779,2.094614624,TCGA-A2-A04V-01A,TCGA-A2-A04V-01A-21W-A050-09,9,0.54038792,TCGA-A2-A04V,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14250,Dead,WITH TUMOR,NA,1920,[Not Available],NA,NA,NA,1470,[Not Available],1,1920,1,1920,1,1470,1,1470,NA,Stage IIA,T2,M0,BRCA.LumA,7
0.077491265,5.081152327,TCGA-HT-7475-01A,TCGA-HT-7475-01A-11D-2024-08,4,0.700380903,TCGA-HT-7475,LGG,67,MALE,WHITE,Oligoastrocytoma,G3,2010,[Not Available],-24686,Alive,TUMOR FREE,530,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,530,0,530,0,530,0,530,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.42754472,3.157652587,TCGA-HU-A4G6-01A,TCGA-HU-A4G6-01A-11D-A24D-08,4,0.142796769,TCGA-HU-A4G6,STAD,74,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G3,2011,[Not Available],-27208,Alive,TUMOR FREE,738,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,738,0,738,0,738,0,738,NA,Stage IA,T1b,M0,GI.EBV,3
4.449989208,1.09915384,TCGA-44-2666-01A,TCGA-44-2666-01A-41D-A27T-08,2,0.667931215,TCGA-44-2666,LUAD,43,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-15970,Dead,WITH TUMOR,97,97,[Not Available],NA,NA,NA,NA,[Not Available],1,97,1,97,NA,NA,1,97,NA,Stage IB,T2,M0,LUAD.4,5
9.316411891,-3.518978318,TCGA-BR-8384-01A,TCGA-BR-8384-01A-21D-2394-08,1,0.72497209,TCGA-BR-8384,STAD,69,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25281,Alive,TUMOR FREE,113,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,113,0,113,0,113,0,113,NA,Stage IIIC,T4b,M0,GI.GS,1
-3.469233907,-3.07293342,TCGA-HU-A4GH-01A,TCGA-HU-A4GH-01A-11D-A24D-08,8,0.514784203,TCGA-HU-A4GH,STAD,75,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-27473,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,358,0,358,0,358,0,358,NA,Stage IA,T1b,M0,GI.HM-SNV,10
10.11601324,-1.262890238,TCGA-FG-7641-01B,TCGA-FG-7641-01B-11D-2253-08,1,0.74517663,TCGA-FG-7641,LGG,31,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-11357,Alive,TUMOR FREE,627,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,627,0,627,0,627,0,627,NA,NA,NA,NA,GBM_LGG.Codel,1
8.453769264,-2.983138083,TCGA-06-0211-01B,TCGA-06-0211-01B-01D-1491-08,1,0.607420338,TCGA-06-0211,GBM,47,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1997,[Not Available],-17515,Dead,WITH TUMOR,360,360,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],53,[Not Available],1,360,1,360,NA,NA,1,53,NA,NA,NA,NA,GBM_LGG.NA,1
-3.32580021,-3.3166616,TCGA-53-7626-01A,TCGA-53-7626-01A-12D-2063-08,8,0.632327977,TCGA-53-7626,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-28024,Dead,WITH TUMOR,NA,929,[Not Available],Locoregional Recurrence,NA,NA,865,Progressive Disease,1,929,1,929,NA,NA,1,865,NA,Stage IIA,T1,M0,LUAD.5,10
-3.691954246,-2.514525511,TCGA-BR-8360-01A,TCGA-BR-8360-01A-11D-2340-08,8,0.42711112,TCGA-BR-8360,STAD,66,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-24394,Alive,TUMOR FREE,188,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,188,0,188,0,188,0,188,NA,Stage IIA,T3,M0,NA,10
-3.869370606,-0.405114109,TCGA-38-4629-01A,TCGA-38-4629-01A-02D-1265-08,0,NA,TCGA-38-4629,LUAD,68,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-25104,Dead,WITH TUMOR,NA,864,[Not Available],NA,NA,NA,379,Complete Remission/Response,1,864,1,864,1,379,1,379,NA,Stage IIB,T3,M0,NA,10
-5.705930478,1.210567355,TCGA-A6-5657-01A,TCGA-A6-5657-01A-01D-1650-10,0,NA,TCGA-A6-5657,COAD,65,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-23920,Alive,TUMOR FREE,962,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,962,0,962,0,962,0,962,NA,Stage IIIB,T3,M0,GI.CIN,9
-5.189126446,2.38004276,TCGA-AA-3841-01A,TCGA-AA-3841-01A-01W-0900-09,12,0.25953439,TCGA-AA-3841,COAD,66,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-24230,Alive,TUMOR FREE,1124,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1124,0,1124,0,1124,0,1124,NA,Stage IIA,T3,M0,NA,8
-0.246745101,5.182976662,TCGA-BR-8682-01A,TCGA-BR-8682-01A-11D-2394-08,4,0.660378167,TCGA-BR-8682,STAD,52,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012,[Not Available],-19165,Alive,TUMOR FREE,991,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,991,0,991,0,991,0,991,NA,Stage IIB,T4a,M0,GI.CIN,6
-5.481870396,2.884736779,TCGA-CD-8527-01A,TCGA-CD-8527-01A-11D-2340-08,0,NA,TCGA-CD-8527,STAD,72,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-26503,Dead,WITH TUMOR,NA,218,[Not Available],Distant Metastasis,Liver,NA,159,Complete Remission/Response,1,218,1,218,1,159,1,159,NA,Stage II,T2,M0,NA,10
-4.284310686,-1.603644954,TCGA-D7-A4YY-01A,TCGA-D7-A4YY-01A-11D-A25D-08,8,0.450191673,TCGA-D7-A4YY,STAD,61,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-22287,Alive,TUMOR FREE,419,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,419,0,419,NA,NA,0,419,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-6.50520968,2.181465143,TCGA-D7-8572-01A,TCGA-D7-8572-01A-11D-2340-08,0,NA,TCGA-D7-8572,STAD,57,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-20870,Alive,WITH TUMOR,511,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,511,0,511,0,511,0,511,NA,Stage IIB,T2,M0,GI.GS,9
9.35809024,-4.967473251,TCGA-HT-7620-01A,TCGA-HT-7620-01A-11D-2253-08,1,0.804769866,TCGA-HT-7620,LGG,40,MALE,WHITE,Oligodendroglioma,G3,2007,[Not Available],-14659,Alive,TUMOR FREE,434,NA,[Not Available],NA,NA,NA,280,Complete Remission/Response,0,434,0,434,1,280,1,280,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.318242482,-1.698239839,TCGA-35-4122-01A,TCGA-35-4122-01A-01D-1105-08,8,0.428632475,TCGA-35-4122,LUAD,69,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25491,Alive,TUMOR FREE,225,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,225,0,225,NA,NA,0,225,NA,Stage IA,T1,M0,NA,10
0.393286608,2.248203995,TCGA-BR-8365-01A,TCGA-BR-8365-01A-21D-2340-08,0,NA,TCGA-BR-8365,STAD,70,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25725,Dead,WITH TUMOR,NA,533,[Not Available],NA,NA,NA,NA,Stable Disease,1,533,1,533,NA,NA,1,533,NA,Stage IIA,T3,M0,GI.CIN,6
9.97493146,-2.637226278,TCGA-BH-A1FR-01A,TCGA-BH-A1FR-01A-11D-A13L-09,1,0.758647012,TCGA-BH-A1FR,BRCA,73,FEMALE,WHITE,"Other, specify",[Not Available],1997,[Not Available],-26684,Dead,WITH TUMOR,NA,1642,[Not Available],NA,NA,NA,NA,[Not Available],1,1642,1,1642,NA,NA,1,1642,NA,Stage IIIB,T4b,M0,BRCA.LumA,1
7.861794352,-3.254943889,TCGA-BH-A0E2-01A,TCGA-BH-A0E2-01A-11W-A071-09,1,0.392400578,TCGA-BH-A0E2,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18152,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,435,0,435,0,435,0,435,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-3.188102645,-3.493425272,TCGA-F4-6570-01A,TCGA-F4-6570-01A-11D-1771-10,8,0.554406815,TCGA-F4-6570,COAD,78,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-28772,Dead,TUMOR FREE,NA,188,[Not Available],NA,NA,NA,NA,[Not Available],1,188,0,188,NA,NA,0,188,NA,Stage IIA,T3,M0,GI.HM-indel,10
-0.698219192,4.05084715,TCGA-DB-5275-01A,TCGA-DB-5275-01A-01D-1468-08,4,0.311956837,TCGA-DB-5275,LGG,36,MALE,WHITE,Oligoastrocytoma,G3,2006,[Not Available],-13371,Alive,TUMOR FREE,1458,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1458,0,1458,0,1458,0,1458,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
-3.842284223,-1.882763808,TCGA-55-6968-01A,TCGA-55-6968-01A-11D-1945-08,8,0.405927712,TCGA-55-6968,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-22344,Dead,WITH TUMOR,NA,1293,[Not Available],NA,NA,NA,NA,Stable Disease,1,1293,1,1293,NA,NA,1,1293,NA,Stage IV,T1,M1,NA,10
-0.604686581,4.432781467,TCGA-HU-A4GD-01A,TCGA-HU-A4GD-01A-11D-A25D-08,4,0.408779085,TCGA-HU-A4GD,STAD,56,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011,[Not Available],-20700,Alive,WITH TUMOR,692,NA,[Not Available],Distant Metastasis,Liver,NA,399,Progressive Disease,0,692,0,692,NA,NA,1,399,NA,Stage IIB,T3,M0,GI.CIN,5
9.388202757,-2.990929526,TCGA-55-8087-01A,TCGA-55-8087-01A-11D-2238-08,1,0.719709034,TCGA-55-8087,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21655,Alive,TUMOR FREE,462,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,462,0,462,0,462,0,462,NA,Stage IB,T2a,MX,NA,1
-4.035607863,-2.321602438,TCGA-HU-A4H4-01A,TCGA-HU-A4H4-01A-21D-A25D-08,8,0.425032021,TCGA-HU-A4H4,STAD,53,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011,[Not Available],-19665,Alive,TUMOR FREE,725,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,725,0,725,0,725,0,725,NA,Stage IIB,T2,M0,GI.HM-indel,10
-1.359302666,3.151362869,TCGA-91-6831-01A,TCGA-91-6831-01A-11D-1855-08,4,0.032682069,TCGA-91-6831,LUAD,66,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-24436,Alive,TUMOR FREE,310,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,310,0,310,0,310,0,310,NA,Stage IB,T2,MX,NA,10
8.879945426,-4.197636849,TCGA-HT-7616-01A,TCGA-HT-7616-01A-11D-2253-08,1,0.750524797,TCGA-HT-7616,LGG,75,MALE,WHITE,Oligodendroglioma,G3,2007,[Not Available],-27685,Dead,WITH TUMOR,NA,7,[Not Available],NA,NA,NA,NA,Progressive Disease,1,7,1,7,NA,NA,1,7,NA,NA,NA,NA,GBM_LGG.Codel,1
-2.371457492,2.234334184,TCGA-D7-A4YT-01A,TCGA-D7-A4YT-01A-11D-A25D-08,0,NA,TCGA-D7-A4YT,STAD,56,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-20742,Alive,TUMOR FREE,434,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,434,0,434,0,434,0,434,NA,Stage IIIA,T2,M0,GI.CIN,10
-7.901583902,2.062707652,TCGA-BH-A18K-01A,TCGA-BH-A18K-01A-11D-A12B-09,9,0.602298718,TCGA-BH-A18K,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-16824,Dead,WITH TUMOR,NA,2763,[Not Available],NA,NA,NA,NA,[Not Available],1,2763,1,2763,NA,NA,1,2763,NA,Stage I,T1,M0,BRCA.LumA,7
-2.405711105,2.367776379,TCGA-05-4430-01A,TCGA-05-4430-01A-02D-1265-08,0,NA,TCGA-05-4430,LUAD,59,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-21884,Alive,TUMOR FREE,761,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,761,0,761,NA,NA,0,761,NA,Stage IB,T2,M0,LUAD.5,10
4.339170933,1.190438987,TCGA-AR-A0TU-01A,TCGA-AR-A0TU-01A-31D-A10G-09,2,0.568835435,TCGA-AR-A0TU,BRCA,35,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13039,Alive,TUMOR FREE,709,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,709,0,709,0,709,0,709,NA,Stage IIA,T2,M0,BRCA.Basal,5
-0.195878337,4.841399181,TCGA-D5-5541-01A,TCGA-D5-5541-01A-01D-1650-10,4,0.42383435,TCGA-D5-5541,COAD,63,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-23109,Alive,TUMOR FREE,1701,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1701,0,1701,0,1701,0,1701,NA,Stage IIIB,T3,M0,GI.CIN,3
-0.582240702,4.086606236,TCGA-CD-8528-01A,TCGA-CD-8528-01A-11D-2340-08,4,0.426176801,TCGA-CD-8528,STAD,43,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],-15986,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,375,0,375,0,375,0,375,NA,Stage IIIA,T4,M0,GI.CIN,5
-4.753709018,1.03229339,TCGA-73-4677-01A,TCGA-73-4677-01A-01D-1265-08,0,NA,TCGA-73-4677,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-27381,Dead,WITH TUMOR,NA,38,[Not Available],NA,NA,NA,NA,Stable Disease,1,38,1,38,NA,NA,1,38,NA,[Discrepancy],T2a,M0,NA,9
-3.719260589,-2.860092193,TCGA-CD-A4MI-01A,TCGA-CD-A4MI-01A-21D-A25D-08,8,0.400508829,TCGA-CD-A4MI,STAD,62,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2011,[Not Available],-22721,Dead,WITH TUMOR,NA,358,[Not Available],Locoregional Recurrence,NA,NA,271,Complete Remission/Response,1,358,1,358,1,271,1,271,NA,Stage IIIA,T3,M0,GI.HM-indel,10
-4.964978069,0.662928841,TCGA-99-8032-01A,TCGA-99-8032-01A-11D-2238-08,0,NA,TCGA-99-8032,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22635,Alive,TUMOR FREE,44,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,44,0,44,0,44,0,44,NA,Stage IA,T1a,M0,NA,10
-1.659426892,3.843478326,TCGA-27-2528-01A,TCGA-27-2528-01A-01D-1494-08,0,NA,TCGA-27-2528,GBM,62,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-22867,Dead,WITH TUMOR,480,480,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],72,[Not Available],1,480,1,480,NA,NA,1,72,NA,NA,NA,NA,GBM_LGG.Classic-like,6
8.84765642,-4.364077801,TCGA-HT-7856-01A,TCGA-HT-7856-01A-11D-2395-08,1,0.75281289,TCGA-HT-7856,LGG,35,MALE,WHITE,Oligodendroglioma,G3,2008,[Not Available],-13145,Alive,TUMOR FREE,1189,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1189,0,1189,0,1189,0,1189,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.621547369,4.778816729,TCGA-A8-A09Q-01A,TCGA-A8-A09Q-01A-11W-A019-09,4,0.441057596,TCGA-A8-A09Q,BRCA,83,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30528,Alive,WITH TUMOR,761,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,761,0,761,NA,NA,0,761,NA,Stage IIIB,T4b,M0,BRCA.LumB,6
-1.370521823,2.410390379,TCGA-97-7546-01A,TCGA-97-7546-01A-11D-2036-08,0,NA,TCGA-97-7546,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-27913,Alive,WITH TUMOR,1285,NA,[Not Available],New Primary Tumor,NA,NA,1255,Progressive Disease,0,1285,0,1285,NA,NA,1,1255,NA,Stage IA,T1,MX,LUAD.5,3
-5.951951305,2.058918874,TCGA-AA-A03J-01A,TCGA-AA-A03J-01A-21W-A096-10,10,0.101618753,TCGA-AA-A03J,COAD,65,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2004,[Not Available],-23986,Alive,TUMOR FREE,1246,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1246,0,1246,0,1246,0,1246,NA,Stage I,T2,M0,GI.CIN,7
-7.835485804,2.138345941,TCGA-E2-A153-01A,TCGA-E2-A153-01A-12D-A12B-09,9,0.467127093,TCGA-E2-A153,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18875,Alive,TUMOR FREE,707,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,707,0,707,0,707,0,707,NA,Stage IIB,T2,M0,BRCA.LumA,7
0.120709146,4.952665382,TCGA-HT-7688-01A,TCGA-HT-7688-01A-11D-2253-08,4,0.666087583,TCGA-HT-7688,LGG,59,MALE,WHITE,Oligodendroglioma,G3,2009,[Not Available],-21844,Alive,TUMOR FREE,964,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,964,0,964,0,964,0,964,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.591890802,-3.865198062,TCGA-49-4512-01A,TCGA-49-4512-01A-21D-1855-08,1,0.655825715,TCGA-49-4512,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-25502,Dead,WITH TUMOR,157,905,[Not Available],NA,NA,NA,NA,Progressive Disease,1,905,1,905,NA,NA,1,905,NA,Stage IIIA,T2,MX,LUAD.5,1
-3.31703189,-3.268208169,TCGA-44-3918-01A,TCGA-44-3918-01A-01D-A271-08,8,0.542906276,TCGA-44-3918,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-22236,Alive,WITH TUMOR,1036,NA,[Not Available],NA,NA,NA,511,Complete Remission/Response,0,1036,0,1036,1,511,1,511,NA,Stage IA,T1,M0,NA,10
-0.688478861,4.692795001,TCGA-DU-7007-01A,TCGA-DU-7007-01A-11D-2024-08,4,0.562282181,TCGA-DU-7007,LGG,33,MALE,WHITE,Astrocytoma,G2,1997,[Not Available],-12245,Dead,NA,NA,1915,[Not Available],NA,NA,NA,NA,[Not Available],1,1915,NA,1915,NA,NA,0,1915,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.378282019,2.225077733,TCGA-AA-3673-01A,TCGA-AA-3673-01A-01W-0900-09,9,0.241776523,TCGA-AA-3673,COAD,53,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-19509,Alive,TUMOR FREE,1522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1522,0,1522,0,1522,0,1522,NA,Stage II,T3,M0,GI.CIN,7
-7.689637219,2.060356375,TCGA-HT-7607-01A,TCGA-HT-7607-01A-11D-2086-08,9,0.498899744,TCGA-HT-7607,LGG,61,FEMALE,WHITE,Astrocytoma,G2,2008,[Not Available],-22585,Dead,WITH TUMOR,NA,96,[Not Available],NA,NA,NA,NA,Progressive Disease,1,96,1,96,NA,NA,1,96,NA,NA,NA,NA,GBM_LGG.Codel,7
1.084139615,3.566261804,TCGA-69-7760-01A,TCGA-69-7760-01A-11D-2167-08,0,NA,TCGA-69-7760,LUAD,73,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26777,Alive,TUMOR FREE,202,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,202,0,202,NA,NA,0,202,NA,Stage IIB,T3,M0,LUAD.5,1
8.990218865,-5.184021757,TCGA-HT-7695-01A,TCGA-HT-7695-01A-11D-2253-08,1,0.854027949,TCGA-HT-7695,LGG,29,FEMALE,WHITE,Oligodendroglioma,G2,2009,[Not Available],-10827,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,442,0,442,0,442,0,442,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.689722598,-2.314026905,TCGA-DU-8158-01A,TCGA-DU-8158-01A-11D-2253-08,6,0.506512371,TCGA-DU-8158,LGG,57,FEMALE,WHITE,Astrocytoma,G3,2001,[Not Available],-21129,Dead,WITH TUMOR,NA,155,[Not Available],NA,NA,NA,NA,[Not Available],1,155,1,155,NA,NA,1,155,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,2
-5.482639231,-1.308180498,TCGA-50-6592-01A,TCGA-50-6592-01A-11D-1753-08,0,NA,TCGA-50-6592,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-26191,Dead,WITH TUMOR,NA,777,[Not Available],NA,NA,NA,NA,Progressive Disease,1,777,1,777,NA,NA,1,777,NA,Stage IB,T2,M0,NA,10
-3.366328201,-3.490561456,TCGA-64-5781-01A,TCGA-64-5781-01A-01D-1625-08,8,0.55433214,TCGA-64-5781,LUAD,55,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-20219,Alive,TUMOR FREE,1559,NA,[Not Available],NA,NA,NA,96,Progressive Disease,0,1559,0,1559,NA,NA,1,96,NA,Stage IB,T2,M0,LUAD.6,10
7.810272521,-1.416101255,TCGA-06-0879-01A,TCGA-06-0879-01A-01D-1492-08,1,0.147377308,TCGA-06-0879,GBM,52,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-19154,Dead,WITH TUMOR,NA,1229,[Not Available],Recurrence,[Not Applicable],[Not Applicable],699,[Not Available],1,1229,1,1229,NA,NA,1,699,NA,NA,NA,NA,NA,1
-6.119609128,3.615399317,TCGA-J2-A4AG-01A,TCGA-J2-A4AG-01A-11D-A24D-08,11,0.493548874,TCGA-J2-A4AG,LUAD,66,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24224,Alive,TUMOR FREE,988,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,988,0,988,0,988,0,988,NA,Stage IA,T1b,MX,NA,8
-3.665350239,-2.54085067,TCGA-75-5126-01A,TCGA-75-5126-01A-01D-1753-08,8,0.38107734,TCGA-75-5126,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],NA,Alive,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,NA,0,NA,NA,NA,0,NA,NA,Stage IIIA,T3,M0,LUAD.6,10
-0.812791055,2.890760895,TCGA-12-3644-01A,TCGA-12-3644-01A-01W-0922-08,0,NA,TCGA-12-3644,GBM,47,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2004,[Not Available],-17468,Dead,WITH TUMOR,1807,1818,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],1142,[Not Available],1,1818,1,1818,NA,NA,1,1142,NA,NA,NA,NA,NA,3
-5.340659607,2.481117353,TCGA-AD-6888-01A,TCGA-AD-6888-01A-11D-1924-10,12,0.384887705,TCGA-AD-6888,COAD,73,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-26816,Dead,WITH TUMOR,NA,472,[Not Available],NA,NA,NA,343,Complete Remission/Response,1,472,1,472,1,343,1,343,NA,Stage IIIB,T3,M0,GI.CIN,8
-5.271688425,1.250021783,TCGA-78-7146-01A,TCGA-78-7146-01A-11D-2036-08,0,NA,TCGA-78-7146,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1999,[Not Available],-26272,Dead,NA,NA,173,[Not Available],NA,NA,NA,NA,[Not Available],1,173,NA,173,NA,NA,0,173,NA,Stage IIIA,T2,M0,NA,10
-5.187304788,2.012282536,TCGA-99-8033-01A,TCGA-99-8033-01A-11D-2238-08,0,NA,TCGA-99-8033,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27342,Dead,WITH TUMOR,NA,656,[Not Available],NA,NA,NA,NA,Progressive Disease,1,656,1,656,NA,NA,1,656,NA,Stage IV,TX,M1,NA,9
-1.824444747,2.902589279,TCGA-50-5045-01A,TCGA-50-5045-01A-01D-1625-08,0,NA,TCGA-50-5045,LUAD,57,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-20961,Dead,WITH TUMOR,NA,2174,[Not Available],Locoregional Recurrence,NA,NA,1433,Progressive Disease,1,2174,1,2174,NA,NA,1,1433,NA,[Discrepancy],T2,M0,NA,6
-4.354656186,-1.262940033,TCGA-78-7156-01A,TCGA-78-7156-01A-11D-2036-08,8,0.209512931,TCGA-78-7156,LUAD,62,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-22720,Dead,NA,NA,976,[Not Available],NA,NA,NA,NA,[Not Available],1,976,NA,976,NA,NA,0,976,NA,Stage IV,T4,M1,LUAD.1,10
-8.026465963,2.094775615,TCGA-12-5301-01A,TCGA-12-5301-01A-01D-1486-08,9,0.443740283,TCGA-12-5301,GBM,59,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-21768,Dead,WITH TUMOR,62,62,[Not Available],NA,NA,NA,NA,[Not Available],1,62,1,62,NA,NA,1,62,NA,NA,NA,NA,NA,7
-6.548112448,-1.406188834,TCGA-A6-6138-01A,TCGA-A6-6138-01A-11D-1771-10,7,0.308269418,TCGA-A6-6138,COAD,61,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-22523,Alive,TUMOR FREE,685,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,685,0,685,NA,NA,0,685,NA,Stage I,T2,M0,GI.CIN,2
8.638028382,-1.816747374,TCGA-67-3772-01A,TCGA-67-3772-01A-01W-0928-08,1,0.505280601,TCGA-67-3772,LUAD,82,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-29989,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,573,0,573,NA,NA,0,573,NA,Stage IB,T2,M0,LUAD.5,1
2.977268005,3.565023682,TCGA-OL-A5RU-01A,TCGA-OL-A5RU-01A-11D-A28B-09,0,NA,TCGA-OL-A5RU,BRCA,63,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23108,Alive,TUMOR FREE,1219,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1219,0,1219,0,1219,0,1219,NA,Stage IIA,T1c,MX,BRCA.LumA,1
-0.696987056,3.715559724,TCGA-E2-A573-01A,TCGA-E2-A573-01A-11D-A29N-09,4,0.306095819,TCGA-E2-A573,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-17689,Alive,TUMOR FREE,1062,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1062,0,1062,0,1062,0,1062,NA,Stage IA,T1c,M0,BRCA.Basal,5
-7.379619712,1.912372471,TCGA-A2-A4S2-01A,TCGA-A2-A4S2-01A-12D-A25Q-09,9,0.301262335,TCGA-A2-A4S2,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22936,Alive,TUMOR FREE,643,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,643,0,643,0,643,0,643,NA,Stage IIIA,T3,M0,BRCA.LumA,7
-0.322045389,2.853553675,TCGA-OL-A66P-01A,TCGA-OL-A66P-01A-11D-A31U-09,4,0.088250506,TCGA-OL-A66P,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Available],-27489,Alive,TUMOR FREE,428,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,428,0,428,0,428,0,428,NA,Stage IIA,T2,MX,BRCA.Her2,3
9.017166115,-4.418061568,TCGA-A2-A0CK-01A,TCGA-A2-A0CK-01A-11D-A228-09,1,0.756463527,TCGA-A2-A0CK,BRCA,60,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22094,Alive,TUMOR FREE,4159,NA,[Not Available],New Primary Tumor,"Other, specify",LEFT BREAST,1364,[Not Available],0,4159,0,4159,1,1364,1,1364,NA,Stage IIIA,T3,M0,BRCA.LumA,1
9.311632449,-4.866846003,TCGA-E9-A5FK-01A,TCGA-E9-A5FK-01A-11D-A27P-09,1,0.761087609,TCGA-E9-A5FK,BRCA,60,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199,Alive,TUMOR FREE,812,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,812,0,812,0,812,0,812,NA,Stage IIIC,T2,M0,BRCA.LumA,1
9.654993048,-4.530868202,TCGA-A2-A3XW-01A,TCGA-A2-A3XW-01A-11D-A23C-09,1,0.704473055,TCGA-A2-A3XW,BRCA,42,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15670,Alive,TUMOR FREE,1712,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1712,0,1712,0,1712,0,1712,NA,Stage IIB,T2,M0,BRCA.Normal,1
-7.746142857,2.424516713,TCGA-OL-A66L-01A,TCGA-OL-A66L-01A-12D-A31U-09,9,0.238555992,TCGA-OL-A66L,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26186,Alive,TUMOR FREE,1301,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1301,0,1301,0,1301,0,1301,NA,Stage IA,T1c,MX,BRCA.LumA,7
-7.351408368,1.54174849,TCGA-LD-A66U-01A,TCGA-LD-A66U-01A-11D-A31U-09,0,NA,TCGA-LD-A66U,BRCA,44,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Evaluated],-16101,Alive,TUMOR FREE,646,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,646,0,646,0,646,0,646,NA,Stage IIB,T2,MX,BRCA.LumA,7
-7.746137189,2.036953902,TCGA-E9-A3X8-01A,TCGA-E9-A3X8-01A-31D-A22X-09,9,0.431933079,TCGA-E9-A3X8,BRCA,48,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17588,Alive,TUMOR FREE,926,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,926,0,926,0,926,0,926,NA,Stage IIB,T2,M0,BRCA.LumA,7
-8.190745148,2.045698961,TCGA-AR-A5QP-01A,TCGA-AR-A5QP-01A-11D-A28B-09,9,0.576191007,TCGA-AR-A5QP,BRCA,54,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19805,Alive,TUMOR FREE,1185,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1185,0,1185,NA,NA,0,1185,NA,Stage IIB,T2,M0,BRCA.LumA,7
9.378722243,-4.59691322,TCGA-A2-A0EP-01A,TCGA-A2-A0EP-01A-52D-A22X-09,1,0.740165198,TCGA-A2-A0EP,BRCA,56,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20585,Alive,TUMOR FREE,3603,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3603,0,3603,0,3603,0,3603,NA,Stage I,T1,M0,BRCA.LumA,1
-0.4612981,4.339011857,TCGA-23-1021-01B,TCGA-23-1021-01B-01W-0486-08,4,0.479242934,TCGA-23-1021,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-16484,Dead,WITH TUMOR,1446,1446,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,1446,1,1446,NA,NA,1,1446,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
9.944333957,-1.53619224,TCGA-GM-A4E0-01A,TCGA-GM-A4E0-01A-12D-A25Q-09,1,0.886952252,TCGA-GM-A4E0,BRCA,67,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24788,Alive,TUMOR FREE,2191,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2191,0,2191,0,2191,0,2191,NA,Stage IIIC,T3,M0,BRCA.LumA,1
-6.394869028,1.552596009,TCGA-A2-A0CR-01A,TCGA-A2-A0CR-01A-11D-A228-09,0,NA,TCGA-A2-A0CR,BRCA,54,FEMALE,ASIAN,Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20075,Alive,TUMOR FREE,3283,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3283,0,3283,NA,NA,0,3283,NA,Stage IIB,T3,M0,BRCA.LumA,9
8.909233792,-4.913026737,TCGA-85-A4PA-01A,TCGA-85-A4PA-01A-11D-A257-08,1,0.816886116,TCGA-85-A4PA,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-22614,Alive,TUMOR FREE,741,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,741,0,741,0,741,0,741,NA,Stage IB,T2a,M0,NA,1
-6.216918248,1.89425975,TCGA-56-A4ZK-01A,TCGA-56-A4ZK-01A-11D-A25L-08,10,0.040854562,TCGA-56-A4ZK,LUSC,76,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-28039,Alive,TUMOR FREE,570,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,570,0,570,0,570,0,570,NA,Stage IB,T2,M0,NA,9
-8.088324075,1.935108021,TCGA-AR-A5QM-01A,TCGA-AR-A5QM-01A-11D-A27P-09,9,0.579881589,TCGA-AR-A5QM,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22780,Alive,TUMOR FREE,2231,NA,[Not Available],New Primary Tumor,"Other, specify",Malignant melanoma,968,[Not Available],0,2231,0,2231,NA,NA,1,968,NA,Stage IIA,T2,M0,BRCA.LumA,7
-4.700530175,1.395765236,TCGA-58-8393-01A,TCGA-58-8393-01A-11D-2323-08,0,NA,TCGA-58-8393,LUSC,68,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-25132,Alive,TUMOR FREE,1058,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1058,0,1058,0,1058,0,1058,NA,Stage IB,T2a,M0,NA,10
-5.67829666,-2.067133679,TCGA-85-8582-01A,TCGA-85-8582-01A-21D-2395-08,0,NA,TCGA-85-8582,LUSC,49,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-18168,Alive,TUMOR FREE,1160,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1160,0,1160,0,1160,0,1160,NA,Stage IA,T1a,M0,NA,10
-7.196199003,2.74268893,TCGA-LL-A5YL-01A,TCGA-LL-A5YL-01A-12D-A29N-09,0,NA,TCGA-LL-A5YL,BRCA,64,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23395,Alive,NA,519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,519,0,519,0,519,0,519,NA,Stage IIB,T2,MX,BRCA.LumA,9
-0.594896952,3.060696961,TCGA-A7-A56D-01A,TCGA-A7-A56D-01A-11D-A27P-09,4,0.069466501,TCGA-A7-A56D,BRCA,84,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30783,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,448,0,448,0,448,0,448,NA,Stage IIA,T2,M0,BRCA.LumA,6
-5.692657966,1.401738358,TCGA-56-A5DS-01A,TCGA-56-A5DS-01A-11D-A27K-08,0,NA,TCGA-56-A5DS,LUSC,72,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-26355,Alive,TUMOR FREE,8,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,8,0,8,0,8,0,8,NA,Stage IB,T2a,MX,NA,9
-0.815019882,3.774094804,TCGA-A2-A3XT-01A,TCGA-A2-A3XT-01A-11D-A22X-09,4,0.354887917,TCGA-A2-A3XT,BRCA,45,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16649,Alive,TUMOR FREE,2770,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2770,0,2770,0,2770,0,2770,NA,Stage IIB,T2,M0,BRCA.Basal,5
4.361779692,1.126128481,TCGA-OL-A66H-01A,TCGA-OL-A66H-01A-11D-A29N-09,2,0.695458653,TCGA-OL-A66H,BRCA,NA,FEMALE,BLACK OR AFRICAN AMERICAN,Mucinous Carcinoma,[Not Available],NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,0,NA,0,NA,NA,Stage IB,T1c,MX,BRCA.LumA,5
-3.723525712,1.05122474,TCGA-58-A46M-01A,TCGA-58-A46M-01A-11D-A24D-08,0,NA,TCGA-58-A46M,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-22592,Alive,TUMOR FREE,1072,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1072,0,1072,0,1072,0,1072,NA,Stage IIB,T2b,M0,NA,10
-7.824986076,2.010015813,TCGA-OL-A5S0-01A,TCGA-OL-A5S0-01A-11D-A28B-09,9,0.556817723,TCGA-OL-A5S0,BRCA,66,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24139,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,620,0,620,0,620,0,620,NA,Stage IIB,T2,MX,BRCA.Basal,7
9.473553952,-4.699481305,TCGA-A3-3373-01A,TCGA-A3-3373-01A-02D-1421-08,1,0.763009753,TCGA-A3-3373,KIRC,54,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-19964,Alive,TUMOR FREE,1621,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1621,0,1621,0,1621,0,1621,NA,Stage I,T1b,M0,KIRC.1,1
-3.213956622,-3.551799992,TCGA-90-A4ED-01A,TCGA-90-A4ED-01A-31D-A257-08,8,0.443126176,TCGA-90-A4ED,LUSC,69,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25453,Alive,TUMOR FREE,615,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,615,0,615,0,615,0,615,NA,Stage IB,T2a,MX,NA,10
1.204086409,3.384706581,TCGA-OL-A66J-01A,TCGA-OL-A66J-01A-11D-A29N-09,0,NA,TCGA-OL-A66J,BRCA,80,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29345,Alive,TUMOR FREE,1996,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1996,0,1996,0,1996,0,1996,NA,Stage I,T1c,MX,BRCA.LumA,1
-3.930514917,1.268517773,TCGA-43-A474-01A,TCGA-43-A474-01A-11D-A24D-08,0,NA,TCGA-43-A474,LUSC,66,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24286,Alive,TUMOR FREE,353,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,353,0,353,0,353,0,353,NA,Stage IIA,T2b,M0,NA,10
-7.663337757,-2.023422798,TCGA-29-1769-01A,TCGA-29-1769-01A-01W-0639-09,6,0.186453285,TCGA-29-1769,OV,40,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-14754,Alive,TUMOR FREE,699,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,699,0,699,0,699,0,699,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
8.944426424,-2.328897831,TCGA-LL-A5YM-01A,TCGA-LL-A5YM-01A-11D-A28B-09,1,0.668035478,TCGA-LL-A5YM,BRCA,88,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32478,Alive,WITH TUMOR,466,NA,[Not Available],Locoregional Recurrence,"Other, specify",Skin left chest wall,258,[Not Available],0,466,0,466,1,258,1,258,NA,Stage IIIB,T4b,M0,BRCA.LumB,1
9.071387623,-4.650872829,TCGA-GM-A5PX-01A,TCGA-GM-A5PX-01A-12D-A28B-09,1,0.804593177,TCGA-GM-A5PX,BRCA,65,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23753,Alive,TUMOR FREE,551,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,551,0,551,0,551,0,551,NA,Stage IIB,T2,M0,BRCA.LumA,1
-6.455943193,-2.070406812,TCGA-J1-A4AH-01A,TCGA-J1-A4AH-01A-31D-A24D-08,0,NA,TCGA-J1-A4AH,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25893,Alive,TUMOR FREE,581,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,581,0,581,0,581,0,581,NA,Stage IIA,T2b,MX,NA,2
0.160803537,4.317102567,TCGA-A7-A4SE-01A,TCGA-A7-A4SE-01A-11D-A25Q-09,4,0.397923103,TCGA-A7-A4SE,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20080,Alive,TUMOR FREE,644,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,644,0,644,0,644,0,644,NA,Stage IIA,T2,M0,BRCA.Basal,6
9.600686081,-5.702527833,TCGA-77-A5FZ-01A,TCGA-77-A5FZ-01A-31D-A27K-08,1,0.877697455,TCGA-77-A5FZ,LUSC,64,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-23436,Dead,NA,NA,3838,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,3838,NA,3838,0,3838,0,3838,NA,Stage IIIB,T4,M0,NA,1
-0.888515599,4.428536627,TCGA-A2-A3XV-01A,TCGA-A2-A3XV-01A-21D-A23C-09,4,0.454427372,TCGA-A2-A3XV,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16971,Alive,TUMOR FREE,996,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,996,0,996,0,996,0,996,NA,Stage IIA,T2,M0,BRCA.Her2,6
-6.290650211,1.633715776,TCGA-OL-A5D6-01A,TCGA-OL-A5D6-01A-21D-A27P-09,10,0.346592841,TCGA-OL-A5D6,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052,Dead,TUMOR FREE,NA,1104,[Not Available],NA,NA,NA,NA,[Not Available],1,1104,0,1104,0,1104,0,1104,NA,Stage IIA,T2,MX,BRCA.Normal,7
-4.064608346,-2.300159625,TCGA-43-8118-01A,TCGA-43-8118-01A-11D-2395-08,8,0.436398848,TCGA-43-8118,LUSC,55,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-20224,Dead,NA,NA,89,[Not Available],NA,NA,NA,NA,[Unknown],1,89,NA,89,NA,NA,0,89,NA,Stage IA,T1b,M0,NA,10
9.666284595,-2.826989202,TCGA-AC-A3QP-01A,TCGA-AC-A3QP-01A-11D-A22X-09,1,0.748690441,TCGA-AC-A3QP,BRCA,79,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29113,Alive,TUMOR FREE,675,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,675,0,675,0,675,0,675,NA,Stage IIB,T2,MX,BRCA.LumA,1
9.593160531,-3.793495045,TCGA-A2-A3XZ-01A,TCGA-A2-A3XZ-01A-42D-A23C-09,1,0.654061115,TCGA-A2-A3XZ,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16978,Alive,TUMOR FREE,1532,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1532,0,1532,0,1532,0,1532,NA,Stage I,T1c,M0,BRCA.Her2,1
-6.480914065,-1.161328754,TCGA-AR-A5QQ-01A,TCGA-AR-A5QQ-01A-11D-A28B-09,7,0.316715475,TCGA-AR-A5QQ,BRCA,68,FEMALE,WHITE,"Other, specify",[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24841,Dead,WITH TUMOR,NA,322,[Not Available],Distant Metastasis,Lung,"Liver, bone, chest wall, adrenal glands",301,[Not Available],1,322,1,322,NA,NA,1,301,NA,Stage IIIA,T3,M0,BRCA.Basal,2
9.596860131,-5.620345981,TCGA-EJ-A46B-01A,TCGA-EJ-A46B-01A-31D-A257-08,1,0.870451138,TCGA-EJ-A46B,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24305,Alive,TUMOR FREE,657,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,657,0,657,0,657,0,657,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-6.057266994,-1.537249616,TCGA-85-8354-01A,TCGA-85-8354-01A-31D-2323-08,7,0.26631557,TCGA-85-8354,LUSC,53,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-19692,Alive,TUMOR FREE,995,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,995,0,995,0,995,0,995,NA,Stage IB,T2a,M0,NA,2
0.190914333,5.037232925,TCGA-EJ-8472-01A,TCGA-EJ-8472-01A-11D-2395-08,4,0.636859195,TCGA-EJ-8472,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23104,Alive,TUMOR FREE,756,NA,[Not Available],Biochemical evidence of disease,NA,NA,196,Partial Remission/Response,0,756,0,756,NA,NA,1,196,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,6
9.350900656,-5.072900213,TCGA-FC-A6HD-01A,TCGA-FC-A6HD-01A-11D-A31L-08,1,0.824037107,TCGA-FC-A6HD,PRAD,77,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-28197,Alive,TUMOR FREE,789,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,789,0,789,0,789,0,789,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-6.391916065,-1.335403692,TCGA-85-8664-01A,TCGA-85-8664-01A-11D-2395-08,7,0.177714607,TCGA-85-8664,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26954,Dead,WITH TUMOR,NA,550,[Not Available],Distant Metastasis,NA,NA,434,Complete Remission/Response,1,550,1,550,1,434,1,434,NA,Stage IIB,T2b,M0,NA,2
-4.640448726,-1.793027926,TCGA-85-A50Z-01A,TCGA-85-A50Z-01A-21D-A25L-08,8,0.430500594,TCGA-85-A50Z,LUSC,57,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-20941,Alive,TUMOR FREE,493,NA,[Not Available],New Primary Tumor,NA,NA,462,Complete Remission/Response,0,493,0,493,0,493,1,462,NA,Stage IIA,T2b,M0,NA,10
-4.641062359,-1.505889208,TCGA-85-8481-01A,TCGA-85-8481-01A-11D-2323-08,8,0.360803387,TCGA-85-8481,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25782,Dead,TUMOR FREE,NA,236,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,236,0,236,NA,NA,0,236,NA,Stage IIB,T3,M0,NA,10
-6.471863913,-1.224858014,TCGA-C8-A3M7-01A,TCGA-C8-A3M7-01A-12D-A21Q-09,7,0.298715168,TCGA-C8-A3M7,BRCA,60,FEMALE,ASIAN,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096,Dead,WITH TUMOR,NA,1034,[Not Available],Locoregional Recurrence,NA,NA,1034,[Not Available],1,1034,1,1034,1,1034,1,1034,NA,Stage IIIB,T4b,M0,BRCA.LumA,2
-7.138933744,-2.463680869,TCGA-58-A46N-01A,TCGA-58-A46N-01A-11D-A24D-08,6,0.201926417,TCGA-58-A46N,LUSC,52,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-19050,Alive,WITH TUMOR,910,NA,[Not Available],Locoregional Recurrence,NA,NA,630,Complete Remission/Response,0,910,0,910,1,630,1,630,NA,Stage IB,T2a,M0,NA,2
-6.511377323,1.278219358,TCGA-JL-A3YX-01A,TCGA-JL-A3YX-01A-11D-A22X-09,0,NA,TCGA-JL-A3YX,BRCA,46,FEMALE,ASIAN,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,NA,352,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,352,0,352,0,352,0,352,NA,Stage IIA,T2,M0,BRCA.LumA,7
-4.71555202,-1.216997832,TCGA-NC-A5HI-01A,TCGA-NC-A5HI-01A-11D-A26M-08,8,0.263229376,TCGA-NC-A5HI,LUSC,68,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-24981,Alive,TUMOR FREE,1743,NA,[Not Available],New Primary Tumor,NA,NA,70,Complete Remission/Response,0,1743,0,1743,0,1743,1,70,NA,Stage IB,T2,M0,NA,10
-0.104089425,3.191244187,TCGA-24-2033-01A,TCGA-24-2033-01A-01W-0722-08,4,0.243687327,TCGA-24-2033,OV,87,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1995,[Not Available],-31977,Dead,WITH TUMOR,562,562,[Not Available],Recurrence,[Not Applicable],[Not Applicable],351,Partial Remission/Response,1,562,1,562,NA,NA,1,351,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,3
8.96980168,-4.642008068,TCGA-A7-A4SC-01A,TCGA-A7-A4SC-01A-12D-A25Q-09,1,0.818942146,TCGA-A7-A4SC,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23008,Alive,TUMOR FREE,446,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,446,0,446,0,446,0,446,NA,Stage IIB,T3,MX,BRCA.LumA,1
-4.164840995,0.530077371,TCGA-85-A53L-01A,TCGA-85-A53L-01A-21D-A26M-08,4,0.060586187,TCGA-85-A53L,LUSC,63,MALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-23065,Alive,TUMOR FREE,377,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,377,0,377,0,377,0,377,NA,Stage IIA,T2b,M0,NA,10
-7.597834116,1.840392965,TCGA-LL-A50Y-01A,TCGA-LL-A50Y-01A-11D-A25Q-09,9,0.296596876,TCGA-LL-A50Y,BRCA,84,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30934,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,762,0,762,0,762,0,762,NA,Stage IIA,T2,MX,BRCA.LumA,7
9.700700875,-1.846695908,TCGA-21-A5DI-01A,TCGA-21-A5DI-01A-31D-A26M-08,1,0.84644019,TCGA-21-A5DI,LUSC,77,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-28374,Alive,TUMOR FREE,979,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,979,0,979,0,979,0,979,NA,Stage IA,T1b,M0,NA,1
-3.866029129,-2.130042848,TCGA-77-A5G3-01A,TCGA-77-A5G3-01A-31D-A27K-08,8,0.327802519,TCGA-77-A5G3,LUSC,63,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-23171,Alive,TUMOR FREE,4570,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4570,0,4570,0,4570,0,4570,NA,Stage IIB,T2,M0,NA,10
-8.054232242,2.125168224,TCGA-BH-A42V-01A,TCGA-BH-A42V-01A-11D-A243-09,9,0.58378131,TCGA-BH-A42V,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15158,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,635,0,635,0,635,0,635,NA,Stage IB,T1c,M0,BRCA.LumA,7
-6.234590128,1.581065319,TCGA-56-A4BY-01A,TCGA-56-A4BY-01A-11D-A24D-08,10,0.333675807,TCGA-56-A4BY,LUSC,66,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24445,Dead,WITH TUMOR,NA,543,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,543,1,543,NA,NA,1,543,NA,Stage IB,T2a,MX,NA,9
-6.406072856,-1.434227382,TCGA-L3-A4E7-01A,TCGA-L3-A4E7-01A-11D-A257-08,7,0.273705134,TCGA-L3-A4E7,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-26232,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,392,0,392,0,392,0,392,NA,Stage IB,T2a,M0,NA,2
-1.962006853,2.358284931,TCGA-56-8629-01A,TCGA-56-8629-01A-11D-2395-08,0,NA,TCGA-56-8629,LUSC,63,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-23346,Alive,TUMOR FREE,481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,481,0,481,0,481,0,481,NA,Stage IIA,T2b,MX,NA,10
-2.871759229,1.928474172,TCGA-77-A5GH-01A,TCGA-77-A5GH-01A-11D-A27K-08,0,NA,TCGA-77-A5GH,LUSC,81,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-29843,Alive,NA,1182,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1182,0,1182,0,1182,0,1182,NA,Stage IB,T2a,M0,NA,10
9.300860587,-3.63727355,TCGA-NC-A5HE-01A,TCGA-NC-A5HE-01A-11D-A26M-08,1,0.662505342,TCGA-NC-A5HE,LUSC,60,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-22179,Alive,TUMOR FREE,2336,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2336,0,2336,0,2336,0,2336,NA,Stage IIB,T2,M0,NA,6
-3.395616729,-3.08324352,TCGA-85-A4CL-01A,TCGA-85-A4CL-01A-41D-A26M-08,8,0.511321173,TCGA-85-A4CL,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24005,Dead,TUMOR FREE,NA,921,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,921,0,921,0,921,0,921,NA,Stage IA,T1b,M0,NA,10
-6.610136563,-1.246959198,TCGA-OL-A5DA-01A,TCGA-OL-A5DA-01A-11D-A27P-09,7,0.285201295,TCGA-OL-A5DA,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22411,Alive,TUMOR FREE,1783,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1783,0,1783,0,1783,0,1783,NA,Stage IIA,T2,MX,BRCA.LumA,2
4.636313422,1.247688876,TCGA-BP-4993-01A,TCGA-BP-4993-01A-02D-1421-08,2,0.242027369,TCGA-BP-4993,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-21407,Alive,TUMOR FREE,177,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,177,0,177,NA,NA,0,177,NA,Stage I,T1a,M0,KIRC.1,5
-4.441054464,-0.403746977,TCGA-LA-A446-01A,TCGA-LA-A446-01A-21D-A257-08,0,NA,TCGA-LA-A446,LUSC,68,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25199,Alive,TUMOR FREE,401,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,401,0,401,0,401,0,401,NA,Stage IA,T1b,MX,NA,10
8.715894003,-4.446870712,TCGA-25-2393-01A,TCGA-25-2393-01A-01W-0799-08,1,0.744771266,TCGA-25-2393,OV,81,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-29585,Dead,WITH TUMOR,1157,1157,[Not Available],Recurrence,[Not Applicable],[Not Applicable],305,Partial Remission/Response,1,1157,1,1157,NA,NA,1,305,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,1
9.175963868,-4.469631636,TCGA-BP-4962-01A,TCGA-BP-4962-01A-01D-1462-08,1,0.802305639,TCGA-BP-4962,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-21255,Alive,TUMOR FREE,1785,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1785,0,1785,NA,NA,0,1785,NA,Stage II,T2,M0,KIRC.4,1
-5.734450107,-2.142275115,TCGA-E2-A14R-01A,TCGA-E2-A14R-01A-11D-A10Y-09,0,NA,TCGA-E2-A14R,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22686,Alive,TUMOR FREE,1174,NA,[Not Available],New Primary Tumor,"Other, specify",Endometrial,971,[Not Available],0,1174,0,1174,0,1174,1,971,NA,Stage IIA,T2,M0,BRCA.Basal,2
9.945998395,-1.617612827,TCGA-AN-A0FN-01A,TCGA-AN-A0FN-01A-11W-A050-09,1,0.874251339,TCGA-AN-A0FN,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22629,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,218,0,218,0,218,0,218,NA,Stage IA,T1c,M0,BRCA.LumA,1
9.474772656,-3.918910193,TCGA-AA-3860-01A,TCGA-AA-3860-01A-02W-0900-09,1,0.71030711,TCGA-AA-3860,COAD,53,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-19449,Alive,TUMOR FREE,945,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,945,0,945,0,945,0,945,NA,Stage IIIB,T3,M0,NA,1
9.619064831,-2.487337468,TCGA-DU-7302-01A,TCGA-DU-7302-01A-11D-2086-08,1,0.758945365,TCGA-DU-7302,LGG,48,FEMALE,WHITE,Oligodendroglioma,G3,2006,[Not Available],-17656,Alive,WITH TUMOR,1834,NA,[Not Available],NA,NA,NA,1374,Progressive Disease,0,1834,0,1834,NA,NA,1,1374,NA,NA,NA,NA,GBM_LGG.Codel,1
9.814694989,-3.001018435,TCGA-HW-7486-01A,TCGA-HW-7486-01A-11D-2024-08,1,0.693809668,TCGA-HW-7486,LGG,37,MALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-13546,Alive,TUMOR FREE,1721,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1721,0,1721,NA,NA,0,1721,NA,NA,NA,NA,GBM_LGG.Codel,1
0.047512179,4.784915231,TCGA-HT-7609-01A,TCGA-HT-7609-01A-11D-2086-08,4,0.680928164,TCGA-HT-7609,LGG,34,MALE,WHITE,Oligoastrocytoma,G3,2007,[Not Available],-12607,Alive,TUMOR FREE,1399,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1399,0,1399,NA,NA,0,1399,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.397799474,1.666295848,TCGA-A2-A0EO-01A,TCGA-A2-A0EO-01A-11W-A050-09,0,NA,TCGA-A2-A0EO,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Peri (6-12 months since last menstrual period),-19880,Alive,TUMOR FREE,2442,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2442,0,2442,NA,NA,0,2442,NA,Stage IA,T1,M0,BRCA.LumA,8
9.809332938,-2.62496101,TCGA-A2-A0T6-01A,TCGA-A2-A0T6-01A-11D-A099-09,1,0.750394988,TCGA-A2-A0T6,BRCA,50,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18334,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,575,0,575,0,575,0,575,NA,Stage IIB,T3,M0,BRCA.LumA,1
0.254030482,4.620215317,TCGA-DH-5140-01A,TCGA-DH-5140-01A-01D-1468-08,4,0.482846013,TCGA-DH-5140,LGG,38,FEMALE,WHITE,Oligoastrocytoma,G3,2007,[Not Available],-13943,Dead,WITH TUMOR,NA,607,[Not Available],NA,NA,NA,NA,Progressive Disease,1,607,1,607,NA,NA,1,607,NA,NA,NA,NA,GBM_LGG.PA-like,6
-4.385794036,1.695120062,TCGA-D5-6529-01A,TCGA-D5-6529-01A-11D-1771-10,0,NA,TCGA-D5-6529,COAD,69,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-25394,Alive,WITH TUMOR,614,NA,[Not Available],NA,NA,NA,386,[Not Available],0,614,0,614,NA,NA,1,386,NA,Stage IIA,T3,M0,GI.CIN,8
-7.309787695,1.655991477,TCGA-DU-7006-01A,TCGA-DU-7006-01A-11D-2024-08,0,NA,TCGA-DU-7006,LGG,60,FEMALE,WHITE,Astrocytoma,G3,1995,[Not Available],-21990,Dead,WITH TUMOR,NA,349,[Not Available],NA,NA,NA,NA,Progressive Disease,1,349,1,349,NA,NA,1,349,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
0.347699819,4.680627982,TCGA-HT-8106-01A,TCGA-HT-8106-01A-11D-2395-08,4,0.574693866,TCGA-HT-8106,LGG,53,MALE,WHITE,Astrocytoma,G3,2010,[Not Available],-19555,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,3,0,3,NA,NA,0,3,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.103964626,4.923279284,TCGA-HT-7686-01A,TCGA-HT-7686-01A-11D-2253-08,4,0.717964237,TCGA-HT-7686,LGG,29,FEMALE,WHITE,Astrocytoma,G3,2008,[Not Available],-10724,Alive,TUMOR FREE,1300,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1300,0,1300,0,1300,0,1300,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.276740836,3.581471892,TCGA-AN-A0FT-01A,TCGA-AN-A0FT-01A-11W-A050-09,4,0.229600841,TCGA-AN-A0FT,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23300,Alive,TUMOR FREE,214,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,214,0,214,0,214,0,214,NA,Stage IIB,T2,M0,BRCA.LumA,3
-7.95073514,1.929156886,TCGA-AO-A0JF-01A,TCGA-AO-A0JF-01A-11W-A071-09,9,0.564097659,TCGA-AO-A0JF,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923,Alive,TUMOR FREE,1980,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1980,0,1980,0,1980,0,1980,NA,Stage IIA,T1c,M0,BRCA.LumA,7
9.078711901,-5.242990833,TCGA-AN-A0FK-01A,TCGA-AN-A0FK-01A-11W-A050-09,1,0.8165016,TCGA-AN-A0FK,BRCA,88,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32462,Alive,TUMOR FREE,213,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,213,0,213,0,213,0,213,NA,Stage IIIB,T4,M0,BRCA.LumA,1
-8.020311509,1.986899187,TCGA-BH-A0DO-01B,TCGA-BH-A0DO-01B-11D-A12B-09,9,0.61739975,TCGA-BH-A0DO,BRCA,78,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28529,Alive,TUMOR FREE,1644,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1644,0,1644,0,1644,0,1644,NA,Stage I,T1c,M0,BRCA.LumA,7
-8.119029378,2.080113233,TCGA-E9-A249-01A,TCGA-E9-A249-01A-11D-A167-09,9,0.638633648,TCGA-E9-A249,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16689,Alive,TUMOR FREE,217,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,217,0,217,0,217,0,217,NA,Stage IIA,T2,M0,BRCA.LumB,7
7.725930456,-1.288316498,TCGA-A8-A09M-01A,TCGA-A8-A09M-01A-11W-A019-09,1,0.145039971,TCGA-A8-A09M,BRCA,75,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27455,Alive,TUMOR FREE,1006,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1006,0,1006,0,1006,0,1006,NA,Stage IIIC,T2,M0,BRCA.LumB,6
-5.538065918,2.238536368,TCGA-E2-A14N-01A,TCGA-E2-A14N-01A-31D-A135-09,0,NA,TCGA-E2-A14N,BRCA,37,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13743,Alive,TUMOR FREE,1434,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1434,0,1434,0,1434,0,1434,NA,Stage IIB,T2,M0,BRCA.Basal,6
8.874441489,-3.236392079,TCGA-AR-A1AK-01A,TCGA-AR-A1AK-01A-21D-A12Q-09,1,0.676896092,TCGA-AR-A1AK,BRCA,70,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25825,Alive,TUMOR FREE,3159,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3159,0,3159,0,3159,0,3159,NA,Stage I,T1,M0,BRCA.LumA,1
-5.051520448,2.810736021,TCGA-D5-6534-01A,TCGA-D5-6534-01A-21D-1924-10,0,NA,TCGA-D5-6534,COAD,62,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-22778,Alive,TUMOR FREE,1316,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1316,0,1316,0,1316,0,1316,NA,Stage IIA,T3,M0,GI.CIN,3
-0.373690855,4.909250237,TCGA-GM-A2DF-01A,TCGA-GM-A2DF-01A-11D-A17W-09,4,0.561372152,TCGA-GM-A2DF,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19614,Alive,TUMOR FREE,2155,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2155,0,2155,0,2155,0,2155,NA,Stage IIA,T1c,M0,BRCA.Basal,6
-7.235127452,1.479947127,TCGA-BH-A0DT-01A,TCGA-BH-A0DT-01A-21D-A12B-09,0,NA,TCGA-BH-A0DT,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15078,Alive,TUMOR FREE,2403,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2403,0,2403,0,2403,0,2403,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-0.444472573,4.737721367,TCGA-EW-A1OZ-01A,TCGA-EW-A1OZ-01A-11D-A142-09,4,0.599656538,TCGA-EW-A1OZ,BRCA,56,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20664,Alive,TUMOR FREE,1229,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1229,0,1229,0,1229,0,1229,NA,Stage IIA,T2,M0,BRCA.LumB,6
0.341191281,3.552429509,TCGA-AR-A1AY-01A,TCGA-AR-A1AY-01A-21D-A12Q-09,4,0.203605269,TCGA-AR-A1AY,BRCA,65,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23927,Alive,TUMOR FREE,1026,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1026,0,1026,0,1026,0,1026,NA,Stage I,T1,M0,BRCA.Basal,3
7.794569937,-3.522089919,TCGA-CZ-5470-01A,TCGA-CZ-5470-01A-01D-1501-10,1,0.295471316,TCGA-CZ-5470,KIRC,72,FEMALE,[Not Available],Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-26494,Alive,NA,386,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,386,0,386,NA,NA,0,386,NA,Stage II,T2,M0,KIRC.4,1
-0.19561247,4.064108938,TCGA-OL-A5D7-01A,TCGA-OL-A5D7-01A-11D-A27P-09,4,0.416872531,TCGA-OL-A5D7,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25643,Alive,TUMOR FREE,1780,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1780,0,1780,0,1780,0,1780,NA,Stage IIA,T2,MX,BRCA.Basal,5
-5.900222149,-1.62613653,TCGA-58-8387-01A,TCGA-58-8387-01A-11D-2293-08,0,NA,TCGA-58-8387,LUSC,60,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-21952,Dead,TUMOR FREE,NA,403,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,403,0,403,0,403,0,403,NA,Stage IIA,T2b,M0,NA,2
-7.891087147,2.215142874,TCGA-C8-A3M8-01A,TCGA-C8-A3M8-01A-11D-A20S-09,9,0.436523423,TCGA-C8-A3M8,BRCA,68,FEMALE,ASIAN,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24877,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,394,0,394,0,394,0,394,NA,Stage IA,T1c,M0,BRCA.LumB,7
-5.809200986,-0.861915357,TCGA-85-8351-01A,TCGA-85-8351-01A-11D-2293-08,0,NA,TCGA-85-8351,LUSC,72,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26437,Alive,TUMOR FREE,510,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,510,0,510,0,510,0,510,NA,Stage IIA,T2a,M0,NA,2
-3.977692925,1.78975278,TCGA-58-8391-01A,TCGA-58-8391-01A-11D-2323-08,0,NA,TCGA-58-8391,LUSC,57,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-21102,Alive,WITH TUMOR,2167,NA,[Not Available],Distant Metastasis|New Primary Tumor,NA,NA,2033,Complete Remission/Response,0,2167,0,2167,1,2033,1,2033,NA,Stage IIIA,T2,M0,NA,10
-4.197178352,-1.548178453,TCGA-96-A4JK-01A,TCGA-96-A4JK-01A-11D-A257-08,8,0.317556501,TCGA-96-A4JK,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-23974,Alive,TUMOR FREE,589,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,589,0,589,0,589,0,589,NA,Stage IIA,T2a,M0,NA,10
-5.474602715,2.302323142,TCGA-85-8479-01A,TCGA-85-8479-01A-11D-2323-08,12,0.08442035,TCGA-85-8479,LUSC,66,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24350,Alive,TUMOR FREE,468,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,468,0,468,0,468,0,468,NA,Stage IA,T1a,M0,NA,6
-2.454228547,2.07172513,TCGA-GM-A3XL-01A,TCGA-GM-A3XL-01A-11D-A22X-09,0,NA,TCGA-GM-A3XL,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18171,Alive,TUMOR FREE,2108,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2108,0,2108,0,2108,0,2108,NA,Stage IIA,T2,M0,BRCA.Basal,3
7.783409153,-3.597595221,TCGA-E9-A247-01A,TCGA-E9-A247-01A-11D-A167-09,1,0.341499854,TCGA-E9-A247,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21562,Alive,TUMOR FREE,1186,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1186,0,1186,0,1186,0,1186,NA,Stage IA,T1c,M0,BRCA.LumA,1
9.025412221,-5.033656856,TCGA-E9-A5UO-01A,TCGA-E9-A5UO-01A-11D-A28B-09,1,0.834817584,TCGA-E9-A5UO,BRCA,41,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15050,Alive,TUMOR FREE,785,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,785,0,785,0,785,0,785,NA,Stage IIA,T2,M0,BRCA.LumB,1
-4.041182857,0.397684806,TCGA-56-8504-01A,TCGA-56-8504-01A-11D-2395-08,0,NA,TCGA-56-8504,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-27210,Alive,TUMOR FREE,510,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,510,0,510,0,510,0,510,NA,Stage IB,T2a,MX,NA,10
-4.409456356,-1.047382878,TCGA-85-8584-01A,TCGA-85-8584-01A-11D-2395-08,8,0.102673265,TCGA-85-8584,LUSC,71,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-26081,Dead,TUMOR FREE,NA,383,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,383,0,383,0,383,0,383,NA,Stage IIA,T2a,M0,NA,10
0.153611883,4.569127011,TCGA-A2-A3XX-01A,TCGA-A2-A3XX-01A-21D-A23C-09,4,0.402270376,TCGA-A2-A3XX,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17981,Dead,TUMOR FREE,NA,1439,[Not Available],NA,NA,NA,NA,[Not Available],1,1439,0,1439,0,1439,0,1439,NA,Stage IIA,T2,M0,BRCA.Basal,6
-4.555362151,1.698549423,TCGA-77-A5GB-01B,TCGA-77-A5GB-01B-11D-A27K-08,0,NA,TCGA-77-A5GB,LUSC,90,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-32872,Dead,NA,NA,937,[Not Available],New Primary Tumor,NA,NA,229,Complete Remission/Response,1,937,NA,937,0,937,1,229,NA,Stage IB,T2a,M0,NA,9
9.089236348,-5.694041824,TCGA-OL-A5D8-01A,TCGA-OL-A5D8-01A-11D-A27P-09,1,0.81393328,TCGA-OL-A5D8,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14853,Alive,TUMOR FREE,973,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,973,0,973,NA,NA,0,973,NA,Stage IIB,T3,MX,BRCA.LumA,1
-4.251313992,-0.30493912,TCGA-56-8628-01A,TCGA-56-8628-01A-11D-2395-08,0,NA,TCGA-56-8628,LUSC,78,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-28805,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,616,0,616,0,616,0,616,NA,Stage IA,T1b,MX,NA,10
4.290771203,1.413172234,TCGA-58-A46L-01A,TCGA-58-A46L-01A-11D-A24D-08,2,0.189177469,TCGA-58-A46L,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-26685,Alive,TUMOR FREE,1723,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1723,0,1723,0,1723,0,1723,NA,Stage IIIA,T2,M0,NA,6
9.281327497,-5.199187834,TCGA-D8-A4Z1-01A,TCGA-D8-A4Z1-01A-21D-A25Q-09,1,0.827966565,TCGA-D8-A4Z1,BRCA,68,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25097,Alive,TUMOR FREE,659,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,659,0,659,0,659,0,659,NA,Stage IA,T1c,M0,BRCA.LumA,1
-4.919863233,-1.888445245,TCGA-39-5040-01A,TCGA-39-5040-01A-21D-2122-08,8,0.126832082,TCGA-39-5040,LUSC,59,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-21790,Dead,WITH TUMOR,NA,519,[Not Available],NA,NA,NA,442,Stable Disease,1,519,1,519,NA,NA,1,442,NA,Stage IIIA,T2a,M0,NA,10
-1.378846864,3.387516677,TCGA-85-A510-01A,TCGA-85-A510-01A-11D-A26M-08,4,0.197994846,TCGA-85-A510,LUSC,74,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-27067,Alive,TUMOR FREE,482,NA,[Not Available],Distant Metastasis,NA,NA,363,Complete Remission/Response,0,482,0,482,1,363,1,363,NA,Stage IIB,T2b,M0,NA,6
-6.433127796,-2.006612114,TCGA-43-A475-01A,TCGA-43-A475-01A-11D-A24D-08,0,NA,TCGA-43-A475,LUSC,67,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24680,Alive,TUMOR FREE,296,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,296,0,296,0,296,0,296,NA,Stage IIB,T3,M0,NA,2
-0.40150636,4.61816034,TCGA-E9-A1N9-01A,TCGA-E9-A1N9-01A-11D-A14G-09,4,0.532435734,TCGA-E9-A1N9,BRCA,58,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21228,Alive,TUMOR FREE,1101,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1101,0,1101,0,1101,0,1101,NA,Stage IIA,T2,M0,BRCA.Basal,6
-6.999040736,-2.087678789,TCGA-58-A46K-01A,TCGA-58-A46K-01A-11D-A24D-08,6,0.143099172,TCGA-58-A46K,LUSC,59,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-21867,Dead,WITH TUMOR,NA,1045,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,735,Complete Remission/Response,1,1045,1,1045,1,735,1,735,NA,Stage IIIA,T2,M0,NA,2
8.801334858,-3.216470468,TCGA-E2-A56Z-01A,TCGA-E2-A56Z-01A-12D-A29N-09,1,0.67051228,TCGA-E2-A56Z,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25282,Alive,TUMOR FREE,252,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,252,0,252,0,252,0,252,NA,Stage IIB,T2,M0,BRCA.LumB,1
-6.6497319,2.302211353,TCGA-A2-A0CP-01A,TCGA-A2-A0CP-01A-11W-A050-09,0,NA,TCGA-A2-A0CP,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22133,Alive,TUMOR FREE,2813,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2813,0,2813,0,2813,0,2813,NA,Stage IA,T1c,M0,BRCA.LumA,7
-0.151245691,5.065730285,TCGA-D8-A27N-01A,TCGA-D8-A27N-01A-11D-A16D-09,4,0.584893029,TCGA-D8-A27N,BRCA,36,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13243,Alive,TUMOR FREE,519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,519,0,519,0,519,0,519,NA,Stage IIIA,T2,M0,BRCA.LumB,6
-7.790977923,2.094120278,TCGA-OK-A5Q2-01A,TCGA-OK-A5Q2-01A-11D-A27P-09,9,0.447850138,TCGA-OK-A5Q2,BRCA,59,FEMALE,[Not Evaluated],Infiltrating Lobular Carcinoma,[Not Available],2012,[Unknown],-21555,Alive,NA,64,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,64,0,64,0,64,0,64,NA,Stage II,T2,MX,BRCA.LumA,7
-4.685029795,0.351086287,TCGA-29-1691-01A,TCGA-29-1691-01A-01W-0633-09,0,NA,TCGA-29-1691,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,1995,[Not Available],-18664,Dead,WITH TUMOR,1435,1470,[Not Available],Recurrence,[Not Applicable],[Not Applicable],613,Complete Remission/Response,1,1470,1,1470,1,613,1,613,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,10
-6.052442677,-1.231571111,TCGA-77-8153-01A,TCGA-77-8153-01A-11D-2395-08,0,NA,TCGA-77-8153,LUSC,77,FEMALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-28253,Alive,TUMOR FREE,1992,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1992,0,1992,0,1992,0,1992,NA,Stage IB,T2,M0,NA,2
-4.526844496,-0.208927894,TCGA-85-A4QQ-01A,TCGA-85-A4QQ-01A-41D-A25L-08,0,NA,TCGA-85-A4QQ,LUSC,68,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25065,Dead,TUMOR FREE,NA,927,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,927,0,927,0,927,0,927,NA,Stage IB,T2a,M0,NA,10
-0.751699925,5.071767307,TCGA-98-8020-01A,TCGA-98-8020-01A-11D-2244-08,4,0.360533711,TCGA-98-8020,LUSC,56,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-20509,Dead,WITH TUMOR,NA,84,[Not Available],Distant Metastasis,NA,NA,11,[Unknown],1,84,1,84,NA,NA,1,11,NA,Stage IIIA,T2,M0,NA,4
-3.048336885,1.998829703,TCGA-85-A4JC-01A,TCGA-85-A4JC-01A-11D-A257-08,0,NA,TCGA-85-A4JC,LUSC,84,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-30942,Dead,WITH TUMOR,NA,604,[Not Available],Locoregional Recurrence,NA,NA,548,Complete Remission/Response,1,604,1,604,1,548,1,548,NA,Stage IIA,T2b,M0,NA,10
-4.108998208,1.112155236,TCGA-91-A4BC-01A,TCGA-91-A4BC-01A-11D-A24D-08,0,NA,TCGA-91-A4BC,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21565,Alive,NA,44,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,44,0,44,NA,NA,0,44,NA,Stage IIA,T2b,MX,NA,10
-0.144099235,4.243490356,TCGA-85-A512-01A,TCGA-85-A512-01A-11D-A26M-08,4,0.483594002,TCGA-85-A512,LUSC,46,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-16811,Alive,TUMOR FREE,465,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,465,0,465,0,465,0,465,NA,Stage IIA,T1b,M0,NA,6
-7.78466771,1.868553338,TCGA-E2-A1IU-01A,TCGA-E2-A1IU-01A-11D-A14G-09,9,0.465510334,TCGA-E2-A1IU,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22279,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,337,0,337,0,337,0,337,NA,Stage IA,T1c,M0,BRCA.LumA,7
-5.276988995,1.429704042,TCGA-MP-A4TI-01A,TCGA-MP-A4TI-01A-21D-A24P-08,0,NA,TCGA-MP-A4TI,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-26565,Dead,WITH TUMOR,NA,429,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,84,[Unknown],1,429,1,429,NA,NA,1,84,NA,Stage IIA,T2a,M0,NA,10
-5.659741365,1.137116444,TCGA-D8-A1JK-01A,TCGA-D8-A1JK-01A-11D-A13L-09,0,NA,TCGA-D8-A1JK,BRCA,90,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,612,0,612,0,612,0,612,NA,Stage IIA,T2,M0,BRCA.Basal,10
8.752069796,-3.969598683,TCGA-A2-A0T3-01A,TCGA-A2-A0T3-01A-21D-A10Y-09,1,0.717951592,TCGA-A2-A0T3,BRCA,37,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13680,Alive,TUMOR FREE,1516,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1516,0,1516,0,1516,0,1516,NA,Stage IB,T1c,M0,BRCA.LumB,1
-0.669428624,2.556234165,TCGA-13-1411-01A,TCGA-13-1411-01A-01W-0492-08,4,0.164488474,TCGA-13-1411,OV,81,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-29874,Dead,WITH TUMOR,NA,531,[Not Available],NA,[Not Applicable],[Not Applicable],238,Partial Remission/Response,1,531,1,531,NA,NA,1,238,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
8.988596829,-5.449601384,TCGA-62-8397-01A,TCGA-62-8397-01A-11D-2323-08,1,0.847167155,TCGA-62-8397,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25728,Alive,TUMOR FREE,1289,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1289,0,1289,0,1289,0,1289,NA,Stage IIB,T3,M0,NA,1
9.168364752,-2.546416741,TCGA-BP-5191-01A,TCGA-BP-5191-01A-01D-1429-08,1,0.736718109,TCGA-BP-5191,KIRC,79,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-29207,Alive,TUMOR FREE,967,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,967,0,967,NA,NA,0,967,NA,Stage III,T3a,M0,KIRC.2,1
0.977283195,3.638560515,TCGA-62-8402-01A,TCGA-62-8402-01A-11D-2323-08,0,NA,TCGA-62-8402,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-26934,Dead,WITH TUMOR,NA,1498,[Not Available],Distant Metastasis,NA,NA,772,Complete Remission/Response,1,1498,1,1498,1,772,1,772,NA,Stage IIIA,T2,M0,NA,6
-3.287507753,-3.322402056,TCGA-55-8507-01A,TCGA-55-8507-01A-11D-2393-08,8,0.557176655,TCGA-55-8507,LUAD,53,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-19390,Alive,TUMOR FREE,418,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,418,0,418,0,418,0,418,NA,Stage IA,T1a,MX,NA,10
-5.993930751,3.354485078,TCGA-MP-A4TE-01A,TCGA-MP-A4TE-01A-22D-A25L-08,11,0.424954201,TCGA-MP-A4TE,LUAD,56,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-20627,Dead,WITH TUMOR,NA,896,[Not Available],Locoregional Recurrence,NA,NA,226,Complete Remission/Response,1,896,1,896,1,226,1,226,NA,Stage IIA,T2b,MX,NA,8
-6.369050149,1.889786761,TCGA-BH-A0DL-01A,TCGA-BH-A0DL-01A-11D-A10Y-09,10,0.029887215,TCGA-BH-A0DL,BRCA,64,FEMALE,WHITE,"Other, specify",[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23628,Alive,TUMOR FREE,2381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2381,0,2381,0,2381,0,2381,NA,Stage IIA,T2,M0,BRCA.Basal,7
-7.21793518,-2.286077199,TCGA-10-0930-01A,TCGA-10-0930-01A-02W-0420-08,6,0.248170394,TCGA-10-0930,OV,70,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-25737,Dead,WITH TUMOR,1011,1040,[Not Available],Recurrence,[Not Applicable],[Not Applicable],680,Complete Remission/Response,1,1040,1,1040,1,680,1,680,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
0.177504156,5.119599653,TCGA-E2-A14X-01A,TCGA-E2-A14X-01A-11D-A10Y-09,4,0.691061624,TCGA-E2-A14X,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20105,Alive,TUMOR FREE,972,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,972,0,972,0,972,0,972,NA,Stage IIIA,T2,M0,BRCA.Basal,6
4.231369841,1.252034115,TCGA-97-A4M2-01A,TCGA-97-A4M2-01A-12D-A24P-08,2,0.506321338,TCGA-97-A4M2,LUAD,66,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24313,Alive,TUMOR FREE,624,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,624,0,624,0,624,0,624,NA,Stage IA,T1a,M0,NA,5
9.055043371,-2.51690723,TCGA-CZ-5462-01A,TCGA-CZ-5462-01A-01D-1501-10,1,0.653273238,TCGA-CZ-5462,KIRC,83,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-30659,Dead,WITH TUMOR,NA,311,[Not Available],NA,NA,NA,NA,[Not Available],1,311,1,311,NA,NA,1,311,NA,Stage IV,T1b,M1,KIRC.4,1
0.294869179,3.546721165,TCGA-DU-7309-01A,TCGA-DU-7309-01A-11D-2086-08,4,0.264537115,TCGA-DU-7309,LGG,41,FEMALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-15197,Alive,WITH TUMOR,84,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,84,0,84,NA,NA,0,84,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
-3.866050102,-2.231841809,TCGA-44-8120-01A,TCGA-44-8120-01A-11D-2238-08,8,0.432012959,TCGA-44-8120,LUAD,58,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21188,Alive,TUMOR FREE,260,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,260,0,260,0,260,0,260,NA,Stage IB,T2a,M0,NA,10
-7.713795389,-2.42541634,TCGA-CJ-6032-01A,TCGA-CJ-6032-01A-11D-1669-08,6,0.412853009,TCGA-CJ-6032,KIRC,63,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-23310,Alive,TUMOR FREE,3639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3639,0,3639,0,3639,0,3639,NA,Stage II,T2,M0,KIRC.1,2
-5.877135372,2.976203879,TCGA-78-8655-01A,TCGA-78-8655-01A-11D-2393-08,0,NA,TCGA-78-8655,LUAD,77,FEMALE,[Not Evaluated],Lung Adenocarcinoma,[Not Available],2003,[Not Available],-28379,Alive,NA,2360,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2360,0,2360,0,2360,0,2360,NA,Stage IA,T1,M0,NA,8
-2.828230905,-4.185068786,TCGA-AN-A046-01A,TCGA-AN-A046-01A-21W-A050-09,8,0.090955633,TCGA-AN-A046,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25158,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.LumA,10
-7.397073749,1.541750204,TCGA-BH-A0EB-01A,TCGA-BH-A0EB-01A-11W-A050-09,0,NA,TCGA-BH-A0EB,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25259,Alive,TUMOR FREE,745,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,745,0,745,0,745,0,745,NA,Stage IA,T1c,M0,BRCA.LumA,7
-0.41349555,3.574037566,TCGA-AO-A124-01A,TCGA-AO-A124-01A-11D-A10M-09,4,0.187826032,TCGA-AO-A124,BRCA,38,FEMALE,WHITE,"Other, specify",[Not Available],2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14174,Alive,TUMOR FREE,3506,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3506,0,3506,0,3506,0,3506,NA,Stage IIA,T2,M0,BRCA.Basal,6
0.109322407,4.411674327,TCGA-AR-A254-01A,TCGA-AR-A254-01A-21D-A167-09,4,0.606792819,TCGA-AR-A254,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18270,Alive,TUMOR FREE,2605,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2605,0,2605,0,2605,0,2605,NA,Stage IIIA,T2,M0,BRCA.Her2,6
-8.155732999,1.934154691,TCGA-D8-A1JH-01A,TCGA-D8-A1JH-01A-11D-A188-09,9,0.603078709,TCGA-D8-A1JH,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20497,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,426,0,426,0,426,0,426,NA,Stage IA,T1c,M0,BRCA.LumA,7
-5.372268543,2.694829778,TCGA-AZ-6600-01A,TCGA-AZ-6600-01A-11D-1771-10,12,0.301742963,TCGA-AZ-6600,COAD,64,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-23581,Dead,WITH TUMOR,NA,368,[Not Available],NA,NA,NA,NA,Progressive Disease,1,368,1,368,NA,NA,1,368,NA,Stage IV,T4,M1,GI.CIN,8
-8.076552305,2.113902834,TCGA-AR-A2LK-01A,TCGA-AR-A2LK-01A-11D-A17W-09,9,0.589344366,TCGA-AR-A2LK,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22800,Dead,NA,NA,1649,[Not Available],Distant Metastasis,Bone,NA,1304,[Not Available],1,1649,NA,1649,1,1304,1,1304,NA,Stage III,T3,M0,BRCA.LumB,7
-6.468585124,1.598718699,TCGA-AN-A04C-01A,TCGA-AN-A04C-01A-21W-A050-09,10,0.264357145,TCGA-AN-A04C,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18851,Alive,TUMOR FREE,54,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,54,0,54,NA,NA,0,54,NA,Stage IIB,T2,M0,BRCA.Her2,7
-7.94544542,2.099002016,TCGA-BH-A1EU-01A,TCGA-BH-A1EU-01A-11D-A135-09,9,0.621500648,TCGA-BH-A1EU,BRCA,83,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30339,Dead,TUMOR FREE,NA,1286,[Not Available],NA,NA,NA,NA,[Not Available],1,1286,0,1286,NA,NA,0,1286,NA,Stage I,T1,M0,BRCA.LumA,7
8.828187283,-3.136431609,TCGA-AR-A2LQ-01A,TCGA-AR-A2LQ-01A-22D-A18P-09,1,0.689070489,TCGA-AR-A2LQ,BRCA,59,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21865,Alive,TUMOR FREE,1233,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1233,0,1233,0,1233,0,1233,NA,Stage IIB,T3,M0,BRCA.Normal,1
8.251588343,-2.45360172,TCGA-B0-5698-01A,TCGA-B0-5698-01A-11D-1669-08,1,0.519645751,TCGA-B0-5698,KIRC,77,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-28438,Alive,TUMOR FREE,3631,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3631,0,3631,0,3631,0,3631,NA,Stage I,T1b,M0,KIRC.2,1
4.273656417,1.189653539,TCGA-BP-5198-01A,TCGA-BP-5198-01A-01D-1429-08,2,0.702401195,TCGA-BP-5198,KIRC,72,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-26360,Alive,TUMOR FREE,603,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,603,0,603,NA,NA,0,603,NA,Stage III,T3b,M0,KIRC.3,5
-0.165500029,4.541292241,TCGA-D8-A27F-01A,TCGA-D8-A27F-01A-11D-A16D-09,4,0.308456825,TCGA-D8-A27F,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731,Alive,TUMOR FREE,488,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,488,0,488,0,488,0,488,NA,Stage IIA,T2,M0,BRCA.Basal,6
-3.77490535,-2.579254469,TCGA-C8-A26Y-01A,TCGA-C8-A26Y-01A-11D-A16D-09,8,0.404956628,TCGA-C8-A26Y,BRCA,90,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,394,0,394,0,394,0,394,NA,Stage IIA,T2,M0,BRCA.Her2,10
0.108798975,4.89418819,TCGA-AZ-5403-01A,TCGA-AZ-5403-01A-01D-1650-10,4,0.672534101,TCGA-AZ-5403,COAD,43,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-15983,Dead,WITH TUMOR,NA,1910,[Not Available],NA,NA,NA,304,[Not Available],1,1910,1,1910,NA,NA,1,304,NA,Stage II,T3,MX,GI.CIN,6
-7.65545767,-2.387746384,TCGA-AR-A1AT-01A,TCGA-AR-A1AT-01A-11D-A12Q-09,6,0.455770877,TCGA-AR-A1AT,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22942,Dead,NA,NA,1272,[Not Available],NA,NA,NA,NA,[Not Available],1,1272,NA,1272,0,1272,0,1272,NA,Stage IIA,T2,M0,BRCA.Her2,2
9.594938929,-5.551120863,TCGA-AR-A24W-01A,TCGA-AR-A24W-01A-11D-A17G-09,1,0.839126524,TCGA-AR-A24W,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20123,Alive,TUMOR FREE,1550,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1550,0,1550,0,1550,0,1550,NA,Stage IIB,T2,M0,BRCA.LumA,1
0.269372871,4.895189153,TCGA-A8-A07O-01A,TCGA-A8-A07O-01A-11W-A019-09,4,0.715560734,TCGA-A8-A07O,BRCA,51,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18870,Alive,TUMOR FREE,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,304,0,304,0,304,0,304,NA,Stage IIA,T2,M0,BRCA.Basal,6
-7.690368259,2.197207817,TCGA-E9-A1RH-01A,TCGA-E9-A1RH-01A-21D-A167-09,9,0.463871427,TCGA-E9-A1RH,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23224,Alive,TUMOR FREE,1417,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1417,0,1417,0,1417,0,1417,NA,Stage IIA,T2,M0,BRCA.Her2,7
-7.798131941,1.785910383,TCGA-E2-A1BC-01A,TCGA-E2-A1BC-01A-11D-A14G-09,9,0.524591794,TCGA-E2-A1BC,BRCA,63,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23168,Alive,TUMOR FREE,501,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,501,0,501,NA,NA,0,501,NA,Stage IA,T1c,M0,BRCA.LumA,7
-7.033356114,2.277179757,TCGA-BH-A0W7-01A,TCGA-BH-A0W7-01A-11D-A10Y-09,0,NA,TCGA-BH-A0W7,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-17996,Alive,TUMOR FREE,1363,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1363,0,1363,0,1363,0,1363,NA,Stage I,T1c,M0,BRCA.LumA,9
-7.847015341,-2.556120295,TCGA-A8-A083-01A,TCGA-A8-A083-01A-21W-A019-09,6,0.4073242,TCGA-A8-A083,BRCA,67,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24746,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIB,T3,M0,BRCA.LumA,2
0.076043595,5.032521506,TCGA-DB-5270-01A,TCGA-DB-5270-01A-02D-1468-08,4,0.612158357,TCGA-DB-5270,LGG,38,FEMALE,WHITE,Oligoastrocytoma,G3,2002,[Not Available],-13904,Alive,TUMOR FREE,3733,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3733,0,3733,0,3733,0,3733,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.167208573,2.615972425,TCGA-HT-7689-01A,TCGA-HT-7689-01A-11D-2253-08,4,0.144028375,TCGA-HT-7689,LGG,58,FEMALE,WHITE,Oligodendroglioma,G2,2009,[Not Available],-21331,Alive,TUMOR FREE,455,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,455,0,455,0,455,0,455,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.624564224,-0.089775832,TCGA-A8-A06Q-01A,TCGA-A8-A06Q-01A-11W-A050-09,0,NA,TCGA-A8-A06Q,BRCA,63,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23164,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,0,31,0,31,NA,Stage IIIA,T3,M0,BRCA.LumB,10
7.922717706,-1.307502099,TCGA-A2-A25D-01A,TCGA-A2-A25D-01A-12D-A16D-09,1,0.180314861,TCGA-A2-A25D,BRCA,90,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,552,0,552,NA,NA,0,552,NA,Stage IIIC,T2,M0,BRCA.LumA,1
8.731350154,-4.788900613,TCGA-AR-A0U3-01A,TCGA-AR-A0U3-01A-11D-A10G-09,1,0.735239389,TCGA-AR-A0U3,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21755,Alive,TUMOR FREE,4080,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4080,0,4080,0,4080,0,4080,NA,Stage IIB,T2,M0,BRCA.LumA,1
-8.098535724,1.97208065,TCGA-A8-A0A2-01A,TCGA-A8-A0A2-01A-11W-A050-09,9,0.426888736,TCGA-A8-A0A2,BRCA,66,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24380,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,579,0,579,0,579,0,579,NA,Stage IIA,T2,M0,BRCA.LumA,7
-0.710254255,2.5979466,TCGA-A2-A1G1-01A,TCGA-A2-A1G1-01A-21D-A13L-09,4,0.168365233,TCGA-A2-A1G1,BRCA,85,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31223,Alive,TUMOR FREE,584,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,584,0,584,0,584,0,584,NA,Stage IIB,T2,M0,BRCA.Basal,6
-7.801006497,2.287183836,TCGA-D8-A1XY-01A,TCGA-D8-A1XY-01A-11D-A14K-09,9,0.60555426,TCGA-D8-A1XY,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27106,Alive,TUMOR FREE,503,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,503,0,503,NA,NA,0,503,NA,Stage IIA,T2,MX,BRCA.LumA,7
-3.547001866,-2.689325733,TCGA-D8-A1J8-01A,TCGA-D8-A1J8-01A-11D-A13L-09,8,0.431679411,TCGA-D8-A1J8,BRCA,77,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28444,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,431,0,431,0,431,0,431,NA,Stage IIB,T2,M0,BRCA.LumB,10
2.043218208,1.77066519,TCGA-GM-A2DK-01A,TCGA-GM-A2DK-01A-21D-A17W-09,3,0.519340537,TCGA-GM-A2DK,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198,Alive,TUMOR FREE,2645,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2645,0,2645,0,2645,0,2645,NA,Stage I,T1c,M0,BRCA.LumA,3
9.648042789,-5.76823385,TCGA-AA-3561-01A,TCGA-AA-3561-01A-01D-1953-10,1,0.858882358,TCGA-AA-3561,COAD,72,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-26420,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,424,0,424,0,424,0,424,NA,Stage IIA,T3,M0,NA,1
9.518224224,-3.156161789,TCGA-A1-A0SH-01A,TCGA-A1-A0SH-01A-11D-A099-09,1,0.72032071,TCGA-A1-A0SH,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14595,Alive,TUMOR FREE,1437,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1437,0,1437,0,1437,0,1437,NA,Stage IIA,T2,M0,BRCA.LumA,1
9.456343806,-5.04015475,TCGA-D8-A1JI-01A,TCGA-D8-A1JI-01A-11D-A13L-09,1,0.803687738,TCGA-D8-A1JI,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20072,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,577,0,577,0,577,0,577,NA,Stage IIA,T1c,MX,BRCA.LumB,1
-7.335037851,1.445274178,TCGA-HT-7481-01A,TCGA-HT-7481-01A-11D-2024-08,0,NA,TCGA-HT-7481,LGG,39,MALE,WHITE,Oligodendroglioma,G2,2006,[Not Available],-14306,Alive,WITH TUMOR,2918,NA,[Not Available],NA,NA,NA,880,Stable Disease,0,2918,0,2918,NA,NA,1,880,NA,NA,NA,NA,GBM_LGG.Codel,7
9.794111572,-3.634534149,TCGA-A2-A1G4-01A,TCGA-A2-A1G4-01A-11D-A13L-09,1,0.703815136,TCGA-A2-A1G4,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25966,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,595,0,595,0,595,0,595,NA,Stage IIIA,T3,M0,BRCA.LumB,1
0.157157701,5.112069674,TCGA-DB-5277-01A,TCGA-DB-5277-01A-01D-1468-08,4,0.700419332,TCGA-DB-5277,LGG,34,MALE,WHITE,Astrocytoma,G3,2007,[Not Available],-12725,Dead,WITH TUMOR,NA,1547,[Not Available],NA,NA,NA,1156,Complete Remission/Response,1,1547,1,1547,1,1156,1,1156,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-6.229010446,1.833449558,TCGA-C8-A131-01A,TCGA-C8-A131-01A-11D-A10Y-09,10,0.279325157,TCGA-C8-A131,BRCA,82,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29966,Alive,TUMOR FREE,411,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,411,0,411,0,411,0,411,NA,Stage IIIA,T2,M0,BRCA.Basal,7
9.759466675,-2.377152192,TCGA-A8-A085-01A,TCGA-A8-A085-01A-11W-A019-09,1,0.769039707,TCGA-A8-A085,BRCA,44,MALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-16377,Alive,TUMOR FREE,1124,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1124,0,1124,0,1124,0,1124,NA,Stage IIB,T2,M0,BRCA.LumB,1
9.045585739,-5.232778532,TCGA-BH-A0AU-01A,TCGA-BH-A0AU-01A-11D-A12Q-09,1,0.840080623,TCGA-BH-A0AU,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16688,Alive,TUMOR FREE,1914,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1914,0,1914,0,1914,0,1914,NA,Stage IIA,T2,M0,BRCA.LumB,1
-7.294123207,2.238577591,TCGA-E9-A1NG-01A,TCGA-E9-A1NG-01A-21D-A14K-09,9,0.225069173,TCGA-E9-A1NG,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22896,Dead,TUMOR FREE,NA,786,[Not Available],NA,NA,NA,NA,[Not Available],1,786,0,786,0,786,0,786,NA,Stage IIA,T2,M0,BRCA.LumA,7
-0.767783652,3.778816212,TCGA-D8-A1JG-01B,TCGA-D8-A1JG-01B-11D-A13L-09,4,0.279245281,TCGA-D8-A1JG,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22878,Alive,TUMOR FREE,1612,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1612,0,1612,0,1612,0,1612,NA,Stage IIA,T2,M0,BRCA.Her2,6
-4.529115185,-1.360735688,TCGA-A8-A08R-01A,TCGA-A8-A08R-01A-11W-A050-09,8,0.333590884,TCGA-A8-A08R,BRCA,52,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19298,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,0,30,0,30,NA,Stage IIB,T2,M0,BRCA.Basal,10
-0.502061078,4.349254184,TCGA-C8-A12K-01A,TCGA-C8-A12K-01A-21D-A10Y-09,4,0.471033576,TCGA-C8-A12K,BRCA,80,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29463,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIB,T2,M0,BRCA.Basal,6
7.739952101,-3.434475454,TCGA-BH-A0DG-01A,TCGA-BH-A0DG-01A-21D-A12Q-09,1,0.337803603,TCGA-BH-A0DG,BRCA,30,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11204,Alive,TUMOR FREE,2041,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2041,0,2041,0,2041,0,2041,NA,Stage IIA,T2,M0,BRCA.LumA,1
-7.993571668,2.058926707,TCGA-D8-A1XS-01A,TCGA-D8-A1XS-01A-11D-A14K-09,9,0.509012438,TCGA-D8-A1XS,BRCA,48,MALE,WHITE,"Other, specify",[Not Available],2010,[Not Available],-17708,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,496,0,496,0,496,0,496,NA,Stage IIIC,T2,M0,BRCA.LumB,7
-5.0457066,1.723141037,TCGA-DM-A1D4-01A,TCGA-DM-A1D4-01A-21D-A152-10,0,NA,TCGA-DM-A1D4,COAD,80,MALE,WHITE,Colon Adenocarcinoma,[Not Available],1999,[Not Available],-29403,Dead,NA,2821,2821,[Not Available],NA,NA,NA,1920,[Not Available],1,2821,NA,2821,NA,NA,1,1920,NA,Stage IIA,T3,M0,GI.CIN,10
-8.150651906,1.845324699,TCGA-B6-A0RP-01A,TCGA-B6-A0RP-01A-21D-A099-09,9,0.603547761,TCGA-B6-A0RP,BRCA,73,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],1994,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26941,Dead,WITH TUMOR,NA,3126,[Not Available],Distant Metastasis,Bone,NA,2787,[Not Available],1,3126,1,3126,1,2787,1,2787,NA,[Discrepancy],T2,M0,BRCA.LumA,7
-7.815167672,1.893946092,TCGA-A2-A0YC-01A,TCGA-A2-A0YC-01A-11D-A117-09,9,0.599891108,TCGA-A2-A0YC,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21685,Alive,WITH TUMOR,990,NA,[Not Available],Locoregional Disease,NA,NA,756,[Not Available],0,990,0,990,NA,NA,1,756,NA,Stage IIB,T2,M0,BRCA.LumA,7
3.010303695,3.538828386,TCGA-CF-A47S-01A,TCGA-CF-A47S-01A-11D-A23U-08,0,NA,TCGA-CF-A47S,BLCA,41,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011,[Not Available],-15225,Alive,TUMOR FREE,333,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,333,0,333,0,333,0,333,NA,Stage II,T2,M0,NA,1
-6.037733587,3.380755051,TCGA-E7-A4XJ-01A,TCGA-E7-A4XJ-01A-11D-A26M-08,11,0.486824291,TCGA-E7-A4XJ,BLCA,66,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24279,Dead,TUMOR FREE,NA,68,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,68,0,68,0,68,0,68,NA,Stage II,T2,M0,NA,8
-4.477471993,-1.056979969,TCGA-FD-A5BX-01A,TCGA-FD-A5BX-01A-11D-A26M-08,8,0.079410388,TCGA-FD-A5BX,BLCA,82,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-30276,Dead,WITH TUMOR,NA,173,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,99,Progressive Disease,1,173,1,173,NA,NA,1,99,NA,Stage IV,T3b,MX,NA,10
-4.047221273,-1.809278769,TCGA-K4-A6MB-01A,TCGA-K4-A6MB-01A-11D-A31L-08,8,0.405025782,TCGA-K4-A6MB,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23664,Alive,TUMOR FREE,469,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,469,0,469,NA,NA,0,469,NA,Stage IV,T3b,MX,NA,10
1.279120811,3.344525296,TCGA-FD-A62N-01A,TCGA-FD-A62N-01A-11D-A30E-08,0,NA,TCGA-FD-A62N,BLCA,69,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25297,Alive,TUMOR FREE,82,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,82,0,82,0,82,0,82,NA,Stage III,T3b,MX,NA,6
-5.263688905,-2.018409307,TCGA-FD-A62O-01A,TCGA-FD-A62O-01A-11D-A30E-08,0,NA,TCGA-FD-A62O,BLCA,74,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27310,Dead,TUMOR FREE,NA,216,[Not Available],NA,NA,NA,NA,[Unknown],1,216,0,216,NA,NA,0,216,NA,Stage IV,T3a,MX,NA,10
-5.008397446,1.092558705,TCGA-MP-A4SY-01A,TCGA-MP-A4SY-01A-21D-A24P-08,0,NA,TCGA-MP-A4SY,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-22448,Dead,TUMOR FREE,NA,1501,[Not Available],Locoregional Recurrence,NA,NA,489,Complete Remission/Response,1,1501,0,1501,1,489,1,489,NA,Stage IIB,T2,M0,NA,9
-3.760772458,-2.724499007,TCGA-E5-A4U1-01A,TCGA-E5-A4U1-01A-11D-A31L-08,8,0.374108803,TCGA-E5-A4U1,BLCA,72,MALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-26305,Alive,WITH TUMOR,1181,NA,[Not Available],Distant Metastasis,Bone,NA,705,Complete Remission/Response,0,1181,0,1181,1,705,1,705,NA,Stage II,T2b,M0,NA,10
-5.331473891,-1.440563463,TCGA-FD-A43X-01A,TCGA-FD-A43X-01A-11D-A23U-08,0,NA,TCGA-FD-A43X,BLCA,84,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-30764,Alive,TUMOR FREE,110,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,110,0,110,0,110,0,110,NA,Stage II,T2a,MX,NA,10
9.761605081,-3.984690605,TCGA-MP-A4TJ-01A,TCGA-MP-A4TJ-01A-51D-A25L-08,1,0.641548777,TCGA-MP-A4TJ,LUAD,62,FEMALE,[Unknown],Lung Adenocarcinoma,[Not Available],2006,[Not Available],-22875,Dead,NA,NA,339,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,339,NA,339,0,339,0,339,NA,Stage IA,T1,M0,NA,1
-5.955656272,3.421308291,TCGA-FJ-A3Z9-01A,TCGA-FJ-A3Z9-01A-11D-A26M-08,11,0.510925216,TCGA-FJ-A3Z9,BLCA,72,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26515,Dead,TUMOR FREE,NA,385,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,385,0,385,0,385,0,385,NA,[Not Available],TX,M0,NA,8
9.764288354,-1.737400318,TCGA-MP-A4T6-01A,TCGA-MP-A4T6-01A-32D-A25L-08,1,0.84943489,TCGA-MP-A4T6,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-27993,Dead,TUMOR FREE,NA,1790,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1790,0,1790,0,1790,0,1790,NA,Stage IIIA,T1,MX,NA,1
2.041349003,1.78900592,TCGA-FD-A43Y-01A,TCGA-FD-A43Y-01A-21D-A26M-08,3,0.430979635,TCGA-FD-A43Y,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-23889,Dead,TUMOR FREE,NA,474,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,474,0,474,0,474,0,474,NA,Stage III,T4,MX,NA,3
-4.711708901,-1.620930183,TCGA-CU-A5W6-01A,TCGA-CU-A5W6-01A-11D-A289-08,8,0.328797059,TCGA-CU-A5W6,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25706,Dead,TUMOR FREE,NA,56,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,56,0,56,0,56,0,56,NA,Stage III,T4a,M0,NA,10
9.285199384,-2.493713663,TCGA-MP-A4TH-01A,TCGA-MP-A4TH-01A-31D-A25L-08,1,0.715778918,TCGA-MP-A4TH,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-25759,Alive,TUMOR FREE,741,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,741,0,741,0,741,0,741,NA,Stage IA,T1a,M0,NA,3
1.063696952,3.45288028,TCGA-CF-A47V-01A,TCGA-CF-A47V-01A-11D-A23U-08,0,NA,TCGA-CF-A47V,BLCA,52,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-19265,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage II,T2,M0,NA,6
-7.189445825,-2.073509058,TCGA-FD-A5BZ-01A,TCGA-FD-A5BZ-01A-11D-A289-08,6,0.158330184,TCGA-FD-A5BZ,BLCA,77,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-28451,Dead,WITH TUMOR,NA,835,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,533,[Not Applicable],1,835,1,835,NA,NA,1,533,NA,Stage IV,T3a,MX,NA,2
-5.897046031,-1.687035134,TCGA-97-A4M7-01A,TCGA-97-A4M7-01A-11D-A24P-08,0,NA,TCGA-97-A4M7,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27062,Alive,TUMOR FREE,629,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,629,0,629,0,629,0,629,NA,Stage IA,T1b,M0,NA,10
-4.433944312,-1.823460333,TCGA-BT-A3PK-01A,TCGA-BT-A3PK-01A-21D-A21Z-08,8,0.382026702,TCGA-BT-A3PK,BLCA,80,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-29314,Dead,WITH TUMOR,NA,303,[Not Available],NA,NA,NA,NA,Stable Disease,1,303,1,303,NA,NA,1,303,NA,Stage II,T2b,MX,BLCA.3,10
-0.01089014,3.309288804,TCGA-CF-A47Y-01A,TCGA-CF-A47Y-01A-11D-A23U-08,4,0.356612732,TCGA-CF-A47Y,BLCA,55,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-20432,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,373,0,373,0,373,0,373,NA,Stage II,T2,M0,NA,3
-6.207384886,3.647097753,TCGA-CF-A47T-01A,TCGA-CF-A47T-01A-11D-A23U-08,11,0.32298246,TCGA-CF-A47T,BLCA,58,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011,[Not Available],-21347,Dead,WITH TUMOR,NA,385,[Not Available],Distant Metastasis,Bone,NA,139,Complete Remission/Response,1,385,1,385,1,139,1,139,NA,Stage II,T2,M0,NA,8
2.173713362,1.744308311,TCGA-CF-A47W-01A,TCGA-CF-A47W-01A-11D-A23U-08,3,0.463240349,TCGA-CF-A47W,BLCA,42,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-15497,Alive,TUMOR FREE,368,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,368,0,368,0,368,0,368,NA,Stage II,T2,M0,NA,3
-0.111186573,3.266399732,TCGA-62-8394-01A,TCGA-62-8394-01A-11D-2323-08,4,0.178192574,TCGA-62-8394,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-23758,Dead,TUMOR FREE,NA,139,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,139,0,139,0,139,0,139,NA,Stage IIIB,T4,M0,NA,3
-4.207776678,-2.092117653,TCGA-E5-A4TZ-01A,TCGA-E5-A4TZ-01A-11D-A31L-08,8,0.265188613,TCGA-E5-A4TZ,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-23566,Dead,WITH TUMOR,NA,467,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",soft tissue pelvic mass,435,Progressive Disease,1,467,1,467,NA,NA,1,435,NA,Stage IV,T4b,MX,NA,10
-3.673734144,-2.619581838,TCGA-FD-A62P-01A,TCGA-FD-A62P-01A-32D-A30E-08,8,0.385739961,TCGA-FD-A62P,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27843,Dead,WITH TUMOR,NA,191,[Not Available],NA,NA,NA,NA,[Not Applicable],1,191,1,191,NA,NA,1,191,NA,Stage II,T2b,MX,NA,10
-4.426408842,0.0398408,TCGA-MP-A4TK-01A,TCGA-MP-A4TK-01A-11D-A24P-08,0,NA,TCGA-MP-A4TK,LUAD,56,FEMALE,[Unknown],Lung Adenocarcinoma,[Not Available],2002,[Not Available],-20581,Dead,WITH TUMOR,NA,582,[Not Available],Distant Metastasis,NA,NA,397,Complete Remission/Response,1,582,1,582,1,397,1,397,NA,Stage IIB,T2,MX,NA,10
-3.513125231,-3.141927573,TCGA-55-8506-01A,TCGA-55-8506-01A-11D-2393-08,8,0.61406792,TCGA-55-8506,LUAD,62,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22850,Alive,NA,11,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,11,0,11,NA,NA,0,11,NA,Stage IIB,T3,MX,NA,10
-4.998152233,2.165863271,TCGA-61-1913-01A,TCGA-61-1913-01A-01W-0639-09,0,NA,TCGA-61-1913,OV,48,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-17575,Alive,TUMOR FREE,1488,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1488,0,1488,0,1488,0,1488,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,8
-4.210627997,-1.575855992,TCGA-FD-A43P-01A,TCGA-FD-A43P-01A-31D-A23U-08,8,0.400984485,TCGA-FD-A43P,BLCA,74,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27201,Alive,TUMOR FREE,832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,832,0,832,0,832,0,832,NA,Stage II,T2a,MX,NA,10
-4.543439359,0.800092575,TCGA-E7-A5KE-01A,TCGA-E7-A5KE-01A-11D-A289-08,0,NA,TCGA-E7-A5KE,BLCA,78,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-28714,Alive,TUMOR FREE,17,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,17,0,17,NA,NA,0,17,NA,Stage II,T2a,M0,NA,10
9.476919782,-2.632059478,TCGA-FD-A5BS-01A,TCGA-FD-A5BS-01A-21D-A26M-08,1,0.753376794,TCGA-FD-A5BS,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-24963,Alive,TUMOR FREE,1639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1639,0,1639,0,1639,0,1639,NA,Stage III,T3b,MX,NA,1
-7.819731895,-2.495251211,TCGA-MP-A4T2-01A,TCGA-MP-A4T2-01A-11D-A24P-08,6,0.453236781,TCGA-MP-A4T2,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-26010,Dead,WITH TUMOR,NA,1136,[Not Available],Distant Metastasis,NA,NA,575,Complete Remission/Response,1,1136,1,1136,1,575,1,575,NA,Stage IA,T1,M0,NA,2
7.839174064,-3.17354377,TCGA-91-8496-01A,TCGA-91-8496-01A-11D-2393-08,1,0.389698052,TCGA-91-8496,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23358,Alive,TUMOR FREE,505,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,505,0,505,0,505,0,505,NA,Stage IB,T2a,MX,NA,1
-4.490641631,-1.532536783,TCGA-CF-A47X-01A,TCGA-CF-A47X-01A-31D-A23U-08,8,0.429512071,TCGA-CF-A47X,BLCA,60,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-22200,Alive,TUMOR FREE,384,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,384,0,384,0,384,0,384,NA,Stage II,T2,M0,NA,10
9.838293286,-2.222227334,TCGA-FD-A5BR-01A,TCGA-FD-A5BR-01A-11D-A26M-08,1,0.804046446,TCGA-FD-A5BR,BLCA,57,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-20964,Alive,TUMOR FREE,813,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,813,0,813,0,813,0,813,NA,Stage II,T2b,MX,NA,1
4.15543973,1.201196581,TCGA-55-8206-01A,TCGA-55-8206-01A-11D-2238-08,2,0.567701056,TCGA-55-8206,LUAD,56,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20690,Alive,TUMOR FREE,888,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,888,0,888,0,888,0,888,NA,Stage IA,T1b,M0,NA,5
-1.809234984,1.151749843,TCGA-FD-A5BU-01A,TCGA-FD-A5BU-01A-31D-A26M-08,5,0.558832503,TCGA-FD-A5BU,BLCA,76,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27882,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,588,0,588,0,588,0,588,NA,Stage II,T2b,MX,NA,4
-0.79243643,3.729490864,TCGA-97-8175-01A,TCGA-97-8175-01A-11D-2284-08,4,0.270675129,TCGA-97-8175,LUAD,55,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-20206,Alive,TUMOR FREE,551,NA,[Not Available],Locoregional Recurrence,NA,NA,294,Complete Remission/Response,0,551,0,551,1,294,1,294,NA,Stage IB,T2a,M0,NA,5
-6.406385768,2.292057766,TCGA-FD-A5C0-01A,TCGA-FD-A5C0-01A-11D-A289-08,0,NA,TCGA-FD-A5C0,BLCA,61,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-22500,Dead,WITH TUMOR,NA,550,[Not Available],New Primary Tumor,Lung,NA,27,Complete Remission/Response,1,550,1,550,NA,NA,1,27,NA,Stage IV,T3a,MX,NA,6
-5.854355065,2.952425403,TCGA-MP-A4T7-01A,TCGA-MP-A4T7-01A-11D-A24P-08,0,NA,TCGA-MP-A4T7,LUAD,75,FEMALE,[Unknown],Lung Adenocarcinoma,[Not Available],2005,[Not Available],-27603,Dead,NA,NA,167,[Not Available],NA,NA,NA,NA,[Unknown],1,167,NA,167,NA,NA,0,167,NA,Stage IV,T2,M1,NA,7
-4.441211596,-1.131938395,TCGA-K4-A6FZ-01A,TCGA-K4-A6FZ-01A-11D-A31L-08,8,0.332381746,TCGA-K4-A6FZ,BLCA,75,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27686,Alive,TUMOR FREE,55,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,55,0,55,0,55,0,55,NA,Stage III,T3a,MX,NA,10
-0.900241864,2.533871759,TCGA-FD-A62S-01A,TCGA-FD-A62S-01A-11D-A30E-08,4,0.146627264,TCGA-FD-A62S,BLCA,60,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-22000,Dead,WITH TUMOR,NA,406,[Not Available],Distant Metastasis,"Other, specify",sigmoid colon,306,Progressive Disease,1,406,1,406,NA,NA,1,306,NA,Stage III,T3b,MX,NA,6
-6.965995615,2.104703562,TCGA-FD-A5C1-01A,TCGA-FD-A5C1-01A-11D-A289-08,0,NA,TCGA-FD-A5C1,BLCA,61,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-22505,Alive,TUMOR FREE,1792,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1792,0,1792,0,1792,0,1792,NA,Stage III,T3b,MX,NA,9
-6.24867581,2.206380363,TCGA-55-7724-01A,TCGA-55-7724-01A-11D-2167-08,0,NA,TCGA-55-7724,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27891,Alive,TUMOR FREE,705,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,705,0,705,0,705,0,705,NA,Stage IB,T2a,MX,LUAD.6,10
-6.266345908,-1.135129635,TCGA-BH-A0BV-01A,TCGA-BH-A0BV-01A-11W-A019-09,7,0.257855635,TCGA-BH-A0BV,BRCA,78,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28699,Alive,TUMOR FREE,1519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1519,0,1519,0,1519,0,1519,NA,Stage IIB,T2,M0,BRCA.LumA,2
-5.880582823,1.927833311,TCGA-A8-A07W-01A,TCGA-A8-A07W-01A-11W-A019-09,0,NA,TCGA-A8-A07W,BRCA,76,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27942,Alive,WITH TUMOR,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,304,0,304,NA,NA,0,304,NA,Stage IV,T2,M1,BRCA.LumB,9
9.904825987,-1.742569579,TCGA-55-8505-01A,TCGA-55-8505-01A-11D-2393-08,1,0.758966248,TCGA-55-8505,LUAD,62,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22676,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,440,0,440,0,440,0,440,NA,Stage IIIA,T1a,MX,NA,1
-7.826053546,2.020117305,TCGA-BH-A0BM-01A,TCGA-BH-A0BM-01A-11W-A071-09,9,0.5895215,TCGA-BH-A0BM,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20049,Alive,TUMOR FREE,1876,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1876,0,1876,0,1876,0,1876,NA,Stage IIB,T2,M0,BRCA.LumA,7
-8.152850377,2.029649049,TCGA-E9-A1NH-01A,TCGA-E9-A1NH-01A-11D-A14G-09,9,0.582978658,TCGA-E9-A1NH,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26221,Alive,TUMOR FREE,576,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,576,0,576,0,576,0,576,NA,Stage IIB,T2,M0,BRCA.LumA,7
-5.843715534,-2.011497614,TCGA-AN-A03Y-01A,TCGA-AN-A03Y-01A-21W-A019-09,0,NA,TCGA-AN-A03Y,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24232,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.LumB,2
-6.346423392,1.431631557,TCGA-K4-A4AB-01B,TCGA-K4-A4AB-01B-12D-A289-08,10,0.187577296,TCGA-K4-A4AB,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27922,Alive,NA,84,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,84,0,84,NA,NA,0,84,NA,Stage III,T4a,MX,NA,7
-4.335401225,0.708265626,TCGA-E7-A5KF-01A,TCGA-E7-A5KF-01A-11D-A289-08,0,NA,TCGA-E7-A5KF,BLCA,67,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-24528,Alive,TUMOR FREE,20,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,20,0,20,NA,NA,0,20,NA,Stage II,T2a,M0,NA,10
-4.595798693,-1.808865942,TCGA-E7-A541-01A,TCGA-E7-A541-01A-11D-A26M-08,8,0.341115812,TCGA-E7-A541,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24206,Dead,TUMOR FREE,NA,778,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,778,0,778,0,778,0,778,NA,Stage II,T2b,MX,NA,10
-7.242484877,-2.251365497,TCGA-FD-A5BV-01A,TCGA-FD-A5BV-01A-11D-A26M-08,6,0.378928065,TCGA-FD-A5BV,BLCA,47,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-17501,Dead,WITH TUMOR,NA,163,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Peritoneal carcinomatosis,134,Progressive Disease,1,163,1,163,NA,NA,1,134,NA,Stage III,T3b,MX,NA,2
0.398577132,2.239128977,TCGA-62-8395-01A,TCGA-62-8395-01A-11D-2323-08,0,NA,TCGA-62-8395,LUAD,80,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-29311,Alive,WITH TUMOR,1216,NA,[Not Available],Locoregional Recurrence,NA,NA,395,Complete Remission/Response,0,1216,0,1216,1,395,1,395,NA,Stage IIB,T3,M0,NA,6
-0.510787502,4.092804167,TCGA-LC-A66R-01A,TCGA-LC-A66R-01A-41D-A30E-08,4,0.414369904,TCGA-LC-A66R,BLCA,78,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-28793,Alive,TUMOR FREE,466,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,466,0,466,NA,NA,0,466,NA,Stage IV,T4a,MX,NA,6
-6.058725547,3.574311383,TCGA-MP-A4TD-01A,TCGA-MP-A4TD-01A-32D-A25L-08,11,0.524840801,TCGA-MP-A4TD,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25983,Dead,NA,NA,307,[Not Available],Locoregional Recurrence,NA,NA,226,Complete Remission/Response,1,307,NA,307,1,226,1,226,NA,Stage IIIA,T2,M0,NA,8
-0.89754822,3.992706371,TCGA-BT-A42E-01A,TCGA-BT-A42E-01A-11D-A23U-08,4,0.332603945,TCGA-BT-A42E,BLCA,74,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27045,Alive,TUMOR FREE,1108,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1108,0,1108,0,1108,0,1108,NA,Stage III,T3a,M0,NA,6
0.364332618,4.406622521,TCGA-62-A46U-01A,TCGA-62-A46U-01A-11D-A24D-08,4,0.394657129,TCGA-62-A46U,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-25998,Alive,TUMOR FREE,2067,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2067,0,2067,0,2067,0,2067,NA,Stage IIB,T2,M0,NA,6
0.132803736,3.816581274,TCGA-86-A4P7-01A,TCGA-86-A4P7-01A-11D-A24P-08,4,0.095565549,TCGA-86-A4P7,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23330,Alive,TUMOR FREE,415,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,415,0,415,0,415,0,415,NA,Stage IB,T2a,M0,NA,3
-6.272178796,-2.147877704,TCGA-FT-A61P-01A,TCGA-FT-A61P-01A-11D-A30E-08,0,NA,TCGA-FT-A61P,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-28082,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,337,0,337,NA,NA,0,337,NA,Stage IV,T3b,MX,NA,2
9.521255394,-3.291824071,TCGA-FD-A5BY-01A,TCGA-FD-A5BY-01A-31D-A289-08,1,0.744567741,TCGA-FD-A5BY,BLCA,63,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-23080,Alive,TUMOR FREE,251,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,251,0,251,0,251,0,251,NA,Stage III,T3a,MX,NA,1
-4.495321976,0.910391221,TCGA-95-A4VK-01A,TCGA-95-A4VK-01A-11D-A25L-08,0,NA,TCGA-95-A4VK,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27040,Alive,WITH TUMOR,651,NA,[Not Available],Distant Metastasis,NA,NA,496,Stable Disease,0,651,0,651,NA,NA,1,496,NA,Stage IIIA,T2b,M0,NA,9
-4.626918776,-1.348728391,TCGA-E7-A677-01A,TCGA-E7-A677-01A-11D-A30E-08,8,0.346506272,TCGA-E7-A677,BLCA,81,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-29613,Alive,TUMOR FREE,820,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,820,0,820,0,820,0,820,NA,Stage II,T2b,M0,NA,10
0.516638616,3.350791308,TCGA-FD-A5BT-01A,TCGA-FD-A5BT-01A-11D-A26M-08,4,0.345934629,TCGA-FD-A5BT,BLCA,84,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-30686,Dead,TUMOR FREE,NA,328,[Not Available],NA,NA,NA,NA,[Not Applicable],1,328,0,328,NA,NA,0,328,NA,Stage III,T3b,MX,NA,3
0.12273799,4.817454861,TCGA-25-2404-01A,TCGA-25-2404-01A-01W-0799-08,4,0.596502573,TCGA-25-2404,OV,38,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-14184,Dead,WITH TUMOR,883,883,[Not Available],Recurrence,[Not Applicable],[Not Applicable],426,Complete Remission/Response,1,883,1,883,1,426,1,426,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
9.216168166,-1.43944915,TCGA-E7-A519-01A,TCGA-E7-A519-01A-11D-A26M-08,1,0.593060578,TCGA-E7-A519,BLCA,72,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26427,Alive,TUMOR FREE,508,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,508,0,508,0,508,0,508,NA,Stage II,T2b,M0,NA,6
-7.189714703,-2.425894185,TCGA-BL-A5ZZ-01A,TCGA-BL-A5ZZ-01A-31D-A30E-08,6,0.315167869,TCGA-BL-A5ZZ,BLCA,80,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-29247,Alive,WITH TUMOR,377,NA,[Not Available],Distant Metastasis,Lung,NA,242,Complete Remission/Response,0,377,0,377,1,242,1,242,NA,Stage III,T4a,MX,NA,2
-4.51830308,-1.045100782,TCGA-MP-A4T4-01A,TCGA-MP-A4T4-01A-11D-A25L-08,8,0.175837855,TCGA-MP-A4T4,LUAD,68,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-25052,Dead,NA,NA,2617,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2617,NA,2617,0,2617,0,2617,NA,Stage IIB,T2,M0,NA,10
-4.065774927,-2.203097389,TCGA-LT-A5Z6-01A,TCGA-LT-A5Z6-01A-11D-A289-08,8,0.381519654,TCGA-LT-A5Z6,BLCA,56,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-20746,Alive,TUMOR FREE,474,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,474,0,474,0,474,0,474,NA,Stage II,[Not Available],MX,NA,10
9.857331798,-1.844452837,TCGA-44-A47B-01A,TCGA-44-A47B-01A-11D-A24D-08,1,0.849737456,TCGA-44-A47B,LUAD,79,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28869,Alive,TUMOR FREE,287,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,287,0,287,0,287,0,287,NA,Stage IB,T2a,M0,NA,1
-5.253630851,2.582510687,TCGA-62-A46R-01A,TCGA-62-A46R-01A-11D-A24D-08,12,0.180215529,TCGA-62-A46R,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-20063,Dead,TUMOR FREE,NA,1725,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1725,0,1725,0,1725,0,1725,NA,Stage IB,T2,M0,NA,10
9.093846226,-4.885444442,TCGA-78-8648-01A,TCGA-78-8648-01A-11D-2393-08,1,0.814631316,TCGA-78-8648,LUAD,58,FEMALE,[Not Evaluated],Lung Adenocarcinoma,[Not Available],2002,[Not Available],-21443,Dead,NA,NA,1209,[Not Available],Locoregional Recurrence,NA,NA,720,[Unknown],1,1209,NA,1209,NA,NA,1,720,NA,Stage IIB,T3,M0,NA,1
-0.683183401,2.230364582,TCGA-B0-5706-01A,TCGA-B0-5706-01A-11D-1534-10,0,NA,TCGA-B0-5706,KIRC,45,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-16442,Alive,TUMOR FREE,3205,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3205,0,3205,0,3205,0,3205,NA,Stage II,T2,M0,KIRC.2,1
-4.499710362,-0.235828011,TCGA-55-8207-01A,TCGA-55-8207-01A-11D-2238-08,0,NA,TCGA-55-8207,LUAD,73,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26897,Alive,TUMOR FREE,977,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,977,0,977,0,977,0,977,NA,Stage IB,T2a,MX,NA,10
-2.598962516,1.141451019,TCGA-91-8499-01A,TCGA-91-8499-01A-11D-2393-08,5,0.122154559,TCGA-91-8499,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27853,Alive,NA,36,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,36,0,36,NA,NA,0,36,NA,Stage IA,T1b,MX,NA,10
-5.666939633,2.981603316,TCGA-62-8398-01A,TCGA-62-8398-01A-11D-2323-08,0,NA,TCGA-62-8398,LUAD,55,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-20197,Dead,TUMOR FREE,NA,444,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,444,0,444,0,444,0,444,NA,Stage IIIA,T2,M0,NA,7
-3.579288903,-2.894835398,TCGA-78-8662-01A,TCGA-78-8662-01A-11D-2393-08,8,0.396862001,TCGA-78-8662,LUAD,53,FEMALE,[Not Evaluated],Lung Adenocarcinoma,[Not Available],2000,[Not Available],-19563,Dead,NA,NA,3361,[Not Available],Locoregional Recurrence,NA,NA,3044,Complete Remission/Response,1,3361,NA,3361,1,3044,1,3044,NA,Stage IB,T2,M0,NA,10
-0.000417852,4.63793975,TCGA-62-A471-01A,TCGA-62-A471-01A-12D-A24D-08,4,0.548416063,TCGA-62-A471,LUAD,64,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-23689,Alive,TUMOR FREE,1246,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1246,0,1246,0,1246,0,1246,NA,Stage IIB,T2b,M0,NA,6
-0.310886298,3.478944279,TCGA-EY-A212-01A,TCGA-EY-A212-01A-11D-A14K-09,4,0.194993158,TCGA-EY-A212,UCEC,83,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30680,Dead,WITH TUMOR,NA,310,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,310,1,310,NA,NA,1,310,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.CN high,3
-6.555375105,-1.398604855,TCGA-MP-A4T8-01A,TCGA-MP-A4T8-01A-11D-A24P-08,7,0.308253936,TCGA-MP-A4T8,LUAD,68,MALE,[Unknown],Lung Adenocarcinoma,[Not Available],2006,[Not Available],-25069,Dead,NA,NA,161,[Not Available],NA,NA,NA,NA,[Unknown],1,161,NA,161,NA,NA,0,161,NA,Stage IIIA,T2,M0,NA,2
-4.406176693,1.746063841,TCGA-55-8508-01A,TCGA-55-8508-01A-11D-2393-08,0,NA,TCGA-55-8508,LUAD,60,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22159,Alive,TUMOR FREE,617,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,617,0,617,0,617,0,617,NA,Stage IIA,T2a,MX,NA,9
-3.974276576,1.231530341,TCGA-MP-A4TC-01A,TCGA-MP-A4TC-01A-11D-A24P-08,0,NA,TCGA-MP-A4TC,LUAD,77,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-28471,Dead,TUMOR FREE,NA,74,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,74,0,74,0,74,0,74,NA,Stage IIIA,T1,M0,NA,10
-0.441124196,4.000729487,TCGA-55-8096-01A,TCGA-55-8096-01A-11D-2238-08,4,0.325160438,TCGA-55-8096,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24684,Dead,WITH TUMOR,NA,719,[Not Available],Distant Metastasis,NA,NA,566,Complete Remission/Response,1,719,1,719,1,566,1,566,NA,Stage IB,T2a,MX,NA,6
8.627475192,-1.782344738,TCGA-MP-A4T9-01A,TCGA-MP-A4T9-01A-11D-A24P-08,1,0.502338581,TCGA-MP-A4T9,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-19767,Dead,WITH TUMOR,NA,1265,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,341,Complete Remission/Response,1,1265,1,1265,1,341,1,341,NA,Stage IIIA,T2,MX,NA,1
-5.947134688,2.052825885,TCGA-EY-A214-01A,TCGA-EY-A214-01A-12D-A159-09,0,NA,TCGA-EY-A214,UCEC,66,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24136,Alive,TUMOR FREE,438,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,438,0,438,0,438,0,438,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-3.798727671,-1.832336097,TCGA-78-8640-01A,TCGA-78-8640-01A-11D-2393-08,8,0.313265436,TCGA-78-8640,LUAD,59,MALE,[Not Evaluated],Lung Adenocarcinoma,[Not Available],1994,[Not Available],-21832,Alive,TUMOR FREE,7062,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,7062,0,7062,0,7062,0,7062,NA,Stage IIA,T1,M0,NA,10
-5.295448937,2.677160678,TCGA-IB-7644-01A,TCGA-IB-7644-01A-11D-2154-08,12,0.25953439,TCGA-IB-7644,PAAD,65,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-24043,Dead,WITH TUMOR,NA,394,Pancreatic Cancer,Distant Metastasis,"Other, specify","Omentum, Peritoneal surface, Non regional Lymph nodes",306,Progressive Disease,1,394,1,394,NA,NA,1,306,NA,Stage IV,T3,M1,NA,8
-5.285375141,2.684100835,TCGA-F2-6879-01A,TCGA-F2-6879-01A-11D-2154-08,12,0.26783959,TCGA-F2-6879,PAAD,57,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2009,[Not Available],-20984,Dead,WITH TUMOR,NA,334,NA,Distant Metastasis,NA,NA,183,Complete Remission/Response,1,334,1,334,1,183,1,183,NA,Stage IIB,T3,M0,NA,8
-4.41635447,-0.436638683,TCGA-MP-A4SV-01A,TCGA-MP-A4SV-01A-11D-A24P-08,0,NA,TCGA-MP-A4SV,LUAD,67,MALE,[Unknown],Lung Adenocarcinoma,[Not Available],2001,[Not Available],-24516,Dead,NA,NA,2620,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2620,NA,2620,0,2620,0,2620,NA,Stage IB,T2,M0,NA,10
-0.27209308,3.727812558,TCGA-A5-A0G3-01A,TCGA-A5-A0G3-01A-11W-A062-09,4,0.139182027,TCGA-A5-A0G3,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22421,Alive,WITH TUMOR,1428,NA,[Not Available],NA,NA,NA,795,Complete Remission/Response,0,1428,0,1428,1,795,1,795,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.Notassigned,6
-7.718562886,-2.539978668,TCGA-55-8091-01A,TCGA-55-8091-01A-11D-2238-08,6,0.416682555,TCGA-55-8091,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27385,Alive,TUMOR FREE,600,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,600,0,600,0,600,0,600,NA,Stage IB,T2,MX,NA,2
-0.75609428,2.310992845,TCGA-IB-7885-01A,TCGA-IB-7885-01A-11D-2154-08,0,NA,TCGA-IB-7885,PAAD,78,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-28554,Alive,TUMOR FREE,1257,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1257,0,1257,0,1257,0,1257,NA,Stage IIB,T3,M0,NA,1
-6.275723483,1.980053019,TCGA-D7-A4YX-01A,TCGA-D7-A4YX-01A-11D-A25D-08,10,0.167855503,TCGA-D7-A4YX,STAD,63,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-23249,Alive,TUMOR FREE,1108,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1108,0,1108,0,1108,0,1108,NA,Stage IIB,T3,M0,GI.EBV,7
-4.231305766,-1.782918219,TCGA-69-A59K-01A,TCGA-69-A59K-01A-11D-A25L-08,8,0.395940268,TCGA-69-A59K,LUAD,60,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22093,Alive,TUMOR FREE,591,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,591,0,591,NA,NA,0,591,NA,Stage IIB,T3,M0,NA,10
-5.268943894,2.664169599,TCGA-IB-7652-01A,TCGA-IB-7652-01A-11D-2154-08,12,0.056975917,TCGA-IB-7652,PAAD,49,FEMALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-18129,Alive,TUMOR FREE,1116,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1116,0,1116,0,1116,0,1116,NA,Stage IIB,T3,M0,NA,7
9.080790008,-4.186582238,TCGA-MP-A5C7-01A,TCGA-MP-A5C7-01A-11D-A25L-08,1,0.736301125,TCGA-MP-A5C7,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-28015,Alive,TUMOR FREE,2248,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2248,0,2248,0,2248,0,2248,NA,Stage IB,T2,M0,NA,1
-5.949782459,3.401482746,TCGA-62-A46S-01A,TCGA-62-A46S-01A-11D-A24D-08,11,0.575528462,TCGA-62-A46S,LUAD,73,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-26825,Dead,WITH TUMOR,NA,1653,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,527,Complete Remission/Response,1,1653,1,1653,1,527,1,527,NA,Stage IB,T2,M0,NA,8
8.958846136,-4.928548748,TCGA-FB-A4P5-01A,TCGA-FB-A4P5-01A-11D-A26I-08,1,0.7988569,TCGA-FB-A4P5,PAAD,69,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-25412,Dead,WITH TUMOR,NA,179,NA,NA,NA,NA,NA,[Unknown],1,179,1,179,NA,NA,1,179,NA,Stage IIB,T3,MX,NA,1
8.92332829,-4.702881676,TCGA-CD-8532-01A,TCGA-CD-8532-01A-11D-2340-08,1,0.777692577,TCGA-CD-8532,STAD,52,MALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-19284,Dead,WITH TUMOR,NA,354,[Not Available],Locoregional Recurrence,NA,NA,282,Complete Remission/Response,1,354,1,354,1,282,1,282,NA,Stage II,T3,M0,GI.CIN,1
9.466147738,-4.229887834,TCGA-A3-3316-01A,TCGA-A3-3316-01A-01D-0966-08,1,0.748842229,TCGA-A3-3316,KIRC,57,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-20931,Alive,TUMOR FREE,1493,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1493,0,1493,NA,NA,0,1493,NA,Stage II,T2,M0,KIRC.3,1
-4.628792357,-1.4300784,TCGA-MN-A4N5-01A,TCGA-MN-A4N5-01A-11D-A24P-08,8,0.270461486,TCGA-MN-A4N5,LUAD,63,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23257,Alive,TUMOR FREE,84,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,84,0,84,0,84,0,84,NA,Stage IA,T1a,M0,NA,10
9.494486294,-5.720845382,TCGA-F2-7273-01A,TCGA-F2-7273-01A-11D-2154-08,1,0.844796229,TCGA-F2-7273,PAAD,54,MALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-20071,Dead,WITH TUMOR,NA,592,Pancreatic Cancer,Distant Metastasis,Liver,NA,256,Progressive Disease,1,592,1,592,NA,NA,1,256,NA,Stage IIB,T3,M0,NA,1
0.277860493,3.354745181,TCGA-61-2087-01A,TCGA-61-2087-01A-01W-0722-08,4,0.321506366,TCGA-61-2087,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-18182,Alive,TUMOR FREE,146,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,146,0,146,0,146,0,146,NA,Stage IC,[Not Applicable],[Not Applicable],NA,3
-4.431122023,-1.394097241,TCGA-C8-A1HM-01A,TCGA-C8-A1HM-01A-12D-A135-09,8,0.306718827,TCGA-C8-A1HM,BRCA,74,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27063,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,375,0,375,0,375,0,375,NA,Stage IIA,T2,M0,BRCA.LumB,10
-3.839588642,-2.394601092,TCGA-BT-A3PJ-01A,TCGA-BT-A3PJ-01A-21D-A21Z-08,8,0.437033644,TCGA-BT-A3PJ,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27821,Alive,TUMOR FREE,789,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,789,0,789,0,789,0,789,NA,Stage III,T3b,M0,BLCA.3,10
-0.558364986,4.650468811,TCGA-A6-A56B-01A,TCGA-A6-A56B-01A-31D-A28G-10,4,0.507843642,TCGA-A6-A56B,COAD,57,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-20903,Dead,TUMOR FREE,NA,1711,[Not Available],NA,NA,NA,1678,Complete Remission/Response,1,1711,0,1711,1,1678,1,1678,NA,Stage IIIB,T3,M0,GI.CIN,6
-5.037517661,1.426396727,TCGA-NH-A50V-01A,TCGA-NH-A50V-01A-11D-A28G-10,0,NA,TCGA-NH-A50V,COAD,69,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2012,[Not Available],-25467,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,588,0,588,0,588,0,588,NA,Stage IIIB,T3,M0,GI.CIN,10
-3.878771797,-2.398705709,TCGA-BT-A2LB-01A,TCGA-BT-A2LB-01A-11D-A18F-08,8,0.444527449,TCGA-BT-A2LB,BLCA,73,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-26846,Dead,TUMOR FREE,NA,492,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,492,0,492,0,492,0,492,NA,Stage III,T3a,M0,BLCA.2,10
-6.231178629,1.503417996,TCGA-NH-A50T-01A,TCGA-NH-A50T-01A-11D-A28G-10,10,0.343578989,TCGA-NH-A50T,COAD,68,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2012,[Not Available],-25089,Alive,TUMOR FREE,553,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,553,0,553,0,553,0,553,NA,Stage IIA,T3,MX,GI.CIN,9
-0.67597444,2.186110258,TCGA-E7-A678-01A,TCGA-E7-A678-01A-11D-A30E-08,0,NA,TCGA-E7-A678,BLCA,55,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-20169,Alive,TUMOR FREE,798,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,798,0,798,0,798,0,798,NA,Stage III,T3,M0,NA,3
-6.047787999,-1.241998914,TCGA-QG-A5YV-01A,TCGA-QG-A5YV-01A-11D-A28G-10,0,NA,TCGA-QG-A5YV,COAD,64,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-23499,Alive,TUMOR FREE,1301,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1301,0,1301,0,1301,0,1301,NA,Stage IIIC,T4b,MX,GI.CIN,2
-5.308524922,2.63230138,TCGA-A6-A567-01A,TCGA-A6-A567-01A-31D-A28G-10,12,0.314110429,TCGA-A6-A567,COAD,56,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-20493,Dead,WITH TUMOR,NA,1881,[Not Available],Metastatic,NA,NA,612,[Unknown],1,1881,1,1881,NA,NA,1,612,NA,Stage IV,T3,M1,GI.CIN,8
-6.388306503,1.633073937,TCGA-QG-A5YX-01A,TCGA-QG-A5YX-01A-11D-A28G-10,10,0.404919001,TCGA-QG-A5YX,COAD,61,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-22617,Alive,TUMOR FREE,1003,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1003,0,1003,0,1003,0,1003,NA,Stage IIA,T3,MX,GI.CIN,7
-6.268365023,-1.180871561,TCGA-A6-A566-01A,TCGA-A6-A566-01A-11D-A28G-10,7,0.178333216,TCGA-A6-A566,COAD,55,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2007,[Not Available],-20181,Dead,WITH TUMOR,NA,758,[Not Available],NA,NA,NA,257,Progressive Disease,1,758,1,758,NA,NA,1,257,NA,Stage IIIB,T4,M0,GI.GS,2
-5.085978778,1.890260673,TCGA-AY-A54L-01A,TCGA-AY-A54L-01A-11D-A28G-10,0,NA,TCGA-AY-A54L,COAD,74,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2012,[Not Available],-27074,Alive,WITH TUMOR,525,NA,[Not Available],NA,NA,NA,396,Complete Remission/Response,0,525,0,525,1,396,1,396,NA,Stage I,T2,M0,GI.CIN,9
-4.294525925,-2.049251307,TCGA-A6-A565-01A,TCGA-A6-A565-01A-31D-A28G-10,8,0.375155629,TCGA-A6-A565,COAD,34,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],-12526,Dead,WITH TUMOR,NA,494,[Not Available],NA,NA,NA,301,Progressive Disease,1,494,1,494,NA,NA,1,301,NA,Stage IIIC,T3,MX,GI.HM-indel,10
-7.777060099,-2.472913838,TCGA-HU-A4GY-01A,TCGA-HU-A4GY-01A-21D-A24D-08,6,0.317645542,TCGA-HU-A4GY,STAD,76,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-28113,Alive,TUMOR FREE,8,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,8,0,8,NA,NA,0,8,NA,Stage IIIA,T4,M0,GI.CIN,2
-0.527266081,4.326010813,TCGA-DB-5281-01A,TCGA-DB-5281-01A-01D-1468-08,4,0.472104094,TCGA-DB-5281,LGG,61,MALE,WHITE,Oligoastrocytoma,G3,2006,[Not Available],-22342,Alive,WITH TUMOR,2381,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,2381,0,2381,NA,NA,0,2381,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.924336376,1.971346407,TCGA-67-3770-01A,TCGA-67-3770-01A-01D-0969-08,0,NA,TCGA-67-3770,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-25658,Alive,TUMOR FREE,610,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,610,0,610,NA,NA,0,610,NA,Stage IA,T1,M0,NA,10
-3.528268196,-2.487657571,TCGA-HU-A4H3-01A,TCGA-HU-A4H3-01A-21D-A25D-08,8,0.409245702,TCGA-HU-A4H3,STAD,56,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-20790,Alive,WITH TUMOR,882,NA,[Not Available],Distant Metastasis,"Other, specify",NA,410,Progressive Disease,0,882,0,882,NA,NA,1,410,NA,Stage IIIC,T4a,M0,GI.HM-indel,10
9.055809962,-5.248984164,TCGA-BH-A1FH-01A,TCGA-BH-A1FH-01A-12D-A13L-09,1,0.84493612,TCGA-BH-A1FH,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-17172,Dead,WITH TUMOR,NA,1034,[Not Available],NA,NA,NA,NA,[Not Available],1,1034,1,1034,NA,NA,1,1034,NA,Stage IV,T2,M1,BRCA.LumA,1
9.816272946,-3.753576293,TCGA-A8-A076-01A,TCGA-A8-A076-01A-21W-A019-09,1,0.632755689,TCGA-A8-A076,BRCA,66,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24230,Alive,TUMOR FREE,1642,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1642,0,1642,0,1642,0,1642,NA,Stage IIA,T2,M0,BRCA.LumB,1
2.02312426,1.932095554,TCGA-19-1786-01A,TCGA-19-1786-01A-01W-0643-08,3,0.541444774,TCGA-19-1786,GBM,64,FEMALE,ASIAN,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-23568,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,218,0,218,NA,NA,0,218,NA,NA,NA,NA,NA,3
8.982904527,-4.99610093,TCGA-B6-A0RI-01A,TCGA-B6-A0RI-01A-11W-A071-09,1,0.849428489,TCGA-B6-A0RI,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-16138,Alive,WITH TUMOR,7126,NA,[Not Available],Locoregional Disease,"Other, specify",Chest Wall,1100,[Not Available],0,7126,0,7126,1,1100,1,1100,NA,Stage IIIB,T4b,M0,BRCA.LumA,1
-5.990278734,1.961749013,TCGA-A8-A095-01A,TCGA-A8-A095-01A-11W-A019-09,10,0.01254013,TCGA-A8-A095,BRCA,45,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16742,Alive,TUMOR FREE,1277,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1277,0,1277,0,1277,0,1277,NA,Stage I,T1c,M0,BRCA.LumB,9
-0.868990398,3.657083804,TCGA-DU-8167-01A,TCGA-DU-8167-01A-11D-2253-08,4,0.348596075,TCGA-DU-8167,LGG,69,FEMALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-25262,Alive,TUMOR FREE,471,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,471,0,471,NA,NA,0,471,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
-2.048460741,1.758825264,TCGA-HU-8604-01A,TCGA-HU-8604-01A-11D-2394-08,0,NA,TCGA-HU-8604,STAD,82,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-30178,Alive,TUMOR FREE,694,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,694,0,694,0,694,0,694,NA,Stage IIA,T3,M0,GI.CIN,10
-8.145132493,1.948691994,TCGA-HT-7860-01A,TCGA-HT-7860-01A-11D-2395-08,9,0.424245813,TCGA-HT-7860,LGG,60,FEMALE,WHITE,Astrocytoma,G3,2009,[Not Available],-22034,Alive,TUMOR FREE,15,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,15,0,15,NA,NA,0,15,NA,NA,NA,NA,GBM_LGG.Classic-like,7
8.633994215,-1.861694989,TCGA-05-5429-01A,TCGA-05-5429-01A-01D-1625-08,1,0.53423723,TCGA-05-5429,LUAD,60,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2010,[Not Available],-22066,Dead,TUMOR FREE,NA,275,[Not Available],NA,NA,NA,NA,[Not Applicable],1,275,0,275,NA,NA,0,275,NA,Stage IIIA,T3,M0,LUAD.4,1
2.958836385,3.60415956,TCGA-EW-A1IY-01A,TCGA-EW-A1IY-01A-11D-A188-09,0,NA,TCGA-EW-A1IY,BRCA,38,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122,Alive,TUMOR FREE,258,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,258,0,258,0,258,0,258,NA,Stage I,T1c,MX,BRCA.LumB,1
9.014997378,-5.297905789,TCGA-76-6285-01A,TCGA-76-6285-01A-11D-1696-08,1,0.838732183,TCGA-76-6285,GBM,64,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-23674,Dead,WITH TUMOR,254,254,[Not Available],NA,NA,NA,NA,[Not Available],1,254,1,254,NA,NA,1,254,NA,NA,NA,NA,NA,1
-4.127607684,-1.430090649,TCGA-AZ-6599-01A,TCGA-AZ-6599-01A-11D-1771-10,8,0.252826824,TCGA-AZ-6599,COAD,72,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-26438,Dead,TUMOR FREE,NA,206,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,206,0,206,0,206,0,206,NA,Stage I,T2,MX,GI.GS,10
-6.508022536,2.162596529,TCGA-D8-A1XM-01A,TCGA-D8-A1XM-01A-21D-A14K-09,0,NA,TCGA-D8-A1XM,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21056,Alive,TUMOR FREE,538,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,538,0,538,0,538,0,538,NA,Stage IA,T1c,M0,BRCA.LumA,7
9.01019112,-4.961480837,TCGA-06-6693-01A,TCGA-06-6693-01A-11D-1845-08,1,0.812683883,TCGA-06-6693,GBM,64,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1993,[Not Available],-23585,Dead,WITH TUMOR,15,3667,[Not Available],NA,NA,NA,NA,[Not Available],1,3667,1,3667,NA,NA,1,3667,NA,NA,NA,NA,NA,1
0.199016689,4.948689946,TCGA-AN-A0AL-01A,TCGA-AN-A0AL-01A-11W-A019-09,4,0.415928909,TCGA-AN-A0AL,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15286,Alive,TUMOR FREE,227,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,227,0,227,0,227,0,227,NA,Stage IIIB,T4,M0,BRCA.Basal,6
9.549068694,-3.018010003,TCGA-AR-A24L-01A,TCGA-AR-A24L-01A-11D-A167-09,1,0.746273182,TCGA-AR-A24L,BRCA,26,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9706,Dead,WITH TUMOR,NA,2866,[Not Available],Locoregional Disease,NA,NA,1414,[Not Available],1,2866,1,2866,1,1414,1,1414,NA,Stage IIB,T2,M0,BRCA.LumA,1
-3.436426128,-3.093104535,TCGA-G4-6304-01A,TCGA-G4-6304-01A-11D-1924-10,8,0.390652682,TCGA-G4-6304,COAD,66,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2006,[Not Available],-24172,Alive,TUMOR FREE,1631,NA,[Not Available],NA,NA,NA,859,[Not Available],0,1631,0,1631,NA,NA,1,859,NA,Stage IIB,T4,M0,GI.HM-indel,10
-4.592269437,-0.543031744,TCGA-J2-A4AD-01A,TCGA-J2-A4AD-01A-11D-A24D-08,0,NA,TCGA-J2-A4AD,LUAD,61,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22414,Dead,WITH TUMOR,NA,550,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,524,[Unknown],1,550,1,550,NA,NA,1,524,NA,Stage IA,T1a,MX,NA,10
-5.010286579,1.379116474,TCGA-86-8054-01A,TCGA-86-8054-01A-11D-2238-08,0,NA,TCGA-86-8054,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22584,Alive,TUMOR FREE,1148,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1148,0,1148,0,1148,0,1148,NA,Stage IIB,T2b,M0,NA,9
-5.271303178,2.424237273,TCGA-AA-3814-01A,TCGA-AA-3814-01A-01W-0900-09,12,0.208951604,TCGA-AA-3814,COAD,85,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-31380,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIA,T3,M0,GI.CIN,8
-8.08076239,2.028030408,TCGA-AN-A0XP-01A,TCGA-AN-A0XP-01A-11D-A117-09,9,0.626063454,TCGA-AN-A0XP,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25305,Alive,TUMOR FREE,9,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,9,0,9,0,9,0,9,NA,Stage IIIA,T2,M0,BRCA.LumA,7
0.041389047,4.626191181,TCGA-A7-A13E-01A,TCGA-A7-A13E-01A-11D-A272-09,4,0.59718807,TCGA-A7-A13E,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22690,Dead,WITH TUMOR,NA,614,[Not Available],Distant Metastasis,"Other, specify","Lung, Bone, Liver, Brain and Skin Nodules",556,[Not Available],1,614,1,614,1,556,1,556,NA,Stage IIB,T2,MX,BRCA.Basal,6
9.98452339,-1.546463899,TCGA-AR-A0TY-01A,TCGA-AR-A0TY-01A-12W-A12T-09,1,0.767785462,TCGA-AR-A0TY,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19836,Dead,WITH TUMOR,NA,1699,[Not Available],Distant Metastasis,Bone,NA,544,[Not Available],1,1699,1,1699,1,544,1,544,NA,Stage IIA,T2,M0,BRCA.LumB,1
8.95373356,-5.297763047,TCGA-BH-A1EW-01A,TCGA-BH-A1EW-01A-11D-A135-09,1,0.837117702,TCGA-BH-A1EW,BRCA,38,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14090,Dead,WITH TUMOR,NA,1694,[Not Available],NA,NA,NA,NA,[Not Available],1,1694,1,1694,NA,NA,1,1694,NA,Stage IIA,T2,M0,BRCA.LumA,1
9.410084559,-3.028041866,TCGA-D8-A1XB-01A,TCGA-D8-A1XB-01A-11D-A14G-09,1,0.734034828,TCGA-D8-A1XB,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22976,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,552,0,552,0,552,0,552,NA,Stage IIB,T2,M0,BRCA.LumA,1
-0.387542298,4.50322812,TCGA-C8-A134-01A,TCGA-C8-A134-01A-11D-A10Y-09,4,0.419915037,TCGA-C8-A134,BRCA,52,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-19010,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,383,0,383,0,383,0,383,NA,Stage IIA,T2,M0,BRCA.Basal,6
-5.806177227,-2.014994763,TCGA-D8-A143-01A,TCGA-D8-A143-01A-11D-A10Y-09,0,NA,TCGA-D8-A143,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18984,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,431,0,431,0,431,0,431,NA,Stage IIA,T2,M0,BRCA.Basal,2
-7.881501491,1.843138402,TCGA-A7-A0DB-01A,TCGA-A7-A0DB-01A-11D-A272-09,9,0.583266289,TCGA-A7-A0DB,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20570,Alive,TUMOR FREE,1007,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1007,0,1007,NA,NA,0,1007,NA,Stage IIA,T2,M0,BRCA.LumA,7
-0.523189988,3.981585331,TCGA-A2-A0T2-01A,TCGA-A2-A0T2-01A-11W-A097-09,4,0.407518401,TCGA-A2-A0T2,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24235,Dead,WITH TUMOR,NA,255,[Not Available],NA,NA,NA,NA,[Not Available],1,255,1,255,NA,NA,1,255,NA,Stage IV,T3,M1,BRCA.Basal,6
-5.880603818,1.788742256,TCGA-GM-A2DD-01A,TCGA-GM-A2DD-01A-11D-A17W-09,0,NA,TCGA-GM-A2DD,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415,Alive,TUMOR FREE,2282,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2282,0,2282,0,2282,0,2282,NA,Stage I,T1c,M0,BRCA.Normal,7
-3.385628522,-3.217344683,TCGA-BH-A0B6-01A,TCGA-BH-A0B6-01A-11D-A19Y-09,8,0.593842243,TCGA-BH-A0B6,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-17346,Alive,TUMOR FREE,2483,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2483,0,2483,0,2483,0,2483,NA,Stage I,T1c,M0,NA,10
-3.37114903,-3.323062469,TCGA-95-7039-01A,TCGA-95-7039-01A-11D-1945-08,8,0.618736055,TCGA-95-7039,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-19981,Alive,WITH TUMOR,1272,NA,[Not Available],Locoregional Recurrence,NA,NA,1258,Complete Remission/Response,0,1272,0,1272,1,1258,1,1258,NA,Stage IIB,T3,MX,LUAD.3,10
8.642750697,-4.50855946,TCGA-D8-A1X7-01A,TCGA-D8-A1X7-01A-11D-A14K-09,1,0.763535815,TCGA-D8-A1X7,BRCA,40,FEMALE,WHITE,"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14858,Alive,TUMOR FREE,509,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,509,0,509,0,509,0,509,NA,Stage IIA,T2,MX,BRCA.LumB,1
-7.722464004,1.956516168,TCGA-BH-A0DK-01A,TCGA-BH-A0DK-01A-21W-A071-09,9,0.376502693,TCGA-BH-A0DK,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18237,Alive,TUMOR FREE,423,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,423,0,423,0,423,0,423,NA,Stage IIA,T2,M0,BRCA.LumA,7
-0.764626621,2.29836338,TCGA-A2-A0T5-01A,TCGA-A2-A0T5-01A-21D-A099-09,0,NA,TCGA-A2-A0T5,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14503,Alive,TUMOR FREE,531,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,531,0,531,0,531,0,531,NA,Stage IIA,T2,M0,BRCA.LumA,1
-0.2037839,4.179728176,TCGA-C8-A1HK-01A,TCGA-C8-A1HK-01A-21D-A13L-09,4,0.415672923,TCGA-C8-A1HK,BRCA,53,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),NA,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,366,0,366,0,366,0,366,NA,Stage IIB,T2,M0,BRCA.Her2,6
9.036337139,-4.5635438,TCGA-E9-A2JT-01A,TCGA-E9-A2JT-01A-22D-A18P-09,1,0.796745395,TCGA-E9-A2JT,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23318,Alive,TUMOR FREE,288,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,288,0,288,0,288,0,288,NA,Stage IIA,T2,M0,BRCA.LumA,1
-6.377029051,1.65838707,TCGA-E2-A15E-01A,TCGA-E2-A15E-01A-11D-A12B-09,10,0.214254906,TCGA-E2-A15E,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14894,Alive,TUMOR FREE,630,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,630,0,630,0,630,0,630,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-6.182828855,3.586710007,TCGA-06-2561-01A,TCGA-06-2561-01A-02D-1494-08,11,0.527303929,TCGA-06-2561,GBM,53,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-19505,Dead,WITH TUMOR,NA,537,[Not Available],Recurrence,[Not Applicable],[Not Applicable],78,[Not Available],1,537,1,537,NA,NA,1,78,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,8
4.304660081,1.14903838,TCGA-C8-A1HL-01A,TCGA-C8-A1HL-01A-11D-A135-09,2,0.649241752,TCGA-C8-A1HL,BRCA,38,FEMALE,ASIAN,"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,317,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,317,0,317,0,317,0,317,NA,Stage IIIA,T3,M0,BRCA.LumB,5
-7.738017024,2.307337004,TCGA-32-2495-01A,TCGA-32-2495-01A-01D-1353-08,9,0.222483239,TCGA-32-2495,GBM,59,FEMALE,WHITE,Treated primary GBM,[Not Available],2008,[Not Available],-21860,Dead,WITH TUMOR,457,457,[Not Available],Recurrence,[Not Applicable],[Not Applicable],252,[Not Available],1,457,1,457,NA,NA,1,252,NA,NA,NA,NA,NA,7
-3.970274987,-0.866397255,TCGA-MN-A4N1-01A,TCGA-MN-A4N1-01A-11D-A24P-08,0,NA,TCGA-MN-A4N1,LUAD,60,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21939,Alive,TUMOR FREE,827,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,827,0,827,0,827,0,827,NA,Stage IIA,T2a,M0,NA,10
9.335074812,-5.596967169,TCGA-IB-7897-01A,TCGA-IB-7897-01A-21D-2201-08,1,0.852974877,TCGA-IB-7897,PAAD,53,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-19718,Dead,WITH TUMOR,NA,486,Pancreatic Cancer,Locoregional Recurrence|Distant Metastasis,Liver,NA,397,Progressive Disease,1,486,1,486,NA,NA,1,397,NA,Stage IIB,T3,M0,NA,1
-3.55829546,-2.804660318,TCGA-55-7995-01A,TCGA-55-7995-01A-11D-2184-08,8,0.391214938,TCGA-55-7995,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26837,Alive,TUMOR FREE,889,NA,[Not Available],Locoregional Recurrence,NA,NA,468,Complete Remission/Response,0,889,0,889,1,468,1,468,NA,Stage IA,T1b,M0,NA,10
-6.076973832,3.538625823,TCGA-CS-5390-01A,TCGA-CS-5390-01A-02D-1468-08,11,0.597335741,TCGA-CS-5390,LGG,47,FEMALE,WHITE,Oligodendroglioma,G2,2005,[Not Available],-17460,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,NA,0,NA,0,NA,0,NA,NA,NA,NA,NA,GBM_LGG.Codel,8
-5.363721862,2.693416272,TCGA-IB-8127-01A,TCGA-IB-8127-01A-11D-2396-08,12,0.264954447,TCGA-IB-8127,PAAD,59,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-21676,Alive,WITH TUMOR,522,NA,NA,Locoregional Recurrence|Distant Metastasis,"Other, specify",Tumor Bed and Liver,486,Complete Remission/Response,0,522,0,522,1,486,1,486,NA,Stage IIB,T3,M0,NA,8
10.02179123,-2.115070908,TCGA-D7-8579-01A,TCGA-D7-8579-01A-11D-2340-08,1,0.787907846,TCGA-D7-8579,STAD,66,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-24120,Alive,TUMOR FREE,636,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,636,0,636,0,636,0,636,NA,Stage IIB,T2,M0,GI.GS,1
10.04500755,-2.232777666,TCGA-91-8497-01A,TCGA-91-8497-01A-11D-2393-08,1,0.760615405,TCGA-91-8497,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27632,Dead,TUMOR FREE,NA,434,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,434,0,434,0,434,0,434,NA,Stage IA,T1a,MX,NA,1
-2.234448252,2.510400116,TCGA-55-8085-01A,TCGA-55-8085-01A-11D-2238-08,0,NA,TCGA-55-8085,LUAD,64,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23596,Alive,TUMOR FREE,904,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,904,0,904,0,904,0,904,NA,Stage IA,T1b,M0,NA,10
-2.737119809,-4.356741605,TCGA-IB-7651-01A,TCGA-IB-7651-01A-11D-2154-08,0,NA,TCGA-IB-7651,PAAD,64,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2009,[Not Available],-23580,Dead,WITH TUMOR,NA,603,Pancreatic Cancer,Locoregional Recurrence,NA,NA,492,Complete Remission/Response,1,603,1,603,1,492,1,492,NA,Stage IIB,T3,M0,NA,10
0.139644888,5.118315991,TCGA-DU-7300-01A,TCGA-DU-7300-01A-21D-2086-08,4,0.630369609,TCGA-DU-7300,LGG,53,FEMALE,WHITE,Oligodendroglioma,G3,2006,[Not Available],-19610,Dead,WITH TUMOR,NA,1886,[Not Available],NA,NA,NA,317,Progressive Disease,1,1886,1,1886,NA,NA,1,317,NA,NA,NA,NA,GBM_LGG.Codel,6
4.317097201,1.166396963,TCGA-62-A46V-01A,TCGA-62-A46V-01A-11D-A24D-08,2,0.703955702,TCGA-62-A46V,LUAD,78,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-28495,Alive,TUMOR FREE,2199,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2199,0,2199,0,2199,0,2199,NA,Stage IB,T2,M0,NA,5
-5.335796308,2.595702648,TCGA-IB-7889-01A,TCGA-IB-7889-01A-11D-2154-08,12,0.377658038,TCGA-IB-7889,PAAD,85,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-31393,Dead,WITH TUMOR,NA,481,Pancreatic Cancer,Locoregional Recurrence,NA,NA,352,Progressive Disease,1,481,1,481,NA,NA,1,352,NA,Stage IIB,T3,M0,NA,8
-3.502868852,-3.093261365,TCGA-BR-8368-01A,TCGA-BR-8368-01A-11D-2340-08,8,0.515020396,TCGA-BR-8368,STAD,84,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-30874,Alive,TUMOR FREE,131,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,131,0,131,0,131,0,131,NA,Stage IB,T2,M0,GI.HM-indel,10
-6.72695146,-2.15123948,TCGA-78-8660-01A,TCGA-78-8660-01A-11D-2393-08,6,0.192533169,TCGA-78-8660,LUAD,69,MALE,[Not Evaluated],Lung Adenocarcinoma,[Not Available],2005,[Not Available],-25422,Dead,WITH TUMOR,NA,321,[Not Available],Distant Metastasis,NA,NA,242,[Unknown],1,321,1,321,NA,NA,1,242,NA,Stage IIB,T2,M0,NA,2
-2.013220983,2.470471666,TCGA-55-8204-01A,TCGA-55-8204-01A-11D-2238-08,0,NA,TCGA-55-8204,LUAD,87,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-31818,Alive,TUMOR FREE,515,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,515,0,515,0,515,0,515,NA,Stage IB,T2a,MX,NA,6
9.90087247,-1.760000563,TCGA-IB-A5SQ-01A,TCGA-IB-A5SQ-01A-11D-A32N-08,1,0.8718736,TCGA-IB-A5SQ,PAAD,56,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-20760,Dead,WITH TUMOR,NA,219,NA,Distant Metastasis,Lung,NA,197,Complete Remission/Response,1,219,1,219,1,197,1,197,NA,Stage IB,T2,M0,NA,1
0.073956796,3.244487628,TCGA-E2-A1LL-01A,TCGA-E2-A1LL-01A-11D-A142-09,4,0.402183249,TCGA-E2-A1LL,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27028,Alive,WITH TUMOR,1309,NA,[Not Available],Distant Metastasis,Liver,NA,1303,[Not Available],0,1309,0,1309,1,1303,1,1303,NA,Stage IIIA,T3,MX,BRCA.Basal,3
9.507168867,-5.144531897,TCGA-BH-A1FM-01A,TCGA-BH-A1FM-01A-11D-A13L-09,1,0.812200637,TCGA-BH-A1FM,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-16289,Dead,NA,NA,1388,[Not Available],NA,NA,NA,NA,[Not Available],1,1388,NA,1388,NA,NA,0,1388,NA,Stage IIIA,T2,M0,BRCA.LumB,1
-1.874840742,1.143453836,TCGA-20-1684-01A,TCGA-20-1684-01A-01W-0633-09,5,0.662899541,TCGA-20-1684,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-18755,Alive,TUMOR FREE,581,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,581,0,581,0,581,0,581,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,4
7.805205873,-1.364897146,TCGA-AR-A1AH-01A,TCGA-AR-A1AH-01A-11D-A12B-09,1,0.140554848,TCGA-AR-A1AH,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18991,Alive,TUMOR FREE,3807,NA,[Not Available],New Primary Tumor,"Other, specify",Renal,1136,[Not Available],0,3807,0,3807,0,3807,1,1136,NA,Stage IIB,T2,M0,BRCA.Basal,1
-5.201556382,2.123047863,TCGA-AA-3695-01A,TCGA-AA-3695-01A-01W-0900-09,0,NA,TCGA-AA-3695,COAD,63,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-23164,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IV,T3,M1,NA,9
-7.289965328,1.452688736,TCGA-B6-A0X0-01A,TCGA-B6-A0X0-01A-21D-A10Y-09,0,NA,TCGA-B6-A0X0,BRCA,54,FEMALE,WHITE,"Other, specify",[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-19802,Dead,NA,NA,3945,[Not Available],NA,NA,NA,NA,[Not Available],1,3945,NA,3945,0,3945,0,3945,NA,Stage I,T1c,M0,BRCA.LumA,7
-4.882340141,1.062397873,TCGA-MP-A4TF-01A,TCGA-MP-A4TF-01A-11D-A25L-08,0,NA,TCGA-MP-A4TF,LUAD,58,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-21387,Dead,WITH TUMOR,NA,336,[Not Available],Distant Metastasis,NA,NA,195,Partial Remission/Response,1,336,1,336,NA,NA,1,195,NA,Stage IIA,T2b,M0,NA,10
-5.283725483,2.628819327,TCGA-IB-7886-01A,TCGA-IB-7886-01A-11D-2154-08,12,0.222156892,TCGA-IB-7886,PAAD,80,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2010,[Not Available],-29319,Dead,TUMOR FREE,NA,123,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,123,0,123,0,123,0,123,NA,Stage IIB,T3,M0,NA,8
-3.134279815,-3.603639536,TCGA-86-A4JF-01A,TCGA-86-A4JF-01A-11D-A24P-08,8,0.527334401,TCGA-86-A4JF,LUAD,56,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20491,Dead,WITH TUMOR,NA,737,[Not Available],Distant Metastasis,NA,NA,436,Complete Remission/Response,1,737,1,737,1,436,1,436,NA,Stage IIB,T3,M0,NA,10
9.398683747,-3.754123621,TCGA-A3-3372-01A,TCGA-A3-3372-01A-01D-2094-10,1,0.698333451,TCGA-A3-3372,KIRC,64,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-23528,Alive,TUMOR FREE,735,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,735,0,735,NA,NA,0,735,NA,Stage III,T3,M0,KIRC.2,1
-3.613786209,-2.645745547,TCGA-55-A4DF-01A,TCGA-55-A4DF-01A-11D-A24D-08,8,0.415258012,TCGA-55-A4DF,LUAD,88,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-32432,Dead,WITH TUMOR,NA,614,[Not Available],Distant Metastasis,NA,NA,515,Complete Remission/Response,1,614,1,614,1,515,1,515,NA,Stage IA,T1b,MX,NA,10
-5.281923374,2.620498296,TCGA-IB-7646-01A,TCGA-IB-7646-01A-11D-2154-08,12,0.280508402,TCGA-IB-7646,PAAD,60,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-22148,Dead,WITH TUMOR,NA,145,Pancreatic Cancer,Locoregional Recurrence,Liver,NA,132,Progressive Disease,1,145,1,145,NA,NA,1,132,NA,Stage IIB,T3,M0,NA,8
-4.187440085,-1.961130314,TCGA-53-A4EZ-01A,TCGA-53-A4EZ-01A-12D-A24P-08,8,0.330640973,TCGA-53-A4EZ,LUAD,63,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-23201,Alive,TUMOR FREE,1071,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1071,0,1071,NA,NA,0,1071,NA,Stage IIA,T2a,MX,NA,10
-4.284353198,-1.71024831,TCGA-55-8302-01A,TCGA-55-8302-01A-11D-2323-08,8,0.364723546,TCGA-55-8302,LUAD,54,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20011,Alive,TUMOR FREE,478,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,478,0,478,0,478,0,478,NA,Stage IB,T2,MX,NA,10
-6.008250554,3.419223439,TCGA-F2-A44G-01A,TCGA-F2-A44G-01A-11D-A26I-08,11,0.592151631,TCGA-F2-A44G,PAAD,79,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-29150,Dead,WITH TUMOR,NA,233,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",malignant ascites,214,Complete Remission/Response,1,233,1,233,1,214,1,214,NA,Stage IIB,T3,M0,NA,7
9.089687023,-1.459397122,TCGA-MP-A4SW-01A,TCGA-MP-A4SW-01A-21D-A24P-08,1,0.574688112,TCGA-MP-A4SW,LUAD,53,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-19640,Dead,NA,NA,1778,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1778,NA,1778,0,1778,0,1778,NA,Stage IIB,T2,M0,NA,6
-4.537500208,-0.320482418,TCGA-MP-A4TA-01A,TCGA-MP-A4TA-01A-21D-A24P-08,0,NA,TCGA-MP-A4TA,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-27513,Dead,WITH TUMOR,NA,950,[Not Available],Distant Metastasis,NA,NA,725,Complete Remission/Response,1,950,1,950,1,725,1,725,NA,Stage IA,T1,M0,NA,10
-5.323224864,2.710824231,TCGA-IB-7893-01A,TCGA-IB-7893-01A-11D-2201-08,0,NA,TCGA-IB-7893,PAAD,64,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2009,[Not Available],-23703,Dead,WITH TUMOR,NA,117,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,NA,80,Progressive Disease,1,117,1,117,NA,NA,1,80,NA,Stage IIA,T3,M0,NA,8
-0.075788964,4.8065899,TCGA-D7-8576-01A,TCGA-D7-8576-01A-11D-2340-08,4,0.606788835,TCGA-D7-8576,STAD,54,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-20014,Dead,WITH TUMOR,NA,446,[Not Available],Locoregional Recurrence|Distant Metastasis,Lung,NA,204,Complete Remission/Response,1,446,1,446,1,204,1,204,NA,Stage IIIB,T3,M0,GI.CIN,6
0.166517011,5.177533804,TCGA-DU-7011-01A,TCGA-DU-7011-01A-11D-2024-08,4,0.606150779,TCGA-DU-7011,LGG,25,MALE,WHITE,Oligoastrocytoma,G2,2000,[Not Available],-9322,Dead,WITH TUMOR,NA,3200,[Not Available],NA,NA,NA,NA,Stable Disease,1,3200,1,3200,NA,NA,1,3200,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.681141154,-1.726062544,TCGA-91-A4BD-01A,TCGA-91-A4BD-01A-11D-A24D-08,1,0.839795659,TCGA-91-A4BD,LUAD,78,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28544,Alive,TUMOR FREE,603,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,603,0,603,0,603,0,603,NA,Stage IIA,T1b,MX,NA,1
0.086578039,4.853756777,TCGA-IB-7888-01A,TCGA-IB-7888-01A-11D-2154-08,4,0.605002408,TCGA-IB-7888,PAAD,66,FEMALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-24117,Dead,WITH TUMOR,NA,1332,Pancreatic Cancer,Distant Metastasis,"Other, specify",Retroperitoneum,427,Stable Disease,1,1332,1,1332,NA,NA,1,427,NA,Stage IIA,T3,M0,NA,6
-3.283698664,-3.517798265,TCGA-55-7994-01A,TCGA-55-7994-01A-11D-2184-08,8,0.61406792,TCGA-55-7994,LUAD,81,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-29858,Alive,TUMOR FREE,603,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,603,0,603,0,603,0,603,NA,Stage IIB,T3,MX,NA,10
-7.972448681,2.124088779,TCGA-AO-A12A-01A,TCGA-AO-A12A-01A-21D-A10Y-09,9,0.627049522,TCGA-AO-A12A,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17420,Alive,TUMOR FREE,3112,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3112,0,3112,NA,NA,0,3112,NA,Stage IIA,T2,M0,BRCA.LumA,7
1.410754087,3.218075511,TCGA-A7-A0CD-01A,TCGA-A7-A0CD-01A-11W-A019-09,0,NA,TCGA-A7-A0CD,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Indeterminate (neither Pre or Postmenopausal),-24242,Alive,TUMOR FREE,1165,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1165,0,1165,0,1165,0,1165,NA,Stage I,T1,M0,BRCA.LumA,1
8.757324824,-5.194692527,TCGA-BH-A0HB-01A,TCGA-BH-A0HB-01A-11W-A071-09,1,0.849427841,TCGA-BH-A0HB,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20448,Alive,TUMOR FREE,806,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,806,0,806,0,806,0,806,NA,Stage IA,T1c,M0,BRCA.LumA,1
-8.070989263,2.06711771,TCGA-BH-A0DE-01A,TCGA-BH-A0DE-01A-11D-A10Y-09,9,0.537162875,TCGA-BH-A0DE,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656,Alive,TUMOR FREE,2372,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2372,0,2372,0,2372,0,2372,NA,Stage IIA,T2,M0,BRCA.LumA,7
-5.21374,2.490408574,TCGA-DM-A1D6-01A,TCGA-DM-A1D6-01A-21D-A152-10,12,0.3626339,TCGA-DM-A1D6,COAD,88,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2000,[Not Available],-32302,Dead,NA,1518,1518,[Not Available],NA,NA,NA,NA,[Not Available],1,1518,NA,1518,NA,NA,0,1518,NA,Stage IIA,T3,M0,GI.CIN,8
9.268889734,-2.39500171,TCGA-E2-A15A-01A,TCGA-E2-A15A-01A-11D-A12B-09,1,0.743273296,TCGA-E2-A15A,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16750,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,710,0,710,0,710,0,710,NA,Stage IIIC,T2,M0,BRCA.LumB,1
-0.227139646,4.680434184,TCGA-HT-7855-01A,TCGA-HT-7855-01A-11D-2395-08,4,0.59092441,TCGA-HT-7855,LGG,39,MALE,WHITE,Astrocytoma,G3,2008,[Not Available],-14496,Alive,TUMOR FREE,585,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,585,0,585,0,585,0,585,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.80199044,-1.968716366,TCGA-IB-7890-01A,TCGA-IB-7890-01A-12D-2201-08,0,NA,TCGA-IB-7890,PAAD,73,MALE,[Unknown],Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-26747,Dead,WITH TUMOR,NA,598,Pancreatic Cancer,Distant Metastasis,Liver,NA,519,Progressive Disease,1,598,1,598,NA,NA,1,519,NA,Stage IB,T2,M0,NA,2
-7.770128619,1.992683288,TCGA-HU-A4G2-01A,TCGA-HU-A4G2-01A-11D-A25D-08,9,0.366691648,TCGA-HU-A4G2,STAD,45,MALE,ASIAN,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-16791,Alive,TUMOR FREE,739,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,739,0,739,0,739,0,739,NA,Stage IIB,T3,M0,GI.EBV,7
-5.241376907,0.894736012,TCGA-64-1677-01A,TCGA-64-1677-01A-01W-0928-08,0,NA,TCGA-64-1677,LUAD,77,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-28482,Dead,NA,NA,628,[Not Available],NA,NA,NA,360,[Not Available],1,628,NA,628,NA,NA,1,360,NA,Stage IIIA,T2,M0,LUAD.3,10
9.583383893,-5.614643561,TCGA-FB-A4P6-01A,TCGA-FB-A4P6-01A-12D-A26I-08,1,0.88143497,TCGA-FB-A4P6,PAAD,54,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2012,[Not Available],-19904,Alive,TUMOR FREE,767,NA,NA,Locoregional Recurrence,NA,NA,620,Complete Remission/Response,0,767,0,767,1,620,1,620,NA,Stage IIB,T3,MX,NA,1
9.038816828,-3.15541711,TCGA-BP-5180-01A,TCGA-BP-5180-01A-01D-1429-08,1,0.733317099,TCGA-BP-5180,KIRC,53,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-19413,Alive,TUMOR FREE,2263,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2263,0,2263,NA,NA,0,2263,NA,Stage I,T1a,M0,KIRC.4,1
-1.667719432,1.333933926,TCGA-HT-7469-01A,TCGA-HT-7469-01A-11D-2253-08,5,0.422289009,TCGA-HT-7469,LGG,30,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-11097,Dead,WITH TUMOR,NA,351,[Not Available],NA,NA,NA,92,Progressive Disease,1,351,1,351,NA,NA,1,92,NA,NA,NA,NA,GBM_LGG.PA-like,6
-4.460862395,1.715440749,TCGA-IB-A5SP-01A,TCGA-IB-A5SP-01A-11D-A32N-08,0,NA,TCGA-IB-A5SP,PAAD,77,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-28317,Alive,WITH TUMOR,482,NA,NA,Locoregional Recurrence,"Other, specify",Superior Mesenteric Artery,300,[Unknown],0,482,0,482,NA,NA,1,300,NA,Stage IIA,T3,M0,NA,8
-0.618166023,4.549193031,TCGA-BR-A4CS-01A,TCGA-BR-A4CS-01A-11D-A24D-08,4,0.499976821,TCGA-BR-A4CS,STAD,77,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-28211,Dead,TUMOR FREE,NA,45,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,45,0,45,0,45,0,45,NA,Stage IIIC,T4b,M0,GI.CIN,6
8.927050196,-4.261158616,TCGA-D8-A27E-01A,TCGA-D8-A27E-01A-11D-A16D-09,1,0.720656021,TCGA-D8-A27E,BRCA,66,FEMALE,WHITE,"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315,Alive,TUMOR FREE,530,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,530,0,530,0,530,0,530,NA,Stage IA,T1c,M0,BRCA.LumA,1
-6.178346637,1.866178206,TCGA-IB-A5SS-01A,TCGA-IB-A5SS-01A-11D-A32N-08,10,0.052358632,TCGA-IB-A5SS,PAAD,64,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-23431,Dead,WITH TUMOR,NA,460,Pancreatic Cancer,Distant Metastasis,Liver,NA,66,Complete Remission/Response,1,460,1,460,1,66,1,66,NA,Stage IIB,T3,M0,NA,8
-8.143950057,2.163862136,TCGA-BR-8364-01A,TCGA-BR-8364-01A-11D-2340-08,9,0.57347369,TCGA-BR-8364,STAD,42,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-15389,Alive,TUMOR FREE,675,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,675,0,675,0,675,0,675,NA,Stage IIIC,T4b,M0,GI.CIN,7
-0.891927408,4.220827126,TCGA-AR-A0TP-01A,TCGA-AR-A0TP-01A-11D-A099-09,4,0.440938999,TCGA-AR-A0TP,BRCA,43,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15812,Alive,TUMOR FREE,4275,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4275,0,4275,0,4275,0,4275,NA,Stage IIA,T2,M0,BRCA.Basal,6
-1.78158504,0.973999196,TCGA-A1-A0SF-01A,TCGA-A1-A0SF-01A-11D-A142-09,5,0.659230031,TCGA-A1-A0SF,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19731,Alive,TUMOR FREE,1463,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1463,0,1463,0,1463,0,1463,NA,Stage IIA,T2,M0,BRCA.LumA,4
0.310330905,4.864205667,TCGA-BH-A1F6-01A,TCGA-BH-A1F6-01A-11D-A13L-09,4,0.446542737,TCGA-BH-A1F6,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1996,[Not Available],-18691,Dead,NA,NA,2965,[Not Available],NA,NA,NA,NA,[Not Available],1,2965,NA,2965,NA,NA,0,2965,NA,[Not Available],T4d,MX,BRCA.Basal,6
9.594388207,-5.672457699,TCGA-AC-A2FK-01A,TCGA-AC-A2FK-01A-12D-A17W-09,1,0.872485008,TCGA-AC-A2FK,BRCA,45,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2006,[Not Available],-16627,Alive,TUMOR FREE,2650,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2650,0,2650,0,2650,0,2650,NA,Stage IIIC,T2,M0,BRCA.Normal,1
9.219179234,-5.277923304,TCGA-A8-A090-01A,TCGA-A8-A090-01A-11W-A019-09,1,0.827900297,TCGA-A8-A090,BRCA,74,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27121,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIA,T2,M0,BRCA.LumA,1
-5.296232562,2.630616183,TCGA-IB-A5SO-01A,TCGA-IB-A5SO-01A-11D-A32N-08,12,0.320537081,TCGA-IB-A5SO,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26129,Dead,WITH TUMOR,NA,365,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,NA,276,Progressive Disease,1,365,1,365,NA,NA,1,276,NA,Stage IIB,T3,M0,NA,8
-0.895704293,3.468880297,TCGA-BR-8678-01A,TCGA-BR-8678-01A-11D-2394-08,4,0.278013683,TCGA-BR-8678,STAD,76,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-28037,Alive,TUMOR FREE,754,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,754,0,754,0,754,0,754,NA,Stage IB,T2,M0,GI.CIN,5
4.338081947,1.141724254,TCGA-IB-A5ST-01A,TCGA-IB-A5ST-01A-11D-A32N-08,2,0.685811313,TCGA-IB-A5ST,PAAD,64,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-23672,Alive,TUMOR FREE,635,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,635,0,635,0,635,0,635,NA,Stage IIB,T3,M0,NA,5
-5.212761305,0.987979246,TCGA-DU-7298-01A,TCGA-DU-7298-01A-11D-2024-08,0,NA,TCGA-DU-7298,LGG,38,FEMALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G3,2006,[Not Available],-14205,Dead,WITH TUMOR,NA,576,[Not Available],NA,NA,NA,200,Progressive Disease,1,576,1,576,NA,NA,1,200,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,10
9.37274932,-4.985854365,TCGA-IB-8126-01A,TCGA-IB-8126-01A-11D-2396-08,1,0.781799075,TCGA-IB-8126,PAAD,79,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-29213,Alive,WITH TUMOR,462,NA,NA,Distant Metastasis,Lung,NA,83,Partial Remission/Response,0,462,0,462,NA,NA,1,83,NA,Stage III,T4,M0,NA,1
9.866994777,-4.326679183,TCGA-BR-A4J7-01A,TCGA-BR-A4J7-01A-31D-A25D-08,1,0.622130401,TCGA-BR-A4J7,STAD,49,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012,[Not Available],-17932,Alive,TUMOR FREE,989,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,989,0,989,0,989,0,989,NA,Stage IIB,T4a,M0,GI.CIN,6
-4.42780987,1.783896368,TCGA-IB-7649-01A,TCGA-IB-7649-01A-11D-2154-08,0,NA,TCGA-IB-7649,PAAD,73,FEMALE,[Unknown],Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-26773,Dead,NA,NA,467,NA,Distant Metastasis,Liver,NA,282,Partial Remission/Response,1,467,NA,467,NA,NA,1,282,NA,Stage IIB,T3,M0,NA,8
0.156477999,2.563710823,TCGA-IB-7891-01A,TCGA-IB-7891-01A-11D-2201-08,4,0.204742623,TCGA-IB-7891,PAAD,49,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-18202,Dead,WITH TUMOR,NA,913,Pancreatic Cancer,Distant Metastasis,"Other, specify",Lung and Liver,525,Complete Remission/Response,1,913,1,913,1,525,1,525,NA,Stage IIB,T3,M0,NA,3
9.67283068,-5.440961679,TCGA-BR-8371-01A,TCGA-BR-8371-01A-11D-2340-08,1,0.866517669,TCGA-BR-8371,STAD,62,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-22883,Dead,WITH TUMOR,NA,359,[Not Available],Distant Metastasis,"Other, specify",Brain,357,Progressive Disease,1,359,1,359,NA,NA,1,357,NA,Stage IIIB,T3,M0,GI.GS,1
-7.28137483,1.476903304,TCGA-AN-A0XO-01A,TCGA-AN-A0XO-01A-11D-A10G-09,0,NA,TCGA-AN-A0XO,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21640,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,375,0,375,0,375,0,375,NA,Stage IIIA,T2,M0,BRCA.LumA,7
-1.975147263,2.323479164,TCGA-E9-A1RF-01A,TCGA-E9-A1RF-01A-11D-A159-09,0,NA,TCGA-E9-A1RF,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25119,Alive,TUMOR FREE,200,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,200,0,200,0,200,0,200,NA,Stage IIIA,T2,M0,BRCA.LumA,3
-4.784686043,-1.553700179,TCGA-E2-A10C-01A,TCGA-E2-A10C-01A-21D-A10M-09,8,0.366179546,TCGA-E2-A10C,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19849,Alive,TUMOR FREE,1220,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1220,0,1220,0,1220,0,1220,NA,Stage IIB,T2,M0,BRCA.LumB,10
-5.248199301,2.680862684,TCGA-IB-7645-01A,TCGA-IB-7645-01A-22D-2201-08,12,0.235449583,TCGA-IB-7645,PAAD,44,FEMALE,[Unknown],Pancreas-Adenocarcinoma Ductal Type,G1,2007,[Not Available],-16126,Dead,WITH TUMOR,NA,1502,Pancreatic Cancer,Distant Metastasis,Liver,NA,984,Progressive Disease,1,1502,1,1502,NA,NA,1,984,NA,Stage IIB,T3,M0,NA,8
0.185220123,5.094404897,TCGA-HT-8018-01A,TCGA-HT-8018-01A-11D-2395-08,4,0.694946438,TCGA-HT-8018,LGG,40,FEMALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-14910,Dead,TUMOR FREE,NA,1152,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,1152,0,1152,NA,NA,0,1152,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-6.041490175,2.114011669,TCGA-IB-7647-01A,TCGA-IB-7647-01A-11D-2154-08,0,NA,TCGA-IB-7647,PAAD,41,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-15188,Dead,WITH TUMOR,NA,666,Pancreatic Cancer,Distant Metastasis,Liver,NA,390,Progressive Disease,1,666,1,666,NA,NA,1,390,NA,Stage IIB,T3,M0,NA,7
-6.009332839,2.818748937,TCGA-44-A47A-01A,TCGA-44-A47A-01A-21D-A24D-08,0,NA,TCGA-44-A47A,LUAD,78,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28782,Alive,WITH TUMOR,466,NA,[Not Available],Distant Metastasis,NA,NA,397,Complete Remission/Response,0,466,0,466,1,397,1,397,NA,Stage IB,T2a,MX,NA,3
-5.403076204,2.605127206,TCGA-IB-7887-01A,TCGA-IB-7887-01A-11D-2154-08,12,0.319722458,TCGA-IB-7887,PAAD,62,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2009,[Not Available],-22990,Dead,NA,NA,110,Pancreatic Cancer,NA,NA,NA,NA,[Unknown],1,110,1,110,NA,NA,0,110,NA,Stage IIB,T3,M0,NA,8
-6.177465498,1.509398136,TCGA-HU-8238-01A,TCGA-HU-8238-01A-11D-2340-08,10,0.360267297,TCGA-HU-8238,STAD,56,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-20708,Alive,TUMOR FREE,46,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,46,0,46,0,46,0,46,NA,[Discrepancy],T3,M0,NA,9
0.264084326,5.156387405,TCGA-12-1092-01B,TCGA-12-1092-01B-01W-0611-08,4,0.628638842,TCGA-12-1092,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-21411,Dead,WITH TUMOR,658,661,[Not Available],Recurrence,[Not Applicable],[Not Applicable],637,[Not Available],1,661,1,661,NA,NA,1,637,NA,NA,NA,NA,NA,6
-6.048384058,2.718631937,TCGA-J2-8194-01A,TCGA-J2-8194-01A-11D-2238-08,0,NA,TCGA-J2-8194,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25441,Alive,WITH TUMOR,724,NA,[Not Available],Distant Metastasis,NA,NA,470,Progressive Disease,0,724,0,724,NA,NA,1,470,NA,Stage IIB,T3,MX,NA,9
2.130392403,1.75091264,TCGA-BR-8058-01A,TCGA-BR-8058-01A-31D-2340-08,3,0.456401922,TCGA-BR-8058,STAD,53,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-19658,Alive,TUMOR FREE,1133,NA,[Not Available],New Primary Tumor,"Other, specify",Rectum,89,Complete Remission/Response,0,1133,0,1133,0,1133,1,89,NA,Stage IIIB,T4a,M0,GI.CIN,3
-4.290968946,1.69004129,TCGA-32-2494-01A,TCGA-32-2494-01A-01D-1353-08,0,NA,TCGA-32-2494,GBM,58,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-21198,Dead,WITH TUMOR,632,632,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],488,[Not Available],1,632,1,632,NA,NA,1,488,NA,NA,NA,NA,NA,8
-6.91146598,1.371461572,TCGA-AA-3812-01A,TCGA-AA-3812-01A-01W-0900-09,0,NA,TCGA-AA-3812,COAD,82,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-29980,Alive,TUMOR FREE,1066,NA,[Not Available],NA,NA,NA,762,Complete Remission/Response,0,1066,0,1066,1,762,1,762,NA,Stage IIA,T3,M0,GI.CIN,8
-5.239707837,2.589003117,TCGA-FB-A545-01A,TCGA-FB-A545-01A-11D-A26I-08,12,0.227098046,TCGA-FB-A545,PAAD,72,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26635,Dead,TUMOR FREE,NA,732,Pancreatic Cancer,Distant Metastasis,Liver,NA,378,Complete Remission/Response,1,732,1,732,1,378,1,378,NA,Stage IIB,T3,M0,NA,8
9.591481873,-5.587514704,TCGA-F2-A44H-01A,TCGA-F2-A44H-01A-11D-A26I-08,1,0.843293401,TCGA-F2-A44H,PAAD,65,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24007,Alive,TUMOR FREE,586,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,586,0,586,0,586,0,586,NA,Stage IIA,T3,M0,NA,1
-0.505123125,5.063976507,TCGA-HT-7485-01A,TCGA-HT-7485-01A-11D-2024-08,4,0.453222055,TCGA-HT-7485,LGG,42,MALE,WHITE,Astrocytoma,G2,2006,[Not Available],-15589,Alive,TUMOR FREE,122,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,122,0,122,0,122,0,122,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.228781364,5.314131969,TCGA-CD-8526-01A,TCGA-CD-8526-01A-11D-2340-08,4,0.48688716,TCGA-CD-8526,STAD,73,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],-26840,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,381,0,381,0,381,0,381,NA,Stage IIIA,T3,M0,GI.CIN,6
0.362841111,4.878788088,TCGA-FG-5963-01A,TCGA-FG-5963-01A-11D-1705-08,4,0.642125441,TCGA-FG-5963,LGG,23,MALE,WHITE,Astrocytoma,G3,2009,[Not Available],-8571,Dead,WITH TUMOR,NA,775,[Not Available],NA,NA,NA,395,Progressive Disease,1,775,1,775,NA,NA,1,395,NA,NA,NA,NA,GBM_LGG.PA-like,6
-5.572261506,1.335866493,TCGA-55-7574-01A,TCGA-55-7574-01A-11D-2036-08,0,NA,TCGA-55-7574,LUAD,64,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23703,Dead,WITH TUMOR,NA,995,[Not Available],Distant Metastasis,NA,NA,478,Complete Remission/Response,1,995,1,995,1,478,1,478,NA,Stage IB,T2a,M0,LUAD.6,9
9.793324009,-1.994923759,TCGA-HU-A4H6-01A,TCGA-HU-A4H6-01A-11D-A25D-08,1,0.810032335,TCGA-HU-A4H6,STAD,72,FEMALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-26445,Alive,WITH TUMOR,644,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,644,0,644,0,644,0,644,NA,Stage IIIA,T3,M0,GI.CIN,1
-0.20489939,5.291892194,TCGA-HT-7603-01A,TCGA-HT-7603-01A-21D-2086-08,4,0.500567776,TCGA-HT-7603,LGG,29,MALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-10883,Alive,TUMOR FREE,705,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,705,0,705,0,705,0,705,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.20985082,-3.581854088,TCGA-AA-A022-01A,TCGA-AA-A022-01A-21D-A17O-10,8,0.460268236,TCGA-AA-A022,COAD,88,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-32446,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage II,T4,M0,NA,10
-2.83503999,1.040188509,TCGA-BH-A0BZ-01A,TCGA-BH-A0BZ-01A-31D-A12Q-09,5,0.069337657,TCGA-BH-A0BZ,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21856,Alive,TUMOR FREE,2255,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2255,0,2255,0,2255,0,2255,NA,Stage IIIA,T3,M0,BRCA.LumB,10
-5.554688104,1.653594485,TCGA-D8-A1Y1-01A,TCGA-D8-A1Y1-01A-21D-A14K-09,0,NA,TCGA-D8-A1Y1,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29474,Dead,WITH TUMOR,NA,302,[Not Available],NA,NA,NA,NA,[Not Available],1,302,1,302,NA,NA,1,302,NA,Stage IIIA,T3,MX,BRCA.LumB,10
9.232916199,-1.479939837,TCGA-FG-7637-01A,TCGA-FG-7637-01A-11D-2086-08,1,0.675869484,TCGA-FG-7637,LGG,49,MALE,WHITE,Oligoastrocytoma,G2,2009,[Not Available],-18084,Alive,WITH TUMOR,1219,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1219,0,1219,NA,NA,0,1219,NA,NA,NA,NA,GBM_LGG.Codel,1
-3.790181594,-2.549743428,TCGA-BR-8382-01A,TCGA-BR-8382-01A-11D-2394-08,8,0.419501422,TCGA-BR-8382,STAD,67,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-24737,Dead,TUMOR FREE,NA,762,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,762,0,762,0,762,0,762,NA,Stage IIIC,T4b,M0,GI.HM-indel,10
-3.988838154,-1.906110185,TCGA-38-4625-01A,TCGA-38-4625-01A-01D-1553-08,8,0.310341871,TCGA-38-4625,LUAD,66,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-24241,Alive,NA,2973,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2973,0,2973,0,2973,0,2973,NA,Stage IB,T2a,M0,NA,10
-7.21740167,-2.564473373,TCGA-BR-A44U-01A,TCGA-BR-A44U-01A-11D-A24D-08,6,0.308647306,TCGA-BR-A44U,STAD,70,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-25577,Dead,TUMOR FREE,NA,422,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,422,0,422,0,422,0,422,NA,Stage IIIB,T3,M0,GI.CIN,2
-1.913478751,1.044825355,TCGA-A8-A09V-01A,TCGA-A8-A09V-01A-11D-A045-09,5,0.61524046,TCGA-A8-A09V,BRCA,51,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18628,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,457,0,457,0,457,0,457,NA,Stage IIA,T2,M0,BRCA.LumA,4
-4.821777215,0.748026222,TCGA-A6-4105-01A,TCGA-A6-4105-01A-02D-1771-10,0,NA,TCGA-A6-4105,COAD,79,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29097,Dead,TUMOR FREE,NA,442,[Not Available],NA,NA,NA,364,[Not Available],1,442,0,442,NA,NA,1,364,NA,Stage IIA,T3,M0,GI.CIN,9
-0.443033075,4.446912432,TCGA-D8-A27M-01A,TCGA-D8-A27M-01A-11D-A16D-09,4,0.489079286,TCGA-D8-A27M,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21910,Alive,TUMOR FREE,410,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,410,0,410,0,410,0,410,NA,Stage IA,T1c,M0,BRCA.Basal,6
0.109845862,5.072278683,TCGA-HT-7690-01A,TCGA-HT-7690-01A-11D-2253-08,4,0.60162548,TCGA-HT-7690,LGG,29,MALE,WHITE,Oligoastrocytoma,G3,2009,[Not Available],-10673,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3,0,3,NA,NA,0,3,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.670885719,-2.445590737,TCGA-HU-8245-01A,TCGA-HU-8245-01A-11D-2340-08,6,0.411433325,TCGA-HU-8245,STAD,72,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G3,2011,[Not Available],-26521,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,552,0,552,0,552,0,552,NA,Stage IIA,T3,M0,NA,2
-5.263473885,1.03161809,TCGA-CD-A48C-01A,TCGA-CD-A48C-01A-11D-A24D-08,0,NA,TCGA-CD-A48C,STAD,79,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-29203,Dead,WITH TUMOR,NA,353,[Not Available],Locoregional Recurrence,NA,NA,230,Complete Remission/Response,1,353,1,353,1,230,1,230,NA,Stage IIB,T3,M0,GI.CIN,10
0.102342028,4.82922987,TCGA-HU-8243-01A,TCGA-HU-8243-01A-11D-2340-08,4,0.531300652,TCGA-HU-8243,STAD,66,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011,[Not Available],-24187,Dead,WITH TUMOR,NA,180,Stomach Cancer,Distant Metastasis,Liver,NA,132,Partial Remission/Response,1,180,1,180,NA,NA,1,132,NA,Stage IIIC,T4a,M0,NA,6
-0.973625791,3.053447019,TCGA-BR-8690-01A,TCGA-BR-8690-01A-11D-2394-08,4,0.12988275,TCGA-BR-8690,STAD,54,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-19855,Alive,TUMOR FREE,325,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,325,0,325,0,325,0,325,NA,Stage IIIB,T3,M0,NA,10
-4.540352314,-1.661178707,TCGA-73-4668-01A,TCGA-73-4668-01A-01D-1265-08,8,0.32697211,TCGA-73-4668,LUAD,66,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24255,Alive,WITH TUMOR,467,NA,[Not Available],NA,NA,NA,236,Complete Remission/Response,0,467,0,467,1,236,1,236,NA,Stage IIB,T2,M0,NA,10
-5.408982423,-1.271261763,TCGA-06-1801-01A,TCGA-06-1801-01A-02W-0643-08,0,NA,TCGA-06-1801,GBM,56,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-20538,Dead,WITH TUMOR,NA,360,[Not Available],Recurrence,[Not Applicable],[Not Applicable],232,[Not Available],1,360,1,360,NA,NA,1,232,NA,NA,NA,NA,NA,10
8.595360317,-4.239626864,TCGA-D8-A1XR-01A,TCGA-D8-A1XR-01A-11D-A14K-09,1,0.709905903,TCGA-D8-A1XR,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20488,Alive,TUMOR FREE,482,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,482,0,482,0,482,0,482,NA,Stage IIB,T2,M0,BRCA.LumB,1
8.440196473,-3.584303234,TCGA-E2-A10A-01A,TCGA-E2-A10A-01A-21D-A10Y-09,1,0.638773236,TCGA-E2-A10A,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15085,Alive,WITH TUMOR,1229,NA,[Not Available],Distant Metastasis,Bone,NA,75,[Not Available],0,1229,0,1229,1,75,1,75,NA,Stage IIB,T3,M0,BRCA.LumA,1
-4.520806175,1.658085163,TCGA-F4-6461-01A,TCGA-F4-6461-01A-11D-1771-10,0,NA,TCGA-F4-6461,COAD,41,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-15151,Dead,WITH TUMOR,NA,338,[Not Available],NA,NA,NA,288,[Not Available],1,338,1,338,NA,NA,1,288,NA,Stage IIIC,T4b,M0,GI.CIN,9
8.684028779,-4.17714361,TCGA-BR-A453-01A,TCGA-BR-A453-01A-11D-A24D-08,1,0.709605702,TCGA-BR-A453,STAD,51,MALE,ASIAN,"Stomach Adenocarcinoma, Signet Ring Type",G3,2012,[Not Available],-18988,Dead,TUMOR FREE,NA,185,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,185,0,185,NA,NA,0,185,NA,Stage IV,T4a,M1,GI.GS,1
-5.195163563,2.286848235,TCGA-AA-3655-01A,TCGA-AA-3655-01A-02D-1719-10,12,0.025249894,TCGA-AA-3655,COAD,68,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-24896,Alive,TUMOR FREE,1856,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1856,0,1856,0,1856,0,1856,NA,Stage II,T3,M0,GI.CIN,8
0.483960325,4.734185234,TCGA-HT-7880-01A,TCGA-HT-7880-01A-11D-2395-08,4,0.425550031,TCGA-HT-7880,LGG,30,MALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-11043,Alive,TUMOR FREE,162,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,162,0,162,NA,NA,0,162,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.247364607,3.480136444,TCGA-DU-7019-01A,TCGA-DU-7019-01A-11D-2024-08,4,0.350902003,TCGA-DU-7019,LGG,39,MALE,WHITE,Oligoastrocytoma,[Discrepancy],2009,[Not Available],-14279,Alive,TUMOR FREE,800,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,800,0,800,NA,NA,0,800,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
8.319194546,-3.206762814,TCGA-EB-A5SF-01A,TCGA-EB-A5SF-01A-11D-A30X-08,1,0.603452388,TCGA-EB-A5SF,SKCM,78,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-28772,Dead,TUMOR FREE,NA,369,[Not Available],NA,NA,NA,NA,[Not Available],1,369,0,369,NA,NA,0,369,NA,Stage IIC,T4b,M0,NA,1
-7.732582996,-2.486831209,TCGA-HW-7491-01A,TCGA-HW-7491-01A-11D-2024-08,6,0.53718378,TCGA-HW-7491,LGG,35,MALE,WHITE,Oligodendroglioma,G2,2009,[Not Available],-12874,Alive,WITH TUMOR,2078,NA,[Not Available],NA,NA,NA,2197,Progressive Disease,0,2078,0,2078,NA,NA,1,2197,NA,NA,NA,NA,GBM_LGG.Codel,2
9.324688881,-5.53665688,TCGA-CS-6670-01A,TCGA-CS-6670-01A-11D-1893-08,1,0.840560806,TCGA-CS-6670,LGG,43,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-16066,Alive,WITH TUMOR,1426,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,1426,0,1426,NA,NA,0,1426,NA,NA,NA,NA,GBM_LGG.Codel,1
-3.542930775,-3.330804684,TCGA-A6-6141-01A,TCGA-A6-6141-01A-11D-1771-10,8,0.608425614,TCGA-A6-6141,COAD,31,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-11391,Alive,TUMOR FREE,255,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,255,0,255,NA,NA,0,255,NA,Stage IIA,T3,M0,NA,10
-8.059938674,1.926268717,TCGA-AC-A23E-01A,TCGA-AC-A23E-01A-11D-A159-09,9,0.519539381,TCGA-AC-A23E,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,[Not Available],-18500,Alive,TUMOR FREE,698,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,698,0,698,0,698,0,698,NA,Stage IIB,T2,MX,BRCA.LumA,7
8.826260524,-1.989384933,TCGA-HT-8107-01A,TCGA-HT-8107-01A-13D-2395-08,1,0.634389681,TCGA-HT-8107,LGG,62,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-22880,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,14,0,14,NA,NA,0,14,NA,NA,NA,NA,GBM_LGG.PA-like,1
8.800307103,-4.049841997,TCGA-DH-5144-01A,TCGA-DH-5144-01A-01D-1468-08,1,0.734011412,TCGA-DH-5144,LGG,56,FEMALE,WHITE,Oligodendroglioma,G3,2009,[Not Available],-20558,Alive,TUMOR FREE,748,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,748,0,748,0,748,0,748,NA,NA,NA,NA,GBM_LGG.Codel,1
-6.347375579,1.671220495,TCGA-CS-4942-01A,TCGA-CS-4942-01A-01D-1468-08,10,0.16934104,TCGA-CS-4942,LGG,44,FEMALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G3,2006,[Not Available],-16297,Dead,WITH TUMOR,NA,1335,[Not Available],NA,NA,NA,1184,Progressive Disease,1,1335,1,1335,NA,NA,1,1184,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,7
-8.223129883,2.182216829,TCGA-DU-5852-01A,TCGA-DU-5852-01A-11D-1705-08,9,0.440051333,TCGA-DU-5852,LGG,61,FEMALE,WHITE,Oligoastrocytoma,G3,2010,[Not Available],-22348,Dead,WITH TUMOR,NA,205,[Not Available],NA,NA,NA,24,Progressive Disease,1,205,1,205,NA,NA,1,24,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
4.354695768,1.183536862,TCGA-ER-A2NF-01A,TCGA-ER-A2NF-01A-11D-A19A-08,2,0.656196727,TCGA-ER-A2NF,SKCM,53,MALE,WHITE,NA,[Not Available],2010,[Not Available],-19499,Dead,WITH TUMOR,NA,877,[Not Available],NA,NA,NA,230,[Not Available],1,877,1,877,NA,NA,1,230,NA,Stage IIIB,T3b,M0,SKCM.-,1
-7.59728384,2.120673316,TCGA-AR-A0TZ-01A,TCGA-AR-A0TZ-01A-12D-A099-09,9,0.415392261,TCGA-AR-A0TZ,BRCA,43,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15720,Dead,NA,NA,3262,[Not Available],Distant Metastasis,Bone,NA,1313,[Not Available],1,3262,NA,3262,1,1313,1,1313,NA,[Discrepancy],T2,M1,BRCA.LumA,7
0.405993487,4.696154367,TCGA-HT-8013-01A,TCGA-HT-8013-01A-11D-2395-08,4,0.410224735,TCGA-HT-8013,LGG,37,FEMALE,WHITE,Oligoastrocytoma,G2,2005,[Not Available],-13753,Dead,WITH TUMOR,NA,1933,[Not Available],NA,NA,NA,1306,Stable Disease,1,1933,1,1933,NA,NA,1,1306,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.06844708,1.523036339,TCGA-F4-6809-01A,TCGA-F4-6809-01A-11D-1835-10,0,NA,TCGA-F4-6809,COAD,52,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-19039,Dead,WITH TUMOR,NA,403,[Not Available],NA,NA,NA,NA,[Not Available],1,403,1,403,NA,NA,1,403,NA,Stage IVA,T3,M1,GI.CIN,9
0.471040173,3.601269368,TCGA-BH-A0DI-01A,TCGA-BH-A0DI-01A-21D-A12Q-09,4,0.23647673,TCGA-BH-A0DI,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23327,Alive,TUMOR FREE,912,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,912,0,912,0,912,0,912,NA,Stage IIB,T2,M0,BRCA.LumA,3
-6.350073623,3.567897472,TCGA-ER-A2NB-01A,TCGA-ER-A2NB-01A-12D-A196-08,11,0.137531818,TCGA-ER-A2NB,SKCM,57,MALE,WHITE,NA,[Not Available],2010,[Not Available],-20938,Dead,WITH TUMOR,NA,857,[Not Available],NA,NA,NA,461,[Not Available],1,857,1,857,NA,NA,1,461,NA,Stage IIIB,T4b,M0,SKCM.RAS_Hotspot_Mutants,7
9.294759836,-4.738240205,TCGA-EZ-7264-01A,TCGA-EZ-7264-01A-11D-2024-08,1,0.788690435,TCGA-EZ-7264,LGG,47,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-17432,Alive,WITH TUMOR,1201,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1201,0,1201,NA,NA,0,1201,NA,NA,NA,NA,GBM_LGG.Codel,1
0.00951696,4.386988281,TCGA-DU-6396-01A,TCGA-DU-6396-01A-11D-1705-08,4,0.479489094,TCGA-DU-6396,LGG,31,FEMALE,WHITE,Oligoastrocytoma,G3,1996,[Not Available],-11427,Dead,WITH TUMOR,NA,2286,[Not Available],NA,NA,NA,106,Progressive Disease,1,2286,1,2286,NA,NA,1,106,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.891256664,-1.942811514,TCGA-BH-A18H-01A,TCGA-BH-A18H-01A-11D-A12B-09,0,NA,TCGA-BH-A18H,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23065,Alive,TUMOR FREE,652,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,652,0,652,0,652,0,652,NA,Stage IA,T1b,M0,BRCA.LumA,2
9.256214403,-5.800884747,TCGA-AG-3583-01A,TCGA-AG-3583-01A-01D-1989-10,1,0.863204302,TCGA-AG-3583,READ,66,MALE,[Not Available],Rectal Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],-24107,Dead,WITH TUMOR,NA,610,[Not Available],NA,NA,NA,NA,[Not Available],1,610,1,610,NA,NA,1,610,NA,Stage IV,T3,M1,NA,1
8.953756684,-4.343579865,TCGA-A6-6648-01A,TCGA-A6-6648-01A-11D-1771-10,1,0.75425492,TCGA-A6-6648,COAD,56,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-20641,Alive,WITH TUMOR,766,NA,[Not Available],NA,NA,NA,686,[Not Available],0,766,0,766,NA,NA,1,686,NA,Stage IVA,T3,M1a,GI.CIN,1
-1.117895442,3.810529926,TCGA-EI-6506-01A,TCGA-EI-6506-01A-11D-1733-10,4,0.362911168,TCGA-EI-6506,READ,78,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-28587,Alive,TUMOR FREE,625,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,625,0,625,NA,NA,0,625,NA,Stage IIA,T3,M0,GI.CIN,5
-7.560025861,-2.277537567,TCGA-DU-5872-01A,TCGA-DU-5872-01A-11D-1705-08,6,0.442486683,TCGA-DU-5872,LGG,43,FEMALE,BLACK OR AFRICAN AMERICAN,Oligoastrocytoma,G2,2009,[Not Available],-15986,Alive,WITH TUMOR,532,NA,[Not Available],NA,NA,NA,265,Progressive Disease,0,532,0,532,NA,NA,1,265,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,2
9.59338952,-5.27396891,TCGA-HT-7875-01A,TCGA-HT-7875-01A-11D-2395-08,1,0.725790512,TCGA-HT-7875,LGG,56,MALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-20613,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,10,0,10,NA,NA,0,10,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.876733431,3.775179035,TCGA-HW-7490-01A,TCGA-HW-7490-01A-11D-2024-08,4,0.423014279,TCGA-HW-7490,LGG,41,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-15092,Alive,WITH TUMOR,1387,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1387,0,1387,NA,NA,0,1387,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
0.230153029,4.823469458,TCGA-E1-5303-01A,TCGA-E1-5303-01A-01D-1468-08,4,0.702338091,TCGA-E1-5303,LGG,38,MALE,WHITE,Astrocytoma,G3,1998,[Not Available],-14212,Dead,WITH TUMOR,NA,2052,[Not Available],NA,NA,NA,156,Progressive Disease,1,2052,1,2052,NA,NA,1,156,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.883269705,2.286694023,TCGA-A2-A0EX-01A,TCGA-A2-A0EX-01A-21W-A050-09,9,0.460851958,TCGA-A2-A0EX,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16858,Alive,TUMOR FREE,752,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,752,0,752,0,752,0,752,NA,Stage IIB,T3,M0,BRCA.LumA,7
0.206590202,5.33854319,TCGA-AR-A2LH-01A,TCGA-AR-A2LH-01A-31D-A18P-09,4,0.566752508,TCGA-AR-A2LH,BRCA,55,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20288,Dead,NA,NA,616,[Not Available],Distant Metastasis,Bone,NA,434,[Not Available],1,616,NA,616,1,434,1,434,NA,Stage III,T3,M0,BRCA.Normal,6
-0.395273295,3.901592108,TCGA-AZ-6603-01A,TCGA-AZ-6603-01A-11D-1835-10,4,0.248346844,TCGA-AZ-6603,COAD,77,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2002,[Not Available],-28424,Dead,TUMOR FREE,NA,899,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,899,0,899,0,899,0,899,NA,[Not Available],T2,MX,GI.CIN,6
-0.191312964,5.012853404,TCGA-D8-A1X5-01A,TCGA-D8-A1X5-01A-11D-A14G-09,4,0.60109083,TCGA-D8-A1X5,BRCA,81,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29734,Alive,TUMOR FREE,565,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,565,0,565,0,565,0,565,NA,Stage IIIC,T2,MX,BRCA.LumB,6
0.049750897,5.09495279,TCGA-CS-5393-01A,TCGA-CS-5393-01A-01D-1468-08,4,0.704819598,TCGA-CS-5393,LGG,39,MALE,WHITE,Astrocytoma,G3,2008,[Not Available],-14418,Alive,TUMOR FREE,1222,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1222,0,1222,0,1222,0,1222,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.82606279,-1.949246944,TCGA-DU-8162-01A,TCGA-DU-8162-01A-21D-2253-08,1,0.589700947,TCGA-DU-8162,LGG,61,FEMALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-22596,Dead,WITH TUMOR,NA,444,[Not Available],NA,NA,NA,402,Progressive Disease,1,444,1,444,NA,NA,1,402,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.324595709,-3.160175687,TCGA-14-1043-01B,TCGA-14-1043-01B-11D-1845-08,1,0.749756835,TCGA-14-1043,GBM,61,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2004,[Not Available],-22392,Dead,WITH TUMOR,24,24,[Not Available],NA,NA,NA,NA,[Not Available],1,24,1,24,NA,NA,1,24,NA,NA,NA,NA,NA,1
2.101367748,1.766927072,TCGA-FG-A70Z-01A,TCGA-FG-A70Z-01A-12D-A33T-08,3,0.341132736,TCGA-FG-A70Z,LGG,53,FEMALE,BLACK OR AFRICAN AMERICAN,Oligoastrocytoma,G3,2011,[Not Available],-19717,Alive,WITH TUMOR,328,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,328,0,328,NA,NA,0,328,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,3
2.10046378,1.808276775,TCGA-HT-7684-01A,TCGA-HT-7684-01A-11D-2253-08,3,0.516116996,TCGA-HT-7684,LGG,58,MALE,WHITE,Oligoastrocytoma,G3,2008,[Not Available],-21352,Alive,TUMOR FREE,184,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,184,0,184,0,184,0,184,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
-4.324987857,-1.061195067,TCGA-49-4487-01A,TCGA-49-4487-01A-21D-1855-08,8,0.124711073,TCGA-49-4487,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1992,[Not Available],-26583,Dead,WITH TUMOR,NA,855,[Not Available],NA,NA,NA,697,Complete Remission/Response,1,855,1,855,1,697,1,697,NA,Stage IA,T1,M0,LUAD.6,10
-7.040864751,-2.163308568,TCGA-AF-2693-01A,TCGA-AF-2693-01A-02D-1733-10,6,0.138052256,TCGA-AF-2693,READ,75,MALE,WHITE,[Not Available],[Not Available],2009,[Not Available],-27443,Alive,TUMOR FREE,1155,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1155,0,1155,NA,NA,0,1155,NA,Stage I,T2,MX,GI.CIN,2
-3.069953526,-3.661629787,TCGA-G4-6628-01A,TCGA-G4-6628-01A-11D-1835-10,8,0.406879054,TCGA-G4-6628,COAD,78,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2006,[Not Available],-28772,Alive,TUMOR FREE,2424,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2424,0,2424,0,2424,0,2424,NA,Stage I,T2,M0,GI.HM-indel,10
0.51084189,2.108691534,TCGA-CS-6186-01A,TCGA-CS-6186-01A-12D-2024-08,0,NA,TCGA-CS-6186,LGG,58,MALE,WHITE,Oligoastrocytoma,G3,2009,[Not Available],-21321,Dead,WITH TUMOR,NA,538,[Not Available],NA,NA,NA,188,Progressive Disease,1,538,1,538,NA,NA,1,188,NA,NA,NA,NA,GBM_LGG.Classic-like,6
8.840161128,-2.133877774,TCGA-32-4213-01A,TCGA-32-4213-01A-01D-1353-08,1,0.63227792,TCGA-32-4213,GBM,47,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-17237,Alive,WITH TUMOR,604,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],353,[Not Available],0,604,0,604,NA,NA,1,353,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.582794347,-5.687391855,TCGA-HT-7680-01A,TCGA-HT-7680-01A-11D-2253-08,1,0.864285164,TCGA-HT-7680,LGG,32,FEMALE,WHITE,Astrocytoma,G2,2010,[Not Available],-11970,Alive,TUMOR FREE,23,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,23,0,23,NA,NA,0,23,NA,NA,NA,NA,GBM_LGG.PA-like,1
0.152612891,4.93835196,TCGA-HT-A614-01A,TCGA-HT-A614-01A-11D-A29Q-08,4,0.632169565,TCGA-HT-A614,LGG,47,MALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-17392,Alive,WITH TUMOR,82,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,82,0,82,NA,NA,0,82,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.123781776,-1.635528328,TCGA-HT-7857-01A,TCGA-HT-7857-01A-11D-2395-08,0,NA,TCGA-HT-7857,LGG,24,FEMALE,WHITE,Astrocytoma,G3,2006,[Not Available],-8912,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,7,0,7,NA,NA,0,7,NA,NA,NA,NA,GBM_LGG.PA-like,2
-0.317890512,4.822978395,TCGA-HT-7610-01A,TCGA-HT-7610-01A-21D-2086-08,4,0.510495166,TCGA-HT-7610,LGG,25,FEMALE,WHITE,Oligoastrocytoma,G2,2007,[Not Available],-9447,Alive,TUMOR FREE,1706,NA,[Not Available],NA,NA,NA,1205,Stable Disease,0,1706,0,1706,NA,NA,1,1205,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.734078136,-2.506604286,TCGA-19-1791-01A,TCGA-19-1791-01A-01W-0643-08,6,0.235421087,TCGA-19-1791,GBM,82,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-30065,Alive,WITH TUMOR,4,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4,0,4,NA,NA,0,4,NA,NA,NA,NA,NA,2
9.353016322,-2.566135964,TCGA-HT-7467-01A,TCGA-HT-7467-01A-11D-2024-08,1,0.775379194,TCGA-HT-7467,LGG,54,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-19944,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3,0,3,0,3,0,3,NA,NA,NA,NA,GBM_LGG.Codel,1
-5.756805111,-1.211349653,TCGA-73-4662-01A,TCGA-73-4662-01A-01D-1265-08,0,NA,TCGA-73-4662,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-23762,Alive,TUMOR FREE,2515,NA,[Not Available],NA,NA,NA,21,Complete Remission/Response,0,2515,0,2515,1,21,1,21,NA,Stage IA,T1,M0,LUAD.3,2
-5.390409867,2.533576853,TCGA-AA-3967-01A,TCGA-AA-3967-01A-01W-1073-09,0,NA,TCGA-AA-3967,COAD,77,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-28216,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,943,0,943,0,943,0,943,NA,Stage IIIB,T3,M0,NA,9
-6.48455678,-1.236410313,TCGA-AH-6897-01A,TCGA-AH-6897-01A-11D-1924-10,7,0.27338786,TCGA-AH-6897,READ,48,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-17536,Alive,TUMOR FREE,804,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,804,0,804,0,804,0,804,NA,Stage I,T2,M0,GI.CIN,2
9.328219264,-5.15496497,TCGA-DU-6400-01A,TCGA-DU-6400-01A-12D-1705-08,1,0.781881062,TCGA-DU-6400,LGG,66,FEMALE,WHITE,Oligodendroglioma,G2,1998,[Not Available],-24122,Dead,WITH TUMOR,NA,37,[Not Available],NA,NA,NA,NA,[Not Available],1,37,1,37,NA,NA,1,37,NA,NA,NA,NA,GBM_LGG.Codel,1
0.030650752,5.186980106,TCGA-HT-7602-01A,TCGA-HT-7602-01A-21D-2086-08,4,0.584764842,TCGA-HT-7602,LGG,21,MALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-7946,Alive,TUMOR FREE,908,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,908,0,908,NA,NA,0,908,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.108558597,5.210407661,TCGA-HW-7489-01A,TCGA-HW-7489-01A-11D-2024-08,4,0.65347718,TCGA-HW-7489,LGG,38,MALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-14201,Dead,WITH TUMOR,NA,1262,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1262,1,1262,NA,NA,1,1262,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.139551146,5.263016805,TCGA-CS-6667-01A,TCGA-CS-6667-01A-12D-2024-08,4,0.608017391,TCGA-CS-6667,LGG,39,FEMALE,WHITE,Astrocytoma,G2,2010,[Not Available],-14375,Alive,WITH TUMOR,1469,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1469,0,1469,NA,NA,0,1469,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
4.311101975,1.15947409,TCGA-R8-A6MK-01A,TCGA-R8-A6MK-01A-11D-A32B-08,2,0.619366261,TCGA-R8-A6MK,LGG,40,MALE,WHITE,Oligodendroglioma,G2,2005,[Not Available],-14716,Alive,NA,2702,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2702,0,2702,NA,NA,0,2702,NA,NA,NA,NA,GBM_LGG.Codel,5
-4.60010226,-0.242290516,TCGA-EB-A4XL-01A,TCGA-EB-A4XL-01A-11D-A27K-08,0,NA,TCGA-EB-A4XL,SKCM,56,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-20486,Alive,TUMOR FREE,777,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,777,0,777,NA,NA,0,777,NA,Stage IIC,T4b,M0,SKCM.-,10
-4.580317636,-1.000628924,TCGA-78-7542-01A,TCGA-78-7542-01A-21D-2063-08,8,0.103501078,TCGA-78-7542,LUAD,56,MALE,WHITE,Lung Adenocarcinoma,[Not Available],1993,[Not Available],-20763,Dead,NA,NA,321,[Not Available],NA,NA,NA,NA,[Not Available],1,321,NA,321,NA,NA,0,321,NA,Stage IB,T2,M0,LUAD.3,10
-7.346555901,2.05168087,TCGA-19-5954-01A,TCGA-19-5954-01A-11D-1696-08,9,0.271398437,TCGA-19-5954,GBM,72,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-26355,Dead,WITH TUMOR,NA,368,[Not Available],NA,NA,NA,NA,Stable Disease,1,368,1,368,NA,NA,1,368,NA,NA,NA,NA,NA,7
-5.788933079,1.895911053,TCGA-AG-3725-01A,TCGA-AG-3725-01A-11D-1733-10,0,NA,TCGA-AG-3725,READ,90,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2005,[Not Available],-32872,Alive,TUMOR FREE,638,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,638,0,638,NA,NA,0,638,NA,Stage III,T3,M0,GI.CIN,8
-7.819333689,2.228251401,TCGA-CK-6747-01A,TCGA-CK-6747-01A-11D-1835-10,9,0.342125287,TCGA-CK-6747,COAD,87,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-32052,Alive,TUMOR FREE,2523,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2523,0,2523,0,2523,0,2523,NA,Stage IIA,T3,MX,GI.GS,7
-0.071206785,4.742021203,TCGA-FG-6689-01A,TCGA-FG-6689-01A-11D-1893-08,4,0.595487227,TCGA-FG-6689,LGG,30,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-11312,Alive,WITH TUMOR,454,NA,[Not Available],NA,NA,NA,119,Progressive Disease,0,454,0,454,NA,NA,1,119,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.104827076,-5.065630949,TCGA-27-2519-01A,TCGA-27-2519-01A-01D-1494-08,1,0.835297448,TCGA-27-2519,GBM,48,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-17715,Dead,WITH TUMOR,NA,550,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],256,[Not Available],1,550,1,550,NA,NA,1,256,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.142209467,-5.182956009,TCGA-DU-7009-01A,TCGA-DU-7009-01A-11D-2024-08,1,0.757952195,TCGA-DU-7009,LGG,32,FEMALE,WHITE,Oligodendroglioma,G2,2000,[Not Available],-11854,Dead,WITH TUMOR,NA,4695,[Not Available],NA,NA,NA,2960,Progressive Disease,1,4695,1,4695,NA,NA,1,2960,NA,NA,NA,NA,GBM_LGG.Codel,1
7.755391403,-3.474854766,TCGA-HT-A615-01A,TCGA-HT-A615-01A-11D-A29Q-08,1,0.341303,TCGA-HT-A615,LGG,38,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-13892,Alive,TUMOR FREE,515,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,515,0,515,0,515,0,515,NA,NA,NA,NA,GBM_LGG.Codel,1
8.869803988,-4.614905249,TCGA-CS-6188-01A,TCGA-CS-6188-01A-11D-1893-08,1,0.751483722,TCGA-CS-6188,LGG,48,MALE,WHITE,Astrocytoma,G3,2009,[Not Available],-17729,Dead,WITH TUMOR,NA,814,[Not Available],NA,NA,NA,647,Progressive Disease,1,814,1,814,NA,NA,1,647,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.337514435,-5.442563757,TCGA-FG-8186-01A,TCGA-FG-8186-01A-11D-2253-08,1,0.823381484,TCGA-FG-8186,LGG,42,FEMALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-15431,Alive,WITH TUMOR,487,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,487,0,487,NA,NA,0,487,NA,NA,NA,NA,GBM_LGG.Codel,1
-8.060752192,2.180885921,TCGA-41-2572-01A,TCGA-41-2572-01A-01D-1353-08,9,0.371698107,TCGA-41-2572,GBM,67,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-24505,Dead,WITH TUMOR,406,406,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],122,[Not Available],1,406,1,406,NA,NA,1,122,NA,NA,NA,NA,GBM_LGG.Classic-like,7
0.15107758,5.157728432,TCGA-HT-7483-01A,TCGA-HT-7483-01A-11D-2024-08,4,0.630751822,TCGA-HT-7483,LGG,14,MALE,WHITE,Oligoastrocytoma,G2,1998,[Not Available],-5267,Alive,TUMOR FREE,5255,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,5255,0,5255,0,5255,0,5255,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.788839919,2.518621529,TCGA-64-5774-01A,TCGA-64-5774-01A-01D-1625-08,0,NA,TCGA-64-5774,LUAD,60,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-22059,Alive,TUMOR FREE,2676,NA,[Not Available],NA,NA,NA,246,Complete Remission/Response,0,2676,0,2676,1,246,1,246,NA,Stage IB,T2,M0,LUAD.2,8
-5.348871091,2.513117739,TCGA-AA-3854-01A,TCGA-AA-3854-01A-01W-0900-09,12,0.228298862,TCGA-AA-3854,COAD,71,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-26022,Alive,TUMOR FREE,1096,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1096,0,1096,0,1096,0,1096,NA,Stage I,T2,M0,GI.GS,9
-2.932145958,-4.034670221,TCGA-G4-6588-01A,TCGA-G4-6588-01A-11D-1771-10,8,0.211096425,TCGA-G4-6588,COAD,58,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-21532,Alive,TUMOR FREE,796,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,796,0,796,NA,NA,0,796,NA,Stage IIA,T3,M0,GI.HM-indel,10
-8.16986439,1.949680566,TCGA-HT-7882-01A,TCGA-HT-7882-01A-11D-2395-08,9,0.528985531,TCGA-HT-7882,LGG,66,MALE,WHITE,Oligodendroglioma,G3,2010,[Not Available],-24450,Dead,WITH TUMOR,NA,113,[Not Available],NA,NA,NA,NA,Progressive Disease,1,113,1,113,NA,NA,1,113,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
8.778101189,-1.885932627,TCGA-DU-7012-01A,TCGA-DU-7012-01A-11D-2024-08,1,0.554196786,TCGA-DU-7012,LGG,74,FEMALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G3,2001,[Not Available],-27039,Dead,WITH TUMOR,NA,199,[Not Available],NA,NA,NA,NA,Progressive Disease,1,199,1,199,NA,NA,1,199,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.354166249,-5.375175587,TCGA-HT-8109-01A,TCGA-HT-8109-01A-11D-2395-08,1,0.845118155,TCGA-HT-8109,LGG,64,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-23486,Alive,TUMOR FREE,169,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,169,0,169,NA,NA,0,169,NA,NA,NA,NA,GBM_LGG.Codel,1
0.238272825,5.207552461,TCGA-HT-7693-01A,TCGA-HT-7693-01A-11D-2253-08,4,0.5383525,TCGA-HT-7693,LGG,51,FEMALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-18956,Alive,TUMOR FREE,533,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,533,0,533,NA,NA,0,533,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-8.029552022,1.999104072,TCGA-DU-5870-01A,TCGA-DU-5870-01A-11D-1705-08,9,0.582780541,TCGA-DU-5870,LGG,34,FEMALE,WHITE,Oligodendroglioma,G2,1995,[Not Available],-12764,Alive,WITH TUMOR,5546,NA,[Not Available],NA,NA,NA,4347,Progressive Disease,0,5546,0,5546,NA,NA,1,4347,NA,NA,NA,NA,GBM_LGG.Codel,7
9.728372341,-2.950692656,TCGA-E1-5318-01A,TCGA-E1-5318-01A-01D-1468-08,1,0.724329689,TCGA-E1-5318,LGG,42,FEMALE,WHITE,Oligodendroglioma,G2,1997,[Not Available],-15372,Dead,WITH TUMOR,2379,2379,[Not Available],NA,NA,NA,362,Progressive Disease,1,2379,1,2379,NA,NA,1,362,NA,NA,NA,NA,GBM_LGG.Codel,1
-2.619783763,1.645277541,TCGA-ER-A196-01A,TCGA-ER-A196-01A-11D-A197-08,0,NA,TCGA-ER-A196,SKCM,64,FEMALE,WHITE,NA,[Not Available],2007,[Not Available],-23533,Alive,TUMOR FREE,1785,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1785,0,1785,NA,NA,0,1785,NA,Stage IIC,T4b,M0,SKCM.Triple_WT,10
-6.413187357,2.318199911,TCGA-E9-A1R0-01A,TCGA-E9-A1R0-01A-22D-A16D-09,0,NA,TCGA-E9-A1R0,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21394,Alive,TUMOR FREE,860,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,860,0,860,NA,NA,0,860,NA,Stage IIA,T1c,M0,BRCA.LumA,7
2.147973992,1.837894232,TCGA-AN-A0FD-01A,TCGA-AN-A0FD-01A-11W-A050-09,3,0.472190062,TCGA-AN-A0FD,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26007,Alive,TUMOR FREE,196,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,196,0,196,0,196,0,196,NA,Stage IIA,T2,M0,BRCA.LumA,3
-7.125675062,2.116551061,TCGA-AC-A23C-01A,TCGA-AC-A23C-01A-12D-A167-09,9,0.284151192,TCGA-AC-A23C,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22751,Alive,TUMOR FREE,585,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,585,0,585,0,585,0,585,NA,Stage IIB,T2,MX,BRCA.LumA,8
8.730823965,-3.265552792,TCGA-A2-A04R-01A,TCGA-A2-A04R-01A-41D-A117-09,1,0.658877352,TCGA-A2-A04R,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13483,Alive,TUMOR FREE,3709,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3709,0,3709,0,3709,0,3709,NA,Stage IA,T1,M0,BRCA.LumB,1
-7.976119005,1.829884366,TCGA-A2-A0EV-01A,TCGA-A2-A0EV-01A-11W-A050-09,9,0.43960046,TCGA-A2-A0EV,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29285,Alive,TUMOR FREE,968,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,968,0,968,0,968,0,968,NA,Stage IA,T1c,M0,BRCA.LumA,7
4.554819206,1.083923849,TCGA-AR-A2LR-01A,TCGA-AR-A2LR-01A-12D-A18P-09,2,0.612680366,TCGA-AR-A2LR,BRCA,49,FEMALE,WHITE,Metaplastic Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18214,Alive,TUMOR FREE,1742,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1742,0,1742,0,1742,0,1742,NA,Stage I,T1,M0,NA,5
8.821761109,-4.956812887,TCGA-E2-A15D-01A,TCGA-E2-A15D-01A-11D-A10Y-09,1,0.846949958,TCGA-E2-A15D,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17224,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,526,0,526,0,526,0,526,NA,Stage IIA,T2,M0,BRCA.LumA,1
-8.078956697,2.078482188,TCGA-B6-A0IC-01A,TCGA-B6-A0IC-01A-11W-A050-09,9,0.487120289,TCGA-B6-A0IC,BRCA,90,FEMALE,WHITE,"Other, specify",[Not Available],1992,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Dead,TUMOR FREE,NA,1542,[Not Available],NA,NA,NA,NA,[Not Available],1,1542,0,1542,0,1542,0,1542,NA,Stage X,T2,MX,BRCA.LumA,7
-7.666643419,-2.362827938,TCGA-EW-A1PD-01A,TCGA-EW-A1PD-01A-11D-A142-09,6,0.490454334,TCGA-EW-A1PD,BRCA,61,MALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,[Not Available],-22536,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,424,0,424,0,424,0,424,NA,Stage IIA,T1c,M0,BRCA.LumA,2
-7.250984897,-2.260505488,TCGA-44-6147-01A,TCGA-44-6147-01A-31D-A27T-08,6,0.355023824,TCGA-44-6147,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-24631,Alive,TUMOR FREE,845,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,845,0,845,0,845,0,845,NA,Stage IA,T1b,M0,NA,2
8.742687229,-1.883440791,TCGA-81-5910-01A,TCGA-81-5910-01A-11D-1696-08,1,0.571887299,TCGA-81-5910,GBM,64,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-23567,Dead,WITH TUMOR,NA,49,[Not Available],NA,NA,NA,NA,[Not Available],1,49,1,49,NA,NA,1,49,NA,NA,NA,NA,NA,1
-5.777063892,-2.067472543,TCGA-28-2513-01A,TCGA-28-2513-01A-01D-1494-08,0,NA,TCGA-28-2513,GBM,69,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-25421,Alive,WITH TUMOR,222,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],75,[Not Available],0,222,0,222,NA,NA,1,75,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,2
1.765566067,1.964568685,TCGA-BH-A0BW-01A,TCGA-BH-A0BW-01A-11D-A10Y-09,3,0.49039277,TCGA-BH-A0BW,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25974,Alive,TUMOR FREE,2371,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2371,0,2371,0,2371,0,2371,NA,Stage I,T1c,M0,BRCA.Basal,3
-8.011201334,2.061572045,TCGA-AC-A2FF-01A,TCGA-AC-A2FF-01A-11D-A17D-09,9,0.615335448,TCGA-AC-A2FF,BRCA,40,FEMALE,ASIAN,Infiltrating Lobular Carcinoma,[Not Available],2006,[Not Available],NA,Alive,TUMOR FREE,2759,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2759,0,2759,0,2759,0,2759,NA,Stage IIB,T2,MX,BRCA.LumA,7
-6.38036888,1.723874684,TCGA-A2-A0CW-01A,TCGA-A2-A0CW-01A-21D-A10Y-09,10,0.188373158,TCGA-A2-A0CW,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541,Alive,TUMOR FREE,3283,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3283,0,3283,0,3283,0,3283,NA,Stage IIB,T2,M0,BRCA.LumB,7
8.930763225,-5.166793015,TCGA-BH-A0E7-01A,TCGA-BH-A0E7-01A-11W-A050-09,1,0.846014834,TCGA-BH-A0E7,BRCA,79,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29115,Alive,TUMOR FREE,1363,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1363,0,1363,0,1363,0,1363,NA,Stage IIB,T2,M0,BRCA.LumA,1
-0.682140849,4.99815105,TCGA-AG-3882-01A,TCGA-AG-3882-01A-01W-0899-10,4,0.442440844,TCGA-AG-3882,READ,66,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-24198,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,608,0,608,NA,NA,0,608,NA,Stage I,T2,M0,GI.CIN,6
0.296266588,5.096645427,TCGA-76-4929-01A,TCGA-76-4929-01A-01D-1486-08,4,0.660164135,TCGA-76-4929,GBM,76,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-27831,Dead,WITH TUMOR,111,111,[Not Available],NA,NA,NA,NA,[Not Available],1,111,1,111,NA,NA,1,111,NA,NA,NA,NA,GBM_LGG.Classic-like,6
-3.797158081,-2.050699399,TCGA-EB-A6QY-01A,TCGA-EB-A6QY-01A-12D-A32N-08,8,0.38711852,TCGA-EB-A6QY,SKCM,71,MALE,WHITE,NA,[Not Available],2013,[Not Available],-26216,Alive,TUMOR FREE,382,NA,[Not Available],Regional lymph node,NA,NA,36,[Not Available],0,382,0,382,NA,NA,1,36,NA,Stage IIC,T4b,M0,NA,10
-8.045909554,1.864048195,TCGA-B6-A0RN-01A,TCGA-B6-A0RN-01A-12D-A099-09,9,0.632399045,TCGA-B6-A0RN,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22077,Alive,TUMOR FREE,8008,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,8008,0,8008,0,8008,0,8008,NA,Stage IA,T1c,M0,BRCA.LumA,7
-0.860329367,4.250613042,TCGA-49-4488-01A,TCGA-49-4488-01A-01D-1753-08,4,0.269339313,TCGA-49-4488,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1992,[Not Available],-27332,Dead,NA,NA,869,[Not Available],NA,NA,NA,634,[Not Available],1,869,NA,869,NA,NA,1,634,NA,Stage IA,T1,MX,LUAD.3,6
9.456270979,-4.716349819,TCGA-26-5135-01A,TCGA-26-5135-01A-01D-1486-08,1,0.721239722,TCGA-26-5135,GBM,72,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-26490,Dead,NA,NA,270,[Not Available],NA,NA,NA,NA,[Unknown],1,270,NA,270,NA,NA,0,270,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.03527643,-4.095044244,TCGA-74-6584-01A,TCGA-74-6584-01A-11D-1845-08,1,0.760677437,TCGA-74-6584,GBM,55,FEMALE,[Not Available],Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-20232,Alive,WITH TUMOR,228,NA,[Not Available],NA,[Not Applicable],[Not Applicable],91,[Not Available],0,228,0,228,NA,NA,1,91,NA,NA,NA,NA,NA,1
-6.50483348,1.710376624,TCGA-AO-A0JE-01A,TCGA-AO-A0JE-01A-11W-A071-09,10,0.24094528,TCGA-AO-A0JE,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19516,Alive,TUMOR FREE,2335,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2335,0,2335,NA,NA,0,2335,NA,Stage IIIA,T2,M0,BRCA.Her2,7
-5.542948799,2.878250886,TCGA-B6-A1KN-01A,TCGA-B6-A1KN-01A-11D-A13L-09,12,0.120366431,TCGA-B6-A1KN,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21183,Alive,TUMOR FREE,4233,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4233,0,4233,0,4233,0,4233,NA,Stage IIIB,T4b,M0,BRCA.LumB,8
-7.225904077,-2.042084772,TCGA-D8-A142-01A,TCGA-D8-A142-01A-11D-A10Y-09,6,0.264436568,TCGA-D8-A142,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27313,Alive,TUMOR FREE,425,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,425,0,425,0,425,0,425,NA,Stage IIB,T3,M0,BRCA.Basal,2
-1.72792564,4.044311463,TCGA-55-1594-01A,TCGA-55-1594-01A-01D-1040-01,10,0.103153527,TCGA-55-1594,LUAD,68,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-25008,Alive,TUMOR FREE,1178,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1178,0,1178,NA,NA,0,1178,NA,Stage IIIA,T2,M0,LUAD.2,6
-7.957102702,2.024007428,TCGA-AR-A2LM-01A,TCGA-AR-A2LM-01A-11D-A17W-09,9,0.659577298,TCGA-AR-A2LM,BRCA,49,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18053,Alive,TUMOR FREE,1935,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1935,0,1935,0,1935,0,1935,NA,Stage II,T1,M0,BRCA.LumA,7
-4.640148436,-1.507919508,TCGA-12-0778-01A,TCGA-12-0778-01A-01W-0348-08,8,0.443772906,TCGA-12-0778,GBM,53,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-19460,Dead,WITH TUMOR,452,454,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],232,[Not Available],1,454,1,454,NA,NA,1,232,NA,NA,NA,NA,NA,10
-6.374408545,1.604164323,TCGA-02-2485-01A,TCGA-02-2485-01A-01D-1494-08,10,0.071725583,TCGA-02-2485,GBM,53,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-19494,Alive,WITH TUMOR,470,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],186,[Not Available],0,470,0,470,NA,NA,1,186,NA,NA,NA,NA,GBM_LGG.Classic-like,7
8.607787854,-3.775891122,TCGA-A8-A099-01A,TCGA-A8-A099-01A-11W-A019-09,1,0.673355044,TCGA-A8-A099,BRCA,76,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28063,Alive,NA,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,304,0,304,NA,NA,0,304,NA,Stage X,T4b,MX,BRCA.LumA,1
-8.042926161,2.065767195,TCGA-14-3476-01B,TCGA-14-3476-01B-01D-1353-08,9,0.63617884,TCGA-14-3476,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-27172,Dead,NA,12,12,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],9,[Not Available],1,12,NA,12,NA,NA,1,9,NA,NA,NA,NA,NA,7
9.219874858,-5.415235306,TCGA-A8-A091-01A,TCGA-A8-A091-01A-11W-A019-09,1,0.790445584,TCGA-A8-A091,BRCA,61,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22554,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,243,[Not Available],0,1004,0,1004,1,243,1,243,NA,Stage IIA,T2,M0,BRCA.LumA,1
-0.732292012,2.429445493,TCGA-B6-A0RL-01A,TCGA-B6-A0RL-01A-11D-A099-09,4,0.08252415,TCGA-B6-A0RL,BRCA,60,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1993,[Not Available],-22238,Dead,TUMOR FREE,NA,2469,[Not Available],NA,NA,NA,NA,[Not Available],1,2469,0,2469,0,2469,0,2469,NA,Stage IIA,T2,M0,BRCA.LumB,6
-7.69382174,2.161804662,TCGA-A8-A08O-01A,TCGA-A8-A08O-01A-21W-A071-09,9,0.425979675,TCGA-A8-A08O,BRCA,45,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16681,Alive,WITH TUMOR,943,NA,[Not Available],NA,NA,NA,762,[Not Available],0,943,0,943,NA,NA,1,762,NA,Stage IV,T2,M1,BRCA.LumA,7
-4.456118319,0.230475226,TCGA-78-7158-01A,TCGA-78-7158-01A-11D-2036-08,0,NA,TCGA-78-7158,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-21742,Dead,WITH TUMOR,NA,179,[Not Available],NA,NA,NA,132,Progressive Disease,1,179,1,179,NA,NA,1,132,NA,Stage IIIB,T4,M0,LUAD.4,10
4.115594013,1.272018543,TCGA-28-1749-01A,TCGA-28-1749-01A-01W-0643-08,2,0.313293142,TCGA-28-1749,GBM,73,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-26765,Alive,WITH TUMOR,280,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],280,[Not Available],0,280,0,280,NA,NA,1,280,NA,NA,NA,NA,NA,5
8.386919923,-1.607692106,TCGA-32-1991-01A,TCGA-32-1991-01A-01D-1353-08,1,0.526435087,TCGA-32-1991,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-22021,Dead,WITH TUMOR,515,515,[Not Available],Recurrence,[Not Applicable],[Not Applicable],345,[Not Available],1,515,1,515,NA,NA,1,345,NA,NA,NA,NA,NA,1
2.97449473,3.554664758,TCGA-GM-A2DN-01A,TCGA-GM-A2DN-01A-11D-A17W-09,0,NA,TCGA-GM-A2DN,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21288,Alive,TUMOR FREE,3091,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3091,0,3091,0,3091,0,3091,NA,Stage IIA,T2,M0,BRCA.LumA,1
-5.304893283,2.741747709,TCGA-A6-2685-01A,TCGA-A6-2685-01A-01D-1408-10,12,0.298125982,TCGA-A6-2685,COAD,48,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-17757,Alive,TUMOR FREE,1133,NA,[Not Available],Locoregional Disease,NA,NA,948,[Not Available],0,1133,0,1133,NA,NA,1,948,NA,Stage IIA,T3,M0,GI.CIN,8
-3.847778275,0.446248654,TCGA-14-1396-01A,TCGA-14-1396-01A-01W-0611-08,0,NA,TCGA-14-1396,GBM,78,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-28753,Dead,WITH TUMOR,34,34,[Not Available],NA,NA,NA,NA,[Not Available],1,34,1,34,NA,NA,1,34,NA,NA,NA,NA,NA,10
-5.195998558,2.268254591,TCGA-DC-5337-01A,TCGA-DC-5337-01A-01D-1657-10,0,NA,TCGA-DC-5337,READ,69,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-25202,Alive,TUMOR FREE,792,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,792,0,792,NA,NA,0,792,NA,Stage I,T1,M0,GI.GS,8
-6.329488319,-1.522013536,TCGA-A2-A04P-01A,TCGA-A2-A04P-01A-31D-A128-09,7,0.07133248,TCGA-A2-A04P,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13238,Dead,WITH TUMOR,NA,548,[Not Available],Distant Metastasis,Bone,NA,102,[Not Available],1,548,1,548,NA,NA,1,102,NA,Stage IIIC,T2,M0,BRCA.Basal,2
-7.176332939,-2.431096771,TCGA-G4-6317-01A,TCGA-G4-6317-01A-11D-1719-10,6,0.111841595,TCGA-G4-6317,COAD,51,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-18822,Alive,TUMOR FREE,1095,NA,[Not Available],Metastatic,NA,NA,592,[Not Available],0,1095,0,1095,NA,NA,1,592,NA,Stage IIIC,T3,MX,GI.CIN,2
-3.566178174,-2.905353879,TCGA-95-7043-01A,TCGA-95-7043-01A-11D-1945-08,8,0.406092071,TCGA-95-7043,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23165,Dead,WITH TUMOR,NA,503,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,503,1,503,NA,NA,1,503,NA,Stage IA,T1a,MX,LUAD.2,10
-5.473560927,2.809258961,TCGA-49-4510-01A,TCGA-49-4510-01A-01D-1265-08,12,0.148031255,TCGA-49-4510,LUAD,51,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-18762,Dead,WITH TUMOR,NA,896,[Not Available],Distant Metastasis,NA,NA,502,Stable Disease,1,896,1,896,NA,NA,1,502,NA,Stage IIB,T2,M0,LUAD.1,8
7.964744182,-3.519777626,TCGA-41-2573-01A,TCGA-41-2573-01A-01D-1495-08,1,0.368758076,TCGA-41-2573,GBM,59,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-21911,Alive,WITH TUMOR,272,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],167,[Not Available],0,272,0,272,NA,NA,1,167,NA,NA,NA,NA,NA,1
9.175922851,-2.854995751,TCGA-A8-A07L-01A,TCGA-A8-A07L-01A-11W-A019-09,1,0.765694755,TCGA-A8-A07L,BRCA,58,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428,Alive,TUMOR FREE,975,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,975,0,975,0,975,0,975,NA,Stage IIIA,T3,M0,BRCA.LumB,1
-7.628027741,-2.360185274,TCGA-A2-A04Y-01A,TCGA-A2-A04Y-01A-21W-A050-09,6,0.478335981,TCGA-A2-A04Y,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19533,Alive,TUMOR FREE,1099,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1099,0,1099,0,1099,0,1099,NA,Stage IIB,T2,M0,BRCA.LumB,2
-6.416467318,3.286728804,TCGA-86-7713-01A,TCGA-86-7713-01A-11D-2063-08,0,NA,TCGA-86-7713,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25791,Alive,TUMOR FREE,1157,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1157,0,1157,0,1157,0,1157,NA,Stage IIA,T2b,M0,LUAD.2,8
9.428051629,-2.697767453,TCGA-32-4719-01A,TCGA-32-4719-01A-01D-1353-08,1,0.767322949,TCGA-32-4719,GBM,73,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-26691,Dead,WITH TUMOR,330,330,[Not Available],NA,NA,NA,NA,[Not Available],1,330,1,330,NA,NA,1,330,NA,NA,NA,NA,NA,1
-6.268471414,1.58870886,TCGA-AC-A3OD-01A,TCGA-AC-A3OD-01A-11D-A21Q-09,10,0.268960362,TCGA-AC-A3OD,BRCA,68,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25186,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,451,0,451,0,451,0,451,NA,Stage IIB,T2,MX,BRCA.LumA,7
9.607529302,-5.651021651,TCGA-EW-A1PG-01A,TCGA-EW-A1PG-01A-11D-A142-09,1,0.835897861,TCGA-EW-A1PG,BRCA,53,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19464,Alive,TUMOR FREE,1051,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1051,0,1051,0,1051,0,1051,NA,Stage IIB,T2,MX,BRCA.Normal,1
9.505232735,-5.460047197,TCGA-E9-A1R6-01A,TCGA-E9-A1R6-01A-11D-A14G-09,1,0.814132453,TCGA-E9-A1R6,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23347,Alive,TUMOR FREE,339,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,339,0,339,0,339,0,339,NA,Stage IIA,T2,M0,BRCA.LumA,1
-1.241365479,3.933284586,TCGA-C8-A275-01A,TCGA-C8-A275-01A-21D-A16D-09,4,0.226377474,TCGA-C8-A275,BRCA,56,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20774,Alive,TUMOR FREE,1,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1,0,1,0,1,0,1,NA,Stage IIA,T1,M0,BRCA.Her2,5
8.794562826,-4.934476993,TCGA-27-2524-01A,TCGA-27-2524-01A-01D-1494-08,1,0.820415768,TCGA-27-2524,GBM,56,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-20555,Dead,WITH TUMOR,231,231,[Not Available],NA,NA,NA,NA,[Not Available],1,231,1,231,NA,NA,1,231,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-8.029152727,1.818485362,TCGA-B6-A0RG-01A,TCGA-B6-A0RG-01A-11W-A071-09,9,0.563885913,TCGA-B6-A0RG,BRCA,26,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1991,Indeterminate (neither Pre or Postmenopausal),-9840,Alive,TUMOR FREE,2082,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2082,0,2082,0,2082,0,2082,NA,Stage IIB,T3,M0,BRCA.LumA,7
-2.971024036,-3.963350336,TCGA-BH-A18G-01A,TCGA-BH-A18G-01A-11D-A12B-09,8,0.334325041,TCGA-BH-A18G,BRCA,81,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29820,Alive,TUMOR FREE,149,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,149,0,149,0,149,0,149,NA,Stage IA,T1c,M0,BRCA.Basal,10
0.050047206,4.612575262,TCGA-A8-A06O-01A,TCGA-A8-A06O-01A-11W-A019-09,4,0.583005384,TCGA-A8-A06O,BRCA,60,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22157,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,396,0,396,0,396,0,396,NA,Stage I,T1c,M0,BRCA.LumB,6
-6.746649154,-2.085050398,TCGA-BH-A18T-01A,TCGA-BH-A18T-01A-11D-A12B-09,6,0.024400588,TCGA-BH-A18T,BRCA,70,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25674,Dead,WITH TUMOR,NA,224,[Not Available],NA,NA,NA,NA,[Not Available],1,224,1,224,NA,NA,1,224,NA,Stage IIA,T2,M0,BRCA.Basal,2
8.682394308,-1.829425981,TCGA-12-0616-01A,TCGA-12-0616-01A-01D-1492-08,1,0.537453385,TCGA-12-0616,GBM,36,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-13451,Dead,WITH TUMOR,439,448,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],398,[Not Available],1,448,1,448,NA,NA,1,398,NA,NA,NA,NA,GBM_LGG.NA,1
-0.825602884,4.680064194,TCGA-EW-A3U0-01A,TCGA-EW-A3U0-01A-11D-A228-09,4,0.458747036,TCGA-EW-A3U0,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22520,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,532,0,532,0,532,0,532,NA,Stage IIIA,T3,M0,BRCA.Basal,6
0.143536741,4.390599794,TCGA-A8-A08X-01A,TCGA-A8-A08X-01A-21W-A019-09,4,0.462384481,TCGA-A8-A08X,BRCA,43,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15705,Alive,TUMOR FREE,1308,NA,[Not Available],NA,NA,NA,366,[Not Available],0,1308,0,1308,1,366,1,366,NA,Stage IIIC,T4d,M0,BRCA.Her2,6
4.173674489,1.293820699,TCGA-06-0166-01A,TCGA-06-0166-01A-01D-1491-08,2,0.426345547,TCGA-06-0166,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2001,[Not Available],-18902,Dead,WITH TUMOR,161,178,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],66,[Not Available],1,178,1,178,NA,NA,1,66,NA,NA,NA,NA,NA,5
-5.123467932,-1.838188395,TCGA-EB-A51B-01A,TCGA-EB-A51B-01A-11D-A27K-08,0,NA,TCGA-EB-A51B,SKCM,53,MALE,WHITE,NA,[Not Available],2012,[Not Available],-19645,Alive,TUMOR FREE,931,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,931,0,931,NA,NA,0,931,NA,Stage IIC,T4b,M0,SKCM.-,10
10.15262272,-2.101736226,TCGA-GK-A6C7-01A,TCGA-GK-A6C7-01A-11D-A33K-10,1,0.702358219,TCGA-GK-A6C7,KIRC,76,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,[Not Available],2012,[Not Available],-28107,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,61,0,61,0,61,0,61,NA,Stage I,T1a,MX,NA,6
-5.183373619,2.093034927,TCGA-AG-3726-01A,TCGA-AG-3726-01A-02W-0899-10,0,NA,TCGA-AG-3726,READ,63,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2006,[Not Available],-23345,Alive,TUMOR FREE,243,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,243,0,243,NA,NA,0,243,NA,Stage I,T2,M0,GI.CIN,9
-6.507325565,-1.230245068,TCGA-CA-5255-01A,TCGA-CA-5255-01A-11D-1835-10,7,0.38418857,TCGA-CA-5255,COAD,45,MALE,ASIAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-16743,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,376,0,376,0,376,0,376,NA,Stage IIA,T3,M0,GI.CIN,2
9.398776773,-5.692413418,TCGA-AG-3594-01A,TCGA-AG-3594-01A-02D-1989-10,1,0.846863827,TCGA-AG-3594,READ,77,MALE,[Not Available],Rectal Mucinous Adenocarcinoma,[Not Available],2007,[Not Available],-28277,Dead,WITH TUMOR,NA,61,[Not Available],NA,NA,NA,NA,[Not Available],1,61,1,61,NA,NA,1,61,NA,Stage IIA,T3,M0,NA,1
-7.629044189,-2.428785264,TCGA-QH-A65V-01A,TCGA-QH-A65V-01A-11D-A29Q-08,6,0.484887309,TCGA-QH-A65V,LGG,43,FEMALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-15850,Alive,WITH TUMOR,384,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,384,0,384,NA,NA,0,384,NA,NA,NA,NA,GBM_LGG.Codel,2
-4.37944416,-0.619456999,TCGA-BF-A3DM-01A,TCGA-BF-A3DM-01A-11D-A20D-08,0,NA,TCGA-BF-A3DM,SKCM,63,MALE,WHITE,NA,[Not Available],2011,[Not Available],-23076,Alive,TUMOR FREE,601,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,601,0,601,NA,NA,0,601,NA,Stage IIA,T2b,M0,SKCM.BRAF_Hotspot_Mutants,10
-0.188895126,5.064751992,TCGA-H7-A6C5-01A,TCGA-H7-A6C5-01A-11D-A30E-08,4,0.625985472,TCGA-H7-A6C5,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-23808,Alive,TUMOR FREE,642,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,642,0,642,0,642,0,642,NA,Stage II,T2,M0,NA,6
-0.160938644,5.320895171,TCGA-H7-A6C4-01A,TCGA-H7-A6C4-01A-11D-A30E-08,4,0.620921105,TCGA-H7-A6C4,HNSC,35,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-13137,Alive,TUMOR FREE,414,NA,[Not Available],Locoregional Recurrence,Distant Metastasis,stoma site,235,Complete Remission/Response,0,414,0,414,NA,NA,1,235,NA,Stage IVA,T2,M0,NA,6
9.060911426,-2.595130377,TCGA-CV-A6JN-01A,TCGA-CV-A6JN-01A-11D-A31L-08,1,0.656985351,TCGA-CV-A6JN,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-19635,Alive,TUMOR FREE,906,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,906,0,906,0,906,0,906,NA,[Not Available],[Not Available],[Not Available],NA,1
-4.463166969,-1.758658673,TCGA-CV-A6JM-01A,TCGA-CV-A6JM-01A-11D-A31L-08,8,0.360399789,TCGA-CV-A6JM,HNSC,85,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-31147,Dead,TUMOR FREE,NA,194,[Not Available],Locoregional Recurrence,Oropharynx,NA,107,Complete Remission/Response,1,194,0,194,NA,NA,1,107,NA,[Not Available],[Not Available],[Not Available],NA,10
9.434633044,-2.866127078,TCGA-HW-A5KJ-01A,TCGA-HW-A5KJ-01A-12D-A27K-08,1,0.77385419,TCGA-HW-A5KJ,LGG,68,MALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-24966,Dead,WITH TUMOR,NA,962,[Not Available],NA,NA,NA,615,Progressive Disease,1,962,1,962,NA,NA,1,615,NA,NA,NA,NA,GBM_LGG.Codel,1
-5.205573102,2.2641896,TCGA-DM-A1D7-01A,TCGA-DM-A1D7-01A-11D-A152-10,12,0.040193361,TCGA-DM-A1D7,COAD,82,MALE,WHITE,[Discrepancy],[Not Available],2000,[Not Available],-30142,Dead,NA,NA,405,[Not Available],NA,NA,NA,80,[Not Available],1,405,NA,405,NA,NA,1,80,NA,Stage IIA,T3,M0,GI.GS,8
-6.089046376,3.427172697,TCGA-G5-6572-01A,TCGA-G5-6572-01A-11D-1826-10,11,0.549820935,TCGA-G5-6572,READ,56,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2004,[Not Available],-20475,Dead,TUMOR FREE,NA,1432,[Not Available],NA,NA,NA,NA,[Not Available],1,1432,0,1432,NA,NA,0,1432,NA,[Not Available],[Not Available],[Not Available],NA,8
-4.844261118,-1.543460931,TCGA-EB-A553-01A,TCGA-EB-A553-01A-12D-A27K-08,8,0.367427382,TCGA-EB-A553,SKCM,62,MALE,WHITE,NA,[Not Available],2012,[Not Available],-22972,Alive,TUMOR FREE,226,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,226,0,226,NA,NA,0,226,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-3.913904747,-1.904741489,TCGA-UC-A7PF-01A,TCGA-UC-A7PF-01A-11D-A351-09,8,0.401214359,TCGA-UC-A7PF,CESC,44,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,G2,1999,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16412,Dead,NA,NA,2859,NA,NA,NA,NA,NA,[Not Available],1,2859,NA,2859,NA,NA,0,2859,NA,Stage IB1,T1b1,M0,NA,10
-5.658428764,2.49442777,TCGA-CN-A642-01A,TCGA-CN-A642-01A-12D-A30E-08,0,NA,TCGA-CN-A642,HNSC,57,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2012,[Not Available],-21011,Dead,WITH TUMOR,NA,82,[Not Available],NA,NA,NA,NA,Progressive Disease,1,82,1,82,NA,NA,1,82,NA,Stage IVB,T4a,M0,NA,8
-0.719914103,2.232799173,TCGA-J4-A67M-01A,TCGA-J4-A67M-01A-11D-A30E-08,0,NA,TCGA-J4-A67M,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-20211,Alive,TUMOR FREE,941,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,941,0,941,0,941,0,941,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-6.361819316,-1.497471321,TCGA-R2-A69V-01A,TCGA-R2-A69V-01A-11D-A32I-09,7,0.215611904,TCGA-R2-A69V,CESC,42,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2011,Peri (6-12 months since last menstrual period),-15479,Alive,TUMOR FREE,596,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,596,0,596,0,596,0,596,NA,Stage IB,T1b,M0,NA,10
-7.835091096,-2.463540148,TCGA-UC-A7PD-01A,TCGA-UC-A7PD-01A-11D-A351-09,6,0.261943855,TCGA-UC-A7PD,CESC,21,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G2,1997,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7855,Dead,WITH TUMOR,NA,355,Cervical Cancer,Locoregional Recurrence,NA,vaginal cuff,202,Complete Remission/Response,1,355,1,355,1,202,1,202,NA,Stage IB,T1b,M0,NA,2
-4.87665408,0.566565994,TCGA-Q1-A73P-01A,TCGA-Q1-A73P-01A-11D-A32I-09,0,NA,TCGA-Q1-A73P,CESC,45,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G1,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16450,Alive,TUMOR FREE,483,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,483,0,483,0,483,0,483,NA,Stage IB1,T1b,MX,NA,10
4.241448367,1.249616858,TCGA-Q1-A73R-01A,TCGA-Q1-A73R-01A-11D-A33O-09,2,0.543796919,TCGA-Q1-A73R,CESC,45,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,GX,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16701,Alive,TUMOR FREE,567,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,567,0,567,0,567,0,567,NA,Stage I,TX,MX,NA,5
-5.597301268,2.086412858,TCGA-55-8301-01A,TCGA-55-8301-01A-11D-2284-08,0,NA,TCGA-55-8301,LUAD,58,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21535,Alive,WITH TUMOR,534,NA,[Not Available],Locoregional Recurrence,NA,NA,238,Complete Remission/Response,0,534,0,534,1,238,1,238,NA,Stage IB,T2a,MX,NA,10
-4.557310968,1.300892897,TCGA-PN-A8MA-01A,TCGA-PN-A8MA-01A-11D-A36J-09,0,NA,TCGA-PN-A8MA,CESC,43,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15918,Alive,WITH TUMOR,90,NA,NA,NA,NA,NA,NA,Stable Disease,0,90,0,90,NA,NA,0,90,NA,Stage IIB,T2b,M0,NA,10
-2.902634976,0.962324473,TCGA-MY-A913-01A,TCGA-MY-A913-01A-11D-A37N-09,0,NA,TCGA-MY-A913,CESC,28,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10379,Alive,TUMOR FREE,524,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,524,0,524,0,524,0,524,NA,Stage IIA,Tis,M1,NA,10
9.102642395,-5.418261947,TCGA-HC-A6AQ-01A,TCGA-HC-A6AQ-01A-11D-A30E-08,1,0.731110347,TCGA-HC-A6AQ,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22208,Alive,TUMOR FREE,106,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,106,0,106,NA,NA,0,106,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-5.607956006,2.793982628,TCGA-CK-4947-01B,TCGA-CK-4947-01B-11D-1650-10,0,NA,TCGA-CK-4947,COAD,46,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2003,[Not Available],-16980,Alive,WITH TUMOR,534,NA,[Not Available],NA,NA,NA,21,Stable Disease,0,534,0,534,NA,NA,1,21,NA,Stage IIIB,T4,M0,GI.GS,8
0.20795496,3.366569058,TCGA-HW-8319-01A,TCGA-HW-8319-01A-11D-2395-08,4,0.359166605,TCGA-HW-8319,LGG,34,FEMALE,WHITE,Astrocytoma,G3,2011,[Not Available],-12557,Dead,WITH TUMOR,NA,1209,[Not Available],NA,NA,NA,997,Partial Remission/Response,1,1209,1,1209,NA,NA,1,997,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
-8.008359663,1.913219871,TCGA-06-0171-01A,TCGA-06-0171-01A-02D-1491-08,9,0.598335284,TCGA-06-0171,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-24085,Dead,WITH TUMOR,396,399,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],117,[Not Available],1,399,1,399,NA,NA,1,117,NA,NA,NA,NA,NA,7
-6.306357428,2.275091705,TCGA-JW-A852-01A,TCGA-JW-A852-01A-11D-A351-09,0,NA,TCGA-JW-A852,CESC,42,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15682,Dead,WITH TUMOR,NA,252,Cervical Cancer,New Primary Tumor,NA,Breast,153,Complete Remission/Response,1,252,1,252,0,252,1,153,NA,Stage IIB,T2b,MX,NA,9
8.028513896,-4.350572047,TCGA-LP-A5U3-01A,TCGA-LP-A5U3-01A-11D-A28B-09,1,0.52689707,TCGA-LP-A5U3,CESC,40,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14698,Alive,TUMOR FREE,25,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,25,0,25,0,25,0,25,NA,Stage IB1,T1b1,M0,NA,1
-2.968719581,-3.936950955,TCGA-JW-A5VL-01A,TCGA-JW-A5VL-01A-11D-A28B-09,8,0.223551037,TCGA-JW-A5VL,CESC,37,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G1,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13604,Alive,TUMOR FREE,474,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,474,0,474,0,474,0,474,NA,Stage IB2,T1b2,MX,NA,10
-7.98178826,2.048597471,TCGA-JW-A69B-01A,TCGA-JW-A69B-01A-11D-A32I-09,9,0.467146631,TCGA-JW-A69B,CESC,44,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,GX,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16080,Alive,TUMOR FREE,863,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,863,0,863,0,863,0,863,NA,Stage IB2,T1b2,MX,NA,7
-5.090495674,0.178323485,TCGA-JW-A5VJ-01A,TCGA-JW-A5VJ-01A-11D-A28B-09,0,NA,TCGA-JW-A5VJ,CESC,56,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20714,Alive,WITH TUMOR,652,NA,NA,Distant Metastasis,Head & Neck,NA,267,Progressive Disease,0,652,0,652,NA,NA,1,267,NA,Stage IIB,T2b,MX,NA,10
9.19001581,-2.13589838,TCGA-JW-A5VK-01A,TCGA-JW-A5VK-01A-11D-A28B-09,1,0.69612994,TCGA-JW-A5VK,CESC,43,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15965,Alive,TUMOR FREE,623,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,623,0,623,0,623,0,623,NA,Stage IB2,T1b2,MX,NA,1
7.721428615,-3.289321298,TCGA-FU-A770-01A,TCGA-FU-A770-01A-11D-A33O-09,1,0.327811292,TCGA-FU-A770,CESC,33,FEMALE,WHITE,Endocervical Adenocarcinoma of the Usual Type,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12248,Alive,TUMOR FREE,34,NA,NA,NA,NA,NA,NA,[Unknown],0,34,0,34,NA,NA,0,34,NA,Stage IIIB,T2a2,MX,NA,1
0.127162619,5.163712972,TCGA-S9-A6U8-01A,TCGA-S9-A6U8-01A-21D-A33T-08,4,0.702215579,TCGA-S9-A6U8,LGG,24,MALE,WHITE,Astrocytoma,G2,2005,[Not Available],-9044,Dead,WITH TUMOR,NA,2988,[Not Available],NA,NA,NA,367,Partial Remission/Response,1,2988,1,2988,NA,NA,1,367,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
1.189432188,3.491457316,TCGA-JW-A5VG-01A,TCGA-JW-A5VG-01A-11D-A28B-09,0,NA,TCGA-JW-A5VG,CESC,35,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13109,Alive,TUMOR FREE,834,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,834,0,834,0,834,0,834,NA,Stage IIA,T2a,MX,NA,1
-0.604190731,4.321153123,TCGA-EX-A8YF-01A,TCGA-EX-A8YF-01A-11D-A37N-09,4,0.547996052,TCGA-EX-A8YF,CESC,44,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16258,Alive,WITH TUMOR,473,NA,NA,Locoregional Recurrence,"Other, specify",Vagina,396,Complete Remission/Response,0,473,0,473,1,396,1,396,NA,Stage IB1,T2a1,M0,NA,1
-3.724171481,-2.458763894,TCGA-50-6590-01A,TCGA-50-6590-01A-12D-1855-08,8,0.431179194,TCGA-50-6590,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-26444,Dead,TUMOR FREE,NA,1288,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1288,0,1288,0,1288,0,1288,NA,Stage IB,T2,M0,NA,10
9.647653253,-2.979646339,TCGA-AO-A0JJ-01A,TCGA-AO-A0JJ-01A-11W-A071-09,1,0.731961246,TCGA-AO-A0JJ,BRCA,54,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19758,Alive,TUMOR FREE,1887,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1887,0,1887,0,1887,0,1887,NA,Stage IIB,T2,M0,BRCA.LumA,1
-3.311530892,-3.379493462,TCGA-AA-3966-01A,TCGA-AA-3966-01A-01W-1073-09,8,0.635432543,TCGA-AA-3966,COAD,89,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-32537,Alive,WITH TUMOR,61,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,61,0,61,NA,NA,0,61,NA,Stage IIA,T3,M0,GI.HM-indel,10
-3.199333544,-3.495145192,TCGA-EI-6507-01A,TCGA-EI-6507-01A-11D-1733-10,8,0.620425958,TCGA-EI-6507,READ,60,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-22176,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,607,0,607,NA,NA,0,607,NA,Stage IIA,T3,M0,GI.HM-indel,10
-7.663949537,2.037036185,TCGA-AR-A2LO-01A,TCGA-AR-A2LO-01A-31D-A18P-09,9,0.356781546,TCGA-AR-A2LO,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17080,Alive,TUMOR FREE,1198,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1198,0,1198,0,1198,0,1198,NA,Stage IIB,T2,M0,BRCA.LumA,7
-1.620219123,3.985031822,TCGA-CM-5341-01A,TCGA-CM-5341-01A-01D-1408-10,0,NA,TCGA-CM-5341,COAD,82,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-30163,Alive,TUMOR FREE,884,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,884,0,884,0,884,0,884,NA,Stage IIIA,T2,M0,GI.CIN,6
9.812972081,-3.052150175,TCGA-M7-A724-01A,TCGA-M7-A724-01A-12D-A32B-08,1,0.679111099,TCGA-M7-A724,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23595,Alive,WITH TUMOR,889,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,889,0,889,NA,NA,0,889,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-6.053365174,2.241330689,TCGA-BF-A1PV-01A,TCGA-BF-A1PV-01A-11D-A19A-08,0,NA,TCGA-BF-A1PV,SKCM,74,FEMALE,WHITE,NA,[Not Available],2010,[Not Available],-27124,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,14,0,14,NA,NA,0,14,NA,Stage IIC,T4b,M0,SKCM.RAS_Hotspot_Mutants,10
8.577168907,-3.462017974,TCGA-EK-A3GN-01A,TCGA-EK-A3GN-01A-11D-A20U-09,1,0.693781825,TCGA-EK-A3GN,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2005,[Not Available],-17425,Alive,WITH TUMOR,27,NA,NA,NA,NA,NA,NA,[Not Available],0,27,0,27,NA,NA,0,27,NA,Stage IIIB,TX,[Not Available],NA,1
-4.004682132,-0.440852797,TCGA-EK-A3GM-01A,TCGA-EK-A3GM-01A-11D-A20U-09,0,NA,TCGA-EK-A3GM,CESC,65,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23879,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIA,[Not Available],[Not Available],NA,10
-5.895511132,3.378967228,TCGA-55-8615-01A,TCGA-55-8615-01A-11D-2393-08,11,0.402508989,TCGA-55-8615,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24786,Alive,WITH TUMOR,446,NA,[Not Available],Distant Metastasis,NA,NA,224,Complete Remission/Response,0,446,0,446,1,224,1,224,NA,Stage IIIA,T3,MX,NA,8
-3.025797818,0.987255925,TCGA-EB-A4P0-01A,TCGA-EB-A4P0-01A-41D-A25O-08,0,NA,TCGA-EB-A4P0,SKCM,82,MALE,WHITE,NA,[Not Available],2012,[Not Available],-30225,Dead,TUMOR FREE,NA,326,[Not Available],NA,NA,NA,NA,[Not Available],1,326,0,326,NA,NA,0,326,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-3.240164296,-3.400432483,TCGA-EK-A3GK-01A,TCGA-EK-A3GK-01A-11D-A20U-09,8,0.488641426,TCGA-EK-A3GK,CESC,33,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G3,2009,[Not Available],-12207,Alive,TUMOR FREE,15,NA,NA,NA,NA,NA,NA,[Not Available],0,15,0,15,NA,NA,0,15,NA,Stage IB1,T1b1,MX,NA,10
0.435930443,4.598194493,TCGA-HC-A6AP-01A,TCGA-HC-A6AP-01A-11D-A30E-08,4,0.015149721,TCGA-HC-A6AP,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22318,Alive,NA,71,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,71,0,71,NA,NA,0,71,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-4.735066417,-1.752623754,TCGA-EK-A3GJ-01A,TCGA-EK-A3GJ-01A-21D-A20U-09,8,0.304062866,TCGA-EK-A3GJ,CESC,51,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Cervical Squamous Cell Carcinoma,G3,2010,[Not Available],-18630,Alive,[Discrepancy],3,NA,NA,NA,NA,NA,NA,[Not Available],0,3,0,3,NA,NA,0,3,NA,Stage IB1,T1b1,[Not Available],NA,10
-0.776622965,4.874844636,TCGA-12-0662-01A,TCGA-12-0662-01A-01W-0348-08,4,0.532597667,TCGA-12-0662,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-18717,Dead,WITH TUMOR,1161,1161,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],600,[Not Available],1,1161,1,1161,NA,NA,1,600,NA,NA,NA,NA,NA,6
-6.882929772,1.687502638,TCGA-EK-A2RO-01A,TCGA-EK-A2RO-01A-11D-A18J-09,0,NA,TCGA-EK-A2RO,CESC,59,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21844,Alive,WITH TUMOR,2,NA,NA,NA,NA,NA,NA,[Not Available],0,2,0,2,NA,NA,0,2,NA,Stage IIB,[Not Available],[Not Available],NA,9
-5.535591486,2.846644383,TCGA-AF-5654-01A,TCGA-AF-5654-01A-01D-1657-10,12,0.180684921,TCGA-AF-5654,READ,73,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-26738,Dead,TUMOR FREE,NA,512,[Not Available],NA,NA,NA,NA,[Not Available],1,512,0,512,NA,NA,0,512,NA,Stage I,T2,M0,NA,10
-3.865816202,-1.91980769,TCGA-05-4432-01A,TCGA-05-4432-01A-01D-1265-08,8,0.208537416,TCGA-05-4432,LUAD,66,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-24350,Alive,TUMOR FREE,761,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,761,0,761,0,761,0,761,NA,Stage IIB,T2,M0,LUAD.2,10
-3.344189313,0.81470113,TCGA-AZ-4614-01A,TCGA-AZ-4614-01A-01D-1408-10,0,NA,TCGA-AZ-4614,COAD,71,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-26267,Dead,WITH TUMOR,NA,172,[Not Available],NA,NA,NA,NA,[Not Available],1,172,1,172,NA,NA,1,172,NA,Stage IVA,T4a,M1,GI.CIN,3
-0.143035567,4.651466655,TCGA-AG-3893-01A,TCGA-AG-3893-01A-01W-1073-09,4,0.550936104,TCGA-AG-3893,READ,74,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-27272,Alive,TUMOR FREE,1065,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1065,0,1065,0,1065,0,1065,NA,Stage IIIB,T3,M0,GI.CIN,6
-5.751987144,1.172686998,TCGA-EK-A2RN-01A,TCGA-EK-A2RN-01A-12D-A20U-09,0,NA,TCGA-EK-A2RN,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16487,Alive,WITH TUMOR,71,NA,NA,NA,NA,NA,NA,[Not Available],0,71,0,71,NA,NA,0,71,NA,Stage IB1,T2b,MX,NA,10
-7.334038232,1.490945307,TCGA-G6-A5PC-01A,TCGA-G6-A5PC-01A-11D-A33K-10,0,NA,TCGA-G6-A5PC,KIRC,54,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G4,2012,[Not Available],-20029,Dead,WITH TUMOR,NA,242,[Not Available],NA,NA,NA,NA,Progressive Disease,1,242,1,242,NA,NA,1,242,NA,Stage IV,T1b,M1,NA,7
1.884398166,1.973741892,TCGA-EK-A2RM-01A,TCGA-EK-A2RM-01A-21D-A18J-09,3,0.218817928,TCGA-EK-A2RM,CESC,40,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2009,[Not Available],-14842,Alive,WITH TUMOR,50,NA,NA,NA,NA,NA,NA,[Not Available],0,50,0,50,NA,NA,0,50,NA,Stage IB,[Not Available],[Not Available],NA,3
-0.667957313,2.306771706,TCGA-06-0749-01A,TCGA-06-0749-01A-01D-1492-08,0,NA,TCGA-06-0749,GBM,50,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-18571,Dead,WITH TUMOR,66,82,[Not Available],NA,NA,NA,NA,[Not Available],1,82,1,82,NA,NA,1,82,NA,NA,NA,NA,GBM_LGG.NA,1
9.564303417,-5.651233051,TCGA-EJ-A46H-01A,TCGA-EJ-A46H-01A-31D-A26M-08,1,0.856656978,TCGA-EJ-A46H,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22059,Alive,TUMOR FREE,724,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,724,0,724,0,724,0,724,NA,[Not Applicable],T2c,[Not Applicable],NA,1
1.267102925,2.230014288,TCGA-EB-A6QZ-01A,TCGA-EB-A6QZ-01A-12D-A32N-08,0,NA,TCGA-EB-A6QZ,SKCM,76,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-28078,Dead,WITH TUMOR,NA,352,[Not Available],Regional lymph node|Distant Metastasis,[Not Available]|Brain,[Not Applicable]|[Not Applicable],129,[Not Available],1,352,1,352,NA,NA,1,129,NA,Stage IIA,T3a,M0,NA,3
-4.825797485,0.692751286,TCGA-EK-A2RK-01A,TCGA-EK-A2RK-01A-11D-A18J-09,0,NA,TCGA-EK-A2RK,CESC,67,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541,Alive,NA,13,NA,NA,NA,NA,NA,NA,[Not Available],0,13,0,13,NA,NA,0,13,NA,Stage IA2,T1b1,MX,NA,10
-4.122009806,-1.836150425,TCGA-EK-A2RJ-01A,TCGA-EK-A2RJ-01A-11D-A18J-09,8,0.476652354,TCGA-EK-A2RJ,CESC,51,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2009,[Not Available],-18664,Alive,TUMOR FREE,53,NA,NA,NA,NA,NA,NA,[Not Available],0,53,0,53,NA,NA,0,53,NA,Stage IB2,T1b2,MX,NA,10
-7.173246691,2.291774548,TCGA-AA-3696-01A,TCGA-AA-3696-01A-01W-0900-09,9,0.120388963,TCGA-AA-3696,COAD,75,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27667,Dead,WITH TUMOR,NA,153,[Not Available],NA,NA,NA,NA,[Unknown],1,153,1,153,NA,NA,1,153,NA,Stage IV,T3,M1,GI.GS,7
9.305841121,-2.713042652,TCGA-AG-4001-01A,TCGA-AG-4001-01A-02W-1073-09,1,0.76276209,TCGA-AG-4001,READ,74,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-27302,Alive,TUMOR FREE,1096,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1096,0,1096,NA,NA,0,1096,NA,Stage IIA,T3,M0,GI.CIN,1
9.068298551,-1.862617957,TCGA-S9-A6WL-01A,TCGA-S9-A6WL-01A-21D-A33T-08,1,0.662540016,TCGA-S9-A6WL,LGG,52,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-19234,Alive,WITH TUMOR,946,NA,[Not Available],NA,NA,NA,240,Progressive Disease,0,946,0,946,NA,NA,1,240,NA,NA,NA,NA,GBM_LGG.Codel,1
10.25995438,-1.318372499,TCGA-J4-A83K-01A,TCGA-J4-A83K-01A-11D-A34U-08,1,0.812938141,TCGA-J4-A83K,PRAD,52,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-19299,Alive,TUMOR FREE,328,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,328,0,328,0,328,0,328,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-6.91414595,-2.129171673,TCGA-EK-A2RC-01A,TCGA-EK-A2RC-01A-11D-A18J-09,6,0.194363389,TCGA-EK-A2RC,CESC,33,FEMALE,[Not Available],Cervical Squamous Cell Carcinoma,G3,2009,[Not Available],-12353,Alive,TUMOR FREE,129,NA,NA,NA,NA,NA,NA,[Not Available],0,129,0,129,NA,NA,0,129,NA,Stage IB1,[Not Available],[Not Available],NA,2
0.054929337,5.132494629,TCGA-S9-A7R3-01A,TCGA-S9-A7R3-01A-11D-A34J-08,4,0.528324568,TCGA-S9-A7R3,LGG,28,FEMALE,WHITE,Astrocytoma,G2,2006,[Not Available],-10342,Alive,TUMOR FREE,3013,NA,[Not Available],NA,NA,NA,970,Partial Remission/Response,0,3013,0,3013,NA,NA,1,970,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.773922607,0.875430256,TCGA-EK-A2RD-01A,TCGA-EK-A2RD-01A-12D-A20U-09,0,NA,TCGA-EK-A2RD,CESC,47,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17191,Alive,TUMOR FREE,2,NA,NA,NA,NA,NA,NA,[Not Available],0,2,0,2,NA,NA,0,2,NA,Stage IB1,T1b1,MX,NA,9
-7.330383315,-2.454671786,TCGA-RD-A7BW-01A,TCGA-RD-A7BW-01A-11D-A32N-08,6,0.199851863,TCGA-RD-A7BW,STAD,68,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2004,[Not Available],-25036,Dead,TUMOR FREE,NA,156,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,156,0,156,0,156,0,156,NA,Stage IB,T2,M0,GI.CIN,2
0.384093061,2.268599481,TCGA-EK-A2R7-01A,TCGA-EK-A2R7-01A-11D-A18J-09,0,NA,TCGA-EK-A2R7,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16487,Alive,TUMOR FREE,27,NA,NA,NA,NA,NA,NA,[Not Available],0,27,0,27,NA,NA,0,27,NA,Stage IB,T1b1,M0,NA,5
0.271703359,3.515912477,TCGA-S9-A6WQ-01A,TCGA-S9-A6WQ-01A-12D-A34A-08,4,0.265795369,TCGA-S9-A6WQ,LGG,57,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-21133,Alive,WITH TUMOR,428,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,428,0,428,NA,NA,0,428,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
9.050273904,-2.601155961,TCGA-M7-A721-01A,TCGA-M7-A721-01A-12D-A32B-08,1,0.64267912,TCGA-M7-A721,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-25585,Alive,TUMOR FREE,400,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,400,0,400,0,400,0,400,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-4.175610296,-1.626627452,TCGA-EK-A2PM-01A,TCGA-EK-A2PM-01A-11D-A18J-09,8,0.402432372,TCGA-EK-A2PM,CESC,81,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29747,Alive,WITH TUMOR,18,NA,NA,NA,NA,NA,NA,[Not Available],0,18,0,18,NA,NA,0,18,NA,Stage IIB,[Not Available],[Not Available],NA,10
-0.256156044,4.679524111,TCGA-06-0237-01A,TCGA-06-0237-01A-02D-1491-08,4,0.519153911,TCGA-06-0237,GBM,75,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-27735,Dead,WITH TUMOR,315,415,[Not Available],NA,NA,NA,NA,[Not Available],1,415,1,415,NA,NA,1,415,NA,NA,NA,NA,NA,6
-6.453769009,1.620399723,TCGA-32-2634-01A,TCGA-32-2634-01A-01D-1495-08,10,0.151887429,TCGA-32-2634,GBM,82,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-29964,Alive,TUMOR FREE,693,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,693,0,693,NA,NA,0,693,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-3.463116608,-3.039652673,TCGA-K4-A54R-01A,TCGA-K4-A54R-01A-11D-A26M-08,8,0.516166962,TCGA-K4-A54R,BLCA,59,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-21601,Alive,TUMOR FREE,842,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,842,0,842,0,842,0,842,NA,Stage II,T2b,MX,NA,10
0.021684456,4.811309004,TCGA-HT-A5RB-01A,TCGA-HT-A5RB-01A-11D-A289-08,4,0.68235907,TCGA-HT-A5RB,LGG,24,MALE,WHITE,Astrocytoma,G2,2011,[Not Available],-8820,Alive,NA,3,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3,0,3,NA,NA,0,3,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
7.605255734,-3.34943623,TCGA-AA-A004-01A,TCGA-AA-A004-01A-01W-A00E-09,1,0.288098587,TCGA-AA-A004,COAD,76,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27943,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,424,0,424,0,424,0,424,NA,Stage IIA,T3,M0,NA,1
-5.394287229,2.481356648,TCGA-78-7161-01A,TCGA-78-7161-01A-11D-2036-08,12,0.105067329,TCGA-78-7161,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25294,Dead,WITH TUMOR,NA,291,[Not Available],NA,NA,NA,162,Progressive Disease,1,291,1,291,NA,NA,1,162,NA,Stage IIB,T3,M0,LUAD.2,8
-3.678662614,-2.735793025,TCGA-EK-A2PG-01A,TCGA-EK-A2PG-01A-11D-A18J-09,8,0.407018209,TCGA-EK-A2PG,CESC,88,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32500,Alive,NA,46,NA,NA,NA,NA,NA,NA,[Not Available],0,46,0,46,NA,NA,0,46,NA,[Not Available],[Not Available],[Not Available],NA,10
4.501128031,0.933885392,TCGA-EK-A2GZ-01A,TCGA-EK-A2GZ-01A-11D-A17W-09,2,0.515830012,TCGA-EK-A2GZ,CESC,64,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23599,Alive,WITH TUMOR,383,NA,NA,NA,NA,NA,NA,[Not Available],0,383,0,383,NA,NA,0,383,NA,Stage IIIB,[Not Available],[Not Available],NA,5
-0.927870124,4.509308384,TCGA-19-1390-01A,TCGA-19-1390-01A-01D-1495-08,4,0.433837834,TCGA-19-1390,GBM,63,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-23063,Dead,NA,772,772,[Not Available],NA,NA,NA,NA,[Not Available],1,772,NA,772,NA,NA,0,772,NA,NA,NA,NA,GBM_LGG.Classic-like,6
9.554351077,-5.18394136,TCGA-S9-A6UB-01A,TCGA-S9-A6UB-01A-21D-A33T-08,1,0.818024545,TCGA-S9-A6UB,LGG,52,MALE,WHITE,Oligodendroglioma,G2,2005,[Not Available],-19223,Alive,TUMOR FREE,3761,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3761,0,3761,0,3761,0,3761,NA,NA,NA,NA,GBM_LGG.Codel,1
-7.496579331,-2.392776477,TCGA-K7-A6G5-01A,TCGA-K7-A6G5-01A-11D-A30V-10,6,0.391659492,TCGA-K7-A6G5,LIHC,66,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-24233,Alive,TUMOR FREE,512,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,512,0,512,NA,NA,0,512,NA,Stage I,T1,MX,LIHC.iCluster:2,2
4.713716534,1.055791398,TCGA-EA-A97N-01A,TCGA-EA-A97N-01A-11D-A387-09,1,0.600281881,TCGA-EA-A97N,CESC,38,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13984,Alive,TUMOR FREE,11,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,11,0,11,0,11,0,11,NA,Stage IB2,T1b2,M0,NA,6
-4.730067152,0.086688604,TCGA-05-4405-01A,TCGA-05-4405-01A-21D-1855-08,0,NA,TCGA-05-4405,LUAD,74,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2006,[Not Available],-27241,Alive,TUMOR FREE,610,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,610,0,610,NA,NA,0,610,NA,Stage IB,T2,M0,LUAD.3,10
8.975529119,-4.476380709,TCGA-FG-A713-01A,TCGA-FG-A713-01A-11D-A32B-08,1,0.772274728,TCGA-FG-A713,LGG,74,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-27232,Alive,TUMOR FREE,622,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,622,0,622,0,622,0,622,NA,NA,NA,NA,GBM_LGG.Codel,1
8.782964569,-2.04653782,TCGA-EA-A411-01A,TCGA-EA-A411-01A-11D-A243-09,4,0.247934657,TCGA-EA-A411,CESC,50,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18561,Alive,TUMOR FREE,747,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,747,0,747,0,747,0,747,NA,Stage IB1,T1b1,M0,NA,6
10.14078398,-1.173569375,TCGA-06-5412-01A,TCGA-06-5412-01A-01D-1696-08,9,0.144014603,TCGA-06-5412,GBM,78,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-28762,Dead,WITH TUMOR,138,138,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88,[Not Available],1,138,1,138,NA,NA,1,88,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-0.183058623,4.570009048,TCGA-19-2625-01A,TCGA-19-2625-01A-01D-1495-08,4,0.638400672,TCGA-19-2625,GBM,76,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-27930,Dead,TUMOR FREE,124,124,[Not Available],NA,NA,NA,NA,[Not Available],1,124,0,124,NA,NA,0,124,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-1.936991394,1.480797408,TCGA-D5-6898-01A,TCGA-D5-6898-01A-11D-1924-10,5,0.499608828,TCGA-D5-6898,COAD,51,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-18874,Alive,TUMOR FREE,229,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,229,0,229,NA,NA,0,229,NA,Stage I,T2,M0,GI.CIN,4
-5.354887483,2.753223999,TCGA-F5-6702-01A,TCGA-F5-6702-01A-11D-1826-10,12,0.303854961,TCGA-F5-6702,READ,71,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-26123,Alive,WITH TUMOR,452,NA,[Not Available],NA,NA,NA,368,Progressive Disease,0,452,0,452,NA,NA,1,368,NA,Stage IVA,T3,M1,GI.CIN,8
-3.467981516,-3.108399367,TCGA-55-7281-01A,TCGA-55-7281-01A-11D-2036-08,8,0.5165171,TCGA-55-7281,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25870,Alive,WITH TUMOR,872,NA,[Not Available],Distant Metastasis,NA,NA,339,Complete Remission/Response,0,872,0,872,1,339,1,339,NA,Stage IA,T1b,M0,LUAD.3,10
-3.221612598,-3.467297546,TCGA-AA-3845-01A,TCGA-AA-3845-01A-01W-0995-10,8,0.588856312,TCGA-AA-3845,COAD,86,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-31593,Dead,WITH TUMOR,NA,0,[Not Available],NA,NA,NA,NA,[Not Available],1,0,1,0,NA,NA,1,0,NA,Stage IIA,T3,M0,GI.HM-indel,10
-8.215640792,2.130909864,TCGA-G9-6498-01A,TCGA-G9-6498-01A-12D-A30X-08,9,0.459839634,TCGA-G9-6498,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-19568,Alive,TUMOR FREE,1952,NA,[Not Available],Biochemical evidence of disease,NA,NA,1342,Complete Remission/Response,0,1952,0,1952,1,1342,1,1342,NA,[Not Applicable],T3a,[Not Applicable],NA,7
-3.023596707,-3.895737895,TCGA-BF-A1Q0-01A,TCGA-BF-A1Q0-01A-21D-A19A-08,8,0.234891673,TCGA-BF-A1Q0,SKCM,80,MALE,WHITE,NA,[Not Available],2010,[Not Available],-29380,Alive,TUMOR FREE,831,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,831,0,831,NA,NA,0,831,NA,Stage IIC,T4b,M0,SKCM.Triple_WT,10
9.575095031,-5.363423427,TCGA-AA-3526-01A,TCGA-AA-3526-01A-02D-1953-10,1,0.848317529,TCGA-AA-3526,COAD,57,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-21123,Alive,TUMOR FREE,580,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,580,0,580,0,580,0,580,NA,Stage I,T2,M0,NA,1
-0.688565172,5.035511555,TCGA-HW-A5KM-01A,TCGA-HW-A5KM-01A-11D-A27K-08,4,0.42222278,TCGA-HW-A5KM,LGG,35,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-12845,Alive,WITH TUMOR,630,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,630,0,630,NA,NA,0,630,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.677461766,-1.393744195,TCGA-EB-A5FP-01A,TCGA-EB-A5FP-01A-11D-A27K-08,0,NA,TCGA-EB-A5FP,SKCM,65,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-23833,Dead,WITH TUMOR,NA,454,[Not Available],Regional lymph node|Distant Metastasis,[Not Available]|Lung,[Not Applicable]|[Not Applicable],24,[Not Available],1,454,1,454,NA,NA,1,24,NA,Stage IV,T4b,M1b,SKCM.-,10
0.331485421,5.101452721,TCGA-S9-A6TU-01A,TCGA-S9-A6TU-01A-12D-A32B-08,4,0.49595857,TCGA-S9-A6TU,LGG,38,MALE,WHITE,Astrocytoma,G2,2007,[Not Available],-14108,Alive,WITH TUMOR,2650,NA,[Not Available],NA,NA,NA,1475,Partial Remission/Response,0,2650,0,2650,NA,NA,1,1475,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.057725529,-4.907753579,TCGA-C8-A26Z-01A,TCGA-C8-A26Z-01A-11D-A16D-09,1,0.791219457,TCGA-C8-A26Z,BRCA,59,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,470,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,470,0,470,0,470,0,470,NA,Stage IIA,T2,M0,BRCA.LumA,1
-7.485125326,2.180003621,TCGA-E9-A295-01A,TCGA-E9-A295-01A-11D-A16D-09,9,0.205168895,TCGA-E9-A295,BRCA,71,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25957,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,375,0,375,0,375,0,375,NA,Stage IIA,T2,M0,BRCA.LumA,7
8.696383562,-4.79322342,TCGA-14-0781-01B,TCGA-14-0781-01B-01D-1696-08,1,0.814458871,TCGA-14-0781,GBM,49,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-17903,Dead,WITH TUMOR,29,29,[Not Available],NA,NA,NA,NA,[Not Available],1,29,1,29,NA,NA,1,29,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-2.414636297,2.40927993,TCGA-AN-A0XN-01A,TCGA-AN-A0XN-01A-21D-A10G-09,0,NA,TCGA-AN-A0XN,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25029,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIIA,T2,M0,BRCA.LumA,3
-7.929171929,2.250631255,TCGA-EW-A1J2-01A,TCGA-EW-A1J2-01A-21D-A13L-09,9,0.548917797,TCGA-EW-A1J2,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18558,Alive,TUMOR FREE,403,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,403,0,403,0,403,0,403,NA,[Discrepancy],T1c,MX,BRCA.LumA,7
1.899846901,1.925507617,TCGA-E2-A1IG-01A,TCGA-E2-A1IG-01A-11D-A142-09,3,0.598166826,TCGA-E2-A1IG,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16757,Alive,TUMOR FREE,2140,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2140,0,2140,0,2140,0,2140,NA,Stage IIB,T2,M0,BRCA.LumA,3
9.296854306,-1.591594607,TCGA-BH-A0EI-01A,TCGA-BH-A0EI-01A-11D-A10Y-09,1,0.750785247,TCGA-BH-A0EI,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Peri (6-12 months since last menstrual period),-18741,Alive,TUMOR FREE,1926,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1926,0,1926,0,1926,0,1926,NA,Stage IIA,T1c,M0,BRCA.LumA,1
8.698353776,-4.758077793,TCGA-A8-A0A4-01A,TCGA-A8-A0A4-01A-11W-A019-09,1,0.735535505,TCGA-A8-A0A4,BRCA,73,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26693,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,396,0,396,0,396,0,396,NA,Stage IIA,T2,M0,BRCA.LumA,1
-2.864342488,-4.135391668,TCGA-AC-A23H-01A,TCGA-AC-A23H-01A-11D-A159-09,0,NA,TCGA-AC-A23H,BRCA,90,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Dead,WITH TUMOR,NA,174,[Not Available],NA,NA,NA,NA,[Not Available],1,174,1,174,NA,NA,1,174,NA,Stage IIA,T2,M0,BRCA.Her2,10
9.764565082,-3.510043158,TCGA-D8-A1XC-01A,TCGA-D8-A1XC-01A-11D-A14G-09,1,0.667810116,TCGA-D8-A1XC,BRCA,85,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31220,Dead,WITH TUMOR,NA,377,[Not Available],NA,NA,NA,NA,[Not Available],1,377,1,377,NA,NA,1,377,NA,Stage IIIB,T4b,M0,BRCA.LumA,1
-8.031000044,2.161469237,TCGA-BH-A0DV-01A,TCGA-BH-A0DV-01A-21D-A12Q-09,9,0.600374578,TCGA-BH-A0DV,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Peri (6-12 months since last menstrual period),-19781,Alive,TUMOR FREE,2064,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2064,0,2064,0,2064,0,2064,NA,Stage IIIA,T2,M0,BRCA.LumA,7
9.097843114,-5.432767664,TCGA-E2-A15R-01A,TCGA-E2-A15R-01A-11D-A10Y-09,1,0.825117989,TCGA-E2-A15R,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23570,Alive,TUMOR FREE,1732,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1732,0,1732,0,1732,0,1732,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-1.974609481,1.284456769,TCGA-EA-A3QD-01A,TCGA-EA-A3QD-01A-32D-A22X-09,5,0.60783469,TCGA-EA-A3QD,CESC,59,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21655,Alive,TUMOR FREE,397,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,397,0,397,0,397,0,397,NA,Stage IIIB,T1b1,M0,NA,4
10.08230962,-2.051473459,TCGA-DS-A7WI-01A,TCGA-DS-A7WI-01A-12D-A351-09,1,0.670176062,TCGA-DS-A7WI,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15970,Dead,WITH TUMOR,NA,252,Cervical Cancer,Locoregional Recurrence,"Other, specify",Retroperitoneum,206,Complete Remission/Response,1,252,1,252,1,206,1,206,NA,Stage IIA2,T2a2,MX,NA,1
9.589014223,-3.090253885,TCGA-69-7764-01A,TCGA-69-7764-01A-11D-2167-08,1,0.702795478,TCGA-69-7764,LUAD,75,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-27693,Alive,TUMOR FREE,414,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,414,0,414,NA,NA,0,414,NA,Stage IA,T1b,M0,LUAD.1,1
8.906031643,-2.438629203,TCGA-DS-A7WH-01A,TCGA-DS-A7WH-01A-22D-A351-09,1,0.636151227,TCGA-DS-A7WH,CESC,34,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12644,Alive,TUMOR FREE,533,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,533,0,533,0,533,0,533,NA,Stage IB1,T1b1,MX,NA,6
-0.017588922,4.983691456,TCGA-14-0871-01A,TCGA-14-0871-01A-01D-1492-08,4,0.557469205,TCGA-14-0871,GBM,74,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-27387,Dead,NA,880,880,[Not Available],NA,NA,NA,NA,[Not Available],1,880,NA,880,NA,NA,0,880,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,6
-7.966460209,1.989787469,TCGA-DS-A7WF-01A,TCGA-DS-A7WF-01A-11D-A351-09,9,0.346036968,TCGA-DS-A7WF,CESC,41,FEMALE,[Unknown],Adenosquamous,G3,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15319,Dead,WITH TUMOR,NA,492,Cervical Cancer,Distant Metastasis,Lung,NA,321,Partial Remission/Response,1,492,1,492,NA,NA,1,321,NA,Stage IB2,T1b2,MX,NA,7
-0.262870749,4.78205939,TCGA-76-6664-01A,TCGA-76-6664-01A-11D-1845-08,4,0.578647985,TCGA-76-6664,GBM,49,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-18054,Alive,WITH TUMOR,1101,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1101,0,1101,NA,NA,0,1101,NA,NA,NA,NA,NA,6
-7.749626962,-2.447643242,TCGA-06-0221-01A,TCGA-06-0221-01A-01D-1491-08,6,0.490102448,TCGA-06-0221,GBM,31,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-11333,Dead,WITH TUMOR,548,603,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],260,[Not Available],1,603,1,603,NA,NA,1,260,NA,NA,NA,NA,NA,2
-7.679102327,-2.590728031,TCGA-C5-A907-01A,TCGA-C5-A907-01A-11D-A37N-09,6,0.404693606,TCGA-C5-A907,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,[Not Available],-17304,Alive,TUMOR FREE,448,NA,NA,NA,NA,NA,NA,[Not Available],0,448,0,448,NA,NA,0,448,NA,Stage IB2,[Not Available],[Not Available],NA,2
-7.285068723,2.789093572,TCGA-41-3393-01A,TCGA-41-3393-01A-01D-1353-08,0,NA,TCGA-41-3393,GBM,81,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-29904,Dead,WITH TUMOR,135,135,[Not Available],NA,NA,NA,NA,[Not Available],1,135,1,135,NA,NA,1,135,NA,NA,NA,NA,NA,1
-0.015186551,4.920255401,TCGA-28-5207-01A,TCGA-28-5207-01A-01D-1486-08,4,0.487016326,TCGA-28-5207,GBM,71,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-25975,Dead,WITH TUMOR,275,343,[Not Available],NA,NA,NA,NA,[Not Available],1,343,1,343,NA,NA,1,343,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-5.269994087,2.418703127,TCGA-AG-4021-01A,TCGA-AG-4021-01A-01D-1733-10,12,0.325674039,TCGA-AG-4021,READ,84,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2005,[Not Available],-31015,Dead,WITH TUMOR,NA,121,[Not Available],NA,NA,NA,0,[Not Available],1,121,1,121,NA,NA,1,0,NA,Stage IV,T3,M1,GI.CIN,8
9.021850675,-3.787875576,TCGA-BH-A204-01A,TCGA-BH-A204-01A-11D-A159-09,1,0.716540054,TCGA-BH-A204,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529,Dead,NA,NA,2534,[Not Available],NA,NA,NA,NA,[Not Available],1,2534,NA,2534,NA,NA,0,2534,NA,Stage IIB,T2,M0,BRCA.LumB,1
-6.992199961,1.928768349,TCGA-80-5607-01A,TCGA-80-5607-01A-31D-1945-08,9,0.059740614,TCGA-80-5607,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],NA,Alive,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage IIB,T2,M0,LUAD.4,7
-2.949178036,-4.014519683,TCGA-EA-A410-01A,TCGA-EA-A410-01A-11D-A243-09,8,0.201461608,TCGA-EA-A410,CESC,51,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18720,Alive,TUMOR FREE,803,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,803,0,803,0,803,0,803,NA,Stage IIA2,T2a2,M0,NA,10
-4.661591529,-1.355109842,TCGA-C5-A902-01A,TCGA-C5-A902-01A-11D-A37N-09,8,0.264084826,TCGA-C5-A902,CESC,35,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2008,[Not Available],-12959,Alive,TUMOR FREE,149,NA,NA,NA,NA,NA,NA,[Not Available],0,149,0,149,NA,NA,0,149,NA,Stage IB2,[Not Available],[Not Available],NA,10
1.771831017,1.922215051,TCGA-C5-A901-01A,TCGA-C5-A901-01A-11D-A37N-09,3,0.32532098,TCGA-C5-A901,CESC,44,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2000,[Not Available],-16186,Alive,TUMOR FREE,518,NA,NA,NA,NA,NA,NA,[Not Available],0,518,0,518,NA,NA,0,518,NA,[Not Available],TX,MX,NA,3
-5.747131449,2.994667731,TCGA-55-7725-01A,TCGA-55-7725-01A-11D-2167-08,0,NA,TCGA-55-7725,LUAD,68,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-24848,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,442,0,442,0,442,0,442,NA,Stage IA,T1a,MX,LUAD.4,8
9.153486088,-3.720469454,TCGA-C5-A8ZZ-01A,TCGA-C5-A8ZZ-01A-11D-A37N-09,1,0.739044347,TCGA-C5-A8ZZ,CESC,41,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15262,Alive,TUMOR FREE,636,NA,NA,NA,NA,NA,NA,[Not Available],0,636,0,636,NA,NA,0,636,NA,Stage IIB,[Not Available],[Not Available],NA,1
9.59236627,-5.682572794,TCGA-C5-A8YT-01A,TCGA-C5-A8YT-01A-11D-A37N-09,1,0.873718994,TCGA-C5-A8YT,CESC,36,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2008,[Not Available],-13253,Dead,WITH TUMOR,NA,633,NA,NA,NA,NA,NA,[Not Available],1,633,1,633,NA,NA,1,633,NA,Stage IB1,[Not Available],[Not Available],NA,1
9.242570834,-5.217271369,TCGA-28-2502-01B,TCGA-28-2502-01B-01D-1494-08,1,0.737050422,TCGA-28-2502,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-23807,Alive,NA,20,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,20,0,20,NA,NA,0,20,NA,NA,NA,NA,NA,1
9.51785286,-5.687739979,TCGA-AR-A252-01A,TCGA-AR-A252-01A-11D-A167-09,1,0.857426858,TCGA-AR-A252,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18611,Alive,TUMOR FREE,2838,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2838,0,2838,0,2838,0,2838,NA,Stage I,T1,M0,BRCA.LumA,1
8.689059915,-4.847163569,TCGA-12-0615-01A,TCGA-12-0615-01A-01D-1492-08,1,0.796131431,TCGA-12-0615,GBM,78,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-28583,Dead,WITH TUMOR,426,467,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],160,[Not Available],1,467,1,467,NA,NA,1,160,NA,NA,NA,NA,NA,1
-0.565628088,5.094652583,TCGA-06-0188-01A,TCGA-06-0188-01A-01D-1491-08,4,0.5272762,TCGA-06-0188,GBM,71,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-26080,Dead,WITH TUMOR,NA,1356,[Not Available],NA,[Not Applicable],[Not Applicable],310,[Not Available],1,1356,1,1356,NA,NA,1,310,NA,NA,NA,NA,NA,6
1.125842558,3.580615279,TCGA-AO-A03V-01A,TCGA-AO-A03V-01A-11D-A10Y-09,0,NA,TCGA-AO-A03V,BRCA,41,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Peri (6-12 months since last menstrual period),-15284,Alive,TUMOR FREE,1351,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1351,0,1351,0,1351,0,1351,NA,Stage I,T1c,M0,BRCA.LumA,1
-7.437385629,1.871706152,TCGA-AQ-A1H2-01A,TCGA-AQ-A1H2-01A-11D-A13L-09,9,0.14957187,TCGA-AQ-A1H2,BRCA,84,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30958,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,475,0,475,0,475,0,475,NA,Stage IIIA,T2,MX,BRCA.LumA,7
-1.88259595,1.154310632,TCGA-50-5072-01A,TCGA-50-5072-01A-21D-1855-08,5,0.653772449,TCGA-50-5072,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-27036,Dead,WITH TUMOR,NA,250,[Not Available],Distant Metastasis,NA,NA,213,Progressive Disease,1,250,1,250,NA,NA,1,213,NA,Stage IIIA,T2,M0,LUAD.6,4
-5.249057003,2.761309236,TCGA-C5-A905-01A,TCGA-C5-A905-01A-11D-A37N-09,12,0.106081753,TCGA-C5-A905,CESC,37,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,1994,[Not Available],-13584,Alive,TUMOR FREE,4879,NA,NA,NA,NA,NA,NA,[Not Available],0,4879,0,4879,NA,NA,0,4879,NA,Stage IB,T1b,MX,NA,8
-4.170723851,-2.172352778,TCGA-62-8399-01A,TCGA-62-8399-01A-21D-2323-08,8,0.385298335,TCGA-62-8399,LUAD,62,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-22952,Alive,TUMOR FREE,2696,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2696,0,2696,0,2696,0,2696,NA,Stage IIIA,T2,M0,NA,10
-2.800316393,1.874289626,TCGA-C5-A8YQ-01A,TCGA-C5-A8YQ-01A-11D-A37N-09,0,NA,TCGA-C5-A8YQ,CESC,79,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28873,Dead,WITH TUMOR,NA,715,Cervical Cancer,NA,NA,NA,NA,[Not Available],1,715,1,715,NA,NA,1,715,NA,Stage IB1,[Not Available],[Not Available],NA,6
-4.568150761,-0.495414909,TCGA-C5-A8XK-01A,TCGA-C5-A8XK-01A-11D-A37N-09,0,NA,TCGA-C5-A8XK,CESC,30,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2000,[Not Available],-11268,Alive,TUMOR FREE,3039,NA,NA,NA,NA,NA,NA,[Not Available],0,3039,0,3039,NA,NA,0,3039,NA,[Not Available],[Not Available],[Not Available],NA,10
-4.72346564,-1.753217783,TCGA-C5-A8XJ-01A,TCGA-C5-A8XJ-01A-11D-A37N-09,8,0.372565663,TCGA-C5-A8XJ,CESC,74,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-27087,Alive,TUMOR FREE,4467,NA,NA,NA,NA,NA,NA,[Not Available],0,4467,0,4467,NA,NA,0,4467,NA,Stage IB,[Not Available],[Not Available],NA,10
9.88753756,-1.938071706,TCGA-C5-A8XI-01A,TCGA-C5-A8XI-01A-11D-A37N-09,1,0.835146398,TCGA-C5-A8XI,CESC,69,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25220,Alive,TUMOR FREE,254,NA,NA,NA,NA,NA,NA,[Not Available],0,254,0,254,NA,NA,0,254,NA,Stage IB2,T1b2,MX,NA,1
-6.529000327,1.607722119,TCGA-BH-A0GY-01A,TCGA-BH-A0GY-01A-11W-A071-09,10,0.202414855,TCGA-BH-A0GY,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24493,Alive,TUMOR FREE,923,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,923,0,923,0,923,0,923,NA,Stage IIA,T2,M0,BRCA.LumA,7
-8.072355774,1.959260737,TCGA-AO-A0J7-01A,TCGA-AO-A0J7-01A-11W-A050-09,9,0.459270627,TCGA-AO-A0J7,BRCA,71,FEMALE,WHITE,"Other, specify",[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26281,Alive,TUMOR FREE,618,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,618,0,618,0,618,0,618,NA,Stage IIB,T2,M0,BRCA.LumB,7
-0.191591618,5.124080706,TCGA-14-1821-01A,TCGA-14-1821-01A-01W-0643-08,4,0.5644886,TCGA-14-1821,GBM,31,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-11329,Dead,WITH TUMOR,541,541,[Not Available],Recurrence,[Not Applicable],[Not Applicable],331,[Not Available],1,541,1,541,NA,NA,1,331,NA,NA,NA,NA,NA,6
8.833698064,-3.735144768,TCGA-A8-A08G-01A,TCGA-A8-A08G-01A-11W-A019-09,1,0.73853761,TCGA-A8-A08G,BRCA,41,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14976,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,607,0,607,0,607,0,607,NA,Stage IIA,T2,M0,BRCA.LumB,1
-5.51300801,1.472148227,TCGA-C5-A8YR-01A,TCGA-C5-A8YR-01A-12D-A37N-09,0,NA,TCGA-C5-A8YR,CESC,56,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,1994,[Not Available],-20672,Dead,NA,NA,837,NA,Locoregional Recurrence,NA,regional recurrence NOS,272,[Not Available],1,837,NA,837,NA,NA,1,272,NA,Stage IB,T1b,M0,NA,9
-6.983064906,-2.05513295,TCGA-55-6971-01A,TCGA-55-6971-01A-11D-1945-08,6,0.092767496,TCGA-55-6971,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-21734,Alive,TUMOR FREE,1400,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1400,0,1400,0,1400,0,1400,NA,Stage IB,T2,MX,LUAD.6,2
9.063441424,-3.710888672,TCGA-69-7763-01A,TCGA-69-7763-01A-11D-2167-08,1,0.750789627,TCGA-69-7763,LUAD,69,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-25316,Alive,NA,690,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,690,0,690,NA,NA,0,690,NA,Stage IA,T1b,M0,LUAD.4,1
-6.641973634,2.330138575,TCGA-C8-A135-01A,TCGA-C8-A135-01A-11D-A10Y-09,0,NA,TCGA-C8-A135,BRCA,64,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23667,Alive,TUMOR FREE,393,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,393,0,393,0,393,0,393,NA,Stage IIB,T2,M0,BRCA.Her2,7
8.618072061,-1.927138878,TCGA-06-0881-01A,TCGA-06-0881-01A-02D-1492-08,1,0.530254181,TCGA-06-0881,GBM,50,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-18278,Dead,WITH TUMOR,NA,504,[Not Available],Recurrence,[Not Applicable],[Not Applicable],141,[Not Available],1,504,1,504,NA,NA,1,141,NA,NA,NA,NA,NA,1
0.524885131,4.848009639,TCGA-E9-A1RB-01A,TCGA-E9-A1RB-01A-11D-A17G-09,4,0.481397004,TCGA-E9-A1RB,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14755,Dead,TUMOR FREE,NA,976,[Not Available],NA,NA,NA,NA,[Not Available],1,976,0,976,0,976,0,976,NA,Stage IIA,T2,M0,BRCA.LumB,6
-5.326461549,2.72829383,TCGA-12-0707-01A,TCGA-12-0707-01A-01W-0348-08,12,0.253869785,TCGA-12-0707,GBM,55,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1997,[Not Available],-20136,Dead,NA,0,864,[Not Available],NA,NA,NA,NA,[Not Available],1,864,NA,864,NA,NA,0,864,NA,NA,NA,NA,NA,8
-7.783538181,-2.511584601,TCGA-C8-A12X-01A,TCGA-C8-A12X-01A-11D-A10Y-09,6,0.320336892,TCGA-C8-A12X,BRCA,62,FEMALE,ASIAN,Mucinous Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22889,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,0,385,0,385,NA,Stage IIB,T2,M0,BRCA.LumA,2
9.04268922,-3.423712797,TCGA-75-6205-01A,TCGA-75-6205-01A-11D-1753-08,1,0.707142857,TCGA-75-6205,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2006,[Not Available],NA,Dead,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,NA,1,NA,NA,NA,1,NA,NA,Stage IB,T2a,M0,LUAD.6,1
-7.694913762,2.215186388,TCGA-78-7162-01A,TCGA-78-7162-01A-21D-2063-08,9,0.333510635,TCGA-78-7162,LUAD,75,MALE,WHITE,Lung Adenocarcinoma,[Not Available],1991,[Not Available],-27593,Dead,NA,NA,3169,[Not Available],NA,NA,NA,2218,[Not Available],1,3169,NA,3169,NA,NA,1,2218,NA,Stage IA,T1,M0,LUAD.5,7
8.788581513,-1.964073106,TCGA-12-3648-01A,TCGA-12-3648-01A-01W-0922-08,1,0.659161262,TCGA-12-3648,GBM,61,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-22463,Dead,WITH TUMOR,784,819,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],86,[Not Available],1,819,1,819,NA,NA,1,86,NA,NA,NA,NA,NA,1
0.120134562,5.193600543,TCGA-D8-A1JM-01A,TCGA-D8-A1JM-01A-11D-A13L-09,4,0.65392013,TCGA-D8-A1JM,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21602,Alive,TUMOR FREE,590,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,590,0,590,0,590,0,590,NA,Stage IIB,T2,M0,BRCA.Basal,6
-6.634009965,-1.316469671,TCGA-AC-A2FO-01A,TCGA-AC-A2FO-01A-11D-A17W-09,7,0.185690207,TCGA-AC-A2FO,BRCA,65,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23928,Alive,TUMOR FREE,2255,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2255,0,2255,0,2255,0,2255,NA,Stage IIB,T2,MX,BRCA.LumA,2
-6.131940847,-1.553137264,TCGA-55-8299-01A,TCGA-55-8299-01A-11D-2284-08,7,0.028377655,TCGA-55-8299,LUAD,61,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22626,Dead,WITH TUMOR,NA,469,[Not Available],Distant Metastasis,NA,NA,274,Complete Remission/Response,1,469,1,469,1,274,1,274,NA,Stage IA,T1b,MX,NA,2
-1.26373063,4.23780054,TCGA-06-2559-01A,TCGA-06-2559-01A-01D-1494-08,4,0.324938842,TCGA-06-2559,GBM,83,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-30580,Dead,WITH TUMOR,150,150,[Not Available],NA,NA,NA,NA,[Not Available],1,150,1,150,NA,NA,1,150,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-0.964646085,4.53006666,TCGA-14-0813-01A,TCGA-14-0813-01A-01D-1492-08,4,0.4192003,TCGA-14-0813,GBM,78,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2004,[Not Available],-28582,Dead,NA,41,41,[Not Available],NA,NA,NA,NA,[Not Available],1,41,NA,41,NA,NA,0,41,NA,NA,NA,NA,NA,6
-3.623194449,0.632789561,TCGA-EB-A430-01A,TCGA-EB-A430-01A-11D-A24R-08,0,NA,TCGA-EB-A430,SKCM,83,MALE,WHITE,NA,[Not Available],2012,[Not Available],-30344,Alive,TUMOR FREE,-2,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-4.567461883,1.332632825,TCGA-GM-A2DI-01A,TCGA-GM-A2DI-01A-31D-A18P-09,0,NA,TCGA-GM-A2DI,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030,Alive,TUMOR FREE,2590,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2590,0,2590,0,2590,0,2590,NA,Stage I,T1c,M0,BRCA.LumA,9
-7.753875589,-2.341462048,TCGA-12-0657-01A,TCGA-12-0657-01A-01W-0348-08,6,0.498241327,TCGA-12-0657,GBM,69,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1996,[Not Available],-25413,Dead,WITH TUMOR,3,3,[Not Available],NA,NA,NA,NA,[Not Available],1,3,1,3,NA,NA,1,3,NA,NA,NA,NA,NA,2
-8.030364683,2.148074965,TCGA-A8-A0A9-01A,TCGA-A8-A0A9-01A-11W-A019-09,9,0.380884178,TCGA-A8-A0A9,BRCA,80,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29370,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,822,0,822,0,822,0,822,NA,Stage IIA,T2,M0,BRCA.LumA,7
0.252689944,4.752053665,TCGA-16-0849-01A,TCGA-16-0849-01A-01W-0424-08,4,0.417246549,TCGA-16-0849,GBM,54,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-19939,Alive,NA,793,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,793,0,793,NA,NA,0,793,NA,NA,NA,NA,NA,6
9.448794094,-5.396377972,TCGA-AR-A24R-01A,TCGA-AR-A24R-01A-11D-A167-09,1,0.802292129,TCGA-AR-A24R,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642,Alive,TUMOR FREE,3430,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3430,0,3430,0,3430,0,3430,NA,Stage IIIA,T1,M0,BRCA.LumB,1
9.389446586,-2.665602086,TCGA-05-4422-01A,TCGA-05-4422-01A-01D-1265-08,1,0.764631841,TCGA-05-4422,LUAD,68,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-24837,Alive,NA,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,NA,NA,0,365,NA,Stage IB,T2,M0,LUAD.1,1
-1.86527991,1.105229074,TCGA-A7-A4SD-01A,TCGA-A7-A4SD-01A-11D-A25Q-09,5,0.662471446,TCGA-A7-A4SD,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19131,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,441,0,441,0,441,0,441,NA,Stage IIA,T2,M0,BRCA.Basal,4
10.19327407,-1.657680309,TCGA-12-0826-01A,TCGA-12-0826-01A-01W-0424-08,1,0.860051894,TCGA-12-0826,GBM,38,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1999,[Not Available],-13887,Dead,NA,845,845,[Not Available],NA,NA,NA,NA,[Not Available],1,845,NA,845,NA,NA,0,845,NA,NA,NA,NA,NA,1
-4.486261339,1.68972022,TCGA-E9-A226-01A,TCGA-E9-A226-01A-21D-A159-09,0,NA,TCGA-E9-A226,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16511,Dead,WITH TUMOR,NA,1048,[Not Available],Distant Metastasis,Bone,NA,790,[Not Available],1,1048,1,1048,1,790,1,790,NA,Stage IIIA,T2,M0,BRCA.LumB,8
0.22786909,3.370583765,TCGA-BH-A0BG-01A,TCGA-BH-A0BG-01A-11D-A10Y-09,4,0.325155266,TCGA-BH-A0BG,BRCA,73,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26988,Alive,TUMOR FREE,1871,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1871,0,1871,0,1871,0,1871,NA,Stage I,T1,M0,BRCA.Basal,3
0.50730588,2.231388986,TCGA-EW-A1P7-01A,TCGA-EW-A1P7-01A-21D-A142-09,0,NA,TCGA-EW-A1P7,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21750,Alive,WITH TUMOR,915,NA,[Not Available],Distant Metastasis,"Other, specify",mediastinal lymph nodes,729,[Not Available],0,915,0,915,1,729,1,729,NA,Stage IIA,T2,M0,BRCA.Normal,6
-7.869406731,2.245139351,TCGA-A8-A0A1-01A,TCGA-A8-A0A1-01A-11W-A019-09,9,0.489429643,TCGA-A8-A0A1,BRCA,84,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30742,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,0,365,0,365,NA,Stage IIA,T2,M0,BRCA.LumA,7
8.751258747,-3.510771997,TCGA-AC-A2BM-01A,TCGA-AC-A2BM-01A-11D-A21Q-09,1,0.714457134,TCGA-AC-A2BM,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2005,[Not Available],-15212,Alive,TUMOR FREE,3022,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3022,0,3022,0,3022,0,3022,NA,Stage IIB,T2,MX,BRCA.LumB,1
4.398562551,1.327080569,TCGA-D8-A1Y0-01A,TCGA-D8-A1Y0-01A-11D-A14K-09,2,0.220977895,TCGA-D8-A1Y0,BRCA,65,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24083,Alive,TUMOR FREE,472,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,472,0,472,NA,NA,0,472,NA,Stage IIIA,T1c,MX,BRCA.LumA,5
9.504796025,-5.793619466,TCGA-AO-A0JI-01A,TCGA-AO-A0JI-01A-21W-A100-09,1,0.880671263,TCGA-AO-A0JI,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694,Alive,TUMOR FREE,1528,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1528,0,1528,0,1528,0,1528,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-7.885419075,1.980195693,TCGA-AR-A24M-01A,TCGA-AR-A24M-01A-11D-A167-09,9,0.360713875,TCGA-AR-A24M,BRCA,38,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14119,Alive,TUMOR FREE,3660,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3660,0,3660,0,3660,0,3660,NA,Stage IIIA,T2,M0,BRCA.LumA,7
-6.311384034,1.320481155,TCGA-BH-A0BF-01A,TCGA-BH-A0BF-01A-21D-A12Q-09,10,0.115228698,TCGA-BH-A0BF,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20691,Dead,TUMOR FREE,NA,1324,[Not Available],NA,NA,NA,NA,[Not Available],1,1324,0,1324,0,1324,0,1324,NA,Stage IIB,T2,M0,BRCA.LumB,7
0.070504246,5.279773044,TCGA-DU-6399-01A,TCGA-DU-6399-01A-12D-1705-08,4,0.433123843,TCGA-DU-6399,LGG,54,MALE,WHITE,Oligodendroglioma,G2,1998,[Not Available],-19906,Dead,WITH TUMOR,NA,2000,[Not Available],NA,NA,NA,1629,Progressive Disease,1,2000,1,2000,NA,NA,1,1629,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.300235757,4.958412951,TCGA-HT-7606-01A,TCGA-HT-7606-01A-11D-2086-08,4,0.616333735,TCGA-HT-7606,LGG,30,FEMALE,WHITE,Astrocytoma,G2,2008,[Not Available],-11233,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,526,0,526,0,526,0,526,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.087483582,-1.379321192,TCGA-DD-A4NI-01A,TCGA-DD-A4NI-01A-11D-A27I-10,0,NA,TCGA-DD-A4NI,LIHC,67,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-24516,Alive,TUMOR FREE,816,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,816,0,816,0,816,0,816,NA,Stage II,T2,M0,LIHC.iCluster:2,2
-0.078493107,5.130420859,TCGA-DU-7301-01A,TCGA-DU-7301-01A-11D-2086-08,4,0.58239102,TCGA-DU-7301,LGG,53,MALE,WHITE,Oligodendroglioma,G2,2006,[Not Available],-19644,Dead,WITH TUMOR,NA,788,[Not Available],NA,NA,NA,366,Progressive Disease,1,788,1,788,NA,NA,1,366,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.612255123,-5.704713348,TCGA-ED-A627-01A,TCGA-ED-A627-01A-12D-A30V-10,1,0.855249615,TCGA-ED-A627,LIHC,74,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-27303,Alive,TUMOR FREE,423,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,423,0,423,0,423,0,423,NA,Stage I,T1,M0,LIHC.iCluster:1,1
7.645418214,-3.405641722,TCGA-D8-A27W-01A,TCGA-D8-A27W-01A-11D-A16D-09,1,0.263169203,TCGA-D8-A27W,BRCA,55,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20173,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,373,0,373,0,373,0,373,NA,Stage IIIB,T4b,M0,BRCA.LumB,1
-2.93366133,0.671275591,TCGA-EW-A1PB-01A,TCGA-EW-A1PB-01A-11D-A142-09,0,NA,TCGA-EW-A1PB,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25770,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,608,0,608,0,608,0,608,NA,Stage IIIA,T3,MX,BRCA.Basal,10
-6.525426347,1.662457503,TCGA-BH-A1FD-01A,TCGA-BH-A1FD-01A-11W-A14Q-09,10,0.079492001,TCGA-BH-A1FD,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24940,Dead,WITH TUMOR,NA,1009,[Not Available],NA,NA,NA,NA,[Not Available],1,1009,1,1009,NA,NA,1,1009,NA,Stage I,T1c,M0,BRCA.LumB,7
0.17216206,2.472424298,TCGA-GM-A2DO-01A,TCGA-GM-A2DO-01A-11D-A19Y-09,4,0.111660419,TCGA-GM-A2DO,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19842,Alive,TUMOR FREE,2596,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2596,0,2596,0,2596,0,2596,NA,Stage I,T1c,M0,BRCA.LumB,6
9.722291318,-1.569042673,TCGA-D3-A5GT-01A,TCGA-D3-A5GT-01A-12D-A30X-08,1,0.869221928,TCGA-D3-A5GT,SKCM,43,MALE,WHITE,NA,[Not Available],2012,[Not Available],-15935,Alive,WITH TUMOR,487,NA,[Not Available],Distant Metastasis|Distant Metastasis|Regional lymph node,Lung|Liver|[Not Available],[Not Applicable]|[Not Applicable]|[Not Applicable],291,[Not Available],0,487,0,487,NA,NA,1,291,NA,Stage IIIC,T2b,M0,NA,3
9.796350557,-2.334145811,TCGA-DD-A4NS-01A,TCGA-DD-A4NS-01A-11D-A30V-10,1,0.769647884,TCGA-DD-A4NS,LIHC,61,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2005,[Not Available],-22638,Dead,WITH TUMOR,NA,2456,[Not Available],Extrahepatic Recurrence,Bone,NA,893,[Not Available],1,2456,1,2456,1,893,1,893,NA,Stage I,T1,M0,LIHC.iCluster:1,1
8.862668712,-5.043135383,TCGA-DD-A4NO-01A,TCGA-DD-A4NO-01A-11D-A28X-10,1,0.793219935,TCGA-DD-A4NO,LIHC,65,MALE,WHITE,Hepatocellular Carcinoma,G1,2007,[Not Available],-24090,Alive,WITH TUMOR,2245,NA,[Not Available],Locoregional Recurrence,Liver,NA,990,[Not Available],0,2245,0,2245,1,990,1,990,NA,Stage I,T1,M0,LIHC.iCluster:2,1
9.466808844,-1.304030013,TCGA-CS-4941-01A,TCGA-CS-4941-01A-01D-1468-08,0,NA,TCGA-CS-4941,LGG,67,MALE,WHITE,Astrocytoma,G3,2005,[Not Available],-24578,Dead,WITH TUMOR,NA,234,[Not Available],NA,NA,NA,9,Stable Disease,1,234,1,234,NA,NA,1,9,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-4.130654207,-1.573740093,TCGA-ER-A19K-01A,TCGA-ER-A19K-01A-21D-A197-08,8,0.294791344,TCGA-ER-A19K,SKCM,79,FEMALE,WHITE,NA,[Not Available],2006,[Not Available],-28916,Dead,WITH TUMOR,NA,469,[Not Available],Regional lymph node,"Other, Specify",Neck- cervical lymphnode,211,[Not Available],1,469,1,469,NA,NA,1,211,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-7.520139182,1.923315672,TCGA-E2-A15K-01A,TCGA-E2-A15K-01A-11D-A12Q-09,9,0.384064236,TCGA-E2-A15K,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21514,Alive,TUMOR FREE,275,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,275,0,275,0,275,0,275,NA,Stage IIB,T2,M0,BRCA.LumB,7
0.29682645,3.557235714,TCGA-D8-A1XA-01A,TCGA-D8-A1XA-01A-11D-A14G-09,4,0.240584775,TCGA-D8-A1XA,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23387,Alive,TUMOR FREE,839,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,839,0,839,0,839,0,839,NA,Stage IA,T1c,M0,BRCA.LumA,3
-7.922969857,2.027903596,TCGA-A8-A09C-01A,TCGA-A8-A09C-01A-11W-A019-09,9,0.533061654,TCGA-A8-A09C,BRCA,69,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25355,Alive,NA,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage X,T2,MX,BRCA.LumB,7
-7.3228822,-2.329113034,TCGA-AR-A1AI-01A,TCGA-AR-A1AI-01A-11D-A12Q-09,6,0.275316289,TCGA-AR-A1AI,BRCA,47,FEMALE,WHITE,Medullary Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17229,Alive,TUMOR FREE,3296,NA,[Not Available],New Primary Tumor,"Other, specify",Contralateral Breast,588,[Not Available],0,3296,0,3296,1,588,1,588,NA,Stage IIA,T2,M0,BRCA.Basal,2
-0.951528868,4.618417065,TCGA-E2-A15M-01A,TCGA-E2-A15M-01A-11D-A12B-09,4,0.493433169,TCGA-E2-A15M,BRCA,66,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24266,Dead,TUMOR FREE,NA,336,[Not Available],NA,NA,NA,NA,[Not Available],1,336,0,336,0,336,0,336,NA,Stage IIA,T2,M0,BRCA.LumA,6
-5.395549903,-1.278385675,TCGA-A1-A0SO-01A,TCGA-A1-A0SO-01A-22D-A099-09,0,NA,TCGA-A1-A0SO,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24826,Alive,TUMOR FREE,852,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,852,0,852,0,852,0,852,NA,Stage IIB,T2,M0,BRCA.Basal,10
-7.740733885,-2.491419448,TCGA-FV-A3I0-01A,TCGA-FV-A3I0-01A-11D-A22F-10,6,0.524953491,TCGA-FV-A3I0,LIHC,76,FEMALE,WHITE,Hepatocholangiocarcinoma (Mixed),G2,2011,[Not Available],-28101,Alive,WITH TUMOR,848,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,159,[Not Available],0,848,0,848,1,159,1,159,NA,Stage II,T2,M0,NA,2
-0.134512597,3.062750504,TCGA-EA-A3Y4-01A,TCGA-EA-A3Y4-01A-51D-A243-09,4,0.22531027,TCGA-EA-A3Y4,CESC,40,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14706,Alive,TUMOR FREE,1122,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1122,0,1122,0,1122,0,1122,NA,Stage IB,T1b,M0,NA,3
2.971279717,3.562874781,TCGA-EA-A6QX-01A,TCGA-EA-A6QX-01A-12D-A33O-09,0,NA,TCGA-EA-A6QX,CESC,49,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2013,Peri (6-12 months since last menstrual period),-18035,Alive,TUMOR FREE,730,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,730,0,730,0,730,0,730,NA,Stage IIIB,T1b1,M0,NA,1
9.4318953,-2.939574322,TCGA-71-6725-01A,TCGA-71-6725-01A-11D-1855-08,1,0.737283485,TCGA-71-6725,LUAD,48,FEMALE,ASIAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-17793,Alive,WITH TUMOR,256,NA,[Not Available],Locoregional Recurrence,NA,NA,164,Progressive Disease,0,256,0,256,NA,NA,1,164,NA,Stage IB,T2,M0,LUAD.3,6
-7.385564022,-2.346242626,TCGA-HM-A6W2-01A,TCGA-HM-A6W2-01A-21D-A33O-09,6,0.249692097,TCGA-HM-A6W2,CESC,34,FEMALE,BLACK OR AFRICAN AMERICAN,Adenosquamous,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12775,Alive,TUMOR FREE,287,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,287,0,287,NA,NA,0,287,NA,Stage IVB,T2a,M1,NA,2
10.02880322,-2.167206118,TCGA-DU-8168-01A,TCGA-DU-8168-01A-11D-2253-08,1,0.788939744,TCGA-DU-8168,LGG,55,FEMALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-20136,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,431,0,431,NA,NA,0,431,NA,NA,NA,NA,GBM_LGG.Codel,1
-6.25324469,1.549396342,TCGA-EA-A5FO-01A,TCGA-EA-A5FO-01A-21D-A28B-09,10,0.271485414,TCGA-EA-A5FO,CESC,59,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21561,Alive,TUMOR FREE,815,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,815,0,815,0,815,0,815,NA,Stage IB1,T1b1,M0,NA,7
-0.079709985,4.809211131,TCGA-38-4630-01A,TCGA-38-4630-01A-01D-1265-08,4,0.609645594,TCGA-38-4630,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2000,[Not Available],-27667,Dead,WITH TUMOR,NA,1073,[Not Available],NA,NA,NA,524,Complete Remission/Response,1,1073,1,1073,1,524,1,524,NA,Stage IB,T2,M0,NA,6
-5.961052088,3.387116057,TCGA-DD-A3A4-01A,TCGA-DD-A3A4-01A-11D-A22F-10,11,0.399704299,TCGA-DD-A3A4,LIHC,37,MALE,WHITE,Hepatocellular Carcinoma,G3,1998,[Not Available],-13739,Dead,WITH TUMOR,NA,612,[Not Available],Intrahepatic Recurrence,Liver,NA,87,[Not Available],1,612,1,612,1,87,1,87,NA,Stage IIIA,T3,M0,LIHC.iCluster:2,8
10.0632276,-1.709572909,TCGA-D9-A4Z5-01A,TCGA-D9-A4Z5-01A-11D-A25O-08,1,0.839753872,TCGA-D9-A4Z5,SKCM,68,MALE,WHITE,NA,[Not Available],2012,[Not Available],-24979,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,218,0,218,NA,NA,0,218,NA,Stage IIB,T4a,M0,SKCM.Triple_WT,1
4.269741912,1.21589958,TCGA-FU-A5XV-01A,TCGA-FU-A5XV-01A-11D-A28B-09,2,0.55225988,TCGA-FU-A5XV,CESC,32,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11692,Alive,TUMOR FREE,321,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,321,0,321,0,321,0,321,NA,Stage IIIB,T1b2,MX,NA,5
-8.106384823,2.010881207,TCGA-FG-8187-01A,TCGA-FG-8187-01A-11D-2253-08,9,0.657857154,TCGA-FG-8187,LGG,31,MALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-11684,Alive,TUMOR FREE,611,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,611,0,611,0,611,0,611,NA,NA,NA,NA,GBM_LGG.Codel,7
8.718263212,-4.30057634,TCGA-EA-A78R-01A,TCGA-EA-A78R-01A-11D-A32I-09,1,0.724808411,TCGA-EA-A78R,CESC,54,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G2,2013,Peri (6-12 months since last menstrual period),-19942,Alive,TUMOR FREE,410,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,410,0,410,0,410,0,410,NA,Stage IB1,T1b1,M0,NA,1
-4.794331192,-1.266698931,TCGA-80-5608-01A,TCGA-80-5608-01A-31D-1945-08,8,0.286643896,TCGA-80-5608,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,2832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2832,0,2832,0,2832,0,2832,NA,Stage IA,T1,M0,LUAD.2,10
-7.836287994,2.167819771,TCGA-EA-A1QS-01A,TCGA-EA-A1QS-01A-61D-A22X-09,9,0.561571305,TCGA-EA-A1QS,CESC,46,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16923,Alive,TUMOR FREE,1203,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1203,0,1203,0,1203,0,1203,NA,Stage IB1,T1b1,M0,NA,7
-7.00033151,-2.149141605,TCGA-JW-A5VI-01A,TCGA-JW-A5VI-01A-11D-A28B-09,6,0.054868309,TCGA-JW-A5VI,CESC,45,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16444,Alive,WITH TUMOR,747,NA,NA,Distant Metastasis,Lung,NA,558,Complete Remission/Response,0,747,0,747,1,558,1,558,NA,Stage IIB,T2b,MX,NA,2
-3.220406914,-3.388456249,TCGA-55-8089-01A,TCGA-55-8089-01A-11D-2238-08,8,0.615857773,TCGA-55-8089,LUAD,56,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-20576,Dead,TUMOR FREE,NA,702,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,702,0,702,0,702,0,702,NA,Stage IA,T1a,M0,NA,10
9.200617933,-4.658678847,TCGA-E9-A3HO-01A,TCGA-E9-A3HO-01A-11D-A20S-09,1,0.764485578,TCGA-E9-A3HO,BRCA,49,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18046,Alive,TUMOR FREE,1158,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1158,0,1158,0,1158,0,1158,NA,Stage IIA,T2,M0,BRCA.LumB,1
-3.535829159,-3.000040247,TCGA-A6-6653-01A,TCGA-A6-6653-01A-11D-1771-10,8,0.497593589,TCGA-A6-6653,COAD,82,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-29996,Alive,TUMOR FREE,742,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,742,0,742,0,742,0,742,NA,Stage I,T2,M0,GI.HM-indel,10
8.64857617,-4.588919945,TCGA-C5-A2LV-01A,TCGA-C5-A2LV-01A-11D-A18J-09,1,0.769459853,TCGA-C5-A2LV,CESC,36,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13447,Alive,TUMOR FREE,2234,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2234,0,2234,0,2234,0,2234,NA,Stage IB,T1b,MX,NA,1
9.739552996,-2.532519163,TCGA-IK-8125-01A,TCGA-IK-8125-01A-11D-2253-08,1,0.693428347,TCGA-IK-8125,LGG,62,MALE,WHITE,Oligoastrocytoma,G3,2009,[Not Available],-22745,Alive,TUMOR FREE,1301,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1301,0,1301,0,1301,0,1301,NA,NA,NA,NA,GBM_LGG.Codel,1
-2.469329793,1.181233191,TCGA-C5-A1BL-01A,TCGA-C5-A1BL-01A-11D-A13W-08,5,0.192884785,TCGA-C5-A1BL,CESC,32,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,1994,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11723,Alive,TUMOR FREE,5271,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,5271,0,5271,0,5271,0,5271,NA,Stage IB,[Not Available],[Not Available],NA,10
-1.813636273,1.420425222,TCGA-EK-A2RB-01A,TCGA-EK-A2RB-01A-11D-A18J-09,5,0.557248283,TCGA-EK-A2RB,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2011,[Not Available],-17752,Alive,TUMOR FREE,9,NA,NA,NA,NA,NA,NA,[Not Available],0,9,0,9,NA,NA,0,9,NA,Stage IVB,[Not Available],[Not Available],NA,3
9.240921574,-4.0684732,TCGA-C5-A7CM-01A,TCGA-C5-A7CM-01A-11D-A33O-09,1,0.754618972,TCGA-C5-A7CM,CESC,35,FEMALE,WHITE,Endocervical Adenocarcinoma of the Usual Type,G2,2012,[Not Available],-12853,Alive,TUMOR FREE,619,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,619,0,619,0,619,0,619,NA,Stage IB2,[Not Available],[Not Available],NA,1
9.598684119,-1.213492346,TCGA-EA-A5ZD-01A,TCGA-EA-A5ZD-01A-11D-A28B-09,1,0.723717252,TCGA-EA-A5ZD,CESC,40,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14629,Alive,TUMOR FREE,830,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,830,0,830,0,830,0,830,NA,Stage IB1,T1b1,M0,NA,1
-4.030091043,-2.115903438,TCGA-C5-A1MH-01A,TCGA-C5-A1MH-01A-11D-A14W-08,8,0.383957088,TCGA-C5-A1MH,CESC,71,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26234,Dead,WITH TUMOR,NA,1186,Cervical Cancer,Distant Metastasis,Lung,NA,178,Complete Remission/Response,1,1186,1,1186,1,178,1,178,NA,Stage IIIB,[Not Available],[Not Available],NA,10
-7.272896367,-2.493550908,TCGA-C5-A1M6-01A,TCGA-C5-A1M6-01A-11D-A13W-08,6,0.250413176,TCGA-C5-A1M6,CESC,55,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20090,Dead,WITH TUMOR,NA,955,Cervical Cancer,Distant Metastasis,Lung,NA,316,Complete Remission/Response,1,955,1,955,1,316,1,316,NA,Stage IIB,[Not Available],[Not Available],NA,2
-8.257559506,2.083672275,TCGA-C5-A2M2-01A,TCGA-C5-A2M2-01A-21D-A18J-09,9,0.605337516,TCGA-C5-A2M2,CESC,56,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20480,Dead,NA,NA,1011,NA,NA,NA,NA,NA,[Not Available],1,1011,NA,1011,NA,NA,0,1011,NA,Stage IB2,[Not Available],[Not Available],NA,7
-2.033714695,1.18899383,TCGA-C5-A1M7-01A,TCGA-C5-A1M7-01A-11D-A13W-08,5,0.610208183,TCGA-C5-A1M7,CESC,37,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,1999,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13808,Alive,TUMOR FREE,1409,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1409,0,1409,0,1409,0,1409,NA,Stage IB,T1b,MX,NA,4
-5.826528864,-2.253876358,TCGA-C5-A1MP-01A,TCGA-C5-A1MP-01A-11D-A14W-08,0,NA,TCGA-C5-A1MP,CESC,34,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12692,Alive,TUMOR FREE,109,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,109,0,109,0,109,0,109,NA,Stage IB2,T1b2,MX,NA,2
-0.353821063,3.913648971,TCGA-E1-5304-01A,TCGA-E1-5304-01A-01D-1468-08,4,0.450698999,TCGA-E1-5304,LGG,42,MALE,WHITE,Astrocytoma,G3,1999,[Not Available],-15481,Dead,WITH TUMOR,NA,1251,[Not Available],NA,NA,NA,903,Stable Disease,1,1251,1,1251,NA,NA,1,903,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,6
-2.983604583,0.967623435,TCGA-EK-A2PL-01A,TCGA-EK-A2PL-01A-11D-A18J-09,0,NA,TCGA-EK-A2PL,CESC,36,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-13384,Alive,WITH TUMOR,13,NA,NA,NA,NA,NA,NA,[Not Available],0,13,0,13,NA,NA,0,13,NA,Stage IIIB,[Not Available],[Not Available],NA,10
-1.813055416,1.066730788,TCGA-DU-7290-01A,TCGA-DU-7290-01A-11D-2024-08,5,0.529867466,TCGA-DU-7290,LGG,45,FEMALE,WHITE,Astrocytoma,G3,1995,[Not Available],-16667,Dead,WITH TUMOR,NA,315,[Not Available],NA,NA,NA,NA,[Not Available],1,315,1,315,NA,NA,1,315,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,4
0.354028184,2.31062615,TCGA-EA-A5ZF-01A,TCGA-EA-A5ZF-01A-11D-A28B-09,0,NA,TCGA-EA-A5ZF,CESC,56,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G2,2012,Peri (6-12 months since last menstrual period),-20506,Alive,WITH TUMOR,828,NA,NA,Locoregional Recurrence,Cervix,NA,440,Complete Remission/Response,0,828,0,828,1,440,1,440,NA,Stage IB1,T1b1,M0,NA,6
-3.262556909,-3.12547779,TCGA-69-7980-01A,TCGA-69-7980-01A-11D-2184-08,8,0.539205169,TCGA-69-7980,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25583,Alive,TUMOR FREE,411,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,411,0,411,0,411,0,411,NA,Stage I,T1b,M0,LUAD.5,10
3.86131872,1.42655141,TCGA-EK-A2IP-01A,TCGA-EK-A2IP-01A-11D-A17W-09,0,NA,TCGA-EK-A2IP,CESC,28,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2006,[Not Available],-10347,Alive,NA,202,NA,NA,NA,NA,NA,NA,[Not Available],0,202,0,202,NA,NA,0,202,NA,Stage IB1,T1b1,MX,NA,6
4.034883509,1.269514907,TCGA-EK-A2PK-01A,TCGA-EK-A2PK-01A-11D-A18J-09,2,0.347404544,TCGA-EK-A2PK,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2006,Indeterminate (neither Pre or Postmenopausal),-15939,Alive,TUMOR FREE,12,NA,NA,NA,NA,NA,NA,[Not Available],0,12,0,12,NA,NA,0,12,NA,Stage IB1,[Not Available],[Not Available],NA,5
9.480015565,-5.768090057,TCGA-HT-7471-01A,TCGA-HT-7471-01A-11D-2253-08,1,0.874273912,TCGA-HT-7471,LGG,37,FEMALE,WHITE,Oligodendroglioma,G3,2010,[Not Available],-13564,Alive,TUMOR FREE,4,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4,0,4,NA,NA,0,4,NA,NA,NA,NA,GBM_LGG.Codel,1
-1.459911585,3.880037732,TCGA-55-7573-01A,TCGA-55-7573-01A-11D-2036-08,4,0.084159677,TCGA-55-7573,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26302,Alive,TUMOR FREE,487,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,487,0,487,0,487,0,487,NA,Stage IA,T1b,MX,LUAD.5,5
-3.360713704,-3.275796891,TCGA-ER-A194-01A,TCGA-ER-A194-01A-11D-A197-08,8,0.615622287,TCGA-ER-A194,SKCM,77,MALE,WHITE,NA,[Not Available],2005,[Not Available],-28175,Dead,WITH TUMOR,NA,1354,[Not Available],NA,NA,NA,NA,[Not Available],1,1354,1,1354,NA,NA,1,1354,NA,[Not Available],[Not Available],M0,SKCM.RAS_Hotspot_Mutants,10
0.166701597,5.159486075,TCGA-DU-7299-01A,TCGA-DU-7299-01A-21D-2024-08,4,0.694580706,TCGA-DU-7299,LGG,33,MALE,WHITE,Astrocytoma,G3,2006,[Not Available],-12266,Dead,WITH TUMOR,NA,1339,[Not Available],NA,NA,NA,675,Progressive Disease,1,1339,1,1339,NA,NA,1,675,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.599839543,-2.812308391,TCGA-05-4424-01A,TCGA-05-4424-01A-22D-1855-08,8,0.391654141,TCGA-05-4424,LUAD,70,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25689,Alive,WITH TUMOR,913,NA,[Not Available],Distant Metastasis,NA,NA,153,Progressive Disease,0,913,0,913,NA,NA,1,153,NA,Stage IIB,T3,M0,LUAD.5,10
8.606262032,-1.930959715,TCGA-14-1395-01B,TCGA-14-1395-01B-11D-1845-08,1,0.532907554,TCGA-14-1395,GBM,52,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-19237,Dead,WITH TUMOR,42,42,[Not Available],NA,NA,NA,NA,[Not Available],1,42,1,42,NA,NA,1,42,NA,NA,NA,NA,NA,1
-4.929107113,0.688469229,TCGA-D5-6535-01A,TCGA-D5-6535-01A-11D-1719-10,0,NA,TCGA-D5-6535,COAD,80,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29278,Alive,TUMOR FREE,460,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,460,0,460,NA,NA,0,460,NA,Stage IIIB,T3,MX,GI.CIN,10
-7.95345191,2.117799541,TCGA-E2-A1L8-01A,TCGA-E2-A1L8-01A-11D-A13L-09,9,0.507956337,TCGA-E2-A1L8,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19187,Alive,TUMOR FREE,2240,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2240,0,2240,0,2240,0,2240,NA,Stage IIB,T2,M0,BRCA.LumA,7
-5.735803468,-2.209809964,TCGA-EB-A44N-01A,TCGA-EB-A44N-01A-11D-A25O-08,0,NA,TCGA-EB-A44N,SKCM,59,MALE,WHITE,NA,[Not Available],2012,[Not Available],-21623,Dead,WITH TUMOR,NA,205,[Not Available],Regional lymph node|Distant Metastasis|Distant Metastasis,[Not Available]|Bone|Liver,[Not Applicable]|[Not Applicable]|[Not Applicable],115,[Not Available],1,205,1,205,NA,NA,1,115,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,2
-0.373427408,4.684050696,TCGA-E1-5307-01A,TCGA-E1-5307-01A-01D-1893-08,4,0.575065992,TCGA-E1-5307,LGG,62,FEMALE,WHITE,Astrocytoma,G3,2000,[Not Available],-22837,Dead,WITH TUMOR,NA,1762,[Not Available],NA,NA,NA,1452,Stable Disease,1,1762,1,1762,NA,NA,1,1452,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.936229432,3.349566626,TCGA-55-6984-01A,TCGA-55-6984-01A-11D-1945-08,11,0.231550294,TCGA-55-6984,LUAD,71,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],NA,Dead,WITH TUMOR,NA,760,[Not Available],NA,NA,NA,724,Complete Remission/Response,1,760,1,760,1,724,1,724,NA,Stage IIB,T2,M0,NA,8
-7.338019736,1.46301453,TCGA-CS-5395-01A,TCGA-CS-5395-01A-01D-1468-08,0,NA,TCGA-CS-5395,LGG,43,MALE,BLACK OR AFRICAN AMERICAN,Oligodendroglioma,G2,2007,[Not Available],-15848,Dead,WITH TUMOR,NA,639,[Not Available],NA,NA,NA,287,Progressive Disease,1,639,1,639,NA,NA,1,287,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
-6.108306005,3.439506708,TCGA-55-6975-01A,TCGA-55-6975-01A-11D-1945-08,11,0.469870009,TCGA-55-6975,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],NA,Dead,WITH TUMOR,NA,118,[Not Available],NA,NA,NA,NA,Progressive Disease,1,118,1,118,NA,NA,1,118,NA,Stage IIB,T2,M0,NA,8
-0.178161438,2.701002222,TCGA-44-A47G-01A,TCGA-44-A47G-01A-21D-A24D-08,4,0.059299025,TCGA-44-A47G,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26800,Alive,TUMOR FREE,351,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,351,0,351,0,351,0,351,NA,Stage IA,T1,M0,NA,6
-2.1358784,1.317432373,TCGA-D8-A1J9-01A,TCGA-D8-A1J9-01A-11D-A13L-09,5,0.518223278,TCGA-D8-A1J9,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17879,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,532,0,532,0,532,0,532,NA,Stage IA,T1c,M0,BRCA.LumB,10
-8.119611309,2.010034691,TCGA-AG-3602-01A,TCGA-AG-3602-01A-02D-1989-10,9,0.600234151,TCGA-AG-3602,READ,66,FEMALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2007,[Not Available],-24350,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIIC,T3,M0,NA,7
-7.546322478,-2.234897402,TCGA-BH-A0B5-01A,TCGA-BH-A0B5-01A-11D-A12Q-09,6,0.439555916,TCGA-BH-A0B5,BRCA,40,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14920,Alive,TUMOR FREE,2136,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2136,0,2136,NA,NA,0,2136,NA,Stage IIIA,T2,M0,BRCA.LumA,2
-5.325798961,1.952433031,TCGA-G4-6314-01A,TCGA-G4-6314-01A-11D-1719-10,0,NA,TCGA-G4-6314,COAD,76,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-27958,Alive,WITH TUMOR,1093,NA,[Not Available],NA,NA,NA,38,[Not Available],0,1093,0,1093,NA,NA,1,38,NA,Stage IV,T3,M1,NA,8
-0.321741861,4.604783398,TCGA-AC-A2QH-01A,TCGA-AC-A2QH-01A-11D-A18P-09,4,0.565122074,TCGA-AC-A2QH,BRCA,58,FEMALE,WHITE,Metaplastic Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21488,Alive,TUMOR FREE,1005,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1005,0,1005,0,1005,0,1005,NA,Stage IIB,T3,MX,BRCA.Basal,6
-3.096441463,-3.592855079,TCGA-05-4382-01A,TCGA-05-4382-01A-01D-1931-08,8,0.508860732,TCGA-05-4382,LUAD,68,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24868,Alive,TUMOR FREE,607,NA,[Not Available],Distant Metastasis,NA,NA,334,Complete Remission/Response,0,607,0,607,1,334,1,334,NA,Stage IB,T2,M0,LUAD.6,10
-7.371769612,2.084532147,TCGA-12-0821-01A,TCGA-12-0821-01A-01D-1492-08,9,0.372814146,TCGA-12-0821,GBM,62,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-22949,Dead,WITH TUMOR,323,323,[Not Available],Recurrence,[Not Applicable],[Not Applicable],259,[Not Available],1,323,1,323,NA,NA,1,259,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,7
2.098392206,1.793218025,TCGA-06-0219-01A,TCGA-06-0219-01A-01D-1491-08,3,0.57604776,TCGA-06-0219,GBM,67,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-24488,Dead,WITH TUMOR,11,22,[Not Available],NA,NA,NA,NA,[Not Available],1,22,1,22,NA,NA,1,22,NA,NA,NA,NA,GBM_LGG.NA,3
-0.461909578,4.128029928,TCGA-55-7903-01A,TCGA-55-7903-01A-11D-2167-08,4,0.426108578,TCGA-55-7903,LUAD,64,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23509,Alive,TUMOR FREE,567,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,567,0,567,0,567,0,567,NA,Stage IA,T1b,MX,LUAD.3,6
9.656386513,-2.591557923,TCGA-26-1799-01A,TCGA-26-1799-01A-02W-0643-08,1,0.778005619,TCGA-26-1799,GBM,68,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-25171,Dead,WITH TUMOR,285,285,[Not Available],Recurrence,[Not Applicable],[Not Applicable],213,[Not Available],1,285,1,285,NA,NA,1,213,NA,NA,NA,NA,NA,1
8.63520952,-1.883040342,TCGA-12-3652-01A,TCGA-12-3652-01A-01D-1495-08,1,0.555560705,TCGA-12-3652,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-21920,Dead,WITH TUMOR,1050,1062,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],203,[Not Available],1,1062,1,1062,NA,NA,1,203,NA,NA,NA,NA,GBM_LGG.Classic-like,1
9.269978772,-1.522825337,TCGA-AO-A12D-01A,TCGA-AO-A12D-01A-11D-A10Y-09,1,0.690338478,TCGA-AO-A12D,BRCA,43,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15774,Alive,TUMOR FREE,2515,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2515,0,2515,0,2515,0,2515,NA,Stage IIA,T1c,M0,BRCA.Her2,1
-7.261084548,2.261404346,TCGA-E2-A1IF-01A,TCGA-E2-A1IF-01A-11D-A142-09,9,0.100924612,TCGA-E2-A1IF,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27341,Alive,TUMOR FREE,1138,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1138,0,1138,0,1138,0,1138,NA,Stage I,T1c,M0,BRCA.LumA,7
-5.988892444,3.249201884,TCGA-67-3773-01A,TCGA-67-3773-01A-01D-1040-01,11,0.421553585,TCGA-67-3773,LUAD,84,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-30706,Alive,TUMOR FREE,427,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,427,0,427,NA,NA,0,427,NA,Stage IB,T2,M0,LUAD.4,8
1.104341979,3.51636333,TCGA-50-6595-01A,TCGA-50-6595-01A-12D-1855-08,0,NA,TCGA-50-6595,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-27197,Dead,WITH TUMOR,NA,189,[Not Available],Distant Metastasis,NA,NA,182,Progressive Disease,1,189,1,189,NA,NA,1,182,NA,Stage IIIA,T2,M0,LUAD.6,1
-5.846807797,2.379388647,TCGA-FG-5965-01B,TCGA-FG-5965-01B-11D-1893-08,0,NA,TCGA-FG-5965,LGG,39,FEMALE,WHITE,Oligoastrocytoma,G2,2008,[Not Available],-14249,Dead,WITH TUMOR,NA,1120,[Not Available],NA,NA,NA,715,Stable Disease,1,1120,1,1120,NA,NA,1,715,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,8
8.805451973,-4.478599296,TCGA-55-6986-01A,TCGA-55-6986-01A-11D-1945-08,1,0.774015565,TCGA-55-6986,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],NA,Alive,TUMOR FREE,3261,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3261,0,3261,0,3261,0,3261,NA,Stage IB,T2,M0,LUAD.4,1
-1.865016152,2.240498422,TCGA-50-5931-01A,TCGA-50-5931-01A-11D-1753-08,0,NA,TCGA-50-5931,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-27733,Dead,WITH TUMOR,NA,434,[Not Available],Distant Metastasis,NA,NA,425,Progressive Disease,1,434,1,434,NA,NA,1,425,NA,Stage IB,T2,M0,LUAD.2,10
-4.132555212,0.461473072,TCGA-AF-2691-01A,TCGA-AF-2691-01A-01D-1989-10,0,NA,TCGA-AF-2691,READ,48,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-17759,Alive,TUMOR FREE,1309,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1309,0,1309,0,1309,0,1309,NA,Stage I,T1,M0,NA,10
8.810106946,-5.368367707,TCGA-B6-A0WY-01A,TCGA-B6-A0WY-01A-11D-A10G-09,1,0.753490778,TCGA-B6-A0WY,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1996,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14778,Dead,WITH TUMOR,NA,3461,[Not Available],Distant Metastasis,Bone,NA,2011,[Not Available],1,3461,1,3461,1,2011,1,2011,NA,Stage IIIA,T3,M0,BRCA.LumA,1
-7.886674164,-2.497432218,TCGA-C8-A1HN-01A,TCGA-C8-A1HN-01A-11D-A135-09,6,0.569137089,TCGA-C8-A1HN,BRCA,56,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20712,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,394,0,394,0,394,0,394,NA,Stage IIA,T2,M0,BRCA.LumB,2
-3.706523296,-2.435719385,TCGA-D5-6927-01A,TCGA-D5-6927-01A-21D-1924-10,8,0.36847942,TCGA-D5-6927,COAD,34,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-12737,Alive,TUMOR FREE,287,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,287,0,287,NA,NA,0,287,NA,Stage IIA,T3,M0,GI.HM-indel,10
-1.050887521,4.20929158,TCGA-AG-4009-01A,TCGA-AG-4009-01A-01W-1073-09,4,0.345825717,TCGA-AG-4009,READ,83,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-30559,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,426,0,426,NA,NA,0,426,NA,Stage I,T2,M0,NA,6
-0.009295522,5.220344676,TCGA-HT-7472-01A,TCGA-HT-7472-01A-11D-2024-08,4,0.475246558,TCGA-HT-7472,LGG,38,MALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-13968,Alive,TUMOR FREE,1,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1,0,1,NA,NA,0,1,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.303748909,1.902573272,TCGA-55-7910-01A,TCGA-55-7910-01A-11D-2167-08,0,NA,TCGA-55-7910,LUAD,50,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-18289,Alive,WITH TUMOR,1040,NA,[Not Available],NA,NA,NA,1018,Complete Remission/Response,0,1040,0,1040,1,1018,1,1018,NA,Stage IIA,T2b,M0,NA,10
-6.389083675,1.615058652,TCGA-76-6662-01A,TCGA-76-6662-01A-11D-1845-08,10,0.178534185,TCGA-76-6662,GBM,58,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-21511,Dead,WITH TUMOR,NA,1048,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],205,[Not Available],1,1048,1,1048,NA,NA,1,205,NA,NA,NA,NA,NA,7
-3.41163664,-3.251823951,TCGA-05-4427-01A,TCGA-05-4427-01A-21D-1855-08,8,0.592265796,TCGA-05-4427,LUAD,65,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-23893,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,791,0,791,0,791,0,791,NA,Stage IIB,T2,M0,NA,10
-3.723196515,-2.597180272,TCGA-DU-7294-01A,TCGA-DU-7294-01A-11D-2024-08,8,0.316378217,TCGA-DU-7294,LGG,53,FEMALE,WHITE,Oligodendroglioma,G2,2003,[Not Available],-19616,Alive,TUMOR FREE,2869,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,2869,0,2869,NA,NA,0,2869,NA,NA,NA,NA,GBM_LGG.Codel,10
-3.224836285,-3.351792774,TCGA-D8-A1XK-01A,TCGA-D8-A1XK-01A-21D-A14K-09,8,0.628430655,TCGA-D8-A1XK,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20092,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,441,0,441,0,441,0,441,NA,Stage IIB,T2,MX,BRCA.Basal,10
-3.32741408,1.112601305,TCGA-73-4658-01A,TCGA-73-4658-01A-01D-1753-08,0,NA,TCGA-73-4658,LUAD,80,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],-29508,Dead,TUMOR FREE,1600,1600,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1600,0,1600,0,1600,0,1600,NA,Stage IB,T2,M0,LUAD.4,10
-0.151307509,4.680308461,TCGA-28-1753-01A,TCGA-28-1753-01A-01D-1494-08,4,0.607525018,TCGA-28-1753,GBM,53,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-19366,Alive,WITH TUMOR,37,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,37,0,37,NA,NA,0,37,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-5.16916005,2.674786778,TCGA-CS-5396-01A,TCGA-CS-5396-01A-02D-1468-08,12,0.241446921,TCGA-CS-5396,LGG,53,FEMALE,WHITE,Oligodendroglioma,G3,2010,[Not Available],-19399,Alive,WITH TUMOR,1631,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1631,0,1631,NA,NA,0,1631,NA,NA,NA,NA,GBM_LGG.Codel,8
-3.832935071,2.082452721,TCGA-86-7954-01A,TCGA-86-7954-01A-11D-2184-08,0,NA,TCGA-86-7954,LUAD,68,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25062,Alive,TUMOR FREE,605,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,605,0,605,0,605,0,605,NA,Stage IB,T2,M0,NA,10
-6.186756785,3.054171573,TCGA-67-3774-01A,TCGA-67-3774-01A-01D-1040-01,0,NA,TCGA-67-3774,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-26704,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,NA,NA,0,385,NA,Stage IB,T2,M0,LUAD.1,9
-5.103478252,2.007187621,TCGA-BM-6198-01A,TCGA-BM-6198-01A-11D-1733-10,0,NA,TCGA-BM-6198,READ,73,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-26837,Alive,TUMOR FREE,646,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,646,0,646,0,646,0,646,NA,Stage IIIB,T3,[Not Available],NA,9
-5.552335165,1.264847614,TCGA-BH-A18V-01A,TCGA-BH-A18V-01A-11D-A12B-09,0,NA,TCGA-BH-A18V,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-17682,Dead,NA,NA,1556,[Not Available],NA,NA,NA,NA,[Not Available],1,1556,NA,1556,0,1556,0,1556,NA,Stage IIB,T2,M0,BRCA.Basal,3
2.953310447,3.592058641,TCGA-AN-A0XR-01A,TCGA-AN-A0XR-01A-11D-A10G-09,0,NA,TCGA-AN-A0XR,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20381,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIIA,T2,M0,BRCA.LumB,1
-0.05556889,3.187401537,TCGA-CI-6621-01A,TCGA-CI-6621-01A-11D-1826-10,4,0.349671541,TCGA-CI-6621,READ,63,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-23240,Alive,NA,419,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,419,0,419,NA,NA,0,419,NA,Stage IIIB,T3,MX,GI.CIN,3
8.601029524,-1.849470019,TCGA-FG-6692-01A,TCGA-FG-6692-01A-11D-1893-08,1,0.523824296,TCGA-FG-6692,LGG,63,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-23374,Dead,WITH TUMOR,NA,561,[Not Available],NA,NA,NA,NA,Stable Disease,1,561,1,561,NA,NA,1,561,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-6.37706667,-1.41046555,TCGA-69-8253-01A,TCGA-69-8253-01A-11D-2284-08,7,0.397475443,TCGA-69-8253,LUAD,59,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21771,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,426,0,426,0,426,0,426,NA,Stage IIA,T1a,MX,NA,2
-7.966558378,2.000936835,TCGA-FG-5962-01B,TCGA-FG-5962-01B-11D-1893-08,9,0.559660244,TCGA-FG-5962,LGG,54,MALE,WHITE,Oligodendroglioma,G3,2009,[Not Available],-19818,Alive,WITH TUMOR,1453,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1453,0,1453,NA,NA,0,1453,NA,NA,NA,NA,GBM_LGG.Codel,7
-6.125908608,3.62211652,TCGA-55-8512-01A,TCGA-55-8512-01A-11D-2393-08,11,0.557368114,TCGA-55-8512,LUAD,41,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-15266,Dead,WITH TUMOR,NA,607,[Not Available],NA,NA,NA,NA,Progressive Disease,1,607,1,607,NA,NA,1,607,NA,Stage IV,T1a,M1b,NA,8
9.179414625,-5.056721071,TCGA-HW-7495-01A,TCGA-HW-7495-01A-11D-2024-08,1,0.84076033,TCGA-HW-7495,LGG,45,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-16460,Alive,WITH TUMOR,1078,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1078,0,1078,NA,NA,0,1078,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.99919676,3.294788336,TCGA-44-A479-01A,TCGA-44-A479-01A-31D-A24D-08,0,NA,TCGA-44-A479,LUAD,73,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27024,Alive,TUMOR FREE,486,NA,[Not Available],New Primary Tumor,NA,NA,437,Complete Remission/Response,0,486,0,486,0,486,1,437,NA,Stage IB,T2,MX,NA,10
-5.420069693,2.787463502,TCGA-05-4403-01A,TCGA-05-4403-01A-01D-1265-08,12,0.179800894,TCGA-05-4403,LUAD,76,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2006,[Not Available],-27881,Alive,NA,578,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,578,0,578,NA,NA,0,578,NA,Stage IB,T2,M0,LUAD.4,8
-0.28739908,4.392549233,TCGA-D8-A1JL-01A,TCGA-D8-A1JL-01A-11D-A13L-09,4,0.551022513,TCGA-D8-A1JL,BRCA,72,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26484,Alive,TUMOR FREE,611,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,611,0,611,0,611,0,611,NA,Stage IIA,T2,M0,BRCA.Basal,6
8.479223509,-4.542270942,TCGA-E9-A1QZ-01A,TCGA-E9-A1QZ-01A-21D-A167-09,1,0.723532763,TCGA-E9-A1QZ,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22397,Alive,TUMOR FREE,755,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,755,0,755,0,755,0,755,NA,Stage IIA,T2,M0,BRCA.LumA,1
3.801056632,1.373856651,TCGA-05-4402-01A,TCGA-05-4402-01A-01D-1265-08,0,NA,TCGA-05-4402,LUAD,57,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],-20819,Dead,TUMOR FREE,NA,244,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,244,0,244,NA,NA,0,244,NA,Stage IV,T2,M1,LUAD.2,6
-6.402172165,2.381784269,TCGA-74-6575-01A,TCGA-74-6575-01A-11D-1845-08,0,NA,TCGA-74-6575,GBM,73,FEMALE,[Not Available],Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-26827,Alive,WITH TUMOR,636,NA,[Not Available],NA,[Not Applicable],[Not Applicable],93,[Not Available],0,636,0,636,NA,NA,1,93,NA,NA,NA,NA,NA,7
-0.333487981,3.934080471,TCGA-CK-4952-01A,TCGA-CK-4952-01A-01D-1719-10,4,0.216296367,TCGA-CK-4952,COAD,48,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2007,[Not Available],-17826,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,475,0,475,NA,NA,0,475,NA,Stage IIIC,T4,M0,GI.CIN,6
0.129215924,2.496036869,TCGA-BH-A1F2-01A,TCGA-BH-A1F2-01A-31D-A13L-09,4,0.156258041,TCGA-BH-A1F2,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-19701,Dead,TUMOR FREE,NA,959,[Not Available],NA,NA,NA,NA,[Not Available],1,959,0,959,NA,NA,0,959,NA,Stage IIIB,T4b,M0,BRCA.LumB,6
9.071384658,-4.329097202,TCGA-AN-A0AR-01A,TCGA-AN-A0AR-01A-11W-A019-09,1,0.764651767,TCGA-AN-A0AR,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20152,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.Basal,1
-0.704767416,3.728043266,TCGA-CS-6666-01A,TCGA-CS-6666-01A-11D-1893-08,4,0.328922587,TCGA-CS-6666,LGG,22,MALE,WHITE,Astrocytoma,G3,2010,[Not Available],-8340,Alive,TUMOR FREE,1428,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1428,0,1428,NA,NA,0,1428,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,5
-1.901159394,0.993308247,TCGA-62-A472-01A,TCGA-62-A472-01A-11D-A24D-08,5,0.575090135,TCGA-62-A472,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25893,Alive,WITH TUMOR,910,NA,[Not Available],Locoregional Recurrence,NA,NA,290,Complete Remission/Response,0,910,0,910,1,290,1,290,NA,Stage IIB,T3,M0,NA,4
-0.022645618,5.201829293,TCGA-DU-5871-01A,TCGA-DU-5871-01A-12D-1705-08,4,0.650725867,TCGA-DU-5871,LGG,37,FEMALE,WHITE,Oligoastrocytoma,G2,2009,[Not Available],-13673,Alive,TUMOR FREE,576,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,576,0,576,NA,NA,0,576,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-6.064252231,3.173029942,TCGA-75-7030-01A,TCGA-75-7030-01A-11D-1945-08,11,0.233847302,TCGA-75-7030,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,NA,0,NA,0,NA,0,NA,NA,Stage IIB,T3,M0,LUAD.6,7
-4.026530739,-1.215003316,TCGA-44-6777-01A,TCGA-44-6777-01A-11D-1855-08,8,0.250095052,TCGA-44-6777,LUAD,85,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-31234,Dead,TUMOR FREE,NA,987,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,987,0,987,0,987,0,987,NA,Stage IB,T2,MX,LUAD.5,10
-5.872061278,3.229439475,TCGA-55-6983-01A,TCGA-55-6983-01A-11D-1945-08,11,0.360756755,TCGA-55-6983,LUAD,81,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],NA,Alive,TUMOR FREE,2823,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2823,0,2823,0,2823,0,2823,NA,Stage IIB,T2,M0,LUAD.4,8
9.788483417,-1.936515341,TCGA-50-5942-01A,TCGA-50-5942-01A-21D-1753-08,1,0.860279335,TCGA-50-5942,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24781,Alive,WITH TUMOR,1847,NA,[Not Available],Locoregional Recurrence,NA,NA,1378,Stable Disease,0,1847,0,1847,NA,NA,1,1378,NA,Stage IA,T1,M0,LUAD.4,1
8.828291388,-3.00469193,TCGA-BH-A0AZ-01A,TCGA-BH-A0AZ-01A-21D-A12Q-09,1,0.676375926,TCGA-BH-A0AZ,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465,Alive,TUMOR FREE,1919,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1919,0,1919,0,1919,0,1919,NA,Stage IIIA,T3,cM0 (i+),BRCA.LumA,1
-4.089276528,-1.862917991,TCGA-38-4631-01A,TCGA-38-4631-01A-01D-1753-08,8,0.221211162,TCGA-38-4631,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],1997,[Not Available],-26538,Dead,WITH TUMOR,NA,354,[Not Available],NA,NA,NA,NA,Progressive Disease,1,354,1,354,NA,NA,1,354,NA,Stage IB,T2,M0,LUAD.6,10
-6.495662929,2.261359027,TCGA-02-0047-01A,TCGA-02-0047-01A-01D-1490-08,0,NA,TCGA-02-0047,GBM,78,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-28759,Dead,WITH TUMOR,448,448,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],57,[Not Available],1,448,1,448,NA,NA,1,57,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,7
0.548043054,2.168323272,TCGA-04-1353-01A,TCGA-04-1353-01A-01D-1526-09,0,NA,TCGA-04-1353,OV,64,FEMALE,ASIAN,Serous Cystadenocarcinoma,[Not Available],2003,[Not Available],-23611,Alive,NA,16,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,16,0,16,NA,NA,0,16,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.381389916,1.586676874,TCGA-CM-6675-01A,TCGA-CM-6675-01A-11D-1835-10,10,0.25538729,TCGA-CM-6675,COAD,35,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-12935,Alive,WITH TUMOR,397,NA,[Not Available],NA,NA,NA,337,[Not Available],0,397,0,397,NA,NA,1,337,NA,Stage IVB,T3,M1b,GI.CIN,6
3.962508025,1.29060035,TCGA-AA-3952-01A,TCGA-AA-3952-01A-01W-0995-10,2,0.178155337,TCGA-AA-3952,COAD,68,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-24868,Dead,WITH TUMOR,NA,61,[Not Available],NA,NA,NA,NA,[Not Available],1,61,1,61,NA,NA,1,61,NA,Stage IIIC,T3,M0,GI.CIN,5
-6.516973165,2.260649149,TCGA-CK-6751-01A,TCGA-CK-6751-01A-11D-1835-10,0,NA,TCGA-CK-6751,COAD,88,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2002,[Not Available],-32354,Alive,TUMOR FREE,3780,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3780,0,3780,NA,NA,0,3780,NA,Stage I,T2,MX,GI.GS,7
-5.333319509,-1.491232514,TCGA-55-8514-01A,TCGA-55-8514-01A-11D-2393-08,0,NA,TCGA-55-8514,LUAD,70,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-25608,Alive,TUMOR FREE,520,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,520,0,520,0,520,0,520,NA,Stage IB,T2a,MX,NA,2
-6.093700611,3.498343069,TCGA-75-6206-01A,TCGA-75-6206-01A-11D-1753-08,11,0.499815998,TCGA-75-6206,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,2590,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2590,0,2590,0,2590,0,2590,NA,Stage IB,T2,M0,NA,8
-6.494687529,-1.902557018,TCGA-86-7955-01A,TCGA-86-7955-01A-11D-2184-08,0,NA,TCGA-86-7955,LUAD,62,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22772,Alive,TUMOR FREE,1072,NA,[Not Available],Locoregional Recurrence,NA,NA,820,Complete Remission/Response,0,1072,0,1072,1,820,1,820,NA,Stage IB,T2a,M0,NA,10
-4.514033742,1.85922776,TCGA-50-5932-01A,TCGA-50-5932-01A-11D-1753-08,0,NA,TCGA-50-5932,LUAD,75,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-27454,Dead,WITH TUMOR,1091,1235,[Not Available],Locoregional Recurrence,NA,NA,1090,Progressive Disease,1,1235,1,1235,NA,NA,1,1090,NA,Stage IIB,T2,M0,LUAD.1,10
-4.237936453,-2.189276208,TCGA-55-8511-01A,TCGA-55-8511-01A-11D-2393-08,8,0.445098394,TCGA-55-8511,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26986,Alive,WITH TUMOR,552,NA,[Not Available],NA,NA,NA,460,Complete Remission/Response,0,552,0,552,1,460,1,460,NA,Stage IB,T2a,MX,NA,10
9.367400663,-3.73501095,TCGA-76-6192-01A,TCGA-76-6192-01A-11D-1696-08,1,0.704470531,TCGA-76-6192,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-27322,Dead,WITH TUMOR,100,100,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],76,[Not Available],1,100,1,100,NA,NA,1,76,NA,NA,NA,NA,NA,1
-7.929940869,1.992910236,TCGA-E2-A1IL-01A,TCGA-E2-A1IL-01A-11D-A14G-09,9,0.490885493,TCGA-E2-A1IL,BRCA,78,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28495,Alive,TUMOR FREE,118,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,118,0,118,0,118,0,118,NA,Stage IIA,T1c,M0,BRCA.LumA,7
0.012755695,3.430280947,TCGA-E9-A22E-01A,TCGA-E9-A22E-01A-11D-A159-09,4,0.423945595,TCGA-E9-A22E,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574,Alive,TUMOR FREE,1269,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1269,0,1269,0,1269,0,1269,NA,Stage IIIA,T2,M0,BRCA.LumB,3
4.331507682,1.119471746,TCGA-C8-A1HO-01A,TCGA-C8-A1HO-01A-11D-A13L-09,2,0.63992164,TCGA-C8-A1HO,BRCA,34,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12715,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,375,0,375,0,375,0,375,NA,Stage IIIC,T3,M0,BRCA.LumA,5
-7.653552965,2.384385444,TCGA-E9-A1RA-01A,TCGA-E9-A1RA-01A-11D-A14G-09,9,0.317653274,TCGA-E9-A1RA,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17699,Alive,TUMOR FREE,1369,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1369,0,1369,0,1369,0,1369,NA,Stage IA,T1c,M0,BRCA.LumA,7
-0.350439257,4.333573779,TCGA-05-4384-01A,TCGA-05-4384-01A-01D-1753-08,4,0.462980902,TCGA-05-4384,LUAD,66,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24411,Alive,WITH TUMOR,426,NA,[Not Available],Distant Metastasis,NA,NA,183,Progressive Disease,0,426,0,426,NA,NA,1,183,NA,Stage IIIA,T2,M0,LUAD.1,6
-6.022970267,3.469997731,TCGA-35-3615-01A,TCGA-35-3615-01A-01D-1040-01,11,0.542617804,TCGA-35-3615,LUAD,57,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-21076,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,14,0,14,NA,NA,0,14,NA,Stage IB,T2,M0,LUAD.4,8
-6.285632789,3.463800686,TCGA-55-6978-01A,TCGA-55-6978-01A-11D-1945-08,11,0.129037499,TCGA-55-6978,LUAD,81,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],NA,Dead,WITH TUMOR,NA,176,[Not Available],NA,NA,NA,42,Progressive Disease,1,176,1,176,NA,NA,1,42,NA,Stage IIA,T2b,MX,LUAD.6,7
-3.276045517,-3.3983057,TCGA-86-8073-01A,TCGA-86-8073-01A-11D-2238-08,8,0.542657135,TCGA-86-8073,LUAD,58,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21214,Alive,TUMOR FREE,740,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,740,0,740,0,740,0,740,NA,Stage IB,T2a,M0,NA,10
-5.793166902,3.279027398,TCGA-55-6642-01A,TCGA-55-6642-01A-11D-1855-08,11,0.136838546,TCGA-55-6642,LUAD,63,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-23107,Alive,TUMOR FREE,2449,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2449,0,2449,0,2449,0,2449,NA,Stage IB,T2,MX,LUAD.2,8
10.13393739,-1.58256567,TCGA-32-2638-01A,TCGA-32-2638-01A-01D-1495-08,1,0.799304159,TCGA-32-2638,GBM,67,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-24658,Dead,WITH TUMOR,NA,766,[Not Available],NA,NA,NA,NA,[Not Available],1,766,1,766,NA,NA,1,766,NA,NA,NA,NA,GBM_LGG.Classic-like,1
9.005206396,-4.977535719,TCGA-69-7761-01A,TCGA-69-7761-01A-11D-2167-08,1,0.80178288,TCGA-69-7761,LUAD,84,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-31041,Alive,TUMOR FREE,186,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,186,0,186,NA,NA,0,186,NA,Stage IB,T2a,MX,LUAD.6,1
-5.194420654,2.069231567,TCGA-86-8056-01A,TCGA-86-8056-01A-11D-2238-08,0,NA,TCGA-86-8056,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23369,Alive,TUMOR FREE,139,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,139,0,139,0,139,0,139,NA,Stage IIIA,T4,M0,NA,10
9.821880532,-3.528675976,TCGA-27-1833-01A,TCGA-27-1833-01A-01D-1494-08,1,0.671526196,TCGA-27-1833,GBM,67,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-24592,Dead,WITH TUMOR,555,737,[Not Available],Recurrence,[Not Applicable],[Not Applicable],469,[Not Available],1,737,1,737,NA,NA,1,469,NA,NA,NA,NA,NA,1
9.329420229,-5.84085193,TCGA-BH-A28Q-01A,TCGA-BH-A28Q-01A-11D-A16D-09,1,0.815110573,TCGA-BH-A28Q,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16882,Alive,TUMOR FREE,1119,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1119,0,1119,NA,NA,0,1119,NA,Stage IIB,T2,M0,BRCA.LumA,1
-5.287229674,2.674577745,TCGA-AF-6672-01A,TCGA-AF-6672-01A-11D-1826-10,12,0.258752976,TCGA-AF-6672,READ,43,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-15965,Alive,WITH TUMOR,748,NA,[Not Available],Metastatic,NA,NA,279,Progressive Disease,0,748,0,748,NA,NA,1,279,NA,Stage IV,T4a,MX,GI.CIN,8
8.86786496,-4.015559226,TCGA-A1-A0SG-01A,TCGA-A1-A0SG-01A-11D-A142-09,1,0.691859524,TCGA-A1-A0SG,BRCA,61,FEMALE,WHITE,"Other, specify",[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380,Alive,NA,434,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,434,0,434,0,434,0,434,NA,Stage IIB,T2,M0,BRCA.LumA,1
-5.613672631,1.367778499,TCGA-A2-A04W-01A,TCGA-A2-A04W-01A-31D-A10Y-09,0,NA,TCGA-A2-A04W,BRCA,50,FEMALE,WHITE,"Other, specify",[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18345,Alive,TUMOR FREE,3102,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3102,0,3102,0,3102,0,3102,NA,Stage IIB,T2,M0,BRCA.Her2,9
-7.591789399,-2.378691491,TCGA-E9-A22G-01A,TCGA-E9-A22G-01A-11D-A159-09,6,0.343597848,TCGA-E9-A22G,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17300,Alive,TUMOR FREE,1239,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1239,0,1239,0,1239,0,1239,NA,Stage IIA,T2,M0,BRCA.Basal,2
1.35491476,3.288378485,TCGA-A2-A0CT-01A,TCGA-A2-A0CT-01A-31W-A071-09,0,NA,TCGA-A2-A0CT,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25959,Alive,TUMOR FREE,2289,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2289,0,2289,0,2289,0,2289,NA,Stage IIA,T2,M0,BRCA.LumA,6
-4.150681753,-1.985854224,TCGA-64-1676-01A,TCGA-64-1676-01A-01D-0969-08,8,0.484276456,TCGA-64-1676,LUAD,58,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-21428,Alive,TUMOR FREE,1728,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1728,0,1728,0,1728,0,1728,NA,Stage IA,T1a,M0,LUAD.3,10
-4.141236137,-1.973548535,TCGA-69-7978-01A,TCGA-69-7978-01A-11D-2184-08,8,0.408271495,TCGA-69-7978,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21785,Alive,[Discrepancy],134,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,134,0,134,NA,NA,0,134,NA,Stage IIB,T2b,MX,NA,10
9.94823626,-4.134318423,TCGA-G5-6641-01A,TCGA-G5-6641-01A-11D-1826-10,1,0.618927211,TCGA-G5-6641,READ,67,MALE,WHITE,Rectal Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-24486,Alive,TUMOR FREE,804,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,804,0,804,NA,NA,0,804,NA,Stage IIIA,T1,MX,GI.CIN,1
4.511172446,1.224475141,TCGA-06-0158-01A,TCGA-06-0158-01A-01D-1491-08,2,0.579912337,TCGA-06-0158,GBM,73,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-26856,Dead,WITH TUMOR,166,329,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],90,[Not Available],1,329,1,329,NA,NA,1,90,NA,NA,NA,NA,GBM_LGG.NA,5
9.173811753,-5.350826569,TCGA-D8-A27K-01A,TCGA-D8-A27K-01A-11D-A16D-09,1,0.783928407,TCGA-D8-A27K,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17426,Alive,TUMOR FREE,1461,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1461,0,1461,0,1461,0,1461,NA,Stage IIB,T2,M0,BRCA.LumA,1
-5.171498059,-1.377295436,TCGA-A2-A0EQ-01A,TCGA-A2-A0EQ-01A-11W-A050-09,8,0.167090252,TCGA-A2-A0EQ,BRCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543,Alive,TUMOR FREE,2426,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2426,0,2426,0,2426,0,2426,NA,Stage IIA,T2,M0,BRCA.Her2,2
9.001323499,-5.548555154,TCGA-AA-3560-01A,TCGA-AA-3560-01A-01D-1953-10,1,0.804554808,TCGA-AA-3560,COAD,72,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-26359,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,608,0,608,0,608,0,608,NA,Stage IIIC,T3,M0,NA,1
-0.784792959,4.483069485,TCGA-AF-2687-01A,TCGA-AF-2687-01A-02D-1733-10,4,0.416030692,TCGA-AF-2687,READ,57,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-21098,Alive,TUMOR FREE,1427,NA,[Not Available],NA,NA,NA,1267,Complete Remission/Response,0,1427,0,1427,1,1267,1,1267,NA,Stage IIIC,T3,M0,GI.CIN,6
-5.015437727,1.335332537,TCGA-67-4679-01B,TCGA-67-4679-01B-01D-1753-08,0,NA,TCGA-67-4679,LUAD,69,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-25202,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,448,0,448,NA,NA,0,448,NA,[Discrepancy],T3,M0,NA,10
-6.469215265,-1.529942848,TCGA-44-7661-01A,TCGA-44-7661-01A-11D-2063-08,7,0.153732067,TCGA-44-7661,LUAD,69,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25483,Dead,WITH TUMOR,NA,557,[Not Available],Locoregional Recurrence,NA,NA,335,Complete Remission/Response,1,557,1,557,1,335,1,335,NA,Stage IB,T2a,M0,NA,2
-8.209197151,1.894216772,TCGA-97-8177-01A,TCGA-97-8177-01A-11D-2284-08,9,0.484455079,TCGA-97-8177,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21648,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Evaluated],0,499,0,499,NA,NA,0,499,NA,Stage IB,T2a,M0,NA,7
-4.702213937,0.062633818,TCGA-64-5779-01A,TCGA-64-5779-01A-01D-1625-08,0,NA,TCGA-64-5779,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-22305,Alive,TUMOR FREE,864,NA,[Not Available],Distant Metastasis,NA,NA,795,Stable Disease,0,864,0,864,NA,NA,1,795,NA,Stage IIIA,T2,M0,NA,10
-0.588240304,5.109200636,TCGA-AN-A0FY-01A,TCGA-AN-A0FY-01A-11W-A050-09,4,0.431669235,TCGA-AN-A0FY,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20347,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IA,T1c,M0,BRCA.LumB,6
9.029334363,-5.368113384,TCGA-06-6697-01A,TCGA-06-6697-01A-11D-1845-08,1,0.774243454,TCGA-06-6697,GBM,65,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-23763,Alive,WITH TUMOR,391,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],306,[Not Available],0,391,0,391,NA,NA,1,306,NA,NA,NA,NA,NA,1
-7.88404315,2.221455386,TCGA-19-2620-01A,TCGA-19-2620-01A-01D-1495-08,9,0.583161116,TCGA-19-2620,GBM,70,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-25665,Dead,TUMOR FREE,148,148,[Not Available],NA,NA,NA,NA,[Not Available],1,148,0,148,NA,NA,0,148,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-8.192719609,2.027906563,TCGA-AR-A0TR-01A,TCGA-AR-A0TR-01A-11D-A099-09,9,0.510774923,TCGA-AR-A0TR,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25190,Dead,NA,NA,160,[Not Available],NA,NA,NA,NA,[Not Available],1,160,NA,160,0,160,0,160,NA,Stage IIB,T2,M0,BRCA.LumA,7
0.215913179,2.552481637,TCGA-76-6663-01A,TCGA-76-6663-01A-11D-1845-08,4,0.184374527,TCGA-76-6663,GBM,44,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-16126,Dead,WITH TUMOR,NA,567,[Not Available],NA,NA,NA,NA,[Not Available],1,567,1,567,NA,NA,1,567,NA,NA,NA,NA,NA,6
9.177621851,-4.72342555,TCGA-BH-A0E9-01B,TCGA-BH-A0E9-01B-11D-A10Y-09,1,0.760862333,TCGA-BH-A0E9,BRCA,53,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415,Alive,TUMOR FREE,2489,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2489,0,2489,0,2489,0,2489,NA,Stage IIB,T2,M0,BRCA.LumA,1
0.123545398,2.60690414,TCGA-E2-A1LS-01A,TCGA-E2-A1LS-01A-12D-A159-09,4,0.138341777,TCGA-E2-A1LS,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16887,Alive,TUMOR FREE,1604,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1604,0,1604,0,1604,0,1604,NA,Stage IA,T1c,M0,BRCA.Basal,6
-6.747111585,-1.913259379,TCGA-AY-6196-01A,TCGA-AY-6196-01A-11D-1719-10,0,NA,TCGA-AY-6196,COAD,47,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-17311,Alive,TUMOR FREE,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,NA,NA,0,6,NA,Stage IIIC,T3,[Not Available],GI.CIN,2
-5.613114479,1.182086569,TCGA-91-6840-01A,TCGA-91-6840-01A-11D-1945-08,0,NA,TCGA-91-6840,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21854,Alive,TUMOR FREE,372,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,372,0,372,0,372,0,372,NA,Stage IA,T1b,M0,LUAD.2,9
-4.578691811,-0.880517643,TCGA-55-7283-01A,TCGA-55-7283-01A-11D-2036-08,8,0.116926891,TCGA-55-7283,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27946,Alive,WITH TUMOR,609,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,609,0,609,NA,NA,0,609,NA,Stage IIIA,T3,MX,LUAD.4,10
-2.00295936,1.216267092,TCGA-HT-7604-01A,TCGA-HT-7604-01A-11D-2086-08,5,0.666933889,TCGA-HT-7604,LGG,50,MALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G2,2003,[Not Available],-18443,Alive,TUMOR FREE,3725,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,3725,0,3725,NA,NA,0,3725,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,4
9.217038352,-2.630165575,TCGA-CS-6665-01A,TCGA-CS-6665-01A-11D-1893-08,1,0.763869041,TCGA-CS-6665,LGG,51,FEMALE,WHITE,Astrocytoma,G3,2010,[Not Available],-18977,Alive,WITH TUMOR,1568,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1568,0,1568,NA,NA,0,1568,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,1
0.276237613,3.480221043,TCGA-FG-8182-01A,TCGA-FG-8182-01A-11D-2253-08,4,0.138882318,TCGA-FG-8182,LGG,35,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-12972,Alive,WITH TUMOR,416,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,416,0,416,NA,NA,0,416,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
-5.755559034,-2.2041032,TCGA-HT-7677-01A,TCGA-HT-7677-01A-11D-2253-08,0,NA,TCGA-HT-7677,LGG,53,MALE,WHITE,Oligodendroglioma,G3,2009,[Not Available],-19610,Alive,[Discrepancy],494,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,494,0,494,NA,NA,0,494,NA,NA,NA,NA,GBM_LGG.Codel,2
8.99760267,-4.520487273,TCGA-DU-6394-01A,TCGA-DU-6394-01A-11D-1705-08,1,0.823595065,TCGA-DU-6394,LGG,53,MALE,WHITE,Oligodendroglioma,G3,1994,[Not Available],-19541,Dead,WITH TUMOR,NA,682,[Not Available],NA,NA,NA,353,Progressive Disease,1,682,1,682,NA,NA,1,353,NA,NA,NA,NA,GBM_LGG.Codel,1
-8.131597622,1.985404092,TCGA-AC-A3HN-01A,TCGA-AC-A3HN-01A-11D-A20S-09,9,0.581037072,TCGA-AC-A3HN,BRCA,87,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32061,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,496,0,496,0,496,0,496,NA,Stage IIB,T2,MX,BRCA.LumA,7
8.250090881,-3.895742968,TCGA-AA-3856-01A,TCGA-AA-3856-01A-01W-0900-09,1,0.536142723,TCGA-AA-3856,COAD,59,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-21670,Alive,WITH TUMOR,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage IIA,T3,M0,GI.CIN,3
0.159184214,3.321546446,TCGA-HT-8105-01A,TCGA-HT-8105-01A-11D-2395-08,4,0.415942789,TCGA-HT-8105,LGG,54,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-20041,Alive,TUMOR FREE,190,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,190,0,190,NA,NA,0,190,NA,NA,NA,NA,GBM_LGG.Codel,3
0.183072186,4.841170108,TCGA-DU-8163-01A,TCGA-DU-8163-01A-11D-2253-08,4,0.572352448,TCGA-DU-8163,LGG,29,MALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-10824,Alive,WITH TUMOR,629,NA,[Not Available],NA,NA,NA,509,Progressive Disease,0,629,0,629,NA,NA,1,509,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.881662446,-1.446040267,TCGA-D9-A4Z2-01A,TCGA-D9-A4Z2-01A-11D-A24R-08,1,0.849489053,TCGA-D9-A4Z2,SKCM,50,MALE,WHITE,NA,[Not Available],2012,[Not Available],-18462,Dead,WITH TUMOR,NA,190,[Not Available],Distant Metastasis,Lung,NA,80,[Not Available],1,190,1,190,NA,NA,1,80,NA,Stage IIIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,1
-0.114592786,4.847417426,TCGA-DU-6407-01A,TCGA-DU-6407-01A-13D-1705-08,4,0.494657714,TCGA-DU-6407,LGG,35,FEMALE,WHITE,Oligodendroglioma,G2,2001,[Not Available],-13021,Dead,WITH TUMOR,NA,2875,[Not Available],NA,NA,NA,2397,Progressive Disease,1,2875,1,2875,NA,NA,1,2397,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.722627973,-2.512301566,TCGA-FG-5964-01A,TCGA-FG-5964-01A-11D-1705-08,6,0.56018418,TCGA-FG-5964,LGG,62,MALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-22735,Alive,WITH TUMOR,1588,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1588,0,1588,NA,NA,0,1588,NA,NA,NA,NA,GBM_LGG.Codel,2
2.965541381,3.583994513,TCGA-E2-A15I-01A,TCGA-E2-A15I-01A-21D-A135-09,0,NA,TCGA-E2-A15I,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163,Alive,TUMOR FREE,1692,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1692,0,1692,0,1692,0,1692,NA,Stage IIA,T2,M0,BRCA.LumA,1
9.389692741,-5.692560422,TCGA-AA-3517-01A,TCGA-AA-3517-01A-01D-1953-10,1,0.840855648,TCGA-AA-3517,COAD,60,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-22099,Alive,TUMOR FREE,1186,NA,[Not Available],NA,NA,NA,821,Complete Remission/Response,0,1186,0,1186,1,821,1,821,NA,Stage IIA,T3,M0,NA,1
-6.433168766,1.680892808,TCGA-B6-A0RH-01A,TCGA-B6-A0RH-01A-21D-A10Y-09,10,0.205839689,TCGA-B6-A0RH,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1991,Indeterminate (neither Pre or Postmenopausal),-18759,Dead,TUMOR FREE,NA,6456,[Not Available],Locoregional Disease,"Other, specify",Chest Wall,2165,[Not Available],1,6456,0,6456,1,2165,1,2165,NA,Stage IIA,T2,M0,BRCA.Her2,7
8.661889095,-1.858784169,TCGA-BH-A1EN-01A,TCGA-BH-A1EN-01A-11D-A17G-09,1,0.540185863,TCGA-BH-A1EN,BRCA,78,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28724,Dead,TUMOR FREE,NA,2127,[Not Available],NA,NA,NA,NA,[Not Available],1,2127,0,2127,0,2127,0,2127,NA,Stage IIA,T2,M0,BRCA.Her2,1
9.246844944,-4.47873734,TCGA-73-4675-01A,TCGA-73-4675-01A-01D-1265-08,1,0.790967359,TCGA-73-4675,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-21614,Dead,TUMOR FREE,NA,922,[Not Available],Locoregional Recurrence,NA,NA,361,Progressive Disease,1,922,0,922,NA,NA,1,361,NA,Stage IIIA,T3,M0,LUAD.4,1
-3.965906191,-1.373669911,TCGA-44-7662-01A,TCGA-44-7662-01A-11D-2063-08,8,0.240842951,TCGA-44-7662,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22543,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,218,0,218,0,218,0,218,NA,Stage IB,T2a,MX,LUAD.3,10
8.857531538,-4.801596866,TCGA-HT-8108-01A,TCGA-HT-8108-01A-11D-2395-08,1,0.785091782,TCGA-HT-8108,LGG,26,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-9539,Alive,TUMOR FREE,76,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,76,0,76,NA,NA,0,76,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
9.625614252,-2.056532222,TCGA-DU-6402-01A,TCGA-DU-6402-01A-11D-1705-08,1,0.794805848,TCGA-DU-6402,LGG,52,MALE,WHITE,Astrocytoma,G3,1998,[Not Available],-19207,Dead,WITH TUMOR,NA,214,[Not Available],NA,NA,NA,103,Progressive Disease,1,214,1,214,NA,NA,1,103,NA,NA,NA,NA,GBM_LGG.Classic-like,1
1.560895576,2.122894533,TCGA-97-7547-01A,TCGA-97-7547-01A-11D-2036-08,3,0.2814558,TCGA-97-7547,LUAD,67,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-24737,Alive,WITH TUMOR,1965,NA,[Not Available],NA,NA,NA,775,Progressive Disease,0,1965,0,1965,NA,NA,1,775,NA,Stage IB,T2,MX,NA,3
-4.475241933,-0.219377185,TCGA-97-7554-01A,TCGA-97-7554-01A-11D-2036-08,8,0.078177334,TCGA-97-7554,LUAD,83,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-30327,Alive,TUMOR FREE,775,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,775,0,775,0,775,0,775,NA,Stage IIIA,T2a,M0,LUAD.3,10
-3.388367975,-3.370504923,TCGA-78-7155-01A,TCGA-78-7155-01A-11D-2036-08,8,0.536131655,TCGA-78-7155,LUAD,68,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-24863,Dead,NA,NA,1171,[Not Available],NA,NA,NA,209,[Not Available],1,1171,NA,1171,NA,NA,1,209,NA,Stage IB,T2,M0,LUAD.2,10
-7.312635945,-2.199531097,TCGA-A2-A0CL-01A,TCGA-A2-A0CL-01A-11D-A10Y-09,6,0.373571737,TCGA-A2-A0CL,BRCA,37,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13556,Alive,TUMOR FREE,3015,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3015,0,3015,NA,NA,0,3015,NA,Stage IIIA,T3,M0,BRCA.Normal,2
-6.076926519,1.529000764,TCGA-BH-A203-01A,TCGA-BH-A203-01A-12D-A167-09,10,0.340089844,TCGA-BH-A203,BRCA,78,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28609,Dead,WITH TUMOR,NA,1174,[Not Available],NA,NA,NA,NA,[Not Available],1,1174,1,1174,NA,NA,1,1174,NA,Stage IIB,T2,M0,BRCA.Her2,7
-7.886106408,2.260445398,TCGA-A2-A0D3-01A,TCGA-A2-A0D3-01A-11D-A10Y-09,9,0.405209221,TCGA-A2-A0D3,BRCA,42,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15524,Alive,TUMOR FREE,1873,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1873,0,1873,0,1873,0,1873,NA,Stage IA,T1c,M0,BRCA.LumA,7
9.174319189,-5.361786902,TCGA-19-A6J4-01A,TCGA-19-A6J4-01A-11D-A33T-08,1,0.766448701,TCGA-19-A6J4,GBM,68,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2013,[Not Available],-25058,Dead,WITH TUMOR,NA,121,[Not Available],NA,NA,NA,NA,[Unknown],1,121,1,121,NA,NA,1,121,NA,NA,NA,NA,NA,1
-0.238834664,5.312607686,TCGA-E1-5322-01A,TCGA-E1-5322-01A-01D-1468-08,4,0.454867835,TCGA-E1-5322,LGG,38,FEMALE,WHITE,Oligoastrocytoma,G2,1999,[Not Available],-13903,Dead,NA,NA,3978,[Not Available],NA,NA,NA,1085,Stable Disease,1,3978,NA,3978,NA,NA,1,1085,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.102045992,-2.029029546,TCGA-55-8205-01A,TCGA-55-8205-01A-11D-2238-08,8,0.373939667,TCGA-55-8205,LUAD,76,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28063,Alive,WITH TUMOR,599,NA,[Not Available],Distant Metastasis,NA,NA,495,Progressive Disease,0,599,0,599,NA,NA,1,495,NA,Stage IIA,T2b,M0,NA,10
-1.403134541,4.052909221,TCGA-HT-7479-01A,TCGA-HT-7479-01A-11D-2024-08,4,0.168084812,TCGA-HT-7479,LGG,44,MALE,WHITE,Astrocytoma,G3,2011,[Not Available],-16137,Alive,TUMOR FREE,1227,NA,[Not Available],NA,NA,NA,705,Complete Remission/Response,0,1227,0,1227,1,705,1,705,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.308859089,4.933922914,TCGA-62-A46Y-01A,TCGA-62-A46Y-01A-11D-A24D-08,4,0.697387596,TCGA-62-A46Y,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-25905,Dead,WITH TUMOR,NA,414,[Not Available],Distant Metastasis,NA,NA,314,Complete Remission/Response,1,414,1,414,1,314,1,314,NA,Stage IIIA,T2,M0,NA,6
8.218674058,-2.373945715,TCGA-06-1806-01A,TCGA-06-1806-01A-02D-1845-08,1,0.511272215,TCGA-06-1806,GBM,47,MALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2009,[Not Available],-17296,Dead,WITH TUMOR,NA,466,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],256,Progressive Disease,1,466,1,466,NA,NA,1,256,NA,NA,NA,NA,NA,1
-3.879014715,-2.298100462,TCGA-D9-A4Z3-01A,TCGA-D9-A4Z3-01A-11D-A25O-08,8,0.447449029,TCGA-D9-A4Z3,SKCM,73,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-26812,Alive,TUMOR FREE,505,NA,[Not Available],Locoregional Recurrence,NA,NA,100,[Not Available],0,505,0,505,NA,NA,1,100,NA,Stage IIIC,T4b,M0,SKCM.RAS_Hotspot_Mutants,10
-7.474840185,-2.020784914,TCGA-HT-8104-01A,TCGA-HT-8104-01A-11D-2395-08,6,0.061601083,TCGA-HT-8104,LGG,51,FEMALE,WHITE,Astrocytoma,G3,2010,[Not Available],-18748,Alive,TUMOR FREE,372,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,372,0,372,NA,NA,0,372,NA,NA,NA,NA,GBM_LGG.Classic-like,2
-3.688851309,0.677413175,TCGA-55-8614-01A,TCGA-55-8614-01A-11D-2393-08,0,NA,TCGA-55-8614,LUAD,76,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27924,Alive,TUMOR FREE,536,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,536,0,536,0,536,0,536,NA,Stage IB,T2a,MX,NA,3
-0.311657046,5.02093128,TCGA-HT-7601-01A,TCGA-HT-7601-01A-11D-2086-08,4,0.581121772,TCGA-HT-7601,LGG,30,FEMALE,WHITE,Astrocytoma,G3,2008,[Not Available],-10989,Alive,TUMOR FREE,153,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,153,0,153,NA,NA,0,153,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.807118067,-5.381019409,TCGA-CS-5394-01A,TCGA-CS-5394-01A-01D-1468-08,1,0.769942179,TCGA-CS-5394,LGG,40,MALE,WHITE,Astrocytoma,G3,2005,[Not Available],-14920,Alive,NA,8,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,8,0,8,NA,NA,0,8,NA,NA,NA,NA,GBM_LGG.Codel,1
8.478741084,-1.796743754,TCGA-71-8520-01A,TCGA-71-8520-01A-11D-2393-08,1,0.436871843,TCGA-71-8520,LUAD,60,FEMALE,ASIAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-21921,Dead,WITH TUMOR,NA,210,[Not Available],Locoregional Recurrence,NA,NA,179,Complete Remission/Response,1,210,1,210,1,179,1,179,NA,Stage IB,T2,M0,NA,6
-6.131694539,3.549585647,TCGA-55-7284-01B,TCGA-55-7284-01B-11D-2238-08,11,0.569266311,TCGA-55-7284,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27087,Dead,WITH TUMOR,NA,243,[Not Available],Distant Metastasis,NA,NA,231,Complete Remission/Response,1,243,1,243,1,231,1,231,NA,Stage IIB,T3,MX,NA,8
-7.743483662,1.813007495,TCGA-EW-A1PE-01A,TCGA-EW-A1PE-01A-11D-A142-09,9,0.498808099,TCGA-EW-A1PE,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694,Alive,TUMOR FREE,320,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,320,0,320,0,320,0,320,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-7.841550738,-2.450749838,TCGA-D8-A1JT-01A,TCGA-D8-A1JT-01A-31D-A13L-09,6,0.554884249,TCGA-D8-A1JT,BRCA,70,FEMALE,WHITE,"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25677,Alive,TUMOR FREE,405,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,405,0,405,0,405,0,405,NA,Stage IIA,T2,M0,BRCA.LumB,2
-7.169950576,-1.907727391,TCGA-B6-A0I8-01A,TCGA-B6-A0I8-01A-11W-A050-09,6,0.125719744,TCGA-B6-A0I8,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-17073,Dead,WITH TUMOR,NA,749,[Not Available],Locoregional Disease,"Other, specify",Pectoral muscle,746,[Not Available],1,749,1,749,NA,NA,1,746,NA,Stage X,T1,M0,BRCA.LumA,2
9.40796072,-2.467722951,TCGA-A2-A0EU-01A,TCGA-A2-A0EU-01A-22W-A071-09,1,0.792486082,TCGA-A2-A0EU,BRCA,79,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29144,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1043,0,1043,0,1043,0,1043,NA,Stage IA,T1c,M0,BRCA.LumA,1
-2.009247919,1.096412909,TCGA-19-4065-01A,TCGA-19-4065-01A-01D-2280-08,5,0.637170419,TCGA-19-4065,GBM,36,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-13257,Alive,WITH TUMOR,214,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],70,[Not Available],0,214,0,214,NA,NA,1,70,NA,NA,NA,NA,GBM_LGG.NA,4
9.282619922,-5.576908323,TCGA-HT-7605-01A,TCGA-HT-7605-01A-11D-2086-08,1,0.871232191,TCGA-HT-7605,LGG,38,MALE,WHITE,Oligodendroglioma,G2,2008,[Not Available],-13892,Alive,NA,139,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,139,0,139,NA,NA,0,139,NA,NA,NA,NA,GBM_LGG.Codel,1
0.033129636,5.042886789,TCGA-DH-5143-01A,TCGA-DH-5143-01A-01D-1468-08,4,0.602385177,TCGA-DH-5143,LGG,30,MALE,WHITE,Oligoastrocytoma,G3,2009,[Not Available],-11291,Alive,WITH TUMOR,1401,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1401,0,1401,NA,NA,0,1401,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.168421809,2.676027075,TCGA-64-5815-01A,TCGA-64-5815-01A-01D-1625-08,12,0.209914644,TCGA-64-5815,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-27280,Alive,TUMOR FREE,866,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,866,0,866,0,866,0,866,NA,Stage IIB,T2,M0,NA,8
0.296114739,5.021436532,TCGA-DU-6408-01A,TCGA-DU-6408-01A-11D-1705-08,4,0.466063637,TCGA-DU-6408,LGG,23,FEMALE,WHITE,Oligodendroglioma,G3,1998,[Not Available],-8752,Dead,NA,NA,3470,[Not Available],NA,NA,NA,2097,Progressive Disease,1,3470,NA,3470,NA,NA,1,2097,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-5.132524456,2.051815218,TCGA-44-7672-01A,TCGA-44-7672-01A-11D-2063-08,0,NA,TCGA-44-7672,LUAD,52,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-19200,Alive,TUMOR FREE,719,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,719,0,719,0,719,0,719,NA,Stage IA,T1b,M0,LUAD.6,8
-0.302209457,4.515472358,TCGA-DH-5142-01A,TCGA-DH-5142-01A-01D-1468-08,4,0.54977089,TCGA-DH-5142,LGG,29,MALE,WHITE,Astrocytoma,G3,2008,[Not Available],-10678,Alive,WITH TUMOR,1943,NA,[Not Available],NA,NA,NA,1627,Stable Disease,0,1943,0,1943,NA,NA,1,1627,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.237062682,-1.732656426,TCGA-78-7537-01A,TCGA-78-7537-01A-11D-2063-08,1,0.409833463,TCGA-78-7537,LUAD,72,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2002,[Not Available],-26610,Dead,NA,NA,1622,[Not Available],NA,NA,NA,NA,[Not Available],1,1622,NA,1622,NA,NA,0,1622,NA,Stage IB,T2,M0,LUAD.4,6
-6.144940481,-1.684158398,TCGA-83-5908-01A,TCGA-83-5908-01A-21D-2284-08,0,NA,TCGA-83-5908,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-21760,Alive,TUMOR FREE,824,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,824,0,824,NA,NA,0,824,NA,Stage IA,T1,M0,NA,2
-4.983263683,1.36027451,TCGA-05-4417-01A,TCGA-05-4417-01A-22D-1855-08,0,NA,TCGA-05-4417,LUAD,51,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-18780,Alive,TUMOR FREE,455,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,455,0,455,NA,NA,0,455,NA,Stage IB,T2,M0,LUAD.6,10
8.65907449,-2.06901973,TCGA-CM-5344-01A,TCGA-CM-5344-01A-21D-1719-10,1,0.611684566,TCGA-CM-5344,COAD,39,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-14426,Alive,TUMOR FREE,670,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,670,0,670,NA,NA,0,670,NA,Stage IIIB,T3,M0,GI.CIN,1
-2.735851757,-4.341561308,TCGA-EI-6917-01A,TCGA-EI-6917-01A-11D-1924-10,0,NA,TCGA-EI-6917,READ,33,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-12113,Alive,TUMOR FREE,531,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,531,0,531,NA,NA,0,531,NA,Stage IIIA,T3,M0,GI.HM-SNV,10
8.868502119,-5.230948036,TCGA-FG-6691-01A,TCGA-FG-6691-01A-11D-1893-08,1,0.827632152,TCGA-FG-6691,LGG,23,FEMALE,WHITE,Astrocytoma,G2,2011,[Not Available],-8403,Alive,WITH TUMOR,1257,NA,[Not Available],NA,NA,NA,913,Complete Remission/Response,0,1257,0,1257,1,913,1,913,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
4.575933245,1.083310326,TCGA-50-5935-01A,TCGA-50-5935-01A-11D-1753-08,2,0.607071188,TCGA-50-5935,LUAD,86,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-31610,Dead,TUMOR FREE,653,653,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,653,0,653,0,653,0,653,NA,Stage IA,T1,M0,LUAD.4,5
8.86815866,-4.371748124,TCGA-CS-6669-01A,TCGA-CS-6669-01A-11D-1893-08,1,0.768713765,TCGA-CS-6669,LGG,26,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-9809,Alive,WITH TUMOR,1494,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1494,0,1494,NA,NA,0,1494,NA,NA,NA,NA,GBM_LGG.PA-like,1
-4.536664279,-1.846120424,TCGA-49-6767-01A,TCGA-49-6767-01A-11D-1855-08,8,0.360463261,TCGA-49-6767,LUAD,46,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-17108,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,677,0,677,NA,NA,0,677,NA,Stage IIB,T3,MX,LUAD.3,10
-6.040544307,3.53528675,TCGA-EB-A5VU-01A,TCGA-EB-A5VU-01A-21D-A32N-08,11,0.449554978,TCGA-EB-A5VU,SKCM,56,MALE,ASIAN,NA,[Not Available],2012,[Not Available],-20610,Dead,WITH TUMOR,NA,321,[Not Available],Locoregional Recurrence,NA,NA,217,[Not Available],1,321,1,321,NA,NA,1,217,NA,Stage IIIB,T4b,M0,NA,8
-0.282768794,5.23538561,TCGA-91-6847-01A,TCGA-91-6847-01A-11D-1945-08,4,0.468884868,TCGA-91-6847,LUAD,62,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2002,[Not Available],-22862,Alive,WITH TUMOR,842,NA,[Not Available],Distant Metastasis,NA,NA,772,Progressive Disease,0,842,0,842,NA,NA,1,772,NA,Stage IB,T2,MX,LUAD.3,6
-6.217195619,3.640464114,TCGA-44-2665-01A,TCGA-44-2665-01A-01D-A271-08,11,0.508599664,TCGA-44-2665,LUAD,55,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-20349,Alive,TUMOR FREE,1301,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1301,0,1301,NA,NA,0,1301,NA,Stage IIB,T2,M0,LUAD.5,8
9.038754114,-5.192140749,TCGA-HT-8113-01A,TCGA-HT-8113-01A-11D-2395-08,1,0.857126617,TCGA-HT-8113,LGG,49,FEMALE,BLACK OR AFRICAN AMERICAN,Oligodendroglioma,G2,2006,[Not Available],-18173,Alive,TUMOR FREE,900,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,900,0,900,0,900,0,900,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.003559651,-1.756996038,TCGA-69-7765-01A,TCGA-69-7765-01A-11D-2167-08,8,0.256177838,TCGA-69-7765,LUAD,56,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-20625,Alive,NA,165,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,165,0,165,NA,NA,0,165,NA,[Discrepancy],T4,MX,LUAD.3,10
-3.385072794,-3.061495895,TCGA-A6-6780-01A,TCGA-A6-6780-01A-11D-A270-10,8,0.427386956,TCGA-A6-6780,COAD,74,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-27250,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,612,0,612,0,612,0,612,NA,Stage IIA,T3,MX,NA,10
-5.265289226,2.672681785,TCGA-AF-6655-01A,TCGA-AF-6655-01A-11D-1826-10,12,0.271309722,TCGA-AF-6655,READ,66,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-24417,Alive,TUMOR FREE,609,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,609,0,609,0,609,0,609,NA,Stage IIIA,T2,M0,GI.CIN,8
-0.138087993,4.548099009,TCGA-FG-8191-01A,TCGA-FG-8191-01A-11D-2253-08,4,0.566085691,TCGA-FG-8191,LGG,30,MALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-11252,Alive,WITH TUMOR,992,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,992,0,992,NA,NA,0,992,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-1.896409686,2.030262569,TCGA-44-3396-01A,TCGA-44-3396-01A-01D-1553-08,0,NA,TCGA-44-3396,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-27073,Alive,TUMOR FREE,1130,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1130,0,1130,0,1130,0,1130,NA,Stage IIIA,T2,M0,LUAD.6,10
-4.915773806,1.081723313,TCGA-55-1595-01A,TCGA-55-1595-01A-01D-0969-08,0,NA,TCGA-55-1595,LUAD,74,FEMALE,ASIAN,Lung Adenocarcinoma,[Not Available],2004,[Not Available],NA,Alive,TUMOR FREE,1479,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1479,0,1479,0,1479,0,1479,NA,Stage IA,T1,M0,NA,10
-6.328821999,1.614998244,TCGA-DU-8165-01A,TCGA-DU-8165-01A-11D-2253-08,10,0.197501266,TCGA-DU-8165,LGG,60,FEMALE,WHITE,Oligodendroglioma,G3,2011,[Not Available],-21964,Alive,TUMOR FREE,582,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,582,0,582,NA,NA,0,582,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
-1.038285281,4.381083565,TCGA-44-2655-01A,TCGA-44-2655-01A-01D-1553-08,4,0.416062686,TCGA-44-2655,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-23854,Alive,TUMOR FREE,1324,NA,[Not Available],New Primary Tumor,NA,NA,1009,Complete Remission/Response,0,1324,0,1324,0,1324,1,1009,NA,Stage IA,T1,M0,LUAD.1,6
-3.575592471,-2.967517462,TCGA-55-1592-01A,TCGA-55-1592-01A-01D-0969-08,8,0.417205803,TCGA-55-1592,LUAD,65,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],NA,Dead,WITH TUMOR,NA,701,[Not Available],NA,NA,NA,452,Complete Remission/Response,1,701,1,701,1,452,1,452,NA,Stage IA,T2,M0,LUAD.2,10
-6.596064803,-1.251061837,TCGA-DU-7018-01A,TCGA-DU-7018-01A-11D-2024-08,7,0.218008744,TCGA-DU-7018,LGG,57,FEMALE,WHITE,Oligodendroglioma,G3,2006,[Not Available],-21019,Dead,WITH TUMOR,NA,933,[Not Available],NA,NA,NA,338,Progressive Disease,1,933,1,933,NA,NA,1,338,NA,NA,NA,NA,GBM_LGG.Codel,2
-3.483901556,-3.027478397,TCGA-44-7670-01A,TCGA-44-7670-01A-11D-2063-08,8,0.449322842,TCGA-44-7670,LUAD,47,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-17392,Alive,TUMOR FREE,882,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,882,0,882,0,882,0,882,NA,Stage IIA,T1b,M0,LUAD.2,10
-6.111366517,3.463132924,TCGA-55-8090-01A,TCGA-55-8090-01A-11D-2238-08,11,0.369073315,TCGA-55-8090,LUAD,80,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-29235,Dead,WITH TUMOR,NA,598,[Not Available],Distant Metastasis,NA,NA,548,Complete Remission/Response,1,598,1,598,1,548,1,548,NA,Stage IA,T1a,M0,NA,8
-5.250840942,-1.221514353,TCGA-EB-A44P-01A,TCGA-EB-A44P-01A-11D-A25O-08,0,NA,TCGA-EB-A44P,SKCM,58,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-21519,Alive,TUMOR FREE,741,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,741,0,741,NA,NA,0,741,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,2
9.092988407,-5.44814007,TCGA-DH-5141-01A,TCGA-DH-5141-01A-01D-1468-08,1,0.841638306,TCGA-DH-5141,LGG,32,MALE,WHITE,Oligodendroglioma,G3,2005,[Not Available],-11846,Alive,NA,968,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,968,0,968,NA,NA,0,968,NA,NA,NA,NA,GBM_LGG.Codel,1
-5.164229914,1.315054839,TCGA-05-4244-01A,TCGA-05-4244-01A-01D-1105-08,0,NA,TCGA-05-4244,LUAD,70,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2009,[Not Available],-25752,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IV,T2,M1,NA,10
-0.282735322,4.930366101,TCGA-86-8280-01A,TCGA-86-8280-01A-11D-2284-08,4,0.594021673,TCGA-86-8280,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-19977,Alive,TUMOR FREE,701,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,701,0,701,0,701,0,701,NA,Stage IIA,T2b,M0,NA,6
-8.074982621,1.869192869,TCGA-E9-A1RC-01A,TCGA-E9-A1RC-01A-11D-A159-09,9,0.524985294,TCGA-E9-A1RC,BRCA,56,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20795,Alive,TUMOR FREE,1224,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1224,0,1224,0,1224,0,1224,NA,Stage IIIC,T4b,M0,BRCA.LumA,7
-0.489791061,4.56906943,TCGA-CL-5918-01A,TCGA-CL-5918-01A-11D-1657-10,4,0.529147625,TCGA-CL-5918,READ,90,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-32873,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,218,0,218,0,218,0,218,NA,Stage IIA,T3,MX,GI.CIN,6
-2.866230663,-4.151103015,TCGA-AZ-6598-01A,TCGA-AZ-6598-01A-11D-1771-10,0,NA,TCGA-AZ-6598,COAD,77,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-28182,Dead,TUMOR FREE,NA,1503,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1503,0,1503,0,1503,0,1503,NA,Stage II,T3,MX,GI.HM-indel,10
4.315603433,1.179722847,TCGA-BH-A201-01A,TCGA-BH-A201-01A-11D-A14K-09,2,0.713071907,TCGA-BH-A201,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23423,Alive,TUMOR FREE,856,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,856,0,856,NA,NA,0,856,NA,Stage IA,T1,M0,BRCA.LumA,5
-6.453053567,-1.562221086,TCGA-AG-A014-01A,TCGA-AG-A014-01A-02W-A00K-09,7,0.148038149,TCGA-AG-A014,READ,86,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-31718,Alive,WITH TUMOR,485,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,485,0,485,NA,NA,0,485,NA,Stage I,T2,M0,NA,2
8.78261121,-4.897443588,TCGA-HT-8010-01A,TCGA-HT-8010-01A-11D-2395-08,1,0.737008235,TCGA-HT-8010,LGG,64,FEMALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-23680,Alive,TUMOR FREE,50,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,50,0,50,NA,NA,0,50,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.452225496,0.701101241,TCGA-78-7159-01A,TCGA-78-7159-01A-11D-2036-08,0,NA,TCGA-78-7159,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-22261,Alive,NA,1974,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1974,0,1974,0,1974,0,1974,NA,Stage IA,T1,M0,LUAD.2,10
-2.748346928,-4.340809369,TCGA-DU-6392-01A,TCGA-DU-6392-01A-11D-1705-08,0,NA,TCGA-DU-6392,LGG,35,FEMALE,WHITE,Astrocytoma,G3,1993,[Not Available],-12836,Alive,TUMOR FREE,6423,NA,[Not Available],NA,NA,NA,950,Progressive Disease,0,6423,0,6423,NA,NA,1,950,NA,NA,NA,NA,GBM_LGG.PA-like,10
-4.568218315,-1.665342753,TCGA-55-8616-01A,TCGA-55-8616-01A-11D-2393-08,8,0.315895686,TCGA-55-8616,LUAD,58,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21225,Alive,TUMOR FREE,48,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,48,0,48,NA,NA,0,48,NA,Stage IB,T2a,M0,NA,10
-4.25853174,-1.825796976,TCGA-91-6829-01A,TCGA-91-6829-01A-21D-1855-08,8,0.4850207,TCGA-91-6829,LUAD,78,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-28841,Dead,TUMOR FREE,NA,1258,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1258,0,1258,NA,NA,0,1258,NA,Stage IB,T2,MX,LUAD.2,10
0.155069618,5.190475236,TCGA-DU-6542-01A,TCGA-DU-6542-01A-11D-1893-08,4,0.691134188,TCGA-DU-6542,LGG,25,MALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-9380,Alive,WITH TUMOR,73,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,73,0,73,NA,NA,0,73,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.069557399,4.703925116,TCGA-44-6779-01A,TCGA-44-6779-01A-11D-1855-08,4,0.55303595,TCGA-44-6779,LUAD,50,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-18469,Dead,WITH TUMOR,NA,500,[Not Available],NA,NA,NA,232,Progressive Disease,1,500,1,500,NA,NA,1,232,NA,Stage IIB,T2,MX,LUAD.6,4
-4.081342371,-1.246066297,TCGA-05-4390-01A,TCGA-05-4390-01A-02D-1753-08,8,0.096673566,TCGA-05-4390,LUAD,58,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],2005,[Not Available],-21430,Alive,TUMOR FREE,1126,NA,[Not Available],NA,NA,NA,395,Progressive Disease,0,1126,0,1126,NA,NA,1,395,NA,Stage IB,T2,M0,LUAD.2,10
-4.547416795,0.508271973,TCGA-99-8028-01A,TCGA-99-8028-01A-11D-2238-08,0,NA,TCGA-99-8028,LUAD,50,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-18542,Alive,TUMOR FREE,1118,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1118,0,1118,0,1118,0,1118,NA,Stage IA,T1a,M0,NA,10
-5.531154513,-1.424823378,TCGA-78-7152-01A,TCGA-78-7152-01A-11D-2036-08,8,0,TCGA-78-7152,LUAD,65,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-23782,Dead,WITH TUMOR,NA,1215,[Not Available],NA,NA,NA,1202,Complete Remission/Response,1,1215,1,1215,1,1202,1,1202,NA,Stage IB,T2,M0,LUAD.4,10
-4.527354008,0.826365822,TCGA-86-A456-01A,TCGA-86-A456-01A-11D-A24D-08,0,NA,TCGA-86-A456,LUAD,78,FEMALE,ASIAN,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28533,Alive,TUMOR FREE,896,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,896,0,896,0,896,0,896,NA,Stage IA,T1a,M0,NA,10
9.337118645,-5.160619407,TCGA-E2-A15O-01A,TCGA-E2-A15O-01A-11D-A10Y-09,1,0.766635787,TCGA-E2-A15O,BRCA,89,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32583,Alive,TUMOR FREE,1545,NA,[Not Available],Locoregional Recurrence,NA,NA,1210,[Not Available],0,1545,0,1545,1,1210,1,1210,NA,Stage I,T1c,M0,BRCA.LumA,1
-7.869688876,2.059737039,TCGA-AA-3522-01A,TCGA-AA-3522-01A-01W-0831-10,9,0.598477614,TCGA-AA-3522,COAD,67,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-24653,Alive,TUMOR FREE,1127,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1127,0,1127,0,1127,0,1127,NA,Stage IIA,T3,M0,NA,7
-8.322939929,2.189310038,TCGA-D8-A27L-01A,TCGA-D8-A27L-01A-11D-A16D-09,9,0.535795626,TCGA-D8-A27L,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18025,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,499,0,499,0,499,0,499,NA,Stage IIIA,T1c,M0,BRCA.LumA,7
-5.162794183,2.540966266,TCGA-F5-6571-01A,TCGA-F5-6571-01A-12D-1826-10,12,0.240391108,TCGA-F5-6571,READ,62,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-22666,Alive,WITH TUMOR,1288,NA,[Not Available],Metastatic,NA,NA,122,Complete Remission/Response,0,1288,0,1288,1,122,1,122,NA,Stage IIA,T3,M0,GI.CIN,8
-6.656194419,-1.479786313,TCGA-DM-A1D0-01A,TCGA-DM-A1D0-01A-11D-A152-10,0,NA,TCGA-DM-A1D0,COAD,79,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-28875,Alive,NA,3974,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3974,0,3974,NA,NA,0,3974,NA,Stage IIA,T3,M0,GI.CIN,2
0.320963965,3.559065947,TCGA-26-1442-01A,TCGA-26-1442-01A-01D-1696-08,4,0.23537079,TCGA-26-1442,GBM,43,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-15950,Alive,WITH TUMOR,953,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,953,0,953,NA,NA,0,953,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
1.995524898,1.832357511,TCGA-06-0157-01A,TCGA-06-0157-01A-01D-1491-08,3,0.456260619,TCGA-06-0157,GBM,63,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-23128,Dead,WITH TUMOR,97,97,[Not Available],NA,NA,NA,NA,[Not Available],1,97,1,97,NA,NA,1,97,NA,NA,NA,NA,GBM_LGG.NA,3
7.628771094,-3.320493945,TCGA-BH-A0B1-01A,TCGA-BH-A0B1-01A-12W-A071-09,2,0.419502022,TCGA-BH-A0B1,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315,Alive,TUMOR FREE,1148,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1148,0,1148,0,1148,0,1148,NA,Stage IIB,T2,M0,BRCA.LumA,1
-8.201457545,2.07132764,TCGA-BH-A0H9-01A,TCGA-BH-A0H9-01A-11W-A071-09,9,0.373750608,TCGA-BH-A0H9,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25289,Alive,TUMOR FREE,1247,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1247,0,1247,0,1247,0,1247,NA,Stage IIA,T2,M0,BRCA.LumA,7
-7.915376181,2.144111177,TCGA-A2-A3KC-01A,TCGA-A2-A3KC-01A-11D-A20S-09,9,0.374618927,TCGA-A2-A3KC,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20401,Alive,TUMOR FREE,1102,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1102,0,1102,0,1102,0,1102,NA,Stage IIB,T2,M0,BRCA.LumA,7
-6.373653769,1.410389703,TCGA-BH-A1FE-01A,TCGA-BH-A1FE-01A-11D-A13L-09,10,0.21110163,TCGA-BH-A1FE,BRCA,31,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-11650,Dead,WITH TUMOR,NA,2273,[Not Available],NA,NA,NA,NA,[Not Available],1,2273,1,2273,NA,NA,1,2273,NA,Stage IIB,T2,M0,BRCA.LumA,7
9.20209734,-5.055598149,TCGA-E9-A22A-01A,TCGA-E9-A22A-01A-11D-A159-09,1,0.847219666,TCGA-E9-A22A,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27288,Alive,TUMOR FREE,1189,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1189,0,1189,0,1189,0,1189,NA,Stage IIA,T2,M0,BRCA.LumB,1
-6.333205122,1.337969401,TCGA-BH-A0BC-01A,TCGA-BH-A0BC-01A-22D-A099-09,10,0.113409353,TCGA-BH-A0BC,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,974,0,974,0,974,0,974,NA,Stage IIIC,T2,M0,BRCA.LumA,7
-3.642040988,-2.418944432,TCGA-GM-A2D9-01A,TCGA-GM-A2D9-01A-11D-A18P-09,8,0.44661024,TCGA-GM-A2D9,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25490,Dead,WITH TUMOR,NA,1812,[Not Available],Distant Metastasis,Bone,NA,536,[Not Available],1,1812,1,1812,1,536,1,536,NA,Stage I,T1c,M0,BRCA.LumA,10
-0.012392932,4.885436175,TCGA-E9-A243-01A,TCGA-E9-A243-01A-21D-A167-09,4,0.657471678,TCGA-E9-A243,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-19035,Alive,WITH TUMOR,612,NA,[Not Available],Distant Metastasis,Bone,NA,305,[Not Available],0,612,0,612,1,305,1,305,NA,Stage IIA,T2,M0,BRCA.Basal,6
9.411876095,-4.996064966,TCGA-DU-6404-01A,TCGA-DU-6404-01A-11D-1705-08,1,0.826183819,TCGA-DU-6404,LGG,24,FEMALE,WHITE,Oligodendroglioma,G3,2000,[Not Available],-9021,Dead,WITH TUMOR,NA,4068,[Not Available],NA,NA,NA,1154,Progressive Disease,1,4068,1,4068,NA,NA,1,1154,NA,NA,NA,NA,GBM_LGG.PA-like,1
0.020482914,5.225333092,TCGA-DB-5280-01A,TCGA-DB-5280-01A-01D-1468-08,4,0.701753961,TCGA-DB-5280,LGG,43,MALE,WHITE,Oligoastrocytoma,G2,2007,[Not Available],-15836,Alive,TUMOR FREE,1112,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1112,0,1112,0,1112,0,1112,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.967470578,4.304432987,TCGA-AR-A0TV-01A,TCGA-AR-A0TV-01A-21D-A099-09,4,0.382979956,TCGA-AR-A0TV,BRCA,66,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24279,Alive,TUMOR FREE,2288,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2288,0,2288,0,2288,0,2288,NA,Stage IIA,T2,M0,BRCA.LumB,6
-0.924676084,4.503729797,TCGA-78-7535-01A,TCGA-78-7535-01A-11D-2063-08,4,0.441350216,TCGA-78-7535,LUAD,45,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2000,[Not Available],-16571,Dead,WITH TUMOR,NA,949,[Not Available],NA,NA,NA,809,Stable Disease,1,949,1,949,NA,NA,1,809,NA,Stage IB,T2,M0,LUAD.3,6
-6.490094293,-1.31374737,TCGA-E2-A14V-01A,TCGA-E2-A14V-01A-11D-A12B-09,7,0.201101997,TCGA-E2-A14V,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19643,Alive,TUMOR FREE,1042,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1042,0,1042,0,1042,0,1042,NA,Stage IIB,T2,M0,BRCA.Her2,2
-8.068636015,2.118112061,TCGA-A2-A0T4-01A,TCGA-A2-A0T4-01A-31D-A099-09,9,0.550594744,TCGA-A2-A0T4,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22849,Alive,TUMOR FREE,624,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,624,0,624,0,624,0,624,NA,Stage IIA,T2,M0,BRCA.LumA,7
-1.919356854,1.090912109,TCGA-A8-A06Y-01A,TCGA-A8-A06Y-01A-21W-A019-09,5,0.662158646,TCGA-A8-A06Y,BRCA,66,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24442,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,791,[Not Available],0,791,0,791,1,791,1,791,NA,Stage IIA,T2,M0,BRCA.LumA,4
-5.164528883,2.749318854,TCGA-AF-3913-01A,TCGA-AF-3913-01A-02W-1073-09,12,0.228592808,TCGA-AF-3913,READ,60,MALE,BLACK OR AFRICAN AMERICAN,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-21970,Dead,WITH TUMOR,NA,316,[Not Available],NA,NA,NA,NA,[Not Available],1,316,1,316,NA,NA,1,316,NA,Stage IV,T3,M1,NA,8
0.338614176,4.793829775,TCGA-CM-6167-01A,TCGA-CM-6167-01A-11D-1650-10,4,0.402940624,TCGA-CM-6167,COAD,57,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-21031,Alive,TUMOR FREE,456,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,456,0,456,NA,NA,0,456,NA,Stage IIIC,T3,M0,GI.CIN,6
-0.06326952,5.03808569,TCGA-FG-8185-01A,TCGA-FG-8185-01A-11D-2253-08,4,0.604300741,TCGA-FG-8185,LGG,37,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-13621,Alive,TUMOR FREE,433,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,433,0,433,0,433,0,433,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
1.119902915,3.512922221,TCGA-DU-7013-01A,TCGA-DU-7013-01A-11D-2024-08,0,NA,TCGA-DU-7013,LGG,59,MALE,WHITE,Astrocytoma,G3,2001,[Not Available],-21824,Dead,WITH TUMOR,NA,269,[Not Available],NA,NA,NA,187,Progressive Disease,1,269,1,269,NA,NA,1,187,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-0.440409721,3.798759274,TCGA-12-0818-01A,TCGA-12-0818-01A-01W-0424-08,4,0.144771859,TCGA-12-0818,GBM,45,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1994,[Not Available],-16666,Dead,NA,2791,2791,[Not Available],NA,NA,NA,NA,[Not Available],1,2791,NA,2791,NA,NA,0,2791,NA,NA,NA,NA,NA,6
0.240759569,5.107430373,TCGA-DU-8166-01A,TCGA-DU-8166-01A-11D-2253-08,4,0.604134201,TCGA-DU-8166,LGG,29,FEMALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-10641,Alive,WITH TUMOR,516,NA,[Not Available],NA,NA,NA,193,Progressive Disease,0,516,0,516,NA,NA,1,193,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.989823982,2.201121639,TCGA-HT-7874-01A,TCGA-HT-7874-01A-11D-2395-08,9,0.606002062,TCGA-HT-7874,LGG,41,FEMALE,WHITE,Oligodendroglioma,G3,2008,[Not Available],-15045,Alive,TUMOR FREE,1130,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1130,0,1130,0,1130,0,1130,NA,NA,NA,NA,GBM_LGG.Codel,7
-0.674507795,5.075467321,TCGA-12-0619-01A,TCGA-12-0619-01A-01D-1492-08,4,0.481119237,TCGA-12-0619,GBM,60,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-21920,Dead,WITH TUMOR,316,1062,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],203,[Not Available],1,1062,1,1062,NA,NA,1,203,NA,NA,NA,NA,GBM_LGG.NA,6
-7.88743531,2.31864781,TCGA-86-7714-01A,TCGA-86-7714-01A-12D-2167-08,9,0.452546297,TCGA-86-7714,LUAD,61,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22619,Dead,WITH TUMOR,NA,625,[Not Available],NA,NA,NA,NA,Stable Disease,1,625,1,625,NA,NA,1,625,NA,Stage IIIA,T1b,M0,LUAD.4,7
0.007881804,5.139167494,TCGA-AO-A03R-01A,TCGA-AO-A03R-01A-21W-A050-09,4,0.668043156,TCGA-AO-A03R,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20930,Alive,TUMOR FREE,2091,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2091,0,2091,0,2091,0,2091,NA,Stage IIB,T2,M0,BRCA.Normal,6
9.404709394,-5.562239617,TCGA-E9-A24A-01A,TCGA-E9-A24A-01A-11D-A167-09,1,0.862908834,TCGA-E9-A24A,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25370,Alive,TUMOR FREE,747,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,747,0,747,0,747,0,747,NA,Stage IIA,T1c,M0,BRCA.LumA,1
1.191421064,3.472985657,TCGA-CK-5912-01A,TCGA-CK-5912-01A-11D-1650-10,0,NA,TCGA-CK-5912,COAD,81,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2006,[Not Available],-29938,Dead,TUMOR FREE,NA,1493,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1493,0,1493,0,1493,0,1493,NA,Stage I,T2,MX,GI.CIN,1
-1.508804344,4.103857868,TCGA-BH-A0RX-01A,TCGA-BH-A0RX-01A-21D-A099-09,4,0.165998149,TCGA-BH-A0RX,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21857,Alive,TUMOR FREE,170,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,170,0,170,0,170,0,170,NA,Stage IIA,T2,M0,BRCA.Basal,6
-1.943400077,1.102424882,TCGA-D8-A140-01A,TCGA-D8-A140-01A-11D-A10Y-09,5,0.624911364,TCGA-D8-A140,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22900,Alive,TUMOR FREE,403,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,403,0,403,0,403,0,403,NA,Stage IIB,T2,M0,BRCA.LumA,4
0.14853032,4.619988868,TCGA-DY-A1DG-01A,TCGA-DY-A1DG-01A-11D-A152-10,4,0.445844577,TCGA-DY-A1DG,READ,75,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2000,[Not Available],-27396,Dead,NA,NA,1566,[Not Available],NA,NA,NA,592,[Not Available],1,1566,NA,1566,NA,NA,1,592,NA,Stage IVA,T3,M1,GI.CIN,6
9.44852994,-2.069366028,TCGA-74-6581-01A,TCGA-74-6581-01A-11D-1845-08,1,0.725998277,TCGA-74-6581,GBM,77,MALE,[Not Available],Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-28263,Alive,WITH TUMOR,250,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,250,0,250,NA,NA,0,250,NA,NA,NA,NA,NA,1
-0.100785672,5.208306735,TCGA-06-5408-01A,TCGA-06-5408-01A-01D-1696-08,4,0.653088151,TCGA-06-5408,GBM,54,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-20063,Dead,WITH TUMOR,342,357,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],158,[Not Available],1,357,1,357,NA,NA,1,158,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
-7.607802967,-2.3046521,TCGA-75-7025-01A,TCGA-75-7025-01A-12D-1945-08,6,0.495252684,TCGA-75-7025,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,3305,NA,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,1481,Complete Remission/Response,0,3305,0,3305,1,1481,1,1481,NA,Stage IB,T2,M0,LUAD.5,2
-7.331169745,-2.42370399,TCGA-06-0129-01A,TCGA-06-0129-01A-01D-1490-08,6,0.273502808,TCGA-06-0129,GBM,30,MALE,ASIAN,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-11284,Dead,WITH TUMOR,989,1024,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],148,[Not Available],1,1024,1,1024,NA,NA,1,148,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,2
-5.96369053,1.929222611,TCGA-A6-2684-01A,TCGA-A6-2684-01A-01D-A270-10,0,NA,TCGA-A6-2684,COAD,75,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27708,Alive,TUMOR FREE,1127,NA,[Not Available],Locoregional Disease,NA,NA,976,[Not Available],0,1127,0,1127,NA,NA,1,976,NA,Stage I,T2,M0,NA,7
-5.244416142,1.971113543,TCGA-AF-2689-01A,TCGA-AF-2689-01A-01D-1989-10,0,NA,TCGA-AF-2689,READ,41,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2009,[Not Available],-15082,Dead,WITH TUMOR,NA,1201,[Not Available],NA,NA,NA,301,[Not Available],1,1201,1,1201,NA,NA,1,301,NA,Stage IV,T3,M1,NA,9
-5.920685308,-1.678536682,TCGA-AR-A24Q-01A,TCGA-AR-A24Q-01A-12D-A167-09,0,NA,TCGA-AR-A24Q,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18084,Alive,TUMOR FREE,3172,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3172,0,3172,0,3172,0,3172,NA,Stage IIB,T3,M0,BRCA.Basal,3
0.032744008,5.157413152,TCGA-B6-A0X1-01A,TCGA-B6-A0X1-01A-11D-A10G-09,4,0.580967306,TCGA-B6-A0X1,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1994,Indeterminate (neither Pre or Postmenopausal),-17624,Dead,TUMOR FREE,NA,7455,[Not Available],Distant Metastasis,Brain,NA,490,[Not Available],1,7455,0,7455,1,490,1,490,NA,[Discrepancy],T2,M1,BRCA.Basal,6
9.957679375,-2.801771977,TCGA-41-2571-01A,TCGA-41-2571-01A-01D-1495-08,1,0.760207224,TCGA-41-2571,GBM,89,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-32612,Dead,WITH TUMOR,26,26,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],26,[Not Available],1,26,1,26,NA,NA,1,26,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-3.886335889,-1.975597161,TCGA-86-8585-01A,TCGA-86-8585-01A-11D-2393-08,8,0.339545873,TCGA-86-8585,LUAD,57,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20918,Alive,TUMOR FREE,353,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,353,0,353,0,353,0,353,NA,Stage IB,T2a,M0,NA,10
-8.160187288,2.027961606,TCGA-D8-A1JU-01A,TCGA-D8-A1JU-01A-11D-A13L-09,9,0.547567693,TCGA-D8-A1JU,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18733,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,447,0,447,0,447,0,447,NA,Stage IA,T1c,M0,BRCA.LumA,7
-0.165201875,3.172785165,TCGA-F5-6864-01A,TCGA-F5-6864-01A-11D-1924-10,4,0.294218737,TCGA-F5-6864,READ,74,FEMALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-27058,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage IIIB,T3,M0,GI.CIN,3
0.003824006,4.004891759,TCGA-06-1087-01A,TCGA-06-1087-01A-02W-0611-08,4,0.363342856,TCGA-06-1087,GBM,75,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-27658,Dead,WITH TUMOR,109,123,[Not Available],Recurrence,[Not Applicable],[Not Applicable],109,[Not Available],1,123,1,123,NA,NA,1,109,NA,NA,NA,NA,NA,6
-5.030847163,1.198731173,TCGA-DM-A0XD-01A,TCGA-DM-A0XD-01A-12D-A152-10,0,NA,TCGA-DM-A0XD,COAD,65,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-23966,Dead,NA,NA,743,[Not Available],NA,NA,NA,484,[Not Available],1,743,NA,743,NA,NA,1,484,NA,Stage IIA,T3,M0,GI.CIN,9
-7.758571274,-2.51006786,TCGA-AO-A1KP-01A,TCGA-AO-A1KP-01A-11D-A13L-09,6,0.541930354,TCGA-AO-A1KP,BRCA,77,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28247,Alive,TUMOR FREE,2953,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2953,0,2953,0,2953,0,2953,NA,Stage IIA,T1,M0,BRCA.LumB,2
8.74832284,-5.000243209,TCGA-A2-A3KD-01A,TCGA-A2-A3KD-01A-12D-A20S-09,1,0.817529448,TCGA-A2-A3KD,BRCA,47,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17372,Alive,TUMOR FREE,1206,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1206,0,1206,NA,NA,0,1206,NA,Stage IIIA,T3,M0,BRCA.LumA,1
-7.342395888,2.29890174,TCGA-CM-6678-01A,TCGA-CM-6678-01A-11D-1835-10,9,0.208393993,TCGA-CM-6678,COAD,63,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-23070,Alive,WITH TUMOR,335,NA,[Not Available],Metastatic,NA,NA,0,[Not Available],0,335,0,335,NA,NA,1,0,NA,Stage IVA,T4a,M1a,GI.CIN,7
-5.198190082,1.299089261,TCGA-55-7911-01A,TCGA-55-7911-01A-11D-2167-08,0,NA,TCGA-55-7911,LUAD,70,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25746,Alive,TUMOR FREE,537,NA,[Not Available],New Primary Tumor,NA,NA,515,Complete Remission/Response,0,537,0,537,0,537,1,515,NA,Stage IA,T1a,MX,LUAD.4,10
-7.147239155,-2.512756827,TCGA-28-5216-01A,TCGA-28-5216-01A-01D-1486-08,6,0.23383346,TCGA-28-5216,GBM,52,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-19239,Alive,TUMOR FREE,415,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,415,0,415,NA,NA,0,415,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,2
0.223511858,4.967599447,TCGA-EI-6509-01A,TCGA-EI-6509-01A-11D-1733-10,4,0.666906815,TCGA-EI-6509,READ,53,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2010,[Not Available],-19666,Alive,WITH TUMOR,517,NA,[Not Available],Metastatic,NA,NA,90,[Not Available],0,517,0,517,NA,NA,1,90,NA,Stage IIIC,T3,M0,GI.CIN,6
8.462632777,-3.483202724,TCGA-06-0126-01A,TCGA-06-0126-01A-01D-1490-08,1,0.646646202,TCGA-06-0126,GBM,86,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2001,[Not Available],-31627,Dead,NA,3,211,[Not Available],NA,NA,NA,NA,[Unknown],1,211,NA,211,NA,NA,0,211,NA,NA,NA,NA,NA,1
-7.968840858,2.259551954,TCGA-A8-A0A6-01A,TCGA-A8-A0A6-01A-12W-A071-09,9,0.532671689,TCGA-A8-A0A6,BRCA,64,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,640,0,640,0,640,0,640,NA,Stage IIIC,T2,M0,BRCA.LumA,7
9.042687066,-5.360834749,TCGA-A2-A0ER-01A,TCGA-A2-A0ER-01A-21W-A050-09,1,0.843429408,TCGA-A2-A0ER,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021,Alive,TUMOR FREE,2263,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2263,0,2263,0,2263,0,2263,NA,Stage IB,T1c,M0,BRCA.LumA,1
9.18271068,-5.357586421,TCGA-06-6700-01A,TCGA-06-6700-01A-12D-1845-08,1,0.859631108,TCGA-06-6700,GBM,76,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-27850,Alive,WITH TUMOR,145,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,145,0,145,NA,NA,0,145,NA,NA,NA,NA,NA,1
-3.959654289,-2.020497327,TCGA-75-6214-01A,TCGA-75-6214-01A-41D-1945-08,8,0.480230123,TCGA-75-6214,LUAD,NA,FEMALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Dead,WITH TUMOR,NA,1115,[Not Available],Distant Metastasis,NA,NA,419,Complete Remission/Response,1,1115,1,1115,1,419,1,419,NA,Stage IIIA,T2,M0,LUAD.2,10
-7.235892518,1.437323459,TCGA-BH-A0BD-01A,TCGA-BH-A0BD-01A-11W-A050-09,0,NA,TCGA-BH-A0BD,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17275,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,554,0,554,0,554,0,554,NA,Stage IIA,T1c,M0,BRCA.LumB,7
-8.001541025,1.927221211,TCGA-BH-A0BO-01A,TCGA-BH-A0BO-01A-23D-A12B-09,9,0.525153065,TCGA-BH-A0BO,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19767,Alive,TUMOR FREE,2197,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2197,0,2197,0,2197,0,2197,NA,Stage I,T1b,M0,BRCA.LumA,7
9.550122027,-4.447875786,TCGA-AR-A0TT-01A,TCGA-AR-A0TT-01A-31D-A099-09,1,0.730353424,TCGA-AR-A0TT,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19679,Alive,TUMOR FREE,3316,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3316,0,3316,0,3316,0,3316,NA,Stage IIIA,T2,M0,BRCA.LumB,1
-7.691278364,-2.509745597,TCGA-E2-A14Q-01A,TCGA-E2-A14Q-01A-11D-A12B-09,6,0.540979599,TCGA-E2-A14Q,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18507,Alive,TUMOR FREE,1163,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1163,0,1163,0,1163,0,1163,NA,Stage IIB,T2,M0,BRCA.LumA,2
-3.979086154,-2.204786545,TCGA-50-5933-01A,TCGA-50-5933-01A-11D-1753-08,8,0.368169335,TCGA-50-5933,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-26377,Dead,TUMOR FREE,2370,2393,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2393,0,2393,0,2393,0,2393,NA,Stage IIIB,T4,M0,LUAD.3,10
4.591916559,0.973747198,TCGA-14-1455-01A,TCGA-14-1455-01A-01W-0643-08,2,0.7181123,TCGA-14-1455,GBM,61,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-22562,Dead,WITH TUMOR,28,28,[Not Available],NA,NA,NA,NA,[Not Available],1,28,1,28,NA,NA,1,28,NA,NA,NA,NA,NA,5
-7.940603301,2.235036044,TCGA-19-2619-01A,TCGA-19-2619-01A-01D-1495-08,9,0.484823916,TCGA-19-2619,GBM,55,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-20159,Alive,WITH TUMOR,294,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],146,[Not Available],0,294,0,294,NA,NA,1,146,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
8.963042249,-3.191558573,TCGA-AR-A1AR-01A,TCGA-AR-A1AR-01A-31D-A135-09,1,0.738991015,TCGA-AR-A1AR,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18482,Dead,WITH TUMOR,NA,524,[Not Available],New Primary Tumor,"Other, specify",Breast,268,[Not Available],1,524,1,524,1,268,1,268,NA,Stage IIIA,T1,M0,BRCA.Basal,1
-7.783281731,2.058695195,TCGA-D8-A27P-01A,TCGA-D8-A27P-01A-11D-A16D-09,9,0.294494619,TCGA-D8-A27P,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23576,Alive,TUMOR FREE,49,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,49,0,49,0,49,0,49,NA,Stage IA,T1c,M0,BRCA.LumA,7
9.547620595,-5.125944735,TCGA-B6-A0X4-01A,TCGA-B6-A0X4-01A-11D-A10G-09,1,0.778497028,TCGA-B6-A0X4,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22688,Dead,WITH TUMOR,NA,860,[Not Available],Distant Metastasis,Bone,NA,716,[Not Available],1,860,1,860,1,716,1,716,NA,Stage IIB,T2,M0,BRCA.LumA,1
-4.910143649,1.290594115,TCGA-75-7027-01A,TCGA-75-7027-01A-11D-1945-08,0,NA,TCGA-75-7027,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],NA,[Not Available],NA,Alive,TUMOR FREE,3059,NA,[Not Available],Locoregional Recurrence,NA,NA,2949,Complete Remission/Response,0,3059,0,3059,1,2949,1,2949,NA,Stage IB,T2,M0,LUAD.2,10
-0.172732213,4.586673263,TCGA-73-4676-01A,TCGA-73-4676-01A-01D-1753-08,4,0.558909298,TCGA-73-4676,LUAD,45,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-16746,Dead,WITH TUMOR,NA,281,[Not Available],NA,NA,NA,NA,[Unknown],1,281,1,281,NA,NA,1,281,NA,Stage IIA,T2a,M0,LUAD.3,6
9.829755695,-1.712296128,TCGA-BH-A0HO-01A,TCGA-BH-A0HO-01A-11W-A050-09,1,0.867876935,TCGA-BH-A0HO,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17710,Alive,TUMOR FREE,76,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,76,0,76,0,76,0,76,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-5.81002152,1.421231326,TCGA-41-5651-01A,TCGA-41-5651-01A-01D-1696-08,10,0.070633012,TCGA-41-5651,GBM,59,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-21698,Dead,WITH TUMOR,NA,460,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],210,[Not Available],1,460,1,460,NA,NA,1,210,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-6.542553559,1.941094846,TCGA-06-2566-01A,TCGA-06-2566-01A-01W-0837-08,0,NA,TCGA-06-2566,GBM,23,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-8428,Dead,WITH TUMOR,182,182,[Not Available],NA,NA,NA,NA,[Not Available],1,182,1,182,NA,NA,1,182,NA,NA,NA,NA,NA,9
-7.270318138,2.711291124,TCGA-12-0820-01A,TCGA-12-0820-01A-01W-0424-08,0,NA,TCGA-12-0820,GBM,40,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1997,[Not Available],-14878,Dead,WITH TUMOR,562,562,[Not Available],Recurrence,[Not Applicable],[Not Applicable],272,[Not Available],1,562,1,562,NA,NA,1,272,NA,NA,NA,NA,NA,7
-7.662413984,2.078324284,TCGA-E9-A1RE-01A,TCGA-E9-A1RE-01A-11D-A159-09,9,0.482675451,TCGA-E9-A1RE,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27392,Alive,TUMOR FREE,1419,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1419,0,1419,0,1419,0,1419,NA,Stage IIIA,T2,M0,BRCA.LumB,7
8.684927102,-3.739549495,TCGA-A8-A09K-01A,TCGA-A8-A09K-01A-11W-A019-09,1,0.657152961,TCGA-A8-A09K,BRCA,68,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24960,Alive,TUMOR FREE,912,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,912,0,912,0,912,0,912,NA,Stage IIA,T1c,M0,NA,1
0.498519084,2.243550355,TCGA-A2-A0CV-01A,TCGA-A2-A0CV-01A-31D-A10Y-09,0,NA,TCGA-A2-A0CV,BRCA,41,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15289,Alive,TUMOR FREE,3011,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3011,0,3011,0,3011,0,3011,NA,Stage IIB,T2,M0,BRCA.LumA,6
-5.356551442,1.272626077,TCGA-E2-A1IN-01A,TCGA-E2-A1IN-01A-11D-A13L-09,0,NA,TCGA-E2-A1IN,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199,Alive,TUMOR FREE,675,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,675,0,675,0,675,0,675,NA,Stage I,T1c,M0,BRCA.LumA,9
9.361505152,-5.094652097,TCGA-BH-A18N-01A,TCGA-BH-A18N-01A-11D-A12B-09,1,0.826470202,TCGA-BH-A18N,BRCA,88,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-32404,Dead,NA,NA,1148,[Not Available],NA,NA,NA,NA,[Not Available],1,1148,NA,1148,0,1148,0,1148,NA,Stage IIA,T2,M0,BRCA.LumA,1
-7.604652444,1.84960573,TCGA-E2-A1B4-01A,TCGA-E2-A1B4-01A-11D-A12Q-09,9,0.543841707,TCGA-E2-A1B4,BRCA,74,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27241,Dead,TUMOR FREE,NA,1004,[Not Available],NA,NA,NA,NA,[Not Available],1,1004,0,1004,0,1004,0,1004,NA,Stage IIIA,T1c,M0,BRCA.LumA,7
-0.690978814,2.219855846,TCGA-E2-A1LB-01A,TCGA-E2-A1LB-01A-11D-A142-09,0,NA,TCGA-E2-A1LB,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15283,Alive,TUMOR FREE,2306,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2306,0,2306,0,2306,0,2306,NA,Stage IIB,T2,M0,BRCA.Her2,1
0.299850225,3.512265681,TCGA-D8-A1XW-01A,TCGA-D8-A1XW-01A-11D-A14K-09,4,0.216233567,TCGA-D8-A1XW,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19478,Alive,TUMOR FREE,1309,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1309,0,1309,0,1309,0,1309,NA,Stage IIA,T2,M0,BRCA.Normal,3
-0.026633879,2.817325865,TCGA-E2-A1B1-01A,TCGA-E2-A1B1-01A-21D-A12Q-09,4,0.073902927,TCGA-E2-A1B1,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16603,Alive,TUMOR FREE,2653,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2653,0,2653,0,2653,0,2653,NA,Stage IIB,T2,M0,BRCA.LumA,3
9.026540691,-5.736665793,TCGA-B6-A0RM-01A,TCGA-B6-A0RM-01A-11D-A099-09,1,0.804293376,TCGA-B6-A0RM,BRCA,57,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1993,Indeterminate (neither Pre or Postmenopausal),-21047,Dead,TUMOR FREE,NA,2373,[Not Available],NA,NA,NA,NA,[Not Available],1,2373,0,2373,NA,NA,0,2373,NA,Stage X,TX,MX,BRCA.LumA,1
-7.825812224,2.11063538,TCGA-D8-A1JE-01A,TCGA-D8-A1JE-01A-11D-A13L-09,9,0.342845163,TCGA-D8-A1JE,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22683,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,575,0,575,0,575,0,575,NA,Stage IIA,T1c,M0,BRCA.LumB,7
-0.781104901,3.884820224,TCGA-E9-A1ND-01A,TCGA-E9-A1ND-01A-11D-A142-09,4,0.397955391,TCGA-E9-A1ND,BRCA,75,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27400,Alive,TUMOR FREE,1266,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1266,0,1266,0,1266,0,1266,NA,Stage IIB,T2,M0,BRCA.Basal,5
-5.988186206,1.54458528,TCGA-AR-A1AO-01A,TCGA-AR-A1AO-01A-11D-A12Q-09,0,NA,TCGA-AR-A1AO,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17332,Alive,TUMOR FREE,2618,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2618,0,2618,0,2618,0,2618,NA,Stage IIA,T1,M0,BRCA.Normal,7
1.925640117,1.90931506,TCGA-BH-A1FG-01A,TCGA-BH-A1FG-01A-11D-A13L-09,3,0.61414972,TCGA-BH-A1FG,BRCA,88,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32295,Dead,NA,NA,3736,[Not Available],NA,NA,NA,NA,[Not Available],1,3736,NA,3736,NA,NA,0,3736,NA,Stage I,T1c,M0,BRCA.LumA,3
8.913701089,-4.640249138,TCGA-A2-A0CQ-01A,TCGA-A2-A0CQ-01A-21W-A050-09,1,0.810037839,TCGA-A2-A0CQ,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22810,Alive,TUMOR FREE,2695,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2695,0,2695,0,2695,0,2695,NA,Stage IA,T1,M0,BRCA.LumA,1
8.840467318,-3.745238922,TCGA-BH-A1F5-01A,TCGA-BH-A1F5-01A-12D-A13L-09,1,0.705746131,TCGA-BH-A1F5,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2002,[Not Available],-22842,Dead,TUMOR FREE,NA,2712,[Not Available],NA,NA,NA,NA,[Not Available],1,2712,0,2712,NA,NA,0,2712,NA,Stage IIA,T1c,M0,NA,1
9.590898033,-4.300490937,TCGA-E9-A22D-01A,TCGA-E9-A22D-01A-11D-A159-09,1,0.704038372,TCGA-E9-A22D,BRCA,38,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14115,Alive,TUMOR FREE,1248,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1248,0,1248,0,1248,0,1248,NA,Stage IIA,T2,M0,BRCA.LumB,1
-4.573750565,0.36883055,TCGA-D1-A1NS-01A,TCGA-D1-A1NS-01A-11D-A14G-09,0,NA,TCGA-D1-A1NS,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19638,Alive,TUMOR FREE,43,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,43,0,43,0,43,0,43,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.70095481,-2.166981491,TCGA-BH-A0GZ-01A,TCGA-BH-A0GZ-01A-11W-A071-09,1,0.70218466,TCGA-BH-A0GZ,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22714,Alive,TUMOR FREE,328,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,328,0,328,0,328,0,328,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-6.230893732,1.551964188,TCGA-A2-A0SW-01A,TCGA-A2-A0SW-01A-11D-A099-09,10,0.352410361,TCGA-A2-A0SW,BRCA,82,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30085,Dead,WITH TUMOR,NA,1365,[Not Available],NA,NA,NA,653,[Not Available],1,1365,1,1365,NA,NA,1,653,NA,Stage IV,T2,M1,BRCA.LumB,7
9.048455297,-3.222278963,TCGA-E2-A1LA-01A,TCGA-E2-A1LA-01A-11D-A142-09,1,0.669456773,TCGA-E2-A1LA,BRCA,59,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21773,Alive,TUMOR FREE,748,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,748,0,748,0,748,0,748,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-0.281698104,5.068311326,TCGA-EO-A2CG-01A,TCGA-EO-A2CG-01A-12D-A17W-09,4,0.559077894,TCGA-EO-A2CG,UCEC,69,FEMALE,ASIAN,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25279,Alive,TUMOR FREE,1564,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1564,0,1564,0,1564,0,1564,NA,Stage IA,[Not Applicable],[Not Applicable],NA,6
-0.76910663,2.367506257,TCGA-A2-A0YE-01A,TCGA-A2-A0YE-01A-11D-A10G-09,0,NA,TCGA-A2-A0YE,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17727,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,554,0,554,0,554,0,554,NA,Stage IIB,T2,M0,BRCA.Basal,1
2.972092061,3.576702094,TCGA-AO-A12H-01A,TCGA-AO-A12H-01A-11D-A10Y-09,0,NA,TCGA-AO-A12H,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,"Other, specify",[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-25515,Alive,TUMOR FREE,1234,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1234,0,1234,0,1234,0,1234,NA,Stage IIA,T2,M0,BRCA.LumA,1
-8.145958782,2.100033325,TCGA-BH-A0EA-01A,TCGA-BH-A0EA-01A-11D-A10Y-09,9,0.51545911,TCGA-BH-A0EA,BRCA,72,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26548,Dead,TUMOR FREE,NA,991,[Not Available],NA,NA,NA,NA,[Not Available],1,991,0,991,0,991,0,991,NA,Stage IIA,T1c,M0,BRCA.LumA,7
9.085166117,-5.143735405,TCGA-BQ-5894-01A,TCGA-BQ-5894-01A-11D-1589-08,1,0.800842194,TCGA-BQ-5894,KIRP,42,MALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-15510,Alive,WITH TUMOR,84,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,84,0,84,NA,NA,0,84,NA,Stage IV,T3b,M1,KIRP.C2c - CIMP,1
9.241038069,-4.155741296,TCGA-CJ-5675-01A,TCGA-CJ-5675-01A-11D-1534-10,1,0.750403246,TCGA-CJ-5675,KIRC,70,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-25617,Alive,WITH TUMOR,3936,NA,[Not Available],NA,NA,NA,900,Complete Remission/Response,0,3936,0,3936,1,900,1,900,NA,Stage II,T2a,M0,KIRC.4,1
9.558560847,-5.343995627,TCGA-HZ-7920-01A,TCGA-HZ-7920-01A-11D-2201-08,1,0.85714275,TCGA-HZ-7920,PAAD,71,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-26167,Dead,TUMOR FREE,NA,236,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,236,0,236,0,236,0,236,NA,Stage IB,T2,MX,NA,1
9.118708608,-3.608338162,TCGA-HZ-8317-01A,TCGA-HZ-8317-01A-11D-2396-08,1,0.638888284,TCGA-HZ-8317,PAAD,69,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2012,[Not Available],-25214,Dead,WITH TUMOR,NA,378,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,378,1,378,NA,NA,1,378,NA,Stage IIB,T3,MX,NA,1
0.078473664,3.095887135,TCGA-HZ-7918-01A,TCGA-HZ-7918-01A-11D-2154-08,4,0.299207838,TCGA-HZ-7918,PAAD,72,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-26573,Alive,WITH TUMOR,969,NA,NA,Distant Metastasis,Liver,NA,542,Complete Remission/Response,0,969,0,969,1,542,1,542,NA,Stage IIB,T3,M0,NA,3
2.157763736,1.771594505,TCGA-DW-5561-01A,TCGA-DW-5561-01A-01D-1589-08,3,0.385686996,TCGA-DW-5561,KIRP,51,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-18744,Alive,[Discrepancy],414,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,414,0,414,NA,NA,0,414,NA,Stage I,T1a,M0,KIRP.C1,3
8.792991086,-5.016834153,TCGA-B3-3926-01A,TCGA-B3-3926-01A-02D-1402-10,1,0.788891816,TCGA-B3-3926,KIRP,59,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-21876,Alive,TUMOR FREE,883,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,883,0,883,0,883,0,883,NA,Stage I,T1,M0,KIRP.C1,1
2.608583426,1.874101637,TCGA-BQ-5878-01A,TCGA-BQ-5878-01A-11D-1589-08,0,NA,TCGA-BQ-5878,KIRP,79,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-29010,Alive,WITH TUMOR,1938,NA,[Not Available],NA,NA,NA,1022,[Not Available],0,1938,0,1938,NA,NA,1,1022,NA,Stage III,T3a,M0,KIRP.C2b,3
8.932137893,-2.065430932,TCGA-A4-7287-01A,TCGA-A4-7287-01A-11D-2136-08,1,0.672718532,TCGA-A4-7287,KIRP,75,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-27621,Dead,WITH TUMOR,NA,597,[Not Available],NA,NA,NA,234,Complete Remission/Response,1,597,1,597,1,234,1,234,NA,Stage I,T1,MX,NA,1
-3.970517452,0.759693245,TCGA-BQ-7060-01A,TCGA-BQ-7060-01A-11D-1961-08,0,NA,TCGA-BQ-7060,KIRP,53,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-19479,Alive,TUMOR FREE,214,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,214,0,214,NA,NA,0,214,NA,Stage I,T1a,M0,KIRP.C1,10
2.493688394,1.84547515,TCGA-BQ-5879-01A,TCGA-BQ-5879-01A-11D-1589-08,3,0.032102643,TCGA-BQ-5879,KIRP,32,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-11862,Dead,WITH TUMOR,NA,697,[Not Available],NA,NA,NA,130,[Not Available],1,697,1,697,NA,NA,1,130,NA,Stage III,T3b,M0,KIRP.C2c - CIMP,3
2.676680737,2.928827945,TCGA-BP-5009-01A,TCGA-BP-5009-01A-01D-1462-08,0,NA,TCGA-BP-5009,KIRC,52,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-19052,Dead,WITH TUMOR,NA,1092,[Not Available],NA,NA,NA,324,[Not Available],1,1092,1,1092,NA,NA,1,324,NA,Stage I,T1b,M0,NA,3
-5.438519027,2.660769884,TCGA-HZ-A4BH-01A,TCGA-HZ-A4BH-01A-11D-A26I-08,12,0.096286212,TCGA-HZ-A4BH,PAAD,75,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-27637,Alive,WITH TUMOR,194,NA,NA,NA,NA,NA,NA,[Unknown],0,194,0,194,NA,NA,0,194,NA,Stage IIB,T3,MX,NA,8
-5.24675429,2.605431188,TCGA-HZ-A49G-01A,TCGA-HZ-A49G-01A-11D-A26I-08,12,0.094623259,TCGA-HZ-A49G,PAAD,58,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-21491,Alive,WITH TUMOR,660,NA,NA,NA,NA,NA,NA,Progressive Disease,0,660,0,660,NA,NA,0,660,NA,Stage IIB,T2,MX,NA,8
8.765484303,-3.216781898,TCGA-AL-3468-01A,TCGA-AL-3468-01A-02D-1402-10,1,0.656740884,TCGA-AL-3468,KIRP,74,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-27205,Dead,TUMOR FREE,NA,2331,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2331,0,2331,0,2331,0,2331,NA,Stage II,T2,M0,NA,5
-2.848213789,1.639242572,TCGA-G7-6793-01A,TCGA-G7-6793-01A-11D-1961-08,0,NA,TCGA-G7-6793,KIRP,60,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-22215,Dead,WITH TUMOR,NA,336,[Not Available],NA,NA,NA,NA,[Not Available],1,336,1,336,NA,NA,1,336,NA,Stage IV,T3a,MX,KIRP.C2c - CIMP,10
1.317758283,2.238616888,TCGA-BQ-7045-01A,TCGA-BQ-7045-01A-31D-1961-08,0,NA,TCGA-BQ-7045,KIRP,78,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2001,[Not Available],-28709,Dead,TUMOR FREE,NA,1468,[Not Available],NA,NA,NA,NA,[Not Available],1,1468,0,1468,NA,NA,0,1468,NA,Stage I,T1b,M0,KIRP.C1,3
4.155808931,1.250882825,TCGA-BQ-5889-01A,TCGA-BQ-5889-01A-11D-1589-08,2,0.543259651,TCGA-BQ-5889,KIRP,63,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-23267,Dead,WITH TUMOR,NA,329,[Not Available],NA,NA,NA,-35,[Not Available],1,329,1,329,NA,NA,1,NA,NA,Stage IV,T3b,M1,KIRP.C2a,5
-7.558705122,-2.087397346,TCGA-BP-5199-01A,TCGA-BP-5199-01A-01D-1429-08,6,0.056582335,TCGA-BP-5199,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2006,[Not Available],-21256,Alive,TUMOR FREE,1355,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1355,0,1355,NA,NA,0,1355,NA,Stage II,T2,M0,NA,2
-0.304742305,2.999527298,TCGA-G7-6796-01A,TCGA-G7-6796-01A-11D-1961-08,4,0.064238257,TCGA-G7-6796,KIRP,58,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-21252,Alive,TUMOR FREE,2173,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2173,0,2173,0,2173,0,2173,NA,Stage I,T1a,MX,KIRP.C2a,3
8.842711865,-3.690341394,TCGA-BQ-5875-01A,TCGA-BQ-5875-01A-11D-1589-08,1,0.6306121,TCGA-BQ-5875,KIRP,66,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-24153,Alive,TUMOR FREE,2639,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2639,0,2639,NA,NA,0,2639,NA,Stage III,T3a,M0,KIRP.C2b,1
1.26519071,2.266885794,TCGA-GL-6846-01A,TCGA-GL-6846-01A-11D-1961-08,0,NA,TCGA-GL-6846,KIRP,52,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],1996,[Not Available],-19012,Alive,TUMOR FREE,5925,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5925,0,5925,NA,NA,0,5925,NA,Stage IV,T4,MX,KIRP.C1,3
-7.645738726,-2.040433993,TCGA-EV-5901-01A,TCGA-EV-5901-01A-11D-1589-08,6,0.105806494,TCGA-EV-5901,KIRP,47,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-17275,Alive,TUMOR FREE,1040,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1040,0,1040,NA,NA,0,1040,NA,Stage I,T1,M0,KIRP.C1,2
-7.241339258,-2.570607881,TCGA-GL-7773-01A,TCGA-GL-7773-01A-11D-2136-08,6,0.158365005,TCGA-GL-7773,KIRP,63,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-23239,Alive,TUMOR FREE,393,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,393,0,393,0,393,0,393,NA,Stage I,T1a,MX,KIRP.C1,2
9.540460132,-4.792405881,TCGA-B9-7268-01A,TCGA-B9-7268-01A-11D-2136-08,1,0.783746279,TCGA-B9-7268,KIRP,59,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-21705,Alive,TUMOR FREE,671,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,671,0,671,0,671,0,671,NA,Stage II,T2,M0,KIRP.C1,1
8.940482249,-4.964484729,TCGA-G7-6792-01A,TCGA-G7-6792-01A-21D-1961-08,1,0.785664676,TCGA-G7-6792,KIRP,40,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-14664,Alive,TUMOR FREE,2765,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2765,0,2765,0,2765,0,2765,NA,Stage I,T1b,MX,KIRP.C1,1
-6.269753869,3.413208419,TCGA-BQ-5884-01A,TCGA-BQ-5884-01A-11D-1589-08,11,0.228934377,TCGA-BQ-5884,KIRP,59,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-21730,Alive,TUMOR FREE,792,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,792,0,792,NA,NA,0,792,NA,Stage I,T1a,M0,KIRP.C2a,8
9.051064872,-3.287413055,TCGA-BH-A0C0-01A,TCGA-BH-A0C0-01A-21W-A071-09,1,0.722780466,TCGA-BH-A0C0,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006,Alive,TUMOR FREE,1270,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1270,0,1270,0,1270,0,1270,NA,Stage IIA,T1c,M0,BRCA.LumB,1
9.08818923,-2.874257087,TCGA-DW-7838-01A,TCGA-DW-7838-01A-11D-2136-08,1,0.706935131,TCGA-DW-7838,KIRP,66,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-24247,Alive,WITH TUMOR,744,NA,[Not Available],NA,NA,NA,380,[Not Available],0,744,0,744,NA,NA,1,380,NA,Stage I,T1b,MX,KIRP.C1,1
9.677482306,-1.723928259,TCGA-B2-5639-01A,TCGA-B2-5639-01A-01D-1534-10,1,0.840468895,TCGA-B2-5639,KIRC,46,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-17045,Dead,WITH TUMOR,NA,1003,[Not Available],NA,NA,NA,163,Progressive Disease,1,1003,1,1003,NA,NA,1,163,NA,Stage IV,T3,M1,NA,1
-3.980003677,-2.015646053,TCGA-HE-7129-01A,TCGA-HE-7129-01A-11D-1961-08,8,0.436284991,TCGA-HE-7129,KIRP,NA,MALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],NA,Alive,TUMOR FREE,2492,NA,[Not Available],NA,NA,NA,2399,Complete Remission/Response,0,2492,0,2492,1,2399,1,2399,NA,Stage II,T2,M0,KIRP.C1,10
-7.803957717,-2.457911992,TCGA-BQ-7058-01A,TCGA-BQ-7058-01A-11D-1961-08,6,0.560341967,TCGA-BQ-7058,KIRP,81,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-29856,Dead,WITH TUMOR,NA,343,[Not Available],NA,NA,NA,50,[Not Available],1,343,1,343,NA,NA,1,50,NA,Stage III,T3,M0,KIRP.C2b,2
2.06358006,1.761725875,TCGA-DW-5560-01A,TCGA-DW-5560-01A-01D-1589-08,3,0.482684336,TCGA-DW-5560,KIRP,38,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-13964,Alive,TUMOR FREE,1486,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1486,0,1486,0,1486,0,1486,NA,Stage I,T1b,M0,KIRP.C1,3
-4.413328798,1.691038708,TCGA-D1-A1O5-01A,TCGA-D1-A1O5-01A-11D-A14G-09,0,NA,TCGA-D1-A1O5,UCEC,61,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22580,Alive,TUMOR FREE,458,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,458,0,458,0,458,0,458,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,9
4.17274422,1.242162246,TCGA-BQ-7061-01A,TCGA-BQ-7061-01A-11D-1961-08,2,0.361614803,TCGA-BQ-7061,KIRP,83,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-30662,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,218,0,218,NA,NA,0,218,NA,Stage I,T1b,M0,KIRP.C2b,5
0.646479017,4.569922429,TCGA-H6-A45N-01A,TCGA-H6-A45N-01A-11D-A26I-08,4,0.25842457,TCGA-H6-A45N,PAAD,88,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-32475,Dead,WITH TUMOR,NA,421,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,NA,363,Progressive Disease,1,421,1,421,NA,NA,1,363,NA,Stage IIB,T3,MX,NA,6
-5.131872755,2.078211075,TCGA-HZ-8637-01A,TCGA-HZ-8637-01A-11D-2396-08,0,NA,TCGA-HZ-8637,PAAD,76,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-27929,Dead,TUMOR FREE,NA,517,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,517,0,517,0,517,0,517,NA,Stage IIB,T3,MX,NA,8
0.23509967,5.285655281,TCGA-61-1995-01A,TCGA-61-1995-01A-01W-0722-08,4,0.688126923,TCGA-61-1995,OV,43,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-16016,Alive,WITH TUMOR,61,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,61,0,61,NA,NA,0,61,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-5.532057145,2.574785819,TCGA-HZ-8005-01A,TCGA-HZ-8005-01A-11D-2201-08,12,0.262698343,TCGA-HZ-8005,PAAD,81,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-29674,Dead,WITH TUMOR,NA,120,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,120,1,120,NA,NA,1,120,NA,Stage IIB,T3,MX,NA,10
9.28174364,-5.405537162,TCGA-B3-8121-01A,TCGA-B3-8121-01A-21D-2396-08,1,0.841408069,TCGA-B3-8121,KIRP,48,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-17760,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage I,T1,MX,KIRP.C1,1
-4.555423456,1.621469104,TCGA-D1-A0ZV-01A,TCGA-D1-A0ZV-01A-11D-A10M-09,0,NA,TCGA-D1-A0ZV,UCEC,58,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21374,Alive,TUMOR FREE,728,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,728,0,728,0,728,0,728,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,8
9.370581748,-4.828093912,TCGA-DW-7834-01A,TCGA-DW-7834-01A-11D-2136-08,1,0.782739983,TCGA-DW-7834,KIRP,53,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2001,[Not Available],-19660,Alive,TUMOR FREE,3950,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3950,0,3950,NA,NA,0,3950,NA,Stage I,T1,MX,KIRP.C1,1
-4.749620024,-1.709453924,TCGA-HE-7128-01A,TCGA-HE-7128-01A-11D-1961-08,8,0.39018718,TCGA-HE-7128,KIRP,NA,MALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage I,T1,MX,KIRP.C1,10
0.427394526,2.22440734,TCGA-DW-7840-01A,TCGA-DW-7840-01A-11D-2136-08,0,NA,TCGA-DW-7840,KIRP,60,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-22141,Alive,NA,114,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,114,0,114,NA,NA,0,114,NA,Stage I,T1b,MX,KIRP.C1,6
-5.258256865,2.600779544,TCGA-HZ-7925-01A,TCGA-HZ-7925-01A-11D-2154-08,12,0.275231992,TCGA-HZ-7925,PAAD,66,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-24150,Dead,WITH TUMOR,NA,614,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",Regional LNs,364,Complete Remission/Response,1,614,1,614,1,364,1,364,NA,Stage IIB,T3,MX,NA,8
-6.058587568,3.20284696,TCGA-HZ-8636-01A,TCGA-HZ-8636-01A-21D-2396-08,11,0.368041812,TCGA-HZ-8636,PAAD,58,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-21501,Dead,WITH TUMOR,NA,545,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,545,1,545,NA,NA,1,545,NA,Stage IV,T3,M1,NA,8
9.579003444,-5.753941702,TCGA-HZ-7924-01A,TCGA-HZ-7924-01A-11D-2154-08,1,0.849868472,TCGA-HZ-7924,PAAD,60,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-22090,Alive,WITH TUMOR,840,NA,NA,Distant Metastasis,NA,Liver,831,Complete Remission/Response,0,840,0,840,1,831,1,831,NA,Stage IIA,T3,MX,NA,1
-3.628864656,-2.661371349,TCGA-AP-A0LE-01A,TCGA-AP-A0LE-01A-11D-A127-09,8,0.352607718,TCGA-AP-A0LE,UCEC,57,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20967,Alive,TUMOR FREE,3357,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3357,0,3357,0,3357,0,3357,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
9.564213868,-4.744610221,TCGA-CJ-5684-01A,TCGA-CJ-5684-01A-11D-1534-10,1,0.793952864,TCGA-CJ-5684,KIRC,61,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-22561,Alive,TUMOR FREE,2231,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2231,0,2231,NA,NA,0,2231,NA,Stage III,T3a,M0,KIRC.1,1
9.326175412,-5.110265,TCGA-A4-7732-01A,TCGA-A4-7732-01A-11D-2136-08,1,0.810115944,TCGA-A4-7732,KIRP,55,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-20226,Alive,TUMOR FREE,582,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,582,0,582,0,582,0,582,NA,[Not Available],T2a,MX,KIRP.C1,1
-7.346905346,-2.546843478,TCGA-BQ-5890-01A,TCGA-BQ-5890-01A-11D-1589-08,6,0.169682833,TCGA-BQ-5890,KIRP,69,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-25272,Alive,TUMOR FREE,233,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,233,0,233,NA,NA,0,233,NA,Stage III,T3a,M0,KIRP.C2b,2
9.125029883,-5.26459785,TCGA-A4-7828-01A,TCGA-A4-7828-01A-11D-2136-08,1,0.790817942,TCGA-A4-7828,KIRP,74,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-27122,Alive,TUMOR FREE,238,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,238,0,238,0,238,0,238,NA,Stage I,T1a,M0,NA,3
-3.494513315,-2.791464611,TCGA-DZ-6133-01A,TCGA-DZ-6133-01A-11D-1961-08,8,0.437611615,TCGA-DZ-6133,KIRP,66,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-24311,Dead,TUMOR FREE,NA,1557,[Not Available],NA,NA,NA,NA,[Not Available],1,1557,0,1557,NA,NA,0,1557,NA,Stage I,T1a,MX,KIRP.C1,10
9.610339338,-5.676141101,TCGA-HZ-8638-01A,TCGA-HZ-8638-01A-11D-2396-08,1,0.861904669,TCGA-HZ-8638,PAAD,84,FEMALE,WHITE,Pancreas-Colloid (mucinous non-cystic) Carcinoma,GX,2012,[Not Available],-30821,Dead,TUMOR FREE,NA,151,Surgical Complications,NA,NA,NA,NA,Complete Remission/Response,1,151,0,151,0,151,0,151,NA,Stage IA,T1,MX,NA,1
9.263667018,-4.285811693,TCGA-HZ-8003-01A,TCGA-HZ-8003-01A-21D-2201-08,1,0.777621219,TCGA-HZ-8003,PAAD,65,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-23868,Dead,WITH TUMOR,NA,596,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,1,596,1,596,NA,NA,1,596,NA,Stage IIB,T3,MX,NA,1
7.831320724,-3.623787607,TCGA-A3-3370-01A,TCGA-A3-3370-01A-02D-1421-08,1,0.33926361,TCGA-A3-3370,KIRC,48,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-17621,Alive,TUMOR FREE,2274,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2274,0,2274,0,2274,0,2274,NA,Stage I,T1b,M0,KIRC.1,1
-4.025750321,-2.10200759,TCGA-HE-7130-01A,TCGA-HE-7130-01A-11D-1961-08,8,0.44683329,TCGA-HE-7130,KIRP,NA,FEMALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],NA,Alive,TUMOR FREE,1770,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1770,0,1770,0,1770,0,1770,NA,Stage III,T3,M0,NA,10
4.286350597,1.178012044,TCGA-BQ-7051-01A,TCGA-BQ-7051-01A-12D-1961-08,2,0.655563724,TCGA-BQ-7051,KIRP,74,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-27120,Alive,TUMOR FREE,1533,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1533,0,1533,NA,NA,0,1533,NA,Stage II,T2,M0,KIRP.C1,6
2.037109288,1.856790856,TCGA-BQ-5888-01A,TCGA-BQ-5888-01A-11D-1589-08,3,0.610304133,TCGA-BQ-5888,KIRP,74,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-27346,Alive,TUMOR FREE,403,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,403,0,403,NA,NA,0,403,NA,Stage I,T1a,M0,KIRP.C2a,3
-0.761675309,2.324759481,TCGA-B9-5156-01A,TCGA-B9-5156-01A-01D-1589-08,0,NA,TCGA-B9-5156,KIRP,51,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-18841,Alive,TUMOR FREE,1338,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1338,0,1338,0,1338,0,1338,NA,[Not Available],T1a,[Not Available],KIRP.C1,6
-0.760742552,2.323959418,TCGA-B9-4117-01A,TCGA-B9-4117-01A-02D-1402-10,0,NA,TCGA-B9-4117,KIRP,48,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-17622,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,14,0,14,NA,NA,0,14,NA,[Not Available],T2,[Not Available],KIRP.C1,1
-5.271557398,2.382176813,TCGA-HZ-7926-01A,TCGA-HZ-7926-01A-11D-2154-08,12,0.102257561,TCGA-HZ-7926,PAAD,57,MALE,BLACK OR AFRICAN AMERICAN,Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-21024,Dead,WITH TUMOR,NA,518,Pancreatic Cancer,Distant Metastasis,Lung,NA,340,Progressive Disease,1,518,1,518,NA,NA,1,340,NA,Stage IIB,T3,MX,NA,8
-5.203275205,2.721904198,TCGA-HZ-7922-01A,TCGA-HZ-7922-01A-11D-2154-08,12,0.082780358,TCGA-HZ-7922,PAAD,61,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-22413,Alive,NA,4,NA,NA,NA,NA,NA,NA,[Not Applicable],0,4,0,4,NA,NA,0,4,NA,Stage IIB,T3,MX,NA,8
8.869131139,-3.498883392,TCGA-HZ-8002-01A,TCGA-HZ-8002-01A-11D-2201-08,1,0.73281125,TCGA-HZ-8002,PAAD,61,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-22433,Dead,WITH TUMOR,NA,366,NA,NA,NA,NA,NA,[Unknown],1,366,1,366,NA,NA,1,366,NA,Stage IIB,T3,MX,NA,1
-5.287491218,2.588333668,TCGA-H6-8124-01A,TCGA-H6-8124-01A-11D-2396-08,12,0.197089565,TCGA-H6-8124,PAAD,56,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-20741,Alive,WITH TUMOR,392,NA,NA,Distant Metastasis,Liver,NA,259,Complete Remission/Response,0,392,0,392,1,259,1,259,NA,Stage IIB,T3,M0,NA,8
-6.145635957,3.50038549,TCGA-HZ-7919-01A,TCGA-HZ-7919-01A-11D-2154-08,11,0.5624215,TCGA-HZ-7919,PAAD,52,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-19064,Dead,WITH TUMOR,NA,593,Pancreatic Cancer,NA,NA,NA,NA,[Unknown],1,593,1,593,NA,NA,1,593,NA,Stage IIB,T3,M0,NA,8
-7.827427868,-2.485099531,TCGA-CW-5581-01A,TCGA-CW-5581-01A-02D-1534-10,6,0.47627427,TCGA-CW-5581,KIRC,44,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2003,[Not Available],-16195,Alive,TUMOR FREE,2799,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2799,0,2799,NA,NA,0,2799,NA,Stage I,T1b,M0,KIRC.1,2
-8.012990051,1.988205784,TCGA-BH-A0HI-01A,TCGA-BH-A0HI-01A-11D-A099-09,9,0.452860798,TCGA-BH-A0HI,BRCA,78,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28644,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,620,0,620,0,620,0,620,NA,Stage IA,T1c,M0,BRCA.LumA,7
4.365074346,1.138994716,TCGA-BQ-5880-01A,TCGA-BQ-5880-01A-11D-1589-08,2,0.67946178,TCGA-BQ-5880,KIRP,79,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-29053,Dead,WITH TUMOR,NA,1314,[Not Available],NA,NA,NA,972,[Not Available],1,1314,1,1314,NA,NA,1,972,NA,Stage III,T3a,M0,KIRP.C2a,5
9.435783053,-2.360236331,TCGA-DW-7839-01A,TCGA-DW-7839-01A-11D-2136-08,1,0.779037245,TCGA-DW-7839,KIRP,58,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-21347,Alive,TUMOR FREE,419,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,419,0,419,NA,NA,0,419,NA,Stage I,T1b,MX,KIRP.C1,1
9.565371669,-2.596022837,TCGA-B8-5165-01A,TCGA-B8-5165-01A-01D-1421-08,1,0.774434955,TCGA-B8-5165,KIRC,43,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-15898,Alive,TUMOR FREE,737,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,737,0,737,0,737,0,737,NA,Stage I,T1a,M0,KIRC.1,1
8.799722728,-1.996452749,TCGA-AL-7173-01A,TCGA-AL-7173-01A-11D-2136-08,1,0.663555372,TCGA-AL-7173,KIRP,72,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-26326,Alive,WITH TUMOR,2060,NA,[Not Available],NA,NA,NA,332,Progressive Disease,0,2060,0,2060,NA,NA,1,332,NA,Stage IV,T3,M0,KIRP.C2a,1
8.211540447,-3.923998405,TCGA-DW-7842-01A,TCGA-DW-7842-01A-11D-2136-08,1,0.52917984,TCGA-DW-7842,KIRP,52,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-19166,Alive,WITH TUMOR,92,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,92,0,92,NA,NA,0,92,NA,Stage I,T1a,MX,KIRP.C1,1
8.909290898,-4.646889073,TCGA-BP-4982-01A,TCGA-BP-4982-01A-01D-1462-08,1,0.780201466,TCGA-BP-4982,KIRC,42,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-15451,Alive,TUMOR FREE,1014,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1014,0,1014,NA,NA,0,1014,NA,Stage I,T1b,M0,KIRC.1,1
-2.159226164,1.250303637,TCGA-23-1030-01A,TCGA-23-1030-01A-02W-0486-08,5,0.623465778,TCGA-23-1030,OV,64,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-23416,Alive,TUMOR FREE,886,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],544,Complete Remission/Response,0,886,0,886,1,544,1,544,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,4
2.041855647,1.807331936,TCGA-BQ-5882-01A,TCGA-BQ-5882-01A-11D-1589-08,3,0.588335814,TCGA-BQ-5882,KIRP,54,MALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-20042,Dead,WITH TUMOR,NA,658,[Not Available],NA,NA,NA,340,[Not Available],1,658,1,658,NA,NA,1,340,NA,Stage III,T3b,M0,KIRP.C2b,3
-8.105025051,1.944143578,TCGA-A4-7585-01A,TCGA-A4-7585-01A-11D-2136-08,9,0.549267607,TCGA-A4-7585,KIRP,67,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-24778,Dead,TUMOR FREE,NA,1070,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1070,0,1070,0,1070,0,1070,NA,Stage III,T3a,M0,KIRP.C2a,7
9.204202398,-2.071857372,TCGA-BQ-5876-01A,TCGA-BQ-5876-01A-11D-1589-08,1,0.686623013,TCGA-BQ-5876,KIRP,75,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-27409,Alive,TUMOR FREE,586,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,586,0,586,NA,NA,0,586,NA,Stage I,T1a,M0,KIRP.C2b,1
9.346463961,-4.498554837,TCGA-DV-5568-01A,TCGA-DV-5568-01A-01D-1534-10,1,0.788394356,TCGA-DV-5568,KIRC,26,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2009,[Not Available],-9714,Alive,WITH TUMOR,370,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,370,0,370,NA,NA,0,370,NA,Stage I,T1a,M0,NA,1
4.42361093,1.114494799,TCGA-B0-5077-01A,TCGA-B0-5077-01A-01D-1462-08,2,0.729689925,TCGA-B0-5077,KIRC,77,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-28405,Dead,TUMOR FREE,NA,1317,[Not Available],NA,NA,NA,NA,[Not Available],1,1317,0,1317,NA,NA,0,1317,NA,Stage I,T1a,M0,KIRC.2,5
2.061595114,1.814915288,TCGA-CJ-4907-01A,TCGA-CJ-4907-01A-01D-1429-08,3,0.491346043,TCGA-CJ-4907,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-21208,Alive,TUMOR FREE,1499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1499,0,1499,NA,NA,0,1499,NA,Stage III,T3b,M0,KIRC.1,3
10.02731788,-2.191704155,TCGA-B0-5707-01A,TCGA-B0-5707-01A-11D-1534-10,1,0.788197777,TCGA-B0-5707,KIRC,39,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-14598,Alive,TUMOR FREE,3744,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3744,0,3744,0,3744,0,3744,NA,Stage I,T1a,M0,KIRC.NA,1
-3.390405161,-3.359232919,TCGA-AJ-A2QO-01A,TCGA-AJ-A2QO-01A-11D-A18P-09,8,0.624726497,TCGA-AJ-A2QO,UCEC,85,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31222,Dead,TUMOR FREE,NA,1045,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1045,0,1045,0,1045,0,1045,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-7.070041791,1.418475707,TCGA-A8-A06U-01A,TCGA-A8-A06U-01A-11W-A019-09,0,NA,TCGA-A8-A06U,BRCA,80,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29525,Dead,TUMOR FREE,NA,883,[Not Available],NA,NA,NA,NA,[Not Available],1,883,0,883,0,883,0,883,NA,Stage IIB,T2,M0,BRCA.LumA,7
0.150558611,3.460719727,TCGA-13-1498-01A,TCGA-13-1498-01A-01W-0549-09,4,0.303086335,TCGA-13-1498,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-26820,Dead,WITH TUMOR,NA,2012,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],534,Partial Remission/Response,1,2012,1,2012,NA,NA,1,534,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,3
-6.934738789,1.800134752,TCGA-AJ-A2QN-01A,TCGA-AJ-A2QN-01A-11D-A18P-09,0,NA,TCGA-AJ-A2QN,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21915,Alive,TUMOR FREE,1069,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1069,0,1069,0,1069,0,1069,NA,Stage II,[Not Applicable],[Not Applicable],NA,7
9.547138251,-4.907005481,TCGA-E9-A245-01A,TCGA-E9-A245-01A-22D-A16D-09,1,0.798186882,TCGA-E9-A245,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17363,Alive,TUMOR FREE,26,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,26,0,26,0,26,0,26,NA,Stage IIB,T2,M0,BRCA.LumA,1
9.26145947,-3.128387326,TCGA-E2-A15T-01A,TCGA-E2-A15T-01A-11D-A10Y-09,1,0.723167935,TCGA-E2-A15T,BRCA,65,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24054,Alive,TUMOR FREE,1563,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1563,0,1563,0,1563,0,1563,NA,Stage IIA,T2,M0,BRCA.LumB,1
8.874890463,-4.510889657,TCGA-D8-A13Y-01A,TCGA-D8-A13Y-01A-11D-A10Y-09,1,0.777145258,TCGA-D8-A13Y,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19028,Alive,TUMOR FREE,1728,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1728,0,1728,0,1728,0,1728,NA,Stage IA,T1c,M0,BRCA.LumB,1
-6.094186096,3.552254472,TCGA-29-1696-01A,TCGA-29-1696-01A-01W-0633-09,11,0.55256165,TCGA-29-1696,OV,43,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2003,[Not Available],-15818,Dead,WITH TUMOR,1025,1032,[Not Available],Recurrence,[Not Applicable],[Not Applicable],342,Partial Remission/Response,1,1032,1,1032,NA,NA,1,342,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,8
-0.187899271,4.840542948,TCGA-13-0910-01A,TCGA-13-0910-01A-01W-0420-08,4,0.691080515,TCGA-13-0910,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-21473,Alive,WITH TUMOR,3548,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1212,Complete Remission/Response,0,3548,0,3548,1,1212,1,1212,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-5.586654823,1.130506073,TCGA-D1-A3DH-01A,TCGA-D1-A3DH-01A-11D-A19Y-09,0,NA,TCGA-D1-A3DH,UCEC,71,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25935,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,573,0,573,0,573,0,573,NA,Stage IA,[Not Applicable],[Not Applicable],NA,9
2.068080652,1.873146807,TCGA-BH-A18L-01A,TCGA-BH-A18L-01A-32D-A12B-09,3,0.444857057,TCGA-BH-A18L,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,[Not Available],-18519,Dead,NA,NA,811,[Not Available],NA,NA,NA,NA,[Not Available],1,811,NA,811,0,811,0,811,NA,Stage IIIA,T3,M0,BRCA.LumB,3
-0.335331982,4.028621795,TCGA-13-0768-01A,TCGA-13-0768-01A-01W-0371-08,4,0.351094171,TCGA-13-0768,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-26999,Dead,WITH TUMOR,NA,1784,[Not Available],NA,[Not Applicable],[Not Applicable],398,Complete Remission/Response,1,1784,1,1784,1,398,1,398,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
-0.574654073,5.037063859,TCGA-13-0905-01B,TCGA-13-0905-01B-01W-0492-08,4,0.53402021,TCGA-13-0905,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-18757,Alive,WITH TUMOR,3746,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1535,Complete Remission/Response,0,3746,0,3746,1,1535,1,1535,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.541798433,-1.165884318,TCGA-AP-A0LJ-01A,TCGA-AP-A0LJ-01A-11W-A062-09,7,0.239296227,TCGA-AP-A0LJ,UCEC,42,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15577,Alive,TUMOR FREE,1421,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1421,0,1421,0,1421,0,1421,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,2
-5.739164542,-2.052432432,TCGA-E9-A1R4-01A,TCGA-E9-A1R4-01A-21D-A14G-09,0,NA,TCGA-E9-A1R4,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24181,Alive,TUMOR FREE,186,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,186,0,186,0,186,0,186,NA,Stage IA,T1c,M0,BRCA.LumB,2
-0.20002676,4.701968662,TCGA-EY-A1GM-01A,TCGA-EY-A1GM-01A-12D-A14G-09,4,0.570529581,TCGA-EY-A1GM,UCEC,60,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22010,Dead,WITH TUMOR,NA,995,[Not Available],Locoregional Recurrence,NA,NA,791,Complete Remission/Response,1,995,1,995,1,791,1,791,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,3
-0.801439675,3.631756858,TCGA-13-2060-01A,TCGA-13-2060-01A-01W-0799-08,4,0.214543309,TCGA-13-2060,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-18635,Alive,WITH TUMOR,2369,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1475,Complete Remission/Response,0,2369,0,2369,NA,NA,1,1475,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,5
-7.440886831,-2.383110526,TCGA-EO-A3AS-01A,TCGA-EO-A3AS-01A-11D-A19Y-09,6,0.307211999,TCGA-EO-A3AS,UCEC,86,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31450,Alive,TUMOR FREE,1046,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1046,0,1046,0,1046,0,1046,NA,Stage IA,[Not Applicable],[Not Applicable],NA,2
-0.327255681,4.940352641,TCGA-EY-A3L3-01A,TCGA-EY-A3L3-01A-11D-A228-09,4,0.520464941,TCGA-EY-A3L3,UCEC,82,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30138,Alive,TUMOR FREE,832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,832,0,832,0,832,0,832,NA,Stage IA,[Not Applicable],[Not Applicable],NA,6
-6.922684276,-1.893766615,TCGA-24-2288-01A,TCGA-24-2288-01A-01W-0799-08,6,0.078791045,TCGA-24-2288,OV,70,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-25831,Dead,WITH TUMOR,25,25,[Not Available],NA,NA,NA,NA,[Not Available],1,25,1,25,NA,NA,1,25,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,2
-7.737006082,1.778516368,TCGA-AC-A2B8-01A,TCGA-AC-A2B8-01A-11D-A17D-09,9,0.278843862,TCGA-AC-A2B8,BRCA,84,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31003,Alive,TUMOR FREE,677,NA,[Not Available],New Primary Tumor,"Other, specify",Rectum,654,[Not Available],0,677,0,677,0,677,1,654,NA,Stage IIB,T3,M0,BRCA.LumA,7
0.278750598,4.864055781,TCGA-24-2254-01A,TCGA-24-2254-01A-01W-0722-08,4,0.666772965,TCGA-24-2254,OV,66,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-24407,Dead,WITH TUMOR,1736,1736,[Not Available],Recurrence,[Not Applicable],[Not Applicable],606,Complete Remission/Response,1,1736,1,1736,1,606,1,606,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
2.30065763,1.747615638,TCGA-AO-A0J9-01A,TCGA-AO-A0J9-01A-11W-A050-09,3,0.446365064,TCGA-AO-A0J9,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22642,Alive,WITH TUMOR,1613,NA,[Not Available],Distant Metastasis,Bone,NA,1066,[Not Available],0,1613,0,1613,1,1066,1,1066,NA,Stage IIIC,T2,M0,BRCA.LumA,3
-6.463402886,1.680668535,TCGA-C8-A278-01A,TCGA-C8-A278-01A-11D-A167-09,10,0.166111766,TCGA-C8-A278,BRCA,61,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22598,Alive,TUMOR FREE,297,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,297,0,297,0,297,0,297,NA,Stage IIIA,T2,M0,BRCA.Her2,7
0.300127309,4.695067414,TCGA-B6-A0I6-01A,TCGA-B6-A0I6-01A-11D-A128-09,4,0.426095717,TCGA-B6-A0I6,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1990,Indeterminate (neither Pre or Postmenopausal),-18014,Dead,WITH TUMOR,NA,991,[Not Available],Distant Metastasis,"Other, specify",Skin and bone,859,[Not Available],1,991,1,991,1,859,1,859,NA,Stage IIA,T1c,M0,BRCA.Basal,6
-3.186964965,-3.632397937,TCGA-EY-A1GD-01A,TCGA-EY-A1GD-01A-11D-A13L-09,8,0.594065977,TCGA-EY-A1GD,UCEC,51,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18638,Alive,TUMOR FREE,1639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1639,0,1639,0,1639,0,1639,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-7.278493119,2.424196945,TCGA-B5-A0JS-01A,TCGA-B5-A0JS-01A-11D-A10B-09,9,0,TCGA-B5-A0JS,UCEC,54,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19995,Alive,TUMOR FREE,2627,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2627,0,2627,0,2627,0,2627,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-6.688262171,-1.26196044,TCGA-AJ-A3BI-01A,TCGA-AJ-A3BI-01A-11D-A20S-09,7,0.164973283,TCGA-AJ-A3BI,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24623,Alive,TUMOR FREE,575,NA,[Not Available],Locoregional Recurrence,"Other, specify",Anterior Abd. Mass,373,[Not Available],0,575,0,575,NA,NA,1,373,NA,Stage IA,[Not Applicable],[Not Applicable],NA,2
-1.912856312,1.199791582,TCGA-AO-A03T-01A,TCGA-AO-A03T-01A-21W-A050-09,5,0.649323137,TCGA-AO-A03T,BRCA,42,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15540,Alive,TUMOR FREE,2124,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2124,0,2124,0,2124,0,2124,NA,Stage IIB,T2,M0,BRCA.Normal,4
9.196320296,-4.205902986,TCGA-A8-A0AB-01A,TCGA-A8-A0AB-01A-11W-A050-09,1,0.661551065,TCGA-A8-A0AB,BRCA,54,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19814,Alive,TUMOR FREE,518,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,518,0,518,0,518,0,518,NA,Stage IIA,T2,M0,BRCA.LumA,1
-8.155683278,2.201536279,TCGA-EW-A1J1-01A,TCGA-EW-A1J1-01A-11D-A188-09,9,0.43742627,TCGA-EW-A1J1,BRCA,38,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,575,0,575,0,575,0,575,NA,Stage IIB,T2,M0,BRCA.LumA,7
-0.346338177,4.162526892,TCGA-A7-A0DA-01A,TCGA-A7-A0DA-01A-31D-A10Y-09,4,0.416327974,TCGA-A7-A0DA,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22708,Alive,TUMOR FREE,1085,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1085,0,1085,0,1085,0,1085,NA,Stage IIA,T2,M0,BRCA.Basal,6
8.878295211,-3.001560753,TCGA-B8-5162-01A,TCGA-B8-5162-01A-01D-1421-08,1,0.734838756,TCGA-B8-5162,KIRC,62,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-23008,Alive,TUMOR FREE,36,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,36,0,36,NA,NA,0,36,NA,Stage II,T2a,M0,NA,1
-0.278590179,3.804940362,TCGA-24-1616-01A,TCGA-24-1616-01A-01W-0553-09,4,0.160610609,TCGA-24-1616,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-20785,Dead,WITH TUMOR,1163,1163,[Not Available],Recurrence,[Not Applicable],[Not Applicable],405,Complete Remission/Response,1,1163,1,1163,1,405,1,405,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-4.380224358,-1.145933901,TCGA-A5-A0VQ-01A,TCGA-A5-A0VQ-01A-11D-A10B-09,8,0.14499995,TCGA-A5-A0VQ,UCEC,62,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,485,0,485,0,485,0,485,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
8.974489844,-3.786213531,TCGA-B5-A11Q-01A,TCGA-B5-A11Q-01A-11D-A122-09,1,0.729511191,TCGA-B5-A11Q,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23538,Alive,TUMOR FREE,976,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,976,0,976,0,976,0,976,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,1
2.390122183,1.83530891,TCGA-E9-A2JS-01A,TCGA-E9-A2JS-01A-11D-A17W-09,3,0.167363075,TCGA-E9-A2JS,BRCA,72,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26407,Dead,WITH TUMOR,NA,904,[Not Available],Distant Metastasis,Bone,Liver,524,[Not Available],1,904,1,904,1,524,1,524,NA,Stage IIB,T2,M0,BRCA.LumB,3
-6.344796629,1.648217215,TCGA-AR-A24T-01A,TCGA-AR-A24T-01A-11D-A167-09,10,0.065238455,TCGA-AR-A24T,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17135,Alive,TUMOR FREE,3202,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3202,0,3202,0,3202,0,3202,NA,Stage IIIC,T3,M0,BRCA.LumA,7
-0.224237749,4.228905107,TCGA-B6-A0I9-01A,TCGA-B6-A0I9-01A-11W-A050-09,4,0.447026016,TCGA-B6-A0I9,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-22798,Dead,WITH TUMOR,NA,362,[Not Available],NA,NA,NA,NA,[Not Available],1,362,1,362,NA,NA,1,362,NA,Stage IV,T3,M1,BRCA.Her2,6
-6.534996479,1.716173646,TCGA-29-1762-01A,TCGA-29-1762-01A-01W-0633-09,10,0.054626719,TCGA-29-1762,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,1998,[Not Available],-21879,Dead,WITH TUMOR,2606,2634,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1375,Complete Remission/Response,1,2634,1,2634,NA,NA,1,1375,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Proliferative,7
-8.158531813,1.972575725,TCGA-E2-A1IO-01A,TCGA-E2-A1IO-01A-11D-A142-09,9,0.525037116,TCGA-E2-A1IO,BRCA,37,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13671,Alive,TUMOR FREE,1855,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1855,0,1855,0,1855,0,1855,NA,Stage I,T1c,M0,BRCA.LumA,7
-5.064031667,2.455032042,TCGA-HZ-8315-01A,TCGA-HZ-8315-01A-11D-2396-08,12,0.333051379,TCGA-HZ-8315,PAAD,54,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-19839,Dead,WITH TUMOR,NA,299,Pancreatic Cancer,NA,NA,NA,NA,[Unknown],1,299,1,299,NA,NA,1,299,NA,Stage IIA,T3,MX,NA,10
0.231990565,5.069257804,TCGA-AR-A1AX-01A,TCGA-AR-A1AX-01A-11D-A12Q-09,4,0.611341705,TCGA-AR-A1AX,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23507,Alive,TUMOR FREE,2629,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2629,0,2629,0,2629,0,2629,NA,Stage I,T1,M0,BRCA.LumA,6
-7.343601661,-2.515005683,TCGA-B0-4823-01A,TCGA-B0-4823-01A-02D-1421-08,6,0.315005308,TCGA-B0-4823,KIRC,88,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2002,[Not Available],-32290,Dead,TUMOR FREE,NA,454,[Not Available],NA,NA,NA,NA,[Not Available],1,454,0,454,NA,NA,0,454,NA,Stage I,T1a,M0,KIRC.1,2
-5.276731171,2.55984191,TCGA-HZ-A4BK-01A,TCGA-HZ-A4BK-01A-11D-A26I-08,12,0.402920698,TCGA-HZ-A4BK,PAAD,72,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-26503,Alive,WITH TUMOR,657,NA,NA,NA,NA,NA,NA,Progressive Disease,0,657,0,657,NA,NA,0,657,NA,Stage IIB,T3,MX,NA,8
9.298597777,-4.230230367,TCGA-13-1505-01A,TCGA-13-1505-01A-01D-0472-01,1,0.726891394,TCGA-13-1505,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-23238,Alive,WITH TUMOR,1998,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1561,Complete Remission/Response,0,1998,0,1998,1,1561,1,1561,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,1
-3.063295406,-3.8545079,TCGA-FI-A2F4-01A,TCGA-FI-A2F4-01A-11D-A17D-09,8,0.306561044,TCGA-FI-A2F4,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23621,Alive,TUMOR FREE,2230,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2230,0,2230,0,2230,0,2230,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-3.100384499,-3.881933546,TCGA-AX-A2HJ-01A,TCGA-AX-A2HJ-01A-11D-A17D-09,8,0.244012817,TCGA-AX-A2HJ,UCEC,35,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2009,[Not Available],-13112,Alive,TUMOR FREE,935,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,935,0,935,0,935,0,935,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-7.370360771,1.51677237,TCGA-BH-A18J-01A,TCGA-BH-A18J-01A-11D-A12B-09,0,NA,TCGA-BH-A18J,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2000,[Not Available],-20678,Dead,WITH TUMOR,NA,612,[Not Available],NA,NA,NA,NA,[Not Available],1,612,1,612,NA,NA,1,612,NA,Stage IV,T4b,M1,BRCA.LumA,7
-7.85708746,1.982507722,TCGA-D8-A1JP-01A,TCGA-D8-A1JP-01A-11D-A13L-09,9,0.415074925,TCGA-D8-A1JP,BRCA,73,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26862,Alive,TUMOR FREE,639,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,639,0,639,0,639,0,639,NA,Stage IA,T1c,M0,BRCA.LumA,7
9.688932024,-5.52168759,TCGA-B6-A0WS-01A,TCGA-B6-A0WS-01A-11D-A10Y-09,1,0.852279007,TCGA-B6-A0WS,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-21230,Dead,TUMOR FREE,NA,2965,[Not Available],NA,NA,NA,NA,[Not Available],1,2965,0,2965,NA,NA,0,2965,NA,Stage X,T1c,MX,BRCA.LumA,1
-6.070973412,3.49933499,TCGA-HZ-A49H-01A,TCGA-HZ-A49H-01A-11D-A26I-08,11,0.58550141,TCGA-HZ-A49H,PAAD,68,FEMALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24891,Alive,TUMOR FREE,491,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,491,0,491,0,491,0,491,NA,Stage IIB,T3,MX,NA,8
-0.050960761,5.300333929,TCGA-E9-A1N4-01A,TCGA-E9-A1N4-01A-11D-A14K-09,4,0.513583029,TCGA-E9-A1N4,BRCA,41,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15055,Alive,TUMOR FREE,1000,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1000,0,1000,0,1000,0,1000,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-0.858457297,3.737852757,TCGA-HZ-8001-01A,TCGA-HZ-8001-01A-11D-2201-08,4,0.381255876,TCGA-HZ-8001,PAAD,69,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-25227,Alive,TUMOR FREE,706,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,706,0,706,0,706,0,706,NA,Stage III,T4,MX,NA,5
-5.244120258,2.534049291,TCGA-HZ-A49I-01A,TCGA-HZ-A49I-01A-12D-A26I-08,12,0.222288805,TCGA-HZ-A49I,PAAD,77,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-28454,Dead,WITH TUMOR,NA,308,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,1,308,1,308,NA,NA,1,308,NA,Stage IIB,T3,MX,NA,8
7.800063439,-1.340927356,TCGA-HZ-7289-01A,TCGA-HZ-7289-01A-11D-2154-08,1,0.122758775,TCGA-HZ-7289,PAAD,77,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-28174,Dead,WITH TUMOR,NA,661,Pancreatic Cancer,Distant Metastasis,Liver,NA,228,[Unknown],1,661,1,661,NA,NA,1,228,NA,Stage IIB,T3,MX,NA,6
8.895498409,-4.577258221,TCGA-42-2588-01A,TCGA-42-2588-01A-01D-1526-09,1,0.797036907,TCGA-42-2588,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-22377,Dead,WITH TUMOR,NA,880,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],112,Progressive Disease,1,880,1,880,NA,NA,1,112,NA,Stage IV,[Not Applicable],[Not Applicable],NA,1
-0.927422729,4.079943568,TCGA-BH-A0B7-01A,TCGA-BH-A0B7-01A-12D-A10Y-09,4,0.407261717,TCGA-BH-A0B7,BRCA,42,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15593,Alive,TUMOR FREE,2559,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2559,0,2559,0,2559,0,2559,NA,Stage IIB,T2,M0,BRCA.Her2,5
-6.096540088,1.561702243,TCGA-D8-A1JJ-01A,TCGA-D8-A1JJ-01A-31D-A14K-09,10,0.135216687,TCGA-D8-A1JJ,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19966,Alive,TUMOR FREE,611,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,611,0,611,0,611,0,611,NA,Stage IIA,T2,M0,BRCA.LumB,7
9.486569582,-5.376818489,TCGA-B6-A0IA-01A,TCGA-B6-A0IA-01A-11W-A050-09,1,0.825840086,TCGA-B6-A0IA,BRCA,51,FEMALE,WHITE,"Other, specify",[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-18748,Alive,TUMOR FREE,8391,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,8391,0,8391,0,8391,0,8391,NA,Stage IIA,T2,M0,BRCA.LumA,1
-7.494729456,-2.511395487,TCGA-A8-A07P-01A,TCGA-A8-A07P-01A-11W-A019-09,6,0.476561705,TCGA-A8-A07P,BRCA,68,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24929,Alive,TUMOR FREE,334,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,334,0,334,0,334,0,334,NA,Stage IIB,T2,M0,BRCA.LumA,2
-0.329015909,4.955809681,TCGA-AR-A24P-01A,TCGA-AR-A24P-01A-11D-A167-09,4,0.63805351,TCGA-AR-A24P,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17490,Alive,NA,84,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,84,0,84,0,84,0,84,NA,Stage I,T1,M0,BRCA.LumA,6
8.947194935,-4.277793735,TCGA-B6-A0WT-01A,TCGA-B6-A0WT-01A-11D-A10G-09,1,0.725804743,TCGA-B6-A0WT,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22362,Alive,TUMOR FREE,5739,NA,[Not Available],New Primary Tumor,"Other, specify",right breast cancer contralateral,3862,[Not Available],0,5739,0,5739,1,3862,1,3862,NA,Stage IIB,T2,M0,BRCA.LumA,1
9.636530827,-5.047189973,TCGA-E9-A1N3-01A,TCGA-E9-A1N3-01A-12D-A159-09,1,0.814943912,TCGA-E9-A1N3,BRCA,70,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25714,Alive,TUMOR FREE,1059,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1059,0,1059,0,1059,0,1059,NA,Stage IIIA,T1c,M0,BRCA.LumA,1
-0.144040753,5.335590204,TCGA-E2-A1B0-01A,TCGA-E2-A1B0-01A-11D-A12Q-09,4,0.710664599,TCGA-E2-A1B0,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18346,Alive,TUMOR FREE,1631,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1631,0,1631,0,1631,0,1631,NA,Stage IIIA,T2,M0,BRCA.Her2,6
9.275694618,-5.673663327,TCGA-A8-A07F-01A,TCGA-A8-A07F-01A-11W-A019-09,1,0.849170593,TCGA-A8-A07F,BRCA,65,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23742,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,577,0,577,0,577,0,577,NA,Stage IIB,T2,M0,BRCA.LumA,1
-7.886898476,2.142147231,TCGA-A7-A26E-01A,TCGA-A7-A26E-01A-11D-A272-09,9,0.513082371,TCGA-A7-A26E,BRCA,71,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26274,Alive,TUMOR FREE,954,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,954,0,954,0,954,0,954,NA,Stage IIIA,T3,MX,BRCA.LumA,7
-7.360212101,1.449817127,TCGA-BH-A0H3-01A,TCGA-BH-A0H3-01A-11D-A12Q-09,0,NA,TCGA-BH-A0H3,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17152,Alive,TUMOR FREE,1928,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1928,0,1928,0,1928,0,1928,NA,Stage I,T1c,M0,BRCA.LumA,7
-7.062266912,1.763485911,TCGA-E2-A1BD-01A,TCGA-E2-A1BD-01A-11D-A12Q-09,9,0.025117082,TCGA-E2-A1BD,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19627,Alive,TUMOR FREE,1133,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1133,0,1133,0,1133,0,1133,NA,Stage IIA,T2,M0,BRCA.LumA,7
9.457364889,-4.620953845,TCGA-AC-A2FG-01A,TCGA-AC-A2FG-01A-11D-A17D-09,1,0.816125695,TCGA-AC-A2FG,BRCA,79,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29211,Alive,TUMOR FREE,1853,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1853,0,1853,0,1853,0,1853,NA,Stage IIB,T2,MX,BRCA.LumA,1
8.493123521,-3.853013719,TCGA-GM-A2DA-01A,TCGA-GM-A2DA-01A-11D-A18P-09,1,0.728842061,TCGA-GM-A2DA,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16854,Dead,WITH TUMOR,NA,6593,[Not Available],Distant Metastasis,Bone,NA,3014,[Not Available],1,6593,1,6593,1,3014,1,3014,NA,Stage IIB,T2,M0,BRCA.LumA,1
-7.29950263,1.40256412,TCGA-E9-A229-01A,TCGA-E9-A229-01A-31D-A17G-09,0,NA,TCGA-E9-A229,BRCA,37,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13817,Alive,TUMOR FREE,1148,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1148,0,1148,0,1148,0,1148,NA,Stage IA,T1c,M0,BRCA.LumA,7
-1.180085796,3.558075086,TCGA-BH-A0HX-01A,TCGA-BH-A0HX-01A-21W-A071-09,4,0.334988552,TCGA-BH-A0HX,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19900,Alive,TUMOR FREE,829,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,829,0,829,0,829,0,829,NA,Stage IIB,T2,M0,BRCA.LumA,5
-0.325823044,4.989202604,TCGA-BG-A0M7-01A,TCGA-BG-A0M7-01A-11W-A062-09,4,0.505041346,TCGA-BG-A0M7,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096,Alive,TUMOR FREE,1937,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1937,0,1937,0,1937,0,1937,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.CN low,6
9.442837837,-2.429791176,TCGA-E2-A1B5-01A,TCGA-E2-A1B5-01A-21D-A12Q-09,1,0.72470019,TCGA-E2-A1B5,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17039,Alive,TUMOR FREE,984,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,984,0,984,0,984,0,984,NA,Stage IIA,T2,M0,BRCA.LumA,1
-6.533853895,-1.190311415,TCGA-BH-A208-01A,TCGA-BH-A208-01A-11D-A159-09,7,0.300024844,TCGA-BH-A208,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1995,[Not Available],-17715,Dead,TUMOR FREE,NA,1759,[Not Available],NA,NA,NA,NA,[Not Available],1,1759,0,1759,NA,NA,0,1759,NA,Stage IIB,T2,M0,BRCA.Normal,2
-0.028062404,4.121262665,TCGA-EO-A1Y5-01A,TCGA-EO-A1Y5-01A-11D-A159-09,4,0.260664984,TCGA-EO-A1Y5,UCEC,63,FEMALE,[Not Available],Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23251,Alive,TUMOR FREE,332,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,332,0,332,0,332,0,332,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.CN high,6
-8.059610895,1.884722749,TCGA-D8-A1JS-01A,TCGA-D8-A1JS-01A-11D-A13L-09,9,0.321587368,TCGA-D8-A1JS,BRCA,77,FEMALE,WHITE,"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28178,Alive,TUMOR FREE,371,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,371,0,371,0,371,0,371,NA,Stage IA,T1c,M0,BRCA.LumA,7
-7.757531252,-2.45066107,TCGA-E9-A1R2-01A,TCGA-E9-A1R2-01A-11D-A14G-09,6,0.559076071,TCGA-E9-A1R2,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18936,Alive,TUMOR FREE,1063,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1063,0,1063,NA,NA,0,1063,NA,Stage IIIC,T2,MX,BRCA.LumA,2
-6.387899184,1.263770422,TCGA-FI-A2D2-01A,TCGA-FI-A2D2-01A-11D-A17D-09,10,0.011295339,TCGA-FI-A2D2,UCEC,66,FEMALE,WHITE,Mixed serous and endometrioid,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24260,Dead,WITH TUMOR,NA,2352,[Not Available],Locoregional Recurrence,Lung,Liver,1917,Complete Remission/Response,1,2352,1,2352,1,1917,1,1917,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN high,7
9.831448605,-2.51160161,TCGA-B5-A121-01A,TCGA-B5-A121-01A-31D-A122-09,1,0.70461271,TCGA-B5-A121,UCEC,57,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21018,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,504,0,504,0,504,0,504,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,1
-7.598148473,1.795413861,TCGA-AN-A0FS-01A,TCGA-AN-A0FS-01A-11W-A050-09,9,0.36209669,TCGA-AN-A0FS,BRCA,55,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-20352,Alive,TUMOR FREE,210,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,210,0,210,0,210,0,210,NA,Stage IA,T1c,M0,BRCA.LumA,7
8.293734492,-4.414896852,TCGA-B0-5084-01A,TCGA-B0-5084-01A-01D-1462-08,1,0.826366362,TCGA-B0-5084,KIRC,33,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-12219,Dead,WITH TUMOR,NA,222,[Not Available],NA,NA,NA,65,[Not Available],1,222,1,222,NA,NA,1,65,NA,Stage IV,T3a,M1,NA,1
9.454531201,-2.761299098,TCGA-B0-5694-01A,TCGA-B0-5694-01A-11D-1534-10,1,0.680217304,TCGA-B0-5694,KIRC,71,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-26060,Dead,WITH TUMOR,NA,480,[Not Available],NA,NA,NA,288,[Not Available],1,480,1,480,NA,NA,1,288,NA,Stage III,T3a,M0,KIRC.2,1
4.328219474,1.308945171,TCGA-B8-5164-01A,TCGA-B8-5164-01A-01D-1421-08,2,0.430137697,TCGA-B8-5164,KIRC,65,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-23863,Alive,TUMOR FREE,26,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,26,0,26,NA,NA,0,26,NA,Stage III,T3a,M0,KIRC.1,5
0.059400587,5.071974995,TCGA-24-1413-01A,TCGA-24-1413-01A-01W-0494-09,4,0.691060531,TCGA-24-1413,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-18846,Alive,TUMOR FREE,192,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,192,0,192,0,192,0,192,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
9.281444897,-4.879458446,TCGA-B4-5844-01A,TCGA-B4-5844-01A-11D-1669-08,1,0.744780308,TCGA-B4-5844,KIRC,61,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G1,2010,[Not Available],-22409,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,7,0,7,NA,NA,0,7,NA,Stage II,T2,M0,NA,1
-4.152556731,-1.798303608,TCGA-HT-8564-01A,TCGA-HT-8564-01A-11D-2395-08,8,0.350412937,TCGA-HT-8564,LGG,47,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-17499,Alive,WITH TUMOR,478,NA,[Not Available],NA,NA,NA,120,Progressive Disease,0,478,0,478,NA,NA,1,120,NA,NA,NA,NA,GBM_LGG.PA-like,10
-7.400474835,-2.429636161,TCGA-24-1436-01A,TCGA-24-1436-01A-01W-0549-09,6,0.268575585,TCGA-24-1436,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-20881,Dead,WITH TUMOR,260,260,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,260,1,260,NA,NA,1,260,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,2
-6.196762981,-1.23308263,TCGA-13-2057-01A,TCGA-13-2057-01A-02D-1526-09,0,NA,TCGA-13-2057,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-21554,Alive,WITH TUMOR,2434,NA,[Not Available],NA,[Not Applicable],[Not Applicable],897,Complete Remission/Response,0,2434,0,2434,1,897,1,897,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
-0.694718651,4.801745519,TCGA-13-1484-01A,TCGA-13-1484-01A-01W-0545-08,4,0.509361325,TCGA-13-1484,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-22698,Dead,WITH TUMOR,NA,3785,[Not Available],Recurrence,[Not Applicable],[Not Applicable],497,Complete Remission/Response,1,3785,1,3785,1,497,1,497,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
8.631683117,-4.336602079,TCGA-B8-5552-01B,TCGA-B8-5552-01B-11D-1669-08,1,0.739373199,TCGA-B8-5552,KIRC,41,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-15219,Alive,TUMOR FREE,1046,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1046,0,1046,0,1046,0,1046,NA,Stage I,T1b,M0,KIRC.1,1
9.148406109,-1.673162064,TCGA-DV-5565-01A,TCGA-DV-5565-01A-01D-1534-10,1,0.694568328,TCGA-DV-5565,KIRC,59,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-21642,Alive,WITH TUMOR,1329,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1329,0,1329,NA,NA,0,1329,NA,Stage I,T1a,M0,KIRC.3,1
10.15991761,-1.709521672,TCGA-DB-A64O-01A,TCGA-DB-A64O-01A-11D-A29Q-08,1,0.878503613,TCGA-DB-A64O,LGG,59,MALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-21811,Dead,WITH TUMOR,NA,775,[Not Available],NA,NA,NA,430,Stable Disease,1,775,1,775,NA,NA,1,430,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
8.570881233,-4.781393734,TCGA-FG-A60K-01A,TCGA-FG-A60K-01A-11D-A29Q-08,1,0.785766438,TCGA-FG-A60K,LGG,34,FEMALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-12445,Alive,WITH TUMOR,542,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,542,0,542,NA,NA,0,542,NA,NA,NA,NA,GBM_LGG.Codel,1
8.78962806,-2.785317105,TCGA-CZ-5989-01A,TCGA-CZ-5989-01A-11D-1669-08,1,0.648583518,TCGA-CZ-5989,KIRC,60,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-22170,Alive,TUMOR FREE,1905,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1905,0,1905,NA,NA,0,1905,NA,Stage II,T2,M0,KIRC.1,1
7.725027241,-3.391322177,TCGA-DB-A64L-01A,TCGA-DB-A64L-01A-11D-A29Q-08,1,0.303366324,TCGA-DB-A64L,LGG,67,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-24690,Alive,WITH TUMOR,736,NA,[Not Available],NA,NA,NA,724,Complete Remission/Response,0,736,0,736,1,724,1,724,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.962134601,-1.550978579,TCGA-24-1469-01A,TCGA-24-1469-01A-01W-0553-09,8,0.086911914,TCGA-24-1469,OV,71,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-25937,Alive,TUMOR FREE,277,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,277,0,277,0,277,0,277,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,10
0.046970165,5.260823505,TCGA-DB-A64S-01A,TCGA-DB-A64S-01A-11D-A29Q-08,4,0.668429105,TCGA-DB-A64S,LGG,20,MALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-7389,Alive,TUMOR FREE,835,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,835,0,835,0,835,0,835,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-1.811764909,1.012350374,TCGA-CZ-5468-01A,TCGA-CZ-5468-01A-01D-1501-10,5,0.515649145,TCGA-CZ-5468,KIRC,84,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-30729,Dead,WITH TUMOR,59,59,[Not Available],NA,NA,NA,NA,[Not Available],1,59,1,59,NA,NA,1,59,NA,Stage IV,T3b,M1,KIRC.3,4
-0.556635345,2.213681521,TCGA-B8-4621-01A,TCGA-B8-4621-01A-01D-1501-10,0,NA,TCGA-B8-4621,KIRC,63,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-23176,Alive,TUMOR FREE,788,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,788,0,788,0,788,0,788,NA,Stage I,T1b,M0,KIRC.4,3
9.507312151,-2.455013045,TCGA-BP-4963-01A,TCGA-BP-4963-01A-01D-1462-08,1,0.754033104,TCGA-BP-4963,KIRC,63,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-23373,Alive,TUMOR FREE,1834,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1834,0,1834,NA,NA,0,1834,NA,Stage I,T1b,M0,KIRC.2,1
8.693025676,-1.903674359,TCGA-FG-A4MW-01A,TCGA-FG-A4MW-01A-11D-A26M-08,1,0.570604379,TCGA-FG-A4MW,LGG,63,MALE,WHITE,Oligoastrocytoma,G3,2012,[Not Available],-23077,Dead,WITH TUMOR,NA,559,[Not Available],NA,NA,NA,226,Stable Disease,1,559,1,559,NA,NA,1,226,NA,NA,NA,NA,GBM_LGG.Classic-like,1
1.963503706,1.94434412,TCGA-BP-5000-01A,TCGA-BP-5000-01A-01D-1462-08,3,0.529809873,TCGA-BP-5000,KIRC,40,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-14868,Alive,TUMOR FREE,563,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,563,0,563,NA,NA,0,563,NA,Stage I,T1b,M0,KIRC.2,3
-0.206973921,4.853840786,TCGA-30-1891-01A,TCGA-30-1891-01A-01W-0699-08,4,0.523357118,TCGA-30-1891,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2004,[Not Available],-22344,Dead,WITH TUMOR,914,914,[Not Available],Recurrence,[Not Applicable],[Not Applicable],181,Partial Remission/Response,1,914,1,914,NA,NA,1,181,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-0.841015524,4.63459208,TCGA-61-2003-01A,TCGA-61-2003-01A-01W-0722-08,4,0.362557644,TCGA-61-2003,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2008,[Not Available],-19605,Alive,WITH TUMOR,122,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,122,0,122,NA,NA,0,122,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
1.103153675,3.523294641,TCGA-FG-A60J-01A,TCGA-FG-A60J-01A-11D-A289-08,0,NA,TCGA-FG-A60J,LGG,47,FEMALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-17339,Alive,TUMOR FREE,449,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,449,0,449,0,449,0,449,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-7.831554888,-2.43567941,TCGA-A3-3365-01A,TCGA-A3-3365-01A-01D-0966-08,6,0.502484396,TCGA-A3-3365,KIRC,46,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-16915,Alive,NA,873,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,873,0,873,NA,NA,0,873,NA,Stage I,T1a,M0,KIRC.1,2
8.808283569,-4.197631395,TCGA-A8-A082-01A,TCGA-A8-A082-01A-11W-A019-09,1,0.70861009,TCGA-A8-A082,BRCA,58,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21338,Alive,TUMOR FREE,549,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,549,0,549,0,549,0,549,NA,Stage IIB,T2,M0,BRCA.LumB,1
-2.846612291,1.436519351,TCGA-04-1361-01A,TCGA-04-1361-01A-01W-0492-08,0,NA,TCGA-04-1361,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-20860,Alive,NA,989,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],927,Stable Disease,0,989,0,989,NA,NA,1,927,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,6
-7.769143315,1.916752221,TCGA-A2-A1G0-01A,TCGA-A2-A1G0-01A-11D-A13L-09,9,0.38788806,TCGA-A2-A1G0,BRCA,49,FEMALE,WHITE,"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18002,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,616,0,616,0,616,0,616,NA,Stage IIB,T2,M0,BRCA.LumA,7
9.40264032,-2.92223847,TCGA-CJ-6027-01A,TCGA-CJ-6027-01A-11D-1669-08,1,0.729569739,TCGA-CJ-6027,KIRC,77,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2003,[Not Available],-28359,Dead,TUMOR FREE,NA,3615,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,3615,0,3615,0,3615,0,3615,NA,Stage I,T1a,M0,KIRC.3,1
-0.188716812,4.234495059,TCGA-D8-A1XT-01A,TCGA-D8-A1XT-01A-11D-A14K-09,4,0.419401472,TCGA-D8-A1XT,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22448,Alive,TUMOR FREE,506,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,506,0,506,0,506,0,506,NA,Stage IIA,T1c,M0,BRCA.Her2,6
-6.72015095,-2.192603852,TCGA-13-0903-01A,TCGA-13-0903-01A-01W-0420-08,6,0.115309871,TCGA-13-0903,OV,42,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-15705,Alive,TUMOR FREE,3887,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3887,0,3887,NA,NA,0,3887,NA,Stage IV,[Not Applicable],[Not Applicable],NA,2
-7.358336612,1.515950679,TCGA-BP-4960-01A,TCGA-BP-4960-01A-01D-1462-08,0,NA,TCGA-BP-4960,KIRC,46,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-17099,Alive,TUMOR FREE,2172,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2172,0,2172,NA,NA,0,2172,NA,Stage II,T2,M0,KIRC.2,7
-7.922806247,2.137966452,TCGA-A8-A09D-01A,TCGA-A8-A09D-01A-11W-A019-09,9,0.611390634,TCGA-A8-A09D,BRCA,47,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17440,Alive,TUMOR FREE,1522,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1522,0,1522,0,1522,0,1522,NA,Stage IIB,T2,M0,BRCA.LumA,7
-8.059250451,2.309410966,TCGA-A8-A08T-01A,TCGA-A8-A08T-01A-21W-A019-09,9,0.392053543,TCGA-A8-A08T,BRCA,64,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23560,Dead,WITH TUMOR,NA,3409,[Not Available],NA,NA,NA,2557,[Not Available],1,3409,1,3409,NA,NA,1,2557,NA,Stage IV,T2,M1,BRCA.LumA,7
-7.289081861,2.142898076,TCGA-BG-A0VV-01A,TCGA-BG-A0VV-01A-21D-A122-09,9,0.203576432,TCGA-BG-A0VV,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19581,Alive,TUMOR FREE,1553,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1553,0,1553,0,1553,0,1553,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-8.051809916,2.10925025,TCGA-D8-A27T-01A,TCGA-D8-A27T-01A-11D-A16D-09,9,0.637337627,TCGA-D8-A27T,BRCA,53,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19591,Alive,TUMOR FREE,398,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,398,0,398,0,398,0,398,NA,Stage IIIC,T2,M0,BRCA.LumA,7
0.18274802,5.101552712,TCGA-BH-A0AV-01A,TCGA-BH-A0AV-01A-31D-A10Y-09,4,0.565125758,TCGA-BH-A0AV,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-19314,Alive,TUMOR FREE,1820,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1820,0,1820,0,1820,0,1820,NA,Stage I,T1c,M0,BRCA.Basal,6
-7.823701723,-2.450880717,TCGA-AJ-A3EJ-01A,TCGA-AJ-A3EJ-01A-11D-A19Y-09,6,0.465001722,TCGA-AJ-A3EJ,UCEC,74,FEMALE,WHITE,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27317,Dead,WITH TUMOR,NA,50,[Not Available],NA,NA,NA,NA,[Not Available],1,50,1,50,NA,NA,1,50,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,2
2.984897576,3.564526531,TCGA-BG-A0YU-01A,TCGA-BG-A0YU-01A-21D-A10M-09,0,NA,TCGA-BG-A0YU,UCEC,37,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13644,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,451,0,451,0,451,0,451,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,1
0.003666445,4.9182993,TCGA-20-1682-01A,TCGA-20-1682-01A-01W-0633-09,4,0.618610973,TCGA-20-1682,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,GX,2007,[Not Available],-20583,Alive,TUMOR FREE,837,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,837,0,837,0,837,0,837,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
9.077158558,-4.781042378,TCGA-C8-A137-01A,TCGA-C8-A137-01A-11D-A10Y-09,1,0.824145629,TCGA-C8-A137,BRCA,34,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12729,Alive,WITH TUMOR,379,NA,[Not Available],Locoregional Recurrence,NA,NA,136,[Not Available],0,379,0,379,1,136,1,136,NA,Stage IIB,T2,M0,BRCA.Her2,1
-1.757165218,2.031273177,TCGA-C8-A27B-01A,TCGA-C8-A27B-01A-11D-A167-09,0,NA,TCGA-C8-A27B,BRCA,48,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-17763,Alive,TUMOR FREE,439,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,439,0,439,0,439,0,439,NA,Stage IIB,T3,M0,BRCA.Basal,3
2.962630557,3.554997264,TCGA-E2-A1L9-01A,TCGA-E2-A1L9-01A-11D-A13L-09,0,NA,TCGA-E2-A1L9,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14868,Alive,TUMOR FREE,598,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,598,0,598,0,598,0,598,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-0.804900859,3.800944674,TCGA-61-1906-01A,TCGA-61-1906-01A-01W-0639-09,4,0.326357157,TCGA-61-1906,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-20378,Dead,WITH TUMOR,1038,1038,[Not Available],Recurrence,[Not Applicable],[Not Applicable],236,Complete Remission/Response,1,1038,1,1038,1,236,1,236,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
8.838388169,-3.696072861,TCGA-BH-A0B4-01A,TCGA-BH-A0B4-01A-11W-A019-09,1,0.717748283,TCGA-BH-A0B4,BRCA,65,MALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-23980,Alive,TUMOR FREE,1191,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1191,0,1191,0,1191,0,1191,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-2.734650702,-4.352426631,TCGA-AP-A1DK-01A,TCGA-AP-A1DK-01A-11D-A135-09,0,NA,TCGA-AP-A1DK,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19509,Alive,TUMOR FREE,2767,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2767,0,2767,0,2767,0,2767,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.01007747,-1.176379463,TCGA-D1-A17F-01A,TCGA-D1-A17F-01A-11D-A12J-09,7,0.137606271,TCGA-D1-A17F,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116,Alive,TUMOR FREE,39,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,39,0,39,0,39,0,39,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,2
-5.927406483,-1.775198475,TCGA-DI-A2QY-01A,TCGA-DI-A2QY-01A-12D-A19Y-09,0,NA,TCGA-DI-A2QY,UCEC,64,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23398,Dead,TUMOR FREE,NA,3349,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,3349,0,3349,0,3349,0,3349,NA,Stage IIB,[Not Applicable],[Not Applicable],NA,9
-7.294892335,1.47186247,TCGA-C8-A12U-01A,TCGA-C8-A12U-01A-11D-A10Y-09,0,NA,TCGA-C8-A12U,BRCA,46,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17045,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,0,385,0,385,NA,Stage IIB,T2,M0,BRCA.LumB,7
9.637006212,-2.803114739,TCGA-D8-A1JB-01A,TCGA-D8-A1JB-01A-11D-A13L-09,1,0.742711871,TCGA-D8-A1JB,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19822,Alive,TUMOR FREE,1688,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1688,0,1688,0,1688,0,1688,NA,Stage IIB,T2,M0,BRCA.LumA,1
-5.775964377,-2.042510087,TCGA-24-1435-01A,TCGA-24-1435-01A-01W-0549-09,0,NA,TCGA-24-1435,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-21107,Dead,WITH TUMOR,1324,1324,[Not Available],Recurrence,[Not Applicable],[Not Applicable],505,Complete Remission/Response,1,1324,1,1324,1,505,1,505,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
-2.730573346,-4.367981899,TCGA-DI-A1BU-01A,TCGA-DI-A1BU-01A-11D-A135-09,0,NA,TCGA-DI-A1BU,UCEC,55,FEMALE,WHITE,Mixed serous and endometrioid,G3,2008,[Not Available],-20114,Alive,TUMOR FREE,1195,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1195,0,1195,0,1195,0,1195,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-4.664978713,-1.413467449,TCGA-A8-A0A7-01A,TCGA-A8-A0A7-01A-11W-A019-09,8,0.386958933,TCGA-A8-A0A7,BRCA,57,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20940,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,0,30,0,30,NA,Stage IIB,T2,M0,BRCA.Her2,10
-1.492743717,3.287322192,TCGA-23-1116-01A,TCGA-23-1116-01A-01W-0486-08,0,NA,TCGA-23-1116,OV,83,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-30464,Dead,WITH TUMOR,NA,592,[Not Available],Recurrence,[Not Applicable],[Not Applicable],286,Complete Remission/Response,1,592,1,592,1,286,1,286,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
4.288227567,1.300832172,TCGA-BP-5186-01A,TCGA-BP-5186-01A-01D-1429-08,2,0.608985021,TCGA-BP-5186,KIRC,50,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-18348,Alive,TUMOR FREE,693,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,693,0,693,NA,NA,0,693,NA,Stage I,T1a,M0,KIRC.NA,5
-6.991325367,2.308313109,TCGA-EY-A2OO-01A,TCGA-EY-A2OO-01A-11D-A19Y-09,0,NA,TCGA-EY-A2OO,UCEC,56,FEMALE,WHITE,Mixed serous and endometrioid,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20797,Alive,TUMOR FREE,1392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1392,0,1392,0,1392,0,1392,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
-6.638284873,-1.232902919,TCGA-D1-A102-01A,TCGA-D1-A102-01A-11D-A10M-09,7,0.251121314,TCGA-D1-A102,UCEC,49,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Peri (6-12 months since last menstrual period),-17991,Alive,TUMOR FREE,135,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,135,0,135,0,135,0,135,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,2
-6.652521411,-1.609160503,TCGA-13-0791-01A,TCGA-13-0791-01A-01W-0371-08,0,NA,TCGA-13-0791,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-21380,Dead,WITH TUMOR,NA,1224,[Not Available],Recurrence,[Not Applicable],[Not Applicable],281,Complete Remission/Response,1,1224,1,1224,1,281,1,281,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
0.039099309,4.829312389,TCGA-C8-A12O-01A,TCGA-C8-A12O-01A-11D-A10Y-09,4,0.577585076,TCGA-C8-A12O,BRCA,50,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18506,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,0,385,0,385,NA,Stage IIA,T2,M0,BRCA.LumA,6
-4.686985905,-1.553819963,TCGA-BH-A18P-01A,TCGA-BH-A18P-01A-11D-A12B-09,8,0.263870852,TCGA-BH-A18P,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,[Not Available],-22222,Dead,WITH TUMOR,NA,921,[Not Available],NA,NA,NA,NA,[Not Available],1,921,1,921,NA,NA,1,921,NA,Stage I,T1,M0,BRCA.Her2,10
-0.646990359,3.693691849,TCGA-AQ-A04H-01B,TCGA-AQ-A04H-01B-11D-A10M-09,4,0.310693839,TCGA-AQ-A04H,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22539,Alive,TUMOR FREE,754,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,754,0,754,0,754,0,754,NA,Stage IIIA,T2,MX,BRCA.LumB,5
-0.841260271,3.714382475,TCGA-61-1895-01A,TCGA-61-1895-01A-01W-0639-09,4,0.379217898,TCGA-61-1895,OV,52,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-19060,Alive,TUMOR FREE,44,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,44,0,44,NA,NA,0,44,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,5
-6.509764,-1.338421663,TCGA-AX-A1C8-01A,TCGA-AX-A1C8-01A-11D-A135-09,7,0.271441054,TCGA-AX-A1C8,UCEC,77,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28452,Alive,NA,776,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,776,0,776,NA,NA,0,776,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.CN high,2
2.134460159,1.797006872,TCGA-BH-A0DD-01A,TCGA-BH-A0DD-01A-31D-A12Q-09,3,0.525048518,TCGA-BH-A0DD,BRCA,58,MALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-21386,Alive,TUMOR FREE,2486,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2486,0,2486,0,2486,0,2486,NA,Stage IIB,T2,M0,BRCA.LumB,3
-8.103753186,2.145595657,TCGA-BG-A0W1-01A,TCGA-BG-A0W1-01A-12D-A10G-09,9,0.298519969,TCGA-BG-A0W1,UCEC,89,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32750,Alive,TUMOR FREE,1607,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1607,0,1607,0,1607,0,1607,NA,Stage II,[Not Applicable],[Not Applicable],UCEC.CN low,7
9.536990925,-2.414433317,TCGA-A2-A1FW-01A,TCGA-A2-A1FW-01A-11D-A13L-09,1,0.788018648,TCGA-A2-A1FW,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22779,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,528,0,528,0,528,0,528,NA,Stage IIIA,T3,M0,BRCA.LumB,1
-0.473574516,2.834569826,TCGA-36-2534-01A,TCGA-36-2534-01A-01D-1526-09,4,0.156550482,TCGA-36-2534,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-26621,Alive,WITH TUMOR,907,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],383,Partial Remission/Response,0,907,0,907,NA,NA,1,383,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
1.815669826,2.057716447,TCGA-GI-A2C8-01A,TCGA-GI-A2C8-01A-11D-A16D-09,3,0.253171147,TCGA-GI-A2C8,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,[Not Available],-23103,Alive,NA,225,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,225,0,225,0,225,0,225,NA,Stage IIIB,T4b,MX,BRCA.LumA,3
9.312877177,-3.405625371,TCGA-A8-A09E-01A,TCGA-A8-A09E-01A-11W-A019-09,1,0.728434189,TCGA-A8-A09E,BRCA,73,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724,Alive,WITH TUMOR,1492,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1492,0,1492,NA,NA,0,1492,NA,Stage IIIB,T4b,M0,NA,1
-6.430859111,1.734348145,TCGA-BH-A202-01A,TCGA-BH-A202-01A-11D-A14K-09,10,0.373302548,TCGA-BH-A202,BRCA,60,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22052,Alive,TUMOR FREE,795,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,795,0,795,NA,NA,0,795,NA,Stage II,T2,M0,BRCA.LumB,7
-0.540440521,3.511087084,TCGA-29-2434-01A,TCGA-29-2434-01A-01D-1526-09,4,0.237194609,TCGA-29-2434,OV,52,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-18997,Alive,TUMOR FREE,349,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,349,0,349,0,349,0,349,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
-5.833683375,2.957948434,TCGA-B5-A0JX-01A,TCGA-B5-A0JX-01A-21D-A14K-09,0,NA,TCGA-B5-A0JX,UCEC,62,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22834,Alive,TUMOR FREE,1787,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1787,0,1787,0,1787,0,1787,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-8.126057819,2.018394965,TCGA-AR-A1AV-01A,TCGA-AR-A1AV-01A-21D-A12Q-09,9,0.506278553,TCGA-AR-A1AV,BRCA,68,MALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-24875,Alive,TUMOR FREE,1864,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1864,0,1864,0,1864,0,1864,NA,Stage IIB,T2,M0,BRCA.LumA,7
9.152316636,-4.214441276,TCGA-E9-A248-01A,TCGA-E9-A248-01A-11D-A167-09,1,0.736695482,TCGA-E9-A248,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-18684,Alive,TUMOR FREE,59,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,59,0,59,0,59,0,59,NA,Stage IIA,T2,M0,BRCA.Her2,1
-8.072204123,2.054182859,TCGA-D8-A146-01A,TCGA-D8-A146-01A-31D-A10Y-09,9,0.408994058,TCGA-D8-A146,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20861,Alive,TUMOR FREE,643,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,643,0,643,0,643,0,643,NA,Stage IIA,T2,MX,NA,7
0.17573559,2.631347889,TCGA-30-1855-01A,TCGA-30-1855-01A-01W-0639-09,4,0.165714878,TCGA-30-1855,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-22394,Dead,WITH TUMOR,75,75,[Not Available],NA,NA,NA,NA,[Not Available],1,75,1,75,NA,NA,1,75,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-8.154546885,2.068447219,TCGA-AN-A0XS-01A,TCGA-AN-A0XS-01A-22D-A10G-09,9,0.360634031,TCGA-AN-A0XS,BRCA,63,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23358,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIIA,T2,M0,BRCA.LumA,7
-0.730336095,3.708614263,TCGA-13-0804-01A,TCGA-13-0804-01A-01W-0372-09,4,0.32097134,TCGA-13-0804,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-27021,Dead,WITH TUMOR,1073,1073,[Not Available],Recurrence,[Not Applicable],[Not Applicable],329,Complete Remission/Response,1,1073,1,1073,1,329,1,329,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
0.272444952,4.506452815,TCGA-24-1550-01A,TCGA-24-1550-01A-01W-0551-08,4,0.529414289,TCGA-24-1550,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1997,[Not Available],-18049,Dead,WITH TUMOR,1249,1249,[Not Available],Recurrence,[Not Applicable],[Not Applicable],892,Complete Remission/Response,1,1249,1,1249,1,892,1,892,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-7.134496682,1.738943575,TCGA-BP-4985-01A,TCGA-BP-4985-01A-01D-1462-08,0,NA,TCGA-BP-4985,KIRC,72,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2006,[Not Available],-26611,Dead,WITH TUMOR,NA,952,[Not Available],NA,NA,NA,205,[Not Available],1,952,1,952,NA,NA,1,205,NA,Stage III,T3a,M0,KIRC.3,7
-6.215101292,1.625642851,TCGA-GM-A2DH-01A,TCGA-GM-A2DH-01A-11D-A17W-09,10,0.324625564,TCGA-GM-A2DH,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21344,Alive,TUMOR FREE,2193,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2193,0,2193,0,2193,0,2193,NA,Stage I,T1c,M0,BRCA.Her2,8
8.970845872,-3.423598161,TCGA-C8-A12M-01A,TCGA-C8-A12M-01A-11D-A135-09,1,0.716967358,TCGA-C8-A12M,BRCA,70,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25811,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,358,0,358,0,358,0,358,NA,Stage IIA,T2,M0,BRCA.LumB,1
-7.999878798,1.924847137,TCGA-A8-A07Z-01A,TCGA-A8-A07Z-01A-11W-A019-09,9,0.613614534,TCGA-A8-A07Z,BRCA,85,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31351,Alive,TUMOR FREE,1371,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1371,0,1371,0,1371,0,1371,NA,Stage IIA,T2,M0,BRCA.LumA,7
-0.765050661,4.535457323,TCGA-24-1843-01A,TCGA-24-1843-01A-01W-0639-09,4,0.469660172,TCGA-24-1843,OV,66,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-24469,Alive,NA,106,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,106,0,106,0,106,0,106,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
9.605503835,-5.665747566,TCGA-EW-A1P5-01A,TCGA-EW-A1P5-01A-11D-A142-09,1,0.878999199,TCGA-EW-A1P5,BRCA,77,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28177,Alive,TUMOR FREE,703,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,703,0,703,0,703,0,703,NA,Stage IIB,T2,M0,BRCA.LumA,1
8.87790292,-3.876578035,TCGA-04-1346-01A,TCGA-04-1346-01A-01W-0486-08,1,0.733905088,TCGA-04-1346,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2003,[Not Available],-26865,Alive,TUMOR FREE,1993,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1993,0,1993,0,1993,0,1993,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-6.717638953,-2.277573771,TCGA-24-1426-01A,TCGA-24-1426-01A-01W-0549-09,6,0.065969334,TCGA-24-1426,OV,43,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-15949,Alive,TUMOR FREE,163,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,163,0,163,0,163,0,163,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
0.415070227,2.128208715,TCGA-A8-A08H-01A,TCGA-A8-A08H-01A-21W-A019-09,0,NA,TCGA-A8-A08H,BRCA,66,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24137,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIA,T2,M0,BRCA.Normal,6
0.067055081,5.149339745,TCGA-BH-A0C3-01A,TCGA-BH-A0C3-01A-21D-A12Q-09,4,0.584818403,TCGA-BH-A0C3,BRCA,47,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17221,Alive,WITH TUMOR,2709,NA,[Not Available],Distant Metastasis,Bone,NA,2674,[Not Available],0,2709,0,2709,1,2674,1,2674,NA,Stage I,T1c,M0,BRCA.LumB,6
-7.684549264,1.722760488,TCGA-A2-A0T7-01A,TCGA-A2-A0T7-01A-21D-A099-09,9,0.242183344,TCGA-A2-A0T7,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18756,Alive,TUMOR FREE,631,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,631,0,631,0,631,0,631,NA,Stage IIA,T2,M0,BRCA.LumA,7
-6.478016774,1.513825777,TCGA-E2-A14Z-01A,TCGA-E2-A14Z-01A-11D-A10Y-09,10,0.151534464,TCGA-E2-A14Z,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23682,Dead,WITH TUMOR,NA,563,[Not Available],Distant Metastasis,Bone,NA,188,[Not Available],1,563,1,563,1,188,1,188,NA,Stage I,T1c,M0,BRCA.LumA,7
9.812756372,-4.287235139,TCGA-EW-A1J6-01A,TCGA-EW-A1J6-01A-11D-A188-09,1,0.683919779,TCGA-EW-A1J6,BRCA,70,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25830,Alive,TUMOR FREE,875,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,875,0,875,0,875,0,875,NA,Stage I,T1c,M0,BRCA.LumB,1
9.36724181,-4.537539402,TCGA-A2-A25E-01A,TCGA-A2-A25E-01A-11D-A167-09,1,0.726779138,TCGA-A2-A25E,BRCA,34,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12601,Alive,TUMOR FREE,3204,NA,[Not Available],Locoregional Recurrence,"Other, specify",Left Chest Wall,2989,[Not Available],0,3204,0,3204,1,2989,1,2989,NA,Stage IIIA,T2,M0,BRCA.LumB,1
9.422495828,-4.711205771,TCGA-C8-A26X-01A,TCGA-C8-A26X-01A-31D-A16D-09,1,0.781758461,TCGA-C8-A26X,BRCA,58,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21463,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,376,0,376,0,376,0,376,NA,Stage IIA,T1,M0,BRCA.Her2,1
2.969773387,3.56380279,TCGA-BH-A0BS-01A,TCGA-BH-A0BS-01A-11D-A12Q-09,0,NA,TCGA-BH-A0BS,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20374,Alive,TUMOR FREE,2612,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2612,0,2612,0,2612,0,2612,NA,Stage IIIA,T3,M0,BRCA.LumA,1
-7.967924884,2.235602587,TCGA-AO-A1KR-01A,TCGA-AO-A1KR-01A-12D-A142-09,9,0.457451924,TCGA-AO-A1KR,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18900,Alive,TUMOR FREE,2513,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2513,0,2513,0,2513,0,2513,NA,Stage IIA,T2,M0,BRCA.Basal,7
-7.471373284,2.275836932,TCGA-B6-A0RQ-01A,TCGA-B6-A0RQ-01A-11D-A10Y-09,9,0.309445556,TCGA-B6-A0RQ,BRCA,68,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],1994,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25010,Dead,TUMOR FREE,NA,4267,[Not Available],NA,NA,NA,NA,[Not Available],1,4267,0,4267,0,4267,0,4267,NA,Stage IIB,T3,M0,BRCA.Normal,7
-1.142435342,4.31554269,TCGA-BH-A0BL-01A,TCGA-BH-A0BL-01A-11D-A10Y-09,4,0.443798663,TCGA-BH-A0BL,BRCA,35,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12841,Alive,TUMOR FREE,2278,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2278,0,2278,0,2278,0,2278,NA,Stage I,T1c,M0,BRCA.Basal,6
9.658310136,-2.16312296,TCGA-E2-A15S-01A,TCGA-E2-A15S-01A-11D-A10Y-09,1,0.760542751,TCGA-E2-A15S,BRCA,34,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-12671,Alive,TUMOR FREE,428,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,428,0,428,0,428,0,428,NA,Stage IIB,T2,M0,BRCA.LumB,1
8.915915994,-3.517084977,TCGA-BH-A0C7-01B,TCGA-BH-A0C7-01B-11D-A10Y-09,1,0.729252235,TCGA-BH-A0C7,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Peri (6-12 months since last menstrual period),-17871,Alive,TUMOR FREE,2767,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2767,0,2767,0,2767,0,2767,NA,Stage IIB,T2,M0,BRCA.LumB,1
4.290646818,1.004796353,TCGA-BH-A209-01A,TCGA-BH-A209-01A-11D-A17G-09,2,0.621481559,TCGA-BH-A209,BRCA,77,FEMALE,BLACK OR AFRICAN AMERICAN,Medullary Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28403,Dead,TUMOR FREE,NA,3959,[Not Available],NA,NA,NA,NA,[Not Available],1,3959,0,3959,NA,NA,0,3959,NA,Stage I,T1c,M0,BRCA.LumB,5
1.591416103,1.998138535,TCGA-D8-A1XF-01A,TCGA-D8-A1XF-01A-11D-A14G-09,3,0.340405236,TCGA-D8-A1XF,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16787,Alive,TUMOR FREE,463,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,463,0,463,NA,NA,0,463,NA,Stage IIA,T2,M0,BRCA.LumB,3
8.889582194,-4.428796363,TCGA-BH-A1EX-01A,TCGA-BH-A1EX-01A-11D-A13L-09,1,0.804271846,TCGA-BH-A1EX,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24544,Dead,WITH TUMOR,NA,1508,[Not Available],NA,NA,NA,NA,[Not Available],1,1508,1,1508,NA,NA,1,1508,NA,Stage IIB,T2,M0,BRCA.LumA,1
8.621331434,-2.048540697,TCGA-A7-A3RF-01A,TCGA-A7-A3RF-01A-11D-A228-09,1,0.56413793,TCGA-A7-A3RF,BRCA,79,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29184,Alive,WITH TUMOR,408,NA,[Not Available],Distant Metastasis,Bone,NA,174,[Not Available],0,408,0,408,1,174,1,174,NA,Stage IIA,T2,M0,BRCA.LumA,1
0.40271304,3.683613589,TCGA-A8-A079-01A,TCGA-A8-A079-01A-21W-A019-09,4,0.230810754,TCGA-A8-A079,BRCA,69,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25294,Alive,TUMOR FREE,274,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,274,0,274,0,274,0,274,NA,Stage IIIB,T4b,M0,BRCA.LumB,3
-3.822126264,-0.411730756,TCGA-T3-A92M-01A,TCGA-T3-A92M-01A-31D-A391-08,0,NA,TCGA-T3-A92M,HNSC,52,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-19247,Alive,WITH TUMOR,417,NA,[Not Available],Distant Metastasis,Distant Metastasis,(Rt) Lung,417,[Unknown],0,417,0,417,NA,NA,1,417,NA,Stage IVA,T4a,MX,NA,10
-0.271361101,5.351508304,TCGA-IQ-A6SH-01A,TCGA-IQ-A6SH-01A-12D-A34J-08,4,0.474233157,TCGA-IQ-A6SH,HNSC,55,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G1,2013,[Not Available],-20109,Alive,TUMOR FREE,471,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,471,0,471,NA,NA,0,471,NA,Stage III,T2,M0,NA,6
0.27648676,4.74767874,TCGA-IQ-A6SG-01A,TCGA-IQ-A6SG-01A-12D-A34J-08,4,0.524928644,TCGA-IQ-A6SG,HNSC,61,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-22529,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,579,0,579,0,579,0,579,NA,Stage III,T3,M0,NA,6
0.141390841,4.913536816,TCGA-B5-A0KB-01B,TCGA-B5-A0KB-01B-11D-A14G-09,4,0.704008726,TCGA-B5-A0KB,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22669,Alive,WITH TUMOR,824,NA,[Not Available],Locoregional Disease,"Other, specify",cul de sac mass,689,Complete Remission/Response,0,824,0,824,1,689,1,689,NA,Stage IB,[Not Applicable],[Not Applicable],NA,6
-5.512717697,2.234505484,TCGA-D6-A6EN-01A,TCGA-D6-A6EN-01A-11D-A31L-08,0,NA,TCGA-D6-A6EN,HNSC,71,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2013,[Not Available],-26294,Alive,TUMOR FREE,687,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,687,0,687,0,687,0,687,NA,Stage III,T2,M0,NA,8
-0.615420101,4.746532643,TCGA-CX-A4AQ-01A,TCGA-CX-A4AQ-01A-11D-A25D-08,4,0.541678108,TCGA-CX-A4AQ,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-20709,Alive,TUMOR FREE,1555,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1555,0,1555,NA,NA,0,1555,NA,Stage IVA,T2,M0,NA,6
9.217410664,-2.776548612,TCGA-BH-A18M-01A,TCGA-BH-A18M-01A-11D-A12B-09,1,0.700164721,TCGA-BH-A18M,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-14532,Dead,NA,NA,2207,[Not Available],NA,NA,NA,NA,[Not Available],1,2207,NA,2207,0,2207,0,2207,NA,Stage IIIA,T3,M0,BRCA.LumA,1
0.203606307,5.064110614,TCGA-EW-A1PA-01A,TCGA-EW-A1PA-01A-11D-A142-09,4,0.6905579,TCGA-EW-A1PA,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21837,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,575,0,575,0,575,0,575,NA,Stage IIB,T2,M0,BRCA.LumA,6
9.761509774,-1.686139151,TCGA-24-1565-01A,TCGA-24-1565-01A-01W-0551-08,1,0.866098035,TCGA-24-1565,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1997,[Not Available],-27048,Dead,WITH TUMOR,312,312,[Not Available],Recurrence,[Not Applicable],[Not Applicable],145,Partial Remission/Response,1,312,1,312,NA,NA,1,145,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-7.082069528,1.64260822,TCGA-A5-A0GN-01A,TCGA-A5-A0GN-01A-11W-A062-09,0,NA,TCGA-A5-A0GN,UCEC,65,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24020,Alive,TUMOR FREE,1841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1841,0,1841,0,1841,0,1841,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN high,7
-7.084244126,2.233272106,TCGA-B8-5550-01A,TCGA-B8-5550-01A-01D-1534-10,9,0.132000424,TCGA-B8-5550,KIRC,71,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-25937,Alive,WITH TUMOR,1476,NA,[Not Available],NA,NA,NA,694,Complete Remission/Response,0,1476,0,1476,1,694,1,694,NA,Stage III,T3a,M0,KIRC.3,7
8.993356622,-1.374427999,TCGA-B0-5119-01A,TCGA-B0-5119-01A-02D-1421-08,1,0.569786191,TCGA-B0-5119,KIRC,61,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-22607,Alive,TUMOR FREE,1552,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1552,0,1552,0,1552,0,1552,NA,Stage I,T1b,M0,KIRC.1,6
9.350027176,-4.133868964,TCGA-A1-A0SN-01A,TCGA-A1-A0SN-01A-11D-A142-09,1,0.746338938,TCGA-A1-A0SN,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18401,Alive,TUMOR FREE,1196,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1196,0,1196,0,1196,0,1196,NA,Stage IIA,T1c,MX,BRCA.LumB,1
2.993944537,3.576175729,TCGA-E9-A22H-01A,TCGA-E9-A22H-01A-11D-A159-09,0,NA,TCGA-E9-A22H,BRCA,42,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15504,Alive,TUMOR FREE,1232,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1232,0,1232,0,1232,0,1232,NA,Stage IIB,T2,M0,BRCA.LumB,1
8.882838754,-5.218601834,TCGA-B0-5102-01A,TCGA-B0-5102-01A-01D-1421-08,1,0.788171173,TCGA-B0-5102,KIRC,74,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,1999,[Not Available],-27152,Dead,[Discrepancy],NA,2764,[Not Available],NA,NA,NA,2734,[Not Available],1,2764,NA,2764,NA,NA,1,2734,NA,Stage I,T1,M0,KIRC.4,1
2.794650138,3.565065668,TCGA-C8-A26V-01A,TCGA-C8-A26V-01A-11D-A16D-09,0,NA,TCGA-C8-A26V,BRCA,47,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-17468,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,616,0,616,0,616,0,616,NA,Stage IIIA,T3,M0,BRCA.LumB,6
-6.008843155,2.94504223,TCGA-E2-A14W-01A,TCGA-E2-A14W-01A-11D-A12B-09,0,NA,TCGA-E2-A14W,BRCA,78,MALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-28664,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,974,0,974,0,974,0,974,NA,Stage IIA,T2,M0,BRCA.LumB,8
7.841130099,-1.346914845,TCGA-CJ-4900-01A,TCGA-CJ-4900-01A-01D-1462-08,1,0.145911964,TCGA-CJ-4900,KIRC,69,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2006,[Not Available],-25508,Dead,WITH TUMOR,NA,1714,[Not Available],NA,NA,NA,NA,[Not Available],1,1714,1,1714,NA,NA,1,1714,NA,Stage IV,T4,M1,NA,1
-1.113292081,3.365442631,TCGA-FV-A3R2-01A,TCGA-FV-A3R2-01A-11D-A22F-10,0,NA,TCGA-FV-A3R2,LIHC,75,MALE,WHITE,Hepatocellular Carcinoma,[Not Available],2005,[Not Available],-27530,Dead,TUMOR FREE,NA,194,[Not Available],NA,NA,NA,NA,[Not Available],1,194,0,194,0,194,0,194,NA,Stage I,T1,MX,LIHC.NA,3
-0.466265935,4.504141714,TCGA-G3-A5SM-01A,TCGA-G3-A5SM-01A-12D-A28X-10,4,0.583034711,TCGA-G3-A5SM,LIHC,58,MALE,WHITE,Hepatocellular Carcinoma,G3,2012,[Not Available],-21236,Alive,TUMOR FREE,520,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,252,[Not Available],0,520,0,520,1,252,1,252,NA,Stage II,T2,M0,LIHC.iCluster:2,6
-4.149220776,-2.209949948,TCGA-AP-A1DP-01A,TCGA-AP-A1DP-01A-11D-A135-09,8,0.317320572,TCGA-AP-A1DP,UCEC,70,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25601,Dead,WITH TUMOR,NA,1081,[Not Available],Metastatic,"Other, specify","Lung, liver, lymph nodes",831,Complete Remission/Response,1,1081,1,1081,1,831,1,831,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.994927386,2.066995954,TCGA-D1-A16V-01A,TCGA-D1-A16V-01A-11D-A12J-09,9,0.031499257,TCGA-D1-A16V,UCEC,78,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28635,Dead,TUMOR FREE,NA,120,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,120,0,120,0,120,0,120,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-0.37424892,5.148673602,TCGA-36-2537-01A,TCGA-36-2537-01A-01D-1526-09,4,0.500750566,TCGA-36-2537,OV,39,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2008,[Not Available],-14595,Alive,WITH TUMOR,788,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],431,Partial Remission/Response,0,788,0,788,NA,NA,1,431,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
9.706476919,-2.332233058,TCGA-DD-A39V-01A,TCGA-DD-A39V-01A-11D-A20W-10,1,0.735654785,TCGA-DD-A39V,LIHC,77,MALE,WHITE,Hepatocellular Carcinoma,G3,2000,[Not Available],-28254,Dead,WITH TUMOR,NA,643,[Not Available],Extrahepatic Recurrence,"Other, specify",second or third rib posteriorly,455,[Not Available],1,643,1,643,1,455,1,455,NA,Stage II,T2,M0,LIHC.iCluster:3,1
-0.121971537,4.880277194,TCGA-24-1424-01A,TCGA-24-1424-01A-01W-0549-09,4,0.561986134,TCGA-24-1424,OV,67,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-24545,Alive,TUMOR FREE,183,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,183,0,183,0,183,0,183,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
0.15442808,4.99689441,TCGA-29-1771-01A,TCGA-29-1771-01A-01W-0633-09,4,0.545445303,TCGA-29-1771,OV,76,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2007,[Not Available],-28093,Alive,WITH TUMOR,686,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],595,Complete Remission/Response,0,686,0,686,1,595,1,595,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-5.783391726,-2.171279392,TCGA-10-0933-01A,TCGA-10-0933-01A-01W-0420-08,0,NA,TCGA-10-0933,OV,77,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-28433,Dead,WITH TUMOR,356,446,[Not Available],Recurrence,[Not Applicable],[Not Applicable],356,Complete Remission/Response,1,446,1,446,1,356,1,356,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
-4.224084449,-2.004245095,TCGA-D1-A163-01A,TCGA-D1-A163-01A-11D-A12J-09,8,0.185208454,TCGA-D1-A163,UCEC,50,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Peri (6-12 months since last menstrual period),-18604,Alive,TUMOR FREE,991,NA,[Not Available],Metastatic,"Other, specify",Paraaortic retroperitoneal lymphnode,223,Complete Remission/Response,0,991,0,991,1,223,1,223,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.MSI,10
-1.784909647,3.531083024,TCGA-CQ-5334-01A,TCGA-CQ-5334-01A-01D-1683-08,0,NA,TCGA-CQ-5334,HNSC,87,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-32024,Dead,WITH TUMOR,NA,129,[Not Available],NA,Oral Cavity,NA,50,Progressive Disease,1,129,1,129,NA,NA,1,50,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,3
-3.51115172,-3.092495349,TCGA-EO-A22T-01A,TCGA-EO-A22T-01A-21D-A18P-09,8,0.642184663,TCGA-EO-A22T,UCEC,56,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20608,Alive,TUMOR FREE,2035,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2035,0,2035,0,2035,0,2035,NA,Stage II,[Not Applicable],[Not Applicable],NA,10
-0.916138997,3.095161033,TCGA-DD-A3A7-01A,TCGA-DD-A3A7-01A-11D-A22F-10,4,0.015972252,TCGA-DD-A3A7,LIHC,67,MALE,[Unknown],Hepatocellular Carcinoma,G3,1998,[Not Available],-24599,Dead,WITH TUMOR,NA,419,[Not Available],Intrahepatic Recurrence,Liver,NA,144,[Not Available],1,419,1,419,1,144,1,144,NA,Stage IIIB,T3b,M0,LIHC.iCluster:2,10
9.205136144,-5.048999879,TCGA-DD-A4ND-01A,TCGA-DD-A4ND-01A-11D-A25V-10,1,0.761035829,TCGA-DD-A4ND,LIHC,56,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2007,[Not Available],-20782,Alive,TUMOR FREE,2746,NA,[Not Available],New Primary Tumor,"Other, specify",breast cancer,15,[Not Available],0,2746,0,2746,0,2746,1,15,NA,Stage I,T1,M0,LIHC.iCluster:2,1
9.482230882,-3.064159714,TCGA-29-2431-01A,TCGA-29-2431-01A-01D-1526-09,1,0.66274236,TCGA-29-2431,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2006,[Not Available],-21833,Alive,WITH TUMOR,1285,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],960,Complete Remission/Response,0,1285,0,1285,1,960,1,960,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-0.961172807,4.748387498,TCGA-EO-A1Y7-01A,TCGA-EO-A1Y7-01A-11D-A159-09,4,0.403751423,TCGA-EO-A1Y7,UCEC,65,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24085,Alive,WITH TUMOR,1495,NA,[Not Available],Distant Metastasis,Lung,NA,880,Progressive Disease,0,1495,0,1495,NA,NA,1,880,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,6
-0.147850884,5.019513803,TCGA-24-1467-01A,TCGA-24-1467-01A-01W-0545-08,4,0.679118228,TCGA-24-1467,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1998,[Not Available],-18652,Dead,WITH TUMOR,3224,3224,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1253,Complete Remission/Response,1,3224,1,3224,1,1253,1,1253,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-6.293603187,1.259341013,TCGA-61-2111-01A,TCGA-61-2111-01A-01W-0722-08,10,0.14280769,TCGA-61-2111,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1998,[Not Available],-22517,Alive,WITH TUMOR,3825,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],2205,Complete Remission/Response,0,3825,0,3825,NA,NA,1,2205,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Proliferative,9
-0.855888317,4.424747835,TCGA-24-2298-01A,TCGA-24-2298-01A-01W-0799-08,4,0.496270356,TCGA-24-2298,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1993,[Not Available],-20453,Dead,WITH TUMOR,1620,1620,[Not Available],Recurrence,[Not Applicable],[Not Applicable],469,Complete Remission/Response,1,1620,1,1620,1,469,1,469,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-0.045119686,4.943128431,TCGA-36-2551-01A,TCGA-36-2551-01A-01D-1526-09,4,0.552436484,TCGA-36-2551,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-21045,Alive,WITH TUMOR,492,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],338,Complete Remission/Response,0,492,0,492,1,338,1,338,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-0.199150749,5.174141255,TCGA-13-1403-01A,TCGA-13-1403-01A-01W-0492-08,4,0.617512252,TCGA-13-1403,OV,48,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-17697,Dead,WITH TUMOR,NA,2345,[Not Available],NA,[Not Applicable],[Not Applicable],418,Complete Remission/Response,1,2345,1,2345,1,418,1,418,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-7.698645648,2.38779642,TCGA-HD-7832-01A,TCGA-HD-7832-01A-11D-2129-08,9,0.279127081,TCGA-HD-7832,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-19192,Alive,TUMOR FREE,836,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,836,0,836,NA,NA,0,836,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,7
1.858746671,1.897402272,TCGA-BP-5170-01A,TCGA-BP-5170-01A-01D-1429-08,3,0.578645968,TCGA-BP-5170,KIRC,55,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-20229,Alive,TUMOR FREE,2412,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2412,0,2412,NA,NA,0,2412,NA,Stage I,T1a,M0,KIRC.4,3
-3.976343223,-1.812342561,TCGA-AX-A2IN-01A,TCGA-AX-A2IN-01A-12D-A17W-09,8,0.4074953,TCGA-AX-A2IN,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23275,Dead,WITH TUMOR,NA,947,[Not Available],New Primary Tumor,"Other, specify",Right Breast,257,[Not Available],1,947,1,947,NA,NA,1,257,NA,Stage IC,[Not Applicable],[Not Applicable],NA,10
-7.142134849,-2.439139808,TCGA-25-1315-01A,TCGA-25-1315-01A-01W-0494-09,6,0.292722648,TCGA-25-1315,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-18263,Dead,WITH TUMOR,1553,1583,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],153,Partial Remission/Response,1,1583,1,1583,NA,NA,1,153,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,2
-4.540389966,-1.38750468,TCGA-ED-A459-01A,TCGA-ED-A459-01A-11D-A25V-10,8,0.416215673,TCGA-ED-A459,LIHC,47,MALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-17402,Alive,TUMOR FREE,910,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,910,0,910,0,910,0,910,NA,Stage II,T2,M0,LIHC.iCluster:2,10
-7.431381622,-2.581727062,TCGA-D1-A15Z-01A,TCGA-D1-A15Z-01A-11D-A122-09,6,0.303231139,TCGA-D1-A15Z,UCEC,72,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26638,Dead,TUMOR FREE,NA,58,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,58,0,58,0,58,0,58,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,2
-0.983199096,4.437432986,TCGA-CV-5978-01A,TCGA-CV-5978-01A-11D-1683-08,4,0.408923957,TCGA-CV-5978,HNSC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-19480,Dead,WITH TUMOR,215,215,[Not Available],NA,NA,NA,NA,[Not Available],1,215,1,215,NA,NA,1,215,NA,Stage IVB,T4a,[Not Available],HNSC.Classical,6
-1.127687989,4.251931172,TCGA-G3-A5SL-01A,TCGA-G3-A5SL-01A-11D-A27I-10,4,0.345775587,TCGA-G3-A5SL,LIHC,70,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-25671,Alive,TUMOR FREE,621,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,621,0,621,0,621,0,621,NA,Stage II,T2,M0,LIHC.iCluster:2,6
-6.159080825,3.626100719,TCGA-20-0996-01A,TCGA-20-0996-01A-03W-0486-08,11,0.421517842,TCGA-20-0996,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2001,[Not Available],-21572,Alive,WITH TUMOR,2196,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2196,0,2196,NA,NA,0,2196,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,8
8.6214873,-4.32566311,TCGA-24-1470-01A,TCGA-24-1470-01A-01W-0553-09,1,0.734496835,TCGA-24-1470,OV,54,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-20007,Alive,TUMOR FREE,105,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,105,0,105,0,105,0,105,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,1
-0.264913332,4.12379289,TCGA-30-1853-01A,TCGA-30-1853-01A-02W-0699-08,4,0.390781418,TCGA-30-1853,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-21404,Dead,WITH TUMOR,1103,1103,[Not Available],Recurrence,[Not Applicable],[Not Applicable],634,Complete Remission/Response,1,1103,1,1103,1,634,1,634,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-0.974658529,4.081679672,TCGA-42-2591-01A,TCGA-42-2591-01A-01D-1526-09,4,0.34649951,TCGA-42-2591,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,GX,2009,[Not Available],-18654,Alive,TUMOR FREE,1240,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1240,0,1240,0,1240,0,1240,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-0.341950715,4.573217463,TCGA-13-1489-01A,TCGA-13-1489-01A-01W-0549-09,4,0.56217695,TCGA-13-1489,OV,70,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2002,[Not Available],-25768,Dead,TUMOR FREE,NA,2553,[Not Available],Recurrence,[Not Applicable],[Not Applicable],806,Complete Remission/Response,1,2553,0,2553,1,806,1,806,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
9.236207287,-1.552245338,TCGA-09-1675-01B,TCGA-09-1675-01B-01W-0633-09,1,0.617220186,TCGA-09-1675,OV,50,FEMALE,[Not Available],Serous Cystadenocarcinoma,G2,2001,[Not Available],-18596,Alive,TUMOR FREE,2967,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2967,0,2967,0,2967,0,2967,NA,Stage IC,[Not Applicable],[Not Applicable],NA,1
0.251511517,3.451981761,TCGA-23-2643-01A,TCGA-23-2643-01A-01D-1526-09,4,0.293566812,TCGA-23-2643,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-27093,Alive,TUMOR FREE,143,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,143,0,143,0,143,0,143,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
9.642118308,-5.762037833,TCGA-36-2540-01A,TCGA-36-2540-01A-01D-1526-09,1,0.846473674,TCGA-36-2540,OV,26,FEMALE,WHITE,Serous Cystadenocarcinoma,G1,2008,[Not Available],-9760,Alive,WITH TUMOR,724,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],665,Complete Remission/Response,0,724,0,724,1,665,1,665,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-0.317327884,4.917000006,TCGA-13-0904-01A,TCGA-13-0904-01A-02W-0420-08,4,0.575486583,TCGA-13-0904,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-23278,Dead,WITH TUMOR,NA,1532,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],330,Partial Remission/Response,1,1532,1,1532,NA,NA,1,330,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-7.686482258,2.053676535,TCGA-B8-5553-01A,TCGA-B8-5553-01A-01D-1534-10,9,0.352433489,TCGA-B8-5553,KIRC,67,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-24729,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,435,0,435,NA,NA,0,435,NA,Stage I,T1b,M0,KIRC.1,7
-1.526972269,3.82940451,TCGA-BC-A5W4-01A,TCGA-BC-A5W4-01A-11D-A28X-10,4,0.196690522,TCGA-BC-A5W4,LIHC,69,MALE,WHITE,Hepatocellular Carcinoma,G3,2012,[Not Available],-25503,Dead,TUMOR FREE,NA,547,[Not Available],Locoregional Recurrence,NA,NA,384,[Not Available],1,547,0,547,NA,NA,1,384,NA,Stage IIIA,T3a,M0,LIHC.iCluster:3,5
-0.796833761,3.617153719,TCGA-FV-A496-01A,TCGA-FV-A496-01A-11D-A25V-10,4,0.162802956,TCGA-FV-A496,LIHC,84,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-30950,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage I,T1,M0,LIHC.iCluster:2,5
-0.560483655,4.825350243,TCGA-CQ-5330-01A,TCGA-CQ-5330-01A-01D-1683-08,4,0.552623481,TCGA-CQ-5330,HNSC,69,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-25255,Alive,TUMOR FREE,1897,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1897,0,1897,NA,NA,0,1897,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,6
-4.382782117,-1.949173002,TCGA-A5-A0GH-01A,TCGA-A5-A0GH-01A-21W-A062-09,8,0.347270745,TCGA-A5-A0GH,UCEC,57,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21090,Alive,TUMOR FREE,2254,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2254,0,2254,0,2254,0,2254,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.366777782,4.148519275,TCGA-24-1564-01A,TCGA-24-1564-01A-01W-0551-08,4,0.403068972,TCGA-24-1564,OV,67,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1997,[Not Available],-24668,Dead,WITH TUMOR,787,787,[Not Available],Recurrence,[Not Applicable],[Not Applicable],221,Complete Remission/Response,1,787,1,787,1,221,1,221,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
0.19896935,4.970543536,TCGA-13-1511-01A,TCGA-13-1511-01A-01W-0545-08,4,0.58354278,TCGA-13-1511,OV,52,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,2008,[Not Available],-19258,Dead,WITH TUMOR,NA,1650,[Not Available],NA,[Not Applicable],[Not Applicable],459,Partial Remission/Response,1,1650,1,1650,NA,NA,1,459,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-0.219765856,5.051915875,TCGA-25-2409-01A,TCGA-25-2409-01A-01W-0799-08,4,0.591341741,TCGA-25-2409,OV,71,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-26267,Dead,WITH TUMOR,821,821,[Not Available],Recurrence,[Not Applicable],[Not Applicable],304,Complete Remission/Response,1,821,1,821,NA,NA,1,304,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-0.454773819,4.703804245,TCGA-13-1405-01A,TCGA-13-1405-01A-01W-0494-09,4,0.543831608,TCGA-13-1405,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-18218,Dead,WITH TUMOR,NA,868,[Not Available],NA,[Not Applicable],[Not Applicable],228,Complete Remission/Response,1,868,1,868,NA,NA,1,228,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
4.313661802,1.178547309,TCGA-24-1434-01A,TCGA-24-1434-01A-01W-0545-08,2,0.698417168,TCGA-24-1434,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-21810,Dead,WITH TUMOR,568,568,[Not Available],Recurrence,[Not Applicable],[Not Applicable],337,Partial Remission/Response,1,568,1,568,NA,NA,1,337,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
9.734355513,-1.534692113,TCGA-04-1341-01A,TCGA-04-1341-01A-01W-0486-08,1,0.812763804,TCGA-04-1341,OV,85,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-31215,Alive,NA,33,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,33,0,33,0,33,0,33,NA,[Not Available],[Not Applicable],[Not Applicable],NA,1
0.200574761,4.766922905,TCGA-13-0765-01A,TCGA-13-0765-01A-01W-0372-09,4,0.706143458,TCGA-13-0765,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-18574,Dead,WITH TUMOR,NA,1389,[Not Available],Recurrence,[Not Applicable],[Not Applicable],668,Complete Remission/Response,1,1389,1,1389,1,668,1,668,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.322344824,1.543996236,TCGA-29-1770-01A,TCGA-29-1770-01A-01W-0633-09,0,NA,TCGA-29-1770,OV,54,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2007,[Not Available],-20015,Alive,WITH TUMOR,741,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],377,Complete Remission/Response,0,741,0,741,1,377,1,377,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
8.665508809,-4.843020006,TCGA-CJ-5681-01A,TCGA-CJ-5681-01A-11D-1534-10,1,0.776855909,TCGA-CJ-5681,KIRC,44,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2003,[Not Available],-16121,Dead,WITH TUMOR,NA,552,[Not Available],NA,NA,NA,17,[Not Available],1,552,1,552,NA,NA,1,17,NA,Stage IV,T3a,M1,KIRC.1,1
9.395181691,-4.516941194,TCGA-DQ-7591-01A,TCGA-DQ-7591-01A-11D-2078-08,1,0.813061559,TCGA-DQ-7591,HNSC,62,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G4,2011,[Not Available],-22798,Alive,TUMOR FREE,622,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,622,0,622,NA,NA,0,622,NA,[Not Available],TX,[Not Available],HNSC.Atypical,1
4.060103463,1.323958132,TCGA-DD-A39Z-01A,TCGA-DD-A39Z-01A-11D-A20W-10,2,0.153706059,TCGA-DD-A39Z,LIHC,43,FEMALE,[Not Available],Hepatocellular Carcinoma,G2,1996,[Not Available],-15930,Dead,TUMOR FREE,NA,601,[Not Available],NA,NA,NA,NA,[Not Available],1,601,0,601,0,601,0,601,NA,Stage II,T2,M0,LIHC.iCluster:2,5
-6.434873471,1.645745803,TCGA-24-1416-01A,TCGA-24-1416-01A-01W-0549-09,10,0.127323348,TCGA-24-1416,OV,34,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-12772,Alive,TUMOR FREE,194,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,194,0,194,NA,NA,0,194,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Differentiated,7
-0.984041917,3.828733009,TCGA-23-1123-01A,TCGA-23-1123-01A-01W-0486-08,4,0.460018219,TCGA-23-1123,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1998,[Not Available],-21552,Dead,WITH TUMOR,NA,1018,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1018,1,1018,NA,NA,1,1018,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,5
9.287761686,-5.760555996,TCGA-25-2408-01A,TCGA-25-2408-01A-01W-0799-08,1,0.82624099,TCGA-25-2408,OV,37,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2005,[Not Available],-13606,Dead,WITH TUMOR,943,943,[Not Available],Recurrence,[Not Applicable],[Not Applicable],334,Partial Remission/Response,1,943,1,943,NA,NA,1,334,NA,Stage IV,[Not Applicable],[Not Applicable],NA,1
9.239006841,-5.198573748,TCGA-DD-A4NP-01A,TCGA-DD-A4NP-01A-11D-A28X-10,1,0.811262505,TCGA-DD-A4NP,LIHC,32,MALE,WHITE,Hepatocellular Carcinoma,G3,2005,[Not Available],-11838,Alive,TUMOR FREE,3308,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,1286,[Not Available],0,3308,0,3308,1,1286,1,1286,NA,Stage I,T1,M0,LIHC.iCluster:2,1
-4.579669788,-1.556085531,TCGA-D1-A0ZS-01A,TCGA-D1-A0ZS-01A-11D-A122-09,8,0.395853182,TCGA-D1-A0ZS,UCEC,54,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19821,Alive,TUMOR FREE,148,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,148,0,148,0,148,0,148,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-6.726583302,-2.010050335,TCGA-AP-A0LF-01A,TCGA-AP-A0LF-01A-11D-A122-09,0,NA,TCGA-AP-A0LF,UCEC,82,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30027,Alive,WITH TUMOR,2859,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,2859,0,2859,NA,NA,0,2859,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.CN high,2
4.113487809,1.250093272,TCGA-36-2530-01A,TCGA-36-2530-01A-01D-1526-09,2,0.367080706,TCGA-36-2530,OV,38,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,2007,[Not Available],-13885,Alive,WITH TUMOR,1004,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],630,Complete Remission/Response,0,1004,0,1004,1,630,1,630,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
-5.989976237,1.990225136,TCGA-23-2084-01A,TCGA-23-2084-01A-02W-0722-08,10,0.050118074,TCGA-23-2084,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-16493,Dead,WITH TUMOR,NA,1516,[Not Available],Recurrence,[Not Applicable],[Not Applicable],619,Complete Remission/Response,1,1516,1,1516,NA,NA,1,619,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-0.220809745,4.654041526,TCGA-24-1849-01A,TCGA-24-1849-01A-01W-0639-09,4,0.449092356,TCGA-24-1849,OV,80,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-29555,Alive,TUMOR FREE,176,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,176,0,176,0,176,0,176,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
-3.342802739,1.841572169,TCGA-61-2113-01A,TCGA-61-2113-01A-01W-0722-08,0,NA,TCGA-61-2113,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-19722,Dead,NA,676,676,[Not Available],Recurrence,[Not Applicable],[Not Applicable],291,[Not Available],1,676,NA,676,NA,NA,1,291,NA,Stage IIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,10
-7.638549489,2.480315825,TCGA-B5-A11F-01A,TCGA-B5-A11F-01A-11D-A10M-09,9,0.18001603,TCGA-B5-A11F,UCEC,55,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20171,Alive,TUMOR FREE,5651,NA,[Not Available],Metastatic,Bone,NA,1610,Complete Remission/Response,0,5651,0,5651,1,1610,1,1610,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-6.716010796,-2.262984149,TCGA-CC-A3M9-01A,TCGA-CC-A3M9-01A-11D-A20W-10,6,0.013103155,TCGA-CC-A3M9,LIHC,45,MALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-16460,Dead,WITH TUMOR,NA,300,[Not Available],Locoregional Recurrence,NA,NA,219,[Not Available],1,300,1,300,1,219,1,219,NA,Stage IIIA,T3,M0,LIHC.iCluster:1,2
-0.451741267,4.981069744,TCGA-CJ-4920-01A,TCGA-CJ-4920-01A-01D-1429-08,4,0.462977387,TCGA-CJ-4920,KIRC,64,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-23656,Dead,TUMOR FREE,NA,139,[Not Available],NA,NA,NA,NA,[Not Available],1,139,0,139,NA,NA,0,139,NA,Stage I,T1b,M0,KIRC.3,6
1.992497419,1.851877671,TCGA-DD-A4NA-01A,TCGA-DD-A4NA-01A-11D-A25V-10,3,0.584093928,TCGA-DD-A4NA,LIHC,67,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2009,[Not Available],-24603,Alive,TUMOR FREE,1008,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1008,0,1008,0,1008,0,1008,NA,Stage IIIC,T2,M0,LIHC.iCluster:1,3
4.539661324,1.186471575,TCGA-B0-5116-01A,TCGA-B0-5116-01A-02D-1421-08,2,0.664495435,TCGA-B0-5116,KIRC,52,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-19352,Alive,WITH TUMOR,1274,NA,[Not Available],NA,NA,NA,1129,Complete Remission/Response,0,1274,0,1274,1,1129,1,1129,NA,Stage III,T3b,M0,KIRC.4,5
0.438968703,2.161510962,TCGA-DD-A4NL-01A,TCGA-DD-A4NL-01A-11D-A28X-10,0,NA,TCGA-DD-A4NL,LIHC,46,MALE,WHITE,Hepatocellular Carcinoma,G1,2007,[Not Available],-16874,Alive,TUMOR FREE,1711,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1711,0,1711,0,1711,0,1711,NA,Stage I,T1,M0,LIHC.iCluster:1,6
9.529516101,-2.698088264,TCGA-BP-4989-01A,TCGA-BP-4989-01A-01D-1462-08,1,0.786721179,TCGA-BP-4989,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-21382,Alive,TUMOR FREE,118,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,118,0,118,NA,NA,0,118,NA,Stage III,T3a,M0,KIRC.2,1
-0.68094712,4.446686677,TCGA-29-1774-01A,TCGA-29-1774-01A-01W-0639-09,4,0.523132219,TCGA-29-1774,OV,82,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-29991,Alive,WITH TUMOR,527,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],234,Progressive Disease,0,527,0,527,NA,NA,1,234,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-1.893533431,1.341460659,TCGA-G3-A5SJ-01A,TCGA-G3-A5SJ-01A-11D-A27I-10,5,0.500149542,TCGA-G3-A5SJ,LIHC,59,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-21848,Alive,TUMOR FREE,698,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,308,[Not Available],0,698,0,698,1,308,1,308,NA,Stage I,T1,M0,LIHC.iCluster:3,3
-7.620145887,-2.460733977,TCGA-DD-A4NR-01A,TCGA-DD-A4NR-01A-11D-A30V-10,6,0.526756944,TCGA-DD-A4NR,LIHC,85,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2005,[Not Available],-31386,Dead,TUMOR FREE,NA,9,[Not Available],NA,NA,NA,NA,[Not Available],1,9,0,9,0,9,0,9,NA,Stage I,T1,M0,LIHC.iCluster:1,2
-7.164780156,2.040686776,TCGA-BC-A69H-01A,TCGA-BC-A69H-01A-11D-A30V-10,9,0.126601035,TCGA-BC-A69H,LIHC,64,MALE,WHITE,Hepatocellular Carcinoma,G3,2013,[Not Available],-23380,Alive,TUMOR FREE,444,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,444,0,444,0,444,0,444,NA,Stage II,T2,M0,LIHC.iCluster:1,9
-7.791461798,-2.544936439,TCGA-BP-5006-01A,TCGA-BP-5006-01A-01D-1462-08,6,0.54528394,TCGA-BP-5006,KIRC,61,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-22324,Alive,TUMOR FREE,840,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,840,0,840,NA,NA,0,840,NA,Stage I,T1a,M0,NA,2
-8.192790845,1.997149319,TCGA-A7-A0CG-01A,TCGA-A7-A0CG-01A-11W-A019-09,9,0.422107351,TCGA-A7-A0CG,BRCA,78,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28596,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1043,0,1043,NA,NA,0,1043,NA,Stage IIA,T2,M0,BRCA.LumA,7
8.923683897,-3.724112457,TCGA-AX-A05U-01A,TCGA-AX-A05U-01A-11W-A027-09,1,0.727085547,TCGA-AX-A05U,UCEC,56,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20533,Alive,TUMOR FREE,903,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,903,0,903,0,903,0,903,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,1
-7.422688194,2.210344356,TCGA-AX-A1CN-01A,TCGA-AX-A1CN-01A-11D-A135-09,9,0.050709855,TCGA-AX-A1CN,UCEC,54,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19860,Alive,WITH TUMOR,1143,NA,[Not Available],New Primary Tumor,Lung,NA,1105,[Not Available],0,1143,0,1143,NA,NA,1,1105,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
0.122410929,2.50482598,TCGA-04-1347-01A,TCGA-04-1347-01A-01D-A324-10,4,0.169186523,TCGA-04-1347,OV,81,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-29695,Alive,TUMOR FREE,1919,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1919,0,1919,NA,NA,0,1919,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
0.018535583,5.228147233,TCGA-36-2552-01A,TCGA-36-2552-01A-01D-1526-09,4,0.647596329,TCGA-36-2552,OV,64,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2009,[Not Available],-23379,Alive,TUMOR FREE,349,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,349,0,349,NA,NA,0,349,NA,Stage IIC,[Not Applicable],[Not Applicable],NA,6
-6.710752538,1.893196731,TCGA-BS-A0V7-01A,TCGA-BS-A0V7-01A-21D-A122-09,0,NA,TCGA-BS-A0V7,UCEC,48,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Endometrioid endometrial adenocarcinoma,G1,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17810,Alive,TUMOR FREE,1934,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1934,0,1934,0,1934,0,1934,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,8
-1.938328302,2.319065207,TCGA-13-0920-01A,TCGA-13-0920-01A-01W-0420-08,0,NA,TCGA-13-0920,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-24064,Dead,WITH TUMOR,NA,1484,[Not Available],Recurrence,[Not Applicable],[Not Applicable],297,Complete Remission/Response,1,1484,1,1484,1,297,1,297,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,10
-4.618063055,-1.649560986,TCGA-A5-A0GG-01A,TCGA-A5-A0GG-01A-11D-A122-09,8,0.199798289,TCGA-A5-A0GG,UCEC,76,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27809,Alive,TUMOR FREE,3762,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3762,0,3762,0,3762,0,3762,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-4.275230411,-0.126785959,TCGA-AX-A3G3-01A,TCGA-AX-A3G3-01A-11D-A20S-09,0,NA,TCGA-AX-A3G3,UCEC,58,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21308,Alive,NA,42,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,42,0,42,NA,NA,0,42,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,10
-3.423548442,-3.251771707,TCGA-BG-A221-01A,TCGA-BG-A221-01A-21D-A159-09,8,0.543285366,TCGA-BG-A221,UCEC,84,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30960,Alive,TUMOR FREE,55,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,55,0,55,0,55,0,55,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-6.119719131,-1.265234302,TCGA-AX-A2H7-01A,TCGA-AX-A2H7-01A-12D-A18P-09,7,0.186700795,TCGA-AX-A2H7,UCEC,87,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,[Not Available],-32100,Dead,WITH TUMOR,NA,1241,[Not Available],Metastatic,Lung,NA,684,Complete Remission/Response,1,1241,1,1241,1,684,1,684,NA,Stage IC,[Not Applicable],[Not Applicable],NA,2
-5.331645016,2.748946308,TCGA-A5-A1OK-01A,TCGA-A5-A1OK-01A-11D-A14K-09,12,0.218295907,TCGA-A5-A1OK,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23179,Alive,TUMOR FREE,917,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,917,0,917,0,917,0,917,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,8
-5.462832996,2.328528568,TCGA-29-1777-01A,TCGA-29-1777-01A-01W-0639-09,12,0.195999474,TCGA-29-1777,OV,47,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2008,[Not Available],-17356,Alive,WITH TUMOR,374,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,374,0,374,NA,NA,0,374,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-0.870898426,2.996043722,TCGA-AR-A0TS-01A,TCGA-AR-A0TS-01A-11D-A10Y-09,4,0.093288879,TCGA-AR-A0TS,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17141,Alive,TUMOR FREE,2558,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2558,0,2558,0,2558,0,2558,NA,Stage IIB,T2,M0,BRCA.Basal,5
-1.430989673,2.976218436,TCGA-61-1904-01A,TCGA-61-1904-01A-01W-0639-09,4,0.110998127,TCGA-61-1904,OV,60,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-22009,Alive,TUMOR FREE,276,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,276,0,276,0,276,0,276,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.886395637,-2.290949705,TCGA-59-2352-01A,TCGA-59-2352-01A-01W-0799-08,6,0.004683844,TCGA-59-2352,OV,78,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],NA,Dead,WITH TUMOR,NA,286,[Not Available],NA,NA,NA,NA,[Not Available],1,286,1,286,NA,NA,1,286,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,2
-7.413737839,2.248949631,TCGA-D8-A1JN-01A,TCGA-D8-A1JN-01A-11D-A13L-09,9,0.159399893,TCGA-D8-A1JN,BRCA,80,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29331,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,620,0,620,0,620,0,620,NA,Stage IIIC,T3,MX,BRCA.LumA,8
-7.405817044,2.104061476,TCGA-E2-A15P-01A,TCGA-E2-A15P-01A-11D-A10Y-09,9,0.300987894,TCGA-E2-A15P,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22524,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,595,0,595,0,595,0,595,NA,Stage IA,T1c,M0,BRCA.LumA,7
-7.34718955,-2.446237155,TCGA-D8-A13Z-01A,TCGA-D8-A13Z-01A-11D-A10Y-09,6,0.352848227,TCGA-D8-A13Z,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18942,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,635,0,635,0,635,0,635,NA,[Not Available],T2,M0,BRCA.Her2,2
-0.868583732,4.561209477,TCGA-CR-7373-01A,TCGA-CR-7373-01A-11D-2012-08,4,0.310617751,TCGA-CR-7373,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-24448,Alive,TUMOR FREE,889,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,889,0,889,NA,NA,0,889,NA,Stage IVA,T4a,M0,HNSC.Basal,6
-6.278118038,1.198337528,TCGA-61-1738-01A,TCGA-61-1738-01A-01W-0639-09,10,0.087489036,TCGA-61-1738,OV,60,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2005,[Not Available],-21965,Dead,WITH TUMOR,1089,1089,[Not Available],Recurrence,[Not Applicable],[Not Applicable],276,Progressive Disease,1,1089,1,1089,NA,NA,1,276,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,7
-4.054353362,-1.484626386,TCGA-B5-A11J-01A,TCGA-B5-A11J-01A-11D-A122-09,8,0.123270539,TCGA-B5-A11J,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485,Alive,TUMOR FREE,1656,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1656,0,1656,0,1656,0,1656,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-6.277630143,3.132398965,TCGA-EY-A2OQ-01A,TCGA-EY-A2OQ-01A-11D-A19Y-09,0,NA,TCGA-EY-A2OQ,UCEC,61,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22309,Alive,TUMOR FREE,885,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,885,0,885,0,885,0,885,NA,Stage IA,[Not Applicable],[Not Applicable],NA,8
-4.626161124,-1.400471059,TCGA-AJ-A2QM-01A,TCGA-AJ-A2QM-01A-11D-A18P-09,8,0.376451767,TCGA-AJ-A2QM,UCEC,67,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24776,Alive,TUMOR FREE,894,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,894,0,894,0,894,0,894,NA,Stage II,[Not Applicable],[Not Applicable],NA,10
-0.604297525,4.971192774,TCGA-13-1404-01A,TCGA-13-1404-01A-01W-0494-09,4,0.474443087,TCGA-13-1404,OV,48,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-17784,Alive,WITH TUMOR,2469,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1581,Complete Remission/Response,0,2469,0,2469,1,1581,1,1581,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
9.987523339,-2.010661728,TCGA-B5-A0K4-01A,TCGA-B5-A0K4-01A-11W-A062-09,1,0.799437246,TCGA-B5-A0K4,UCEC,51,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18631,Alive,TUMOR FREE,1757,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1757,0,1757,0,1757,0,1757,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,1
-8.212676409,1.984689906,TCGA-AN-A049-01A,TCGA-AN-A049-01A-21W-A019-09,9,0.607385958,TCGA-AN-A049,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22710,Alive,TUMOR FREE,19,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,19,0,19,NA,NA,0,19,NA,Stage IIA,T2,M0,BRCA.LumA,7
9.517489795,-2.72707238,TCGA-AO-A03P-01A,TCGA-AO-A03P-01A-11W-A019-09,1,0.777687422,TCGA-AO-A03P,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19724,Dead,WITH TUMOR,NA,2911,[Not Available],Distant Metastasis,Liver,NA,1922,[Not Available],1,2911,1,2911,NA,NA,1,1922,NA,Stage IIB,T2,M0,BRCA.LumB,1
-0.59249437,4.858164019,TCGA-23-2077-01A,TCGA-23-2077-01A-01W-0722-08,4,0.558032181,TCGA-23-2077,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-16552,Alive,TUMOR FREE,3525,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1232,Complete Remission/Response,0,3525,0,3525,1,1232,1,1232,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-4.116731246,-2.16564152,TCGA-CN-5369-01A,TCGA-CN-5369-01A-01D-1434-08,8,0.276009885,TCGA-CN-5369,HNSC,90,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2006,[Not Available],-32871,Dead,TUMOR FREE,NA,380,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,380,0,380,NA,NA,0,380,NA,Stage IVA,T4a,M0,HNSC.Basal,10
-1.018966783,4.579002611,TCGA-25-1313-01A,TCGA-25-1313-01A-01W-0492-08,4,0.357711552,TCGA-25-1313,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-22982,Dead,WITH TUMOR,820,820,[Not Available],Recurrence,[Not Applicable],[Not Applicable],394,Complete Remission/Response,1,820,1,820,NA,NA,1,394,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-2.805458662,-4.24531324,TCGA-E6-A1LX-01A,TCGA-E6-A1LX-01A-11D-A14G-09,0,NA,TCGA-E6-A1LX,UCEC,40,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731,Alive,TUMOR FREE,711,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,711,0,711,0,711,0,711,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.902085925,-2.42877505,TCGA-FI-A2EX-01A,TCGA-FI-A2EX-01A-11D-A17D-09,6,0.13128308,TCGA-FI-A2EX,UCEC,58,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21489,Alive,WITH TUMOR,284,NA,[Not Available],Metastatic,NA,NA,213,Complete Remission/Response,0,284,0,284,1,213,1,213,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN high,2
-3.137672745,-3.679785944,TCGA-E6-A1M0-01A,TCGA-E6-A1M0-01A-11D-A142-09,8,0.379611204,TCGA-E6-A1M0,UCEC,56,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629,Alive,TUMOR FREE,1793,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1793,0,1793,0,1793,0,1793,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
0.045923151,4.702971896,TCGA-59-2355-01A,TCGA-59-2355-01A-01W-0799-08,4,0.55775085,TCGA-59-2355,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],NA,Dead,WITH TUMOR,NA,65,[Not Available],NA,NA,NA,NA,[Not Available],1,65,1,65,NA,NA,1,65,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
10.03383152,-2.024050922,TCGA-61-1901-01A,TCGA-61-1901-01A-01W-0639-09,1,0.838442911,TCGA-61-1901,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-24042,Dead,WITH TUMOR,347,347,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],329,Stable Disease,1,347,1,347,NA,NA,1,329,NA,Stage IV,[Not Applicable],[Not Applicable],NA,1
1.710279173,1.968171638,TCGA-AN-A041-01A,TCGA-AN-A041-01A-11W-A050-09,3,0.261044835,TCGA-AN-A041,BRCA,29,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10812,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,7,0,7,0,7,0,7,NA,Stage IIB,T2,M0,BRCA.LumA,3
0.117991427,3.433962285,TCGA-24-2036-01A,TCGA-24-2036-01A-01W-0722-08,4,0.231694198,TCGA-24-2036,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1996,[Not Available],-18582,Dead,WITH TUMOR,1947,1947,[Not Available],Recurrence,[Not Applicable],[Not Applicable],914,Complete Remission/Response,1,1947,1,1947,1,914,1,914,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,3
-3.351346916,-3.053449437,TCGA-BG-A2L7-01A,TCGA-BG-A2L7-01A-11D-A18P-09,8,0.312968278,TCGA-BG-A2L7,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,[Not Available],-25091,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,612,0,612,0,612,0,612,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-3.419108952,-3.219547278,TCGA-AX-A3G8-01A,TCGA-AX-A3G8-01A-11D-A228-09,8,0.586485975,TCGA-AX-A3G8,UCEC,76,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27899,Alive,NA,36,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,36,0,36,NA,NA,0,36,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-5.82099048,-2.057417398,TCGA-AX-A2H8-01A,TCGA-AX-A2H8-01A-11D-A17D-09,0,NA,TCGA-AX-A2H8,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23448,Alive,TUMOR FREE,1861,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1861,0,1861,0,1861,0,1861,NA,Stage IB,[Not Applicable],[Not Applicable],NA,2
-6.498234207,1.725961616,TCGA-BH-A0BT-01A,TCGA-BH-A0BT-01A-11D-A12Q-09,10,0.196393216,TCGA-BH-A0BT,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-20625,Alive,TUMOR FREE,2365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2365,0,2365,0,2365,0,2365,NA,Stage IIA,T1c,M0,BRCA.LumA,7
0.219701545,4.691547991,TCGA-13-1492-01A,TCGA-13-1492-01A-01W-0545-08,4,0.637798378,TCGA-13-1492,OV,66,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-24332,Dead,TUMOR FREE,NA,3819,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,3819,0,3819,0,3819,0,3819,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
8.00237757,-3.101474942,TCGA-13-0755-01A,TCGA-13-0755-01A-01W-0371-08,1,0.492765014,TCGA-13-0755,OV,75,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-27438,Dead,WITH TUMOR,76,76,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],34,Progressive Disease,1,76,1,76,NA,NA,1,34,NA,Stage IV,[Not Applicable],[Not Applicable],NA,1
0.381618433,3.615853482,TCGA-D8-A1XJ-01A,TCGA-D8-A1XJ-01A-11D-A14K-09,4,0.33198147,TCGA-D8-A1XJ,BRCA,76,FEMALE,WHITE,"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27967,Alive,TUMOR FREE,664,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,664,0,664,0,664,0,664,NA,Stage IIIA,T3,MX,BRCA.Her2,3
-7.323243454,2.44142193,TCGA-AR-A1AL-01A,TCGA-AR-A1AL-01A-21D-A12Q-09,9,0.153890265,TCGA-AR-A1AL,BRCA,60,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22023,Alive,TUMOR FREE,2971,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2971,0,2971,0,2971,0,2971,NA,Stage IIIA,T3,M0,BRCA.LumA,7
-7.236452385,-2.49884118,TCGA-AR-A0U1-01A,TCGA-AR-A0U1-01A-11D-A10Y-09,6,0.098026015,TCGA-AR-A0U1,BRCA,36,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13467,Alive,TUMOR FREE,4052,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4052,0,4052,0,4052,0,4052,NA,Stage IIB,T2,M0,NA,2
-0.713523779,4.774476826,TCGA-A7-A26G-01A,TCGA-A7-A26G-01A-21D-A167-09,4,0.563600913,TCGA-A7-A26G,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18362,Alive,TUMOR FREE,722,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,722,0,722,0,722,0,722,NA,Stage IIA,T2,M0,BRCA.Basal,6
-1.609517705,1.447340703,TCGA-B6-A0IB-01A,TCGA-B6-A0IB-01A-11W-A050-09,5,0.59403638,TCGA-B6-A0IB,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-23646,Dead,WITH TUMOR,NA,3941,[Not Available],Distant Metastasis,"Other, specify","lung, bone, liver",2717,[Not Available],1,3941,1,3941,NA,NA,1,2717,NA,Stage IV,T3,M1,BRCA.LumB,4
8.61721203,-4.452269777,TCGA-A2-A0CM-01A,TCGA-A2-A0CM-01A-31W-A050-09,1,0.73586514,TCGA-A2-A0CM,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14969,Dead,WITH TUMOR,NA,754,[Not Available],NA,NA,NA,382,[Not Available],1,754,1,754,1,382,1,382,NA,Stage IIA,T2,M0,BRCA.Basal,1
-0.096319774,3.146932472,TCGA-E9-A1N8-01A,TCGA-E9-A1N8-01A-11D-A142-09,4,0.326272888,TCGA-E9-A1N8,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17652,Alive,TUMOR FREE,1039,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1039,0,1039,0,1039,0,1039,NA,Stage IIA,T2,M0,BRCA.Basal,3
-1.942643192,1.521504577,TCGA-A2-A0YJ-01A,TCGA-A2-A0YJ-01A-11D-A10G-09,5,0.512314471,TCGA-A2-A0YJ,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14448,Alive,WITH TUMOR,566,NA,[Not Available],Distant Metastasis,"Other, specify",Left Cervical Lymph Node,559,[Not Available],0,566,0,566,1,559,1,559,NA,Stage IIIA,T3,M0,BRCA.Basal,4
-4.676147165,-0.809803003,TCGA-C8-A274-01A,TCGA-C8-A274-01A-11D-A16D-09,8,0.030003628,TCGA-C8-A274,BRCA,63,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23337,Alive,TUMOR FREE,508,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,508,0,508,0,508,0,508,NA,Stage IIA,T2,M0,BRCA.LumB,10
-0.233717414,3.649106092,TCGA-D8-A147-01A,TCGA-D8-A147-01A-11D-A10Y-09,4,0.000664308,TCGA-D8-A147,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Indeterminate (neither Pre or Postmenopausal),-16736,Alive,TUMOR FREE,584,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,584,0,584,0,584,0,584,NA,[Not Available],T2,M0,BRCA.Basal,3
-7.796047006,2.189034115,TCGA-A2-A0YI-01A,TCGA-A2-A0YI-01A-31D-A10M-09,9,0.474747314,TCGA-A2-A0YI,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22961,Alive,TUMOR FREE,1505,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1505,0,1505,0,1505,0,1505,NA,Stage I,T1c,M0,BRCA.LumA,7
-4.459383196,1.711464113,TCGA-GM-A3NW-01A,TCGA-GM-A3NW-01A-21D-A228-09,0,NA,TCGA-GM-A3NW,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041,Alive,TUMOR FREE,3361,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3361,0,3361,0,3361,0,3361,NA,Stage IIA,T2,M0,BRCA.LumA,9
-7.495110863,2.089594443,TCGA-EW-A1P0-01A,TCGA-EW-A1P0-01A-11D-A142-09,9,0.298866082,TCGA-EW-A1P0,BRCA,55,FEMALE,WHITE,"Other, specify",[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20107,Alive,TUMOR FREE,1251,NA,[Not Available],Distant Metastasis,"Other, specify",mediastinal lymph node,1094,[Not Available],0,1251,0,1251,1,1094,1,1094,NA,Stage IIB,T2,MX,BRCA.LumB,7
-7.433610979,2.172913368,TCGA-AO-A0JA-01A,TCGA-AO-A0JA-01A-11W-A071-09,9,0.296384723,TCGA-AO-A0JA,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13307,Alive,WITH TUMOR,655,NA,[Not Available],Distant Metastasis,Bone,NA,143,[Not Available],0,655,0,655,1,143,1,143,NA,Stage IIIC,T2,M0,BRCA.LumA,7
-0.323818152,3.43540673,TCGA-BH-A1FC-01A,TCGA-BH-A1FC-01A-11D-A13L-09,4,0.21149638,TCGA-BH-A1FC,BRCA,78,FEMALE,BLACK OR AFRICAN AMERICAN,Medullary Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28706,Dead,TUMOR FREE,NA,3472,[Not Available],NA,NA,NA,NA,[Not Available],1,3472,0,3472,NA,NA,0,3472,NA,Stage IIA,T1c,M0,BRCA.Basal,3
-7.630187871,1.891769956,TCGA-A2-A04N-01A,TCGA-A2-A04N-01A-11D-A10Y-09,9,0.256597596,TCGA-A2-A04N,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24155,Alive,TUMOR FREE,4354,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4354,0,4354,0,4354,0,4354,NA,Stage IA,T1c,M0,BRCA.LumA,7
0.244733083,5.166542039,TCGA-E2-A1II-01A,TCGA-E2-A1II-01A-11D-A142-09,4,0.448873941,TCGA-E2-A1II,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18788,Alive,TUMOR FREE,1025,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1025,0,1025,0,1025,0,1025,NA,Stage I,T1c,M0,BRCA.Basal,6
-6.414219104,-1.184885053,TCGA-C8-A1HE-01A,TCGA-C8-A1HE-01A-11D-A188-09,7,0.327265275,TCGA-C8-A1HE,BRCA,59,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,375,0,375,0,375,0,375,NA,Stage IIA,T2,M0,BRCA.LumA,2
-0.536272784,2.586601592,TCGA-D8-A1XZ-01A,TCGA-D8-A1XZ-01A-11D-A14K-09,4,0.222620535,TCGA-D8-A1XZ,BRCA,81,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29916,Alive,TUMOR FREE,466,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,466,0,466,0,466,0,466,NA,Stage IIIA,T1c,MX,BRCA.LumB,6
9.033924373,-5.570006672,TCGA-A2-A0ES-01A,TCGA-A2-A0ES-01A-11D-A10Y-09,1,0.8433501,TCGA-A2-A0ES,BRCA,52,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19160,Alive,TUMOR FREE,2190,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2190,0,2190,0,2190,0,2190,NA,Stage IIA,T2,M0,BRCA.LumA,1
-6.474250523,-1.195080492,TCGA-B6-A0IE-01A,TCGA-B6-A0IE-01A-11W-A050-09,7,0.318030483,TCGA-B6-A0IE,BRCA,38,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed Histology (please specify),[Not Available],1995,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13982,Dead,WITH TUMOR,NA,1993,[Not Available],Distant Metastasis,Bone,NA,834,[Not Available],1,1993,1,1993,1,834,1,834,NA,Stage IIIA,T3,M0,BRCA.LumA,2
-6.566775363,1.414759171,TCGA-E2-A14Y-01A,TCGA-E2-A14Y-01A-21D-A12B-09,10,0.190234535,TCGA-E2-A14Y,BRCA,35,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13004,Alive,TUMOR FREE,2109,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2109,0,2109,0,2109,0,2109,NA,Stage IIA,T2,M0,BRCA.Basal,7
-7.620687314,-2.381077765,TCGA-AO-A0J3-01A,TCGA-AO-A0J3-01A-11W-A050-09,6,0.571099697,TCGA-AO-A0J3,BRCA,67,FEMALE,WHITE,"Other, specify",[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24519,Alive,TUMOR FREE,651,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,651,0,651,0,651,0,651,NA,Stage IIB,T2,M0,BRCA.LumB,2
9.620067165,-5.309812388,TCGA-EW-A1J3-01A,TCGA-EW-A1J3-01A-11D-A13L-09,1,0.796232304,TCGA-EW-A1J3,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22332,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,504,0,504,0,504,0,504,NA,Stage IA,T1c,M0,BRCA.LumA,1
9.307034777,-2.733145082,TCGA-AR-A24H-01A,TCGA-AR-A24H-01A-11D-A167-09,1,0.769918912,TCGA-AR-A24H,BRCA,65,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24046,Alive,TUMOR FREE,4894,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4894,0,4894,0,4894,0,4894,NA,Stage IIA,T2,M0,BRCA.LumB,6
9.562952454,-5.773855647,TCGA-EW-A1P3-01A,TCGA-EW-A1P3-01A-11D-A142-09,1,0.819106928,TCGA-EW-A1P3,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17637,Alive,TUMOR FREE,1611,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1611,0,1611,0,1611,0,1611,NA,Stage IIA,T2,MX,BRCA.LumA,1
1.360500821,3.294484058,TCGA-AR-A1AN-01A,TCGA-AR-A1AN-01A-11D-A12Q-09,0,NA,TCGA-AR-A1AN,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16974,Alive,TUMOR FREE,2920,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2920,0,2920,0,2920,0,2920,NA,Stage IIA,T2,M0,BRCA.LumA,1
8.941740061,-4.830062783,TCGA-G7-6789-01A,TCGA-G7-6789-01A-11D-1961-08,1,0.835705892,TCGA-G7-6789,KIRP,53,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-19593,Dead,WITH TUMOR,NA,122,[Not Available],NA,NA,NA,NA,[Not Available],1,122,1,122,NA,NA,1,122,NA,Stage IV,T3a,MX,KIRP.C2b,1
-4.336245378,-0.445942025,TCGA-BQ-7044-01A,TCGA-BQ-7044-01A-11D-1961-08,0,NA,TCGA-BQ-7044,KIRP,73,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2000,[Not Available],-26831,Alive,TUMOR FREE,3760,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3760,0,3760,NA,NA,0,3760,NA,Stage III,T3a,M0,KIRP.C2b,10
-7.736811101,-2.514265143,TCGA-EU-5905-01A,TCGA-EU-5905-01A-11D-1669-08,6,0.42511353,TCGA-EU-5905,KIRC,67,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-24475,Alive,TUMOR FREE,119,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,119,0,119,NA,NA,0,119,NA,Stage I,T1,M0,KIRC.NA,2
7.773273592,-1.392032361,TCGA-DD-A1EF-01A,TCGA-DD-A1EF-01A-11D-A12Z-10,1,0.115348747,TCGA-DD-A1EF,LIHC,57,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2007,[Not Available],-21165,Dead,WITH TUMOR,NA,394,[Not Available],NA,NA,NA,NA,[Not Available],1,394,1,394,NA,NA,1,394,NA,Stage I,T1,M0,LIHC.iCluster:1,6
-8.152707833,1.947082287,TCGA-DZ-6134-01A,TCGA-DZ-6134-01A-11D-1961-08,9,0.508581568,TCGA-DZ-6134,KIRP,69,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-25529,Alive,TUMOR FREE,1856,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1856,0,1856,NA,NA,0,1856,NA,Stage I,T1a,MX,KIRP.C2a,7
1.553404991,2.047418301,TCGA-FV-A2QQ-01A,TCGA-FV-A2QQ-01A-11D-A22F-10,3,0.12129208,TCGA-FV-A2QQ,LIHC,80,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-29354,Alive,TUMOR FREE,729,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,729,0,729,0,729,0,729,NA,Stage I,T1,MX,LIHC.iCluster:2,3
-1.147581977,3.361422947,TCGA-BQ-7053-01A,TCGA-BQ-7053-01A-11D-1961-08,0,NA,TCGA-BQ-7053,KIRP,57,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-20837,Alive,TUMOR FREE,1516,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1516,0,1516,NA,NA,0,1516,NA,Stage III,T3,M0,KIRP.C2a,6
-6.789682051,-2.358419527,TCGA-A3-3346-01A,TCGA-A3-3346-01A-01D-0966-08,6,0.241040557,TCGA-A3-3346,KIRC,68,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-25118,Dead,WITH TUMOR,NA,137,[Not Available],NA,NA,NA,114,Progressive Disease,1,137,1,137,NA,NA,1,114,NA,Stage I,T1b,M0,KIRC.NA,2
-3.381110992,-3.238706519,TCGA-D8-A1XQ-01A,TCGA-D8-A1XQ-01A-11D-A14K-09,8,0.561499745,TCGA-D8-A1XQ,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25345,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,499,0,499,0,499,0,499,NA,Stage IIA,T2,M0,BRCA.Basal,10
1.944208957,1.896874108,TCGA-DD-A4NH-01A,TCGA-DD-A4NH-01A-11D-A27I-10,3,0.449979401,TCGA-DD-A4NH,LIHC,65,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2011,[Not Available],-23865,Alive,WITH TUMOR,917,NA,[Not Available],Extrahepatic Recurrence,Lung,NA,161,[Not Available],0,917,0,917,1,161,1,161,NA,Stage IIIB,T3b,M0,LIHC.iCluster:1,3
2.059360031,1.888026259,TCGA-BQ-5885-01A,TCGA-BQ-5885-01A-11D-1589-08,3,0.435813964,TCGA-BQ-5885,KIRP,63,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-23173,Alive,TUMOR FREE,921,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,921,0,921,NA,NA,0,921,NA,Stage III,T3,M0,KIRP.C2a,3
-0.774659605,2.29480401,TCGA-CZ-4859-01A,TCGA-CZ-4859-01A-02D-1429-08,0,NA,TCGA-CZ-4859,KIRC,59,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-21842,Alive,TUMOR FREE,1787,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1787,0,1787,NA,NA,0,1787,NA,Stage I,T1,M0,KIRC.1,6
8.953375792,-2.860831363,TCGA-A8-A06T-01A,TCGA-A8-A06T-01A-11W-A019-09,1,0.693355929,TCGA-A8-A06T,BRCA,75,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27393,Alive,TUMOR FREE,1614,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1614,0,1614,0,1614,0,1614,NA,Stage IIIA,T3,M0,BRCA.LumA,1
9.432829558,-4.136008051,TCGA-BH-A0HQ-01A,TCGA-BH-A0HQ-01A-11W-A050-09,1,0.736254559,TCGA-BH-A0HQ,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20719,Alive,TUMOR FREE,1121,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1121,0,1121,0,1121,0,1121,NA,Stage IIA,T2,M0,BRCA.LumA,1
9.332990255,-5.118416043,TCGA-A7-A2KD-01A,TCGA-A7-A2KD-01A-31D-A21Q-09,1,0.704968772,TCGA-A7-A2KD,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19563,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,679,0,679,0,679,0,679,NA,Stage IIIA,T2,MX,BRCA.LumB,1
9.426337724,-2.811034649,TCGA-DZ-6135-01A,TCGA-DZ-6135-01A-11D-1961-08,1,0.741423978,TCGA-DZ-6135,KIRP,45,MALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-16468,Alive,TUMOR FREE,2269,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,2269,0,2269,NA,NA,0,2269,NA,Stage I,T1a,MX,KIRP.C1,1
8.728881617,-4.260913466,TCGA-AL-3466-01A,TCGA-AL-3466-01A-02D-1402-10,1,0.700553877,TCGA-AL-3466,KIRP,41,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-15181,Dead,WITH TUMOR,NA,293,[Not Available],NA,NA,NA,138,[Not Available],1,293,1,293,NA,NA,1,138,NA,Stage IV,T3b,M1,KIRP.C2b,1
4.203483103,1.308275252,TCGA-A4-7288-01A,TCGA-A4-7288-01A-11D-2136-08,2,0.661480354,TCGA-A4-7288,KIRP,71,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-26268,Alive,TUMOR FREE,1857,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1857,0,1857,0,1857,0,1857,NA,[Not Available],T1a,MX,KIRP.C1,5
-7.803565085,-2.367117212,TCGA-B1-5398-01A,TCGA-B1-5398-01A-02D-1589-08,6,0.542487667,TCGA-B1-5398,KIRP,73,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-26820,Alive,TUMOR FREE,1251,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1251,0,1251,0,1251,0,1251,NA,Stage III,T3b,M0,KIRP.C2a,2
-2.85399054,1.060216703,TCGA-BQ-7059-01A,TCGA-BQ-7059-01A-11D-1961-08,0,NA,TCGA-BQ-7059,KIRP,71,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-26136,Alive,TUMOR FREE,232,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,232,0,232,NA,NA,0,232,NA,Stage I,T1b,M0,KIRP.C1,10
4.350694525,1.284302995,TCGA-B0-5121-01A,TCGA-B0-5121-01A-02D-1421-08,2,0.707980134,TCGA-B0-5121,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-20635,Alive,TUMOR FREE,1485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1485,0,1485,0,1485,0,1485,NA,Stage I,T1b,M0,KIRC.2,5
7.770486969,-3.481235107,TCGA-BQ-7055-01A,TCGA-BQ-7055-01A-11D-1961-08,1,0.34669267,TCGA-BQ-7055,KIRP,73,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-26749,Alive,TUMOR FREE,799,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,799,0,799,NA,NA,0,799,NA,Stage I,T1a,M0,KIRP.C2a,1
-7.343781944,1.527746206,TCGA-BH-A0HN-01A,TCGA-BH-A0HN-01A-11D-A099-09,0,NA,TCGA-BH-A0HN,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24731,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,516,0,516,0,516,0,516,NA,Stage IA,T1c,M0,BRCA.LumA,7
9.015434664,-2.888092115,TCGA-B1-7332-01A,TCGA-B1-7332-01A-11D-2136-08,1,0.690158799,TCGA-B1-7332,KIRP,60,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-22277,Alive,TUMOR FREE,1141,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1141,0,1141,0,1141,0,1141,NA,Stage II,T2a,MX,KIRP.C1,1
-1.856423457,1.153596898,TCGA-A1-A0SP-01A,TCGA-A1-A0SP-01A-11D-A099-09,5,0.665315527,TCGA-A1-A0SP,BRCA,40,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-14954,Alive,TUMOR FREE,584,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,584,0,584,0,584,0,584,NA,Stage IIA,T2,M0,BRCA.Basal,4
0.039468056,2.405363186,TCGA-BQ-7048-01A,TCGA-BQ-7048-01A-11D-1961-08,4,0.075710478,TCGA-BQ-7048,KIRP,64,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2003,[Not Available],-23460,Alive,WITH TUMOR,2839,NA,[Not Available],NA,NA,NA,229,[Not Available],0,2839,0,2839,NA,NA,1,229,NA,Stage III,T3a,M0,KIRP.C2b,6
2.109722986,1.812100962,TCGA-B0-5705-01A,TCGA-B0-5705-01A-11D-1534-10,3,0.512462167,TCGA-B0-5705,KIRC,65,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2002,[Not Available],-23746,Alive,TUMOR FREE,4537,NA,[Not Available],NA,NA,NA,842,Complete Remission/Response,0,4537,0,4537,1,842,1,842,NA,Stage I,T1,M0,KIRC.1,3
8.81307115,-4.243275765,TCGA-G7-7501-01A,TCGA-G7-7501-01A-11D-2201-08,1,0.736866545,TCGA-G7-7501,KIRP,55,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-20165,Dead,WITH TUMOR,NA,624,[Not Available],NA,NA,NA,110,Progressive Disease,1,624,1,624,NA,NA,1,110,NA,Stage III,T3a,MX,KIRP.C2a,1
4.307026042,1.114007001,TCGA-BQ-5886-01A,TCGA-BQ-5886-01A-11D-1589-08,2,0.69431032,TCGA-BQ-5886,KIRP,75,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-27670,Alive,TUMOR FREE,792,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,792,0,792,NA,NA,0,792,NA,Stage III,T3a,M0,KIRP.C2a,5
8.727589416,-4.859807133,TCGA-GL-7966-01A,TCGA-GL-7966-01A-11D-2201-08,1,0.797004301,TCGA-GL-7966,KIRP,28,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-10428,Alive,WITH TUMOR,112,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,112,0,112,NA,NA,0,112,NA,Stage III,T3,MX,KIRP.C2c - CIMP,1
9.315370023,-5.157587214,TCGA-BP-4970-01A,TCGA-BP-4970-01A-01D-1462-08,1,0.745318454,TCGA-BP-4970,KIRC,44,MALE,ASIAN,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-16228,Alive,TUMOR FREE,433,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,433,0,433,NA,NA,0,433,NA,Stage III,T1a,M0,KIRC.1,1
-4.189515259,-1.964298496,TCGA-DZ-6132-01A,TCGA-DZ-6132-01A-11D-1961-08,8,0.467437855,TCGA-DZ-6132,KIRP,69,MALE,[Not Available],Kidney Papillary Renal Cell Carcinoma,[Not Available],2003,[Not Available],-25417,Alive,TUMOR FREE,2460,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2460,0,2460,NA,NA,0,2460,NA,Stage I,T1a,MX,KIRP.C1,10
-3.118736,-3.62036536,TCGA-G7-6797-01A,TCGA-G7-6797-01A-11D-1961-08,8,0.43858542,TCGA-G7-6797,KIRP,46,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-17004,Alive,TUMOR FREE,765,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,765,0,765,NA,NA,0,765,NA,Stage III,T1a,MX,KIRP.C1,10
7.861489146,-1.358172198,TCGA-DZ-6131-01A,TCGA-DZ-6131-01A-11D-1961-08,1,0.210388321,TCGA-DZ-6131,KIRP,31,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2003,[Not Available],-11487,Alive,TUMOR FREE,2429,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2429,0,2429,NA,NA,0,2429,NA,Stage III,T3a,MX,KIRP.C2b,6
8.872143317,-3.931227638,TCGA-B0-5692-01A,TCGA-B0-5692-01A-11D-1534-10,1,0.709745308,TCGA-B0-5692,KIRC,66,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-24140,Alive,TUMOR FREE,3944,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3944,0,3944,0,3944,0,3944,NA,Stage III,T3b,M0,KIRC.4,1
8.61020617,-3.049037927,TCGA-DD-A4NJ-01A,TCGA-DD-A4NJ-01A-11D-A27I-10,1,0.607446766,TCGA-DD-A4NJ,LIHC,54,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-19964,Alive,WITH TUMOR,928,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,549,[Not Available],0,928,0,928,1,549,1,549,NA,Stage II,T2,M0,LIHC.NA,1
-6.523713383,-1.980899454,TCGA-FV-A23B-01A,TCGA-FV-A23B-01A-11D-A16V-10,0,NA,TCGA-FV-A23B,LIHC,70,FEMALE,WHITE,Hepatocellular Carcinoma,[Not Available],2005,[Not Available],-25788,Dead,WITH TUMOR,NA,1852,[Not Available],Locoregional Recurrence,Liver,NA,1453,[Not Available],1,1852,1,1852,1,1453,1,1453,NA,Stage II,T2,M0,LIHC.iCluster:2,2
4.218095994,1.310810766,TCGA-DD-A39X-01A,TCGA-DD-A39X-01A-11D-A20W-10,2,0.549261921,TCGA-DD-A39X,LIHC,78,FEMALE,WHITE,Hepatocellular Carcinoma,G2,1998,[Not Available],-28528,Dead,WITH TUMOR,NA,1694,[Not Available],Intrahepatic Recurrence,Liver,NA,1032,[Not Available],1,1694,1,1694,1,1032,1,1032,NA,Stage I,T1,M0,LIHC.iCluster:1,5
8.09445324,-2.413326751,TCGA-DD-A3A3-01A,TCGA-DD-A3A3-01A-11D-A22F-10,1,0.514904735,TCGA-DD-A3A3,LIHC,45,MALE,ASIAN,Hepatocellular Carcinoma,G2,1999,[Not Available],-16708,Dead,NA,NA,535,[Not Available],NA,NA,NA,NA,[Not Available],1,535,NA,535,0,535,0,535,NA,Stage I,T1,M0,LIHC.iCluster:1,1
-6.94865335,2.429567439,TCGA-D1-A16D-01A,TCGA-D1-A16D-01A-11D-A12J-09,0,NA,TCGA-D1-A16D,UCEC,49,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Peri (6-12 months since last menstrual period),-17933,Alive,TUMOR FREE,1141,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1141,0,1141,0,1141,0,1141,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.CN low,7
-0.184107949,3.084844565,TCGA-FV-A4ZQ-01A,TCGA-FV-A4ZQ-01A-11D-A25V-10,4,0.268391302,TCGA-FV-A4ZQ,LIHC,52,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-19090,Alive,TUMOR FREE,12,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,12,0,12,0,12,0,12,NA,Stage I,T1,M0,LIHC.iCluster:2,3
0.874522446,3.558394233,TCGA-36-2548-01A,TCGA-36-2548-01A-01D-1526-09,0,NA,TCGA-36-2548,OV,57,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2008,[Not Available],-20897,Alive,WITH TUMOR,431,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],395,[Not Available],0,431,0,431,NA,NA,1,395,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
9.001761626,-4.880449749,TCGA-13-0911-01A,TCGA-13-0911-01A-01W-0420-08,1,0.785697189,TCGA-13-0911,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-20276,Dead,WITH TUMOR,NA,1355,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],279,Partial Remission/Response,1,1355,1,1355,NA,NA,1,279,NA,Stage IV,[Not Applicable],[Not Applicable],NA,1
10.11117194,-1.959182481,TCGA-BP-5181-01A,TCGA-BP-5181-01A-01D-1429-08,1,0.8075349,TCGA-BP-5181,KIRC,58,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-21514,Alive,TUMOR FREE,1495,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1495,0,1495,NA,NA,0,1495,NA,Stage I,T1b,M0,NA,1
-0.729368667,2.257426092,TCGA-B8-5158-01A,TCGA-B8-5158-01A-01D-1421-08,0,NA,TCGA-B8-5158,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2010,[Not Available],-20764,Alive,TUMOR FREE,1218,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1218,0,1218,0,1218,0,1218,NA,Stage III,T3a,M0,KIRC.3,1
-3.189957141,-3.545802083,TCGA-AX-A063-01A,TCGA-AX-A063-01A-11W-A027-09,8,0.538360149,TCGA-AX-A063,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23045,Alive,TUMOR FREE,2417,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2417,0,2417,0,2417,0,2417,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-4.265132665,-1.783349764,TCGA-AX-A06H-01A,TCGA-AX-A06H-01A-11D-A122-09,8,0.410311378,TCGA-AX-A06H,UCEC,60,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22270,Alive,WITH TUMOR,833,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,833,0,833,0,833,0,833,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-1.890037848,1.218060317,TCGA-13-1499-01A,TCGA-13-1499-01A-01W-0549-09,5,0.623644486,TCGA-13-1499,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-20668,Alive,WITH TUMOR,3500,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],583,Complete Remission/Response,0,3500,0,3500,1,583,1,583,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,4
-7.340991461,2.420140173,TCGA-BS-A0TG-01A,TCGA-BS-A0TG-01A-32D-A10B-09,0,NA,TCGA-BS-A0TG,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22043,Alive,WITH TUMOR,2371,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2371,0,2371,0,2371,0,2371,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,7
8.624752726,-2.867892721,TCGA-D1-A3DG-01A,TCGA-D1-A3DG-01A-11D-A19Y-09,1,0.559975156,TCGA-D1-A3DG,UCEC,81,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29771,Dead,TUMOR FREE,NA,130,[Not Available],NA,NA,NA,NA,[Not Available],1,130,0,130,NA,NA,0,130,NA,Stage IVB,[Not Applicable],[Not Applicable],NA,6
8.806819002,-4.700054675,TCGA-13-0921-01A,TCGA-13-0921-01A-01W-0420-08,1,0.822711362,TCGA-13-0921,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-26606,Dead,TUMOR FREE,NA,1483,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1483,0,1483,0,1483,0,1483,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
9.413677058,-5.193921515,TCGA-A4-7915-01A,TCGA-A4-7915-01A-11D-2201-08,1,0.832888743,TCGA-A4-7915,KIRP,35,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-12832,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,7,0,7,NA,NA,0,7,NA,Stage II,T2b,MX,KIRP.C2c - CIMP,1
-7.306656375,2.077732565,TCGA-BK-A0CA-01A,TCGA-BK-A0CA-01A-21D-A272-09,9,0.127842962,TCGA-BK-A0CA,UCEC,61,FEMALE,WHITE,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22378,Alive,TUMOR FREE,1064,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1064,0,1064,0,1064,0,1064,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.CN low,7
8.189737399,-2.532262799,TCGA-BQ-7046-01A,TCGA-BQ-7046-01A-11D-1961-08,1,0.494837583,TCGA-BQ-7046,KIRP,61,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2002,[Not Available],-22337,Alive,TUMOR FREE,2948,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2948,0,2948,NA,NA,0,2948,NA,Stage I,T1a,M0,KIRP.C1,1
1.89706026,1.985670909,TCGA-G7-6790-01A,TCGA-G7-6790-01A-11D-1961-08,3,0.271124641,TCGA-G7-6790,KIRP,57,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-21169,Alive,TUMOR FREE,1575,NA,[Not Available],NA,NA,NA,1558,[Not Available],0,1575,0,1575,NA,NA,1,1558,NA,Stage I,T1a,MX,KIRP.C1,3
1.325001105,3.303442207,TCGA-A4-8098-01A,TCGA-A4-8098-01A-11D-2396-08,0,NA,TCGA-A4-8098,KIRP,73,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-26685,Alive,TUMOR FREE,896,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,896,0,896,0,896,0,896,NA,Stage I,T1a,MX,KIRP.C2b,1
4.57579259,0.980892089,TCGA-B4-5832-01A,TCGA-B4-5832-01A-11D-1669-08,2,0.402586233,TCGA-B4-5832,KIRC,65,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-23806,Alive,TUMOR FREE,155,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,155,0,155,0,155,0,155,NA,Stage III,T3b,M0,NA,5
2.168712746,1.73799259,TCGA-BQ-7062-01A,TCGA-BQ-7062-01A-11D-1961-08,3,0.599648928,TCGA-BQ-7062,KIRP,64,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-23559,Alive,TUMOR FREE,116,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,116,0,116,NA,NA,0,116,NA,Stage I,T1a,M0,KIRP.C1,3
-0.990878602,4.486672649,TCGA-61-2018-01A,TCGA-61-2018-01A-01W-0722-08,4,0.362917351,TCGA-61-2018,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-22929,Alive,TUMOR FREE,1381,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1381,0,1381,0,1381,0,1381,NA,Stage IC,[Not Applicable],[Not Applicable],NA,6
7.574481626,-3.295531526,TCGA-DW-7837-01A,TCGA-DW-7837-01A-11D-2136-08,1,0.269485801,TCGA-DW-7837,KIRP,43,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-15891,Alive,WITH TUMOR,1142,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1142,0,1142,NA,NA,0,1142,NA,Stage I,T1b,MX,KIRP.C1,1
9.636283563,-3.935481818,TCGA-A4-7286-01A,TCGA-A4-7286-01A-11D-2136-08,1,0.669326118,TCGA-A4-7286,KIRP,42,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-15631,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,554,0,554,0,554,0,554,NA,[Not Available],T3a,[Not Available],KIRP.C2a,1
-1.532531935,1.033447715,TCGA-A4-7734-01A,TCGA-A4-7734-01A-11D-2136-08,5,0.400470515,TCGA-A4-7734,KIRP,53,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-19612,Alive,TUMOR FREE,27,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,27,0,27,NA,NA,0,27,NA,Stage I,T1a,MX,KIRP.C1,4
-3.322394127,-3.380032614,TCGA-B5-A11G-01A,TCGA-B5-A11G-01A-13D-A122-09,8,0.533457599,TCGA-B5-A11G,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25995,Alive,TUMOR FREE,3448,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3448,0,3448,0,3448,0,3448,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
9.807318995,-1.845572114,TCGA-BQ-5893-01A,TCGA-BQ-5893-01A-11D-1589-08,1,0.837168977,TCGA-BQ-5893,KIRP,61,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-22320,Dead,WITH TUMOR,NA,241,[Not Available],NA,NA,NA,188,[Not Available],1,241,1,241,NA,NA,1,188,NA,Stage IV,T3a,M1,KIRP.C2c - CIMP,1
9.329671473,-5.366551914,TCGA-DW-7841-01A,TCGA-DW-7841-01A-11D-2136-08,1,0.8334852,TCGA-DW-7841,KIRP,61,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-22403,Alive,TUMOR FREE,445,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,445,0,445,NA,NA,0,445,NA,Stage I,T1b,MX,KIRP.C1,1
-5.959562612,2.972022499,TCGA-EV-5903-01A,TCGA-EV-5903-01A-11D-1589-08,0,NA,TCGA-EV-5903,KIRP,57,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-20888,Alive,TUMOR FREE,757,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,757,0,757,NA,NA,0,757,NA,Stage I,T1a,M0,KIRP.C1,5
-0.248871504,4.270612134,TCGA-13-1504-01A,TCGA-13-1504-01A-01W-0545-08,4,0.519865999,TCGA-13-1504,OV,68,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-25008,Dead,WITH TUMOR,NA,1059,[Not Available],NA,[Not Applicable],[Not Applicable],548,Complete Remission/Response,1,1059,1,1059,1,548,1,548,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
4.298913791,1.154468613,TCGA-09-2056-01B,TCGA-09-2056-01B-01W-0722-08,2,0.527263008,TCGA-09-2056,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-22864,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
9.238897295,-5.694772786,TCGA-BP-5178-01A,TCGA-BP-5178-01A-01D-1429-08,1,0.802852894,TCGA-BP-5178,KIRC,71,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2004,[Not Available],-26070,Dead,WITH TUMOR,NA,1912,[Not Available],NA,NA,NA,396,[Not Available],1,1912,1,1912,NA,NA,1,396,NA,Stage IV,T3a,M1,KIRC.4,1
-6.421477989,1.596892559,TCGA-BQ-5881-01A,TCGA-BQ-5881-01A-11D-1589-08,0,NA,TCGA-BQ-5881,KIRP,69,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-25481,Alive,TUMOR FREE,1454,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1454,0,1454,NA,NA,0,1454,NA,Stage I,T1a,M0,KIRP.C2a,7
-6.907256371,-2.178083738,TCGA-B0-5713-01A,TCGA-B0-5713-01A-11D-1669-08,6,0.25309904,TCGA-B0-5713,KIRC,75,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-27644,Alive,TUMOR FREE,2782,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2782,0,2782,0,2782,0,2782,NA,Stage III,T3b,M0,KIRC.1,2
-5.994115842,3.419654555,TCGA-BQ-5883-01A,TCGA-BQ-5883-01A-11D-1589-08,11,0.554233141,TCGA-BQ-5883,KIRP,79,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-28877,Alive,TUMOR FREE,1242,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1242,0,1242,NA,NA,0,1242,NA,Stage I,T1a,M0,KIRP.C2a,8
-0.921141099,4.978906488,TCGA-25-1320-01A,TCGA-25-1320-01A-01W-0492-08,4,0.273485547,TCGA-25-1320,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-24018,Dead,WITH TUMOR,1124,1155,[Not Available],Recurrence,[Not Applicable],[Not Applicable],424,Progressive Disease,1,1155,1,1155,NA,NA,1,424,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-4.623264881,-1.542693668,TCGA-BS-A0TE-01A,TCGA-BS-A0TE-01A-11D-A10B-09,8,0.292582251,TCGA-BS-A0TE,UCEC,35,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12983,Dead,WITH TUMOR,NA,146,[Not Available],NA,NA,NA,58,Progressive Disease,1,146,1,146,NA,NA,1,58,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.MSI,10
9.487370595,-2.022522837,TCGA-B3-3925-01A,TCGA-B3-3925-01A-02D-1402-10,1,0.772042868,TCGA-B3-3925,KIRP,52,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-19224,Alive,TUMOR FREE,1029,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1029,0,1029,0,1029,0,1029,NA,Stage III,T3a,M0,KIRP.C1,1
9.691683108,-3.046813854,TCGA-A4-7584-01A,TCGA-A4-7584-01A-11D-2136-08,1,0.714787686,TCGA-A4-7584,KIRP,59,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-21782,Alive,TUMOR FREE,650,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,650,0,650,0,650,0,650,NA,Stage I,T1a,MX,KIRP.C1,1
-6.558685432,2.343906035,TCGA-EV-5902-01A,TCGA-EV-5902-01A-11D-1589-08,0,NA,TCGA-EV-5902,KIRP,58,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-21344,Alive,TUMOR FREE,578,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,578,0,578,NA,NA,0,578,NA,Stage I,T1,M0,KIRP.C1,7
9.750501276,-2.060559443,TCGA-BQ-7050-01A,TCGA-BQ-7050-01A-11D-1961-08,1,0.782351516,TCGA-BQ-7050,KIRP,53,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-19550,Alive,TUMOR FREE,1864,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1864,0,1864,NA,NA,0,1864,NA,Stage I,T1a,M0,KIRP.C2a,1
4.200179117,1.27890782,TCGA-BP-5182-01A,TCGA-BP-5182-01A-01D-1429-08,2,0.57821184,TCGA-BP-5182,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-20597,Alive,TUMOR FREE,1165,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1165,0,1165,NA,NA,0,1165,NA,Stage I,T1a,M0,KIRC.3,5
-4.960083834,-1.632175934,TCGA-A4-7583-01A,TCGA-A4-7583-01A-11D-2136-08,0,NA,TCGA-A4-7583,KIRP,60,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-21962,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3,0,3,NA,NA,0,3,NA,Stage I,T1,M0,KIRP.C1,10
8.725713048,-3.345712205,TCGA-G7-7502-01A,TCGA-G7-7502-01A-11D-2201-08,1,0.68069588,TCGA-G7-7502,KIRP,83,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-30346,Alive,TUMOR FREE,786,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,786,0,786,0,786,0,786,NA,Stage I,T1b,MX,KIRP.C1,1
9.508690278,-3.050654865,TCGA-CZ-5460-01A,TCGA-CZ-5460-01A-01D-1501-10,1,0.769013373,TCGA-CZ-5460,KIRC,55,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-20392,Alive,WITH TUMOR,2873,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2873,0,2873,NA,NA,0,2873,NA,Stage IV,T3b,M1,KIRC.4,1
1.635735486,2.020427509,TCGA-BQ-7056-01A,TCGA-BQ-7056-01A-11D-1961-08,3,0.005423913,TCGA-BQ-7056,KIRP,75,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-27467,Alive,WITH TUMOR,612,NA,[Not Available],NA,NA,NA,143,[Not Available],0,612,0,612,NA,NA,1,143,NA,Stage III,T3b,M0,NA,3
-0.564079424,5.090583569,TCGA-24-2019-01A,TCGA-24-2019-01A-02W-0722-08,4,0.44398854,TCGA-24-2019,OV,46,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-17009,Alive,NA,148,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,148,0,148,NA,NA,0,148,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
0.339363235,5.050735575,TCGA-25-2399-01A,TCGA-25-2399-01A-01W-0799-08,4,0.466631787,TCGA-25-2399,OV,80,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-29373,Dead,WITH TUMOR,608,608,[Not Available],Recurrence,[Not Applicable],[Not Applicable],243,Partial Remission/Response,1,608,1,608,NA,NA,1,243,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-7.798408865,-2.367001609,TCGA-61-1910-01A,TCGA-61-1910-01A-01W-0639-09,6,0.518032235,TCGA-61-1910,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-20779,Alive,TUMOR FREE,1127,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1127,0,1127,0,1127,0,1127,NA,Stage IIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,2
-2.026627325,1.121486627,TCGA-B8-4143-01A,TCGA-B8-4143-01A-01D-1806-10,5,0.608974802,TCGA-B8-4143,KIRC,66,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2002,[Not Available],-24132,Dead,WITH TUMOR,NA,709,[Not Available],NA,NA,NA,NA,[Not Available],1,709,1,709,NA,NA,1,709,NA,Stage IV,T3a,M1,KIRC.3,4
9.845420801,-2.051105129,TCGA-BQ-5892-01A,TCGA-BQ-5892-01A-11D-1589-08,1,0.786275723,TCGA-BQ-5892,KIRP,51,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-18785,Alive,TUMOR FREE,364,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,364,0,364,NA,NA,0,364,NA,Stage I,T1b,M0,KIRP.C2a,1
4.379800977,1.234136805,TCGA-CJ-5689-01A,TCGA-CJ-5689-01A-11D-1534-10,2,0.718284082,TCGA-CJ-5689,KIRC,90,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2005,[Not Available],-32872,Dead,TUMOR FREE,NA,1620,[Not Available],NA,NA,NA,NA,[Not Available],1,1620,0,1620,NA,NA,0,1620,NA,Stage I,T1b,M0,KIRC.3,5
9.368657316,-5.582209219,TCGA-BQ-5887-01A,TCGA-BQ-5887-01A-11D-1961-08,1,0.856832949,TCGA-BQ-5887,KIRP,54,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-19747,Alive,TUMOR FREE,771,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,771,0,771,NA,NA,0,771,NA,Stage III,T3a,M0,KIRP.C2b,1
-7.594488131,-2.121674035,TCGA-B9-5155-01A,TCGA-B9-5155-01A-01D-1589-08,6,0.156986848,TCGA-B9-5155,KIRP,71,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-26149,Alive,TUMOR FREE,665,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,665,0,665,0,665,0,665,NA,Stage III,T3a,[Not Available],KIRP.C1,2
-0.736925335,2.222817562,TCGA-B9-4116-01A,TCGA-B9-4116-01A-02D-1402-10,0,NA,TCGA-B9-4116,KIRP,75,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-27692,Alive,TUMOR FREE,627,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,627,0,627,NA,NA,0,627,NA,[Not Available],T2a,[Not Available],KIRP.C1,1
-2.241961754,1.13163171,TCGA-A4-7996-01A,TCGA-A4-7996-01A-11D-2201-08,5,0.39258349,TCGA-A4-7996,KIRP,61,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-22559,Alive,TUMOR FREE,506,NA,[Not Available],NA,NA,NA,493,Complete Remission/Response,0,506,0,506,1,493,1,493,NA,Stage I,T1a,MX,KIRP.C1,4
10.12705781,-1.753789909,TCGA-DW-7836-01A,TCGA-DW-7836-01A-11D-2136-08,1,0.824497216,TCGA-DW-7836,KIRP,55,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-20269,Alive,TUMOR FREE,1093,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1093,0,1093,NA,NA,0,1093,NA,Stage I,T1a,MX,KIRP.C1,1
-4.012310855,-0.567977667,TCGA-BQ-7049-01A,TCGA-BQ-7049-01A-11D-1961-08,0,NA,TCGA-BQ-7049,KIRP,45,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-16717,Dead,TUMOR FREE,NA,1364,[Not Available],NA,NA,NA,NA,[Not Available],1,1364,0,1364,NA,NA,0,1364,NA,Stage I,T1a,M0,NA,10
-2.079992898,1.158685273,TCGA-A3-3385-01A,TCGA-A3-3385-01A-02D-1421-08,5,0.548537889,TCGA-A3-3385,KIRC,46,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-17114,Alive,TUMOR FREE,1993,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1993,0,1993,0,1993,0,1993,NA,Stage I,T1a,M0,KIRC.1,4
8.856704402,-4.083348824,TCGA-J7-6720-01A,TCGA-J7-6720-01A-11D-2136-08,1,0.744996041,TCGA-J7-6720,KIRP,42,MALE,ASIAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-15620,Alive,TUMOR FREE,388,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,388,0,388,0,388,0,388,NA,Stage I,T1,M0,KIRP.C1,1
8.681672861,-3.381903007,TCGA-BP-5201-01A,TCGA-BP-5201-01A-01D-1429-08,1,0.654440452,TCGA-BP-5201,KIRC,63,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2008,[Not Available],-23125,Alive,WITH TUMOR,951,NA,[Not Available],NA,NA,NA,-19,[Not Available],0,951,0,951,NA,NA,1,NA,NA,Stage IV,T3b,M1,KIRC.4,1
-1.22652532,2.537040281,TCGA-G7-6795-01A,TCGA-G7-6795-01A-11D-1961-08,0,NA,TCGA-G7-6795,KIRP,56,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2008,[Not Available],-20478,Alive,TUMOR FREE,1194,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1194,0,1194,NA,NA,0,1194,NA,Stage I,T1a,MX,KIRP.C1,3
9.741699916,-1.934999654,TCGA-BQ-5891-01A,TCGA-BQ-5891-01A-11D-1589-08,1,0.789701597,TCGA-BQ-5891,KIRP,57,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-20945,Alive,TUMOR FREE,29,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,29,0,29,NA,NA,0,29,NA,Stage III,T3b,M0,KIRP.C2b,1
-7.744118558,-2.549454196,TCGA-BQ-5877-01A,TCGA-BQ-5877-01A-11D-1589-08,6,0.23148082,TCGA-BQ-5877,KIRP,60,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2004,[Not Available],-22095,Dead,WITH TUMOR,NA,270,[Not Available],NA,NA,NA,127,[Not Available],1,270,1,270,NA,NA,1,127,NA,Stage IV,T3a,M1,KIRP.C2b,2
-6.399387346,1.277563093,TCGA-Z4-A9VC-01A,TCGA-Z4-A9VC-01A-11D-A37C-09,10,0.092503062,TCGA-Z4-A9VC,SARC,37,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2013,[Not Available],-13576,Alive,TUMOR FREE,407,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,407,0,407,0,407,0,407,NA,NA,NA,NA,NA,7
8.250115999,-3.793066136,TCGA-Z4-A8JB-01A,TCGA-Z4-A8JB-01A-23D-A37C-09,1,0.569820947,TCGA-Z4-A8JB,SARC,24,FEMALE,WHITE,Desmoid Tumor,[Not Available],2013,[Not Available],-9123,Alive,TUMOR FREE,133,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,133,0,133,0,133,0,133,NA,NA,NA,NA,NA,1
9.430662119,-2.113626715,TCGA-KD-A5QU-01A,TCGA-KD-A5QU-01A-11D-A27P-09,1,0.707319477,TCGA-KD-A5QU,SARC,41,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-15018,Dead,WITH TUMOR,NA,1073,[Not Available],Distant Metastasis,Lung,NA,1060,[Not Available],1,1073,1,1073,1,1060,1,1060,NA,NA,NA,NA,NA,1
0.072014888,5.194902629,TCGA-KD-A5QT-01A,TCGA-KD-A5QT-01A-11D-A27P-09,4,0.68668386,TCGA-KD-A5QT,SARC,69,FEMALE,[Not Evaluated],Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-25249,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,499,0,499,0,499,0,499,NA,NA,NA,NA,NA,6
-0.195232115,4.200393726,TCGA-KD-A5QS-01A,TCGA-KD-A5QS-01A-11D-A27P-09,4,0.300571823,TCGA-KD-A5QS,SARC,55,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2009,[Not Available],-20410,Dead,WITH TUMOR,NA,1941,[Not Available],Distant Metastasis,Bone,NA,351,[Not Available],1,1941,1,1941,NA,NA,1,351,NA,NA,NA,NA,NA,6
-0.398112343,3.764301472,TCGA-A5-A7WK-01A,TCGA-A5-A7WK-01A-11D-A34Q-09,4,0.224159837,TCGA-A5-A7WK,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed serous and endometrioid,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26044,Alive,WITH TUMOR,560,NA,[Not Available],Locoregional Recurrence,"Other, specify",Paraaortic lymph node,350,Complete Remission/Response,0,560,0,560,1,350,1,350,NA,Stage IA,[Not Applicable],[Not Applicable],NA,6
-0.703336978,2.196110156,TCGA-BG-A0MA-01A,TCGA-BG-A0MA-01A-11D-A17D-09,0,NA,TCGA-BG-A0MA,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22036,Dead,WITH TUMOR,NA,326,[Not Available],Metastatic,Bone,NA,70,Progressive Disease,1,326,1,326,NA,NA,1,70,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,3
-5.030296165,0.716661953,TCGA-4E-A92E-01A,TCGA-4E-A92E-01A-11D-A37N-09,0,NA,TCGA-4E-A92E,UCEC,54,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19818,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,13,0,13,0,13,0,13,NA,Stage I,[Not Applicable],[Not Applicable],NA,10
9.905209436,-1.473833084,TCGA-Z4-AAPG-01A,TCGA-Z4-AAPG-01A-11D-A38Z-09,1,0.802014785,TCGA-Z4-AAPG,SARC,64,FEMALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013,[Not Available],-23390,Alive,TUMOR FREE,486,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,486,0,486,0,486,0,486,NA,NA,NA,NA,NA,1
9.586781329,-3.969321811,TCGA-Z4-AAPF-01A,TCGA-Z4-AAPF-01A-11D-A38Z-09,1,0.717526552,TCGA-Z4-AAPF,SARC,35,FEMALE,WHITE,Sarcoma; synovial; poorly differentiated,[Not Available],2013,[Not Available],-12959,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,485,0,485,0,485,0,485,NA,NA,NA,NA,NA,1
-0.229625475,2.924877002,TCGA-AR-A251-01A,TCGA-AR-A251-01A-12D-A167-09,4,0.084381539,TCGA-AR-A251,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771,Alive,TUMOR FREE,3030,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3030,0,3030,0,3030,0,3030,NA,Stage IIIA,T2,M0,BRCA.Basal,6
-5.31454983,2.581541369,TCGA-DF-A2KR-01A,TCGA-DF-A2KR-01A-11D-A17W-09,12,0.338750765,TCGA-DF-A2KR,UCEC,84,FEMALE,[Not Evaluated],Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31007,Alive,TUMOR FREE,2178,NA,[Not Available],New Primary Tumor,Lung,NA,2113,Complete Remission/Response,0,2178,0,2178,0,2178,1,2113,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,8
-2.963199839,-4.033633943,TCGA-DF-A2KN-01A,TCGA-DF-A2KN-01A-11D-A17W-09,8,0.18665513,TCGA-DF-A2KN,UCEC,NA,FEMALE,[Not Evaluated],Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,67,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,67,0,67,0,67,0,67,NA,Stage IC,[Not Applicable],[Not Applicable],NA,10
-7.269762923,2.010028078,TCGA-A5-A0RA-01A,TCGA-A5-A0RA-01A-21D-A10B-09,9,0.212106369,TCGA-A5-A0RA,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25060,Alive,TUMOR FREE,884,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,884,0,884,0,884,0,884,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
3.012203526,3.59465813,TCGA-A5-AB3J-01A,TCGA-A5-AB3J-01A-11D-A403-09,0,NA,TCGA-A5-AB3J,UCEC,52,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2013,Peri (6-12 months since last menstrual period),-19020,Alive,TUMOR FREE,512,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,512,0,512,0,512,0,512,NA,Stage II,[Not Applicable],[Not Applicable],NA,5
7.894972619,-3.473617426,TCGA-BH-A0HK-01A,TCGA-BH-A0HK-01A-11W-A071-09,1,0.348495672,TCGA-BH-A0HK,BRCA,81,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29751,Alive,TUMOR FREE,178,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,178,0,178,0,178,0,178,NA,Stage IIB,T2,M0,BRCA.LumA,1
-2.755645625,-4.349386443,TCGA-AX-A1CE-01A,TCGA-AX-A1CE-01A-11D-A135-09,0,NA,TCGA-AX-A1CE,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21969,Alive,TUMOR FREE,1037,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,1037,0,1037,NA,NA,0,1037,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-2.746568318,-4.339468493,TCGA-DF-A2KU-01A,TCGA-DF-A2KU-01A-11D-A17W-09,0,NA,TCGA-DF-A2KU,UCEC,NA,FEMALE,[Not Evaluated],Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,3067,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3067,0,3067,0,3067,0,3067,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
9.186805927,-4.64548576,TCGA-A2-A0YD-01A,TCGA-A2-A0YD-01A-11D-A10G-09,1,0.816208137,TCGA-A2-A0YD,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021,Alive,TUMOR FREE,769,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,769,0,769,0,769,0,769,NA,Stage IIB,T3,M0,BRCA.LumA,1
9.436466264,-5.191109931,TCGA-EW-A1OX-01A,TCGA-EW-A1OX-01A-11D-A142-09,1,0.815898444,TCGA-EW-A1OX,BRCA,43,FEMALE,WHITE,Mucinous Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15837,Alive,TUMOR FREE,911,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,911,0,911,0,911,0,911,NA,Stage IIA,T2,MX,BRCA.LumB,1
9.017346364,-2.774993607,TCGA-AJ-A3I9-01A,TCGA-AJ-A3I9-01A-11D-A228-09,1,0.65892901,TCGA-AJ-A3I9,UCEC,52,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19139,Dead,WITH TUMOR,NA,519,[Not Available],Distant Metastasis,Bone,NA,370,Complete Remission/Response,1,519,1,519,1,370,1,370,NA,Stage II,[Not Applicable],[Not Applicable],NA,1
0.225519359,4.742401182,TCGA-23-1111-01A,TCGA-23-1111-01A-01W-0639-09,4,0.551658002,TCGA-23-1111,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-23171,Alive,NA,98,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,98,0,98,NA,NA,0,98,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-0.76293632,4.804023721,TCGA-13-1512-01A,TCGA-13-1512-01A-01W-0545-08,4,0.478797231,TCGA-13-1512,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-18134,Alive,WITH TUMOR,442,NA,[Not Available],NA,[Not Applicable],[Not Applicable],427,[Not Available],0,442,0,442,NA,NA,1,427,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-7.526937771,2.369557697,TCGA-B5-A1MZ-01A,TCGA-B5-A1MZ-01A-11D-A142-09,9,0.15666544,TCGA-B5-A1MZ,UCEC,54,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Indeterminate (neither Pre or Postmenopausal),-19955,Alive,TUMOR FREE,1598,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,613,Complete Remission/Response,0,1598,0,1598,1,613,1,613,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
0.073907253,4.884578583,TCGA-D8-A1Y3-01A,TCGA-D8-A1Y3-01A-11D-A159-09,4,0.651327488,TCGA-D8-A1Y3,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22317,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,430,0,430,0,430,0,430,NA,Stage IIIA,T2,MX,BRCA.LumB,6
-4.470434651,-1.267256773,TCGA-A2-A25A-01A,TCGA-A2-A25A-01A-12D-A16D-09,8,0.323954988,TCGA-A2-A25A,BRCA,44,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16084,Alive,TUMOR FREE,3276,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3276,0,3276,0,3276,0,3276,NA,Stage IIA,T2,M0,BRCA.Normal,10
-7.994121704,2.033287972,TCGA-A2-A0CS-01A,TCGA-A2-A0CS-01A-11D-A10Y-09,9,0.591343922,TCGA-A2-A0CS,BRCA,73,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26817,Dead,TUMOR FREE,NA,2348,[Not Available],NA,NA,NA,NA,[Not Available],1,2348,0,2348,NA,NA,0,2348,NA,Stage IV,T4b,M1,BRCA.LumA,7
-7.78848077,2.16602528,TCGA-D8-A1XO-01A,TCGA-D8-A1XO-01A-11D-A14K-09,9,0.368078953,TCGA-D8-A1XO,BRCA,56,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20606,Alive,TUMOR FREE,1682,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1682,0,1682,0,1682,0,1682,NA,Stage IIB,T2,M0,BRCA.LumA,7
-5.353312285,2.770263102,TCGA-04-1362-01A,TCGA-04-1362-01A-01W-0492-08,12,0.146146081,TCGA-04-1362,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-21745,Dead,WITH TUMOR,NA,1348,[Not Available],Recurrence,[Not Applicable],[Not Applicable],223,[Not Available],1,1348,1,1348,NA,NA,1,223,NA,Stage IIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,8
-6.629502562,-1.333974771,TCGA-A5-A0VO-01A,TCGA-A5-A0VO-01A-21D-A10G-09,7,0.337074348,TCGA-A5-A0VO,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23547,Dead,TUMOR FREE,NA,875,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,875,0,875,0,875,0,875,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,2
-2.949796151,-4.042853764,TCGA-EY-A1G8-01A,TCGA-EY-A1G8-01A-11D-A13L-09,8,0.06402568,TCGA-EY-A1G8,UCEC,83,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30517,Dead,TUMOR FREE,NA,456,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,456,0,456,0,456,0,456,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-7.721518359,1.897921597,TCGA-AR-A24O-01A,TCGA-AR-A24O-01A-11D-A167-09,9,0.463754526,TCGA-AR-A24O,BRCA,43,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15977,Alive,WITH TUMOR,3607,NA,[Not Available],NA,NA,NA,2561,[Not Available],0,3607,0,3607,1,2561,1,2561,NA,Stage IIIA,T3,M0,BRCA.LumA,7
-1.661787174,1.228320596,TCGA-24-1428-01A,TCGA-24-1428-01A-01W-0549-09,5,0.582416812,TCGA-24-1428,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-18306,Alive,WITH TUMOR,529,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],448,Complete Remission/Response,0,529,0,529,1,448,1,448,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,4
-4.797207944,2.27317266,TCGA-BS-A0V8-01A,TCGA-BS-A0V8-01A-11D-A122-09,0,NA,TCGA-BS-A0V8,UCEC,68,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24981,Alive,TUMOR FREE,2544,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2544,0,2544,0,2544,0,2544,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.CN high,6
-0.640129945,3.856816967,TCGA-EO-A22Y-01A,TCGA-EO-A22Y-01A-11D-A17W-09,4,0.171373412,TCGA-EO-A22Y,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25127,Alive,TUMOR FREE,1567,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1567,0,1567,0,1567,0,1567,NA,Stage IA,[Not Applicable],[Not Applicable],NA,5
-7.942372127,1.858429199,TCGA-A7-A13G-01A,TCGA-A7-A13G-01A-11D-A13L-09,9,0.560194857,TCGA-A7-A13G,BRCA,79,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28969,Alive,TUMOR FREE,718,NA,[Not Available],New Primary Tumor,"Other, specify","Skin, right leg",586,[Not Available],0,718,0,718,0,718,1,586,NA,Stage IIA,T2,MX,BRCA.LumA,7
7.792362049,-1.372120879,TCGA-29-1766-01A,TCGA-29-1766-01A-01W-0633-09,1,0.145375561,TCGA-29-1766,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2006,[Not Available],-27359,Dead,WITH TUMOR,1190,1199,[Not Available],Recurrence,[Not Applicable],[Not Applicable],672,Progressive Disease,1,1199,1,1199,NA,NA,1,672,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
9.692259549,-3.067858025,TCGA-B6-A2IU-01A,TCGA-B6-A2IU-01A-32D-A19T-09,1,0.721214089,TCGA-B6-A2IU,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],1998,Indeterminate (neither Pre or Postmenopausal),-22905,Alive,WITH TUMOR,5176,NA,[Not Available],New Primary Tumor,"Other, specify",Lung,4224,[Not Available],0,5176,0,5176,0,5176,1,4224,NA,Stage IIA,T2,M0,BRCA.LumA,1
-7.25507264,2.869944109,TCGA-ED-A5KG-01A,TCGA-ED-A5KG-01A-11D-A27I-10,0,NA,TCGA-ED-A5KG,LIHC,60,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-22258,Alive,WITH TUMOR,854,NA,[Not Available],New Primary Tumor,"Other, specify",Kidney,110,[Not Available],0,854,0,854,0,854,1,110,NA,Stage II,T2,M0,LIHC.iCluster:1,1
-8.136924484,1.967447431,TCGA-D1-A0ZP-01A,TCGA-D1-A0ZP-01A-21D-A10M-09,9,0.570964158,TCGA-D1-A0ZP,UCEC,59,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21581,Alive,TUMOR FREE,911,NA,[Not Available],Locoregional Disease,"Other, specify",Recurrent endometrial carcinoma in retriponeal lymphnodes,629,Complete Remission/Response,0,911,0,911,NA,NA,1,629,NA,Stage IVA,[Not Applicable],[Not Applicable],UCEC.CN high,7
-4.495662715,1.571868557,TCGA-C8-A1HF-01A,TCGA-C8-A1HF-01A-11D-A135-09,0,NA,TCGA-C8-A1HF,BRCA,48,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,332,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,332,0,332,0,332,0,332,NA,Stage IIA,T2,M0,BRCA.Her2,9
-7.220731051,2.469278303,TCGA-D1-A168-01A,TCGA-D1-A168-01A-31D-A12J-09,0,NA,TCGA-D1-A168,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24586,Alive,TUMOR FREE,1098,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1098,0,1098,0,1098,0,1098,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
9.264665819,-5.277813003,TCGA-ED-A66X-01A,TCGA-ED-A66X-01A-11D-A30V-10,1,0.85576058,TCGA-ED-A66X,LIHC,35,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-12947,Alive,TUMOR FREE,406,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,124,[Not Available],0,406,0,406,1,124,1,124,NA,Stage IIIA,T3a,M0,LIHC.iCluster:1,1
-7.542870285,-2.410068671,TCGA-FV-A495-01A,TCGA-FV-A495-01A-11D-A25V-10,6,0.494092281,TCGA-FV-A495,LIHC,51,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-18740,Alive,TUMOR FREE,1,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1,0,1,0,1,0,1,NA,Stage II,T2,M0,LIHC.iCluster:2,2
-0.284603001,5.037412917,TCGA-25-2401-01A,TCGA-25-2401-01A-01W-0799-08,4,0.652480915,TCGA-25-2401,OV,64,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-23711,Dead,NA,90,90,[Not Available],NA,NA,NA,NA,[Not Available],1,90,NA,90,NA,NA,0,90,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-1.342837026,2.715077154,TCGA-GI-A2C9-01A,TCGA-GI-A2C9-01A-11D-A21Q-09,0,NA,TCGA-GI-A2C9,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21534,Alive,TUMOR FREE,3342,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3342,0,3342,0,3342,0,3342,NA,Stage IIB,T3,MX,BRCA.Basal,10
-0.33271524,4.281412249,TCGA-23-2641-01A,TCGA-23-2641-01A-01D-1526-09,4,0.540260428,TCGA-23-2641,OV,85,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-31232,Alive,NA,84,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,84,0,84,NA,NA,0,84,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
8.40080586,-3.233177114,TCGA-E2-A14O-01A,TCGA-E2-A14O-01A-31D-A10Y-09,1,0.622540497,TCGA-E2-A14O,BRCA,76,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27837,Alive,TUMOR FREE,1359,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1359,0,1359,0,1359,0,1359,NA,Stage IIIA,T3,M0,BRCA.LumB,1
-5.809513864,-2.03768343,TCGA-CC-5259-01A,TCGA-CC-5259-01A-31D-A20W-10,0,NA,TCGA-CC-5259,LIHC,60,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-21946,Alive,WITH TUMOR,250,NA,[Not Available],Locoregional Recurrence,Liver,NA,180,[Not Available],0,250,0,250,1,180,1,180,NA,Stage IIIC,T4,M0,LIHC.NA,2
-0.923857263,4.40706738,TCGA-DD-A4NG-01A,TCGA-DD-A4NG-01A-11D-A27I-10,4,0.216002938,TCGA-DD-A4NG,LIHC,77,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-28234,Dead,WITH TUMOR,NA,802,[Not Available],Locoregional Recurrence,Liver,NA,430,[Not Available],1,802,1,802,1,430,1,430,NA,Stage IIIA,T3a,M0,LIHC.NA,3
-8.092322678,1.935349,TCGA-D1-A161-01A,TCGA-D1-A161-01A-11D-A122-09,9,0.387842553,TCGA-D1-A161,UCEC,78,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28695,Alive,TUMOR FREE,892,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,892,0,892,0,892,0,892,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.CN low,7
-7.570553428,-2.518952505,TCGA-DD-A3A5-01A,TCGA-DD-A3A5-01A-11D-A22F-10,6,0.161338908,TCGA-DD-A3A5,LIHC,66,FEMALE,WHITE,Hepatocellular Carcinoma,G2,1996,[Not Available],-24288,Dead,WITH TUMOR,NA,3125,[Not Available],Intrahepatic Recurrence,Liver,NA,84,[Not Available],1,3125,1,3125,1,84,1,84,NA,Stage III,T3,M0,LIHC.iCluster:3,2
-7.229964843,-2.244721231,TCGA-DD-A3A8-01A,TCGA-DD-A3A8-01A-11D-A22F-10,6,0.449423954,TCGA-DD-A3A8,LIHC,75,MALE,WHITE,Hepatocellular Carcinoma,G2,2001,[Not Available],-27524,Dead,TUMOR FREE,NA,11,[Not Available],NA,NA,NA,NA,[Not Available],1,11,0,11,0,11,0,11,NA,Stage II,T2,M0,LIHC.iCluster:2,2
-7.574424711,1.785031603,TCGA-DD-A4NE-01A,TCGA-DD-A4NE-01A-11D-A27I-10,9,0.006184444,TCGA-DD-A4NE,LIHC,75,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2011,[Not Available],-27549,Dead,WITH TUMOR,NA,660,[Not Available],Locoregional Recurrence,Liver,NA,190,[Not Available],1,660,1,660,1,190,1,190,NA,Stage IIIA,T3a,M0,LIHC.NA,7
-4.475871588,-1.741429342,TCGA-DD-A3A9-01A,TCGA-DD-A3A9-01A-11D-A25V-10,8,0.437090068,TCGA-DD-A3A9,LIHC,64,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2001,[Not Available],-23526,Dead,WITH TUMOR,NA,931,[Not Available],Extrahepatic Recurrence,Lung,NA,289,[Not Available],1,931,1,931,NA,NA,1,289,NA,Stage IVB,T4,M1,LIHC.iCluster:1,10
0.241433771,3.35582798,TCGA-A5-A0R7-01A,TCGA-A5-A0R7-01A-31D-A10B-09,4,0.356753815,TCGA-A5-A0R7,UCEC,55,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20250,Alive,TUMOR FREE,535,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,535,0,535,0,535,0,535,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN high,3
-1.654307266,3.836067135,TCGA-DD-A4NQ-01A,TCGA-DD-A4NQ-01A-21D-A28X-10,4,0.052443951,TCGA-DD-A4NQ,LIHC,60,MALE,WHITE,Hepatocellular Carcinoma,G3,2007,[Not Available],-22111,Dead,WITH TUMOR,NA,373,[Not Available],Intrahepatic Recurrence,Liver,NA,126,[Not Available],1,373,1,373,1,126,1,126,NA,Stage II,T2,M0,LIHC.iCluster:3,6
7.755497782,-3.46458062,TCGA-B6-A0IN-01A,TCGA-B6-A0IN-01A-11W-A050-09,1,0.313076967,TCGA-B6-A0IN,BRCA,45,FEMALE,WHITE,"Other, specify",[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-16705,Dead,WITH TUMOR,NA,2573,[Not Available],Distant Metastasis,"Other, specify","bone, brain",1412,[Not Available],1,2573,1,2573,1,1412,1,1412,NA,Stage X,T1c,MX,BRCA.LumB,1
-7.783633382,2.016240218,TCGA-AQ-A0Y5-01A,TCGA-AQ-A0Y5-01A-11D-A14K-09,9,0.507794829,TCGA-AQ-A0Y5,BRCA,70,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25793,Dead,TUMOR FREE,NA,172,[Not Available],NA,NA,NA,NA,[Not Available],1,172,0,172,0,172,0,172,NA,Stage IIIA,T2,MX,BRCA.LumA,7
9.224733356,-1.393067841,TCGA-DD-A4NK-01A,TCGA-DD-A4NK-01A-11D-A28X-10,1,0.68629055,TCGA-DD-A4NK,LIHC,80,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2004,[Not Available],-29244,Dead,WITH TUMOR,NA,1210,[Not Available],Intrahepatic Recurrence,Liver,NA,89,[Not Available],1,1210,1,1210,1,89,1,89,NA,Stage IIIA,T3,M0,LIHC.NA,6
4.315177193,1.251354948,TCGA-DD-A3A2-01A,TCGA-DD-A3A2-01A-11D-A20W-10,2,0.652070524,TCGA-DD-A3A2,LIHC,76,FEMALE,WHITE,Hepatocellular Carcinoma,G1,1998,[Not Available],-27930,Dead,TUMOR FREE,NA,2131,[Not Available],NA,NA,NA,NA,[Not Available],1,2131,0,2131,0,2131,0,2131,NA,Stage I,T1,M0,LIHC.iCluster:2,5
-1.789702209,0.925617053,TCGA-24-1430-01A,TCGA-24-1430-01A-01W-0545-08,5,0.581745156,TCGA-24-1430,OV,68,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-24939,Dead,WITH TUMOR,863,863,[Not Available],Recurrence,[Not Applicable],[Not Applicable],449,Complete Remission/Response,1,863,1,863,1,449,1,449,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,4
8.963255696,-2.900493507,TCGA-04-1648-01A,TCGA-04-1648-01A-01W-0639-09,1,0.695112698,TCGA-04-1648,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2003,[Not Available],-21113,Dead,NA,NA,871,[Not Available],Recurrence,[Not Applicable],[Not Applicable],412,[Not Available],1,871,NA,871,NA,NA,1,412,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
0.118821935,5.197058925,TCGA-AR-A24U-01A,TCGA-AR-A24U-01A-11D-A167-09,4,0.713868706,TCGA-AR-A24U,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17523,Alive,TUMOR FREE,3128,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3128,0,3128,0,3128,0,3128,NA,Stage IIA,T1,M0,BRCA.Her2,6
0.181642549,4.929900496,TCGA-13-0886-01A,TCGA-13-0886-01A-01W-0420-08,4,0.664069288,TCGA-13-0886,OV,67,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-24724,Alive,TUMOR FREE,4665,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4665,0,4665,0,4665,0,4665,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-4.637675542,1.27811351,TCGA-D5-6531-01A,TCGA-D5-6531-01A-11D-1719-10,0,NA,TCGA-D5-6531,COAD,75,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-27633,Alive,TUMOR FREE,540,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,540,0,540,NA,NA,0,540,NA,Stage IIA,T3,M0,GI.CIN,9
-3.318572378,-3.271417043,TCGA-AO-A128-01A,TCGA-AO-A128-01A-11D-A10M-09,8,0.598756743,TCGA-AO-A128,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22340,Alive,TUMOR FREE,3248,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3248,0,3248,0,3248,0,3248,NA,Stage IIA,T2,M0,BRCA.Basal,10
-3.300784433,-3.218637318,TCGA-AX-A1C9-01A,TCGA-AX-A1C9-01A-11D-A135-09,8,0.568914523,TCGA-AX-A1C9,UCEC,73,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26903,Alive,TUMOR FREE,802,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,802,0,802,NA,NA,0,802,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-3.443608652,-3.27855683,TCGA-AZ-4615-01A,TCGA-AZ-4615-01A-01D-1408-10,8,0.606122596,TCGA-AZ-4615,COAD,84,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-30908,Alive,WITH TUMOR,1002,NA,[Not Available],NA,NA,NA,688,[Not Available],0,1002,0,1002,NA,NA,1,688,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-7.153742327,1.427771886,TCGA-A6-5660-01A,TCGA-A6-5660-01A-01D-1650-10,0,NA,TCGA-A6-5660,COAD,73,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-26803,Alive,TUMOR FREE,888,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,888,0,888,0,888,0,888,NA,Stage IIIC,T3,M0,GI.CIN,8
-5.724874171,0.79692508,TCGA-AJ-A3IA-01A,TCGA-AJ-A3IA-01A-11D-A20S-09,0,NA,TCGA-AJ-A3IA,UCEC,77,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28470,Alive,TUMOR FREE,633,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,633,0,633,0,633,0,633,NA,Stage IB,[Not Applicable],[Not Applicable],NA,9
-5.726559816,-2.156724701,TCGA-AZ-6606-01A,TCGA-AZ-6606-01A-11D-1835-10,0,NA,TCGA-AZ-6606,COAD,81,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-29704,Dead,WITH TUMOR,NA,357,[Not Available],NA,NA,NA,NA,Progressive Disease,1,357,1,357,NA,NA,1,357,NA,Stage IV,T4,M1,GI.CIN,2
9.869894235,-3.21260867,TCGA-A2-A25F-01A,TCGA-A2-A25F-01A-11D-A167-09,1,0.635238184,TCGA-A2-A25F,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24319,Alive,TUMOR FREE,322,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,322,0,322,0,322,0,322,NA,Stage IIA,T2,M0,BRCA.Basal,1
-2.974312687,-3.887272622,TCGA-AA-3811-01A,TCGA-AA-3811-01A-01W-0995-10,8,0.223175392,TCGA-AA-3811,COAD,84,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-30893,Dead,WITH TUMOR,NA,306,[Not Available],NA,NA,NA,NA,[Unknown],1,306,1,306,NA,NA,1,306,NA,Stage III,T3,M0,GI.HM-indel,10
-3.704235264,-2.251699375,TCGA-EY-A1GQ-01A,TCGA-EY-A1GQ-01A-21D-A13L-09,8,0.426242027,TCGA-EY-A1GQ,UCEC,76,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27905,Alive,WITH TUMOR,544,NA,[Not Available],Metastatic,"Other, specify","R external iliac node, presacral peritoneal implant, ascitic fluid",334,Complete Remission/Response,0,544,0,544,1,334,1,334,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-5.649217696,-0.840997637,TCGA-AX-A064-01A,TCGA-AX-A064-01A-11W-A027-09,0,NA,TCGA-AX-A064,UCEC,81,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29625,Alive,TUMOR FREE,1517,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1517,0,1517,0,1517,0,1517,NA,Stage IIA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-5.114228346,2.043911404,TCGA-AZ-6608-01A,TCGA-AZ-6608-01A-11D-1835-10,12,0.034047427,TCGA-AZ-6608,COAD,55,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-20094,Dead,[Discrepancy],NA,59,[Not Available],NA,NA,NA,NA,Progressive Disease,1,59,NA,59,NA,NA,0,59,NA,Stage IIIA,T2,M0,NA,9
-5.127683051,2.494733856,TCGA-D5-6539-01A,TCGA-D5-6539-01A-11D-1719-10,12,0.280597618,TCGA-D5-6539,COAD,45,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-16703,Alive,TUMOR FREE,380,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,380,0,380,NA,NA,0,380,NA,[Discrepancy],T3,M0,GI.CIN,8
-7.290496387,-2.322106052,TCGA-24-1847-01A,TCGA-24-1847-01A-01W-0633-09,6,0.36326479,TCGA-24-1847,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-16529,Alive,TUMOR FREE,343,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,343,0,343,NA,NA,0,343,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,2
-7.29573948,1.946271269,TCGA-DS-A5RQ-01A,TCGA-DS-A5RQ-01A-11D-A28B-09,9,0.199201601,TCGA-DS-A5RQ,CESC,80,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29526,Alive,TUMOR FREE,512,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,512,0,512,0,512,0,512,NA,Stage IB1,T1b1,MX,NA,9
-3.915565692,-2.269043142,TCGA-BS-A0UM-01A,TCGA-BS-A0UM-01A-11W-A10C-09,8,0.397550826,TCGA-BS-A0UM,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23400,Alive,WITH TUMOR,2644,NA,[Not Available],Metastatic,Brain,NA,1454,Complete Remission/Response,0,2644,0,2644,1,1454,1,1454,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.579537819,-5.521140888,TCGA-AO-A1KO-01A,TCGA-AO-A1KO-01A-31D-A188-09,1,0.847241044,TCGA-AO-A1KO,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16817,Alive,TUMOR FREE,622,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,622,0,622,0,622,0,622,NA,Stage IIB,T3,M0,BRCA.Normal,1
-5.087920625,-1.334045314,TCGA-23-1022-01A,TCGA-23-1022-01A-02W-0486-08,0,NA,TCGA-23-1022,OV,67,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-24798,Dead,WITH TUMOR,NA,1511,[Not Available],Recurrence,[Not Applicable],[Not Applicable],450,Complete Remission/Response,1,1511,1,1511,1,450,1,450,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
2.200552925,1.6679456,TCGA-E2-A1LI-01A,TCGA-E2-A1LI-01A-12D-A159-09,3,0.559799183,TCGA-E2-A1LI,BRCA,57,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21064,Alive,TUMOR FREE,3121,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3121,0,3121,NA,NA,0,3121,NA,Stage IIB,T2,M0,BRCA.Basal,3
-5.740565528,2.771709696,TCGA-A2-A0SX-01A,TCGA-A2-A0SX-01A-12D-A099-09,0,NA,TCGA-A2-A0SX,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17774,Alive,WITH TUMOR,1534,NA,[Not Available],NA,NA,NA,1239,[Not Available],0,1534,0,1534,1,1239,1,1239,NA,Stage IA,T1c,M0,BRCA.Basal,8
-0.401890887,3.015328021,TCGA-24-1471-01A,TCGA-24-1471-01A-01W-0551-08,4,0.116499375,TCGA-24-1471,OV,60,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-22081,Alive,NA,36,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,36,0,36,NA,NA,0,36,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-1.271817838,4.061395539,TCGA-Q1-A6DW-01A,TCGA-Q1-A6DW-01A-11D-A32I-09,4,0.288376727,TCGA-Q1-A6DW,CESC,44,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16200,Alive,NA,534,NA,NA,NA,NA,NA,NA,[Unknown],0,534,0,534,NA,NA,0,534,NA,Stage I,TX,MX,NA,6
-7.631853313,2.300505042,TCGA-AX-A2HH-01A,TCGA-AX-A2HH-01A-11D-A17D-09,9,0.142545025,TCGA-AX-A2HH,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-21924,Alive,WITH TUMOR,540,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,540,0,540,NA,NA,0,540,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-3.375636955,-3.229144913,TCGA-IR-A3LH-01A,TCGA-IR-A3LH-01A-21D-A20U-09,8,0.517724411,TCGA-IR-A3LH,CESC,49,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G4,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18118,Alive,TUMOR FREE,2394,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2394,0,2394,0,2394,0,2394,NA,Stage IIA1,T2a1,M0,NA,10
-4.170489072,-0.430123035,TCGA-EA-A43B-01A,TCGA-EA-A43B-01A-81D-A243-09,0,NA,TCGA-EA-A43B,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15871,Alive,TUMOR FREE,791,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,791,0,791,0,791,0,791,NA,Stage IB1,T1b1,M0,NA,10
9.437199365,-4.271987892,TCGA-E9-A1RG-01A,TCGA-E9-A1RG-01A-11D-A14G-09,1,0.766195262,TCGA-E9-A1RG,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22788,Alive,TUMOR FREE,647,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,647,0,647,0,647,0,647,NA,Stage IIIA,T1c,M0,BRCA.LumB,1
-7.349686725,2.037672815,TCGA-E9-A1RD-01A,TCGA-E9-A1RD-01A-11D-A159-09,9,0.219516703,TCGA-E9-A1RD,BRCA,67,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24719,Alive,TUMOR FREE,34,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,34,0,34,0,34,0,34,NA,Stage IIA,T2,M0,BRCA.LumA,7
-3.598019735,-2.958492944,TCGA-D1-A2G0-01A,TCGA-D1-A2G0-01A-11D-A17D-09,8,0.481637448,TCGA-D1-A2G0,UCEC,70,FEMALE,WHITE,Mixed serous and endometrioid,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25573,Alive,TUMOR FREE,1484,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1484,0,1484,NA,NA,0,1484,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-3.303143774,-3.24930256,TCGA-IR-A3LA-01A,TCGA-IR-A3LA-01A-11D-A22X-09,8,0.615936246,TCGA-IR-A3LA,CESC,60,FEMALE,WHITE,Endometrioid Adenocarcinoma of Endocervix,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949,Alive,TUMOR FREE,4172,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,4172,0,4172,0,4172,0,4172,NA,Stage IB1,T1b1,M0,NA,10
-2.776039797,-4.283533143,TCGA-B5-A0JY-01A,TCGA-B5-A0JY-01A-11D-A10B-09,0,NA,TCGA-B5-A0JY,UCEC,50,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18475,Alive,TUMOR FREE,2107,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2107,0,2107,0,2107,0,2107,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.POLE,10
1.985395138,1.815408112,TCGA-IR-A3LC-01A,TCGA-IR-A3LC-01A-11D-A20U-09,3,0.457861048,TCGA-IR-A3LC,CESC,40,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14697,Alive,TUMOR FREE,3935,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,3935,0,3935,0,3935,0,3935,NA,Stage IB1,T1b1,M0,NA,3
-6.698998121,1.966457274,TCGA-LP-A4AW-01A,TCGA-LP-A4AW-01A-11D-A243-09,0,NA,TCGA-LP-A4AW,CESC,52,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G1,2011,Peri (6-12 months since last menstrual period),-19079,Alive,TUMOR FREE,27,NA,NA,NA,NA,NA,NA,[Not Available],0,27,0,27,NA,NA,0,27,NA,Stage IA,T1b,M0,NA,9
-7.247297316,-2.147202032,TCGA-B6-A0RS-01A,TCGA-B6-A0RS-01A-11D-A099-09,6,0.340947104,TCGA-B6-A0RS,BRCA,38,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1988,Indeterminate (neither Pre or Postmenopausal),-14134,Dead,WITH TUMOR,NA,3063,[Not Available],New Primary Tumor,"Other, specify",Breast,2041,[Not Available],1,3063,1,3063,1,2041,1,2041,NA,Stage IIA,T2,M0,BRCA.Her2,2
-3.868927937,1.046020457,TCGA-E2-A1LG-01A,TCGA-E2-A1LG-01A-21D-A14K-09,0,NA,TCGA-E2-A1LG,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-18492,Alive,TUMOR FREE,1523,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1523,0,1523,0,1523,0,1523,NA,Stage IIA,T2,M0,BRCA.Basal,10
-6.274918101,1.348589017,TCGA-A2-A0YT-01A,TCGA-A2-A0YT-01A-11D-A10G-09,10,0.214253404,TCGA-A2-A0YT,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20482,Dead,TUMOR FREE,NA,723,[Not Available],NA,NA,NA,NA,[Not Available],1,723,0,723,0,723,0,723,NA,Stage IIIB,T4b,M0,BRCA.LumB,7
-4.123366438,1.451848655,TCGA-09-1674-01A,TCGA-09-1674-01A-01W-0633-09,0,NA,TCGA-09-1674,OV,79,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-28878,Alive,WITH TUMOR,260,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,260,0,260,0,260,0,260,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,4
-5.771906438,-1.374480775,TCGA-D1-A16J-01A,TCGA-D1-A16J-01A-11D-A12J-09,0,NA,TCGA-D1-A16J,UCEC,61,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22319,Alive,TUMOR FREE,910,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,910,0,910,0,910,0,910,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.CN low,2
-4.048493203,-2.166495263,TCGA-IR-A3LL-01A,TCGA-IR-A3LL-01A-11D-A20U-09,8,0.452731571,TCGA-IR-A3LL,CESC,60,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22123,Alive,TUMOR FREE,1106,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1106,0,1106,0,1106,0,1106,NA,Stage IB1,T1b1,M0,NA,10
-6.100311721,1.638064302,TCGA-BH-A0B0-01A,TCGA-BH-A0B0-01A-21D-A10Y-09,10,0.209651364,TCGA-BH-A0B0,BRCA,56,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Peri (6-12 months since last menstrual period),-20776,Alive,TUMOR FREE,2477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2477,0,2477,0,2477,0,2477,NA,Stage I,T1c,M0,BRCA.LumA,7
9.187178174,-1.634697884,TCGA-A7-A26J-01A,TCGA-A7-A26J-01A-11D-A272-09,1,0.722628378,TCGA-A7-A26J,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17930,Alive,TUMOR FREE,627,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,627,0,627,0,627,0,627,NA,Stage IIA,T2,M0,BRCA.LumA,1
-0.743657483,3.852952479,TCGA-AA-3667-01A,TCGA-AA-3667-01A-01W-0900-09,4,0.414162475,TCGA-AA-3667,COAD,36,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-13302,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,426,0,426,0,426,0,426,NA,Stage I,T2,M0,GI.CIN,3
-1.818861846,2.107019806,TCGA-C8-A12P-01A,TCGA-C8-A12P-01A-11D-A10Y-09,0,NA,TCGA-C8-A12P,BRCA,55,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20332,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,358,0,358,0,358,0,358,NA,Stage IIB,T2,M0,BRCA.Her2,3
-0.201991501,4.311071734,TCGA-09-2053-01C,TCGA-09-2053-01C-01W-0722-08,4,0.284311974,TCGA-09-2053,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-26433,Alive,TUMOR FREE,1209,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1209,0,1209,0,1209,0,1209,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-7.06943368,2.155135544,TCGA-BH-A18F-01A,TCGA-BH-A18F-01A-11D-A12B-09,9,0.141047724,TCGA-BH-A18F,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-18594,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1001,0,1001,0,1001,0,1001,NA,Stage IIA,T2,M0,BRCA.LumA,7
-8.004550679,1.878843211,TCGA-AN-A0FF-01A,TCGA-AN-A0FF-01A-11W-A050-09,9,0.524151631,TCGA-AN-A0FF,BRCA,32,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11929,Alive,TUMOR FREE,172,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,172,0,172,0,172,0,172,NA,Stage IA,T1b,M0,BRCA.LumB,7
0.374708197,5.072527177,TCGA-AR-A1AJ-01A,TCGA-AR-A1AJ-01A-21D-A12Q-09,4,0.704524017,TCGA-AR-A1AJ,BRCA,83,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30489,Alive,TUMOR FREE,3072,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3072,0,3072,0,3072,0,3072,NA,Stage I,T1,M0,BRCA.Basal,6
0.08471813,4.201397436,TCGA-EW-A2FR-01A,TCGA-EW-A2FR-01A-11D-A21Q-09,4,0.396324233,TCGA-EW-A2FR,BRCA,59,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628,Alive,TUMOR FREE,1673,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1673,0,1673,0,1673,0,1673,NA,Stage IIIC,T1b,MX,BRCA.Her2,6
1.855561877,1.966192191,TCGA-EW-A2FS-01A,TCGA-EW-A2FS-01A-11D-A17D-09,3,0.504951809,TCGA-EW-A2FS,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15302,Alive,TUMOR FREE,1604,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1604,0,1604,0,1604,0,1604,NA,Stage IIB,T2,MX,BRCA.LumA,3
-1.129164629,3.458896745,TCGA-BH-A0BP-01A,TCGA-BH-A0BP-01A-11D-A10Y-09,4,0.151415589,TCGA-BH-A0BP,BRCA,76,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27917,Dead,TUMOR FREE,NA,2296,[Not Available],NA,NA,NA,NA,[Not Available],1,2296,0,2296,0,2296,0,2296,NA,Stage I,T1c,M0,BRCA.LumA,6
9.593899379,-5.510161981,TCGA-C8-A138-01A,TCGA-C8-A138-01A-11D-A10Y-09,1,0.815799442,TCGA-C8-A138,BRCA,54,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20053,Alive,TUMOR FREE,380,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,380,0,380,0,380,0,380,NA,Stage IIIA,T2,M0,BRCA.Her2,1
1.907554265,1.872720617,TCGA-C8-A273-01A,TCGA-C8-A273-01A-11D-A16D-09,3,0.606822068,TCGA-C8-A273,BRCA,29,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,513,0,513,0,513,0,513,NA,Stage IIB,T2,M0,BRCA.LumA,3
0.189573596,5.260958683,TCGA-C8-A12V-01A,TCGA-C8-A12V-01A-11D-A10Y-09,4,0.523025678,TCGA-C8-A12V,BRCA,55,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20346,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,NA,NA,0,385,NA,Stage IIA,T2,M0,BRCA.Basal,6
2.519036451,1.843728927,TCGA-A8-A06Z-01A,TCGA-A8-A06Z-01A-11W-A019-09,3,0,TCGA-A8-A06Z,BRCA,84,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30984,Alive,NA,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage IIB,T3,M0,BRCA.LumB,3
9.347862179,-2.846438569,TCGA-A7-A13F-01A,TCGA-A7-A13F-01A-11D-A12Q-09,1,0.77374996,TCGA-A7-A13F,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16363,Alive,TUMOR FREE,765,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,765,0,765,0,765,0,765,NA,Stage IIIA,T3,M0,BRCA.LumB,1
-0.668202705,4.818031409,TCGA-C8-A12W-01A,TCGA-C8-A12W-01A-11D-A10Y-09,4,0.526487299,TCGA-C8-A12W,BRCA,49,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18140,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,0,385,0,385,NA,Stage IIIB,T4,M0,BRCA.LumB,6
-1.992053524,1.207637799,TCGA-EP-A2KC-01A,TCGA-EP-A2KC-01A-11D-A20W-10,5,0.588206337,TCGA-EP-A2KC,LIHC,62,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-22677,Dead,TUMOR FREE,NA,19,[Not Available],NA,NA,NA,NA,[Not Available],1,19,0,19,0,19,0,19,NA,Stage I,T1,MX,LIHC.iCluster:3,4
0.094696878,4.522075186,TCGA-BC-A10R-01A,TCGA-BC-A10R-01A-11D-A12Z-10,4,0.405360664,TCGA-BC-A10R,LIHC,66,FEMALE,WHITE,Hepatocellular Carcinoma,G2,1999,[Not Available],-24274,Dead,WITH TUMOR,NA,308,[Not Available],Intrahepatic Recurrence,NA,NA,199,[Not Available],1,308,1,308,1,199,1,199,NA,[Not Available],T3,MX,LIHC.iCluster:1,6
-0.228310831,4.524448961,TCGA-06-0190-01A,TCGA-06-0190-01A-01D-1491-08,4,0.501976462,TCGA-06-0190,GBM,62,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-22835,Dead,WITH TUMOR,313,317,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],88,[Not Available],1,317,1,317,NA,NA,1,88,NA,NA,NA,NA,GBM_LGG.NA,6
-7.425684169,-2.475355153,TCGA-FV-A3R3-01A,TCGA-FV-A3R3-01A-11D-A22F-10,6,0.30611579,TCGA-FV-A3R3,LIHC,38,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-14231,Dead,TUMOR FREE,NA,366,[Not Available],NA,NA,NA,NA,[Not Available],1,366,0,366,0,366,0,366,NA,Stage I,T1,MX,LIHC.NA,2
5.007307753,0.712620237,TCGA-BC-4073-01B,TCGA-BC-4073-01B-02D-A12Z-10,2,0.203711999,TCGA-BC-4073,LIHC,73,MALE,WHITE,Hepatocellular Carcinoma,G3,2009,[Not Available],-26795,Alive,WITH TUMOR,849,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,849,0,849,NA,NA,0,849,NA,Stage IIIA,T3,MX,LIHC.iCluster:3,6
-0.656601885,3.971570982,TCGA-G3-A25W-01A,TCGA-G3-A25W-01A-11D-A16V-10,4,0.312348668,TCGA-G3-A25W,LIHC,79,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2010,[Not Available],-29018,Alive,TUMOR FREE,935,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,935,0,935,0,935,0,935,NA,Stage IIIB,T3b,M0,NA,3
8.406772001,-1.364801443,TCGA-76-6282-01A,TCGA-76-6282-01A-11D-1696-08,1,0.424329791,TCGA-76-6282,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-23323,Dead,WITH TUMOR,519,519,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],458,[Not Available],1,519,1,519,NA,NA,1,458,NA,NA,NA,NA,NA,1
9.536868448,-2.420350957,TCGA-06-0214-01A,TCGA-06-0214-01A-02D-1491-08,1,0.734659375,TCGA-06-0214,GBM,66,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],1998,[Not Available],-24187,Dead,WITH TUMOR,378,457,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],48,[Not Available],1,457,1,457,NA,NA,1,48,NA,NA,NA,NA,NA,1
-2.321820943,1.179578762,TCGA-B0-5712-01A,TCGA-B0-5712-01A-11D-1669-08,5,0.398629639,TCGA-B0-5712,KIRC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-24988,Alive,WITH TUMOR,2722,NA,[Not Available],NA,NA,NA,725,[Not Available],0,2722,0,2722,NA,NA,1,725,NA,Stage IV,T2,M1,NA,6
4.415972942,1.09747521,TCGA-BC-A10T-01A,TCGA-BC-A10T-01A-11D-A12Z-10,2,0.649945317,TCGA-BC-A10T,LIHC,76,MALE,WHITE,Hepatocellular Carcinoma,G1,2000,[Not Available],-27944,Dead,WITH TUMOR,NA,837,[Not Available],Extrahepatic Recurrence,Pulmonary,NA,598,[Not Available],1,837,1,837,NA,NA,1,598,NA,[Not Available],T4,MX,LIHC.iCluster:3,5
-5.836538158,1.608951313,TCGA-CC-5263-01A,TCGA-CC-5263-01A-01D-A12Z-10,0,NA,TCGA-CC-5263,LIHC,35,MALE,ASIAN,Hepatocellular Carcinoma,G1,2010,[Not Available],-12863,Dead,TUMOR FREE,NA,129,[Not Available],NA,NA,NA,NA,[Not Available],1,129,0,129,NA,NA,0,129,NA,Stage IIIA,T3,M0,LIHC.iCluster:3,6
8.592258684,-1.660241232,TCGA-06-0185-01A,TCGA-06-0185-01A-01D-1491-08,1,0.521582475,TCGA-06-0185,GBM,54,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-19923,Alive,WITH TUMOR,2246,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],711,[Not Available],0,2246,0,2246,NA,NA,1,711,NA,NA,NA,NA,NA,6
-7.993867575,-2.625385721,TCGA-ES-A2HT-01A,TCGA-ES-A2HT-01A-12D-A183-10,6,0.288876892,TCGA-ES-A2HT,LIHC,54,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G2,2007,[Not Available],-20023,Dead,TUMOR FREE,NA,438,[Not Available],NA,NA,NA,NA,[Not Available],1,438,0,438,0,438,0,438,NA,Stage I,T1,MX,LIHC.iCluster:1,2
-6.139725666,3.620081336,TCGA-B0-5400-01A,TCGA-B0-5400-01A-01D-1501-10,11,0.539362297,TCGA-B0-5400,KIRC,59,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2008,[Not Available],-21819,Alive,TUMOR FREE,1733,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1733,0,1733,0,1733,0,1733,NA,Stage III,T3b,M0,KIRC.4,7
9.582143738,-2.554523843,TCGA-14-0865-01B,TCGA-14-0865-01B-01W-0643-08,1,0.765241643,TCGA-14-0865,GBM,67,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-24797,Dead,WITH TUMOR,502,502,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],215,[Not Available],1,502,1,502,NA,NA,1,215,NA,NA,NA,NA,NA,1
-0.575676209,5.014923958,TCGA-DD-A1EI-01A,TCGA-DD-A1EI-01A-11D-A12Z-10,4,0.468244626,TCGA-DD-A1EI,LIHC,46,MALE,ASIAN,Hepatocellular Carcinoma,G2,2008,[Not Available],-17097,Alive,TUMOR FREE,183,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,183,0,183,0,183,0,183,NA,Stage I,T1,M0,LIHC.iCluster:1,6
-5.6249402,3.327008574,TCGA-DD-A113-01A,TCGA-DD-A113-01A-11D-A12Z-10,1,0.082385503,TCGA-DD-A113,LIHC,55,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2006,[Not Available],-20188,Alive,WITH TUMOR,2425,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,1676,[Not Available],0,2425,0,2425,1,1676,1,1676,NA,Stage II,T2,M0,LIHC.iCluster:1,6
9.037987026,-4.344500321,TCGA-28-1750-01A,TCGA-28-1750-01A-01W-0643-08,1,0.761922862,TCGA-28-1750,GBM,40,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-14817,Alive,WITH TUMOR,254,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],116,[Not Available],0,254,0,254,NA,NA,1,116,NA,NA,NA,NA,NA,1
-0.055976203,4.854551131,TCGA-BC-A216-01A,TCGA-BC-A216-01A-11D-A152-10,4,0.5265508,TCGA-BC-A216,LIHC,62,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2008,[Not Available],-22968,Alive,TUMOR FREE,1351,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1351,0,1351,0,1351,0,1351,NA,Stage IIIA,T3,M0,LIHC.iCluster:3,6
-1.149024821,4.002628054,TCGA-BC-A10U-01A,TCGA-BC-A10U-01A-11D-A12Z-10,4,0.298737561,TCGA-BC-A10U,LIHC,69,MALE,WHITE,Hepatocellular Carcinoma,G2,2000,[Not Available],-25305,Dead,WITH TUMOR,NA,837,[Not Available],Intrahepatic Recurrence,NA,NA,586,[Not Available],1,837,1,837,NA,NA,1,586,NA,[Not Available],T2,MX,LIHC.iCluster:3,6
-1.514786163,4.111821634,TCGA-DD-A114-01A,TCGA-DD-A114-01A-11D-A12Z-10,4,0.09729534,TCGA-DD-A114,LIHC,42,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G3,2005,[Not Available],-15410,Dead,TUMOR FREE,NA,1149,[Not Available],NA,NA,NA,NA,[Not Available],1,1149,0,1149,0,1149,0,1149,NA,Stage II,T2,M0,LIHC.iCluster:1,6
9.437675566,-2.530536476,TCGA-EP-A3RK-01A,TCGA-EP-A3RK-01A-11D-A22F-10,1,0.739042677,TCGA-EP-A3RK,LIHC,73,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-26985,Alive,WITH TUMOR,363,NA,[Not Available],Locoregional Recurrence,Liver,NA,320,[Not Available],0,363,0,363,NA,NA,1,320,NA,Stage IIIA,T3a,MX,LIHC.iCluster:2,1
8.56473022,-1.807521904,TCGA-32-1982-01A,TCGA-32-1982-01A-01D-1494-08,1,0.499770486,TCGA-32-1982,GBM,76,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-27764,Dead,WITH TUMOR,142,142,[Not Available],NA,NA,NA,NA,[Not Available],1,142,1,142,NA,NA,1,142,NA,NA,NA,NA,GBM_LGG.Classic-like,5
9.185592863,-5.17559652,TCGA-BC-A10Y-01A,TCGA-BC-A10Y-01A-11D-A12Z-10,1,0.80232718,TCGA-BC-A10Y,LIHC,76,MALE,WHITE,Hepatocellular Carcinoma,G3,2002,[Not Available],-28049,Dead,WITH TUMOR,NA,711,[Not Available],Intrahepatic Recurrence,NA,NA,400,[Not Available],1,711,1,711,1,400,1,400,NA,[Not Available],T4,MX,LIHC.iCluster:3,1
-0.20323861,2.968840983,TCGA-DD-A118-01A,TCGA-DD-A118-01A-11D-A12Z-10,4,0.039171361,TCGA-DD-A118,LIHC,77,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2003,[Not Available],-28406,Alive,NA,3437,NA,[Not Available],Extrahepatic Recurrence,"Other, specify","lateral to the C-loop of the duodenum, anterior to the right  kidney",658,[Not Available],0,3437,0,3437,1,658,1,658,NA,Stage II,T2,M0,LIHC.iCluster:1,6
-4.391867507,1.787556218,TCGA-EP-A3JL-01A,TCGA-EP-A3JL-01A-11D-A20W-10,0,NA,TCGA-EP-A3JL,LIHC,76,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-27886,Alive,TUMOR FREE,303,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,303,0,303,NA,NA,0,303,NA,Stage I,T1,MX,LIHC.iCluster:2,9
10.01409119,-4.010904979,TCGA-DD-A115-01A,TCGA-DD-A115-01A-11D-A12Z-10,1,0.581157971,TCGA-DD-A115,LIHC,53,MALE,WHITE,Hepatocellular Carcinoma,G2,2002,[Not Available],-19697,Dead,WITH TUMOR,NA,2542,[Not Available],Intrahepatic Recurrence,Liver,NA,469,[Not Available],1,2542,1,2542,1,469,1,469,NA,Stage IIIA,T3,M0,LIHC.iCluster:3,6
4.103725078,1.308402389,TCGA-DD-A11C-01A,TCGA-DD-A11C-01A-11D-A12Z-10,2,0.625778209,TCGA-DD-A11C,LIHC,69,MALE,WHITE,Hepatocellular Carcinoma,G3,2006,[Not Available],-25403,Alive,TUMOR FREE,662,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,662,0,662,NA,NA,0,662,NA,Stage I,T1,M0,LIHC.iCluster:3,5
-0.168092537,4.485631293,TCGA-FV-A3I1-01A,TCGA-FV-A3I1-01A-11D-A22F-10,4,0.594835506,TCGA-FV-A3I1,LIHC,81,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],NA,Dead,TUMOR FREE,NA,247,[Not Available],NA,NA,NA,NA,[Not Available],1,247,0,247,0,247,0,247,NA,Stage II,T2,MX,LIHC.iCluster:3,6
-7.607118926,-2.404221392,TCGA-LP-A4AX-01A,TCGA-LP-A4AX-01A-12D-A243-09,6,0.474439659,TCGA-LP-A4AX,CESC,45,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2011,Peri (6-12 months since last menstrual period),-16544,Alive,TUMOR FREE,380,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,380,0,380,0,380,0,380,NA,Stage IB1,T1b1,M0,NA,2
-3.584668315,-2.735733972,TCGA-EY-A2OM-01A,TCGA-EY-A2OM-01A-11D-A18P-09,8,0.388830934,TCGA-EY-A2OM,UCEC,55,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20398,Alive,TUMOR FREE,694,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,694,0,694,0,694,0,694,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
0.818583384,2.185224493,TCGA-FU-A3YQ-01A,TCGA-FU-A3YQ-01A-11D-A22X-09,0,NA,TCGA-FU-A3YQ,CESC,35,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G1,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12816,Alive,TUMOR FREE,861,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,861,0,861,0,861,0,861,NA,Stage IB1,T1b1,MX,NA,3
1.700396222,1.96810306,TCGA-LP-A4AU-01A,TCGA-LP-A4AU-01A-32D-A243-09,3,0.315629657,TCGA-LP-A4AU,CESC,35,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13074,Alive,TUMOR FREE,343,NA,NA,NA,NA,NA,NA,[Not Available],0,343,0,343,NA,NA,0,343,NA,Stage IIIB,T2,M0,NA,3
-8.017836837,2.082731926,TCGA-Q1-A5R1-01A,TCGA-Q1-A5R1-01A-11D-A28B-09,9,0.548783744,TCGA-Q1-A5R1,CESC,32,FEMALE,WHITE,Mucinous Adenocarcinoma of Endocervical Type,G2,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11705,Alive,TUMOR FREE,474,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,474,0,474,0,474,0,474,NA,Stage IB1,T1b1,MX,NA,7
-0.768443785,3.817114636,TCGA-36-2543-01A,TCGA-36-2543-01A-01D-1526-09,4,0.197650461,TCGA-36-2543,OV,85,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2008,[Not Available],-31211,Dead,WITH TUMOR,68,68,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],27,Progressive Disease,1,68,1,68,NA,NA,1,27,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
9.901812058,-2.386253201,TCGA-BP-5169-01A,TCGA-BP-5169-01A-01D-1429-08,1,0.749385377,TCGA-BP-5169,KIRC,70,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2004,[Not Available],-25615,Alive,TUMOR FREE,193,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,193,0,193,NA,NA,0,193,NA,Stage I,T1b,M0,KIRC.2,1
9.808093007,-2.854061284,TCGA-MU-A5YI-01A,TCGA-MU-A5YI-01A-11D-A32I-09,4,0.375412733,TCGA-MU-A5YI,CESC,60,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21927,Alive,WITH TUMOR,1053,NA,NA,Distant Metastasis,"Other, specify",Thoracic Spine,630,[Not Available],0,1053,0,1053,NA,NA,1,630,NA,Stage IA1,T1a1,MX,NA,6
-4.396989889,-1.094677532,TCGA-D1-A17B-01A,TCGA-D1-A17B-01A-22D-A12J-09,8,0.13934827,TCGA-D1-A17B,UCEC,69,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25504,Alive,TUMOR FREE,213,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,213,0,213,0,213,0,213,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-2.035289425,1.194749891,TCGA-Q1-A6DT-01A,TCGA-Q1-A6DT-01A-11D-A32I-09,5,0.578115091,TCGA-Q1-A6DT,CESC,55,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,GX,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20286,Dead,WITH TUMOR,NA,275,Cervical Cancer,NA,NA,NA,NA,[Not Available],1,275,1,275,NA,NA,1,275,NA,Stage I,TX,MX,NA,4
9.54950634,-4.496510629,TCGA-CJ-4923-01A,TCGA-CJ-4923-01A-01D-1429-08,1,0.743857053,TCGA-CJ-4923,KIRC,63,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2004,[Not Available],-23353,Dead,WITH TUMOR,NA,572,[Not Available],NA,NA,NA,25,[Not Available],1,572,1,572,NA,NA,1,25,NA,Stage IV,T3a,M1,KIRC.4,1
-8.162383165,2.199569233,TCGA-Q1-A6DV-01A,TCGA-Q1-A6DV-01A-11D-A32I-09,9,0.266467223,TCGA-Q1-A6DV,CESC,36,FEMALE,ASIAN,Mucinous Adenocarcinoma of Endocervical Type,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13166,Alive,TUMOR FREE,491,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,491,0,491,0,491,0,491,NA,Stage IB1,T1b1,M0,NA,7
9.594905272,-1.905549321,TCGA-CW-6090-01A,TCGA-CW-6090-01A-11D-1669-08,1,0.744746595,TCGA-CW-6090,KIRC,68,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2003,[Not Available],-24909,Alive,TUMOR FREE,2552,NA,[Not Available],NA,NA,NA,2780,[Not Available],0,2552,0,2552,NA,NA,1,2780,NA,Stage I,T1b,M0,KIRC.3,1
-7.875262721,1.750448404,TCGA-AX-A06J-01A,TCGA-AX-A06J-01A-11W-A027-09,9,0.293139726,TCGA-AX-A06J,UCEC,71,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26000,Alive,TUMOR FREE,913,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,913,0,913,0,913,0,913,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-1.854267067,1.019638783,TCGA-EX-A69M-01A,TCGA-EX-A69M-01A-11D-A32I-09,5,0.587449223,TCGA-EX-A69M,CESC,62,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22917,Dead,TUMOR FREE,NA,253,NA,New Primary Tumor,Lung,NA,77,Complete Remission/Response,1,253,0,253,0,253,1,77,NA,Stage IB2,T1b2,M0,NA,4
-5.17651603,-0.976526062,TCGA-AJ-A3OL-01A,TCGA-AJ-A3OL-01A-11D-A228-09,0,NA,TCGA-AJ-A3OL,UCEC,55,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20115,Dead,WITH TUMOR,NA,449,[Not Available],Distant Metastasis,"Other, specify","Lung, Liver, and Brain",424,Complete Remission/Response,1,449,1,449,1,424,1,424,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,10
-1.057762891,3.073214482,TCGA-29-1699-01A,TCGA-29-1699-01A-01W-0633-09,4,0.120390214,TCGA-29-1699,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-21130,Dead,NA,16,1106,[Not Available],NA,NA,NA,NA,[Not Available],1,1106,NA,1106,NA,NA,0,1106,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
0.115351317,4.356509476,TCGA-24-1603-01A,TCGA-24-1603-01A-01W-0551-08,4,0.410384771,TCGA-24-1603,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1996,[Not Available],-19681,Dead,WITH TUMOR,2742,2742,[Not Available],Recurrence,[Not Applicable],[Not Applicable],992,Complete Remission/Response,1,2742,1,2742,1,992,1,992,NA,Stage IIIB,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
2.976568333,3.572229191,TCGA-EX-A449-01A,TCGA-EX-A449-01A-11D-A243-09,0,NA,TCGA-EX-A449,CESC,42,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G1,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15559,Alive,TUMOR FREE,447,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,447,0,447,NA,NA,0,447,NA,Stage IVB,T1b1,M1,NA,1
0.32793942,3.565985225,TCGA-CJ-4913-01A,TCGA-CJ-4913-01A-01D-1429-08,4,0.184241864,TCGA-CJ-4913,KIRC,45,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2006,[Not Available],-16757,Dead,WITH TUMOR,NA,1173,[Not Available],NA,NA,NA,538,[Not Available],1,1173,1,1173,NA,NA,1,538,NA,Stage III,T3a,M0,NA,3
9.276285428,-2.5417296,TCGA-CJ-4869-01A,TCGA-CJ-4869-01A-02D-1429-08,1,0.744395503,TCGA-CJ-4869,KIRC,49,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-17923,Alive,WITH TUMOR,2554,NA,[Not Available],NA,NA,NA,1754,[Not Available],0,2554,0,2554,NA,NA,1,1754,NA,Stage III,T2,M0,NA,1
-5.55229101,1.386899065,TCGA-FU-A40J-01A,TCGA-FU-A40J-01A-11D-A243-09,0,NA,TCGA-FU-A40J,CESC,38,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14182,Alive,TUMOR FREE,426,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,426,0,426,0,426,0,426,NA,Stage IIIB,T2a1,MX,NA,10
2.072660201,1.763330735,TCGA-BP-5195-01A,TCGA-BP-5195-01A-02D-1429-08,3,0.533197153,TCGA-BP-5195,KIRC,75,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2008,[Not Available],-27547,Alive,TUMOR FREE,749,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,749,0,749,NA,NA,0,749,NA,Stage I,T1a,M0,KIRC.3,3
-6.143500635,3.633408782,TCGA-IR-A3LB-01A,TCGA-IR-A3LB-01A-11D-A243-09,11,0.489956391,TCGA-IR-A3LB,CESC,53,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19374,Dead,WITH TUMOR,NA,2032,NA,Distant Metastasis,Lung,NA,317,Complete Remission/Response,1,2032,1,2032,1,317,1,317,NA,Stage IB1,T1b1,M0,NA,8
0.181057101,4.326390278,TCGA-23-2647-01A,TCGA-23-2647-01A-01D-1526-09,4,0.374069133,TCGA-23-2647,OV,49,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,2009,[Not Available],-18205,Alive,NA,135,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,135,0,135,NA,NA,0,135,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.685150024,1.937967833,TCGA-A7-A26H-01A,TCGA-A7-A26H-01A-11D-A167-09,0,NA,TCGA-A7-A26H,BRCA,72,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26423,Alive,WITH TUMOR,724,NA,[Not Available],Distant Metastasis,Liver,NA,291,[Not Available],0,724,0,724,1,291,1,291,NA,Stage IIA,T1,M0,BRCA.LumA,9
8.535205932,-4.715273188,TCGA-IR-A3L7-01A,TCGA-IR-A3L7-01A-21D-A20U-09,1,0.733504863,TCGA-IR-A3L7,CESC,37,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2000,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13559,Alive,TUMOR FREE,4483,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,4483,0,4483,0,4483,0,4483,NA,Stage IB1,T1b1,M0,NA,1
-1.898739497,3.682234981,TCGA-C5-A1BI-01B,TCGA-C5-A1BI-01B-11D-A13W-08,0,NA,TCGA-C5-A1BI,CESC,31,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2001,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11564,Alive,TUMOR FREE,1112,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1112,0,1112,0,1112,0,1112,NA,Stage IIIB,[Not Available],[Not Available],NA,6
1.420255493,1.884341258,TCGA-EX-A1H6-01B,TCGA-EX-A1H6-01B-11D-A22X-09,3,0.02068248,TCGA-EX-A1H6,CESC,38,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14214,Alive,TUMOR FREE,241,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,241,0,241,0,241,0,241,NA,Stage IB1,T1b1,MX,NA,3
8.65482602,-4.278415235,TCGA-B8-5546-01A,TCGA-B8-5546-01A-01D-1534-10,1,0.687686011,TCGA-B8-5546,KIRC,38,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-14113,Alive,TUMOR FREE,505,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,505,0,505,NA,NA,0,505,NA,Stage I,T1b,M0,KIRC.1,1
7.71705325,-3.343605171,TCGA-DD-A1EC-01A,TCGA-DD-A1EC-01A-21D-A12Z-10,1,0.358324522,TCGA-DD-A1EC,LIHC,20,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2004,[Not Available],-7363,Alive,NA,602,NA,[Not Available],Extrahepatic Recurrence,"Other, specify",peritoneal,299,[Not Available],0,602,0,602,1,299,1,299,NA,Stage I,T1,M0,LIHC.iCluster:1,1
0.169149409,4.403753392,TCGA-24-1431-01A,TCGA-24-1431-01A-01D-0472-01,4,0.382748523,TCGA-24-1431,OV,67,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-24758,Dead,WITH TUMOR,583,567,[Not Available],Recurrence,[Not Applicable],[Not Applicable],199,[Not Available],1,567,1,567,NA,NA,1,199,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
2.003342505,1.874950599,TCGA-B8-4153-01B,TCGA-B8-4153-01B-11D-1669-08,3,0.574737268,TCGA-B8-4153,KIRC,74,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-27031,Alive,WITH TUMOR,762,NA,[Not Available],NA,NA,NA,223,[Not Available],0,762,0,762,NA,NA,1,223,NA,Stage III,T3a,M0,KIRC.2,3
0.604112505,2.108197407,TCGA-DD-A1ED-01A,TCGA-DD-A1ED-01A-11D-A152-10,0,NA,TCGA-DD-A1ED,LIHC,68,MALE,WHITE,Hepatocellular Carcinoma,G1,2006,[Not Available],-25039,Alive,TUMOR FREE,2301,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2301,0,2301,0,2301,0,2301,NA,Stage I,T1,M0,LIHC.iCluster:1,6
0.170772335,5.42411577,TCGA-DD-A1EJ-01A,TCGA-DD-A1EJ-01A-11D-A152-10,4,0.409382511,TCGA-DD-A1EJ,LIHC,71,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2008,[Not Available],-26009,Dead,WITH TUMOR,NA,1005,[Not Available],Intrahepatic Recurrence,Liver,NA,263,[Not Available],1,1005,1,1005,1,263,1,263,NA,Stage IIIC,T1,M0,LIHC.iCluster:3,1
-7.523402824,-2.196887983,TCGA-BC-A3KF-01A,TCGA-BC-A3KF-01A-11D-A20W-10,6,0.238180954,TCGA-BC-A3KF,LIHC,66,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-24328,Alive,TUMOR FREE,8,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,8,0,8,0,8,0,8,NA,Stage I,T1,M0,LIHC.iCluster:3,2
-6.457471779,1.760357148,TCGA-AR-A24K-01A,TCGA-AR-A24K-01A-11D-A167-09,10,0.175007686,TCGA-AR-A24K,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16961,Alive,TUMOR FREE,1548,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1548,0,1548,0,1548,0,1548,NA,Stage IIA,T2,M0,BRCA.LumB,7
9.155191613,-4.150845009,TCGA-E2-A15J-01A,TCGA-E2-A15J-01A-11D-A12Q-09,1,0.739135905,TCGA-E2-A15J,BRCA,51,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771,Alive,TUMOR FREE,1640,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1640,0,1640,0,1640,0,1640,NA,Stage I,T1c,M0,BRCA.LumA,1
8.444117354,-3.458587775,TCGA-C8-A1HI-01A,TCGA-C8-A1HI-01A-11D-A135-09,1,0.634106981,TCGA-C8-A1HI,BRCA,40,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,343,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,343,0,343,0,343,0,343,NA,Stage IIIA,T2,M0,BRCA.LumA,1
9.502150393,-1.831040029,TCGA-CF-A9FL-01A,TCGA-CF-A9FL-01A-11D-A38G-08,1,0.711073293,TCGA-CF-A9FL,BLCA,85,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-31099,Dead,WITH TUMOR,NA,565,[Not Available],Locoregional (Urothelial tumor event),NA,NA,322,Complete Remission/Response,1,565,1,565,1,322,1,322,NA,Stage III,T3b,M0,NA,1
-7.325953591,1.455724266,TCGA-A8-A06P-01A,TCGA-A8-A06P-01A-11W-A019-09,0,NA,TCGA-A8-A06P,BRCA,63,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23011,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,396,0,396,0,396,0,396,NA,Stage IIIA,T1c,M0,BRCA.LumA,7
0.0282246,5.018534607,TCGA-AR-A0U0-01A,TCGA-AR-A0U0-01A-11D-A10G-09,4,0.614627447,TCGA-AR-A0U0,BRCA,73,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26993,Alive,TUMOR FREE,1988,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1988,0,1988,0,1988,0,1988,NA,Stage IIB,T2,M0,BRCA.Basal,6
-0.741728031,2.413275759,TCGA-FU-A3TQ-01A,TCGA-FU-A3TQ-01A-11D-A22X-09,0,NA,TCGA-FU-A3TQ,CESC,55,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20302,Alive,TUMOR FREE,795,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,795,0,795,0,795,0,795,NA,Stage IIIB,T2b,MX,NA,6
9.521022794,-2.935310613,TCGA-EX-A69L-01A,TCGA-EX-A69L-01A-11D-A32I-09,1,0.748637889,TCGA-EX-A69L,CESC,41,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15121,Alive,TUMOR FREE,602,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,602,0,602,0,602,0,602,NA,Stage IB1,T1b1,M0,NA,6
-3.197466408,-3.459941022,TCGA-IR-A3LK-01A,TCGA-IR-A3LK-01A-12D-A20U-09,8,0.583710414,TCGA-IR-A3LK,CESC,69,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25440,Dead,WITH TUMOR,NA,908,Cervical Cancer,Distant Metastasis,"Other, specify","thoracic lymph nodes, liver, abdominal wall",574,Complete Remission/Response,1,908,1,908,1,574,1,574,NA,Stage IB2,T1b2,M0,NA,10
0.68273273,2.222019764,TCGA-EA-A439-01A,TCGA-EA-A439-01A-11D-A243-09,0,NA,TCGA-EA-A439,CESC,50,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18529,Alive,TUMOR FREE,965,NA,NA,Locoregional Recurrence,Cervix,NA,316,Complete Remission/Response,0,965,0,965,1,316,1,316,NA,Stage IIA1,T2a1,M0,NA,6
9.519171008,-1.16569801,TCGA-BH-A0E1-01A,TCGA-BH-A0E1-01A-11W-A071-09,1,0.694565842,TCGA-BH-A0E1,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Peri (6-12 months since last menstrual period),-19192,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,477,0,477,0,477,0,477,NA,Stage IIB,T2,M0,BRCA.LumA,1
-7.5800997,2.199565666,TCGA-FU-A3WB-01A,TCGA-FU-A3WB-01A-11D-A22X-09,9,0.315134584,TCGA-FU-A3WB,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,[Unknown],-15833,Alive,TUMOR FREE,491,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,491,0,491,0,491,0,491,NA,Stage IIA2,T2a2,MX,NA,7
-3.162565903,1.374452984,TCGA-KQ-A41O-01A,TCGA-KQ-A41O-01A-12D-A34U-08,0,NA,TCGA-KQ-A41O,BLCA,84,MALE,[Unknown],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-30774,Alive,TUMOR FREE,1538,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1538,0,1538,NA,NA,0,1538,NA,Stage IV,T3,M0,NA,10
8.386535829,-3.221911179,TCGA-HM-A3JJ-01A,TCGA-HM-A3JJ-01A-21D-A21Q-09,1,0.62491695,TCGA-HM-A3JJ,CESC,40,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14736,Dead,WITH TUMOR,NA,659,Cervical Cancer,Distant Metastasis,NA,NA,385,Complete Remission/Response,1,659,1,659,1,385,1,385,NA,Stage IB1,T1b1,MX,NA,1
-2.934893642,-4.028660094,TCGA-KQ-A41N-01A,TCGA-KQ-A41N-01A-11D-A339-08,8,0.191502665,TCGA-KQ-A41N,BLCA,73,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-26837,Alive,TUMOR FREE,1604,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1604,0,1604,0,1604,0,1604,NA,Stage III,T3b,M0,NA,10
0.16208446,5.092247837,TCGA-A2-A0ST-01A,TCGA-A2-A0ST-01A-12D-A099-09,4,0.60822271,TCGA-A2-A0ST,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22922,Alive,WITH TUMOR,3017,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3017,0,3017,0,3017,0,3017,NA,Stage IIA,T1c,M0,BRCA.Basal,6
-0.645627498,2.196840426,TCGA-FU-A3TX-01A,TCGA-FU-A3TX-01A-11D-A22X-09,0,NA,TCGA-FU-A3TX,CESC,78,FEMALE,[Not Evaluated],Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28825,Alive,NA,45,NA,NA,NA,NA,NA,NA,[Unknown],0,45,0,45,NA,NA,0,45,NA,Stage IB2,T1b2,M0,NA,1
-4.6297667,0.937262061,TCGA-KQ-A41S-01A,TCGA-KQ-A41S-01A-12D-A339-08,0,NA,TCGA-KQ-A41S,BLCA,87,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-32041,Alive,TUMOR FREE,35,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,35,0,35,0,35,0,35,NA,Stage III,T4a,MX,NA,10
-3.259327208,-3.170330032,TCGA-KQ-A41R-01A,TCGA-KQ-A41R-01A-21D-A34U-08,8,0.592805901,TCGA-KQ-A41R,BLCA,80,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-29351,Alive,TUMOR FREE,1350,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1350,0,1350,0,1350,0,1350,NA,Stage II,T2,MX,NA,10
-4.473692209,-0.367848057,TCGA-KQ-A41Q-01A,TCGA-KQ-A41Q-01A-11D-A339-08,0,NA,TCGA-KQ-A41Q,BLCA,89,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-32511,Alive,NA,1429,NA,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,1314,[Unknown],0,1429,0,1429,NA,NA,1,1314,NA,Stage III,T3b,MX,NA,10
-6.167189718,1.261949252,TCGA-IR-A3LF-01A,TCGA-IR-A3LF-01A-21D-A22X-09,0,NA,TCGA-IR-A3LF,CESC,64,FEMALE,WHITE,Endocervical Adenocarcinoma of the Usual Type,G2,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23721,Alive,TUMOR FREE,2949,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2949,0,2949,0,2949,0,2949,NA,Stage IB1,T1b1,M0,NA,9
-4.273844836,-2.050943071,TCGA-KQ-A41P-01A,TCGA-KQ-A41P-01A-12D-A339-08,8,0.426282603,TCGA-KQ-A41P,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27816,Alive,WITH TUMOR,1094,NA,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,178,Stable Disease,0,1094,0,1094,NA,NA,1,178,NA,Stage IV,T3b,M1,NA,10
-1.417965171,2.953708998,TCGA-A2-A3Y0-01A,TCGA-A2-A3Y0-01A-11D-A23C-09,4,0.085827234,TCGA-A2-A3Y0,BRCA,57,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21024,Alive,TUMOR FREE,1546,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1546,0,1546,NA,NA,0,1546,NA,Stage IIB,T2,M0,BRCA.Basal,6
8.881440563,-4.060542944,TCGA-OL-A66O-01A,TCGA-OL-A66O-01A-11D-A31U-09,1,0.743848002,TCGA-OL-A66O,BRCA,39,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14272,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,528,0,528,0,528,0,528,NA,Stage IIB,T2,MX,BRCA.LumA,1
-3.890746705,-2.340700596,TCGA-XF-A9ST-01A,TCGA-XF-A9ST-01A-11D-A42E-08,8,0.434965072,TCGA-XF-A9ST,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-25080,Dead,NA,NA,128,[Not Available],NA,NA,NA,NA,[Unknown],1,128,NA,128,NA,NA,0,128,NA,Stage III,T3b,MX,NA,10
-4.494654226,-1.429475157,TCGA-XF-A9SP-01A,TCGA-XF-A9SP-01A-11D-A391-08,8,0.349116127,TCGA-XF-A9SP,BLCA,59,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-21776,Dead,WITH TUMOR,NA,454,[Not Available],Locoregional (Urothelial tumor event),Renal Pelvis,NA,310,Stable Disease,1,454,1,454,NA,NA,1,310,NA,Stage III,T3b,MX,NA,10
9.032091693,-5.259940207,TCGA-LL-A440-01A,TCGA-LL-A440-01A-11D-A243-09,1,0.841782837,TCGA-LL-A440,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22497,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,759,0,759,0,759,0,759,NA,Stage IA,T1c,MX,BRCA.LumA,1
-3.342185554,1.37901605,TCGA-XF-A9SM-01A,TCGA-XF-A9SM-01A-11D-A42E-08,0,NA,TCGA-XF-A9SM,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-27826,Alive,TUMOR FREE,1048,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1048,0,1048,0,1048,0,1048,NA,Stage III,T3b,MX,NA,10
-1.331410097,4.420436017,TCGA-XF-A9SK-01A,TCGA-XF-A9SK-01A-11D-A42E-08,4,0.279870445,TCGA-XF-A9SK,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-24019,Dead,WITH TUMOR,NA,486,[Not Available],Distant Metastasis,Bone,NA,382,Stable Disease,1,486,1,486,NA,NA,1,382,NA,Stage IV,T3b,MX,NA,6
-4.232145982,-1.77507929,TCGA-LP-A4AV-01A,TCGA-LP-A4AV-01A-11D-A243-09,8,0.445466555,TCGA-LP-A4AV,CESC,63,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G2,2011,[Not Evaluated],NA,Alive,TUMOR FREE,0,NA,NA,NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IB,T1b,M0,NA,10
-4.323011287,-2.105593257,TCGA-UY-A9PH-01A,TCGA-UY-A9PH-01A-11D-A38G-08,8,0.309642662,TCGA-UY-A9PH,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-26654,Alive,TUMOR FREE,1561,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1561,0,1561,0,1561,0,1561,NA,Stage II,T2b,MX,NA,10
-6.30963786,-1.725154751,TCGA-AR-A256-01A,TCGA-AR-A256-01A-11D-A167-09,0,NA,TCGA-AR-A256,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2001,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642,Dead,NA,NA,2854,[Not Available],Locoregional Disease,NA,NA,1640,[Not Available],1,2854,NA,2854,1,1640,1,1640,NA,Stage IIA,T2,M0,BRCA.Basal,2
9.953446797,-1.840157235,TCGA-BH-A0B8-01A,TCGA-BH-A0B8-01A-21W-A071-09,1,0.837198327,TCGA-BH-A0B8,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23380,Alive,TUMOR FREE,1569,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1569,0,1569,0,1569,0,1569,NA,Stage I,T1b,M0,BRCA.LumA,6
4.417783551,1.103094302,TCGA-E9-A3QA-01A,TCGA-E9-A3QA-01A-61D-A228-09,2,0.415121196,TCGA-E9-A3QA,BRCA,33,FEMALE,WHITE,Medullary Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12142,Alive,TUMOR FREE,918,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,918,0,918,0,918,0,918,NA,Stage IIA,T2,M0,BRCA.Basal,5
-4.416390459,1.690934927,TCGA-D8-A3Z6-01A,TCGA-D8-A3Z6-01A-11D-A23C-09,0,NA,TCGA-D8-A3Z6,BRCA,56,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629,Alive,TUMOR FREE,563,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,563,0,563,0,563,0,563,NA,Stage IIIC,T3,M0,BRCA.LumA,8
-6.628614532,2.260640817,TCGA-EW-A423-01A,TCGA-EW-A423-01A-11D-A243-09,0,NA,TCGA-EW-A423,BRCA,75,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27627,Alive,TUMOR FREE,533,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,533,0,533,0,533,0,533,NA,Stage IIA,T2,MX,BRCA.LumA,7
9.170664973,-5.665398187,TCGA-OL-A5RY-01A,TCGA-OL-A5RY-01A-21D-A28B-09,1,0.762554939,TCGA-OL-A5RY,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19216,Alive,TUMOR FREE,752,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,752,0,752,0,752,0,752,NA,Stage IIA,T1c,MX,BRCA.Normal,1
-6.354768819,-1.113317506,TCGA-A2-A0YH-01A,TCGA-A2-A0YH-01A-11D-A10G-09,7,0.248549898,TCGA-A2-A0YH,BRCA,53,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19596,Alive,TUMOR FREE,659,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,659,0,659,0,659,0,659,NA,Stage IIIA,T2,M0,BRCA.LumB,2
0.100670401,2.48451832,TCGA-AO-A0JB-01A,TCGA-AO-A0JB-01A-11W-A071-09,4,0.171167914,TCGA-AO-A0JB,BRCA,50,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18561,Alive,TUMOR FREE,1542,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1542,0,1542,0,1542,0,1542,NA,Stage IIIA,T3,M0,BRCA.Normal,6
-7.885928856,-2.519064399,TCGA-61-1900-01A,TCGA-61-1900-01A-01W-0639-09,6,0.555318412,TCGA-61-1900,OV,51,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2008,[Not Available],-18963,Alive,TUMOR FREE,176,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,176,0,176,NA,NA,0,176,NA,Stage IIIB,[Not Applicable],[Not Applicable],OVCA.Proliferative,2
0.092328422,4.685387654,TCGA-A1-A0SK-01A,TCGA-A1-A0SK-01A-12D-A099-09,4,0.57140919,TCGA-A1-A0SK,BRCA,54,FEMALE,ASIAN,"Other, specify",[Not Available],2007,Indeterminate (neither Pre or Postmenopausal),-20048,Dead,WITH TUMOR,NA,967,[Not Available],NA,NA,NA,NA,[Not Available],1,967,1,967,NA,NA,1,967,NA,Stage IIA,T2,M0,BRCA.Basal,6
-0.460616955,4.423842649,TCGA-D8-A1X9-01A,TCGA-D8-A1X9-01A-12D-A159-09,4,0.375045921,TCGA-D8-A1X9,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24417,Alive,TUMOR FREE,727,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,727,0,727,NA,NA,0,727,NA,Stage IIB,T2,M0,BRCA.LumA,6
-0.7194672,3.810059669,TCGA-OL-A66I-01A,TCGA-OL-A66I-01A-21D-A29N-09,4,0.25286525,TCGA-OL-A66I,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Evaluated],-13458,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,714,0,714,0,714,0,714,NA,Stage IIA,T1c,MX,BRCA.Basal,5
-7.896864724,2.265869656,TCGA-AQ-A54O-01A,TCGA-AQ-A54O-01A-11D-A25Q-09,9,0.5909213,TCGA-AQ-A54O,BRCA,51,MALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,[Not Available],-18694,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1001,0,1001,0,1001,0,1001,NA,Stage IIA,T2,M0,BRCA.LumB,7
9.844127339,-3.972500082,TCGA-BP-5173-01A,TCGA-BP-5173-01A-01D-1429-08,1,0.618824803,TCGA-BP-5173,KIRC,75,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-27436,Dead,TUMOR FREE,NA,62,[Not Available],NA,NA,NA,NA,[Not Available],1,62,0,62,NA,NA,0,62,NA,Stage I,T1a,M0,KIRC.4,1
9.85324589,-2.638088279,TCGA-OL-A66N-01A,TCGA-OL-A66N-01A-12D-A31U-09,1,0.781470582,TCGA-OL-A66N,BRCA,59,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21608,Alive,TUMOR FREE,792,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,792,0,792,0,792,0,792,NA,Stage IIIC,T3,MX,BRCA.LumA,1
0.395927947,4.916649476,TCGA-AO-A03O-01A,TCGA-AO-A03O-01A-11W-A019-09,4,0.543540163,TCGA-AO-A03O,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25362,Dead,TUMOR FREE,NA,2483,[Not Available],NA,NA,NA,NA,[Not Available],1,2483,0,2483,0,2483,0,2483,NA,Stage IIA,T2,M0,BRCA.LumB,6
-3.518897151,-3.020587365,TCGA-D8-A27G-01A,TCGA-D8-A27G-01A-11D-A16D-09,8,0.458829025,TCGA-D8-A27G,BRCA,75,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27521,Alive,TUMOR FREE,409,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,409,0,409,0,409,0,409,NA,Stage IIA,T2,M0,BRCA.LumA,10
-4.480420355,1.466173435,TCGA-23-1032-01A,TCGA-23-1032-01A-02W-0486-08,0,NA,TCGA-23-1032,OV,73,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2002,[Not Available],-26715,Dead,WITH TUMOR,68,84,[Not Available],NA,NA,NA,NA,[Not Available],1,84,1,84,NA,NA,1,84,NA,Stage IV,[Not Applicable],[Not Applicable],NA,10
1.076829871,3.548798908,TCGA-B6-A0I1-01A,TCGA-B6-A0I1-01A-11D-A21Q-09,0,NA,TCGA-B6-A0I1,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26902,Dead,TUMOR FREE,NA,2361,[Not Available],Distant Metastasis,Lung,NA,1120,[Not Available],1,2361,0,2361,1,1120,1,1120,NA,Stage IIA,T2,M0,BRCA.Basal,1
-0.818195017,3.750781779,TCGA-A2-A4S3-01A,TCGA-A2-A4S3-01A-21D-A25Q-09,4,0.306078756,TCGA-A2-A4S3,BRCA,59,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21762,Alive,TUMOR FREE,666,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,666,0,666,0,666,0,666,NA,Stage IIB,T2,M0,BRCA.LumB,5
9.111322153,-4.397743518,TCGA-AC-A6IV-01A,TCGA-AC-A6IV-01A-12D-A33E-09,1,0.754578289,TCGA-AC-A6IV,BRCA,47,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-17521,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,568,0,568,0,568,0,568,NA,Stage IIB,T2,MX,BRCA.LumA,1
8.266522407,-3.972914475,TCGA-AR-A5QN-01A,TCGA-AR-A5QN-01A-12D-A28B-09,1,0.55476258,TCGA-AR-A5QN,BRCA,68,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25089,Alive,TUMOR FREE,1013,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1013,0,1013,NA,NA,0,1013,NA,Stage IIIC,T2,M0,BRCA.LumA,1
7.721318958,-3.414313595,TCGA-BH-A42U-01A,TCGA-BH-A42U-01A-12D-A243-09,1,0.300915359,TCGA-BH-A42U,BRCA,80,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29330,Alive,TUMOR FREE,3364,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3364,0,3364,0,3364,0,3364,NA,Stage IIA,T2,M0,BRCA.Normal,1
-4.03699251,-1.799377403,TCGA-BH-A2L8-01A,TCGA-BH-A2L8-01A-11D-A18P-09,8,0.302104124,TCGA-BH-A2L8,BRCA,45,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16658,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,612,0,612,0,612,0,612,NA,Stage IIA,T2,M0,BRCA.LumA,10
1.187548326,3.360412693,TCGA-A2-A0T0-01A,TCGA-A2-A0T0-01A-22D-A099-09,0,NA,TCGA-A2-A0T0,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21575,Alive,TUMOR FREE,533,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,533,0,533,0,533,0,533,NA,Stage IIB,T2,M0,BRCA.Basal,10
-7.200134909,1.428324646,TCGA-A7-A0D9-01A,TCGA-A7-A0D9-01A-31W-A071-09,0,NA,TCGA-A7-A0D9,BRCA,37,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13836,Alive,TUMOR FREE,1139,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1139,0,1139,0,1139,0,1139,NA,Stage IIA,T2,M0,BRCA.LumA,7
7.921739876,-1.404469837,TCGA-BH-A1EO-01A,TCGA-BH-A1EO-01A-11D-A135-09,1,0.184750022,TCGA-BH-A1EO,BRCA,68,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25136,Dead,TUMOR FREE,NA,2798,[Not Available],NA,NA,NA,NA,[Not Available],1,2798,0,2798,NA,NA,0,2798,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-0.583633409,5.062673467,TCGA-BH-A18Q-01A,TCGA-BH-A18Q-01A-12D-A12B-09,4,0.483322039,TCGA-BH-A18Q,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-20675,Dead,NA,NA,1692,[Not Available],NA,NA,NA,NA,[Not Available],1,1692,NA,1692,0,1692,0,1692,NA,Stage IIB,T2,M0,BRCA.Basal,6
-8.279018126,2.044373,TCGA-AN-A0AM-01A,TCGA-AN-A0AM-01A-11W-A050-09,9,0.188176557,TCGA-AN-A0AM,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20713,Alive,TUMOR FREE,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5,0,5,0,5,0,5,NA,Stage IIA,T2,M0,BRCA.LumB,7
8.804268458,-4.494471703,TCGA-AR-A2LN-01A,TCGA-AR-A2LN-01A-21D-A18P-09,1,0.750267576,TCGA-AR-A2LN,BRCA,65,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23992,Alive,TUMOR FREE,1161,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1161,0,1161,0,1161,0,1161,NA,Stage IIA,T2,M0,BRCA.LumA,1
8.913628267,-4.027258237,TCGA-27-1832-01A,TCGA-27-1832-01A-01D-1494-08,1,0.716856244,TCGA-27-1832,GBM,59,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-21678,Dead,WITH TUMOR,0,300,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],176,[Not Available],1,300,1,300,NA,NA,1,176,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
4.104440132,1.306122977,TCGA-E2-A2P6-01A,TCGA-E2-A2P6-01A-11D-A19Y-09,2,0.300938149,TCGA-E2-A2P6,BRCA,77,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28411,Alive,TUMOR FREE,1051,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1051,0,1051,0,1051,0,1051,NA,Stage IIB,T2,M0,BRCA.LumA,6
-7.75488682,1.989040661,TCGA-27-2523-01A,TCGA-27-2523-01A-01D-1494-08,9,0.42847679,TCGA-27-2523,GBM,63,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-23034,Dead,WITH TUMOR,489,489,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],402,[Not Available],1,489,1,489,NA,NA,1,402,NA,NA,NA,NA,GBM_LGG.Classic-like,7
-0.672871373,2.218660175,TCGA-28-2514-01A,TCGA-28-2514-01A-02D-1494-08,0,NA,TCGA-28-2514,GBM,45,MALE,ASIAN,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-16737,Alive,NA,160,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,160,0,160,NA,NA,0,160,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-0.552657263,3.770275648,TCGA-19-1386-01A,TCGA-19-1386-01A-01W-0643-08,4,0.367822781,TCGA-19-1386,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-18678,Dead,WITH TUMOR,276,276,[Not Available],Recurrence,[Not Applicable],[Not Applicable],237,[Not Available],1,276,1,276,NA,NA,1,237,NA,NA,NA,NA,NA,10
7.771527952,-1.353768892,TCGA-B6-A0RV-01A,TCGA-B6-A0RV-01A-11D-A099-09,1,0.135205911,TCGA-B6-A0RV,BRCA,42,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-15507,Alive,TUMOR FREE,5156,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5156,0,5156,0,5156,0,5156,NA,Stage IIIA,T3,M0,BRCA.LumA,1
-6.422688582,-1.240373355,TCGA-A8-A093-01A,TCGA-A8-A093-01A-11W-A019-09,7,0.343586618,TCGA-A8-A093,BRCA,61,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22373,Alive,TUMOR FREE,546,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,546,0,546,0,546,0,546,NA,Stage IIA,T2,M0,BRCA.LumA,2
-0.461356875,5.031370957,TCGA-E2-A1B6-01A,TCGA-E2-A1B6-01A-31D-A12Q-09,4,0.559110058,TCGA-E2-A1B6,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16370,Alive,TUMOR FREE,867,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,867,0,867,0,867,0,867,NA,Stage IIA,T2,M0,BRCA.Basal,6
-6.208120668,1.457159593,TCGA-5N-A9KI-01A,TCGA-5N-A9KI-01A-31D-A42E-08,10,0.133542462,TCGA-5N-A9KI,BLCA,76,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27777,Dead,TUMOR FREE,NA,76,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,76,0,76,0,76,0,76,NA,Stage III,T4,MX,NA,9
-7.395048363,-2.355700402,TCGA-5N-A9KM-01A,TCGA-5N-A9KM-01A-11D-A42E-08,6,0.378640141,TCGA-5N-A9KM,BLCA,73,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26906,Dead,WITH TUMOR,NA,530,[Not Available],NA,NA,NA,276,Complete Remission/Response,1,530,1,530,1,276,1,276,NA,Stage III,T4a,MX,NA,2
1.816249006,1.901909217,TCGA-G3-A3CG-01A,TCGA-G3-A3CG-01A-11D-A20W-10,3,0.389431867,TCGA-G3-A3CG,LIHC,80,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-29432,Alive,WITH TUMOR,673,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,329,[Not Available],0,673,0,673,NA,NA,1,329,NA,Stage I,T1,M0,NA,3
-7.903701363,-2.463950058,TCGA-HC-A4ZV-01A,TCGA-HC-A4ZV-01A-11D-A26M-08,6,0.429307191,TCGA-HC-A4ZV,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20634,Alive,WITH TUMOR,23,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,23,0,23,NA,NA,0,23,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,2
9.912767225,-2.880084348,TCGA-HC-7233-01A,TCGA-HC-7233-01A-11D-2114-08,1,0.61966912,TCGA-HC-7233,PRAD,73,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],NA,Alive,TUMOR FREE,1355,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1355,0,1355,0,1355,0,1355,NA,[Not Applicable],T2a,[Not Applicable],PRAD.8-other,1
-0.319935226,4.869796909,TCGA-HC-8216-01A,TCGA-HC-8216-01A-11D-A29Q-08,4,0.343952573,TCGA-HC-8216,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21428,Alive,TUMOR FREE,682,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,682,0,682,0,682,0,682,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,3
9.678062019,-5.717626336,TCGA-FC-A66V-01A,TCGA-FC-A66V-01A-21D-A30E-08,1,0.874169969,TCGA-FC-A66V,PRAD,74,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-27282,Alive,TUMOR FREE,524,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,524,0,524,0,524,0,524,NA,[Not Applicable],T3b,[Not Applicable],NA,1
7.950521945,-3.720383879,TCGA-EJ-8469-01A,TCGA-EJ-8469-01A-11D-2395-08,1,0.38889545,TCGA-EJ-8469,PRAD,46,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],-17014,Alive,WITH TUMOR,2324,NA,[Not Available],Locoregional Recurrence,NA,NA,1925,Partial Remission/Response,0,2324,0,2324,NA,NA,1,1925,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.555239362,-4.692589524,TCGA-FC-A5OB-01A,TCGA-FC-A5OB-01A-11D-A29Q-08,1,0.749828659,TCGA-FC-A5OB,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-19413,Alive,WITH TUMOR,680,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,680,0,680,NA,NA,0,680,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
7.777092139,-1.356124077,TCGA-FC-7961-01A,TCGA-FC-7961-01A-11D-A29Q-08,1,0.166124476,TCGA-FC-7961,PRAD,62,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22888,Alive,TUMOR FREE,469,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,469,0,469,0,469,0,469,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
9.958017366,-2.14686544,TCGA-J4-8200-01A,TCGA-J4-8200-01A-11D-A29Q-08,1,0.775836565,TCGA-J4-8200,PRAD,47,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-17167,Alive,TUMOR FREE,1218,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1218,0,1218,0,1218,0,1218,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-0.919249618,2.285199378,TCGA-EP-A26S-01A,TCGA-EP-A26S-01A-11D-A16V-10,4,0.01792972,TCGA-EP-A26S,LIHC,70,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-25677,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,608,0,608,NA,NA,0,608,NA,Stage I,T1,MX,LIHC.iCluster:3,6
8.091002112,-2.39484161,TCGA-HC-7212-01A,TCGA-HC-7212-01A-11D-2114-08,1,0.477180249,TCGA-HC-7212,PRAD,56,MALE,WHITE,Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-20576,Alive,TUMOR FREE,870,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,870,0,870,0,870,0,870,NA,[Not Applicable],T2a,[Not Applicable],PRAD.1-ERG,1
-6.109871761,3.014650205,TCGA-HC-7817-01B,TCGA-HC-7817-01B-11D-A29Q-08,0,NA,TCGA-HC-7817,PRAD,52,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19207,Alive,TUMOR FREE,928,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,928,0,928,0,928,0,928,NA,[Not Applicable],T3b,[Not Applicable],NA,8
9.294027134,-5.214763026,TCGA-DD-A11B-01A,TCGA-DD-A11B-01A-11D-A12Z-10,1,0.775414589,TCGA-DD-A11B,LIHC,73,MALE,WHITE,Hepatocellular Carcinoma,G2,2005,[Not Available],-26857,Dead,TUMOR FREE,NA,14,[Not Available],NA,NA,NA,NA,[Not Available],1,14,0,14,NA,NA,0,14,NA,Stage I,T1,M0,LIHC.iCluster:2,1
-5.75948272,-2.193933275,TCGA-HC-A6AS-01A,TCGA-HC-A6AS-01A-11D-A30E-08,0,NA,TCGA-HC-A6AS,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-25661,Alive,TUMOR FREE,44,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,44,0,44,NA,NA,0,44,NA,[Not Applicable],T2a,[Not Applicable],NA,2
9.314503005,-5.555607401,TCGA-HC-A6AL-01A,TCGA-HC-A6AL-01A-11D-A30E-08,1,0.85340764,TCGA-HC-A6AL,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23618,Alive,TUMOR FREE,67,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,67,0,67,NA,NA,0,67,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.923236963,-2.519651494,TCGA-HC-A6HX-01A,TCGA-HC-A6HX-01A-11D-A31L-08,1,0.643394492,TCGA-HC-A6HX,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20263,Alive,TUMOR FREE,38,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,38,0,38,NA,NA,0,38,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.260174224,-5.196311793,TCGA-J4-A67N-01A,TCGA-J4-A67N-01A-11D-A30E-08,1,0.789450596,TCGA-J4-A67N,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22420,Alive,WITH TUMOR,937,NA,[Not Available],Biochemical evidence of disease,NA,NA,442,Partial Remission/Response,0,937,0,937,NA,NA,1,442,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.501872152,-4.857827107,TCGA-14-0736-01A,TCGA-14-0736-01A-01D-2280-08,1,0.77705608,TCGA-14-0736,GBM,49,MALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],1999,[Not Available],-18219,Dead,WITH TUMOR,460,460,[Not Available],Recurrence,[Not Applicable],[Not Applicable],128,[Not Available],1,460,1,460,NA,NA,1,128,NA,NA,NA,NA,NA,1
0.229253874,4.978867349,TCGA-41-2575-01A,TCGA-41-2575-01A-01D-1495-08,4,0.48068258,TCGA-41-2575,GBM,75,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-27587,Dead,WITH TUMOR,290,290,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],131,[Not Available],1,290,1,290,NA,NA,1,131,NA,NA,NA,NA,NA,6
-5.792961352,-2.175989102,TCGA-02-0055-01A,TCGA-02-0055-01A-01D-1490-08,0,NA,TCGA-02-0055,GBM,62,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-22798,Dead,WITH TUMOR,76,76,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],6,[Not Available],1,76,1,76,NA,NA,1,6,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,2
-0.821387106,4.349236435,TCGA-12-1598-01A,TCGA-12-1598-01A-01W-0643-08,4,0.430518944,TCGA-12-1598,GBM,75,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-27730,Dead,WITH TUMOR,287,476,[Not Available],NA,NA,NA,NA,[Not Available],1,476,1,476,NA,NA,1,476,NA,NA,NA,NA,NA,6
4.054641007,1.305552443,TCGA-DD-A11A-01A,TCGA-DD-A11A-01A-11D-A12Z-10,2,0.102911998,TCGA-DD-A11A,LIHC,67,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G3,2004,[Not Available],-24646,Alive,NA,79,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,79,0,79,0,79,0,79,NA,Stage I,T1,M0,LIHC.iCluster:2,6
9.904182145,-2.748973462,TCGA-ES-A2HS-01A,TCGA-ES-A2HS-01A-11D-A183-10,1,0.746182799,TCGA-ES-A2HS,LIHC,80,MALE,WHITE,Hepatocellular Carcinoma,G2,2008,[Not Available],-29268,Dead,TUMOR FREE,NA,688,[Not Available],NA,NA,NA,NA,[Not Available],1,688,0,688,0,688,0,688,NA,Stage I,T1,MX,LIHC.iCluster:2,1
-4.48126549,-1.476235719,TCGA-G3-A3CK-01A,TCGA-G3-A3CK-01A-11D-A20W-10,8,0.398883907,TCGA-G3-A3CK,LIHC,61,MALE,ASIAN,Hepatocellular Carcinoma,G2,2011,[Not Available],-22462,Alive,TUMOR FREE,585,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,585,0,585,0,585,0,585,NA,Stage I,T1,M0,LIHC.iCluster:2,10
-0.517317965,3.138814833,TCGA-DD-A1EB-01A,TCGA-DD-A1EB-01A-11D-A12Z-10,0,NA,TCGA-DD-A1EB,LIHC,72,FEMALE,[Not Available],Hepatocellular Carcinoma,G2,2001,[Not Available],-26471,Alive,[Discrepancy],2017,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,505,[Not Available],0,2017,0,2017,1,505,1,505,NA,Stage I,T1,M0,LIHC.iCluster:2,6
-5.728298856,-2.177781389,TCGA-FV-A2QR-01A,TCGA-FV-A2QR-01A-11D-A20W-10,0,NA,TCGA-FV-A2QR,LIHC,75,MALE,WHITE,Hepatocellular Carcinoma,G1,2006,[Not Available],NA,Dead,WITH TUMOR,NA,581,[Not Available],Extrahepatic Recurrence,NA,NA,561,[Not Available],1,581,1,581,NA,NA,1,561,NA,Stage I,T1,M0,LIHC.iCluster:3,2
9.830554666,-2.749095857,TCGA-AC-A3YI-01A,TCGA-AC-A3YI-01A-21D-A23C-09,1,0.739004263,TCGA-AC-A3YI,BRCA,74,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27143,Alive,TUMOR FREE,707,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,707,0,707,0,707,0,707,NA,Stage IIIC,T1c,MX,BRCA.Normal,1
0.237250804,3.729818478,TCGA-CJ-5677-01A,TCGA-CJ-5677-01A-11D-1534-10,4,0.231612953,TCGA-CJ-5677,KIRC,54,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2004,[Not Available],-19849,Dead,WITH TUMOR,NA,782,[Not Available],NA,NA,NA,288,[Not Available],1,782,1,782,NA,NA,1,288,NA,Stage IV,T3a,M1,KIRC.4,3
-2.577022034,1.258827737,TCGA-OL-A5RW-01A,TCGA-OL-A5RW-01A-11D-A28B-09,5,0.110414813,TCGA-OL-A5RW,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14638,Alive,TUMOR FREE,1106,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1106,0,1106,0,1106,0,1106,NA,Stage IIA,T1c,MX,BRCA.Basal,10
9.074103982,-3.844686668,TCGA-OL-A66K-01A,TCGA-OL-A66K-01A-11D-A29N-09,1,0.72882934,TCGA-OL-A66K,BRCA,72,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26299,Dead,TUMOR FREE,NA,1275,[Not Available],NA,NA,NA,NA,[Not Available],1,1275,0,1275,0,1275,0,1275,NA,Stage IIA,T2,MX,BRCA.LumA,1
-0.252153856,3.833467,TCGA-57-1992-01A,TCGA-57-1992-01A-01W-0699-08,4,0.208128236,TCGA-57-1992,OV,62,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2006,[Not Available],NA,Alive,TUMOR FREE,882,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,882,0,882,0,882,0,882,NA,Stage IC,[Not Applicable],[Not Applicable],NA,6
4.495019176,1.015847589,TCGA-B0-5690-01A,TCGA-B0-5690-01A-11D-1534-10,2,0.543845667,TCGA-B0-5690,KIRC,53,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G1,2004,[Not Available],-19685,Alive,WITH TUMOR,3392,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,3392,0,3392,NA,NA,0,3392,NA,Stage I,T1b,M0,KIRC.1,5
9.159256574,-4.433257824,TCGA-OL-A5RV-01A,TCGA-OL-A5RV-01A-12D-A28B-09,1,0.706165102,TCGA-OL-A5RV,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15820,Alive,TUMOR FREE,1062,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1062,0,1062,0,1062,0,1062,NA,Stage IIIC,T2,MX,BRCA.LumA,1
8.5406388,-1.709769951,TCGA-OL-A5RZ-01A,TCGA-OL-A5RZ-01A-11D-A28B-09,1,0.525423024,TCGA-OL-A5RZ,BRCA,57,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21038,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,679,0,679,0,679,0,679,NA,Stage IA,T1b,MX,BRCA.Her2,6
8.965909461,-5.10017043,TCGA-A2-A3XU-01A,TCGA-A2-A3XU-01A-12D-A22X-09,1,0.814362022,TCGA-A2-A3XU,BRCA,35,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-13046,Dead,WITH TUMOR,NA,912,[Not Available],Distant Metastasis,Bone,NA,574,[Not Available],1,912,1,912,1,574,1,574,NA,Stage IIB,T2,M0,BRCA.Basal,1
-1.576067438,4.10745984,TCGA-E9-A5FL-01A,TCGA-E9-A5FL-01A-11D-A27P-09,0,NA,TCGA-E9-A5FL,BRCA,65,FEMALE,WHITE,Metaplastic Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24053,Alive,TUMOR FREE,24,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,24,0,24,0,24,0,24,NA,Stage IIB,T3,M0,BRCA.Basal,6
-6.618638914,-2.163758544,TCGA-85-8666-01A,TCGA-85-8666-01A-11D-2395-08,0,NA,TCGA-85-8666,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-23906,Dead,TUMOR FREE,NA,687,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,687,0,687,0,687,0,687,NA,Stage IB,T2a,M0,NA,2
-4.642422638,1.086636237,TCGA-85-8580-01A,TCGA-85-8580-01A-31D-2395-08,0,NA,TCGA-85-8580,LUSC,52,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-19301,Alive,TUMOR FREE,1113,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1113,0,1113,0,1113,0,1113,NA,Stage IB,T2a,M0,NA,9
-8.156684084,2.068337384,TCGA-OL-A5RX-01A,TCGA-OL-A5RX-01A-11D-A28B-09,9,0.588759945,TCGA-OL-A5RX,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18942,Alive,TUMOR FREE,878,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,878,0,878,0,878,0,878,NA,Stage IA,T1c,MX,BRCA.LumA,7
4.298217035,0.874954776,TCGA-B4-5838-01A,TCGA-B4-5838-01A-11D-1669-08,2,0.573065223,TCGA-B4-5838,KIRC,52,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-19242,Alive,WITH TUMOR,166,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,166,0,166,NA,NA,0,166,NA,[Discrepancy],T3,M0,NA,1
-1.878086383,1.044147831,TCGA-E9-A54Y-01A,TCGA-E9-A54Y-01A-11D-A25Q-09,5,0.653365927,TCGA-E9-A54Y,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23057,Alive,TUMOR FREE,725,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,725,0,725,0,725,0,725,NA,Stage IIIA,T2,M0,BRCA.LumB,4
-1.029305553,4.905653376,TCGA-A2-A4S1-01A,TCGA-A2-A4S1-01A-21D-A25Q-09,4,0.355976912,TCGA-A2-A4S1,BRCA,66,FEMALE,WHITE,Metaplastic Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24353,Alive,TUMOR FREE,820,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,820,0,820,0,820,0,820,NA,Stage IIA,T2,M0,BRCA.Basal,6
-0.179587881,5.219652027,TCGA-85-A50M-01A,TCGA-85-A50M-01A-21D-A25L-08,4,0.694092611,TCGA-85-A50M,LUSC,47,MALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-17429,Dead,TUMOR FREE,NA,826,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,826,0,826,0,826,0,826,NA,Stage IIA,T2b,M0,NA,6
-1.861400905,3.037952815,TCGA-85-8352-01A,TCGA-85-8352-01A-31D-2323-08,0,NA,TCGA-85-8352,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24788,Dead,WITH TUMOR,NA,161,[Not Available],Distant Metastasis,NA,NA,128,Complete Remission/Response,1,161,1,161,1,128,1,128,NA,Stage IIIA,T3,M0,NA,10
9.793656307,-2.907465754,TCGA-A7-A425-01A,TCGA-A7-A425-01A-11D-A243-09,1,0.722658053,TCGA-A7-A425,BRCA,70,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25678,Alive,WITH TUMOR,447,NA,[Not Available],Locoregional Recurrence,"Other, specify",Left Breast,419,[Not Available],0,447,0,447,1,419,1,419,NA,Stage IIIC,T3,MX,BRCA.LumA,1
9.267686832,-4.653014751,TCGA-AS-3777-01A,TCGA-AS-3777-01A-01D-0966-08,1,0.772603176,TCGA-AS-3777,KIRC,63,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,[Not Available],2009,[Not Available],-23039,Alive,TUMOR FREE,1238,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1238,0,1238,NA,NA,0,1238,NA,Stage I,T1a,M0,NA,1
4.431983438,1.155852762,TCGA-B0-5700-01A,TCGA-B0-5700-01A-11D-1534-10,2,0.668713987,TCGA-B0-5700,KIRC,77,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2009,[Not Available],-28184,Alive,TUMOR FREE,1790,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1790,0,1790,0,1790,0,1790,NA,Stage I,T1a,M0,KIRC.NA,5
-7.597020038,2.082578567,TCGA-AC-A3YJ-01A,TCGA-AC-A3YJ-01A-11D-A22X-09,9,0.46450584,TCGA-AC-A3YJ,BRCA,66,FEMALE,WHITE,"Other, specify",[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24439,Alive,TUMOR FREE,754,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,754,0,754,0,754,0,754,NA,Stage IIA,T2,MX,BRCA.LumA,7
9.327312687,-3.759173442,TCGA-GM-A5PV-01A,TCGA-GM-A5PV-01A-11D-A28B-09,1,0.72081203,TCGA-GM-A5PV,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23215,Alive,TUMOR FREE,412,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,412,0,412,0,412,0,412,NA,Stage IIB,T2,M0,BRCA.LumA,1
-4.946575235,1.669823161,TCGA-43-A56V-01A,TCGA-43-A56V-01A-11D-A26M-08,0,NA,TCGA-43-A56V,LUSC,61,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-22475,Alive,WITH TUMOR,366,NA,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,355,Complete Remission/Response,0,366,0,366,1,355,1,355,NA,Stage IIIA,T2a,M0,NA,10
-4.45848801,1.432249762,TCGA-85-8353-01A,TCGA-85-8353-01A-21D-2293-08,0,NA,TCGA-85-8353,LUSC,72,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26549,Dead,WITH TUMOR,NA,94,[Not Available],NA,NA,NA,NA,Stable Disease,1,94,1,94,NA,NA,1,94,NA,Stage IIIA,T3,M0,NA,9
3.001393939,3.586208552,TCGA-E2-A570-01A,TCGA-E2-A570-01A-11D-A29N-09,0,NA,TCGA-E2-A570,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17456,Alive,TUMOR FREE,931,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,931,0,931,0,931,0,931,NA,Stage IB,T1c,M0,BRCA.LumA,1
-3.769926521,-2.374995101,TCGA-MF-A522-01A,TCGA-MF-A522-01A-11D-A25L-08,8,0.443429108,TCGA-MF-A522,LUSC,54,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-20051,Dead,WITH TUMOR,NA,360,[Not Available],Distant Metastasis,NA,NA,173,Partial Remission/Response,1,360,1,360,NA,NA,1,173,NA,Stage IB,T2a,MX,NA,10
4.400604379,1.158389502,TCGA-BC-A10Q-01A,TCGA-BC-A10Q-01A-11D-A12Z-10,2,0.664204628,TCGA-BC-A10Q,LIHC,72,FEMALE,WHITE,Hepatocellular Carcinoma,[Not Available],1998,[Not Available],-26400,Dead,WITH TUMOR,NA,1135,[Not Available],Intrahepatic Recurrence,NA,NA,340,[Not Available],1,1135,1,1135,NA,NA,1,340,NA,[Not Available],T2,MX,NA,5
-6.311090189,-1.842437792,TCGA-56-7731-01A,TCGA-56-7731-01A-11D-2122-08,0,NA,TCGA-56-7731,LUSC,66,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-24441,Dead,TUMOR FREE,NA,3,[Not Available],NA,NA,NA,NA,[Not Applicable],1,3,0,3,NA,NA,0,3,NA,Stage IB,T2a,MX,NA,2
-6.878558584,-1.968801116,TCGA-85-A4QR-01A,TCGA-85-A4QR-01A-11D-A257-08,0,NA,TCGA-85-A4QR,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24756,Alive,TUMOR FREE,600,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,600,0,600,0,600,0,600,NA,Stage IB,T2a,M0,NA,2
-1.904442009,0.985400774,TCGA-G3-A25T-01A,TCGA-G3-A25T-01A-11D-A16V-10,5,0.59502019,TCGA-G3-A25T,LIHC,45,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2007,[Not Available],-16461,Alive,WITH TUMOR,1553,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,452,[Not Available],0,1553,0,1553,1,452,1,452,NA,Stage IIIA,T3,M0,LIHC.iCluster:1,4
1.45953498,2.136830648,TCGA-CC-5258-01A,TCGA-CC-5258-01A-01D-A12Z-10,0,NA,TCGA-CC-5258,LIHC,48,MALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-17586,Dead,TUMOR FREE,NA,129,[Not Available],NA,NA,NA,NA,[Not Available],1,129,0,129,NA,NA,0,129,NA,Stage II,T2,M0,LIHC.iCluster:1,3
-7.998611116,2.157823087,TCGA-BH-A0W5-01A,TCGA-BH-A0W5-01A-11D-A10G-09,9,0.558272271,TCGA-BH-A0W5,BRCA,77,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-28304,Alive,TUMOR FREE,1288,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1288,0,1288,0,1288,0,1288,NA,Stage IIA,T1c,M0,BRCA.LumA,7
8.977026426,-3.429275409,TCGA-56-A4ZJ-01A,TCGA-56-A4ZJ-01A-11D-A25L-08,1,0.65946022,TCGA-56-A4ZJ,LUSC,75,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-27516,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,640,0,640,0,640,0,640,NA,Stage IA,T1a,M0,NA,1
-3.11745213,-3.535912776,TCGA-A8-A09Z-01A,TCGA-A8-A09Z-01A-11W-A019-09,8,0.590978117,TCGA-A8-A09Z,BRCA,83,FEMALE,[Not Available],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30590,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T3,M0,BRCA.LumB,10
-1.064113584,4.598012332,TCGA-76-6193-01A,TCGA-76-6193-01A-11D-1696-08,4,0.49513022,TCGA-76-6193,GBM,78,MALE,[Not Available],Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-28742,Dead,NA,82,82,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],64,[Not Available],1,82,NA,82,NA,NA,1,64,NA,NA,NA,NA,NA,6
-6.70731418,-1.425717016,TCGA-29-1761-01A,TCGA-29-1761-01A-01W-0633-09,7,0.194484742,TCGA-29-1761,OV,80,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,1998,[Not Available],-29337,Dead,WITH TUMOR,517,528,[Not Available],NA,NA,NA,NA,Stable Disease,1,528,1,528,NA,NA,1,528,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,2
-1.556206111,3.15922081,TCGA-06-5858-01A,TCGA-06-5858-01A-01D-1696-08,4,0.026269999,TCGA-06-5858,GBM,45,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-16662,Alive,WITH TUMOR,187,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],97,[Not Available],0,187,0,187,NA,NA,1,97,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,6
2.071500253,1.806064822,TCGA-B4-5377-01A,TCGA-B4-5377-01A-01D-1501-10,3,0.609419418,TCGA-B4-5377,KIRC,68,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-25115,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,365,0,365,NA,NA,0,365,NA,Stage IV,T3,M1,KIRC.1,3
4.373374916,1.170512445,TCGA-B0-5402-01A,TCGA-B0-5402-01A-01D-1501-10,2,0.651708238,TCGA-B0-5402,KIRC,64,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2010,[Not Available],-23477,Alive,WITH TUMOR,1290,NA,[Not Available],NA,NA,NA,444,Progressive Disease,0,1290,0,1290,NA,NA,1,444,NA,Stage IV,T4,M0,KIRC.1,5
-4.169161376,-1.955414085,TCGA-56-8625-01A,TCGA-56-8625-01A-11D-2395-08,8,0.379724288,TCGA-56-8625,LUSC,66,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24188,Dead,WITH TUMOR,NA,315,[Not Available],Distant Metastasis,NA,NA,272,Progressive Disease,1,315,1,315,NA,NA,1,272,NA,Stage IIIA,T3,MX,NA,10
-4.63930661,0.70006856,TCGA-85-A4JB-01A,TCGA-85-A4JB-01A-51D-A25L-08,0,NA,TCGA-85-A4JB,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-27315,Alive,TUMOR FREE,942,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,942,0,942,0,942,0,942,NA,Stage IIB,T3,M0,NA,10
-1.120773213,3.615608955,TCGA-BC-A217-01A,TCGA-BC-A217-01A-11D-A152-10,4,0.300017163,TCGA-BC-A217,LIHC,75,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2010,[Not Available],-27411,Dead,TUMOR FREE,NA,1397,[Not Available],NA,NA,NA,NA,[Not Available],1,1397,0,1397,0,1397,0,1397,NA,Stage II,T2,M0,LIHC.iCluster:3,5
-7.092436796,-2.126963012,TCGA-85-A4CN-01A,TCGA-85-A4CN-01A-11D-A24D-08,6,0.336667465,TCGA-85-A4CN,LUSC,56,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-20490,Alive,TUMOR FREE,1038,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1038,0,1038,0,1038,0,1038,NA,Stage IIB,T2b,M0,NA,2
-5.142033494,-1.613383842,TCGA-90-A4EE-01A,TCGA-90-A4EE-01A-11D-A257-08,0,NA,TCGA-90-A4EE,LUSC,53,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-19676,Alive,TUMOR FREE,688,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,688,0,688,0,688,0,688,NA,Stage IIA,T2a,MX,NA,10
-7.283944045,-2.639666409,TCGA-CC-A3MC-01A,TCGA-CC-A3MC-01A-11D-A22F-10,6,0.403083659,TCGA-CC-A3MC,LIHC,54,MALE,ASIAN,Hepatocellular Carcinoma,G2,2011,[Not Available],-20067,Alive,WITH TUMOR,363,NA,[Not Available],Locoregional Recurrence,Liver,NA,297,[Not Available],0,363,0,363,1,297,1,297,NA,Stage IIIA,T3,M0,LIHC.iCluster:1,2
8.5535419,-4.94662747,TCGA-DD-A1E9-01A,TCGA-DD-A1E9-01A-21D-A152-10,1,0.852359618,TCGA-DD-A1E9,LIHC,70,MALE,WHITE,Hepatocellular Carcinoma,G2,2002,[Not Available],-25808,Dead,NA,NA,2759,[Not Available],Intrahepatic Recurrence,Liver,NA,720,[Not Available],1,2759,NA,2759,1,720,1,720,NA,Stage I,T1,M0,NA,1
-5.749272635,-2.20991474,TCGA-13-1412-01A,TCGA-13-1412-01A-01W-0492-08,0,NA,TCGA-13-1412,OV,41,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-15119,Dead,WITH TUMOR,NA,984,[Not Available],NA,[Not Applicable],[Not Applicable],409,Complete Remission/Response,1,984,1,984,NA,NA,1,409,NA,Stage IV,[Not Applicable],[Not Applicable],NA,2
2.978290703,3.566798006,TCGA-D8-A141-01A,TCGA-D8-A141-01A-11D-A10Y-09,0,NA,TCGA-D8-A141,BRCA,40,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Indeterminate (neither Pre or Postmenopausal),-14626,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,626,0,626,0,626,0,626,NA,[Not Available],T1c,M0,BRCA.LumA,1
0.226023149,3.442214557,TCGA-28-2509-01A,TCGA-28-2509-01A-01D-1494-08,4,0.234927402,TCGA-28-2509,GBM,77,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-28240,Alive,NA,145,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,145,0,145,NA,NA,0,145,NA,NA,NA,NA,GBM_LGG.Classic-like,3
-2.701551608,-4.398702383,TCGA-06-5416-01A,TCGA-06-5416-01A-01D-1486-08,0,NA,TCGA-06-5416,GBM,23,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-8533,Alive,WITH TUMOR,204,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,204,0,204,NA,NA,0,204,NA,NA,NA,NA,GBM_LGG.NA,10
3.065045757,1.647705557,TCGA-G3-A25V-01A,TCGA-G3-A25V-01A-11D-A16V-10,2,0.027811609,TCGA-G3-A25V,LIHC,68,MALE,WHITE,Hepatocellular Carcinoma,G2,2010,[Not Available],-25144,Alive,WITH TUMOR,860,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,489,[Not Available],0,860,0,860,1,489,1,489,NA,Stage I,T1,M0,LIHC.iCluster:2,3
1.458398346,2.126655031,TCGA-56-8626-01A,TCGA-56-8626-01A-11D-2395-08,0,NA,TCGA-56-8626,LUSC,59,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-21908,Dead,TUMOR FREE,NA,302,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,302,0,302,0,302,0,302,NA,Stage IA,T1a,MX,NA,3
-6.114647194,1.203515964,TCGA-G3-A25U-01A,TCGA-G3-A25U-01A-11D-A16V-10,10,0.078372081,TCGA-G3-A25U,LIHC,63,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2007,[Not Available],-23207,Alive,TUMOR FREE,1636,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1636,0,1636,0,1636,0,1636,NA,Stage I,T1,M0,LIHC.iCluster:3,9
9.3975212,-3.943540775,TCGA-B0-5096-01A,TCGA-B0-5096-01A-01D-1421-08,1,0.717405011,TCGA-B0-5096,KIRC,72,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,GX,1998,[Not Available],-26574,Dead,TUMOR FREE,NA,68,[Not Available],NA,NA,NA,NA,[Not Available],1,68,0,68,NA,NA,0,68,NA,Stage III,T3a,M0,KIRC.3,5
-6.988831956,2.010125804,TCGA-C8-A12T-01A,TCGA-C8-A12T-01A-11D-A10Y-09,0,NA,TCGA-C8-A12T,BRCA,43,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIA,T2,M0,BRCA.Her2,9
0.238562798,5.257099088,TCGA-CC-5260-01A,TCGA-CC-5260-01A-01D-A12Z-10,4,0.309528603,TCGA-CC-5260,LIHC,61,FEMALE,ASIAN,Hepatocellular Carcinoma,G1,2010,[Not Available],-22345,Dead,TUMOR FREE,NA,87,[Not Available],NA,NA,NA,NA,[Not Available],1,87,0,87,NA,NA,0,87,NA,Stage IIIC,T4,M0,LIHC.iCluster:1,1
-7.63944878,2.167238231,TCGA-EW-A1IW-01A,TCGA-EW-A1IW-01A-11D-A13L-09,9,0.31742774,TCGA-EW-A1IW,BRCA,80,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529,Alive,TUMOR FREE,371,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,371,0,371,0,371,0,371,NA,Stage IIB,T2,MX,BRCA.LumA,7
9.604012435,-5.729825666,TCGA-BC-A10X-01A,TCGA-BC-A10X-01A-11D-A12Z-10,1,0.839993998,TCGA-BC-A10X,LIHC,52,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2002,[Not Available],-19140,Dead,TUMOR FREE,NA,770,[Not Available],NA,NA,NA,NA,[Not Available],1,770,0,770,0,770,0,770,NA,Stage IIIA,T3a,MX,LIHC.iCluster:1,1
-4.920461048,2.021655143,TCGA-85-A511-01A,TCGA-85-A511-01A-21D-A25L-08,0,NA,TCGA-85-A511,LUSC,62,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-22759,Dead,WITH TUMOR,NA,455,[Not Available],Distant Metastasis,NA,NA,390,Complete Remission/Response,1,455,1,455,1,390,1,390,NA,Stage IIB,T2b,M0,NA,6
-7.195162731,-1.611560097,TCGA-G3-A3CH-01A,TCGA-G3-A3CH-01A-11D-A22F-10,0,NA,TCGA-G3-A3CH,LIHC,53,MALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-19473,Alive,WITH TUMOR,780,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,116,[Not Available],0,780,0,780,1,116,1,116,NA,Stage IIIA,T3a,M0,LIHC.iCluster:1,2
-7.620219055,-2.018544317,TCGA-BP-4998-01A,TCGA-BP-4998-01A-01D-1462-08,6,0.176030459,TCGA-BP-4998,KIRC,49,MALE,ASIAN,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-17997,Alive,TUMOR FREE,932,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,932,0,932,NA,NA,0,932,NA,Stage I,T1a,M0,KIRC.2,2
9.141724643,-4.963992631,TCGA-CC-5261-01A,TCGA-CC-5261-01A-01D-A12Z-10,1,0.790908669,TCGA-CC-5261,LIHC,44,MALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-16373,Dead,TUMOR FREE,NA,97,[Not Available],NA,NA,NA,NA,[Not Available],1,97,0,97,NA,NA,0,97,NA,Stage II,T2,M0,LIHC.iCluster:1,1
4.169057634,1.025982511,TCGA-G3-A3CI-01A,TCGA-G3-A3CI-01A-11D-A20W-10,2,0.512383326,TCGA-G3-A3CI,LIHC,71,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-26224,Alive,TUMOR FREE,180,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,180,0,180,0,180,0,180,NA,Stage I,T1,M0,LIHC.iCluster:1,3
8.803590155,-1.902081305,TCGA-E1-A7YM-01A,TCGA-E1-A7YM-01A-11D-A34A-08,1,0.591376974,TCGA-E1-A7YM,LGG,63,MALE,WHITE,Astrocytoma,G3,2010,[Not Available],-23263,Dead,WITH TUMOR,NA,648,[Not Available],NA,NA,NA,88,Progressive Disease,1,648,1,648,NA,NA,1,88,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-0.480493957,4.506269874,TCGA-P5-A736-01A,TCGA-P5-A736-01A-11D-A32B-08,4,0.486380506,TCGA-P5-A736,LGG,44,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-16300,Alive,TUMOR FREE,230,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,230,0,230,0,230,0,230,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.658285982,-3.761938395,TCGA-R5-A805-01A,TCGA-R5-A805-01A-11D-A364-08,1,0.677440309,TCGA-R5-A805,STAD,71,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005,[Not Available],-26122,Dead,WITH TUMOR,NA,281,Stomach Cancer,NA,NA,NA,NA,[Not Available],1,281,1,281,NA,NA,1,281,NA,Stage IIIB,T3,M0,GI.CIN,1
0.11613948,5.324599239,TCGA-P5-A735-01A,TCGA-P5-A735-01A-11D-A32B-08,4,0.522315836,TCGA-P5-A735,LGG,38,FEMALE,WHITE,Astrocytoma,G2,2013,[Not Available],-14152,Alive,TUMOR FREE,292,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,292,0,292,0,292,0,292,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.107653801,5.325417228,TCGA-VQ-A8E7-01B,TCGA-VQ-A8E7-01B-11D-A410-08,4,0.594531151,TCGA-VQ-A8E7,STAD,59,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-21664,Alive,WITH TUMOR,1138,NA,[Not Available],Distant Metastasis,"Other, specify",Adrenal,1048,Stable Disease,0,1138,0,1138,NA,NA,1,1048,NA,Stage IV,T3,M1,GI.CIN,6
8.798947769,-1.883607709,TCGA-E1-A7Z2-01A,TCGA-E1-A7Z2-01A-21D-A34J-08,1,0.567117491,TCGA-E1-A7Z2,LGG,58,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-21341,Dead,WITH TUMOR,NA,398,[Not Available],NA,NA,NA,213,Progressive Disease,1,398,1,398,NA,NA,1,213,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
9.394137679,-4.17860742,TCGA-E1-A7YY-01A,TCGA-E1-A7YY-01A-11D-A34J-08,1,0.71012124,TCGA-E1-A7YY,LGG,27,FEMALE,WHITE,Oligodendroglioma,G2,1998,[Not Available],-9867,Dead,WITH TUMOR,NA,4445,[Not Available],NA,NA,NA,958,Stable Disease,1,4445,1,4445,NA,NA,1,958,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-3.799372371,-2.706496941,TCGA-R5-A7ZI-01A,TCGA-R5-A7ZI-01A-11D-A34U-08,8,0.438919803,TCGA-R5-A7ZI,STAD,44,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2009,[Not Available],-16396,Alive,TUMOR FREE,2267,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2267,0,2267,NA,NA,0,2267,NA,Stage IV,T4,M1,GI.HM-indel,10
-0.346466237,4.958542581,TCGA-E1-A7YU-01A,TCGA-E1-A7YU-01A-11D-A34J-08,4,0.568259848,TCGA-E1-A7YU,LGG,42,MALE,WHITE,Oligoastrocytoma,G3,1996,[Not Available],-15345,Dead,WITH TUMOR,NA,23,[Not Available],NA,NA,NA,NA,[Unknown],1,23,1,23,NA,NA,1,23,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
2.204635521,1.665487186,TCGA-R5-A7ZR-01A,TCGA-R5-A7ZR-01A-11D-A34U-08,3,0.613824738,TCGA-R5-A7ZR,STAD,70,FEMALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008,[Not Available],-25795,Dead,WITH TUMOR,NA,185,[Unknown],NA,NA,NA,NA,Progressive Disease,1,185,1,185,NA,NA,1,185,NA,Stage III,T3,M0,GI.CIN,3
-4.4619653,0.412726581,TCGA-R5-A7ZE-01B,TCGA-R5-A7ZE-01B-11D-A34U-08,0,NA,TCGA-R5-A7ZE,STAD,66,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-24328,Dead,WITH TUMOR,NA,554,[Unknown],NA,NA,NA,NA,Progressive Disease,1,554,1,554,NA,NA,1,554,NA,Stage IIIA,T3,M0,GI.CIN,10
9.139862963,-3.560144441,TCGA-E1-A7YN-01A,TCGA-E1-A7YN-01A-11D-A34A-08,1,0.686032301,TCGA-E1-A7YN,LGG,63,FEMALE,WHITE,Astrocytoma,G3,2010,[Not Available],-23180,Dead,WITH TUMOR,NA,727,[Not Available],NA,NA,NA,420,Stable Disease,1,727,1,727,NA,NA,1,420,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-0.883514339,5.132284589,TCGA-R5-A7ZF-01A,TCGA-R5-A7ZF-01A-11D-A34U-08,4,0.348987593,TCGA-R5-A7ZF,STAD,65,FEMALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012,[Not Available],-23908,Dead,WITH TUMOR,NA,259,Stomach Cancer,NA,NA,NA,NA,Progressive Disease,1,259,1,259,NA,NA,1,259,NA,Stage IV,T4a,M1,GI.CIN,6
-7.388426427,2.182846379,TCGA-VQ-A8PF-01A,TCGA-VQ-A8PF-01A-11D-A410-08,9,0.267650707,TCGA-VQ-A8PF,STAD,76,MALE,[Not Evaluated],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012,[Not Available],-28116,Dead,TUMOR FREE,NA,76,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,76,0,76,0,76,0,76,NA,Stage IIIB,T3,M0,GI.EBV,7
10.03251514,-1.539776114,TCGA-P5-A737-01A,TCGA-P5-A737-01A-11D-A32B-08,1,0.855210624,TCGA-P5-A737,LGG,47,MALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-17390,Alive,TUMOR FREE,372,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,372,0,372,0,372,0,372,NA,NA,NA,NA,GBM_LGG.Codel,1
-5.568051916,-2.208380284,TCGA-VQ-A8PH-01A,TCGA-VQ-A8PH-01A-12D-A410-08,0,NA,TCGA-VQ-A8PH,STAD,62,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-22940,Dead,WITH TUMOR,NA,389,[Not Available],Locoregional Recurrence,NA,NA,377,Progressive Disease,1,389,1,389,NA,NA,1,377,NA,Stage IIIB,T3,M0,GI.CIN,2
-7.657042796,-2.35843965,TCGA-P5-A77X-01A,TCGA-P5-A77X-01A-11D-A32B-08,6,0.519641242,TCGA-P5-A77X,LGG,55,FEMALE,WHITE,Oligoastrocytoma,G2,2013,[Not Available],-20128,Alive,TUMOR FREE,105,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,105,0,105,0,105,0,105,NA,NA,NA,NA,GBM_LGG.Codel,2
-7.84429609,-2.474164103,TCGA-VQ-A8PS-01A,TCGA-VQ-A8PS-01A-11D-A410-08,6,0.414129955,TCGA-VQ-A8PS,STAD,76,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009,[Not Available],-28035,Dead,WITH TUMOR,NA,406,Stomach Cancer,Distant Metastasis,Liver,NA,131,Progressive Disease,1,406,1,406,NA,NA,1,131,NA,Stage IIIA,T3,M0,NA,2
0.24209124,5.012468686,TCGA-TQ-A7RN-01A,TCGA-TQ-A7RN-01A-11D-A33T-08,4,0.643217436,TCGA-TQ-A7RN,LGG,32,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-11823,Alive,WITH TUMOR,1026,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1026,0,1026,NA,NA,0,1026,NA,NA,NA,NA,GBM_LGG.Codel,6
0.126925291,4.897703473,TCGA-TQ-A7RM-01A,TCGA-TQ-A7RM-01A-11D-A33T-08,4,0.612508075,TCGA-TQ-A7RM,LGG,41,FEMALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-15154,Alive,WITH TUMOR,1116,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1116,0,1116,NA,NA,0,1116,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.293465243,4.830748765,TCGA-TQ-A7RK-01A,TCGA-TQ-A7RK-01A-11D-A33T-08,4,0.55424887,TCGA-TQ-A7RK,LGG,29,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-10742,Alive,TUMOR FREE,1341,NA,[Not Available],NA,NA,NA,858,Complete Remission/Response,0,1341,0,1341,1,858,1,858,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.273335423,4.172741079,TCGA-TQ-A7RF-01A,TCGA-TQ-A7RF-01A-11D-A33T-08,4,0.389966667,TCGA-TQ-A7RF,LGG,27,FEMALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-9919,Alive,WITH TUMOR,650,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,650,0,650,NA,NA,0,650,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
2.147280528,1.763043623,TCGA-VQ-A91N-01A,TCGA-VQ-A91N-01A-11D-A410-08,3,0.28594392,TCGA-VQ-A91N,STAD,59,FEMALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009,[Not Available],-21753,Dead,WITH TUMOR,NA,570,Stomach Cancer,Locoregional Recurrence,NA,NA,438,Progressive Disease,1,570,1,570,NA,NA,1,438,NA,Stage IV,T4,M0,GI.CIN,3
-0.146612958,3.976720658,TCGA-P5-A780-01A,TCGA-P5-A780-01A-12D-A32B-08,4,0.447903567,TCGA-P5-A780,LGG,44,FEMALE,WHITE,Astrocytoma,G3,2013,[Not Available],-16161,Alive,TUMOR FREE,72,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,72,0,72,0,72,0,72,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-1.766819138,2.35149247,TCGA-VQ-A91S-01A,TCGA-VQ-A91S-01A-11D-A410-08,0,NA,TCGA-VQ-A91S,STAD,63,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2012,[Not Available],-23187,Alive,TUMOR FREE,1000,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1000,0,1000,0,1000,0,1000,NA,Stage IIIB,T4b,M0,GI.CIN,10
-6.303503196,3.505508637,TCGA-TQ-A7RP-01A,TCGA-TQ-A7RP-01A-21D-A34A-08,11,0.409379865,TCGA-TQ-A7RP,LGG,66,MALE,BLACK OR AFRICAN AMERICAN,Oligoastrocytoma,G2,2012,[Not Available],-24109,Alive,WITH TUMOR,914,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,914,0,914,NA,NA,0,914,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,8
-0.104511056,4.133782075,TCGA-VQ-A923-01A,TCGA-VQ-A923-01A-11D-A410-08,4,0.411627482,TCGA-VQ-A923,STAD,90,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2008,[Not Available],-32873,Dead,TUMOR FREE,NA,61,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,1,61,0,61,0,61,0,61,NA,Stage IIIA,T3,M0,GI.EBV,6
-0.599769098,5.115588652,TCGA-TQ-A7RV-01A,TCGA-TQ-A7RV-01A-21D-A34A-08,4,0.427662328,TCGA-TQ-A7RV,LGG,27,MALE,WHITE,Astrocytoma,G2,2009,[Not Available],-10167,Alive,WITH TUMOR,1868,NA,[Not Available],NA,NA,NA,530,Partial Remission/Response,0,1868,0,1868,NA,NA,1,530,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-1.717874893,1.287939066,TCGA-VQ-A94O-01A,TCGA-VQ-A94O-01A-11D-A410-08,5,0.575297831,TCGA-VQ-A94O,STAD,74,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-27306,Dead,WITH TUMOR,NA,640,Stomach Cancer,Distant Metastasis,Liver,NA,185,Progressive Disease,1,640,1,640,NA,NA,1,185,NA,Stage IIIC,T4a,M0,GI.CIN,4
7.820077244,-1.357473449,TCGA-TQ-A7RU-01A,TCGA-TQ-A7RU-01A-21D-A34A-08,1,0.14227337,TCGA-TQ-A7RU,LGG,51,MALE,WHITE,Oligodendroglioma,G2,2011,[Not Available],-18990,Alive,WITH TUMOR,1032,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1032,0,1032,NA,NA,0,1032,NA,NA,NA,NA,GBM_LGG.Codel,1
-4.332823783,1.600066331,TCGA-VQ-A92D-01A,TCGA-VQ-A92D-01A-11D-A410-08,0,NA,TCGA-VQ-A92D,STAD,67,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009,[Not Available],-24595,Alive,TUMOR FREE,2032,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2032,0,2032,0,2032,0,2032,NA,Stage IB,T2b,M0,GI.CIN,4
9.258038518,-4.679723823,TCGA-TQ-A7RS-01A,TCGA-TQ-A7RS-01A-12D-A33T-08,1,0.744859178,TCGA-TQ-A7RS,LGG,25,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-9172,Alive,TUMOR FREE,-1,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.51348496,5.111542166,TCGA-TQ-A7RR-01A,TCGA-TQ-A7RR-01A-21D-A34A-08,4,0.472093537,TCGA-TQ-A7RR,LGG,38,MALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-14022,Alive,TUMOR FREE,787,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,787,0,787,NA,NA,0,787,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
4.375353613,1.170272723,TCGA-TQ-A7RQ-01A,TCGA-TQ-A7RQ-01A-11D-A33T-08,2,0.588526794,TCGA-TQ-A7RQ,LGG,38,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-14187,Alive,TUMOR FREE,795,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,795,0,795,0,795,0,795,NA,NA,NA,NA,GBM_LGG.Codel,5
-3.927694201,0.456031218,TCGA-VQ-A94R-01A,TCGA-VQ-A94R-01A-11D-A410-08,0,NA,TCGA-VQ-A94R,STAD,63,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-23246,Dead,WITH TUMOR,NA,1294,Stomach Cancer,Locoregional Recurrence,NA,NA,1018,Progressive Disease,1,1294,1,1294,NA,NA,1,1018,NA,[Discrepancy],T4a,M0,GI.CIN,10
-0.47062975,4.674846308,TCGA-VQ-A94U-01A,TCGA-VQ-A94U-01A-12D-A410-08,4,0.361024008,TCGA-VQ-A94U,STAD,70,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2012,[Not Available],-25925,Alive,TUMOR FREE,819,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,819,0,819,0,819,0,819,NA,Stage IIB,T4a,M0,GI.CIN,3
-6.043535334,3.480649949,TCGA-VQ-A94T-01A,TCGA-VQ-A94T-01A-11D-A410-08,11,0.570279902,TCGA-VQ-A94T,STAD,73,MALE,[Unknown],"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-26702,Dead,WITH TUMOR,NA,342,[Not Available],Locoregional Recurrence,NA,NA,296,Progressive Disease,1,342,1,342,NA,NA,1,296,NA,Stage IIIB,T3,M0,GI.CIN,8
-4.408052019,1.651477108,TCGA-VQ-AA64-01A,TCGA-VQ-AA64-01A-11D-A410-08,0,NA,TCGA-VQ-AA64,STAD,68,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-25109,Dead,WITH TUMOR,NA,560,Stomach Cancer,NA,NA,NA,NA,[Unknown],1,560,1,560,NA,NA,1,560,NA,Stage IIIB,T3,M0,GI.CIN,9
0.01718822,5.133517366,TCGA-VQ-AA6A-01A,TCGA-VQ-AA6A-01A-11D-A410-08,4,0.621820319,TCGA-VQ-AA6A,STAD,56,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012,[Not Available],-20764,Alive,TUMOR FREE,1184,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1184,0,1184,0,1184,0,1184,NA,Stage IIIC,T4,M0,GI.CIN,6
-7.159585746,2.511890157,TCGA-VQ-AA69-01A,TCGA-VQ-AA69-01A-11D-A410-08,0,NA,TCGA-VQ-AA69,STAD,35,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-13087,Alive,TUMOR FREE,864,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,864,0,864,0,864,0,864,NA,Stage IIIA,T3,M0,GI.EBV,7
-7.971103485,1.97506395,TCGA-BH-A0W3-01A,TCGA-BH-A0W3-01A-11D-A10G-09,9,0.539676513,TCGA-BH-A0W3,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Indeterminate (neither Pre or Postmenopausal),-21369,Alive,TUMOR FREE,728,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,728,0,728,NA,NA,0,728,NA,Stage IIA,T1c,M0,BRCA.LumB,7
-7.542957123,2.206917501,TCGA-AA-A01C-01A,TCGA-AA-A01C-01A-01W-A00E-09,9,0.351748891,TCGA-AA-A01C,COAD,75,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27729,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,457,0,457,NA,NA,0,457,NA,Stage IIIA,T2,M0,NA,7
-2.931156789,-4.060781338,TCGA-AA-3510-01A,TCGA-AA-3510-01A-01D-1408-10,8,0.108113021,TCGA-AA-3510,COAD,70,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-25902,Alive,TUMOR FREE,1946,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1946,0,1946,0,1946,0,1946,NA,Stage II,T3,M0,GI.HM-SNV,10
-5.782564134,1.675593223,TCGA-D5-6538-01A,TCGA-D5-6538-01A-11D-1719-10,0,NA,TCGA-D5-6538,COAD,79,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29194,Alive,TUMOR FREE,521,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,521,0,521,NA,NA,0,521,NA,Stage IIIB,T3,M0,GI.CIN,9
-3.228882351,-3.21377199,TCGA-AU-6004-01A,TCGA-AU-6004-01A-11D-1719-10,8,0.582093835,TCGA-AU-6004,COAD,69,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-25259,Alive,TUMOR FREE,824,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,824,0,824,NA,NA,0,824,NA,Stage I,T2,M0,GI.HM-indel,10
9.188742044,-4.43423008,TCGA-VQ-AA6F-01A,TCGA-VQ-AA6F-01A-31D-A410-08,1,0.781752492,TCGA-VQ-AA6F,STAD,57,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010,[Not Available],-21170,Alive,TUMOR FREE,1646,NA,[Not Available],Locoregional Recurrence|New Primary Tumor,"Other, specify",NA,546,Progressive Disease,0,1646,0,1646,NA,NA,1,546,NA,Stage IIB,T3,M0,GI.CIN,1
-3.38526985,-3.209197935,TCGA-VQ-AA6D-01A,TCGA-VQ-AA6D-01A-11D-A410-08,8,0.636348442,TCGA-VQ-AA6D,STAD,52,FEMALE,[Unknown],"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2013,[Not Available],-19090,Alive,TUMOR FREE,521,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,521,0,521,0,521,0,521,NA,Stage IIIA,T4a,M0,GI.HM-indel,10
-4.378821881,-1.575552151,TCGA-BS-A0TA-01A,TCGA-BS-A0TA-01A-11D-A10B-09,8,0.268812783,TCGA-BS-A0TA,UCEC,58,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21505,Dead,WITH TUMOR,NA,740,[Not Available],NA,NA,NA,394,Stable Disease,1,740,1,740,NA,NA,1,394,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.416894572,2.977561785,TCGA-VQ-AA6I-01A,TCGA-VQ-AA6I-01A-11D-A410-08,4,0.094609776,TCGA-VQ-AA6I,STAD,68,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-25091,Dead,WITH TUMOR,NA,491,Stomach Cancer,Locoregional Recurrence,NA,NA,475,Progressive Disease,1,491,1,491,NA,NA,1,475,NA,Stage IIIB,T3,M0,GI.CIN,3
-7.231510604,1.606543101,TCGA-DM-A28C-01A,TCGA-DM-A28C-01A-11D-A16V-10,0,NA,TCGA-DM-A28C,COAD,74,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-27073,Dead,NA,2475,2475,[Not Available],NA,NA,NA,1929,[Not Available],1,2475,NA,2475,NA,NA,1,1929,NA,Stage IIA,T3,M0,GI.GS,7
-5.086888486,1.722715813,TCGA-AA-A02W-01A,TCGA-AA-A02W-01A-01W-A00E-09,0,NA,TCGA-AA-A02W,COAD,73,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-26693,Alive,TUMOR FREE,1247,NA,[Not Available],NA,NA,NA,1005,Complete Remission/Response,0,1247,0,1247,1,1005,1,1005,NA,Stage I,T2,M0,NA,8
-4.982899237,1.860919134,TCGA-AA-3502-01A,TCGA-AA-3502-01A-01D-1408-10,0,NA,TCGA-AA-3502,COAD,73,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2003,[Not Available],-26724,Alive,WITH TUMOR,1065,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1065,0,1065,0,1065,0,1065,NA,Stage I,T2,M0,GI.GS,9
-2.920824267,-4.0673459,TCGA-D5-6928-01A,TCGA-D5-6928-01A-11D-1924-10,8,0.055171722,TCGA-D5-6928,COAD,80,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-29411,Alive,TUMOR FREE,354,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,354,0,354,NA,NA,0,354,NA,Stage IIA,T3,M0,GI.HM-indel,10
-7.918706301,1.952013677,TCGA-E2-A1L6-01A,TCGA-E2-A1L6-01A-11D-A13L-09,9,0.654172912,TCGA-E2-A1L6,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16403,Alive,TUMOR FREE,1648,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1648,0,1648,0,1648,0,1648,NA,Stage IIA,T1c,M0,BRCA.LumA,7
-5.664092028,2.658703719,TCGA-CA-5796-01A,TCGA-CA-5796-01A-01D-1650-10,0,NA,TCGA-CA-5796,COAD,52,FEMALE,ASIAN,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-19353,Alive,TUMOR FREE,377,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,377,0,377,0,377,0,377,NA,Stage IIA,T3,M0,GI.GS,8
4.142983522,1.256346383,TCGA-E2-A14T-01A,TCGA-E2-A14T-01A-11D-A10Y-09,2,0.444552521,TCGA-E2-A14T,BRCA,52,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19237,Alive,TUMOR FREE,2311,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2311,0,2311,0,2311,0,2311,NA,Stage IIA,T2,M0,BRCA.LumA,5
-6.642381371,-1.240170888,TCGA-BH-A1ET-01A,TCGA-BH-A1ET-01A-11D-A135-09,7,0.162860359,TCGA-BH-A1ET,BRCA,55,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-20425,Dead,TUMOR FREE,NA,2520,[Not Available],NA,NA,NA,NA,[Not Available],1,2520,0,2520,NA,NA,0,2520,NA,Stage I,T1,M0,BRCA.LumA,2
-3.46540213,-3.169323992,TCGA-AJ-A23O-01A,TCGA-AJ-A23O-01A-11D-A159-09,8,0.610659898,TCGA-AJ-A23O,UCEC,69,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25433,Dead,TUMOR FREE,NA,312,[Not Available],NA,NA,NA,NA,[Not Available],1,312,0,312,NA,NA,0,312,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-3.308586475,-3.444927207,TCGA-D1-A15X-01A,TCGA-D1-A15X-01A-11D-A122-09,8,0.519400423,TCGA-D1-A15X,UCEC,45,FEMALE,WHITE,Serous endometrial adenocarcinoma,High Grade,2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16532,Alive,TUMOR FREE,909,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,909,0,909,0,909,0,909,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,10
-7.217542306,1.436984205,TCGA-A8-A06R-01A,TCGA-A8-A06R-01A-11D-A015-09,0,NA,TCGA-A8-A06R,BRCA,69,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477,Alive,TUMOR FREE,547,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,547,0,547,0,547,0,547,NA,Stage IIB,T2,M0,BRCA.LumB,7
-6.025146602,3.477837735,TCGA-XF-A9SU-01A,TCGA-XF-A9SU-01A-31D-A391-08,11,0.555837514,TCGA-XF-A9SU,BLCA,74,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-27068,Dead,WITH TUMOR,NA,182,[Not Available],Distant Metastasis,Liver,NA,103,Progressive Disease,1,182,1,182,NA,NA,1,103,NA,Stage IV,T3b,MX,NA,8
-7.73963633,1.857773483,TCGA-E2-A15L-01A,TCGA-E2-A15L-01A-11D-A12B-09,9,0.368089722,TCGA-E2-A15L,BRCA,65,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23845,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,626,0,626,0,626,0,626,NA,Stage IIA,T2,M0,BRCA.LumA,7
-6.400943555,1.627158906,TCGA-AR-A1AW-01A,TCGA-AR-A1AW-01A-21D-A12Q-09,10,0.180484706,TCGA-AR-A1AW,BRCA,65,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23855,Alive,TUMOR FREE,2632,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2632,0,2632,0,2632,0,2632,NA,Stage IIA,T2,M0,BRCA.LumB,7
0.458122239,2.20956731,TCGA-EW-A2FW-01A,TCGA-EW-A2FW-01A-11D-A17D-09,0,NA,TCGA-EW-A2FW,BRCA,52,FEMALE,WHITE,"Other, specify",[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19085,Alive,TUMOR FREE,672,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,672,0,672,0,672,0,672,NA,Stage IIA,T2,MX,BRCA.LumB,6
-3.175239283,-3.388553346,TCGA-AA-3949-01A,TCGA-AA-3949-01A-01W-0995-10,8,0.566185152,TCGA-AA-3949,COAD,87,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-32081,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,791,0,791,0,791,0,791,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-5.086761193,1.618710014,TCGA-AA-3660-01A,TCGA-AA-3660-01A-01D-1719-10,0,NA,TCGA-AA-3660,COAD,51,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-18932,Alive,TUMOR FREE,2375,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2375,0,2375,0,2375,0,2375,NA,Stage II,T3,M0,GI.CIN,10
9.236251434,-1.442027762,TCGA-BH-A0DS-01A,TCGA-BH-A0DS-01A-11W-A071-09,1,0.652459527,TCGA-BH-A0DS,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25944,Alive,TUMOR FREE,78,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,78,0,78,0,78,0,78,NA,Stage IIIA,T2,M0,BRCA.LumA,6
-6.210255043,2.423095521,TCGA-FF-8046-01A,TCGA-FF-8046-01A-11D-2210-10,0,NA,TCGA-FF-8046,DLBC,51,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011,[Not Available],-18853,Alive,TUMOR FREE,751,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,751,0,751,0,751,0,751,NA,NA,NA,NA,NA,8
-6.972216431,-2.29655115,TCGA-FF-8043-01A,TCGA-FF-8043-01A-11D-2210-10,6,0.242553672,TCGA-FF-8043,DLBC,70,FEMALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010,[Not Available],-25612,Alive,TUMOR FREE,965,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,965,0,965,0,965,0,965,NA,NA,NA,NA,NA,2
1.717227951,1.998723839,TCGA-FF-8062-01A,TCGA-FF-8062-01A-11D-2210-10,3,0.312565636,TCGA-FF-8062,DLBC,60,FEMALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2011,[Not Available],-21959,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,679,0,679,0,679,0,679,NA,NA,NA,NA,NA,3
-5.428037469,-2.034499115,TCGA-FF-8042-01A,TCGA-FF-8042-01A-11D-2210-10,0,NA,TCGA-FF-8042,DLBC,57,FEMALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010,[Not Available],-21005,Alive,TUMOR FREE,946,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,946,0,946,0,946,0,946,NA,NA,NA,NA,NA,10
-2.940794566,1.188536493,TCGA-FF-8061-01A,TCGA-FF-8061-01A-11D-2210-10,0,NA,TCGA-FF-8061,DLBC,42,MALE,ASIAN,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2010,[Not Available],-15358,Alive,TUMOR FREE,832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,832,0,832,0,832,0,832,NA,NA,NA,NA,NA,4
8.886899508,-5.132232726,TCGA-AR-A1AU-01A,TCGA-AR-A1AU-01A-11D-A12Q-09,1,0.7610783,TCGA-AR-A1AU,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14564,Alive,TUMOR FREE,2868,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2868,0,2868,0,2868,0,2868,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-3.853970168,-2.431564822,TCGA-B7-A5TI-01A,TCGA-B7-A5TI-01A-11D-A31L-08,8,0.43804001,TCGA-B7-A5TI,STAD,52,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012,[Not Available],-19014,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,595,0,595,0,595,0,595,NA,Stage IIIC,T4,M0,GI.HM-indel,10
-6.297926077,1.717711009,TCGA-HC-A9TH-01A,TCGA-HC-A9TH-01A-11D-A41K-08,10,0.398303883,TCGA-HC-A9TH,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-21460,Alive,WITH TUMOR,844,NA,[Not Available],Biochemical evidence of disease,"Other, specify",Biochemical,351,Partial Remission/Response,0,844,0,844,NA,NA,1,351,NA,[Not Applicable],T3b,[Not Applicable],NA,7
-5.382024316,2.083159411,TCGA-B7-A5TJ-01A,TCGA-B7-A5TJ-01A-11D-A31L-08,0,NA,TCGA-B7-A5TJ,STAD,74,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2012,[Not Available],-27057,Alive,TUMOR FREE,335,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,335,0,335,0,335,0,335,NA,Stage IIB,T4a,M0,GI.CIN,9
8.729374669,-4.801308974,TCGA-HC-A9TE-01A,TCGA-HC-A9TE-01A-11D-A41K-08,1,0.804311964,TCGA-HC-A9TE,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23543,Alive,WITH TUMOR,587,NA,[Not Available],Biochemical evidence of disease,"Other, specify",Biochemical,216,Partial Remission/Response,0,587,0,587,NA,NA,1,216,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-8.137285563,2.021001985,TCGA-BH-A0BQ-01A,TCGA-BH-A0BQ-01A-21D-A10Y-09,9,0.547805506,TCGA-BH-A0BQ,BRCA,39,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14494,Alive,TUMOR FREE,2255,NA,[Not Available],Locoregional Recurrence,"Other, specify",Dermis and epidermis,1709,[Not Available],0,2255,0,2255,1,1709,1,1709,NA,Stage I,T1c,M0,BRCA.LumA,7
-7.589776916,-2.09923223,TCGA-KB-A93G-01A,TCGA-KB-A93G-01A-11D-A397-08,6,0.2897561,TCGA-KB-A93G,STAD,68,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G1,2013,[Not Available],-24924,Alive,TUMOR FREE,613,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,613,0,613,0,613,0,613,NA,Stage IB,T2,M0,NA,2
-1.316139208,4.214372466,TCGA-KB-A93J-01A,TCGA-KB-A93J-01A-11D-A397-08,4,0.333701531,TCGA-KB-A93J,STAD,78,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2008,[Not Available],-28599,Alive,NA,1124,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1124,0,1124,0,1124,0,1124,NA,Stage II,T2b,M0,GI.CIN,6
-3.088010149,1.015356551,TCGA-55-7913-01B,TCGA-55-7913-01B-11D-2238-08,0,NA,TCGA-55-7913,LUAD,61,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22326,Dead,WITH TUMOR,NA,561,[Not Available],Distant Metastasis,NA,NA,480,Complete Remission/Response,1,561,1,561,1,480,1,480,NA,Stage IA,T1b,MX,NA,10
8.906536943,-5.252442183,TCGA-IN-AB1V-01A,TCGA-IN-AB1V-01A-21D-A410-08,1,0.774278682,TCGA-IN-AB1V,STAD,63,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013,[Not Available],-23030,Alive,TUMOR FREE,479,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,479,0,479,0,479,0,479,NA,Stage IA,T1b,M0,GI.CIN,1
10.00680989,-2.117785097,TCGA-Y6-A9XI-01A,TCGA-Y6-A9XI-01A-11D-A41K-08,1,0.835780364,TCGA-Y6-A9XI,PRAD,72,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-26471,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,526,0,526,0,526,0,526,NA,[Not Applicable],[Discrepancy],[Not Applicable],NA,1
9.227344774,-5.160191087,TCGA-XQ-A8TB-01A,TCGA-XQ-A8TB-01A-11D-A364-08,1,0.843904969,TCGA-XQ-A8TB,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24623,Alive,TUMOR FREE,770,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,770,0,770,0,770,0,770,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-6.488299801,-1.310973325,TCGA-XQ-A8TA-01A,TCGA-XQ-A8TA-01A-11D-A364-08,7,0.309800345,TCGA-XQ-A8TA,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-21889,Dead,WITH TUMOR,NA,146,Prostate Cancer,NA,NA,NA,NA,Progressive Disease,1,146,1,146,NA,NA,1,146,NA,[Not Applicable],[Not Available],[Not Applicable],PRAD.3-ETV4,2
-2.576664701,1.100213257,TCGA-FP-A9TM-01A,TCGA-FP-A9TM-01A-11D-A397-08,5,0.055212508,TCGA-FP-A9TM,STAD,77,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013,[Not Available],-28376,Alive,TUMOR FREE,189,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,189,0,189,0,189,0,189,NA,[Discrepancy],T1b,M0,GI.CIN,4
-0.539828182,4.741747517,TCGA-J9-A8CK-01A,TCGA-J9-A8CK-01A-11D-A34U-08,4,0.48115478,TCGA-J9-A8CK,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24285,Alive,TUMOR FREE,321,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,321,0,321,NA,NA,0,321,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,6
-7.385056674,2.89286517,TCGA-B7-A5TK-01A,TCGA-B7-A5TK-01A-12D-A31L-08,9,0.017402887,TCGA-B7-A5TK,STAD,51,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-18750,Alive,TUMOR FREE,288,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,288,0,288,0,288,0,288,NA,Stage IIIA,T4,M0,GI.EBV,7
-0.694769451,4.612236758,TCGA-GM-A2DB-01A,TCGA-GM-A2DB-01A-31D-A19Y-09,4,0.523149022,TCGA-GM-A2DB,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22883,Alive,TUMOR FREE,2406,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2406,0,2406,0,2406,0,2406,NA,Stage IIA,T2,M0,BRCA.Her2,6
-1.767000484,3.372929628,TCGA-R5-A7O7-01A,TCGA-R5-A7O7-01A-11D-A33T-08,0,NA,TCGA-R5-A7O7,STAD,51,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010,[Not Available],-18984,Alive,TUMOR FREE,1389,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1389,0,1389,NA,NA,0,1389,NA,Stage IV,T3,M1,GI.CIN,6
0.131268921,5.017471596,TCGA-E1-A7YL-01A,TCGA-E1-A7YL-01A-11D-A34A-08,4,0.616777659,TCGA-E1-A7YL,LGG,46,MALE,WHITE,Astrocytoma,G3,2009,[Not Available],-16982,Dead,WITH TUMOR,NA,492,[Not Available],NA,NA,NA,91,Progressive Disease,1,492,1,492,NA,NA,1,91,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
8.938790866,-2.048333705,TCGA-E1-A7YJ-01A,TCGA-E1-A7YJ-01A-11D-A34A-08,1,0.640397218,TCGA-E1-A7YJ,LGG,55,MALE,WHITE,Astrocytoma,G3,2008,[Not Available],-20180,Dead,WITH TUMOR,NA,592,[Not Available],NA,NA,NA,516,Stable Disease,1,592,1,592,NA,NA,1,516,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-0.075171759,4.466739208,TCGA-EW-A1P4-01A,TCGA-EW-A1P4-01A-21D-A142-09,4,0.529212718,TCGA-EW-A1P4,BRCA,43,FEMALE,WHITE,Medullary Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15989,Alive,TUMOR FREE,907,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,907,0,907,0,907,0,907,NA,Stage IIA,T2,M0,BRCA.Basal,6
9.812425835,-3.694203284,TCGA-B9-A5W9-01A,TCGA-B9-A5W9-01A-11D-A28G-10,1,0.66525653,TCGA-B9-A5W9,KIRP,40,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-14668,Alive,TUMOR FREE,5,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,5,0,5,0,5,0,5,NA,Stage I,T1b,MX,KIRP.C1,1
8.94860872,-4.07126121,TCGA-B0-5100-01A,TCGA-B0-5100-01A-01D-1421-08,1,0.718276163,TCGA-B0-5100,KIRC,72,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,1998,[Not Available],-26478,Dead,WITH TUMOR,NA,1913,[Not Available],NA,NA,NA,1426,[Not Available],1,1913,1,1913,NA,NA,1,1426,NA,Stage III,T3a,M0,KIRC.3,1
9.285437368,-2.752746467,TCGA-HE-A5NF-01A,TCGA-HE-A5NF-01A-11D-A26P-10,1,0.75249135,TCGA-HE-A5NF,KIRP,58,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-21524,Alive,TUMOR FREE,2582,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2582,0,2582,0,2582,0,2582,NA,Stage I,T1a,[Not Available],KIRP.C1,1
4.09287946,0.840524228,TCGA-B9-A69E-01A,TCGA-B9-A69E-01A-11D-A31X-10,2,0.406153623,TCGA-B9-A69E,KIRP,71,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-26198,Alive,TUMOR FREE,452,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,452,0,452,0,452,0,452,NA,Stage III,T3a,[Not Available],KIRP.C2a,1
0.013644569,5.335168668,TCGA-25-1319-01A,TCGA-25-1319-01A-01D-0452-01,4,0.553724552,TCGA-25-1319,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-26786,Dead,NA,1977,1977,[Not Available],Recurrence,[Not Applicable],[Not Applicable],730,[Not Available],1,1977,NA,1977,NA,NA,1,730,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
0.05119483,4.134969346,TCGA-A4-A57E-01A,TCGA-A4-A57E-01A-11D-A26P-10,4,0.437643589,TCGA-A4-A57E,KIRP,59,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-21885,Dead,WITH TUMOR,NA,258,[Not Available],NA,NA,NA,NA,Progressive Disease,1,258,1,258,NA,NA,1,258,NA,Stage IV,T2a,M1,KIRP.C2a,6
10.0631147,-2.950834714,TCGA-CZ-5986-01A,TCGA-CZ-5986-01A-11D-1669-08,1,0.668589097,TCGA-CZ-5986,KIRC,61,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-22456,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,373,0,373,NA,NA,0,373,NA,Stage I,T1,M0,KIRC.1,1
4.246756292,1.172925673,TCGA-IZ-A6M9-01A,TCGA-IZ-A6M9-01A-11D-A31X-10,2,0.447922167,TCGA-IZ-A6M9,KIRP,63,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-23149,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,376,0,376,0,376,0,376,NA,Stage I,T1a,MX,KIRP.C1,5
-6.805555304,1.353106095,TCGA-A3-3376-01A,TCGA-A3-3376-01A-02D-1421-08,0,NA,TCGA-A3-3376,KIRC,51,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-18954,Dead,TUMOR FREE,NA,1696,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1696,0,1696,0,1696,0,1696,NA,Stage I,T1a,M0,KIRC.NA,7
7.739085395,-3.408694923,TCGA-PJ-A5Z9-01A,TCGA-PJ-A5Z9-01A-11D-A28G-10,1,0.318178442,TCGA-PJ-A5Z9,KIRP,80,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-29365,Alive,TUMOR FREE,540,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,540,0,540,0,540,0,540,NA,Stage I,T1b,MX,KIRP.C1,1
7.870537164,-4.347968939,TCGA-A4-8310-01A,TCGA-A4-8310-01A-11D-2396-08,0,NA,TCGA-A4-8310,KIRP,58,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-21312,Alive,TUMOR FREE,780,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,780,0,780,0,780,0,780,NA,Stage III,T3a,MX,KIRP.C1,1
4.405797886,1.036670343,TCGA-B9-A5W8-01A,TCGA-B9-A5W8-01A-11D-A28G-10,2,0.547354911,TCGA-B9-A5W8,KIRP,50,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-18440,Alive,TUMOR FREE,524,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,524,0,524,0,524,0,524,NA,Stage II,T2b,M0,KIRP.C2a,5
0.312012319,3.392484775,TCGA-CZ-5463-01A,TCGA-CZ-5463-01A-01D-1501-10,4,0.29315936,TCGA-CZ-5463,KIRC,76,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-27911,Alive,NA,662,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,662,0,662,NA,NA,0,662,NA,Stage II,T2,M0,KIRC.1,3
8.920121155,-3.047540379,TCGA-CZ-5984-01A,TCGA-CZ-5984-01A-11D-1669-08,1,0.67752787,TCGA-CZ-5984,KIRC,51,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-18775,Alive,TUMOR FREE,2067,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2067,0,2067,NA,NA,0,2067,NA,Stage I,T1b,M0,KIRC.4,1
0.113945699,5.18778422,TCGA-23-2072-01A,TCGA-23-2072-01A-01W-0722-08,4,0.561105356,TCGA-23-2072,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-21523,Dead,WITH TUMOR,NA,759,[Not Available],Recurrence,[Not Applicable],[Not Applicable],476,Complete Remission/Response,1,759,1,759,NA,NA,1,476,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
9.123895624,-5.384020168,TCGA-BP-5174-01A,TCGA-BP-5174-01A-01D-1429-08,1,0.827623931,TCGA-BP-5174,KIRC,45,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-16693,Alive,TUMOR FREE,2257,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2257,0,2257,NA,NA,0,2257,NA,Stage I,T1a,M0,KIRC.4,1
9.593247764,-4.592412223,TCGA-B0-5083-01A,TCGA-B0-5083-01A-02D-1421-08,1,0.756288199,TCGA-B0-5083,KIRC,63,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-23034,Dead,WITH TUMOR,NA,1045,[Not Available],NA,NA,NA,NA,[Not Available],1,1045,1,1045,NA,NA,1,1045,NA,Stage I,T1a,M0,NA,1
0.251686282,3.549641566,TCGA-36-2533-01A,TCGA-36-2533-01A-01D-1526-09,4,0.201682173,TCGA-36-2533,OV,55,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2007,[Not Available],-20187,NA,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,NA,NA,NA,NA,0,NA,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
10.01914168,-1.905830337,TCGA-B0-5399-01A,TCGA-B0-5399-01A-01D-1501-10,1,0.830678672,TCGA-B0-5399,KIRC,46,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-17145,Alive,TUMOR FREE,1411,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1411,0,1411,0,1411,0,1411,NA,Stage I,T1b,M0,KIRC.4,1
9.452424533,-4.135499629,TCGA-BP-5185-01A,TCGA-BP-5185-01A-01D-1429-08,1,0.739393063,TCGA-BP-5185,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-20470,Alive,WITH TUMOR,1132,NA,[Not Available],NA,NA,NA,736,[Not Available],0,1132,0,1132,NA,NA,1,736,NA,Stage I,T1a,M0,KIRC.NA,1
4.318050901,1.142252781,TCGA-B0-5703-01A,TCGA-B0-5703-01A-11D-1534-10,2,0.669840554,TCGA-B0-5703,KIRC,73,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2009,[Not Available],-26897,Alive,TUMOR FREE,2246,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2246,0,2246,0,2246,0,2246,NA,Stage I,T1b,M0,KIRC.2,5
-0.121184704,5.126094257,TCGA-FG-A4MX-01A,TCGA-FG-A4MX-01A-11D-A26M-08,4,0.491392955,TCGA-FG-A4MX,LGG,47,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-17381,Alive,TUMOR FREE,569,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,569,0,569,0,569,0,569,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.091838706,-5.406880535,TCGA-DB-A64R-01A,TCGA-DB-A64R-01A-11D-A29Q-08,1,0.864599374,TCGA-DB-A64R,LGG,24,FEMALE,[Not Evaluated],Oligodendroglioma,G2,2012,[Not Available],-8947,Alive,TUMOR FREE,955,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,955,0,955,0,955,0,955,NA,NA,NA,NA,GBM_LGG.Codel,1
0.991745393,3.651928222,TCGA-HT-8563-01A,TCGA-HT-8563-01A-11D-2395-08,0,NA,TCGA-HT-8563,LGG,30,FEMALE,WHITE,Astrocytoma,G3,2011,[Not Available],-11305,Alive,TUMOR FREE,860,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,860,0,860,0,860,0,860,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.826707163,-4.689222758,TCGA-DB-A64P-01A,TCGA-DB-A64P-01A-11D-A29Q-08,1,0.816869557,TCGA-DB-A64P,LGG,40,MALE,WHITE,Oligodendroglioma,G3,2012,[Not Available],-14936,Alive,TUMOR FREE,916,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,916,0,916,0,916,0,916,NA,NA,NA,NA,GBM_LGG.Codel,1
1.04666558,3.519824209,TCGA-29-1705-01A,TCGA-29-1705-01A-01W-0633-09,0,NA,TCGA-29-1705,OV,47,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2005,[Not Available],-17530,Dead,WITH TUMOR,555,555,[Not Available],Recurrence,[Not Applicable],[Not Applicable],283,Complete Remission/Response,1,555,1,555,1,283,1,283,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,1
0.53072737,2.166935653,TCGA-HT-A5RA-01A,TCGA-HT-A5RA-01A-11D-A289-08,0,NA,TCGA-HT-A5RA,LGG,65,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-23769,Alive,WITH TUMOR,832,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,832,0,832,NA,NA,0,832,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,6
9.599961097,-3.154787989,TCGA-FG-A6J1-01A,TCGA-FG-A6J1-01A-11D-A31L-08,1,0.737568384,TCGA-FG-A6J1,LGG,44,FEMALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-16106,Alive,WITH TUMOR,500,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,500,0,500,NA,NA,0,500,NA,NA,NA,NA,GBM_LGG.Codel,1
-3.429012468,-2.845150934,TCGA-AP-A1DO-01A,TCGA-AP-A1DO-01A-11D-A135-09,8,0.370451348,TCGA-AP-A1DO,UCEC,62,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22787,Alive,TUMOR FREE,952,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,952,0,952,0,952,0,952,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.806526302,-3.566181399,TCGA-HT-7681-01A,TCGA-HT-7681-01A-11D-2395-08,1,0.648305443,TCGA-HT-7681,LGG,29,FEMALE,WHITE,Oligoastrocytoma,G2,2009,[Not Available],-10790,Alive,TUMOR FREE,1359,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1359,0,1359,0,1359,0,1359,NA,NA,NA,NA,GBM_LGG.Codel,1
0.260989523,4.425922394,TCGA-FG-A6IZ-01A,TCGA-FG-A6IZ-01A-11D-A31L-08,4,0.19979897,TCGA-FG-A6IZ,LGG,60,MALE,WHITE,Oligodendroglioma,G2,2013,[Not Available],-22275,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,457,0,457,0,457,0,457,NA,NA,NA,NA,GBM_LGG.Codel,1
-0.037983075,4.89476292,TCGA-HT-7676-01A,TCGA-HT-7676-01A-11D-2395-08,4,0.609730315,TCGA-HT-7676,LGG,26,MALE,WHITE,Oligodendroglioma,G2,2009,[Not Available],-9667,Alive,TUMOR FREE,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5,0,5,NA,NA,0,5,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.553164792,4.276339151,TCGA-25-2396-01A,TCGA-25-2396-01A-01W-0799-08,4,0.357309876,TCGA-25-2396,OV,71,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-26145,Dead,NA,92,92,[Not Available],NA,NA,NA,NA,[Not Available],1,92,NA,92,NA,NA,0,92,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,5
0.080180018,5.115063446,TCGA-DH-A66D-01A,TCGA-DH-A66D-01A-11D-A31L-08,4,0.534715258,TCGA-DH-A66D,LGG,43,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-15866,Alive,WITH TUMOR,846,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,846,0,846,NA,NA,0,846,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
8.88088725,-1.991129087,TCGA-DU-A5TY-01A,TCGA-DU-A5TY-01A-11D-A289-08,1,0.623080708,TCGA-DU-A5TY,LGG,46,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-16945,Dead,WITH TUMOR,NA,1033,[Not Available],NA,NA,NA,526,[Discrepancy],1,1033,1,1033,NA,NA,1,526,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-0.00258307,5.289088495,TCGA-DU-A5TU-01A,TCGA-DU-A5TU-01A-11D-A289-08,4,0.711212204,TCGA-DU-A5TU,LGG,62,FEMALE,WHITE,Astrocytoma,G2,2013,[Not Available],-22811,Alive,WITH TUMOR,796,NA,[Not Available],NA,NA,NA,186,Progressive Disease,0,796,0,796,NA,NA,1,186,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-1.446103435,4.30530261,TCGA-DB-A64X-01A,TCGA-DB-A64X-01A-11D-A29Q-08,4,0.216584022,TCGA-DB-A64X,LGG,56,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-20625,Alive,TUMOR FREE,563,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,563,0,563,NA,NA,0,563,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-8.164921042,1.949128723,TCGA-DB-A64V-01A,TCGA-DB-A64V-01A-11D-A29Q-08,9,0.465435476,TCGA-DB-A64V,LGG,54,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-19950,Alive,TUMOR FREE,889,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,889,0,889,NA,NA,0,889,NA,NA,NA,NA,GBM_LGG.Codel,7
-5.826987855,1.677118784,TCGA-A5-A3LO-01A,TCGA-A5-A3LO-01A-11D-A228-09,10,0.180659758,TCGA-A5-A3LO,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23401,Alive,TUMOR FREE,776,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,776,0,776,0,776,0,776,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
0.282753975,3.531515514,TCGA-DU-A5TW-01A,TCGA-DU-A5TW-01A-11D-A289-08,4,0.234800918,TCGA-DU-A5TW,LGG,33,FEMALE,BLACK OR AFRICAN AMERICAN,Astrocytoma,G3,2012,[Not Available],-12107,Alive,WITH TUMOR,760,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,760,0,760,NA,NA,0,760,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
-6.125533148,3.574860346,TCGA-24-2038-01A,TCGA-24-2038-01A-01W-0722-08,11,0.570094672,TCGA-24-2038,OV,68,FEMALE,WHITE,Serous Cystadenocarcinoma,GB,2000,[Not Available],-24957,Dead,WITH TUMOR,1354,1354,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1169,Complete Remission/Response,1,1354,1,1354,1,1169,1,1169,NA,Stage IIIA,[Not Applicable],[Not Applicable],OVCA.Differentiated,8
-5.370433875,1.172806433,TCGA-25-2398-01A,TCGA-25-2398-01A-01D-0704-01,0,NA,TCGA-25-2398,OV,71,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-26267,Dead,WITH TUMOR,1369,1369,[Not Available],Recurrence,[Not Applicable],[Not Applicable],577,Complete Remission/Response,1,1369,1,1369,1,577,1,577,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
8.997097665,-5.233113379,TCGA-FG-A60L-01A,TCGA-FG-A60L-01A-12D-A31L-08,1,0.830651707,TCGA-FG-A60L,LGG,34,FEMALE,WHITE,Astrocytoma,G2,2012,[Not Available],-12580,Alive,TUMOR FREE,655,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,655,0,655,0,655,0,655,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
0.000409975,5.261926468,TCGA-DH-A66B-01A,TCGA-DH-A66B-01A-11D-A29Q-08,4,0.605115172,TCGA-DH-A66B,LGG,52,MALE,WHITE,Astrocytoma,G3,2010,[Not Available],-19156,Alive,WITH TUMOR,1279,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1279,0,1279,NA,NA,0,1279,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-7.629636038,2.042244691,TCGA-DB-A64W-01A,TCGA-DB-A64W-01A-11D-A29Q-08,9,0.389310993,TCGA-DB-A64W,LGG,65,FEMALE,WHITE,Oligoastrocytoma,G3,2012,[Not Available],-23936,Dead,TUMOR FREE,NA,438,[Not Available],NA,NA,NA,NA,Stable Disease,1,438,0,438,NA,NA,0,438,NA,NA,NA,NA,GBM_LGG.Codel,7
-7.120984253,1.694270016,TCGA-BS-A0UT-01A,TCGA-BS-A0UT-01A-11D-A10B-09,0,NA,TCGA-BS-A0UT,UCEC,62,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22775,Alive,TUMOR FREE,2212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2212,0,2212,0,2212,0,2212,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.CN low,7
-8.098628207,1.851144214,TCGA-DU-A5TT-01A,TCGA-DU-A5TT-01A-11D-A289-08,9,0.546800503,TCGA-DU-A5TT,LGG,70,MALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-25726,Alive,WITH TUMOR,743,NA,[Not Available],NA,NA,NA,584,[Discrepancy],0,743,0,743,NA,NA,1,584,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
0.526538967,4.943915945,TCGA-DU-A5TR-01A,TCGA-DU-A5TR-01A-11D-A289-08,4,0.559136554,TCGA-DU-A5TR,LGG,51,MALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-18791,Alive,TUMOR FREE,908,NA,[Not Available],NA,NA,NA,848,[Discrepancy],0,908,0,908,NA,NA,1,848,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.325902859,5.101464183,TCGA-DB-A4XC-01A,TCGA-DB-A4XC-01A-11D-A26M-08,4,0.610909734,TCGA-DB-A4XC,LGG,26,MALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-9705,Alive,TUMOR FREE,1421,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1421,0,1421,NA,NA,0,1421,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.038306834,5.223904637,TCGA-DB-A4XD-01A,TCGA-DB-A4XD-01A-11D-A27K-08,4,0.660019219,TCGA-DB-A4XD,LGG,32,MALE,WHITE,Astrocytoma,G3,2010,[Not Available],-11741,Alive,TUMOR FREE,1210,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1210,0,1210,0,1210,0,1210,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.119735015,4.817975374,TCGA-DU-A5TP-01A,TCGA-DU-A5TP-01A-11D-A289-08,4,0.522836827,TCGA-DU-A5TP,LGG,33,MALE,WHITE,Astrocytoma,G3,2012,[Not Available],-12111,Alive,TUMOR FREE,1012,NA,[Not Available],NA,NA,NA,203,[Discrepancy],0,1012,0,1012,NA,NA,1,203,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
9.162943709,-5.298980964,TCGA-DB-A64U-01A,TCGA-DB-A64U-01A-11D-A29Q-08,1,0.76371999,TCGA-DB-A64U,LGG,38,FEMALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-14019,Alive,TUMOR FREE,846,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,846,0,846,0,846,0,846,NA,NA,NA,NA,GBM_LGG.Codel,1
-6.429728342,1.60134434,TCGA-DH-A66G-01A,TCGA-DH-A66G-01A-21D-A31L-08,0,NA,TCGA-DH-A66G,LGG,49,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-18199,Alive,WITH TUMOR,523,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,523,0,523,NA,NA,0,523,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,7
0.76032694,2.095691175,TCGA-61-1907-01A,TCGA-61-1907-01A-01W-0639-09,0,NA,TCGA-61-1907,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-23204,Alive,WITH TUMOR,952,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],743,Stable Disease,0,952,0,952,NA,NA,1,743,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,3
-0.277639337,5.232055911,TCGA-P5-A5F1-01A,TCGA-P5-A5F1-01A-11D-A289-08,4,0.453541392,TCGA-P5-A5F1,LGG,30,MALE,WHITE,Astrocytoma,G2,2012,[Not Available],-11070,Alive,TUMOR FREE,179,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,179,0,179,NA,NA,0,179,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.034756533,5.029505064,TCGA-HT-7884-01B,TCGA-HT-7884-01B-11D-2395-08,4,0.608145241,TCGA-HT-7884,LGG,44,FEMALE,WHITE,Astrocytoma,G2,2011,[Not Available],-16280,Alive,[Discrepancy],343,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,343,0,343,NA,NA,0,343,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-0.629898166,2.22167111,TCGA-DH-A66F-01A,TCGA-DH-A66F-01A-11D-A29Q-08,0,NA,TCGA-DH-A66F,LGG,49,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-18193,Alive,TUMOR FREE,523,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,523,0,523,0,523,0,523,NA,NA,NA,NA,GBM_LGG.Codel,1
0.024681913,5.274915958,TCGA-FG-A4MT-01A,TCGA-FG-A4MT-01A-11D-A26M-08,4,0.674764596,TCGA-FG-A4MT,LGG,27,FEMALE,WHITE,Oligodendroglioma,G2,2010,[Not Available],-10082,Alive,TUMOR FREE,1164,NA,[Not Available],NA,NA,NA,499,Complete Remission/Response,0,1164,0,1164,1,499,1,499,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.676811991,-2.273145149,TCGA-AP-A1E1-01A,TCGA-AP-A1E1-01A-11D-A135-09,8,0.451530439,TCGA-AP-A1E1,UCEC,74,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27072,Alive,TUMOR FREE,1395,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1395,0,1395,0,1395,0,1395,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-0.056984352,5.385586065,TCGA-P5-A5EW-01A,TCGA-P5-A5EW-01A-11D-A27K-08,4,0.673667123,TCGA-P5-A5EW,LGG,20,FEMALE,WHITE,Astrocytoma,G2,2012,[Not Available],-7612,Alive,TUMOR FREE,204,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,204,0,204,NA,NA,0,204,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-3.087299873,-3.729639406,TCGA-A6-2686-01A,TCGA-A6-2686-01A-01D-1408-10,8,0.362841471,TCGA-A6-2686,COAD,81,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-29623,Dead,TUMOR FREE,NA,1126,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1126,0,1126,0,1126,0,1126,NA,Stage IIA,T3,M0,GI.HM-indel,10
7.832774396,-1.425103525,TCGA-FG-8189-01B,TCGA-FG-8189-01B-11D-A289-08,1,0.161483039,TCGA-FG-8189,LGG,33,FEMALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-12384,Alive,WITH TUMOR,685,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,685,0,685,NA,NA,0,685,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-5.496429193,2.545959768,TCGA-AA-3971-01A,TCGA-AA-3971-01A-01W-0995-10,12,0.231853985,TCGA-AA-3971,COAD,58,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-21518,Alive,TUMOR FREE,489,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,489,0,489,0,489,0,489,NA,Stage III,T3,M0,GI.CIN,8
-0.096059714,5.452532585,TCGA-13-0916-01A,TCGA-13-0916-01A-01W-0420-08,4,0.69547531,TCGA-13-0916,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-18189,Alive,TUMOR FREE,1785,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1785,0,1785,0,1785,0,1785,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
0.37561869,4.330289451,TCGA-DB-A4XE-01A,TCGA-DB-A4XE-01A-11D-A27K-08,4,0.077830831,TCGA-DB-A4XE,LGG,27,FEMALE,WHITE,Oligoastrocytoma,G3,2011,[Not Available],-10150,Alive,TUMOR FREE,1139,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1139,0,1139,0,1139,0,1139,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,3
7.7823724,-1.352614257,TCGA-DH-A669-01A,TCGA-DH-A669-01A-12D-A31L-08,1,0.154342627,TCGA-DH-A669,LGG,70,MALE,WHITE,Oligodendroglioma,G3,2007,[Not Available],-25809,Dead,TUMOR FREE,NA,919,[Not Available],NA,NA,NA,260,Stable Disease,1,919,0,919,NA,NA,1,260,NA,NA,NA,NA,GBM_LGG.Codel,1
10.1847476,-1.195401165,TCGA-HT-7854-01A,TCGA-HT-7854-01A-11D-2253-08,1,0.759848467,TCGA-HT-7854,LGG,62,MALE,WHITE,Astrocytoma,G2,2010,[Not Available],-22738,Alive,TUMOR FREE,1201,NA,[Not Available],NA,NA,NA,1147,Stable Disease,0,1201,0,1201,NA,NA,1,1147,NA,NA,NA,NA,GBM_LGG.PA-like,1
0.211592777,5.307266217,TCGA-FG-A4MY-01A,TCGA-FG-A4MY-01A-11D-A26M-08,4,0.501975738,TCGA-FG-A4MY,LGG,44,FEMALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-16310,Alive,WITH TUMOR,721,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,721,0,721,NA,NA,0,721,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.100799268,5.267653602,TCGA-DB-A4XB-01A,TCGA-DB-A4XB-01A-11D-A26M-08,4,0.660486622,TCGA-DB-A4XB,LGG,38,MALE,WHITE,Astrocytoma,G3,2011,[Not Available],-13990,Alive,TUMOR FREE,919,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,919,0,919,NA,NA,0,919,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
-4.513979346,1.569398065,TCGA-A6-2674-01A,TCGA-A6-2674-01A-02D-A270-10,0,NA,TCGA-A6-2674,COAD,71,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-26292,Alive,TUMOR FREE,1331,NA,[Not Available],NA,NA,NA,735,Complete Remission/Response,0,1331,0,1331,NA,NA,1,735,NA,Stage IV,T3,M1,NA,9
9.385706154,-5.141471903,TCGA-DU-8161-01A,TCGA-DU-8161-01A-11D-2253-08,1,0.841059438,TCGA-DU-8161,LGG,63,FEMALE,WHITE,Oligoastrocytoma,G3,2009,[Not Available],-23064,Dead,WITH TUMOR,NA,722,[Not Available],NA,NA,NA,111,Progressive Disease,1,722,1,722,NA,NA,1,111,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-5.838860115,3.252959606,TCGA-CK-6748-01A,TCGA-CK-6748-01A-11D-1835-10,11,0,TCGA-CK-6748,COAD,45,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],-16529,Alive,WITH TUMOR,61,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,61,0,61,NA,NA,0,61,NA,Stage IV,T3,M1,GI.CIN,8
-0.004421956,4.236734654,TCGA-DB-A4XF-01A,TCGA-DB-A4XF-01A-11D-A27K-08,4,0.387075502,TCGA-DB-A4XF,LGG,41,FEMALE,WHITE,Astrocytoma,G3,2011,[Not Available],-15066,Alive,TUMOR FREE,1021,NA,[Not Available],NA,NA,NA,468,Stable Disease,0,1021,0,1021,NA,NA,1,468,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,6
0.211389301,5.327539889,TCGA-13-0757-01A,TCGA-13-0757-01A-01D-0356-01,4,0.626836989,TCGA-13-0757,OV,71,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-25999,Dead,WITH TUMOR,340,340,[Not Available],Recurrence,[Not Applicable],[Not Applicable],293,Complete Remission/Response,1,340,1,340,1,293,1,293,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-3.355494816,-3.150348416,TCGA-G4-6309-01A,TCGA-G4-6309-01A-21D-1835-10,8,0.630622013,TCGA-G4-6309,COAD,40,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-14729,Alive,TUMOR FREE,2600,NA,[Not Available],NA,NA,NA,2176,Complete Remission/Response,0,2600,0,2600,1,2176,1,2176,NA,Stage IIIB,T3,M0,GI.HM-indel,10
8.324284242,-3.420898432,TCGA-DB-A4X9-01A,TCGA-DB-A4X9-01A-11D-A26M-08,1,0.581814227,TCGA-DB-A4X9,LGG,33,FEMALE,WHITE,Oligoastrocytoma,G2,2010,[Not Available],-12131,Alive,TUMOR FREE,1412,NA,[Not Available],NA,NA,NA,501,Complete Remission/Response,0,1412,0,1412,1,501,1,501,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-2.967833655,-4.011836384,TCGA-EO-A3AY-01A,TCGA-EO-A3AY-01A-12D-A19Y-09,8,0.158656683,TCGA-EO-A3AY,UCEC,58,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21291,Alive,WITH TUMOR,1158,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Vault,1163,Complete Remission/Response,0,1158,0,1158,1,1163,1,1163,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
9.417725551,-4.623850297,TCGA-QH-A6CU-01A,TCGA-QH-A6CU-01A-11D-A31L-08,1,0.76891168,TCGA-QH-A6CU,LGG,52,FEMALE,WHITE,Oligodendroglioma,G3,2013,[Not Available],-19149,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,451,0,451,NA,NA,0,451,NA,NA,NA,NA,GBM_LGG.Codel,1
8.356783036,-3.41608063,TCGA-KV-A6GD-01A,TCGA-KV-A6GD-01A-11D-A31X-10,1,0.579972989,TCGA-KV-A6GD,KIRP,85,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-31217,Alive,TUMOR FREE,560,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,560,0,560,0,560,0,560,NA,Stage I,T1b,M0,KIRP.C2a,1
7.67716124,-1.253336812,TCGA-FG-A6J3-01A,TCGA-FG-A6J3-01A-11D-A31L-08,1,0.165535511,TCGA-FG-A6J3,LGG,52,FEMALE,WHITE,Astrocytoma,G3,2012,[Not Available],-19138,Alive,WITH TUMOR,677,NA,[Not Available],NA,NA,NA,285,Progressive Disease,0,677,0,677,NA,NA,1,285,NA,NA,NA,NA,GBM_LGG.G-CIMP-low,1
9.098743291,-5.407924304,TCGA-DB-A4XA-01A,TCGA-DB-A4XA-01A-11D-A26M-08,1,0.82997613,TCGA-DB-A4XA,LGG,30,MALE,WHITE,Oligoastrocytoma,G2,2012,[Not Available],-11195,Alive,WITH TUMOR,573,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,573,0,573,NA,NA,0,573,NA,NA,NA,NA,GBM_LGG.Codel,1
8.792867634,-3.66770172,TCGA-HT-7873-01B,TCGA-HT-7873-01B-11D-2395-08,1,0.740812996,TCGA-HT-7873,LGG,29,MALE,WHITE,Oligoastrocytoma,G2,2011,[Not Available],-10805,Alive,WITH TUMOR,718,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,718,0,718,NA,NA,0,718,NA,NA,NA,NA,GBM_LGG.G-CIMP-high,1
-8.218773411,1.945927192,TCGA-DB-A64Q-01A,TCGA-DB-A64Q-01A-11D-A29Q-08,9,0.546316148,TCGA-DB-A64Q,LGG,31,FEMALE,[Unknown],Oligoastrocytoma,G2,2012,[Not Available],-11637,Alive,TUMOR FREE,182,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,182,0,182,NA,NA,0,182,NA,NA,NA,NA,GBM_LGG.Codel,7
-0.654287367,4.009127961,TCGA-CM-5862-01A,TCGA-CM-5862-01A-01D-1650-10,4,0.36492817,TCGA-CM-5862,COAD,80,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29493,Dead,WITH TUMOR,NA,153,[Not Available],NA,NA,NA,31,[Not Available],1,153,1,153,NA,NA,1,31,NA,Stage IVA,T3,M1a,GI.CIN,5
-2.961627306,-3.956594153,TCGA-CA-6718-01A,TCGA-CA-6718-01A-11D-1835-10,8,0.25053315,TCGA-CA-6718,COAD,46,MALE,ASIAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-17109,Dead,WITH TUMOR,NA,306,[Not Available],NA,NA,NA,207,Complete Remission/Response,1,306,1,306,1,207,1,207,NA,Stage IIA,T3,M0,GI.HM-SNV,10
-0.738241633,3.708567042,TCGA-04-1348-01A,TCGA-04-1348-01A-01W-0492-08,4,0.360850789,TCGA-04-1348,OV,44,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-16236,Dead,WITH TUMOR,NA,1483,[Not Available],Recurrence,[Not Applicable],[Not Applicable],575,Complete Remission/Response,1,1483,1,1483,1,575,1,575,NA,Stage IIIB,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,5
-0.995090743,4.58343962,TCGA-20-0987-01A,TCGA-20-0987-01A-02W-0486-08,4,0.400607854,TCGA-20-0987,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-22287,Dead,WITH TUMOR,NA,701,[Not Available],Recurrence,[Not Applicable],[Not Applicable],442,[Not Available],1,701,1,701,NA,NA,1,442,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
9.629036711,-5.348685936,TCGA-P5-A5F6-01A,TCGA-P5-A5F6-01A-11D-A289-08,1,0.863886314,TCGA-P5-A5F6,LGG,26,MALE,WHITE,Oligodendroglioma,G2,2012,[Not Available],-9575,Alive,TUMOR FREE,39,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,39,0,39,NA,NA,0,39,NA,NA,NA,NA,GBM_LGG.PA-like,1
9.331538921,-4.8390444,TCGA-A4-8311-01A,TCGA-A4-8311-01A-11D-2396-08,1,0.821683882,TCGA-A4-8311,KIRP,60,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-22220,Alive,TUMOR FREE,729,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,729,0,729,0,729,0,729,NA,Stage I,T1a,MX,KIRP.C1,1
9.350215423,-4.514690859,TCGA-GL-A4EM-01A,TCGA-GL-A4EM-01A-11D-A25F-10,1,0.761562576,TCGA-GL-A4EM,KIRP,61,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-22635,Alive,TUMOR FREE,32,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,32,0,32,NA,NA,0,32,NA,Stage I,T1b,MX,KIRP.C2a,1
-0.791241718,2.419764889,TCGA-GL-A59R-01A,TCGA-GL-A59R-01A-11D-A26P-10,4,0.047538094,TCGA-GL-A59R,KIRP,79,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-29046,Alive,TUMOR FREE,378,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,378,0,378,0,378,0,378,NA,Stage III,T3c,MX,KIRP.C1,6
4.35933457,1.200577689,TCGA-HE-A5NL-01A,TCGA-HE-A5NL-01A-11D-A26P-10,2,0.672067912,TCGA-HE-A5NL,KIRP,51,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-18913,Alive,TUMOR FREE,767,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,767,0,767,0,767,0,767,NA,Stage I,T1a,MX,KIRP.C1,5
-0.540055767,4.476532625,TCGA-09-1670-01A,TCGA-09-1670-01A-01W-0633-09,4,0.416865841,TCGA-09-1670,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-21147,Alive,WITH TUMOR,547,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],547,Complete Remission/Response,0,547,0,547,1,547,1,547,NA,Stage IIIA,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
2.105159889,1.801751863,TCGA-BP-4971-01A,TCGA-BP-4971-01A-01D-1462-08,3,0.387171086,TCGA-BP-4971,KIRC,40,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-14675,Alive,TUMOR FREE,1487,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1487,0,1487,NA,NA,0,1487,NA,Stage III,T3a,M0,KIRC.2,3
-4.408895108,1.470959458,TCGA-CM-4751-01A,TCGA-CM-4751-01A-02D-1835-10,0,NA,TCGA-CM-4751,COAD,62,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-22891,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,822,0,822,0,822,0,822,NA,Stage IIIB,T3,M0,GI.CIN,9
-2.165805595,1.29785136,TCGA-BH-A0H5-01A,TCGA-BH-A0H5-01A-21D-A10Y-09,5,0.608428469,TCGA-BH-A0H5,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16719,Alive,TUMOR FREE,1620,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1620,0,1620,0,1620,0,1620,NA,Stage I,T1c,M0,BRCA.LumA,4
-0.295262894,4.243242507,TCGA-CK-5915-01A,TCGA-CK-5915-01A-11D-1650-10,4,0.47633871,TCGA-CK-5915,COAD,63,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-23040,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage I,T2,MX,GI.CIN,6
-3.362568747,-3.247997652,TCGA-AA-3877-01A,TCGA-AA-3877-01A-01W-0995-10,8,0.609075672,TCGA-AA-3877,COAD,83,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2007,[Not Available],-30377,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,943,0,943,0,943,0,943,NA,Stage I,T1,M0,GI.HM-indel,10
-5.183060168,1.412133736,TCGA-DM-A1DA-01A,TCGA-DM-A1DA-01A-11D-A152-10,0,NA,TCGA-DM-A1DA,COAD,71,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],1999,[Not Available],-26169,Dead,NA,228,228,[Not Available],NA,NA,NA,NA,[Not Available],1,228,NA,228,NA,NA,0,228,NA,Stage IIIC,T3,M0,GI.CIN,9
8.64091439,-3.568385871,TCGA-CM-6170-01A,TCGA-CM-6170-01A-11D-1650-10,1,0.650016013,TCGA-CM-6170,COAD,73,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-26663,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,457,0,457,NA,NA,0,457,NA,Stage I,T2,M0,GI.CIN,1
-6.545179769,2.53904847,TCGA-AA-3973-01A,TCGA-AA-3973-01A-01W-0995-10,0,NA,TCGA-AA-3973,COAD,69,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-25536,Alive,WITH TUMOR,397,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,397,0,397,NA,NA,0,397,NA,Stage IV,T4,M1,GI.CIN,8
-6.194298877,1.793626608,TCGA-A5-A2K4-01A,TCGA-A5-A2K4-01A-11D-A18P-09,10,0.335201361,TCGA-A5-A2K4,UCEC,69,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25270,Dead,WITH TUMOR,NA,871,[Not Available],Metastatic,"Other, specify",Bowel,528,Complete Remission/Response,1,871,1,871,1,528,1,528,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,7
-6.442048207,-1.387512651,TCGA-G4-6298-01A,TCGA-G4-6298-01A-11D-1719-10,7,0.140475411,TCGA-G4-6298,COAD,90,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2005,[Not Available],-32873,Dead,WITH TUMOR,NA,715,[Not Available],NA,NA,NA,291,[Not Available],1,715,1,715,NA,NA,1,291,NA,Stage IIIB,T4a,MX,GI.CIN,2
-7.41761519,2.228946318,TCGA-D8-A1Y2-01A,TCGA-D8-A1Y2-01A-11D-A159-09,9,0.217607764,TCGA-D8-A1Y2,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26021,Alive,TUMOR FREE,433,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,433,0,433,0,433,0,433,NA,Stage IIA,T2,MX,BRCA.LumB,7
-3.900008223,-2.297285314,TCGA-AP-A0LS-01A,TCGA-AP-A0LS-01A-11D-A14G-09,8,0.436284991,TCGA-AP-A0LS,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126,Alive,TUMOR FREE,2904,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2904,0,2904,0,2904,0,2904,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-4.052387032,-2.266033983,TCGA-FI-A2D4-01A,TCGA-FI-A2D4-01A-12D-A17D-09,8,0.402049492,TCGA-FI-A2D4,UCEC,44,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163,Dead,WITH TUMOR,NA,243,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,243,1,243,NA,NA,1,243,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
4.30609751,1.163898845,TCGA-A2-A1FV-01A,TCGA-A2-A1FV-01A-11D-A13L-09,2,0.699231129,TCGA-A2-A1FV,BRCA,74,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27287,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,714,0,714,0,714,0,714,NA,Stage IIB,T3,M0,BRCA.LumA,5
-5.760742358,2.155502714,TCGA-D5-6532-01A,TCGA-D5-6532-01A-11D-1719-10,0,NA,TCGA-D5-6532,COAD,61,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-22344,Alive,TUMOR FREE,555,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,555,0,555,NA,NA,0,555,NA,Stage IIA,T3,M0,GI.GS,9
1.7441733,1.985872911,TCGA-A4-A5XZ-01A,TCGA-A4-A5XZ-01A-11D-A31X-10,3,0.222504312,TCGA-A4-A5XZ,KIRP,65,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-24006,Alive,TUMOR FREE,479,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,479,0,479,0,479,0,479,NA,Stage II,T2a,MX,KIRP.C1,3
1.130481896,3.516390931,TCGA-GL-8500-01A,TCGA-GL-8500-01A-11D-2396-08,0,NA,TCGA-GL-8500,KIRP,63,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-23338,Alive,TUMOR FREE,841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,841,0,841,0,841,0,841,NA,Stage I,T1b,MX,KIRP.C1,1
-0.55575548,3.790227118,TCGA-B9-A44B-01A,TCGA-B9-A44B-01A-11D-A25F-10,4,0.132961937,TCGA-B9-A44B,KIRP,70,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-25763,Alive,TUMOR FREE,361,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,361,0,361,NA,NA,0,361,NA,Stage III,T3b,[Not Available],KIRP.C2b,6
9.856688462,-2.125633438,TCGA-AN-A0AS-01A,TCGA-AN-A0AS-01A-11W-A019-09,1,0.819920898,TCGA-AN-A0AS,BRCA,70,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25658,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-0.599042761,5.074605528,TCGA-AZ-4323-01A,TCGA-AZ-4323-01A-21D-1835-10,4,0.383782276,TCGA-AZ-4323,COAD,37,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2002,[Not Available],-13755,Dead,WITH TUMOR,NA,43,[Not Available],NA,NA,NA,NA,[Not Available],1,43,1,43,NA,NA,1,43,NA,Stage IV,T4,M1,GI.GS,6
-3.637014069,-2.749232306,TCGA-CM-4746-01A,TCGA-CM-4746-01A-01D-1408-10,8,0.373317526,TCGA-CM-4746,COAD,61,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-22403,Alive,TUMOR FREE,1126,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1126,0,1126,0,1126,0,1126,NA,Stage I,T2,M0,GI.HM-indel,10
8.853036038,-3.981940688,TCGA-BH-A1FL-01A,TCGA-BH-A1FL-01A-11D-A13L-09,1,0.7218784,TCGA-BH-A1FL,BRCA,69,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-25558,Dead,WITH TUMOR,NA,1673,[Not Available],NA,NA,NA,NA,[Not Available],1,1673,1,1673,NA,NA,1,1673,NA,Stage IIB,T2,M0,BRCA.LumA,1
10.01667657,-1.571704427,TCGA-04-1646-01A,TCGA-04-1646-01A-01W-0639-09,1,0.876454594,TCGA-04-1646,OV,60,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-22207,Dead,WITH TUMOR,NA,848,[Not Available],Recurrence,[Not Applicable],[Not Applicable],508,[Not Available],1,848,1,848,NA,NA,1,508,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-7.636548553,-2.329126352,TCGA-A4-8630-01A,TCGA-A4-8630-01A-11D-2396-08,6,0.48404892,TCGA-A4-8630,KIRP,59,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-21884,Alive,TUMOR FREE,436,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,436,0,436,0,436,0,436,NA,Stage I,T1b,MX,KIRP.C1,2
9.350440406,-4.775957327,TCGA-G7-A4TM-01A,TCGA-G7-A4TM-01A-11D-A31X-10,1,0.780245433,TCGA-G7-A4TM,KIRP,40,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-14966,Alive,TUMOR FREE,768,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,768,0,768,0,768,0,768,NA,Stage I,T1a,MX,KIRP.C1,1
-2.192883352,1.222014326,TCGA-61-1722-01A,TCGA-61-1722-01A-01D-1556-09,5,0.512328149,TCGA-61-1722,OV,89,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-32853,Alive,WITH TUMOR,246,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,246,0,246,NA,NA,0,246,NA,Stage IB,[Not Applicable],[Not Applicable],NA,4
-7.218585983,-2.487770871,TCGA-IA-A40U-01A,TCGA-IA-A40U-01A-11D-A25F-10,6,0.225940416,TCGA-IA-A40U,KIRP,56,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-20463,Alive,TUMOR FREE,511,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,511,0,511,0,511,0,511,NA,Stage III,T3b,MX,KIRP.C1,2
9.168203508,-2.844000032,TCGA-PJ-A5Z8-01A,TCGA-PJ-A5Z8-01A-11D-A28G-10,1,0.743190747,TCGA-PJ-A5Z8,KIRP,60,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-21968,Alive,TUMOR FREE,600,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,600,0,600,0,600,0,600,NA,Stage I,T1a,M0,KIRP.C2a,1
4.304842487,1.238617302,TCGA-HE-A5NH-01A,TCGA-HE-A5NH-01A-11D-A26P-10,2,0.629240207,TCGA-HE-A5NH,KIRP,62,MALE,[Not Evaluated],Kidney Papillary Renal Cell Carcinoma,[Not Available],NA,[Not Available],-22888,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,791,0,791,0,791,0,791,NA,Stage I,T1a,[Not Available],KIRP.C1,5
-2.857928511,-4.18044413,TCGA-AP-A1E0-01A,TCGA-AP-A1E0-01A-11D-A135-09,0,NA,TCGA-AP-A1E0,UCEC,40,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14653,Alive,TUMOR FREE,1832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1832,0,1832,0,1832,0,1832,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-2.039233184,1.26362714,TCGA-BH-A1FN-01A,TCGA-BH-A1FN-01A-11D-A13L-09,5,0.547289698,TCGA-BH-A1FN,BRCA,34,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1997,[Not Available],-12525,Dead,WITH TUMOR,NA,2192,[Not Available],NA,NA,NA,NA,[Not Available],1,2192,1,2192,NA,NA,1,2192,NA,Stage IIA,T2,M0,BRCA.LumB,4
-7.639297906,2.597708343,TCGA-DM-A28A-01A,TCGA-DM-A28A-01A-21D-A16V-10,9,0.098897024,TCGA-DM-A28A,COAD,78,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-28833,Dead,NA,805,805,[Not Available],NA,NA,NA,NA,[Not Available],1,805,NA,805,NA,NA,0,805,NA,Stage IIIC,T3,M0,GI.CIN,7
-0.823861881,3.944616526,TCGA-G4-6299-01A,TCGA-G4-6299-01A-11D-1771-10,4,0.296295335,TCGA-G4-6299,COAD,69,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2005,[Not Available],-25318,Alive,TUMOR FREE,2268,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2268,0,2268,NA,NA,0,2268,NA,Stage IIIC,T3,M0,GI.CIN,6
-0.918576675,4.421311997,TCGA-D5-6929-01A,TCGA-D5-6929-01A-31D-1924-10,4,0.438083421,TCGA-D5-6929,COAD,49,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-17919,Alive,TUMOR FREE,408,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,408,0,408,NA,NA,0,408,NA,Stage IV,T3,M1,GI.CIN,6
-7.01843634,2.324392435,TCGA-HV-A7OP-01A,TCGA-HV-A7OP-01A-11D-A33T-08,0,NA,TCGA-HV-A7OP,PAAD,72,MALE,ASIAN,Pancreas-Adenocarcinoma-Other Subtype,GX,2012,[Not Available],-26322,Alive,NA,978,NA,NA,Distant Metastasis,Liver,NA,342,[Discrepancy],0,978,0,978,NA,NA,1,342,NA,Stage IIB,T3,M0,NA,7
-6.389259422,-1.444521816,TCGA-HV-A7OL-01A,TCGA-HV-A7OL-01A-11D-A33T-08,7,0.35420134,TCGA-HV-A7OL,PAAD,70,MALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-25768,Alive,NA,252,NA,NA,Distant Metastasis,Non-regional / Distant Lymph Nodes,NA,123,Stable Disease,0,252,0,252,NA,NA,1,123,NA,Stage IIA,T3,MX,NA,2
-3.197970468,1.055235248,TCGA-37-A5EM-01A,TCGA-37-A5EM-01A-21D-A27K-08,0,NA,TCGA-37-A5EM,LUSC,49,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-18011,Alive,TUMOR FREE,867,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,867,0,867,0,867,0,867,NA,Stage II,T2,M0,NA,10
-4.245319919,0.276933301,TCGA-37-A5EL-01A,TCGA-37-A5EL-01A-11D-A26M-08,0,NA,TCGA-37-A5EL,LUSC,53,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-19371,Dead,WITH TUMOR,NA,1143,[Not Available],Distant Metastasis,NA,NA,946,[Discrepancy],1,1143,1,1143,NA,NA,1,946,NA,Stage IIB,T3,M0,NA,10
9.382343966,-4.658902703,TCGA-XN-A8T5-01A,TCGA-XN-A8T5-01A-12D-A36O-08,1,0.812672069,TCGA-XN-A8T5,PAAD,53,FEMALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2012,[Not Available],-19707,Alive,WITH TUMOR,720,NA,NA,Distant Metastasis,Liver,NA,242,Progressive Disease,0,720,0,720,NA,NA,1,242,NA,Stage IB,T2,M0,NA,1
-5.193731381,2.281256099,TCGA-XN-A8T3-01A,TCGA-XN-A8T3-01A-11D-A36O-08,12,0.047821005,TCGA-XN-A8T3,PAAD,67,MALE,WHITE,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24810,Alive,WITH TUMOR,951,NA,NA,NA,NA,NA,NA,Progressive Disease,0,951,0,951,NA,NA,0,951,NA,Stage IB,T2,M0,NA,8
-6.246497901,-1.453539175,TCGA-HZ-A9TJ-01A,TCGA-HZ-A9TJ-01A-11D-A40W-08,7,0.170719657,TCGA-HZ-A9TJ,PAAD,70,MALE,WHITE,Pancreas-Adenocarcinoma-Other Subtype,G2,2013,[Not Available],-25849,Alive,WITH TUMOR,603,NA,NA,Distant Metastasis,Peritoneal Surfaces,NA,555,[Unknown],0,603,0,603,NA,NA,1,555,NA,Stage IV,T3,M1,NA,2
-5.209184295,2.198921842,TCGA-HV-AA8X-01A,TCGA-HV-AA8X-01A-11D-A397-08,0,NA,TCGA-HV-AA8X,PAAD,75,FEMALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27662,Dead,WITH TUMOR,NA,532,NA,Distant Metastasis,"Other, specify",Omentum,375,[Discrepancy],1,532,1,532,NA,NA,1,375,NA,Stage IIB,T2,MX,NA,8
-5.325865734,2.666067964,TCGA-HV-AA8V-01A,TCGA-HV-AA8V-01A-11D-A40W-08,12,0.171011541,TCGA-HV-AA8V,PAAD,50,MALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-18357,Alive,NA,920,NA,NA,Distant Metastasis,"Other, specify",bone,526,[Discrepancy],0,920,0,920,NA,NA,1,526,NA,Stage IIB,T3,MX,NA,8
-0.814001633,4.490108859,TCGA-AN-A0FV-01A,TCGA-AN-A0FV-01A-11W-A019-09,4,0.464117931,TCGA-AN-A0FV,BRCA,58,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21479,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,10,0,10,0,10,0,10,NA,Stage IIA,T2,M0,BRCA.Her2,6
-1.029780504,2.880521982,TCGA-56-8082-01A,TCGA-56-8082-01A-11D-2244-08,4,0.064583195,TCGA-56-8082,LUSC,80,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-29440,Alive,TUMOR FREE,455,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,455,0,455,0,455,0,455,NA,Stage IIA,T2b,MX,NA,3
-0.918645398,2.998079657,TCGA-56-7823-01B,TCGA-56-7823-01B-11D-2244-08,0,NA,TCGA-56-7823,LUSC,58,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-21344,Alive,TUMOR FREE,1011,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1011,0,1011,0,1011,0,1011,NA,Stage IIA,T1b,M0,NA,3
-1.21954669,3.508774675,TCGA-37-A5EN-01A,TCGA-37-A5EN-01A-21D-A26M-08,4,0.185092123,TCGA-37-A5EN,LUSC,59,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-21600,Alive,TUMOR FREE,660,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,660,0,660,0,660,0,660,NA,Stage IIIB,T4,M0,NA,6
0.089120759,5.052135245,TCGA-76-6660-01A,TCGA-76-6660-01A-11D-1845-08,4,0.621646813,TCGA-76-6660,GBM,73,MALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2010,[Not Available],-26913,Dead,WITH TUMOR,NA,114,[Not Available],NA,NA,NA,NA,[Not Available],1,114,1,114,NA,NA,1,114,NA,NA,NA,NA,NA,6
-5.738479602,-0.803200298,TCGA-AO-A0JC-01A,TCGA-AO-A0JC-01A-11W-A071-09,0,NA,TCGA-AO-A0JC,BRCA,64,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404,Alive,TUMOR FREE,1547,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1547,0,1547,0,1547,0,1547,NA,Stage IIA,T2,M0,BRCA.LumA,10
-0.90613264,4.860673859,TCGA-76-6283-01A,TCGA-76-6283-01A-11D-1845-08,4,0.361370258,TCGA-76-6283,GBM,71,FEMALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2007,[Not Available],-26002,Dead,WITH TUMOR,NA,165,[Not Available],NA,NA,NA,NA,[Not Available],1,165,1,165,NA,NA,1,165,NA,NA,NA,NA,NA,6
-6.568126821,-2.222328086,TCGA-56-8201-01A,TCGA-56-8201-01A-11D-2244-08,0,NA,TCGA-56-8201,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-27211,Dead,WITH TUMOR,NA,397,[Not Available],NA,NA,NA,NA,[Unknown],1,397,1,397,NA,NA,1,397,NA,Stage IIB,T3,MX,NA,2
-2.45035932,1.329833951,TCGA-56-8083-01A,TCGA-56-8083-01A-11D-2244-08,5,0.452250015,TCGA-56-8083,LUSC,56,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-20696,Alive,TUMOR FREE,150,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,150,0,150,NA,NA,0,150,NA,Stage IB,T2a,MX,NA,4
0.434855476,2.244257865,TCGA-D8-A27I-01A,TCGA-D8-A27I-01A-11D-A16D-09,0,NA,TCGA-D8-A27I,BRCA,58,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21327,Alive,TUMOR FREE,439,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,439,0,439,0,439,0,439,NA,Stage IIIA,T1c,M0,BRCA.LumA,6
-1.144980245,4.312451391,TCGA-ZJ-AAXJ-01A,TCGA-ZJ-AAXJ-01A-11D-A42O-09,4,0.401056085,TCGA-ZJ-AAXJ,CESC,43,FEMALE,[Unknown],Cervical Squamous Cell Carcinoma,[Not Available],2010,[Unknown],-16007,Alive,NA,0,NA,NA,NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T2b,MX,NA,6
-6.545566684,-1.319212726,TCGA-VQ-AA6K-01A,TCGA-VQ-AA6K-01A-11D-A410-08,7,0.223717709,TCGA-VQ-AA6K,STAD,59,MALE,WHITE,"Stomach Adenocarcinoma, Signet Ring Type",G3,2012,[Not Available],-21901,Dead,WITH TUMOR,NA,378,Stomach Cancer,Locoregional Recurrence,NA,NA,332,Progressive Disease,1,378,1,378,NA,NA,1,332,NA,Stage IIIC,T4a,M0,GI.CIN,2
-2.801802405,-4.257938426,TCGA-2W-A8YY-01A,TCGA-2W-A8YY-01A-11D-A37N-09,0,NA,TCGA-2W-A8YY,CESC,51,FEMALE,WHITE,Adenosquamous,G3,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18886,Alive,TUMOR FREE,533,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,533,0,533,0,533,0,533,NA,Stage IB2,T2a2,M0,NA,10
-6.43403106,-1.112810979,TCGA-VB-A8QN-01A,TCGA-VB-A8QN-01A-11D-A382-10,7,0.333755153,TCGA-VB-A8QN,DLBC,55,MALE,WHITE,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),[Not Available],2013,[Not Available],-20270,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,0,0,0,NA,NA,0,0,NA,NA,NA,NA,NA,2
-1.985340497,1.225953782,TCGA-E9-A244-01A,TCGA-E9-A244-01A-11D-A167-09,5,0.599995311,TCGA-E9-A244,BRCA,54,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19778,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,21,0,21,0,21,0,21,NA,Stage IIA,T2,M0,BRCA.Basal,4
-6.685956706,-1.239570556,TCGA-A2-A0EN-01A,TCGA-A2-A0EN-01A-13D-A099-09,7,0.051126613,TCGA-A2-A0EN,BRCA,70,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25771,Alive,TUMOR FREE,4088,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4088,0,4088,0,4088,0,4088,NA,Stage IIA,T2,M0,BRCA.LumA,2
8.958260316,-3.372118496,TCGA-A8-A07U-01A,TCGA-A8-A07U-01A-11W-A050-09,1,0.716040719,TCGA-A8-A07U,BRCA,66,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24411,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,760,0,760,0,760,0,760,NA,Stage IIIA,T2,M0,BRCA.Basal,1
-7.958405238,2.08250948,TCGA-A8-A08P-01A,TCGA-A8-A08P-01A-11W-A019-09,9,0.485756899,TCGA-A8-A08P,BRCA,70,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25598,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,943,0,943,0,943,0,943,NA,Stage IIIA,T2,M0,BRCA.LumB,7
-6.995893062,-1.55141428,TCGA-B0-5106-01A,TCGA-B0-5106-01A-01D-1421-08,0,NA,TCGA-B0-5106,KIRC,64,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-23547,Dead,TUMOR FREE,NA,1598,[Not Available],NA,NA,NA,NA,[Not Available],1,1598,0,1598,NA,NA,0,1598,NA,Stage I,T1a,M0,KIRC.2,2
4.420958466,1.163415633,TCGA-B0-5107-01A,TCGA-B0-5107-01A-01D-1421-08,2,0.524981275,TCGA-B0-5107,KIRC,65,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-23929,Dead,WITH TUMOR,NA,927,[Not Available],NA,NA,NA,549,[Not Available],1,927,1,927,NA,NA,1,549,NA,Stage IV,T2,M1,KIRC.4,5
-5.801400752,-2.148898055,TCGA-29-1693-01A,TCGA-29-1693-01A-01W-0633-09,0,NA,TCGA-29-1693,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-26300,Alive,WITH TUMOR,3096,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],694,Complete Remission/Response,0,3096,0,3096,1,694,1,694,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,2
8.800363122,-3.355768104,TCGA-BP-5194-01A,TCGA-BP-5194-01A-02D-1429-08,1,0.698502914,TCGA-BP-5194,KIRC,39,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2008,[Not Available],-14551,Alive,TUMOR FREE,408,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,408,0,408,NA,NA,0,408,NA,Stage I,T1a,M0,KIRC.1,1
-0.983405558,3.710370002,TCGA-61-1919-01A,TCGA-61-1919-01A-01W-0699-08,4,0.2986944,TCGA-61-1919,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2001,[Not Available],-21199,Dead,NA,1161,1161,[Not Available],Recurrence,[Not Applicable],[Not Applicable],439,Complete Remission/Response,1,1161,NA,1161,1,439,1,439,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,5
4.375276444,1.153248288,TCGA-CW-5587-01A,TCGA-CW-5587-01A-01D-1534-10,2,0.625172805,TCGA-CW-5587,KIRC,62,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2003,[Not Available],-22693,Alive,TUMOR FREE,2226,NA,[Not Available],NA,NA,NA,2003,[Not Available],0,2226,0,2226,NA,NA,1,2003,NA,Stage III,T3b,M0,KIRC.1,5
10.22405789,-1.350850383,TCGA-B8-4151-01A,TCGA-B8-4151-01A-01D-1806-10,1,0.802374255,TCGA-B8-4151,KIRC,51,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2009,[Not Available],-18760,Alive,TUMOR FREE,1299,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1299,0,1299,0,1299,0,1299,NA,Stage III,T3a,M0,KIRC.4,1
0.113406772,4.723209534,TCGA-HV-A5A5-01A,TCGA-HV-A5A5-01A-11D-A26I-08,4,0.654064548,TCGA-HV-A5A5,PAAD,61,FEMALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-22329,Alive,NA,289,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,289,0,289,0,289,0,289,NA,Stage IIB,T3,M0,NA,6
-6.154661114,3.557633979,TCGA-HV-A5A4-01A,TCGA-HV-A5A4-01A-11D-A26I-08,11,0.588294549,TCGA-HV-A5A4,PAAD,72,FEMALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26311,Alive,NA,232,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,232,0,232,0,232,0,232,NA,Stage IIA,T3,MX,NA,8
-6.185069,-1.35629813,TCGA-T9-A92H-01A,TCGA-T9-A92H-01A-11D-A36X-10,7,0.001794904,TCGA-T9-A92H,COAD,82,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2013,[Not Available],-30058,Alive,WITH TUMOR,362,NA,[Not Available],NA,NA,NA,81,Complete Remission/Response,0,362,0,362,1,81,1,81,NA,Stage IIA,T3,M0,GI.CIN,2
-5.135821893,1.576724561,TCGA-SS-A7HO-01A,TCGA-SS-A7HO-01A-21D-A36X-10,0,NA,TCGA-SS-A7HO,COAD,44,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-16416,Alive,WITH TUMOR,1829,NA,[Not Available],Locoregional Disease,NA,NA,506,Complete Remission/Response,0,1829,0,1829,1,506,1,506,NA,Stage IIB,T4a,M0,GI.CIN,9
-5.12521761,1.55210717,TCGA-5M-AATE-01A,TCGA-5M-AATE-01A-11D-A40P-10,0,NA,TCGA-5M-AATE,COAD,76,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-27870,Alive,WITH TUMOR,1200,NA,[Not Available],NA,NA,NA,810,Progressive Disease,0,1200,0,1200,NA,NA,1,810,NA,Stage IIA,T3,M0,GI.CIN,8
-3.077273481,-3.781069323,TCGA-5M-AAT6-01A,TCGA-5M-AAT6-01A-11D-A40P-10,8,0.275448348,TCGA-5M-AAT6,COAD,40,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-14852,Dead,WITH TUMOR,NA,290,[Not Available],NA,NA,NA,219,Progressive Disease,1,290,1,290,NA,NA,1,219,NA,Stage IV,T4a,M1a,GI.HM-indel,10
-6.094960586,3.595389208,TCGA-HV-A5A6-01A,TCGA-HV-A5A6-01A-11D-A26I-08,11,0.505539928,TCGA-HV-A5A6,PAAD,65,FEMALE,ASIAN,Pancreas-Adenocarcinoma Ductal Type,G1,2001,[Not Available],-24025,Dead,WITH TUMOR,NA,2036,Other malignancy,Distant Metastasis,Lung,NA,1511,Complete Remission/Response,1,2036,0,2036,1,1511,1,1511,NA,Stage IIB,T3,M0,NA,8
4.292014415,1.239748951,TCGA-IA-A40X-01A,TCGA-IA-A40X-01A-11D-A25F-10,2,0.635489611,TCGA-IA-A40X,KIRP,49,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-18239,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,608,0,608,0,608,0,608,NA,Stage I,T1a,MX,KIRP.C2a,5
-8.008830666,2.241013867,TCGA-IZ-8195-01A,TCGA-IZ-8195-01A-31D-2396-08,9,0.565742016,TCGA-IZ-8195,KIRP,82,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-29963,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,677,0,677,0,677,0,677,NA,Stage II,T2a,MX,KIRP.C1,7
8.945986801,-5.248283221,TCGA-DW-7963-01B,TCGA-DW-7963-01B-11D-A28G-10,1,0.845723109,TCGA-DW-7963,KIRP,43,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-15967,Alive,TUMOR FREE,1240,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1240,0,1240,0,1240,0,1240,NA,Stage I,T1b,MX,KIRP.C1,1
4.446358162,1.118212544,TCGA-A4-8517-01A,TCGA-A4-8517-01A-11D-2396-08,2,0.662494021,TCGA-A4-8517,KIRP,71,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-26090,Alive,TUMOR FREE,597,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,597,0,597,0,597,0,597,NA,Stage I,T1a,MX,KIRP.C1,5
-5.325944842,2.450391903,TCGA-DM-A28E-01A,TCGA-DM-A28E-01A-11D-A16V-10,12,0.311992402,TCGA-DM-A28E,COAD,72,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-26602,Alive,NA,3648,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3648,0,3648,NA,NA,0,3648,NA,Stage IIA,T3,M0,GI.CIN,8
-0.549259333,4.971902478,TCGA-24-0980-01A,TCGA-24-0980-01A-01W-0420-08,4,0.593749978,TCGA-24-0980,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-19579,Dead,WITH TUMOR,233,233,[Not Available],Recurrence,[Not Applicable],[Not Applicable],145,Progressive Disease,1,233,1,233,NA,NA,1,145,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
8.804922543,-5.012606567,TCGA-B0-5702-01A,TCGA-B0-5702-01A-11D-1534-10,1,0.785246568,TCGA-B0-5702,KIRC,71,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-26186,Alive,TUMOR FREE,2172,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2172,0,2172,0,2172,0,2172,NA,Stage I,T1b,M0,KIRC.NA,1
-3.898637677,1.343418897,TCGA-13-0906-01A,TCGA-13-0906-01A-01D-A312-08,0,NA,TCGA-13-0906,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-18383,Alive,TUMOR FREE,3619,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3619,0,3619,0,3619,0,3619,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-7.124071057,1.437721571,TCGA-A4-A4ZT-01A,TCGA-A4-A4ZT-01A-11D-A26P-10,0,NA,TCGA-A4-A4ZT,KIRP,71,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-26058,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,516,0,516,0,516,0,516,NA,Stage I,T1b,MX,KIRP.C1,7
-7.777337785,-2.337177493,TCGA-A4-A48D-01A,TCGA-A4-A48D-01A-11D-A25F-10,6,0.290582009,TCGA-A4-A48D,KIRP,84,MALE,BLACK OR AFRICAN AMERICAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-31038,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage I,T1b,MX,KIRP.C2a,2
-7.400694453,2.483131376,TCGA-FI-A2F9-01A,TCGA-FI-A2F9-01A-11D-A17D-09,0,NA,TCGA-FI-A2F9,UCEC,79,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28886,Alive,TUMOR FREE,1803,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1803,0,1803,0,1803,0,1803,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
0.619729809,2.393040903,TCGA-GL-A59T-01A,TCGA-GL-A59T-01A-21D-A28G-10,0,NA,TCGA-GL-A59T,KIRP,46,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-17142,Alive,TUMOR FREE,546,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,546,0,546,0,546,0,546,NA,Stage I,T1b,MX,KIRP.C1,6
8.908182407,-3.274206464,TCGA-A4-8515-01A,TCGA-A4-8515-01A-11D-2396-08,1,0.709458511,TCGA-A4-8515,KIRP,47,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-17345,Alive,TUMOR FREE,709,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,709,0,709,0,709,0,709,NA,Stage I,T1a,MX,KIRP.C1,1
4.485816489,1.009842932,TCGA-A4-A5Y0-01A,TCGA-A4-A5Y0-01A-11D-A31X-10,2,0.631869342,TCGA-A4-A5Y0,KIRP,61,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-22341,Alive,TUMOR FREE,252,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,252,0,252,0,252,0,252,NA,Stage I,T1b,MX,KIRP.C2b,5
1.195940286,3.455653681,TCGA-IA-A40Y-01A,TCGA-IA-A40Y-01A-11D-A25F-10,0,NA,TCGA-IA-A40Y,KIRP,60,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-21996,Alive,TUMOR FREE,62,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,62,0,62,0,62,0,62,NA,Stage III,T3a,MX,KIRP.C2b,5
-7.817302442,-2.561190799,TCGA-IZ-8196-01A,TCGA-IZ-8196-01A-11D-2396-08,6,0.513684687,TCGA-IZ-8196,KIRP,50,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-18540,Alive,TUMOR FREE,649,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,649,0,649,0,649,0,649,NA,Stage I,T1a,MX,KIRP.C1,2
-7.600388864,2.281536648,TCGA-B5-A11X-01A,TCGA-B5-A11X-01A-11D-A10M-09,9,0.036532314,TCGA-B5-A11X,UCEC,66,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24217,Alive,TUMOR FREE,596,NA,[Not Available],Metastatic,"Other, specify",lymph nodes,397,[Not Available],0,596,0,596,NA,NA,1,397,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
9.847237957,-2.928368399,TCGA-B8-A54I-01A,TCGA-B8-A54I-01A-21D-A33K-10,1,0.766879573,TCGA-B8-A54I,KIRC,48,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2012,[Not Available],-17722,Alive,TUMOR FREE,150,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,150,0,150,0,150,0,150,NA,Stage I,T1b,MX,NA,1
-3.800789436,-2.240158659,TCGA-KU-A66S-01A,TCGA-KU-A66S-01A-21D-A30E-08,8,0.407044904,TCGA-KU-A66S,HNSC,69,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma Basaloid Type,G2,2012,[Not Available],-25454,Dead,WITH TUMOR,NA,406,[Not Available],Distant Metastasis,Distant Metastasis,Brain Metastasis,389,Complete Remission/Response,1,406,1,406,1,389,1,389,NA,Stage III,T1,MX,NA,10
0.131316131,3.244015422,TCGA-C9-A480-01A,TCGA-C9-A480-01A-12D-A24D-08,4,0.370873239,TCGA-C9-A480,HNSC,45,FEMALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-16567,Alive,TUMOR FREE,386,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,386,0,386,0,386,0,386,NA,Stage III,T3,M0,NA,3
-4.192506553,-0.649079026,TCGA-CN-A63U-01A,TCGA-CN-A63U-01A-11D-A30E-08,0,NA,TCGA-CN-A63U,HNSC,50,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-18272,Alive,TUMOR FREE,964,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,964,0,964,NA,NA,0,964,NA,Stage IVA,T3,MX,NA,10
2.009764947,1.898076,TCGA-B2-A4SR-01A,TCGA-B2-A4SR-01A-11D-A25V-10,3,0.584246306,TCGA-B2-A4SR,KIRC,61,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,[Not Available],2012,[Not Available],-22637,Alive,TUMOR FREE,507,NA,[Not Available],NA,NA,NA,266,Complete Remission/Response,0,507,0,507,1,266,1,266,NA,Stage II,T2a,M0,NA,3
2.11745269,1.787580175,TCGA-B8-A54J-01A,TCGA-B8-A54J-01A-11D-A33K-10,3,0.56505825,TCGA-B8-A54J,KIRC,60,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-22071,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,528,0,528,0,528,0,528,NA,Stage II,T2a,MX,NA,3
9.210642392,-2.163851478,TCGA-D1-A0ZZ-01A,TCGA-D1-A0ZZ-01A-11D-A10M-09,1,0.74450537,TCGA-D1-A0ZZ,UCEC,80,FEMALE,WHITE,Mixed serous and endometrioid,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29420,Alive,TUMOR FREE,686,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,686,0,686,0,686,0,686,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN high,3
-0.673985512,4.920001316,TCGA-IQ-A61G-01A,TCGA-IQ-A61G-01A-11D-A30E-08,4,0.545135917,TCGA-IQ-A61G,HNSC,57,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-21066,Alive,WITH TUMOR,360,NA,[Not Available],NA,Oral Cavity,NA,249,Progressive Disease,0,360,0,360,NA,NA,1,249,NA,Stage IVA,T4a,MX,NA,6
-4.569630448,-0.999872541,TCGA-P3-A5Q5-01A,TCGA-P3-A5Q5-01A-11D-A28R-08,8,0.203540601,TCGA-P3-A5Q5,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2004,[Not Available],-19728,Alive,TUMOR FREE,910,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,910,0,910,NA,NA,0,910,NA,Stage IVA,T2,MX,NA,10
-0.409589753,4.678542614,TCGA-04-1649-01A,TCGA-04-1649-01A-01W-0639-09,4,0.553962776,TCGA-04-1649,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-27165,Alive,NA,1966,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1672,[Not Available],0,1966,0,1966,NA,NA,1,1672,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-1.134295716,3.538371769,TCGA-42-2589-01A,TCGA-42-2589-01A-01D-1526-09,4,0.261353298,TCGA-42-2589,OV,54,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-19852,Alive,WITH TUMOR,1278,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],364,Complete Remission/Response,0,1278,0,1278,1,364,1,364,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
0.065757762,3.282123178,TCGA-D6-A4ZB-01A,TCGA-D6-A4ZB-01A-11D-A25D-08,4,0.387699049,TCGA-D6-A4ZB,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-22455,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,376,0,376,0,376,0,376,NA,Stage III,T3,M0,NA,3
0.093754016,5.136725223,TCGA-F7-A620-01A,TCGA-F7-A620-01A-11D-A28R-08,4,0.688294093,TCGA-F7-A620,HNSC,47,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-17475,Alive,TUMOR FREE,543,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,543,0,543,0,543,0,543,NA,Stage III,T3,M0,NA,6
-1.893039718,2.396421661,TCGA-F7-A623-01A,TCGA-F7-A623-01A-11D-A28R-08,0,NA,TCGA-F7-A623,HNSC,70,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-25592,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,616,0,616,NA,NA,0,616,NA,Stage IVA,T1,M0,NA,6
-0.24531472,3.143330252,TCGA-F7-A50I-01A,TCGA-F7-A50I-01A-11D-A28R-08,4,0.234800918,TCGA-F7-A50I,HNSC,72,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-26373,Alive,TUMOR FREE,92,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,92,0,92,NA,NA,0,92,NA,Stage IVA,T4a,M0,NA,3
-4.023724254,-2.195782595,TCGA-BA-A6DA-01A,TCGA-BA-A6DA-01A-31D-A31L-08,8,0.416485672,TCGA-BA-A6DA,HNSC,41,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-15004,Alive,TUMOR FREE,351,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,351,0,351,NA,NA,0,351,NA,Stage IVA,T4a,M0,NA,10
-5.83392163,0.965828978,TCGA-BA-A6DF-01A,TCGA-BA-A6DF-01A-11D-A30E-08,0,NA,TCGA-BA-A6DF,HNSC,80,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-29283,Dead,TUMOR FREE,NA,238,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,238,0,238,NA,NA,0,238,NA,Stage IVA,T4a,M0,NA,9
9.52710906,-3.609353671,TCGA-MT-A51X-01A,TCGA-MT-A51X-01A-11D-A25Y-08,1,0.703474047,TCGA-MT-A51X,HNSC,30,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-10976,Alive,TUMOR FREE,242,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,242,0,242,NA,NA,0,242,NA,Stage IVA,T1,M0,NA,1
-2.967592409,-3.969848925,TCGA-F7-A624-01A,TCGA-F7-A624-01A-22D-A30E-08,8,0.231069469,TCGA-F7-A624,HNSC,73,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2012,[Not Available],-26667,Alive,TUMOR FREE,378,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,378,0,378,0,378,0,378,NA,Stage II,T2,M0,NA,10
4.586628167,0.984611378,TCGA-CJ-5679-01A,TCGA-CJ-5679-01A-11D-1534-10,2,0.642095955,TCGA-CJ-5679,KIRC,73,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2003,[Not Available],-26858,Dead,WITH TUMOR,NA,679,[Not Available],NA,NA,NA,595,[Not Available],1,679,1,679,NA,NA,1,595,NA,Stage III,T3b,M0,KIRC.4,5
0.36866834,4.574167224,TCGA-13-1510-01A,TCGA-13-1510-01A-02W-0545-08,4,0.354293805,TCGA-13-1510,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-22708,Dead,WITH TUMOR,NA,1359,[Not Available],NA,[Not Applicable],[Not Applicable],1189,[Not Available],1,1359,1,1359,NA,NA,1,1189,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
0.043854394,5.113979273,TCGA-BA-A6DB-01A,TCGA-BA-A6DB-01A-11D-A30E-08,4,0.564991356,TCGA-BA-A6DB,HNSC,24,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-8967,Alive,WITH TUMOR,216,NA,[Not Available],Locoregional Disease,Cervical Lymph Nodes,NA,208,Complete Remission/Response,0,216,0,216,1,208,1,208,NA,Stage I,T1,M0,NA,6
-0.32346533,4.658372447,TCGA-F7-A61W-01A,TCGA-F7-A61W-01A-11D-A28R-08,4,0.546754303,TCGA-F7-A61W,HNSC,51,MALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-18879,Alive,TUMOR FREE,14,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,14,0,14,NA,NA,0,14,NA,Stage IVA,T2,M0,NA,6
0.189891472,3.42724238,TCGA-IQ-A61H-01A,TCGA-IQ-A61H-01A-11D-A30E-08,4,0.243566203,TCGA-IQ-A61H,HNSC,76,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-27990,Alive,TUMOR FREE,1138,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1138,0,1138,0,1138,0,1138,NA,Stage II,T2,MX,NA,3
0.132124828,4.824862591,TCGA-IQ-A61O-01A,TCGA-IQ-A61O-01A-11D-A30E-08,4,0.547308867,TCGA-IQ-A61O,HNSC,43,MALE,WHITE,"Head & Neck Squamous Cell Carcinoma, Spindle Cell Variant",GX,2012,[Not Available],-15920,Dead,TUMOR FREE,NA,421,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,421,0,421,NA,NA,0,421,NA,Stage IVA,T2,MX,NA,6
-4.445364621,-0.540440821,TCGA-P3-A5QF-01A,TCGA-P3-A5QF-01A-11D-A28R-08,0,NA,TCGA-P3-A5QF,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-18035,Dead,WITH TUMOR,NA,330,[Not Available],NA,Distant Metastasis,Lung,140,[Unknown],1,330,1,330,NA,NA,1,140,NA,Stage IVA,T4,MX,NA,10
-0.724557361,3.771978611,TCGA-BA-A6DE-01A,TCGA-BA-A6DE-01A-22D-A31L-08,4,0.320254489,TCGA-BA-A6DE,HNSC,70,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-25874,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,440,0,440,0,440,0,440,NA,Stage II,T2,M0,NA,5
1.764989761,1.846165076,TCGA-F7-A61V-01A,TCGA-F7-A61V-01A-11D-A28R-08,3,0.397022301,TCGA-F7-A61V,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-19857,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,759,0,759,0,759,0,759,NA,Stage II,T2,M0,NA,3
-7.653209648,1.954899727,TCGA-BP-4981-01A,TCGA-BP-4981-01A-01D-1462-08,9,0.094462049,TCGA-BP-4981,KIRC,75,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-27676,Dead,TUMOR FREE,NA,1097,[Not Available],NA,NA,NA,NA,[Not Available],1,1097,0,1097,NA,NA,0,1097,NA,Stage III,T3a,M0,KIRC.2,1
-4.381013245,-1.290629631,TCGA-AP-A1DM-01A,TCGA-AP-A1DM-01A-21D-A135-09,8,0.362101146,TCGA-AP-A1DM,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22239,Alive,TUMOR FREE,1700,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1700,0,1700,0,1700,0,1700,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.126286536,-1.36577301,TCGA-F7-A50J-01A,TCGA-F7-A50J-01A-21D-A28R-08,0,NA,TCGA-F7-A50J,HNSC,67,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-24758,Alive,TUMOR FREE,947,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,947,0,947,0,947,0,947,NA,Stage III,T3,M0,NA,2
-0.136541223,4.25548821,TCGA-IQ-A61L-01A,TCGA-IQ-A61L-01A-11D-A30E-08,4,0.434661827,TCGA-IQ-A61L,HNSC,72,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-26506,Alive,WITH TUMOR,416,NA,[Not Available],Locoregional Recurrence,Oral Cavity,NA,156,Progressive Disease,0,416,0,416,NA,NA,1,156,NA,Stage II,T2,M0,NA,6
-0.922803232,3.642009265,TCGA-A6-6652-01A,TCGA-A6-6652-01A-11D-1771-10,4,0.270139339,TCGA-A6-6652,COAD,59,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-21638,Alive,WITH TUMOR,751,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,751,0,751,NA,NA,0,751,NA,Stage IVA,T3,M1,GI.CIN,5
-6.408016659,1.582845832,TCGA-61-2092-01A,TCGA-61-2092-01A-01W-0722-08,10,0.147876924,TCGA-61-2092,OV,57,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-21072,Alive,TUMOR FREE,1573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1573,0,1573,0,1573,0,1573,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,7
-6.531856408,-1.147889665,TCGA-DM-A28M-01A,TCGA-DM-A28M-01A-12D-A16V-10,7,0.228441074,TCGA-DM-A28M,COAD,63,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2003,[Not Available],-23043,Alive,NA,2895,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2895,0,2895,NA,NA,0,2895,NA,Stage IIA,T3,M0,GI.CIN,2
8.71018608,-4.167075249,TCGA-BP-5189-01A,TCGA-BP-5189-01A-02D-1429-08,1,0.73975641,TCGA-BP-5189,KIRC,60,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-22156,Dead,WITH TUMOR,NA,822,[Not Available],NA,NA,NA,634,[Not Available],1,822,1,822,NA,NA,1,634,NA,Stage I,T1b,M0,KIRC.1,1
-0.073956031,5.357834538,TCGA-IQ-A61J-01A,TCGA-IQ-A61J-01A-11D-A30E-08,4,0.625493923,TCGA-IQ-A61J,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-19913,Alive,TUMOR FREE,1021,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1021,0,1021,NA,NA,0,1021,NA,Stage IVA,T2,M0,NA,6
-1.997677837,1.174763258,TCGA-C9-A47Z-01A,TCGA-C9-A47Z-01A-11D-A24D-08,5,0.615776251,TCGA-C9-A47Z,HNSC,72,FEMALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-26592,Dead,TUMOR FREE,NA,191,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,191,0,191,0,191,0,191,NA,Stage III,T2,M0,NA,4
-1.213965919,4.41237699,TCGA-CN-A63Y-01A,TCGA-CN-A63Y-01A-11D-A30E-08,4,0.3588009,TCGA-CN-A63Y,HNSC,46,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-17125,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,504,0,504,0,504,0,504,NA,Stage II,T2,MX,NA,6
-1.640743825,3.829096958,TCGA-CN-A49B-01A,TCGA-CN-A49B-01A-31D-A24D-08,0,NA,TCGA-CN-A49B,HNSC,71,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-26155,Alive,TUMOR FREE,904,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,904,0,904,0,904,0,904,NA,Stage III,T3,MX,NA,6
-6.183544249,1.595722111,TCGA-F7-A61S-01A,TCGA-F7-A61S-01A-11D-A28R-08,10,0.307833557,TCGA-F7-A61S,HNSC,62,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-22655,Alive,TUMOR FREE,576,NA,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,NA,213,Complete Remission/Response,0,576,0,576,1,213,1,213,NA,Stage III,T3,M0,NA,7
-0.818755092,3.337998103,TCGA-BA-A6D8-01A,TCGA-BA-A6D8-01A-31D-A31L-08,4,0.107797528,TCGA-BA-A6D8,HNSC,59,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-21778,Alive,WITH TUMOR,850,NA,[Not Available],Distant Metastasis,Oral Cavity,R Floor of Mouth,849,Complete Remission/Response,0,850,0,850,NA,NA,1,849,NA,Stage IVA,T4a,M0,NA,5
-0.391181991,4.327597824,TCGA-P3-A5Q6-01A,TCGA-P3-A5Q6-01A-11D-A28R-08,4,0.425265495,TCGA-P3-A5Q6,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2005,[Not Available],-17917,Dead,WITH TUMOR,NA,480,[Not Available],NA,Distant Metastasis,Lung,280,Complete Remission/Response,1,480,1,480,NA,NA,1,280,NA,Stage IVA,T4a,MX,NA,6
0.279530569,4.785330045,TCGA-P3-A5QA-01A,TCGA-P3-A5QA-01A-11D-A28R-08,4,0.534458546,TCGA-P3-A5QA,HNSC,41,MALE,[Unknown],Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-15125,Alive,TUMOR FREE,2182,NA,[Not Available],Locoregional Disease,Oral Cavity,tongue,1601,Complete Remission/Response,0,2182,0,2182,1,1601,1,1601,NA,Stage I,T1,MX,NA,6
-3.323853902,-3.232249597,TCGA-CK-6746-01A,TCGA-CK-6746-01A-11D-1835-10,8,0.581882476,TCGA-CK-6746,COAD,84,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-30957,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIB,T4b,MX,GI.HM-indel,10
-3.081942008,-3.610528794,TCGA-AA-A01R-01A,TCGA-AA-A01R-01A-21D-A17O-10,8,0.461242616,TCGA-AA-A01R,COAD,47,MALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2004,[Not Available],-17289,Alive,WITH TUMOR,1065,NA,[Not Available],NA,NA,NA,608,Partial Remission/Response,0,1065,0,1065,NA,NA,1,608,NA,Stage III,T3,M0,GI.HM-indel,10
-0.210381178,4.538905013,TCGA-24-2281-01A,TCGA-24-2281-01A-01W-0799-08,4,0.553922448,TCGA-24-2281,OV,68,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-25019,Alive,TUMOR FREE,1357,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1357,0,1357,0,1357,0,1357,NA,Stage IIA,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-1.882748884,1.278738021,TCGA-13-0899-01A,TCGA-13-0899-01A-01W-0420-08,5,0.568447774,TCGA-13-0899,OV,60,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-22031,Dead,WITH TUMOR,NA,2012,[Not Available],Recurrence,[Not Applicable],[Not Applicable],547,Complete Remission/Response,1,2012,1,2012,1,547,1,547,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,4
9.688011638,-1.239724177,TCGA-CJ-5686-01A,TCGA-CJ-5686-01A-11D-1669-08,1,0.651303651,TCGA-CJ-5686,KIRC,59,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2005,[Not Available],-21836,Alive,TUMOR FREE,2038,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2038,0,2038,NA,NA,0,2038,NA,Stage I,T1b,M0,KIRC.1,1
9.541070254,-3.065216688,TCGA-B8-5549-01A,TCGA-B8-5549-01A-01D-1534-10,1,0.736732253,TCGA-B8-5549,KIRC,53,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-19561,Alive,TUMOR FREE,194,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,194,0,194,0,194,0,194,NA,Stage I,T1b,M0,KIRC.1,1
3.882146314,1.359281142,TCGA-06-0119-01A,TCGA-06-0119-01A-08D-1490-08,0,NA,TCGA-06-0119,GBM,81,FEMALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2005,[Not Available],-29606,Dead,WITH TUMOR,NA,82,[Not Available],NA,NA,NA,NA,[Not Available],1,82,1,82,NA,NA,1,82,NA,NA,NA,NA,NA,5
8.551078825,-1.853594333,TCGA-06-0142-01A,TCGA-06-0142-01A-01D-1490-08,1,0.529628508,TCGA-06-0142,GBM,81,MALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2002,[Not Available],-29642,Dead,WITH TUMOR,NA,67,[Not Available],NA,NA,NA,NA,[Not Available],1,67,1,67,NA,NA,1,67,NA,NA,NA,NA,NA,1
-6.160495779,3.608337527,TCGA-CN-A63V-01A,TCGA-CN-A63V-01A-11D-A28R-08,11,0.43206999,TCGA-CN-A63V,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-21734,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,679,0,679,NA,NA,0,679,NA,Stage IVA,T4a,MX,NA,8
-8.222395511,1.857013659,TCGA-MZ-A6I9-01A,TCGA-MZ-A6I9-01A-11D-A31L-08,9,0.617082203,TCGA-MZ-A6I9,HNSC,68,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-24939,Dead,WITH TUMOR,NA,489,[Not Available],Distant Metastasis,Distant Metastasis,"lung, mediastinal lymph node",246,[Not Applicable],1,489,1,489,NA,NA,1,246,NA,[Not Available],[Not Available],[Not Available],NA,7
9.676373187,-5.783942515,TCGA-06-0165-01A,TCGA-06-0165-01A-01D-1491-08,1,0.83984311,TCGA-06-0165,GBM,52,MALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2001,[Not Available],-19198,Dead,WITH TUMOR,NA,324,[Not Available],NA,NA,NA,NA,[Unknown],1,324,1,324,NA,NA,1,324,NA,NA,NA,NA,NA,1
-1.210946201,3.153176896,TCGA-D5-6924-01A,TCGA-D5-6924-01A-11D-1924-10,0,NA,TCGA-D5-6924,COAD,68,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-24964,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,435,0,435,NA,NA,0,435,NA,Stage IIA,T3,M0,GI.CIN,6
-0.502339849,4.016485578,TCGA-D6-A4Z9-01A,TCGA-D6-A4Z9-01A-11D-A25D-08,4,0.164349956,TCGA-D6-A4Z9,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-21659,Alive,TUMOR FREE,539,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,539,0,539,NA,NA,0,539,NA,Stage IVA,T2,M0,NA,5
9.67450663,-2.403302337,TCGA-P3-A5QE-01A,TCGA-P3-A5QE-01A-11D-A28R-08,1,0.794534888,TCGA-P3-A5QE,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma Basaloid Type,G2,2009,[Not Available],-18002,Alive,TUMOR FREE,1559,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1559,0,1559,0,1559,0,1559,NA,Stage III,T2,MX,NA,1
-4.55503734,-1.499277539,TCGA-IR-A3LI-01A,TCGA-IR-A3LI-01A-11D-A20U-09,8,0.466179486,TCGA-IR-A3LI,CESC,48,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G2,2005,Peri (6-12 months since last menstrual period),-17741,Alive,TUMOR FREE,2493,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2493,0,2493,NA,NA,0,2493,NA,Stage IVB,T2b,M1,NA,10
10.11750127,-1.616438906,TCGA-06-0151-01A,TCGA-06-0151-01A-01D-1491-08,1,0.842781678,TCGA-06-0151,GBM,32,FEMALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],1995,[Not Available],-11956,Dead,WITH TUMOR,NA,1417,[Not Available],NA,NA,NA,NA,[Not Available],1,1417,1,1417,NA,NA,1,1417,NA,NA,NA,NA,NA,1
8.711644363,-1.89715828,TCGA-OX-A56R-01A,TCGA-OX-A56R-01A-11D-A33T-08,1,0.542080584,TCGA-OX-A56R,GBM,68,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-25178,Dead,WITH TUMOR,NA,180,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,180,1,180,NA,NA,1,180,NA,NA,NA,NA,NA,1
-3.267380067,-3.420775901,TCGA-CM-5861-01A,TCGA-CM-5861-01A-01D-1650-10,8,0.535121506,TCGA-CM-5861,COAD,63,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-23253,Alive,TUMOR FREE,457,NA,[Not Available],Locoregional Disease,NA,NA,335,[Not Available],0,457,0,457,NA,NA,1,335,NA,Stage IIA,T3,M0,GI.HM-indel,10
0.493849829,2.22143754,TCGA-AA-3519-01A,TCGA-AA-3519-01A-02D-1953-10,0,NA,TCGA-AA-3519,COAD,63,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-23131,Alive,TUMOR FREE,276,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,276,0,276,0,276,0,276,NA,Stage III,T3,M0,NA,6
0.186641907,3.769755659,TCGA-42-2587-01A,TCGA-42-2587-01A-01D-1526-09,4,0.24246417,TCGA-42-2587,OV,75,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-27510,Alive,TUMOR FREE,722,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,722,0,722,0,722,0,722,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.865380486,-2.354445917,TCGA-61-1915-01A,TCGA-61-1915-01A-01W-0639-09,6,0.083672161,TCGA-61-1915,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-18424,Alive,TUMOR FREE,2061,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2061,0,2061,0,2061,0,2061,NA,Stage IIC,[Not Applicable],[Not Applicable],NA,2
8.962238093,-4.626722734,TCGA-06-0140-01A,TCGA-06-0140-01A-01D-1490-08,1,0.80699126,TCGA-06-0140,GBM,86,MALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2003,[Not Available],-31566,Dead,WITH TUMOR,NA,6,[Not Available],NA,NA,NA,NA,[Not Available],1,6,1,6,NA,NA,1,6,NA,NA,NA,NA,NA,1
8.652813191,-4.911348688,TCGA-06-0240-01A,TCGA-06-0240-01A-03D-1491-08,1,0.762418511,TCGA-06-0240,GBM,57,MALE,WHITE,Glioblastoma Multiforme (GBM),[Not Available],2007,[Not Available],-20937,Dead,WITH TUMOR,NA,621,[Not Available],NA,NA,NA,NA,[Unknown],1,621,1,621,NA,NA,1,621,NA,NA,NA,NA,NA,1
9.521578145,-4.317394469,TCGA-B0-4945-01A,TCGA-B0-4945-01A-01D-1421-08,1,0.716725289,TCGA-B0-4945,KIRC,75,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2003,[Not Available],-27523,Dead,TUMOR FREE,NA,2145,[Not Available],NA,NA,NA,NA,[Not Available],1,2145,0,2145,NA,NA,0,2145,NA,Stage I,T1a,M0,KIRC.1,1
10.03919047,-2.340787649,TCGA-CZ-5452-01A,TCGA-CZ-5452-01A-01D-1501-10,1,0.678123272,TCGA-CZ-5452,KIRC,69,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-25486,Alive,TUMOR FREE,1789,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1789,0,1789,NA,NA,0,1789,NA,Stage II,T2,M0,KIRC.4,1
-5.989995745,3.391105578,TCGA-A6-5664-01A,TCGA-A6-5664-01A-21D-1835-10,11,0.27637077,TCGA-A6-5664,COAD,80,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29426,Alive,WITH TUMOR,672,NA,[Not Available],NA,NA,NA,183,[Not Available],0,672,0,672,NA,NA,1,183,NA,Stage IIIC,T4a,MX,GI.GS,8
-7.190594154,-2.586298541,TCGA-04-1638-01A,TCGA-04-1638-01A-01W-0639-09,6,0.220364729,TCGA-04-1638,OV,57,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2002,[Not Available],-20987,Dead,TUMOR FREE,NA,1686,[Not Available],Recurrence,[Not Applicable],[Not Applicable],298,[Not Available],1,1686,0,1686,NA,NA,1,298,NA,Stage IV,[Not Applicable],[Not Applicable],NA,2
1.14526033,3.515482723,TCGA-CV-6959-01A,TCGA-CV-6959-01A-11D-1912-08,0,NA,TCGA-CV-6959,HNSC,48,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-17679,Dead,WITH TUMOR,NA,256,[Not Available],Locoregional Recurrence,NA,"Rt. Neck mass, skin",103,[Not Available],1,256,1,256,NA,NA,1,103,NA,Stage III,T3,[Not Available],HNSC.Basal,1
-3.491683742,-2.904597465,TCGA-CK-5913-01A,TCGA-CK-5913-01A-11D-1650-10,8,0.475850649,TCGA-CK-5913,COAD,58,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-21399,Alive,TUMOR FREE,1561,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1561,0,1561,0,1561,0,1561,NA,Stage IIA,T3,MX,GI.HM-indel,10
8.63169764,-4.618004819,TCGA-A6-2678-01A,TCGA-A6-2678-01A-01D-1953-10,1,0.716122565,TCGA-A6-2678,COAD,43,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-16030,Alive,TUMOR FREE,1286,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1286,0,1286,0,1286,0,1286,NA,Stage IIIB,T3,M0,NA,1
-7.152320663,-2.492233421,TCGA-EU-5906-01A,TCGA-EU-5906-01A-11D-1669-08,6,0.094600621,TCGA-EU-5906,KIRC,55,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-20246,Alive,TUMOR FREE,206,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,206,0,206,NA,NA,0,206,NA,Stage I,T1b,M0,KIRC.NA,2
0.587044837,2.215075707,TCGA-AA-3684-01A,TCGA-AA-3684-01A-02W-0900-09,0,NA,TCGA-AA-3684,COAD,65,FEMALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2007,[Not Available],-23741,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IV,T4,M1,GI.GS,3
9.137399924,-4.657532957,TCGA-D8-A1XG-01A,TCGA-D8-A1XG-01A-11D-A14G-09,1,0.803094193,TCGA-D8-A1XG,BRCA,86,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31748,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,448,0,448,0,448,0,448,NA,Stage IIIB,T4b,M0,BRCA.LumA,1
-7.520219819,-2.403131074,TCGA-A6-6137-01A,TCGA-A6-6137-01A-11D-1771-10,6,0.267436096,TCGA-A6-6137,COAD,55,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-20095,Alive,TUMOR FREE,824,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,824,0,824,0,824,0,824,NA,Stage IIIB,T3,M0,GI.CIN,2
-5.245548495,2.114595745,TCGA-DM-A1D9-01A,TCGA-DM-A1D9-01A-11D-A152-10,12,0.133158822,TCGA-DM-A1D9,COAD,67,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-24514,Alive,NA,4270,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4270,0,4270,NA,NA,0,4270,NA,Stage IIA,T3,M0,GI.CIN,9
-6.236125142,1.731418981,TCGA-D8-A1JF-01A,TCGA-D8-A1JF-01A-11D-A13L-09,10,0.231765781,TCGA-D8-A1JF,BRCA,79,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29199,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,366,0,366,0,366,0,366,NA,Stage IIIA,T1c,M0,BRCA.Her2,7
-1.434683834,4.011284341,TCGA-F4-6460-01A,TCGA-F4-6460-01A-11D-1771-10,4,0.149617637,TCGA-F4-6460,COAD,51,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-18637,Dead,WITH TUMOR,NA,972,[Not Available],NA,NA,NA,313,Complete Remission/Response,1,972,1,972,1,313,1,313,NA,Stage IIIB,T3,M0,GI.CIN,10
-2.800781966,-4.255298681,TCGA-AZ-4315-01A,TCGA-AZ-4315-01A-01D-1408-10,0,NA,TCGA-AZ-4315,COAD,61,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2006,[Not Available],-22340,Alive,TUMOR FREE,1776,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1776,0,1776,NA,NA,0,1776,NA,Stage IIA,T3,M0,GI.HM-SNV,10
-7.843140507,2.112523228,TCGA-76-4928-01B,TCGA-76-4928-01B-01D-1486-08,9,0.320388604,TCGA-76-4928,GBM,85,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2005,[Not Available],-31267,Dead,WITH TUMOR,94,94,[Not Available],NA,NA,NA,NA,[Not Available],1,94,1,94,NA,NA,1,94,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
9.120945086,-3.900024992,TCGA-E3-A3E0-01A,TCGA-E3-A3E0-01A-11D-A20C-08,1,0.747216915,TCGA-E3-A3E0,THCA,34,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-12645,Alive,TUMOR FREE,2019,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2019,0,2019,0,2019,0,2019,NA,Stage I,T2,MX,THCA.5,1
-4.581393747,1.919504403,TCGA-HD-7229-01A,TCGA-HD-7229-01A-11D-2012-08,0,NA,TCGA-HD-7229,HNSC,60,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-22076,Alive,WITH TUMOR,1027,NA,[Not Available],Locoregional Recurrence,Larynx,NA,162,Progressive Disease,0,1027,0,1027,NA,NA,1,162,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,6
-4.205094608,-1.361974491,TCGA-BS-A0VI-01A,TCGA-BS-A0VI-01A-11D-A14G-09,8,0.181301431,TCGA-BS-A0VI,UCEC,58,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198,Alive,TUMOR FREE,2646,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2646,0,2646,0,2646,0,2646,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-7.346639745,-2.634957603,TCGA-DV-A4VX-01A,TCGA-DV-A4VX-01A-11D-A25V-10,6,0.194042421,TCGA-DV-A4VX,KIRC,59,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G4,2008,[Not Available],-21670,Dead,WITH TUMOR,NA,1626,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1626,1,1626,NA,NA,1,1626,NA,Stage IV,T3b,MX,NA,2
-0.511915068,2.246712977,TCGA-A3-A6NI-01A,TCGA-A3-A6NI-01A-11D-A33K-10,4,0.150218059,TCGA-A3-A6NI,KIRC,47,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2011,[Not Available],-17190,Alive,TUMOR FREE,1018,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1018,0,1018,0,1018,0,1018,NA,Stage I,T1a,MX,NA,3
-5.982736497,3.436656869,TCGA-EY-A72D-01A,TCGA-EY-A72D-01A-12D-A34Q-09,11,0.392786513,TCGA-EY-A72D,UCEC,87,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31818,Alive,TUMOR FREE,179,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,179,0,179,0,179,0,179,NA,Stage II,[Not Applicable],[Not Applicable],NA,8
-6.252122975,1.207281334,TCGA-FI-A3PX-01A,TCGA-FI-A3PX-01A-11D-A228-09,10,0.075944837,TCGA-FI-A3PX,UCEC,57,FEMALE,WHITE,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21063,Alive,TUMOR FREE,2384,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2384,0,2384,0,2384,0,2384,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,7
-3.935290194,-2.438545306,TCGA-PG-A6IB-01A,TCGA-PG-A6IB-01A-21D-A31U-09,8,0.417107509,TCGA-PG-A6IB,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969,Alive,TUMOR FREE,648,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,648,0,648,0,648,0,648,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-4.751926607,-2.009903876,TCGA-34-5928-01A,TCGA-34-5928-01A-11D-1817-08,8,0.125318928,TCGA-34-5928,LUSC,83,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-30334,Alive,TUMOR FREE,1196,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1196,0,1196,0,1196,0,1196,NA,Stage IIB,T2,M0,LUSC.secretory,10
9.461559009,-5.614987182,TCGA-86-A4P8-01A,TCGA-86-A4P8-01A-11D-A24P-08,1,0.859990916,TCGA-86-A4P8,LUAD,59,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-21738,Alive,TUMOR FREE,805,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,805,0,805,0,805,0,805,NA,Stage IIIA,T1b,MX,NA,1
-2.125915966,2.349000942,TCGA-60-2719-01A,TCGA-60-2719-01A-01D-1522-08,0,NA,TCGA-60-2719,LUSC,83,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-30379,Alive,TUMOR FREE,1297,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1297,0,1297,0,1297,0,1297,NA,Stage IB,T1,M0,LUSC.primitive,6
-0.804537798,3.40870109,TCGA-E6-A8L9-01A,TCGA-E6-A8L9-01A-21D-A37N-09,4,0.083107479,TCGA-E6-A8L9,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22333,Alive,TUMOR FREE,1013,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1013,0,1013,0,1013,0,1013,NA,Stage IB,[Not Applicable],[Not Applicable],NA,6
-7.141421637,-2.118227476,TCGA-DS-A0VK-01A,TCGA-DS-A0VK-01A-21D-A10S-08,6,0.270282517,TCGA-DS-A0VK,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,1996,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16792,Dead,WITH TUMOR,NA,1118,NA,Distant Metastasis,"Other, specify",Vagina,209,Progressive Disease,1,1118,1,1118,NA,NA,1,209,NA,Stage IB,T1b1,M0,NA,2
-0.113323705,3.911062303,TCGA-C5-A1MN-01A,TCGA-C5-A1MN-01A-11D-A14W-08,4,0.327129017,TCGA-C5-A1MN,CESC,42,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15499,Dead,TUMOR FREE,NA,1245,NA,NA,NA,NA,NA,Complete Remission/Response,1,1245,0,1245,0,1245,0,1245,NA,Stage IIIB,[Not Available],[Not Available],NA,6
-4.383273982,-1.367761919,TCGA-DS-A0VM-01A,TCGA-DS-A0VM-01A-11D-A10S-08,8,0.382201544,TCGA-DS-A0VM,CESC,51,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18839,Alive,TUMOR FREE,3589,NA,NA,Distant Metastasis,Lung,NA,868,Complete Remission/Response,0,3589,0,3589,1,868,1,868,NA,Stage IB,T1b1,M0,NA,10
9.567730685,-2.574424891,TCGA-T7-A92I-01A,TCGA-T7-A92I-01A-11D-A36X-10,1,0.789164583,TCGA-T7-A92I,KIRC,47,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G1,2013,[Not Available],-17331,Alive,TUMOR FREE,356,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,356,0,356,0,356,0,356,NA,Stage I,T1a,MX,NA,1
-6.202783354,1.147979174,TCGA-EO-A3B1-01A,TCGA-EO-A3B1-01A-12D-A19Y-09,10,0.03245897,TCGA-EO-A3B1,UCEC,63,FEMALE,[Not Available],Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23162,Alive,TUMOR FREE,820,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,820,0,820,0,820,0,820,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
1.133208104,3.456180712,TCGA-FU-A2QG-01A,TCGA-FU-A2QG-01A-11D-A18J-09,0,NA,TCGA-FU-A2QG,CESC,29,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Peri (6-12 months since last menstrual period),-10865,Alive,TUMOR FREE,579,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,579,0,579,0,579,0,579,NA,Stage IB1,T1b1,[Not Available],NA,1
-3.130929809,-3.70382502,TCGA-DR-A0ZM-01A,TCGA-DR-A0ZM-01A-12D-A10S-08,8,0.25877326,TCGA-DR-A0ZM,CESC,61,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22464,Alive,TUMOR FREE,1791,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1791,0,1791,0,1791,0,1791,NA,Stage IIIB,T2b,M0,NA,10
10.02480106,-1.506911611,TCGA-DJ-A3V6-01A,TCGA-DJ-A3V6-01A-11D-A22Z-08,1,0.885948743,TCGA-DJ-A3V6,THCA,54,MALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-19870,Alive,TUMOR FREE,818,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,818,0,818,0,818,0,818,NA,Stage III,T3,M0,NA,1
7.707664728,-1.270813866,TCGA-C5-A1M5-01A,TCGA-C5-A1M5-01A-11D-A13W-08,1,0.096155835,TCGA-C5-A1M5,CESC,53,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,1996,Indeterminate (neither Pre or Postmenopausal),-19672,Dead,WITH TUMOR,NA,2052,Cervical Cancer,Distant Metastasis,"Other, specify",Regional recurrence NOS,693,Complete Remission/Response,1,2052,1,2052,1,693,1,693,NA,Stage IB,T1b,M0,NA,1
-0.871837761,4.533441452,TCGA-C5-A1MF-01A,TCGA-C5-A1MF-01A-11D-A13W-08,1,0.592980592,TCGA-C5-A1MF,CESC,49,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17911,Alive,TUMOR FREE,1617,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1617,0,1617,0,1617,0,1617,NA,Stage IB2,T1b2,MX,NA,6
0.259234577,2.71011798,TCGA-CV-6937-01A,TCGA-CV-6937-01A-11D-2012-08,4,0.174806743,TCGA-CV-6937,HNSC,71,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2003,[Not Available],-26156,Dead,TUMOR FREE,NA,624,[Not Available],NA,NA,NA,NA,[Not Available],1,624,0,624,NA,NA,0,624,NA,Stage II,T2,[Not Available],HNSC.Classical,6
-2.022543953,1.355266556,TCGA-BB-4224-01A,TCGA-BB-4224-01A-01D-1434-08,5,0.559451061,TCGA-BB-4224,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2004,[Not Available],-19119,Alive,WITH TUMOR,278,NA,[Not Available],NA,Oral Cavity,NA,175,Progressive Disease,0,278,0,278,NA,NA,1,175,NA,Stage IVA,T2,[Not Available],HNSC.Basal,4
-0.18023744,3.102089513,TCGA-DQ-7592-01A,TCGA-DQ-7592-01A-11D-2078-08,4,0.293796869,TCGA-DQ-7592,HNSC,57,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-21041,Alive,TUMOR FREE,1143,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1143,0,1143,NA,NA,0,1143,NA,[Not Available],TX,[Not Available],HNSC.Basal,3
-6.075020418,-1.276650079,TCGA-CV-6960-01A,TCGA-CV-6960-01A-41D-2012-08,7,0.065384156,TCGA-CV-6960,HNSC,49,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G3,1999,[Not Available],-18194,Dead,TUMOR FREE,NA,862,[Not Available],NA,NA,NA,NA,[Not Available],1,862,0,862,NA,NA,0,862,NA,Stage III,T3,[Not Available],HNSC.Classical,2
1.002209328,3.590839271,TCGA-CR-6493-01A,TCGA-CR-6493-01A-11D-1870-08,0,NA,TCGA-CR-6493,HNSC,69,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-25432,Dead,WITH TUMOR,NA,282,[Not Available],Locoregional Recurrence,Oral Cavity,Right gingiva,247,Complete Remission/Response,1,282,1,282,NA,NA,1,247,NA,Stage IVA,T3,[Not Available],HNSC.Basal,1
-2.793401885,-4.258895123,TCGA-AX-A06F-01A,TCGA-AX-A06F-01A-11W-A027-09,0,NA,TCGA-AX-A06F,UCEC,59,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21624,Alive,TUMOR FREE,1748,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1748,0,1748,NA,NA,0,1748,NA,Stage IVA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-0.487038102,4.105992513,TCGA-DQ-5624-01A,TCGA-DQ-5624-01A-01D-1870-08,4,0.385314531,TCGA-DQ-5624,HNSC,43,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-15867,Alive,TUMOR FREE,1778,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1778,0,1778,NA,NA,0,1778,NA,[Not Available],TX,[Not Available],HNSC.Basal,6
-6.537117115,1.854255954,TCGA-B5-A3FD-01A,TCGA-B5-A3FD-01A-11D-A19Y-09,10,0.156601619,TCGA-B5-A3FD,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2009,Indeterminate (neither Pre or Postmenopausal),-25813,Dead,TUMOR FREE,NA,1197,[Not Available],Locoregional Recurrence,"Other, specify",endometrium,562,[Not Available],1,1197,0,1197,NA,NA,1,562,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
-3.38052902,-3.230988976,TCGA-B5-A5OC-01A,TCGA-B5-A5OC-01A-21D-A27P-09,8,0.544485073,TCGA-B5-A5OC,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2011,[Not Available],-26109,Alive,TUMOR FREE,1249,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1249,0,1249,NA,NA,0,1249,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,10
-7.446614294,-2.279311,TCGA-B5-A5OD-01A,TCGA-B5-A5OD-01A-11D-A31U-09,6,0.351588084,TCGA-B5-A5OD,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2011,[Not Available],-24775,Alive,TUMOR FREE,1038,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1038,0,1038,NA,NA,0,1038,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
-0.56039332,4.676814859,TCGA-B5-A5OE-01A,TCGA-B5-A5OE-01A-11D-A31U-09,4,0.503456273,TCGA-B5-A5OE,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2011,[Not Available],-24905,Alive,TUMOR FREE,1063,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1063,0,1063,NA,NA,0,1063,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,6
-0.963183704,4.660971964,TCGA-05-5423-01A,TCGA-05-5423-01A-01D-1625-08,4,0.36603979,TCGA-05-5423,LUAD,65,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2006,[Not Available],-23863,Alive,TUMOR FREE,151,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,151,0,151,NA,NA,0,151,NA,Stage IIB,T2,M0,LUAD.5,6
-3.684291119,-2.997432792,TCGA-AJ-A8CW-01A,TCGA-AJ-A8CW-01A-11D-A37N-09,8,0.524768903,TCGA-AJ-A8CW,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23554,Alive,TUMOR FREE,4,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,4,0,4,NA,NA,0,4,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-6.510729243,-1.174988616,TCGA-B5-A3F9-01A,TCGA-B5-A3F9-01A-21D-A228-09,7,0.2871129,TCGA-B5-A3F9,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20523,Alive,TUMOR FREE,4155,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4155,0,4155,NA,NA,0,4155,NA,Stage IB,[Not Applicable],[Not Applicable],NA,2
-3.284648258,-3.17148739,TCGA-98-8021-01A,TCGA-98-8021-01A-11D-2244-08,8,0.513710194,TCGA-98-8021,LUSC,75,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-27738,Alive,TUMOR FREE,937,NA,[Not Available],Locoregional Recurrence,NA,NA,918,Complete Remission/Response,0,937,0,937,1,918,1,918,NA,Stage IA,T1a,M0,NA,10
-2.796217064,-4.261919314,TCGA-B5-A3FA-01A,TCGA-B5-A3FA-01A-11D-A19Y-09,0,NA,TCGA-B5-A3FA,UCEC,73,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26850,Alive,TUMOR FREE,2929,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2929,0,2929,NA,NA,0,2929,NA,Stage IC,[Not Applicable],[Not Applicable],NA,10
-7.896067562,1.92185151,TCGA-B5-A3FB-01A,TCGA-B5-A3FB-01A-11D-A19Y-09,9,0.303463473,TCGA-B5-A3FB,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26779,Alive,TUMOR FREE,2844,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2844,0,2844,NA,NA,0,2844,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
-2.919797892,-4.082549171,TCGA-B5-A1MR-01A,TCGA-B5-A1MR-01A-31D-A14G-09,0,NA,TCGA-B5-A1MR,UCEC,65,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017,Alive,TUMOR FREE,6859,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,6859,0,6859,0,6859,0,6859,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.089200856,3.510708583,TCGA-KS-A41I-01A,TCGA-KS-A41I-01A-11D-A23M-08,11,0.45669153,TCGA-KS-A41I,THCA,47,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2002,[Not Available],-17196,Alive,TUMOR FREE,486,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,486,0,486,0,486,0,486,NA,Stage I,T1,M0,THCA.1,8
-2.91097883,-4.156765814,TCGA-CV-7568-01A,TCGA-CV-7568-01A-11D-2229-08,8,0.270690856,TCGA-CV-7568,HNSC,48,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,1995,[Not Available],-17670,Dead,NA,NA,927,[Not Available],NA,NA,NA,NA,[Not Available],1,927,NA,927,NA,NA,0,927,NA,Stage IVA,T4a,[Not Available],NA,10
9.330766406,-1.965641305,TCGA-A8-A097-01A,TCGA-A8-A097-01A-11W-A050-09,1,0.689562055,TCGA-A8-A097,BRCA,65,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23741,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,0,365,0,365,NA,Stage IIB,T2,M0,BRCA.LumA,6
10.0360051,-1.57574939,TCGA-BJ-A0Z9-01A,TCGA-BJ-A0Z9-01A-11D-A10S-08,1,0.867620249,TCGA-BJ-A0Z9,THCA,57,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010,[Not Available],-21061,Alive,TUMOR FREE,1257,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1257,0,1257,NA,NA,0,1257,NA,Stage III,T3,MX,THCA.4,1
9.01750308,-3.616583704,TCGA-D1-A165-01A,TCGA-D1-A165-01A-11D-A12J-09,1,0.70981311,TCGA-D1-A165,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23526,Alive,TUMOR FREE,20,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,20,0,20,0,20,0,20,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,1
1.52548357,2.163113997,TCGA-41-3392-01A,TCGA-41-3392-01A-01D-1495-08,0,NA,TCGA-41-3392,GBM,88,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-32351,Dead,WITH TUMOR,30,30,[Not Available],NA,NA,NA,NA,[Not Available],1,30,1,30,NA,NA,1,30,NA,NA,NA,NA,NA,3
0.488261605,4.884434197,TCGA-CR-7376-01A,TCGA-CR-7376-01A-11D-2129-08,4,0.487936126,TCGA-CR-7376,HNSC,83,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-30670,Alive,TUMOR FREE,972,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,972,0,972,0,972,0,972,NA,Stage III,T2,M0,HNSC.Mesenchymal,6
10.04192374,-1.47346117,TCGA-EL-A3GU-01A,TCGA-EL-A3GU-01A-11D-A21A-08,1,0.853425073,TCGA-EL-A3GU,THCA,72,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-26632,Alive,WITH TUMOR,4137,NA,[Not Available],Distant Metastasis,Lung,NA,544,[Not Available],0,4137,0,4137,1,544,1,544,NA,Stage III,T3,M0,THCA.4,1
-3.55035048,0.676043187,TCGA-CR-7371-01A,TCGA-CR-7371-01A-11D-2012-08,0,NA,TCGA-CR-7371,HNSC,45,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-16568,Dead,NA,NA,94,[Not Available],NA,NA,NA,NA,[Not Available],1,94,NA,94,NA,NA,0,94,NA,Stage III,T3,M0,HNSC.Atypical,10
9.282755019,-4.28224564,TCGA-CZ-5985-01A,TCGA-CZ-5985-01A-11D-1669-08,1,0.791497839,TCGA-CZ-5985,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-21242,Alive,TUMOR FREE,1997,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1997,0,1997,NA,NA,0,1997,NA,Stage II,T2,M0,KIRC.1,1
9.563206661,-5.359699501,TCGA-55-8619-01A,TCGA-55-8619-01A-11D-2393-08,1,0.782974659,TCGA-55-8619,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26616,Alive,TUMOR FREE,416,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,416,0,416,0,416,0,416,NA,Stage IIB,T3,MX,NA,1
-4.605901016,-0.43844774,TCGA-21-5783-01A,TCGA-21-5783-01A-41D-2184-08,0,NA,TCGA-21-5783,LUSC,76,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-27904,Dead,NA,NA,2680,[Not Available],NA,NA,NA,NA,[Not Available],1,2680,NA,2680,NA,NA,0,2680,NA,Stage IB,T2,M0,NA,10
4.474636287,1.220004651,TCGA-ET-A2N4-01A,TCGA-ET-A2N4-01A-12D-A19J-08,2,0.639785557,TCGA-ET-A2N4,THCA,53,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008,[Not Available],-19671,Alive,TUMOR FREE,81,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,81,0,81,NA,NA,0,81,NA,Stage III,T3,MX,THCA.5,5
-6.36008082,1.861906234,TCGA-EW-A1PC-01B,TCGA-EW-A1PC-01B-11D-A21Q-09,10,0.113312556,TCGA-EW-A1PC,BRCA,66,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24434,Alive,TUMOR FREE,187,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,187,0,187,0,187,0,187,NA,Stage IIB,T3,MX,BRCA.LumB,7
9.850051563,-1.476965201,TCGA-ET-A3BQ-01B,TCGA-ET-A3BQ-01B-11D-A202-08,1,0.823644558,TCGA-ET-A3BQ,THCA,27,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-10034,Alive,TUMOR FREE,2331,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2331,0,2331,0,2331,0,2331,NA,Stage I,T2,MX,THCA.5,1
-3.654544321,-2.581525614,TCGA-D1-A17D-01A,TCGA-D1-A17D-01A-12D-A12J-09,8,0.420118127,TCGA-D1-A17D,UCEC,58,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21441,Alive,TUMOR FREE,926,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,926,0,926,0,926,0,926,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.910627035,3.646275164,TCGA-AA-3679-01A,TCGA-AA-3679-01A-02W-0900-09,4,0.394377994,TCGA-AA-3679,COAD,59,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-21611,Alive,WITH TUMOR,457,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,457,0,457,NA,NA,0,457,NA,Stage IV,T3,M1,GI.CIN,5
-5.848280055,2.855692859,TCGA-BP-4967-01A,TCGA-BP-4967-01A-01D-1462-08,0,NA,TCGA-BP-4967,KIRC,76,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-27857,Alive,TUMOR FREE,205,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,205,0,205,NA,NA,0,205,NA,Stage III,T3a,M0,KIRC.2,7
-5.548665922,1.062675965,TCGA-12-0775-01A,TCGA-12-0775-01A-01W-0348-08,0,NA,TCGA-12-0775,GBM,75,FEMALE,BLACK OR AFRICAN AMERICAN,Untreated primary (de novo) GBM,[Not Available],2004,[Not Available],-27565,Dead,WITH TUMOR,167,232,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],94,[Not Available],1,232,1,232,NA,NA,1,94,NA,NA,NA,NA,NA,10
-7.268953915,2.147799217,TCGA-41-3915-01A,TCGA-41-3915-01A-01D-1353-08,9,0.095212125,TCGA-41-3915,GBM,48,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-17880,Dead,WITH TUMOR,NA,360,[Not Available],Locoregional Disease,[Not Applicable],[Not Applicable],288,[Not Available],1,360,1,360,NA,NA,1,288,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,7
-5.348199758,1.250769884,TCGA-78-7148-01A,TCGA-78-7148-01A-11D-2036-08,0,NA,TCGA-78-7148,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2001,[Not Available],-25990,Dead,NA,NA,626,[Not Available],NA,NA,NA,182,[Not Available],1,626,NA,626,NA,NA,1,182,NA,Stage IIB,T2,M0,LUAD.1,10
-0.923426349,3.737557568,TCGA-61-2613-01A,TCGA-61-2613-01A-01W-1092-09,4,0.348646225,TCGA-61-2613,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1998,[Not Available],-26779,Dead,WITH TUMOR,945,945,[Not Available],Recurrence,[Not Applicable],[Not Applicable],358,Stable Disease,1,945,1,945,NA,NA,1,358,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-5.314474776,-1.829361956,TCGA-77-7337-01A,TCGA-77-7337-01A-21D-2042-08,0,NA,TCGA-77-7337,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2000,[Not Available],-24065,Dead,NA,NA,3253,[Not Available],NA,NA,NA,NA,[Not Available],1,3253,NA,3253,NA,NA,0,3253,NA,Stage IIB,T2,M0,NA,10
10.1365513,-1.747253214,TCGA-DJ-A3V7-01A,TCGA-DJ-A3V7-01A-11D-A23M-08,1,0.873142305,TCGA-DJ-A3V7,THCA,44,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-16257,Alive,TUMOR FREE,706,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,706,0,706,0,706,0,706,NA,Stage III,T3,M0,THCA.3,1
-5.821785424,2.964318783,TCGA-CM-4744-01A,TCGA-CM-4744-01A-01D-1408-10,0,NA,TCGA-CM-4744,COAD,69,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-25506,Alive,TUMOR FREE,609,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,609,0,609,0,609,0,609,NA,Stage I,T2,M0,GI.CIN,9
-7.497777793,2.282038221,TCGA-A5-A0GX-01A,TCGA-A5-A0GX-01A-11W-A062-09,9,0.029190411,TCGA-A5-A0GX,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19625,Alive,TUMOR FREE,2088,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2088,0,2088,0,2088,0,2088,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
2.981275206,3.567328558,TCGA-AR-A24X-01A,TCGA-AR-A24X-01A-11D-A167-09,0,NA,TCGA-AR-A24X,BRCA,52,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030,Alive,TUMOR FREE,3004,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3004,0,3004,0,3004,0,3004,NA,Stage IIA,T2,M0,BRCA.LumA,1
9.948919369,-2.166806875,TCGA-DJ-A2PS-01A,TCGA-DJ-A2PS-01A-11D-A18F-08,1,0.797680256,TCGA-DJ-A2PS,THCA,40,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-14916,Alive,TUMOR FREE,797,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,797,0,797,0,797,0,797,NA,Stage I,T3,M0,THCA.2,1
-4.195760239,-2.310520411,TCGA-DJ-A2QB-01A,TCGA-DJ-A2QB-01A-11D-A19J-08,8,0.381034597,TCGA-DJ-A2QB,THCA,53,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-19601,Alive,TUMOR FREE,1070,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1070,0,1070,NA,NA,0,1070,NA,Stage IVA,T3,M0,THCA.1,10
8.944684363,-2.564441276,TCGA-CQ-6227-01A,TCGA-CQ-6227-01A-11D-1912-08,1,0.677946887,TCGA-CQ-6227,HNSC,77,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-28466,Dead,WITH TUMOR,NA,129,[Not Available],NA,NA,NA,NA,Progressive Disease,1,129,1,129,NA,NA,1,129,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,1
-7.437323492,2.223547024,TCGA-D1-A16B-01A,TCGA-D1-A16B-01A-11D-A12J-09,9,0.032766946,TCGA-D1-A16B,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23450,Alive,TUMOR FREE,1106,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1106,0,1106,0,1106,0,1106,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.CN low,7
9.170152217,-5.283067439,TCGA-CR-7392-01A,TCGA-CR-7392-01A-11D-2012-08,1,0.788377929,TCGA-CR-7392,HNSC,67,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2009,[Not Available],-24650,Alive,TUMOR FREE,1425,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1425,0,1425,NA,NA,0,1425,NA,Stage IVA,T3,M0,HNSC.Mesenchymal,1
-7.922846875,2.145530811,TCGA-06-6388-01A,TCGA-06-6388-01A-12D-1845-08,9,0.544108702,TCGA-06-6388,GBM,64,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2011,[Not Available],-23519,Dead,WITH TUMOR,120,159,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],85,[Not Available],1,159,1,159,NA,NA,1,85,NA,NA,NA,NA,NA,7
0.304991745,4.673405975,TCGA-29-2432-01A,TCGA-29-2432-01A-01D-1526-09,4,0.593452503,TCGA-29-2432,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-22605,Dead,WITH TUMOR,360,653,[Not Available],Recurrence,[Not Applicable],[Not Applicable],174,Progressive Disease,1,653,1,653,NA,NA,1,174,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-0.636097319,2.260142751,TCGA-DS-A3LQ-01A,TCGA-DS-A3LQ-01A-21D-A21Q-09,4,0.092602038,TCGA-DS-A3LQ,CESC,46,FEMALE,[Not Available],Cervical Squamous Cell Carcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16861,Alive,TUMOR FREE,699,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,699,0,699,0,699,0,699,NA,Stage IIIB,T3b,M0,NA,5
-1.888558081,0.976739159,TCGA-DS-A1OD-01A,TCGA-DS-A1OD-01A-11D-A14W-08,5,0.491432716,TCGA-DS-A1OD,CESC,49,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17954,Alive,TUMOR FREE,3874,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,3874,0,3874,0,3874,0,3874,NA,Stage IB1,T1b1,M0,NA,4
-0.814538078,2.375428809,TCGA-FU-A3NI-01A,TCGA-FU-A3NI-01A-11D-A21Q-09,0,NA,TCGA-FU-A3NI,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533,Dead,TUMOR FREE,NA,638,NA,NA,NA,NA,NA,[Not Available],1,638,0,638,NA,NA,0,638,NA,Stage IB1,T1b1,MX,NA,6
-4.440810642,-1.523923419,TCGA-C5-A1MK-01A,TCGA-C5-A1MK-01A-11D-A14W-08,8,0.425382008,TCGA-C5-A1MK,CESC,79,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28939,Dead,WITH TUMOR,NA,74,Cervical Cancer,NA,NA,NA,NA,Progressive Disease,1,74,1,74,NA,NA,1,74,NA,Stage IIIB,[Not Available],[Not Available],NA,10
-1.414155333,3.115579635,TCGA-CN-4734-01A,TCGA-CN-4734-01A-01D-1434-08,4,0.037134702,TCGA-CN-4734,HNSC,70,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-25753,Alive,TUMOR FREE,1690,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1690,0,1690,0,1690,0,1690,NA,Stage II,T2,[Not Available],NA,6
-4.449263782,-1.444876725,TCGA-22-5472-01A,TCGA-22-5472-01A-01D-1632-08,8,0.338254667,TCGA-22-5472,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-24482,Dead,TUMOR FREE,NA,1975,[Not Available],NA,NA,NA,746,Complete Remission/Response,1,1975,0,1975,1,746,1,746,NA,Stage IB,T2a,M0,LUSC.basal,10
9.809997642,-1.707638397,TCGA-EL-A4KH-01A,TCGA-EL-A4KH-01A-11D-A257-08,1,0.841938512,TCGA-EL-A4KH,THCA,36,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-13275,Alive,TUMOR FREE,823,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,823,0,823,0,823,0,823,NA,Stage I,T2,M0,THCA.5,1
-6.069972865,3.192479722,TCGA-FU-A3EO-01A,TCGA-FU-A3EO-01A-11D-A20U-09,11,0.073717007,TCGA-FU-A3EO,CESC,55,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20207,Alive,TUMOR FREE,490,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,490,0,490,0,490,0,490,NA,Stage IIB,T2b,MX,NA,8
-1.268034767,3.181368189,TCGA-39-5037-01A,TCGA-39-5037-01A-01D-1441-08,0,NA,TCGA-39-5037,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-23868,Alive,TUMOR FREE,1690,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1690,0,1690,0,1690,0,1690,NA,Stage IIA,T1b,M0,LUSC.classical,6
-5.390639785,0.697068881,TCGA-FU-A3HY-01A,TCGA-FU-A3HY-01A-11D-A21Q-09,0,NA,TCGA-FU-A3HY,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17228,Alive,TUMOR FREE,954,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,954,0,954,0,954,0,954,NA,Stage IB2,T1b2,MX,NA,10
-7.442508471,-2.314569396,TCGA-CZ-4865-01A,TCGA-CZ-4865-01A-02D-1501-10,6,0.297858417,TCGA-CZ-4865,KIRC,70,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-25709,Dead,TUMOR FREE,NA,166,[Not Available],NA,NA,NA,NA,[Not Available],1,166,0,166,NA,NA,0,166,NA,Stage I,T1a,M0,NA,2
-1.88270163,1.924936794,TCGA-FU-A23L-01A,TCGA-FU-A23L-01A-11D-A16O-08,0,NA,TCGA-FU-A23L,CESC,60,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21962,Alive,TUMOR FREE,725,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,725,0,725,0,725,0,725,NA,Stage IIA1,T2a1,MX,NA,6
-0.748443568,3.561493782,TCGA-42-2582-01A,TCGA-42-2582-01A-01D-1526-09,4,0.231793843,TCGA-42-2582,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-17961,Dead,WITH TUMOR,NA,1447,[Not Available],Recurrence,[Not Applicable],[Not Applicable],616,Stable Disease,1,1447,1,1447,NA,NA,1,616,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
4.009470806,1.450451614,TCGA-BI-A0VR-01A,TCGA-BI-A0VR-01A-11D-A10S-08,2,0,TCGA-BI-A0VR,CESC,53,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19473,Alive,TUMOR FREE,1505,NA,NA,NA,NA,NA,NA,[Not Available],0,1505,0,1505,NA,NA,0,1505,NA,Stage IIIB,T2b,M0,NA,5
-6.401583292,-1.281448815,TCGA-EA-A3HT-01A,TCGA-EA-A3HT-01A-61D-A21Q-09,7,0.354649276,TCGA-EA-A3HT,CESC,68,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G1,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25138,Alive,TUMOR FREE,954,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,954,0,954,0,954,0,954,NA,Stage IB,T1b,M0,NA,2
-5.736177463,1.635458637,TCGA-CV-7406-01A,TCGA-CV-7406-01A-11D-2078-08,0,NA,TCGA-CV-7406,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,1999,[Not Available],-18250,Dead,NA,NA,1748,[Not Available],NA,NA,NA,NA,[Not Available],1,1748,NA,1748,NA,NA,0,1748,NA,Stage II,T2,[Not Available],HNSC.Atypical,9
-7.293977117,-2.20648683,TCGA-DS-A0VN-01A,TCGA-DS-A0VN-01A-21D-A10S-08,6,0.219447769,TCGA-DS-A0VN,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17433,Alive,TUMOR FREE,3609,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,3609,0,3609,0,3609,0,3609,NA,Stage IB,T1b2,M0,NA,2
-7.566121097,-2.450092861,TCGA-09-0365-01A,TCGA-09-0365-01A-02W-0371-08,6,0.526352454,TCGA-09-0365,OV,70,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-25703,Dead,WITH TUMOR,NA,288,[Not Available],Recurrence,[Not Applicable],[Not Applicable],251,Complete Remission/Response,1,288,1,288,1,251,1,251,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
9.622813942,-4.119157777,TCGA-BI-A0VS-01A,TCGA-BI-A0VS-01A-11D-A10S-08,1,0.694934437,TCGA-BI-A0VS,CESC,48,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17839,Alive,TUMOR FREE,1735,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1735,0,1735,0,1735,0,1735,NA,Stage IB,T1b1,M0,NA,1
-5.784431471,2.900093493,TCGA-C5-A1BK-01B,TCGA-C5-A1BK-01B-11D-A13W-08,0,NA,TCGA-C5-A1BK,CESC,36,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,1994,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13297,Alive,TUMOR FREE,5385,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,5385,0,5385,0,5385,0,5385,NA,Stage IB,T1b,MX,NA,3
-3.252594405,-3.360596508,TCGA-EA-A3HS-01A,TCGA-EA-A3HS-01A-11D-A20U-09,8,0.50900591,TCGA-EA-A3HS,CESC,35,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G1,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13117,Alive,TUMOR FREE,959,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,959,0,959,0,959,0,959,NA,Stage IB,T1b,M0,NA,10
-3.464629567,-3.009336702,TCGA-49-6743-01A,TCGA-49-6743-01A-11D-1855-08,8,0.48992759,TCGA-49-6743,LUAD,81,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-29807,Alive,TUMOR FREE,1621,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1621,0,1621,0,1621,0,1621,NA,Stage IIIA,T1,MX,NA,10
-6.146365486,3.579986349,TCGA-EL-A3T2-01A,TCGA-EL-A3T2-01A-11D-A22D-08,11,0.5316022,TCGA-EL-A3T2,THCA,55,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-20403,Alive,WITH TUMOR,988,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,pretracheal lymph node,903,[Not Available],0,988,0,988,1,903,1,903,NA,Stage III,T2,M0,THCA.1,8
9.828714479,-1.698114775,TCGA-DJ-A2PZ-01A,TCGA-DJ-A2PZ-01A-21D-A18F-08,1,0.870961502,TCGA-DJ-A2PZ,THCA,63,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-23332,Alive,TUMOR FREE,256,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,256,0,256,0,256,0,256,NA,Stage III,T3,M0,THCA.4,1
1.983933598,1.828013424,TCGA-EM-A22M-01A,TCGA-EM-A22M-01A-11D-A17V-08,3,0.320037308,TCGA-EM-A22M,THCA,52,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-19059,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,442,0,442,0,442,0,442,NA,Stage I,T1b,MX,THCA.NA,3
-4.764559022,-0.416785402,TCGA-EB-A3Y6-01A,TCGA-EB-A3Y6-01A-21D-A23B-08,0,NA,TCGA-EB-A3Y6,SKCM,56,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-20605,Alive,TUMOR FREE,126,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,126,0,126,NA,NA,0,126,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
8.659561295,-3.621629899,TCGA-EM-A22N-01A,TCGA-EM-A22N-01A-11D-A17V-08,1,0.703245419,TCGA-EM-A22N,THCA,68,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-25035,Alive,TUMOR FREE,324,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,324,0,324,NA,NA,0,324,NA,Stage I,T1b,MX,THCA.1,1
10.04416341,-1.529244958,TCGA-J8-A3YD-01A,TCGA-J8-A3YD-01A-11D-A22Z-08,1,0.831451028,TCGA-J8-A3YD,THCA,47,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-17416,Alive,TUMOR FREE,968,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,968,0,968,0,968,0,968,NA,Stage III,T1b,M0,THCA.2,1
9.588512898,-5.060031454,TCGA-BJ-A0ZF-01A,TCGA-BJ-A0ZF-01A-11D-A10S-08,1,0.801232308,TCGA-BJ-A0ZF,THCA,54,FEMALE,WHITE,"Other, specify",[Not Available],2010,[Not Available],-19978,Alive,WITH TUMOR,1217,NA,[Not Available],Locoregional Recurrence,NA,NA,735,[Not Available],0,1217,0,1217,1,735,1,735,NA,Stage II,T2,M0,NA,1
-5.620903523,3.024472796,TCGA-91-6849-01A,TCGA-91-6849-01A-11D-1945-08,12,0.075428353,TCGA-91-6849,LUAD,75,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-27676,Alive,NA,35,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,35,0,35,NA,NA,0,35,NA,Stage IIIA,T2,MX,LUAD.4,8
-1.390480852,3.46430112,TCGA-39-5021-01A,TCGA-39-5021-01A-01D-1441-08,4,0.13627027,TCGA-39-5021,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-25895,Dead,WITH TUMOR,2057,2086,[Not Available],NA,NA,NA,1875,Complete Remission/Response,1,2086,1,2086,1,1875,1,1875,NA,Stage IB,T2a,M0,LUSC.primitive,6
9.795811521,-1.687522971,TCGA-EL-A3CU-01A,TCGA-EL-A3CU-01A-11D-A19J-08,1,0.864338013,TCGA-EL-A3CU,THCA,70,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000,[Not Available],-25881,Alive,TUMOR FREE,4780,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4780,0,4780,0,4780,0,4780,NA,Stage III,T1,M0,THCA.4,1
-8.07978661,1.982538374,TCGA-FE-A237-01A,TCGA-FE-A237-01A-11D-A16O-08,9,0.523267099,TCGA-FE-A237,THCA,19,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-7207,Alive,TUMOR FREE,3431,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,492,[Not Available],0,3431,0,3431,1,492,1,492,NA,Stage I,T3,MX,THCA.4,7
9.656603336,-4.398010565,TCGA-12-1093-01A,TCGA-12-1093-01A-01W-0611-08,1,0.684294027,TCGA-12-1093,GBM,66,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2006,[Not Available],-24297,Dead,WITH TUMOR,364,486,[Not Available],Recurrence,[Not Applicable],[Not Applicable],322,[Not Available],1,486,1,486,NA,NA,1,322,NA,NA,NA,NA,NA,6
9.978508912,-1.70529732,TCGA-IM-A3EB-01A,TCGA-IM-A3EB-01A-11D-A202-08,1,0.875658689,TCGA-IM-A3EB,THCA,32,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-11822,Alive,TUMOR FREE,1488,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1488,0,1488,0,1488,0,1488,NA,Stage I,T3,MX,THCA.4,1
2.057094843,1.822327285,TCGA-DJ-A1QE-01A,TCGA-DJ-A1QE-01A-21D-A14W-08,3,0.371438611,TCGA-DJ-A1QE,THCA,62,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003,[Not Available],-22645,Alive,TUMOR FREE,4134,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4134,0,4134,0,4134,0,4134,NA,Stage III,T3,M0,THCA.4,3
8.832873017,-5.124883278,TCGA-BG-A0MT-01A,TCGA-BG-A0MT-01A-11D-A10B-09,1,0.762550304,TCGA-BG-A0MT,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23574,Alive,TUMOR FREE,644,NA,[Not Available],Locoregional Disease,"Other, specify",locally in the endometrium,565,Partial Remission/Response,0,644,0,644,NA,NA,1,565,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,1
8.712169321,-1.849461486,TCGA-91-6835-01A,TCGA-91-6835-01A-11D-1855-08,1,0.5317854,TCGA-91-6835,LUAD,81,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-29887,Alive,TUMOR FREE,79,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,79,0,79,0,79,0,79,NA,Stage IA,T1,M0,LUAD.5,6
10.07989557,-1.426791812,TCGA-EL-A3MW-01A,TCGA-EL-A3MW-01A-11D-A20C-08,1,0.873090923,TCGA-EL-A3MW,THCA,55,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2003,[Not Available],-20186,Alive,TUMOR FREE,3305,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3305,0,3305,0,3305,0,3305,NA,Stage II,T2,M0,THCA.5,1
9.383436989,-2.639577208,TCGA-BJ-A0ZB-01A,TCGA-BJ-A0ZB-01A-11D-A10S-08,1,0.775575598,TCGA-BJ-A0ZB,THCA,66,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-24415,Alive,TUMOR FREE,122,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,122,0,122,NA,NA,0,122,NA,Stage IVA,T3,M0,THCA.4,1
7.837137486,-3.451357646,TCGA-19-5951-01A,TCGA-19-5951-01A-11D-1696-08,1,0.392238404,TCGA-19-5951,GBM,76,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-27995,Dead,WITH TUMOR,244,244,[Not Available],NA,NA,NA,NA,[Not Available],1,244,1,244,NA,NA,1,244,NA,NA,NA,NA,NA,1
0.535978048,2.240493414,TCGA-EM-A2CJ-01A,TCGA-EM-A2CJ-01A-11D-A17V-08,0,NA,TCGA-EM-A2CJ,THCA,49,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-18168,Alive,TUMOR FREE,1447,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1447,0,1447,0,1447,0,1447,NA,Stage I,T1b,MX,THCA.1,3
-3.744754075,-2.489535552,TCGA-BG-A0M4-01A,TCGA-BG-A0M4-01A-11W-A10C-09,8,0.412290341,TCGA-BG-A0M4,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22090,Alive,TUMOR FREE,2167,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2167,0,2167,0,2167,0,2167,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
9.312863756,-4.868816493,TCGA-EL-A3GO-01A,TCGA-EL-A3GO-01A-11D-A202-08,1,0.7642774,TCGA-EL-A3GO,THCA,31,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-11604,Alive,WITH TUMOR,1973,NA,[Not Available],Locoregional Recurrence,NA,Lt. Thyroid,6,[Not Available],0,1973,0,1973,1,6,1,6,NA,Stage I,T2,M0,THCA.1,1
-4.483041754,-0.343068486,TCGA-52-7810-01A,TCGA-52-7810-01A-11D-2122-08,0,NA,TCGA-52-7810,LUSC,60,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-22241,Alive,TUMOR FREE,923,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,923,0,923,0,923,0,923,NA,Stage IIB,T3,M0,NA,10
0.126230309,5.17273134,TCGA-AJ-A3EM-01A,TCGA-AJ-A3EM-01A-11D-A20S-09,4,0.687724686,TCGA-AJ-A3EM,UCEC,69,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25557,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,677,0,677,0,677,0,677,NA,Stage IB,[Not Applicable],[Not Applicable],NA,6
-3.471668943,-3.064088236,TCGA-44-2656-01A,TCGA-44-2656-01A-41D-A27T-08,8,0.620655387,TCGA-44-2656,LUAD,59,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-21766,Alive,TUMOR FREE,1429,NA,[Not Available],New Primary Tumor,NA,NA,568,Complete Remission/Response,0,1429,0,1429,0,1429,1,568,NA,Stage IB,T2,M0,LUAD.3,10
9.150927288,-3.826473117,TCGA-ZP-A9D0-01A,TCGA-ZP-A9D0-01A-11D-A36X-10,1,0.721373695,TCGA-ZP-A9D0,LIHC,67,FEMALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G1,2011,[Not Available],-24525,Alive,TUMOR FREE,1091,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1091,0,1091,0,1091,0,1091,NA,[Not Available],T1,MX,NA,1
-1.511154813,3.926258542,TCGA-ZP-A9D1-01A,TCGA-ZP-A9D1-01A-11D-A382-10,4,0.073219072,TCGA-ZP-A9D1,LIHC,56,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-20584,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,21,0,21,0,21,0,21,NA,[Not Available],T1,MX,NA,6
-0.747331757,3.849483585,TCGA-ZP-A9D2-01A,TCGA-ZP-A9D2-01A-11D-A382-10,4,0.32852411,TCGA-ZP-A9D2,LIHC,51,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-18717,Dead,WITH TUMOR,NA,765,[Not Available],Intrahepatic Recurrence,Liver,NA,315,[Not Available],1,765,1,765,1,315,1,315,NA,[Not Available],T2,MX,NA,5
4.212215284,1.17412764,TCGA-ZS-A9CD-01A,TCGA-ZS-A9CD-01A-11D-A36X-10,2,0.723830718,TCGA-ZS-A9CD,LIHC,73,MALE,WHITE,Hepatocellular Carcinoma,G2,2010,[Not Available],-26915,Dead,NA,NA,1386,[Not Available],Intrahepatic Recurrence,Liver,NA,371,[Not Available],1,1386,NA,1386,1,371,1,371,NA,Stage II,T2,MX,NA,5
-7.645453279,-2.393508338,TCGA-ZS-A9CG-01A,TCGA-ZS-A9CG-01A-11D-A36X-10,6,0.344453162,TCGA-ZS-A9CG,LIHC,55,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-20100,Alive,TUMOR FREE,341,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,341,0,341,0,341,0,341,NA,Stage II,T2,MX,NA,2
9.883540153,-2.539812926,TCGA-CE-A482-01A,TCGA-CE-A482-01A-11D-A23U-08,1,0.73797034,TCGA-CE-A482,THCA,27,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-10192,Alive,TUMOR FREE,325,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,325,0,325,0,325,0,325,NA,Stage I,T1,M0,THCA.5,1
-6.565639369,-1.2365868,TCGA-AP-A1E3-01A,TCGA-AP-A1E3-01A-11D-A135-09,7,0.294293439,TCGA-AP-A1E3,UCEC,45,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16544,Alive,WITH TUMOR,847,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,847,0,847,NA,NA,0,847,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.Notassigned,2
10.07337211,-1.930687862,TCGA-FY-A3R8-01A,TCGA-FY-A3R8-01A-11D-A21Z-08,1,0.846310652,TCGA-FY-A3R8,THCA,62,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-22824,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,477,0,477,0,477,0,477,NA,Stage III,T3,MX,THCA.4,1
8.898294762,-1.978127367,TCGA-06-0878-01A,TCGA-06-0878-01A-01D-1492-08,1,0.65895252,TCGA-06-0878,GBM,74,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-27319,Alive,WITH TUMOR,218,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],66,[Not Available],0,218,0,218,NA,NA,1,66,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-0.094759629,4.657913573,TCGA-WQ-AB4B-01A,TCGA-WQ-AB4B-01A-11D-A40P-10,4,0.543701088,TCGA-WQ-AB4B,LIHC,62,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-22769,Alive,WITH TUMOR,395,NA,[Not Available],Intrahepatic Recurrence,NA,NA,273,[Not Available],0,395,0,395,1,273,1,273,NA,Stage II,T2,M0,NA,6
8.005566742,-2.352628094,TCGA-ZP-A9CV-01A,TCGA-ZP-A9CV-01A-11D-A382-10,1,0.414767699,TCGA-ZP-A9CV,LIHC,59,MALE,WHITE,Hepatocellular Carcinoma,G1,2011,[Not Available],-21633,Dead,WITH TUMOR,NA,1088,[Not Available],NA,NA,NA,NA,[Not Available],1,1088,1,1088,NA,NA,1,1088,NA,[Not Available],T1,MX,NA,6
10.28506749,-1.877908481,TCGA-ZP-A9CY-01A,TCGA-ZP-A9CY-01A-11D-A382-10,1,0.765150386,TCGA-ZP-A9CY,LIHC,66,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2011,[Not Available],-24223,Alive,TUMOR FREE,782,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,782,0,782,0,782,0,782,NA,[Not Available],T1,MX,NA,1
4.235003441,1.245214555,TCGA-50-6597-01A,TCGA-50-6597-01A-11D-1855-08,2,0.652241033,TCGA-50-6597,LUAD,79,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-29195,Dead,TUMOR FREE,NA,1268,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,1268,0,1268,NA,NA,0,1268,NA,Stage IB,T2,M0,LUAD.5,5
1.713186832,2.032625265,TCGA-UB-A7ME-01A,TCGA-UB-A7ME-01A-11D-A33K-10,3,0.437452016,TCGA-UB-A7ME,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-18846,Alive,TUMOR FREE,486,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,486,0,486,0,486,0,486,NA,Stage I,T1,MX,LIHC.iCluster:1,3
-5.546159988,1.643390006,TCGA-UB-A7MF-01A,TCGA-UB-A7MF-01A-11D-A33K-10,0,NA,TCGA-UB-A7MF,LIHC,56,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-20815,Dead,WITH TUMOR,NA,214,[Not Available],Intrahepatic Recurrence,Liver,NA,133,[Not Available],1,214,1,214,1,133,1,133,NA,Stage IIIA,T3a,MX,LIHC.iCluster:1,9
-0.900766315,4.576890694,TCGA-85-8048-01A,TCGA-85-8048-01A-11D-2244-08,4,0.37709873,TCGA-85-8048,LUSC,62,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-22907,Alive,TUMOR FREE,765,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,765,0,765,0,765,0,765,NA,Stage IA,T1,M0,NA,5
-7.928587774,-2.518907207,TCGA-UB-AA0V-01A,TCGA-UB-AA0V-01A-11D-A382-10,6,0.470380988,TCGA-UB-AA0V,LIHC,69,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2013,[Not Available],-25340,Alive,TUMOR FREE,314,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,314,0,314,0,314,0,314,NA,Stage I,[Discrepancy],MX,NA,2
-3.921702415,-1.632051295,TCGA-WQ-A9G7-01A,TCGA-WQ-A9G7-01A-11D-A36X-10,8,0.340072398,TCGA-WQ-A9G7,LIHC,71,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2013,[Not Available],NA,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,0,30,0,30,NA,[Not Available],T3a,M0,NA,10
9.931199148,-1.697654392,TCGA-EL-A3N3-01A,TCGA-EL-A3N3-01A-11D-A20C-08,1,0.840546676,TCGA-EL-A3N3,THCA,53,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2000,[Not Available],-19513,Alive,TUMOR FREE,5423,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5423,0,5423,0,5423,0,5423,NA,Stage II,T3,M0,THCA.4,1
9.578360215,-5.025941936,TCGA-14-1037-01A,TCGA-14-1037-01A-01W-0643-08,1,0.812669464,TCGA-14-1037,GBM,66,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2002,[Not Available],-24426,Dead,WITH TUMOR,587,587,[Not Available],Recurrence,[Not Applicable],[Not Applicable],326,[Not Available],1,587,1,587,NA,NA,1,326,NA,NA,NA,NA,NA,1
-0.865315077,3.691283389,TCGA-CV-6934-01A,TCGA-CV-6934-01A-11D-1912-08,4,0.297502824,TCGA-CV-6934,HNSC,66,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1998,[Not Available],-24180,Dead,WITH TUMOR,NA,65,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,65,1,65,NA,NA,1,65,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,5
-5.094777804,-1.714529695,TCGA-DI-A1NO-01A,TCGA-DI-A1NO-01A-31D-A159-09,8,0.032186284,TCGA-DI-A1NO,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24996,Dead,WITH TUMOR,NA,285,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,285,1,285,NA,NA,1,285,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
0.325564068,4.52917271,TCGA-D1-A16I-01A,TCGA-D1-A16I-01A-11D-A12J-09,4,0.60559976,TCGA-D1-A16I,UCEC,62,FEMALE,WHITE,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22836,Dead,TUMOR FREE,NA,350,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,350,0,350,0,350,0,350,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.CN high,6
9.938248283,-2.08888564,TCGA-GE-A2C6-01A,TCGA-GE-A2C6-01A-11D-A17V-08,1,0.823692661,TCGA-GE-A2C6,THCA,33,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-12068,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,381,0,381,NA,NA,0,381,NA,Stage I,T2,MX,THCA.4,1
8.88125256,-1.902961835,TCGA-19-2624-01A,TCGA-19-2624-01A-01D-1495-08,1,0.655693847,TCGA-19-2624,GBM,51,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-18891,Dead,TUMOR FREE,5,5,[Not Available],NA,NA,NA,NA,[Not Available],1,5,0,5,NA,NA,0,5,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-1.013756048,4.839708894,TCGA-RG-A7D4-01A,TCGA-RG-A7D4-01A-12D-A33Q-10,4,0.389039938,TCGA-RG-A7D4,LIHC,69,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-25302,Alive,TUMOR FREE,1098,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1098,0,1098,0,1098,0,1098,NA,Stage II,T2,M0,LIHC.iCluster:3,6
-7.733254442,-2.322578366,TCGA-UB-A7MA-01A,TCGA-UB-A7MA-01A-11D-A33Q-10,6,0.45563181,TCGA-UB-A7MA,LIHC,62,FEMALE,WHITE,Hepatocholangiocarcinoma (Mixed),G2,2013,[Not Available],-22843,Alive,WITH TUMOR,848,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,221,[Not Available],0,848,0,848,NA,NA,1,221,NA,Stage II,T2b,M0,NA,2
-1.121014042,3.445122776,TCGA-UB-A7MC-01A,TCGA-UB-A7MC-01A-11D-A33Q-10,4,0.218766572,TCGA-UB-A7MC,LIHC,59,MALE,WHITE,Hepatocellular Carcinoma,G3,2013,[Not Available],-21733,Alive,WITH TUMOR,500,NA,[Not Available],Extrahepatic Recurrence,"Other, specify",Adrenal glands,359,[Not Available],0,500,0,500,1,359,1,359,NA,Stage IIIA,T3a,MX,LIHC.iCluster:3,5
8.929937879,-1.985182786,TCGA-RC-A7SF-01A,TCGA-RC-A7SF-01A-11D-A34Z-10,1,0.609518714,TCGA-RC-A7SF,LIHC,66,MALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-24432,Alive,WITH TUMOR,579,NA,[Not Available],Locoregional Recurrence,Liver,NA,502,[Not Available],0,579,0,579,1,502,1,502,NA,Stage I,T1,M0,LIHC.iCluster:3,1
-2.306201695,1.175548965,TCGA-RC-A7SH-01A,TCGA-RC-A7SH-01A-11D-A382-10,5,0.391878397,TCGA-RC-A7SH,LIHC,42,MALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-15560,Alive,WITH TUMOR,468,NA,[Not Available],Extrahepatic Recurrence,Lung,NA,91,[Not Available],0,468,0,468,1,91,1,91,NA,Stage II,T2,M0,NA,4
-4.522224886,0.844628763,TCGA-64-5775-01A,TCGA-64-5775-01A-01D-1625-08,0,NA,TCGA-64-5775,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-26058,Dead,WITH TUMOR,NA,62,[Not Available],NA,NA,NA,NA,Progressive Disease,1,62,1,62,NA,NA,1,62,NA,Stage IIIA,T4,M0,LUAD.3,10
-1.325669463,3.186922536,TCGA-79-5596-01A,TCGA-79-5596-01A-31D-1945-08,4,0.118735151,TCGA-79-5596,LUSC,NA,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage IIIA,T3,M0,NA,6
-6.105785023,-1.992263444,TCGA-RC-A7SK-01A,TCGA-RC-A7SK-01A-11D-A34Z-10,0,NA,TCGA-RC-A7SK,LIHC,59,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-21814,Alive,TUMOR FREE,472,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,312,[Not Available],0,472,0,472,1,312,1,312,NA,Stage I,T1,M0,LIHC.iCluster:3,2
9.57882418,-3.639532038,TCGA-AX-A3G6-01A,TCGA-AX-A3G6-01A-11D-A20S-09,1,0.687174051,TCGA-AX-A3G6,UCEC,67,FEMALE,WHITE,Serous endometrial adenocarcinoma,G2,2010,[Not Available],-24681,Alive,NA,8,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,8,0,8,NA,NA,0,8,NA,Stage IA,[Not Applicable],[Not Applicable],NA,1
10.10437378,-1.442497405,TCGA-EL-A3T3-01A,TCGA-EL-A3T3-01A-11D-A22D-08,1,0.855930325,TCGA-EL-A3T3,THCA,63,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-23043,Alive,TUMOR FREE,4017,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4017,0,4017,0,4017,0,4017,NA,Stage II,T2,M0,THCA.3,1
-1.844782873,1.177370057,TCGA-CV-7243-01A,TCGA-CV-7243-01A-11D-2012-08,5,0.615726823,TCGA-CV-7243,HNSC,50,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-18466,Alive,TUMOR FREE,954,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,954,0,954,NA,NA,0,954,NA,Stage III,T2,[Not Available],HNSC.Basal,4
-7.183149767,1.709608783,TCGA-B5-A11O-01A,TCGA-B5-A11O-01A-11D-A122-09,0,NA,TCGA-B5-A11O,UCEC,62,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22720,Alive,TUMOR FREE,2609,NA,[Not Available],New Primary Tumor,"Other, specify",Right Breast,1924,Complete Remission/Response,0,2609,0,2609,0,2609,1,1924,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,9
10.0797344,-2.106170422,TCGA-EY-A210-01A,TCGA-EY-A210-01A-11D-A159-09,1,0.764333876,TCGA-EY-A210,UCEC,82,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30095,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,383,0,383,0,383,0,383,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.Notassigned,1
-3.551061545,-3.106111292,TCGA-EY-A1GK-01A,TCGA-EY-A1GK-01A-11D-A13L-09,8,0.50143409,TCGA-EY-A1GK,UCEC,74,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27127,Alive,TUMOR FREE,693,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,693,0,693,0,693,0,693,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.382677118,-4.86973744,TCGA-KR-A7K8-01A,TCGA-KR-A7K8-01A-11D-A33K-10,1,0.824870391,TCGA-KR-A7K8,LIHC,57,MALE,[Unknown],Hepatocellular Carcinoma,G1,2012,[Not Available],-20914,Alive,TUMOR FREE,906,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,906,0,906,0,906,0,906,NA,Stage I,T1,M0,LIHC.iCluster:2,1
-7.896030365,2.237689422,TCGA-PD-A5DF-01A,TCGA-PD-A5DF-01A-11D-A27I-10,9,0.435732598,TCGA-PD-A5DF,LIHC,58,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2007,[Not Available],-21414,Dead,WITH TUMOR,NA,639,[Not Available],NA,NA,NA,NA,[Not Available],1,639,1,639,NA,NA,1,639,NA,Stage IIIB,T4,M0,LIHC.iCluster:3,7
-4.294712861,1.230390628,TCGA-55-5899-01A,TCGA-55-5899-01A-11D-1625-08,0,NA,TCGA-55-5899,LUAD,58,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],NA,Alive,TUMOR FREE,930,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,930,0,930,0,930,0,930,NA,[Discrepancy],T1a,M0,NA,10
-5.06964094,-1.938463839,TCGA-44-4112-01A,TCGA-44-4112-01A-31D-A27T-08,0,NA,TCGA-44-4112,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-22106,Dead,WITH TUMOR,NA,808,[Not Available],NA,NA,NA,619,Complete Remission/Response,1,808,1,808,1,619,1,619,NA,Stage IB,T2a,M0,LUAD.3,10
-6.535517359,1.403719214,TCGA-66-2755-01A,TCGA-66-2755-01A-01D-1522-08,0,NA,TCGA-66-2755,LUSC,63,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-23348,Alive,TUMOR FREE,28,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,28,0,28,NA,NA,0,28,NA,Stage IB,T2,M0,LUSC.secretory,9
9.188084094,-2.80917827,TCGA-G3-AAV7-01A,TCGA-G3-AAV7-01A-11D-A382-10,1,0.666032155,TCGA-G3-AAV7,LIHC,38,MALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-14229,Alive,TUMOR FREE,361,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,361,0,361,0,361,0,361,NA,Stage II,T2,M0,NA,6
4.256962444,1.18386073,TCGA-GJ-A9DB-01A,TCGA-GJ-A9DB-01A-11D-A36X-10,2,0.644708455,TCGA-GJ-A9DB,LIHC,68,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-25020,Dead,NA,NA,67,[Not Available],NA,NA,NA,NA,[Not Available],1,67,NA,67,0,67,0,67,NA,Stage I,T1,MX,NA,5
-7.512824914,2.24913625,TCGA-HP-A5N0-01A,TCGA-HP-A5N0-01A-11D-A28X-10,9,0.172060687,TCGA-HP-A5N0,LIHC,90,FEMALE,[Not Evaluated],Hepatocellular Carcinoma,[Not Available],NA,[Not Available],-32120,Dead,WITH TUMOR,NA,1147,[Not Available],Locoregional Recurrence,Liver,NA,179,[Not Available],1,1147,1,1147,1,179,1,179,NA,[Not Available],TX,M0,LIHC.iCluster:2,7
9.734491948,-2.101395164,TCGA-K7-A5RF-01A,TCGA-K7-A5RF-01A-11D-A28X-10,1,0.791295923,TCGA-K7-A5RF,LIHC,64,MALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-23557,Alive,TUMOR FREE,631,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,205,[Not Available],0,631,0,631,1,205,1,205,NA,Stage I,T1,MX,LIHC.iCluster:2,1
-6.496048709,-1.320759266,TCGA-K7-A5RG-01A,TCGA-K7-A5RG-01A-11D-A28X-10,7,0.350668184,TCGA-K7-A5RG,LIHC,66,MALE,BLACK OR AFRICAN AMERICAN,Hepatocellular Carcinoma,G1,2012,[Not Available],-24218,Alive,TUMOR FREE,519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,519,0,519,0,519,0,519,NA,Stage I,T1,MX,LIHC.iCluster:2,2
-3.993058949,0.682356379,TCGA-CN-5356-01A,TCGA-CN-5356-01A-01D-1434-08,0,NA,TCGA-CN-5356,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-20540,Alive,TUMOR FREE,1409,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1409,0,1409,0,1409,0,1409,NA,Stage III,T3,[Not Available],HNSC.Mesenchymal,10
10.11302119,-1.458203039,TCGA-KS-A4I3-01A,TCGA-KS-A4I3-01A-11D-A257-08,1,0.863634391,TCGA-KS-A4I3,THCA,41,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-14992,Alive,TUMOR FREE,1329,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1329,0,1329,NA,NA,0,1329,NA,Stage I,T3,M0,THCA.3,1
9.676917263,-5.410160428,TCGA-28-5214-01A,TCGA-28-5214-01A-01D-1486-08,1,0.688624334,TCGA-28-5214,GBM,53,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-19520,Dead,WITH TUMOR,NA,713,[Not Available],Locoregional Disease,[Not Applicable],[Not Applicable],247,[Not Applicable],1,713,1,713,NA,NA,1,247,NA,NA,NA,NA,NA,1
4.375231717,1.098040666,TCGA-DJ-A3VM-01A,TCGA-DJ-A3VM-01A-11D-A23M-08,2,0.716070068,TCGA-DJ-A3VM,THCA,68,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-24896,Alive,TUMOR FREE,840,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,840,0,840,0,840,0,840,NA,Stage II,T2,M0,THCA.1,5
-5.011913809,1.283137147,TCGA-DM-A1D8-01A,TCGA-DM-A1D8-01A-11D-A152-10,0,NA,TCGA-DM-A1D8,COAD,50,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-18311,Dead,NA,383,383,[Not Available],NA,NA,NA,NA,[Not Available],1,383,NA,383,NA,NA,0,383,NA,[Not Available],T3,[Not Available],GI.CIN,8
0.123964545,2.679607701,TCGA-DM-A28H-01A,TCGA-DM-A28H-01A-11D-A16V-10,4,0.14537697,TCGA-DM-A28H,COAD,50,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2002,[Not Available],-18325,Alive,NA,3561,NA,[Not Available],Locoregional Disease,NA,NA,484,[Not Available],0,3561,0,3561,NA,NA,1,484,NA,Stage IIIC,T3,M0,GI.CIN,6
0.466114678,2.176388577,TCGA-AJ-A6NU-01A,TCGA-AJ-A6NU-01A-11D-A34Q-09,0,NA,TCGA-AJ-A6NU,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23498,Alive,TUMOR FREE,632,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,632,0,632,0,632,0,632,NA,Stage II,[Not Applicable],[Not Applicable],NA,6
0.26577806,3.52614824,TCGA-DX-A7EU-01A,TCGA-DX-A7EU-01A-22D-A36J-09,4,0.246297615,TCGA-DX-A7EU,SARC,79,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2013,[Not Available],-29211,Alive,TUMOR FREE,721,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,721,0,721,0,721,0,721,NA,NA,NA,NA,NA,3
-0.547359646,2.872103149,TCGA-XF-AAN3-01A,TCGA-XF-AAN3-01A-11D-A42E-08,0,NA,TCGA-XF-AAN3,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-27909,Alive,TUMOR FREE,2625,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2625,0,2625,NA,NA,0,2625,NA,Stage IV,T3b,MX,NA,10
-4.515447306,-1.79261081,TCGA-XF-AAN2-01A,TCGA-XF-AAN2-01A-11D-A42E-08,8,0.447706667,TCGA-XF-AAN2,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-26720,Dead,TUMOR FREE,NA,1869,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1869,0,1869,0,1869,0,1869,NA,Stage II,T2b,MX,NA,10
-1.470742762,3.181639599,TCGA-XF-AAMZ-01A,TCGA-XF-AAMZ-01A-11D-A42E-08,0,NA,TCGA-XF-AAMZ,BLCA,81,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-29667,Dead,WITH TUMOR,NA,1348,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,1344,Partial Remission/Response,1,1348,1,1348,NA,NA,1,1344,NA,Stage IV,T3a,MX,NA,10
-6.693495444,-1.226649682,TCGA-XF-AAMY-01A,TCGA-XF-AAMY-01A-11D-A42E-08,7,0.164500666,TCGA-XF-AAMY,BLCA,78,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-28509,Alive,TUMOR FREE,3011,NA,[Not Available],Distant Metastasis,Lung,NA,637,Complete Remission/Response,0,3011,0,3011,1,637,1,637,NA,Stage III,T3b,MX,NA,2
9.548639371,-4.139669698,TCGA-DX-A8BJ-01A,TCGA-DX-A8BJ-01A-11D-A417-09,1,0.714822206,TCGA-DX-A8BJ,SARC,76,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011,[Not Available],-28091,Dead,TUMOR FREE,NA,284,[Not Available],NA,NA,NA,NA,[Not Available],1,284,0,284,0,284,0,284,NA,NA,NA,NA,NA,1
-0.097693524,5.434697137,TCGA-DX-A8BK-01A,TCGA-DX-A8BK-01A-11D-A37C-09,4,0.624489172,TCGA-DX-A8BK,SARC,61,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2009,[Not Available],-22407,Alive,TUMOR FREE,1885,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1885,0,1885,0,1885,0,1885,NA,NA,NA,NA,NA,6
-7.838011277,-2.459772257,TCGA-DX-A8BG-01A,TCGA-DX-A8BG-01A-12D-A417-09,6,0.507756143,TCGA-DX-A8BG,SARC,83,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2013,[Not Available],-30333,Alive,TUMOR FREE,546,NA,[Not Available],Distant Metastasis,Lung,NA,330,[Not Available],0,546,0,546,1,330,1,330,NA,NA,NA,NA,NA,2
-6.4738826,3.391137614,TCGA-BP-5190-01A,TCGA-BP-5190-01A-01D-1429-08,0,NA,TCGA-BP-5190,KIRC,61,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-22285,Alive,TUMOR FREE,1011,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1011,0,1011,NA,NA,0,1011,NA,Stage I,T1a,M0,KIRC.2,7
-0.196512559,4.557697578,TCGA-DX-A8BH-01A,TCGA-DX-A8BH-01A-11D-A37C-09,4,0.598729491,TCGA-DX-A8BH,SARC,86,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-31770,Dead,WITH TUMOR,NA,439,[Not Available],Distant Metastasis,"Other, specify",Pleura,272,[Not Available],1,439,1,439,1,272,1,272,NA,NA,NA,NA,NA,6
-7.748983345,-2.43868182,TCGA-B0-5709-01A,TCGA-B0-5709-01A-11D-1534-10,6,0.531530561,TCGA-B0-5709,KIRC,62,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2003,[Not Available],-22843,Alive,TUMOR FREE,3974,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3974,0,3974,0,3974,0,3974,NA,Stage III,T3a,M0,KIRC.3,2
-7.56471902,-2.194279796,TCGA-DX-A8BL-01A,TCGA-DX-A8BL-01A-11D-A417-09,6,0.129834363,TCGA-DX-A8BL,SARC,59,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011,[Not Available],-21728,Alive,TUMOR FREE,1373,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1373,0,1373,0,1373,0,1373,NA,NA,NA,NA,NA,2
-5.159202503,2.497503274,TCGA-G4-6294-01A,TCGA-G4-6294-01A-11D-1806-10,12,0.22472012,TCGA-G4-6294,COAD,75,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2004,[Not Available],-27755,Dead,WITH TUMOR,NA,858,[Not Available],NA,NA,NA,517,[Not Available],1,858,1,858,NA,NA,1,517,NA,Stage IV,T3,M1,GI.CIN,9
-0.476892731,5.052144945,TCGA-29-1695-01A,TCGA-29-1695-01A-01W-0633-09,4,0.566163098,TCGA-29-1695,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2003,[Not Available],-22895,Dead,NA,24,1229,[Not Available],NA,NA,NA,NA,[Not Available],1,1229,NA,1229,NA,NA,0,1229,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-5.318084302,3.087715807,TCGA-XF-A9SL-01A,TCGA-XF-A9SL-01A-11D-A391-08,0,NA,TCGA-XF-A9SL,BLCA,69,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-25460,Dead,TUMOR FREE,NA,2020,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2020,0,2020,NA,NA,0,2020,NA,Stage IV,T3a,MX,NA,3
-4.072879054,-1.847474308,TCGA-XF-A9SJ-01A,TCGA-XF-A9SJ-01A-11D-A391-08,8,0.302387525,TCGA-XF-A9SJ,BLCA,83,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-30362,Dead,WITH TUMOR,NA,98,[Not Available],NA,NA,NA,NA,Progressive Disease,1,98,1,98,NA,NA,1,98,NA,Stage IV,T3b,MX,NA,10
-3.969577628,-2.316013044,TCGA-UY-A9PF-01A,TCGA-UY-A9PF-01A-11D-A38G-08,8,0.366713413,TCGA-UY-A9PF,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-28470,Alive,TUMOR FREE,117,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,117,0,117,NA,NA,0,117,NA,Stage IV,T3a,MX,NA,10
-3.265534432,1.408572168,TCGA-UY-A9PE-01A,TCGA-UY-A9PE-01A-11D-A38G-08,0,NA,TCGA-UY-A9PE,BLCA,86,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-31755,Alive,WITH TUMOR,189,NA,[Not Available],Distant Metastasis,Lung,NA,473,Complete Remission/Response,0,189,0,189,NA,NA,1,473,NA,Stage IV,T2b,MX,NA,10
-3.058861096,-3.353239361,TCGA-XF-AAMG-01A,TCGA-XF-AAMG-01A-11D-A42E-08,8,0.451748536,TCGA-XF-AAMG,BLCA,49,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004,[Not Available],-18021,Alive,TUMOR FREE,3364,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3364,0,3364,0,3364,0,3364,NA,Stage III,T4a,MX,NA,10
9.918048173,-1.935068755,TCGA-MT-A7BN-01A,TCGA-MT-A7BN-01A-12D-A34J-08,1,0.858438274,TCGA-MT-A7BN,HNSC,74,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2013,[Not Available],-27162,Alive,WITH TUMOR,469,NA,[Not Available],Distant Metastasis,Distant Metastasis,lung,179,Progressive Disease,0,469,0,469,NA,NA,1,179,NA,Stage IVA,[Not Available],[Not Available],NA,1
-6.173000835,3.254190882,TCGA-XF-A9SV-01A,TCGA-XF-A9SV-01A-21D-A42E-08,11,0.153061787,TCGA-XF-A9SV,BLCA,82,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-30265,Dead,WITH TUMOR,NA,388,[Not Available],Distant Metastasis,Lung,NA,237,Progressive Disease,1,388,1,388,NA,NA,1,237,NA,Stage IV,T4a,M1,NA,7
-7.752883865,-2.521382962,TCGA-DX-A8BM-01A,TCGA-DX-A8BM-01A-11D-A417-09,6,0.508448715,TCGA-DX-A8BM,SARC,60,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011,[Not Available],-22152,Alive,TUMOR FREE,1456,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1456,0,1456,0,1456,0,1456,NA,NA,NA,NA,NA,2
-4.295330875,-0.817356185,TCGA-UY-A9PD-01A,TCGA-UY-A9PD-01A-11D-A38G-08,8,0.058199201,TCGA-UY-A9PD,BLCA,80,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-29565,Alive,TUMOR FREE,542,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,542,0,542,0,542,0,542,NA,Stage III,T3a,MX,NA,10
-3.877130318,-2.320631428,TCGA-UY-A9PB-01A,TCGA-UY-A9PB-01A-11D-A38G-08,8,0.457038606,TCGA-UY-A9PB,BLCA,49,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-17885,Alive,TUMOR FREE,899,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,899,0,899,0,899,0,899,NA,Stage III,T3a,MX,NA,10
-7.256382012,-2.578428546,TCGA-UY-A9PA-01A,TCGA-UY-A9PA-01A-11D-A38G-08,6,0.131749003,TCGA-UY-A9PA,BLCA,48,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-17520,Alive,TUMOR FREE,1072,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1072,0,1072,0,1072,0,1072,NA,Stage III,T3a,MX,NA,2
-0.773485135,4.817612402,TCGA-CJ-5672-01A,TCGA-CJ-5672-01A-11D-1534-10,4,0.527559939,TCGA-CJ-5672,KIRC,84,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-30900,Dead,TUMOR FREE,NA,2190,[Not Available],NA,NA,NA,NA,[Not Available],1,2190,0,2190,NA,NA,0,2190,NA,Stage I,T1a,M0,KIRC.2,6
-3.682318021,-3.091293249,TCGA-DX-A8BP-01A,TCGA-DX-A8BP-01A-11D-A37C-09,8,0.428338883,TCGA-DX-A8BP,SARC,85,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2009,[Not Available],-31382,Alive,WITH TUMOR,428,NA,[Not Available],Distant Metastasis,Lung,NA,216,[Not Available],0,428,0,428,NA,NA,1,216,NA,NA,NA,NA,NA,10
2.144227059,1.796283222,TCGA-BP-5177-01A,TCGA-BP-5177-01A-01D-1429-08,3,0.438031468,TCGA-BP-5177,KIRC,46,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-17147,Alive,TUMOR FREE,293,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,293,0,293,NA,NA,0,293,NA,Stage I,T1a,M0,KIRC.3,3
-6.881736744,-2.206547931,TCGA-57-1993-01A,TCGA-57-1993-01A-01W-0699-08,6,0.218610838,TCGA-57-1993,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-20498,Alive,TUMOR FREE,763,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,763,0,763,NA,NA,0,763,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,2
9.424638288,-4.742127894,TCGA-DX-A8BN-01A,TCGA-DX-A8BN-01A-11D-A37C-09,1,0.739019055,TCGA-DX-A8BN,SARC,78,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011,[Not Available],-28760,Alive,TUMOR FREE,1161,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1161,0,1161,NA,NA,0,1161,NA,NA,NA,NA,NA,1
9.042012881,-5.19298684,TCGA-DX-A8BO-01A,TCGA-DX-A8BO-01A-11D-A417-09,1,0.771916597,TCGA-DX-A8BO,SARC,67,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2011,[Not Available],-24513,Alive,TUMOR FREE,1240,NA,[Not Available],Locoregional Recurrence,"Other, specify",Calf,333,[Not Available],0,1240,0,1240,NA,NA,1,333,NA,NA,NA,NA,NA,1
-0.916847671,2.91476907,TCGA-F4-6808-01A,TCGA-F4-6808-01A-11D-1835-10,4,0.059972043,TCGA-F4-6808,COAD,54,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-19803,Alive,TUMOR FREE,1024,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1024,0,1024,0,1024,0,1024,NA,Stage I,T1,M0,GI.CIN,6
-5.259594688,-2.005439919,TCGA-24-1845-01A,TCGA-24-1845-01A-01W-0639-09,0,NA,TCGA-24-1845,OV,42,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-15599,Alive,NA,116,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,116,0,116,NA,NA,0,116,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
-5.688499919,-2.136742365,TCGA-UY-A78O-01A,TCGA-UY-A78O-01A-12D-A339-08,0,NA,TCGA-UY-A78O,BLCA,75,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-27234,Alive,TUMOR FREE,2312,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2312,0,2312,0,2312,0,2312,NA,Stage II,T2,MX,NA,2
-4.659346071,-1.595432062,TCGA-UY-A78N-01A,TCGA-UY-A78N-01A-12D-A339-08,8,0.292569046,TCGA-UY-A78N,BLCA,80,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-29132,Dead,WITH TUMOR,NA,2641,[Not Available],Distant Metastasis,Renal Pelvis,NA,2472,Complete Remission/Response,1,2641,1,2641,NA,NA,1,2472,NA,Stage IV,T2,MX,NA,10
-5.243660787,0.968149193,TCGA-UY-A78M-01A,TCGA-UY-A78M-01A-21D-A34U-08,0,NA,TCGA-UY-A78M,BLCA,81,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-29706,Dead,WITH TUMOR,NA,690,[Not Available],NA,NA,NA,NA,[Unknown],1,690,1,690,NA,NA,1,690,NA,Stage IV,T2,MX,NA,9
-6.336885748,-2.158394245,TCGA-UY-A78L-01A,TCGA-UY-A78L-01A-12D-A339-08,0,NA,TCGA-UY-A78L,BLCA,62,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-22717,Alive,WITH TUMOR,1127,NA,[Not Available],NA,NA,NA,355,Progressive Disease,0,1127,0,1127,NA,NA,1,355,NA,Stage IV,[Not Available],MX,NA,10
0.304644205,4.280379148,TCGA-UY-A8OD-01A,TCGA-UY-A8OD-01A-11D-A364-08,4,0.290651702,TCGA-UY-A8OD,BLCA,68,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-24588,Alive,TUMOR FREE,3432,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3432,0,3432,0,3432,0,3432,NA,Stage II,T2b,MX,NA,6
-5.780848201,3.182150507,TCGA-UY-A8OC-01A,TCGA-UY-A8OC-01A-11D-A364-08,0,NA,TCGA-UY-A8OC,BLCA,90,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-32918,Dead,WITH TUMOR,NA,92,[Not Available],Distant Metastasis,Lymph Node Only,NA,32,Partial Remission/Response,1,92,1,92,NA,NA,1,32,NA,Stage IV,T4,MX,NA,10
-4.401583523,-1.616641885,TCGA-UY-A8OB-01A,TCGA-UY-A8OB-01A-12D-A42E-08,8,0.388368098,TCGA-UY-A8OB,BLCA,63,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-23360,Alive,TUMOR FREE,2109,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2109,0,2109,NA,NA,0,2109,NA,Stage IV,T3a,MX,NA,10
-4.5830602,-0.077268777,TCGA-UY-A78P-01A,TCGA-UY-A78P-01A-12D-A364-08,0,NA,TCGA-UY-A78P,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-28719,Alive,TUMOR FREE,2380,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2380,0,2380,0,2380,0,2380,NA,Stage II,T2,MX,NA,10
-1.710112999,0.944225415,TCGA-DX-A8BR-01A,TCGA-DX-A8BR-01A-11D-A417-09,5,0.533852758,TCGA-DX-A8BR,SARC,63,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2002,[Not Available],-23302,Alive,TUMOR FREE,4573,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4573,0,4573,0,4573,0,4573,NA,NA,NA,NA,NA,4
-3.406203406,-3.297499588,TCGA-UY-A78K-01A,TCGA-UY-A78K-01A-11D-A339-08,8,0.592538286,TCGA-UY-A78K,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,NA,[Not Available],-22020,Dead,NA,NA,536,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,536,NA,536,NA,NA,0,536,NA,Stage IV,[Not Available],MX,NA,10
-3.012929498,1.223078466,TCGA-K4-AAQO-01A,TCGA-K4-AAQO-01A-11D-A38G-08,0,NA,TCGA-K4-AAQO,BLCA,56,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-20683,Alive,NA,359,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,359,0,359,NA,NA,0,359,NA,Stage III,T3a,MX,NA,10
-7.529626162,2.306903982,TCGA-DX-A8BX-01A,TCGA-DX-A8BX-01A-11D-A37C-09,9,0.216836152,TCGA-DX-A8BX,SARC,52,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006,[Not Available],-19339,Dead,WITH TUMOR,NA,591,[Not Available],NA,NA,NA,NA,[Not Available],1,591,1,591,NA,NA,1,591,NA,NA,NA,NA,NA,7
-3.031469663,-3.837765549,TCGA-AD-6895-01A,TCGA-AD-6895-01A-11D-1924-10,8,0.369969863,TCGA-AD-6895,COAD,84,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-30879,Alive,TUMOR FREE,763,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,763,0,763,0,763,0,763,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-0.644209307,4.577889252,TCGA-DX-A8BV-01A,TCGA-DX-A8BV-01A-11D-A37C-09,4,0.287856274,TCGA-DX-A8BV,SARC,57,MALE,WHITE,Myxofibrosarcoma,[Not Available],2004,[Not Available],-21005,Dead,WITH TUMOR,NA,1845,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,357,[Not Available],1,1845,1,1845,1,357,1,357,NA,NA,NA,NA,NA,5
-2.058548939,1.290916736,TCGA-DX-A8BU-01A,TCGA-DX-A8BU-01A-11D-A37C-09,5,0.616818343,TCGA-DX-A8BU,SARC,58,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006,[Not Available],-21470,Dead,WITH TUMOR,NA,1116,[Not Available],Distant Metastasis,Lung,NA,107,[Not Available],1,1116,1,1116,NA,NA,1,107,NA,NA,NA,NA,NA,4
-1.468736176,4.04788822,TCGA-K4-A5RI-01A,TCGA-K4-A5RI-01A-11D-A289-08,4,0.066277391,TCGA-K4-A5RI,BLCA,67,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24614,Dead,WITH TUMOR,NA,356,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",ileum,236,Progressive Disease,1,356,1,356,NA,NA,1,236,NA,Stage III,T3a,MX,NA,6
8.911555691,-5.673320533,TCGA-AA-3532-01A,TCGA-AA-3532-01A-01D-1953-10,1,0.785953421,TCGA-AA-3532,COAD,63,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-23133,Alive,WITH TUMOR,882,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,882,0,882,NA,NA,0,882,NA,Stage IIA,T3,M0,NA,1
-3.768900193,-2.645766784,TCGA-GC-A4ZW-01A,TCGA-GC-A4ZW-01A-11D-A26M-08,8,0.365268893,TCGA-GC-A4ZW,BLCA,71,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25964,Alive,TUMOR FREE,15,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,15,0,15,NA,NA,0,15,NA,Stage III,T3a,M0,NA,10
-6.319167358,3.155134902,TCGA-FJ-A871-01A,TCGA-FJ-A871-01A-11D-A34U-08,0,NA,TCGA-FJ-A871,BLCA,49,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-18051,Dead,WITH TUMOR,NA,272,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",Pelvic,106,Progressive Disease,1,272,1,272,NA,NA,1,106,NA,Stage III,T3b,MX,NA,8
2.068648926,1.854871369,TCGA-E7-A97Q-01A,TCGA-E7-A97Q-01A-11D-A38G-08,3,0.611086219,TCGA-E7-A97Q,BLCA,60,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-22249,Dead,WITH TUMOR,NA,246,[Not Available],NA,NA,NA,NA,Stable Disease,1,246,1,246,NA,NA,1,246,NA,Stage IV,T4a,MX,NA,3
-4.553326499,1.589647515,TCGA-E7-A97P-01A,TCGA-E7-A97P-01A-11D-A38G-08,0,NA,TCGA-E7-A97P,BLCA,73,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-26956,Dead,TUMOR FREE,NA,437,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,437,0,437,0,437,0,437,NA,Stage II,T2,M0,NA,9
-5.20208563,1.273189914,TCGA-K4-A5RH-01A,TCGA-K4-A5RH-01A-11D-A30E-08,0,NA,TCGA-K4-A5RH,BLCA,69,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25305,Alive,WITH TUMOR,276,NA,[Not Available],Distant Metastasis,Lung,NA,196,Progressive Disease,0,276,0,276,NA,NA,1,196,NA,Stage III,T3a,MX,NA,8
-5.403639,2.368663147,TCGA-4N-A93T-01A,TCGA-4N-A93T-01A-11D-A36X-10,12,0.366074696,TCGA-4N-A93T,COAD,67,MALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2013,[Not Available],-24523,Alive,WITH TUMOR,146,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,146,0,146,NA,NA,0,146,NA,Stage IIIB,T4a,M0,GI.CIN,8
-5.141633408,1.431235073,TCGA-CV-A45P-01A,TCGA-CV-A45P-01A-11D-A24D-08,0,NA,TCGA-CV-A45P,HNSC,82,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1998,[Not Available],-30297,Alive,WITH TUMOR,639,NA,[Not Available],Locoregional Recurrence,Oral Cavity,Floor of mouth,639,Complete Remission/Response,0,639,0,639,1,639,1,639,NA,Stage I,T1,M0,NA,9
-5.744949305,-1.003582199,TCGA-GC-A6I3-01A,TCGA-GC-A6I3-01A-11D-A31L-08,0,NA,TCGA-GC-A6I3,BLCA,90,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-32873,Alive,TUMOR FREE,423,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,423,0,423,NA,NA,0,423,NA,Stage IV,T3a,MX,NA,10
-7.45555114,-2.463768074,TCGA-DX-AATS-01A,TCGA-DX-AATS-01A-12D-A417-09,6,0.282936284,TCGA-DX-AATS,SARC,72,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2008,[Not Available],-26624,Dead,TUMOR FREE,NA,35,[Not Available],NA,NA,NA,NA,[Not Available],1,35,0,35,NA,NA,0,35,NA,NA,NA,NA,NA,2
8.890874889,-4.056013964,TCGA-DX-A8BZ-01A,TCGA-DX-A8BZ-01A-11D-A37C-09,1,0.679974603,TCGA-DX-A8BZ,SARC,78,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2013,[Not Available],-28853,Dead,WITH TUMOR,NA,200,[Not Available],Distant Metastasis,Lung,NA,90,[Not Available],1,200,1,200,1,90,1,90,NA,NA,NA,NA,NA,1
-5.097710638,2.489485484,TCGA-E7-A8O8-01A,TCGA-E7-A8O8-01A-11D-A364-08,12,0.255679979,TCGA-E7-A8O8,BLCA,59,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-21629,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,13,0,13,0,13,0,13,NA,Stage II,T2,M0,NA,9
8.664985854,-2.084449487,TCGA-DX-AB2H-01A,TCGA-DX-AB2H-01A-11D-A38Z-09,1,0.654352665,TCGA-DX-AB2H,SARC,80,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2013,[Not Available],-29569,Alive,TUMOR FREE,482,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,482,0,482,0,482,0,482,NA,NA,NA,NA,NA,1
9.085230986,-5.04749269,TCGA-DX-AB2F-01A,TCGA-DX-AB2F-01A-11D-A387-09,1,0.834307723,TCGA-DX-AB2F,SARC,76,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2013,[Not Available],-27840,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,0,365,0,365,NA,NA,NA,NA,NA,1
9.069237943,-5.670434292,TCGA-DX-AB2G-01A,TCGA-DX-AB2G-01A-11D-A38Z-09,1,0.806039704,TCGA-DX-AB2G,SARC,36,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2013,[Not Available],-13239,Alive,TUMOR FREE,478,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,478,0,478,0,478,0,478,NA,NA,NA,NA,NA,1
4.135988125,1.396092522,TCGA-CZ-5466-01A,TCGA-CZ-5466-01A-01D-1501-10,2,0.653216426,TCGA-CZ-5466,KIRC,67,MALE,[Not Available],Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-24669,Alive,TUMOR FREE,685,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,685,0,685,NA,NA,0,685,NA,Stage III,T3a,M0,KIRC.NA,5
-6.166158453,3.594807225,TCGA-E7-A8O7-01A,TCGA-E7-A8O7-01A-11D-A364-08,11,0.596031454,TCGA-E7-A8O7,BLCA,52,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013,[Not Available],-19063,Alive,TUMOR FREE,466,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,466,0,466,0,466,0,466,NA,Stage II,T2,M0,NA,8
-3.971026283,-2.352724929,TCGA-E7-A85H-01A,TCGA-E7-A85H-01A-11D-A34U-08,8,0.363740605,TCGA-E7-A85H,BLCA,64,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23497,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,394,0,394,0,394,0,394,NA,Stage III,T3,M0,NA,10
-4.60674566,-1.271759969,TCGA-DK-AA76-01A,TCGA-DK-AA76-01A-11D-A391-08,8,0.256706518,TCGA-DK-AA76,BLCA,64,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23542,Alive,WITH TUMOR,366,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,366,0,366,0,366,0,366,NA,Stage II,[Not Available],M0,NA,10
-3.699761425,-2.623318331,TCGA-DK-AA75-01A,TCGA-DK-AA75-01A-11D-A391-08,8,0.417448533,TCGA-DK-AA75,BLCA,82,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-30090,Dead,WITH TUMOR,NA,340,[Not Available],Distant Metastasis,Bone,NA,328,Stable Disease,1,340,1,340,NA,NA,1,328,NA,Stage III,T3,M0,NA,10
-7.076024216,-1.760017325,TCGA-DK-AA74-01A,TCGA-DK-AA74-01A-11D-A391-08,0,NA,TCGA-DK-AA74,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-27730,Alive,TUMOR FREE,1708,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1708,0,1708,0,1708,0,1708,NA,Stage III,T3,M0,NA,10
-4.061787205,-2.287213493,TCGA-DK-AA71-01A,TCGA-DK-AA71-01A-31D-A391-08,8,0.374917301,TCGA-DK-AA71,BLCA,71,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-25950,Alive,WITH TUMOR,415,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,415,0,415,NA,NA,0,415,NA,Stage II,T2b,M0,NA,10
-7.13245081,-1.997318113,TCGA-E7-A7PW-01A,TCGA-E7-A7PW-01A-11D-A34U-08,6,0.191771082,TCGA-E7-A7PW,BLCA,63,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23057,Alive,TUMOR FREE,416,NA,[Not Available],Distant Metastasis,Bone,NA,174,Complete Remission/Response,0,416,0,416,1,174,1,174,NA,Stage III,T3a,M0,NA,2
-4.935166293,-1.208117755,TCGA-E7-A7DU-01A,TCGA-E7-A7DU-01A-11D-A32B-08,8,0.086224725,TCGA-E7-A7DU,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013,[Not Available],-27000,Alive,TUMOR FREE,28,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,28,0,28,0,28,0,28,NA,Stage III,T3,M0,NA,10
-4.337179373,-1.892599311,TCGA-E7-A6MD-01A,TCGA-E7-A6MD-01A-41D-A34U-08,8,0.329544043,TCGA-E7-A6MD,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24180,Alive,NA,129,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,129,0,129,NA,NA,0,129,NA,Stage IV,T4a,M0,NA,10
-4.231168125,-0.880233217,TCGA-DK-AA77-01A,TCGA-DK-AA77-01A-11D-A391-08,8,0.055059899,TCGA-DK-AA77,BLCA,61,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-22365,Alive,TUMOR FREE,618,NA,[Not Available],Distant Metastasis,"Other, specify",Pelvis,467,Stable Disease,0,618,0,618,NA,NA,1,467,NA,Stage II,T2a,M0,NA,10
8.238716941,-3.900637048,TCGA-DX-AB2L-01A,TCGA-DX-AB2L-01A-32D-A417-09,1,0.517966034,TCGA-DX-AB2L,SARC,35,MALE,WHITE,Myxofibrosarcoma,[Not Available],2009,[Not Available],-12974,Alive,TUMOR FREE,2007,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2007,0,2007,NA,NA,0,2007,NA,NA,NA,NA,NA,1
4.189688914,1.184956533,TCGA-DX-AB2O-01A,TCGA-DX-AB2O-01A-12D-A38Z-09,2,0.444829792,TCGA-DX-AB2O,SARC,78,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2007,[Not Available],-28757,Alive,TUMOR FREE,2619,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2619,0,2619,0,2619,0,2619,NA,NA,NA,NA,NA,5
10.14955854,-1.488558008,TCGA-DX-AB2J-01A,TCGA-DX-AB2J-01A-11D-A387-09,1,0.854136494,TCGA-DX-AB2J,SARC,71,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006,[Not Available],-26154,Dead,WITH TUMOR,NA,1235,[Not Available],NA,NA,NA,NA,[Not Available],1,1235,1,1235,NA,NA,1,1235,NA,NA,NA,NA,NA,1
9.07517342,-3.043902799,TCGA-DX-AB2P-01A,TCGA-DX-AB2P-01A-11D-A387-09,1,0.713288947,TCGA-DX-AB2P,SARC,79,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2005,[Not Available],-29136,Dead,WITH TUMOR,NA,367,[Not Available],Locoregional Recurrence,NA,NA,161,[Not Available],1,367,1,367,1,161,1,161,NA,NA,NA,NA,NA,1
-5.337942726,2.138723255,TCGA-DX-AB2Q-01A,TCGA-DX-AB2Q-01A-11D-A38Z-09,0,NA,TCGA-DX-AB2Q,SARC,65,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2009,[Not Available],-23748,Alive,TUMOR FREE,2030,NA,[Not Available],Distant Metastasis,"Other, specify",inguinal lymph node,490,[Not Available],0,2030,0,2030,1,490,1,490,NA,NA,NA,NA,NA,9
-6.992441681,-2.181179882,TCGA-BH-A0AW-01A,TCGA-BH-A0AW-01A-11W-A071-09,6,0.258978657,TCGA-BH-A0AW,BRCA,56,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20468,Alive,TUMOR FREE,622,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,622,0,622,0,622,0,622,NA,Stage IIA,T1c,M0,BRCA.Her2,2
-6.323642327,-1.782721244,TCGA-DK-AA6W-01A,TCGA-DK-AA6W-01A-12D-A391-08,0,NA,TCGA-DK-AA6W,BLCA,78,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-28853,Dead,WITH TUMOR,NA,415,[Not Available],Distant Metastasis,Lung,NA,379,Stable Disease,1,415,1,415,NA,NA,1,379,NA,Stage II,T2,M0,NA,10
8.616762017,-1.945041273,TCGA-EK-A2PI-01A,TCGA-EK-A2PI-01A-11D-A18J-09,1,0.51323174,TCGA-EK-A2PI,CESC,44,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,[Not Available],-16324,Alive,WITH TUMOR,586,NA,NA,NA,NA,NA,NA,[Not Available],0,586,0,586,NA,NA,0,586,NA,Stage IIIB,[Not Available],[Not Available],NA,6
-2.394692188,2.281094541,TCGA-DK-AA6U-01A,TCGA-DK-AA6U-01A-11D-A391-08,0,NA,TCGA-DK-AA6U,BLCA,64,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013,[Not Available],-23611,Alive,TUMOR FREE,578,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,578,0,578,0,578,0,578,NA,Stage II,[Not Available],M0,NA,10
-4.096475549,-2.012243127,TCGA-DK-AA6S-01A,TCGA-DK-AA6S-01A-21D-A391-08,8,0.394291955,TCGA-DK-AA6S,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000,[Not Available],-22027,Alive,TUMOR FREE,5050,NA,[Not Available],Distant Metastasis,"Other, specify",soft tissue pelvic mass,539,Complete Remission/Response,0,5050,0,5050,1,539,1,539,NA,Stage III,T3b,M0,NA,10
-6.515808384,3.277912154,TCGA-EX-A3L1-01A,TCGA-EX-A3L1-01A-11D-A21Q-09,0,NA,TCGA-EX-A3L1,CESC,32,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11943,Alive,TUMOR FREE,463,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,463,0,463,0,463,0,463,NA,Stage IIA1,T2a1,M0,NA,7
-4.331668422,-1.825968162,TCGA-DK-AA6L-01A,TCGA-DK-AA6L-01A-11D-A391-08,8,0.437681559,TCGA-DK-AA6L,BLCA,48,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-17635,Dead,WITH TUMOR,NA,1163,[Not Available],Distant Metastasis,Bone,NA,920,Progressive Disease,1,1163,1,1163,NA,NA,1,920,NA,Stage IV,T3,MX,NA,10
9.714668036,-1.639119519,TCGA-CF-A9FM-01A,TCGA-CF-A9FM-01A-11D-A38G-08,1,0.80994148,TCGA-CF-A9FM,BLCA,50,MALE,ASIAN,[Not Available],High Grade,2013,[Not Available],-18445,Alive,TUMOR FREE,398,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,398,0,398,0,398,0,398,NA,Stage I,T1,M0,NA,3
9.483753265,-2.228345217,TCGA-CF-A9FH-01A,TCGA-CF-A9FH-01A-11D-A38G-08,1,0.759460938,TCGA-CF-A9FH,BLCA,85,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013,[Not Available],-31236,Alive,TUMOR FREE,-64,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,Stage II,T2,M0,NA,1
-4.302176607,-0.347158168,TCGA-DK-AA6R-01A,TCGA-DK-AA6R-01A-11D-A42E-08,0,NA,TCGA-DK-AA6R,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001,[Not Available],-25196,Alive,WITH TUMOR,5041,NA,[Not Available],New Primary Tumor,"Other, specify",Colon,4907,Stable Disease,0,5041,0,5041,NA,NA,1,4907,NA,Stage IV,T4,M0,NA,10
-6.074135488,1.347106018,TCGA-DK-AA6Q-01A,TCGA-DK-AA6Q-01A-11D-A391-08,10,0.087710803,TCGA-DK-AA6Q,BLCA,61,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-22314,Dead,WITH TUMOR,NA,413,[Not Available],Distant Metastasis,Liver,NA,285,Progressive Disease,1,413,1,413,NA,NA,1,285,NA,Stage IV,T3,M0,NA,9
-6.168668032,-1.651656006,TCGA-DK-AA6P-01A,TCGA-DK-AA6P-01A-11D-A391-08,7,0.057991127,TCGA-DK-AA6P,BLCA,72,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-26560,Alive,TUMOR FREE,457,NA,[Not Available],Distant Metastasis,Bone,NA,16,Partial Remission/Response,0,457,0,457,NA,NA,1,16,NA,Stage II,[Not Available],M0,NA,2
-0.393703368,3.904627863,TCGA-DK-AA6M-01A,TCGA-DK-AA6M-01A-11D-A391-08,4,0.280843188,TCGA-DK-AA6M,BLCA,64,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-23574,Alive,TUMOR FREE,1582,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1582,0,1582,NA,NA,0,1582,NA,Stage II,T2,M0,NA,6
-0.620067268,5.065653021,TCGA-DX-AB2V-01A,TCGA-DX-AB2V-01A-11D-A417-09,4,0.532904346,TCGA-DX-AB2V,SARC,81,MALE,WHITE,Myxofibrosarcoma,[Not Available],2006,[Not Available],-29716,Alive,TUMOR FREE,3241,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3241,0,3241,0,3241,0,3241,NA,NA,NA,NA,NA,6
-0.05813236,4.138727417,TCGA-DX-AB2W-01A,TCGA-DX-AB2W-01A-11D-A38Z-09,4,0.398454062,TCGA-DX-AB2W,SARC,62,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2006,[Not Available],-22951,Alive,TUMOR FREE,3238,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3238,0,3238,0,3238,0,3238,NA,NA,NA,NA,NA,6
0.326442536,2.394103591,TCGA-DX-AB2T-01A,TCGA-DX-AB2T-01A-11D-A387-09,0,NA,TCGA-DX-AB2T,SARC,54,FEMALE,BLACK OR AFRICAN AMERICAN,Myxofibrosarcoma,[Not Available],2008,[Not Available],-19749,Alive,TUMOR FREE,2369,NA,[Not Available],Distant Metastasis,Lung,NA,784,[Not Available],0,2369,0,2369,1,784,1,784,NA,NA,NA,NA,NA,6
0.027542025,4.859742979,TCGA-DX-AB2X-01A,TCGA-DX-AB2X-01A-11D-A387-09,4,0.613452813,TCGA-DX-AB2X,SARC,73,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2010,[Not Available],-26736,Dead,WITH TUMOR,NA,404,[Not Available],Locoregional Recurrence,NA,NA,111,[Not Available],1,404,1,404,1,111,1,111,NA,NA,NA,NA,NA,6
-5.256023137,1.771247908,TCGA-DX-AB2Z-01A,TCGA-DX-AB2Z-01A-11D-A387-09,0,NA,TCGA-DX-AB2Z,SARC,87,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2010,[Not Available],-31780,Alive,TUMOR FREE,1533,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1533,0,1533,0,1533,0,1533,NA,NA,NA,NA,NA,8
7.894555512,-1.706197804,TCGA-EA-A3HR-01A,TCGA-EA-A3HR-01A-11D-A20U-09,1,0.170475031,TCGA-EA-A3HR,CESC,57,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20980,Alive,TUMOR FREE,940,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,940,0,940,0,940,0,940,NA,Stage II,T2a,M0,NA,1
-4.110774751,-1.738682238,TCGA-DS-A1OC-01A,TCGA-DS-A1OC-01A-11D-A14W-08,8,0.318233548,TCGA-DS-A1OC,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17357,Alive,TUMOR FREE,376,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,376,0,376,0,376,0,376,NA,Stage IB,T1b1,M0,NA,10
-3.67662637,-2.540893629,TCGA-DS-A1OB-01A,TCGA-DS-A1OB-01A-11D-A16Y-08,8,0.387235478,TCGA-DS-A1OB,CESC,45,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16685,Dead,WITH TUMOR,NA,861,Cervical Cancer,Distant Metastasis,Head & Neck,NA,652,Complete Remission/Response,1,861,1,861,1,652,1,652,NA,Stage IB,T1b2,M0,NA,10
-3.42918439,-3.29716204,TCGA-EA-A3HU-01A,TCGA-EA-A3HU-01A-11D-A20U-09,8,0.545495899,TCGA-EA-A3HU,CESC,43,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15909,Alive,TUMOR FREE,1013,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1013,0,1013,0,1013,0,1013,NA,Stage II,T2a2,M0,NA,10
-1.484838551,2.243968209,TCGA-EA-A3HQ-01A,TCGA-EA-A3HQ-01A-11D-A20U-09,0,NA,TCGA-EA-A3HQ,CESC,60,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21966,Alive,TUMOR FREE,1136,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1136,0,1136,0,1136,0,1136,NA,Stage II,T2a,M0,NA,6
-8.14285792,2.144889962,TCGA-HG-A2PA-01A,TCGA-HG-A2PA-01A-11D-A20U-09,9,0.429466886,TCGA-HG-A2PA,CESC,38,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14025,Dead,WITH TUMOR,NA,773,NA,NA,NA,NA,NA,Complete Remission/Response,1,773,1,773,NA,NA,1,773,NA,Stage IB2,T1b2,M0,NA,7
-2.2505919,1.519856322,TCGA-C5-A2LY-01A,TCGA-C5-A2LY-01A-31D-A18J-09,5,0.348951332,TCGA-C5-A2LY,CESC,30,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11018,Alive,TUMOR FREE,2383,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2383,0,2383,0,2383,0,2383,NA,Stage IB1,T1b1,M0,NA,4
-5.842856355,3.436411717,TCGA-AA-3530-01A,TCGA-AA-3530-01A-01W-0995-10,11,0.253896307,TCGA-AA-3530,COAD,80,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-29402,Alive,TUMOR FREE,580,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,580,0,580,0,580,0,580,NA,Stage I,T2,M0,NA,8
-3.013262035,-3.914321241,TCGA-FU-A3HZ-01A,TCGA-FU-A3HZ-01A-11D-A20U-09,8,0.292319613,TCGA-FU-A3HZ,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23565,Alive,TUMOR FREE,1103,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1103,0,1103,0,1103,0,1103,NA,Stage IIA2,T2a2,M0,NA,10
-6.660441979,2.324151333,TCGA-FU-A23K-01A,TCGA-FU-A23K-01A-11D-A16O-08,0,NA,TCGA-FU-A23K,CESC,28,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10551,Alive,TUMOR FREE,372,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,372,0,372,0,372,0,372,NA,Stage IIIB,T1b1,MX,NA,7
-0.621253827,2.170162963,TCGA-EA-A1QT-01A,TCGA-EA-A1QT-01A-11D-A14W-08,0,NA,TCGA-EA-A1QT,CESC,47,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17475,Alive,TUMOR FREE,1243,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1243,0,1243,0,1243,0,1243,NA,Stage IB,T1b,M0,NA,1
4.41965908,1.244404716,TCGA-12-0692-01A,TCGA-12-0692-01A-01D-1492-08,2,0.680510925,TCGA-12-0692,GBM,75,FEMALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-27519,Dead,WITH TUMOR,80,111,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],35,[Not Available],1,111,1,111,NA,NA,1,35,NA,NA,NA,NA,NA,5
-0.332960584,5.245602437,TCGA-CZ-4856-01A,TCGA-CZ-4856-01A-02D-1429-08,4,0.425845805,TCGA-CZ-4856,KIRC,62,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-22684,Alive,NA,18,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,18,0,18,NA,NA,0,18,NA,Stage I,T1b,M0,KIRC.1,1
-2.747539052,-4.33960451,TCGA-B5-A11E-01A,TCGA-B5-A11E-01A-11D-A10M-09,0,NA,TCGA-B5-A11E,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Peri (6-12 months since last menstrual period),-19458,Alive,TUMOR FREE,1820,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1820,0,1820,0,1820,0,1820,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.POLE,10
-0.552767785,4.654254273,TCGA-CQ-6229-01A,TCGA-CQ-6229-01A-11D-1912-08,4,0.588688927,TCGA-CQ-6229,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-22541,Alive,TUMOR FREE,1179,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1179,0,1179,0,1179,0,1179,NA,Stage II,T2,[Not Available],HNSC.Basal,6
9.057186216,-1.320716809,TCGA-5P-A9KA-01A,TCGA-5P-A9KA-01A-11D-A42J-10,1,0.551915675,TCGA-5P-A9KA,KIRP,61,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-22545,Alive,TUMOR FREE,395,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,395,0,395,0,395,0,395,NA,[Not Available],T1a,MX,NA,6
9.982221056,-2.884117243,TCGA-5P-A9K8-01A,TCGA-5P-A9K8-01A-11D-A42J-10,1,0.704735892,TCGA-5P-A9K8,KIRP,51,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2010,[Not Available],-18880,Alive,TUMOR FREE,1309,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1309,0,1309,0,1309,0,1309,NA,[Not Available],T3a,MX,NA,1
9.497830121,-1.092974591,TCGA-5P-A9K6-01A,TCGA-5P-A9K6-01A-11D-A42J-10,3,0.021059631,TCGA-5P-A9K6,KIRP,64,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2009,[Not Available],-23384,Alive,NA,1914,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1914,0,1914,0,1914,0,1914,NA,[Not Available],T1a,MX,NA,1
-0.785210874,2.814422445,TCGA-31-1950-01A,TCGA-31-1950-01A-01W-0699-08,4,0.058757709,TCGA-31-1950,OV,76,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2007,[Not Available],-28100,Alive,WITH TUMOR,571,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],349,Partial Remission/Response,0,571,0,571,NA,NA,1,349,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
1.713410197,1.989891454,TCGA-J7-A8I2-01A,TCGA-J7-A8I2-01A-12D-A35Z-10,3,0.24141406,TCGA-J7-A8I2,KIRP,75,MALE,ASIAN,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-27431,Alive,WITH TUMOR,307,NA,[Not Available],NA,NA,NA,268,Complete Remission/Response,0,307,0,307,1,268,1,268,NA,Stage I,T1b,M0,NA,3
9.272244012,-5.682405284,TCGA-5P-A9KH-01A,TCGA-5P-A9KH-01A-11D-A42J-10,1,0.82717408,TCGA-5P-A9KH,KIRP,77,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-28193,Alive,TUMOR FREE,2051,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2051,0,2051,0,2051,0,2051,NA,[Not Available],T1a,MX,NA,1
-4.389691065,-1.10119102,TCGA-66-2793-01A,TCGA-66-2793-01A-01D-1267-08,8,0.18484828,TCGA-66-2793,LUSC,68,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-25111,Dead,TUMOR FREE,NA,306,[Not Available],NA,NA,NA,NA,[Not Available],1,306,0,306,NA,NA,0,306,NA,Stage IIIB,T4,M0,LUSC.primitive,10
1.033817249,2.614306358,TCGA-5P-A9KE-01A,TCGA-5P-A9KE-01A-11D-A42J-10,4,0,TCGA-5P-A9KE,KIRP,70,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2011,[Not Available],-25805,Alive,TUMOR FREE,824,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,824,0,824,0,824,0,824,NA,[Not Available],T1b,M0,NA,3
-5.760020919,-2.207894686,TCGA-05-5420-01A,TCGA-05-5420-01A-01D-1625-08,0,NA,TCGA-05-5420,LUAD,67,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-24472,Alive,WITH TUMOR,457,NA,[Not Available],NA,NA,NA,245,Progressive Disease,0,457,0,457,NA,NA,1,245,NA,Stage IIIA,T2,M0,NA,2
8.999896648,-5.768184735,TCGA-ET-A2MX-01A,TCGA-ET-A2MX-01A-11D-A23M-08,1,0.781655571,TCGA-ET-A2MX,THCA,27,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-10044,Alive,TUMOR FREE,2689,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2689,0,2689,0,2689,0,2689,NA,Stage I,T2,MX,THCA.3,1
-7.764299147,-2.485022718,TCGA-5P-A9KC-01A,TCGA-5P-A9KC-01A-11D-A42J-10,6,0.460385937,TCGA-5P-A9KC,KIRP,51,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2013,[Not Available],-18975,Alive,TUMOR FREE,377,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,377,0,377,0,377,0,377,NA,[Not Available],T1b,MX,NA,2
9.677520028,-1.804359073,TCGA-KS-A4I9-01A,TCGA-KS-A4I9-01A-11D-A257-08,1,0.843303701,TCGA-KS-A4I9,THCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-16961,Alive,TUMOR FREE,2658,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2658,0,2658,0,2658,0,2658,NA,Stage I,T1b,M0,THCA.3,1
-2.788415417,-4.278517471,TCGA-BG-A222-01A,TCGA-BG-A222-01A-11D-A159-09,0,NA,TCGA-BG-A222,UCEC,49,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,[Not Available],-18220,Alive,TUMOR FREE,291,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,291,0,291,0,291,0,291,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.856662299,-1.724282417,TCGA-DJ-A3V2-01A,TCGA-DJ-A3V2-01A-11D-A22Z-08,1,0.85734796,TCGA-DJ-A3V2,THCA,44,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-16382,Alive,TUMOR FREE,615,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,615,0,615,0,615,0,615,NA,Stage I,T2,M0,THCA.2,1
2.098084606,1.788259594,TCGA-EL-A3ZG-01A,TCGA-EL-A3ZG-01A-11D-A23M-08,3,0.580796894,TCGA-EL-A3ZG,THCA,15,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2006,[Not Available],-5612,Alive,TUMOR FREE,2724,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2724,0,2724,0,2724,0,2724,NA,Stage I,T3,M0,THCA.3,3
-0.610044039,2.427710207,TCGA-BP-5183-01A,TCGA-BP-5183-01A-01D-1429-08,4,0.090132653,TCGA-BP-5183,KIRC,57,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-20881,Alive,TUMOR FREE,1291,NA,[Not Available],NA,NA,NA,485,[Not Available],0,1291,0,1291,NA,NA,1,485,NA,Stage III,T3a,M0,KIRC.1,1
-5.126597785,2.011794857,TCGA-B5-A11L-01B,TCGA-B5-A11L-01B-21D-A13L-09,12,0.016713681,TCGA-B5-A11L,UCEC,71,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26120,Dead,TUMOR FREE,NA,2240,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Apex,131,Complete Remission/Response,1,2240,0,2240,1,131,1,131,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.Notassigned,9
0.337128474,2.554687187,TCGA-CR-7383-01A,TCGA-CR-7383-01A-11D-2129-08,4,0.13671854,TCGA-CR-7383,HNSC,79,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-29122,Dead,WITH TUMOR,NA,521,[Not Available],NA,Oropharynx,NA,454,Complete Remission/Response,1,521,1,521,1,454,1,454,NA,Stage I,T1,M0,HNSC.Mesenchymal,3
8.618242525,-4.74688241,TCGA-BG-A0M2-01A,TCGA-BG-A0M2-01A-11D-A10O-09,1,0.798781102,TCGA-BG-A0M2,UCEC,62,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22822,Alive,TUMOR FREE,637,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,637,0,637,0,637,0,637,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,1
9.189683043,-4.591698862,TCGA-23-2081-01A,TCGA-23-2081-01A-01W-0722-08,1,0.79348127,TCGA-23-2081,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-18162,Dead,WITH TUMOR,NA,2342,[Not Available],NA,NA,NA,NA,Progressive Disease,1,2342,1,2342,NA,NA,1,2342,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Differentiated,1
-3.893543992,1.223141998,TCGA-34-5241-01A,TCGA-34-5241-01A-01D-1441-08,0,NA,TCGA-34-5241,LUSC,79,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-29098,Dead,TUMOR FREE,NA,515,[Not Available],NA,NA,NA,NA,Stable Disease,1,515,0,515,NA,NA,0,515,NA,Stage IB,T2,M0,LUSC.basal,6
-6.434064069,-1.324778223,TCGA-36-2547-01A,TCGA-36-2547-01A-01D-1526-09,7,0.245411301,TCGA-36-2547,OV,64,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2008,[Not Available],-23706,Alive,NA,624,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,624,0,624,NA,NA,0,624,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
-4.24166605,-0.695980501,TCGA-L9-A444-01A,TCGA-L9-A444-01A-21D-A24D-08,0,NA,TCGA-L9-A444,LUAD,60,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22202,Alive,TUMOR FREE,307,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,307,0,307,0,307,0,307,NA,Stage IA,T1a,MX,NA,10
-7.784977888,2.090589855,TCGA-C8-A12Y-01A,TCGA-C8-A12Y-01A-11D-A12B-09,9,0.324911222,TCGA-C8-A12Y,BRCA,44,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,1476,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1476,0,1476,0,1476,0,1476,NA,Stage IIB,T2,M0,BRCA.LumA,7
-2.208257656,2.133520587,TCGA-43-8116-01A,TCGA-43-8116-01A-11D-2244-08,0,NA,TCGA-43-8116,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26790,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,358,0,358,0,358,0,358,NA,Stage IA,T1b,M0,NA,10
9.640873541,-1.761757837,TCGA-ET-A4KQ-01A,TCGA-ET-A4KQ-01A-12D-A257-08,1,0.77830834,TCGA-ET-A4KQ,THCA,45,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-16685,Alive,TUMOR FREE,955,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,955,0,955,0,955,0,955,NA,Stage II,T2,MX,THCA.1,1
-2.939675479,-3.978523656,TCGA-AJ-A3BH-01A,TCGA-AJ-A3BH-01A-11D-A19Y-09,8,0.24400819,TCGA-AJ-A3BH,UCEC,NA,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,NA,NA,0,NA,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-4.258978912,-1.958704641,TCGA-BS-A0V4-01A,TCGA-BS-A0V4-01A-11D-A14G-09,8,0.332643073,TCGA-BS-A0V4,UCEC,56,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20777,Alive,TUMOR FREE,1810,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1810,0,1810,0,1810,0,1810,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.475892182,-5.525668941,TCGA-EL-A3ZP-01A,TCGA-EL-A3ZP-01A-11D-A23M-08,1,0.868702201,TCGA-EL-A3ZP,THCA,19,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-7101,Alive,TUMOR FREE,1992,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1992,0,1992,0,1992,0,1992,NA,Stage I,T4,M0,THCA.2,1
-1.874001172,1.317695275,TCGA-A2-A0T1-01A,TCGA-A2-A0T1-01A-21D-A099-09,5,0.572266752,TCGA-A2-A0T1,BRCA,55,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20227,Alive,TUMOR FREE,521,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,521,0,521,0,521,0,521,NA,Stage IIIC,T3,M0,BRCA.Her2,4
-0.725044333,3.803622518,TCGA-12-0618-01A,TCGA-12-0618-01A-01D-1492-08,4,0.281205242,TCGA-12-0618,GBM,49,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2003,[Not Available],-18071,Dead,NA,50,395,[Not Available],NA,NA,NA,NA,[Not Available],1,395,NA,395,NA,NA,0,395,NA,NA,NA,NA,GBM_LGG.NA,5
-3.308589863,-3.254511626,TCGA-BS-A0TJ-01A,TCGA-BS-A0TJ-01A-11D-A10B-09,8,0.606731441,TCGA-BS-A0TJ,UCEC,59,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21663,Alive,TUMOR FREE,2068,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2068,0,2068,0,2068,0,2068,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.MSI,10
-7.643351268,2.36939536,TCGA-74-6578-01A,TCGA-74-6578-01A-11D-1845-08,9,0.380816461,TCGA-74-6578,GBM,58,MALE,[Not Available],Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-21464,Alive,WITH TUMOR,436,NA,[Not Available],NA,[Not Applicable],[Not Applicable],222,[Not Available],0,436,0,436,NA,NA,1,222,NA,NA,NA,NA,NA,7
9.56273863,-1.215237408,TCGA-CJ-6031-01A,TCGA-CJ-6031-01A-11D-1669-08,1,0.704617243,TCGA-CJ-6031,KIRC,54,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2003,[Not Available],-19905,Alive,TUMOR FREE,1906,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1906,0,1906,NA,NA,0,1906,NA,Stage I,T1b,M0,KIRC.3,6
-1.913798303,1.169831413,TCGA-13-0723-01A,TCGA-13-0723-01A-02D-0447-09,5,0.683682342,TCGA-13-0723,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-23094,Dead,WITH TUMOR,1204,1204,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],210,Progressive Disease,1,1204,1,1204,NA,NA,1,210,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,4
9.292241117,-4.236820952,TCGA-BH-A0AY-01A,TCGA-BH-A0AY-01A-21W-A019-09,1,0.743709423,TCGA-BH-A0AY,BRCA,62,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22703,Alive,TUMOR FREE,777,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,777,0,777,0,777,0,777,NA,Stage IIA,T2,M0,BRCA.LumA,1
-1.115025646,4.65468577,TCGA-39-5035-01A,TCGA-39-5035-01A-01D-1441-08,4,0.246743765,TCGA-39-5035,LUSC,72,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-26383,Alive,TUMOR FREE,2080,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2080,0,2080,0,2080,0,2080,NA,Stage IA,T1b,M0,LUSC.secretory,6
4.451462232,1.22430224,TCGA-HD-8314-01A,TCGA-HD-8314-01A-11D-2394-08,2,0.621950201,TCGA-HD-8314,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma Basaloid Type,G4,2012,[Not Available],-21517,Alive,TUMOR FREE,670,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,670,0,670,0,670,0,670,NA,Stage III,T1,[Not Available],NA,5
8.787158582,-4.089204742,TCGA-06-0882-01A,TCGA-06-0882-01A-01D-1492-08,1,0.720664649,TCGA-06-0882,GBM,30,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2008,[Not Available],-11112,Dead,WITH TUMOR,NA,632,[Not Available],Recurrence,[Not Applicable],[Not Applicable],213,[Not Available],1,632,1,632,NA,NA,1,213,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,1
9.355255024,-4.375629535,TCGA-B0-5696-01A,TCGA-B0-5696-01A-11D-1534-10,1,0.724192236,TCGA-B0-5696,KIRC,69,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-25552,Alive,WITH TUMOR,2609,NA,[Not Available],NA,NA,NA,1717,Complete Remission/Response,0,2609,0,2609,1,1717,1,1717,NA,Stage III,T3a,M0,KIRC.4,1
8.856859293,-5.124188495,TCGA-DR-A0ZL-01A,TCGA-DR-A0ZL-01A-11D-A10S-08,1,0.815920503,TCGA-DR-A0ZL,CESC,53,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19384,Alive,TUMOR FREE,2669,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2669,0,2669,0,2669,0,2669,NA,Stage IB,T1b1,M0,NA,1
3.000993694,3.554382228,TCGA-BH-A0W4-01A,TCGA-BH-A0W4-01A-11D-A10G-09,0,NA,TCGA-BH-A0W4,BRCA,46,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,[Not Available],-16911,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,759,0,759,NA,NA,0,759,NA,Stage IIA,T2,M0,BRCA.LumA,1
9.590527978,-1.243243305,TCGA-HM-A3JK-01A,TCGA-HM-A3JK-01A-11D-A21Q-09,1,0.712579778,TCGA-HM-A3JK,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23618,Alive,TUMOR FREE,632,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,632,0,632,0,632,0,632,NA,Stage IIA2,T2b,MX,NA,6
-7.199631167,-2.688768763,TCGA-DS-A1OA-01A,TCGA-DS-A1OA-01A-11D-A16Y-08,6,0.186353409,TCGA-DS-A1OA,CESC,77,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28160,Dead,WITH TUMOR,879,879,Cervical Cancer,Locoregional Recurrence,NA,NA,379,[Not Available],1,879,1,879,NA,NA,1,379,NA,Stage IB,T1b1,M0,NA,2
-6.491142221,-1.099548554,TCGA-ZF-AA56-01A,TCGA-ZF-AA56-01A-31D-A391-08,7,0.372410483,TCGA-ZF-AA56,BLCA,79,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-28937,Dead,WITH TUMOR,NA,259,[Not Available],Distant Metastasis,Liver,NA,248,Progressive Disease,1,259,1,259,NA,NA,1,248,NA,Stage III,T4a,MX,NA,2
-4.40041106,0.54159923,TCGA-ZF-AA54-01A,TCGA-ZF-AA54-01A-11D-A391-08,0,NA,TCGA-ZF-AA54,BLCA,71,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-26128,Dead,NA,NA,590,[Not Available],NA,NA,NA,NA,[Unknown],1,590,NA,590,NA,NA,0,590,NA,Stage III,T3,MX,NA,10
-7.868656322,2.217622607,TCGA-AP-A0LN-01A,TCGA-AP-A0LN-01A-11W-A062-09,9,0.66113551,TCGA-AP-A0LN,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20704,Alive,TUMOR FREE,2510,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2510,0,2510,0,2510,0,2510,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-6.194006992,3.429224176,TCGA-AX-A0IW-01A,TCGA-AX-A0IW-01A-11W-A062-09,11,0.303761791,TCGA-AX-A0IW,UCEC,67,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488,Alive,TUMOR FREE,1149,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1149,0,1149,0,1149,0,1149,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN high,8
10.01028839,-1.590459854,TCGA-EM-A3AR-01A,TCGA-EM-A3AR-01A-12D-A20C-08,1,0.878515918,TCGA-EM-A3AR,THCA,41,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-15313,Alive,TUMOR FREE,1133,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1133,0,1133,0,1133,0,1133,NA,Stage I,T1b,MX,THCA.2,1
-0.817105378,3.592101905,TCGA-CN-4726-01A,TCGA-CN-4726-01A-01D-1434-08,4,0.314060123,TCGA-CN-4726,HNSC,68,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-25194,Dead,WITH TUMOR,NA,142,[Not Available],NA,Distant Metastasis,SKIN NECK,79,Progressive Disease,1,142,1,142,NA,NA,1,79,NA,Stage IVA,T3,[Not Available],HNSC.Basal,5
-3.313617641,-3.29610293,TCGA-ZF-AA51-01A,TCGA-ZF-AA51-01A-21D-A391-08,8,0.516124587,TCGA-ZF-AA51,BLCA,69,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-25484,Alive,TUMOR FREE,1714,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1714,0,1714,0,1714,0,1714,NA,Stage II,T2,M0,NA,10
9.337715581,-5.24975639,TCGA-UP-A6WW-01A,TCGA-UP-A6WW-01A-12D-A34J-08,1,0.850661648,TCGA-UP-A6WW,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-21427,Alive,TUMOR FREE,518,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,518,0,518,NA,NA,0,518,NA,[Not Available],[Not Available],[Not Available],NA,1
-3.384719914,-3.123032576,TCGA-ZF-AA4X-01A,TCGA-ZF-AA4X-01A-11D-A38G-08,8,0.430144522,TCGA-ZF-AA4X,BLCA,56,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-20579,Alive,WITH TUMOR,2044,NA,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,1665,Complete Remission/Response,0,2044,0,2044,1,1665,1,1665,NA,Stage II,T2,M0,NA,10
-5.061287101,1.624939164,TCGA-CV-7101-01A,TCGA-CV-7101-01A-11D-2012-08,0,NA,TCGA-CV-7101,HNSC,80,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-29550,Dead,TUMOR FREE,NA,160,[Not Available],NA,NA,NA,NA,[Not Available],1,160,0,160,NA,NA,0,160,NA,Stage II,T2,[Not Available],HNSC.Atypical,10
-5.238327189,1.224422651,TCGA-UF-A7JT-01A,TCGA-UF-A7JT-01A-11D-A34J-08,0,NA,TCGA-UF-A7JT,HNSC,72,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2009,[Not Available],-26375,Dead,WITH TUMOR,NA,993,[Not Available],NA,NA,Cervix,718,Complete Remission/Response,1,993,1,993,NA,NA,1,718,NA,Stage IVA,T4a,M0,NA,10
7.671533496,-3.442596773,TCGA-WA-A7H4-01A,TCGA-WA-A7H4-01A-21D-A34J-08,1,0.279925112,TCGA-WA-A7H4,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2013,[Not Available],-25363,Alive,TUMOR FREE,443,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,443,0,443,0,443,0,443,NA,Stage II,T2,[Not Available],NA,1
-6.39704749,-1.15477555,TCGA-ZF-AA53-01A,TCGA-ZF-AA53-01A-11D-A391-08,7,0.393382383,TCGA-ZF-AA53,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-22035,Alive,TUMOR FREE,1761,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1761,0,1761,0,1761,0,1761,NA,Stage II,T2,M0,NA,2
-6.103955416,-1.096438807,TCGA-ZF-AA52-01A,TCGA-ZF-AA52-01A-12D-A391-08,0,NA,TCGA-ZF-AA52,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-25579,Dead,NA,NA,1077,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,1077,NA,1077,NA,NA,0,1077,NA,Stage III,T3a,MX,NA,2
-2.75039293,0.902416463,TCGA-WA-A7GZ-01A,TCGA-WA-A7GZ-01A-11D-A34J-08,5,0.062748707,TCGA-WA-A7GZ,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-21207,Dead,TUMOR FREE,NA,625,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,625,0,625,0,625,0,625,NA,[Not Available],T2,[Not Available],NA,10
-4.991892802,1.816433503,TCGA-CQ-6223-01A,TCGA-CQ-6223-01A-11D-1912-08,0,NA,TCGA-CQ-6223,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-25266,Alive,TUMOR FREE,1428,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1428,0,1428,NA,NA,0,1428,NA,Stage II,T2,[Not Available],HNSC.Basal,8
7.799405846,-1.378252324,TCGA-DX-A6YR-01A,TCGA-DX-A6YR-01A-33D-A351-09,1,0.156202772,TCGA-DX-A6YR,SARC,75,MALE,WHITE,Myxofibrosarcoma,[Not Available],2011,[Not Available],-27434,Alive,TUMOR FREE,1247,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1247,0,1247,0,1247,0,1247,NA,NA,NA,NA,NA,1
10.01581448,-1.425609883,TCGA-DX-A6BH-01A,TCGA-DX-A6BH-01A-12D-A307-09,1,0.87213009,TCGA-DX-A6BH,SARC,34,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2012,[Not Available],-12742,Alive,WITH TUMOR,821,NA,[Not Available],Locoregional Recurrence,NA,NA,232,[Not Available],0,821,0,821,NA,NA,1,232,NA,NA,NA,NA,NA,1
0.119012487,5.205183573,TCGA-24-2260-01A,TCGA-24-2260-01A-01W-0722-08,4,0.679026453,TCGA-24-2260,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1992,[Not Available],-27112,Dead,WITH TUMOR,1100,1100,[Not Available],Recurrence,[Not Applicable],[Not Applicable],667,Complete Remission/Response,1,1100,1,1100,1,667,1,667,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,6
-3.575845353,-2.686730823,TCGA-59-2349-01A,TCGA-59-2349-01A-01W-0799-08,8,0.402847331,TCGA-59-2349,OV,71,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,1994,[Not Available],NA,Dead,NA,NA,2437,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2437,NA,2437,0,2437,0,2437,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-4.216869703,-1.01429353,TCGA-DX-A6YS-01A,TCGA-DX-A6YS-01A-12D-A351-09,8,0.202210268,TCGA-DX-A6YS,SARC,61,MALE,WHITE,Myxofibrosarcoma,[Not Available],2008,[Not Available],-22310,Alive,TUMOR FREE,2381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2381,0,2381,0,2381,0,2381,NA,NA,NA,NA,NA,10
-3.48054456,-3.069926354,TCGA-DX-A6YT-01A,TCGA-DX-A6YT-01A-21D-A351-09,8,0.485422788,TCGA-DX-A6YT,SARC,31,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2008,[Not Available],-11633,Alive,TUMOR FREE,2044,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2044,0,2044,0,2044,0,2044,NA,NA,NA,NA,NA,10
-4.098694651,-2.286257449,TCGA-ZF-AA4W-01A,TCGA-ZF-AA4W-01A-12D-A38G-08,8,0.347579057,TCGA-ZF-AA4W,BLCA,56,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-20611,Alive,NA,1830,NA,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",penile urethra,1679,Complete Remission/Response,0,1830,0,1830,1,1679,1,1679,NA,Stage III,T3b,MX,NA,10
-5.952169378,0.928283732,TCGA-UF-A7JO-01A,TCGA-UF-A7JO-01A-11D-A34J-08,0,NA,TCGA-UF-A7JO,HNSC,79,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-28951,Dead,WITH TUMOR,NA,631,[Not Available],Locoregional Disease,Oral Cavity,Floor of mouth,525,Complete Remission/Response,1,631,1,631,NA,NA,1,525,NA,Stage IVA,T4a,M0,NA,9
-6.138562422,1.473271208,TCGA-B5-A1N2-01A,TCGA-B5-A1N2-01A-21D-A142-09,10,0.234357406,TCGA-B5-A1N2,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25612,Dead,WITH TUMOR,NA,954,[Not Available],Distant Metastasis,Brain,NA,804,Complete Remission/Response,1,954,1,954,1,804,1,804,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.Notassigned,9
-3.843779988,-2.625570398,TCGA-ZF-AA4V-01A,TCGA-ZF-AA4V-01A-11D-A38G-08,8,0.411943705,TCGA-ZF-AA4V,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-24448,Alive,TUMOR FREE,1806,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1806,0,1806,0,1806,0,1806,NA,Stage III,T3b,M0,NA,10
-1.541005578,4.205682505,TCGA-BS-A0TI-01A,TCGA-BS-A0TI-01A-11D-A10B-09,4,0.123283128,TCGA-BS-A0TI,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23705,Alive,TUMOR FREE,1882,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1882,0,1882,0,1882,0,1882,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.CN high,10
7.811706871,-1.404387902,TCGA-A2-A1FX-01A,TCGA-A2-A1FX-01A-11D-A13L-09,1,0.187634607,TCGA-A2-A1FX,BRCA,61,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22344,Alive,TUMOR FREE,1847,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1847,0,1847,0,1847,0,1847,NA,Stage IIIA,T3,M0,BRCA.LumB,1
-4.771208784,0.401127679,TCGA-ZF-AA4N-01A,TCGA-ZF-AA4N-01A-11D-A38G-08,0,NA,TCGA-ZF-AA4N,BLCA,74,MALE,WHITE,[Not Available],High Grade,2011,[Not Available],-27056,Dead,WITH TUMOR,NA,88,[Not Available],NA,NA,NA,NA,Progressive Disease,1,88,1,88,NA,NA,1,88,NA,Stage II,[Not Available],[Not Available],NA,10
-2.094313188,1.989850697,TCGA-ZF-A9RN-01A,TCGA-ZF-A9RN-01A-11D-A42E-08,0,NA,TCGA-ZF-A9RN,BLCA,67,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-24795,Dead,WITH TUMOR,NA,615,[Not Available],Distant Metastasis,Lung,NA,516,Partial Remission/Response,1,615,1,615,NA,NA,1,516,NA,Stage III,T3b,M0,NA,10
-3.907382615,-2.534127628,TCGA-TN-A7HL-01A,TCGA-TN-A7HL-01A-11D-A34J-08,8,0.415217741,TCGA-TN-A7HL,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-21731,Alive,TUMOR FREE,619,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,619,0,619,NA,NA,0,619,NA,Stage IVA,T3,M0,NA,10
-0.806274304,3.618050531,TCGA-A8-A09N-01A,TCGA-A8-A09N-01A-11W-A019-09,4,0.358246816,TCGA-A8-A09N,BRCA,57,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21002,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,0,31,0,31,NA,Stage IIIC,T2,M0,BRCA.LumB,5
2.12275099,1.84399508,TCGA-UF-A7JK-01A,TCGA-UF-A7JK-01A-11D-A34J-08,3,0.517278413,TCGA-UF-A7JK,HNSC,59,MALE,[Unknown],Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-21696,Dead,WITH TUMOR,NA,424,[Not Available],NA,Larynx,NA,341,Complete Remission/Response,1,424,1,424,NA,NA,1,341,NA,Stage IVA,T4a,M0,NA,3
-7.131446982,1.377928116,TCGA-ZF-AA4U-01A,TCGA-ZF-AA4U-01A-11D-A38G-08,0,NA,TCGA-ZF-AA4U,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-25682,Dead,WITH TUMOR,NA,262,[Not Available],Distant Metastasis,Bone,NA,199,Progressive Disease,1,262,1,262,NA,NA,1,199,NA,Stage III,T4a,MX,NA,7
0.119408655,5.124936481,TCGA-EY-A1GR-01A,TCGA-EY-A1GR-01A-11D-A13L-09,4,0.616037007,TCGA-EY-A1GR,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24784,Alive,TUMOR FREE,536,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,536,0,536,0,536,0,536,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,6
-0.964340068,4.558015542,TCGA-ZF-AA4T-01A,TCGA-ZF-AA4T-01A-11D-A38G-08,4,0.399220485,TCGA-ZF-AA4T,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-23974,Dead,WITH TUMOR,NA,599,[Not Available],Distant Metastasis,Lung,NA,511,[Unknown],1,599,1,599,NA,NA,1,511,NA,Stage IV,T4,MX,NA,6
-2.521865146,1.16706264,TCGA-ZF-AA4R-01A,TCGA-ZF-AA4R-01A-11D-A38G-08,5,0.101699029,TCGA-ZF-AA4R,BLCA,67,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-24537,Dead,WITH TUMOR,NA,1036,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,750,[Unknown],1,1036,1,1036,NA,NA,1,750,NA,Stage IV,T3a,MX,NA,4
8.408757105,-4.071306246,TCGA-DX-A6YX-01A,TCGA-DX-A6YX-01A-11D-A417-09,1,0.70685159,TCGA-DX-A6YX,SARC,68,FEMALE,[Unknown],Myxofibrosarcoma,[Not Available],2005,[Not Available],-24871,Dead,WITH TUMOR,NA,513,[Not Available],Distant Metastasis,Lung,NA,200,[Not Available],1,513,1,513,1,200,1,200,NA,NA,NA,NA,NA,1
-6.333558709,1.800893861,TCGA-CN-6024-01A,TCGA-CN-6024-01A-11D-1683-08,10,0.265416255,TCGA-CN-6024,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-24259,Dead,WITH TUMOR,NA,337,[Not Available],NA,Cervical Lymph Nodes,NA,156,Progressive Disease,1,337,1,337,NA,NA,1,156,NA,Stage IVA,T4a,M0,HNSC.Classical,8
-0.937601451,3.787814025,TCGA-BP-5176-01A,TCGA-BP-5176-01A-01D-1429-08,4,0.443387719,TCGA-BP-5176,KIRC,78,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-28727,Dead,TUMOR FREE,NA,1590,[Not Available],NA,NA,NA,NA,[Not Available],1,1590,0,1590,NA,NA,0,1590,NA,Stage I,T1a,M0,KIRC.4,6
-3.190561709,-3.428065416,TCGA-DX-A6YV-01A,TCGA-DX-A6YV-01A-12D-A351-09,8,0.49610665,TCGA-DX-A6YV,SARC,74,MALE,WHITE,Myxofibrosarcoma,[Not Available],2008,[Not Available],-27053,Dead,WITH TUMOR,NA,1536,[Not Available],Distant Metastasis,"Other, specify",Groin - lymph nodes,516,[Not Available],1,1536,1,1536,1,516,1,516,NA,NA,NA,NA,NA,10
-1.568829781,3.650643607,TCGA-61-1727-01A,TCGA-61-1727-01A-01W-0639-09,4,0.088144618,TCGA-61-1727,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-27203,Alive,TUMOR FREE,564,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,564,0,564,0,564,0,564,NA,Stage IC,[Not Applicable],[Not Applicable],NA,6
-7.50354849,-2.323096551,TCGA-10-0931-01A,TCGA-10-0931-01A-01W-0420-08,6,0.367201284,TCGA-10-0931,OV,44,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-16262,Dead,WITH TUMOR,982,1000,[Not Available],Recurrence,[Not Applicable],[Not Applicable],300,Complete Remission/Response,1,1000,1,1000,1,300,1,300,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
-0.307188706,4.378510264,TCGA-DX-A6Z0-01A,TCGA-DX-A6Z0-01A-13D-A36J-09,4,0.640876562,TCGA-DX-A6Z0,SARC,78,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2006,[Not Available],-28796,Dead,TUMOR FREE,NA,1953,[Not Available],NA,NA,NA,NA,[Not Available],1,1953,0,1953,NA,NA,0,1953,NA,NA,NA,NA,NA,6
-2.159262925,2.257351021,TCGA-22-1012-01A,TCGA-22-1012-01A-01D-1521-08,0,NA,TCGA-22-1012,LUSC,80,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2001,[Not Available],-29273,Dead,TUMOR FREE,NA,429,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,429,0,429,0,429,0,429,NA,Stage IB,T2,M0,LUSC.classical,10
-0.655335523,3.878245259,TCGA-DX-A6Z2-01A,TCGA-DX-A6Z2-01A-12D-A36J-09,4,0.326761776,TCGA-DX-A6Z2,SARC,82,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-30042,Alive,WITH TUMOR,3079,NA,[Not Available],Distant Metastasis,Lung,NA,2659,[Not Available],0,3079,0,3079,1,2659,1,2659,NA,NA,NA,NA,NA,5
-0.251382515,4.412909236,TCGA-ZF-A9RM-01A,TCGA-ZF-A9RM-01A-11D-A38G-08,4,0.440483859,TCGA-ZF-A9RM,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-25642,Alive,TUMOR FREE,1455,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1455,0,1455,0,1455,0,1455,NA,Stage II,T0,MX,NA,6
-4.505827472,-0.025882102,TCGA-A8-A06X-01A,TCGA-A8-A06X-01A-21W-A019-09,0,NA,TCGA-A8-A06X,BRCA,77,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28338,Dead,TUMOR FREE,NA,943,[Not Available],NA,NA,NA,NA,[Not Available],1,943,0,943,0,943,0,943,NA,Stage IIB,T3,M0,BRCA.LumB,10
-4.435605825,-1.777477829,TCGA-ZF-A9RL-01A,TCGA-ZF-A9RL-01A-11D-A38G-08,8,0.437182597,TCGA-ZF-A9RL,BLCA,61,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-22480,Alive,TUMOR FREE,2703,NA,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,1064,Complete Remission/Response,0,2703,0,2703,1,1064,1,1064,NA,Stage II,[Not Available],MX,NA,10
-6.707257635,-2.28098959,TCGA-TN-A7HJ-01A,TCGA-TN-A7HJ-01A-12D-A34J-08,0,NA,TCGA-TN-A7HJ,HNSC,51,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-18809,Alive,TUMOR FREE,403,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,403,0,403,NA,NA,0,403,NA,Stage IVA,T4a,M0,NA,2
-4.546197768,0.132478196,TCGA-ZF-A9RG-01A,TCGA-ZF-A9RG-01A-21D-A42E-08,0,NA,TCGA-ZF-A9RG,BLCA,70,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-25656,Alive,WITH TUMOR,1786,NA,[Not Available],Distant Metastasis,"Other, specify",neck lymph node,440,Complete Remission/Response,0,1786,0,1786,1,440,1,440,NA,Stage III,T3b,MX,NA,10
-6.379852645,-1.163280418,TCGA-D1-A15V-01A,TCGA-D1-A15V-01A-11D-A122-09,7,0.328123405,TCGA-D1-A15V,UCEC,68,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24886,Alive,TUMOR FREE,1201,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1201,0,1201,0,1201,0,1201,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN high,2
-4.472035467,-1.981818199,TCGA-T2-A6X2-01A,TCGA-T2-A6X2-01A-12D-A34J-08,8,0.284295547,TCGA-T2-A6X2,HNSC,82,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-30013,Alive,TUMOR FREE,987,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,987,0,987,0,987,0,987,NA,Stage III,T3,MX,NA,10
-5.800515113,1.264229891,TCGA-ZF-A9RD-01A,TCGA-ZF-A9RD-01A-11D-A42E-08,0,NA,TCGA-ZF-A9RD,BLCA,75,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-27496,Dead,NA,NA,408,[Not Available],NA,NA,NA,NA,[Unknown],1,408,NA,408,NA,NA,0,408,NA,Stage IV,T3a,MX,NA,10
-8.109386074,2.024933785,TCGA-TN-A7HI-01A,TCGA-TN-A7HI-01A-11D-A34J-08,9,0.57813462,TCGA-TN-A7HI,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2013,[Not Available],-20666,Alive,TUMOR FREE,412,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,412,0,412,NA,NA,0,412,NA,Stage IVA,T2,M0,NA,7
8.310979044,-3.453041224,TCGA-BP-5192-01A,TCGA-BP-5192-01A-01D-1429-08,1,0.573652404,TCGA-BP-5192,KIRC,59,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-21891,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,714,0,714,NA,NA,0,714,NA,Stage I,T1a,M0,KIRC.1,1
-2.149190979,2.280597046,TCGA-ZF-A9RF-01A,TCGA-ZF-A9RF-01A-11D-A38G-08,0,NA,TCGA-ZF-A9RF,BLCA,74,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-27281,Alive,TUMOR FREE,1949,NA,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,1565,Complete Remission/Response,0,1949,0,1949,1,1565,1,1565,NA,Stage II,T1,M0,NA,10
-1.378549439,3.083369423,TCGA-T3-A92N-01A,TCGA-T3-A92N-01A-11D-A391-08,0,NA,TCGA-T3-A92N,HNSC,79,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G3,2013,[Not Available],-28879,Dead,WITH TUMOR,NA,95,[Not Available],Distant Metastasis,Distant Metastasis,Lung,46,Progressive Disease,1,95,1,95,NA,NA,1,46,NA,Stage IVA,T2,MX,NA,6
-6.588827767,1.761285784,TCGA-ZF-A9RE-01A,TCGA-ZF-A9RE-01A-11D-A38G-08,10,0.113840217,TCGA-ZF-A9RE,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-28622,Dead,WITH TUMOR,NA,106,[Not Available],NA,NA,NA,NA,Progressive Disease,1,106,1,106,NA,NA,1,106,NA,Stage II,[Not Available],MX,NA,7
7.770137636,-1.363463937,TCGA-DX-A7EL-01A,TCGA-DX-A7EL-01A-12D-A36J-09,1,0.157219429,TCGA-DX-A7EL,SARC,56,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-20767,Alive,TUMOR FREE,2291,NA,[Not Available],Distant Metastasis,Lung,NA,2249,[Not Available],0,2291,0,2291,1,2249,1,2249,NA,NA,NA,NA,NA,1
9.08698016,-4.412320668,TCGA-DX-A7EM-01A,TCGA-DX-A7EM-01A-11D-A36J-09,1,0.712952608,TCGA-DX-A7EM,SARC,61,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-22531,Alive,TUMOR FREE,1892,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1892,0,1892,0,1892,0,1892,NA,NA,NA,NA,NA,1
10.02006384,-1.530711453,TCGA-DX-A7EI-01A,TCGA-DX-A7EI-01A-11D-A33E-09,1,0.882107753,TCGA-DX-A7EI,SARC,78,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2003,[Not Available],-28610,Dead,WITH TUMOR,NA,1049,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,828,[Not Available],1,1049,1,1049,NA,NA,1,828,NA,NA,NA,NA,NA,1
8.770370948,-4.611766345,TCGA-DX-A7EF-01A,TCGA-DX-A7EF-01A-11D-A33E-09,1,0.785605417,TCGA-DX-A7EF,SARC,88,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2005,[Not Available],-32302,Dead,WITH TUMOR,NA,648,[Not Available],Distant Metastasis,Lung,NA,294,[Not Available],1,648,1,648,1,294,1,294,NA,NA,NA,NA,NA,1
0.073657383,4.932699062,TCGA-24-1551-01A,TCGA-24-1551-01A-01W-0551-08,4,0.557375471,TCGA-24-1551,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1997,[Not Available],-19661,Dead,WITH TUMOR,1579,1579,[Not Available],Recurrence,[Not Applicable],[Not Applicable],764,Complete Remission/Response,1,1579,1,1579,1,764,1,764,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
0.157278577,4.41405344,TCGA-36-2532-01A,TCGA-36-2532-01A-01D-1526-09,4,0.409815489,TCGA-36-2532,OV,61,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2007,[Not Available],-22333,Alive,WITH TUMOR,897,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,897,0,897,NA,NA,0,897,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-3.145945261,-3.566915816,TCGA-ZF-A9RC-01A,TCGA-ZF-A9RC-01A-11D-A38G-08,8,0.5084763,TCGA-ZF-A9RC,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-28275,Alive,TUMOR FREE,2868,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2868,0,2868,0,2868,0,2868,NA,Stage III,T3a,MX,NA,10
-3.370147447,-3.221053848,TCGA-B5-A1MW-01A,TCGA-B5-A1MW-01A-11D-A17D-09,8,0.580394402,TCGA-B5-A1MW,UCEC,55,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20183,Alive,TUMOR FREE,447,NA,[Not Available],Locoregional Disease,"Other, specify",vaginal cuff,311,Complete Remission/Response,0,447,0,447,1,311,1,311,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.336626659,1.620266598,TCGA-T2-A6WZ-01A,TCGA-T2-A6WZ-01A-21D-A34J-08,10,0.160892139,TCGA-T2-A6WZ,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-19397,Dead,WITH TUMOR,NA,484,[Not Available],Distant Metastasis,Distant Metastasis,bilateral pulmonary nodules,229,Stable Disease,1,484,1,484,NA,NA,1,229,NA,[Not Available],T3,[Not Available],NA,7
-0.24487257,2.671841922,TCGA-ZF-A9R9-01A,TCGA-ZF-A9R9-01A-11D-A38G-08,4,0.03917332,TCGA-ZF-A9R9,BLCA,58,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-21491,Dead,WITH TUMOR,NA,864,[Not Available],Distant Metastasis,"Other, specify",penis,629,Complete Remission/Response,1,864,1,864,NA,NA,1,629,NA,Stage IV,T3b,MX,NA,6
9.499824057,-3.342933669,TCGA-AN-A0FJ-01A,TCGA-AN-A0FJ-01A-11W-A019-09,1,0.62324382,TCGA-AN-A0FJ,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-21910,Alive,TUMOR FREE,242,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,242,0,242,NA,NA,0,242,NA,Stage IV,T2,M1,BRCA.Basal,1
-5.293975459,1.698769053,TCGA-T2-A6WX-01A,TCGA-T2-A6WX-01A-12D-A34J-08,0,NA,TCGA-T2-A6WX,HNSC,73,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2010,[Not Available],-27005,Dead,WITH TUMOR,NA,209,[Not Available],NA,NA,NA,NA,Progressive Disease,1,209,1,209,NA,NA,1,209,NA,[Not Available],[Not Available],[Not Available],NA,9
-0.249327287,4.524686884,TCGA-AR-A0U2-01A,TCGA-AR-A0U2-01A-11D-A10G-09,4,0.464218195,TCGA-AR-A0U2,BRCA,47,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17390,Dead,WITH TUMOR,NA,2551,[Not Available],Distant Metastasis,Bone,Liver,1609,[Not Available],1,2551,1,2551,1,1609,1,1609,NA,Stage IIIA,T2,M0,BRCA.LumB,6
-7.469546663,2.647008102,TCGA-T2-A6X0-01A,TCGA-T2-A6X0-01A-11D-A34J-08,0,NA,TCGA-T2-A6X0,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2012,[Not Available],-18114,Alive,TUMOR FREE,216,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,216,0,216,NA,NA,0,216,NA,[Not Available],TX,[Not Available],NA,9
-1.893794331,1.441221238,TCGA-RS-A6TO-01A,TCGA-RS-A6TO-01A-32D-A34J-08,5,0.395849142,TCGA-RS-A6TO,HNSC,82,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-30104,Dead,WITH TUMOR,NA,387,[Not Available],Locoregional Recurrence,Oral Cavity,L floor of mouth,338,Complete Remission/Response,1,387,1,387,NA,NA,1,338,NA,Stage IVA,T4,M0,NA,4
-3.255494529,-3.37913446,TCGA-ZF-A9R7-01A,TCGA-ZF-A9R7-01A-11D-A38G-08,8,0.535032636,TCGA-ZF-A9R7,BLCA,76,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-28063,Alive,TUMOR FREE,665,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,665,0,665,0,665,0,665,NA,Stage II,[Not Available],M0,NA,10
-5.949507411,2.543919418,TCGA-ZF-A9R5-01A,TCGA-ZF-A9R5-01A-12D-A42E-08,0,NA,TCGA-ZF-A9R5,BLCA,59,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-21811,Alive,TUMOR FREE,1090,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1090,0,1090,0,1090,0,1090,NA,Stage III,T3,M0,NA,8
9.276452243,-2.435832891,TCGA-RS-A6TP-01A,TCGA-RS-A6TP-01A-12D-A34J-08,1,0.764953249,TCGA-RS-A6TP,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2013,[Not Available],-21393,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,516,0,516,0,516,0,516,NA,Stage II,T2,M0,NA,6
-4.46602508,-0.858633806,TCGA-ZF-A9R4-01A,TCGA-ZF-A9R4-01A-11D-A38G-08,8,0.103815698,TCGA-ZF-A9R4,BLCA,83,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-30398,Alive,TUMOR FREE,921,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,921,0,921,0,921,0,921,NA,Stage II,T2,M0,NA,10
-4.41126975,1.663891742,TCGA-D6-6517-01A,TCGA-D6-6517-01A-11D-1870-08,0,NA,TCGA-D6-6517,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-21791,Alive,WITH TUMOR,292,NA,[Not Available],NA,Distant Metastasis,tracheostoma,161,Progressive Disease,0,292,0,292,NA,NA,1,161,NA,Stage III,T3,[Not Available],HNSC.Basal,9
9.225243817,-4.848160813,TCGA-B2-5633-01A,TCGA-B2-5633-01A-01D-A270-10,1,0.808283535,TCGA-B2-5633,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-20493,Alive,TUMOR FREE,963,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,963,0,963,0,963,0,963,NA,Stage I,T1b,M0,KIRC.1,1
9.424764606,-4.700319297,TCGA-DX-A7ER-01A,TCGA-DX-A7ER-01A-11D-A36J-09,1,0.796611716,TCGA-DX-A7ER,SARC,69,MALE,WHITE,Synovial Sarcoma - Monophasic,[Not Available],2008,[Not Available],-25363,Dead,TUMOR FREE,NA,1466,[Not Available],NA,NA,NA,NA,[Not Available],1,1466,0,1466,0,1466,0,1466,NA,NA,NA,NA,NA,1
10.23836044,-1.939497421,TCGA-DX-A7EO-01A,TCGA-DX-A7EO-01A-11D-A36J-09,1,0.787406457,TCGA-DX-A7EO,SARC,20,FEMALE,WHITE,Synovial Sarcoma - Biphasic,[Not Available],2002,[Not Available],-7604,Alive,TUMOR FREE,4627,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4627,0,4627,0,4627,0,4627,NA,NA,NA,NA,NA,1
9.090494255,-2.730108065,TCGA-DX-A7EQ-01A,TCGA-DX-A7EQ-01A-11D-A387-09,1,0.76053214,TCGA-DX-A7EQ,SARC,72,MALE,WHITE,Synovial Sarcoma - Monophasic,[Not Available],2006,[Not Available],-26503,Dead,WITH TUMOR,NA,897,[Not Available],Distant Metastasis,Lung,NA,251,[Not Available],1,897,1,897,1,251,1,251,NA,NA,NA,NA,NA,1
-5.950753683,1.216942344,TCGA-13-0800-01A,TCGA-13-0800-01A-01W-0371-08,0,NA,TCGA-13-0800,OV,52,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-19087,Alive,TUMOR FREE,2661,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1396,Complete Remission/Response,0,2661,0,2661,1,1396,1,1396,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,9
-0.003145031,5.072428122,TCGA-DX-A7ET-01A,TCGA-DX-A7ET-01A-11D-A36J-09,4,0.615255174,TCGA-DX-A7ET,SARC,71,MALE,BLACK OR AFRICAN AMERICAN,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-26193,Alive,TUMOR FREE,463,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,463,0,463,0,463,0,463,NA,NA,NA,NA,NA,6
-6.644401492,-1.210744076,TCGA-ZF-A9R1-01A,TCGA-ZF-A9R1-01A-11D-A391-08,0,NA,TCGA-ZF-A9R1,BLCA,81,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-29610,Alive,WITH TUMOR,773,NA,[Not Available],Distant Metastasis,Bone,NA,758,Complete Remission/Response,0,773,0,773,NA,NA,1,758,NA,Stage IV,T3b,M0,NA,2
-4.807792388,-1.493770543,TCGA-ZF-A9R0-01A,TCGA-ZF-A9R0-01A-11D-A38G-08,8,0.219642214,TCGA-ZF-A9R0,BLCA,82,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-30222,Dead,WITH TUMOR,NA,680,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",right hemipelvis,559,Progressive Disease,1,680,1,680,NA,NA,1,559,NA,Stage III,T3b,M0,NA,10
-4.488873743,-1.795203082,TCGA-QK-A6VB-01A,TCGA-QK-A6VB-01A-12D-A34J-08,8,0.458764129,TCGA-QK-A6VB,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2013,[Not Available],-24144,Alive,TUMOR FREE,641,NA,[Not Available],New Primary Tumor,NA,Acute myeloid leukemia,613,Complete Remission/Response,0,641,0,641,NA,NA,1,613,NA,Stage IVA,T4a,M0,NA,10
0.181580454,5.363537237,TCGA-ZF-A9R3-01A,TCGA-ZF-A9R3-01A-11D-A38G-08,4,0.438599528,TCGA-ZF-A9R3,BLCA,53,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-19384,Dead,WITH TUMOR,NA,949,[Not Available],Distant Metastasis,Bone,NA,917,Complete Remission/Response,1,949,1,949,1,917,1,917,NA,Stage II,T2,M0,NA,1
-6.899796393,2.017387788,TCGA-ZF-A9R2-01A,TCGA-ZF-A9R2-01A-11D-A391-08,9,0.067896663,TCGA-ZF-A9R2,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-27537,Alive,TUMOR FREE,642,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,642,0,642,0,642,0,642,NA,Stage II,T2b,M0,NA,9
-8.102054097,2.053224526,TCGA-B6-A0I5-01A,TCGA-B6-A0I5-01A-11W-A100-09,9,0.370883635,TCGA-B6-A0I5,BRCA,49,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1988,Indeterminate (neither Pre or Postmenopausal),-18038,Alive,TUMOR FREE,8556,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,8556,0,8556,0,8556,0,8556,NA,Stage IIB,T2,M0,BRCA.LumA,7
0.2754841,3.49387679,TCGA-AW-A1PO-01A,TCGA-AW-A1PO-01A-12D-A159-09,4,0.351847422,TCGA-AW-A1PO,UCEC,66,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24225,Alive,TUMOR FREE,17,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,17,0,17,NA,NA,0,17,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,3
9.70625917,-3.626756736,TCGA-DJ-A1QL-01A,TCGA-DJ-A1QL-01A-11D-A14W-08,1,0.699172728,TCGA-DJ-A1QL,THCA,70,MALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-25713,Alive,TUMOR FREE,535,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,535,0,535,0,535,0,535,NA,Stage II,T2,M0,THCA.1,1
-0.844545059,2.549745705,TCGA-DD-AAE0-01A,TCGA-DD-AAE0-01A-11D-A40R-10,4,0.159403249,TCGA-DD-AAE0,LIHC,45,FEMALE,ASIAN,Hepatocellular Carcinoma,G4,2013,[Not Available],-16732,Alive,TUMOR FREE,555,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,555,0,555,0,555,0,555,NA,Stage IIIA,T3a,M0,NA,6
9.212310549,-5.678403267,TCGA-DD-AAE1-01A,TCGA-DD-AAE1-01A-11D-A40R-10,1,0.805175542,TCGA-DD-AAE1,LIHC,52,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-19073,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,552,0,552,0,552,0,552,NA,Stage I,T1,M0,NA,1
0.832087905,4.427897717,TCGA-DD-AAE2-01A,TCGA-DD-AAE2-01A-11D-A40R-10,0,NA,TCGA-DD-AAE2,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-18695,Alive,TUMOR FREE,638,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,638,0,638,0,638,0,638,NA,Stage I,T1,M0,NA,1
-5.121882856,1.885437682,TCGA-DD-AAE3-01A,TCGA-DD-AAE3-01A-11D-A40R-10,0,NA,TCGA-DD-AAE3,LIHC,50,MALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-18271,Alive,TUMOR FREE,566,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,566,0,566,0,566,0,566,NA,Stage I,T1,M0,NA,9
8.994591418,-1.621327398,TCGA-DD-AADY-01A,TCGA-DD-AADY-01A-11D-A40R-10,1,0.658357216,TCGA-DD-AADY,LIHC,55,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-20233,Alive,TUMOR FREE,555,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,555,0,555,0,555,0,555,NA,Stage I,T1,M0,NA,1
9.27566235,-4.892274227,TCGA-BJ-A0Z0-01A,TCGA-BJ-A0Z0-01A-11D-A10S-08,1,0.784396405,TCGA-BJ-A0Z0,THCA,55,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-20361,Alive,TUMOR FREE,419,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,419,0,419,0,419,0,419,NA,Stage II,T2,MX,THCA.1,1
-6.288186595,1.26508587,TCGA-D1-A16S-01A,TCGA-D1-A16S-01A-11D-A12J-09,10,0.042675733,TCGA-D1-A16S,UCEC,70,FEMALE,WHITE,Serous endometrial adenocarcinoma,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25690,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,568,0,568,0,568,0,568,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.CN high,7
9.484645685,-5.749235839,TCGA-FK-A3SG-01A,TCGA-FK-A3SG-01A-11D-A22D-08,1,0.846910188,TCGA-FK-A3SG,THCA,21,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-7710,Alive,TUMOR FREE,28,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,28,0,28,0,28,0,28,NA,Stage I,T2,MX,THCA.5,1
9.799002747,-2.036211603,TCGA-E3-A3DY-01A,TCGA-E3-A3DY-01A-11D-A20C-08,1,0.789717412,TCGA-E3-A3DY,THCA,37,MALE,WHITE,"Other, specify",[Not Available],2007,[Not Available],-13860,Alive,TUMOR FREE,2815,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2815,0,2815,0,2815,0,2815,NA,Stage I,T3,M0,THCA.2,1
-3.569713575,-2.9577684,TCGA-EO-A22S-01A,TCGA-EO-A22S-01A-11D-A18P-09,8,0.439711961,TCGA-EO-A22S,UCEC,58,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21328,Alive,TUMOR FREE,1872,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1872,0,1872,0,1872,0,1872,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-7.503859773,-2.351183368,TCGA-DD-AADP-01A,TCGA-DD-AADP-01A-11D-A38X-10,6,0.111749952,TCGA-DD-AADP,LIHC,45,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-16760,Alive,TUMOR FREE,458,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,458,0,458,0,458,0,458,NA,Stage I,T1,M0,NA,2
1.634623345,2.011068559,TCGA-DD-AADQ-01A,TCGA-DD-AADQ-01A-11D-A40R-10,3,0.189852436,TCGA-DD-AADQ,LIHC,59,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-21756,Alive,TUMOR FREE,436,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,436,0,436,0,436,0,436,NA,Stage II,T2,M0,NA,3
-7.073272368,-2.205885894,TCGA-DD-AADR-01A,TCGA-DD-AADR-01A-11D-A40R-10,6,0.304313452,TCGA-DD-AADR,LIHC,58,MALE,ASIAN,Hepatocellular Carcinoma,G3,2009,[Not Available],-21217,Alive,TUMOR FREE,2028,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,1700,[Not Available],0,2028,0,2028,1,1700,1,1700,NA,Stage I,T1,M0,NA,2
4.260260735,1.22081573,TCGA-DD-AADS-01A,TCGA-DD-AADS-01A-11D-A40R-10,2,0.444862168,TCGA-DD-AADS,LIHC,63,MALE,ASIAN,Hepatocellular Carcinoma,G2,2013,[Not Available],-23227,Alive,TUMOR FREE,474,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,474,0,474,0,474,0,474,NA,Stage I,T1,M0,NA,5
-7.716387565,-2.407785611,TCGA-DD-AADU-01A,TCGA-DD-AADU-01A-11D-A40R-10,6,0.515809307,TCGA-DD-AADU,LIHC,60,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-21940,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,554,0,554,0,554,0,554,NA,Stage II,T2,M0,NA,2
-0.093514549,4.944006614,TCGA-DD-AADW-01A,TCGA-DD-AADW-01A-11D-A38X-10,4,0.699075943,TCGA-DD-AADW,LIHC,48,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-17781,Alive,TUMOR FREE,587,NA,[Not Available],Locoregional Recurrence,Liver,NA,386,[Not Available],0,587,0,587,1,386,1,386,NA,Stage I,T1,M0,NA,6
-6.067086742,3.500602421,TCGA-DJ-A3UP-01A,TCGA-DJ-A3UP-01A-11D-A22D-08,11,0.531766428,TCGA-DJ-A3UP,THCA,38,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-13899,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,499,0,499,0,499,0,499,NA,Stage I,T2,M0,THCA.1,8
-5.334450101,-1.469312632,TCGA-DD-AADO-01A,TCGA-DD-AADO-01A-11D-A40R-10,0,NA,TCGA-DD-AADO,LIHC,55,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-20139,Alive,TUMOR FREE,453,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,453,0,453,0,453,0,453,NA,Stage I,T1,M0,NA,10
9.975309398,-1.623554357,TCGA-EL-A3GS-01A,TCGA-EL-A3GS-01A-11D-A20C-08,1,0.851280875,TCGA-EL-A3GS,THCA,37,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-13542,Alive,TUMOR FREE,1989,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1989,0,1989,0,1989,0,1989,NA,Stage I,T3,M0,THCA.3,1
-2.709405918,-4.399409521,TCGA-AJ-A3EK-01A,TCGA-AJ-A3EK-01A-11D-A19Y-09,0,NA,TCGA-AJ-A3EK,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Peri (6-12 months since last menstrual period),-19609,Alive,TUMOR FREE,446,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,446,0,446,0,446,0,446,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
9.518807227,-2.028393806,TCGA-DJ-A13U-01A,TCGA-DJ-A13U-01A-11D-A10S-08,1,0.775998142,TCGA-DJ-A13U,THCA,60,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-22130,Alive,TUMOR FREE,1590,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1590,0,1590,0,1590,0,1590,NA,Stage III,T3,M0,THCA.3,1
-7.733831643,-2.400433135,TCGA-DD-AADN-01A,TCGA-DD-AADN-01A-11D-A40R-10,6,0.329012229,TCGA-DD-AADN,LIHC,59,MALE,ASIAN,Hepatocellular Carcinoma,G4,2012,[Not Available],-21632,Alive,TUMOR FREE,898,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,898,0,898,0,898,0,898,NA,Stage I,T1,MX,NA,2
-6.216881079,3.570922934,TCGA-J8-A3O0-01A,TCGA-J8-A3O0-01A-11D-A21A-08,11,0.449392149,TCGA-J8-A3O0,THCA,38,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-14214,Alive,TUMOR FREE,1313,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1313,0,1313,0,1313,0,1313,NA,Stage I,T2,M0,THCA.1,8
0.096801625,5.132193827,TCGA-DD-AADD-01A,TCGA-DD-AADD-01A-11D-A40R-10,4,0.682608692,TCGA-DD-AADD,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G4,2011,[Not Available],-18752,Alive,TUMOR FREE,1231,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1231,0,1231,0,1231,0,1231,NA,Stage I,T1,M0,NA,6
0.332400418,2.149308947,TCGA-DD-AADF-01A,TCGA-DD-AADF-01A-11D-A40R-10,0,NA,TCGA-DD-AADF,LIHC,64,FEMALE,ASIAN,Hepatocellular Carcinoma,G4,2011,[Not Available],-23614,Dead,TUMOR FREE,NA,115,[Not Available],NA,NA,NA,NA,[Not Available],1,115,0,115,0,115,0,115,NA,Stage I,T1,M0,NA,6
9.388523202,-5.370039381,TCGA-DD-AADJ-01A,TCGA-DD-AADJ-01A-11D-A40R-10,1,0.846987541,TCGA-DD-AADJ,LIHC,70,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-25863,Alive,TUMOR FREE,1066,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1066,0,1066,0,1066,0,1066,NA,Stage I,T1,M0,NA,1
-8.145384694,2.031953911,TCGA-DD-AADK-01A,TCGA-DD-AADK-01A-11D-A40R-10,9,0.474173282,TCGA-DD-AADK,LIHC,68,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-25046,Alive,TUMOR FREE,1049,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1049,0,1049,0,1049,0,1049,NA,Stage II,T2,M0,NA,7
0.127734714,3.25641388,TCGA-DD-AADL-01A,TCGA-DD-AADL-01A-11D-A40R-10,4,0.385508986,TCGA-DD-AADL,LIHC,58,MALE,ASIAN,Hepatocellular Carcinoma,G4,2012,[Not Available],-21512,Alive,TUMOR FREE,636,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,636,0,636,0,636,0,636,NA,Stage I,T1,M0,NA,3
-6.741248265,-2.208149395,TCGA-DD-AADM-01A,TCGA-DD-AADM-01A-11D-A40R-10,6,0.189316768,TCGA-DD-AADM,LIHC,58,MALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-21349,Dead,TUMOR FREE,NA,12,[Not Available],NA,NA,NA,NA,[Not Available],1,12,0,12,0,12,0,12,NA,Stage II,T2,M0,NA,2
9.823849412,-1.462781453,TCGA-L6-A4EP-01A,TCGA-L6-A4EP-01A-11D-A257-08,1,0.809985964,TCGA-L6-A4EP,THCA,41,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-15292,Alive,TUMOR FREE,1016,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1016,0,1016,0,1016,0,1016,NA,Stage I,T2,M0,THCA.NA,1
-2.727061526,-4.370998694,TCGA-AX-A2HC-01A,TCGA-AX-A2HC-01A-11D-A17D-09,0,NA,TCGA-AX-A2HC,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2006,[Not Available],-19485,Alive,WITH TUMOR,1044,NA,[Not Available],Metastatic,"Other, specify",Abdomen,756,Complete Remission/Response,0,1044,0,1044,1,756,1,756,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.131283319,3.470840849,TCGA-DJ-A3VG-01A,TCGA-DJ-A3VG-01A-11D-A23M-08,11,0.375573125,TCGA-DJ-A3VG,THCA,40,MALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-14970,Alive,TUMOR FREE,1085,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1085,0,1085,0,1085,0,1085,NA,Stage I,T1b,M0,THCA.1,8
-1.305041018,4.119648523,TCGA-DD-AADB-01A,TCGA-DD-AADB-01A-11D-A40R-10,4,0.317650061,TCGA-DD-AADB,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G4,2011,[Not Available],-18728,Alive,TUMOR FREE,1242,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1242,0,1242,0,1242,0,1242,NA,Stage I,T1,M0,NA,6
-4.532216054,0.70609895,TCGA-85-6798-01A,TCGA-85-6798-01A-11D-1945-08,0,NA,TCGA-85-6798,LUSC,57,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-20837,Dead,WITH TUMOR,NA,195,[Not Available],Distant Metastasis,NA,NA,180,Complete Remission/Response,1,195,1,195,1,180,1,180,NA,Stage IIIA,T3,M0,NA,10
-0.76000903,2.440227793,TCGA-DD-AAD3-01A,TCGA-DD-AAD3-01A-11D-A40R-10,4,0.050986894,TCGA-DD-AAD3,LIHC,43,MALE,ASIAN,Hepatocellular Carcinoma,G2,2011,[Not Available],-15706,Alive,TUMOR FREE,1295,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1295,0,1295,0,1295,0,1295,NA,Stage I,T1,M0,NA,6
-0.001669512,3.237916231,TCGA-BF-A5EP-01A,TCGA-BF-A5EP-01A-12D-A27K-08,4,0.3761216,TCGA-BF-A5EP,SKCM,75,FEMALE,WHITE,NA,[Not Available],2012,[Not Available],-27622,Alive,TUMOR FREE,335,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,335,0,335,NA,NA,0,335,NA,Stage IIIC,T4b,M0,SKCM.-,3
0.005331334,4.149537937,TCGA-DD-AAD5-01A,TCGA-DD-AAD5-01A-11D-A40R-10,4,0.488909656,TCGA-DD-AAD5,LIHC,54,MALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-19748,Alive,WITH TUMOR,1345,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,130,[Not Available],0,1345,0,1345,1,130,1,130,NA,Stage I,T1,M0,NA,6
-7.213343479,-2.001394268,TCGA-DD-AAD6-01A,TCGA-DD-AAD6-01A-11D-A40R-10,0,NA,TCGA-DD-AAD6,LIHC,66,MALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-24185,Alive,TUMOR FREE,672,NA,[Not Available],Locoregional Recurrence,Liver,NA,50,[Not Available],0,672,0,672,1,50,1,50,NA,Stage IIIA,T3a,M0,NA,2
-1.440885497,4.187458058,TCGA-DD-AAD8-01A,TCGA-DD-AAD8-01A-11D-A40R-10,4,0.331360318,TCGA-DD-AAD8,LIHC,73,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2011,[Not Available],-26781,Alive,TUMOR FREE,1219,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1219,0,1219,0,1219,0,1219,NA,Stage I,T1,M0,NA,6
-6.195071256,2.380951177,TCGA-DD-AADA-01A,TCGA-DD-AADA-01A-11D-A40R-10,0,NA,TCGA-DD-AADA,LIHC,66,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-24288,Alive,TUMOR FREE,1233,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1233,0,1233,0,1233,0,1233,NA,Stage I,T1,M0,NA,9
2.976810618,3.572789681,TCGA-D8-A1X8-01A,TCGA-D8-A1X8-01A-11D-A14K-09,0,NA,TCGA-D8-A1X8,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995,Alive,TUMOR FREE,783,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,783,0,783,0,783,0,783,NA,Stage IIIA,T1c,M0,BRCA.LumA,1
-7.810940933,-2.514254395,TCGA-ER-A42H-01A,TCGA-ER-A42H-01A-11D-A24R-08,6,0.539283567,TCGA-ER-A42H,SKCM,76,MALE,WHITE,NA,[Not Available],2010,[Not Available],-28110,Dead,WITH TUMOR,NA,426,[Not Available],NA,NA,NA,259,[Not Available],1,426,1,426,NA,NA,1,259,NA,[Not Available],[Not Available],[Not Available],SKCM.Triple_WT,1
-3.50984053,-2.872088389,TCGA-BF-AAOX-01A,TCGA-BF-AAOX-01A-11D-A397-08,8,0.308145743,TCGA-BF-AAOX,SKCM,83,MALE,WHITE,NA,[Not Available],2013,[Not Available],-30318,Alive,TUMOR FREE,444,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,444,0,444,NA,NA,0,444,NA,Stage IIC,T4b,M0,NA,10
-5.798293619,-2.009731701,TCGA-DD-AAD0-01A,TCGA-DD-AAD0-01A-11D-A40R-10,0,NA,TCGA-DD-AAD0,LIHC,73,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-26781,Alive,WITH TUMOR,137,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,47,[Not Available],0,137,0,137,1,47,1,47,NA,Stage I,T1,M0,NA,2
7.765546833,-1.3441197,TCGA-DD-AAD1-01A,TCGA-DD-AAD1-01A-11D-A40R-10,1,0.125752593,TCGA-DD-AAD1,LIHC,51,FEMALE,ASIAN,Hepatocellular Carcinoma,G4,2010,[Not Available],-18794,Alive,WITH TUMOR,564,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,127,[Not Available],0,564,0,564,NA,NA,1,127,NA,Stage I,T1,M0,NA,6
0.206154098,3.816719392,TCGA-13-0894-01B,TCGA-13-0894-01B-01W-0492-08,4,0.170557078,TCGA-13-0894,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-19466,Dead,WITH TUMOR,1509,1509,[Not Available],Recurrence,[Not Applicable],[Not Applicable],565,Complete Remission/Response,1,1509,1,1509,1,565,1,565,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
2.000990668,1.983242234,TCGA-B5-A11Z-01A,TCGA-B5-A11Z-01A-11D-A10M-09,3,0.521810141,TCGA-B5-A11Z,UCEC,61,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22505,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,528,0,528,0,528,0,528,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,3
-6.271510304,1.828402148,TCGA-77-8146-01A,TCGA-77-8146-01A-11D-2244-08,10,0.155908134,TCGA-77-8146,LUSC,72,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-26533,Alive,NA,3189,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3189,0,3189,0,3189,0,3189,NA,Stage IA,T1,M0,NA,9
0.720494221,3.758296339,TCGA-RC-A6M6-01A,TCGA-RC-A6M6-01A-11D-A32G-10,0,NA,TCGA-RC-A6M6,LIHC,75,MALE,WHITE,Hepatocellular Carcinoma,G3,2011,[Not Available],-27649,Alive,NA,9,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,9,0,9,NA,NA,0,9,NA,Stage II,T2,M0,LIHC.iCluster:1,6
4.393942161,1.109792173,TCGA-RC-A6M5-01A,TCGA-RC-A6M5-01A-11D-A32G-10,2,0.653759838,TCGA-RC-A6M5,LIHC,20,FEMALE,WHITE,Fibrolamellar Carcinoma,G2,2012,[Not Available],-7634,Alive,NA,15,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,15,0,15,NA,NA,0,15,NA,Stage IVA,T1,M0,LIHC.iCluster:1,5
-4.929071542,0.466847615,TCGA-RC-A6M4-01A,TCGA-RC-A6M4-01A-11D-A32G-10,0,NA,TCGA-RC-A6M4,LIHC,74,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2010,[Not Available],-27327,Alive,NA,22,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,22,0,22,NA,NA,0,22,NA,Stage IIIA,T3,MX,LIHC.iCluster:3,10
1.579347572,1.980408154,TCGA-RC-A6M3-01A,TCGA-RC-A6M3-01A-11D-A32G-10,0,NA,TCGA-RC-A6M3,LIHC,24,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Hepatocellular Carcinoma,G3,2009,[Not Available],-8899,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage II,T2,M0,LIHC.iCluster:1,3
-7.325055747,-2.360936372,TCGA-DD-AACS-01A,TCGA-DD-AACS-01A-11D-A40R-10,6,0.114411539,TCGA-DD-AACS,LIHC,39,MALE,ASIAN,Hepatocellular Carcinoma,G3,2009,[Not Available],-14473,Alive,TUMOR FREE,1804,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1804,0,1804,0,1804,0,1804,NA,Stage I,T1,M0,NA,2
0.016688382,4.630945841,TCGA-GJ-A3OU-01A,TCGA-GJ-A3OU-01A-31D-A382-10,4,0.449566398,TCGA-GJ-A3OU,LIHC,59,MALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-21671,Alive,[Discrepancy],879,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,879,[Not Available],0,879,0,879,NA,NA,1,879,NA,Stage I,T1,MX,NA,6
-0.240469101,3.252882096,TCGA-DD-AACU-01A,TCGA-DD-AACU-01A-11D-A40R-10,4,0.358925657,TCGA-DD-AACU,LIHC,59,MALE,ASIAN,Hepatocellular Carcinoma,G3,2010,[Not Available],-21606,Alive,TUMOR FREE,1567,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1567,0,1567,0,1567,0,1567,NA,Stage I,T1,M0,NA,3
0.041498587,4.437215481,TCGA-DD-AAVV-01A,TCGA-DD-AAVV-01A-11D-A40R-10,4,0.290346507,TCGA-DD-AAVV,LIHC,56,MALE,ASIAN,Hepatocellular Carcinoma,G3,2007,[Not Available],-20751,Alive,TUMOR FREE,2455,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2455,0,2455,0,2455,0,2455,NA,Stage II,T2,M0,NA,6
-6.435923094,1.972992302,TCGA-DD-AACW-01A,TCGA-DD-AACW-01A-11D-A40R-10,0,NA,TCGA-DD-AACW,LIHC,43,MALE,ASIAN,Hepatocellular Carcinoma,G3,2010,[Not Available],-15872,Alive,TUMOR FREE,1424,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1424,0,1424,0,1424,0,1424,NA,Stage I,T1,M0,NA,7
-6.371613107,-1.225324817,TCGA-2V-A95S-01A,TCGA-2V-A95S-01A-11D-A36X-10,7,0.254703392,TCGA-2V-A95S,LIHC,NA,MALE,ASIAN,Hepatocellular Carcinoma,G3,NA,[Not Available],NA,Alive,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,NA,0,NA,0,NA,0,NA,NA,Stage II,T2,MX,NA,2
-0.938895236,2.068510752,TCGA-DD-AACX-01A,TCGA-DD-AACX-01A-11D-A40R-10,0,NA,TCGA-DD-AACX,LIHC,66,MALE,ASIAN,Hepatocellular Carcinoma,G3,2010,[Not Available],-24329,Alive,WITH TUMOR,170,NA,[Not Available],Extrahepatic Recurrence,"Other, specify",lymph node,42,[Not Available],0,170,0,170,1,42,1,42,NA,Stage II,T2,M0,NA,6
-1.03499446,2.228097029,TCGA-DD-AACZ-01A,TCGA-DD-AACZ-01A-11D-A40R-10,0,NA,TCGA-DD-AACZ,LIHC,63,FEMALE,ASIAN,Hepatocellular Carcinoma,G4,2010,[Not Available],-23230,Dead,TUMOR FREE,NA,171,[Not Available],Locoregional Recurrence,Liver,NA,88,[Not Available],1,171,0,171,1,88,1,88,NA,Stage I,T1,M0,NA,10
10.03794267,-1.526681306,TCGA-KS-A4I1-01A,TCGA-KS-A4I1-01A-11D-A257-08,1,0.864452785,TCGA-KS-A4I1,THCA,37,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-13538,Alive,TUMOR FREE,812,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,812,0,812,NA,NA,0,812,NA,Stage I,T2,M0,THCA.5,1
9.593092198,-5.800113127,TCGA-FY-A3WA-01A,TCGA-FY-A3WA-01A-11D-A22D-08,1,0.836230326,TCGA-FY-A3WA,THCA,52,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-18993,Alive,TUMOR FREE,519,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,519,0,519,0,519,0,519,NA,Stage I,T1a,MX,THCA.1,1
1.855620581,2.076048628,TCGA-WX-AA47-01A,TCGA-WX-AA47-01A-11D-A38X-10,3,0.439150318,TCGA-WX-AA47,LIHC,33,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-12056,Dead,WITH TUMOR,NA,556,[Not Available],Intrahepatic Recurrence,Liver,NA,103,[Not Available],1,556,1,556,1,103,1,103,NA,Stage IIIA,T3a,MX,NA,3
0.070778375,3.317792212,TCGA-WX-AA44-01A,TCGA-WX-AA44-01A-11D-A38X-10,4,0.426087583,TCGA-WX-AA44,LIHC,64,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2011,[Not Available],-23654,Alive,WITH TUMOR,615,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,246,[Not Available],0,615,0,615,NA,NA,1,246,NA,Stage I,T1,MX,NA,3
-6.382441691,-2.078064745,TCGA-CQ-5326-01A,TCGA-CQ-5326-01A-01D-1870-08,0,NA,TCGA-CQ-5326,HNSC,67,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2007,[Not Available],-24473,Dead,WITH TUMOR,NA,89,[Not Available],NA,NA,NA,NA,Progressive Disease,1,89,1,89,NA,NA,1,89,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,2
9.855807984,-1.978935622,TCGA-DJ-A3UN-01A,TCGA-DJ-A3UN-01A-11D-A22D-08,1,0.852565282,TCGA-DJ-A3UN,THCA,51,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-18871,Alive,TUMOR FREE,986,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,986,0,986,0,986,0,986,NA,Stage I,T1b,M0,THCA.5,1
-7.887993997,-2.490800621,TCGA-KS-A4I5-01A,TCGA-KS-A4I5-01A-11D-A257-08,6,0.402101043,TCGA-KS-A4I5,THCA,49,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-17963,Alive,TUMOR FREE,567,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,567,0,567,NA,NA,0,567,NA,Stage IVA,T1b,M0,THCA.5,2
-0.280250222,3.827543032,TCGA-D1-A1O0-01A,TCGA-D1-A1O0-01A-11D-A17D-09,4,0.230030925,TCGA-D1-A1O0,UCEC,77,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28162,Alive,TUMOR FREE,63,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,63,0,63,0,63,0,63,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,6
0.612563186,4.165542754,TCGA-XR-A8TC-01A,TCGA-XR-A8TC-01A-11D-A35Z-10,4,0.201574119,TCGA-XR-A8TC,LIHC,43,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2011,[Not Available],-15817,Alive,WITH TUMOR,1339,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1339,0,1339,0,1339,0,1339,NA,Stage I,T1,MX,NA,1
-1.930802185,1.190569685,TCGA-DD-AACJ-01A,TCGA-DD-AACJ-01A-11D-A40R-10,5,0.666538474,TCGA-DD-AACJ,LIHC,75,MALE,ASIAN,Hepatocellular Carcinoma,G2,2008,[Not Available],-27528,Alive,WITH TUMOR,2102,NA,[Not Available],Locoregional Recurrence,Liver,NA,100,[Not Available],0,2102,0,2102,1,100,1,100,NA,Stage II,T2,M0,NA,4
-6.34125068,-1.785866689,TCGA-DD-AACL-01A,TCGA-DD-AACL-01A-11D-A40R-10,0,NA,TCGA-DD-AACL,LIHC,66,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2008,[Not Available],-24355,Dead,NA,NA,107,[Not Available],NA,NA,NA,NA,[Not Available],1,107,NA,107,0,107,0,107,NA,Stage I,T1,M0,NA,2
-7.241998795,2.020171284,TCGA-DD-AACM-01A,TCGA-DD-AACM-01A-11D-A40R-10,9,0.138577329,TCGA-DD-AACM,LIHC,48,MALE,ASIAN,Hepatocellular Carcinoma,G3,2009,[Not Available],-17590,Alive,WITH TUMOR,1769,NA,[Not Available],Extrahepatic Recurrence,Lung,NA,1097,[Not Available],0,1769,0,1769,1,1097,1,1097,NA,Stage II,T2,M0,NA,7
-2.08206068,1.789506239,TCGA-21-5784-01A,TCGA-21-5784-01A-01D-1632-08,5,0.163854556,TCGA-21-5784,LUSC,80,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-29362,Alive,TUMOR FREE,1268,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1268,0,1268,0,1268,0,1268,NA,Stage IB,T2,M0,LUSC.basal,6
8.727301983,-3.505860624,TCGA-AC-A3QQ-01A,TCGA-AC-A3QQ-01A-11D-A228-09,1,0.71234813,TCGA-AC-A3QQ,BRCA,54,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-19723,Alive,TUMOR FREE,734,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,734,0,734,NA,NA,0,734,NA,Stage IA,T1c,MX,BRCA.LumA,1
-6.660537657,-1.221054955,TCGA-DD-AACE-01A,TCGA-DD-AACE-01A-11D-A40R-10,7,0.14528099,TCGA-DD-AACE,LIHC,62,MALE,ASIAN,Hepatocellular Carcinoma,G3,2008,[Not Available],-22727,Alive,TUMOR FREE,2184,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,1279,[Not Available],0,2184,0,2184,1,1279,1,1279,NA,Stage I,T1,M0,NA,2
-0.815371302,3.702651873,TCGA-XR-A8TG-01A,TCGA-XR-A8TG-01A-11D-A35Z-10,4,0.314618122,TCGA-XR-A8TG,LIHC,58,MALE,WHITE,Hepatocellular Carcinoma,G2,2012,[Not Available],-21544,Alive,TUMOR FREE,898,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,350,[Not Available],0,898,0,898,1,350,1,350,NA,Stage I,T1,M0,NA,5
-0.572891108,4.330599609,TCGA-DD-AACG-01A,TCGA-DD-AACG-01A-11D-A40R-10,4,0.446641861,TCGA-DD-AACG,LIHC,52,MALE,ASIAN,Hepatocellular Carcinoma,G4,2008,[Not Available],-19174,Dead,WITH TUMOR,NA,469,[Not Available],Intrahepatic Recurrence,Liver,NA,125,[Not Available],1,469,1,469,1,125,1,125,NA,Stage II,T2,M0,NA,3
-1.211521806,2.104262994,TCGA-DD-AACH-01A,TCGA-DD-AACH-01A-11D-A40R-10,0,NA,TCGA-DD-AACH,LIHC,69,MALE,ASIAN,Hepatocellular Carcinoma,G3,2008,[Not Available],-25544,Dead,TUMOR FREE,NA,195,[Not Available],Intrahepatic Recurrence,Liver,NA,83,[Not Available],1,195,0,195,1,83,1,83,NA,Stage II,T2,M0,NA,3
9.61382142,-5.274989632,TCGA-XR-A8TE-01A,TCGA-XR-A8TE-01A-11D-A35Z-10,1,0.845163938,TCGA-XR-A8TE,LIHC,16,MALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-5862,Alive,WITH TUMOR,925,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,210,[Not Available],0,925,0,925,1,210,1,210,NA,Stage IIIA,T3,MX,NA,1
8.582846699,-3.400036619,TCGA-XR-A8TD-01A,TCGA-XR-A8TD-01A-12D-A38X-10,1,0.665036181,TCGA-XR-A8TD,LIHC,49,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2012,[Not Available],-17908,Alive,TUMOR FREE,1030,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1030,0,1030,0,1030,0,1030,NA,Stage IIIB,T3,M0,NA,1
-1.630087683,2.235564636,TCGA-DD-AACI-01A,TCGA-DD-AACI-01A-11D-A40R-10,0,NA,TCGA-DD-AACI,LIHC,69,MALE,ASIAN,Hepatocellular Carcinoma,G3,2008,[Not Available],-25236,Alive,WITH TUMOR,1618,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,1432,[Not Available],0,1618,0,1618,1,1432,1,1432,NA,Stage II,T2,M0,NA,10
9.333495302,-5.165036232,TCGA-FE-A3PA-01A,TCGA-FE-A3PA-01A-12D-A21Z-08,1,0.78069215,TCGA-FE-A3PA,THCA,16,MALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2002,[Not Available],-6068,Alive,TUMOR FREE,3235,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3235,0,3235,NA,NA,0,3235,NA,Stage II,T4,M1,THCA.5,1
-1.885080221,1.217150087,TCGA-AX-A2HK-01A,TCGA-AX-A2HK-01A-11D-A17D-09,5,0.59964032,TCGA-AX-A2HK,UCEC,77,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28316,Dead,WITH TUMOR,NA,90,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,90,1,90,NA,NA,1,90,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.Notassigned,4
-6.34199671,3.44135405,TCGA-EM-A2CU-01A,TCGA-EM-A2CU-01A-12D-A17V-08,11,0.039825927,TCGA-EM-A2CU,THCA,47,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-17231,Alive,WITH TUMOR,400,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,400,0,400,0,400,0,400,NA,Stage III,T2,MX,THCA.5,8
-5.732181453,-1.526394547,TCGA-CV-7099-01A,TCGA-CV-7099-01A-41D-2012-08,0,NA,TCGA-CV-7099,HNSC,85,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2002,[Not Available],-31134,Dead,TUMOR FREE,NA,243,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,243,0,243,0,243,0,243,NA,Stage II,T2,[Not Available],HNSC.Basal,10
-2.844558643,-4.183949398,TCGA-AJ-A3EL-01A,TCGA-AJ-A3EL-01A-11D-A20S-09,0,NA,TCGA-AJ-A3EL,UCEC,47,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Endometrioid endometrial adenocarcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17442,Alive,TUMOR FREE,684,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,684,0,684,0,684,0,684,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-0.945293258,2.548196736,TCGA-AX-A1CA-01A,TCGA-AX-A1CA-01A-12D-A135-09,0,NA,TCGA-AX-A1CA,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2009,[Not Available],-25817,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,974,0,974,NA,NA,0,974,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,3
10.11291431,-1.584219036,TCGA-EL-A3H8-01A,TCGA-EL-A3H8-01A-11D-A20C-08,1,0.885855246,TCGA-EL-A3H8,THCA,35,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-12992,Alive,TUMOR FREE,4577,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4577,0,4577,0,4577,0,4577,NA,Stage I,T3,M0,THCA.3,1
-7.276009682,-2.5386687,TCGA-BA-6871-01A,TCGA-BA-6871-01A-11D-1870-08,6,0.218244316,TCGA-BA-6871,HNSC,75,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-27708,Dead,WITH TUMOR,NA,108,[Not Available],NA,NA,NA,NA,Stable Disease,1,108,1,108,NA,NA,1,108,NA,[Not Available],TX,[Not Available],HNSC.Mesenchymal,2
-6.297171185,3.321806728,TCGA-E3-A3DZ-01A,TCGA-E3-A3DZ-01A-11D-A20C-08,11,0.426554847,TCGA-E3-A3DZ,THCA,55,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-20251,Alive,TUMOR FREE,1436,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1436,0,1436,0,1436,0,1436,NA,Stage III,T3,M0,THCA.1,8
-1.734531474,1.067523733,TCGA-BP-4975-01A,TCGA-BP-4975-01A-01D-1462-08,5,0.59672598,TCGA-BP-4975,KIRC,40,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-14710,Alive,TUMOR FREE,1433,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1433,0,1433,NA,NA,0,1433,NA,Stage I,T1b,M0,KIRC.1,4
-5.930872327,1.198098119,TCGA-AC-A5EH-01A,TCGA-AC-A5EH-01A-11D-A28B-09,10,0.029949584,TCGA-AC-A5EH,BRCA,76,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,[Not Available],-27964,Alive,TUMOR FREE,511,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,511,0,511,0,511,0,511,NA,Stage IIB,T2,MX,BRCA.Her2,9
1.347618611,3.283839811,TCGA-AC-A4ZE-01A,TCGA-AC-A4ZE-01A-11D-A41F-09,0,NA,TCGA-AC-A4ZE,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23284,Alive,TUMOR FREE,890,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,890,0,890,0,890,0,890,NA,Stage IIB,T3,M0,BRCA.LumA,1
-6.926294731,-2.06221905,TCGA-39-5024-01A,TCGA-39-5024-01A-21D-1817-08,6,0.220079947,TCGA-39-5024,LUSC,65,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-23975,Alive,TUMOR FREE,2510,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2510,0,2510,0,2510,0,2510,NA,Stage IIIA,T2a,M0,LUSC.basal,2
-2.022304916,1.311891619,TCGA-23-1029-01B,TCGA-23-1029-01B-01W-0639-09,5,0.591634189,TCGA-23-1029,OV,46,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-16889,Alive,TUMOR FREE,268,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,268,0,268,0,268,0,268,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,4
-0.512288176,4.691064391,TCGA-22-4605-01A,TCGA-22-4605-01A-21D-2122-08,4,0.584021257,TCGA-22-4605,LUSC,78,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-28623,Dead,TUMOR FREE,NA,974,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,974,0,974,0,974,0,974,NA,Stage IB,T2,M0,NA,6
8.920926275,-4.36087512,TCGA-V7-A7HQ-01A,TCGA-V7-A7HQ-01A-11D-A33E-09,1,0.807158112,TCGA-V7-A7HQ,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27684,Alive,TUMOR FREE,2033,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2033,0,2033,0,2033,0,2033,NA,Stage IIIA,T1c,M0,BRCA.LumA,1
1.020284197,3.588911607,TCGA-EW-A6SD-01A,TCGA-EW-A6SD-01A-12D-A33E-09,0,NA,TCGA-EW-A6SD,BRCA,32,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,[Not Available],-12006,Alive,TUMOR FREE,1010,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1010,0,1010,0,1010,0,1010,NA,Stage IIB,T2,M0,BRCA.Her2,1
-4.350780595,1.723212679,TCGA-EW-A6SC-01A,TCGA-EW-A6SC-01A-12D-A32I-09,0,NA,TCGA-EW-A6SC,BRCA,60,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-21918,Alive,TUMOR FREE,952,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,952,0,952,0,952,0,952,NA,Stage IIA,T2,M0,BRCA.LumA,8
-0.469828817,4.520937704,TCGA-EW-A6SB-01A,TCGA-EW-A6SB-01A-12D-A32I-09,4,0.52295589,TCGA-EW-A6SB,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,[Not Available],-22844,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,760,0,760,0,760,0,760,NA,Stage II,T2,M0,BRCA.Basal,6
-7.068533515,-2.449367632,TCGA-AC-A5XU-01A,TCGA-AC-A5XU-01A-11D-A28B-09,6,0.027428614,TCGA-AC-A5XU,BRCA,74,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Available],-27191,Alive,TUMOR FREE,455,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,455,0,455,0,455,0,455,NA,Stage IIB,T3,MX,BRCA.LumA,2
4.445562295,1.098133031,TCGA-AC-A5EI-01A,TCGA-AC-A5EI-01A-11D-A27P-09,2,0.663536016,TCGA-AC-A5EI,BRCA,88,FEMALE,WHITE,"Other, specify",[Not Available],2012,[Not Available],-32375,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,442,0,442,0,442,0,442,NA,Stage IB,T1c,MX,NA,5
9.581059359,-5.812217031,TCGA-DJ-A3US-01A,TCGA-DJ-A3US-01A-11D-A22D-08,1,0.829969301,TCGA-DJ-A3US,THCA,37,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-13634,Alive,TUMOR FREE,998,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,998,0,998,0,998,0,998,NA,Stage I,T1b,M0,THCA.2,1
8.436758389,-3.663371978,TCGA-BB-4228-01A,TCGA-BB-4228-01A-01D-1434-08,1,0.648005672,TCGA-BB-4228,HNSC,50,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,2010,[Not Available],-18536,Alive,TUMOR FREE,559,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,559,0,559,0,559,0,559,NA,Stage III,T3,[Not Available],HNSC.Atypical,1
7.791550843,-1.356883909,TCGA-FK-A3SD-01A,TCGA-FK-A3SD-01A-11D-A22D-08,1,0.149153045,TCGA-FK-A3SD,THCA,61,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-22560,Alive,TUMOR FREE,32,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,32,0,32,0,32,0,32,NA,Stage I,T1,M0,THCA.1,1
4.284535438,1.183914956,TCGA-BP-4999-01A,TCGA-BP-4999-01A-01D-1462-08,2,0.591209672,TCGA-BP-4999,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-20518,Alive,TUMOR FREE,1266,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1266,0,1266,NA,NA,0,1266,NA,Stage I,T1a,M0,KIRC.1,5
-6.063475855,1.793054464,TCGA-FI-A2EU-01A,TCGA-FI-A2EU-01A-11D-A17D-09,10,0.151039088,TCGA-FI-A2EU,UCEC,68,FEMALE,[Not Available],Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24837,Alive,TUMOR FREE,2941,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2941,0,2941,0,2941,0,2941,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
8.909453231,-3.321824399,TCGA-5P-A9JV-01A,TCGA-5P-A9JV-01A-12D-A42J-10,1,0.724779707,TCGA-5P-A9JV,KIRP,49,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2005,[Not Available],-17973,Alive,NA,2043,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2043,0,2043,0,2043,0,2043,NA,[Not Available],T1a,[Not Available],NA,1
9.284271498,-4.347241514,TCGA-5P-A9JU-01A,TCGA-5P-A9JU-01A-11D-A42J-10,1,0.7822686,TCGA-5P-A9JU,KIRP,81,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2012,[Not Available],-29594,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,373,0,373,0,373,0,373,NA,Stage III,T3a,M0,NA,1
-6.43322008,1.678366472,TCGA-5P-A9K3-01A,TCGA-5P-A9K3-01A-11D-A42J-10,10,0.133551718,TCGA-5P-A9K3,KIRP,59,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-21829,Dead,WITH TUMOR,NA,471,[Not Available],NA,NA,NA,17,Partial Remission/Response,1,471,1,471,NA,NA,1,17,NA,[Not Available],T2,MX,NA,7
-1.878847238,1.07193301,TCGA-5P-A9K2-01A,TCGA-5P-A9K2-01A-11D-A42J-10,5,0.517406555,TCGA-5P-A9K2,KIRP,62,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-22964,Alive,TUMOR FREE,2392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2392,0,2392,0,2392,0,2392,NA,[Not Available],T1b,MX,NA,4
8.660084899,-3.771230733,TCGA-5P-A9K0-01A,TCGA-5P-A9K0-01A-11D-A42J-10,1,0.669915529,TCGA-5P-A9K0,KIRP,75,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2007,[Not Available],-27434,Alive,NA,677,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,677,0,677,NA,NA,0,677,NA,[Not Available],T1a,MX,NA,1
0.425417064,5.250147732,TCGA-5P-A9JZ-01A,TCGA-5P-A9JZ-01A-11D-A42J-10,4,0.48082161,TCGA-5P-A9JZ,KIRP,51,FEMALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-18885,Alive,TUMOR FREE,2744,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2744,0,2744,0,2744,0,2744,NA,[Not Available],T1b,[Not Available],NA,1
-0.152069362,3.083319489,TCGA-77-8143-01A,TCGA-77-8143-01A-11D-2244-08,4,0.266308524,TCGA-77-8143,LUSC,76,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-27772,Dead,WITH TUMOR,NA,803,[Not Available],NA,NA,NA,NA,[Unknown],1,803,1,803,NA,NA,1,803,NA,Stage IIIA,T2,M0,NA,3
8.868524906,-2.959172581,TCGA-5P-A9JY-01A,TCGA-5P-A9JY-01A-11D-A42J-10,1,0.729102769,TCGA-5P-A9JY,KIRP,79,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-28881,Dead,TUMOR FREE,NA,1508,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1508,0,1508,0,1508,0,1508,NA,[Not Available],T2,MX,NA,6
7.680928872,-3.397264358,TCGA-5P-A9JW-01A,TCGA-5P-A9JW-01A-11D-A42J-10,1,0.27464664,TCGA-5P-A9JW,KIRP,64,MALE,WHITE,Kidney Papillary Renal Cell Carcinoma,[Not Available],2006,[Not Available],-23570,Alive,NA,3241,NA,[Not Available],NA,NA,NA,3228,Complete Remission/Response,0,3241,0,3241,1,3228,1,3228,NA,[Not Available],T1a,MX,NA,1
-5.952151441,3.45758818,TCGA-EM-A2CM-01A,TCGA-EM-A2CM-01A-11D-A17V-08,11,0.569238578,TCGA-EM-A2CM,THCA,62,FEMALE,[Not Available],"Other, specify",[Not Available],2010,[Not Available],-22726,Alive,WITH TUMOR,1253,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1253,0,1253,0,1253,0,1253,NA,Stage III,T3,MX,NA,8
-3.635359386,-2.894292999,TCGA-D1-A1NZ-01A,TCGA-D1-A1NZ-01A-21D-A14G-09,8,0.386843,TCGA-D1-A1NZ,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22027,Alive,TUMOR FREE,548,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,548,0,548,0,548,0,548,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-5.912380855,3.090177371,TCGA-23-2645-01A,TCGA-23-2645-01A-01W-1091-09,0,NA,TCGA-23-2645,OV,54,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,2009,[Not Available],-19758,Alive,NA,137,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,137,0,137,NA,NA,0,137,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,8
-1.820768635,2.946728037,TCGA-DQ-5629-01A,TCGA-DQ-5629-01A-01D-1870-08,0,NA,TCGA-DQ-5629,HNSC,64,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-23550,Dead,TUMOR FREE,NA,941,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,941,0,941,NA,NA,0,941,NA,[Not Available],TX,[Not Available],HNSC.Classical,6
10.29047097,-1.490742155,TCGA-EL-A4KG-01A,TCGA-EL-A4KG-01A-11D-A257-08,1,0.853959964,TCGA-EL-A4KG,THCA,35,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-12978,Alive,TUMOR FREE,739,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,739,0,739,0,739,0,739,NA,Stage I,T3,M0,THCA.4,1
0.685387095,2.165882441,TCGA-G3-AAV3-01A,TCGA-G3-AAV3-01A-11D-A36X-10,0,NA,TCGA-G3-AAV3,LIHC,58,FEMALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-21449,Alive,TUMOR FREE,412,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,412,0,412,0,412,0,412,NA,Stage II,T2,M0,NA,3
3.982830395,0.999705958,TCGA-G3-AAV4-01A,TCGA-G3-AAV4-01A-11D-A382-10,2,0.184257394,TCGA-G3-AAV4,LIHC,83,FEMALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-30466,Dead,TUMOR FREE,NA,27,[Not Available],NA,NA,NA,NA,[Not Available],1,27,0,27,0,27,0,27,NA,Stage I,T1,M0,NA,6
-5.733011553,-2.209076254,TCGA-G3-AAV6-01A,TCGA-G3-AAV6-01A-21D-A36X-10,0,NA,TCGA-G3-AAV6,LIHC,53,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2013,[Not Available],-19556,Dead,WITH TUMOR,NA,65,[Not Available],Intrahepatic Recurrence,Liver,NA,44,[Not Available],1,65,1,65,1,44,1,44,NA,Stage IIIA,T3a,M0,NA,2
-0.495445976,4.626769272,TCGA-G3-A7M6-01A,TCGA-G3-A7M6-01A-11D-A33Q-10,4,0.579223951,TCGA-G3-A7M6,LIHC,60,FEMALE,WHITE,Hepatocellular Carcinoma,G3,2013,[Not Available],-22205,Alive,WITH TUMOR,632,NA,[Not Available],Locoregional Recurrence,Liver,NA,293,[Not Available],0,632,0,632,1,293,1,293,NA,Stage I,T1,MX,LIHC.iCluster:3,3
-7.896387613,2.035413564,TCGA-G3-A7M8-01A,TCGA-G3-A7M8-01A-11D-A33Q-10,9,0.535957549,TCGA-G3-A7M8,LIHC,31,MALE,ASIAN,Hepatocellular Carcinoma,G1,2013,[Not Available],-11527,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,430,0,430,NA,NA,0,430,NA,Stage I,T1,MX,LIHC.iCluster:2,7
7.701274508,-1.25965066,TCGA-G3-AAUZ-01A,TCGA-G3-AAUZ-01A-11D-A382-10,1,0.059191996,TCGA-G3-AAUZ,LIHC,48,MALE,[Unknown],Hepatocellular Carcinoma,G2,2013,[Not Available],-17760,Alive,TUMOR FREE,480,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,480,0,480,0,480,0,480,NA,Stage I,T1,M0,NA,1
-7.39308142,-2.52687219,TCGA-G3-AAV1-01A,TCGA-G3-AAV1-01A-11D-A382-10,6,0.355205636,TCGA-G3-AAV1,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-18973,Dead,WITH TUMOR,NA,359,[Not Available],Locoregional Recurrence,Liver,NA,49,[Not Available],1,359,1,359,1,49,1,49,NA,Stage IIIC,T4,M0,NA,2
-0.669343941,2.204973879,TCGA-G3-AAV2-01A,TCGA-G3-AAV2-01A-11D-A36X-10,0,NA,TCGA-G3-AAV2,LIHC,50,MALE,WHITE,Hepatocellular Carcinoma,G1,2013,[Not Available],-18363,Alive,TUMOR FREE,372,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,372,0,372,0,372,0,372,NA,Stage I,T1,M0,NA,1
-7.788133911,-2.353890577,TCGA-DD-AAW0-01A,TCGA-DD-AAW0-01A-11D-A40R-10,6,0.527128307,TCGA-DD-AAW0,LIHC,54,MALE,ASIAN,Hepatocellular Carcinoma,G2,2009,[Not Available],-19981,Alive,TUMOR FREE,2015,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2015,0,2015,0,2015,0,2015,NA,Stage I,T1,M0,NA,2
-7.355840787,2.431441437,TCGA-DD-AAW2-01A,TCGA-DD-AAW2-01A-11D-A40P-10,0,NA,TCGA-DD-AAW2,LIHC,69,MALE,ASIAN,Hepatocellular Carcinoma,G2,2009,[Not Available],-25420,Alive,WITH TUMOR,1855,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,391,[Not Available],0,1855,0,1855,1,391,1,391,NA,Stage I,T1,M0,NA,8
0.335731093,3.329499749,TCGA-DD-AAW3-01A,TCGA-DD-AAW3-01A-11D-A40P-10,4,0.344033854,TCGA-DD-AAW3,LIHC,69,MALE,ASIAN,Hepatocellular Carcinoma,G2,2009,[Not Available],-25254,Alive,TUMOR FREE,1633,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1633,0,1633,0,1633,0,1633,NA,Stage I,T1,M0,NA,3
0.084746484,3.295622526,TCGA-DD-AAVU-01A,TCGA-DD-AAVU-01A-11D-A40R-10,4,0.376434007,TCGA-DD-AAVU,LIHC,46,MALE,ASIAN,Hepatocellular Carcinoma,G2,2008,[Not Available],-16889,Alive,TUMOR FREE,2202,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,1630,[Not Available],0,2202,0,2202,1,1630,1,1630,NA,Stage II,T2,M0,NA,3
8.591551591,-2.289687548,TCGA-DD-AAVX-01A,TCGA-DD-AAVX-01A-11D-A40R-10,1,0.585554082,TCGA-DD-AAVX,LIHC,38,MALE,ASIAN,Hepatocellular Carcinoma,G2,2008,[Not Available],-14016,Alive,WITH TUMOR,1718,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,393,[Not Available],0,1718,0,1718,1,393,1,393,NA,Stage II,T2,M0,NA,6
9.5384693,-4.383144336,TCGA-DD-AAVZ-01A,TCGA-DD-AAVZ-01A-11D-A40R-10,1,0.762458441,TCGA-DD-AAVZ,LIHC,38,MALE,ASIAN,Hepatocellular Carcinoma,G2,2009,[Not Available],-14005,Alive,TUMOR FREE,1900,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1900,0,1900,0,1900,0,1900,NA,Stage I,T1,M0,NA,1
9.292787848,-4.211331087,TCGA-BJ-A192-01A,TCGA-BJ-A192-01A-31D-A13W-08,1,0.782003149,TCGA-BJ-A192,THCA,54,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-19878,Alive,TUMOR FREE,1349,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1349,0,1349,NA,NA,0,1349,NA,Stage III,T3,M0,THCA.1,1
9.961958338,-1.625792321,TCGA-ET-A2MY-01A,TCGA-ET-A2MY-01A-11D-A18F-08,1,0.849313202,TCGA-ET-A2MY,THCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-26406,Alive,TUMOR FREE,1787,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1787,0,1787,0,1787,0,1787,NA,Stage I,T1b,MX,THCA.4,1
9.420352144,-1.674797856,TCGA-DD-AAVP-01A,TCGA-DD-AAVP-01A-11D-A40R-10,1,0.709464321,TCGA-DD-AAVP,LIHC,48,MALE,ASIAN,Hepatocellular Carcinoma,G1,2007,[Not Available],-17833,Alive,TUMOR FREE,2752,NA,[Not Available],Locoregional Recurrence,Liver,NA,903,[Not Available],0,2752,0,2752,1,903,1,903,NA,Stage I,T1,M0,NA,1
4.21170429,1.235944611,TCGA-DD-AAVQ-01A,TCGA-DD-AAVQ-01A-11D-A40R-10,2,0.53972534,TCGA-DD-AAVQ,LIHC,38,MALE,ASIAN,Hepatocellular Carcinoma,G2,2007,[Not Available],-13911,Alive,TUMOR FREE,2728,NA,[Not Available],Locoregional Recurrence,Liver,NA,1509,[Not Available],0,2728,0,2728,1,1509,1,1509,NA,Stage I,T1,M0,NA,5
0.905300178,3.473628575,TCGA-DD-AAVR-01A,TCGA-DD-AAVR-01A-11D-A40R-10,0,NA,TCGA-DD-AAVR,LIHC,44,MALE,ASIAN,Hepatocellular Carcinoma,G2,2007,[Not Available],-16157,Alive,TUMOR FREE,2513,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2513,0,2513,0,2513,0,2513,NA,Stage I,T1,M0,NA,3
10.05704229,-2.242592188,TCGA-DD-AAVS-01A,TCGA-DD-AAVS-01A-11D-A40R-10,1,0.755242615,TCGA-DD-AAVS,LIHC,56,MALE,ASIAN,Hepatocellular Carcinoma,G2,2007,[Not Available],-20586,Alive,TUMOR FREE,1823,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1823,0,1823,0,1823,0,1823,NA,Stage I,T1,M0,NA,1
8.879868496,-4.967593232,TCGA-DD-AAEE-01A,TCGA-DD-AAEE-01A-11D-A40R-10,1,0.73873701,TCGA-DD-AAEE,LIHC,55,MALE,ASIAN,Hepatocellular Carcinoma,G4,2012,[Not Available],-20396,Alive,WITH TUMOR,810,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,224,[Not Available],0,810,0,810,1,224,1,224,NA,Stage I,T1,M0,NA,3
1.718632886,1.911648829,TCGA-DD-AAEG-01A,TCGA-DD-AAEG-01A-11D-A38X-10,3,0.399136708,TCGA-DD-AAEG,LIHC,59,FEMALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-21853,Alive,TUMOR FREE,719,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,719,0,719,0,719,0,719,NA,Stage I,T1,M0,NA,3
-6.601592593,-2.041262922,TCGA-DD-AAEH-01A,TCGA-DD-AAEH-01A-11D-A40R-10,0,NA,TCGA-DD-AAEH,LIHC,73,MALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-26894,Alive,TUMOR FREE,784,NA,[Not Available],Extrahepatic Recurrence,Bone,NA,644,[Not Available],0,784,0,784,1,644,1,644,NA,Stage I,T1,M0,NA,2
-6.995151257,-2.290397208,TCGA-DD-AAEK-01A,TCGA-DD-AAEK-01A-11D-A40R-10,6,0.272063504,TCGA-DD-AAEK,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G3,2010,[Not Available],-18757,Alive,TUMOR FREE,1067,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1067,0,1067,0,1067,0,1067,NA,Stage II,T2,M0,NA,2
10.0066676,-1.623501019,TCGA-DJ-A3VA-01A,TCGA-DJ-A3VA-01A-11D-A23M-08,1,0.819952843,TCGA-DJ-A3VA,THCA,39,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-14495,Alive,TUMOR FREE,755,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,755,0,755,0,755,0,755,NA,Stage I,T1b,M0,THCA.3,1
9.809138735,-4.287350827,TCGA-EM-A1YC-01A,TCGA-EM-A1YC-01A-11D-A14W-08,1,0.616997063,TCGA-EM-A1YC,THCA,71,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007,[Not Available],-26143,Alive,TUMOR FREE,2391,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2391,0,2391,0,2391,0,2391,NA,Stage III,T3,MX,THCA.1,1
-1.644326386,3.820571143,TCGA-DD-AAEA-01A,TCGA-DD-AAEA-01A-11D-A40R-10,4,0.073919085,TCGA-DD-AAEA,LIHC,65,MALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-24027,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,575,0,575,0,575,0,575,NA,Stage I,T1,M0,NA,10
-1.244829828,3.529207219,TCGA-DD-AAEB-01A,TCGA-DD-AAEB-01A-11D-A40R-10,4,0.141708576,TCGA-DD-AAEB,LIHC,60,MALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-22121,Alive,TUMOR FREE,478,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,478,0,478,0,478,0,478,NA,Stage I,T1,M0,NA,6
0.117381762,4.536997561,TCGA-DD-AAED-01A,TCGA-DD-AAED-01A-12D-A40R-10,4,0.461976331,TCGA-DD-AAED,LIHC,51,MALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-18722,Alive,WITH TUMOR,763,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,198,[Not Available],0,763,0,763,1,198,1,198,NA,Stage I,T1,M0,NA,6
-7.810184579,-2.488770696,TCGA-DD-AAE4-01A,TCGA-DD-AAE4-01A-11D-A40R-10,6,0.508763885,TCGA-DD-AAE4,LIHC,49,FEMALE,ASIAN,Hepatocellular Carcinoma,G1,2013,[Not Available],-18009,Alive,WITH TUMOR,608,NA,[Not Available],Locoregional Recurrence,Liver,NA,111,[Not Available],0,608,0,608,1,111,1,111,NA,Stage I,T1,M0,NA,2
-7.232702952,-2.435611625,TCGA-DD-AAE6-01A,TCGA-DD-AAE6-01A-11D-A40R-10,6,0.406381884,TCGA-DD-AAE6,LIHC,59,FEMALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-21764,Alive,WITH TUMOR,141,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,105,[Not Available],0,141,0,141,1,105,1,105,NA,Stage I,T1,M0,NA,2
-5.152787906,0.803451935,TCGA-DD-AAE7-01A,TCGA-DD-AAE7-01A-11D-A40R-10,0,NA,TCGA-DD-AAE7,LIHC,72,MALE,ASIAN,Hepatocellular Carcinoma,G2,2012,[Not Available],-26568,Alive,TUMOR FREE,644,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,644,0,644,0,644,0,644,NA,Stage I,T1,M0,NA,10
9.430268474,-2.616893406,TCGA-DD-AAE8-01A,TCGA-DD-AAE8-01A-11D-A40R-10,1,0.759312636,TCGA-DD-AAE8,LIHC,45,MALE,ASIAN,Hepatocellular Carcinoma,G3,2012,[Not Available],-16549,Alive,TUMOR FREE,664,NA,[Not Available],Locoregional Recurrence,Liver,NA,28,[Not Available],0,664,0,664,1,28,1,28,NA,Stage I,T1,M0,NA,1
-5.300834616,-2.109310508,TCGA-CV-7414-01A,TCGA-CV-7414-01A-11D-2078-08,0,NA,TCGA-CV-7414,HNSC,78,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1995,[Not Available],-28603,Dead,NA,NA,14,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,14,NA,14,NA,NA,0,14,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,10
-2.183018661,2.467513087,TCGA-94-8035-01A,TCGA-94-8035-01A-11D-2244-08,0,NA,TCGA-94-8035,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-23399,Alive,TUMOR FREE,122,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,122,0,122,0,122,0,122,NA,Stage IIB,T3,MX,NA,6
-1.538848539,2.892438295,TCGA-CR-7390-01A,TCGA-CR-7390-01A-11D-2012-08,0,NA,TCGA-CR-7390,HNSC,67,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-24575,Alive,TUMOR FREE,1508,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1508,0,1508,NA,NA,0,1508,NA,Stage IVA,T4a,M0,HNSC.Classical,6
9.633189274,-4.205038992,TCGA-B0-4700-01A,TCGA-B0-4700-01A-02D-1534-10,1,0.741387508,TCGA-B0-4700,KIRC,60,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2004,[Not Available],-22034,Dead,WITH TUMOR,NA,1980,[Not Available],NA,NA,NA,NA,[Not Available],1,1980,1,1980,NA,NA,1,1980,NA,Stage IV,T4,M1,KIRC.3,1
-1.747065679,3.626621438,TCGA-63-A5MY-01A,TCGA-63-A5MY-01A-11D-A26M-08,4,0.00781258,TCGA-63-A5MY,LUSC,63,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-23276,Alive,TUMOR FREE,1052,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1052,0,1052,0,1052,0,1052,NA,Stage IA,T1b,M0,NA,6
0.256849278,5.103870248,TCGA-IS-A3K6-01A,TCGA-IS-A3K6-01A-11D-A21Q-09,4,0.629139711,TCGA-IS-A3K6,SARC,55,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2000,[Not Available],-20205,Dead,WITH TUMOR,NA,858,[Not Available],NA,NA,NA,NA,[Not Available],1,858,1,858,NA,NA,1,858,NA,NA,NA,NA,NA,6
-6.440684545,1.754395941,TCGA-CN-6996-01A,TCGA-CN-6996-01A-11D-1912-08,10,0.262167643,TCGA-CN-6996,HNSC,58,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-21447,Dead,WITH TUMOR,NA,530,[Not Available],NA,Cervical Lymph Nodes,SUPRASTERNAL NOTCH NODE,350,Complete Remission/Response,1,530,1,530,NA,NA,1,350,NA,Stage IVA,T3,[Not Available],NA,7
-2.121408365,1.35652533,TCGA-IS-A3K7-01A,TCGA-IS-A3K7-01A-11D-A21Q-09,5,0.620002878,TCGA-IS-A3K7,SARC,63,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2000,[Not Available],-23022,Alive,TUMOR FREE,5204,NA,[Not Available],Distant Metastasis,Lung,NA,119,[Not Available],0,5204,0,5204,1,119,1,119,NA,NA,NA,NA,NA,4
-0.341266042,4.222068201,TCGA-CV-6003-01A,TCGA-CV-6003-01A-11D-1683-08,4,0.477978459,TCGA-CV-6003,HNSC,50,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-18600,Alive,TUMOR FREE,1665,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1665,0,1665,NA,NA,0,1665,NA,Stage III,T2,[Not Available],HNSC.Basal,6
-1.602378895,2.457534065,TCGA-CV-6962-01A,TCGA-CV-6962-01A-11D-1912-08,0,NA,TCGA-CV-6962,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-24103,Dead,TUMOR FREE,NA,126,[Not Available],NA,NA,NA,NA,[Not Available],1,126,0,126,NA,NA,0,126,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,6
7.811492042,-1.390640257,TCGA-IF-A4AK-01A,TCGA-IF-A4AK-01A-21D-A24N-09,1,0.124532114,TCGA-IF-A4AK,SARC,82,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-30141,Alive,TUMOR FREE,1590,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1590,0,1590,0,1590,0,1590,NA,NA,NA,NA,NA,1
-5.432131611,-1.714184015,TCGA-66-2754-01A,TCGA-66-2754-01A-01D-0983-08,0,NA,TCGA-66-2754,LUSC,67,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-24471,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,61,0,61,NA,NA,0,61,NA,Stage IIIA,T2,M0,LUSC.primitive,10
-0.209017002,5.051026643,TCGA-59-2372-01A,TCGA-59-2372-01A-01D-1526-09,4,0.685447501,TCGA-59-2372,OV,73,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2005,[Not Available],NA,Dead,NA,NA,1363,[Not Available],NA,NA,NA,NA,[Not Available],1,1363,NA,1363,NA,NA,0,1363,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-7.719484614,-2.526858951,TCGA-63-A5MV-01A,TCGA-63-A5MV-01A-21D-A26M-08,6,0.384164497,TCGA-63-A5MV,LUSC,69,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-25505,Alive,TUMOR FREE,1100,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1100,0,1100,0,1100,0,1100,NA,Stage IIA,T2b,M0,NA,2
-5.587574889,1.376737592,TCGA-63-A5MU-01A,TCGA-63-A5MU-01A-11D-A26M-08,0,NA,TCGA-63-A5MU,LUSC,48,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-17801,Dead,WITH TUMOR,NA,NA,[Not Available],Distant Metastasis,NA,NA,420,Complete Remission/Response,1,NA,1,NA,1,420,1,420,NA,Stage IIB,T2b,M0,NA,3
-3.962038809,-2.303662534,TCGA-D1-A0ZO-01A,TCGA-D1-A0ZO-01A-11D-A122-09,8,0.108520764,TCGA-D1-A0ZO,UCEC,75,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27482,Alive,TUMOR FREE,602,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,602,0,602,0,602,0,602,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-3.976234175,-1.590825749,TCGA-63-A5MW-01A,TCGA-63-A5MW-01A-11D-A26M-08,8,0.172169677,TCGA-63-A5MW,LUSC,76,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-27892,Alive,TUMOR FREE,1639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1639,0,1639,0,1639,0,1639,NA,Stage IB,T2,M0,NA,10
9.648286821,-3.129324461,TCGA-IS-A3K8-01A,TCGA-IS-A3K8-01A-11D-A21Q-09,1,0.693140599,TCGA-IS-A3K8,SARC,44,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2002,[Not Available],-16265,Alive,TUMOR FREE,4845,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4845,0,4845,0,4845,0,4845,NA,NA,NA,NA,NA,1
-0.46635139,4.475535267,TCGA-IS-A3KA-01A,TCGA-IS-A3KA-01A-11D-A21Q-09,4,0.495653873,TCGA-IS-A3KA,SARC,73,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2004,[Not Available],-26775,Dead,WITH TUMOR,NA,413,[Not Available],Distant Metastasis,Lung,NA,76,[Not Available],1,413,1,413,1,76,1,76,NA,NA,NA,NA,NA,6
-6.644694878,-2.186051006,TCGA-63-A5MT-01A,TCGA-63-A5MT-01A-21D-A26M-08,6,0.021284218,TCGA-63-A5MT,LUSC,74,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-27263,Alive,WITH TUMOR,498,NA,[Not Available],Distant Metastasis,NA,NA,427,Complete Remission/Response,0,498,0,498,1,427,1,427,NA,Stage IIB,T3,M0,NA,2
-7.93661778,2.149032903,TCGA-CN-4741-01A,TCGA-CN-4741-01A-01D-1434-08,9,0.627108028,TCGA-CN-4741,HNSC,75,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-27506,Alive,TUMOR FREE,2239,NA,[Not Available],Locoregional Recurrence,Cervical Lymph Nodes,R NECK,1716,Complete Remission/Response,0,2239,0,2239,NA,NA,1,1716,NA,Stage IVA,T4a,M0,HNSC.Atypical,7
-4.358847713,-1.595383955,TCGA-63-A5MS-01A,TCGA-63-A5MS-01A-11D-A26M-08,8,0.41525489,TCGA-63-A5MS,LUSC,78,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-28827,Alive,TUMOR FREE,2381,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2381,0,2381,0,2381,0,2381,NA,Stage IB,T2,M0,NA,10
-0.302950208,4.931956245,TCGA-IW-A3M6-01A,TCGA-IW-A3M6-01A-11D-A21Q-09,4,0.502863625,TCGA-IW-A3M6,SARC,59,FEMALE,ASIAN,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-21674,Alive,TUMOR FREE,688,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,688,0,688,0,688,0,688,NA,NA,NA,NA,NA,6
-1.37813928,2.484413465,TCGA-CN-6019-01A,TCGA-CN-6019-01A-11D-1683-08,0,NA,TCGA-CN-6019,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-22485,Alive,TUMOR FREE,1038,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1038,0,1038,NA,NA,0,1038,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,3
-3.971927781,-1.362224631,TCGA-BA-4077-01B,TCGA-BA-4077-01B-01D-1434-08,8,0.249075276,TCGA-BA-4077,HNSC,45,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2003,[Not Available],-16536,Dead,WITH TUMOR,NA,1134,[Not Available],NA,NA,NA,NA,Persistent Disease,1,1134,1,1134,NA,NA,1,1134,NA,Stage IVA,T4a,M0,NA,10
-6.19188813,-1.176188738,TCGA-F7-8489-01A,TCGA-F7-8489-01A-31D-2394-08,7,0.365192332,TCGA-F7-8489,HNSC,48,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2012,[Not Available],-17873,Alive,TUMOR FREE,658,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,658,0,658,0,658,0,658,NA,Stage II,T2,M0,NA,2
8.943741391,-5.371164739,TCGA-IW-A3M4-01A,TCGA-IW-A3M4-01A-11D-A21Q-09,1,0.810920274,TCGA-IW-A3M4,SARC,48,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2005,[Not Available],-17721,Alive,TUMOR FREE,2615,NA,[Not Available],Locoregional Disease,NA,NA,2207,[Not Available],0,2615,0,2615,1,2207,1,2207,NA,NA,NA,NA,NA,1
-4.045934272,-2.251977245,TCGA-BG-A0LX-01A,TCGA-BG-A0LX-01A-11W-A062-09,8,0.421796738,TCGA-BG-A0LX,UCEC,57,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20928,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,614,0,614,0,614,0,614,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-4.880885167,-2.040967107,TCGA-66-2763-01A,TCGA-66-2763-01A-01D-1522-08,8,0.088815537,TCGA-66-2763,LUSC,63,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-23315,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage IB,T2,M0,LUSC.basal,10
10.08258235,-1.663295258,TCGA-EL-A3CR-01A,TCGA-EL-A3CR-01A-12D-A202-08,1,0.826450321,TCGA-EL-A3CR,THCA,78,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-28785,Dead,NA,NA,233,[Not Available],NA,NA,NA,NA,[Not Available],1,233,NA,233,NA,NA,0,233,NA,Stage III,T3,M0,THCA.4,1
1.862646227,1.979715932,TCGA-63-A5MN-01A,TCGA-63-A5MN-01A-22D-A27K-08,3,0.401541964,TCGA-63-A5MN,LUSC,78,FEMALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-28677,Dead,WITH TUMOR,NA,345,[Not Available],NA,NA,NA,320,Complete Remission/Response,1,345,1,345,1,320,1,320,NA,Stage IIB,T3,M0,NA,3
-3.269938927,-3.371875925,TCGA-63-A5MM-01A,TCGA-63-A5MM-01A-11D-A26M-08,8,0.392966289,TCGA-63-A5MM,LUSC,69,FEMALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-25348,Dead,WITH TUMOR,NA,456,[Not Available],NA,NA,NA,218,Complete Remission/Response,1,456,1,456,1,218,1,218,NA,Stage IIB,T2,M0,NA,10
-3.906295957,1.69155026,TCGA-43-7658-01A,TCGA-43-7658-01A-11D-2122-08,0,NA,TCGA-43-7658,LUSC,75,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-27734,Dead,WITH TUMOR,NA,2378,[Not Available],Distant Metastasis|New Primary Tumor,NA,NA,2305,Complete Remission/Response,1,2378,1,2378,1,2305,1,2305,NA,Stage IA,T1,M0,NA,10
-0.674414041,2.46433031,TCGA-63-A5MR-01A,TCGA-63-A5MR-01A-31D-A27K-08,4,0.131794158,TCGA-63-A5MR,LUSC,70,FEMALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-25879,Alive,TUMOR FREE,2716,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2716,0,2716,0,2716,0,2716,NA,Stage IB,T2,M0,NA,6
-7.393396937,-2.442324317,TCGA-63-A5MP-01A,TCGA-63-A5MP-01A-11D-A26M-08,6,0.372455507,TCGA-63-A5MP,LUSC,56,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-20818,Alive,WITH TUMOR,769,NA,[Not Available],Locoregional Recurrence,NA,NA,511,Complete Remission/Response,0,769,0,769,1,511,1,511,NA,Stage IIB,T2,M0,NA,2
-0.56541143,5.075003213,TCGA-JV-A5VF-01A,TCGA-JV-A5VF-01A-11D-A29N-09,4,0.527465162,TCGA-JV-A5VF,SARC,69,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-25505,Dead,WITH TUMOR,NA,32,[Not Available],NA,NA,NA,NA,[Not Available],1,32,1,32,NA,NA,1,32,NA,NA,NA,NA,NA,6
8.218209249,-2.392791395,TCGA-JV-A5VE-01A,TCGA-JV-A5VE-01A-11D-A29N-09,1,0.511253529,TCGA-JV-A5VE,SARC,60,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-21933,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,499,0,499,0,499,0,499,NA,NA,NA,NA,NA,1
-5.821957818,1.674897553,TCGA-63-A5ML-01A,TCGA-63-A5ML-01A-31D-A27K-08,0,NA,TCGA-63-A5ML,LUSC,68,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-24947,Alive,TUMOR FREE,1386,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1386,0,1386,0,1386,0,1386,NA,Stage IB,T2,M0,NA,9
-0.778067158,4.999411193,TCGA-BA-6870-01A,TCGA-BA-6870-01A-11D-1870-08,4,0.351002423,TCGA-BA-6870,HNSC,60,FEMALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-22222,Dead,NA,NA,451,[Not Available],NA,NA,NA,NA,[Not Available],1,451,NA,451,NA,NA,0,451,NA,[Not Available],TX,[Not Available],HNSC.Basal,6
-7.615226847,-2.335649178,TCGA-K1-A3PN-01A,TCGA-K1-A3PN-01A-11D-A228-09,6,0.317197524,TCGA-K1-A3PN,SARC,64,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2006,[Not Available],-23631,Alive,TUMOR FREE,3080,NA,[Not Available],NA,NA,NA,1033,[Not Available],0,3080,0,3080,1,1033,1,1033,NA,NA,NA,NA,NA,2
0.077137593,3.332474579,TCGA-CM-6165-01A,TCGA-CM-6165-01A-11D-1650-10,4,0.394796365,TCGA-CM-6165,COAD,74,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-27302,Alive,TUMOR FREE,488,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,488,0,488,NA,NA,0,488,NA,Stage IIA,T3,M0,GI.CIN,6
-3.050645909,-3.879698463,TCGA-09-2044-01B,TCGA-09-2044-01B-01D-0704-01,8,0.334079895,TCGA-09-2044,OV,77,FEMALE,ASIAN,Serous Cystadenocarcinoma,G3,2009,[Not Available],-28231,Alive,TUMOR FREE,186,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,186,0,186,0,186,0,186,NA,Stage IIB,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,10
-4.309691424,-1.715889086,TCGA-56-A62T-01A,TCGA-56-A62T-01A-11D-A401-08,8,0.2943414,TCGA-56-A62T,LUSC,78,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2013,[Not Available],-28522,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,440,0,440,0,440,0,440,NA,Stage IIA,T2b,MX,NA,10
-0.870046663,4.708717764,TCGA-63-A5MJ-01A,TCGA-63-A5MJ-01A-11D-A27K-08,4,0.472942989,TCGA-63-A5MJ,LUSC,54,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-20018,Alive,TUMOR FREE,1824,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1824,0,1824,0,1824,0,1824,NA,Stage IIB,T2,M0,NA,6
-5.240047617,1.504431954,TCGA-63-A5MH-01A,TCGA-63-A5MH-01A-12D-A27K-08,0,NA,TCGA-63-A5MH,LUSC,68,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],NA,[Not Available],-25159,Alive,TUMOR FREE,2026,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2026,0,2026,0,2026,0,2026,NA,Stage IA,T1,M0,NA,9
0.103019425,3.298001863,TCGA-K1-A6RT-01A,TCGA-K1-A6RT-01A-32D-A33E-09,4,0.381893669,TCGA-K1-A6RT,SARC,48,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-17739,Alive,WITH TUMOR,528,NA,[Not Available],Distant Metastasis,Lung,NA,129,[Not Available],0,528,0,528,1,129,1,129,NA,NA,NA,NA,NA,3
-4.198767086,0.41298206,TCGA-56-8308-01A,TCGA-56-8308-01A-11D-2293-08,0,NA,TCGA-56-8308,LUSC,79,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-29139,Alive,WITH TUMOR,517,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,517,0,517,NA,NA,0,517,NA,Stage IIB,T3,MX,NA,10
-3.50097346,-3.139782643,TCGA-D6-6516-01A,TCGA-D6-6516-01A-11D-1870-08,8,0.51608674,TCGA-D6-6516,HNSC,69,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-25242,Alive,TUMOR FREE,773,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,773,0,773,0,773,0,773,NA,Stage I,T1,[Not Available],HNSC.Basal,10
0.184638616,3.501935845,TCGA-KF-A41W-01A,TCGA-KF-A41W-01A-11D-A24N-09,4,0.168522022,TCGA-KF-A41W,SARC,71,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-25969,Alive,TUMOR FREE,356,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,356,0,356,NA,NA,0,356,NA,NA,NA,NA,NA,3
10.12677045,-2.171327722,TCGA-B0-5104-01A,TCGA-B0-5104-01A-01D-1421-08,1,0.751858585,TCGA-B0-5104,KIRC,90,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2002,[Not Available],-32873,Dead,TUMOR FREE,NA,2752,[Not Available],NA,NA,NA,NA,[Not Available],1,2752,0,2752,NA,NA,0,2752,NA,Stage I,T1,M0,KIRC.1,1
8.641507029,-3.437316982,TCGA-K1-A6RU-01A,TCGA-K1-A6RU-01A-11D-A32I-09,1,0.697030379,TCGA-K1-A6RU,SARC,66,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2013,[Not Available],-24356,Dead,WITH TUMOR,NA,711,[Not Available],Distant Metastasis,Bone,NA,142,[Not Available],1,711,1,711,NA,NA,1,142,NA,NA,NA,NA,NA,1
-0.920241656,4.553699841,TCGA-K1-A6RV-01A,TCGA-K1-A6RV-01A-11D-A32I-09,4,0.482659319,TCGA-K1-A6RV,SARC,67,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2013,[Not Available],-24701,Alive,WITH TUMOR,158,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,158,0,158,NA,NA,0,158,NA,NA,NA,NA,NA,6
-0.777634442,3.494514598,TCGA-29-1778-01A,TCGA-29-1778-01A-01W-0639-09,4,0.227147669,TCGA-29-1778,OV,77,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-28147,Alive,TUMOR FREE,454,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,454,0,454,0,454,0,454,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,5
-4.80034743,-1.503021841,TCGA-33-AASL-01A,TCGA-33-AASL-01A-11D-A401-08,8,0.130871884,TCGA-33-AASL,LUSC,57,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2000,[Not Available],-20940,Dead,WITH TUMOR,NA,826,[Not Available],Locoregional Recurrence,NA,NA,149,Progressive Disease,1,826,1,826,NA,NA,1,149,NA,Stage IA,T1,MX,NA,10
0.038642694,2.539734949,TCGA-33-AASJ-01A,TCGA-33-AASJ-01A-11D-A401-08,4,0.104280173,TCGA-33-AASJ,LUSC,60,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],1999,[Not Available],-22179,Dead,WITH TUMOR,NA,3600,[Not Available],Locoregional Recurrence,NA,NA,1135,Complete Remission/Response,1,3600,1,3600,1,1135,1,1135,NA,Stage IB,T2,MX,NA,6
-6.729569149,-2.015208626,TCGA-56-8304-01A,TCGA-56-8304-01A-11D-2323-08,6,0.164575328,TCGA-56-8304,LUSC,73,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26803,Alive,TUMOR FREE,106,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,106,0,106,0,106,0,106,NA,Stage IA,T1b,MX,NA,2
-5.242493332,2.008033736,TCGA-34-A5IX-01A,TCGA-34-A5IX-01A-12D-A27K-08,0,NA,TCGA-34-A5IX,LUSC,80,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-29391,Alive,TUMOR FREE,1031,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1031,0,1031,0,1031,0,1031,NA,Stage IIB,T3,M0,NA,10
8.643684668,-4.909896794,TCGA-34-8456-01A,TCGA-34-8456-01A-21D-2323-08,1,0.79500721,TCGA-34-8456,LUSC,71,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26183,Alive,TUMOR FREE,804,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,804,0,804,0,804,0,804,NA,Stage IIA,T2a,M0,NA,1
-1.978992184,1.175861181,TCGA-CA-5797-01A,TCGA-CA-5797-01A-01D-1650-10,5,0.63119093,TCGA-CA-5797,COAD,56,MALE,ASIAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-20662,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,383,0,383,0,383,0,383,NA,Stage IIA,T3,M0,GI.CIN,4
-3.137867145,-3.576430698,TCGA-A6-5661-01A,TCGA-A6-5661-01A-01D-1650-10,8,0.600782711,TCGA-A6-5661,COAD,80,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29446,Alive,TUMOR FREE,1020,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1020,0,1020,0,1020,0,1020,NA,Stage IIA,T3,M0,GI.HM-indel,10
-3.07562603,1.790537703,TCGA-33-AAS8-01A,TCGA-33-AAS8-01A-11D-A401-08,0,NA,TCGA-33-AAS8,LUSC,59,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],1998,[Not Available],-21675,Dead,TUMOR FREE,NA,1114,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1114,0,1114,0,1114,0,1114,NA,Stage IA,T1,MX,NA,10
-6.545915438,-2.07409194,TCGA-33-A5GW-01A,TCGA-33-A5GW-01A-11D-A27K-08,0,NA,TCGA-33-A5GW,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24586,Dead,TUMOR FREE,NA,9,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,9,0,9,0,9,0,9,NA,Stage IIA,T1a,MX,NA,2
0.201428251,4.717741984,TCGA-13-0923-01A,TCGA-13-0923-01A-01W-0420-08,4,0.486706493,TCGA-13-0923,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-27081,Alive,TUMOR FREE,2547,NA,[Not Available],NA,[Not Applicable],[Not Applicable],1719,Complete Remission/Response,0,2547,0,2547,1,1719,1,1719,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-2.807037661,1.848780163,TCGA-33-AASB-01A,TCGA-33-AASB-01A-11D-A401-08,0,NA,TCGA-33-AASB,LUSC,66,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-24183,Dead,WITH TUMOR,NA,211,[Not Available],Distant Metastasis,NA,NA,30,Progressive Disease,1,211,1,211,NA,NA,1,30,NA,Stage IB,T2,MX,NA,10
8.932745756,-4.628346914,TCGA-BP-4177-01A,TCGA-BP-4177-01A-02D-1421-08,1,0.791005239,TCGA-BP-4177,KIRC,65,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-23955,Alive,TUMOR FREE,1670,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1670,0,1670,NA,NA,0,1670,NA,Stage I,T1a,M0,NA,1
-4.730098804,-1.71016055,TCGA-BB-4223-01A,TCGA-BB-4223-01A-01D-1434-08,8,0.270385656,TCGA-BB-4223,HNSC,48,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2003,[Not Available],-17608,Alive,TUMOR FREE,3221,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3221,0,3221,NA,NA,0,3221,NA,Stage IVA,T2,M0,HNSC.Atypical,10
-0.338953831,4.494096416,TCGA-AU-3779-01A,TCGA-AU-3779-01A-01D-1719-10,4,0.475257308,TCGA-AU-3779,COAD,80,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-29460,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,441,0,441,NA,NA,0,441,NA,Stage IIA,T3,M0,GI.CIN,6
-3.151919308,-3.804385543,TCGA-AY-6197-01A,TCGA-AY-6197-01A-11D-1719-10,8,0.300443415,TCGA-AY-6197,COAD,60,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-21957,Alive,TUMOR FREE,652,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,652,0,652,0,652,0,652,NA,Stage IIA,T3,[Not Available],GI.HM-indel,10
-0.836365999,5.039220067,TCGA-13-0884-01B,TCGA-13-0884-01B-01W-0494-09,4,0.453341271,TCGA-13-0884,OV,39,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-14538,Dead,WITH TUMOR,3260,3260,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1251,Complete Remission/Response,1,3260,1,3260,1,1251,1,1251,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.284551034,-1.164941543,TCGA-DM-A0X9-01A,TCGA-DM-A0X9-01A-11D-A152-10,7,0.363483891,TCGA-DM-A0X9,COAD,71,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2001,[Not Available],-26217,Alive,NA,3641,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3641,0,3641,NA,NA,0,3641,NA,Stage IIA,T3,M0,GI.GS,2
9.76058533,-2.45777773,TCGA-4W-AA9S-01A,TCGA-4W-AA9S-01A-11D-A391-08,1,0.676967134,TCGA-4W-AA9S,GBM,69,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2013,[Not Available],-25545,Alive,TUMOR FREE,44,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,44,0,44,NA,NA,0,44,NA,NA,NA,NA,NA,1
8.572705127,-3.731206946,TCGA-AA-3531-01A,TCGA-AA-3531-01A-01D-1953-10,1,0.693043806,TCGA-AA-3531,COAD,75,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-27514,Alive,TUMOR FREE,1035,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1035,0,1035,0,1035,0,1035,NA,Stage IIA,T3,M0,NA,1
-7.406165773,-2.043240394,TCGA-4W-AA9R-01A,TCGA-4W-AA9R-01A-11D-A391-08,6,0.13021056,TCGA-4W-AA9R,GBM,61,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-22317,Alive,TUMOR FREE,124,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,124,0,124,NA,NA,0,124,NA,NA,NA,NA,NA,2
-0.843765605,4.333739676,TCGA-ZF-AA5H-01A,TCGA-ZF-AA5H-01A-11D-A391-08,4,0.46580748,TCGA-ZF-AA5H,BLCA,60,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-22122,Alive,WITH TUMOR,897,NA,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",peritoneum,177,Stable Disease,0,897,0,897,NA,NA,1,177,NA,Stage IV,T3b,M0,NA,6
-5.060659217,1.482131643,TCGA-ZF-AA58-01A,TCGA-ZF-AA58-01A-12D-A42E-08,0,NA,TCGA-ZF-AA58,BLCA,61,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-22549,Alive,TUMOR FREE,1649,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1649,0,1649,NA,NA,0,1649,NA,Stage IV,T3a,MX,NA,10
-0.597686998,5.064472238,TCGA-06-A7TL-01A,TCGA-06-A7TL-01A-11D-A391-08,4,0.517596017,TCGA-06-A7TL,GBM,30,FEMALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2013,[Not Available],-11297,Alive,WITH TUMOR,539,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],188,Stable Disease,0,539,0,539,NA,NA,1,188,NA,NA,NA,NA,NA,6
-6.231484418,1.586410858,TCGA-ZF-AA5P-01A,TCGA-ZF-AA5P-01A-11D-A391-08,10,0.32543915,TCGA-ZF-AA5P,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-23971,Alive,TUMOR FREE,372,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,372,0,372,NA,NA,0,372,NA,Stage IV,T2b,M0,NA,7
-5.997885314,3.01846613,TCGA-ZF-AA5N-01A,TCGA-ZF-AA5N-01A-11D-A42E-08,0,NA,TCGA-ZF-AA5N,BLCA,62,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013,[Not Available],-22741,Dead,WITH TUMOR,NA,168,[Not Available],NA,NA,NA,NA,Progressive Disease,1,168,1,168,NA,NA,1,168,NA,Stage IV,T2,M1,NA,8
-6.087709003,3.480467188,TCGA-CQ-5324-01A,TCGA-CQ-5324-01A-01D-1683-08,11,0.536491283,TCGA-CQ-5324,HNSC,59,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-21803,Alive,TUMOR FREE,1593,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1593,0,1593,NA,NA,0,1593,NA,Stage III,T3,[Not Available],HNSC.Classical,8
9.819475822,-2.024862365,TCGA-J8-A4HY-01A,TCGA-J8-A4HY-01A-11D-A257-08,1,0.810753884,TCGA-J8-A4HY,THCA,68,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-25106,Alive,TUMOR FREE,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,6,0,6,NA,NA,0,6,NA,Stage IVA,T4a,MX,THCA.1,1
9.194419865,-1.857722133,TCGA-28-2499-01A,TCGA-28-2499-01A-01D-1494-08,1,0.684602184,TCGA-28-2499,GBM,59,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2009,[Not Available],-21838,NA,NA,95,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,95,NA,95,NA,NA,0,95,NA,NA,NA,NA,GBM_LGG.Classic-like,1
-6.520457193,-1.236912504,TCGA-Q1-A5R3-01A,TCGA-Q1-A5R3-01A-11D-A28B-09,7,0.171874198,TCGA-Q1-A5R3,CESC,56,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574,Alive,TUMOR FREE,485,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,485,0,485,0,485,0,485,NA,[Not Available],TX,MX,NA,2
2.025649264,1.848368494,TCGA-DE-A4MD-01A,TCGA-DE-A4MD-01A-11D-A257-08,3,0.556414358,TCGA-DE-A4MD,THCA,71,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-26179,Alive,TUMOR FREE,764,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,267,[Not Available],0,764,0,764,NA,NA,1,267,NA,Stage IVA,T3,M0,THCA.3,3
-6.329327488,2.405263405,TCGA-C5-A2M1-01A,TCGA-C5-A2M1-01A-11D-A18J-09,0,NA,TCGA-C5-A2M1,CESC,37,FEMALE,WHITE,Endocervical Type of Adenocarcinoma,G2,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13835,Alive,TUMOR FREE,1169,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,1169,0,1169,0,1169,0,1169,NA,Stage IB1,T1b1,MX,NA,8
9.623426849,-5.763186309,TCGA-EJ-A7NK-01A,TCGA-EJ-A7NK-01A-12D-A34U-08,1,0.848875379,TCGA-EJ-A7NK,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-21530,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,476,0,476,0,476,0,476,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
-6.036468293,-2.03190031,TCGA-C5-A2LX-01A,TCGA-C5-A2LX-01A-11D-A18J-09,0,NA,TCGA-C5-A2LX,CESC,54,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20070,Alive,TUMOR FREE,2526,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,2526,0,2526,0,2526,0,2526,NA,Stage IB1,T2,MX,NA,10
-1.729718999,0.980832655,TCGA-EJ-A7NM-01A,TCGA-EJ-A7NM-01A-21D-A33T-08,5,0.550865939,TCGA-EJ-A7NM,PRAD,64,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2013,[Not Available],-23603,Alive,TUMOR FREE,128,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,128,0,128,0,128,0,128,NA,[Not Applicable],T3b,[Not Applicable],PRAD.3-ETV4,4
-6.020152751,2.18172016,TCGA-C5-A1BM-01A,TCGA-C5-A1BM-01A-11D-A13W-08,0,NA,TCGA-C5-A1BM,CESC,78,FEMALE,BLACK OR AFRICAN AMERICAN,Cervical Squamous Cell Carcinoma,G2,1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28815,Dead,TUMOR FREE,NA,2520,NA,NA,NA,NA,NA,Complete Remission/Response,1,2520,0,2520,0,2520,0,2520,NA,Stage IB,T2,MX,NA,9
4.443870539,1.087622784,TCGA-EJ-A7NN-01A,TCGA-EJ-A7NN-01A-11D-A33T-08,2,0.601850196,TCGA-EJ-A7NN,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22499,Alive,TUMOR FREE,197,NA,[Not Available],Biochemical evidence of disease,NA,NA,197,Complete Remission/Response,0,197,0,197,1,197,1,197,NA,[Not Applicable],T3b,[Not Applicable],NA,5
-7.857815031,2.281390899,TCGA-C5-A1BE-01B,TCGA-C5-A1BE-01B-11D-A13W-08,9,0.287661034,TCGA-C5-A1BE,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23727,Dead,WITH TUMOR,NA,2094,Cervical Cancer,NA,NA,NA,1674,Complete Remission/Response,1,2094,1,2094,1,1674,1,1674,NA,Stage IB2,T1b,MX,NA,7
9.255563765,-2.367728755,TCGA-EJ-A8FN-01A,TCGA-EJ-A8FN-01A-11D-A34U-08,1,0.771802575,TCGA-EJ-A8FN,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-21506,Alive,TUMOR FREE,329,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,329,0,329,0,329,0,329,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
1.400901137,2.158632451,TCGA-C5-A7CK-01A,TCGA-C5-A7CK-01A-11D-A32I-09,0,NA,TCGA-C5-A7CK,CESC,58,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2001,[Not Available],-21520,Dead,TUMOR FREE,NA,4086,NA,NA,NA,NA,NA,[Not Available],1,4086,0,4086,NA,NA,0,4086,NA,Stage IVA,[Not Available],[Not Available],NA,3
-4.513694818,-1.834127379,TCGA-Q1-A5R2-01A,TCGA-Q1-A5R2-01A-11D-A28B-09,8,0.43406468,TCGA-Q1-A5R2,CESC,64,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23523,Alive,TUMOR FREE,499,NA,NA,NA,NA,NA,NA,[Not Applicable],0,499,0,499,NA,NA,0,499,NA,[Not Available],TX,MX,NA,10
-1.578121187,2.324978944,TCGA-MU-A8JM-01A,TCGA-MU-A8JM-01A-11D-A36J-09,0,NA,TCGA-MU-A8JM,CESC,46,FEMALE,WHITE,Cervical Squamous Cell Carcinoma,G2,2013,[Unknown],-17156,Alive,TUMOR FREE,607,NA,NA,NA,NA,NA,NA,Complete Remission/Response,0,607,0,607,0,607,0,607,NA,Stage IB1,T1b,MX,NA,3
-5.254634175,-1.384946367,TCGA-50-5066-01A,TCGA-50-5066-01A-01D-1625-08,0,NA,TCGA-50-5066,LUAD,72,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-26385,Alive,TUMOR FREE,1442,NA,[Not Available],Distant Metastasis,NA,NA,477,Complete Remission/Response,0,1442,0,1442,1,477,1,477,NA,Stage IB,T2,M0,NA,10
1.926735245,1.971226308,TCGA-EA-A5ZE-01A,TCGA-EA-A5ZE-01A-11D-A28B-09,3,0.578051012,TCGA-EA-A5ZE,CESC,54,FEMALE,ASIAN,Cervical Squamous Cell Carcinoma,G3,2012,Peri (6-12 months since last menstrual period),-19868,Alive,TUMOR FREE,829,NA,NA,Distant Metastasis,"Other, specify","Lymph node, inguinal",425,Complete Remission/Response,0,829,0,829,1,425,1,425,NA,Stage IB1,T1b1,M0,NA,3
9.656824805,-5.80826325,TCGA-55-7816-01A,TCGA-55-7816-01A-11D-2167-08,1,0.797321859,TCGA-55-7816,LUAD,49,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-18170,Dead,WITH TUMOR,NA,468,[Not Available],NA,NA,NA,NA,Progressive Disease,1,468,1,468,NA,NA,1,468,NA,Stage IV,TX,MX,NA,1
9.620786414,-5.311009101,TCGA-EJ-A7NF-01A,TCGA-EJ-A7NF-01A-11D-A33T-08,1,0.757697245,TCGA-EJ-A7NF,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20587,Alive,TUMOR FREE,250,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,250,0,250,0,250,0,250,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
-4.429681098,-1.512621129,TCGA-77-7465-01A,TCGA-77-7465-01A-11D-2042-08,8,0.456361502,TCGA-77-7465,LUSC,58,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-21548,Alive,NA,990,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,990,0,990,0,990,0,990,NA,Stage IIA,T2a,M0,NA,10
0.080290122,4.465127791,TCGA-EJ-A7NH-01A,TCGA-EJ-A7NH-01A-12D-A33T-08,4,0.527156557,TCGA-EJ-A7NH,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20734,Alive,TUMOR FREE,474,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,474,0,474,0,474,0,474,NA,[Not Applicable],T2c,[Not Applicable],PRAD.2-ETV1,6
-4.992787197,2.093028572,TCGA-DC-6683-01A,TCGA-DC-6683-01A-11D-1826-10,0,NA,TCGA-DC-6683,READ,43,MALE,WHITE,Rectal Adenocarcinoma,[Not Available],2011,[Not Available],-15918,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,762,0,762,NA,NA,0,762,NA,Stage IIIB,T3,M0,GI.CIN,8
-6.164646457,3.553420538,TCGA-EJ-A7NJ-01A,TCGA-EJ-A7NJ-01A-22D-A34U-08,11,0.519686611,TCGA-EJ-A7NJ,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-21748,Alive,TUMOR FREE,197,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,197,0,197,0,197,0,197,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,8
-5.711444768,0.907960669,TCGA-BR-4371-01A,TCGA-BR-4371-01A-01D-1158-08,0,NA,TCGA-BR-4371,STAD,71,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008,[Not Available],-26290,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],T2,M0,GI.GS,9
2.987085224,3.579406357,TCGA-DJ-A3VJ-01A,TCGA-DJ-A3VJ-01A-11D-A23M-08,0,NA,TCGA-DJ-A3VJ,THCA,22,MALE,WHITE,"Other, specify",[Not Available],2010,[Not Available],-8341,Alive,TUMOR FREE,1108,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1108,0,1108,0,1108,0,1108,NA,Stage I,T3,M0,THCA.3,1
-1.487063552,2.17413993,TCGA-CA-5254-01A,TCGA-CA-5254-01A-21D-1835-10,0,NA,TCGA-CA-5254,COAD,42,FEMALE,ASIAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-15415,Alive,TUMOR FREE,386,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,386,0,386,0,386,0,386,NA,Stage IIA,T3,M0,GI.CIN,10
1.016318393,2.136643101,TCGA-BR-7958-01A,TCGA-BR-7958-01A-21D-2340-08,0,NA,TCGA-BR-7958,STAD,60,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-22204,Alive,TUMOR FREE,899,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,899,0,899,0,899,0,899,NA,Stage IIIB,T4b,M0,GI.EBV,3
8.809676809,-1.92162785,TCGA-28-5213-01A,TCGA-28-5213-01A-01D-1486-08,1,0.585802448,TCGA-28-5213,GBM,72,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2010,[Not Available],-26491,Alive,WITH TUMOR,951,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,951,0,951,NA,NA,0,951,NA,NA,NA,NA,GBM_LGG.Mesenchymal-like,1
-4.060959615,-2.074133481,TCGA-BA-5152-01A,TCGA-BA-5152-01A-02D-1870-08,8,0.41094049,TCGA-BA-5152,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-20783,Alive,TUMOR FREE,1288,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1288,0,1288,NA,NA,0,1288,NA,Stage IVA,T4a,M0,HNSC.Atypical,10
-7.466613168,-2.074352039,TCGA-AG-3883-01A,TCGA-AG-3883-01A-02W-0899-10,6,0.333355362,TCGA-AG-3883,READ,69,MALE,[Not Available],Rectal Adenocarcinoma,[Not Available],2008,[Not Available],-25415,Alive,WITH TUMOR,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,31,0,31,NA,NA,0,31,NA,Stage I,T2,M0,GI.CIN,2
-5.397384126,-1.422395123,TCGA-BR-7704-01A,TCGA-BR-7704-01A-11D-2053-08,0,NA,TCGA-BR-7704,STAD,69,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25300,Alive,TUMOR FREE,1072,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1072,0,1072,0,1072,0,1072,NA,Stage II,T3,M0,NA,10
9.600478172,-5.827540129,TCGA-06-0141-01A,TCGA-06-0141-01A-01D-1490-08,1,0.835995992,TCGA-06-0141,GBM,62,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2000,[Not Available],-22926,Dead,WITH TUMOR,280,313,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],145,[Not Available],1,313,1,313,NA,NA,1,145,NA,NA,NA,NA,GBM_LGG.LGm6-GBM,1
9.563672272,-5.678759563,TCGA-DJ-A4UQ-01A,TCGA-DJ-A4UQ-01A-11D-A257-08,1,0.845820927,TCGA-DJ-A4UQ,THCA,60,MALE,ASIAN,"Other, specify",[Not Available],2012,[Not Available],-22097,Alive,WITH TUMOR,1005,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1005,0,1005,NA,NA,0,1005,NA,Stage IVA,T3,M0,THCA.2,1
-7.296661869,2.097152644,TCGA-D1-A2G6-01A,TCGA-D1-A2G6-01A-11D-A17D-09,9,0.189093531,TCGA-D1-A2G6,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19547,Dead,WITH TUMOR,NA,258,[Not Available],NA,NA,NA,NA,[Not Available],1,258,1,258,NA,NA,1,258,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-1.042292977,3.222205631,TCGA-CV-7263-01A,TCGA-CV-7263-01A-11D-2012-08,4,0.080180134,TCGA-CV-7263,HNSC,64,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G1,1997,[Not Available],-23513,Dead,WITH TUMOR,NA,560,[Not Available],NA,NA,NA,NA,[Not Available],1,560,1,560,NA,NA,1,560,NA,Stage II,T2,[Not Available],HNSC.Mesenchymal,6
-7.770720955,-2.474912388,TCGA-EJ-A65F-01A,TCGA-EJ-A65F-01A-21D-A30X-08,6,0.33149158,TCGA-EJ-A65F,PRAD,59,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2012,[Not Available],-21681,Alive,[Discrepancy],560,NA,[Not Available],Biochemical evidence of disease,NA,NA,75,Progressive Disease,0,560,0,560,NA,NA,1,75,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,2
9.669100382,-5.879265404,TCGA-EJ-A65G-01A,TCGA-EJ-A65G-01A-21D-A29Q-08,1,0.845610456,TCGA-EJ-A65G,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20821,Alive,TUMOR FREE,666,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,666,0,666,0,666,0,666,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
9.669933028,-5.696322097,TCGA-EJ-A6RA-01A,TCGA-EJ-A6RA-01A-11D-A33T-08,1,0.849245734,TCGA-EJ-A6RA,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-25679,Alive,TUMOR FREE,353,NA,[Not Available],Locoregional Recurrence,NA,NA,353,Partial Remission/Response,0,353,0,353,NA,NA,1,353,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
-5.595876594,1.679734136,TCGA-78-7145-01A,TCGA-78-7145-01A-11D-2036-08,0,NA,TCGA-78-7145,LUAD,52,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2000,[Not Available],-19080,Dead,WITH TUMOR,NA,826,[Not Available],NA,NA,NA,422,[Not Available],1,826,1,826,NA,NA,1,422,NA,Stage IV,T4,M1,LUAD.3,9
9.265321564,-4.595986081,TCGA-97-7552-01A,TCGA-97-7552-01A-11D-2036-08,1,0.685444223,TCGA-97-7552,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-25578,Alive,TUMOR FREE,1932,NA,[Not Available],NA,NA,NA,798,Stable Disease,0,1932,0,1932,NA,NA,1,798,NA,Stage IB,T2,MX,LUAD.6,1
8.723166889,-2.005833916,TCGA-EJ-7218-01B,TCGA-EJ-7218-01B-11D-A32B-08,1,0.570378566,TCGA-EJ-7218,PRAD,71,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-26181,Alive,TUMOR FREE,2542,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2542,0,2542,0,2542,0,2542,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
9.233596673,-5.291030808,TCGA-EJ-7312-01B,TCGA-EJ-7312-01B-21D-A32B-08,1,0.813993488,TCGA-EJ-7312,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21292,Alive,TUMOR FREE,1099,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1099,0,1099,0,1099,0,1099,NA,[Not Applicable],T3b,[Not Applicable],NA,1
4.285967904,1.154789753,TCGA-EJ-7318-01B,TCGA-EJ-7318-01B-11D-A32B-08,2,0.722452901,TCGA-EJ-7318,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-18686,Alive,TUMOR FREE,1029,NA,[Not Available],Locoregional Recurrence,NA,NA,380,Partial Remission/Response,0,1029,0,1029,NA,NA,1,380,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,5
9.525189599,-5.109858724,TCGA-EJ-7325-01B,TCGA-EJ-7325-01B-11D-A32B-08,1,0.786995248,TCGA-EJ-7325,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23029,Alive,TUMOR FREE,1070,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1070,0,1070,0,1070,0,1070,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-8.121283713,2.015985507,TCGA-EW-A2FV-01A,TCGA-EW-A2FV-01A-11D-A17D-09,9,0.608527971,TCGA-EW-A2FV,BRCA,39,FEMALE,WHITE,"Other, specify",[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14316,Alive,TUMOR FREE,788,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,788,0,788,0,788,0,788,NA,Stage IIIC,T3,MX,BRCA.LumA,7
9.440999924,-4.843021724,TCGA-EM-A2OV-01A,TCGA-EM-A2OV-01A-11D-A202-08,1,0.833700653,TCGA-EM-A2OV,THCA,64,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-23656,Alive,TUMOR FREE,674,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,674,0,674,0,674,0,674,NA,Stage II,T2,MX,THCA.1,1
-0.355125761,4.292856814,TCGA-D7-6817-01A,TCGA-D7-6817-01A-11D-1882-08,4,0.416898427,TCGA-D7-6817,STAD,63,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011,[Not Available],-23142,Alive,TUMOR FREE,389,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,389,0,389,NA,NA,0,389,NA,Stage IIIA,T2b,M0,GI.CIN,6
-7.750203119,1.79692454,TCGA-DJ-A2PX-01A,TCGA-DJ-A2PX-01A-11D-A18F-08,9,0.290945855,TCGA-DJ-A2PX,THCA,55,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-20088,Alive,TUMOR FREE,881,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,881,0,881,0,881,0,881,NA,Stage I,T1b,M0,THCA.2,7
-6.80536829,-1.425666091,TCGA-CV-7183-01A,TCGA-CV-7183-01A-11D-2012-08,0,NA,TCGA-CV-7183,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2002,[Not Available],-19358,Alive,TUMOR FREE,3981,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3981,0,3981,0,3981,0,3981,NA,Stage II,T2,[Not Available],HNSC.Basal,2
9.968546303,-1.437792874,TCGA-E8-A419-01A,TCGA-E8-A419-01A-11D-A23M-08,1,0.843075113,TCGA-E8-A419,THCA,30,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-11306,Alive,TUMOR FREE,774,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,774,0,774,0,774,0,774,NA,Stage I,T2,M0,THCA.4,1
-1.849802895,1.062102152,TCGA-CR-6488-01A,TCGA-CR-6488-01A-12D-2078-08,5,0.567832637,TCGA-CR-6488,HNSC,68,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-25176,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,379,0,379,0,379,0,379,NA,Stage II,T2,[Not Available],HNSC.Mesenchymal,4
9.34048986,-1.872648865,TCGA-2A-A8VL-01A,TCGA-2A-A8VL-01A-21D-A377-08,1,0.697457189,TCGA-2A-A8VL,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-18658,Alive,TUMOR FREE,621,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,621,0,621,NA,NA,0,621,NA,[Not Applicable],T2b,[Not Applicable],PRAD.1-ERG,1
9.146934811,-2.167037431,TCGA-2A-A8VO-01A,TCGA-2A-A8VO-01A-11D-A377-08,1,0.667654107,TCGA-2A-A8VO,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20958,Alive,TUMOR FREE,1701,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1701,0,1701,NA,NA,0,1701,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
0.086573116,4.819636178,TCGA-DX-AB30-01A,TCGA-DX-AB30-01A-11D-A38Z-09,4,0.572372646,TCGA-DX-AB30,SARC,53,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2004,[Not Available],-19698,Dead,WITH TUMOR,NA,695,[Not Available],Distant Metastasis,Lung,NA,504,[Not Available],1,695,1,695,1,504,1,504,NA,NA,NA,NA,NA,6
8.940561283,-4.400060021,TCGA-2A-A8VV-01A,TCGA-2A-A8VV-01A-11D-A377-08,1,0.729987307,TCGA-2A-A8VV,PRAD,52,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-19065,Alive,TUMOR FREE,671,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,671,0,671,NA,NA,0,671,NA,[Not Applicable],T2b,[Not Applicable],PRAD.1-ERG,1
8.758852549,-5.176899731,TCGA-2A-A8VX-01A,TCGA-2A-A8VX-01A-11D-A377-08,1,0.821016554,TCGA-2A-A8VX,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25904,Alive,TUMOR FREE,1378,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1378,0,1378,NA,NA,0,1378,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-4.471189768,-1.366443651,TCGA-DX-AB32-01A,TCGA-DX-AB32-01A-11D-A417-09,8,0.323518638,TCGA-DX-AB32,SARC,51,MALE,WHITE,Myxofibrosarcoma,[Not Available],2006,[Not Available],-18631,Alive,TUMOR FREE,3102,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3102,0,3102,0,3102,0,3102,NA,NA,NA,NA,NA,10
9.485091741,-4.775362496,TCGA-2A-A8W1-01A,TCGA-2A-A8W1-01A-11D-A377-08,1,0.753220257,TCGA-2A-A8W1,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19964,Alive,NA,112,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,112,0,112,NA,NA,0,112,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,1
8.852560052,-3.552666928,TCGA-2A-A8W3-01A,TCGA-2A-A8W3-01A-11D-A377-08,1,0.740685166,TCGA-2A-A8W3,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25557,Alive,[Discrepancy],863,NA,[Not Available],Biochemical evidence of disease,NA,NA,198,[Not Available],0,863,0,863,NA,NA,1,198,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,1
-4.577121699,0.215803647,TCGA-55-6972-01A,TCGA-55-6972-01A-11D-1945-08,0,NA,TCGA-55-6972,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2005,[Not Available],-26625,Dead,TUMOR FREE,NA,1632,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1632,0,1632,0,1632,0,1632,NA,Stage IB,T2,M0,LUAD.1,10
-1.49311248,4.00745919,TCGA-56-7580-01A,TCGA-56-7580-01A-11D-2042-08,4,0.21036288,TCGA-56-7580,LUSC,84,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-30740,Alive,TUMOR FREE,925,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,925,0,925,0,925,0,925,NA,Stage IB,T2a,M0,NA,6
-7.224198807,2.833345262,TCGA-DX-AB35-01A,TCGA-DX-AB35-01A-21D-A417-09,0,NA,TCGA-DX-AB35,SARC,65,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2012,[Not Available],-24026,Alive,WITH TUMOR,928,NA,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,284,[Not Available],0,928,0,928,1,284,1,284,NA,NA,NA,NA,NA,7
-0.116853034,4.701802688,TCGA-A6-6142-01A,TCGA-A6-6142-01A-11D-1771-10,4,0.655063174,TCGA-A6-6142,COAD,56,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-20485,Alive,WITH TUMOR,763,NA,[Not Available],NA,NA,NA,654,Complete Remission/Response,0,763,0,763,NA,NA,1,654,NA,Stage IVA,T3,M1a,GI.CIN,6
-2.897550097,-4.078115831,TCGA-BR-4184-01A,TCGA-BR-4184-01A-01D-1126-08,0,NA,TCGA-BR-4184,STAD,70,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007,[Not Available],-25816,Dead,NA,NA,212,[Not Available],NA,NA,NA,NA,[Not Available],1,212,NA,212,NA,NA,0,212,NA,Stage IIIA,T3,MX,NA,10
9.660075544,-5.448162218,TCGA-DJ-A2Q0-01A,TCGA-DJ-A2Q0-01A-11D-A202-08,1,0.821366499,TCGA-DJ-A2Q0,THCA,57,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-20973,Alive,TUMOR FREE,1045,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1045,0,1045,0,1045,0,1045,NA,Stage II,T2,M0,THCA.1,1
-6.587738174,-1.22010089,TCGA-78-7153-01A,TCGA-78-7153-01A-11D-2036-08,7,0.068160744,TCGA-78-7153,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2003,[Not Available],-23922,Alive,NA,3635,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3635,0,3635,0,3635,0,3635,NA,Stage IB,T2,M0,LUAD.4,2
8.823164009,-5.082803209,TCGA-DX-AB36-01A,TCGA-DX-AB36-01A-11D-A417-09,1,0.844257399,TCGA-DX-AB36,SARC,86,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2008,[Not Available],-31704,Dead,NA,NA,1825,[Not Available],NA,NA,NA,NA,[Not Available],1,1825,NA,1825,NA,NA,0,1825,NA,NA,NA,NA,NA,1
1.007450447,3.602602836,TCGA-CG-5730-01A,TCGA-CG-5730-01A-11D-1600-08,0,NA,TCGA-CG-5730,STAD,80,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2005,[Not Available],-29432,Alive,TUMOR FREE,122,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,122,0,122,NA,NA,0,122,NA,Stage IV,T2,M1,NA,6
9.882594861,-1.581621086,TCGA-EM-A1YA-01A,TCGA-EM-A1YA-01A-11D-A14W-08,1,0.869337055,TCGA-EM-A1YA,THCA,74,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-27224,Alive,TUMOR FREE,602,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,602,0,602,0,602,0,602,NA,Stage II,T2,MX,THCA.1,1
9.131449833,-5.319858379,TCGA-ET-A3DS-01A,TCGA-ET-A3DS-01A-11D-A19J-08,1,0.831781683,TCGA-ET-A3DS,THCA,33,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-12252,Alive,TUMOR FREE,2033,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2033,0,2033,0,2033,0,2033,NA,Stage I,T1,MX,THCA.1,1
-5.918957608,2.500014022,TCGA-AA-3680-01A,TCGA-AA-3680-01A-01W-0900-09,0,NA,TCGA-AA-3680,COAD,67,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2006,[Not Available],-24655,Dead,WITH TUMOR,NA,335,[Not Available],NA,NA,NA,NA,Progressive Disease,1,335,1,335,NA,NA,1,335,NA,Stage IV,T4,M1,GI.CIN,8
-0.351074618,4.953505062,TCGA-CG-5718-01A,TCGA-CG-5718-01A-11D-1600-08,4,0.399896393,TCGA-CG-5718,STAD,78,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],-28763,Dead,TUMOR FREE,NA,1095,[Not Available],NA,NA,NA,NA,[Unknown],1,1095,0,1095,NA,NA,0,1095,NA,Stage II,T2b,M0,GI.CIN,3
9.573416979,-5.278440929,TCGA-06-0238-01A,TCGA-06-0238-01A-02D-1492-08,1,0.851838646,TCGA-06-0238,GBM,46,MALE,WHITE,Untreated primary (de novo) GBM,[Not Available],2007,[Not Available],-17037,Dead,WITH TUMOR,359,405,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],311,[Not Available],1,405,1,405,NA,NA,1,311,NA,NA,NA,NA,GBM_LGG.NA,1
4.455214477,1.116807997,TCGA-EM-A2CL-01A,TCGA-EM-A2CL-01A-11D-A17V-08,2,0.653176784,TCGA-EM-A2CL,THCA,31,MALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-11649,Alive,TUMOR FREE,401,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,401,0,401,0,401,0,401,NA,Stage I,T2,MX,THCA.1,5
-6.67567243,-2.16772697,TCGA-BB-7870-01A,TCGA-BB-7870-01A-11D-2229-08,6,0.037359256,TCGA-BB-7870,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2009,[Not Available],-21443,Alive,TUMOR FREE,2016,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2016,0,2016,NA,NA,0,2016,NA,Stage IVA,T4a,[Not Available],NA,2
8.770489334,-3.803262488,TCGA-DX-AB3B-01A,TCGA-DX-AB3B-01A-11D-A417-09,1,0.713158729,TCGA-DX-AB3B,SARC,28,FEMALE,WHITE,Synovial Sarcoma - Monophasic,[Not Available],2009,[Not Available],-10337,Alive,TUMOR FREE,1548,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1548,0,1548,0,1548,0,1548,NA,NA,NA,NA,NA,1
8.949983482,-5.407989306,TCGA-DX-AB3C-01A,TCGA-DX-AB3C-01A-11D-A417-09,1,0.811515178,TCGA-DX-AB3C,SARC,27,MALE,WHITE,Synovial Sarcoma - Monophasic,[Not Available],2008,[Not Available],-10034,Alive,WITH TUMOR,2169,NA,[Not Available],Distant Metastasis,Lung,NA,567,[Not Available],0,2169,0,2169,1,567,1,567,NA,NA,NA,NA,NA,1
-4.390167748,1.338699663,TCGA-96-8170-01A,TCGA-96-8170-01A-11D-2293-08,0,NA,TCGA-96-8170,LUSC,75,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-27558,Alive,TUMOR FREE,531,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,531,0,531,0,531,0,531,NA,Stage IIA,T1a,M0,NA,10
9.349768321,-4.112289649,TCGA-DX-AB3A-01A,TCGA-DX-AB3A-01A-11D-A417-09,1,0.803106215,TCGA-DX-AB3A,SARC,80,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2009,[Not Available],-29230,Dead,WITH TUMOR,NA,978,[Not Available],Locoregional Recurrence,NA,NA,533,[Not Available],1,978,1,978,1,533,1,533,NA,NA,NA,NA,NA,1
-4.407600364,-1.521279146,TCGA-44-2657-01A,TCGA-44-2657-01A-01D-1105-08,8,0.389141333,TCGA-44-2657,LUAD,74,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-27298,Alive,TUMOR FREE,1351,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1351,0,1351,0,1351,0,1351,NA,Stage IB,T2,M0,LUAD.5,10
-1.245081564,3.609160911,TCGA-44-3398-01A,TCGA-44-3398-01A-01D-1105-08,4,0.156558353,TCGA-44-3398,LUAD,77,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-28392,Alive,TUMOR FREE,1163,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1163,0,1163,0,1163,0,1163,NA,Stage IA,T1b,M0,NA,6
-1.425229501,3.942488862,TCGA-33-4587-01A,TCGA-33-4587-01A-11D-2122-08,4,0.017619516,TCGA-33-4587,LUSC,63,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-23062,Dead,WITH TUMOR,NA,1656,[Not Available],NA,NA,NA,NA,Progressive Disease,1,1656,1,1656,NA,NA,1,1656,NA,Stage IB,T2,MX,NA,6
8.87376824,-5.0429073,TCGA-FX-A2QS-01A,TCGA-FX-A2QS-01A-11D-A21Q-09,1,0.784618163,TCGA-FX-A2QS,SARC,61,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-22422,Alive,TUMOR FREE,1495,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1495,0,1495,0,1495,0,1495,NA,NA,NA,NA,NA,1
9.498133949,-5.687760724,TCGA-FX-A3NJ-01A,TCGA-FX-A3NJ-01A-11D-A21Q-09,1,0.851271154,TCGA-FX-A3NJ,SARC,54,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-19903,Alive,TUMOR FREE,947,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,947,0,947,0,947,0,947,NA,NA,NA,NA,NA,1
-3.261148819,-3.295063045,TCGA-BR-4362-01A,TCGA-BR-4362-01A-01D-1158-08,8,0.525669523,TCGA-BR-4362,STAD,74,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-27179,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],TX,M0,GI.HM-indel,10
-3.249978916,-3.435799205,TCGA-AA-A01P-01A,TCGA-AA-A01P-01A-21D-A17O-10,8,0.448432412,TCGA-AA-A01P,COAD,80,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2003,[Not Available],-29554,Dead,WITH TUMOR,NA,1158,[Not Available],NA,NA,NA,762,[Unknown],1,1158,1,1158,NA,NA,1,762,NA,Stage III,T3,M0,GI.HM-indel,10
-5.56071901,2.628831675,TCGA-AA-3851-01A,TCGA-AA-3851-01A-01W-0995-10,12,0.221652987,TCGA-AA-3851,COAD,74,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27090,Alive,WITH TUMOR,1006,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1006,0,1006,NA,NA,0,1006,NA,Stage IIA,T3,M0,GI.CIN,8
9.877485765,-1.609915811,TCGA-KS-A4IC-01A,TCGA-KS-A4IC-01A-11D-A257-08,1,0.868571646,TCGA-KS-A4IC,THCA,45,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-16671,Alive,TUMOR FREE,1073,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1073,0,1073,NA,NA,0,1073,NA,Stage III,T1b,M0,THCA.5,1
-4.349982398,-1.49158926,TCGA-BR-6802-01A,TCGA-BR-6802-01A-11D-1882-08,8,0.384310793,TCGA-BR-6802,STAD,65,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-23915,Alive,TUMOR FREE,940,NA,[Not Available],Distant Metastasis,Non-regional / Distant Lymph Nodes,NA,807,Complete Remission/Response,0,940,0,940,1,807,1,807,NA,Stage IIIA,T3,M0,GI.HM-indel,10
-4.261069943,0.109429365,TCGA-CV-5441-01A,TCGA-CV-5441-01A-01D-1512-08,0,NA,TCGA-CV-5441,HNSC,58,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2003,[Not Available],-21305,Alive,TUMOR FREE,2886,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2886,0,2886,NA,NA,0,2886,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,10
-4.490484727,-1.939008385,TCGA-CR-7364-01A,TCGA-CR-7364-01A-11D-2012-08,8,0.404957672,TCGA-CR-7364,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-24192,Alive,TUMOR FREE,1435,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1435,0,1435,0,1435,0,1435,NA,Stage III,T3,M0,HNSC.Atypical,10
-1.02361322,4.401453027,TCGA-FX-A3RE-01A,TCGA-FX-A3RE-01A-11D-A228-09,4,0.171848196,TCGA-FX-A3RE,SARC,65,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-23757,Alive,TUMOR FREE,660,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,660,0,660,NA,NA,0,660,NA,NA,NA,NA,NA,10
-0.837437925,5.018310276,TCGA-FX-A3TO-01A,TCGA-FX-A3TO-01A-11D-A228-09,4,0.4790023,TCGA-FX-A3TO,SARC,87,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-31868,Alive,TUMOR FREE,618,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,618,0,618,NA,NA,0,618,NA,NA,NA,NA,NA,6
-7.865801922,-2.438971416,TCGA-FX-A3NK-01A,TCGA-FX-A3NK-01A-11D-A21Q-09,6,0.324828244,TCGA-FX-A3NK,SARC,53,MALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2011,[Not Available],-19533,Alive,TUMOR FREE,505,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,505,0,505,0,505,0,505,NA,NA,NA,NA,NA,2
-4.026213003,-1.865282015,TCGA-18-3421-01A,TCGA-18-3421-01A-01D-0983-08,8,0.477292617,TCGA-18-3421,LUSC,65,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-23972,Alive,TUMOR FREE,2645,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2645,0,2645,0,2645,0,2645,NA,Stage IB,T2,M0,LUSC.basal,10
9.613310049,-2.834672975,TCGA-61-2109-01A,TCGA-61-2109-01A-01W-0722-08,1,0.724609692,TCGA-61-2109,OV,40,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-14900,Dead,WITH TUMOR,629,629,[Not Available],Recurrence,[Not Applicable],[Not Applicable],465,[Not Available],1,629,1,629,NA,NA,1,465,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,1
-4.956799249,0.949232126,TCGA-FP-7829-01A,TCGA-FP-7829-01A-11D-2053-08,0,NA,TCGA-FP-7829,STAD,69,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011,[Not Available],-25534,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,594,0,594,0,594,0,594,NA,Stage IIB,T3,M0,GI.CIN,10
9.523922333,-2.16947974,TCGA-FX-A48G-01A,TCGA-FX-A48G-01A-11D-A24N-09,1,0.814282825,TCGA-FX-A48G,SARC,56,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-20756,Dead,WITH TUMOR,NA,605,[Not Available],Distant Metastasis,Lung,NA,168,[Not Available],1,605,1,605,NA,NA,1,168,NA,NA,NA,NA,NA,1
2.464220397,1.879052472,TCGA-FX-A76Y-01A,TCGA-FX-A76Y-01A-11D-A351-09,0,NA,TCGA-FX-A76Y,SARC,49,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2013,[Not Available],-18181,Alive,TUMOR FREE,471,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,471,0,471,0,471,0,471,NA,NA,NA,NA,NA,3
8.724613984,-4.390092521,TCGA-EL-A3T9-01A,TCGA-EL-A3T9-01A-21D-A22D-08,1,0.712762547,TCGA-EL-A3T9,THCA,69,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2005,[Not Available],-25484,Dead,WITH TUMOR,NA,174,[Not Available],NA,NA,NA,NA,[Not Available],1,174,1,174,NA,NA,1,174,NA,Stage IV,T4,MX,THCA.4,1
9.36340764,-4.073951856,TCGA-EY-A1GX-01A,TCGA-EY-A1GX-01A-12D-A13L-09,1,0.70769385,TCGA-EY-A1GX,UCEC,76,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27962,Dead,TUMOR FREE,NA,1127,[Not Available],Locoregional Recurrence,"Other, specify",pelvic mass,743,Complete Remission/Response,1,1127,0,1127,1,743,1,743,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.Notassigned,1
9.6531377,-1.462757474,TCGA-DJ-A2PT-01A,TCGA-DJ-A2PT-01A-11D-A18F-08,1,0.808895667,TCGA-DJ-A2PT,THCA,70,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-25837,Alive,TUMOR FREE,1181,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1181,0,1181,0,1181,0,1181,NA,Stage III,T3,M0,THCA.4,1
-7.830361179,2.434337354,TCGA-D8-A1JC-01A,TCGA-D8-A1JC-01A-11D-A13L-09,9,0.151644735,TCGA-D8-A1JC,BRCA,59,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21898,Alive,TUMOR FREE,480,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,480,0,480,0,480,0,480,NA,Stage IIIA,T2,M0,BRCA.LumB,6
-1.920059301,2.500567383,TCGA-55-A493-01A,TCGA-55-A493-01A-11D-A24D-08,0,NA,TCGA-55-A493,LUAD,54,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-20027,Alive,TUMOR FREE,28,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,28,0,28,NA,NA,0,28,NA,Stage IB,T2a,M0,NA,10
0.325964164,3.657363532,TCGA-CG-4444-01A,TCGA-CG-4444-01A-01D-1158-08,4,0.245079097,TCGA-CG-4444,STAD,76,MALE,[Not Available],"Stomach, Adenocarcinoma, Diffuse Type",G3,2006,[Not Available],-27912,Alive,TUMOR FREE,1431,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1431,0,1431,0,1431,0,1431,NA,Stage IIIA,T2b,M0,GI.CIN,3
9.098993685,-4.270108592,TCGA-IQ-7632-01A,TCGA-IQ-7632-01A-11D-2078-08,1,0.692217534,TCGA-IQ-7632,HNSC,68,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-24986,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,441,0,441,NA,NA,0,441,NA,Stage IVA,T4a,M0,HNSC.Basal,1
9.590728401,-3.839364238,TCGA-CV-7425-01A,TCGA-CV-7425-01A-11D-2078-08,1,0.720780549,TCGA-CV-7425,HNSC,77,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2000,[Not Available],-28368,Dead,WITH TUMOR,NA,1718,[Not Available],NA,NA,NA,NA,[Not Available],1,1718,1,1718,NA,NA,1,1718,NA,Stage III,T3,[Not Available],NA,1
8.611841773,-3.80842453,TCGA-HB-A3L4-01A,TCGA-HB-A3L4-01A-11D-A21Q-09,1,0.716353403,TCGA-HB-A3L4,SARC,46,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2009,[Not Available],-17044,Dead,WITH TUMOR,NA,1061,[Not Available],Distant Metastasis,Lung,NA,326,[Not Available],1,1061,1,1061,1,326,1,326,NA,NA,NA,NA,NA,1
-6.794147463,-2.142138857,TCGA-CV-5434-01A,TCGA-CV-5434-01A-01D-1683-08,6,0.189084182,TCGA-CV-5434,HNSC,60,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2000,[Not Available],-22182,Dead,TUMOR FREE,3295,3314,[Not Available],NA,Distant Metastasis,Lung,1859,Complete Remission/Response,1,3314,0,3314,NA,NA,1,1859,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,2
-1.843116509,1.019629547,TCGA-HB-A3YV-01A,TCGA-HB-A3YV-01A-11D-A24N-09,5,0.50380785,TCGA-HB-A3YV,SARC,75,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-27583,Dead,WITH TUMOR,NA,139,[Not Available],NA,NA,NA,NA,[Not Available],1,139,1,139,NA,NA,1,139,NA,NA,NA,NA,NA,4
8.758092617,-4.924090254,TCGA-FX-A8OO-01A,TCGA-FX-A8OO-01A-11D-A36J-09,1,0.75004142,TCGA-FX-A8OO,SARC,31,FEMALE,WHITE,Sarcoma; synovial; poorly differentiated,[Not Available],2013,[Not Available],-11376,Dead,TUMOR FREE,NA,245,[Not Available],NA,NA,NA,NA,[Not Available],1,245,0,245,0,245,0,245,NA,NA,NA,NA,NA,1
-6.560239308,-2.220841521,TCGA-44-6774-01A,TCGA-44-6774-01A-21D-1855-08,0,NA,TCGA-44-6774,LUAD,56,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-20462,Alive,TUMOR FREE,658,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,658,0,658,0,658,0,658,NA,Stage IIIA,T1,M0,LUAD.2,10
-4.85763414,1.104652509,TCGA-34-5239-01A,TCGA-34-5239-01A-21D-1817-08,0,NA,TCGA-34-5239,LUSC,75,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-27528,Alive,WITH TUMOR,1834,NA,[Not Available],Distant Metastasis,NA,NA,1530,Complete Remission/Response,0,1834,0,1834,1,1530,1,1530,NA,Stage IIIA,T4,M0,LUSC.secretory,10
-4.932380127,1.865103868,TCGA-61-2009-01A,TCGA-61-2009-01A-01W-0722-08,0,NA,TCGA-61-2009,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-23772,Alive,WITH TUMOR,1212,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],101,Complete Remission/Response,0,1212,0,1212,1,101,1,101,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,8
-0.293548533,4.992025905,TCGA-HB-A43Z-01A,TCGA-HB-A43Z-01A-11D-A24N-09,4,0.572589384,TCGA-HB-A43Z,SARC,58,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-21233,Alive,WITH TUMOR,1126,NA,[Not Available],Distant Metastasis,Lung,NA,894,[Not Available],0,1126,0,1126,1,894,1,894,NA,NA,NA,NA,NA,6
-2.742024309,1.057578327,TCGA-D8-A27V-01A,TCGA-D8-A27V-01A-12D-A17D-09,5,0.009348411,TCGA-D8-A27V,BRCA,62,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22958,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,381,0,381,0,381,0,381,NA,Stage IIA,T2,M0,BRCA.LumA,10
9.695280492,-1.912669325,TCGA-DJ-A3UU-01A,TCGA-DJ-A3UU-01A-11D-A22D-08,1,0.847519672,TCGA-DJ-A3UU,THCA,49,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-17919,Alive,WITH TUMOR,713,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,713,0,713,NA,NA,0,713,NA,Stage III,T3,M0,THCA.2,1
-3.716041067,-2.343884805,TCGA-55-A4DG-01A,TCGA-55-A4DG-01A-11D-A24D-08,8,0.387615234,TCGA-55-A4DG,LUAD,71,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26044,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,608,0,608,0,608,0,608,NA,Stage IA,T1b,MX,NA,10
-0.834019859,4.314011889,TCGA-NC-A5HO-01A,TCGA-NC-A5HO-01A-11D-A26M-08,4,0.411194394,TCGA-NC-A5HO,LUSC,70,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-25694,Alive,TUMOR FREE,1336,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1336,0,1336,0,1336,0,1336,NA,Stage IIIA,T3,M0,NA,10
-1.273092637,4.831733687,TCGA-BR-4188-01A,TCGA-BR-4188-01A-01D-1126-08,4,0.226518554,TCGA-BR-4188,STAD,53,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-19585,Dead,NA,NA,226,[Not Available],NA,NA,NA,NA,[Not Available],1,226,NA,226,NA,NA,0,226,NA,[Not Available],TX,M0,NA,6
9.69502195,-2.255603157,TCGA-DJ-A3UR-01A,TCGA-DJ-A3UR-01A-11D-A22D-08,1,0.69225622,TCGA-DJ-A3UR,THCA,51,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-18808,Alive,TUMOR FREE,1105,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1105,0,1105,0,1105,0,1105,NA,Stage III,T3,M0,THCA.5,1
-6.676491264,1.90678146,TCGA-AN-A0AJ-01A,TCGA-AN-A0AJ-01A-11W-A019-09,0,NA,TCGA-AN-A0AJ,BRCA,79,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29131,Alive,TUMOR FREE,303,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,303,0,303,0,303,0,303,NA,Stage IIB,T3,M0,BRCA.LumB,7
10.0228237,-1.752884445,TCGA-BJ-A28X-01A,TCGA-BJ-A28X-01A-11D-A22D-08,1,0.882524163,TCGA-BJ-A28X,THCA,32,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010,[Not Available],-11735,Alive,TUMOR FREE,942,NA,[Not Available],NA,NA,NA,494,[Not Available],0,942,0,942,1,494,1,494,NA,Stage I,T3,M0,THCA.4,1
-6.533595678,-2.178021863,TCGA-AX-A2H2-01A,TCGA-AX-A2H2-01A-11D-A17W-09,0,NA,TCGA-AX-A2H2,UCEC,86,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31524,Dead,TUMOR FREE,NA,145,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,145,0,145,0,145,0,145,NA,Stage IIA,[Not Applicable],[Not Applicable],NA,2
-1.421175294,4.05736497,TCGA-NC-A5HK-01A,TCGA-NC-A5HK-01A-11D-A26M-08,4,0.102989319,TCGA-NC-A5HK,LUSC,58,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-21531,Alive,TUMOR FREE,128,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,128,0,128,0,128,0,128,NA,Stage IIB,T3,M0,NA,10
-4.649881255,-2.199590283,TCGA-CV-7245-01A,TCGA-CV-7245-01A-11D-2012-08,8,0.168956448,TCGA-CV-7245,HNSC,62,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-22646,Alive,TUMOR FREE,797,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,797,0,797,NA,NA,0,797,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,10
-6.802080641,-2.129564824,TCGA-NC-A5HM-01A,TCGA-NC-A5HM-01A-12D-A26M-08,6,0.040389441,TCGA-NC-A5HM,LUSC,76,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-27938,Alive,TUMOR FREE,1212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1212,0,1212,0,1212,0,1212,NA,Stage IB,T2a,M0,NA,2
-0.106744853,3.069318676,TCGA-CV-7446-01A,TCGA-CV-7446-01A-11D-2229-08,0,NA,TCGA-CV-7446,HNSC,66,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1998,[Not Available],-24170,Dead,WITH TUMOR,NA,1093,[Not Available],NA,NA,NA,NA,[Not Available],1,1093,1,1093,NA,NA,1,1093,NA,Stage IVA,T2,[Not Available],NA,3
0.076692541,2.431851992,TCGA-NC-A5HL-01A,TCGA-NC-A5HL-01A-11D-A26M-08,4,0.138040102,TCGA-NC-A5HL,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2010,[Not Available],-26977,Dead,TUMOR FREE,NA,88,[Not Available],NA,NA,NA,NA,[Not Applicable],1,88,0,88,NA,NA,0,88,NA,Stage IIA,T2b,M0,NA,4
9.908306297,-1.863537259,TCGA-DJ-A1QQ-01A,TCGA-DJ-A1QQ-01A-11D-A14W-08,1,0.833587307,TCGA-DJ-A1QQ,THCA,43,MALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-15949,Alive,TUMOR FREE,534,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,534,0,534,0,534,0,534,NA,Stage I,T3,M0,THCA.3,1
4.463553337,0.996275133,TCGA-CN-5361-01A,TCGA-CN-5361-01A-01D-1434-08,2,0.630116545,TCGA-CN-5361,HNSC,80,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-29383,Dead,TUMOR FREE,NA,2120,[Not Available],New Primary Tumor,NA,NA,2062,Complete Remission/Response,1,2120,0,2120,NA,NA,1,2062,NA,Stage IVA,T4a,M0,NA,5
-0.253170206,4.550878255,TCGA-HB-A5W3-01A,TCGA-HB-A5W3-01A-11D-A29N-09,4,0.519470753,TCGA-HB-A5W3,SARC,58,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-21416,Dead,WITH TUMOR,NA,384,[Not Available],NA,NA,NA,NA,[Not Available],1,384,1,384,NA,NA,1,384,NA,NA,NA,NA,NA,6
-0.750510405,2.566870953,TCGA-05-4426-01A,TCGA-05-4426-01A-01D-1265-08,4,0.12381973,TCGA-05-4426,LUAD,71,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2008,[Not Available],-26084,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,457,Complete Remission/Response,0,791,0,791,1,457,1,457,NA,Stage IB,T2,M0,LUAD.5,6
10.02532675,-1.58779076,TCGA-IE-A3OV-01A,TCGA-IE-A3OV-01A-11D-A228-09,1,0.856685851,TCGA-IE-A3OV,SARC,42,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2004,[Not Available],-15607,Dead,WITH TUMOR,NA,2448,[Not Available],Distant Metastasis,Lung,NA,490,[Not Available],1,2448,1,2448,1,490,1,490,NA,NA,NA,NA,NA,1
9.8543988,-1.546588851,TCGA-DJ-A2PW-01A,TCGA-DJ-A2PW-01A-11D-A19J-08,1,0.87454227,TCGA-DJ-A2PW,THCA,65,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-23987,Alive,TUMOR FREE,1060,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1060,0,1060,0,1060,0,1060,NA,Stage III,T3,M0,THCA.5,1
-0.889627843,4.922178574,TCGA-AR-A1AP-01A,TCGA-AR-A1AP-01A-11D-A12Q-09,4,0.435426202,TCGA-AR-A1AP,BRCA,80,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29406,Alive,TUMOR FREE,2856,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2856,0,2856,0,2856,0,2856,NA,Stage I,T1,M0,BRCA.LumA,6
-3.736974238,0.543048212,TCGA-NC-A5HJ-01A,TCGA-NC-A5HJ-01A-11D-A26M-08,0,NA,TCGA-NC-A5HJ,LUSC,59,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-21730,Dead,WITH TUMOR,NA,418,[Not Available],New Primary Tumor,NA,NA,328,Complete Remission/Response,1,418,1,418,0,418,1,328,NA,Stage IIB,T3,M0,NA,10
-2.747860126,1.795488031,TCGA-NC-A5HH-01A,TCGA-NC-A5HH-01A-11D-A26M-08,0,NA,TCGA-NC-A5HH,LUSC,53,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-19485,Alive,TUMOR FREE,37,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,37,0,37,0,37,0,37,NA,Stage IA,T1,M0,NA,10
-6.220419296,1.611607347,TCGA-B5-A0JN-01A,TCGA-B5-A0JN-01A-11D-A10B-09,10,0.340652045,TCGA-B5-A0JN,UCEC,84,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30933,Alive,TUMOR FREE,2445,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2445,0,2445,NA,NA,0,2445,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.027339546,-2.511560713,TCGA-EL-A3MY-01A,TCGA-EL-A3MY-01A-11D-A21A-08,1,0.700053013,TCGA-EL-A3MY,THCA,81,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2004,[Not Available],-29706,Dead,WITH TUMOR,NA,533,[Not Available],NA,NA,NA,NA,[Not Available],1,533,1,533,NA,NA,1,533,NA,Stage IVC,T4,M1,THCA.4,1
-7.819663775,-2.495710759,TCGA-86-8278-01A,TCGA-86-8278-01A-11D-2284-08,6,0.206921162,TCGA-86-8278,LUAD,63,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-23117,Alive,WITH TUMOR,944,NA,[Not Available],NA,NA,NA,29,Complete Remission/Response,0,944,0,944,1,29,1,29,NA,Stage IIB,T2,M0,NA,6
-4.489050048,1.54999791,TCGA-CM-5864-01A,TCGA-CM-5864-01A-01D-1650-10,0,NA,TCGA-CM-5864,COAD,60,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-22219,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,457,0,457,NA,NA,0,457,NA,Stage I,T2,M0,GI.CIN,9
8.882283884,-5.104210263,TCGA-98-A53H-01A,TCGA-98-A53H-01A-12D-A25L-08,1,0.849630079,TCGA-98-A53H,LUSC,76,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-27928,Alive,NA,618,NA,[Not Available],New Primary Tumor,NA,NA,427,Complete Remission/Response,0,618,0,618,0,618,1,427,NA,Stage IA,T1a,M0,NA,1
-5.1538435,-1.312861834,TCGA-NC-A5HF-01A,TCGA-NC-A5HF-01A-11D-A26M-08,0,NA,TCGA-NC-A5HF,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-27038,Dead,WITH TUMOR,NA,138,[Not Available],Distant Metastasis,NA,NA,132,Progressive Disease,1,138,1,138,NA,NA,1,132,NA,Stage IIIB,T4,MX,NA,10
-6.252252408,3.084162557,TCGA-IQ-7631-01A,TCGA-IQ-7631-01A-11D-2078-08,11,0.049236903,TCGA-IQ-7631,HNSC,60,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2011,[Not Available],-22151,Alive,TUMOR FREE,1172,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1172,0,1172,0,1172,0,1172,NA,Stage II,T2,[Not Available],NA,8
-0.980640518,3.620012579,TCGA-98-A53J-01A,TCGA-98-A53J-01A-11D-A26M-08,4,0.408470011,TCGA-98-A53J,LUSC,77,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-28485,Alive,TUMOR FREE,630,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,630,0,630,0,630,0,630,NA,Stage IB,T2a,M0,NA,5
-3.273248939,1.463810798,TCGA-98-A53I-01A,TCGA-98-A53I-01A-31D-A25L-08,0,NA,TCGA-98-A53I,LUSC,64,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-23502,Alive,TUMOR FREE,565,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,565,0,565,0,565,0,565,NA,Stage IIA,T2a,M0,NA,10
-2.075305627,1.338877101,TCGA-IE-A4EJ-01A,TCGA-IE-A4EJ-01A-11D-A24N-09,5,0.492683508,TCGA-IE-A4EJ,SARC,84,FEMALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-30858,Alive,TUMOR FREE,98,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,98,0,98,NA,NA,0,98,NA,NA,NA,NA,NA,4
-6.505187033,-1.291799535,TCGA-CV-6955-01A,TCGA-CV-6955-01A-11D-2012-08,7,0.248120492,TCGA-CV-6955,HNSC,74,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2000,[Not Available],-27261,Dead,WITH TUMOR,NA,334,[Not Available],NA,NA,NA,NA,[Not Available],1,334,1,334,NA,NA,1,334,NA,Stage II,T2,[Not Available],HNSC.Atypical,2
-0.678160103,4.784223287,TCGA-IE-A4EH-01A,TCGA-IE-A4EH-01A-11D-A24N-09,4,0.546839535,TCGA-IE-A4EH,SARC,35,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-12871,Alive,TUMOR FREE,819,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,819,0,819,0,819,0,819,NA,NA,NA,NA,NA,6
0.292461311,5.207106484,TCGA-IE-A4EI-01A,TCGA-IE-A4EI-01A-11D-A24N-09,4,0.721052973,TCGA-IE-A4EI,SARC,67,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-24663,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,594,0,594,0,594,0,594,NA,NA,NA,NA,NA,6
9.888604398,-3.774356303,TCGA-DE-A4MC-01A,TCGA-DE-A4MC-01A-11D-A257-08,1,0.600983873,TCGA-DE-A4MC,THCA,43,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-15996,Alive,TUMOR FREE,913,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,332,[Not Available],0,913,0,913,1,332,1,332,NA,Stage I,T3,M0,THCA.4,1
9.66900772,-2.126199855,TCGA-EL-A3GV-01A,TCGA-EL-A3GV-01A-11D-A21A-08,1,0.748900571,TCGA-EL-A3GV,THCA,65,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2008,[Not Available],-23787,Alive,TUMOR FREE,1532,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1532,0,1532,0,1532,0,1532,NA,Stage III,T3,M0,THCA.5,1
-2.88277651,1.870612368,TCGA-98-A53A-01A,TCGA-98-A53A-01A-11D-A25L-08,0,NA,TCGA-98-A53A,LUSC,70,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-25662,Dead,NA,NA,552,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,552,NA,552,0,552,0,552,NA,Stage IB,T2a,M0,NA,10
-4.398825567,-1.63844008,TCGA-98-A538-01A,TCGA-98-A538-01A-11D-A25L-08,8,0.42870321,TCGA-98-A538,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-24698,Alive,TUMOR FREE,826,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,826,0,826,0,826,0,826,NA,Stage IIB,T3,M0,NA,10
2.979426952,3.569923416,TCGA-BG-A0VT-01A,TCGA-BG-A0VT-01A-11D-A10M-09,0,NA,TCGA-BG-A0VT,UCEC,56,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20602,Alive,TUMOR FREE,1568,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1568,0,1568,0,1568,0,1568,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,1
-5.30781579,2.550383151,TCGA-94-A5I6-01A,TCGA-94-A5I6-01A-21D-A27K-08,12,0.019380866,TCGA-94-A5I6,LUSC,62,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-22949,Alive,WITH TUMOR,538,NA,[Not Available],Distant Metastasis,NA,NA,481,Progressive Disease,0,538,0,538,NA,NA,1,481,NA,Stage IIB,T3,M0,NA,6
9.863466409,-1.593222312,TCGA-EM-A2P0-01A,TCGA-EM-A2P0-01A-11D-A202-08,1,0.867147852,TCGA-EM-A2P0,THCA,33,MALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-12127,Alive,TUMOR FREE,535,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,535,0,535,0,535,0,535,NA,Stage I,T2,MX,THCA.3,1
-6.021697664,3.424031432,TCGA-ET-A39I-01A,TCGA-ET-A39I-01A-11D-A19J-08,11,0.578976537,TCGA-ET-A39I,THCA,83,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2007,[Not Available],-30349,Dead,TUMOR FREE,NA,1011,[Not Available],NA,NA,NA,NA,[Not Available],1,1011,0,1011,0,1011,0,1011,NA,Stage I,T1,MX,THCA.1,8
-8.130738265,1.992084768,TCGA-A8-A08Z-01A,TCGA-A8-A08Z-01A-21W-A019-09,9,0.346049631,TCGA-A8-A08Z,BRCA,76,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003,Alive,TUMOR FREE,1217,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1217,0,1217,0,1217,0,1217,NA,[Discrepancy],T4b,M0,BRCA.LumA,7
-1.60652125,2.901110645,TCGA-86-8281-01A,TCGA-86-8281-01A-11D-2284-08,0,NA,TCGA-86-8281,LUAD,75,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27409,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,Stage IA,T1,M0,NA,10
-6.230699201,-2.044587636,TCGA-94-A5I4-01A,TCGA-94-A5I4-01A-11D-A26M-08,0,NA,TCGA-94-A5I4,LUSC,61,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-22299,Alive,WITH TUMOR,491,NA,[Not Available],Distant Metastasis,NA,NA,314,Complete Remission/Response,0,491,0,491,1,314,1,314,NA,Stage IIA,T2a,MX,NA,2
-7.592537133,-2.345108604,TCGA-AA-3846-01A,TCGA-AA-3846-01A-01W-0995-10,6,0.414536279,TCGA-AA-3846,COAD,74,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27057,Alive,WITH TUMOR,518,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,518,0,518,NA,NA,0,518,NA,Stage IIA,T3,M0,GI.CIN,2
9.465860274,-4.63765095,TCGA-98-A53C-01A,TCGA-98-A53C-01A-11D-A25L-08,1,0.769092381,TCGA-98-A53C,LUSC,77,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2012,[Not Available],-28146,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,822,0,822,0,822,0,822,NA,Stage IA,T1a,M0,NA,1
-4.040237905,-1.903742248,TCGA-WE-A8K4-01A,TCGA-WE-A8K4-01A-12D-A372-08,8,0.352867224,TCGA-WE-A8K4,SKCM,85,MALE,WHITE,NA,[Not Available],2013,[Not Available],-31308,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,614,0,614,NA,NA,0,614,NA,Stage IIB,T4a,M0,NA,10
10.23023949,-1.808400175,TCGA-E2-A1IK-01A,TCGA-E2-A1IK-01A-11D-A17G-09,1,0.786858015,TCGA-E2-A1IK,BRCA,71,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052,Alive,TUMOR FREE,1800,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1800,0,1800,0,1800,0,1800,NA,Stage IIA,T1c,M0,BRCA.LumA,1
-7.137364617,1.540167132,TCGA-BH-A0EE-01A,TCGA-BH-A0EE-01A-11W-A050-09,0,NA,TCGA-BH-A0EE,BRCA,68,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24850,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,943,0,943,0,943,0,943,NA,Stage IIB,T3,M0,BRCA.Her2,9
-3.301854037,1.049688093,TCGA-BR-6458-01A,TCGA-BR-6458-01A-11D-1800-08,0,NA,TCGA-BR-6458,STAD,57,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-21069,Dead,WITH TUMOR,NA,588,[Not Available],Distant Metastasis,Liver,NA,574,Complete Remission/Response,1,588,1,588,1,574,1,574,NA,Stage IIB,T3,M0,GI.CIN,10
9.937797581,-2.06992255,TCGA-CG-4462-01A,TCGA-CG-4462-01A-01D-1158-08,1,0.796278522,TCGA-CG-4462,STAD,72,FEMALE,[Not Available],"Stomach, Adenocarcinoma, Diffuse Type",G3,2008,[Not Available],-26511,Dead,WITH TUMOR,NA,0,[Not Available],NA,NA,NA,NA,[Not Available],1,0,1,0,NA,NA,1,0,NA,Stage IV,T3,M1,GI.GS,1
-6.199156697,3.534862832,TCGA-HR-A5NC-01A,TCGA-HR-A5NC-01A-11D-A27K-08,11,0.527923654,TCGA-HR-A5NC,SKCM,90,FEMALE,[Not Evaluated],NA,[Not Available],NA,[Not Available],-32871,Alive,TUMOR FREE,1000,NA,[Not Available],Locoregional Recurrence,NA,NA,154,[Not Available],0,1000,0,1000,NA,NA,1,154,NA,[Not Available],T4,M0,SKCM.-,8
-2.25096903,1.116537174,TCGA-A2-A0D2-01A,TCGA-A2-A0D2-01A-21W-A050-09,5,0.418594487,TCGA-A2-A0D2,BRCA,45,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16623,Alive,TUMOR FREE,1027,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1027,0,1027,0,1027,0,1027,NA,Stage IIA,T2,M0,BRCA.Basal,4
-3.4150358,-3.090797367,TCGA-BR-8078-01A,TCGA-BR-8078-01A-11D-2340-08,8,0.547773685,TCGA-BR-8078,STAD,70,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-25861,Alive,TUMOR FREE,900,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,900,0,900,0,900,0,900,NA,Stage IIB,T4a,M0,GI.HM-indel,10
-4.954396142,1.532939472,TCGA-GN-A8LN-01A,TCGA-GN-A8LN-01A-11D-A372-08,0,NA,TCGA-GN-A8LN,SKCM,68,MALE,WHITE,NA,[Not Available],2013,[Not Available],-24872,Alive,WITH TUMOR,772,NA,[Not Available],New primary melanoma,NA,NA,186,[Not Available],0,772,0,772,NA,NA,1,186,NA,Stage IIC,T4b,M0,NA,9
9.433796089,-2.460206629,TCGA-GF-A769-01A,TCGA-GF-A769-01A-32D-A32N-08,1,0.715965433,TCGA-GF-A769,SKCM,39,MALE,WHITE,NA,[Not Available],2010,[Not Available],-14304,Dead,WITH TUMOR,NA,1070,[Not Available],NA,NA,NA,NA,[Not Available],1,1070,1,1070,NA,NA,1,1070,NA,Stage IIC,T4b,M0,NA,6
-3.157702996,1.182890198,TCGA-GN-A4U5-01A,TCGA-GN-A4U5-01A-11D-A32N-08,0,NA,TCGA-GN-A4U5,SKCM,61,FEMALE,WHITE,NA,[Not Available],2011,[Not Available],-22499,Alive,TUMOR FREE,1156,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1156,0,1156,NA,NA,0,1156,NA,Stage IB,T2a,M0,NA,10
1.740805831,1.882097545,TCGA-A8-A0AD-01A,TCGA-A8-A0AD-01A-11W-A071-09,3,0.500726506,TCGA-A8-A0AD,BRCA,83,FEMALE,[Not Available],Mixed Histology (please specify),[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30407,Alive,TUMOR FREE,1157,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1157,0,1157,0,1157,0,1157,NA,Stage I,T1c,M0,BRCA.LumA,3
-2.917099338,1.428223879,TCGA-ER-A19T-01A,TCGA-ER-A19T-01A-11D-A19A-08,0,NA,TCGA-ER-A19T,SKCM,51,MALE,WHITE,NA,[Not Available],2006,[Not Available],-18732,Dead,WITH TUMOR,NA,270,[Not Available],Distant Metastasis,Brain,NA,118,[Not Available],1,270,1,270,NA,NA,1,118,NA,Stage IV,T4a,M1a,SKCM.-,10
-7.17901978,-2.411721503,TCGA-CG-5717-01A,TCGA-CG-5717-01A-11D-1600-08,6,0.248605043,TCGA-CG-5717,STAD,58,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006,[Not Available],-21458,Dead,WITH TUMOR,NA,212,[Not Available],NA,NA,NA,120,Progressive Disease,1,212,1,212,NA,NA,1,120,NA,Stage II,T2b,M0,GI.GS,2
9.703622954,-2.192846938,TCGA-ET-A25K-01A,TCGA-ET-A25K-01A-11D-A16O-08,1,0.768870934,TCGA-ET-A25K,THCA,36,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-13351,Alive,TUMOR FREE,2142,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2142,0,2142,0,2142,0,2142,NA,Stage I,T2,MX,THCA.5,1
-0.077569576,3.184628429,TCGA-44-2662-01A,TCGA-44-2662-01A-01D-A271-08,4,0.069045518,TCGA-44-2662,LUAD,65,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2009,[Not Available],-24014,Alive,TUMOR FREE,1280,NA,[Not Available],NA,NA,NA,245,Progressive Disease,0,1280,0,1280,NA,NA,1,245,NA,Stage IB,T2,M0,LUAD.6,10
-8.185363128,2.105149845,TCGA-BR-A4PF-01A,TCGA-BR-A4PF-01A-11D-A25D-08,9,0.521260379,TCGA-BR-A4PF,STAD,72,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012,[Not Available],-26412,Alive,TUMOR FREE,35,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,35,0,35,0,35,0,35,NA,Stage IIIB,T4a,M0,GI.CIN,7
10.09344256,-1.53607497,TCGA-DJ-A3VF-01A,TCGA-DJ-A3VF-01A-11D-A23M-08,1,0.872233112,TCGA-DJ-A3VF,THCA,60,FEMALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-22234,Alive,TUMOR FREE,292,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,292,0,292,NA,NA,0,292,NA,Stage IVA,T3,M0,THCA.4,1
-0.138815727,2.850583211,TCGA-CG-4438-01A,TCGA-CG-4438-01A-01D-1158-08,4,0.039207722,TCGA-CG-4438,STAD,56,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006,[Not Available],-20574,Alive,NA,1645,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1645,0,1645,NA,NA,0,1645,NA,Stage IV,T4,M0,GI.CIN,6
9.642634615,-1.850035207,TCGA-BF-A3DN-01A,TCGA-BF-A3DN-01A-11D-A20D-08,1,0.826483308,TCGA-BF-A3DN,SKCM,81,FEMALE,WHITE,NA,[Not Available],2011,[Not Available],-29801,Alive,TUMOR FREE,717,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,717,0,717,NA,NA,0,717,NA,Stage IIIC,T3b,M0,SKCM.BRAF_Hotspot_Mutants,1
10.09099138,-1.428189919,TCGA-EL-A3H5-01A,TCGA-EL-A3H5-01A-11D-A202-08,1,0.880183887,TCGA-EL-A3H5,THCA,57,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-20926,Alive,TUMOR FREE,2542,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2542,0,2542,NA,NA,0,2542,NA,Stage IVA,T4,M0,THCA.4,1
-7.579333852,2.394205933,TCGA-Z7-A8R5-01A,TCGA-Z7-A8R5-01A-42D-A41F-09,9,0.267473627,TCGA-Z7-A8R5,BRCA,61,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22280,Alive,WITH TUMOR,3287,NA,[Not Available],Locoregional Recurrence,NA,NA,181,[Not Available],0,3287,0,3287,NA,NA,1,181,NA,Stage IIIA,T3,MX,BRCA.LumA,7
-1.793257092,1.085115463,TCGA-Z7-A8R6-01A,TCGA-Z7-A8R6-01A-11D-A41F-09,5,0.573457573,TCGA-Z7-A8R6,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16955,Alive,TUMOR FREE,3256,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3256,0,3256,0,3256,0,3256,NA,Stage I,T1c,M0,BRCA.LumB,6
-3.30872999,-3.118568294,TCGA-BF-A1PX-01A,TCGA-BF-A1PX-01A-12D-A19A-08,8,0.509081628,TCGA-BF-A1PX,SKCM,56,MALE,WHITE,NA,[Not Available],2010,[Not Available],-20626,Dead,TUMOR FREE,NA,282,[Not Available],NA,NA,NA,NA,[Not Available],1,282,0,282,NA,NA,0,282,NA,Stage IIIB,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
9.051821769,-2.416360787,TCGA-BF-A3DJ-01A,TCGA-BF-A3DJ-01A-11D-A20D-08,1,0.617936174,TCGA-BF-A3DJ,SKCM,36,FEMALE,WHITE,NA,[Not Available],2011,[Not Available],-13332,Alive,TUMOR FREE,464,NA,[Not Available],Distant Metastasis,Liver,NA,217,[Not Available],0,464,0,464,NA,NA,1,217,NA,Stage IIIB,T4b,M0,SKCM.BRAF_Hotspot_Mutants,6
0.550902452,2.225423652,TCGA-CG-4476-01A,TCGA-CG-4476-01A-01D-1158-08,0,NA,TCGA-CG-4476,STAD,69,MALE,[Not Available],"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-25506,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIIC,T4b,M0,GI.CIN,6
-3.444448626,-3.059072729,TCGA-CR-7388-01A,TCGA-CR-7388-01A-11D-2012-08,8,0.487661373,TCGA-CR-7388,HNSC,70,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-25728,Dead,WITH TUMOR,NA,823,[Not Available],NA,Cervical Lymph Nodes,Right neck,334,Complete Remission/Response,1,823,1,823,NA,NA,1,334,NA,[Not Available],TX,[Not Available],HNSC.Atypical,10
8.745413939,-4.942506131,TCGA-E8-A432-01A,TCGA-E8-A432-01A-11D-A23M-08,1,0.785132962,TCGA-E8-A432,THCA,57,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-20874,Alive,TUMOR FREE,931,NA,[Not Available],Locoregional Recurrence,NA,NA,720,[Not Available],0,931,0,931,1,720,1,720,NA,Stage II,T2,M0,THCA.5,1
-0.776882317,2.398408141,TCGA-CG-4441-01A,TCGA-CG-4441-01A-01D-1800-08,0,NA,TCGA-CG-4441,STAD,83,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006,[Not Available],-30528,Dead,NA,NA,426,[Not Available],NA,NA,NA,NA,[Not Available],1,426,NA,426,NA,NA,0,426,NA,Stage IIIA,T2,M0,GI.GS,6
9.490590687,-2.41322666,TCGA-BJ-A0Z3-01A,TCGA-BJ-A0Z3-01A-11D-A13W-08,1,0.734294645,TCGA-BJ-A0Z3,THCA,33,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-12295,Alive,TUMOR FREE,497,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,497,0,497,NA,NA,0,497,NA,Stage I,T1,M0,THCA.2,1
-4.18427793,-2.420548704,TCGA-CV-7427-01A,TCGA-CV-7427-01A-11D-2078-08,8,0.18786635,TCGA-CV-7427,HNSC,73,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,1997,[Not Available],-26975,Dead,TUMOR FREE,NA,4760,[Not Available],Locoregional Recurrence,Oral Cavity,Maxilla,3282,Complete Remission/Response,1,4760,0,4760,1,3282,1,3282,NA,Stage II,T2,[Not Available],HNSC.Basal,10
-1.04638083,4.201875105,TCGA-S3-AA17-01A,TCGA-S3-AA17-01A-11D-A41F-09,4,0.386127552,TCGA-S3-AA17,BRCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23642,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,424,0,424,0,424,0,424,NA,Stage IIB,T2,cM0 (i+),BRCA.LumB,6
-8.008708511,2.21130945,TCGA-XX-A899-01A,TCGA-XX-A899-01A-11D-A36J-09,9,0.216820777,TCGA-XX-A899,BRCA,46,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17022,Alive,TUMOR FREE,467,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,467,0,467,0,467,0,467,NA,Stage IIIA,T1c,MX,BRCA.LumA,7
-5.691808594,-1.160577623,TCGA-XX-A89A-01A,TCGA-XX-A89A-01A-11D-A36J-09,0,NA,TCGA-XX-A89A,BRCA,68,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25000,Alive,TUMOR FREE,488,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,488,0,488,0,488,0,488,NA,Stage IIB,T3,MX,BRCA.LumA,10
-4.222477838,-1.231174641,TCGA-05-5425-01A,TCGA-05-5425-01A-02D-1625-08,8,0.223092853,TCGA-05-5425,LUAD,68,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2009,[Not Available],-25020,Alive,WITH TUMOR,882,NA,[Not Available],NA,NA,NA,486,[Not Applicable],0,882,0,882,NA,NA,1,486,NA,Stage IIB,T2b,M0,NA,10
8.950870237,-4.552785892,TCGA-S3-A6ZH-01A,TCGA-S3-A6ZH-01A-22D-A32I-09,5,0.372097119,TCGA-S3-A6ZH,BRCA,29,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,[Unknown],-10832,Alive,TUMOR FREE,641,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,641,0,641,0,641,0,641,NA,Stage IIIC,T3,MX,BRCA.LumA,4
-0.295355214,4.411318438,TCGA-S3-AA0Z-01A,TCGA-S3-AA0Z-01A-11D-A41F-09,4,0.520903268,TCGA-S3-AA0Z,BRCA,63,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23314,Alive,TUMOR FREE,629,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,629,0,629,0,629,0,629,NA,Stage IIB,T2,M0,BRCA.Basal,6
-2.714675589,1.925723584,TCGA-63-7020-01A,TCGA-63-7020-01A-11D-1945-08,0,NA,TCGA-63-7020,LUSC,NA,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],NA,Alive,TUMOR FREE,2133,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2133,0,2133,0,2133,0,2133,NA,Stage IA,T1,M0,NA,6
-5.76593071,-0.573306454,TCGA-S3-AA10-01A,TCGA-S3-AA10-01A-21D-A41F-09,0,NA,TCGA-S3-AA10,BRCA,65,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24075,Alive,TUMOR FREE,586,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,586,0,586,0,586,0,586,NA,Stage IIA,T2,M0,BRCA.Basal,10
-7.525605378,2.326631151,TCGA-S3-AA11-01A,TCGA-S3-AA11-01A-31D-A41F-09,9,0.393469399,TCGA-S3-AA11,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24813,Alive,TUMOR FREE,421,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,421,0,421,0,421,0,421,NA,Stage IIA,T2,M0,BRCA.LumA,7
8.518671294,-4.907634055,TCGA-S3-AA12-01A,TCGA-S3-AA12-01A-11D-A41F-09,1,0.758781691,TCGA-S3-AA12,BRCA,82,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30101,Alive,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,574,0,574,0,574,0,574,NA,Stage IIIA,T3,MX,BRCA.LumA,1
-8.22405532,1.914051437,TCGA-S3-AA14-01A,TCGA-S3-AA14-01A-11D-A41F-09,9,0.625487538,TCGA-S3-AA14,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17352,Alive,TUMOR FREE,529,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,529,0,529,0,529,0,529,NA,Stage I,T1,cM0 (i+),BRCA.LumA,7
-0.092778916,3.502160006,TCGA-S3-AA15-01A,TCGA-S3-AA15-01A-11D-A41F-09,4,0.225557981,TCGA-S3-AA15,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18659,Alive,TUMOR FREE,525,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,525,0,525,0,525,0,525,NA,Stage IIB,T2,cM0 (i+),BRCA.Basal,6
-0.046838816,3.943988319,TCGA-ET-A39P-01A,TCGA-ET-A39P-01A-21D-A19J-08,4,0.323464147,TCGA-ET-A39P,THCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-26817,Alive,TUMOR FREE,2900,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2900,0,2900,NA,NA,0,2900,NA,Stage III,T3,MX,THCA.4,6
-7.785757653,2.144870368,TCGA-CG-5722-01A,TCGA-CG-5722-01A-21D-1600-08,9,0.182309976,TCGA-CG-5722,STAD,67,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005,[Not Available],-24472,Alive,WITH TUMOR,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,30,0,30,NA,NA,0,30,NA,Stage IV,T3,M1,GI.EBV,7
-1.947634407,2.656272591,TCGA-CN-6022-01A,TCGA-CN-6022-01A-21D-1683-08,0,NA,TCGA-CN-6022,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-17971,Dead,WITH TUMOR,NA,281,[Not Available],NA,Cervical Lymph Nodes,NA,101,Progressive Disease,1,281,1,281,NA,NA,1,101,NA,Stage IVA,T4a,M0,HNSC.Mesenchymal,5
-6.15860093,3.583897243,TCGA-DJ-A13S-01A,TCGA-DJ-A13S-01A-11D-A10S-08,11,0.578616593,TCGA-DJ-A13S,THCA,19,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-7099,Alive,TUMOR FREE,265,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,265,0,265,0,265,0,265,NA,Stage I,T1b,M0,THCA.1,8
3.79860148,1.392201592,TCGA-D7-6818-01A,TCGA-D7-6818-01A-11D-1882-08,2,0.002953151,TCGA-D7-6818,STAD,53,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-19391,Dead,WITH TUMOR,NA,376,[Not Available],Locoregional Recurrence,NA,NA,247,Progressive Disease,1,376,1,376,NA,NA,1,247,NA,Stage IIIA,T2,M0,GI.CIN,6
9.591842404,-5.801351681,TCGA-CE-A13K-01A,TCGA-CE-A13K-01A-11D-A10S-08,1,0.848854555,TCGA-CE-A13K,THCA,30,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-11122,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,385,0,385,0,385,0,385,NA,Stage I,T3,M0,THCA.5,1
-5.347086372,1.524384355,TCGA-CV-5435-01A,TCGA-CV-5435-01A-01D-1683-08,0,NA,TCGA-CV-5435,HNSC,57,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2000,[Not Available],-20926,Dead,WITH TUMOR,1438,2319,[Not Available],NA,Distant Metastasis,Lung,284,[Not Available],1,2319,1,2319,NA,NA,1,284,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,8
-7.180246309,1.452930501,TCGA-B5-A11S-01A,TCGA-B5-A11S-01A-11D-A122-09,0,NA,TCGA-B5-A11S,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23085,Alive,TUMOR FREE,2229,NA,[Not Available],New Primary Tumor,"Other, specify",Breast,41,Complete Remission/Response,0,2229,0,2229,0,2229,1,41,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
9.435458853,-4.445725974,TCGA-PL-A8LX-01A,TCGA-PL-A8LX-01A-11D-A41F-09,1,0.78977614,TCGA-PL-A8LX,BRCA,35,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12840,Alive,WITH TUMOR,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5,0,5,NA,NA,0,5,NA,Stage IV,T4,M1,BRCA.LumA,1
9.666194678,-5.051202543,TCGA-PL-A8LY-01A,TCGA-PL-A8LY-01A-11D-A41F-09,1,0.818551597,TCGA-PL-A8LY,BRCA,30,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11199,Alive,WITH TUMOR,8,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,8,0,8,NA,NA,0,8,NA,Stage IIB,T3,M0,BRCA.Normal,1
-7.110631765,-2.490620431,TCGA-PL-A8LZ-01A,TCGA-PL-A8LZ-01A-31D-A36J-09,6,0.057113667,TCGA-PL-A8LZ,BRCA,29,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10869,Alive,TUMOR FREE,302,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,302,0,302,NA,NA,0,302,NA,Stage IIIB,T4b,M0,BRCA.Basal,2
9.120597697,-3.007619617,TCGA-S3-A6ZF-01A,TCGA-S3-A6ZF-01A-32D-A32I-09,1,0.756823683,TCGA-S3-A6ZF,BRCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23650,Alive,TUMOR FREE,572,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,572,0,572,0,572,0,572,NA,Stage IIA,T2,M0,BRCA.LumB,1
-4.556577148,-1.423873557,TCGA-55-6982-01A,TCGA-55-6982-01A-11D-1945-08,8,0.269121526,TCGA-55-6982,LUAD,79,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2004,[Not Available],NA,Dead,WITH TUMOR,NA,995,[Not Available],Distant Metastasis,NA,NA,183,Progressive Disease,1,995,1,995,NA,NA,1,183,NA,Stage IIB,T2,M0,LUAD.5,10
-0.517794796,4.535561786,TCGA-LD-A7W5-01A,TCGA-LD-A7W5-01A-22D-A351-09,4,0.502700638,TCGA-LD-A7W5,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19169,Alive,WITH TUMOR,216,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,216,0,216,NA,NA,0,216,NA,Stage IIIC,T2,M0,BRCA.LumA,6
8.623094043,-4.698343461,TCGA-LD-A9QF-01A,TCGA-LD-A9QF-01A-32D-A41F-09,1,0.743093175,TCGA-LD-A9QF,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26869,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,323,0,323,0,323,0,323,NA,Stage IA,T1c,M0,BRCA.Normal,1
-6.261704319,2.264173221,TCGA-LL-A6FP-01A,TCGA-LL-A6FP-01A-11D-A31U-09,0,NA,TCGA-LL-A6FP,BRCA,90,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,677,0,677,0,677,0,677,NA,Stage IIA,T2,MX,BRCA.LumA,7
0.132043903,5.120845098,TCGA-OL-A6VO-01A,TCGA-OL-A6VO-01A-12D-A33E-09,4,0.562637951,TCGA-OL-A6VO,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2012,[Unknown],-15780,Alive,TUMOR FREE,858,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,858,0,858,0,858,0,858,NA,Stage IA,T1c,MX,BRCA.Basal,6
-4.759096442,1.72990713,TCGA-OL-A6VQ-01A,TCGA-OL-A6VQ-01A-12D-A41F-09,0,NA,TCGA-OL-A6VQ,BRCA,49,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18151,Alive,TUMOR FREE,600,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,600,0,600,0,600,0,600,NA,Stage IIA,T2,MX,BRCA.LumA,9
0.307916303,3.727902092,TCGA-PL-A8LV-01A,TCGA-PL-A8LV-01A-21D-A41F-09,4,0.262904727,TCGA-PL-A8LV,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Medullary Carcinoma,[Not Available],2013,[Unknown],-19746,Alive,WITH TUMOR,-7,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage IIIB,T4,M0,BRCA.Basal,3
-2.301528365,2.054240131,TCGA-CD-5813-01A,TCGA-CD-5813-01A-11D-1600-08,0,NA,TCGA-CD-5813,STAD,60,MALE,ASIAN,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010,[Not Available],-21995,Dead,WITH TUMOR,NA,377,[Not Available],Distant Metastasis,Liver,NA,315,Complete Remission/Response,1,377,1,377,1,315,1,315,NA,Stage II,T3,M0,NA,6
-5.833049271,2.974125463,TCGA-ET-A25I-01A,TCGA-ET-A25I-01A-11D-A16O-08,0,NA,TCGA-ET-A25I,THCA,37,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2008,[Not Available],-13786,Alive,TUMOR FREE,2485,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2485,0,2485,0,2485,0,2485,NA,Stage I,T2,MX,THCA.1,8
-6.219756233,3.602663331,TCGA-DJ-A3UT-01A,TCGA-DJ-A3UT-01A-11D-A22D-08,11,0.527253434,TCGA-DJ-A3UT,THCA,43,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-15767,Alive,TUMOR FREE,1105,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1105,0,1105,0,1105,0,1105,NA,Stage I,T1a,M0,THCA.1,8
-3.36863898,-3.583941221,TCGA-YG-AA3N-01A,TCGA-YG-AA3N-01A-11D-A38G-08,8,0.585572161,TCGA-YG-AA3N,SKCM,67,MALE,[Unknown],NA,[Not Available],2013,[Not Available],-24525,Alive,TUMOR FREE,306,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,306,0,306,NA,NA,0,306,NA,Stage IIC,T4b,M0,NA,10
10.26797599,-1.376228119,TCGA-KK-A7AP-01A,TCGA-KK-A7AP-01A-12D-A33T-08,1,0.797226464,TCGA-KK-A7AP,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20403,Alive,NA,196,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,196,0,196,NA,NA,0,196,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,1
9.663156381,-5.665573096,TCGA-KC-A7FE-01A,TCGA-KC-A7FE-01A-12D-A33T-08,1,0.876589368,TCGA-KC-A7FE,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22718,Alive,TUMOR FREE,352,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,352,0,352,0,352,0,352,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
-5.204921313,1.663659081,TCGA-CV-6943-01A,TCGA-CV-6943-01A-11D-1912-08,0,NA,TCGA-CV-6943,HNSC,74,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-27310,Dead,WITH TUMOR,NA,602,[Not Available],NA,NA,NA,NA,[Not Available],1,602,1,602,NA,NA,1,602,NA,Stage III,T3,[Not Available],HNSC.Mesenchymal,8
0.370074247,2.20131805,TCGA-VT-A80G-01A,TCGA-VT-A80G-01A-11D-A36J-09,0,NA,TCGA-VT-A80G,SARC,66,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013,[Not Available],-24128,Alive,WITH TUMOR,326,NA,[Not Available],Distant Metastasis,Lung,NA,26,[Not Available],0,326,0,326,1,26,1,26,NA,NA,NA,NA,NA,6
-0.429763152,5.26152327,TCGA-VT-A80J-01A,TCGA-VT-A80J-01A-11D-A36J-09,4,0.516241816,TCGA-VT-A80J,SARC,49,FEMALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-17925,Alive,TUMOR FREE,796,NA,[Not Available],Distant Metastasis,"Other, specify",inguinal lymph node,355,[Not Available],0,796,0,796,1,355,1,355,NA,NA,NA,NA,NA,6
-6.385697924,1.635670912,TCGA-UE-A6QT-01A,TCGA-UE-A6QT-01A-12D-A32I-09,10,0.136812516,TCGA-UE-A6QT,SARC,50,FEMALE,ASIAN,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013,[Not Available],-18516,Alive,TUMOR FREE,402,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,402,0,402,0,402,0,402,NA,NA,NA,NA,NA,7
-5.758003637,1.613996607,TCGA-CN-6998-01A,TCGA-CN-6998-01A-23D-2012-08,10,0.210864823,TCGA-CN-6998,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-19447,Dead,WITH TUMOR,NA,357,[Not Available],NA,Oropharynx,tonsil,244,Progressive Disease,1,357,1,357,NA,NA,1,244,NA,Stage IVA,T3,[Not Available],HNSC.Basal,9
-6.36855245,1.628583826,TCGA-D5-6922-01A,TCGA-D5-6922-01A-11D-1924-10,10,0.161729391,TCGA-D5-6922,COAD,76,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-27771,Alive,TUMOR FREE,308,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,308,0,308,NA,NA,0,308,NA,Stage IIIA,T3,M0,GI.CIN,7
1.322852954,3.353824819,TCGA-KC-A7F5-01A,TCGA-KC-A7F5-01A-11D-A33T-08,0,NA,TCGA-KC-A7F5,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-20015,Alive,TUMOR FREE,91,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,91,0,91,0,91,0,91,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-4.658422956,-0.079814865,TCGA-A5-A0GI-01A,TCGA-A5-A0GI-01A-11W-A062-09,0,NA,TCGA-A5-A0GI,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23195,Alive,TUMOR FREE,2682,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2682,0,2682,0,2682,0,2682,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
0.033573773,5.10029094,TCGA-KC-A7FA-01A,TCGA-KC-A7FA-01A-21D-A33T-08,4,0.621584457,TCGA-KC-A7FA,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23208,Alive,TUMOR FREE,598,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,598,0,598,0,598,0,598,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,6
4.259019514,1.173125728,TCGA-VT-AB3D-01A,TCGA-VT-AB3D-01A-12D-A417-09,2,0.692641133,TCGA-VT-AB3D,SARC,71,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013,[Not Available],-26100,Alive,TUMOR FREE,379,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,379,0,379,0,379,0,379,NA,NA,NA,NA,NA,5
2.082150768,1.821912569,TCGA-KC-A7F3-01A,TCGA-KC-A7F3-01A-21D-A33T-08,3,0.323001455,TCGA-KC-A7F3,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24676,Alive,TUMOR FREE,665,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,665,0,665,0,665,0,665,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,3
-7.332942289,-2.358665836,TCGA-KC-A4BV-01A,TCGA-KC-A4BV-01A-31D-A26M-08,6,0.37789764,TCGA-KC-A4BV,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24138,Alive,WITH TUMOR,1328,NA,[Not Available],Biochemical evidence of disease,NA,NA,1328,Complete Remission/Response,0,1328,0,1328,1,1328,1,1328,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,2
8.501957711,-2.984204,TCGA-WK-A8XT-01A,TCGA-WK-A8XT-01A-11D-A37C-09,1,0.631422983,TCGA-WK-A8XT,SARC,40,FEMALE,WHITE,Synovial Sarcoma - Monophasic,[Not Available],2008,[Not Available],-14958,Dead,WITH TUMOR,NA,1262,[Not Available],Locoregional Recurrence,"Other, specify",Flank,599,[Not Available],1,1262,1,1262,1,599,1,599,NA,NA,NA,NA,NA,1
-5.225346355,2.490470592,TCGA-AA-3862-01A,TCGA-AA-3862-01A-01W-0995-10,12,0.19934571,TCGA-AA-3862,COAD,82,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-30163,Alive,TUMOR FREE,914,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,914,0,914,0,914,0,914,NA,Stage IIA,T3,M0,NA,8
-1.927070905,1.048854964,TCGA-WK-A8XS-01A,TCGA-WK-A8XS-01A-11D-A37C-09,5,0.627494959,TCGA-WK-A8XS,SARC,58,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2008,[Not Available],-21521,Alive,TUMOR FREE,2579,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2579,0,2579,0,2579,0,2579,NA,NA,NA,NA,NA,4
-1.152826567,2.70009098,TCGA-22-5471-01A,TCGA-22-5471-01A-01D-1632-08,0,NA,TCGA-22-5471,LUSC,75,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-27749,Alive,NA,1845,NA,[Not Available],NA,NA,NA,229,Complete Remission/Response,0,1845,0,1845,1,229,1,229,NA,Stage IB,T2,M0,LUSC.classical,3
9.032270706,-5.192373924,TCGA-KC-A4BO-01A,TCGA-KC-A4BO-01A-61D-A257-08,1,0.815526275,TCGA-KC-A4BO,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20368,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,607,0,607,0,607,0,607,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.22611335,-5.258153587,TCGA-KC-A4BN-01A,TCGA-KC-A4BN-01A-61D-A257-08,1,0.817492652,TCGA-KC-A4BN,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20392,Alive,TUMOR FREE,1815,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1815,0,1815,0,1815,0,1815,NA,[Not Applicable],T2a,[Not Applicable],PRAD.1-ERG,1
8.981564059,-5.664126507,TCGA-KC-A4BR-01A,TCGA-KC-A4BR-01A-32D-A257-08,1,0.719247742,TCGA-KC-A4BR,PRAD,75,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-27741,Alive,WITH TUMOR,1349,NA,[Not Available],Biochemical evidence of disease,NA,NA,1022,Complete Remission/Response,0,1349,0,1349,1,1022,1,1022,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
4.109595728,1.07282023,TCGA-KC-A4BL-01A,TCGA-KC-A4BL-01A-31D-A257-08,2,0.705174135,TCGA-KC-A4BL,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-24081,Alive,WITH TUMOR,934,NA,[Not Available],Biochemical evidence of disease,NA,NA,193,Partial Remission/Response,0,934,0,934,NA,NA,1,193,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,5
9.808304888,-2.826727903,TCGA-J9-A8CP-01A,TCGA-J9-A8CP-01A-11D-A34U-08,1,0.784168885,TCGA-J9-A8CP,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24299,Alive,TUMOR FREE,386,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,386,0,386,0,386,0,386,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,1
-8.113580204,2.005445175,TCGA-J9-A8CL-01A,TCGA-J9-A8CL-01A-11D-A34U-08,9,0.553600562,TCGA-J9-A8CL,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24145,Alive,WITH TUMOR,405,NA,[Not Available],Biochemical evidence of disease,NA,NA,132,[Unknown],0,405,0,405,NA,NA,1,132,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,7
9.137273024,-3.698756902,TCGA-61-2088-01A,TCGA-61-2088-01A-01W-0722-08,1,0.69155124,TCGA-61-2088,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-18770,Alive,TUMOR FREE,145,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,145,0,145,NA,NA,0,145,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,1
9.132300581,-2.404221678,TCGA-J4-AAU2-01A,TCGA-J4-AAU2-01A-11D-A41K-08,1,0.680632826,TCGA-J4-AAU2,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-21656,Alive,TUMOR FREE,825,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,825,0,825,0,825,0,825,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.08801145,-5.667162311,TCGA-J9-A8CN-01A,TCGA-J9-A8CN-01A-11D-A34U-08,1,0.750813085,TCGA-J9-A8CN,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-19662,Alive,TUMOR FREE,1237,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1237,0,1237,0,1237,0,1237,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
-1.890249753,1.036353039,TCGA-J9-A8CM-01A,TCGA-J9-A8CM-01A-11D-A34U-08,5,0.49949966,TCGA-J9-A8CM,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24118,Alive,WITH TUMOR,463,NA,[Not Available],Biochemical evidence of disease,NA,NA,344,Partial Remission/Response,0,463,0,463,NA,NA,1,344,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,4
8.999668079,-5.494855608,TCGA-J4-AATZ-01A,TCGA-J4-AATZ-01A-11D-A41K-08,1,0.790041245,TCGA-J4-AATZ,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-24226,Alive,WITH TUMOR,412,NA,[Not Available],Biochemical evidence of disease,NA,NA,79,Complete Remission/Response,0,412,0,412,1,79,1,79,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.11446522,-4.537671022,TCGA-HC-A8D0-01A,TCGA-HC-A8D0-01A-11D-A364-08,1,0.800178434,TCGA-HC-A8D0,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22465,Alive,TUMOR FREE,775,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,775,0,775,0,775,0,775,NA,[Not Applicable],T2a,[Not Applicable],PRAD.1-ERG,1
9.485734449,-5.579579057,TCGA-HC-A8CY-01A,TCGA-HC-A8CY-01A-11D-A364-08,1,0.828485124,TCGA-HC-A8CY,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23154,Alive,WITH TUMOR,290,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,290,0,290,NA,NA,0,290,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,1
9.664764209,-5.740907245,TCGA-J4-AATV-01A,TCGA-J4-AATV-01A-11D-A41K-08,1,0.796527951,TCGA-J4-AATV,PRAD,71,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-25943,Alive,WITH TUMOR,553,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,553,0,553,NA,NA,0,553,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.624191945,-5.022948648,TCGA-HC-A76X-01A,TCGA-HC-A76X-01A-11D-A33T-08,1,0.759464058,TCGA-HC-A76X,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22756,Alive,TUMOR FREE,150,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,150,0,150,NA,NA,0,150,NA,[Not Applicable],T2c,[Not Applicable],PRAD.1-ERG,1
9.615571768,-1.597690825,TCGA-HC-A76W-01A,TCGA-HC-A76W-01A-11D-A33T-08,1,0.828167712,TCGA-HC-A76W,PRAD,73,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-26755,Alive,WITH TUMOR,213,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,213,0,213,NA,NA,0,213,NA,[Not Applicable],T3b,[Not Applicable],PRAD.3-ETV4,1
-5.717858614,-2.265941859,TCGA-CJ-6028-01A,TCGA-CJ-6028-01A-11D-1669-08,0,NA,TCGA-CJ-6028,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2003,[Not Available],-21380,Dead,WITH TUMOR,NA,1625,[Not Available],NA,NA,NA,137,[Not Available],1,1625,1,1625,NA,NA,1,137,NA,Stage IV,T3a,M1,KIRC.3,2
8.733573149,-4.896841716,TCGA-EJ-A6RC-01A,TCGA-EJ-A6RC-01A-11D-A32B-08,1,0.744366452,TCGA-EJ-A6RC,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23598,Alive,TUMOR FREE,873,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,873,0,873,0,873,0,873,NA,[Not Applicable],[Not Available],[Not Applicable],PRAD.8-other,1
-5.163202306,2.13638012,TCGA-DM-A1HA-01A,TCGA-DM-A1HA-01A-11D-A152-10,0,NA,TCGA-DM-A1HA,COAD,82,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2000,[Not Available],-30272,Alive,NA,4000,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4000,0,4000,NA,NA,0,4000,NA,Stage IIIC,T3,M0,GI.GS,8
9.062003763,-4.827999679,TCGA-2A-AAYO-01A,TCGA-2A-AAYO-01A-11D-A41K-08,1,0.811922679,TCGA-2A-AAYO,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21183,Alive,TUMOR FREE,1272,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1272,0,1272,0,1272,0,1272,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.257333884,-1.463939888,TCGA-4L-AA1F-01A,TCGA-4L-AA1F-01A-11D-A41K-08,1,0.628314622,TCGA-4L-AA1F,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23665,Alive,TUMOR FREE,350,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,350,0,350,0,350,0,350,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-7.94672247,-2.55789165,TCGA-2A-AAYU-01A,TCGA-2A-AAYU-01A-11D-A41K-08,6,0.43057798,TCGA-2A-AAYU,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-20582,Alive,TUMOR FREE,615,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],0,615,0,615,NA,NA,0,615,NA,[Not Applicable],T3a,[Not Applicable],NA,2
8.848281391,-5.030052423,TCGA-A3-3380-01A,TCGA-A3-3380-01A-01D-0966-08,1,0.790739304,TCGA-A3-3380,KIRC,54,MALE,[Not Available],Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-19828,Alive,TUMOR FREE,567,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,567,0,567,NA,NA,0,567,NA,Stage I,T1,M0,KIRC.1,1
-0.668754934,3.890910261,TCGA-AA-3688-01A,TCGA-AA-3688-01A-01W-0900-09,4,0.475541921,TCGA-AA-3688,COAD,80,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-29220,Alive,WITH TUMOR,578,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,578,0,578,NA,NA,0,578,NA,Stage IV,T3,M1,GI.CIN,6
-1.794707204,1.032943136,TCGA-A3-A8OW-01A,TCGA-A3-A8OW-01A-11D-A36X-10,5,0.557395011,TCGA-A3-A8OW,KIRC,37,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2011,[Not Available],-13546,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,323,0,323,0,323,0,323,NA,Stage III,T3a,MX,NA,4
-7.769574806,-2.547280524,TCGA-A3-A8OU-01A,TCGA-A3-A8OU-01A-11D-A36X-10,6,0.524880659,TCGA-A3-A8OU,KIRC,74,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G1,2011,[Not Available],-27377,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,0,0,0,0,0,0,0,NA,Stage I,T1a,MX,NA,2
-1.592376376,1.338174159,TCGA-A3-A6NN-01A,TCGA-A3-A6NN-01A-12D-A33K-10,5,0.429881698,TCGA-A3-A6NN,KIRC,78,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2012,[Not Available],-28689,Alive,TUMOR FREE,3,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3,0,3,0,3,0,3,NA,Stage I,T1a,MX,NA,3
-7.693080483,-2.273249897,TCGA-G6-A8L8-01A,TCGA-G6-A8L8-01A-21D-A36X-10,6,0.46561802,TCGA-G6-A8L8,KIRC,62,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-22649,Dead,TUMOR FREE,NA,1091,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1091,0,1091,0,1091,0,1091,NA,Stage I,T1b,MX,NA,2
8.852336112,-5.317792884,TCGA-DV-A4W0-01A,TCGA-DV-A4W0-01A-11D-A25V-10,1,0.79737979,TCGA-DV-A4W0,KIRC,55,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-20101,Alive,WITH TUMOR,2470,NA,[Not Available],NA,NA,NA,2008,Stable Disease,0,2470,0,2470,NA,NA,1,2008,NA,Stage I,T1b,MX,NA,1
9.127707782,-5.040431892,TCGA-B8-A54K-01A,TCGA-B8-A54K-01A-11D-A33K-10,1,0.828945607,TCGA-B8-A54K,KIRC,61,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G1,2012,[Not Available],-22627,Alive,TUMOR FREE,469,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,469,0,469,0,469,0,469,NA,Stage I,T1a,MX,NA,1
1.950359399,1.854216337,TCGA-3Z-A93Z-01A,TCGA-3Z-A93Z-01A-11D-A36X-10,3,0.473409223,TCGA-3Z-A93Z,KIRC,69,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2013,[Not Available],-25205,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,385,0,385,0,385,0,385,NA,Stage I,T1a,M0,NA,3
-5.342112257,1.546979422,TCGA-D5-5540-01A,TCGA-D5-5540-01A-01D-1650-10,0,NA,TCGA-D5-5540,COAD,73,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-26972,Alive,TUMOR FREE,1706,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1706,0,1706,0,1706,0,1706,NA,Stage IIA,T3,M0,GI.CIN,9
-5.680996871,-2.193057025,TCGA-O2-A5IB-01A,TCGA-O2-A5IB-01A-11D-A27K-08,0,NA,TCGA-O2-A5IB,LUSC,71,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-26211,Dead,WITH TUMOR,NA,340,[Not Available],Distant Metastasis,NA,NA,253,[Unknown],1,340,1,340,NA,NA,1,253,NA,Stage III,T3,MX,NA,2
-4.339258262,-1.697812034,TCGA-O2-A52S-01A,TCGA-O2-A52S-01A-11D-A25L-08,8,0.358186999,TCGA-O2-A52S,LUSC,57,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-21182,Dead,WITH TUMOR,NA,387,[Not Available],Distant Metastasis,NA,NA,246,[Unknown],1,387,1,387,NA,NA,1,246,NA,Stage III,T4,MX,NA,10
-0.053108778,5.220441161,TCGA-O2-A52W-01A,TCGA-O2-A52W-01A-11D-A26M-08,4,0.479776177,TCGA-O2-A52W,LUSC,63,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-23156,Dead,TUMOR FREE,NA,261,[Not Available],NA,NA,NA,NA,[Not Applicable],1,261,0,261,NA,NA,0,261,NA,Stage I,T2,MX,NA,6
-2.843942753,1.572382982,TCGA-O2-A52V-01A,TCGA-O2-A52V-01A-31D-A25L-08,0,NA,TCGA-O2-A52V,LUSC,75,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-27449,Dead,TUMOR FREE,NA,1335,[Not Available],Distant Metastasis,NA,NA,690,[Unknown],1,1335,0,1335,NA,NA,1,690,NA,Stage II,T3,MX,NA,6
-3.147747745,-3.241741276,TCGA-O2-A52Q-01A,TCGA-O2-A52Q-01A-11D-A26M-08,8,0.414823716,TCGA-O2-A52Q,LUSC,44,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-16429,Dead,WITH TUMOR,NA,113,[Not Available],Distant Metastasis,NA,NA,87,[Unknown],1,113,1,113,NA,NA,1,87,NA,Stage III,T3,MX,NA,10
-4.380998313,-1.917534332,TCGA-O2-A52N-01A,TCGA-O2-A52N-01A-11D-A26M-08,8,0.386596296,TCGA-O2-A52N,LUSC,78,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2005,[Not Available],-28520,Dead,TUMOR FREE,NA,1006,[Not Available],NA,NA,NA,NA,[Unknown],1,1006,0,1006,NA,NA,0,1006,NA,Stage I,T2,MX,NA,10
-3.220406998,-3.413914117,TCGA-A6-3809-01A,TCGA-A6-3809-01A-01D-A270-10,8,0.626059469,TCGA-A6-3809,COAD,71,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-26274,Alive,TUMOR FREE,996,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,996,0,996,NA,NA,0,996,NA,Stage IIB,T4,M0,NA,10
0.084584028,3.323121159,TCGA-NK-A5CX-01A,TCGA-NK-A5CX-01A-11D-A26M-08,4,0.36755146,TCGA-NK-A5CX,LUSC,73,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26879,Alive,TUMOR FREE,111,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,111,0,111,NA,NA,0,111,NA,Stage IIA,T2b,MX,NA,3
-0.360240956,3.015216131,TCGA-NK-A7XE-01A,TCGA-NK-A7XE-01A-12D-A401-08,4,0.153692194,TCGA-NK-A7XE,LUSC,66,MALE,BLACK OR AFRICAN AMERICAN,Lung Squamous Cell Carcinoma,[Not Available],2013,[Not Available],-24319,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,13,0,13,NA,NA,0,13,NA,Stage IIIB,T4,M0,NA,3
9.933153361,-1.458146465,TCGA-FY-A3NN-01A,TCGA-FY-A3NN-01A-11D-A21A-08,1,0.877398265,TCGA-FY-A3NN,THCA,48,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-17613,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage III,T1b,MX,THCA.3,1
-6.502229377,1.623114451,TCGA-CV-7177-01A,TCGA-CV-7177-01A-11D-2012-08,10,0.011449086,TCGA-CV-7177,HNSC,82,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1999,[Not Available],-30180,Dead,WITH TUMOR,NA,663,[Not Available],NA,NA,NA,NA,[Not Available],1,663,1,663,NA,NA,1,663,NA,Stage II,T2,[Not Available],HNSC.Classical,7
-4.21654158,-1.908455221,TCGA-D1-A17U-01A,TCGA-D1-A17U-01A-21D-A12J-09,8,0.475382405,TCGA-D1-A17U,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19544,Alive,TUMOR FREE,697,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,697,0,697,0,697,0,697,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.MSI,10
-6.131623581,3.598665264,TCGA-DJ-A4UR-01A,TCGA-DJ-A4UR-01A-11D-A257-08,11,0.503834859,TCGA-DJ-A4UR,THCA,36,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2012,[Not Available],-13463,Alive,WITH TUMOR,1058,NA,[Not Available],Distant Metastasis,Lung,NA,113,[Not Available],0,1058,0,1058,1,113,1,113,NA,Stage II,T3,M1,THCA.1,8
-5.617790371,1.065470085,TCGA-CX-7082-01A,TCGA-CX-7082-01A-11D-2012-08,0,NA,TCGA-CX-7082,HNSC,82,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-30174,Dead,TUMOR FREE,NA,11,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,11,0,11,NA,NA,0,11,NA,Stage IVA,T2,[Not Available],NA,9
-7.667464516,-2.484618995,TCGA-S2-AA1A-01A,TCGA-S2-AA1A-01A-12D-A397-08,6,0.515441988,TCGA-S2-AA1A,LUAD,68,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-24903,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,513,0,513,0,513,0,513,NA,Stage IA,T1b,M0,NA,2
-8.061004398,2.283915512,TCGA-AC-A6NO-01A,TCGA-AC-A6NO-01A-12D-A33E-09,9,0.574130052,TCGA-AC-A6NO,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,[Unknown],-15996,Alive,TUMOR FREE,51,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,51,0,51,0,51,0,51,NA,Stage IIB,T2,MX,BRCA.LumA,7
-1.331925215,4.293266268,TCGA-LI-A9QH-01A,TCGA-LI-A9QH-01A-11D-A37C-09,4,0.263974203,TCGA-LI-A9QH,SARC,72,FEMALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-26468,Dead,TUMOR FREE,NA,540,[Not Available],Distant Metastasis,Lung,NA,426,[Not Available],1,540,0,540,NA,NA,1,426,NA,NA,NA,NA,NA,6
-7.901664146,1.853835278,TCGA-E2-A576-01A,TCGA-E2-A576-01A-11D-A31U-09,9,0.352507949,TCGA-E2-A576,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25350,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1043,0,1043,0,1043,0,1043,NA,Stage IA,T1c,MX,BRCA.LumA,7
9.201879768,-4.498314835,TCGA-LI-A67I-01A,TCGA-LI-A67I-01A-31D-A307-09,1,0.754813572,TCGA-LI-A67I,SARC,75,FEMALE,WHITE,Myxofibrosarcoma,[Not Available],2013,[Not Available],-27671,Alive,TUMOR FREE,922,NA,[Not Available],Distant Metastasis,Lung,NA,574,[Not Available],0,922,0,922,NA,NA,1,574,NA,NA,NA,NA,NA,1
-5.972976222,1.836755467,TCGA-E2-A9RU-01A,TCGA-E2-A9RU-01A-11D-A41F-09,0,NA,TCGA-E2-A9RU,BRCA,90,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Alive,TUMOR FREE,538,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,538,0,538,0,538,0,538,NA,Stage IIIC,T2,MX,BRCA.LumB,7
-3.33224212,-3.446388239,TCGA-MN-A4N4-01A,TCGA-MN-A4N4-01A-12D-A24P-08,8,0.626107949,TCGA-MN-A4N4,LUAD,57,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2010,[Not Available],-20888,Alive,TUMOR FREE,1175,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1175,0,1175,0,1175,0,1175,NA,Stage IA,T1b,M0,NA,10
9.84988692,-2.841292342,TCGA-MB-A5YA-01A,TCGA-MB-A5YA-01A-11D-A29N-09,1,0.758697583,TCGA-MB-A5YA,SARC,63,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-23115,Alive,TUMOR FREE,15,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,15,0,15,0,15,0,15,NA,NA,NA,NA,NA,1
8.880590111,-5.471372216,TCGA-MB-A8JK-01A,TCGA-MB-A8JK-01A-11D-A36J-09,1,0.807229028,TCGA-MB-A8JK,SARC,49,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-18177,Alive,TUMOR FREE,661,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,661,0,661,NA,NA,0,661,NA,NA,NA,NA,NA,1
-5.939501634,3.260073907,TCGA-95-A4VP-01A,TCGA-95-A4VP-01A-21D-A25L-08,11,0.240658778,TCGA-95-A4VP,LUAD,66,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24130,Alive,WITH TUMOR,605,NA,[Not Available],Distant Metastasis,NA,NA,216,Stable Disease,0,605,0,605,NA,NA,1,216,NA,Stage IIIA,T2b,M0,NA,8
4.334081707,1.134035635,TCGA-MB-A5Y8-01A,TCGA-MB-A5Y8-01A-11D-A29N-09,2,0.625563679,TCGA-MB-A5Y8,SARC,60,FEMALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-22115,Alive,TUMOR FREE,773,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,773,0,773,0,773,0,773,NA,NA,NA,NA,NA,5
8.205176258,-3.935417175,TCGA-A2-A0CU-01A,TCGA-A2-A0CU-01A-12W-A050-09,1,0.536434133,TCGA-A2-A0CU,BRCA,73,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26823,Dead,TUMOR FREE,NA,158,[Not Available],NA,NA,NA,NA,[Not Available],1,158,0,158,NA,NA,0,158,NA,Stage IIA,T2,M0,BRCA.LumA,1
8.734425968,-3.461612528,TCGA-99-AA5R-01A,TCGA-99-AA5R-01A-11D-A397-08,1,0.705483295,TCGA-99-AA5R,LUAD,70,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-25778,Alive,TUMOR FREE,658,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,658,0,658,0,658,0,658,NA,Stage IA,T1a,M0,NA,1
9.380085087,-5.652588559,TCGA-MB-A5Y9-01A,TCGA-MB-A5Y9-01A-11D-A29N-09,1,0.881924316,TCGA-MB-A5Y9,SARC,90,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-32873,Alive,WITH TUMOR,252,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,252,0,252,NA,NA,0,252,NA,NA,NA,NA,NA,1
9.182874114,-4.477796967,TCGA-BR-6564-01A,TCGA-BR-6564-01A-12D-1882-08,1,0.81792888,TCGA-BR-6564,STAD,46,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-17129,Dead,TUMOR FREE,NA,794,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,794,0,794,0,794,0,794,NA,Stage IIIA,T3,M0,GI.CIN,1
0.517680049,2.126218471,TCGA-NJ-A7XG-01A,TCGA-NJ-A7XG-01A-12D-A397-08,0,NA,TCGA-NJ-A7XG,LUAD,49,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-18127,Alive,WITH TUMOR,617,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,617,0,617,NA,NA,0,617,NA,Stage IIIA,T4,M0,NA,6
7.801803168,-3.446273207,TCGA-HF-7136-01A,TCGA-HF-7136-01A-11D-2053-08,1,0.34962373,TCGA-HF-7136,STAD,NA,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008,[Not Available],NA,Alive,WITH TUMOR,NA,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,NA,0,NA,NA,NA,0,NA,NA,Stage IIIA,T3,M0,GI.CIN,1
-3.734291246,0.191301384,TCGA-CV-5430-01A,TCGA-CV-5430-01A-02D-1683-08,0,NA,TCGA-CV-5430,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,1999,[Not Available],-22577,Alive,TUMOR FREE,4241,NA,[Not Available],NA,Distant Metastasis,Lung,783,Complete Remission/Response,0,4241,0,4241,NA,NA,1,783,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,10
0.12357092,5.034156714,TCGA-HD-7831-01A,TCGA-HD-7831-01A-11D-2129-08,4,0.478393068,TCGA-HD-7831,HNSC,74,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-27334,Alive,WITH TUMOR,667,NA,[Not Available],Distant Metastasis,Distant Metastasis,Lung,667,Complete Remission/Response,0,667,0,667,NA,NA,1,667,NA,Stage IVA,T2,[Not Available],HNSC.Mesenchymal,6
-4.85453966,1.462205482,TCGA-ET-A39R-01A,TCGA-ET-A39R-01A-11D-A19J-08,0,NA,TCGA-ET-A39R,THCA,24,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2007,[Not Available],-8828,Alive,TUMOR FREE,2863,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2863,0,2863,0,2863,0,2863,NA,Stage I,T1,MX,THCA.2,10
0.187927166,5.353160263,TCGA-BR-6803-01A,TCGA-BR-6803-01A-11D-1882-08,4,0.62351253,TCGA-BR-6803,STAD,54,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-19751,Alive,TUMOR FREE,949,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,949,0,949,0,949,0,949,NA,Stage IIA,T3,M0,GI.GS,6
-2.740705194,-4.350646241,TCGA-B5-A3FC-01A,TCGA-B5-A3FC-01A-11D-A228-09,0,NA,TCGA-B5-A3FC,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19422,Alive,TUMOR FREE,2185,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2185,0,2185,NA,NA,0,2185,NA,Stage II,[Not Applicable],[Not Applicable],NA,10
9.485129578,-4.663327259,TCGA-ET-A40T-01A,TCGA-ET-A40T-01A-11D-A23M-08,1,0.754810381,TCGA-ET-A40T,THCA,26,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-9531,Alive,TUMOR FREE,1140,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1140,0,1140,NA,NA,0,1140,NA,Stage I,T2,MX,THCA.2,1
-1.739692496,2.804504409,TCGA-CV-6953-01A,TCGA-CV-6953-01A-11D-1912-08,0,NA,TCGA-CV-6953,HNSC,80,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,1997,[Not Available],-29465,Dead,WITH TUMOR,NA,1641,[Not Available],Locoregional Recurrence,Oral Cavity,oral tongue,1521,Complete Remission/Response,1,1641,1,1641,1,1521,1,1521,NA,Stage III,T3,[Not Available],HNSC.Basal,6
8.888674759,-5.204979322,TCGA-CE-A27D-01A,TCGA-CE-A27D-01A-11D-A16O-08,1,0.83750088,TCGA-CE-A27D,THCA,28,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-10536,Alive,TUMOR FREE,374,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,374,0,374,0,374,0,374,NA,Stage I,T2,M0,THCA.2,1
-6.323457301,3.505808334,TCGA-MJ-A68H-01A,TCGA-MJ-A68H-01A-11D-A307-09,11,0.169877659,TCGA-MJ-A68H,SARC,57,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2013,[Not Available],-21105,Alive,TUMOR FREE,456,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,456,0,456,0,456,0,456,NA,NA,NA,NA,NA,8
-4.003413866,-1.850414007,TCGA-86-8673-01A,TCGA-86-8673-01A-11D-2393-08,8,0.306812771,TCGA-86-8673,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-22571,Alive,TUMOR FREE,862,NA,[Not Available],Locoregional Recurrence,NA,NA,636,Complete Remission/Response,0,862,0,862,1,636,1,636,NA,Stage IB,T2,M0,NA,10
-7.170109795,-1.968471476,TCGA-BH-A1FU-01A,TCGA-BH-A1FU-01A-11D-A14G-09,0,NA,TCGA-BH-A1FU,BRCA,44,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],1997,[Not Available],-16174,Dead,WITH TUMOR,NA,1688,[Not Available],NA,NA,NA,NA,[Not Available],1,1688,1,1688,NA,NA,1,1688,NA,Stage IA,T1c,M0,BRCA.Normal,2
9.830786685,-4.300252689,TCGA-MO-A47P-01A,TCGA-MO-A47P-01A-11D-A24N-09,1,0.63324387,TCGA-MO-A47P,SARC,37,FEMALE,ASIAN,Dedifferentiated liposarcoma,[Not Available],2012,[Not Available],-13765,Alive,TUMOR FREE,352,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,352,0,352,0,352,0,352,NA,NA,NA,NA,NA,1
2.109172193,1.766656663,TCGA-MJ-A68J-01A,TCGA-MJ-A68J-01A-11D-A307-09,3,0.42392705,TCGA-MJ-A68J,SARC,55,FEMALE,BLACK OR AFRICAN AMERICAN,Myxofibrosarcoma,[Not Available],2012,[Not Available],-20100,Alive,WITH TUMOR,547,NA,[Not Available],New Primary Tumor,"Other, specify",Foot,268,[Not Available],0,547,0,547,NA,NA,1,268,NA,NA,NA,NA,NA,3
-3.439694064,-3.205711486,TCGA-CK-5916-01A,TCGA-CK-5916-01A-11D-1650-10,8,0.573227264,TCGA-CK-5916,COAD,71,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2003,[Not Available],-26024,Dead,WITH TUMOR,NA,643,[Not Available],NA,NA,NA,292,Progressive Disease,1,643,1,643,NA,NA,1,292,NA,Stage I,T1,M0,GI.HM-indel,10
-0.402585457,3.269818025,TCGA-77-6843-01A,TCGA-77-6843-01A-11D-1945-08,4,0.059810954,TCGA-77-6843,LUSC,74,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-27291,Dead,NA,NA,2224,[Not Available],NA,NA,NA,NA,[Not Available],1,2224,NA,2224,NA,NA,0,2224,NA,Stage IIA,T1,M0,NA,6
9.425069894,-4.548657532,TCGA-MJ-A850-01A,TCGA-MJ-A850-01A-11D-A351-09,1,0.749058203,TCGA-MJ-A850,SARC,28,MALE,WHITE,Synovial Sarcoma - Monophasic,[Not Available],2013,[Not Available],-10451,Alive,TUMOR FREE,681,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,681,0,681,NA,NA,0,681,NA,NA,NA,NA,NA,1
8.665674684,-3.579870088,TCGA-D7-6519-01A,TCGA-D7-6519-01A-11D-1800-08,1,0.743193334,TCGA-D7-6519,STAD,64,FEMALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010,[Not Available],-23413,Alive,WITH TUMOR,625,NA,[Not Available],Distant Metastasis,Liver,cervix,429,Progressive Disease,0,625,0,625,NA,NA,1,429,NA,[Discrepancy],T2,M0,GI.CIN,1
-7.37236919,2.048774326,TCGA-BR-7196-01A,TCGA-BR-7196-01A-11D-2053-08,9,0.188882079,TCGA-BR-7196,STAD,64,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-23611,Alive,WITH TUMOR,666,NA,[Not Available],Distant Metastasis,Lung,NA,348,Complete Remission/Response,0,666,0,666,NA,NA,1,348,NA,Stage IV,T3,M1,GI.EBV,7
9.087923285,-4.729065308,TCGA-E8-A416-01A,TCGA-E8-A416-01A-11D-A23M-08,1,0.780851692,TCGA-E8-A416,THCA,51,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-18932,Alive,TUMOR FREE,952,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,952,0,952,0,952,0,952,NA,Stage I,T1b,M0,THCA.1,1
-3.610586399,-2.765244461,TCGA-BR-7703-01A,TCGA-BR-7703-01A-11D-2053-08,8,0.422460291,TCGA-BR-7703,STAD,81,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011,[Not Available],-29711,Alive,TUMOR FREE,1100,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1100,0,1100,0,1100,0,1100,NA,Stage IA,T1b,M0,GI.HM-indel,10
-6.195492724,-1.168173323,TCGA-CV-6952-01A,TCGA-CV-6952-01A-11D-1912-08,7,0.034637364,TCGA-CV-6952,HNSC,65,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,1996,[Not Available],-23892,Dead,TUMOR FREE,NA,185,[Not Available],NA,NA,NA,NA,[Not Available],1,185,0,185,NA,NA,0,185,NA,Stage IVA,T3,[Not Available],HNSC.Basal,2
10.08053799,-1.498440038,TCGA-H2-A3RI-01A,TCGA-H2-A3RI-01A-11D-A21Z-08,1,0.86833042,TCGA-H2-A3RI,THCA,29,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-10956,Alive,[Discrepancy],335,NA,[Not Available],Locoregional Recurrence,Lymph Node Only,NA,279,[Not Available],0,335,0,335,NA,NA,1,279,NA,Stage I,T3,MX,THCA.3,1
-7.339018823,-1.946039786,TCGA-CV-7103-01A,TCGA-CV-7103-01A-21D-2012-08,6,0.059759958,TCGA-CV-7103,HNSC,49,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2000,[Not Available],-18219,Dead,WITH TUMOR,NA,1591,[Not Available],NA,NA,NA,NA,[Not Available],1,1591,1,1591,NA,NA,1,1591,NA,Stage IVA,T2,[Not Available],HNSC.Classical,2
0.067610466,4.909939472,TCGA-CV-7423-01A,TCGA-CV-7423-01A-11D-2078-08,4,0.496329396,TCGA-CV-7423,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,1997,[Not Available],-24071,Dead,NA,NA,3059,[Not Available],NA,NA,NA,NA,[Not Available],1,3059,NA,3059,NA,NA,0,3059,NA,Stage II,T2,[Not Available],HNSC.Basal,6
-7.581012427,2.419107889,TCGA-AX-A3G1-01A,TCGA-AX-A3G1-01A-11D-A228-09,9,0.289730707,TCGA-AX-A3G1,UCEC,84,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31037,Dead,NA,NA,624,[Not Available],NA,NA,NA,NA,[Not Available],1,624,NA,624,NA,NA,0,624,NA,Stage IC,[Not Applicable],[Not Applicable],NA,7
-1.311692631,3.986783893,TCGA-CN-4742-01A,TCGA-CN-4742-01A-02D-1512-08,4,0.040328914,TCGA-CN-4742,HNSC,48,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-17793,Dead,WITH TUMOR,NA,397,[Not Available],NA,NA,NA,NA,Progressive Disease,1,397,1,397,NA,NA,1,397,NA,Stage IVA,T4a,M0,HNSC.Basal,6
-5.676405505,1.669172988,TCGA-MO-A47R-01A,TCGA-MO-A47R-01A-11D-A24N-09,0,NA,TCGA-MO-A47R,SARC,75,FEMALE,ASIAN,Leiomyosarcoma (LMS),[Not Available],2010,[Not Available],-27731,Dead,WITH TUMOR,NA,318,[Not Available],Distant Metastasis,Brain,NA,259,[Not Available],1,318,1,318,1,259,1,259,NA,NA,NA,NA,NA,7
-0.389285991,4.347453871,TCGA-PC-A5DK-01A,TCGA-PC-A5DK-01A-11D-A27P-09,4,0.466783116,TCGA-PC-A5DK,SARC,63,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2004,[Not Available],-23019,Alive,TUMOR FREE,3740,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3740,0,3740,0,3740,0,3740,NA,NA,NA,NA,NA,6
4.43129781,1.108056323,TCGA-N1-A6IA-01A,TCGA-N1-A6IA-01A-12D-A32I-09,2,0.687358873,TCGA-N1-A6IA,SARC,41,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-15112,Dead,WITH TUMOR,NA,224,[Not Available],Distant Metastasis,Lung,NA,116,[Not Available],1,224,1,224,NA,NA,1,116,NA,NA,NA,NA,NA,5
-3.744009546,-2.491029251,TCGA-55-8092-01A,TCGA-55-8092-01A-11D-2238-08,8,0.374152338,TCGA-55-8092,LUAD,75,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27597,Dead,WITH TUMOR,NA,154,[Not Available],Locoregional Recurrence,NA,NA,127,Complete Remission/Response,1,154,1,154,1,127,1,127,NA,Stage IIB,T3,MX,NA,10
1.94241023,1.89815288,TCGA-PC-A5DN-01A,TCGA-PC-A5DN-01A-12D-A27P-09,3,0.442845142,TCGA-PC-A5DN,SARC,77,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2005,[Not Available],-28421,Dead,TUMOR FREE,NA,1175,[Not Available],NA,NA,NA,NA,[Not Available],1,1175,0,1175,NA,NA,0,1175,NA,NA,NA,NA,NA,3
1.627558552,2.005956523,TCGA-HF-7131-01A,TCGA-HF-7131-01A-11D-2053-08,3,0.195445145,TCGA-HF-7131,STAD,NA,FEMALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007,[Not Available],NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,NA,0,NA,0,NA,0,NA,NA,Stage IB,T2b,MX,NA,3
-3.349689976,-3.491258289,TCGA-G4-6302-01A,TCGA-G4-6302-01A-11D-1719-10,8,0.566833751,TCGA-G4-6302,COAD,90,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2006,[Not Available],-32872,Dead,TUMOR FREE,NA,2047,[Not Available],NA,NA,NA,NA,[Not Available],1,2047,0,2047,NA,NA,0,2047,NA,Stage IIA,T3,M0,GI.HM-indel,10
-1.146935142,3.19961064,TCGA-66-2770-01A,TCGA-66-2770-01A-01D-1522-08,4,0.092208541,TCGA-66-2770,LUSC,79,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-28945,Alive,NA,700,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,700,0,700,NA,NA,0,700,NA,Stage IB,T2,M0,LUSC.classical,10
-1.006434599,3.551727816,TCGA-BR-8060-01A,TCGA-BR-8060-01A-11D-2340-08,4,0.245264199,TCGA-BR-8060,STAD,75,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-27561,Dead,TUMOR FREE,NA,348,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,348,0,348,0,348,0,348,NA,Stage IIB,T2,M0,NA,6
9.514576069,-4.701878415,TCGA-EM-A3FQ-01A,TCGA-EM-A3FQ-01A-11D-A21A-08,1,0.778179253,TCGA-EM-A3FQ,THCA,19,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-7176,Alive,WITH TUMOR,492,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,492,0,492,0,492,0,492,NA,Stage I,T3,MX,THCA.2,1
9.856793532,-1.803565405,TCGA-DJ-A3UQ-01A,TCGA-DJ-A3UQ-01A-11D-A22D-08,1,0.840819184,TCGA-DJ-A3UQ,THCA,45,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-16545,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,595,0,595,0,595,0,595,NA,Stage III,T3,M0,THCA.4,1
-8.106499442,2.054651777,TCGA-A8-A096-01A,TCGA-A8-A096-01A-11W-A019-09,9,0.475287861,TCGA-A8-A096,BRCA,73,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26723,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,0,0,0,0,NA,Stage IIA,T2,M0,BRCA.LumB,7
-3.375014448,-3.166335407,TCGA-BR-6852-01A,TCGA-BR-6852-01A-11D-1882-08,8,0.608867384,TCGA-BR-6852,STAD,64,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-23469,Alive,TUMOR FREE,1367,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1367,0,1367,0,1367,0,1367,NA,Stage IIA,T3,M0,GI.HM-indel,10
-3.483215815,-2.999480261,TCGA-F1-6874-01A,TCGA-F1-6874-01A-11D-1882-08,8,0.388026009,TCGA-F1-6874,STAD,79,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-29083,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,440,0,440,0,440,0,440,NA,Stage IB,T2,M0,GI.HM-indel,10
0.345150858,2.329889471,TCGA-IN-7808-01A,TCGA-IN-7808-01A-11D-2201-08,4,0.029545055,TCGA-IN-7808,STAD,59,MALE,WHITE,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011,[Not Available],-21569,Dead,WITH TUMOR,NA,105,[Not Available],NA,NA,NA,NA,Progressive Disease,1,105,1,105,NA,NA,1,105,NA,[Discrepancy],T3,M1,GI.CIN,6
-0.835345162,2.327840629,TCGA-CV-7095-01A,TCGA-CV-7095-01A-21D-2012-08,4,0.058678403,TCGA-CV-7095,HNSC,87,FEMALE,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2001,[Not Available],-32022,Dead,TUMOR FREE,NA,572,[Not Available],NA,NA,NA,NA,[Not Available],1,572,0,572,NA,NA,0,572,NA,Stage II,T2,[Not Available],HNSC.Basal,6
0.108233599,5.206443881,TCGA-CR-7397-01A,TCGA-CR-7397-01A-11D-2012-08,4,0.551750166,TCGA-CR-7397,HNSC,44,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-16351,Alive,TUMOR FREE,754,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,754,0,754,NA,NA,0,754,NA,Stage IVA,T3,M0,HNSC.Mesenchymal,6
-4.038430023,0.985953585,TCGA-CV-6441-01A,TCGA-CV-6441-01A-11D-1683-08,0,NA,TCGA-CV-6441,HNSC,60,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-22025,Dead,WITH TUMOR,NA,292,[Not Available],Locoregional Recurrence,Oral Cavity,pharyngeal,95,Progressive Disease,1,292,1,292,NA,NA,1,95,NA,Stage III,T3,[Not Available],HNSC.Atypical,10
-4.35320111,-1.629640352,TCGA-CN-4727-01A,TCGA-CN-4727-01A-01D-1434-08,8,0.44930382,TCGA-CN-4727,HNSC,56,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-20748,Alive,TUMOR FREE,1560,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1560,0,1560,NA,NA,0,1560,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,10
-3.549257413,-2.902595681,TCGA-62-A46O-01A,TCGA-62-A46O-01A-11D-A24D-08,8,0.503310905,TCGA-62-A46O,LUAD,65,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-24050,Dead,WITH TUMOR,NA,1454,[Not Available],Locoregional Recurrence|Distant Metastasis,NA,NA,943,Complete Remission/Response,1,1454,1,1454,1,943,1,943,NA,Stage IB,T2,M0,NA,10
9.231179882,-5.091347846,TCGA-57-1586-01A,TCGA-57-1586-01A-02W-0633-09,1,0.84091297,TCGA-57-1586,OV,66,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-24304,Alive,WITH TUMOR,679,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],259,[Not Available],0,679,0,679,NA,NA,1,259,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-6.067026208,-1.683141897,TCGA-66-2800-01A,TCGA-66-2800-01A-01D-1267-08,0,NA,TCGA-66-2800,LUSC,70,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2004,[Not Available],-25810,Alive,TUMOR FREE,1492,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,1492,0,1492,NA,NA,0,1492,NA,Stage IIIB,T4,M0,LUSC.classical,2
-0.411405102,4.849911025,TCGA-QC-A6FX-01A,TCGA-QC-A6FX-01A-11D-A32I-09,4,0.506125371,TCGA-QC-A6FX,SARC,68,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-25113,Alive,TUMOR FREE,637,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,637,0,637,0,637,0,637,NA,NA,NA,NA,NA,6
-5.734888558,-2.217695629,TCGA-A2-A0SU-01A,TCGA-A2-A0SU-01A-11D-A099-09,0,NA,TCGA-A2-A0SU,BRCA,66,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24219,Alive,TUMOR FREE,1662,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1662,0,1662,0,1662,0,1662,NA,Stage IIA,T2,M0,BRCA.LumA,2
-3.040813665,-3.90999276,TCGA-QC-A7B5-01A,TCGA-QC-A7B5-01A-11D-A33E-09,8,0.223436536,TCGA-QC-A7B5,SARC,75,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-27556,Alive,TUMOR FREE,398,NA,[Not Available],New Primary Tumor,"Other, specify",skin,259,[Not Available],0,398,0,398,NA,NA,1,259,NA,NA,NA,NA,NA,10
-3.516636141,-2.895797244,TCGA-BR-6566-01A,TCGA-BR-6566-01A-11D-1800-08,8,0.400402807,TCGA-BR-6566,STAD,64,FEMALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011,[Not Available],-23404,Alive,TUMOR FREE,997,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,997,0,997,0,997,0,997,NA,Stage IIA,T3,M0,GI.HM-indel,10
9.766482163,-1.520536397,TCGA-EL-A4K4-01A,TCGA-EL-A4K4-01A-11D-A257-08,1,0.803979915,TCGA-EL-A4K4,THCA,33,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-12368,Alive,WITH TUMOR,1623,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1623,0,1623,0,1623,0,1623,NA,Stage I,T3,M0,THCA.4,1
-3.60386406,-3.006778213,TCGA-HF-7132-01A,TCGA-HF-7132-01A-11D-2053-08,8,0.329663446,TCGA-HF-7132,STAD,NA,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006,[Not Available],NA,Alive,TUMOR FREE,2351,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2351,0,2351,0,2351,0,2351,NA,Stage II,T2b,M0,GI.HM-indel,10
9.987636428,-2.120514896,TCGA-BG-A0MS-01A,TCGA-BG-A0MS-01A-11D-A10B-09,1,0.752769216,TCGA-BG-A0MS,UCEC,53,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19547,Alive,TUMOR FREE,1882,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1882,0,1882,0,1882,0,1882,NA,Stage IIIC1,[Not Applicable],[Not Applicable],NA,1
-0.014703328,4.850827393,TCGA-AZ-6605-01A,TCGA-AZ-6605-01A-11D-1835-10,4,0.583055645,TCGA-AZ-6605,COAD,77,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2008,[Not Available],-28485,Dead,TUMOR FREE,NA,159,[Not Available],NA,NA,NA,NA,Stable Disease,1,159,0,159,NA,NA,0,159,NA,Stage IIIB,T4,M0,GI.CIN,6
9.371775401,-5.822622445,TCGA-CE-A484-01A,TCGA-CE-A484-01A-11D-A23U-08,1,0.772475543,TCGA-CE-A484,THCA,37,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-13815,Alive,TUMOR FREE,378,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,378,0,378,0,378,0,378,NA,Stage I,T2,M0,THCA.1,1
-7.297991499,2.062836678,TCGA-BR-6706-01A,TCGA-BR-6706-01A-11D-1882-08,9,0.27096979,TCGA-BR-6706,STAD,63,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],-23053,Dead,WITH TUMOR,NA,549,[Not Available],Locoregional Recurrence,NA,NA,402,Complete Remission/Response,1,549,1,549,1,402,1,402,NA,Stage IIIA,T3,M0,GI.EBV,7
-5.650613447,-2.28489737,TCGA-CQ-6225-01A,TCGA-CQ-6225-01A-11D-1912-08,0,NA,TCGA-CQ-6225,HNSC,65,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-23988,Dead,NA,NA,403,[Not Available],NA,Oral Cavity,NA,180,Persistent Disease,1,403,NA,403,NA,NA,1,180,NA,Stage III,T3,[Not Available],HNSC.Atypical,2
9.973280203,-1.441456501,TCGA-E8-A3X7-01A,TCGA-E8-A3X7-01A-11D-A22Z-08,1,0.884249496,TCGA-E8-A3X7,THCA,57,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-20983,Alive,TUMOR FREE,951,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,951,0,951,NA,NA,0,951,NA,Stage IVA,T4a,M0,THCA.4,1
-2.019150841,1.312432561,TCGA-BA-5555-01A,TCGA-BA-5555-01A-01D-1512-08,5,0.620927401,TCGA-BA-5555,HNSC,54,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-19956,Alive,TUMOR FREE,520,NA,[Not Available],NA,Oropharynx,L tonsil,248,Complete Remission/Response,0,520,0,520,NA,NA,1,248,NA,Stage IVA,T3,[Not Available],HNSC.Atypical,4
-6.148793512,3.41773175,TCGA-CQ-7068-01A,TCGA-CQ-7068-01A-11D-2078-08,11,0.560005848,TCGA-CQ-7068,HNSC,80,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-29530,Alive,TUMOR FREE,1309,NA,[Not Available],New Primary Tumor,Oral Cavity,left buccal mucosa,1148,Complete Remission/Response,0,1309,0,1309,0,1309,1,1148,NA,Stage II,T2,[Not Available],HNSC.Basal,8
8.169444429,-3.244127713,TCGA-CR-7372-01A,TCGA-CR-7372-01A-11D-2012-08,1,0.53711759,TCGA-CR-7372,HNSC,45,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2009,[Not Available],-16610,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,759,0,759,0,759,0,759,NA,Stage I,T1,M0,HNSC.Basal,1
-5.339133764,1.08679529,TCGA-CV-7421-01A,TCGA-CV-7421-01A-11D-2078-08,0,NA,TCGA-CV-7421,HNSC,76,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1997,[Not Available],-27961,Dead,NA,NA,2,[Not Available],NA,NA,NA,NA,[Not Available],1,2,NA,2,NA,NA,0,2,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,10
-1.606904956,0.934229108,TCGA-QQ-A5V2-01A,TCGA-QQ-A5V2-01A-11D-A32I-09,5,0.449344742,TCGA-QQ-A5V2,SARC,42,MALE,WHITE,Giant cell 'MFH' / Undifferentiated pleomorphic sarcoma with giant cells,[Not Available],2006,[Not Available],-15420,Alive,NA,56,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,56,0,56,NA,NA,0,56,NA,NA,NA,NA,NA,1
-1.678818378,4.143741687,TCGA-QQ-A5VA-01A,TCGA-QQ-A5VA-01A-12D-A32I-09,0,NA,TCGA-QQ-A5VA,SARC,60,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],1996,[Not Available],-22231,Dead,WITH TUMOR,NA,550,[Not Available],NA,NA,NA,NA,[Not Available],1,550,1,550,NA,NA,1,550,NA,NA,NA,NA,NA,6
-7.802286838,-2.356922187,TCGA-CR-6473-01A,TCGA-CR-6473-01A-11D-1870-08,6,0.443230443,TCGA-CR-6473,HNSC,68,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-24857,Alive,TUMOR FREE,1125,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1125,0,1125,NA,NA,0,1125,NA,[Not Available],[Not Available],[Not Available],HNSC.Atypical,2
-7.346536859,-2.10955441,TCGA-CV-6950-01A,TCGA-CV-6950-01A-11D-1912-08,6,0.409089472,TCGA-CV-6950,HNSC,64,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1994,[Not Available],-23549,Dead,WITH TUMOR,NA,459,[Not Available],Locoregional Recurrence,Oral Cavity,Tonsil,258,Complete Remission/Response,1,459,1,459,NA,NA,1,258,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,2
-0.355788348,4.766147247,TCGA-QQ-A5V9-01A,TCGA-QQ-A5V9-01A-11D-A32I-09,4,0.518125125,TCGA-QQ-A5V9,SARC,76,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],1997,[Not Available],-27977,Dead,WITH TUMOR,NA,1424,[Not Available],Distant Metastasis,Lung,NA,405,[Not Available],1,1424,1,1424,1,405,1,405,NA,NA,NA,NA,NA,6
-5.205944308,-1.858737487,TCGA-64-1679-01A,TCGA-64-1679-01A-21D-2063-08,0,NA,TCGA-64-1679,LUAD,58,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2007,[Not Available],-21310,Alive,TUMOR FREE,2488,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2488,0,2488,0,2488,0,2488,NA,Stage IIIA,T1,M0,LUAD.5,10
2.082891699,1.801600117,TCGA-QQ-A5VB-01A,TCGA-QQ-A5VB-01A-11D-A36J-09,3,0.497666904,TCGA-QQ-A5VB,SARC,53,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],1994,[Not Available],-19654,Dead,WITH TUMOR,NA,1478,[Not Available],Locoregional Recurrence,"Other, specify",Left Pelvis,111,[Not Available],1,1478,1,1478,NA,NA,1,111,NA,NA,NA,NA,NA,3
9.97455652,-1.430572242,TCGA-J8-A3NZ-01A,TCGA-J8-A3NZ-01A-11D-A21A-08,1,0.846274245,TCGA-J8-A3NZ,THCA,52,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-19058,Alive,TUMOR FREE,524,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,524,0,524,0,524,0,524,NA,Stage III,T3,M0,THCA.3,1
-3.882526119,-2.376302998,TCGA-D1-A17H-01A,TCGA-D1-A17H-01A-11D-A12J-09,8,0.356337848,TCGA-D1-A17H,UCEC,61,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22389,Alive,TUMOR FREE,852,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,852,0,852,0,852,0,852,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-7.882958675,1.869168514,TCGA-EW-A1IX-01A,TCGA-EW-A1IX-01A-12D-A142-09,9,0.645064752,TCGA-EW-A1IX,BRCA,48,FEMALE,ASIAN,"Other, specify",[Not Available],2008,Peri (6-12 months since last menstrual period),-17597,Alive,TUMOR FREE,1208,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1208,0,1208,0,1208,0,1208,NA,Stage IIA,T1b,MX,BRCA.LumA,7
9.648626265,-1.884920014,TCGA-E8-A2JQ-01A,TCGA-E8-A2JQ-01A-11D-A19J-08,1,0.798949056,TCGA-E8-A2JQ,THCA,18,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-6684,Alive,TUMOR FREE,356,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,356,0,356,NA,NA,0,356,NA,Stage I,T3,M0,THCA.4,1
0.214681511,5.18761956,TCGA-CQ-7065-01A,TCGA-CQ-7065-01A-11D-2078-08,4,0.580594566,TCGA-CQ-7065,HNSC,40,MALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-14676,Alive,TUMOR FREE,1628,NA,[Not Available],NA,Oral Cavity,NA,230,Complete Remission/Response,0,1628,0,1628,1,230,1,230,NA,Stage II,T2,[Not Available],HNSC.Basal,6
-7.196696654,-2.614773233,TCGA-CN-4730-01A,TCGA-CN-4730-01A-01D-1434-08,6,0.081936318,TCGA-CN-4730,HNSC,62,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-22828,Alive,TUMOR FREE,817,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,817,0,817,NA,NA,0,817,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,2
-7.462980079,2.418700485,TCGA-D1-A16R-01A,TCGA-D1-A16R-01A-11D-A12J-09,9,0.095037534,TCGA-D1-A16R,UCEC,39,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Indeterminate (neither Pre or Postmenopausal),-14465,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,21,0,21,0,21,0,21,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-7.764947739,-2.478772544,TCGA-CV-7413-01A,TCGA-CV-7413-01A-11D-2078-08,6,0.379240036,TCGA-CV-7413,HNSC,74,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1995,[Not Available],-27231,Dead,NA,NA,294,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,294,NA,294,0,294,0,294,NA,Stage II,T2,[Not Available],HNSC.Mesenchymal,2
1.09433679,2.235185005,TCGA-QQ-A8VB-01A,TCGA-QQ-A8VB-01A-11D-A37C-09,0,NA,TCGA-QQ-A8VB,SARC,68,FEMALE,WHITE,Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],1998,[Not Available],-24916,Alive,TUMOR FREE,5723,NA,[Not Available],New Primary Tumor,"Other, specify",gastrointestinal,2682,[Not Available],0,5723,0,5723,NA,NA,1,2682,NA,NA,NA,NA,NA,3
8.731171426,-3.434536228,TCGA-QQ-A8VD-01A,TCGA-QQ-A8VD-01A-42D-A38Z-09,1,0.731286692,TCGA-QQ-A8VD,SARC,56,MALE,WHITE,Desmoid Tumor,[Not Available],2003,[Not Available],-20729,Alive,WITH TUMOR,3964,NA,[Not Available],Locoregional Recurrence,"Other, specify",left abdominal wall,499,[Not Available],0,3964,0,3964,NA,NA,1,499,NA,NA,NA,NA,NA,1
9.806101225,-3.951457892,TCGA-QQ-A5VC-01A,TCGA-QQ-A5VC-01A-31D-A32I-09,1,0.729692527,TCGA-QQ-A5VC,SARC,63,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-23357,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1092,0,1092,0,1092,0,1092,NA,NA,NA,NA,NA,1
-4.877447817,1.916776217,TCGA-39-5029-01A,TCGA-39-5029-01A-01D-1441-08,0,NA,TCGA-39-5029,LUSC,67,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-24713,Dead,WITH TUMOR,NA,740,[Not Available],NA,NA,NA,491,Stable Disease,1,740,1,740,NA,NA,1,491,NA,Stage IIIA,T1b,M0,LUSC.basal,6
-3.952376731,-2.144130193,TCGA-78-7539-01A,TCGA-78-7539-01A-11D-2063-08,8,0.356169992,TCGA-78-7539,LUAD,75,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-27445,Alive,NA,791,NA,[Not Available],Distant Metastasis,NA,NA,688,Complete Remission/Response,0,791,0,791,1,688,1,688,NA,Stage IIA,T2b,M0,LUAD.3,10
-3.363084907,-3.141927299,TCGA-QQ-A8VF-01A,TCGA-QQ-A8VF-01A-11D-A37C-09,8,0.624207741,TCGA-QQ-A8VF,SARC,70,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2005,[Not Available],-25682,Alive,TUMOR FREE,3406,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3406,0,3406,NA,NA,0,3406,NA,NA,NA,NA,NA,10
9.947229707,-1.463282701,TCGA-FY-A40K-01A,TCGA-FY-A40K-01A-11D-A23M-08,1,0.854029582,TCGA-FY-A40K,THCA,46,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-17092,Alive,TUMOR FREE,461,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,461,0,461,0,461,0,461,NA,Stage I,T1a,MX,THCA.5,1
-7.357499495,-2.415705173,TCGA-E2-A150-01A,TCGA-E2-A150-01A-11D-A12B-09,6,0.393725201,TCGA-E2-A150,BRCA,48,FEMALE,WHITE,Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17580,Alive,TUMOR FREE,1935,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1935,0,1935,0,1935,0,1935,NA,Stage IIA,T2,M0,BRCA.Basal,2
-7.843784966,2.187419103,TCGA-B5-A0K1-01A,TCGA-B5-A0K1-01A-11W-A062-09,9,0.319894979,TCGA-B5-A0K1,UCEC,69,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25291,Alive,TUMOR FREE,1110,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1110,0,1110,0,1110,0,1110,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-4.204686511,-1.583111403,TCGA-QQ-A8VG-01A,TCGA-QQ-A8VG-01A-11D-A37C-09,8,0.253348844,TCGA-QQ-A8VG,SARC,52,MALE,WHITE,Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2009,[Not Available],-19304,Dead,WITH TUMOR,NA,1970,[Not Available],New Primary Tumor,Liver,NA,1852,[Not Available],1,1970,1,1970,NA,NA,1,1852,NA,NA,NA,NA,NA,10
-0.575505112,4.019105085,TCGA-CV-5439-01A,TCGA-CV-5439-01A-01D-1683-08,4,0.386367062,TCGA-CV-5439,HNSC,62,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2002,[Not Available],-22686,Dead,WITH TUMOR,546,546,[Not Available],NA,Oropharynx,NA,211,[Not Available],1,546,1,546,NA,NA,1,211,NA,Stage IVA,T3,[Not Available],HNSC.Basal,5
-5.301166778,1.660949564,TCGA-H7-8501-01A,TCGA-H7-8501-01A-11D-2394-08,0,NA,TCGA-H7-8501,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,GX,2012,[Not Available],-19808,Alive,TUMOR FREE,461,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,461,0,461,NA,NA,0,461,NA,Stage IVA,T4a,M0,NA,9
-0.001262896,5.120678509,TCGA-BA-5557-01A,TCGA-BA-5557-01A-01D-1512-08,4,0.603446251,TCGA-BA-5557,HNSC,41,FEMALE,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-15247,Alive,TUMOR FREE,623,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,623,0,623,NA,NA,0,623,NA,Stage III,T1,[Not Available],HNSC.Basal,6
9.57705431,-4.328182765,TCGA-RN-AAAQ-01A,TCGA-RN-AAAQ-01A-21D-A38Z-09,1,0.697268929,TCGA-RN-AAAQ,SARC,52,MALE,WHITE,Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2013,[Not Available],-19123,Alive,WITH TUMOR,510,NA,[Not Available],Locoregional Recurrence,"Other, specify",Left Shoulder,307,[Not Available],0,510,0,510,NA,NA,1,307,NA,NA,NA,NA,NA,1
-0.142573108,4.789307884,TCGA-SG-A6Z4-01A,TCGA-SG-A6Z4-01A-22D-A33E-09,4,0.57766629,TCGA-SG-A6Z4,SARC,47,MALE,WHITE,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,[Not Available],2013,[Not Available],-17368,Alive,WITH TUMOR,576,NA,[Not Available],Distant Metastasis,Lung,NA,105,[Not Available],0,576,0,576,NA,NA,1,105,NA,NA,NA,NA,NA,6
0.04675868,5.156946657,TCGA-QQ-A8VH-01A,TCGA-QQ-A8VH-01A-11D-A37C-09,4,0.64435176,TCGA-QQ-A8VH,SARC,31,FEMALE,WHITE,Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2010,[Not Available],-11599,Dead,WITH TUMOR,NA,320,[Not Available],Locoregional Recurrence,"Other, specify",Spine T6 to apical lung,197,[Not Available],1,320,1,320,NA,NA,1,197,NA,NA,NA,NA,NA,6
1.213314301,2.216541354,TCGA-CN-6988-01A,TCGA-CN-6988-01A-11D-1912-08,0,NA,TCGA-CN-6988,HNSC,47,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-17308,Alive,TUMOR FREE,318,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,318,0,318,NA,NA,0,318,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,3
8.678961285,-4.878157726,TCGA-SG-A6Z7-01A,TCGA-SG-A6Z7-01A-12D-A32I-09,1,0.802505939,TCGA-SG-A6Z7,SARC,44,FEMALE,WHITE,Dedifferentiated liposarcoma,[Not Available],2004,[Not Available],-16188,Dead,TUMOR FREE,NA,118,[Not Available],NA,NA,NA,NA,[Not Available],1,118,0,118,NA,NA,0,118,NA,NA,NA,NA,NA,1
-1.584268068,2.818065852,TCGA-66-2777-01A,TCGA-66-2777-01A-01D-1267-08,4,0.028230679,TCGA-66-2777,LUSC,71,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-26085,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,61,0,61,NA,NA,0,61,NA,Stage IB,T2,M0,LUSC.secretory,6
-4.235765456,-2.029302012,TCGA-AP-A0LG-01A,TCGA-AP-A0LG-01A-11W-A062-09,8,0.477069287,TCGA-AP-A0LG,UCEC,54,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20047,Alive,TUMOR FREE,2015,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2015,0,2015,0,2015,0,2015,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-6.665796784,1.790940392,TCGA-A8-A08F-01A,TCGA-A8-A08F-01A-11W-A019-09,10,0.015993533,TCGA-A8-A08F,BRCA,59,FEMALE,[Not Available],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21641,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1004,0,1004,0,1004,0,1004,NA,Stage IIIC,T2,M0,NA,6
2.008226605,1.859837703,TCGA-A3-3367-01A,TCGA-A3-3367-01A-02D-1421-08,3,0.588842966,TCGA-A3-3367,KIRC,72,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-26489,Alive,TUMOR FREE,2270,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2270,0,2270,0,2270,0,2270,NA,Stage I,T1b,M0,KIRC.1,3
-4.311747333,-0.551490488,TCGA-CV-6936-01A,TCGA-CV-6936-01A-11D-1912-08,0,NA,TCGA-CV-6936,HNSC,68,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2004,[Not Available],-25020,Dead,WITH TUMOR,NA,166,[Not Available],Locoregional Recurrence,Oral Cavity,mandibular,157,Progressive Disease,1,166,1,166,NA,NA,1,157,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,10
0.241431849,2.148729854,TCGA-CV-7091-01A,TCGA-CV-7091-01A-11D-2012-08,0,NA,TCGA-CV-7091,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2001,[Not Available],-19938,Alive,TUMOR FREE,3381,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3381,0,3381,NA,NA,0,3381,NA,Stage I,T1,[Not Available],HNSC.Basal,6
-0.341247124,4.732346515,TCGA-D6-6826-01A,TCGA-D6-6826-01A-11D-1912-08,4,0.547009266,TCGA-D6-6826,HNSC,64,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-23722,Dead,TUMOR FREE,NA,348,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,348,0,348,NA,NA,0,348,NA,Stage IVA,T4a,[Not Available],HNSC.Mesenchymal,6
0.200573904,4.270205872,TCGA-CN-4738-01A,TCGA-CN-4738-01A-02D-1512-08,4,0.494870611,TCGA-CN-4738,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-19621,Dead,NA,NA,436,[Not Available],NA,NA,NA,NA,[Not Available],1,436,NA,436,NA,NA,0,436,NA,Stage IVA,T4a,M0,HNSC.Atypical,6
4.348483622,1.193895112,TCGA-CR-6477-01A,TCGA-CR-6477-01A-11D-1870-08,2,0.580040422,TCGA-CR-6477,HNSC,56,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-20815,Alive,TUMOR FREE,514,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,514,0,514,NA,NA,0,514,NA,[Not Available],[Not Available],[Not Available],HNSC.Mesenchymal,5
-4.803118093,1.899691827,TCGA-CQ-5333-01A,TCGA-CQ-5333-01A-01D-2394-08,0,NA,TCGA-CQ-5333,HNSC,74,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2008,[Not Available],-27110,Dead,WITH TUMOR,NA,341,[Not Available],NA,Oropharynx,NA,176,Complete Remission/Response,1,341,1,341,1,176,1,176,NA,Stage II,T2,[Not Available],NA,9
-7.876321784,-2.407519253,TCGA-SI-AA8B-01A,TCGA-SI-AA8B-01A-11D-A387-09,6,0.404301485,TCGA-SI-AA8B,SARC,80,FEMALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013,[Not Available],-29315,Dead,WITH TUMOR,NA,262,[Not Available],NA,NA,NA,NA,[Not Available],1,262,1,262,NA,NA,1,262,NA,NA,NA,NA,NA,2
4.62902705,0.949462506,TCGA-SI-A71O-01A,TCGA-SI-A71O-01A-12D-A33E-09,2,0.633343546,TCGA-SI-A71O,SARC,29,MALE,WHITE,Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2013,[Not Available],-10710,Dead,WITH TUMOR,NA,694,[Not Available],Distant Metastasis,Lung,NA,264,[Not Available],1,694,1,694,NA,NA,1,264,NA,NA,NA,NA,NA,5
8.908562044,-5.614981179,TCGA-SI-A71P-01A,TCGA-SI-A71P-01A-12D-A33E-09,1,0.677340763,TCGA-SI-A71P,SARC,50,MALE,WHITE,Malignant Peripheral Nerve Sheath Tumors (MPNST),[Not Available],2012,[Not Available],-18367,Alive,TUMOR FREE,771,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,771,0,771,NA,NA,0,771,NA,NA,NA,NA,NA,1
-0.438890743,5.091373386,TCGA-09-1673-01A,TCGA-09-1673-01A-01W-0633-09,4,0.560300129,TCGA-09-1673,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-18599,Alive,WITH TUMOR,92,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,92,0,92,NA,NA,0,92,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
-6.368985366,1.774839981,TCGA-22-4607-01A,TCGA-22-4607-01A-01D-1267-08,10,0.166142047,TCGA-22-4607,LUSC,75,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-27601,Dead,TUMOR FREE,587,587,[Not Available],NA,NA,NA,NA,[Not Available],1,587,0,587,NA,NA,0,587,NA,Stage IB,T2a,M0,LUSC.basal,7
1.095785522,3.556836601,TCGA-KK-A7AU-01A,TCGA-KK-A7AU-01A-11D-A32B-08,0,NA,TCGA-KK-A7AU,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-23118,Alive,TUMOR FREE,1775,NA,[Not Available],Biochemical evidence of disease,NA,NA,207,Progressive Disease,0,1775,0,1775,NA,NA,1,207,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,6
-4.426838065,-1.950116259,TCGA-EW-A1J5-01A,TCGA-EW-A1J5-01A-11D-A13L-09,8,0.378375388,TCGA-EW-A1J5,BRCA,59,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21559,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,477,0,477,0,477,0,477,NA,Stage IIB,T3,M0,BRCA.LumA,10
2.093202927,1.798263014,TCGA-KK-A7AQ-01A,TCGA-KK-A7AQ-01A-11D-A33T-08,3,0.52246228,TCGA-KK-A7AQ,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-22731,Alive,TUMOR FREE,1610,NA,[Not Available],Biochemical evidence of disease,NA,NA,1217,Complete Remission/Response,0,1610,0,1610,1,1217,1,1217,NA,[Not Applicable],T2c,[Not Applicable],NA,3
-1.11978629,3.106212055,TCGA-AX-A1CK-01A,TCGA-AX-A1CK-01A-11D-A135-09,4,0.081496573,TCGA-AX-A1CK,UCEC,58,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21200,Alive,WITH TUMOR,2441,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2441,0,2441,NA,NA,0,2441,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,5
9.658296996,-2.094084894,TCGA-BR-4294-01A,TCGA-BR-4294-01A-01D-1126-08,1,0.782990731,TCGA-BR-4294,STAD,65,MALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009,[Not Available],-23758,Alive,NA,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,[Not Available],T2a,M0,GI.CIN,1
9.070579174,-2.030435941,TCGA-CG-4477-01A,TCGA-CG-4477-01A-01D-1158-08,1,0.669426973,TCGA-CG-4477,STAD,58,FEMALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-21427,Alive,WITH TUMOR,942,NA,[Not Available],NA,NA,NA,365,Progressive Disease,0,942,0,942,NA,NA,1,365,NA,Stage IB,T2a,M0,GI.CIN,1
-2.836337906,-4.200314556,TCGA-CG-5721-01A,TCGA-CG-5721-01A-11D-1600-08,0,NA,TCGA-CG-5721,STAD,58,MALE,[Not Available],"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005,[Not Available],-21244,Alive,TUMOR FREE,183,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,183,0,183,NA,NA,0,183,NA,Stage IV,T4,M0,GI.HM-indel,10
-7.44022619,-2.240423091,TCGA-CG-5725-01A,TCGA-CG-5725-01A-11D-1600-08,6,0.338208682,TCGA-CG-5725,STAD,72,MALE,[Not Available],"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005,[Not Available],-26329,Dead,WITH TUMOR,NA,457,[Not Available],NA,NA,NA,153,Progressive Disease,1,457,1,457,NA,NA,1,153,NA,Stage IB,T2,M0,NA,2
-8.25272355,1.937937943,TCGA-RR-A6KA-01A,TCGA-RR-A6KA-01A-21D-A33T-08,9,0.604913319,TCGA-RR-A6KA,GBM,72,FEMALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-26582,Dead,WITH TUMOR,NA,191,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,191,1,191,NA,NA,1,191,NA,NA,NA,NA,NA,7
-7.910876395,2.173031692,TCGA-RR-A6KC-01A,TCGA-RR-A6KC-01A-31D-A33T-08,9,0.330374009,TCGA-RR-A6KC,GBM,55,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2010,[Not Available],-20302,Dead,NA,NA,625,[Not Available],Recurrence,[Not Applicable],[Not Applicable],369,Complete Remission/Response,1,625,NA,625,1,369,1,369,NA,NA,NA,NA,NA,7
-4.944132172,1.973979867,TCGA-06-A5U0-01A,TCGA-06-A5U0-01A-11D-A33T-08,0,NA,TCGA-06-A5U0,GBM,21,FEMALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-7958,Alive,WITH TUMOR,815,NA,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],100,Progressive Disease,0,815,0,815,NA,NA,1,100,NA,NA,NA,NA,NA,8
0.336649044,3.436867198,TCGA-BR-8077-01A,TCGA-BR-8077-01A-11D-2340-08,4,0.25382684,TCGA-BR-8077,STAD,58,FEMALE,WHITE,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-21413,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,21,0,21,0,21,0,21,NA,Stage IIIB,T4b,M0,GI.CIN,3
9.247274392,-5.592998699,TCGA-06-A7TK-01A,TCGA-06-A7TK-01A-21D-A391-08,1,0.797178053,TCGA-06-A7TK,GBM,64,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2013,[Not Available],-23674,Dead,WITH TUMOR,NA,444,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],342,Progressive Disease,1,444,1,444,NA,NA,1,342,NA,NA,NA,NA,NA,1
8.606107354,-5.094177858,TCGA-19-A60I-01A,TCGA-19-A60I-01A-12D-A33T-08,1,0.794854148,TCGA-19-A60I,GBM,39,MALE,BLACK OR AFRICAN AMERICAN,Glioblastoma Multiforme (GBM),[Not Available],2012,[Not Available],-14437,Alive,WITH TUMOR,541,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,541,0,541,NA,NA,0,541,NA,NA,NA,NA,NA,1
8.781109655,-4.152268467,TCGA-BR-4187-01A,TCGA-BR-4187-01A-01D-1126-08,1,0.704429722,TCGA-BR-4187,STAD,56,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008,[Not Available],-20635,Dead,NA,NA,141,[Not Available],NA,NA,NA,NA,[Not Available],1,141,NA,141,NA,NA,0,141,NA,[Not Available],TX,M0,GI.GS,1
0.204082963,3.391394859,TCGA-FP-7735-01A,TCGA-FP-7735-01A-11D-2053-08,4,0.35921103,TCGA-FP-7735,STAD,77,MALE,BLACK OR AFRICAN AMERICAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-28232,Dead,TUMOR FREE,NA,106,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,106,0,106,0,106,0,106,NA,Stage IB,T2,MX,GI.CIN,3
9.364862137,-4.918357564,TCGA-ET-A3DV-01A,TCGA-ET-A3DV-01A-12D-A202-08,1,0.817249893,TCGA-ET-A3DV,THCA,68,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2001,[Not Available],-24905,Alive,TUMOR FREE,5068,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,5068,0,5068,0,5068,0,5068,NA,Stage II,T3,MX,THCA.1,1
-0.354772732,4.624450434,TCGA-75-6207-01A,TCGA-75-6207-01A-11D-1753-08,4,0.463578637,TCGA-75-6207,LUAD,NA,MALE,[Not Available],Lung Adenocarcinoma,[Not Available],2007,[Not Available],NA,Dead,NA,NA,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,NA,NA,NA,0,NA,0,NA,NA,Stage IIIA,T2,M0,LUAD.3,6
10.23478686,-1.355896013,TCGA-EM-A3SU-01A,TCGA-EM-A3SU-01A-11D-A22Z-08,1,0.796873457,TCGA-EM-A3SU,THCA,43,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-15768,Alive,TUMOR FREE,911,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,911,0,911,0,911,0,911,NA,Stage I,T2,MX,THCA.4,1
-6.265491979,1.559411715,TCGA-E9-A1N5-01A,TCGA-E9-A1N5-01A-11D-A14G-09,10,0.293402723,TCGA-E9-A1N5,BRCA,45,FEMALE,WHITE,Mixed Histology (please specify),[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16736,Alive,TUMOR FREE,1120,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1120,0,1120,0,1120,0,1120,NA,Stage IIB,T2,M0,BRCA.LumA,7
-3.470748779,-2.861031621,TCGA-FS-A1ZN-01A,TCGA-FS-A1ZN-01A-11D-A197-08,8,0.390298173,TCGA-FS-A1ZN,SKCM,43,MALE,WHITE,NA,[Not Available],2002,[Not Available],-15890,Dead,WITH TUMOR,NA,730,[Not Available],NA,NA,NA,361,[Not Available],1,730,1,730,NA,NA,1,361,NA,Stage IIIA,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
10.01062627,-1.831151356,TCGA-CD-5803-01A,TCGA-CD-5803-01A-11D-1600-08,1,0.799634315,TCGA-CD-5803,STAD,78,FEMALE,ASIAN,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010,[Not Available],-28608,Dead,WITH TUMOR,NA,341,[Not Available],Distant Metastasis,Liver,NA,300,Progressive Disease,1,341,1,341,NA,NA,1,300,NA,Stage II,T3,M0,GI.CIN,1
0.970675376,2.108388948,TCGA-EM-A3AQ-01A,TCGA-EM-A3AQ-01A-11D-A20C-08,0,NA,TCGA-EM-A3AQ,THCA,85,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-31198,Alive,TUMOR FREE,904,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,904,0,904,0,904,0,904,NA,Stage I,T1b,MX,THCA.5,3
0.295394606,2.344145144,TCGA-IP-7968-01A,TCGA-IP-7968-01A-11D-2201-08,4,0.11516626,TCGA-IP-7968,STAD,74,MALE,WHITE,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011,[Not Available],-27114,Alive,TUMOR FREE,77,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,77,0,77,NA,NA,0,77,NA,Stage IIIB,T3,MX,GI.CIN,6
-0.754856348,3.769589664,TCGA-C8-A12Z-01A,TCGA-C8-A12Z-01A-11D-A10Y-09,4,0.306427706,TCGA-C8-A12Z,BRCA,45,FEMALE,ASIAN,Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-16508,Alive,TUMOR FREE,382,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,382,0,382,0,382,0,382,NA,Stage IIB,T2,M0,BRCA.Her2,5
-6.896513447,-2.081971907,TCGA-CV-5440-01A,TCGA-CV-5440-01A-01D-1512-08,6,0.179870021,TCGA-CV-5440,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2002,[Not Available],-19197,Alive,TUMOR FREE,3270,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3270,0,3270,NA,NA,0,3270,NA,Stage IVA,T4a,[Not Available],HNSC.Classical,2
9.90566005,-1.529069418,TCGA-55-8513-01A,TCGA-55-8513-01A-11D-2393-08,1,0.834138894,TCGA-55-8513,LUAD,77,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-28284,Alive,WITH TUMOR,791,NA,[Not Available],Distant Metastasis,NA,NA,317,Complete Remission/Response,0,791,0,791,1,317,1,317,NA,Stage IIB,T3,MX,NA,1
9.052930008,-2.791722221,TCGA-CR-7389-01A,TCGA-CR-7389-01A-11D-2012-08,1,0.691061163,TCGA-CR-7389,HNSC,55,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-20169,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,392,0,392,0,392,0,392,NA,[Not Available],TX,[Not Available],HNSC.Atypical,1
9.873704201,-1.341737414,TCGA-EM-A2CS-01A,TCGA-EM-A2CS-01A-11D-A19J-08,1,0.845716451,TCGA-EM-A2CS,THCA,51,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-18990,Alive,WITH TUMOR,841,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,841,0,841,NA,NA,0,841,NA,Stage IVA,T3,MX,THCA.5,1
-6.390804355,-1.9750236,TCGA-CV-7102-01A,TCGA-CV-7102-01A-11D-2012-08,0,NA,TCGA-CV-7102,HNSC,76,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2000,[Not Available],-27805,Dead,NA,NA,56,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,56,NA,56,NA,NA,0,56,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,2
-6.111455362,3.634928701,TCGA-EM-A3OB-01A,TCGA-EM-A3OB-01A-11D-A21Z-08,11,0.291420426,TCGA-EM-A3OB,THCA,33,FEMALE,[Unknown],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-12282,Alive,TUMOR FREE,1176,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1176,0,1176,0,1176,0,1176,NA,Stage I,T2,MX,THCA.1,8
-2.934379653,2.053975108,TCGA-F7-7848-01A,TCGA-F7-7848-01A-11D-2129-08,0,NA,TCGA-F7-7848,HNSC,47,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-17251,Alive,TUMOR FREE,1131,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1131,0,1131,NA,NA,0,1131,NA,Stage IVA,T4a,M0,HNSC.Atypical,10
-3.02121376,-3.902231001,TCGA-D1-A16X-01A,TCGA-D1-A16X-01A-11D-A12J-09,8,0.231382858,TCGA-D1-A16X,UCEC,54,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19799,Alive,TUMOR FREE,111,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,111,0,111,0,111,0,111,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.POLE,10
10.0551997,-2.033469472,TCGA-DJ-A2Q3-01A,TCGA-DJ-A2Q3-01A-11D-A18F-08,1,0.789941987,TCGA-DJ-A2Q3,THCA,61,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2011,[Not Available],-22637,Alive,TUMOR FREE,1224,NA,[Not Available],New Primary Tumor,Lung,NA,385,[Not Available],0,1224,0,1224,0,1224,1,385,NA,Stage III,T3,M0,THCA.4,1
-6.150746767,3.582203719,TCGA-78-7160-01A,TCGA-78-7160-01A-11D-2036-08,11,0.39051428,TCGA-78-7160,LUAD,61,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2008,[Not Available],-22385,Dead,NA,NA,697,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,697,NA,697,NA,NA,0,697,NA,Stage IV,T4,M1,LUAD.6,8
-3.903317175,-2.501340269,TCGA-B5-A0JR-01A,TCGA-B5-A0JR-01A-13W-A062-09,8,0.450152868,TCGA-B5-A0JR,UCEC,73,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26814,Alive,TUMOR FREE,1731,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1731,0,1731,0,1731,0,1731,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-5.989498371,3.492043123,TCGA-FY-A3R9-01A,TCGA-FY-A3R9-01A-11D-A21Z-08,11,0.549514638,TCGA-FY-A3R9,THCA,66,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-24215,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,504,0,504,0,504,0,504,NA,Stage I,T1a,MX,THCA.1,8
-1.541380468,2.951751922,TCGA-CV-6933-01A,TCGA-CV-6933-01A-11D-1912-08,4,0.021172085,TCGA-CV-6933,HNSC,53,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,1998,[Not Available],-19518,Dead,TUMOR FREE,NA,2741,[Not Available],NA,NA,NA,NA,[Not Available],1,2741,0,2741,NA,NA,0,2741,NA,Stage III,T3,[Not Available],HNSC.Classical,10
-5.861467192,-0.569526106,TCGA-CQ-5331-01A,TCGA-CQ-5331-01A-02D-1870-08,0,NA,TCGA-CQ-5331,HNSC,73,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-26901,Alive,TUMOR FREE,1399,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1399,0,1399,NA,NA,0,1399,NA,[Not Available],T2,[Not Available],HNSC.Basal,9
10.04530203,-2.3663724,TCGA-CV-6939-01A,TCGA-CV-6939-01A-11D-1912-08,1,0.66049027,TCGA-CV-6939,HNSC,60,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,1994,[Not Available],-21947,Dead,WITH TUMOR,NA,666,[Not Available],NA,NA,NA,NA,[Not Available],1,666,1,666,NA,NA,1,666,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,1
10.20373765,-1.527681416,TCGA-E8-A414-01A,TCGA-E8-A414-01A-11D-A23M-08,1,0.816292103,TCGA-E8-A414,THCA,45,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-16754,Alive,TUMOR FREE,958,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,958,0,958,0,958,0,958,NA,Stage III,T3,M0,THCA.2,1
-3.156449113,-3.410948161,TCGA-BG-A220-01A,TCGA-BG-A220-01A-11D-A159-09,8,0.623696871,TCGA-BG-A220,UCEC,69,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-25346,Alive,TUMOR FREE,434,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,434,0,434,0,434,0,434,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-0.218021233,5.003154062,TCGA-BA-7269-01A,TCGA-BA-7269-01A-11D-2012-08,4,0.581677155,TCGA-BA-7269,HNSC,61,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G1,2010,[Not Available],-22609,Alive,TUMOR FREE,1273,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1273,0,1273,0,1273,0,1273,NA,Stage III,T2,[Not Available],HNSC.Classical,6
-3.249791646,1.69661666,TCGA-CR-7368-01A,TCGA-CR-7368-01A-11D-2129-08,0,NA,TCGA-CR-7368,HNSC,54,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-19876,Alive,TUMOR FREE,1245,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1245,0,1245,NA,NA,0,1245,NA,Stage IVA,T4a,M0,HNSC.Atypical,10
9.787036127,-3.147789444,TCGA-D6-6827-01A,TCGA-D6-6827-01A-11D-1912-08,1,0.720333528,TCGA-D6-6827,HNSC,55,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2011,[Not Available],-20175,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,568,0,568,0,568,0,568,NA,Stage I,T1,[Not Available],NA,1
-4.509539179,0.930017681,TCGA-91-6828-01A,TCGA-91-6828-01A-11D-1855-08,0,NA,TCGA-91-6828,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-25870,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,323,0,323,0,323,0,323,NA,Stage IA,T1a,M0,LUAD.3,10
8.973976941,-1.733774142,TCGA-38-7271-01A,TCGA-38-7271-01A-11D-2036-08,1,0.645198329,TCGA-38-7271,LUAD,72,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2006,[Not Available],-26440,Dead,WITH TUMOR,NA,800,[Not Available],NA,NA,NA,304,Complete Remission/Response,1,800,1,800,1,304,1,304,NA,Stage IA,T1,M0,NA,6
-4.262700924,1.329203419,TCGA-22-4594-01A,TCGA-22-4594-01A-01D-1267-08,0,NA,TCGA-22-4594,LUSC,60,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2002,[Not Available],-22115,Dead,NA,1470,1470,[Not Available],NA,NA,NA,NA,[Not Available],1,1470,NA,1470,NA,NA,0,1470,NA,Stage IIIA,T3,M0,NA,10
10.07267052,-1.506380826,TCGA-EL-A3H7-01A,TCGA-EL-A3H7-01A-11D-A21A-08,1,0.860499479,TCGA-EL-A3H7,THCA,36,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2002,[Not Available],-13407,Alive,TUMOR FREE,4228,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4228,0,4228,0,4228,0,4228,NA,Stage I,T3,M0,THCA.4,1
-7.239441954,1.369356687,TCGA-CR-6492-01A,TCGA-CR-6492-01A-12D-2078-08,0,NA,TCGA-CR-6492,HNSC,78,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-28600,Alive,TUMOR FREE,479,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,479,0,479,NA,NA,0,479,NA,Stage III,T2,M0,HNSC.Atypical,7
-7.10864867,-2.340211414,TCGA-CN-4735-01A,TCGA-CN-4735-01A-01D-1434-08,6,0.258652275,TCGA-CN-4735,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2010,[Not Available],-19107,Alive,TUMOR FREE,1737,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1737,0,1737,NA,NA,0,1737,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,2
-6.11957011,3.50118649,TCGA-EL-A4KI-01A,TCGA-EL-A4KI-01A-11D-A257-08,11,0.52964777,TCGA-EL-A4KI,THCA,63,MALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-23182,Alive,WITH TUMOR,727,NA,[Not Available],Distant Metastasis,Lung,NA,265,[Not Available],0,727,0,727,1,265,1,265,NA,Stage III,T3,MX,THCA.1,8
-0.3446415,3.781899902,TCGA-DQ-5631-01A,TCGA-DQ-5631-01A-01D-1870-08,4,0.183094004,TCGA-DQ-5631,HNSC,52,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2009,[Not Available],-19172,Dead,WITH TUMOR,548,548,[Not Available],NA,Distant Metastasis,Lung,447,Complete Remission/Response,1,548,1,548,NA,NA,1,447,NA,[Not Available],TX,[Not Available],HNSC.Mesenchymal,6
-0.980169009,3.986464285,TCGA-CR-7379-01A,TCGA-CR-7379-01A-11D-2012-08,4,0.315812853,TCGA-CR-7379,HNSC,78,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-28763,Alive,TUMOR FREE,1036,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1036,0,1036,NA,NA,0,1036,NA,Stage IVA,T4a,M0,HNSC.Basal,6
-6.381424178,1.73885709,TCGA-AX-A2HF-01A,TCGA-AX-A2HF-01A-11D-A17D-09,10,0.207587423,TCGA-AX-A2HF,UCEC,67,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24689,Alive,WITH TUMOR,848,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,848,0,848,0,848,0,848,NA,Stage IB,[Not Applicable],[Not Applicable],NA,7
-6.29579555,-2.025455073,TCGA-CV-7252-01A,TCGA-CV-7252-01A-11D-2012-08,0,NA,TCGA-CV-7252,HNSC,62,FEMALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,1994,[Not Available],-22934,Dead,WITH TUMOR,NA,151,[Not Available],NA,NA,NA,NA,Progressive Disease,1,151,1,151,NA,NA,1,151,NA,Stage IVA,T4a,[Not Available],HNSC.Basal,10
8.783764651,-4.784294158,TCGA-E8-A44M-01A,TCGA-E8-A44M-01A-21D-A23U-08,1,0.779491998,TCGA-E8-A44M,THCA,23,FEMALE,ASIAN,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2012,[Not Available],-8523,Alive,TUMOR FREE,917,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,917,0,917,0,917,0,917,NA,Stage I,T1b,M0,THCA.2,1
9.975719266,-1.39730326,TCGA-DJ-A3UY-01A,TCGA-DJ-A3UY-01A-21D-A22D-08,1,0.795487176,TCGA-DJ-A3UY,THCA,32,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-12004,Alive,TUMOR FREE,1091,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1091,0,1091,0,1091,0,1091,NA,Stage I,T1b,M0,THCA.2,1
-0.355850281,4.932677045,TCGA-CV-5979-01A,TCGA-CV-5979-01A-11D-1683-08,4,0.65854846,TCGA-CV-5979,HNSC,26,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-9567,Alive,TUMOR FREE,1315,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1315,0,1315,NA,NA,0,1315,NA,Stage IVA,T2,[Not Available],HNSC.Basal,6
-7.261466799,1.641555767,TCGA-BG-A0M3-01A,TCGA-BG-A0M3-01A-11W-A10C-09,0,NA,TCGA-BG-A0M3,UCEC,74,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27183,Alive,TUMOR FREE,1071,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1071,0,1071,0,1071,0,1071,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
-3.052841976,-3.8607401,TCGA-QF-A5YS-01A,TCGA-QF-A5YS-01A-11D-A31U-09,8,0.287318556,TCGA-QF-A5YS,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,Mixed serous and endometrioid,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20841,Alive,TUMOR FREE,689,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,689,0,689,0,689,0,689,NA,Stage II,[Not Applicable],[Not Applicable],NA,10
-4.581643679,-1.679121571,TCGA-55-A48Y-01A,TCGA-55-A48Y-01A-11D-A24D-08,8,0.448589403,TCGA-55-A48Y,LUAD,69,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-25384,Alive,TUMOR FREE,630,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,630,0,630,0,630,0,630,NA,Stage IIA,T2b,M0,NA,10
-4.174626192,-0.469237208,TCGA-85-8287-01A,TCGA-85-8287-01A-11D-2293-08,0,NA,TCGA-85-8287,LUSC,72,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-26401,Dead,TUMOR FREE,NA,23,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,23,0,23,0,23,0,23,NA,Stage IA,T1b,M0,NA,10
-4.366381518,-2.126161376,TCGA-60-2726-01A,TCGA-60-2726-01A-01D-1522-08,8,0.311522822,TCGA-60-2726,LUSC,56,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2009,[Not Available],-20618,Dead,TUMOR FREE,358,358,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,358,0,358,0,358,0,358,NA,Stage IIA,T2,M0,LUSC.primitive,10
0.340137009,5.091167979,TCGA-PG-A7D5-01A,TCGA-PG-A7D5-01A-11D-A34Q-09,4,0.644847554,TCGA-PG-A7D5,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006,Alive,TUMOR FREE,1177,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1177,0,1177,NA,NA,0,1177,NA,Stage IA,[Not Applicable],[Not Applicable],NA,6
-0.198764603,3.621655732,TCGA-PG-A914-01A,TCGA-PG-A914-01A-11D-A37N-09,4,0.327305616,TCGA-PG-A914,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992,Alive,TUMOR FREE,687,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,687,0,687,0,687,0,687,NA,Stage IA,[Not Applicable],[Not Applicable],NA,3
-6.355992665,1.190358042,TCGA-PG-A915-01A,TCGA-PG-A915-01A-11D-A37N-09,10,0.042058909,TCGA-PG-A915,UCEC,60,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22119,Alive,TUMOR FREE,249,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,249,0,249,0,249,0,249,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
-7.516950423,1.617760072,TCGA-PG-A916-01A,TCGA-PG-A916-01A-11D-A37N-09,9,0.075325124,TCGA-PG-A916,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617,Alive,TUMOR FREE,522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,522,0,522,0,522,0,522,NA,Stage I,[Not Applicable],[Not Applicable],NA,7
-3.248991128,-3.445720215,TCGA-PG-A917-01A,TCGA-PG-A917-01A-31D-A37N-09,8,0.615421706,TCGA-PG-A917,UCEC,74,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104,Alive,TUMOR FREE,212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,212,0,212,0,212,0,212,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-6.456365962,-1.156063106,TCGA-CQ-6218-01A,TCGA-CQ-6218-01A-11D-1912-08,7,0.275143925,TCGA-CQ-6218,HNSC,52,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2009,[Not Available],-19096,Alive,TUMOR FREE,1253,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1253,0,1253,NA,NA,0,1253,NA,Stage IVA,T3,[Not Available],HNSC.Basal,2
-6.338322638,-1.236518605,TCGA-H7-7774-01A,TCGA-H7-7774-01A-21D-2078-08,7,0.179912848,TCGA-H7-7774,HNSC,75,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-27519,Alive,TUMOR FREE,407,NA,[Not Available],New Primary Tumor,Oral Cavity,hard palate (right),252,Complete Remission/Response,0,407,0,407,NA,NA,1,252,NA,Stage IVA,T4a,[Not Available],HNSC.Atypical,2
0.597853139,3.745153128,TCGA-BA-6868-01B,TCGA-BA-6868-01B-12D-1912-08,0,NA,TCGA-BA-6868,HNSC,53,MALE,BLACK OR AFRICAN AMERICAN,Head & Neck Squamous Cell Carcinoma,G2,2011,[Not Available],-19608,Dead,WITH TUMOR,NA,472,[Not Available],NA,Distant Metastasis,L neck subdermal mets,344,Partial Remission/Response,1,472,1,472,NA,NA,1,344,NA,[Not Available],TX,[Not Available],HNSC.Classical,6
-7.953968211,-2.392071883,TCGA-ET-A3DU-01A,TCGA-ET-A3DU-01A-11D-A19J-08,6,0.467658857,TCGA-ET-A3DU,THCA,21,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2009,[Not Available],-7869,Alive,TUMOR FREE,1911,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1911,0,1911,NA,NA,0,1911,NA,Stage I,T1,MX,THCA.NA,2
-6.970007904,-1.799319669,TCGA-NK-A5CR-01A,TCGA-NK-A5CR-01A-11D-A26M-08,0,NA,TCGA-NK-A5CR,LUSC,77,MALE,[Unknown],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-28126,Alive,TUMOR FREE,2542,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,2542,0,2542,NA,NA,0,2542,NA,Stage IB,T2,MX,NA,2
-6.300587747,-1.124636903,TCGA-NK-A5CT-01A,TCGA-NK-A5CT-01A-31D-A26M-08,7,0.181209121,TCGA-NK-A5CT,LUSC,70,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-25726,Alive,WITH TUMOR,1997,NA,[Not Available],Locoregional Recurrence,NA,NA,1990,Stable Disease,0,1997,0,1997,NA,NA,1,1990,NA,Stage IA,T1,M0,NA,2
-4.5991578,-1.754450477,TCGA-NC-A5HR-01A,TCGA-NC-A5HR-01A-21D-A26M-08,8,0.399781749,TCGA-NC-A5HR,LUSC,75,FEMALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2011,[Not Available],-27629,Alive,TUMOR FREE,1244,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1244,0,1244,0,1244,0,1244,NA,Stage IIA,T2a,M0,NA,10
-7.425997295,-2.437513076,TCGA-95-8039-01A,TCGA-95-8039-01A-11D-2238-08,6,0.387506862,TCGA-95-8039,LUAD,72,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26317,Alive,TUMOR FREE,830,NA,[Not Available],Locoregional Recurrence,NA,NA,228,Complete Remission/Response,0,830,0,830,1,228,1,228,NA,Stage IA,T1,MX,NA,2
-0.569249416,4.522089394,TCGA-95-8494-01A,TCGA-95-8494-01A-11D-2323-08,4,0.529128068,TCGA-95-8494,LUAD,67,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24773,Alive,NA,84,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,84,0,84,0,84,0,84,NA,Stage IIA,T2a,M0,NA,6
-4.410530716,-1.011704626,TCGA-95-A4VN-01A,TCGA-95-A4VN-01A-11D-A25L-08,8,0.294138887,TCGA-95-A4VN,LUAD,62,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-22927,Alive,TUMOR FREE,553,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,553,0,553,NA,NA,0,553,NA,Stage IIA,T2a,M0,NA,10
-6.098232214,3.528517191,TCGA-50-8459-01A,TCGA-50-8459-01A-11D-2323-08,11,0.568548603,TCGA-50-8459,LUAD,68,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-24859,Alive,WITH TUMOR,1119,NA,[Not Available],Locoregional Recurrence,NA,NA,432,Progressive Disease,0,1119,0,1119,NA,NA,1,432,NA,Stage IIB,T3,M0,NA,8
-0.173832405,5.324228265,TCGA-50-8460-01A,TCGA-50-8460-01A-11D-2323-08,4,0.636738176,TCGA-50-8460,LUAD,74,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-27270,Alive,TUMOR FREE,829,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,829,0,829,0,829,0,829,NA,Stage IA,T1a,M0,NA,6
-2.042553592,2.627615137,TCGA-55-8208-01A,TCGA-55-8208-01A-11D-2238-08,0,NA,TCGA-55-8208,LUAD,73,FEMALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-26716,Alive,WITH TUMOR,674,NA,[Not Available],Distant Metastasis,NA,NA,511,Complete Remission/Response,0,674,0,674,1,511,1,511,NA,Stage IA,T1b,M0,NA,10
-3.687898409,-2.768854934,TCGA-73-A9RS-01A,TCGA-73-A9RS-01A-11D-A410-08,8,0.395140577,TCGA-73-A9RS,LUAD,41,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2013,[Not Available],-15162,Dead,WITH TUMOR,NA,340,[Not Available],Locoregional Recurrence,NA,NA,107,Progressive Disease,1,340,1,340,NA,NA,1,107,NA,Stage IIB,T3,M0,NA,10
-5.329710006,2.671389684,TCGA-93-A4JO-01A,TCGA-93-A4JO-01A-21D-A24P-08,12,0.162417515,TCGA-93-A4JO,LUAD,70,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-25898,Dead,TUMOR FREE,NA,33,[Not Available],NA,NA,NA,NA,[Not Applicable],1,33,0,33,NA,NA,0,33,NA,Stage IA,T1a,MX,NA,8
-1.837891332,1.045369928,TCGA-93-A4JQ-01A,TCGA-93-A4JQ-01A-11D-A24P-08,5,0.595114985,TCGA-93-A4JQ,LUAD,49,MALE,WHITE,Lung Adenocarcinoma,[Not Available],2012,[Not Available],-17951,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,526,0,526,0,526,0,526,NA,Stage IA,T1b,MX,NA,4
-4.954889938,1.182315622,TCGA-95-7562-01A,TCGA-95-7562-01A-11D-2238-08,0,NA,TCGA-95-7562,LUAD,71,MALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],2011,[Not Available],-26000,Dead,TUMOR FREE,NA,87,[Not Available],NA,NA,NA,NA,[Not Evaluated],1,87,0,87,NA,NA,0,87,NA,Stage IIA,T2a,M0,NA,9
-3.969968164,-2.019134693,TCGA-49-AARQ-01A,TCGA-49-AARQ-01A-11D-A410-08,8,0.383185403,TCGA-49-AARQ,LUAD,41,FEMALE,BLACK OR AFRICAN AMERICAN,Lung Adenocarcinoma,[Not Available],1996,[Not Available],-15065,Alive,TUMOR FREE,6732,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,6732,0,6732,0,6732,0,6732,NA,Stage I,T2,MX,NA,10
8.787698492,-5.081507982,TCGA-V1-A9ZG-01A,TCGA-V1-A9ZG-01A-11D-A41K-08,1,0.793471529,TCGA-V1-A9ZG,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-23725,Alive,TUMOR FREE,1517,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1517,0,1517,0,1517,0,1517,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.97244298,-2.654675114,TCGA-V1-A9Z9-01A,TCGA-V1-A9Z9-01A-21D-A41K-08,1,0.73944405,TCGA-V1-A9Z9,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-23360,Alive,TUMOR FREE,540,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,540,0,540,0,540,0,540,NA,[Not Applicable],T2c,[Not Applicable],NA,1
0.485250659,2.199496584,TCGA-V1-A9ZI-01A,TCGA-V1-A9ZI-01A-11D-A41K-08,0,NA,TCGA-V1-A9ZI,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-25185,Alive,NA,1640,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1640,0,1640,NA,NA,0,1640,NA,[Not Applicable],T3b,[Not Applicable],NA,6
8.685584187,-3.437737644,TCGA-V1-A9Z8-01A,TCGA-V1-A9Z8-01A-11D-A41K-08,1,0.677971347,TCGA-V1-A9Z8,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-21900,Alive,TUMOR FREE,827,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,827,0,827,0,827,0,827,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.075287597,-2.058146193,TCGA-V1-A9Z7-01A,TCGA-V1-A9Z7-01A-11D-A41K-08,1,0.666078974,TCGA-V1-A9Z7,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-20075,Alive,NA,874,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,874,0,874,0,874,0,874,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.934530075,-3.304421956,TCGA-V1-A9OX-01A,TCGA-V1-A9OX-01A-11D-A41K-08,1,0.61753764,TCGA-V1-A9OX,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-20805,Alive,NA,1134,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1134,0,1134,NA,NA,0,1134,NA,[Not Applicable],T2c,[Not Applicable],NA,1
2.123490012,1.887534761,TCGA-V1-A9OT-01A,TCGA-V1-A9OT-01A-11D-A41K-08,3,0.48660737,TCGA-V1-A9OT,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-22630,Alive,NA,476,NA,[Not Available],Biochemical evidence of disease,NA,NA,292,Progressive Disease,0,476,0,476,NA,NA,1,292,NA,[Not Applicable],T2c,[Not Applicable],NA,3
9.026348549,-5.429975916,TCGA-V1-A9OY-01A,TCGA-V1-A9OY-01A-11D-A41K-08,1,0.847301011,TCGA-V1-A9OY,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-21170,Alive,NA,1067,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1067,0,1067,0,1067,0,1067,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-1.853841662,1.277372293,TCGA-V1-A9OQ-01A,TCGA-V1-A9OQ-01A-11D-A41K-08,5,0.59225539,TCGA-V1-A9OQ,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-24820,Alive,NA,371,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,371,0,371,0,371,0,371,NA,[Not Applicable],T3a,[Not Applicable],NA,4
9.336814529,-5.315363765,TCGA-V1-A9OA-01A,TCGA-V1-A9OA-01A-11D-A41K-08,1,0.755951637,TCGA-V1-A9OA,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-22630,Alive,NA,636,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,636,0,636,0,636,0,636,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.460225569,-5.046624268,TCGA-V1-A9O9-01A,TCGA-V1-A9O9-01A-11D-A41K-08,1,0.818175568,TCGA-V1-A9O9,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-20805,Alive,NA,2870,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2870,0,2870,0,2870,0,2870,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.418181985,-4.673064581,TCGA-V1-A9OF-01A,TCGA-V1-A9OF-01A-11D-A41K-08,1,0.780495983,TCGA-V1-A9OF,PRAD,49,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-18250,Alive,NA,1184,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1184,0,1184,0,1184,0,1184,NA,[Not Applicable],T2c,[Not Applicable],NA,1
2.983302654,3.575077627,TCGA-V1-A8WW-01A,TCGA-V1-A8WW-01A-11D-A377-08,0,NA,TCGA-V1-A8WW,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-21900,Alive,NA,1078,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1078,0,1078,0,1078,0,1078,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
0.110792238,2.577467146,TCGA-V1-A9O5-01A,TCGA-V1-A9O5-01A-11D-A41K-08,4,0.187778442,TCGA-V1-A9O5,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-23725,Alive,NA,1932,NA,[Not Available],Biochemical evidence of disease,NA,NA,124,Complete Remission/Response,0,1932,0,1932,1,124,1,124,NA,[Not Applicable],T4,[Not Applicable],NA,6
9.549056458,-5.659667146,TCGA-V1-A8X3-01A,TCGA-V1-A8X3-01A-11D-A377-08,1,0.778947547,TCGA-V1-A8X3,PRAD,51,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-18980,Alive,NA,202,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,202,0,202,0,202,0,202,NA,[Not Applicable],T2c,[Not Applicable],PRAD.3-ETV4,1
2.209650335,1.692228794,TCGA-V1-A8WS-01A,TCGA-V1-A8WS-01A-11D-A377-08,3,0.451262362,TCGA-V1-A8WS,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-20805,Alive,NA,474,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,474,0,474,NA,NA,0,474,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,3
-5.213873065,1.51898883,TCGA-F4-6807-01A,TCGA-F4-6807-01A-11D-1835-10,0,NA,TCGA-F4-6807,COAD,51,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-18690,Alive,TUMOR FREE,1309,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1309,0,1309,0,1309,0,1309,NA,Stage IIIC,T3,M0,GI.CIN,10
0.427505024,2.232347666,TCGA-V1-A8WN-01A,TCGA-V1-A8WN-01A-11D-A377-08,0,NA,TCGA-V1-A8WN,PRAD,47,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-17520,Alive,NA,924,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,924,0,924,0,924,0,924,NA,[Not Applicable],T2c,[Not Applicable],PRAD.4-FLI1,6
9.636798807,-5.746618849,TCGA-V1-A8MM-01A,TCGA-V1-A8MM-01A-11D-A377-08,1,0.869233414,TCGA-V1-A8MM,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-22265,Alive,NA,1195,NA,[Not Available],Biochemical evidence of disease,NA,NA,990,Complete Remission/Response,0,1195,0,1195,1,990,1,990,NA,[Not Applicable],T3a,[Not Applicable],NA,1
8.989240745,-5.29046565,TCGA-V1-A8ML-01A,TCGA-V1-A8ML-01A-11D-A377-08,1,0.795247361,TCGA-V1-A8ML,PRAD,63,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-23360,Alive,NA,448,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,448,0,448,0,448,0,448,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
8.618818673,-4.343890205,TCGA-V1-A8WL-01A,TCGA-V1-A8WL-01A-11D-A377-08,1,0.657772554,TCGA-V1-A8WL,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-23725,Alive,NA,1948,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1948,0,1948,0,1948,0,1948,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
10.06107116,-1.363716459,TCGA-V1-A8MU-01A,TCGA-V1-A8MU-01A-11D-A377-08,1,0.852889137,TCGA-V1-A8MU,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-20805,Alive,NA,1876,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1876,0,1876,NA,NA,0,1876,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
-3.078439693,-3.653404542,TCGA-D5-6540-01A,TCGA-D5-6540-01A-11D-1719-10,8,0.476015091,TCGA-D5-6540,COAD,66,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-24282,Alive,TUMOR FREE,491,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,491,0,491,NA,NA,0,491,NA,Stage I,T2,M0,GI.HM-indel,10
9.172116244,-4.670396042,TCGA-V1-A8MK-01A,TCGA-V1-A8MK-01A-11D-A364-08,1,0.793207296,TCGA-V1-A8MK,PRAD,41,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-15330,Alive,NA,508,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,508,0,508,0,508,0,508,NA,[Not Applicable],T2c,[Not Applicable],NA,1
7.69923802,-3.416928889,TCGA-MG-AAMC-01A,TCGA-MG-AAMC-01A-11D-A41K-08,1,0.282165364,TCGA-MG-AAMC,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-21846,Alive,TUMOR FREE,173,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,173,0,173,0,173,0,173,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.598209566,-4.485808671,TCGA-KK-A8IM-01A,TCGA-KK-A8IM-01A-11D-A364-08,1,0.711079873,TCGA-KK-A8IM,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20425,Alive,TUMOR FREE,1915,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1915,0,1915,0,1915,0,1915,NA,[Not Applicable],T2c,[Not Applicable],NA,1
-0.062775258,5.150860036,TCGA-V1-A8MJ-01A,TCGA-V1-A8MJ-01A-11D-A364-08,4,0.681613549,TCGA-V1-A8MJ,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-21535,Alive,NA,1791,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,1791,0,1791,NA,NA,0,1791,NA,[Not Applicable],T3a,[Not Applicable],PRAD.2-ETV1,6
9.135579703,-5.580751393,TCGA-V1-A8MG-01A,TCGA-V1-A8MG-01A-11D-A364-08,1,0.861679753,TCGA-V1-A8MG,PRAD,53,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-19710,Alive,NA,857,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,857,0,857,0,857,0,857,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,1
8.906804548,-4.072933306,TCGA-V1-A8MF-01A,TCGA-V1-A8MF-01A-11D-A364-08,1,0.693502534,TCGA-V1-A8MF,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-24090,Alive,NA,1449,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1449,0,1449,0,1449,0,1449,NA,[Not Applicable],T3a,[Not Applicable],PRAD.8-other,1
1.332776384,3.320423774,TCGA-SU-A7E7-01A,TCGA-SU-A7E7-01A-22D-A33T-08,0,NA,TCGA-SU-A7E7,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-22185,Alive,TUMOR FREE,551,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,551,0,551,0,551,0,551,NA,[Not Applicable],T2b,[Not Applicable],PRAD.2-ETV1,1
9.288706861,-5.649286188,TCGA-KK-A8IK-01A,TCGA-KK-A8IK-01A-11D-A364-08,1,0.770004649,TCGA-KK-A8IK,PRAD,56,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-20594,Alive,TUMOR FREE,2052,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2052,0,2052,0,2052,0,2052,NA,[Not Applicable],T2c,[Not Applicable],PRAD.5-SPOP,1
-7.869608555,-2.50892458,TCGA-KK-A8IJ-01A,TCGA-KK-A8IJ-01A-11D-A34U-08,6,0.491723217,TCGA-KK-A8IJ,PRAD,59,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-21793,Alive,NA,1559,NA,[Not Available],New Primary Tumor,"Other, specify",Melanoma in situ of the right midback,307,[Unknown],0,1559,0,1559,NA,NA,1,307,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,2
-0.240412464,4.719473514,TCGA-KK-A8IG-01A,TCGA-KK-A8IG-01A-11D-A364-08,4,0.580569864,TCGA-KK-A8IG,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-20266,Alive,TUMOR FREE,2505,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2505,0,2505,0,2505,0,2505,NA,[Not Applicable],T3a,[Not Applicable],PRAD.6-FOXA1,6
2.4374355,1.865599584,TCGA-KK-A8II-01A,TCGA-KK-A8II-01A-11D-A364-08,3,0.040364412,TCGA-KK-A8II,PRAD,61,MALE,[Not Available],"Prostate Adenocarcinoma, Other Subtype",[Not Available],2004,[Not Available],-22460,Dead,WITH TUMOR,NA,3467,[Unknown],Biochemical evidence of disease,NA,NA,626,Progressive Disease,1,3467,1,3467,NA,NA,1,626,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,3
-8.240874687,1.952206569,TCGA-KK-A8IH-01A,TCGA-KK-A8IH-01A-11D-A364-08,9,0.268001526,TCGA-KK-A8IH,PRAD,50,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-18560,Alive,TUMOR FREE,2013,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2013,0,2013,0,2013,0,2013,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,7
8.761075852,-3.242652598,TCGA-BP-4991-01A,TCGA-BP-4991-01A-01D-1462-08,1,0.665435429,TCGA-BP-4991,KIRC,54,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-19739,Alive,TUMOR FREE,1413,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1413,0,1413,NA,NA,0,1413,NA,Stage I,T1a,M0,KIRC.1,1
0.478818773,2.18959474,TCGA-B0-5812-01A,TCGA-B0-5812-01A-11D-1669-08,0,NA,TCGA-B0-5812,KIRC,53,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2003,[Not Available],-19600,Alive,TUMOR FREE,3834,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3834,0,3834,0,3834,0,3834,NA,Stage I,T1b,M0,KIRC.1,6
3.902335304,1.267434444,TCGA-13-1497-01A,TCGA-13-1497-01A-01W-0549-09,0,NA,TCGA-13-1497,OV,47,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-17528,Alive,TUMOR FREE,3871,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],813,Complete Remission/Response,0,3871,0,3871,1,813,1,813,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
4.44793971,1.063765557,TCGA-X6-A8C4-01A,TCGA-X6-A8C4-01A-11D-A36J-09,2,0.724545124,TCGA-X6-A8C4,SARC,70,FEMALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2013,[Not Available],-25896,Dead,WITH TUMOR,NA,628,[Not Available],Distant Metastasis,Lung,NA,71,[Not Available],1,628,1,628,NA,NA,1,71,NA,NA,NA,NA,NA,5
-0.043660768,4.172068544,TCGA-X6-A8C5-01A,TCGA-X6-A8C5-01A-11D-A36J-09,4,0.382938306,TCGA-X6-A8C5,SARC,63,FEMALE,BLACK OR AFRICAN AMERICAN,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-23350,Alive,TUMOR FREE,1547,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1547,0,1547,0,1547,0,1547,NA,NA,NA,NA,NA,6
-0.720826096,2.341774629,TCGA-G4-6322-01A,TCGA-G4-6322-01A-11D-1719-10,4,0.095474058,TCGA-G4-6322,COAD,65,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-23825,Alive,WITH TUMOR,792,NA,[Not Available],NA,NA,NA,789,[Not Available],0,792,0,792,NA,NA,1,789,NA,Stage IIIB,T3,MX,GI.CIN,5
9.896533784,-2.676013797,TCGA-X9-A973-01A,TCGA-X9-A973-01A-11D-A387-09,1,0.697996724,TCGA-X9-A973,SARC,55,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2011,[Not Available],-20146,Alive,WITH TUMOR,1108,NA,[Not Available],Distant Metastasis,Lung,NA,119,[Not Available],0,1108,0,1108,1,119,1,119,NA,NA,NA,NA,NA,1
8.70541171,-4.164968968,TCGA-X6-A8C6-01A,TCGA-X6-A8C6-01A-11D-A36J-09,1,0.734212694,TCGA-X6-A8C6,SARC,55,MALE,WHITE,Myxofibrosarcoma,[Not Available],2011,[Not Available],-20090,Dead,WITH TUMOR,NA,1067,[Not Available],Distant Metastasis,Bone,"& leg, opposite thigh",408,[Not Available],1,1067,1,1067,NA,NA,1,408,NA,NA,NA,NA,NA,1
8.861727241,-4.67951526,TCGA-13-0717-01A,TCGA-13-0717-01A-01W-0371-08,1,0.765258161,TCGA-13-0717,OV,54,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-20042,Dead,WITH TUMOR,748,748,[Not Available],Recurrence,[Not Applicable],[Not Applicable],294,Complete Remission/Response,1,748,1,748,1,294,1,294,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
9.522003262,-2.862579415,TCGA-X9-A971-01A,TCGA-X9-A971-01A-11D-A387-09,1,0.739421755,TCGA-X9-A971,SARC,52,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2013,[Not Available],-19207,Alive,WITH TUMOR,831,NA,[Not Available],Distant Metastasis,Lung,NA,224,[Not Available],0,831,0,831,1,224,1,224,NA,NA,NA,NA,NA,1
-0.248669287,3.015317898,TCGA-61-1737-01A,TCGA-61-1737-01A-01W-0639-09,4,0.166667231,TCGA-61-1737,OV,42,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-15515,Alive,TUMOR FREE,1364,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1364,0,1364,NA,NA,0,1364,NA,Stage IV,[Not Applicable],[Not Applicable],NA,3
9.182928041,-5.294295733,TCGA-X6-A8C7-01A,TCGA-X6-A8C7-01A-11D-A36J-09,1,0.816525699,TCGA-X6-A8C7,SARC,24,FEMALE,WHITE,Synovial Sarcoma - Biphasic,[Not Available],2013,[Not Available],-9104,Alive,TUMOR FREE,896,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,896,0,896,0,896,0,896,NA,NA,NA,NA,NA,1
-0.69034052,4.114030423,TCGA-24-1850-01A,TCGA-24-1850-01A-01W-0639-09,4,0.464277943,TCGA-24-1850,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-26369,Alive,TUMOR FREE,168,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,168,0,168,0,168,0,168,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,5
-0.339148862,3.901537334,TCGA-DI-A2QU-01A,TCGA-DI-A2QU-01A-11D-A18P-09,4,0.126306005,TCGA-DI-A2QU,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488,Dead,WITH TUMOR,NA,946,[Not Available],NA,NA,NA,NA,[Not Available],1,946,1,946,NA,NA,1,946,NA,Stage IVB,[Not Applicable],[Not Applicable],NA,6
-4.252354358,-2.093393691,TCGA-D1-A176-01A,TCGA-D1-A176-01A-11D-A12J-09,8,0.392524626,TCGA-D1-A176,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24521,Alive,TUMOR FREE,917,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,917,0,917,0,917,0,917,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-5.251237052,2.647291642,TCGA-AZ-5407-01A,TCGA-AZ-5407-01A-01D-1719-10,12,0.328388992,TCGA-AZ-5407,COAD,51,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2007,[Not Available],-18820,Alive,TUMOR FREE,2683,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2683,0,2683,0,2683,0,2683,NA,Stage I,T1,M0,GI.GS,8
9.420240604,-5.235317987,TCGA-AK-3427-01A,TCGA-AK-3427-01A-01D-0966-08,1,0.813953673,TCGA-AK-3427,KIRC,65,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,GX,2004,[Not Available],-24067,Alive,TUMOR FREE,3583,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3583,0,3583,0,3583,0,3583,NA,Stage I,T1a,M0,NA,1
-0.021989737,4.604301912,TCGA-CV-5436-01A,TCGA-CV-5436-01A-01D-1512-08,4,0.51774895,TCGA-CV-5436,HNSC,65,MALE,[Not Available],Head & Neck Squamous Cell Carcinoma,G2,2001,[Not Available],-23923,Dead,WITH TUMOR,548,584,[Not Available],NA,NA,NA,NA,Persistent Disease,1,584,1,584,NA,NA,1,584,NA,Stage IVA,T3,[Not Available],HNSC.Basal,6
8.256508045,-1.342125337,TCGA-B0-5095-01A,TCGA-B0-5095-01A-01D-1421-08,1,0.237873139,TCGA-B0-5095,KIRC,81,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2008,[Not Available],-29921,Dead,TUMOR FREE,NA,245,[Not Available],NA,NA,NA,NA,[Not Available],1,245,0,245,NA,NA,0,245,NA,Stage III,T3a,M0,KIRC.3,1
-3.144231546,-3.622454263,TCGA-A5-A0VP-01A,TCGA-A5-A0VP-01A-21D-A10B-09,8,0.426484518,TCGA-A5-A0VP,UCEC,74,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27335,Alive,TUMOR FREE,1288,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1288,0,1288,0,1288,0,1288,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
1.094531883,3.560372527,TCGA-KL-8324-01A,TCGA-KL-8324-01A-11D-2310-10,0,NA,TCGA-KL-8324,KICH,67,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2000,[Not Available],-24650,Alive,TUMOR FREE,4676,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4676,0,4676,NA,NA,0,4676,NA,Stage II,T2,M0,KICH.Eosin.0,1
9.90442395,-4.83266174,TCGA-KL-8326-01A,TCGA-KL-8326-01A-11D-2310-10,1,0.669531093,TCGA-KL-8326,KICH,69,MALE,WHITE,Kidney Chromophobe,[Not Available],2001,[Not Available],-25267,Alive,TUMOR FREE,3322,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,3322,0,3322,NA,NA,0,3322,NA,Stage III,T3a,M0,KICH.Eosin.1,1
9.655158903,-5.558051581,TCGA-KL-8325-01A,TCGA-KL-8325-01A-11D-2310-10,1,0.810723091,TCGA-KL-8325,KICH,56,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2000,[Not Available],-20768,Dead,TUMOR FREE,NA,725,[Not Available],NA,NA,NA,NA,[Not Available],1,725,0,725,NA,NA,0,725,NA,Stage II,T2,M0,KICH.Eosin.0,1
-3.232117186,0.976052008,TCGA-13-0887-01A,TCGA-13-0887-01A-01W-0420-08,0,NA,TCGA-13-0887,OV,42,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-15669,Dead,WITH TUMOR,2028,2028,[Not Available],Recurrence,[Not Applicable],[Not Applicable],514,Complete Remission/Response,1,2028,1,2028,1,514,1,514,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
0.129199754,3.313670081,TCGA-29-1711-01A,TCGA-29-1711-01A-01W-0633-09,4,0.36216562,TCGA-29-1711,OV,45,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G2,2006,[Not Available],-16485,Alive,TUMOR FREE,1053,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1053,0,1053,0,1053,0,1053,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,3
-7.695640721,-2.518456979,TCGA-KL-8331-01A,TCGA-KL-8331-01A-11D-2310-10,6,0.502638593,TCGA-KL-8331,KICH,48,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2004,[Not Available],-17710,Alive,TUMOR FREE,3010,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,3010,0,3010,NA,NA,0,3010,NA,Stage II,T2,M0,KICH.Eosin.0,2
-0.121227883,3.859873113,TCGA-AA-3697-01A,TCGA-AA-3697-01A-01D-1719-10,4,0.341358526,TCGA-AA-3697,COAD,77,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2003,[Not Available],-28367,Alive,WITH TUMOR,2587,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2587,0,2587,NA,NA,0,2587,NA,Stage II,T3,M0,NA,6
9.519898623,-5.472423815,TCGA-KL-8328-01A,TCGA-KL-8328-01A-11D-2310-10,1,0.825177538,TCGA-KL-8328,KICH,60,MALE,WHITE,Kidney Chromophobe,[Not Available],2003,[Not Available],-21976,Alive,TUMOR FREE,3127,NA,[Not Available],NA,NA,NA,NA,[Not Evaluated],0,3127,0,3127,NA,NA,0,3127,NA,Stage II,T2b,M0,KICH.Eosin.0,1
1.981822709,1.823884285,TCGA-KL-8327-01A,TCGA-KL-8327-01A-11D-2310-10,3,0.502644082,TCGA-KL-8327,KICH,46,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2001,[Not Available],-17121,Alive,TUMOR FREE,4169,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,4169,0,4169,NA,NA,0,4169,NA,Stage I,T1b,M0,KICH.Eosin.0,3
-3.160269768,-3.736528998,TCGA-A6-5665-01A,TCGA-A6-5665-01A-01D-1650-10,8,0.441830794,TCGA-A6-5665,COAD,84,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-30915,Alive,TUMOR FREE,671,NA,[Not Available],NA,NA,NA,529,[Not Available],0,671,0,671,NA,NA,1,529,NA,Stage IIA,T3,M0,GI.HM-indel,10
-7.436345763,-2.324116408,TCGA-KL-8329-01A,TCGA-KL-8329-01A-11D-2310-10,6,0.319398376,TCGA-KL-8329,KICH,57,FEMALE,ASIAN,Kidney Chromophobe,[Not Available],2003,[Not Available],-20972,Alive,TUMOR FREE,2752,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2752,0,2752,NA,NA,0,2752,NA,Stage I,T1b,M0,KICH.Eosin.0,2
-0.719370461,2.494069108,TCGA-29-1703-01A,TCGA-29-1703-01A-01W-0633-09,4,0.039957037,TCGA-29-1703,OV,56,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G2,2005,[Not Available],-20622,Dead,WITH TUMOR,1815,1815,[Not Available],Recurrence,[Not Applicable],[Not Applicable],324,Complete Remission/Response,1,1815,1,1815,1,324,1,324,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,6
9.995458282,-1.970286105,TCGA-BP-5202-01A,TCGA-BP-5202-01A-02D-1429-08,1,0.822361769,TCGA-BP-5202,KIRC,75,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2008,[Not Available],-27556,Alive,TUMOR FREE,29,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,29,0,29,NA,NA,0,29,NA,Stage III,T3a,M0,KIRC.1,1
9.153330071,-4.508897814,TCGA-BP-5187-01A,TCGA-BP-5187-01A-01D-1429-08,1,0.743124773,TCGA-BP-5187,KIRC,54,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-19999,Alive,TUMOR FREE,406,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,406,0,406,NA,NA,0,406,NA,Stage I,T1a,M0,KIRC.2,1
9.397498571,-4.731159314,TCGA-KL-8334-01A,TCGA-KL-8334-01A-11D-2310-10,1,0.758282578,TCGA-KL-8334,KICH,37,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-13602,Alive,TUMOR FREE,2949,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2949,0,2949,NA,NA,0,2949,NA,Stage III,T3a,M0,KICH.Eosin.0,1
9.911820052,-1.505912209,TCGA-B0-5710-01A,TCGA-B0-5710-01A-11D-1669-08,1,0.833846967,TCGA-B0-5710,KIRC,57,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2008,[Not Available],-21168,Alive,WITH TUMOR,2430,NA,[Not Available],NA,NA,NA,1441,Progressive Disease,0,2430,0,2430,NA,NA,1,1441,NA,Stage I,T1b,M0,KIRC.1,1
0.316074613,5.188614036,TCGA-KL-8337-01A,TCGA-KL-8337-01A-11D-2310-10,4,0.606060065,TCGA-KL-8337,KICH,26,MALE,BLACK OR AFRICAN AMERICAN,Kidney Chromophobe,[Not Available],2006,[Not Available],-9819,Alive,TUMOR FREE,1364,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1364,0,1364,NA,NA,0,1364,NA,Stage II,T2,M0,KICH.Eosin.0,6
4.167228536,1.141221267,TCGA-BP-4974-01A,TCGA-BP-4974-01A-01D-1462-08,2,0.565777826,TCGA-BP-4974,KIRC,58,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2006,[Not Available],-21310,Dead,WITH TUMOR,NA,211,[Not Available],NA,NA,NA,35,[Not Available],1,211,1,211,NA,NA,1,35,NA,Stage IV,T3a,M1,KIRC.2,5
0.36828166,4.842099364,TCGA-KL-8336-01A,TCGA-KL-8336-01A-11D-2310-10,4,0.387855196,TCGA-KL-8336,KICH,51,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-18821,Dead,WITH TUMOR,NA,920,[Not Available],NA,NA,NA,47,[Unknown],1,920,1,920,NA,NA,1,47,NA,Stage IV,T3b,M0,KICH.Eosin.0,6
4.413910561,1.102842811,TCGA-KL-8333-01A,TCGA-KL-8333-01A-11D-2310-10,2,0.705144998,TCGA-KL-8333,KICH,69,MALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-25229,Alive,TUMOR FREE,2991,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2991,0,2991,NA,NA,0,2991,NA,Stage II,T2,M0,KICH.Eosin.0,5
9.613243888,-5.723169243,TCGA-KL-8332-01A,TCGA-KL-8332-01A-11D-2310-10,1,0.85324536,TCGA-KL-8332,KICH,55,MALE,WHITE,Kidney Chromophobe,[Not Available],2004,[Not Available],-20128,Alive,TUMOR FREE,2582,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2582,0,2582,NA,NA,0,2582,NA,Stage I,T1b,M0,KICH.Eosin.0,1
-5.396278571,1.950664483,TCGA-AY-5543-01A,TCGA-AY-5543-01A-01D-1650-10,12,0.084691707,TCGA-AY-5543,COAD,65,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-23870,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1004,0,1004,NA,NA,0,1004,NA,Stage IVA,T3,M1,GI.CIN,8
-0.04333167,4.456163287,TCGA-KL-8339-01A,TCGA-KL-8339-01A-11D-2310-10,4,0.350834566,TCGA-KL-8339,KICH,67,MALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-24545,Dead,WITH TUMOR,NA,855,[Not Available],NA,NA,NA,64,[Not Evaluated],1,855,1,855,NA,NA,1,64,NA,Stage IV,T3a,M1,KICH.Eosin.1,6
-0.357696698,5.029382748,TCGA-KL-8338-01A,TCGA-KL-8338-01A-11D-2310-10,4,0.708914929,TCGA-KL-8338,KICH,51,MALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-18667,Alive,TUMOR FREE,2633,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2633,0,2633,NA,NA,0,2633,NA,Stage III,T3a,M0,KICH.Eosin.0,6
-6.001164122,3.498360944,TCGA-25-1316-01A,TCGA-25-1316-01A-01W-0494-09,11,0.334971919,TCGA-25-1316,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-20331,Dead,WITH TUMOR,1126,1279,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],276,Progressive Disease,1,1279,1,1279,NA,NA,1,276,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,8
0.178779729,5.394852237,TCGA-KL-8341-01A,TCGA-KL-8341-01A-11D-2310-10,4,0.603318786,TCGA-KL-8341,KICH,41,MALE,ASIAN,Kidney Chromophobe,[Not Available],2006,[Not Available],-15045,Dead,WITH TUMOR,NA,754,[Not Available],NA,NA,NA,175,[Unknown],1,754,1,754,NA,NA,1,175,NA,Stage IV,T3b,M0,KICH.Eosin.0,6
9.215621009,-4.958563218,TCGA-KL-8340-01A,TCGA-KL-8340-01A-11D-2310-10,1,0.796148812,TCGA-KL-8340,KICH,34,MALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-12696,Alive,TUMOR FREE,2024,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2024,0,2024,NA,NA,0,2024,NA,Stage II,T2,M0,KICH.Eosin.0,1
-6.360018661,-1.42457133,TCGA-AA-3848-01A,TCGA-AA-3848-01A-01W-0900-09,7,0.347854943,TCGA-AA-3848,COAD,82,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-30194,Dead,WITH TUMOR,NA,306,[Not Available],NA,NA,NA,NA,[Unknown],1,306,1,306,NA,NA,1,306,NA,Stage IIIC,T3,M0,GI.CIN,2
8.847785423,-4.886157575,TCGA-25-1328-01A,TCGA-25-1328-01A-01W-0492-08,1,0.778239594,TCGA-25-1328,OV,38,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-13911,Dead,WITH TUMOR,1979,2009,[Not Available],Recurrence,[Not Applicable],[Not Applicable],244,Partial Remission/Response,1,2009,1,2009,NA,NA,1,244,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,1
9.014315936,-4.014428986,TCGA-KL-8346-01A,TCGA-KL-8346-01A-11D-2310-10,1,0.744929958,TCGA-KL-8346,KICH,62,MALE,WHITE,Kidney Chromophobe,[Not Available],2008,[Not Available],-22651,Alive,TUMOR FREE,1897,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1897,0,1897,NA,NA,0,1897,NA,Stage II,T2b,M0,KICH.Eosin.0,1
10.14821294,-1.368829916,TCGA-KL-8345-01A,TCGA-KL-8345-01A-11D-2310-10,1,0.854238621,TCGA-KL-8345,KICH,75,MALE,WHITE,Kidney Chromophobe,[Not Available],2008,[Not Available],-27412,Alive,TUMOR FREE,1665,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1665,0,1665,NA,NA,0,1665,NA,Stage III,T3a,M0,KICH.Eosin.0,1
-0.994724373,3.364664253,TCGA-20-0991-01A,TCGA-20-0991-01A-03D-0428-01,4,0.091580462,TCGA-20-0991,OV,78,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-28694,Alive,TUMOR FREE,797,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,797,0,797,0,797,0,797,NA,Stage IIB,[Not Applicable],[Not Applicable],NA,6
9.178899172,-3.669804938,TCGA-KM-8439-01A,TCGA-KM-8439-01A-11D-2310-10,1,0.655528699,TCGA-KM-8439,KICH,30,MALE,WHITE,Kidney Chromophobe,[Not Available],2011,[Not Available],-11266,Alive,WITH TUMOR,708,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,708,0,708,NA,NA,0,708,NA,Stage I,T1b,MX,KICH.Eosin.1,1
-7.924452945,2.077570433,TCGA-B8-5163-01A,TCGA-B8-5163-01A-01D-1421-08,9,0.463001565,TCGA-B8-5163,KIRC,63,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-23293,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,822,0,822,0,822,0,822,NA,Stage III,T3a,M0,KIRC.3,7
9.602028468,-5.303653371,TCGA-KL-8342-01A,TCGA-KL-8342-01A-11D-2310-10,1,0.831425584,TCGA-KL-8342,KICH,45,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-16550,Alive,TUMOR FREE,2248,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,2248,0,2248,NA,NA,0,2248,NA,Stage II,T2b,M0,KICH.Eosin.0,1
9.318336618,-5.815664994,TCGA-KL-8344-01A,TCGA-KL-8344-01A-11D-2310-10,1,0.856051923,TCGA-KL-8344,KICH,51,MALE,WHITE,Kidney Chromophobe,[Not Available],2007,[Not Available],-18742,Alive,TUMOR FREE,876,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,876,0,876,NA,NA,0,876,NA,Stage III,T3a,M0,KICH.Eosin.1,1
8.948162599,-4.421896608,TCGA-KL-8343-01A,TCGA-KL-8343-01A-11D-2310-10,1,0.784576899,TCGA-KL-8343,KICH,72,MALE,WHITE,Kidney Chromophobe,[Not Available],2007,[Not Available],-26562,Dead,WITH TUMOR,NA,2172,[Not Available],NA,NA,NA,NA,[Unknown],1,2172,1,2172,NA,NA,1,2172,NA,Stage III,T3,M0,KICH.Eosin.1,1
-7.228702121,1.670551415,TCGA-A6-3808-01A,TCGA-A6-3808-01A-01W-0995-10,0,NA,TCGA-A6-3808,COAD,73,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-26666,Alive,TUMOR FREE,1014,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1014,0,1014,NA,NA,0,1014,NA,Stage IIA,T3,M0,NA,9
9.224320119,-4.413351571,TCGA-KM-8441-01A,TCGA-KM-8441-01A-11D-2310-10,1,0.703398758,TCGA-KM-8441,KICH,61,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2011,[Not Available],-22303,Alive,WITH TUMOR,876,NA,[Not Available],NA,NA,NA,876,Complete Remission/Response,0,876,0,876,1,876,1,876,NA,Stage I,T1b,MX,KICH.Eosin.1,1
9.168232663,-5.455926709,TCGA-KM-8442-01A,TCGA-KM-8442-01A-11D-2310-10,1,0.801796277,TCGA-KM-8442,KICH,38,MALE,[Unknown],Kidney Chromophobe,[Not Available],2009,[Not Available],-14212,Alive,TUMOR FREE,1437,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1437,0,1437,NA,NA,0,1437,NA,Stage II,T2,MX,KICH.Eosin.0,1
0.099857693,2.252855465,TCGA-BG-A0MU-01A,TCGA-BG-A0MU-01A-11D-A10B-09,4,0.100408791,TCGA-BG-A0MU,UCEC,78,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28621,Alive,TUMOR FREE,617,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,617,0,617,0,617,0,617,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.CN low,6
-3.359104453,-3.279258908,TCGA-AA-3713-01A,TCGA-AA-3713-01A-21D-1719-10,8,0.59659669,TCGA-AA-3713,COAD,68,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2005,[Not Available],-24927,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,579,0,579,NA,NA,0,579,NA,Stage IV,T3,M1,GI.HM-indel,10
0.200657512,3.437864705,TCGA-24-1474-01A,TCGA-24-1474-01A-01W-0551-08,4,0.429913478,TCGA-24-1474,OV,57,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2000,[Not Available],-20902,Dead,WITH TUMOR,676,676,[Not Available],Recurrence,[Not Applicable],[Not Applicable],332,Partial Remission/Response,1,676,1,676,NA,NA,1,332,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,3
9.296282853,-5.02307038,TCGA-CW-6097-01A,TCGA-CW-6097-01A-11D-1669-08,1,0.773926018,TCGA-CW-6097,KIRC,32,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2004,[Not Available],-11701,Dead,WITH TUMOR,NA,571,[Not Available],NA,NA,NA,457,[Not Available],1,571,1,571,NA,NA,1,457,NA,Stage III,T3a,M0,NA,1
8.706161743,-4.623536938,TCGA-KM-8476-01A,TCGA-KM-8476-01A-11D-2310-10,1,0.710406768,TCGA-KM-8476,KICH,47,MALE,WHITE,Kidney Chromophobe,[Not Available],2002,[Not Available],-17240,Alive,TUMOR FREE,3745,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3745,0,3745,0,3745,0,3745,NA,Stage I,T1,MX,KICH.Eosin.0,1
9.540661349,-2.285441394,TCGA-KM-8443-01A,TCGA-KM-8443-01A-11D-2310-10,1,0.760351487,TCGA-KM-8443,KICH,57,MALE,WHITE,Kidney Chromophobe,[Not Available],2009,[Not Available],-21183,Alive,TUMOR FREE,1520,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1520,0,1520,0,1520,0,1520,NA,Stage II,T2,MX,KICH.Eosin.1,1
9.617763753,-2.528220359,TCGA-KM-8639-01A,TCGA-KM-8639-01A-11D-2397-10,1,0.783258672,TCGA-KM-8639,KICH,67,MALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-24640,Alive,TUMOR FREE,953,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,953,0,953,0,953,0,953,NA,Stage I,T1a,MX,KICH.Eosin.1,1
-7.891824154,-2.420604048,TCGA-KM-8477-01A,TCGA-KM-8477-01A-11D-2310-10,6,0.435006699,TCGA-KM-8477,KICH,56,MALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-20491,Alive,TUMOR FREE,1553,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1553,0,1553,0,1553,0,1553,NA,Stage I,T1a,MX,KICH.Eosin.1,2
-3.25538735,-3.436632591,TCGA-CM-6162-01A,TCGA-CM-6162-01A-11D-1650-10,8,0.565489201,TCGA-CM-6162,COAD,48,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-17624,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,365,0,365,NA,NA,0,365,NA,Stage IIIB,T3,M0,GI.HM-indel,10
-6.987169383,2.267339525,TCGA-AA-3852-01A,TCGA-AA-3852-01A-01W-0900-09,0,NA,TCGA-AA-3852,COAD,88,MALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2009,[Not Available],-32203,Dead,WITH TUMOR,NA,0,[Not Available],NA,NA,NA,NA,[Not Available],1,0,1,0,NA,NA,1,0,NA,Stage IIA,T3,M0,GI.GS,9
9.500427385,-5.103434027,TCGA-BP-4795-01A,TCGA-BP-4795-01A-02D-1421-08,1,0.794142726,TCGA-BP-4795,KIRC,74,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-27162,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,620,0,620,NA,NA,0,620,NA,Stage I,T1a,M0,NA,1
-2.985522041,-3.855426008,TCGA-AD-6889-01A,TCGA-AD-6889-01A-11D-1924-10,8,0.419710164,TCGA-AD-6889,COAD,76,MALE,ASIAN,Colon Adenocarcinoma,[Not Available],2005,[Not Available],NA,Dead,TUMOR FREE,NA,2532,[Not Available],NA,NA,NA,1516,Complete Remission/Response,1,2532,0,2532,1,1516,1,1516,NA,Stage IIA,T3,M0,GI.HM-indel,10
-3.752498757,-2.693437136,TCGA-AA-3833-01A,TCGA-AA-3833-01A-01W-0900-09,8,0.415998008,TCGA-AA-3833,COAD,63,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-23011,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,485,0,485,0,485,0,485,NA,Stage IIA,T3,M0,GI.HM-indel,10
-1.059124732,3.487776833,TCGA-AA-3980-01A,TCGA-AA-3980-01A-02W-0995-10,4,0.265753728,TCGA-AA-3980,COAD,89,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-32630,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,822,0,822,0,822,0,822,NA,Stage I,T2,M0,NA,5
-6.058794531,1.72111643,TCGA-AA-3712-01A,TCGA-AA-3712-01A-21D-1719-10,10,0.12190594,TCGA-AA-3712,COAD,65,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2004,[Not Available],-23831,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,0,0,0,NA,NA,0,0,NA,Stage III,T3,M0,GI.CIN,9
-0.300531063,4.18173941,TCGA-24-1104-01A,TCGA-24-1104-01A-01W-0488-09,4,0.46201419,TCGA-24-1104,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-20527,Dead,WITH TUMOR,1933,1933,[Not Available],Recurrence,[Not Applicable],[Not Applicable],959,Complete Remission/Response,1,1933,1,1933,NA,NA,1,959,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
9.794190279,-4.381779342,TCGA-CJ-5680-01A,TCGA-CJ-5680-01A-11D-1534-10,1,0.66462092,TCGA-CJ-5680,KIRC,65,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2003,[Not Available],-23778,Dead,WITH TUMOR,NA,768,[Not Available],NA,NA,NA,153,[Not Available],1,768,1,768,NA,NA,1,153,NA,Stage IV,T3a,M1,KIRC.4,1
-3.991318327,-2.532607133,TCGA-B0-5098-01A,TCGA-B0-5098-01A-01D-1421-08,8,0.430601569,TCGA-B0-5098,KIRC,53,FEMALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G3,1998,[Not Available],-19620,Dead,[Discrepancy],NA,1584,[Not Available],NA,NA,NA,NA,[Not Available],1,1584,NA,1584,NA,NA,0,1584,NA,Stage I,T1,M0,NA,10
-7.126770524,2.786351706,TCGA-CM-6680-01A,TCGA-CM-6680-01A-11D-1835-10,0,NA,TCGA-CM-6680,COAD,78,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-28701,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,366,0,366,NA,NA,0,366,NA,Stage IIIB,T3,M0,GI.CIN,7
-6.003411215,3.529561521,TCGA-CF-A3MI-01A,TCGA-CF-A3MI-01A-11D-A20D-08,11,0.574373872,TCGA-CF-A3MI,BLCA,62,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011,[Not Available],-22716,Alive,TUMOR FREE,370,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,370,0,370,0,370,0,370,NA,Stage II,T2,M0,BLCA.1,8
-3.993361936,-1.814975777,TCGA-FD-A3SN-01A,TCGA-FD-A3SN-01A-12D-A22Z-08,8,0.358811188,TCGA-FD-A3SN,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-29169,Alive,TUMOR FREE,887,NA,[Not Available],Distant Metastasis,Lung,NA,110,Progressive Disease,0,887,0,887,NA,NA,1,110,NA,Stage III,T3b,MX,BLCA.2,10
-4.522066631,-1.468797996,TCGA-GD-A2C5-01A,TCGA-GD-A2C5-01A-12D-A17V-08,8,0.380913353,TCGA-GD-A2C5,BLCA,53,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-19498,Alive,WITH TUMOR,812,NA,[Not Available],Metastatic,Lung,NA,214,Progressive Disease,0,812,0,812,NA,NA,1,214,NA,Stage IV,T3a,MX,BLCA.2,10
-4.3239599,-0.848920109,TCGA-H4-A2HO-01A,TCGA-H4-A2HO-01A-11D-A17V-08,8,0.048239477,TCGA-H4-A2HO,BLCA,53,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-19630,Alive,TUMOR FREE,46,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,46,0,46,0,46,0,46,NA,Stage III,T4a,MX,BLCA.1,10
-7.53986287,-2.186913113,TCGA-DK-A1AE-01A,TCGA-DK-A1AE-01A-11D-A13W-08,6,0.407760367,TCGA-DK-A1AE,BLCA,84,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-30707,Alive,WITH TUMOR,491,NA,[Not Available],Metastatic,Bone,NA,211,Progressive Disease,0,491,0,491,NA,NA,1,211,NA,Stage III,T3,M0,BLCA.3,2
-3.306020509,-3.22688553,TCGA-AX-A3G9-01A,TCGA-AX-A3G9-01A-11D-A228-09,8,0.50437411,TCGA-AX-A3G9,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-23361,Alive,NA,558,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,558,0,558,NA,NA,0,558,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
0.001784044,3.872048215,TCGA-25-2397-01A,TCGA-25-2397-01A-01D-0704-01,4,0.210086918,TCGA-25-2397,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-21581,Dead,NA,365,365,[Not Available],NA,NA,NA,NA,[Not Available],1,365,NA,365,NA,NA,0,365,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-6.287214135,2.094358157,TCGA-24-2035-01A,TCGA-24-2035-01A-01W-0722-08,0,NA,TCGA-24-2035,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1996,[Not Available],-23855,Dead,WITH TUMOR,857,857,[Not Available],Recurrence,[Not Applicable],[Not Applicable],287,Partial Remission/Response,1,857,1,857,NA,NA,1,287,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
9.81118513,-4.091120215,TCGA-29-2429-01A,TCGA-29-2429-01A-01D-1526-09,1,0.634996764,TCGA-29-2429,OV,79,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-29156,Dead,WITH TUMOR,NA,421,[Not Available],NA,NA,NA,NA,[Unknown],1,421,1,421,NA,NA,1,421,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-3.071859447,-3.718104034,TCGA-DK-A3WW-01A,TCGA-DK-A3WW-01A-22D-A23M-08,8,0.381302378,TCGA-DK-A3WW,BLCA,57,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-20909,Alive,TUMOR FREE,633,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,633,0,633,0,633,0,633,NA,Stage III,T3,M0,BLCA.3,10
-0.964897027,3.198890315,TCGA-GV-A3JW-01A,TCGA-GV-A3JW-01A-11D-A20D-08,4,0.042463132,TCGA-GV-A3JW,BLCA,74,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27091,Alive,WITH TUMOR,649,NA,[Not Available],Distant Metastasis,Bone,NA,271,Stable Disease,0,649,0,649,NA,NA,1,271,NA,Stage II,T2,MX,BLCA.1,6
-5.64277721,1.047998655,TCGA-K4-A3WS-01A,TCGA-K4-A3WS-01A-11D-A22Z-08,0,NA,TCGA-K4-A3WS,BLCA,66,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-24124,Alive,TUMOR FREE,761,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,761,0,761,0,761,0,761,NA,Stage III,T3a,MX,BLCA.2,10
-6.864956567,-2.409642825,TCGA-GU-A42Q-01A,TCGA-GU-A42Q-01A-11D-A23U-08,0,NA,TCGA-GU-A42Q,BLCA,67,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24534,Dead,TUMOR FREE,NA,344,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,344,0,344,0,344,0,344,NA,Stage III,T3b,M0,NA,2
-3.870714072,0.851247095,TCGA-CF-A1HS-01A,TCGA-CF-A1HS-01A-11D-A13W-08,0,NA,TCGA-CF-A1HS,BLCA,75,FEMALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-27565,Alive,WITH TUMOR,382,NA,[Not Available],Distant Metastasis,"Other, specify",Pelvis,133,Complete Remission/Response,0,382,0,382,1,133,1,133,NA,Stage III,T3,M0,BLCA.3,10
-3.006853295,-3.912413598,TCGA-A5-A2K3-01A,TCGA-A5-A2K3-01A-11D-A17W-09,8,0.216390377,TCGA-A5-A2K3,UCEC,68,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24907,Alive,TUMOR FREE,2012,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2012,0,2012,0,2012,0,2012,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-4.493528979,-1.648286632,TCGA-DK-A1A7-01A,TCGA-DK-A1A7-01A-11D-A13W-08,8,0.40981323,TCGA-DK-A1A7,BLCA,67,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-24499,Alive,WITH TUMOR,560,NA,[Not Available],Metastatic,Lung,NA,112,[Not Available],0,560,0,560,NA,NA,1,112,NA,Stage IV,T3,M0,BLCA.1,10
-2.733460668,-4.363495872,TCGA-A5-A0G2-01A,TCGA-A5-A0G2-01A-11W-A062-09,0,NA,TCGA-A5-A0G2,UCEC,57,FEMALE,ASIAN,Serous endometrial adenocarcinoma,G3,1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20953,Alive,WITH TUMOR,4549,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4549,0,4549,0,4549,0,4549,NA,Stage IIIB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-5.103159461,-1.324729605,TCGA-FJ-A3ZE-01A,TCGA-FJ-A3ZE-01A-11D-A23M-08,0,NA,TCGA-FJ-A3ZE,BLCA,65,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-23866,Dead,WITH TUMOR,NA,324,[Not Available],Distant Metastasis,Bone,NA,152,Progressive Disease,1,324,1,324,NA,NA,1,152,NA,Stage IV,[Not Available],M1,BLCA.1,10
0.413335156,4.584742467,TCGA-CU-A0YN-01A,TCGA-CU-A0YN-01A-21D-A10S-08,4,0.445914389,TCGA-CU-A0YN,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005,[Not Available],-21927,Dead,NA,NA,393,[Not Available],NA,NA,NA,NA,[Not Available],1,393,NA,393,NA,NA,0,393,NA,Stage III,T3a,M0,BLCA.3,6
0.008651734,4.346830192,TCGA-31-1959-01A,TCGA-31-1959-01A-01W-0699-08,4,0.407906833,TCGA-31-1959,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2009,[Not Available],-18247,Alive,WITH TUMOR,67,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,67,0,67,NA,NA,0,67,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
-4.491745709,-1.987067922,TCGA-EY-A2OP-01A,TCGA-EY-A2OP-01A-11D-A19Y-09,8,0.439787889,TCGA-EY-A2OP,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23090,Alive,TUMOR FREE,944,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,944,0,944,0,944,0,944,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-2.72146571,-4.373628143,TCGA-FI-A2D0-01A,TCGA-FI-A2D0-01A-11D-A17D-09,0,NA,TCGA-FI-A2D0,UCEC,55,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Peri (6-12 months since last menstrual period),-20393,Alive,TUMOR FREE,1213,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1213,0,1213,0,1213,0,1213,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-6.895456702,-2.21620468,TCGA-24-2030-01A,TCGA-24-2030-01A-01W-0722-08,6,0.27106785,TCGA-24-2030,OV,87,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1995,[Not Available],-31900,Dead,WITH TUMOR,1641,1701,[Not Available],Recurrence,[Not Applicable],[Not Applicable],646,Complete Remission/Response,1,1701,1,1701,1,646,1,646,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
-4.672507503,-1.896349962,TCGA-GV-A3QI-01A,TCGA-GV-A3QI-01A-11D-A21Z-08,8,0.266214204,TCGA-GV-A3QI,BLCA,47,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-17383,Alive,WITH TUMOR,1110,NA,[Not Available],Distant Metastasis,"Other, specify",Abdominal wall,768,Complete Remission/Response,0,1110,0,1110,1,768,1,768,NA,Stage III,T3b,MX,BLCA.1,10
-7.8398116,1.98276152,TCGA-B8-5159-01A,TCGA-B8-5159-01A-01D-1421-08,9,0.425931887,TCGA-B8-5159,KIRC,61,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2010,[Not Available],-22462,Alive,TUMOR FREE,722,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,722,0,722,0,722,0,722,NA,Stage I,T1a,M0,KIRC.1,7
-6.905077575,-2.377478277,TCGA-GV-A3QF-01A,TCGA-GV-A3QF-01A-31D-A22Z-08,6,0.016572191,TCGA-GV-A3QF,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-28890,Dead,TUMOR FREE,NA,617,[Not Available],NA,NA,NA,NA,Stable Disease,1,617,0,617,NA,NA,0,617,NA,Stage IV,T3b,MX,BLCA.1,2
-7.460383599,2.258431371,TCGA-AP-A0LV-01A,TCGA-AP-A0LV-01A-11W-A062-09,9,0.043737583,TCGA-AP-A0LV,UCEC,39,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14556,Alive,TUMOR FREE,763,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,763,0,763,0,763,0,763,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-3.93518372,0.343473279,TCGA-BS-A0UA-01A,TCGA-BS-A0UA-01A-11D-A122-09,0,NA,TCGA-BS-A0UA,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24872,Alive,TUMOR FREE,3495,NA,[Not Available],Locoregional Disease,"Other, specify",endometrium,520,Complete Remission/Response,0,3495,0,3495,1,520,1,520,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-3.279697078,-3.316875447,TCGA-MV-A51V-01A,TCGA-MV-A51V-01A-11D-A26M-08,8,0.593600624,TCGA-MV-A51V,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27430,Alive,TUMOR FREE,410,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,410,0,410,0,410,0,410,NA,Stage III,T3a,M0,NA,10
1.962628772,1.89455266,TCGA-E7-A3X6-01A,TCGA-E7-A3X6-01A-12D-A22Z-08,3,0.55725996,TCGA-E7-A3X6,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011,[Not Available],-25584,Dead,WITH TUMOR,NA,904,[Not Available],Distant Metastasis,Bone,NA,369,Complete Remission/Response,1,904,1,904,1,369,1,369,NA,Stage II,T2,M0,BLCA.1,3
-4.997952786,-1.627766898,TCGA-DK-A1A6-01A,TCGA-DK-A1A6-01A-11D-A13W-08,8,0.121340017,TCGA-DK-A1A6,BLCA,53,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-19554,Alive,TUMOR FREE,2020,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2020,0,2020,NA,NA,0,2020,NA,Stage IV,T2a,M0,BLCA.1,10
-0.811013857,2.852163578,TCGA-DK-A2HX-01A,TCGA-DK-A2HX-01A-12D-A18F-08,4,0.174526798,TCGA-DK-A2HX,BLCA,80,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-29332,Dead,TUMOR FREE,NA,1420,[Not Available],NA,NA,NA,NA,[Not Available],1,1420,0,1420,NA,NA,0,1420,NA,Stage IV,T3,M0,BLCA.2,6
-1.734116947,2.009387688,TCGA-G2-A2EL-01A,TCGA-G2-A2EL-01A-12D-A18F-08,0,NA,TCGA-G2-A2EL,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-28370,Dead,WITH TUMOR,NA,819,[Not Available],Distant Metastasis,Bone,NA,105,Stable Disease,1,819,1,819,NA,NA,1,105,NA,Stage II,[Not Available],M0,NA,10
9.846002673,-1.782007724,TCGA-CF-A3MF-01A,TCGA-CF-A3MF-01A-12D-A21A-08,1,0.760409533,TCGA-CF-A3MF,BLCA,34,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011,[Not Available],-12557,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,383,0,383,0,383,0,383,NA,Stage III,T3,M0,BLCA.1,1
-1.53819583,2.395063396,TCGA-C4-A0EZ-01A,TCGA-C4-A0EZ-01A-21D-A10S-08,0,NA,TCGA-C4-A0EZ,BLCA,69,FEMALE,[Not Available],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-25202,Dead,WITH TUMOR,NA,273,[Not Available],NA,NA,NA,NA,Partial Remission/Response,1,273,1,273,NA,NA,1,273,NA,Stage IV,T3a,M1,NA,3
-4.276702167,-1.739766816,TCGA-DK-A1A5-01A,TCGA-DK-A1A5-01A-11D-A13W-08,8,0.468892079,TCGA-DK-A1A5,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-29111,Dead,TUMOR FREE,NA,65,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,65,0,65,0,65,0,65,NA,Stage II,T2b,M0,BLCA.2,10
0.286025749,4.457925558,TCGA-13-1496-01A,TCGA-13-1496-01A-01W-0545-08,4,0.500477669,TCGA-13-1496,OV,65,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-23993,Dead,NA,129,129,[Not Available],NA,NA,NA,NA,[Not Available],1,129,NA,129,NA,NA,0,129,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
9.976691833,-2.169964926,TCGA-25-2042-01A,TCGA-25-2042-01A-01W-0799-08,1,0.766091826,TCGA-25-2042,OV,60,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-22127,Dead,WITH TUMOR,396,396,[Not Available],NA,NA,NA,NA,Progressive Disease,1,396,1,396,NA,NA,1,396,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.460012749,1.759423121,TCGA-A6-5656-01A,TCGA-A6-5656-01A-21D-A270-10,10,0.084800289,TCGA-A6-5656,COAD,74,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-27184,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1001,0,1001,0,1001,0,1001,NA,Stage I,T2,M0,NA,7
-6.513298203,1.53346799,TCGA-B5-A11I-01A,TCGA-B5-A11I-01A-11D-A10M-09,10,0.116670553,TCGA-B5-A11I,UCEC,65,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23857,Alive,TUMOR FREE,2303,NA,[Not Available],Metastatic,Lung,NA,705,Complete Remission/Response,0,2303,0,2303,NA,NA,1,705,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.CN high,7
9.432799286,-3.233209243,TCGA-13-2065-01A,TCGA-13-2065-01A-01D-1526-09,1,0.736633196,TCGA-13-2065,OV,71,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2009,[Not Available],-25973,Alive,WITH TUMOR,1993,NA,[Not Available],NA,[Not Applicable],[Not Applicable],946,Complete Remission/Response,0,1993,0,1993,1,946,1,946,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
-2.987221619,-3.985760737,TCGA-EY-A1GI-01A,TCGA-EY-A1GI-01A-11D-A13L-09,0,NA,TCGA-EY-A1GI,UCEC,52,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19117,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,710,0,710,0,710,0,710,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-4.778202354,0.375867838,TCGA-BT-A20O-01A,TCGA-BT-A20O-01A-21D-A14W-08,0,NA,TCGA-BT-A20O,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003,[Not Available],-27534,Dead,WITH TUMOR,NA,370,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,315,Progressive Disease,1,370,1,370,NA,NA,1,315,NA,Stage III,T3a,MX,BLCA.4,10
9.674798557,-2.420199207,TCGA-CJ-4901-01A,TCGA-CJ-4901-01A-01D-1429-08,1,0.747736569,TCGA-CJ-4901,KIRC,47,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-17396,Alive,TUMOR FREE,1450,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1450,0,1450,NA,NA,0,1450,NA,Stage III,T3b,M0,KIRC.3,1
-4.463218238,-1.597420252,TCGA-FJ-A3Z7-01A,TCGA-FJ-A3Z7-01A-12D-A23M-08,8,0.429986235,TCGA-FJ-A3Z7,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-28052,Alive,TUMOR FREE,945,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,945,0,945,NA,NA,0,945,NA,Stage IV,T4a,MX,BLCA.2,10
-2.217776508,1.599269813,TCGA-GV-A3QH-01A,TCGA-GV-A3QH-01A-11D-A21Z-08,5,0.211171182,TCGA-GV-A3QH,BLCA,67,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-24681,Dead,TUMOR FREE,NA,258,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,125,Stable Disease,1,258,0,258,NA,NA,1,125,NA,Stage II,[Not Available],MX,BLCA.1,10
-6.099133662,1.380111906,TCGA-DK-A1AB-01A,TCGA-DK-A1AB-01A-11D-A13W-08,10,0.202050318,TCGA-DK-A1AB,BLCA,74,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-27126,Dead,NA,NA,508,[Not Available],Metastatic,Lung,NA,364,Progressive Disease,1,508,NA,508,NA,NA,1,364,NA,Stage IV,T4a,M0,BLCA.3,10
2.927771185,3.61584918,TCGA-AX-A1CI-01A,TCGA-AX-A1CI-01A-11D-A135-09,0,NA,TCGA-AX-A1CI,UCEC,61,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582,Alive,TUMOR FREE,2600,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2600,0,2600,NA,NA,0,2600,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,1
10.08579703,-2.838719042,TCGA-FD-A3SQ-01A,TCGA-FD-A3SQ-01A-21D-A22Z-08,1,0.743977784,TCGA-FD-A3SQ,BLCA,62,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-22687,Dead,WITH TUMOR,NA,1423,[Not Available],Locoregional (Urothelial tumor event),"Other, specify",sigmoid colon,991,Stable Disease,1,1423,1,1423,NA,NA,1,991,NA,Stage IV,T3a,MX,BLCA.2,1
-5.583026232,1.247620129,TCGA-D1-A17A-01A,TCGA-D1-A17A-01A-11D-A12J-09,0,NA,TCGA-D1-A17A,UCEC,59,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21560,Alive,TUMOR FREE,48,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,48,0,48,0,48,0,48,NA,Stage IIA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-5.34142806,1.687230661,TCGA-DK-A3IV-01A,TCGA-DK-A3IV-01A-22D-A21A-08,0,NA,TCGA-DK-A3IV,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-22237,Dead,WITH TUMOR,NA,294,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,212,Stable Disease,1,294,1,294,NA,NA,1,212,NA,Stage II,[Not Available],M0,BLCA.1,6
9.003641776,-2.588333744,TCGA-CF-A3MG-01A,TCGA-CF-A3MG-01A-11D-A20D-08,1,0.653110026,TCGA-CF-A3MG,BLCA,48,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011,[Not Available],-17600,Alive,TUMOR FREE,369,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,369,0,369,0,369,0,369,NA,Stage II,T2,M0,BLCA.1,6
-3.446204488,-3.144863876,TCGA-DK-A2I4-01A,TCGA-DK-A2I4-01A-11D-A21A-08,8,0.308810999,TCGA-DK-A2I4,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001,[Not Available],-29037,Alive,TUMOR FREE,4343,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4343,0,4343,0,4343,0,4343,NA,Stage III,T3b,M0,BLCA.4,10
8.434296678,-3.946859317,TCGA-CU-A0YO-01A,TCGA-CU-A0YO-01A-11D-A10S-08,1,0.573861911,TCGA-CU-A0YO,BLCA,84,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-30817,Dead,WITH TUMOR,NA,149,[Not Available],Metastatic,"Other, specify",peritoneum,118,Complete Remission/Response,1,149,1,149,NA,NA,1,118,NA,Stage IV,T3a,MX,BLCA.2,6
-5.176498974,-1.471793059,TCGA-CF-A1HR-01A,TCGA-CF-A1HR-01A-11D-A13W-08,8,0.085597694,TCGA-CF-A1HR,BLCA,62,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-22777,Alive,WITH TUMOR,389,NA,[Not Available],Distant Metastasis,Liver,NA,294,Complete Remission/Response,0,389,0,389,1,294,1,294,NA,Stage III,T3,M0,BLCA.2,10
-7.124653123,1.696326174,TCGA-CM-5349-01A,TCGA-CM-5349-01A-21D-1719-10,0,NA,TCGA-CM-5349,COAD,68,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-24867,Alive,TUMOR FREE,915,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,915,0,915,NA,NA,0,915,NA,Stage IIA,T3,M0,GI.CIN,7
-5.469627763,1.276581004,TCGA-23-1122-01A,TCGA-23-1122-01A-01W-0486-08,0,NA,TCGA-23-1122,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1998,[Not Available],-19537,Dead,WITH TUMOR,NA,1189,[Not Available],Recurrence,[Not Applicable],[Not Applicable],447,Complete Remission/Response,1,1189,1,1189,1,447,1,447,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,9
4.488208754,1.085397576,TCGA-BL-A13I-01A,TCGA-BL-A13I-01A-11D-A271-08,2,0.448718857,TCGA-BL-A13I,BLCA,57,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-20885,Dead,WITH TUMOR,NA,223,[Not Available],Metastatic,NA,NA,216,Progressive Disease,1,223,1,223,NA,NA,1,216,NA,Stage III,T3,M0,BLCA.4,5
-3.37277694,-3.196614911,TCGA-FI-A2D6-01A,TCGA-FI-A2D6-01A-11D-A17D-09,8,0.541643697,TCGA-FI-A2D6,UCEC,74,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27060,Dead,TUMOR FREE,NA,767,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,767,0,767,0,767,0,767,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-4.483292352,-0.340768965,TCGA-E7-A4IJ-01A,TCGA-E7-A4IJ-01A-31D-A26M-08,0,NA,TCGA-E7-A4IJ,BLCA,56,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-20723,Dead,WITH TUMOR,NA,674,[Not Available],Distant Metastasis,Bone,NA,620,Complete Remission/Response,1,674,1,674,1,620,1,620,NA,Stage II,T2b,M0,NA,10
4.316886341,1.265713357,TCGA-D1-A0ZN-01A,TCGA-D1-A0ZN-01A-11D-A122-09,2,0.430857665,TCGA-D1-A0ZN,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Peri (6-12 months since last menstrual period),-22026,Alive,TUMOR FREE,512,NA,[Not Available],New Primary Tumor,"Other, specify",Breast left,448,Complete Remission/Response,0,512,0,512,0,512,1,448,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,5
-5.952511898,1.454508275,TCGA-EY-A1GW-01A,TCGA-EY-A1GW-01A-22D-A13L-09,0,NA,TCGA-EY-A1GW,UCEC,73,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26979,Dead,WITH TUMOR,NA,337,[Not Available],Metastatic,Liver,NA,190,Progressive Disease,1,337,1,337,NA,NA,1,190,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-0.84616189,2.329811783,TCGA-BT-A20X-01A,TCGA-BT-A20X-01A-11D-A16O-08,0,NA,TCGA-BT-A20X,BLCA,56,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-20519,Dead,WITH TUMOR,NA,251,[Not Available],NA,NA,NA,NA,Progressive Disease,1,251,1,251,NA,NA,1,251,NA,Stage IV,T4a,M0,NA,6
-0.847645758,4.091153414,TCGA-K4-A3WU-01B,TCGA-K4-A3WU-01B-11D-A23M-08,4,0.25303446,TCGA-K4-A3WU,BLCA,87,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-32134,Alive,TUMOR FREE,105,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,105,0,105,NA,NA,0,105,NA,Stage III,T4a,MX,BLCA.2,10
8.885607732,-5.353629523,TCGA-BP-4992-01A,TCGA-BP-4992-01A-01D-1462-08,1,0.849906132,TCGA-BP-4992,KIRC,66,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-24438,Alive,TUMOR FREE,501,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,501,0,501,NA,NA,0,501,NA,Stage I,T1b,M0,KIRC.2,1
-3.512929003,-2.883223194,TCGA-G2-A2EO-01A,TCGA-G2-A2EO-01A-11D-A17V-08,8,0.438106489,TCGA-G2-A2EO,BLCA,69,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-25440,Dead,TUMOR FREE,NA,1804,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1804,0,1804,0,1804,0,1804,NA,Stage III,T3a,M0,BLCA.2,10
-4.191266407,-2.168109523,TCGA-BT-A20J-01A,TCGA-BT-A20J-01A-11D-A14W-08,8,0.425196429,TCGA-BT-A20J,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,1999,[Not Available],-27646,Dead,WITH TUMOR,NA,579,[Not Available],Distant Metastasis,"Other, specify",Adrenal,254,Progressive Disease,1,579,1,579,NA,NA,1,254,NA,Stage II,T2b,MX,BLCA.4,10
-2.504684022,1.134895846,TCGA-DK-A3IK-01A,TCGA-DK-A3IK-01A-32D-A21A-08,5,0.257884983,TCGA-DK-A3IK,BLCA,87,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-32076,Dead,TUMOR FREE,NA,146,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,146,0,146,NA,NA,0,146,NA,Stage IV,T3,M0,BLCA.2,10
-4.374448697,-1.73821966,TCGA-DK-A3IN-01A,TCGA-DK-A3IN-01A-11D-A20D-08,8,0.443687948,TCGA-DK-A3IN,BLCA,72,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-26562,Dead,TUMOR FREE,NA,250,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,250,0,250,0,250,0,250,NA,Stage III,T4a,M0,BLCA.2,10
-4.027697452,-1.555267697,TCGA-FD-A3B6-01A,TCGA-FD-A3B6-01A-21D-A20D-08,0,NA,TCGA-FD-A3B6,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27541,Dead,TUMOR FREE,NA,1005,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,1005,0,1005,0,1005,0,1005,NA,Stage II,T2b,MX,BLCA.4,10
-3.11855788,1.603215914,TCGA-DK-A1AD-01A,TCGA-DK-A1AD-01A-11D-A13W-08,0,NA,TCGA-DK-A1AD,BLCA,69,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2002,[Not Available],-25317,Alive,TUMOR FREE,3420,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3420,0,3420,NA,NA,0,3420,NA,Stage IV,T3b,M0,BLCA.2,6
0.10950209,3.437374355,TCGA-29-1783-01A,TCGA-29-1783-01A-01W-0633-09,4,0.346221453,TCGA-29-1783,OV,58,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-21284,Alive,TUMOR FREE,220,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,220,0,220,NA,NA,0,220,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,3
-0.810911269,4.76556093,TCGA-23-1027-01A,TCGA-23-1027-01A-02W-0486-08,4,0.460684592,TCGA-23-1027,OV,48,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-17588,Dead,NA,966,976,[Not Available],Recurrence,[Not Applicable],[Not Applicable],114,Progressive Disease,1,976,NA,976,NA,NA,1,114,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
0.25075433,3.473335004,TCGA-13-0897-01A,TCGA-13-0897-01A-01W-0420-08,4,0.298314187,TCGA-13-0897,OV,54,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-19894,Dead,WITH TUMOR,NA,2182,[Not Available],Recurrence,[Not Applicable],[Not Applicable],554,Complete Remission/Response,1,2182,1,2182,1,554,1,554,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,3
-7.683395286,2.416788365,TCGA-AJ-A3BK-01A,TCGA-AJ-A3BK-01A-11D-A19Y-09,9,0.11700558,TCGA-AJ-A3BK,UCEC,68,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24943,Alive,TUMOR FREE,1031,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1031,0,1031,0,1031,0,1031,NA,Stage IC,[Not Applicable],[Not Applicable],NA,7
9.240338525,-3.757566815,TCGA-CZ-5467-01A,TCGA-CZ-5467-01A-01D-1501-10,1,0.693484121,TCGA-CZ-5467,KIRC,86,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-31473,Dead,WITH TUMOR,NA,73,[Not Available],NA,NA,NA,62,[Not Available],1,73,1,73,NA,NA,1,62,NA,Stage III,T3a,M0,KIRC.1,1
9.428528105,-4.936282173,TCGA-AX-A06L-01A,TCGA-AX-A06L-01A-11D-A122-09,1,0.751061344,TCGA-AX-A06L,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294,Alive,TUMOR FREE,1845,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1845,0,1845,0,1845,0,1845,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,1
-4.918555735,1.293000105,TCGA-DK-A3IQ-01A,TCGA-DK-A3IQ-01A-31D-A20D-08,0,NA,TCGA-DK-A3IQ,BLCA,74,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27194,Dead,WITH TUMOR,NA,539,[Not Available],Locoregional (Urothelial tumor event),Lymph Node Only,NA,250,Complete Remission/Response,1,539,1,539,1,250,1,250,NA,Stage III,T3,M0,NA,10
8.928784743,-2.978550333,TCGA-GC-A3BM-01A,TCGA-GC-A3BM-01A-11D-A22Z-08,1,0.678523546,TCGA-GC-A3BM,BLCA,70,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-25609,Dead,WITH TUMOR,NA,651,[Not Available],NA,NA,NA,NA,Progressive Disease,1,651,1,651,NA,NA,1,651,NA,Stage II,T2b,M0,BLCA.1,6
-3.560128439,-2.918455526,TCGA-DK-A2I1-01A,TCGA-DK-A2I1-01A-11D-A17V-08,8,0.482620212,TCGA-DK-A2I1,BLCA,73,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-26726,Alive,TUMOR FREE,546,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,546,0,546,0,546,0,546,NA,Stage II,T2b,M0,BLCA.2,10
-4.249258406,0.642306692,TCGA-CU-A0YR-01A,TCGA-CU-A0YR-01A-12D-A10S-08,0,NA,TCGA-CU-A0YR,BLCA,83,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-30674,Dead,WITH TUMOR,NA,460,[Not Available],Metastatic,Lymph Node Only,NA,219,Complete Remission/Response,1,460,1,460,NA,NA,1,219,NA,Stage IV,T2,M0,BLCA.2,10
-3.229216928,-3.387337839,TCGA-DK-A3X1-01A,TCGA-DK-A3X1-01A-12D-A22Z-08,8,0.57905177,TCGA-DK-A3X1,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-28757,Alive,TUMOR FREE,2009,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2009,0,2009,0,2009,0,2009,NA,Stage III,T3,M0,BLCA.2,10
-4.532613283,-1.425048642,TCGA-GV-A3JX-01A,TCGA-GV-A3JX-01A-11D-A20D-08,8,0.406569609,TCGA-GV-A3JX,BLCA,59,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-21888,Alive,TUMOR FREE,581,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,581,0,581,0,581,0,581,NA,Stage III,T3b,MX,BLCA.2,10
-0.863171833,3.742596159,TCGA-04-1356-01A,TCGA-04-1356-01A-01W-0492-08,4,0.35664247,TCGA-04-1356,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-22855,Dead,WITH TUMOR,NA,1499,[Not Available],Recurrence,[Not Applicable],[Not Applicable],156,Progressive Disease,1,1499,1,1499,NA,NA,1,156,NA,Stage IIC,[Not Applicable],[Not Applicable],NA,5
-3.523839181,-3.05906296,TCGA-D1-A177-01A,TCGA-D1-A177-01A-21D-A12J-09,8,0.436553779,TCGA-D1-A177,UCEC,70,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25602,Alive,TUMOR FREE,548,NA,[Not Available],Locoregional Disease,"Other, specify",paraaortic lymph nodes,347,Complete Remission/Response,0,548,0,548,1,347,1,347,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
1.348013402,3.300898265,TCGA-B5-A1MY-01A,TCGA-B5-A1MY-01A-11D-A142-09,0,NA,TCGA-B5-A1MY,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805,Dead,WITH TUMOR,NA,361,[Not Available],Locoregional Disease,"Other, specify",peritoneum,333,[Not Available],1,361,1,361,NA,NA,1,333,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.CN high,1
-3.504629279,-2.864393179,TCGA-DI-A0WH-01A,TCGA-DI-A0WH-01A-12D-A12J-09,8,0.350234713,TCGA-DI-A0WH,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-23692,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,496,0,496,0,496,0,496,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-4.530657232,-2.104634346,TCGA-D1-A1NY-01A,TCGA-D1-A1NY-01A-11D-A16D-09,8,0.25664204,TCGA-D1-A1NY,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24683,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,513,0,513,0,513,0,513,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-0.316833955,4.605966346,TCGA-WK-A8XY-01A,TCGA-WK-A8XY-01A-11D-A37C-09,4,0.456737138,TCGA-WK-A8XY,SARC,53,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-19597,Dead,WITH TUMOR,NA,1991,[Not Available],Locoregional Recurrence,"Other, specify",Intraabdominal,103,[Not Available],1,1991,1,1991,NA,NA,1,103,NA,NA,NA,NA,NA,6
-0.602052697,3.917341175,TCGA-WK-A8XX-01A,TCGA-WK-A8XX-01A-11D-A37C-09,4,0.470649912,TCGA-WK-A8XX,SARC,70,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-25701,Dead,WITH TUMOR,NA,1164,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneum,111,[Not Available],1,1164,1,1164,1,111,1,111,NA,NA,NA,NA,NA,5
-6.463727705,1.658664294,TCGA-61-1730-01A,TCGA-61-1730-01A-01W-0639-09,10,7.78E-05,TCGA-61-1730,OV,78,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-28508,Dead,WITH TUMOR,132,132,[Not Available],NA,NA,NA,NA,[Not Available],1,132,1,132,NA,NA,1,132,NA,Stage IC,[Not Applicable],[Not Applicable],NA,8
-5.803688326,-2.056593651,TCGA-WP-A9GB-01A,TCGA-WP-A9GB-01A-11D-A37C-09,0,NA,TCGA-WP-A9GB,SARC,59,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],NA,Dead,WITH TUMOR,NA,261,[Not Available],Distant Metastasis,Lung,NA,214,[Not Available],1,261,1,261,NA,NA,1,214,NA,NA,NA,NA,NA,2
9.641584572,-5.550772251,TCGA-X2-A95T-01A,TCGA-X2-A95T-01A-11D-A37C-09,1,0.829193075,TCGA-X2-A95T,SARC,49,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2009,[Not Available],-18079,Alive,TUMOR FREE,1927,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1927,0,1927,0,1927,0,1927,NA,NA,NA,NA,NA,1
0.384052445,5.034185552,TCGA-WK-A8XZ-01A,TCGA-WK-A8XZ-01A-11D-A37C-09,4,0.500640922,TCGA-WK-A8XZ,SARC,56,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2007,[Not Available],-20460,Dead,WITH TUMOR,NA,1722,[Not Available],Distant Metastasis,"Other, specify",Scalp,89,[Not Available],1,1722,1,1722,1,89,1,89,NA,NA,NA,NA,NA,6
-2.319283148,2.366151593,TCGA-13-0807-01B,TCGA-13-0807-01B-02W-0420-08,0,NA,TCGA-13-0807,OV,54,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-19890,Dead,NA,414,414,[Not Available],NA,NA,NA,NA,[Not Available],1,414,NA,414,NA,NA,0,414,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
8.916740292,-4.79303338,TCGA-04-1644-01B,TCGA-04-1644-01B-01D-1526-09,1,0.728718491,TCGA-04-1644,OV,48,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-17725,Dead,WITH TUMOR,NA,1487,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],634,Partial Remission/Response,1,1487,1,1487,NA,NA,1,634,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,1
9.498206765,-3.155470669,TCGA-B4-5835-01A,TCGA-B4-5835-01A-11D-1669-08,1,0.727913405,TCGA-B4-5835,KIRC,64,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-23408,Alive,TUMOR FREE,16,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,16,0,16,NA,NA,0,16,NA,Stage I,T1,M0,NA,1
9.620233841,-5.636138664,TCGA-X6-A7W8-01A,TCGA-X6-A7W8-01A-21D-A351-09,1,0.862989646,TCGA-X6-A7W8,SARC,89,MALE,WHITE,Myxofibrosarcoma,[Not Available],2011,[Not Available],-32848,Dead,WITH TUMOR,NA,804,[Not Available],Distant Metastasis,Lung,NA,146,[Not Available],1,804,1,804,NA,NA,1,146,NA,NA,NA,NA,NA,1
-3.870030797,-2.462366102,TCGA-X6-A7WA-01A,TCGA-X6-A7WA-01A-12D-A351-09,8,0.427675794,TCGA-X6-A7WA,SARC,90,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2012,[Not Available],-32872,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1092,0,1092,NA,NA,0,1092,NA,NA,NA,NA,NA,10
8.923078491,-2.566835594,TCGA-X6-A8C2-01A,TCGA-X6-A8C2-01A-11D-A36J-09,1,0.677131131,TCGA-X6-A8C2,SARC,56,MALE,WHITE,Undifferentiated Pleomorphic Sarcoma (UPS),[Not Available],2012,[Not Available],-20507,Alive,WITH TUMOR,1070,NA,[Not Available],New Primary Tumor,Lung,NA,7,[Not Available],0,1070,0,1070,NA,NA,1,7,NA,NA,NA,NA,NA,3
-3.736698517,-2.605450032,TCGA-X6-A7WB-01A,TCGA-X6-A7WB-01A-11D-A351-09,8,0.403915645,TCGA-X6-A7WB,SARC,58,FEMALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-21467,Dead,WITH TUMOR,NA,550,[Not Available],Distant Metastasis,Lung,NA,104,[Not Available],1,550,1,550,NA,NA,1,104,NA,NA,NA,NA,NA,10
0.289280649,4.991531462,TCGA-04-1336-01A,TCGA-04-1336-01A-01W-0486-08,4,0.670954042,TCGA-04-1336,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-20271,Alive,TUMOR FREE,1495,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1495,0,1495,0,1495,0,1495,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,6
0.64390195,3.477022577,TCGA-04-1342-01A,TCGA-04-1342-01A-01W-0486-08,0,NA,TCGA-04-1342,OV,80,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2006,[Not Available],-29501,Dead,WITH TUMOR,NA,563,[Not Available],NA,NA,NA,NA,Progressive Disease,1,563,1,563,NA,NA,1,563,NA,Stage IV,[Not Applicable],[Not Applicable],NA,10
-0.388930086,4.122764004,TCGA-X6-A7WC-01A,TCGA-X6-A7WC-01A-12D-A351-09,4,0.371196864,TCGA-X6-A7WC,SARC,74,MALE,WHITE,Leiomyosarcoma (LMS),[Not Available],2011,[Not Available],-27252,Alive,TUMOR FREE,1379,NA,[Not Available],Distant Metastasis,Lung,NA,301,[Not Available],0,1379,0,1379,1,301,1,301,NA,NA,NA,NA,NA,3
-3.135558622,-3.552188798,TCGA-AX-A2HA-01A,TCGA-AX-A2HA-01A-12D-A18P-09,8,0.532851764,TCGA-AX-A2HA,UCEC,35,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2005,[Not Available],-13142,Alive,TUMOR FREE,2475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2475,0,2475,0,2475,0,2475,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
0.2536276,2.322489951,TCGA-B0-5701-01A,TCGA-B0-5701-01A-11D-1534-10,4,0.03004951,TCGA-B0-5701,KIRC,65,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2007,[Not Available],-23915,Alive,TUMOR FREE,2461,NA,[Not Available],NA,NA,NA,224,Complete Remission/Response,0,2461,0,2461,1,224,1,224,NA,Stage III,T3b,M0,KIRC.4,6
2.135353067,1.773949449,TCGA-KK-A8ID-01A,TCGA-KK-A8ID-01A-11D-A364-08,3,0.457924004,TCGA-KK-A8ID,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25851,Alive,TUMOR FREE,2107,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2107,0,2107,0,2107,0,2107,NA,[Not Applicable],T3b,[Not Applicable],PRAD.8-other,3
2.081639344,1.831361476,TCGA-KK-A8IC-01A,TCGA-KK-A8IC-01A-11D-A364-08,3,0.499968226,TCGA-KK-A8IC,PRAD,54,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-19902,Alive,WITH TUMOR,2051,NA,[Not Available],Biochemical evidence of disease,NA,NA,1060,Progressive Disease,0,2051,0,2051,NA,NA,1,1060,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,3
8.460978646,-4.480718601,TCGA-KK-A8I8-01A,TCGA-KK-A8I8-01A-11D-A364-08,1,0.725237974,TCGA-KK-A8I8,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-25546,Alive,TUMOR FREE,967,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,967,0,967,0,967,0,967,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.608605763,-5.814096548,TCGA-KK-A8IA-01A,TCGA-KK-A8IA-01A-11D-A364-08,1,0.842903717,TCGA-KK-A8IA,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-25284,Alive,NA,1931,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1931,0,1931,NA,NA,0,1931,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
9.564555213,-4.774131568,TCGA-KK-A8I9-01A,TCGA-KK-A8I9-01A-11D-A364-08,1,0.766925051,TCGA-KK-A8I9,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22295,Alive,WITH TUMOR,1001,NA,[Not Available],Biochemical evidence of disease,NA,NA,940,Complete Remission/Response,0,1001,0,1001,1,940,1,940,NA,[Not Applicable],T3a,[Not Applicable],PRAD.5-SPOP,1
8.581781657,-5.034402186,TCGA-KK-A8I6-01A,TCGA-KK-A8I6-01A-11D-A364-08,1,0.82988762,TCGA-KK-A8I6,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21499,Alive,TUMOR FREE,668,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,668,0,668,0,668,0,668,NA,[Not Applicable],T3a,[Not Applicable],PRAD.1-ERG,1
9.800695422,-2.95657097,TCGA-KK-A8I5-01A,TCGA-KK-A8I5-01A-11D-A364-08,1,0.766724115,TCGA-KK-A8I5,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2006,[Not Available],-20337,Alive,TUMOR FREE,3096,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3096,0,3096,0,3096,0,3096,NA,[Not Applicable],T2b,[Not Applicable],PRAD.1-ERG,1
9.665140278,-5.848467587,TCGA-KK-A8I7-01A,TCGA-KK-A8I7-01A-21D-A364-08,1,0.863755847,TCGA-KK-A8I7,PRAD,55,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2009,[Not Available],-20256,Alive,TUMOR FREE,2002,NA,[Not Available],Biochemical evidence of disease,NA,NA,1088,Progressive Disease,0,2002,0,2002,NA,NA,1,1088,NA,[Not Applicable],T3b,[Not Applicable],NA,1
9.317862782,-5.561817056,TCGA-KK-A8I4-01A,TCGA-KK-A8I4-01A-11D-A364-08,1,0.712075355,TCGA-KK-A8I4,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2008,[Not Available],-23706,Alive,WITH TUMOR,2259,NA,[Not Available],Distant Metastasis,Bone,NA,1162,Progressive Disease,0,2259,0,2259,NA,NA,1,1162,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,1
-0.871767604,3.651152161,TCGA-KK-A7B4-01A,TCGA-KK-A7B4-01A-11D-A32B-08,4,0.273599416,TCGA-KK-A7B4,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-23644,Alive,WITH TUMOR,987,NA,[Not Available],Biochemical evidence of disease,NA,NA,637,Stable Disease,0,987,0,987,NA,NA,1,637,NA,[Not Applicable],T3b,[Not Applicable],PRAD.1-ERG,5
9.421839918,-5.279770895,TCGA-KK-A7B0-01A,TCGA-KK-A7B0-01A-11D-A32B-08,1,0.868476617,TCGA-KK-A7B0,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24756,Alive,TUMOR FREE,1329,NA,[Not Available],Biochemical evidence of disease,NA,NA,606,Stable Disease,0,1329,0,1329,NA,NA,1,606,NA,[Not Applicable],T3b,[Not Applicable],NA,1
2.002110867,1.870573397,TCGA-KK-A7B3-01A,TCGA-KK-A7B3-01A-11D-A33T-08,3,0.505223743,TCGA-KK-A7B3,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22830,Alive,TUMOR FREE,899,NA,[Not Available],Biochemical evidence of disease,NA,NA,294,Complete Remission/Response,0,899,0,899,1,294,1,294,NA,[Not Applicable],T3b,[Not Applicable],PRAD.2-ETV1,3
9.279975385,-4.913682162,TCGA-KK-A7AW-01A,TCGA-KK-A7AW-01A-11D-A32B-08,1,0.78280304,TCGA-KK-A7AW,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-20869,Alive,TUMOR FREE,1054,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1054,0,1054,NA,NA,0,1054,NA,[Not Applicable],T3a,[Not Applicable],NA,1
-6.644104614,-1.215173727,TCGA-B5-A0K7-01A,TCGA-B5-A0K7-01A-11W-A10C-09,7,0.067112512,TCGA-B5-A0K7,UCEC,64,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23429,Alive,TUMOR FREE,1933,NA,[Not Available],Metastatic,"Other, specify",vagina,322,Complete Remission/Response,0,1933,0,1933,1,322,1,322,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,2
-7.303656346,2.44762068,TCGA-B5-A11M-01A,TCGA-B5-A11M-01A-11D-A122-09,0,NA,TCGA-B5-A11M,UCEC,43,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16063,Alive,TUMOR FREE,1362,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1362,0,1362,0,1362,0,1362,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
0.300265127,5.365069398,TCGA-FI-A2CX-01A,TCGA-FI-A2CX-01A-11D-A17D-09,4,0.638697406,TCGA-FI-A2CX,UCEC,82,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30224,Alive,TUMOR FREE,2031,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2031,0,2031,0,2031,0,2031,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,6
-4.075163875,1.175659149,TCGA-B5-A3S1-01A,TCGA-B5-A3S1-01A-11D-A228-09,0,NA,TCGA-B5-A3S1,UCEC,71,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26031,Alive,WITH TUMOR,902,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,902,0,902,0,902,0,902,NA,Stage IIIC1,[Not Applicable],[Not Applicable],NA,9
-3.809406252,-2.558003661,TCGA-A5-A2K7-01A,TCGA-A5-A2K7-01A-11D-A17W-09,8,0.440556607,TCGA-A5-A2K7,UCEC,41,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14980,Alive,TUMOR FREE,1063,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1063,0,1063,0,1063,0,1063,NA,Stage II,[Not Applicable],[Not Applicable],NA,10
-7.356497046,2.152354302,TCGA-EY-A1GP-01A,TCGA-EY-A1GP-01A-11D-A13L-09,9,4.36E-05,TCGA-EY-A1GP,UCEC,54,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20011,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,573,0,573,0,573,0,573,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-4.082000516,-2.112974157,TCGA-BK-A0C9-01A,TCGA-BK-A0C9-01A-11W-A027-09,8,0.392617803,TCGA-BK-A0C9,UCEC,57,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20876,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1092,0,1092,0,1092,0,1092,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.MSI,10
-7.102773184,2.302333848,TCGA-A5-A0R8-01A,TCGA-A5-A0R8-01A-11D-A10B-09,0,NA,TCGA-A5-A0R8,UCEC,81,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29777,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,42,Complete Remission/Response,0,596,0,596,1,42,1,42,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
-6.532969672,-1.195219853,TCGA-AP-A1DQ-01A,TCGA-AP-A1DQ-01A-11D-A135-09,7,0.100344238,TCGA-AP-A1DQ,UCEC,76,FEMALE,WHITE,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27815,Dead,WITH TUMOR,NA,1423,[Not Available],Metastatic,"Other, specify","Lymph nodes, lung, bone",905,Complete Remission/Response,1,1423,1,1423,1,905,1,905,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.CN high,2
-5.231829553,2.731326569,TCGA-XV-AAZY-01A,TCGA-XV-AAZY-01A-12D-A401-08,12,0.212662735,TCGA-XV-AAZY,SKCM,76,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-27938,Alive,TUMOR FREE,405,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,405,0,405,NA,NA,0,405,NA,Stage IIIC,T4,M0,NA,8
-6.949391027,2.439886862,TCGA-XV-AAZW-01A,TCGA-XV-AAZW-01A-12D-A401-08,0,NA,TCGA-XV-AAZW,SKCM,62,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-22778,Dead,WITH TUMOR,NA,393,[Not Available],NA,NA,NA,NA,[Not Available],1,393,1,393,NA,NA,1,393,NA,Stage II,T4,M0,NA,6
9.567687378,-1.902675614,TCGA-XV-AAZV-01A,TCGA-XV-AAZV-01A-11D-A401-08,1,0.74794136,TCGA-XV-AAZV,SKCM,56,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-20545,Alive,TUMOR FREE,412,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,412,0,412,NA,NA,0,412,NA,Stage II,T4,M0,NA,1
4.269379185,1.183622358,TCGA-XV-A9W5-01A,TCGA-XV-A9W5-01A-11D-A38G-08,2,0.606001562,TCGA-XV-A9W5,SKCM,51,MALE,WHITE,NA,[Not Available],2013,[Not Available],-18739,Alive,WITH TUMOR,392,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,392,0,392,NA,NA,0,392,NA,I/II NOS,T2,M0,NA,5
-3.21243435,-3.523273414,TCGA-AD-5900-01A,TCGA-AD-5900-01A-11D-1650-10,8,0.434108544,TCGA-AD-5900,COAD,67,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-24776,Alive,TUMOR FREE,370,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,370,0,370,0,370,0,370,NA,Stage I,T2,MX,GI.HM-indel,10
-6.168261424,3.398369762,TCGA-XV-A9VZ-01A,TCGA-XV-A9VZ-01A-11D-A38G-08,11,0.492885279,TCGA-XV-A9VZ,SKCM,90,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-32873,Alive,TUMOR FREE,11,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,11,0,11,NA,NA,0,11,NA,Stage II,T4,M0,NA,8
-3.683461781,-2.421680505,TCGA-DA-A960-01A,TCGA-DA-A960-01A-11D-A372-08,8,0.420456947,TCGA-DA-A960,SKCM,73,MALE,WHITE,NA,[Not Available],2012,[Not Available],-26708,Alive,TUMOR FREE,804,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,804,0,804,NA,NA,0,804,NA,Stage IIB,T3b,M0,NA,10
-6.486642497,-1.262485238,TCGA-AA-3850-01A,TCGA-AA-3850-01A-01W-0995-10,7,0.127370606,TCGA-AA-3850,COAD,74,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-27090,Dead,WITH TUMOR,NA,0,[Not Available],NA,NA,NA,NA,[Not Available],1,0,1,0,NA,NA,1,0,NA,Stage I,T2,M0,GI.GS,2
-5.50470501,2.659161326,TCGA-CK-4950-01A,TCGA-CK-4950-01A-01D-1719-10,0,NA,TCGA-CK-4950,COAD,68,FEMALE,BLACK OR AFRICAN AMERICAN,Colon Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],-24944,Alive,TUMOR FREE,2599,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2599,0,2599,0,2599,0,2599,NA,Stage IIIB,T3,M0,GI.GS,8
9.505809062,-5.788806176,TCGA-BF-AAP8-01A,TCGA-BF-AAP8-01A-11D-A401-08,1,0.853376081,TCGA-BF-AAP8,SKCM,58,MALE,WHITE,NA,[Not Available],2013,[Not Available],-21414,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,447,0,447,NA,NA,0,447,NA,Stage IIC,T4b,M0,NA,1
-4.77192573,-1.876429805,TCGA-BF-AAP7-01A,TCGA-BF-AAP7-01A-11D-A401-08,8,0.364597249,TCGA-BF-AAP7,SKCM,76,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-28073,Alive,TUMOR FREE,318,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,318,0,318,NA,NA,0,318,NA,Stage IIC,T4b,M0,NA,10
1.736119284,2.011735342,TCGA-BF-AAP6-01A,TCGA-BF-AAP6-01A-11D-A401-08,3,0.093355216,TCGA-BF-AAP6,SKCM,55,MALE,WHITE,NA,[Not Available],2013,[Not Available],-20384,Alive,TUMOR FREE,325,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,325,0,325,NA,NA,0,325,NA,Stage III,T4b,M0,NA,3
-0.93126617,3.954344364,TCGA-DM-A28F-01A,TCGA-DM-A28F-01A-11D-A16V-10,4,0.358081104,TCGA-DM-A28F,COAD,73,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2002,[Not Available],-26856,Dead,NA,1094,1094,[Not Available],NA,NA,NA,NA,[Not Available],1,1094,NA,1094,NA,NA,0,1094,NA,Stage IIIB,T3,M0,GI.CIN,6
-4.040804135,-2.087725503,TCGA-BF-AAP1-01A,TCGA-BF-AAP1-01A-11D-A397-08,8,0.443518651,TCGA-BF-AAP1,SKCM,86,MALE,WHITE,NA,[Not Available],2013,[Not Available],-31666,Alive,TUMOR FREE,409,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,409,0,409,NA,NA,0,409,NA,Stage IIC,T4b,M0,NA,10
-3.458269433,-3.118903172,TCGA-BF-AAP4-01A,TCGA-BF-AAP4-01A-11D-A401-08,8,0.592427958,TCGA-BF-AAP4,SKCM,61,MALE,WHITE,NA,[Not Available],2013,[Not Available],-22303,Alive,TUMOR FREE,335,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,335,0,335,NA,NA,0,335,NA,Stage IIC,T4b,M0,NA,10
-3.636685963,-3.177630463,TCGA-BF-AAP2-01A,TCGA-BF-AAP2-01A-11D-A401-08,8,0.533868477,TCGA-BF-AAP2,SKCM,62,MALE,WHITE,NA,[Not Available],2013,[Not Available],-22734,Alive,TUMOR FREE,405,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,405,0,405,NA,NA,0,405,NA,Stage IIB,T3b,M0,NA,10
-5.38837314,0.90409187,TCGA-BF-AAOU-01A,TCGA-BF-AAOU-01A-12D-A397-08,0,NA,TCGA-BF-AAOU,SKCM,73,FEMALE,WHITE,NA,[Not Available],2013,[Not Available],-26750,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,476,0,476,NA,NA,0,476,NA,Stage IIC,T4b,M0,NA,10
9.688544839,-1.745502899,TCGA-BF-A9VF-01A,TCGA-BF-A9VF-01A-11D-A372-08,1,0.853182863,TCGA-BF-A9VF,SKCM,77,MALE,WHITE,NA,[Not Available],2013,[Not Available],-28312,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,440,0,440,NA,NA,0,440,NA,Stage IIC,T4b,M0,NA,1
-5.06414549,1.512968541,TCGA-AA-A02K-01A,TCGA-AA-A02K-01A-21W-A096-10,0,NA,TCGA-AA-A02K,COAD,50,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2009,[Not Available],-18506,Dead,WITH TUMOR,NA,426,[Not Available],NA,NA,NA,306,Progressive Disease,1,426,1,426,NA,NA,1,306,NA,Stage IV,T4,M1,NA,9
-3.544974577,-2.927040943,TCGA-BF-A5EQ-01A,TCGA-BF-A5EQ-01A-21D-A27K-08,8,0.405130096,TCGA-BF-A5EQ,SKCM,63,MALE,WHITE,NA,[Not Available],2012,[Not Available],-23353,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,323,0,323,NA,NA,0,323,NA,Stage IIC,T4b,M0,SKCM.BRAF_Hotspot_Mutants,10
-3.862384682,-1.923577669,TCGA-BF-A5EO-01A,TCGA-BF-A5EO-01A-12D-A27K-08,8,0.327523067,TCGA-BF-A5EO,SKCM,65,MALE,WHITE,NA,[Not Available],2012,[Not Available],-23940,Alive,TUMOR FREE,703,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,703,0,703,NA,NA,0,703,NA,Stage IIC,T4b,M0,SKCM.RAS_Hotspot_Mutants,10
3.796105446,1.321149193,TCGA-BF-A5ER-01A,TCGA-BF-A5ER-01A-12D-A27K-08,0,NA,TCGA-BF-A5ER,SKCM,63,MALE,WHITE,NA,[Not Available],2012,[Not Available],-23199,Alive,TUMOR FREE,327,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,327,0,327,NA,NA,0,327,NA,Stage IIC,T4b,M0,SKCM.-,6
9.130357874,-5.192648819,TCGA-KN-8422-01A,TCGA-KN-8422-01A-11D-2310-10,1,0.854378562,TCGA-KN-8422,KICH,28,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-10303,Alive,TUMOR FREE,775,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,775,0,775,0,775,0,775,NA,Stage I,T1a,[Not Available],KICH.Eosin.0,1
-3.146392424,-3.400650976,TCGA-EO-A3AU-01A,TCGA-EO-A3AU-01A-21D-A19Y-09,8,0.619273537,TCGA-EO-A3AU,UCEC,72,FEMALE,[Not Available],Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26406,Alive,TUMOR FREE,1543,NA,[Not Available],New Primary Tumor,Lung,NA,1178,Complete Remission/Response,0,1543,0,1543,0,1543,1,1178,NA,Stage II,[Not Applicable],[Not Applicable],NA,10
-5.831480172,1.594112272,TCGA-F4-6805-01A,TCGA-F4-6805-01A-11D-1835-10,10,0.01765008,TCGA-F4-6805,COAD,58,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-21241,Alive,TUMOR FREE,1047,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1047,0,1047,0,1047,0,1047,NA,Stage IIA,T3,M0,GI.CIN,7
-0.614396218,3.860140596,TCGA-61-2104-01A,TCGA-61-2104-01A-01W-0722-08,4,0.44671564,TCGA-61-2104,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2003,[Not Available],-19432,Alive,NA,2338,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1680,Complete Remission/Response,0,2338,0,2338,1,1680,1,1680,NA,Stage IIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,5
9.144001533,-4.445122385,TCGA-CZ-4866-01A,TCGA-CZ-4866-01A-01D-1501-10,1,0.692345346,TCGA-CZ-4866,KIRC,79,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-28878,Alive,WITH TUMOR,3267,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3267,0,3267,NA,NA,0,3267,NA,Stage I,T1,M0,KIRC.1,1
-2.91104065,-4.07461691,TCGA-AA-A00N-01A,TCGA-AA-A00N-01A-02D-A17O-10,8,0.15674777,TCGA-AA-A00N,COAD,75,MALE,[Not Available],Colon Mucinous Adenocarcinoma,[Not Available],2008,[Not Available],-27667,Dead,WITH TUMOR,NA,122,[Not Available],NA,NA,NA,NA,[Not Available],1,122,1,122,NA,NA,1,122,NA,Stage IIB,T4,M0,NA,10
-0.2211203,4.552593744,TCGA-57-1994-01A,TCGA-57-1994-01A-01W-0894-08,4,0.49683486,TCGA-57-1994,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,[Not Available],2004,[Not Available],-23062,Alive,NA,761,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,761,0,761,NA,NA,0,761,NA,[Not Available],[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
0.968785847,3.603597104,TCGA-29-1702-01A,TCGA-29-1702-01A-01W-0633-09,0,NA,TCGA-29-1702,OV,84,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2005,[Not Available],-30910,Dead,WITH TUMOR,568,728,[Not Available],Recurrence,[Not Applicable],[Not Applicable],286,Complete Remission/Response,1,728,1,728,1,286,1,286,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,1
-6.346675635,1.268525718,TCGA-EY-A1GJ-01A,TCGA-EY-A1GJ-01A-12D-A142-09,10,0.336420083,TCGA-EY-A1GJ,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26715,Alive,TUMOR FREE,727,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,727,0,727,0,727,0,727,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
7.97869449,-3.156874442,TCGA-AA-3831-01A,TCGA-AA-3831-01A-01W-0900-09,1,0.483048923,TCGA-AA-3831,COAD,66,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2008,[Not Available],-24411,Alive,TUMOR FREE,547,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,547,0,547,0,547,0,547,NA,Stage IIA,T3,M0,GI.GS,1
0.131901285,5.411045353,TCGA-A6-5667-01A,TCGA-A6-5667-01A-21D-1719-10,4,0.473617981,TCGA-A6-5667,COAD,40,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-14756,Alive,TUMOR FREE,887,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,887,0,887,0,887,0,887,NA,Stage IIIB,T3,MX,GI.CIN,6
-0.012584549,4.554322679,TCGA-KN-8424-01A,TCGA-KN-8424-01A-11D-2310-10,4,0.565269479,TCGA-KN-8424,KICH,42,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-15384,Alive,TUMOR FREE,1983,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1983,0,1983,0,1983,0,1983,NA,Stage I,T1b,[Not Available],KICH.Eosin.0,6
-5.419043722,0.877717133,TCGA-A6-5659-01A,TCGA-A6-5659-01A-01D-A270-10,0,NA,TCGA-A6-5659,COAD,82,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-30028,Alive,TUMOR FREE,926,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,926,0,926,0,926,0,926,NA,Stage I,T2,M0,NA,9
8.199814597,-3.901371832,TCGA-B2-5635-01A,TCGA-B2-5635-01A-01D-A270-10,1,0.506439499,TCGA-B2-5635,KIRC,74,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-27183,Alive,TUMOR FREE,755,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,755,0,755,0,755,0,755,NA,Stage I,T1a,M0,KIRC.2,1
2.102884272,1.900336979,TCGA-KN-8425-01A,TCGA-KN-8425-01A-11D-2310-10,3,0.587905824,TCGA-KN-8425,KICH,53,MALE,WHITE,Kidney Chromophobe,[Not Available],2005,[Not Available],-19692,Alive,TUMOR FREE,3179,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3179,0,3179,0,3179,0,3179,NA,Stage I,T1b,[Not Available],KICH.Eosin.0,3
9.106548539,-1.910745894,TCGA-BP-5184-01A,TCGA-BP-5184-01A-01D-1429-08,1,0.682214303,TCGA-BP-5184,KIRC,54,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-19746,Alive,TUMOR FREE,1133,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1133,0,1133,NA,NA,0,1133,NA,Stage I,T1a,M0,KIRC.NA,1
-1.330811094,3.97952889,TCGA-23-2078-01A,TCGA-23-2078-01A-01W-0722-08,4,0.21310082,TCGA-23-2078,OV,66,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-24223,Alive,TUMOR FREE,2661,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2661,0,2661,0,2661,0,2661,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-5.41455541,2.121590819,TCGA-D5-7000-01A,TCGA-D5-7000-01A-11D-1924-10,0,NA,TCGA-D5-7000,COAD,79,FEMALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2011,[Not Available],-28913,Alive,TUMOR FREE,312,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,312,0,312,NA,NA,0,312,NA,Stage I,T2,M0,GI.CIN,8
-0.787957672,4.300476534,TCGA-59-2348-01A,TCGA-59-2348-01A-01W-0799-08,4,0.331931431,TCGA-59-2348,OV,59,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1994,[Not Available],NA,Alive,TUMOR FREE,5481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,5481,0,5481,0,5481,0,5481,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
1.76330078,1.879839327,TCGA-CZ-5461-01A,TCGA-CZ-5461-01A-01D-1501-10,3,0.44673174,TCGA-CZ-5461,KIRC,52,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2006,[Not Available],-19030,Dead,WITH TUMOR,330,330,[Not Available],NA,NA,NA,48,[Not Available],1,330,1,330,NA,NA,1,48,NA,Stage IV,T1b,M1,KIRC.1,3
0.203289358,2.546770073,TCGA-A6-2675-01A,TCGA-A6-2675-01A-02D-1719-10,4,0.150008887,TCGA-A6-2675,COAD,78,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2009,[Not Available],-28813,Alive,TUMOR FREE,1321,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1321,0,1321,0,1321,0,1321,NA,Stage IIA,T3,MX,GI.CIN,6
9.350724194,-5.688360876,TCGA-KN-8429-01A,TCGA-KN-8429-01A-11D-2310-10,1,0.886894776,TCGA-KN-8429,KICH,38,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-13903,Alive,TUMOR FREE,2650,NA,[Not Available],NA,NA,NA,1989,Complete Remission/Response,0,2650,0,2650,1,1989,1,1989,NA,Stage III,T3a,[Not Available],KICH.Eosin.0,1
8.960190131,-1.933310681,TCGA-CZ-5465-01A,TCGA-CZ-5465-01A-01D-1806-10,1,0.623235639,TCGA-CZ-5465,KIRC,76,FEMALE,[Not Available],Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-27838,Dead,TUMOR FREE,NA,2564,[Not Available],NA,NA,NA,NA,[Not Available],1,2564,0,2564,NA,NA,0,2564,NA,Stage III,T3b,M0,KIRC.1,1
-7.564329185,-2.45510419,TCGA-CM-6677-01A,TCGA-CM-6677-01A-11D-1835-10,6,0.389014007,TCGA-CM-6677,COAD,75,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-27575,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,337,0,337,NA,NA,0,337,NA,Stage IIA,T3,M0,GI.CIN,2
4.501117139,1.147421963,TCGA-AZ-4682-01B,TCGA-AZ-4682-01B-01D-1408-10,2,0.630873645,TCGA-AZ-4682,COAD,61,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2006,[Not Available],-22409,Dead,WITH TUMOR,NA,680,[Not Available],NA,NA,NA,NA,[Not Available],1,680,1,680,NA,NA,1,680,NA,Stage IVA,T3,M1,GI.CIN,5
-5.856036772,2.695302081,TCGA-AX-A3GB-01A,TCGA-AX-A3GB-01A-11D-A228-09,0,NA,TCGA-AX-A3GB,UCEC,73,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724,Alive,NA,440,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,440,0,440,NA,NA,0,440,NA,Stage IB,[Not Applicable],[Not Applicable],NA,8
-3.765656848,-2.668321525,TCGA-BG-A0MQ-01A,TCGA-BG-A0MQ-01A-11D-A10B-09,8,0.368517148,TCGA-BG-A0MQ,UCEC,71,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26284,Alive,WITH TUMOR,1817,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1817,0,1817,NA,NA,0,1817,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.3797594,3.631622645,TCGA-D1-A169-01A,TCGA-D1-A169-01A-11D-A12J-09,4,0.166440377,TCGA-D1-A169,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23238,Alive,WITH TUMOR,1135,NA,[Not Available],Metastatic,"Other, specify",Bladder nodule,519,Complete Remission/Response,0,1135,0,1135,NA,NA,1,519,NA,Stage IV,[Not Applicable],[Not Applicable],UCEC.CN high,6
-2.304541004,1.87521455,TCGA-25-1326-01A,TCGA-25-1326-01A-01W-0492-08,0,NA,TCGA-25-1326,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-22339,Dead,WITH TUMOR,945,1249,[Not Available],Recurrence,[Not Applicable],[Not Applicable],396,Partial Remission/Response,1,1249,1,1249,NA,NA,1,396,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,10
-6.079792556,3.634423195,TCGA-09-1664-01A,TCGA-09-1664-01A-01W-0639-09,11,0.50206564,TCGA-09-1664,OV,37,FEMALE,WHITE,Serous Cystadenocarcinoma,G1,2002,[Not Available],-13739,Dead,NA,NA,2279,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2279,NA,2279,0,2279,0,2279,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,8
-4.453361885,-0.64295285,TCGA-D1-A17M-01A,TCGA-D1-A17M-01A-21D-A12J-09,0,NA,TCGA-D1-A17M,UCEC,56,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20685,Alive,TUMOR FREE,311,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,311,0,311,0,311,0,311,NA,Stage II,[Not Applicable],[Not Applicable],UCEC.MSI,10
0.201622613,3.381699861,TCGA-FI-A2F8-01A,TCGA-FI-A2F8-01A-12D-A17D-09,4,0.344050587,TCGA-FI-A2F8,UCEC,64,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23649,Alive,WITH TUMOR,933,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,933,0,933,0,933,0,933,NA,Stage II,[Not Applicable],[Not Applicable],UCEC.CN high,3
8.874938686,-5.022893223,TCGA-AX-A1C7-01A,TCGA-AX-A1C7-01A-11D-A135-09,1,0.835610312,TCGA-AX-A1C7,UCEC,77,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28198,Alive,NA,1054,NA,[Not Available],NA,NA,NA,390,[Not Applicable],0,1054,0,1054,NA,NA,1,390,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN high,1
-0.72502803,3.585146672,TCGA-61-2612-01A,TCGA-61-2612-01A-01W-1092-09,4,0.309932063,TCGA-61-2612,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2002,[Not Available],-23074,Dead,WITH TUMOR,193,193,[Not Available],Recurrence,[Not Applicable],[Not Applicable],179,Stable Disease,1,193,1,193,NA,NA,1,179,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
-6.182479149,1.648851877,TCGA-D1-A16N-01A,TCGA-D1-A16N-01A-11D-A12J-09,10,0.248813788,TCGA-D1-A16N,UCEC,51,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Peri (6-12 months since last menstrual period),-18787,Alive,TUMOR FREE,945,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,945,0,945,0,945,0,945,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.MSI,9
-7.554376956,2.287644608,TCGA-B5-A0K0-01A,TCGA-B5-A0K0-01A-11W-A062-09,9,0.021540984,TCGA-B5-A0K0,UCEC,48,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Indeterminate (neither Pre or Postmenopausal),-17810,Alive,TUMOR FREE,1478,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1478,0,1478,0,1478,0,1478,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
0.146095172,2.793671486,TCGA-09-2049-01D,TCGA-09-2049-01D-01W-0799-08,4,0.056185215,TCGA-09-2049,OV,64,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1999,[Not Available],-23410,Alive,WITH TUMOR,3419,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],953,Complete Remission/Response,0,3419,0,3419,1,953,1,953,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-6.549763513,-1.309840912,TCGA-BS-A0TD-01A,TCGA-BS-A0TD-01A-11D-A10B-09,7,0.213662778,TCGA-BS-A0TD,UCEC,65,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23950,Alive,TUMOR FREE,2379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2379,0,2379,0,2379,0,2379,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,2
-3.826525497,-2.560385542,TCGA-G2-A3VY-01A,TCGA-G2-A3VY-01A-11D-A22Z-08,8,0.408259918,TCGA-G2-A3VY,BLCA,66,MALE,ASIAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-24112,Alive,WITH TUMOR,536,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,536,0,536,NA,NA,0,536,NA,Stage II,[Not Available],[Not Available],BLCA.1,10
10.03415599,-2.778147831,TCGA-A3-3358-01A,TCGA-A3-3358-01A-01D-1534-10,1,0.710290644,TCGA-A3-3358,KIRC,57,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-21087,Alive,TUMOR FREE,1307,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1307,0,1307,NA,NA,0,1307,NA,Stage I,T1a,M0,KIRC.4,1
-4.977197777,0.505785788,TCGA-A5-A0GW-01A,TCGA-A5-A0GW-01A-11W-A062-09,0,NA,TCGA-A5-A0GW,UCEC,46,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17092,Alive,TUMOR FREE,706,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,706,0,706,0,706,0,706,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-0.816771594,2.733303416,TCGA-FD-A3SP-01A,TCGA-FD-A3SP-01A-31D-A22Z-08,4,0.212701431,TCGA-FD-A3SP,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-22005,Alive,TUMOR FREE,783,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,783,0,783,0,783,0,783,NA,Stage III,T3b,MX,BLCA.4,6
-0.351632607,4.444437334,TCGA-GD-A3OS-01A,TCGA-GD-A3OS-01A-12D-A21Z-08,4,0.464210002,TCGA-GD-A3OS,BLCA,54,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-19776,Alive,WITH TUMOR,638,NA,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,223,Progressive Disease,0,638,0,638,NA,NA,1,223,NA,Stage II,[Not Available],MX,BLCA.4,6
-7.034218436,-2.417312437,TCGA-23-2649-01A,TCGA-23-2649-01A-01D-1526-09,6,0.030945573,TCGA-23-2649,OV,60,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-22210,Alive,NA,116,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,116,0,116,NA,NA,0,116,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,2
9.737769785,-1.613329064,TCGA-25-1312-01A,TCGA-25-1312-01A-01W-0492-08,1,0.840095236,TCGA-25-1312,OV,69,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-25537,Dead,NA,31,31,[Not Available],NA,NA,NA,NA,[Not Available],1,31,NA,31,NA,NA,0,31,NA,Stage IV,[Not Applicable],[Not Applicable],OVCA.Proliferative,1
-3.178246121,-3.540936452,TCGA-A5-A0GP-01A,TCGA-A5-A0GP-01A-11W-A062-09,8,0.64943112,TCGA-A5-A0GP,UCEC,58,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21365,Alive,TUMOR FREE,1416,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1416,0,1416,0,1416,0,1416,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.POLE,10
9.305451799,-4.409260563,TCGA-BP-5175-01A,TCGA-BP-5175-01A-01D-1429-08,1,0.707154415,TCGA-BP-5175,KIRC,60,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-21949,Alive,TUMOR FREE,932,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,932,0,932,NA,NA,0,932,NA,Stage I,T1a,M0,KIRC.4,1
9.344909659,-2.78097047,TCGA-EU-5904-01A,TCGA-EU-5904-01A-11D-1669-08,1,0.767043375,TCGA-EU-5904,KIRC,47,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G1,2009,[Not Available],-17468,Alive,TUMOR FREE,551,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,551,0,551,NA,NA,0,551,NA,Stage I,T1,M0,KIRC.NA,1
-7.138855484,-1.779587589,TCGA-C4-A0F1-01A,TCGA-C4-A0F1-01A-11D-A10S-08,6,0.010211412,TCGA-C4-A0F1,BLCA,71,MALE,[Not Available],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006,[Not Available],-26178,Alive,TUMOR FREE,89,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,89,0,89,NA,NA,0,89,NA,Stage III,T3b,M0,BLCA.3,10
-1.888466288,2.057505341,TCGA-GV-A40G-01A,TCGA-GV-A40G-01A-11D-A23M-08,0,NA,TCGA-GV-A40G,BLCA,77,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-28204,Alive,TUMOR FREE,580,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,580,0,580,0,580,0,580,NA,Stage II,T2a,MX,BLCA.1,3
1.253992051,3.432154663,TCGA-B0-4827-01A,TCGA-B0-4827-01A-02D-1421-08,0,NA,TCGA-B0-4827,KIRC,77,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G4,2002,[Not Available],-28467,Dead,WITH TUMOR,NA,885,[Not Available],NA,NA,NA,668,[Not Available],1,885,1,885,NA,NA,1,668,NA,Stage III,T3b,M0,KIRC.3,6
-2.705190879,-4.425098259,TCGA-EO-A22U-01A,TCGA-EO-A22U-01A-11D-A17W-09,0,NA,TCGA-EO-A22U,UCEC,83,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30557,Alive,TUMOR FREE,1407,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1407,0,1407,0,1407,0,1407,NA,Stage IB,[Not Applicable],[Not Applicable],NA,10
-1.75561467,1.205164204,TCGA-CU-A3QU-01A,TCGA-CU-A3QU-01A-11D-A22Z-08,5,0.569937858,TCGA-CU-A3QU,BLCA,58,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-21233,Alive,TUMOR FREE,158,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,158,0,158,NA,NA,0,158,NA,Stage IV,T2b,M0,BLCA.1,4
-7.540049826,-2.396192169,TCGA-29-1697-01A,TCGA-29-1697-01A-01W-0633-09,6,0.401745443,TCGA-29-1697,OV,62,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-22933,Dead,WITH TUMOR,949,949,[Not Available],Recurrence,[Not Applicable],[Not Applicable],500,Complete Remission/Response,1,949,1,949,1,500,1,500,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,2
-5.628548416,-1.955553012,TCGA-13-1481-01A,TCGA-13-1481-01A-01W-0549-09,0,NA,TCGA-13-1481,OV,76,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2000,[Not Available],-27898,Dead,TUMOR FREE,2648,2648,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,2648,0,2648,0,2648,0,2648,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,10
-0.563061778,5.066724137,TCGA-61-2094-01A,TCGA-61-2094-01A-01W-0722-08,4,0.557679872,TCGA-61-2094,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2003,[Not Available],-23273,Alive,TUMOR FREE,2182,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2182,0,2182,0,2182,0,2182,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-1.234507825,3.39812613,TCGA-24-1844-01A,TCGA-24-1844-01A-01W-0639-09,4,0.133537153,TCGA-24-1844,OV,64,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-23542,Alive,NA,113,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,113,0,113,NA,NA,0,113,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
1.235141502,3.427330323,TCGA-BP-4976-01A,TCGA-BP-4976-01A-01D-1462-08,0,NA,TCGA-BP-4976,KIRC,77,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-28380,Alive,TUMOR FREE,1632,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1632,0,1632,NA,NA,0,1632,NA,Stage I,T1a,M0,NA,6
0.064768127,4.678781167,TCGA-CZ-5459-01A,TCGA-CZ-5459-01A-01D-1501-10,4,0.475961575,TCGA-CZ-5459,KIRC,63,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-23318,Alive,TUMOR FREE,1683,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1683,0,1683,NA,NA,0,1683,NA,Stage III,T3b,M0,KIRC.NA,6
8.904611615,-4.987666493,TCGA-CW-5583-01A,TCGA-CW-5583-01A-02D-1534-10,1,0.785095456,TCGA-CW-5583,KIRC,51,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2003,[Not Available],-18666,Alive,TUMOR FREE,2489,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2489,0,2489,NA,NA,0,2489,NA,Stage I,T1a,M0,KIRC.1,1
9.400006433,-5.24263241,TCGA-CW-5591-01A,TCGA-CW-5591-01A-01D-1534-10,1,0.810505317,TCGA-CW-5591,KIRC,56,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-20712,Alive,WITH TUMOR,2271,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2271,0,2271,NA,NA,0,2271,NA,Stage IV,T3a,M1,KIRC.1,1
0.125265376,5.316891716,TCGA-FD-A3B7-01A,TCGA-FD-A3B7-01A-31D-A20D-08,4,0.600493885,TCGA-FD-A3B7,BLCA,66,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-24245,Dead,WITH TUMOR,NA,122,[Not Available],Distant Metastasis,Lymph Node Only,NA,110,Progressive Disease,1,122,1,122,NA,NA,1,110,NA,Stage III,T3a,MX,BLCA.4,6
0.051773448,4.416973071,TCGA-BT-A2LD-01A,TCGA-BT-A2LD-01A-12D-A20D-08,4,0.318079618,TCGA-BT-A2LD,BLCA,78,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-28673,Dead,WITH TUMOR,NA,623,[Not Available],Distant Metastasis,"Other, specify",brain and spinal cord,555,Progressive Disease,1,623,1,623,NA,NA,1,555,NA,Stage IV,T3a,M0,BLCA.4,6
-0.084222957,2.911124689,TCGA-FD-A3N6-01A,TCGA-FD-A3N6-01A-11D-A21A-08,4,0.098192046,TCGA-FD-A3N6,BLCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-15758,Alive,TUMOR FREE,851,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,851,0,851,0,851,0,851,NA,Stage II,T2b,MX,NA,3
-6.878778498,-2.118875792,TCGA-61-1914-01A,TCGA-61-1914-01A-01W-0639-09,6,0.287827156,TCGA-61-1914,OV,65,FEMALE,[Not Available],Serous Cystadenocarcinoma,G3,2003,[Not Available],-23850,Alive,WITH TUMOR,1722,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],1674,Complete Remission/Response,0,1722,0,1722,1,1674,1,1674,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,2
-7.141366335,2.300996663,TCGA-BG-A0M9-01A,TCGA-BG-A0M9-01A-21W-A10C-09,9,0.07122749,TCGA-BG-A0M9,UCEC,73,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26708,Alive,TUMOR FREE,2270,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2270,0,2270,0,2270,0,2270,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
-3.398008736,-3.109283831,TCGA-AP-A1DR-01A,TCGA-AP-A1DR-01A-11D-A135-09,8,0.539975486,TCGA-AP-A1DR,UCEC,59,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21904,Alive,TUMOR FREE,1495,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1495,0,1495,0,1495,0,1495,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
1.316828945,3.360377923,TCGA-CZ-5988-01A,TCGA-CZ-5988-01A-11D-1669-08,0,NA,TCGA-CZ-5988,KIRC,38,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-14131,Alive,TUMOR FREE,693,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,693,0,693,NA,NA,0,693,NA,Stage I,T1b,M0,KIRC.3,1
-6.240748442,1.282106671,TCGA-A5-A1OG-01A,TCGA-A5-A1OG-01A-11D-A14G-09,10,0.175007686,TCGA-A5-A1OG,UCEC,65,FEMALE,ASIAN,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23956,Dead,WITH TUMOR,NA,973,[Not Available],Metastatic,Lung,NA,337,Complete Remission/Response,1,973,1,973,1,337,1,337,NA,Stage IIIC2,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-3.302656096,-3.53931278,TCGA-BS-A0TC-01A,TCGA-BS-A0TC-01A-11D-A10B-09,8,0.604908096,TCGA-BS-A0TC,UCEC,69,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25560,Alive,TUMOR FREE,2602,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2602,0,2602,0,2602,0,2602,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.POLE,10
1.490088967,2.004404095,TCGA-GV-A3QK-01B,TCGA-GV-A3QK-01B-11D-A23M-08,0,NA,TCGA-GV-A3QK,BLCA,56,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-20802,Alive,WITH TUMOR,832,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,832,0,832,NA,NA,0,832,NA,Stage IV,T4a,M0,BLCA.1,3
-4.782041987,-1.702734802,TCGA-BT-A2LA-01A,TCGA-BT-A2LA-01A-11D-A18F-08,8,0.239883801,TCGA-BT-A2LA,BLCA,54,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-20032,Alive,TUMOR FREE,522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,522,0,522,0,522,0,522,NA,Stage III,T3a,M0,NA,10
-4.328509139,-1.836193934,TCGA-DK-A3IS-01A,TCGA-DK-A3IS-01A-21D-A21A-08,8,0.405752538,TCGA-DK-A3IS,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-25098,Alive,TUMOR FREE,1529,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1529,0,1529,0,1529,0,1529,NA,Stage II,T2a,M0,BLCA.1,10
-4.221076735,-1.977265021,TCGA-FD-A3SO-01A,TCGA-FD-A3SO-01A-11D-A22Z-08,8,0.357967686,TCGA-FD-A3SO,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25147,Dead,WITH TUMOR,NA,168,[Not Available],Locoregional (Urothelial tumor event),Renal Pelvis,NA,143,Progressive Disease,1,168,1,168,NA,NA,1,143,NA,Stage IV,T3a,MX,BLCA.3,10
0.039902929,2.53087766,TCGA-13-1483-01A,TCGA-13-1483-01A-01W-0549-09,4,0.160295152,TCGA-13-1483,OV,61,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-22342,Dead,WITH TUMOR,895,895,[Not Available],Recurrence,[Not Applicable],[Not Applicable],297,Partial Remission/Response,1,895,1,895,NA,NA,1,297,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-4.149903052,-1.814206967,TCGA-D1-A16F-01A,TCGA-D1-A16F-01A-11D-A12J-09,8,0.389532636,TCGA-D1-A16F,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22242,Alive,TUMOR FREE,80,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,80,0,80,0,80,0,80,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
9.763392875,-2.655398332,TCGA-B0-5115-01A,TCGA-B0-5115-01A-01D-1421-08,1,0.730635911,TCGA-B0-5115,KIRC,43,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2009,[Not Available],-15935,Alive,WITH TUMOR,1604,NA,[Not Available],NA,NA,NA,75,Progressive Disease,0,1604,0,1604,NA,NA,1,75,NA,Stage IV,T2,M1,KIRC.1,1
-5.439839216,1.459918337,TCGA-BL-A0C8-01A,TCGA-BL-A0C8-01A-11D-A271-08,0,NA,TCGA-BL-A0C8,BLCA,73,MALE,WHITE,[Not Available],High Grade,2009,[Not Available],-26819,Alive,NA,1219,NA,[Not Available],Locoregional (Urothelial tumor event),Bladder,NA,630,Complete Remission/Response,0,1219,0,1219,1,630,1,630,NA,Stage I,T1,M0,NA,9
-4.299745167,-1.547469039,TCGA-BT-A20N-01A,TCGA-BT-A20N-01A-11D-A14W-08,8,0.446208303,TCGA-BT-A20N,BLCA,72,MALE,[Not Available],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003,[Not Available],-26456,Dead,WITH TUMOR,NA,795,[Not Available],NA,NA,NA,NA,Progressive Disease,1,795,1,795,NA,NA,1,795,NA,Stage III,T3a,MX,BLCA.1,10
-2.229029864,2.42639204,TCGA-DK-A3IL-01A,TCGA-DK-A3IL-01A-11D-A20D-08,0,NA,TCGA-DK-A3IL,BLCA,79,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-29047,Dead,TUMOR FREE,NA,413,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,413,0,413,NA,NA,0,413,NA,Stage IV,T3,M0,BLCA.2,10
8.780999069,-3.21130253,TCGA-BP-4973-01A,TCGA-BP-4973-01A-01D-1462-08,1,0.639953252,TCGA-BP-4973,KIRC,47,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-17461,Alive,TUMOR FREE,1384,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1384,0,1384,NA,NA,0,1384,NA,Stage III,T3a,M0,KIRC.2,1
-3.262582836,-2.970384477,TCGA-G2-A2EJ-01A,TCGA-G2-A2EJ-01A-11D-A17V-08,8,0.441799923,TCGA-G2-A2EJ,BLCA,56,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-20649,Alive,TUMOR FREE,1460,NA,[Not Available],Distant Metastasis,Lung,NA,910,Complete Remission/Response,0,1460,0,1460,1,910,1,910,NA,Stage II,[Not Available],M0,BLCA.3,10
-3.756541889,-2.525254879,TCGA-DK-A1A3-01A,TCGA-DK-A1A3-01A-11D-A13W-08,8,0.442309997,TCGA-DK-A1A3,BLCA,60,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-22235,Dead,WITH TUMOR,NA,665,[Not Available],NA,NA,NA,NA,[Not Available],1,665,1,665,NA,NA,1,665,NA,Stage IV,T3,M0,BLCA.2,10
9.848936293,-2.429797315,TCGA-A3-3308-01A,TCGA-A3-3308-01A-01D-2094-10,1,0.719407407,TCGA-A3-3308,KIRC,77,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2006,[Not Available],-28287,Alive,TUMOR FREE,16,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,16,0,16,NA,NA,0,16,NA,Stage III,T3b,M0,KIRC.3,1
8.77413248,-4.618980598,TCGA-CJ-4916-01A,TCGA-CJ-4916-01A-01D-1429-08,1,0.81573308,TCGA-CJ-4916,KIRC,69,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2007,[Not Available],-25470,Alive,TUMOR FREE,1373,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1373,0,1373,NA,NA,0,1373,NA,Stage III,T3a,M0,KIRC.2,1
-1.681123664,3.126087015,TCGA-HQ-A2OE-01A,TCGA-HQ-A2OE-01A-11D-A202-08,0,NA,TCGA-HQ-A2OE,BLCA,69,MALE,[Not Evaluated],Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2007,[Not Available],NA,Alive,NA,1174,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,1174,0,1174,NA,NA,0,1174,NA,[Not Available],T2a,MX,BLCA.1,6
9.505978828,-5.197885476,TCGA-B4-5834-01A,TCGA-B4-5834-01A-11D-1669-08,1,0.796410421,TCGA-B4-5834,KIRC,59,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G1,2010,[Not Available],-21713,Alive,TUMOR FREE,38,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,38,0,38,NA,NA,0,38,NA,Stage I,T1,M0,NA,1
9.57047364,-4.674440155,TCGA-B0-5697-01A,TCGA-B0-5697-01A-11D-1534-10,1,0.772848332,TCGA-B0-5697,KIRC,50,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-18486,Alive,TUMOR FREE,2630,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2630,0,2630,0,2630,0,2630,NA,Stage I,T1a,M0,KIRC.4,1
-6.307778602,3.471681298,TCGA-DK-A3WY-01A,TCGA-DK-A3WY-01A-11D-A22Z-08,11,0.292744927,TCGA-DK-A3WY,BLCA,67,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001,[Not Available],-24536,Alive,TUMOR FREE,4967,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,4967,0,4967,0,4967,0,4967,NA,Stage III,T3,M0,BLCA.4,8
-0.125562758,4.563832381,TCGA-K4-A4AC-01A,TCGA-K4-A4AC-01A-21D-A26M-08,4,0.546919846,TCGA-K4-A4AC,BLCA,83,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-30655,Dead,WITH TUMOR,NA,278,[Not Available],Distant Metastasis,"Other, specify",psoas,170,Partial Remission/Response,1,278,1,278,NA,NA,1,170,NA,Stage II,T2b,MX,NA,6
9.157502174,-2.678826045,TCGA-KN-8419-01A,TCGA-KN-8419-01A-11D-2310-10,1,0.72088735,TCGA-KN-8419,KICH,43,MALE,BLACK OR AFRICAN AMERICAN,Kidney Chromophobe,[Not Available],2004,[Not Available],-15769,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,714,0,714,0,714,0,714,NA,Stage II,T2,[Not Available],KICH.Eosin.1,1
8.425615674,-1.600759798,TCGA-DK-A1AA-01A,TCGA-DK-A1AA-01A-11D-A13W-08,1,0.509789591,TCGA-DK-A1AA,BLCA,57,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-21093,Alive,TUMOR FREE,578,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,578,0,578,0,578,0,578,NA,Stage III,T3,M0,BLCA.1,6
-0.630214941,4.908962685,TCGA-G2-A2EK-01A,TCGA-G2-A2EK-01A-22D-A18F-08,4,0.561643711,TCGA-G2-A2EK,BLCA,57,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-20995,Alive,WITH TUMOR,485,NA,[Not Available],Distant Metastasis,Renal Pelvis,NA,485,Stable Disease,0,485,0,485,NA,NA,1,485,NA,Stage II,[Not Available],M0,BLCA.2,6
-3.291008422,-3.336327128,TCGA-E6-A2P9-01A,TCGA-E6-A2P9-01A-11D-A19Y-09,8,0.405053068,TCGA-E6-A2P9,UCEC,65,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24088,Alive,TUMOR FREE,1386,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1386,0,1386,0,1386,0,1386,NA,Stage IA,[Not Applicable],[Not Applicable],NA,10
-0.728232694,3.093109361,TCGA-GC-A3RB-01A,TCGA-GC-A3RB-01A-12D-A21Z-08,4,0.043997685,TCGA-GC-A3RB,BLCA,54,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-20021,Alive,TUMOR FREE,582,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,582,0,582,0,582,0,582,NA,Stage III,T3b,M0,BLCA.1,10
-2.682563168,0.977604351,TCGA-GU-A42P-01A,TCGA-GU-A42P-01A-11D-A23U-08,0,NA,TCGA-GU-A42P,BLCA,72,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26546,Dead,TUMOR FREE,NA,332,[Not Available],NA,NA,NA,NA,Stable Disease,1,332,0,332,NA,NA,0,332,NA,Stage IV,T3a,M0,NA,10
-2.258943486,2.144105102,TCGA-BL-A3JM-01A,TCGA-BL-A3JM-01A-12D-A21A-08,0,NA,TCGA-BL-A3JM,BLCA,62,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-23000,Dead,WITH TUMOR,NA,205,[Not Available],Metastatic,Bone,NA,111,Progressive Disease,1,205,1,205,NA,NA,1,111,NA,Stage III,T3,M0,BLCA.4,6
-0.029485904,2.72996325,TCGA-BT-A20U-01A,TCGA-BT-A20U-01A-11D-A14W-08,4,0.047001963,TCGA-BT-A20U,BLCA,70,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-25761,Dead,TUMOR FREE,NA,455,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,455,0,455,0,455,0,455,NA,Stage III,T3a,M0,BLCA.3,6
9.515656063,-4.74966544,TCGA-ZG-A9NI-01A,TCGA-ZG-A9NI-01A-11D-A41K-08,1,0.803302705,TCGA-ZG-A9NI,PRAD,73,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-26697,Alive,TUMOR FREE,132,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,132,0,132,0,132,0,132,NA,[Not Applicable],T3b,[Not Applicable],NA,1
0.09378993,5.059577466,TCGA-ZG-A9M4-01A,TCGA-ZG-A9M4-01A-11D-A41K-08,4,0.705692859,TCGA-ZG-A9M4,PRAD,65,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24030,Alive,WITH TUMOR,547,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,547,0,547,NA,NA,0,547,NA,[Not Applicable],T3b,[Not Applicable],NA,6
0.466768479,2.199434375,TCGA-ZG-A9LZ-01A,TCGA-ZG-A9LZ-01A-11D-A41K-08,0,NA,TCGA-ZG-A9LZ,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-24132,Alive,WITH TUMOR,692,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,692,0,692,NA,NA,0,692,NA,[Not Applicable],T3b,[Not Applicable],NA,6
1.854584565,2.002006176,TCGA-ZG-A9N3-01A,TCGA-ZG-A9N3-01A-11D-A41K-08,3,0.606555459,TCGA-ZG-A9N3,PRAD,73,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-26902,Alive,WITH TUMOR,349,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,349,0,349,NA,NA,0,349,NA,[Not Applicable],T3b,[Not Applicable],NA,3
8.994921101,-5.000841016,TCGA-ZG-A9MC-01A,TCGA-ZG-A9MC-01A-31D-A41K-08,1,0.794073604,TCGA-ZG-A9MC,PRAD,69,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-25477,Alive,WITH TUMOR,455,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,455,0,455,NA,NA,0,455,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-3.771465154,-2.497879358,TCGA-H4-A2HQ-01A,TCGA-H4-A2HQ-01A-11D-A17V-08,8,0.412588327,TCGA-H4-A2HQ,BLCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010,[Not Available],-23538,Alive,WITH TUMOR,590,NA,[Not Available],Distant Metastasis,Lung,NA,318,Complete Remission/Response,0,590,0,590,NA,NA,1,318,NA,Stage IV,[Not Available],M1,BLCA.1,10
-6.264620885,-1.734670834,TCGA-AX-A2H4-01A,TCGA-AX-A2H4-01A-21D-A18P-09,0,NA,TCGA-AX-A2H4,UCEC,66,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24234,Dead,WITH TUMOR,NA,916,[Not Available],Locoregional Disease,"Other, specify","Vaginal cuff, iliac",520,Complete Remission/Response,1,916,1,916,1,520,1,520,NA,Stage IIIA,[Not Applicable],[Not Applicable],NA,10
-1.065927321,2.477270511,TCGA-C4-A0F0-01A,TCGA-C4-A0F0-01A-12D-A10S-08,4,0.122952752,TCGA-C4-A0F0,BLCA,60,MALE,[Not Available],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-22068,Alive,TUMOR FREE,59,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,59,0,59,NA,NA,0,59,NA,Stage II,T2b,M0,BLCA.3,6
-7.520939265,-2.130984836,TCGA-GV-A40E-01A,TCGA-GV-A40E-01A-12D-A23M-08,6,0.362080734,TCGA-GV-A40E,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-27569,Dead,WITH TUMOR,NA,261,[Not Available],Distant Metastasis,Lung,NA,219,Stable Disease,1,261,1,261,NA,NA,1,219,NA,Stage II,[Not Available],MX,BLCA.3,2
-5.113029713,1.843071443,TCGA-GU-A42R-01A,TCGA-GU-A42R-01A-11D-A23M-08,0,NA,TCGA-GU-A42R,BLCA,68,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-25134,Dead,WITH TUMOR,NA,577,[Not Available],Distant Metastasis,Lung,NA,91,Progressive Disease,1,577,1,577,NA,NA,1,91,NA,Stage IV,T4a,MX,BLCA.1,6
4.437998645,1.280157428,TCGA-ZG-A9LY-01A,TCGA-ZG-A9LY-01A-11D-A41K-08,2,0.703251264,TCGA-ZG-A9LY,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-21942,Alive,TUMOR FREE,370,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,370,0,370,0,370,0,370,NA,[Not Applicable],T3b,[Not Applicable],NA,5
0.164350136,2.082995883,TCGA-E7-A3Y1-01A,TCGA-E7-A3Y1-01A-11D-A22Z-08,0,NA,TCGA-E7-A3Y1,BLCA,57,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012,[Not Available],-20917,Alive,TUMOR FREE,163,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,163,0,163,0,163,0,163,NA,Stage II,[Not Available],M0,BLCA.1,6
9.155494243,-5.750387118,TCGA-ZG-A9LU-01A,TCGA-ZG-A9LU-01A-11D-A41K-08,1,0.772467287,TCGA-ZG-A9LU,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-24742,Alive,WITH TUMOR,579,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,579,0,579,NA,NA,0,579,NA,[Not Applicable],T3a,[Not Applicable],NA,1
8.622673731,-4.753546324,TCGA-ZG-A9LS-01A,TCGA-ZG-A9LS-01A-12D-A41K-08,1,0.652970756,TCGA-ZG-A9LS,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-23540,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,516,0,516,0,516,0,516,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-0.421115218,4.900080837,TCGA-AJ-A3BF-01A,TCGA-AJ-A3BF-01A-11D-A20S-09,4,0.545981075,TCGA-AJ-A3BF,UCEC,65,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23906,Alive,TUMOR FREE,551,NA,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneal LNs,384,Complete Remission/Response,0,551,0,551,1,384,1,384,NA,Stage IIIC2,[Not Applicable],[Not Applicable],NA,6
-7.426020697,2.240033852,TCGA-EY-A1GL-01A,TCGA-EY-A1GL-01A-11D-A13L-09,9,0.044384644,TCGA-EY-A1GL,UCEC,51,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18761,Alive,TUMOR FREE,1014,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1014,0,1014,0,1014,0,1014,NA,Stage II,[Not Applicable],[Not Applicable],UCEC.Notassigned,7
-1.567570203,3.088937447,TCGA-G2-A3IB-01A,TCGA-G2-A3IB-01A-11D-A20D-08,0,NA,TCGA-G2-A3IB,BLCA,66,MALE,BLACK OR AFRICAN AMERICAN,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-24149,Dead,WITH TUMOR,NA,220,[Not Available],NA,NA,NA,NA,Progressive Disease,1,220,1,220,NA,NA,1,220,NA,Stage II,[Not Available],MX,BLCA.3,5
-7.420705302,-2.312656355,TCGA-GC-A3RD-01A,TCGA-GC-A3RD-01A-12D-A22Z-08,6,0.268926184,TCGA-GC-A3RD,BLCA,83,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-30529,Alive,TUMOR FREE,428,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,428,0,428,0,428,0,428,NA,Stage III,T3a,M0,BLCA.1,2
-3.508392093,-3.002502043,TCGA-BT-A0YX-01A,TCGA-BT-A0YX-01A-11D-A10S-08,8,0.537725375,TCGA-BT-A0YX,BLCA,70,FEMALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009,[Not Available],-25570,Dead,WITH TUMOR,NA,400,[Not Available],Metastatic,"Other, specify",lower abdominal wall and right pelvis,326,Progressive Disease,1,400,1,400,NA,NA,1,326,NA,Stage III,T3b,M0,BLCA.3,10
-3.097762362,-3.441611857,TCGA-DK-A1AC-01A,TCGA-DK-A1AC-01A-11D-A13W-08,8,0.540790557,TCGA-DK-A1AC,BLCA,72,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000,[Not Available],-26307,Alive,TUMOR FREE,3981,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3981,0,3981,0,3981,0,3981,NA,Stage III,T3b,M0,BLCA.2,10
0.398757329,5.249158374,TCGA-ZG-A9LB-01A,TCGA-ZG-A9LB-01A-11D-A41K-08,4,0.623399497,TCGA-ZG-A9LB,PRAD,72,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-26447,Alive,WITH TUMOR,583,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,583,0,583,NA,NA,0,583,NA,[Not Applicable],T3b,[Not Applicable],NA,6
9.358676167,-2.773616518,TCGA-ZG-A9L9-01A,TCGA-ZG-A9L9-01A-11D-A41K-08,1,0.772320639,TCGA-ZG-A9L9,PRAD,60,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22108,Alive,WITH TUMOR,617,NA,[Not Available],Biochemical evidence of disease,NA,NA,51,Progressive Disease,0,617,0,617,NA,NA,1,51,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-1.266246277,2.954418804,TCGA-GC-A3OO-01A,TCGA-GC-A3OO-01A-11D-A22Z-08,4,0.061952913,TCGA-GC-A3OO,BLCA,79,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-29065,Alive,TUMOR FREE,481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,481,0,481,0,481,0,481,NA,Stage II,T2b,M0,BLCA.2,6
4.360482407,1.093906291,TCGA-ZG-A9L4-01A,TCGA-ZG-A9L4-01A-11D-A41K-08,2,0.510134527,TCGA-ZG-A9L4,PRAD,61,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-22388,Alive,NA,1108,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,1108,0,1108,NA,NA,0,1108,NA,[Not Applicable],T3b,[Not Applicable],NA,5
8.980241571,-4.589436145,TCGA-ZG-A9L6-01A,TCGA-ZG-A9L6-01A-11D-A41K-08,1,0.818901622,TCGA-ZG-A9L6,PRAD,64,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-23681,Alive,WITH TUMOR,687,NA,[Not Available],Biochemical evidence of disease,NA,NA,664,Partial Remission/Response,0,687,0,687,NA,NA,1,664,NA,[Not Applicable],T3b,[Not Applicable],NA,1
8.653995654,-3.745789434,TCGA-ZG-A9L5-01A,TCGA-ZG-A9L5-01A-12D-A41K-08,1,0.671618275,TCGA-ZG-A9L5,PRAD,58,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-21293,Alive,WITH TUMOR,908,NA,[Not Available],NA,NA,NA,NA,Progressive Disease,0,908,0,908,NA,NA,0,908,NA,[Not Applicable],T4,[Not Applicable],NA,1
-4.541971483,-1.571741919,TCGA-FJ-A3ZF-01A,TCGA-FJ-A3ZF-01A-11D-A23M-08,8,0.366135077,TCGA-FJ-A3ZF,BLCA,73,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012,[Not Available],-26825,Alive,TUMOR FREE,524,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,524,0,524,0,524,0,524,NA,Stage III,[Not Available],M0,BLCA.1,10
10.12019111,-2.16239978,TCGA-BT-A0S7-01A,TCGA-BT-A0S7-01A-11D-A10S-08,1,0.822049482,TCGA-BT-A0S7,BLCA,75,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007,[Not Available],-27533,Dead,WITH TUMOR,NA,200,[Not Available],NA,NA,NA,NA,Progressive Disease,1,200,1,200,NA,NA,1,200,NA,Stage III,T4a,MX,BLCA.3,1
-0.159147833,3.978426105,TCGA-D1-A1NW-01A,TCGA-D1-A1NW-01A-11D-A14K-09,4,0.118058171,TCGA-D1-A1NW,UCEC,72,FEMALE,WHITE,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26556,Alive,TUMOR FREE,22,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,22,0,22,NA,NA,0,22,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.Notassigned,6
-6.196564684,1.099347218,TCGA-FD-A43N-01A,TCGA-FD-A43N-01A-11D-A23U-08,10,0.032236711,TCGA-FD-A43N,BLCA,76,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-27833,Alive,TUMOR FREE,699,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,699,0,699,NA,NA,0,699,NA,Stage III,T3a,MX,NA,9
-7.090159831,-2.008197814,TCGA-C4-A0F6-01A,TCGA-C4-A0F6-01A-11D-A10S-08,0,NA,TCGA-C4-A0F6,BLCA,82,FEMALE,[Not Available],Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008,[Not Available],-29951,Alive,TUMOR FREE,700,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,700,0,700,NA,NA,0,700,NA,Stage III,T3b,M0,BLCA.2,2
-0.273366777,5.007621138,TCGA-ZG-A9L1-01A,TCGA-ZG-A9L1-01A-11D-A41K-08,4,0.530313334,TCGA-ZG-A9L1,PRAD,66,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2010,[Not Available],-24214,Alive,WITH TUMOR,1302,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1302,0,1302,NA,NA,0,1302,NA,[Not Applicable],T3b,[Not Applicable],NA,6
-4.600960202,1.638405289,TCGA-GD-A3OQ-01A,TCGA-GD-A3OQ-01A-32D-A21Z-08,0,NA,TCGA-GD-A3OQ,BLCA,48,MALE,WHITE,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011,[Not Available],-17682,Alive,NA,95,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,95,0,95,NA,NA,0,95,NA,Stage IV,T4a,MX,BLCA.1,9
0.326330064,3.667488777,TCGA-ZG-A9L0-01A,TCGA-ZG-A9L0-01A-11D-A41K-08,4,0.222153183,TCGA-ZG-A9L0,PRAD,71,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-26055,Alive,TUMOR FREE,355,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,355,0,355,NA,NA,0,355,NA,[Not Applicable],T3b,[Not Applicable],NA,3
-6.26982375,3.522046598,TCGA-ZG-A9L2-01A,TCGA-ZG-A9L2-01A-31D-A41K-08,11,0.229698283,TCGA-ZG-A9L2,PRAD,70,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],-25573,Alive,WITH TUMOR,1154,NA,[Not Available],Biochemical evidence of disease,NA,NA,180,Stable Disease,0,1154,0,1154,NA,NA,1,180,NA,[Not Applicable],T3b,[Not Applicable],NA,8
9.408068936,-2.271610881,TCGA-ZG-A9KY-01A,TCGA-ZG-A9KY-01A-11D-A41K-08,1,0.765878862,TCGA-ZG-A9KY,PRAD,73,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2013,[Not Available],-27000,Alive,NA,130,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,130,0,130,NA,NA,0,130,NA,[Not Applicable],T4,[Not Applicable],NA,1
-7.202995351,2.411306517,TCGA-D1-A16O-01A,TCGA-D1-A16O-01A-11D-A12J-09,9,0.026270648,TCGA-D1-A16O,UCEC,44,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16114,Alive,TUMOR FREE,1023,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1023,0,1023,0,1023,0,1023,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
-7.90328774,2.062514505,TCGA-AJ-A3NG-01A,TCGA-AJ-A3NG-01A-11D-A228-09,9,0.478042967,TCGA-AJ-A3NG,UCEC,83,FEMALE,WHITE,Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30351,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,475,0,475,0,475,0,475,NA,Stage II,[Not Applicable],[Not Applicable],NA,7
8.949840378,-5.223419396,TCGA-XJ-A83H-01A,TCGA-XJ-A83H-01A-11D-A34U-08,1,0.830017986,TCGA-XJ-A83H,PRAD,57,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2007,[Not Available],NA,Alive,NA,1280,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,0,1280,0,1280,NA,NA,0,1280,NA,[Not Applicable],T2c,[Not Applicable],PRAD.8-other,1
8.795104219,-4.474620227,TCGA-XJ-A83F-01A,TCGA-XJ-A83F-01A-11D-A34U-08,1,0.750100628,TCGA-XJ-A83F,PRAD,67,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2011,[Not Available],NA,Alive,TUMOR FREE,1127,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1127,0,1127,0,1127,0,1127,NA,[Not Applicable],T3a,[Not Applicable],NA,1
9.781903006,-2.514734623,TCGA-V1-A9ZR-01A,TCGA-V1-A9ZR-01A-11D-A41K-08,1,0.711571406,TCGA-V1-A9ZR,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-25185,Alive,TUMOR FREE,1361,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1361,0,1361,0,1361,0,1361,NA,[Not Applicable],T4,[Not Applicable],NA,1
8.744973785,-4.740326542,TCGA-XK-AAK1-01A,TCGA-XK-AAK1-01A-11D-A41K-08,1,0.770835382,TCGA-XK-AAK1,PRAD,62,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],2012,[Not Available],-22965,Alive,TUMOR FREE,979,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,979,0,979,0,979,0,979,NA,[Not Applicable],T2c,[Not Applicable],NA,1
9.492406173,-5.560324694,TCGA-V1-A9ZK-01A,TCGA-V1-A9ZK-01A-11D-A41K-08,1,0.850061704,TCGA-V1-A9ZK,PRAD,68,MALE,[Not Available],Prostate Adenocarcinoma Acinar Type,[Not Available],NA,[Not Available],-25185,Alive,TUMOR FREE,1383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1383,0,1383,0,1383,0,1383,NA,[Not Applicable],T3b,[Not Applicable],NA,1
-5.871382299,1.656332246,TCGA-BG-A0M8-01A,TCGA-BG-A0M8-01A-12D-A10B-09,10,0.039202116,TCGA-BG-A0M8,UCEC,50,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2008,Indeterminate (neither Pre or Postmenopausal),-18308,Alive,TUMOR FREE,2020,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2020,0,2020,0,2020,0,2020,NA,Stage IA,[Not Applicable],[Not Applicable],NA,7
-3.557822152,-2.87151783,TCGA-AX-A1C4-01A,TCGA-AX-A1C4-01A-11D-A135-09,8,0.415476231,TCGA-AX-A1C4,UCEC,52,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Indeterminate (neither Pre or Postmenopausal),-19209,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,404,0,404,NA,NA,0,404,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-0.101325517,4.39518864,TCGA-AX-A1CR-01A,TCGA-AX-A1CR-01A-12D-A135-09,4,0.50776399,TCGA-AX-A1CR,UCEC,70,FEMALE,WHITE,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25812,Alive,TUMOR FREE,701,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,701,0,701,NA,NA,0,701,NA,Stage IIB,[Not Applicable],[Not Applicable],NA,6
-6.298595114,1.834084064,TCGA-A5-A0R6-01A,TCGA-A5-A0R6-01A-11D-A10B-09,10,0.280782861,TCGA-A5-A0R6,UCEC,64,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23449,Alive,TUMOR FREE,1153,NA,[Not Available],New Primary Tumor,"Other, specify",Rectum,961,Complete Remission/Response,0,1153,0,1153,0,1153,1,961,NA,Stage IIIC1,[Not Applicable],[Not Applicable],UCEC.CN high,7
-2.76002165,-4.320181651,TCGA-A5-A0G1-01A,TCGA-A5-A0G1-01A-11D-A122-09,0,NA,TCGA-A5-A0G1,UCEC,67,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24477,Dead,TUMOR FREE,NA,3251,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,3251,0,3251,0,3251,0,3251,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-0.060789587,4.455106114,TCGA-13-1501-01A,TCGA-13-1501-01A-01W-0545-08,4,0.582813307,TCGA-13-1501,OV,50,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-18393,Dead,WITH TUMOR,NA,1314,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],392,Partial Remission/Response,1,1314,1,1314,NA,NA,1,392,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
4.409410509,1.140699063,TCGA-BP-4972-01A,TCGA-BP-4972-01A-01D-1462-08,2,0.678972256,TCGA-BP-4972,KIRC,43,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2006,[Not Available],-16038,Alive,TUMOR FREE,1502,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1502,0,1502,NA,NA,0,1502,NA,Stage III,T3a,M0,KIRC.1,5
-2.271800981,1.271107702,TCGA-AX-A1CF-01A,TCGA-AX-A1CF-01A-11D-A135-09,5,0.510574354,TCGA-AX-A1CF,UCEC,69,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G3,2004,[Not Available],-25300,Alive,WITH TUMOR,2337,NA,[Not Available],NA,NA,NA,875,Progressive Disease,0,2337,0,2337,NA,NA,1,875,NA,Stage IVB,[Not Applicable],[Not Applicable],UCEC.Notassigned,4
-2.764806469,-4.289642175,TCGA-AX-A0J0-01A,TCGA-AX-A0J0-01A-11D-A117-09,0,NA,TCGA-AX-A0J0,UCEC,47,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17466,Alive,TUMOR FREE,1220,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1220,0,1220,0,1220,0,1220,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.POLE,10
-4.2011613,-2.122564773,TCGA-D1-A1O7-01A,TCGA-D1-A1O7-01A-11D-A14G-09,8,0.455414933,TCGA-D1-A1O7,UCEC,60,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22037,Alive,TUMOR FREE,32,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,32,0,32,0,32,0,32,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
0.117098917,5.058730912,TCGA-04-1369-01A,TCGA-04-1369-01A-02D-1526-09,4,0.526712387,TCGA-04-1369,OV,53,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2004,[Not Available],-19571,Dead,WITH TUMOR,NA,642,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],315,[Not Available],1,642,1,642,NA,NA,1,315,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-2.286344837,1.205373575,TCGA-13-0885-01A,TCGA-13-0885-01A-02W-0420-08,5,0.442432051,TCGA-13-0885,OV,70,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2000,[Not Available],-25763,Alive,NA,3388,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3388,0,3388,0,3388,0,3388,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,4
8.978558949,-5.305291872,TCGA-BP-4961-01A,TCGA-BP-4961-01A-01D-1462-08,1,0.762788987,TCGA-BP-4961,KIRC,47,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-17284,Alive,TUMOR FREE,1935,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1935,0,1935,NA,NA,0,1935,NA,Stage I,T1a,M0,KIRC.1,1
7.737691725,-3.439828942,TCGA-BP-4760-01A,TCGA-BP-4760-01A-02D-1421-08,1,0.332318082,TCGA-BP-4760,KIRC,69,MALE,BLACK OR AFRICAN AMERICAN,Kidney Clear Cell Renal Carcinoma,G2,2004,[Not Available],-25268,Alive,WITH TUMOR,2361,NA,[Not Available],NA,NA,NA,1457,[Not Available],0,2361,0,2361,NA,NA,1,1457,NA,Stage I,T1a,M0,NA,1
0.277740831,4.930277176,TCGA-61-1903-01A,TCGA-61-1903-01A-01W-0639-09,4,0.554040272,TCGA-61-1903,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2007,[Not Available],-20381,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,396,0,396,0,396,0,396,NA,Stage IB,[Not Applicable],[Not Applicable],NA,6
9.009968891,-5.635338317,TCGA-B8-4146-01B,TCGA-B8-4146-01B-11D-1669-08,1,0.773772361,TCGA-B8-4146,KIRC,41,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2009,[Not Available],-15063,Alive,TUMOR FREE,511,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,511,0,511,0,511,0,511,NA,Stage I,T1b,M0,KIRC.1,1
2.172114284,1.75086208,TCGA-AC-A7VB-01A,TCGA-AC-A7VB-01A-11D-A351-09,3,0.403855943,TCGA-AC-A7VB,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2013,[Unknown],-18806,Alive,TUMOR FREE,250,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,250,0,250,0,250,0,250,NA,Stage IIA,T1c,MX,BRCA.LumB,3
-3.144209647,-3.7068929,TCGA-5L-AAT1-01A,TCGA-5L-AAT1-01A-12D-A41F-09,8,0.384820822,TCGA-5L-AAT1,BRCA,63,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23225,Alive,WITH TUMOR,1471,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1471,0,1471,NA,NA,0,1471,NA,Stage IV,T2,M1,NA,10
-5.441188443,1.222652787,TCGA-5L-AAT0-01A,TCGA-5L-AAT0-01A-12D-A41F-09,0,NA,TCGA-5L-AAT0,BRCA,42,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15393,Alive,TUMOR FREE,1477,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1477,0,1477,NA,NA,0,1477,NA,Stage IIA,T2,M0,BRCA.LumA,10
-7.50487044,1.700655938,TCGA-AC-A8OS-01A,TCGA-AC-A8OS-01A-12D-A41F-09,9,0.270445143,TCGA-AC-A8OS,BRCA,71,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26248,Alive,TUMOR FREE,70,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,70,0,70,0,70,0,70,NA,Stage IIA,T2,MX,BRCA.LumA,7
-1.628935438,1.265545557,TCGA-AC-A7VC-01A,TCGA-AC-A7VC-01A-11D-A351-09,5,0.515749756,TCGA-AC-A7VC,BRCA,56,FEMALE,WHITE,Metaplastic Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20479,Alive,TUMOR FREE,1,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1,0,1,0,1,0,1,NA,Stage IIB,T3,MX,BRCA.Basal,4
9.601084142,-2.296719903,TCGA-4H-AAAK-01A,TCGA-4H-AAAK-01A-12D-A41F-09,1,0.727521255,TCGA-4H-AAAK,BRCA,50,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18371,Alive,TUMOR FREE,348,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,348,0,348,0,348,0,348,NA,Stage IIIA,T2,M0,BRCA.LumA,1
-7.603458202,1.784420446,TCGA-3C-AALK-01A,TCGA-3C-AALK-01A-11D-A41F-09,9,0.287816332,TCGA-3C-AALK,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,[Unknown],-19074,Alive,TUMOR FREE,1448,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1448,0,1448,NA,NA,0,1448,NA,Stage IA,T1c,M0,BRCA.LumA,7
10.0473486,-1.949893653,TCGA-3C-AALJ-01A,TCGA-3C-AALJ-01A-31D-A41F-09,1,0.821492723,TCGA-3C-AALJ,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22848,Alive,TUMOR FREE,1474,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1474,0,1474,0,1474,0,1474,NA,Stage IIB,T2,M0,BRCA.LumB,1
9.811531643,-1.537833125,TCGA-DJ-A13L-01A,TCGA-DJ-A13L-01A-11D-A21Z-08,1,0.726541265,TCGA-DJ-A13L,THCA,85,MALE,WHITE,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),[Not Available],2010,[Not Available],-31388,Alive,TUMOR FREE,303,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,303,0,303,0,303,0,303,NA,Stage I,T1b,M0,THCA.4,1
-7.814003363,-2.396643357,TCGA-WX-AA46-01A,TCGA-WX-AA46-01A-11D-A38X-10,6,0.298044943,TCGA-WX-AA46,LIHC,61,MALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-22639,Alive,TUMOR FREE,756,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,756,0,756,0,756,0,756,NA,Stage II,T2,MX,NA,2
0.220773923,4.371016952,TCGA-T1-A6J8-01A,TCGA-T1-A6J8-01A-11D-A32G-10,4,0.518964935,TCGA-T1-A6J8,LIHC,68,MALE,WHITE,Hepatocellular Carcinoma,G2,2013,[Not Available],-24853,Alive,TUMOR FREE,23,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,23,0,23,NA,NA,0,23,NA,[Not Available],T1,M0,NA,6
-3.881227412,-2.473796917,TCGA-3C-AALI-01A,TCGA-3C-AALI-01A-11D-A41F-09,8,0.458940278,TCGA-3C-AALI,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18538,Alive,TUMOR FREE,4005,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,4005,0,4005,0,4005,0,4005,NA,Stage IIB,T2,M0,BRCA.Her2,10
-0.645698472,2.158063773,TCGA-3C-AAAU-01A,TCGA-3C-AAAU-01A-11D-A41F-09,0,NA,TCGA-3C-AAAU,BRCA,55,FEMALE,WHITE,Infiltrating Lobular Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20211,Alive,WITH TUMOR,4047,NA,[Not Available],Distant Metastasis,Lung,NA,1808,[Not Available],0,4047,0,4047,1,1808,1,1808,NA,Stage X,TX,MX,BRCA.LumA,3
8.91331974,-5.264382814,TCGA-DJ-A3VK-01A,TCGA-DJ-A3VK-01A-11D-A23M-08,1,0.81571677,TCGA-DJ-A3VK,THCA,63,MALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-23255,Alive,TUMOR FREE,753,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,753,0,753,0,753,0,753,NA,Stage III,T3,M0,THCA.1,1
8.501740066,-4.216295454,TCGA-MR-A520-01A,TCGA-MR-A520-01A-11D-A25V-10,1,0.717823718,TCGA-MR-A520,LIHC,58,MALE,WHITE,Hepatocellular Carcinoma,G1,2012,[Not Available],-21398,Alive,TUMOR FREE,229,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,229,0,229,NA,NA,0,229,NA,Stage I,T1,MX,LIHC.iCluster:2,1
0.306154718,3.628344384,TCGA-K7-AAU7-01A,TCGA-K7-AAU7-01A-11D-A382-10,4,0.140280448,TCGA-K7-AAU7,LIHC,61,MALE,WHITE,Hepatocholangiocarcinoma (Mixed),G2,2013,[Not Available],-22476,Alive,WITH TUMOR,359,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,58,[Not Available],0,359,0,359,NA,NA,1,58,NA,Stage II,T2a,MX,NA,3
0.695683595,4.52824153,TCGA-DD-AADV-01A,TCGA-DD-AADV-01A-11D-A38X-10,4,0.222488117,TCGA-DD-AADV,LIHC,50,MALE,ASIAN,Hepatocellular Carcinoma,G3,2013,[Not Available],-18300,Alive,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,574,0,574,0,574,0,574,NA,Stage I,T1,M0,NA,6
-7.342067194,-2.283495446,TCGA-DD-AADG-01A,TCGA-DD-AADG-01A-11D-A40R-10,6,0.272720217,TCGA-DD-AADG,LIHC,70,MALE,ASIAN,Hepatocellular Carcinoma,G3,2011,[Not Available],-25887,Alive,TUMOR FREE,1145,NA,[Not Available],Intrahepatic Recurrence,Liver,NA,270,[Not Available],0,1145,0,1145,1,270,1,270,NA,Stage IIIA,T3a,M0,NA,2
-7.1576616,2.949491006,TCGA-DD-AAW1-01A,TCGA-DD-AAW1-01A-11D-A40P-10,0,NA,TCGA-DD-AAW1,LIHC,55,MALE,ASIAN,Hepatocellular Carcinoma,G2,2009,[Not Available],-20288,Alive,TUMOR FREE,1989,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1989,0,1989,0,1989,0,1989,NA,Stage IIIA,T3,M0,NA,7
-0.431040041,3.864052348,TCGA-DD-AAEI-01A,TCGA-DD-AAEI-01A-11D-A40R-10,4,0.372684499,TCGA-DD-AAEI,LIHC,72,MALE,ASIAN,Hepatocellular Carcinoma,G2,2010,[Not Available],-26465,Alive,WITH TUMOR,1531,NA,[Not Available],Extrahepatic Recurrence,Bone,NA,491,[Not Available],0,1531,0,1531,1,491,1,491,NA,Stage I,T1,M0,NA,10
-1.920014361,1.205936575,TCGA-CV-7236-01A,TCGA-CV-7236-01A-11D-2012-08,5,0.622340032,TCGA-CV-7236,HNSC,77,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,2007,[Not Available],-28250,Dead,TUMOR FREE,NA,144,[Not Available],NA,NA,NA,NA,[Not Available],1,144,0,144,NA,NA,0,144,NA,Stage IVA,T3,[Not Available],HNSC.Mesenchymal,4
-3.40452331,-3.334372806,TCGA-D1-A16Y-01A,TCGA-D1-A16Y-01A-31D-A12J-09,8,0.626957236,TCGA-D1-A16Y,UCEC,56,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20455,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,532,0,532,0,532,0,532,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.POLE,10
-0.958598945,4.762028442,TCGA-CV-6935-01A,TCGA-CV-6935-01A-11D-1912-08,4,0.445359398,TCGA-CV-6935,HNSC,67,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G3,1999,[Not Available],-24799,Dead,WITH TUMOR,NA,295,[Not Available],NA,NA,NA,NA,[Not Available],1,295,1,295,NA,NA,1,295,NA,Stage IVA,T3,[Not Available],HNSC.Classical,6
9.540529014,-3.157199817,TCGA-KO-8408-01A,TCGA-KO-8408-01A-11D-2310-10,1,0.724455048,TCGA-KO-8408,KICH,47,MALE,WHITE,Kidney Chromophobe,[Not Available],2004,[Not Available],-17299,Dead,TUMOR FREE,NA,507,[Not Available],NA,NA,NA,46,[Not Available],1,507,0,507,NA,NA,1,46,NA,Stage III,T3a,[Not Available],KICH.Eosin.1,1
-6.830925521,-2.520579812,TCGA-13-0760-01A,TCGA-13-0760-01A-01W-0371-08,0,NA,TCGA-13-0760,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2006,[Not Available],-23036,Dead,NA,351,351,[Not Available],NA,NA,NA,NA,[Not Available],1,351,NA,351,NA,NA,0,351,NA,Stage IV,[Not Applicable],[Not Applicable],NA,2
-0.340813838,4.211242781,TCGA-24-1418-01A,TCGA-24-1418-01A-01W-0549-09,4,0.46009057,TCGA-24-1418,OV,68,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-24842,Alive,TUMOR FREE,243,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,243,0,243,0,243,0,243,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Mesenchymal,6
-7.06173376,-2.472301554,TCGA-66-2768-01A,TCGA-66-2768-01A-01W-0877-08,6,0.152630618,TCGA-66-2768,LUSC,57,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-20970,Alive,TUMOR FREE,61,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,61,0,61,NA,NA,0,61,NA,Stage IIB,T2,M0,LUSC.basal,2
-6.609999546,2.591596781,TCGA-D1-A15W-01A,TCGA-D1-A15W-01A-11D-A122-09,0,NA,TCGA-D1-A15W,UCEC,58,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21545,Alive,TUMOR FREE,915,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,915,0,915,0,915,0,915,NA,Stage IIIC,[Not Applicable],[Not Applicable],UCEC.CN low,8
1.377017636,2.120502718,TCGA-AS-3778-01A,TCGA-AS-3778-01A-01D-0966-08,0,NA,TCGA-AS-3778,KIRC,35,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G1,2010,[Not Available],-12937,Alive,TUMOR FREE,43,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,43,0,43,NA,NA,0,43,NA,Stage I,T1a,M0,NA,3
-1.014943058,4.461856725,TCGA-CV-7238-01A,TCGA-CV-7238-01A-11D-2012-08,4,0.31324817,TCGA-CV-7238,HNSC,69,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2007,[Not Available],-25471,Alive,TUMOR FREE,2727,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2727,0,2727,0,2727,0,2727,NA,Stage II,T2,[Not Available],HNSC.Mesenchymal,6
-0.404506152,5.093423134,TCGA-D1-A17C-01A,TCGA-D1-A17C-01A-11D-A12J-09,4,0.639228752,TCGA-D1-A17C,UCEC,78,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28571,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,30,0,30,0,30,0,30,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,6
8.190787833,-3.894651785,TCGA-KO-8410-01A,TCGA-KO-8410-01A-11D-2310-10,1,0.518477715,TCGA-KO-8410,KICH,74,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2004,[Not Available],-27084,Alive,TUMOR FREE,3136,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,3136,0,3136,NA,NA,0,3136,NA,Stage I,T1b,M0,KICH.Eosin.0,1
-0.04999326,4.447165055,TCGA-29-1784-01A,TCGA-29-1784-01A-02W-0633-09,4,0.585233497,TCGA-29-1784,OV,55,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-20210,Alive,TUMOR FREE,163,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,163,0,163,0,163,0,163,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
0.960113131,3.697916373,TCGA-24-2261-01A,TCGA-24-2261-01A-01W-0722-08,0,NA,TCGA-24-2261,OV,76,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1992,[Not Available],-27897,Dead,WITH TUMOR,24,24,[Not Available],NA,NA,NA,NA,[Not Available],1,24,1,24,NA,NA,1,24,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-5.31659446,2.030434269,TCGA-29-1775-01A,TCGA-29-1775-01A-01W-0639-09,12,0.056534145,TCGA-29-1775,OV,51,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,2008,[Not Available],-18943,Alive,WITH TUMOR,376,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],341,Complete Remission/Response,0,376,0,376,1,341,1,341,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-4.777929181,1.969437729,TCGA-77-8154-01A,TCGA-77-8154-01A-11D-2244-08,0,NA,TCGA-77-8154,LUSC,67,MALE,[Not Evaluated],Lung Squamous Cell Carcinoma,[Not Available],2008,[Not Available],-24640,Alive,TUMOR FREE,1841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1841,0,1841,0,1841,0,1841,NA,Stage IA,T1,M0,NA,6
-7.017088441,-2.391017351,TCGA-CM-5348-01A,TCGA-CM-5348-01A-21D-1719-10,6,0.1132578,TCGA-CM-5348,COAD,72,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-26543,Alive,TUMOR FREE,699,NA,[Not Available],NA,NA,NA,NA,[Unknown],0,699,0,699,NA,NA,0,699,NA,Stage IIIB,T3,M0,GI.CIN,2
9.895742964,-1.42291355,TCGA-EM-A22I-01A,TCGA-EM-A22I-01A-11D-A17V-08,1,0.878149813,TCGA-EM-A22I,THCA,52,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-19003,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,448,0,448,NA,NA,0,448,NA,Stage III,T3,MX,THCA.4,1
-3.135664946,-3.499147961,TCGA-EY-A1GU-01A,TCGA-EY-A1GU-01A-11D-A13L-09,8,0.631416196,TCGA-EY-A1GU,UCEC,66,FEMALE,BLACK OR AFRICAN AMERICAN,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24304,Dead,TUMOR FREE,NA,997,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,997,0,997,0,997,0,997,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.Notassigned,10
-7.083901954,1.422063841,TCGA-EY-A2ON-01A,TCGA-EY-A2ON-01A-21D-A18P-09,0,NA,TCGA-EY-A2ON,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22624,Dead,WITH TUMOR,NA,610,[Not Available],NA,NA,NA,226,Progressive Disease,1,610,1,610,NA,NA,1,226,NA,Stage IVB,[Not Applicable],[Not Applicable],NA,7
9.104149316,-4.960538827,TCGA-CZ-5469-01A,TCGA-CZ-5469-01A-01D-1501-10,1,0.789039774,TCGA-CZ-5469,KIRC,41,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2007,[Not Available],-15242,Dead,WITH TUMOR,NA,946,[Not Available],NA,NA,NA,110,[Not Available],1,946,1,946,NA,NA,1,110,NA,Stage II,T2,M0,KIRC.4,1
-8.062525397,2.228253632,TCGA-CR-7401-01A,TCGA-CR-7401-01A-11D-2012-08,9,0.45428755,TCGA-CR-7401,HNSC,64,MALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-23420,Alive,TUMOR FREE,1077,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1077,0,1077,0,1077,0,1077,NA,Stage I,T1,M0,HNSC.Basal,7
-1.945709172,1.268474385,TCGA-FI-A2EW-01A,TCGA-FI-A2EW-01A-11D-A17D-09,5,0.633232322,TCGA-FI-A2EW,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,Serous endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26267,Alive,WITH TUMOR,1795,NA,[Not Available],Metastatic,Liver,NA,1169,Complete Remission/Response,0,1795,0,1795,1,1169,1,1169,NA,Stage IIB,[Not Applicable],[Not Applicable],UCEC.CN high,6
-0.111488537,5.064594632,TCGA-KO-8413-01A,TCGA-KO-8413-01A-11D-2310-10,4,0.707644023,TCGA-KO-8413,KICH,46,MALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-17067,Alive,TUMOR FREE,3038,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3038,0,3038,0,3038,0,3038,NA,Stage I,T1,M0,KICH.Eosin.0,6
9.839707472,-2.743274672,TCGA-B4-5836-01A,TCGA-B4-5836-01A-11D-1669-08,1,0.733579601,TCGA-B4-5836,KIRC,61,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-22341,Alive,TUMOR FREE,141,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],0,141,0,141,NA,NA,0,141,NA,Stage I,T1b,M0,NA,1
-6.066936956,3.458937338,TCGA-D5-5539-01A,TCGA-D5-5539-01A-01D-1650-10,11,0.506524211,TCGA-D5-5539,COAD,60,MALE,WHITE,Colon Mucinous Adenocarcinoma,[Not Available],2010,[Not Available],-22097,Alive,WITH TUMOR,596,NA,[Not Available],NA,NA,NA,579,[Not Available],0,596,0,596,NA,NA,1,579,NA,Stage IIIA,T3,M0,GI.CIN,8
-7.306959804,2.26993213,TCGA-D1-A0ZU-01A,TCGA-D1-A0ZU-01A-11D-A10M-09,9,0.017033067,TCGA-D1-A0ZU,UCEC,34,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12458,Alive,TUMOR FREE,872,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,872,0,872,0,872,0,872,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.CN low,7
0.325167598,4.802277069,TCGA-CQ-5329-01A,TCGA-CQ-5329-01A-01D-1683-08,4,0.421450055,TCGA-CQ-5329,HNSC,46,FEMALE,WHITE,Head & Neck Squamous Cell Carcinoma,G2,2008,[Not Available],-17028,Alive,TUMOR FREE,2143,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2143,0,2143,0,2143,0,2143,NA,Stage II,T2,[Not Available],HNSC.Mesenchymal,6
0.603430288,2.193235001,TCGA-CZ-5982-01A,TCGA-CZ-5982-01A-11D-1669-08,0,NA,TCGA-CZ-5982,KIRC,59,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2005,[Not Available],-21592,Alive,TUMOR FREE,2439,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,2439,0,2439,NA,NA,0,2439,NA,Stage I,T1a,M0,KIRC.1,6
9.092494986,-5.205589354,TCGA-B2-5636-01A,TCGA-B2-5636-01A-02D-1534-10,1,0.740388343,TCGA-B2-5636,KIRC,79,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-28901,Alive,TUMOR FREE,919,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,919,0,919,0,919,0,919,NA,Stage I,T1a,M0,KIRC.3,1
9.25575919,-4.835180121,TCGA-KO-8415-01A,TCGA-KO-8415-01A-11D-2310-10,1,0.793271634,TCGA-KO-8415,KICH,44,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2007,[Not Available],-16395,Alive,TUMOR FREE,2939,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2939,0,2939,0,2939,0,2939,NA,Stage I,T1,M0,KICH.Eosin.0,1
0.194103813,4.7082544,TCGA-KO-8414-01A,TCGA-KO-8414-01A-11D-2310-10,4,0.563818874,TCGA-KO-8414,KICH,50,FEMALE,WHITE,Kidney Chromophobe,[Not Available],2006,[Not Available],-18502,Alive,TUMOR FREE,3212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3212,0,3212,0,3212,0,3212,NA,Stage II,T2,M0,KICH.Eosin.0,6
8.908520687,-4.487164368,TCGA-29-1694-01A,TCGA-29-1694-01A-01W-0633-09,1,0.77269491,TCGA-29-1694,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,GX,2002,[Not Available],-16523,Dead,WITH TUMOR,NA,1187,[Not Available],NA,NA,NA,NA,Stable Disease,1,1187,1,1187,NA,NA,1,1187,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,1
-1.63605083,3.396954317,TCGA-30-1714-01A,TCGA-30-1714-01A-02W-0633-09,0,NA,TCGA-30-1714,OV,68,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-25032,Dead,WITH TUMOR,1158,1158,[Not Available],Recurrence,[Not Applicable],[Not Applicable],241,Complete Remission/Response,1,1158,1,1158,NA,NA,1,241,NA,Stage IV,[Not Applicable],[Not Applicable],NA,6
0.145733311,3.346654286,TCGA-04-1655-01A,TCGA-04-1655-01A-01W-0633-09,4,0.417415796,TCGA-04-1655,OV,49,FEMALE,WHITE,Serous Cystadenocarcinoma,G2,1999,[Not Available],-17988,Dead,NA,NA,1380,[Not Available],Recurrence,[Not Applicable],[Not Applicable],819,[Not Available],1,1380,NA,1380,NA,NA,1,819,NA,Stage IIIB,[Not Applicable],[Not Applicable],NA,3
-6.572053941,1.709380822,TCGA-77-8009-01A,TCGA-77-8009-01A-11D-2184-08,10,0.029277967,TCGA-77-8009,LUSC,68,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-25037,Dead,NA,NA,1695,[Not Available],NA,NA,NA,607,Complete Remission/Response,1,1695,NA,1695,1,607,1,607,NA,Stage IIB,T2,M0,NA,7
-0.246470569,3.105022353,TCGA-29-1698-01A,TCGA-29-1698-01A-01W-0633-09,4,0.102566807,TCGA-29-1698,OV,53,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2004,[Not Available],-19611,Alive,WITH TUMOR,2078,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],181,Complete Remission/Response,0,2078,0,2078,1,181,1,181,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,3
-0.033724973,4.776271625,TCGA-KO-8416-01A,TCGA-KO-8416-01A-11D-2310-10,4,0.604092945,TCGA-KO-8416,KICH,41,MALE,WHITE,Kidney Chromophobe,[Not Available],2007,[Not Available],-15261,Alive,TUMOR FREE,2752,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2752,0,2752,0,2752,0,2752,NA,Stage III,T3a,M0,KICH.Eosin.0,6
-3.089468676,-3.668003396,TCGA-B5-A11H-01A,TCGA-B5-A11H-01A-11D-A122-09,8,0.407656017,TCGA-B5-A11H,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24556,Alive,TUMOR FREE,2687,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2687,0,2687,0,2687,0,2687,NA,Stage IIIA,[Not Applicable],[Not Applicable],UCEC.MSI,10
-4.38302295,-1.212709074,TCGA-22-5492-01A,TCGA-22-5492-01A-01D-1632-08,8,0.228040545,TCGA-22-5492,LUSC,73,FEMALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2003,[Not Available],-26838,Dead,NA,506,506,[Not Available],NA,NA,NA,NA,[Not Available],1,506,NA,506,NA,NA,0,506,NA,Stage IIIA,T2a,M0,LUSC.secretory,10
9.568040386,-5.140679944,TCGA-CJ-5671-01A,TCGA-CJ-5671-01A-11D-1534-10,1,0.866027297,TCGA-CJ-5671,KIRC,51,MALE,WHITE,Kidney Clear Cell Renal Carcinoma,G3,2004,[Not Available],-18954,Alive,TUMOR FREE,3987,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,3987,0,3987,0,3987,0,3987,NA,Stage I,T1a,M0,KIRC.3,1
0.748954308,2.461863361,TCGA-B0-5113-01A,TCGA-B0-5113-01A-01D-1421-08,0,NA,TCGA-B0-5113,KIRC,69,FEMALE,WHITE,Kidney Clear Cell Renal Carcinoma,G2,2010,[Not Available],-25369,Alive,TUMOR FREE,1175,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1175,0,1175,0,1175,0,1175,NA,Stage III,T3a,M0,KIRC.1,6
-0.752171513,2.850424961,TCGA-29-1701-01A,TCGA-29-1701-01A-01W-0633-09,4,0.10845895,TCGA-29-1701,OV,56,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-20737,Dead,WITH TUMOR,514,515,[Not Available],Recurrence,[Not Applicable],[Not Applicable],298,Partial Remission/Response,1,515,1,515,NA,NA,1,298,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Immunoreactive,6
-1.4622689,3.82637672,TCGA-AA-3955-01A,TCGA-AA-3955-01A-02W-0995-10,0,NA,TCGA-AA-3955,COAD,38,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2010,[Not Available],-14186,Alive,TUMOR FREE,638,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,638,0,638,0,638,0,638,NA,Stage IIIB,T2,M0,NA,5
-6.338943864,1.276391418,TCGA-D1-A17T-01A,TCGA-D1-A17T-01A-11D-A12J-09,0,NA,TCGA-D1-A17T,UCEC,67,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24652,Alive,TUMOR FREE,71,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,71,0,71,0,71,0,71,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-2.839561295,0.888606818,TCGA-CR-6484-01A,TCGA-CR-6484-01A-11D-1870-08,5,0,TCGA-CR-6484,HNSC,67,FEMALE,ASIAN,Head & Neck Squamous Cell Carcinoma,G2,2010,[Not Available],-24569,Alive,TUMOR FREE,354,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,354,0,354,NA,NA,0,354,NA,Stage IVA,T4a,M0,HNSC.Mesenchymal,10
-8.152613255,2.075129833,TCGA-BG-A18A-01A,TCGA-BG-A18A-01A-21D-A12J-09,9,0.525755188,TCGA-BG-A18A,UCEC,74,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27086,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,426,0,426,0,426,0,426,NA,Stage IA,[Not Applicable],[Not Applicable],UCEC.CN low,7
-0.673373021,3.941129382,TCGA-24-1425-01A,TCGA-24-1425-01A-02W-0553-09,4,0.31217965,TCGA-24-1425,OV,45,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2008,[Not Available],-16764,Alive,TUMOR FREE,181,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,181,0,181,0,181,0,181,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,5
-4.946685156,1.906372342,TCGA-24-2280-01A,TCGA-24-2280-01A-01W-0799-08,0,NA,TCGA-24-2280,OV,74,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2004,[Not Available],-27356,Alive,WITH TUMOR,2143,NA,[Not Available],Recurrence,[Not Applicable],[Not Applicable],535,Complete Remission/Response,0,2143,0,2143,1,535,1,535,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,6
-3.408337605,1.37364331,TCGA-23-1117-01A,TCGA-23-1117-01A-02W-0486-08,0,NA,TCGA-23-1117,OV,42,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,1998,[Not Available],-15690,Dead,WITH TUMOR,NA,1013,[Not Available],Recurrence,[Not Applicable],[Not Applicable],418,Complete Remission/Response,1,1013,1,1013,1,418,1,418,NA,Stage IIIC,[Not Applicable],[Not Applicable],NA,10
-2.844264454,-4.15408751,TCGA-AA-3492-01A,TCGA-AA-3492-01A-01D-1408-10,0,NA,TCGA-AA-3492,COAD,90,FEMALE,[Not Available],Colon Adenocarcinoma,[Not Available],2002,[Not Available],-32871,Dead,TUMOR FREE,NA,92,[Not Available],NA,NA,NA,NA,[Unknown],1,92,0,92,NA,NA,0,92,NA,Stage II,T3,M0,GI.HM-indel,10
9.775376476,-2.133382435,TCGA-23-1809-01A,TCGA-23-1809-01A-01W-0633-09,1,0.821795802,TCGA-23-1809,OV,63,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2009,[Not Available],-23111,Alive,NA,16,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,16,0,16,NA,NA,0,16,NA,Stage IIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,1
0.175043637,3.245494475,TCGA-CM-6676-01A,TCGA-CM-6676-01A-11D-1835-10,4,0.275742882,TCGA-CM-6676,COAD,82,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2011,[Not Available],-30223,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,337,0,337,NA,NA,0,337,NA,Stage I,T2,M0,GI.CIN,3
-6.843556082,-2.435809016,TCGA-25-1323-01A,TCGA-25-1323-01A-01W-0494-09,6,0.142704416,TCGA-25-1323,OV,72,FEMALE,WHITE,Serous Cystadenocarcinoma,G3,2001,[Not Available],-26602,Dead,WITH TUMOR,365,395,[Not Available],Progression of Disease,[Not Applicable],[Not Applicable],365,Complete Remission/Response,1,395,1,395,1,365,1,365,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Proliferative,2
-6.250838568,3.450668044,TCGA-AA-3986-01A,TCGA-AA-3986-01A-02W-0995-10,11,0.318597967,TCGA-AA-3986,COAD,73,MALE,[Not Available],Colon Adenocarcinoma,[Not Available],2007,[Not Available],-26967,Alive,TUMOR FREE,580,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,580,0,580,0,580,0,580,NA,Stage I,T2,M0,GI.GS,8
0.209307123,3.481262069,TCGA-G4-6303-01A,TCGA-G4-6303-01A-11D-1771-10,4,0.202719729,TCGA-G4-6303,COAD,54,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2006,[Not Available],-19800,Dead,WITH TUMOR,NA,2003,[Not Available],NA,NA,NA,872,[Not Available],1,2003,1,2003,NA,NA,1,872,NA,Stage IV,T3,M1,GI.CIN,3
0.011353625,5.310447937,TCGA-29-1776-01A,TCGA-29-1776-01A-01W-0639-09,4,0.486413577,TCGA-29-1776,OV,63,FEMALE,BLACK OR AFRICAN AMERICAN,Serous Cystadenocarcinoma,G3,2008,[Not Available],-23016,Alive,WITH TUMOR,360,NA,[Not Available],NA,NA,NA,NA,Stable Disease,0,360,0,360,NA,NA,0,360,NA,Stage IIIC,[Not Applicable],[Not Applicable],OVCA.Differentiated,6
-5.373291477,2.267069579,TCGA-D5-6536-01A,TCGA-D5-6536-01A-11D-1719-10,0,NA,TCGA-D5-6536,COAD,73,MALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-26890,Alive,WITH TUMOR,543,NA,[Not Available],Locoregional Disease,NA,NA,493,[Not Available],0,543,0,543,NA,NA,1,493,NA,Stage IIA,T3,M0,GI.CIN,8
-5.460742619,1.612401744,TCGA-D5-6533-01A,TCGA-D5-6533-01A-11D-1719-10,0,NA,TCGA-D5-6533,COAD,68,FEMALE,WHITE,Colon Adenocarcinoma,[Not Available],2010,[Not Available],-24971,Alive,TUMOR FREE,775,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,775,0,775,0,775,0,775,NA,[Discrepancy],T4b,M0,GI.CIN,9
10.03470449,-1.456177125,TCGA-ET-A2N0-01A,TCGA-ET-A2N0-01A-11D-A18F-08,1,0.855219044,TCGA-ET-A2N0,THCA,51,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2010,[Not Available],-18692,Alive,TUMOR FREE,1600,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1600,0,1600,0,1600,0,1600,NA,Stage III,T1b,MX,THCA.4,1
-2.837372288,-4.185873526,TCGA-BS-A0UF-01A,TCGA-BS-A0UF-01A-11D-A10B-09,0,NA,TCGA-BS-A0UF,UCEC,65,FEMALE,ASIAN,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23771,Alive,TUMOR FREE,2611,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,2611,0,2611,0,2611,0,2611,NA,Stage IB,[Not Applicable],[Not Applicable],UCEC.POLE,10
-5.198378708,1.025885957,TCGA-BS-A0U7-01A,TCGA-BS-A0U7-01A-21D-A10B-09,0,NA,TCGA-BS-A0U7,UCEC,63,FEMALE,WHITE,Endometrioid endometrial adenocarcinoma,G2,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23166,Dead,TUMOR FREE,NA,935,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,935,0,935,0,935,0,935,NA,Stage IC,[Not Applicable],[Not Applicable],UCEC.MSI,10
9.62521743,-5.811512382,TCGA-60-2716-01A,TCGA-60-2716-01A-01D-1522-08,1,0.766875988,TCGA-60-2716,LUSC,39,MALE,[Not Available],Lung Squamous Cell Carcinoma,[Not Available],2007,[Not Available],-14345,Alive,TUMOR FREE,1475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1475,0,1475,0,1475,0,1475,NA,Stage IIB,T2,M0,NA,1
-4.359632671,-1.600607245,TCGA-39-5030-01A,TCGA-39-5030-01A-01D-1441-08,8,0.449266198,TCGA-39-5030,LUSC,81,FEMALE,ASIAN,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-29893,Dead,NA,59,59,[Not Available],NA,NA,NA,NA,Complete Remission/Response,1,59,NA,59,0,59,0,59,NA,Stage IIIA,T2a,M0,LUSC.secretory,10
9.865501778,-1.562745919,TCGA-EL-A3N2-01A,TCGA-EL-A3N2-01A-11D-A20C-08,1,0.814407766,TCGA-EL-A3N2,THCA,24,FEMALE,WHITE,Thyroid Papillary Carcinoma - Classical/usual,[Not Available],2011,[Not Available],-8989,Alive,TUMOR FREE,902,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,902,0,902,0,902,0,902,NA,Stage I,T2,M0,THCA.3,1
0.288795753,3.372317095,TCGA-AP-A05J-01A,TCGA-AP-A05J-01A-11W-A027-09,4,0.157334054,TCGA-AP-A05J,UCEC,66,FEMALE,WHITE,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24119,Alive,TUMOR FREE,1122,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,0,1122,0,1122,0,1122,0,1122,NA,Stage II,[Not Applicable],[Not Applicable],UCEC.CN high,3
8.756036485,-4.057156101,TCGA-EM-A2OY-01A,TCGA-EM-A2OY-01A-11D-A202-08,1,0.724120665,TCGA-EM-A2OY,THCA,46,FEMALE,[Not Available],Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-17075,Alive,TUMOR FREE,983,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,983,0,983,0,983,0,983,NA,Stage II,T2,MX,THCA.1,1
9.814651475,-1.629346794,TCGA-L6-A4ET-01A,TCGA-L6-A4ET-01A-11D-A257-08,1,0.827158186,TCGA-L6-A4ET,THCA,49,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2011,[Not Available],-17978,Alive,TUMOR FREE,664,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,664,0,664,NA,NA,0,664,NA,Stage IVC,T3,M1,THCA.5,1
9.810684872,-1.792534013,TCGA-EL-A3GQ-01A,TCGA-EL-A3GQ-01A-11D-A202-08,1,0.858242117,TCGA-EL-A3GQ,THCA,72,FEMALE,WHITE,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),[Not Available],2010,[Not Available],-26478,Alive,TUMOR FREE,1528,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,1528,0,1528,0,1528,0,1528,NA,Stage I,T1,M0,THCA.2,1
-4.119049092,-2.159810086,TCGA-37-3792-01A,TCGA-37-3792-01A-01D-0983-08,8,0.451676736,TCGA-37-3792,LUSC,69,MALE,WHITE,Lung Squamous Cell Carcinoma,[Not Available],2006,[Not Available],-25502,Alive,TUMOR FREE,12,NA,[Not Available],NA,NA,NA,NA,[Not Available],0,12,0,12,NA,NA,0,12,NA,Stage IB,T2,M0,NA,10
-6.084090544,3.539466927,TCGA-EM-A22Q-01A,TCGA-EM-A22Q-01A-11D-A17V-08,11,0.490495862,TCGA-EM-A22Q,THCA,36,MALE,[Not Available],Thyroid Papillary Carcinoma - Follicul,,,,,,,,,,,,,,,,,,,,,,,,,,,,
